PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hayton, EJ; Rose, A; Ibrahimsa, U; Del Sorbo, M; Capone, S; Crook, A; Black, AP; Dorrell, L; Hanke, T				Hayton, Emma-Jo; Rose, Annie; Ibrahimsa, Umar; Del Sorbo, Mariarosaria; Capone, Stefania; Crook, Alison; Black, Antony P.; Dorrell, Lucy; Hanke, Tomas			Safety and Tolerability of Conserved Region Vaccines Vectored by Plasmid DNA, Simian Adenovirus and Modified Vaccinia Virus Ankara Administered to Human Immunodeficiency Virus Type 1-Uninfected Adults in a Randomized, Single-Blind Phase I Trial	PLOS ONE			English	Article							T-CELL RESPONSES; HIV-1; RECOMBINANT; BOOST; IMMUNOGENICITY; STEP; ANTIBODIES; CANDIDATE; CHILDREN; LESSONS	Trial Design: HIV-1 vaccine development has advanced slowly due to viral antigenic diversity, poor immunogenicity and recently, safety concerns associated with human adenovirus serotype-5 vectors. To tackle HIV-1 variation, we designed a unique T-cell immunogen HIVconsv from functionally conserved regions of the HIV-1 proteome, which were presented to the immune system using a heterologous prime-boost combination of plasmid DNA, a non-replicating simian (chimpanzee) adenovirus ChAdV-63 and a non-replicating poxvirus, modified vaccinia virus Ankara. A block-randomized, single-blind, placebo-controlled phase I trial HIV-CORE 002 administered for the first time candidate HIV-1- vaccines or placebo to 32 healthy HIV-1/2-uninfected adults in Oxford, UK and elicited high frequencies of HIV-1-specific T cells capable of inhibiting HIV-1 replication in vitro. Here, detail safety and tolerability of these vaccines are reported. Methods: Local and systemic reactogenicity data were collected using structured interviews and study-specific diary cards. Data on all other adverse events were collected using open questions. Serum neutralizing antibody titres to ChAdV-63 were determined before and after vaccination. Results: Two volunteers withdrew for vaccine-unrelated reasons. No vaccine-related serious adverse events or reactions occurred during 190 person-months of follow-up. Local and systemic events after vaccination occurred in 27/32 individuals and most were mild (severity grade 1) and predominantly transient (<48 hours). Myalgia and flu-like symptoms were more strongly associated with MVA than ChAdV63 or DNA vectors and more common in vaccine recipients than in placebo. There were no intercurrent HIV-1 infections during follow-up. 2/24 volunteers had low ChAdV-63-neutralizing titres at baseline and 7 increased their titres to over 200 with a median (range) of 633 (231-1533) post-vaccination, which is of no safety concern. Conclusions: These data demonstrate safety and good tolerability of the pSG2.HIVconsv DNA, ChAdV63.HIVconsv and MVA. HIVconsv vaccines and together with their high immunogenicity support their further development towards efficacy studies.	[Hayton, Emma-Jo; Rose, Annie; Ibrahimsa, Umar; Crook, Alison; Black, Antony P.; Dorrell, Lucy; Hanke, Tomas] Univ Oxford, Churchill Hosp, Jenner Inst, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Del Sorbo, Mariarosaria; Capone, Stefania] Okairos, Rome, Italy; [Dorrell, Lucy; Hanke, Tomas] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford OX3 9DU, England; [Dorrell, Lucy] Univ Oxford, Nuffield Dept, Oxford, England; [Dorrell, Lucy; Hanke, Tomas] Univ Oxford, Jenner Inst Labs, Oxford, England	University of Oxford; Jenner Institute; University of Oxford; University of Oxford; University of Oxford	Hanke, T (corresponding author), Univ Oxford, Churchill Hosp, Jenner Inst, Ctr Clin Vaccinol & Trop Med, Oxford, England.	tomas.hanke@ndm.ox.ac.uk		Capone, Stefania/0000-0002-2272-120X	MRC UK [G0701669, G1001757, MR/J008605/1, MR/J002070/1]; EDCTP [CT.2006.33111.002, SP.2011.41304.002]; EC [305632]; MRC [G0701669, MR/J008605/1, G1001757] Funding Source: UKRI; Medical Research Council [G0701669, G1001757, MR/J008605/1] Funding Source: researchfish	MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EDCTP; EC(European CommissionEuropean Commission Joint Research Centre); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	TH received grants from MRC UK (G0701669, G1001757 and MR/J008605/1) and EDCTP (CT.2006.33111.002 and SP.2011.41304.002). LC received grants from MRC UK (G0701669 and MR/J002070/1) and the EC (305632). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altfeld M, 2003, AIDS, V17, P2581, DOI 10.1097/00002030-200312050-00005; Aste-Amezaga M, 2004, HUM GENE THER, V15, P293, DOI 10.1089/104303404322886147; Bejon P, 2006, CLIN INFECT DIS, V42, P1102, DOI 10.1086/501459; Borthwick N, 2014, MOL THER, V22, P464, DOI 10.1038/mt.2013.248; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Cebere I, 2006, VACCINE, V24, P417, DOI 10.1016/j.vaccine.2005.08.041; Colloca S, 2012, SCI TRANSL MED, V4, P1; Currier JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013983; Dorrell L, 2007, VACCINE, V25, P3277, DOI 10.1016/j.vaccine.2007.01.005; Dudareva M, 2009, VACCINE, V27, P3501, DOI 10.1016/j.vaccine.2009.03.080; Duerr A, 2006, CLIN INFECT DIS, V43, P500, DOI 10.1086/505979; Duerr A, 2013, J INFECT DIS, V207, P690, DOI 10.1093/infdis/jis738; Estcourt MJ, 2004, IMMUNOL REV, V199, P144, DOI 10.1111/j.0105-2896.2004.00151.x; Ferguson AL, 2013, IMMUNITY, V38, P606, DOI 10.1016/j.immuni.2012.11.022; Frahm N, 2012, J CLIN INVEST, V122, P359, DOI 10.1172/JCI60202; Gilbert P, 2013, PRESENTATION METAANA; Gilbert SC, 2006, VACCINE, V24, P4554, DOI 10.1016/j.vaccine.2005.08.048; Graham BS, 2006, J INFECT DIS, V194, P1650, DOI 10.1086/509259; Gray GE, 2014, LANCET INFECT DIS; Hammer SM, 2013, N ENGL J MED; Hanke T, 2014, EXPERT OPIN BIOL TH, V14, P601, DOI 10.1517/14712598.2014.885946; Hutnick NA, 2010, VACCINE, V28, P1932, DOI 10.1016/j.vaccine.2009.10.091; Im Eung-Jun, 2004, Expert Rev Vaccines, V3, pS89, DOI 10.1586/14760584.3.4.S89; Jaoko W, 2008, VACCINE, V26, P2788, DOI 10.1016/j.vaccine.2008.02.071; Keefer MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041936; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; Knudsen ML, 2012, J VIROL, V86, P4082, DOI 10.1128/JVI.06535-11; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; McCormack S, 2008, VACCINE, V26, P3162, DOI 10.1016/j.vaccine.2008.02.072; Mehendale S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055831; O'Hara GA, 2012, J INFECT DIS, V205, P772, DOI 10.1093/infdis/jir850; Ogwang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057726; Ondondo B, 2013, VACCINE, V31, P5594, DOI 10.1016/j.vaccine.2013.06.068; Paris R, 2014, CLIN VACCINE IMMUNOL; Ramanathan VD, 2009, AIDS RES HUM RETROV, V25, P1107, DOI 10.1089/aid.2009.0096; Richie TL, 2013, J INFECT DIS, V207, P689, DOI 10.1093/infdis/jis737; Rosario M, 2012, AIDS, V26, P275, DOI 10.1097/QAD.0b013e32834ed9b2; Rosario M, 2010, EUR J IMMUNOL, V40, P1973, DOI 10.1002/eji.201040344; Sheehy SH, 2012, MOL THER, V20, P2355, DOI 10.1038/mt.2012.223; Sheehy SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031208; Sheehy SH, 2011, MOL THER, V19, P2269, DOI 10.1038/mt.2011.176; Sutter Gerd, 2003, Current Drug Targets - Infectious Disorders, V3, P263, DOI 10.2174/1568005033481123	43	55	57	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101591	10.1371/journal.pone.0101591	http://dx.doi.org/10.1371/journal.pone.0101591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007091	gold, Green Published, Green Submitted			2022-12-27	WOS:000339040600049
J	Wolny, E; Braszewska-Zalewska, A; Hasterok, R				Wolny, Elzbieta; Braszewska-Zalewska, Agnieszka; Hasterok, Robert			Spatial Distribution of Epigenetic Modifications in Brachypodium distachyon Embryos during Seed Maturation and Germination	PLOS ONE			English	Article							GENE-EXPRESSION; ARABIDOPSIS-THALIANA; REPETITIVE ELEMENTS; DNA HYPOMETHYLATION; CHROMATIN; DORMANCY; HETEROCHROMATIN; ENDOSPERM; DEMETHYLATION; ESTABLISHMENT	Seed development involves a plethora of spatially and temporally synchronised genetic and epigenetic processes. Although it has been shown that epigenetic mechanisms, such as DNA methylation and chromatin remodelling, act on a large number of genes during seed development and germination, to date the global levels of histone modifications have not been studied in a tissue-specific manner in plant embryos. In this study we analysed the distribution of three epigenetic markers, i.e. H4K5ac, H3K4me2 and H3K4me1 in 'matured', 'dry' and 'germinating' embryos of a model grass, Brachypodium distachyon (Brachypodium). Our results indicate that the abundance of these modifications differs considerably in various organs and tissues of the three types of Brachypodium embryos. Embryos from matured seeds were characterised by the highest level of H4K5ac in RAM and epithelial cells of the scutellum, whereas this modification was not observed in the coleorhiza. In this type of embryos H3K4me2 was most evident in epithelial cells of the scutellum. In 'dry' embryos H4K5ac was highest in the coleorhiza but was not present in the nuclei of the scutellum. H3K4me1 was the most elevated in the coleoptile but absent from the coleorhiza, whereas H3K4me2 was the most prominent in leaf primordia and RAM. In embryos from germinating seeds H4K5ac was the most evident in the scutellum but not present in the coleoptile, similarly H3K4me1 was the highest in the scutellum and very low in the coleoptile, while the highest level of H3K4me2 was observed in the coleoptile and the lowest in the coleorhiza. The distinct patterns of epigenetic modifications that were observed may be involved in the switch of the gene expression profiles in specific organs of the developing embryo and may be linked with the physiological changes that accompany seed desiccation, imbibition and germination.	[Wolny, Elzbieta; Braszewska-Zalewska, Agnieszka; Hasterok, Robert] Univ Silesia Katowice, Fac Biol & Environm Protect, Dept Plant Anat & Cytol, Katowice, Poland	University of Silesia in Katowice	Hasterok, R (corresponding author), Univ Silesia Katowice, Fac Biol & Environm Protect, Dept Plant Anat & Cytol, Katowice, Poland.	robert.hasterok@us.edu.pl	Hasterok, Robert/A-1629-2008	Wolny, Elzbieta/0000-0001-7588-4830; Braszewska, Agnieszka/0000-0003-0997-8753; Hasterok, Robert/0000-0001-6667-2721	Polish National Science Centre [2012/04/A/NZ3/00572, 2011/01/B/NZ3/00177]	Polish National Science Centre	The authors acknowledge financial support from the Polish National Science Centre (grants no. 2012/04/A/NZ3/00572 and 2011/01/B/NZ3/00177). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriotis VME, 2010, NEW PHYTOL, V187, P791, DOI 10.1111/j.1469-8137.2010.03311.x; Angelovici R, 2010, TRENDS PLANT SCI, V15, P211, DOI 10.1016/j.tplants.2010.01.003; Ariizumi T, 2013, PLANT PHYSIOL, V162, P2125, DOI 10.1104/pp.113.219451; Barrero JM, 2012, NEW PHYTOL, V193, P376, DOI 10.1111/j.1469-8137.2011.03938.x; Benoit M, 2013, GENE, V526, P39, DOI 10.1016/j.gene.2013.01.060; Bentsink Leonie, 2008, Arabidopsis Book, V6, pe0119, DOI 10.1199/tab.0119; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; BINO RJ, 1993, ANN BOT-LONDON, V72, P181, DOI 10.1006/anbo.1993.1097; Braszewska-Zalewska A, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.26711; Braszewska-Zalewska A, 2012, GENOME, V55, P68, DOI [10.1139/G11-076, 10.1139/g11-076]; Braszewska-Zalewska A, 2010, GENOME, V53, P203, DOI [10.1139/g09-088, 10.1139/G09-088]; Braszewska-Zalewska AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069204; Cadman CSC, 2006, PLANT J, V46, P805, DOI 10.1111/j.1365-313X.2006.02738.x; COMAI L, 1990, P NATL ACAD SCI USA, V87, P2671, DOI 10.1073/pnas.87.7.2671; DELTOUR R, 1985, J CELL SCI, V75, P43; Douet J, 2008, PLANT CELL PHYSIOL, V49, P1783, DOI 10.1093/pcp/pcn152; Draper J, 2001, PLANT PHYSIOL, V127, P1539, DOI 10.1104/pp.010196; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Fischer C, 1996, PLANT J, V9, P659, DOI 10.1046/j.1365-313X.1996.9050659.x; Fischer-Iglesias C, 2001, PLANT J, V26, P115, DOI 10.1046/j.1365-313x.2001.01013.x; Fransz P, 2011, PLANT J, V66, P4, DOI 10.1111/j.1365-313X.2011.04526.x; Garvin DF, 2008, CROP SCI, V48, pS69, DOI 10.2135/cropsci2007.06.0332tpg; Gehring M, 2009, SCIENCE, V324, P1447, DOI 10.1126/science.1171609; Guillon F, 2012, J EXP BOT, V63, P739, DOI 10.1093/jxb/err298; Guillon F, 2011, J EXP BOT, V62, P1001, DOI 10.1093/jxb/erq332; Gutierrez L, 2007, TRENDS PLANT SCI, V12, P294, DOI 10.1016/j.tplants.2007.06.003; Holdsworth MJ, 2008, TRENDS PLANT SCI, V13, P7, DOI 10.1016/j.tplants.2007.11.002; Hsieh TF, 2005, ANNU REV PLANT BIOL, V56, P327, DOI 10.1146/annurev.arplant.56.032604.144118; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kapazoglou A, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-172; KOORNNEEF M, 1980, THEOR APPL GENET, V58, P257, DOI 10.1007/BF00265176; Lauria M, 2004, PLANT CELL, V16, P510, DOI 10.1105/tpc.017780; Leubner-Metzger G, 2005, PLANT J, V41, P133, DOI 10.1111/j.1365-313X.2004.02284.x; Liu YX, 2007, PLANT CELL, V19, P433, DOI 10.1105/tpc.106.049221; Long JA, 2006, SCIENCE, V312, P1520, DOI 10.1126/science.1123841; Mathieu O, 2003, PLANT CELL, V15, P2929, DOI 10.1105/tpc.017467; Muller K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051532; Mur LAJ, 2011, NEW PHYTOL, V191, P334, DOI 10.1111/j.1469-8137.2011.03748.x; Nakabayashi K, 2005, PLANT J, V41, P697, DOI 10.1111/j.1365-313X.2005.02337.x; Nonogaki H, 2010, PLANT SCI, V179, P574, DOI 10.1016/j.plantsci.2010.02.010; North H, 2010, PLANT J, V61, P971, DOI 10.1111/j.1365-313X.2009.04095.x; Okamoto M, 2006, PLANT PHYSIOL, V141, P97, DOI 10.1104/pp.106.079475; Opanowicz M, 2011, J EXP BOT, V62, P735, DOI 10.1093/jxb/erq309; Osborne DJ, 2002, DESICCATION SURVIVAL, P350; Pecinka A, 2010, PLANT CELL, V22, P3118, DOI 10.1105/tpc.110.078493; Rajjou L, 2012, ANNU REV PLANT BIOL, V63, P507, DOI 10.1146/annurev-arplant-042811-105550; Servet C, 2010, MOL PLANT, V3, P670, DOI 10.1093/mp/ssq018; STEEDMAN HF, 1957, NATURE, V179, P1345, DOI 10.1038/1791345a0; Tessadori F, 2007, J CELL SCI, V120, P1200, DOI 10.1242/jcs.000026; Tessadori F, 2007, PLANT J, V50, P848, DOI 10.1111/j.1365-313X.2007.03093.x; Tessadori F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000638; van Zanten M, 2013, EPIGENETIC MEMORY CO, P261; van Zanten M, 2012, PLANT SIGNAL BEHAV, V7, P338, DOI 10.4161/psb.19281; van Zanten M, 2011, P NATL ACAD SCI USA, V108, P20219, DOI 10.1073/pnas.1117726108; Vicente-Carbajosa J, 2005, INT J DEV BIOL, V49, P645, DOI 10.1387/ijdb.052046jc; Weitbrecht K, 2011, J EXP BOT, V62, P3289, DOI 10.1093/jxb/err030; Willmann MR, 2011, PLANT PHYSIOL, V155, P1871, DOI 10.1104/pp.110.171355; Yamauchi Y, 2004, PLANT CELL, V16, P367, DOI 10.1105/tpc.018143; Zemach A, 2010, P NATL ACAD SCI USA, V107, P18729, DOI 10.1073/pnas.1009695107; Zhang H, 2009, MOL PLANT, V2, P610, DOI 10.1093/mp/ssp027; Zhang L, 2012, PLANT MOL BIOL, V79, P285, DOI 10.1007/s11103-012-9912-3; Zhang L, 2011, PHYSIOL PLANTARUM, V143, P287, DOI 10.1111/j.1399-3054.2011.01496.x; Zhang MS, 2011, PLANT PHYSIOL, V156, P1955, DOI 10.1104/pp.111.176842; Zheng J, 2012, NEW PHYTOL, V193, P605, DOI 10.1111/j.1469-8137.2011.03969.x	66	17	17	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101246	10.1371/journal.pone.0101246	http://dx.doi.org/10.1371/journal.pone.0101246			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006668	gold, Green Submitted, Green Published			2022-12-27	WOS:000339040600032
J	Le Goff, G; Goodman, SM; Elguero, E; Robert, V				Le Goff, Gilbert; Goodman, Steven M.; Elguero, Eric; Robert, Vincent			Survey of the Mosquitoes (Diptera: Culicidae) of Mayotte	PLOS ONE			English	Article							ANOPHELES-GAMBIAE COMPLEX; INDIAN-OCEAN; COMOROS ARCHIPELAGO; MALARIA VECTOR; ISLAND; IDENTIFICATION; BIODIVERSITY; REUNION; EPIDEMIOLOGY; TRANSMISSION	A transversal survey of immature mosquitoes was conducted on Mayotte Island (France) in the Comoros Archipelago, western Indian Ocean, with the aim to inventory the Culicidae and to document inter-species relationships in different habitats. In total 420 habitats were sampled for larvae and/or pupae mosquitoes, resulting in more than 6,000 specimens. Forty species belonging to 15 genera were collected, with eight taxa integrated for the first time to the Mayotte mosquito list. The most frequently recorded species were Stegomyia aegypti, St. albopicta, Anopheles gambiae and Eretmapodites subsimplicipes, the first three species being known vectors of viruses and parasites transmitted to humans. Mean species richness in habitats ranged from 1.00 to 3.29, with notable differences between habitats. For example, water-filled axils of banana leaves, tree-holes and crab-holes had low species richness, while cut bamboo, water pools, abandoned tires and marsh and swamp water had notably higher species richness. Twenty-seven mosquito species belonging to 12 genera were routinely collected (in >= 20% of at least one type of larval habitat) suggesting that multiple species play a role in the biocenosis of these aquatic habitats. Multispecies association was observed in 52% of the habitats. The co-occurrence of up to six species belonging to five genera was recorded in a single habitat. The mosquitoes of Mayotte show notable biogeographical affinities to those of Madagascar, as compared to the African continent. These two potential source areas are nearly equidistant from Mayotte, which in turn indicates biased dispersal from east to west. Our findings suggest that with relatively short-term intensive sampling in different habitats, it is possible to approach exhaustive species inventories based on collection of larvae. Mayotte, with its modest elevation range and land surface, has a notable species richness of mosquitoes with 45 well-documented species belonging to 15 genera.	[Le Goff, Gilbert; Elguero, Eric; Robert, Vincent] Univ Montpellier, Inst Rech Dev, CNRS 5290, IRD 224, F-34059 Montpellier, France; [Goodman, Steven M.] Field Museum Nat Hist, Chicago, IL 60605 USA; [Goodman, Steven M.] Assoc Vahatra, Antananarivo, Madagascar	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Field Museum of Natural History (Chicago)	Robert, V (corresponding author), Univ Montpellier, Inst Rech Dev, CNRS 5290, IRD 224, F-34059 Montpellier, France.	vincent.robert@ird.fr		ROBERT, Vincent/0000-0003-1738-1842; Le Goff, Gilbert/0000-0001-9913-8736	Institut de Recherche pour le Developpement (IRD); Agence Regionale de Sante-Ocean Indien	Institut de Recherche pour le Developpement (IRD); Agence Regionale de Sante-Ocean Indien	Funding for this work was provided by the Institut de Recherche pour le Developpement (IRD) and Agence Regionale de Sante-Ocean Indien. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, TYP ECH COMM ENTR MA; Ayala D, 2006, ACTA TROP, V97, P292, DOI 10.1016/j.actatropica.2005.12.002; Bagny L, 2009, J MED ENTOMOL, V46, P198, DOI 10.1603/033.046.0204; Basset Y, 2012, SCIENCE, V338, P1481, DOI 10.1126/science.1226727; BOISIER P, 1994, ANN SOC BELG MED TR, V74, P217; Bousses P., 2013, Bulletin de la Societe de Pathologie Exotique, V106, P113, DOI 10.1007/s13149-013-0288-7; Brunhes J, 1997, ANN SOC ENTOMOL FR, V33, P173; BRUNHES J, 1978, Memoires du Museum National d'Histoire Naturelle Serie A Zoologie, V109, P193; BRUNHES J, 1977, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V15, P131; BRUNHES J, 1971, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V9, P335; BRUNHES J, 1977, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V15, P153; Brunhes J, 1995, FAUNE MADAGASCAR, V85; BRYGOO E. R., 1955, BULL SOC PATHOL EXOT, V48, P833; Carpentier M, 2006, UNIVERS MAORE, V5, P28; Chauvet G, 1967, MISSION ENTOMOLOGIQU; Clements A. N., 1992, BIOL MOSQUITOES, V1; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; da Cunha Ramos H, 2004, FAUNE MADAGASCAR, V91; DAVIDSON G, 1964, Riv Malariol, V43, P167; DIAMOND JM, 1985, NATURE, V315, P538, DOI 10.1038/315538a0; Didham RK, 2013, INSECT CONSERV DIVER, V6, P1, DOI 10.1111/icad.12022; Edwards F. W., 1920, Bulletin of Entomological Research London, V11, DOI 10.1017/S0007485300044539; Edwards F. W., 1935, Bull cnt Res London, V26, P127, DOI 10.1017/S0007485300038116; Edwards FW, 1912, B ENTOMOL RES, V3, P1; Elissa N, 2005, J AM MOSQUITO CONTR, V21, P472, DOI 10.2987/8756-971X(2006)21[472:ROAFAI]2.0.CO;2; ERWIN T L, 1982, Coleopterists Bulletin, V36, P74; Erwin T.L., 1983, Bulletin of the Entomological Society of America, V29, P14; Erwin T. L., 1983, Tropical rain forest: ecology and management. Special Publication Number 2 of the British Ecological Society, P59; Fattorini S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062118; Garcia FH, 2012, ZOOTAXA, P1; GASTON KJ, 1991, CONSERV BIOL, V5, P283, DOI 10.1111/j.1523-1739.1991.tb00140.x; GASTON KJ, 1992, FUNCT ECOL, V6, P243, DOI 10.2307/2389513; Gillies MT, 1987, FAUNE MADAGASCAR; GILLOT PY, 1994, EARTH PLANET SC LETT, V122, P291, DOI 10.1016/0012-821X(94)90003-5; Girod R, 2004, PARASITE, V11, P74; Goodman SM, 2010, ACTA CHIROPTEROL, V12, P117, DOI 10.3161/150811010X504635; Greenacre M., 2007, CORRES ANAL PRACTICE; Grjebine A., 1956, Naturaliste Malgache Tananarive, V8, P160; Grjebine A, 1966, FAUNE MADAGASCAR; Hamilton AJ, 2013, OECOLOGIA, V171, P357, DOI 10.1007/s00442-012-2434-5; HARBACH R E, 1981, Mosquito Systematics, V13, P201; Harbach R.E., 1980, TAXONOMISTS GLOSSARY; Harbach RE, 2014, MOSQUITO TAXONOMIC I; Hopkins GHE, 1952, MOSQUITOES ETHIOPIAN, V2nd; HUANG Y-M, 1979, Mosquito Systematics, V11, P221; Huang YM, 2004, ZOOTAXA, P1; HUNT RH, 1986, J MED ENTOMOL, V23, P655, DOI 10.1093/jmedent/23.6.655; INSEE, 2012, INSEE MAYOTTE INFOS, V61, P1; Janzen D. H., 2000, Biodiversity, V1, P7; Janzen DH, 2004, J APPL ECOL, V41, P181, DOI 10.1111/j.1365-2664.2004.00879.x; Janzen DH, 1996, ASC NEWSLETTER, V24, P49; Johanson KA, 2009, ZOOTAXA, P1; JULVEZ J, 1987, B SOC PATHOL EXOT, V80, P505; JULVEZ J, 1994, ANN SOC ENTOMOL FR, V30, P391; Julvez J, 1998, B SOC PATHOL EXOT, V91, P99; Julvez L, 1988, B SOC PATHOL EXOT, V81, P847; Jury MR., 2003, NATURAL HIST MADAGAS, P75; LAVERGNE J., 1950, Revue Coloniale de Medecine et de Chirurgie, V22, P134; Le Goff G, 2013, PARASITE, V20, DOI 10.1051/parasite/2013030; Le Goff G, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-207; Leong PTJM, 2003, PARASITE, V10, P273, DOI 10.1051/parasite/2003103273; Leponce Maurice, 2010, Abc Taxa, V8, P18; Lernout T, 2011, East Afr J Public Health, V8, P155; Louette M, 1999, ANN SCI ZOOLOGIQUES, V284, P1; LOUNIBOS LP, 1980, B ENTOMOL RES, V70, P309, DOI 10.1017/S0007485300007598; Lourenco Wilson R., 2009, Boletin de la SEA, V44, P35; Marsden CD, 2013, EVOL APPL, V6, P706, DOI 10.1111/eva.12056; Mattingly P. F., 1955, Bulletin of Entomological Research London, V46, P69, DOI 10.1017/S0007485300030777; MCCARTHY D. D., 1943, East African Medical Journal, V20, P293; MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025; Nichols BJ, 2007, SOUTHEAST NAT, V6, P27, DOI 10.1656/1528-7092(2007)6[27:TSATBI]2.0.CO;2; Nougier J., 1986, Journal of African Earth Sciences, V5, P135, DOI 10.1016/0899-5362(86)90003-5; PAULIAN RENAUD, 1964, BULL SOC ENTOMOL FRANCE, V69, P167; PETRARCA V, 1990, Parassitologia (Rome), V32, P371; Randrianambinintsoa FJ, 2013, PARASITE, V20, DOI 10.1051/parasite/2013005; Receveur M C, 2004, Bull Soc Pathol Exot, V97, P265; Reinert JF, 2004, ZOOL J LINN SOC-LOND, V142, P289, DOI 10.1111/j.1096-3642.2004.00144.x; Reinert JF, 2009, EUROPEAN MOSQUITO B, P68; Reinert John F., 1999, Contributions of the American Entomological Institute, V31, P1; Renault P, 2012, MED MALADIES INFECT, V42, P93, DOI 10.1016/j.medmal.2011.12.002; Robert V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-31; Rocha S, 2005, BELG J ZOOL, V135, P39; SABATINELLI G, 1994, PARASITE, V1, P71, DOI 10.1051/parasite/1994011071; Sabatinelli G., 1988, Parassitologia (Rome), V30, P178; Sabatinelli G., 1988, Parassitologia (Rome), V30, P176; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Service M, 1993, MOSQUITO ECOLOGY FIE; Sissoko D, 2008, T ROY SOC TROP MED H, V102, P780, DOI 10.1016/j.trstmh.2008.02.018; Sissoko D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014141; Sissoko D, 2009, EMERG INFECT DIS, V15, P568, DOI 10.3201/eid1504.081045; Sissoko D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003066; STORK NE, 1993, BIODIVERS CONSERV, V2, P215, DOI 10.1007/BF00056669; SUBRA R, 1975, TROPENMED PARASITOL, V26, P48; Subra R, 1973, CAHIER ORSTOM, V11, P225; Theobald FV, 1910, MONOGRAPH CULICIDAE, VV; Theobald FV, 1911, NOVAE CULICIDAE 1, P9; Tsy JMLP, 2003, MALARIA J, V2; Ventrillon E., 1905, Archives de Parasitologie, Vix, P441; Ventrillon E, 1906, B MUS HIST NAT BELG, V11, P427; Yoshimura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033325; Zeller HG, 1998, B SOC PATHOL EXOT, V91, P56	102	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e100696	10.1371/journal.pone.0100696	http://dx.doi.org/10.1371/journal.pone.0100696			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004163	Green Published, Green Submitted, gold			2022-12-27	WOS:000339242700011
J	Miyata, K; Ramaseshadri, P; Zhang, YJ; Segers, G; Bolognesi, R; Tomoyasu, Y				Miyata, Keita; Ramaseshadri, Parthasarathy; Zhang, Yuanji; Segers, Gerrit; Bolognesi, Renata; Tomoyasu, Yoshinori			Establishing an In Vivo Assay System to Identify Components Involved in Environmental RNA Interference in the Western Corn Rootworm	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; PROTEIN; DSRNA; GENE; YELLOW; EVOLUTION; CELLS; EBONY	The discovery of environmental RNA interference (RNAi), in which gene expression is suppressed via feeding with double-stranded RNA (dsRNA) molecules, opened the door to the practical application of RNAi-based techniques in crop pest management. The western corn rootworm (WCR, Diabrotica virgifera virgifera) is one of the most devastating corn pests in North America. Interestingly, WCR displays a robust environmental RNAi response, raising the possibility of applying an RNAi-based pest management strategy to this pest. Understanding the molecular mechanisms involved in the WCR environmental RNAi process will allow for determining the rate limiting steps involved with dsRNA toxicity and potential dsRNA resistance mechanisms in WCR. In this study, we have established a two-step in vivo assay system, which allows us to evaluate the involvement of genes in environmental RNAi in WCR. We show that laccase 2 and ebony, critical cuticle pigmentation/tanning genes, can be used as marker genes in our assay system, with ebony being a more stable marker to monitor RNAi activity. In addition, we optimized the dsRNA dose and length for the assay, and confirmed that this assay system is sensitive to detect well-known RNAi components such as Dicer-2 and Argonaute-2. We also evaluated two WCR sid1- like (sil) genes with this assay system. This system will be useful to quickly survey candidate systemic RNAi genes in WCR, and also will be adaptable for a genome-wide RNAi screening to give us an unbiased view of the environmental/systemic RNAi pathway in WCR.	[Miyata, Keita; Tomoyasu, Yoshinori] Miami Univ, Dept Biol, Oxford, OH 45056 USA; [Ramaseshadri, Parthasarathy; Zhang, Yuanji; Segers, Gerrit; Bolognesi, Renata] Monsanto Co, Div Biotechnol, Chesterfield, MO USA	University System of Ohio; Miami University; Monsanto	Tomoyasu, Y (corresponding author), Miami Univ, Dept Biol, Oxford, OH 45056 USA.	tomoyay@MiamiOH.edu	Tomoyasu, Yoshinori/D-3061-2017	Tomoyasu, Yoshinori/0000-0001-9824-3454	Miami University; Monsanto Company	Miami University; Monsanto Company	This work was in part supported by Miami University. Miami University had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Monsanto Company funded the work. PR, YZ, GS and RB, scientists employed by Monsanto Company were involved in study design, decision to publish, and preparation of the manuscript.	Alves AP, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14122; Arakane Y, 2005, P NATL ACAD SCI USA, V102, P11337, DOI 10.1073/pnas.0504982102; Arakane Y, 2010, INSECT BIOCHEM MOLEC, V40, P259, DOI 10.1016/j.ibmb.2010.01.012; Bargmann CI, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews1005; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Belles X, 2010, ANNU REV ENTOMOL, V55, P111, DOI 10.1146/annurev-ento-112408-085301; Bolognesi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047534; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Devos Y, 2013, TRANSGENIC RES, V22, P269, DOI 10.1007/s11248-012-9657-4; Dunbar MW, 2013, J ECON ENTOMOL, V106, P168, DOI 10.1603/EC11291; Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836; Feinberg EH, 2003, SCIENCE, V301, P1545, DOI 10.1126/science.1087117; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Futahashi R, 2008, GENETICS, V180, P1995, DOI 10.1534/genetics.108.096388; Hinas A, 2012, CURR BIOL, V22, P1938, DOI 10.1016/j.cub.2012.08.020; HOPKINS TL, 1992, ANNU REV ENTOMOL, V37, P273, DOI 10.1146/annurev.en.37.010192.001421; Hunter CP, 2006, COLD SPRING HARB SYM, V71, P95, DOI 10.1101/sqb.2006.71.060; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Jose AM, 2012, P NATL ACAD SCI USA, V109, P14520, DOI 10.1073/pnas.1201153109; Kobayashi I, 2012, INSECT BIOCHEM MOLEC, V42, P148, DOI 10.1016/j.ibmb.2011.11.007; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Miller SC, 2008, DEV GENES EVOL, V218, P505, DOI 10.1007/s00427-008-0238-8; Miller SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047431; Mon H, 2012, RNA BIOL, V9, P40, DOI 10.4161/rna.9.1.18084; Narva KE, 2013, ADV BIOCHEM ENG BIOT, V136, P135, DOI 10.1007/10_2013_195; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Ramaseshadri P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054270; Rocheleau CE, 2012, CURR BIOL, V22, pR873, DOI 10.1016/j.cub.2012.08.039; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Scott JG, 2013, J INSECT PHYSIOL, V59, P1212, DOI 10.1016/j.jinsphys.2013.08.014; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Swevers L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020250; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tijsterman M, 2004, CURR BIOL, V14, P111, DOI 10.1016/j.cub.2003.12.029; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Tomoyasu Y, 2009, CURR BIOL, V19, P2057, DOI 10.1016/j.cub.2009.11.014; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Ulvila J, 2006, J BIOL CHEM, V281, P14370, DOI 10.1074/jbc.M513868200; WALTER MF, 1991, DEV BIOL, V147, P32, DOI 10.1016/S0012-1606(05)80005-3; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; Winston WM, 2007, P NATL ACAD SCI USA, V104, P10565, DOI 10.1073/pnas.0611282104; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X; Wittkopp PJ, 2002, DEVELOPMENT, V129, P1849; WRIGHT TRF, 1987, ADV GENET, V24, P127, DOI 10.1016/s0065-2660(08)60008-5	50	56	58	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101661	10.1371/journal.pone.0101661	http://dx.doi.org/10.1371/journal.pone.0101661			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003334	Green Submitted, gold, Green Published			2022-12-27	WOS:000339242700049
J	Nam, KH; Kie, JH; Lee, MJ; Chang, TI; Kang, EW; Kim, DW; Lim, BJ; Park, JT; Kwon, YE; Kim, YL; Park, KS; An, SY; Oh, HJ; Yoo, TH; Kang, SW; Choi, KH; Jeong, HJ; Han, DS; Han, SH				Nam, Ki Heon; Kie, Jeong Hae; Lee, Mi Jung; Chang, Tae-Ik; Kang, Ea Wha; Kim, Dong Wook; Lim, Beom Jin; Park, Jung Tak; Kwon, Young Eun; Kim, Yung Ly; Park, Kyoung Sook; An, Seong Yeong; Oh, Hyung Jung; Yoo, Tae-Hyun; Kang, Shin-Wook; Choi, Kyu Hun; Jeong, Hyeon Joo; Han, Dae-Suk; Han, Seung Hyeok			Optimal Proteinuria Target for Renoprotection in Patients with IgA Nephropathy	PLOS ONE			English	Article							PREDICTING PROGRESSION; NATURAL-HISTORY; OUTCOMES; THERAPY; CHINESE; DISEASE	Background: Proteinuria is a target for renoprotection in kidney diseases. However, optimal level of proteinuria reduction in IgA nephropathy (IgAN) is unknown. Methods: We conducted a retrospective observational study in 500 patients with biopsy-proven IgAN. Time-averaged proteinuria (TA-P) was calculated as the mean of every 6 month period of measurements of spot urine protein-to-creatinine ratio. The study endpoints were a 50% decline in estimated glomerular filtration rate (eGFR), onset of end-stage renal disease (ESRD), and slope of eGFR. Results: During a median follow-up duration of 65 (12-154) months, a 50% decline in eGFR occurred in 1 (0.8%) patient with TA-P of <0.3 g/g compared to 6 (2.7%) patients with TA-P of 0.3-0.99 g/g (hazard ratio, 2.82; P = 0.35). Risk of reaching a 50% decline in eGFR markedly increased in patients with TA-P of 1.0-2.99 - g/g (P = 0.002) and those with TA-P >= 3.0 g/g (P<0.001). ESRD did not occur in patients with TA-P<1.0 g/g compared to 26 (20.0%) and 8 (57.1%) patients with TA-P of 1.02.99 and >= 3.0 g/g, respectively. Kidney function of these two groups deteriorated faster than those with TA-P<1.0 g/g (P<0.001). However, patients with TA-P of 0.3-0.99 g/g had a greater decline of eGFR than patients with TA-P<0.3 g/g (-0.41 +/- 1.68 vs. -0.73 +/- 2.82 ml/min/1.73 m(2)/year, P = 0.03). Conclusion: In this study, patients with TA-P<1.0 g/g show favorable outcomes. However, given the faster eGFR decline in patients with TA-P of 0.3-0.99 g/g than in patients with TA-P<0.3 g/g, the ultimate optimal goal of proteinuria reduction can be lowered in the management of IgAN.	[Nam, Ki Heon; Lee, Mi Jung; Park, Jung Tak; Kwon, Young Eun; Kim, Yung Ly; Park, Kyoung Sook; An, Seong Yeong; Oh, Hyung Jung; Yoo, Tae-Hyun; Kang, Shin-Wook; Choi, Kyu Hun; Han, Dae-Suk; Han, Seung Hyeok] Yonsei Univ, Coll Med, Dept Internal Med, Div Nephrol, Seoul, South Korea; [Kie, Jeong Hae] NHIS Ilsan Hosp, Dept Pathol, Goyang Shi, Gyeonggi Do, South Korea; [Chang, Tae-Ik; Kang, Ea Wha] NHIS Ilsan Hosp, Dept Internal Med, Goyang Shi, Gyeonggi Do, South Korea; [Kim, Dong Wook] Yonsei Univ, Coll Med, Biostat Collaborat Unit, Seoul, South Korea; [Lim, Beom Jin; Jeong, Hyeon Joo] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Kang, Shin-Wook] Yonsei Univ, Severance Biomed Sci Inst, Brain Korea 21, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; National Health Insurance Service; NHIS Ilsan Hospital; National Health Insurance Service; NHIS Ilsan Hospital; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University	Han, SH (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Div Nephrol, Seoul, South Korea.	hansh@yuhs.ac	Han, Seung Hyeok/K-4559-2018; Han, Seung Hyeok/W-8825-2019	Han, Seung Hyeok/0000-0001-7923-5635; Han, Seung Hyeok/0000-0001-7923-5635; Lee, Mi Jung/0000-0001-8888-029X; Choi, Kyu Hun/0000-0003-0095-9011; Lim, Beom Jin/0000-0003-2856-0133; Yoo, Tae-Hyun/0000-0002-9183-4507; Jeong, Hyeon Joo/0000-0002-9695-1227; Kie, Jeong Hae/0000-0003-1782-5650; Nam, Ki Heon/0000-0001-7312-7027; Park, Jung Tak/0000-0002-2325-8982; Kang, Shin-Wook/0000-0002-5677-4756	Yonsei University College of Medicine [6-2012-0033]; Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A102065]	Yonsei University College of Medicine(General Electric); Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by a faculty research grant of Yonsei University College of Medicine for 2012 (6-2012-0033); and by a grant of the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A102065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbour SJ, 2012, AM J KIDNEY DIS, V59, P865, DOI 10.1053/j.ajkd.2012.02.326; Barratt J, 2005, J AM SOC NEPHROL, V16, P2088, DOI 10.1681/ASN.2005020134; Bartosik LP, 2001, AM J KIDNEY DIS, V38, P728, DOI 10.1053/ajkd.2001.27689; Berthoux F, 2011, J AM SOC NEPHROL, V22, P752, DOI 10.1681/ASN.2010040355; Berthoux FC, 2008, SEMIN NEPHROL, V28, P4, DOI 10.1016/j.semnephrol.2007.10.001; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Cattran DC, 2008, NEPHROL DIAL TRANSPL, V23, P2247, DOI 10.1093/ndt/gfm919; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Coppo R, 2005, J NEPHROL, V18, P503; de Zeeuw D, 2004, KIDNEY INT, V65, P2309, DOI 10.1111/j.1523-1755.2004.00653.x; Donadio JV, 2002, NEPHROL DIAL TRANSPL, V17, P1197, DOI 10.1093/ndt/17.7.1197; Frimat L, 1997, NEPHROL DIAL TRANSPL, V12, P2569; Geddes CC, 2003, NEPHROL DIAL TRANSPL, V18, P1541, DOI 10.1093/ndt/gfg207; Gutierrez E, 2012, J AM SOC NEPHROL, V23, P1753, DOI 10.1681/ASN.2012010063; Hladunewich MA, 2009, CLIN J AM SOC NEPHRO, V4, P1417, DOI 10.2215/CJN.01330209; Jafar TH, 2003, ANN INTERN MED, V139, P244, DOI 10.7326/0003-4819-139-4-200308190-00006; Jafar TH, 2001, KIDNEY INT, V60, P1131, DOI 10.1046/j.1523-1755.2001.0600031131.x; Le WB, 2012, NEPHROL DIAL TRANSPL, V27, P1479, DOI 10.1093/ndt/gfr527; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Li PKT, 2002, NEPHROL DIAL TRANSPL, V17, P64, DOI 10.1093/ndt/17.1.64; Lv JC, 2012, J AM SOC NEPHROL, V23, P1108, DOI 10.1681/ASN.2011111112; Lv JC, 2009, AM J KIDNEY DIS, V53, P26, DOI 10.1053/j.ajkd.2008.07.029; Pozzi C, 2004, J AM SOC NEPHROL, V15, P157, DOI 10.1097/01.ASN.0000103869.08096.4F; Price CP, 2005, CLIN CHEM, V51, P1577, DOI 10.1373/clinchem.2005.049742; Radford MG, 1997, J AM SOC NEPHROL, V8, P199; Radhakrishnan J, 2012, KIDNEY INT, V82, P840, DOI 10.1038/ki.2012.280; Reich HN, 2007, J AM SOC NEPHROL, V18, P3177, DOI 10.1681/ASN.2007050526; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Rosselli JL, 2011, ANN PHARMACOTHER, V45, P1284, DOI 10.1345/aph.1Q122	30	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101935	10.1371/journal.pone.0101935	http://dx.doi.org/10.1371/journal.pone.0101935			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003873	Green Published, Green Submitted, gold			2022-12-27	WOS:000339242700090
J	Perkins, SM; Shinohara, ET; DeWees, T; Frangoul, H				Perkins, Stephanie M.; Shinohara, Eric T.; DeWees, Todd; Frangoul, Haydar			Outcome for Children with Metastatic Solid Tumors over the Last Four Decades	PLOS ONE			English	Article							HIGH-RISK NEUROBLASTOMA; HISTOLOGY WILMS-TUMOR; INTERGROUP RHABDOMYOSARCOMA; EWINGS-SARCOMA; ONCOLOGY GROUP; 13-CIS-RETINOIC ACID; PROGNOSTIC-FACTORS; CHEMOTHERAPY; TRIAL; OSTEOSARCOMA	Background: Outcomes for pediatric solid tumors have significantly improved over the last 30 years. However, much of this improvement is due to improved outcome for patients with localized disease. Here we evaluate overall survival (OS) for pediatric patients with metastatic disease over the last 40 years. Procedure: The United States Surveillance, Epidemiology, and End Results (SEER) database was used to conduct this study. Patients diagnosed between 0 and 18 years of age with metastatic Ewings sarcoma, neuroblastoma, osteosarcoma, rhabdomyosarcoma or Wilms tumor were included in the analysis. Results: 3,009 patients diagnosed between 1973-2010 met inclusion criteria for analysis. OS at 10 years for patients diagnosed between 1973-1979, 1980-1989, 1990-1999 and 2000-2010 was 28.3%, 37.2%, 44.7% and 49.3%, respectively (p<0.001). For patients diagnosed between 2000-2010, 10-year OS for patients with Ewing sarcoma, neuroblastoma, osteosarcoma, rhabdomyosarcoma and Wilms tumor was 30.6%, 54.4%, 29.3%, 27.5%, and 76.6%, respectively, as compared to 13.8%, 25.1%, 13.6%, 17.9% and 57.1%, respectively, for patients diagnosed between 1973-1979. OS for neuroblastoma significantly increased with each decade. For patients with osteosarcoma and Ewing sarcoma, there was no improvement in OS over the last two decades. There was no improvement in outcome for patients with rhabdomyosarcoma or Wilms tumor over the last 30 years. Conclusions: OS for pediatric patients with metastatic solid tumors has significantly improved since the 1970s. However, outcome has changed little for some malignancies in the last 20-30 years. These data underscore the importance of continued collaboration and studies to improve outcome for these patients.	[Perkins, Stephanie M.; DeWees, Todd] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO USA; [Shinohara, Eric T.] Vanderbilt Univ, Sch Med, Dept Radiat Oncol, Nashville, TN 37212 USA; [Frangoul, Haydar] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA	Washington University (WUSTL); Vanderbilt University; Vanderbilt University	Frangoul, H (corresponding author), Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA.	Haydar.frangoul@vanderbilt.edu		DeWees, Todd/0000-0003-3897-3011				Balamuth NJ, 2010, LANCET ONCOL, V11, P184, DOI 10.1016/S1470-2045(09)70286-4; Breneman JC, 2003, J CLIN ONCOL, V21, P78, DOI 10.1200/JCO.2003.06.129; BRESLOW NE, 1986, CANCER-AM CANCER SOC, V58, P2501, DOI 10.1002/1097-0142(19861201)58:11<2501::AID-CNCR2820581125>3.0.CO;2-V; Carli M, 2004, J CLIN ONCOL, V22, P4787, DOI 10.1200/JCO.2004.04.083; CRIST W, 1995, J CLIN ONCOL, V13, P610, DOI 10.1200/JCO.1995.13.3.610; Dome JS, 2006, J CLIN ONCOL, V24, P2352, DOI 10.1200/JCO.2005.04.7852; Green DM, 2013, J PEDIATR SURG, V48, P14, DOI 10.1016/j.jpedsurg.2012.10.012; Green DM, 1996, MED PEDIATR ONCOL, V26, P147; Grier HE, 2003, NEW ENGL J MED, V348, P694, DOI 10.1056/NEJMoa020890; JAFFE N, 1976, CANCER, V38, P1925, DOI 10.1002/1097-0142(197611)38:5<1925::AID-CNCR2820380510>3.0.CO;2-J; Jaffe N, 2009, CANCER TREAT RES, V152, P239, DOI 10.1007/978-1-4419-0284-9_12; Kager L, 2003, J CLIN ONCOL, V21, P2011, DOI 10.1200/JCO.2003.08.132; Kalapurakal JA, 2004, LANCET ONCOL, V5, P37, DOI 10.1016/S1470-2045(03)01322-6; Ladenstein R, 2010, J CLIN ONCOL, V28, P3284, DOI 10.1200/JCO.2009.22.9864; Malempati S, 2012, PEDIATR BLOOD CANCER, V59, P5, DOI 10.1002/pbc.24118; Matthay KK, 2009, J CLIN ONCOL, V27, P1007, DOI 10.1200/JCO.2007.13.8925; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; MAURER HM, 1993, CANCER-AM CANCER SOC, V71, P1904, DOI 10.1002/1097-0142(19930301)71:5<1904::AID-CNCR2820710530>3.0.CO;2-X; MAURER HM, 1988, CANCER-AM CANCER SOC, V61, P209, DOI 10.1002/1097-0142(19880115)61:2<209::AID-CNCR2820610202>3.0.CO;2-L; MEYERS PA, 1993, J CLIN ONCOL, V11, P449, DOI 10.1200/JCO.1993.11.3.449; NESBIT ME, 1990, J CLIN ONCOL, V8, P1664, DOI 10.1200/JCO.1990.8.10.1664; Park JR, 2013, PEDIATR BLOOD CANCER, V60, P985, DOI 10.1002/pbc.24433; Seibel NL, 2007, CANCER, V109, P1646, DOI 10.1002/cncr.22553; Smith MA, 2010, J CLIN ONCOL, V28, P2625, DOI 10.1200/JCO.2009.27.0421; Womer RB, 2012, J CLIN ONCOL, V30, P4148, DOI 10.1200/JCO.2011.41.5703; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123	26	50	55	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e100396	10.1371/journal.pone.0100396	http://dx.doi.org/10.1371/journal.pone.0100396			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003594	Green Published, Green Submitted, gold			2022-12-27	WOS:000339242700006
J	Pouplin, T; Phuong, PN; Toi, PV; Pouplin, JN; Farrar, J				Pouplin, Thomas; Pham Nguyen Phuong; Pham Van Toi; Julie Nguyen Pouplin; Farrar, Jeremy			Isoniazid, Pyrazinamide and Rifampicin Content Variation in Split Fixed-Dose Combination Tablets	PLOS ONE			English	Article							TUBERCULOSIS; CHILDREN; PHARMACOKINETICS; BIOAVAILABILITY	Setting: In most developing countries, paediatric tuberculosis is treated with split tablets leading to potential inaccuracy in the dose delivery and drug exposure. There is no data on the quality of first-line drugs content in split fixed-dose combination tablets. Objective: To determine Isoniazid, Pyrazinamide and Rifampicin content uniformity in split FDC tablets used in the treatment of childhood tuberculosis. Design: Drug contents of 15 whole tablets, 30 half tablets and 36 third tablets were analysed by high performance liquid chromatography. The content uniformity was assessed by comparing drug content measured in split portions with their expected amounts and the quality of split portions was assessed applying qualitative specifications for whole tablets. Results: All whole tablets measurements fell into the USP proxy for the three drugs. But a significant number of half and third portions was found outside the tolerated variation range and the split formulation failed the requirements for content uniformity. To correct for the inaccuracy of splitting the tablets into equal portions, a weight-adjustment strategy was used but this did not improve the findings. Conclusion: In split tablets the content of the three drugs is non-uniform and exceeded the USP recommendations. There is an absolute need to make child-friendly formulations available for the treatment of childhood tuberculosis.	[Pouplin, Thomas; Pham Nguyen Phuong; Pham Van Toi; Julie Nguyen Pouplin] Mahidol Univ, Fac Trop Med, Mahidol Univ Oxford Trop Med Res Programme, Bangkok, Thailand; [Farrar, Jeremy] Wellcome Trust Major Overseas Programme, Oxford Univ Clin Res Unit Vietnam, Ctr Trop Med, Ho Chi Minh City, Vietnam; [Pouplin, Thomas; Farrar, Jeremy] Univ Oxford, Ctr Trop Med, Nuffield Dept Med, Oxford, England	Mahidol University; University of Oxford	Pouplin, T (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Univ Oxford Trop Med Res Programme, Bangkok, Thailand.	thomas@tropmedres.ac	Farrar, Jeremy J./HGA-7610-2022	PHAM VAN, TOI/0000-0002-6496-5464; Farrar, Jeremy/0000-0002-2700-623X	Wellcome Trust Major Oversea Program, Vietnam [089276/B/09/Z]	Wellcome Trust Major Oversea Program, Vietnam	This work was supported by the Wellcome Trust Major Oversea Program, Vietnam (Grant 089276/B/09/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, MON 905 UNIFORMITY D, V905; Donald PR, 2007, INT J TUBERC LUNG D, V11, P1162; Donald PR, 2011, TUBERCULOSIS, V91, P196, DOI 10.1016/j.tube.2011.02.004; Ellard GA, 1999, INT J TUBERC LUNG D, V3, pS301; Enarson PM, 2005, INT J TUBERC LUNG D, V9, P727; European Medicines Agency, 2008, ICH Q4B ANN 6 UN DOS; Graham SM, 2006, ANTIMICROB AGENTS CH, V50, P407, DOI 10.1128/AAC.50.2.407-413.2006; Graham SM, 2011, PAEDIATR RESPIR REV, V12, P22, DOI 10.1016/j.prrv.2010.09.005; Hill SW, 2009, J MANAGE CARE PHARM, V15, P253, DOI 10.18553/jmcp.2009.15.3.253; KOUP JR, 1986, THER DRUG MONIT, V8, P17, DOI 10.1097/00007691-198603000-00004; Nahirya-Ntege P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036186; Schaaf HS, 2005, ARCH DIS CHILD, V90, P614, DOI 10.1136/adc.2004.052175; Singh S, 2001, INT J PHARMACEUT, V228, P5, DOI 10.1016/S0378-5173(01)00754-2; Swaminathan S, 2010, CLIN INFECT DIS, V50, pS184, DOI 10.1086/651490; Thee S, 2009, INT J TUBERC LUNG D, V13, P1106; UNICEF/WHO, 2010, SOURC PRIC SEL MED C	16	19	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e102047	10.1371/journal.pone.0102047	http://dx.doi.org/10.1371/journal.pone.0102047			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004128	Green Published, Green Submitted, gold			2022-12-27	WOS:000339242700101
J	Xiang, XC; Deng, L; Zhang, JL; Zhang, XD; Lei, TJ; Luan, GX; Yang, CL; Xiao, ZX; Li, Q; Li, QT				Xiang, Xiaocong; Deng, Li; Zhang, Jingli; Zhang, Xudong; Lei, Tingjun; Luan, Guangxin; Yang, Chunlei; Xiao, Zhi-Xiong; Li, Qian; Li, Qintong			A Distinct Expression Pattern of Cyclin K in Mammalian Testes Suggests a Functional Role in Spermatogenesis	PLOS ONE			English	Article							RNA-POLYMERASE-II; CELL SELF-RENEWAL; EMBRYONIC STEM-CELLS; TERMINAL DOMAIN; IN-VIVO; KINASE; PLURIPOTENCY; TRANSCRIPTION; GERMLINE; CDK9	Germ cell and embryonic stem cells are inextricably linked in many aspects. Remarkably both can generate all somatic cell types in organisms. Yet the molecular regulation accounting for these similarities is not fully understood. Cyclin K was previously thought to associate with CDK9 to regulate gene expression. However, we and others have recently shown that its cognate interacting partners are CDK12 and CDK13 in mammalian cells. We further demonstrated that cyclin K is essential for embryonic stem cell maintenance. In this study, we examined the expression of cyclin K in various murine and human tissues. We found that cyclin K is highly expressed in mammalian testes in a developmentally regulated manner. During neonatal spermatogenesis, cyclin K is highly expressed in gonocytes and spermatogonial stem cells. In adult testes, cyclin K can be detected in spermatogonial stem cells but is absent in differentiating spermatogonia, spermatids and spermatozoa. Interestingly, the strongest expression of cyclin K is detected in primary spermatocytes. In addition, we found that cyclin K is highly expressed in human testicular cancers. Knockdown of cyclin K in a testicular cancer cell line markedly reduces cell proliferation. Collectively, we suggest that cyclin K may be a novel molecular link between germ cell development, cancer development and embryonic stem cell maintenance.	[Xiang, Xiaocong; Deng, Li; Zhang, Xudong; Lei, Tingjun; Luan, Guangxin; Yang, Chunlei; Xiao, Zhi-Xiong; Li, Qintong] Sichuan Univ, Coll Life Sci, Key Lab Bioresources & Ecoenvironm, Ctr Growth Metab & Aging, Chengdu 610064, Sichuan, Peoples R China; [Xiang, Xiaocong; Deng, Li; Zhang, Xudong; Lei, Tingjun; Luan, Guangxin; Yang, Chunlei; Xiao, Zhi-Xiong; Li, Qintong] Sichuan Univ, Coll Life Sci, State Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China; [Zhang, Jingli; Li, Qian] 363 Hosp, Aviat Ind Corp China, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Aviation Industry Corporation of China (AVIC)	Li, QT (corresponding author), Sichuan Univ, Coll Life Sci, Key Lab Bioresources & Ecoenvironm, Ctr Growth Metab & Aging, Chengdu 610064, Sichuan, Peoples R China.	liqintong@scu.edu.cn		Li, Qintong/0000-0002-8447-9770	National Basic Research Program of China/973 [2011CB504200, 2012CB910700]; National Natural Science Foundation of China [31171260, 81261120399, 81330054, J1103518]; Science and Technology Department of Sichuan Province [2013JQ0041]	National Basic Research Program of China/973(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Sichuan Province	Financial support is provided by grants from the National Basic Research Program of China/973 (2011CB504200 and 2012CB910700), the National Natural Science Foundation of China (31171260, 81261120399, 81330054, and J1103518), and the Science and Technology Department of Sichuan Province (2013JQ0041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartkowiak B, 2010, GENE DEV, V24, P2303, DOI 10.1101/gad.1968210; Blazek D, 2011, GENE DEV, V25, P2158, DOI 10.1101/gad.16962311; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Cheng SWG, 2012, MOL CELL BIOL, V32, P4691, DOI 10.1128/MCB.06267-11; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Culty M, 2009, BIRTH DEFECTS RES C, V87, P1, DOI 10.1002/bdrc.20142; Dai Q, 2012, J BIOL CHEM, V287, P25344, DOI 10.1074/jbc.M111.321760; De Rooij DG, 2000, J ANDROL, V21, P776; Edwards MC, 1998, MOL CELL BIOL, V18, P4291, DOI 10.1128/MCB.18.7.4291; Evans M, 2011, NAT REV MOL CELL BIO, V12, P680, DOI 10.1038/nrm3190; Even Y, 2006, J CELL BIOCHEM, V99, P890, DOI 10.1002/jcb.20986; Fu TJ, 1999, J BIOL CHEM, V274, P34527, DOI 10.1074/jbc.274.49.34527; Gassei K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053976; Ghamari A, 2013, GENE DEV, V27, P767, DOI 10.1101/gad.216200.113; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kanatsu-Shinohara M, 2013, ANNU REV CELL DEV BI, V29, P163, DOI 10.1146/annurev-cellbio-101512-122353; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Ko TK, 2001, J CELL SCI, V114, P2591; Kuijk EW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010987; Leitch HG, 2013, DEVELOPMENT, V140, P2495, DOI 10.1242/dev.091603; Leroy X, 2002, J HISTOCHEM CYTOCHEM, V50, P283, DOI 10.1177/002215540205000216; Lin X, 2002, J BIOL CHEM, V277, P16873, DOI 10.1074/jbc.M200117200; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Oatley JM, 2012, PHYSIOL REV, V92, P577, DOI 10.1152/physrev.00025.2011; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Singh SR, 2011, J CELL MOL MED, V15, P468, DOI 10.1111/j.1582-4934.2010.01242.x; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910	34	9	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101539	10.1371/journal.pone.0101539	http://dx.doi.org/10.1371/journal.pone.0101539			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004108	Green Submitted, gold, Green Published			2022-12-27	WOS:000339242700037
J	Church, JE; Trieu, J; Sheorey, R; Chee, AYM; Naim, T; Baum, DM; Ryall, JG; Gregorevic, P; Lynch, GS				Church, Jarrod E.; Trieu, Jennifer; Sheorey, Radhika; Chee, Annabel Y. -M.; Naim, Timur; Baum, Dale M.; Ryall, James G.; Gregorevic, Paul; Lynch, Gordon S.			Functional beta-Adrenoceptors Are Important for Early Muscle Regeneration in Mice through Effects on Myoblast Proliferation and Differentiation	PLOS ONE			English	Article							RAT SKELETAL-MUSCLE; BETA-2-ADRENERGIC RECEPTOR; IN-VITRO; CLENBUTEROL; EXPRESSION; INJURY; HYPERTROPHY; FIBERS; REPAIR; GENE	Muscles can be injured in different ways and the trauma and subsequent loss of function and physical capacity can impact significantly on the lives of patients through physical impairments and compromised quality of life. The relative success of muscle repair after injury will largely determine the extent of functional recovery. Unfortunately, regenerative processes are often slow and incomplete, and so developing novel strategies to enhance muscle regeneration is important. While the capacity to enhance muscle repair by stimulating beta(2)-adrenoceptors (beta-ARs) using beta(2)-AR agonists (beta(2)-agonists) has been demonstrated previously, the exact role beta-ARs play in regulating the regenerative process remains unclear. To investigate beta-AR-mediated signaling in muscle regeneration after myotoxic damage, we examined the regenerative capacity of tibialis anterior and extensor digitorum longus muscles from mice lacking either beta(1)-AR (beta(1)-KO) and/or beta(2)-ARs (beta(2)-KO), testing the hypothesis that muscles from mice lacking the beta(2)-AR would exhibit impaired functional regeneration after damage compared with muscles from beta(1)-KO or beta(1)/b(2)-AR null (beta(1)/beta(2)-KO) KO mice. At 7 days post-injury, regenerating muscles from beta(1)/beta(2)-KO mice produced less force than those of controls but muscles from beta(1)-KO or beta(2)-KO mice did not exhibit any delay in functional restoration. Compared with controls, beta(1)/beta(2)-KO mice exhibited an enhanced inflammatory response to injury, which delayed early muscle regeneration, but an enhanced myoblast proliferation later during regeneration ensured a similar functional recovery (to controls) by 14 days post-injury. This apparent redundancy in the beta-AR signaling pathway was unexpected and may have important implications for manipulating beta-AR signaling to improve the rate, extent and efficacy of muscle regeneration to enhance functional recovery after injury.	[Church, Jarrod E.; Trieu, Jennifer; Sheorey, Radhika; Chee, Annabel Y. -M.; Naim, Timur; Baum, Dale M.; Ryall, James G.; Lynch, Gordon S.] Univ Melbourne, Dept Physiol, Basic & Clin Myol Lab, Melbourne, Vic 3010, Australia; [Gregorevic, Paul] Baker IDI Heart & Diabet Inst, Lab Muscle Res & Therapeut Dev, Melbourne, Vic, Australia	University of Melbourne; Baker Heart and Diabetes Institute	Lynch, GS (corresponding author), Univ Melbourne, Dept Physiol, Basic & Clin Myol Lab, Melbourne, Vic 3010, Australia.	gsl@unimelb.edu.au	Ryall, James/J-9771-2019; Gregorevic, Paul/AAH-6040-2021; Lynch, Gordon/G-9553-2015	Ryall, James/0000-0003-4702-1143; Gregorevic, Paul/0000-0002-7418-8945; Lynch, Gordon/0000-0001-9220-9810; Church, Jarrod/0000-0001-8266-4043	National Health and Medical Research Council (NHMRC) of Australia [509313, 1026231]; Association Francaise contre les Myopathies (AFM, France); NHMRC Career Development Fellowship; NHMRC Overseas Postdoctoral Fellowship; Pfizer Senior Research Fellowship	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Association Francaise contre les Myopathies (AFM, France)(Association Francaise contre les Myopathies); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Overseas Postdoctoral Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Pfizer Senior Research Fellowship	This work was supported by the National Health and Medical Research Council (NHMRC) of Australia (Project grants: 509313; 1026231). JEC was supported by a postdoctoral fellowship from the Association Francaise contre les Myopathies (AFM, France). PG was supported by a NHMRC Career Development Fellowship and formerly a Pfizer Senior Research Fellowship. JGR is supported by a NHMRC Overseas Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 1999, J ALLERGY CLIN IMMUN, V104, pS10, DOI 10.1016/S0091-6749(99)70269-1; Beitzel F, 2004, J APPL PHYSIOL, V96, P1385, DOI 10.1152/japplphysiol.01081.2003; Beitzel F, 2007, AM J PHYSIOL-ENDOC M, V293, pE932, DOI 10.1152/ajpendo.00175.2007; Boost KA, 2007, ACTA ANAESTH SCAND, V51, P900, DOI 10.1111/j.1399-6576.2007.01363.x; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Bunn JR, 2004, J ORTHOP RES, V22, P1336, DOI 10.1016/j.orthres.2004.03.013; CAIRNS SP, 1993, BRIT J PHARMACOL, V110, P1133, DOI 10.1111/j.1476-5381.1993.tb13932.x; Chruscinski AJ, 1999, J BIOL CHEM, V274, P16694, DOI 10.1074/jbc.274.24.16694; Delday MI, 1997, AM J PHYSIOL-ENDOC M, V272, pE941, DOI 10.1152/ajpendo.1997.272.5.E941; Egerman MA, 2014, CRIT REV BIOCHEM MOL, V49, P59, DOI 10.3109/10409238.2013.857291; EMERY PW, 1984, BIOSCIENCE REP, V4, P83, DOI 10.1007/BF01120827; Gehrig SM, 2010, AM J PATHOL, V176, P29, DOI 10.2353/ajpath.2010.090760; Gregorevic P, 2004, J PHYSIOL-LONDON, V558, P549, DOI 10.1113/jphysiol.2004.066217; Ha TNV, 1999, BRIT J PHARMACOL, V126, P1717, DOI 10.1038/sj.bjp.0702482; Harcourt LJ, 2005, AM J PATHOL, V166, P1131, DOI 10.1016/S0002-9440(10)62333-4; Hinkle RT, 2002, MUSCLE NERVE, V25, P729, DOI 10.1002/mus.10092; Hong EG, 2009, DIABETES, V58, P2525, DOI 10.2337/db08-1261; Huang YC, 2005, J APPL PHYSIOL, V98, P706, DOI 10.1152/japplphysiol.00273.2004; Izeboud CA, 1999, J RECEPT SIGNAL TR R, V19, P191, DOI 10.3109/10799899909036645; Izeboud CA, 1999, INFLAMM RES, V48, P497, DOI 10.1007/s000110050493; Jones SW, 2004, J PHARMACOL EXP THER, V311, P1225, DOI 10.1124/jpet.104.071589; KIM YS, 1991, BIOCHEM PHARMACOL, V42, P1783, DOI 10.1016/0006-2952(91)90516-8; Kiriazis H, 2008, BRIT J PHARMACOL, V153, P684, DOI 10.1038/sj.bjp.0707622; Lang CH, 2008, J TRAUMA, V64, P477, DOI 10.1097/01.TA.0000249375.43015.01; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Lundby C, 2005, EUR J APPL PHYSIOL, V95, P351, DOI 10.1007/s00421-005-0022-7; Lynch GS, 2008, PHYSIOL REV, V88, P729, DOI 10.1152/physrev.00028.2007; Lynch GS, 2007, PHARMACOL THERAPEUT, V113, P461, DOI 10.1016/j.pharmthera.2006.11.004; MALTIN CA, 1993, AM J PHYSIOL, V265, pE176, DOI 10.1152/ajpendo.1993.265.1.E176; Minetti GC, 2014, MOL CELL BIOL, V34, P619, DOI 10.1128/MCB.00957-13; Minetti GC, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002038; Murphy KT, 2010, FASEB J, V24, P4433, DOI 10.1096/fj.10-159608; Plant DR, 2006, MUSCLE NERVE, V34, P577, DOI 10.1002/mus.20616; Ryall JG, 2008, J APPL PHYSIOL, V105, P165, DOI 10.1152/japplphysiol.00317.2007; Ryall JG, 2010, CLIN EXP PHARMACOL P, V37, P397, DOI 10.1111/j.1440-1681.2009.05312.x; Schertzer JD, 2006, GENE THER, V13, P1657, DOI 10.1038/sj.gt.3302817; TIDBALL JG, 1995, MED SCI SPORT EXER, V27, P1022, DOI 10.1249/00005768-199507000-00011; Van Miert ASJPAM, 2002, VET RES COMMUN, V26, P111, DOI 10.1023/A:1014043601287	38	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101379	10.1371/journal.pone.0101379	http://dx.doi.org/10.1371/journal.pone.0101379			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000590	Green Published, gold, Green Submitted			2022-12-27	WOS:000338637300039
J	Girod, M; Enjalbert, Q; Brunet, C; Antoine, R; Lemoine, J; Lukac, I; Radman, M; Krisko, A; Dugourd, P				Girod, Marion; Enjalbert, Quentin; Brunet, Claire; Antoine, Rodolphe; Lemoine, Jerome; Lukac, Iva; Radman, Miroslav; Krisko, Anita; Dugourd, Philippe			Structural Basis of Protein Oxidation Resistance: A Lysozyme Study	PLOS ONE			English	Article							2-DIMENSIONAL LIQUID-CHROMATOGRAPHY; CARBONYLATED PROTEINS; CONTAINING PEPTIDES; ESCHERICHIA-COLI; IDENTIFICATION; SITES; MITOCHONDRIA	Accumulation of oxidative damage in proteins correlates with aging since it can cause irreversible and progressive degeneration of almost all cellular functions. Apparently, native protein structures have evolved intrinsic resistance to oxidation since perfectly folded proteins are, by large most robust. Here we explore the structural basis of protein resistance to radiation-induced oxidation using chicken egg white lysozyme in the native and misfolded form. We study the differential resistance to oxidative damage of six different parts of native and misfolded lysozyme by a targeted tandem/mass spectrometry approach of its tryptic fragments. The decay of the amount of each lysozyme fragment with increasing radiation dose is found to be a two steps process, characterized by a double exponential evolution of their amounts: the first one can be largely attributed to oxidation of specific amino acids, while the second one corresponds to further degradation of the protein. By correlating these results to the structural parameters computed from molecular dynamics (MD) simulations, we find the protein parts with increased root-mean-square deviation (RMSD) to be more susceptible to modifications. In addition, involvement of amino acid side-chains in hydrogen bonds has a protective effect against oxidation Increased exposure to solvent of individual amino acid side chains correlates with high susceptibility to oxidative and other modifications like side chain fragmentation. Generally, while none of the structural parameters alone can account for the fate of peptides during radiation, together they provide an insight into the relationship between protein structure and susceptibility to oxidation.	[Girod, Marion; Enjalbert, Quentin; Brunet, Claire; Antoine, Rodolphe; Lemoine, Jerome; Dugourd, Philippe] Univ Lyon, F-69622 Lyon, France; [Girod, Marion; Lemoine, Jerome] Univ Lyon 1, CNRS, UMR 5280, Inst Sci Anal, F-69365 Lyon, France; [Enjalbert, Quentin; Brunet, Claire; Antoine, Rodolphe; Dugourd, Philippe] Univ Lyon 1, CNRS, UMR 5306, Inst Lumiere Matiere, F-69365 Lyon, France; [Lukac, Iva; Radman, Miroslav; Krisko, Anita] Mediterranean Inst Life Sci, Split, Croatia; [Lukac, Iva] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Liverpool L3 5UX, Merseyside, England; [Radman, Miroslav] Univ Paris 05, Fac Med, INSERM, U1001, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Liverpool John Moores University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Krisko, A (corresponding author), Mediterranean Inst Life Sci, Split, Croatia.	anita.krisko@medils.hr; philippe.dugourd@univ-lyon1.fr	Antoine, Rodolphe/I-5571-2019; Dugourd, Philippe/H-6574-2018; lemoine, jerome/C-4272-2014; Radman, Miroslav/HDM-5955-2022	Antoine, Rodolphe/0000-0001-5682-8550; Dugourd, Philippe/0000-0003-4395-1140; lemoine, jerome/0000-0002-5497-6880; Radman, Miroslav/0000-0002-7034-4365; Radman, Miroslav/0000-0003-0216-3148; Lukac, Iva/0000-0003-1160-4806; GIROD, Marion/0000-0003-0728-2111	European Research Council under the European Union [320659]	European Research Council under the European Union(European Research Council (ERC))	The research leading to these results (PD) has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013 Grant agreement No 320659). AK, MR and PD thank the CNRS (Centre National de la Recherche Scientifique) Franco-Croatian international laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, MAESTR VERS 9 3; Bauer F, 2007, FEBS LETT, V581, P1555, DOI 10.1016/j.febslet.2007.03.012; Bollineni RC, 2011, J PROTEOMICS, V74, P2338, DOI 10.1016/j.jprot.2011.07.002; Dasgupta J, 2003, PROTEIN ENG, V16, P489, DOI 10.1093/protein/gzg070; Dukan S, 2000, P NATL ACAD SCI USA, V97, P5746, DOI 10.1073/pnas.100422497; EISENHABER F, 1995, J COMPUT CHEM, V16, P273, DOI 10.1002/jcc.540160303; Fedorova M, 2014, MASS SPECTROM REV, V33, P79, DOI 10.1002/mas.21381; FERGUSON DL, 1992, PLANT PHYSIOL, V100, P529, DOI 10.1104/pp.100.1.529; Fredriksson A, 2005, J BACTERIOL, V187, P4207, DOI 10.1128/JB.187.12.4207-4213.2005; Gevaert K, 2002, MOL CELL PROTEOMICS, V1, P896, DOI 10.1074/mcp.M200061-MCP200; Ghesquiere B, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006866; Guo J, 2011, J PROTEOMICS, V74, P2360, DOI 10.1016/j.jprot.2011.07.013; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Krisko A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003810; Krisko A, 2010, P NATL ACAD SCI USA, V107, P14373, DOI 10.1073/pnas.1009312107; Kristensen BK, 2004, PHYTOCHEMISTRY, V65, P1839, DOI 10.1016/j.phytochem.2004.04.007; Madian AG, 2010, J PROTEOME RES, V9, P3766, DOI 10.1021/pr1002609; Madian AG, 2010, J PROTEOME RES, V9, P1330, DOI 10.1021/pr900890k; MAISONNEUVE E, 2009, PLOS ONE, V4; Meany DL, 2007, PROTEOMICS, V7, P1150, DOI 10.1002/pmic.200600450; Milic I, 2013, ANAL CHEM, V85, P156, DOI 10.1021/ac302356z; Mirzaei H, 2005, ANAL CHEM, V77, P2386, DOI 10.1021/ac0484373; Moller IM, 2011, J PROTEOMICS, V74, P2228, DOI 10.1016/j.jprot.2011.05.004; Orioli M, 2005, J CHROMATOGR B, V827, P109, DOI 10.1016/j.jchromb.2005.04.025; Rao RSP, 2011, PROTEOMICS, V11, P4166, DOI 10.1002/pmic.201100223; Shacter E, 2000, DRUG METAB REV, V32, P307, DOI 10.1081/DMR-100102336; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G	29	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101642	10.1371/journal.pone.0101642	http://dx.doi.org/10.1371/journal.pone.0101642			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999730	Green Submitted, Green Published, gold			2022-12-27	WOS:000338637300065
J	Ishida, H; Matsumoto, A				Ishida, Hisashi; Matsumoto, Atsushi			Free-Energy Landscape of Reverse tRNA Translocation through the Ribosome Analyzed by Electron Microscopy Density Maps and Molecular Dynamics Simulations	PLOS ONE			English	Article							ELONGATION-FACTOR-G; SARCIN-RICIN LOOP; EF-G; MESSENGER-RNA; BIOMOLECULAR SIMULATIONS; CRYOELECTRON MICROSCOPY; PRETRANSLOCATION STATE; INTERSUBUNIT ROTATION; THERMUS-THERMOPHILUS; CRYSTAL-STRUCTURE	To understand the mechanism of reverse tRNA translocation in the ribosome, all-atom molecular dynamics simulations of the ribosome-tRNAs-mRNA-EFG complex were performed. The complex at the post-translocational state was directed towards the translocational and pre-translocational states by fitting the complex into cryo-EM density maps. Between a series of the fitting simulations, umbrella sampling simulations were performed to obtain the free-energy landscape. Multistep structural changes, such as a ratchet-like motion and rotation of the head of the small subunit were observed. The free-energy landscape showed that there were two main free-energy barriers: one between the post-translocational and intermediate states, and the other between the pre-translocational and intermediate states. The former corresponded to a clockwise rotation, which was coupled to the movement of P-tRNA over the P/E-gate made of G1338, A1339 and A790 in the small subunit. The latter corresponded to an anticlockwise rotation of the head, which was coupled to the location of the two tRNAs in the hybrid state. This indicates that the coupled motion of the head rotation and tRNA translocation plays an important role in opening and closing of the P/E-gate during the ratchet-like movement in the ribosome. Conformational change of EF-G was interpreted to be the result of the combination of the external motion by L12 around an axis passing near the sarcin-ricin loop, and internal hinge-bending motion. These motions contributed to the movement of domain IV of EF-G to maintain its interaction with A/P-tRNA.	[Ishida, Hisashi] Japan Atom Energy Agcy, Quantum Beam Sci Directorate, Kyoto, Japan; Japan Atom Energy Agcy, Ctr Computat Sci & E Syst, Kyoto, Japan	Japan Atomic Energy Agency; Japan Atomic Energy Agency	Ishida, H (corresponding author), Japan Atom Energy Agcy, Quantum Beam Sci Directorate, Kyoto, Japan.	ishida.hisashi@jaea.go.jp			Japan Society of the Promotion of Science (JSPS) KAKENHI [22570165]; Japan Atomic Energy Agency	Japan Society of the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Atomic Energy Agency(Japan Atomic Energy Agency)	H. I. was supported by a Grant-in-Aid for Scientific Research (C) from the Japan Society of the Promotion of Science (JSPS) KAKENHI (22570165) and Japan Atomic Energy Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi NM, 2005, RNA, V11, P1624, DOI 10.1261/rna.2118105; AEVARSSON A, 1994, EMBO J, V13, P3669, DOI 10.1002/j.1460-2075.1994.tb06676.x; Agirrezabala X, 2012, P NATL ACAD SCI USA, V109, P6094, DOI 10.1073/pnas.1201288109; Agirrezabala X, 2009, Q REV BIOPHYS, V42, P159, DOI 10.1017/S0033583509990060; Agrawal RK, 2001, J MOL BIOL, V311, P777, DOI 10.1006/jmbi.2001.4907; Al-Karadaghi S, 1996, STRUCTURE, V4, P555, DOI 10.1016/S0969-2126(96)00061-5; Auffinger P, 2007, J CHEM THEORY COMPUT, V3, P1851, DOI 10.1021/ct700143s; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; Bock LV, 2013, NAT STRUCT MOL BIOL, V20, P1390, DOI 10.1038/nsmb.2690; Brilot AF, 2013, P NATL ACAD SCI USA, V110, P20994, DOI 10.1073/pnas.1311423110; Chasles M., 1830, B SCI MATHEMATIQUES, V4, P321; Chen J, 2012, CURR OPIN STRUC BIOL, V22, P804, DOI 10.1016/j.sbi.2012.09.004; Chen Y, 2013, NAT STRUCT MOL BIOL, V20, P1077, DOI 10.1038/nsmb.2645; Connell SR, 2008, NAT STRUCT MOL BIOL, V15, P910, DOI 10.1038/nsmb.1469; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; Cornish PV, 2008, MOL CELL, V30, P578, DOI 10.1016/j.molcel.2008.05.004; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; Deserno M, 1998, J CHEM PHYS, V109, P7678, DOI 10.1063/1.477414; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; Dlugosz M, 2011, BIOPOLYMERS, V95, P616, DOI 10.1002/bip.21619; Ermolenko DN, 2007, J MOL BIOL, V370, P530, DOI 10.1016/j.jmb.2007.04.042; Ermolenko DN, 2011, NAT STRUCT MOL BIOL, V18, P457, DOI 10.1038/nsmb.2011; Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Garcia-Ortega L, 2010, NUCLEIC ACIDS RES, V38, P4108, DOI 10.1093/nar/gkq151; Guo Z, 2012, P NATL ACAD SCI US; Hansson S, 2005, FEBS LETT, V579, P4492, DOI 10.1016/j.febslet.2005.07.016; Hansson S, 2005, J MOL BIOL, V348, P939, DOI 10.1016/j.jmb.2005.02.066; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Hockney R.W., 1998, COMPUTER SIMULATION; Horan LH, 2007, P NATL ACAD SCI USA, V104, P4881, DOI 10.1073/pnas.0700762104; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Ishida H, 2014, PROTEINS EARLY VIEW, DOI [10.1002/prot.24553, DOI 10.1002/PROT.24553]; Ishida H, 2011, PROG NUCL SCI TECHNO, V2, P470, DOI DOI 10.15669/PNST.2.470; Ishida H, 2010, J COMPUT CHEM, V31, P2317, DOI 10.1002/jcc.21525; Ishida H, 2008, BIOPHYS J, V95, P5962, DOI 10.1529/biophysj.108.134890; Jenner L, 2005, SCIENCE, V308, P120, DOI 10.1126/science.1105639; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Konevega AL, 2007, NAT STRUCT MOL BIOL, V14, P318, DOI 10.1038/nsmb1221; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lancaster L, 2005, MOL CELL, V20, P623, DOI 10.1016/j.molcel.2005.10.006; Laurberg M, 2000, J MOL BIOL, V303, P593, DOI 10.1006/jmbi.2000.4168; Lehninger A., 1993, PRINCIPLES BIOCH; Li W, 2011, PROTEINS, V79, P1478, DOI 10.1002/prot.22976; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Maragliano L, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2212942; Marshall RA, 2008, P NATL ACAD SCI USA, V105, P15364, DOI 10.1073/pnas.0805299105; Martemyanov KA, 2000, J BIOL CHEM, V275, P35820, DOI 10.1074/jbc.M002656200; Martyna GJ, 1996, MOL PHYS, V87, P1117, DOI 10.1080/00268979600100761; Matsumoto A, 2009, STRUCTURE, V17, P1605, DOI 10.1016/j.str.2009.09.017; Orzechowski M, 2008, BIOPHYS J, V95, P5692, DOI 10.1529/biophysj.108.139451; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poornam GP, 2009, PROTEINS, V76, P201, DOI 10.1002/prot.22339; Pulk A, 2013, SCIENCE, V340, P1544, DOI 10.1126/science.1235970; Ramrath DJF, 2013, P NATL ACAD SCI USA, V110, P20964, DOI 10.1073/pnas.1320387110; Ratje AH, 2010, NATURE, V468, P713, DOI 10.1038/nature09547; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Savelsbergh A, 2005, EMBO J, V24, P4316, DOI 10.1038/sj.emboj.7600884; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Shi XY, 2012, J MOL BIOL, V419, P125, DOI 10.1016/j.jmb.2012.03.016; Shoji S, 2006, MOL CELL, V24, P931, DOI 10.1016/j.molcel.2006.11.025; Shoji S, 2009, ACS CHEM BIOL, V4, P93, DOI 10.1021/cb8002946; Spiegel PC, 2007, RNA, V13, P1473, DOI 10.1261/rna.601507; Tama F, 2003, P NATL ACAD SCI USA, V100, P9319, DOI 10.1073/pnas.1632476100; Taylor DJ, 2007, EMBO J, V26, P2421, DOI 10.1038/sj.emboj.7601677; Tourigny DS, 2013, SCIENCE, V340, P1542, DOI 10.1126/science.1235490; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Vaiana AC, 2006, BIOCHIMIE, V88, P1061, DOI 10.1016/j.biochi.2006.06.006; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Whitford PC, 2011, P NATL ACAD SCI USA, V108, P18943, DOI 10.1073/pnas.1108363108; Yamamoto H, 2014, NAT REV MICROBIOL, V12, P89, DOI 10.1038/nrmicro3176; Zhou J, 2013, SCIENCE, V340, P1543, DOI 10.1126/science.1236086; Zhou R, 1996, J CHEM PHYS, V87, P1117	75	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101951	10.1371/journal.pone.0101951	http://dx.doi.org/10.1371/journal.pone.0101951			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999999	Green Published, gold			2022-12-27	WOS:000338637300107
J	Jang, J; Di, DYW; Lee, A; Unno, T; Sadowsky, MJ; Hur, HG				Jang, Jeonghwan; Di, Doris Y. W.; Lee, Anna; Unno, Tatsuya; Sadowsky, Michael J.; Hur, Hor-Gil			Seasonal and Genotypic Changes in Escherichia coli Phylogenetic Groups in the Yeongsan River Basin of South Korea	PLOS ONE			English	Article							POPULATION-STRUCTURE; GROUP B2; VIRULENCE; DIVERSITY; STRAINS; PCR; WATER; ANIMALS; DNA; PERSISTENCE	With 3,480 E. coli strains isolated from the Yeongsan River basin, South Korea, correlations between phylogenetic groups and horizontal fluorophore enhanced rep-PCR (HFERP) genotypes were examined, and environmental factors affecting E. coli phylogenetic groups in the river water were determined. Interestingly, multidimentional scaling (MDS) analyses based on HFERP DNA fingerprint data indicated that E. coli in phylogenetic groups A and B1 were uniquely clustered. Results of self-organized maps (SOMs) analyses also indicated that E. coli phylogenetic groups were seasonally affected by water temperature, with greater occurrences of phylogenetic groups A and B1 in low and high temperature seasons, respectively. The presence of E. coli in phylogenetic groups A and B1 were inversely related. Furthermore, redundancy analysis (RDA) revealed that phylogenetic group B1 correlated positively with temperature, strain diversity, and biochemical oxygen demand (BOD) but negatively with phylogenetic group A. Results of this study indicated that while E. coli strains could be clustered based on their genotypes and environment conditions, their phylogenetic groups did not change in relation to the same conditions. The distributional differences of phylogenetic groups among E. coli populations in different environments may be caused by different genomic adaptability and plasticity of E. coli strains belonging to each phylogenetic group. Although several previous studies have reported different E. coli ecological structures depending on their origins, this study is a first description of the specific environmental factors affecting E. coli phylogenetic groups in river water.	[Jang, Jeonghwan; Di, Doris Y. W.; Lee, Anna; Hur, Hor-Gil] Gwangju Inst Sci & Technol, Sch Environm Sci & Engn, Kwangju, South Korea; [Hur, Hor-Gil] Gwangju Inst Sci & Technol, Int Environm Anal & Educ Ctr, Kwangju, South Korea; [Unno, Tatsuya] Jeju Natl Univ, Coll Mol Life Sci, Cheju, South Korea; [Sadowsky, Michael J.] Univ Minnesota, Dept Soil Water & Climate, St Paul, MN 55108 USA; [Sadowsky, Michael J.] Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Jeju National University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Hur, HG (corresponding author), Gwangju Inst Sci & Technol, Sch Environm Sci & Engn, Kwangju, South Korea.	hghur@gist.ac.kr	Jang, Jeonghwan/AAD-9837-2020; Sadowsky, Michael/J-2507-2016; Unno, Tatsuya/C-1522-2012	Sadowsky, Michael/0000-0001-8779-2781; Unno, Tatsuya/0000-0003-2373-2100; DI, DORIS YOONG WEN/0000-0002-0503-9030	National Research Foundation of Korea - Korean Government (MEST) [NRF: 2011-0029860]; GSR(GIST Specialized Research) Project; Gwangju Regional Environmental Technology Development Center [10-2-70-73]	National Research Foundation of Korea - Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government); GSR(GIST Specialized Research) Project; Gwangju Regional Environmental Technology Development Center	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by the National Research Foundation of Korea Grant funded by the Korean Government (MEST) (NRF: 2011-0029860) and the GSR(GIST Specialized Research) Project through a grant provided by GIST in 2014. The authors also wish to acknowledge a grant-in-aid for research from the Gwangju Regional Environmental Technology Development Center (10-2-70-73).	Bergthorsson U, 1998, MOL BIOL EVOL, V15, P6, DOI 10.1093/oxfordjournals.molbev.a025847; Boer SI, 2009, ISME J, V3, P780, DOI 10.1038/ismej.2009.29; Byappanahalli MN, 1998, WATER SCI TECHNOL, V38, P171, DOI 10.1016/S0273-1223(98)00820-8; Byappanahalli MN, 2006, ENVIRON MICROBIOL, V8, P504, DOI 10.1111/j.1462-2920.2005.00916.x; CIEBIN BW, 1995, APPL ENVIRON MICROB, V61, P3940, DOI 10.1128/AEM.61.11.3940-3942.1995; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Clermont O, 2011, INFECT GENET EVOL, V11, P654, DOI 10.1016/j.meegid.2011.02.005; Dombek PE, 2000, APPL ENVIRON MICROB, V66, P2572, DOI 10.1128/AEM.66.6.2572-2577.2000; Duriez P, 2001, MICROBIOL-SGM, V147, P1671, DOI 10.1099/00221287-147-6-1671; Escobar-Paramo P, 2004, APPL ENVIRON MICROB, V70, P5698, DOI 10.1128/AEM.70.9.5698-5700.2004; Feng P, 1998, J INFECT DIS, V177, P1750, DOI 10.1086/517438; Gevrey M, 2004, FRESHWATER BIOL, V49, P208, DOI 10.1046/j.1365-2426.2003.01174.x; Gordon DM, 2008, ENVIRON MICROBIOL, V10, P2484, DOI 10.1111/j.1462-2920.2008.01669.x; Gordon DM, 2005, MICROBIOL-SGM, V151, P15, DOI 10.1099/mic.0.27425-0; GORDON DM, 2004, ESCHERICHIA COLI SAL; GOULLET P, 1989, J GEN MICROBIOL, V135, P135; HERZER PJ, 1990, J BACTERIOL, V172, P6175, DOI 10.1128/jb.172.11.6175-6181.1990; Ishii S, 2006, APPL ENVIRON MICROB, V72, P612, DOI 10.1128/AEM.72.1.612-621.2006; Ishii S, 2009, ENVIRON MICROBIOL, V11, P733, DOI 10.1111/j.1462-2920.2008.01856.x; Jang J, 2011, ENVIRON MICROBIOL, V13, P3103, DOI 10.1111/j.1462-2920.2011.02541.x; Jaureguy F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560; Johnson JR, 2003, J INFECT DIS, V188, P759, DOI 10.1086/377455; Johnson JR, 2001, INFECT IMMUN, V69, P5363, DOI 10.1128/IAI.69.9.5363-5374.2001; Johnson JR, 2000, J INFECT DIS, V181, P261, DOI 10.1086/315217; Johnson LK, 2004, APPL ENVIRON MICROB, V70, P4478, DOI 10.1128/AEM.70.8.4478-4485.2004; Le Gall T, 2007, MOL BIOL EVOL, V24, P2373, DOI 10.1093/molbev/msm172; Luo CW, 2011, P NATL ACAD SCI USA, V108, P7200, DOI 10.1073/pnas.1015622108; Moissenet D, 2010, J CLIN MICROBIOL, V48, P2459, DOI 10.1128/JCM.00529-10; Nowrouzian F, 2003, PEDIATR RES, V54, P8, DOI 10.1203/01.PDR.0000069843.20655.EE; Nowrouzian FL, 2006, MICROBES INFECT, V8, P834, DOI 10.1016/j.micinf.2005.10.011; Park YS, 2003, ECOL MODEL, V160, P265, DOI 10.1016/S0304-3800(02)00258-2; Park YS, 2003, CONSERV BIOL, V17, P1748, DOI 10.1111/j.1523-1739.2003.00430.x; Paton AW, 1998, J CLIN MICROBIOL, V36, P598, DOI 10.1128/JCM.36.2.598-602.1998; Picard B, 1999, INFECT IMMUN, V67, P546, DOI 10.1128/IAI.67.2.546-553.1999; Ratajczak M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-222; Sadowsky MJ, 2011, FECAL BACTERIA, P295; Sambrook J., 2001, MOL CLONING LAB MANU; Smilauer JLaP, MULTIVARIATE ANAL EC; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Tuang FN, 1999, FEMS MICROBIOL LETT, V177, P249, DOI 10.1111/j.1574-6968.1999.tb13740.x; Tudesque L, 2008, WATER RES, V42, P732, DOI 10.1016/j.watres.2007.08.001; Unno T, 2009, APPL ENVIRON MICROB, V75, P5659, DOI 10.1128/AEM.00443-09; USEPA, 2006, 1603 USEPA; Walk ST, 2007, ENVIRON MICROBIOL, V9, P2274, DOI 10.1111/j.1462-2920.2007.01341.x; Walk ST, 2009, APPL ENVIRON MICROB, V75, P6534, DOI 10.1128/AEM.01262-09; Weber M, 2011, ISME J, V5, P918, DOI 10.1038/ismej.2010.180	48	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e100585	10.1371/journal.pone.0100585	http://dx.doi.org/10.1371/journal.pone.0100585			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999864	Green Published, gold, Green Submitted			2022-12-27	WOS:000338637300010
J	Li, Q; Zhao, WN; Wei, YM; Han, X; Han, ZY; Zhang, YB; Qi, SX; Xu, YG				Li, Qi; Zhao, WenNa; Wei, YaMei; Han, Xu; Han, ZhanYing; Zhang, YanBo; Qi, ShunXiang; Xu, YongGang			Analysis of Incidence and Related Factors of Hemorrhagic Fever with Renal Syndrome in Hebei Province, China	PLOS ONE			English	Article								Background: Hemorrhagic fever with renal syndrome (HFRS) is an important infectious disease in Hebei province, China. The average annual incidence is 3.10/100000. Although the incidence of HFRS is stable with a general decline in trend since 2004, an increase in the trend was observed in 2011. Few studies have been conducted to investigate the underlying risk factors for this disease. Methods: The epidemiological data of HFRS and the population data, meteorology, and remote sensing aspects of cities in Hebei province from 1999 to 2011 were collected. The epidemiological data included the population density in the region, seasonal data and rat density and rat's virus carriage rate. The data were analyzed by descriptive study, correlation analysis and multivariate linear analysis. Results: There were 26837 cases of HFRS was reported from 1999 to 2011. The infection occurred mainly in males, aged 20 similar to 49 years, who were farmers. Rattus norvegicus was the main host animal. The incidence of HFRS was related to NDVI value, rat density and rat's virus carriage rate by multiple linear regression (F = 25.936, P<0.01). The pseudo- R-2 value for the model was 0.644. Conclusion: The incidence of HFRS was related to NDVI value, rat density and rat's virus carriage rate. Control of these factors should be used to prevent HFRS in Hebei province.	[Li, Qi; Zhao, WenNa; Wei, YaMei; Han, Xu; Han, ZhanYing; Zhang, YanBo; Qi, ShunXiang; Xu, YongGang] Hebei Prov Ctr Dis Prevent & Control, Inst Viral Dis Prevent & Control, Shijiazhuang, Hebei Province, Peoples R China		Li, Q (corresponding author), Hebei Prov Ctr Dis Prevent & Control, Inst Viral Dis Prevent & Control, Shijiazhuang, Hebei Province, Peoples R China.	liqinew@126.com			Natural Science Foundation of Hebei province, PR China [C2007000944]; Hebei Province Science and Technology and Development Plan Program of Hebei Province, PR China [07276101D-114]	Natural Science Foundation of Hebei province, PR China(Natural Science Foundation of Hebei Province); Hebei Province Science and Technology and Development Plan Program of Hebei Province, PR China	The authors gratefully acknowledge financial support from the Natural Science Foundation of Hebei province, PR China (No. C2007000944) and Hebei Province Science and Technology and Development Plan Program of Hebei Province, PR China (No. 07276101D-114) (http://www.hebstd.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi P, 2003, JAMA-J AM MED ASSOC, V289, P176, DOI 10.1001/jama.289.2.176-d; Bi P, 2002, INT J EPIDEMIOL, V31, P189, DOI 10.1093/ije/31.1.189; Dong Yi, 2009, Zhongguo Xuexichongbing Fangzhi Zazhi, V21, P98; Engelthaler DM, 1999, EMERG INFECT DIS, V5, P87, DOI 10.3201/eid0501.990110; [方立群 Fang Liqun], 2003, [中华流行病学杂志, Chinese Journal of Epidemiology], V24, P265; Lin T, 2002, CHINA PUBLIC HLTH, V18, P104; Liu J, 2012, EPIDEMIOL INFECT, V1, P1, DOI DOI 10.5897/AJB12.763; Liu XD, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-331; Luo CW, 2003, CHINESE J VECTOR BIO, V14, P451; Luo L, 2005, MODERN PREVENTIVE ME, V32, P205; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; Wen Liang, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P263; Zhang Yong-Zhen, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P466; Zhang YZ, 2010, EMERG INFECT DIS, V16, P1195, DOI 10.3201/eid1608.090470; 陈化新, 2002, [中华流行病学杂志, Chinese Journal of Epidemiology], V23, P63; 陈化新, 1999, [中国公共卫生, China Public Health], V15, P616	16	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101348	10.1371/journal.pone.0101348	http://dx.doi.org/10.1371/journal.pone.0101348			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000390	Green Submitted, Green Published, gold			2022-12-27	WOS:000338637300036
J	Lukasse, M; Helbig, A; Benth, JS; Eberhard-Gran, M				Lukasse, Mirjam; Helbig, Anne; Benth, Jurate Saltyte; Eberhard-Gran, Malin			Antenatal Maternal Emotional Distress and Duration of Pregnancy	PLOS ONE			English	Article							SPONTANEOUS PRETERM BIRTH; INTERNATIONAL DIAGNOSTIC INTERVIEW; NORWEGIAN-MOTHER; PSYCHOLOGICAL DISTRESS; PSYCHOSOCIAL STRESS; SYSTEMATIC ANALYSIS; GESTATIONAL-AGE; GLOBAL REPORT; CHILD-COHORT; TIME TRENDS	Objective(s): We sought to prospectively study the association between antenatal emotional distress and gestational length birth well as preterm birth. Study Design: We followed up 40,077 primiparous women in the Norwegian Mother and Child Cohort Study. Emotional distress was reported in a short form of the Hopkins Symptom Checklist-25 (SCL-5) at 17 and 30 weeks of gestation. Gestational length at birth, obtained from the Medical Birth Registry of Norway, was used as continuous (gestational length in days) and categorized (early preterm (22-31 weeks) and late preterm (32-36 weeks) versus term birth (>= 37 weeks)) outcome, using linear and logistic regression analysis, respectively. Births were divided into spontaneous and provider-initiated. Results: Of all women, 7.4% reported emotional distress at 17 weeks, 6.0% at 30 weeks and 5.1% had a preterm birth. All measurements of emotional distress at 30 weeks were significantly associated with a reduction of gestational length, in days, for provider-initiated births at term. Emotional distress at 30 weeks showed a reduced duration of pregnancy at birth of 2.40 days for provider-initiated births at term. An increase in emotional distress from 17 to 30 weeks was associated with a reduction of gestational length at birth of 2.13 days for provider-initiated births at term. Sustained high emotional distress was associated with a reduction of gestational length at birth of 2.82 days for provider-initiated births. Emotional distress did not increase the risk of either early or late preterm birth. Conclusion: Emotional distress at 30 weeks, an increase in emotional distress from 17 to 30 weeks and sustained high levels of emotional distress were associated with a reduction in gestational length in days for provider-initiated term birth. We found no significant association between emotional distress and the risk of preterm birth.	[Lukasse, Mirjam] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway; [Lukasse, Mirjam] Oslo & Akershus Univ, Coll Appl Sci, Dept Hlth Nutr & Management, Oslo, Norway; [Helbig, Anne] Oslo Univ Hosp, Norwegian Resource Ctr Womens Hlth, Oslo, Norway; [Helbig, Anne] Oslo Univ Hosp, Dept Obstet, Oslo, Norway; [Benth, Jurate Saltyte] Univ Oslo, Inst Clin Med, Lorenskog, Norway; [Benth, Jurate Saltyte] Akershus Univ Hosp, Hlth Serv Res Ctr, Lorenskog, Norway; [Eberhard-Gran, Malin] Akershus Univ Hosp, Div Mental Hlth, Norwegian Inst Publ Hlth, Lorenskog, Norway; [Eberhard-Gran, Malin] Akershus Univ Hosp, Hlth Serv Res Ctr, Lorenskog, Norway	Norwegian University of Science & Technology (NTNU); Oslo Metropolitan University (OsloMet); University of Oslo; University of Oslo; University of Oslo; University of Oslo; Norwegian Institute of Public Health (NIPH); University of Oslo; University of Oslo	Lukasse, M (corresponding author), Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway.	Mirjam.Lukasse@hioa.no			Norwegian Research Council [204292]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	Mirjam Lukasse received a postdoctoral fellowship from the Norwegian Research Council, Grant no. 204292 (http://www.forskningsradet.no/no/Forsiden/1173185591033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderdice F, 2012, J PSYCHOSOM OBST GYN, V33, P62, DOI 10.3109/0167482X.2012.673040; [Anonymous], BORN TOO SOON GLOB A; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Chen MJ, 2011, AM J OBSTET GYNECOL, V205, P402, DOI 10.1016/j.ajog.2011.05.003; Class QA, 2011, PSYCHOSOM MED, V73, P234, DOI 10.1097/PSY.0b013e31820a62ce; Copper RL, 1996, AM J OBSTET GYNECOL, V175, P1286, DOI 10.1016/S0002-9378(96)70042-X; Dunkel Schetter C, 2009, CURR DIR PSYCHOL SCI, V4; Dunkel-Schetter C., 2011, HDB STRESS SCI BIOL, P321; Entringer S, 2010, STRESS, V13, P258, DOI 10.3109/10253890903349501; Eriksen W, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-290; Field T, 2010, INFANT BEHAV DEV, V33, P23, DOI 10.1016/j.infbeh.2009.10.004; Glynn LM, 2008, HEALTH PSYCHOL, V27, P43, DOI 10.1037/0278-6133.27.1.43; Glynn LM, 2004, J PSYCHOSOM RES, V56, P47, DOI 10.1016/S0022-3999(03)00133-8; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Goldenberg RL, 2012, AM J OBSTET GYNECOL, V206, P113, DOI 10.1016/j.ajog.2011.10.865; Gravett MG, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S2; Gyamfi-Bannerman C, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.08.007; Harville E, 2010, OBSTET GYNECOL SURV, V65, P713, DOI 10.1097/OGX.0b013e31820eddbe; HEDEGAARD M, 1993, BMJ-BRIT MED J, V307, P234, DOI 10.1136/bmj.307.6898.234; HESBACHER PT, 1980, J CLIN PSYCHIAT, V41, P6; Hobel CJ, 2008, CLIN OBSTET GYNECOL, V51, P333, DOI 10.1097/GRF.0b013e31816f2709; Khashan AS, 2009, HUM REPROD, V24, P429, DOI 10.1093/humrep/den418; Khatibi A, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.002; Kramer MS, 2009, AM J EPIDEMIOL, V169, P1319, DOI 10.1093/aje/kwp061; Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S1; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Mackey MC, 2000, J ADV NURS, V32, P666, DOI 10.1046/j.1365-2648.2000.01526.x; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; Morken NH, 2011, EUR J OBSTET GYN R B, V159, P310, DOI 10.1016/j.ejogrb.2011.08.006; Morken NH, 2008, ACTA OBSTET GYN SCAN, V87, P1374, DOI 10.1080/00016340802491508; NETTELBLADT P, 1993, SOC PSYCH PSYCH EPID, V28, P130, DOI 10.1007/BF00801743; Nilsen RM, 2009, PAEDIATR PERINAT EP, V23, P597, DOI 10.1111/j.1365-3016.2009.01062.x; Nordeng H, 2012, J CLIN PSYCHOPHARM, V32, P186, DOI 10.1097/JCP.0b013e3182490eaf; Orr ST, 2007, PSYCHOSOM MED, V69, P566, DOI 10.1097/PSY.0b013e3180cac25d; Penacoba-Puente C, 2011, ACTA OBSTET GYN SCAN, V90, P1030, DOI 10.1111/j.1600-0412.2011.01208.x; Profit J, 2010, PEDIATRICS, V125, P320, DOI 10.1542/peds.2008-3140; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Rondo PHC, 2003, EUR J CLIN NUTR, V57, P266, DOI 10.1038/sj.ejcn.1601526; Sandanger I, 1998, SOC PSYCH PSYCH EPID, V33, P345, DOI 10.1007/s001270050064; Schetter CD, 2012, CURR OPIN PSYCHIATR, V25, P141, DOI 10.1097/YCO.0b013e3283503680; Skjaerven R, 2000, ACTA OBSTET GYN SCAN, V79, P440, DOI 10.1034/j.1600-0412.2000.079006440.x; Strand BH, 2003, NORD J PSYCHIAT, V57, P113, DOI 10.1080/08039480310000932; TAMBS K, 1993, ACTA PSYCHIAT SCAND, V87, P364, DOI 10.1111/j.1600-0447.1993.tb03388.x; Tambs K, 2009, TWIN RES HUM GENET, V12, P158, DOI 10.1375/twin.12.2.158; Tegethoff M, 2010, PSYCHOSOM MED, V72, P419, DOI 10.1097/PSY.0b013e3181d2f0b0; Teixeira C, 2009, J AFFECT DISORDERS, V119, P142, DOI 10.1016/j.jad.2009.03.005; Tita ATN, 2009, NEW ENGL J MED, V360, P111, DOI 10.1056/NEJMoa0803267; WADHWA PD, 1993, AM J OBSTET GYNECOL, V169, P858, DOI 10.1016/0002-9378(93)90016-C; Yoder BA, 2008, OBSTET GYNECOL, V111, P814, DOI 10.1097/AOG.0b013e31816499f4	49	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101682	10.1371/journal.pone.0101682	http://dx.doi.org/10.1371/journal.pone.0101682			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7WB	25000409	Green Published, gold, Green Submitted			2022-12-27	WOS:000338637300070
J	Novotna, A; Korhonova, M; Bartonkova, I; Soshilov, AA; Denison, MS; Bogdanova, K; Kolar, M; Bednar, P; Dvorak, Z				Novotna, Aneta; Korhonova, Martina; Bartonkova, Iveta; Soshilov, Anatoly A.; Denison, Michael S.; Bogdanova, Katerina; Kolar, Milan; Bednar, Petr; Dvorak, Zdenek			Enantiospecific Effects of Ketoconazole on Aryl Hydrocarbon Receptor	PLOS ONE			English	Article							HUMAN GLUCOCORTICOID-RECEPTOR; PREGNANE-X-RECEPTOR; CELL-LINE; DIABETES-MELLITUS; GENE-EXPRESSION; HEPATIC-INJURY; CYP3A4; INHIBITION; INDUCTION; CONSTRUCTION	Azole antifungal ketoconazole (KET) was demonstrated to activate aryl hydrocarbon receptor (AhR). Since clinically used KET is a racemic mixture of two cis-enantiomers (2R,4S)-(+)-KET and (2S,4R)-(-)-KET,we examined the effects of KET enantiomers on AhR signaling pathway. (+)-KET dose-dependently activated AhR in human gene reporter cell line AZ-AHR,and displayed 5-20x higher agonist activity (efficacy),as compared to (-)-KET; both enantiomers were AhR antagonists with equal potency (IC50). Consistently,(+)-KET strongly induced CYP1A1 mRNA and protein in human HepG2 cells,while (-)-KET exerted less than 10% of (+)-KET activity. In primary human hepatocytes,both enantiomers preferentially induced CYP1A2 over CYP1A1 mRNA and protein,and the potency of (+)-KET was slightly higher as compared to (-)-KET. Ligand binding assay with guinea pig liver cytosols revealed that both (+)-KET and (-)-KET are weak ligands of AhR that displaced [H-3]-TCDD with comparable potency. Similarly,both enantiomers weakly transformed AhR to DNA-binding form with similar potency,as showed by EMSA,in guinea pig liver cytosolic extracts and nuclear extracts from mouse Hepa-1 cells. We also examined effects of KET on glucocorticoid receptor (GR),a regulator of AhR activity. Both KET enantiomers antagonized GR with similar potency,as revealed by gene reporter assay in AZ-GR cell line and down-regulation of tyrosine aminotransferase mRNA in human hepatocytes. Finally,we demonstrate enantiospecific antifungal activities of KET enantiomers in six Candida spp. strains. In conclusion,the significance of current study is providing the first evidence of enatiospecific effects of cis-enantiomers of ketoconazole on AhR-CYP1A pathway.	[Novotna, Aneta; Korhonova, Martina; Bartonkova, Iveta; Bednar, Petr; Dvorak, Zdenek] Palacky Univ, Fac Sci, Reg Ctr Adv Technol & Mat, CR-77147 Olomouc, Czech Republic; [Soshilov, Anatoly A.; Denison, Michael S.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [Bogdanova, Katerina; Kolar, Milan] Palacky Univ, Fac Med & Dent, Dept Microbiol, CR-77147 Olomouc, Czech Republic	Palacky University Olomouc; University of California System; University of California Davis; Palacky University Olomouc	Dvorak, Z (corresponding author), Palacky Univ, Fac Sci, Reg Ctr Adv Technol & Mat, CR-77147 Olomouc, Czech Republic.	moulin@email.cz	Grycova, Aneta/AGH-1515-2022; Kolář, Milan/AAB-4423-2021; KOLÁŘ, Milan/ACL-9884-2022	Grycova, Aneta/0000-0002-2134-1125; Kolář, Milan/0000-0003-4621-8868; KOLÁŘ, Milan/0000-0003-4621-8868; Dvorak, Zdenek/0000-0002-3938-3585; Bogdanova, Katerina/0000-0003-3014-2213; Bednar, Petr/0000-0001-7070-6015	Czech Science Agency [GACR 13-01809S]; U. S. National Institute of Environmental Health Sciences;  [PrF-2014-004]	Czech Science Agency; U. S. National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); 	This research was supported by the Czech Science Agency [Grant GACR 13-01809S] (to ZD); a Superfund Research Grant from the U. S. National Institute of Environmental Health Sciences (to MSD); and by the student project [PrF-2014-004] (to ZD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allqvist A, 2007, EUR J CLIN PHARMACOL, V63, P173, DOI 10.1007/s00228-006-0230-z; Arakaki R, 2010, EXPERT OPIN INV DRUG, V19, P185, DOI 10.1517/13543780903381411; Babin M, 2005, TOXICOL IN VITRO, V19, P899, DOI 10.1016/j.tiv.2005.06.037; BENSON GD, 1988, DIGEST DIS SCI, V33, P240, DOI 10.1007/BF01535739; BERCOFF E, 1985, GUT, V26, P636, DOI 10.1136/gut.26.6.636; Boxenbaum H, 1999, J PHARM PHARM SCI, V2, P47; Castro-Puyana M, 2006, J CHROMATOGR A, V1114, P170, DOI 10.1016/j.chroma.2006.02.030; DANESHMEND TK, 1988, CLIN PHARMACOKINET, V14, P13, DOI 10.2165/00003088-198814010-00002; DENISON MS, 2002, CURR PROTOC TOXICOL, pCH4; Dilmaghanian S, 2004, CHIRALITY, V16, P79, DOI 10.1002/chir.10294; Duret C, 2006, MOL PHARMACOL, V70, P329, DOI 10.1124/mol.105.022046; Dvorak Z, 2011, TOXICOL LETT, V202, P129, DOI 10.1016/j.toxlet.2011.01.027; Hasselberg Linda, 2005, Comp Hepatol, V4, P2, DOI 10.1186/1476-5926-4-2; Jack SM, 2011, SUBST ABUSE TREAT PR, V6, DOI 10.1186/1747-597X-6-29; Korashy HM, 2007, TOXICOL SCI, V97, P32, DOI 10.1093/toxsci/kfm012; Monostory K, 2011, CURR DRUG METAB, V12, P154, DOI 10.2174/138920011795016854; Novotna A, 2012, EUR J PHARM SCI, V47, P842, DOI 10.1016/j.ejps.2012.10.003; Novotna A, 2011, ENVIRON SCI TECHNOL, V45, P10133, DOI 10.1021/es2029334; PONT A, 1984, ARCH INTERN MED, V144, P2150, DOI 10.1001/archinte.144.11.2150; ROTSTEIN DM, 1992, J MED CHEM, V35, P2818, DOI 10.1021/jm00093a015; Schwartz SL, 2008, CLIN THER, V30, P1081, DOI 10.1016/j.clinthera.2008.05.021; SONINO N, 1991, CLIN ENDOCRINOL, V35, P347, DOI 10.1111/j.1365-2265.1991.tb03547.x; Stresser DM, 2000, DRUG METAB DISPOS, V28, P1440; STRICKER BHC, 1986, J HEPATOL, V3, P399, DOI 10.1016/S0168-8278(86)80495-0; Sun GB, 2005, TOXICOL LETT, V155, P277, DOI 10.1016/j.toxlet.2004.10.006; Svecova L, 2008, DRUG METAB DISPOS, V36, P339, DOI 10.1124/dmd.107.018341; Vrzal R, 2008, EUR J PHARMACOL, V581, P244, DOI 10.1016/j.ejphar.2007.11.059	27	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101832	10.1371/journal.pone.0101832	http://dx.doi.org/10.1371/journal.pone.0101832			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000292	Green Published, Green Submitted, gold			2022-12-27	WOS:000338637300092
J	Chauhan, JS; Dhanda, SK; Singla, D; Agarwal, SM; Raghava, GPS				Chauhan, Jagat Singh; Dhanda, Sandeep Kumar; Singla, Deepak; Agarwal, Subhash M.; Raghava, Gajendra P. S.		Open Source Drug Discovery Consort	QSAR-Based Models for Designing Quinazoline/Imidazothiazoles/Pyrazolopyrimidines Based Inhibitors against Wild and Mutant EGFR	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; TYROSINE KINASE-ACTIVITY; FACTOR RECEPTOR; LUNG-CANCER; MOLECULAR DOCKING; SMO ALGORITHM; ATP-BINDING; IMPROVEMENTS; DERIVATIVES; PROTEIN	Overexpression of EGFR is responsible for causing a number of cancers, including lung cancer as it activates various downstream signaling pathways. Thus, it is important to control EGFR function in order to treat the cancer patients. It is well established that inhibiting ATP binding within the EGFR kinase domain regulates its function. The existing quinazoline derivative based drugs used for treating lung cancer that inhibits the wild type of EGFR. In this study, we have made a systematic attempt to develop QSAR models for designing quinazoline derivatives that could inhibit wild EGFR and imidazothiazoles/pyrazolopyrimidines derivatives against mutant EGFR. In this study, three types of prediction methods have been developed to design inhibitors against EGFR (wild, mutant and both). First, we developed models for predicting inhibitors against wild type EGFR by training and testing on dataset containing 128 quinazoline based inhibitors. This dataset was divided into two subsets called wild_train and wild_valid containing 103 and 25 inhibitors respectively. The models were trained and tested on wild_train dataset while performance was evaluated on the wild_valid called validation dataset. We achieved a maximum correlation between predicted and experimentally determined inhibition (IC50) of 0.90 on validation dataset. Secondly, we developed models for predicting inhibitors against mutant EGFR (L858R) on mutant_train, and mutant_valid dataset and achieved a maximum correlation between 0.834 to 0.850 on these datasets. Finally, an integrated hybrid model has been developed on a dataset containing wild and mutant inhibitors and got maximum correlation between 0.761 to 0.850 on different datasets. In order to promote open source drug discovery, we developed a webserver for designing inhibitors against wild and mutant EGFR along with providing standalone (http://osddlinux.osdd.net/) and Galaxy (http://osddlinux.osdd.net:8001) version of software. We hope our webserver (http://crdd.osdd.net/oscadd/ntegfr/) will play a vital role in designing new anticancer drugs.	[Chauhan, Jagat Singh; Dhanda, Sandeep Kumar; Singla, Deepak; Raghava, Gajendra P. S.] Inst Microbial Technol CSIR, Bioinformat Ctr, Chandigarh, India; [Open Source Drug Discovery Consort] CSIR, OSDD Consortium, Delhi, India; [Agarwal, Subhash M.] Inst Cytol & Prevent Oncol, Bioinformat Div, Noida, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Open Source Drug Discovery; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cancer Prevention & Research (NICPR)	Agarwal, SM (corresponding author), Inst Cytol & Prevent Oncol, Bioinformat Div, Noida, India.	smagarwal@yahoo.com; raghava@imtech.res.in	Agarwal, Subhash Mohan/L-3162-2019; Raghava, Gajendra P.S./AAA-2413-2022; Singla, Deepak/C-9629-2015; Raghava, Gajendra/B-1717-2009; Dhanda, Sandeep Kumar/J-8471-2016	Raghava, Gajendra P.S./0000-0002-8902-2876; Singla, Deepak/0000-0003-0131-7950; Dhanda, Sandeep Kumar/0000-0003-1381-7434; Agarwal, Subhash Mohan/0000-0001-6685-789X	Council of Scientific and Industrial Research (CSIR) [BSC0121]; Department of Biotechnology (DBT) [BTISNET]; Indian Council of Medical Research (ICMR) Government of India	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Indian Council of Medical Research (ICMR) Government of India(Indian Council of Medical Research (ICMR))	The authors are thankful to the Council of Scientific and Industrial Research (CSIR) (project open source drug discovery (OSDD) and GENESIS BSC0121), Department of Biotechnology (DBT) (project BTISNET) and Indian Council of Medical Research (ICMR) Government of India for financial. SMA is thankful to Department of Biotechnology-IYBA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chauhan JS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-434; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Du HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022367; Fidanze SD, 2010, BIOORG MED CHEM LETT, V20, P2452, DOI 10.1016/j.bmcl.2010.03.015; Garg A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-125; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; Hou TJ, 2003, J CHEM INF COMP SCI, V43, P273, DOI 10.1021/ci025552a; Hubbard RD, 2009, BIOORG MED CHEM LETT, V19, P1718, DOI 10.1016/j.bmcl.2009.01.086; Joachims T, 1999, ADVANCES IN KERNEL METHODS, P169; Keerthi SS, 2001, NEURAL COMPUT, V13, P637, DOI 10.1162/089976601300014493; Kumar A, 2008, J CLIN ONCOL, V26, P1742, DOI 10.1200/JCO.2007.12.1178; Manley PW, 2002, EUR J CANCER, V38, pS19, DOI 10.1016/S0959-8049(02)80599-8; Mao LS, 2004, J MOL BIOL, V336, P787, DOI 10.1016/j.jmb.2003.12.056; Merlo Valentina, 2011, Front Biosci (Schol Ed), V3, P501, DOI 10.2741/s168; Mitsudomi T, 2010, JPN J CLIN ONCOL, V40, P101, DOI 10.1093/jjco/hyp174; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nandi S, 2010, MOL DIVERS, V14, P27, DOI 10.1007/s11030-009-9137-9; Noolvi MN, 2013, J SAUDI CHEM SOC, V17, P361, DOI 10.1016/j.jscs.2011.04.017; Pasha FA, 2010, J MOL MODEL, V16, P263, DOI 10.1007/s00894-009-0534-x; Platt J., 1998, SEQUENTIAL MINIMAL O; Raghav D, 2013, INTERDISCIP SCI, V5, P60, DOI 10.1007/s12539-013-0149-x; Shevade SK, 2000, IEEE T NEURAL NETWOR, V11, P1188, DOI 10.1109/72.870050; Shibata T, 1996, TUMOR BIOL, V17, P168, DOI 10.1159/000217979; Singh SK, 2006, EUR J MED CHEM, V41, P1310, DOI 10.1016/j.ejmech.2006.06.010; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; THOMPSON AM, 1995, J MED CHEM, V38, P3780, DOI 10.1021/jm00019a007; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Vema A, 2003, BIOORGAN MED CHEM, V11, P4643, DOI 10.1016/S0968-0896(03)00482-6; Vulpetti Anna, 2004, Farmaco (Lausanne), V59, P759; Wakeling AE, 1996, BREAST CANCER RES TR, V38, P67, DOI 10.1007/BF01803785; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang GZ, 2010, REPRODUCTIVE HEALTH AND GENDER EQUALITY: METHOD, MEASUREMENT, AND IMPLICATIONS, P1; Yang SC, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002189; Yap CW, 2011, J COMPUT CHEM, V32, P1466, DOI 10.1002/jcc.21707; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	38	33	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101079	10.1371/journal.pone.0101079	http://dx.doi.org/10.1371/journal.pone.0101079			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992720	Green Published, gold, Green Submitted			2022-12-27	WOS:000341253400040
J	Raghavan, RK; Neises, D; Goodin, DG; Andresen, DA; Ganta, RR				Raghavan, Ram K.; Neises, Daniel; Goodin, Douglas G.; Andresen, Daniel A.; Ganta, Roman R.			Bayesian Spatio-Temporal Analysis and Geospatial Risk Factors of Human Monocytic Ehrlichiosis	PLOS ONE			English	Article							CLIMATE-CHANGE; UNITED-STATES; TICK; DISTRIBUTIONS; EPIDEMIOLOGY; CHAFFEENSIS; IXODIDAE; HABITAT; ACARI	Variations in spatio-temporal patterns of Human Monocytic Ehrlichiosis (HME) infection in the state of Kansas, USA were examined and the relationship between HME relative risk and various environmental, climatic and socio-economic variables were evaluated. HME data used in the study was reported to the Kansas Department of Health and Environment between years 2005-2012, and geospatial variables representing the physical environment [National Land cover/Land use, NASA Moderate Resolution Imaging Spectroradiometer (MODIS)], climate [NASA MODIS, Prediction of Worldwide Renewable Energy (POWER)], and socio-economic conditions (US Census Bureau) were derived from publicly available sources. Following univariate screening of candidate variables using logistic regressions, two Bayesian hierarchical models were fit; a partial spatio-temporal model with random effects and a spatio-temporal interaction term, and a second model that included additional covariate terms. The best fitting model revealed that spatio-temporal autocorrelation in Kansas increased steadily from 2005-2012, and identified poverty status, relative humidity, and an interactive factor, 'diumal temperature range x mixed forest area' as significant county-level risk factors for HME. The identification of significant spatio-temporal pattern and new risk factors are important in the context of HME prevention, for future research in the areas of ecology and evolution of HME, and as well as climate change impacts on tick-borne diseases.	[Raghavan, Ram K.] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Kansas State Vet Diagnost Lab, Manhattan, KS 66506 USA; [Neises, Daniel] Kansas Dept Hlth & Environm, Bur Epidemiol & Publ Hlth Informat, Topeka, KS USA; [Goodin, Douglas G.] Kansas State Univ, Coll Arts & Sci, Dept Geog, Manhattan, KS 66506 USA; [Andresen, Daniel A.] Kansas State Univ, Coll Engn, Dept Comp & Informat Sci, Manhattan, KS 66506 USA; [Ganta, Roman R.] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA	Kansas State University; Kansas State University; Kansas State University; Kansas State University	Raghavan, RK (corresponding author), Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Kansas State Vet Diagnost Lab, Manhattan, KS 66506 USA.	rkraghavan@vet.k-state.edu		Raghavan, Ram/0000-0002-2657-3398	National Institutes of Health, USA [AI070908]; Kansas State Veterinary Diagnostic Laboratory; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI070908, R01AI070908] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kansas State Veterinary Diagnostic Laboratory; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by the National Institutes of Health, USA grant # AI070908 and Kansas State Veterinary Diagnostic Laboratory. This manuscript is contribution number 14-205-J from the Kansas Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, BAYESIAN DIS MAPPING; Berger KA, 2013, INT J REMOTE SENS, V34, P73, DOI 10.1080/01431161.2012.705447; BISHOPP FC, 1945, J PARASITOL, V31, P1, DOI 10.2307/3273061; Braganza K, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019998; Demma LJ, 2005, AM J TROP MED HYG, V73, P400, DOI 10.4269/ajtmh.2005.73.400; Dorny P, 2004, INT J PARASITOL, V34, P569, DOI 10.1016/j.ijpara.2003.11.014; Eckman RS, 2012, APPL ENERG, V90, P206, DOI 10.1016/j.apenergy.2011.03.001; FOTHERINGHAM AS, 1991, ENVIRON PLANN A, V23, P1025, DOI 10.1068/a231025; Gelman A, 2004, BAYESIAN DATA ANAL, P283; Gilbert L, 2010, OECOLOGIA, V162, P217, DOI 10.1007/s00442-009-1430-x; Godfrey ER, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-35; Goodin DouglasG., 2004, CLIMATE WEATHER ATLA; Gray JS, 2009, INTERDISCIPLINARY PE, V2009; HAIR JA, 1975, J MED ENTOMOL, V12, P37, DOI 10.1093/jmedent/12.1.37; Hosmer DW, 1990, MODEL BUILDING STRAT, P91; KARL TR, 1991, GEOPHYS RES LETT, V18, P2253, DOI 10.1029/91GL02900; KARL TR, 1993, B AM METEOROL SOC, V74, P1007, DOI 10.1175/1520-0477(1993)074<1007:ANPORG>2.0.CO;2; Lawson A.B., 2013, BAYESIAN DIS MAPPING, V32; Manangan JS, 2007, VECTOR-BORNE ZOONOT, V7, P563, DOI 10.1089/vbz.2007.0116; Ochanda H., 2006, International Journal of Tropical Insect Science, V26, P101, DOI 10.1079/IJT2006107; Patz JA, 2000, INT J PARASITOL, V30, P1395, DOI 10.1016/S0020-7519(00)00141-7; Pavelites JJ, 2011, FORENSIC SCI MED PAT, V7, P287, DOI 10.1007/s12024-010-9219-0; Raghavan RK, 2013, GEOSPATIAL HEALTH, V7, P169, DOI 10.4081/gh.2013.78; Raghavan RK, VECTOR BORNE ZOONOTI; Randolph SE, 2010, VET PARASITOL, V167, P92, DOI 10.1016/j.vetpar.2009.09.011; Randolph SE, 1999, J MED ENTOMOL, V36, P741, DOI 10.1093/jmedent/36.6.741; Rodgers SE, 2007, J MED ENTOMOL, V44, P372, DOI 10.1603/0022-2585(2007)44[372:DOETSA]2.0.CO;2; SCHWARTZ MD, 1995, ANN ASSOC AM GEOGR, V85, P553, DOI 10.1111/j.1467-8306.1995.tb01812.x; Stefanoff P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045511; Suss J, 2008, PARASITOL RES, V103, pS157; Sumilo D, 2008, REV MED VIROL, V18, P81, DOI 10.1002/rmv.566; Wimberly MC, 2008, GLOBAL ECOL BIOGEOGR, V17, P189, DOI 10.1111/j.1466-8238.2007.00353.x; Wimberly MC, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-15; Yabsley MJ, 2005, AM J TROP MED HYG, V72, P840, DOI 10.4269/ajtmh.2005.72.840; Yoder JA, 2012, INT J ACAROL, V38, P334, DOI 10.1080/01647954.2011.647073	35	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100850	10.1371/journal.pone.0100850	http://dx.doi.org/10.1371/journal.pone.0100850			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992684	Green Published, Green Submitted, gold			2022-12-27	WOS:000341253400032
J	Wang, L; Qu, Y; Fu, X; Zhao, M; Wang, S				Wang, L.; Qu, Y.; Fu, X.; Zhao, M.; Wang, S.			Isolation, Purification and Properties of an R-Phycocyanin from the Phycobilisomes of a Marine Red Macroalga Polysiphonia urceolata (vol 9, e87833, 2014)	PLOS ONE			English	Correction																		Wang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087833	1	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101724	10.1371/journal.pone.0101724	http://dx.doi.org/10.1371/journal.pone.0101724			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992364	Green Published, gold			2022-12-27	WOS:000341253400109
J	Gao, J; Lv, F; Li, J; Wu, ZY; Qi, J				Gao, Jia; Lv, Fang; Li, Jia; Wu, Zongyong; Qi, Jun			Serum Cytokeratin 19 Fragment, CK19-2G2, as a Newly Identified Biomarker for Lung Cancer	PLOS ONE			English	Article							POLYPEPTIDE-SPECIFIC-ANTIGEN; MARKERS; CYFRA-21-1	Background: CK19-2G2, a new fragment of cytokeratin 19, is a potential tumor marker for diagnosing lung cancer. The preoperative level of serum CK19-2G2 has been demonstrated to be associated with tumor metastasis and survival of breast cancer patients. This study investigated the postoperative dynamic changes in serum CK19-2G2 levels and its clinical significance in lung cancer patients. Materials and Methods: Preoperative serum CK19-2G2 levels were measured in 630 lung cancer patients and were compared with individuals with benign pulmonary diseases (n = 134) and healthy volunteers (n = 263). In 352 cases, the patients underwent surgery. In these patients, in addition to preoperative assays, serum CK19-2G2 was also monitored at 1 week and 1 month after the operation. Results: The preoperative baseline levels of serum CK19-2G2 was significantly higher in lung cancer patients than patients with benign diseases and healthy controls (P < 0.001). The postoperative levels of CK19-2G2 declined significantly within 1 week after tumor resection. Hereafter, a further decrease was observed in the patients who underwent palliative operations, while for the patients in the radical resection group, their CK19-2G2 levels stabilized. Conclusion: CK19-2G2 may be a candidate marker for diagnosing and monitoring a patient's response to lung cancer treatment. In addition, CK19-2G2 may be an indicator for micrometastases in lung cancer patients.	[Gao, Jia; Li, Jia; Wu, Zongyong; Qi, Jun] Chinese Acad Med Sci, Canc Inst & Hosp, Clin Lab, Beijing 100730, Peoples R China; [Gao, Jia; Lv, Fang; Li, Jia; Wu, Zongyong; Qi, Jun] Peking Union Med Coll, Beijing 100021, Peoples R China; [Lv, Fang] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Thorac Surg, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Qi, J (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, Clin Lab, Beijing 100730, Peoples R China.	qijun5610@163.com			Capital Medical Development Research Fund	Capital Medical Development Research Fund	This study was supported by the Capital Medical Development Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barak V, 2004, CLIN BIOCHEM, V37, P529, DOI 10.1016/j.clinbiochem.2004.05.009; Ettinger David S, 2006, J Natl Compr Canc Netw, V4, P548; Gao Jia, 2008, Zhonghua Zhongliu Zazhi, V30, P930; Kong YA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057092; Ku NO, 2001, J BIOL CHEM, V276, P26792, DOI 10.1074/jbc.M103315200; Liang ZK, 2013, CLIN LAB, V59, P551, DOI 10.7754/Clin.Lab.2012.120511; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Nisman B, 1998, CANCER-AM CANCER SOC, V82, P1850, DOI 10.1002/(SICI)1097-0142(19980515)82:10<1850::AID-CNCR6>3.0.CO;2-R; OSBORN M, 1982, CELL, V31, P303, DOI 10.1016/0092-8674(82)90122-2; PUJOL JL, 1993, CANCER RES, V53, P61; Rydlander L, 1996, EUR J BIOCHEM, V241, P309, DOI 10.1111/j.1432-1033.1996.00309.x; Sheard MA, 2002, J CELL BIOCHEM, V85, P670, DOI 10.1002/jcb.10173; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138	13	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101979	10.1371/journal.pone.0101979	http://dx.doi.org/10.1371/journal.pone.0101979			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006982	Green Published, gold, Green Submitted			2022-12-27	WOS:000339040600085
J	Lehmann, S; Heiervang, ER; Havik, T; Havik, OE				Lehmann, Stine; Heiervang, Einar R.; Havik, Toril; Havik, Odd E.			Screening Foster Children for Mental Disorders: Properties of the Strengths and Difficulties Questionnaire	PLOS ONE			English	Article							PSYCHIATRIC-DISORDERS; RISK-FACTORS; HEALTH; SDQ; PREVALENCE; VERSION; SCORES; PSYCHOPATHOLOGY; ADOLESCENTS; VALIDITY	Background: High prevalence of mental disorders among foster children highlight the need to examine the mental health of children placed out of home. We examined the properties of the Strengths and Difficulties Questionnaire (SDQ) in screening school-aged foster children for mental disorders. Methods: Foster parents and teachers of 279 foster children completed the SDQ and the diagnostic interview Developmental and Well-Being Assessment (DAWBA). Using the diagnoses derived from the DAWBA as the standard, we examined the performance of the SDQ scales as dimensional measures of mental health problems using receiver operating characteristic (ROC) analyses. Recommended cut-off scores were derived from ROC coordinates. The SDQ predictive algorithms were also examined. Results: ROC analyses supported the screening properties of the SDQ Total difficulties and Impact scores (AUC = 0.80-0.83). Logistic regression analyses showed that the prevalence of mental disorders increased linearly with higher SDQ Total difficulties scores (X-2 = 121.47, df = 13, p<. 001) and Impact scores (X-2 = 69.93, df = 6, p<. 001). Our results indicated that there is an additive value of combining the scores from the Total difficulties and Impact scales, where scores above cut-off on any of the two scales predicted disorders with high sensitivity (89.1%), but moderate specificity (62.1%). Scores above cut-off on both scales yielded somewhat lower sensitivity (73.4%), but higher specificity (81.1%). The SDQ multi-informant algorithm showed low discriminative ability for the main diagnostic categories, with an exception being the SDQ Conduct subscale, which accurately predicted the absence of behavioural disorders (LHR- = 0.00). Conclusions: The results support the use of the SDQ Total difficulties and Impact scales when screening foster children for mental health problems. Cut-off values for both scales are suggested. The SDQ multi-informant algorithms are not recommended for mental health screening of foster children in Norway.	[Lehmann, Stine; Havik, Odd E.] Univ Bergen, Fac Psychol, Dept Clin Psychol, Bergen, Norway; [Lehmann, Stine] Reg Off Children & Family Affairs, Tonsberg, Norway; [Heiervang, Einar R.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Heiervang, Einar R.] Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway; [Havik, Toril] Reg Ctr Child & Youth Mental Hlth & Child Welfare, Uni Hlth, Uni Res, Bergen, Norway	University of Bergen; University of Oslo; University of Oslo	Lehmann, S (corresponding author), Univ Bergen, Fac Psychol, Dept Clin Psychol, Bergen, Norway.	stine.lehmann@uni.no			regional office for Child and Family Affairs, Southern Norway	regional office for Child and Family Affairs, Southern Norway	The study was funded by the regional office for Child and Family Affairs, Southern Norway. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T.M., 2001, MANUAL ASEBA SCH AGE; Akobeng AK, 2007, ACTA PAEDIATR, V96, P338, DOI 10.1111/j.1651-2227.2006.00180.x; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Borg A-M, 2013, NORD J PSYCHIAT, P1; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Bourdon KH, 2005, J AM ACAD CHILD PSY, V44, P557, DOI 10.1097/01.chi.0000159157.57075.c8; Brondbo P, 2011, CHILD ADOLESCENT PSY, V5, P1; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; FAGAN TJ, 1975, NEW ENGL J MED, V293, P257; Fischer JE, 2003, INTENS CARE MED, V29, P1043, DOI 10.1007/s00134-003-1761-8; Ford T, 2007, BRIT J PSYCHIAT, V190, P319, DOI 10.1192/bjp.bp.106.025023; Goodman A, 2012, BRIT J PSYCHIAT, V200, P426, DOI 10.1192/bjp.bp.111.104380; Goodman A, 2011, J CHILD PSYCHOL PSYC, V52, P100, DOI 10.1111/j.1469-7610.2010.02278.x; Goodman A, 2009, J AM ACAD CHILD PSY, V48, P400, DOI 10.1097/CHI.0b013e3181985068; Goodman R, 1999, J CHILD PSYCHOL PSYC, V40, P791, DOI 10.1017/S0021963099004096; Goodman R, 2000, J CHILD PSYCHOL PSYC, V41, P645, DOI 10.1017/S0021963099005909; Goodman R, 2000, EUR CHILD ADOLES PSY, V9, P129, DOI 10.1007/s007870050008; Goodman R, 1998, EUR CHILD ADOLES PSY, V7, P125, DOI 10.1007/s007870050057; Goodman R, 2004, EUR CHILD ADOLES PSY, V13, P25, DOI 10.1007/s00787-004-2005-3; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 1999, J ABNORM CHILD PSYCH, V27, P17, DOI 10.1023/A:1022658222914; Goodman R, 2000, BRIT J PSYCHIAT, V177, P534, DOI 10.1192/bjp.177.6.534; Heiervang E, 2007, J AM ACAD CHILD PSY, V46, P438, DOI 10.1097/chi.0b013e31803062bf; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Hysing M, 2007, J CHILD PSYCHOL PSYC, V48, P785, DOI 10.1111/j.1469-7610.2007.01755.x; Janssens A, 2009, EUR CHILD ADOLES PSY, V18, P691, DOI 10.1007/s00787-009-0030-y; Lehmann S, 2013, CHILD ADOL PSYCH MEN, V7, DOI 10.1186/1753-2000-7-39; Malmberg M, 2003, NORD J PSYCHIAT, V57, P357, DOI 10.1080/08039480310002697; Marasco J., 2011, UMAP J, V32, P279; Martin MJ, 2010, DEV PSYCHOPATHOL, V22, P695, DOI 10.1017/S0954579410000374; McGee S, 2002, J GEN INTERN MED, V17, P646; McMillen JC, 2005, J AM ACAD CHILD PSY, V44, P88, DOI 10.1097/01.chi.0000145806.24274.d2; Meltzer H, 2003, INT REV PSYCHIATR, V15, P185, DOI 10.1080/0954026021000046155; Rutter M, 2000, DEV PSYCHOPATHOL, V12, P265, DOI 10.1017/S0954579400003023; Stone LL, 2010, CLIN CHILD FAM PSYCH, V13, P254, DOI 10.1007/s10567-010-0071-2; Stringaris A, 2013, J ABNORMAL CHILD PSY, P1; Sveen TH, 2013, J AM ACAD CHILD PSY, V52, P728, DOI 10.1016/j.jaac.2013.04.010; Tarren-Sweeney M, 2013, CHILD YOUTH SERV REV, V35, P771, DOI 10.1016/j.childyouth.2013.01.025; World Health Organization, 1992, ICD 10 CLASSIFICATIO	39	16	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102134	10.1371/journal.pone.0102134	http://dx.doi.org/10.1371/journal.pone.0102134			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL3PK	25006669	Green Published, Green Submitted, gold			2022-12-27	WOS:000339040600098
J	Moscoso, M; Esteban-Torres, M; Menendez, M; Garcia, E				Moscoso, Miriam; Esteban-Torres, Maria; Menendez, Margarita; Garcia, Ernesto			In Vitro Bactericidal and Bacteriolytic Activity of Ceragenin CSA-13 against Planktonic Cultures and Biofilms of Streptococcus pneumoniae and Other Pathogenic Streptococci	PLOS ONE			English	Article							CATIONIC STEROID COMPOUNDS; PSEUDOMONAS-AERUGINOSA; CELL-WALL; PNEUMOCOCCAL STRAINS; EXTRACELLULAR-DNA; ENZYME-ACTIVITY; WILD-TYPE; ACID; TOLERANCE; AUTOLYSIN	Ceragenin CSA-13, a cationic steroid, is here reported to show a concentration-dependent bactericidal/bacteriolytic activity against pathogenic streptococci, including multidrug-resistant Streptococcus pneumoniae. The autolysis promoted by CSA-13 in pneumococcal cultures appears to be due to the triggering of the major S. pneumoniae autolysin LytA, an N-acetylmuramoyl-L-alanine amidase. CSA-13 also disintegrated pneumococcal biofilms in a very efficient manner, although at concentrations slightly higher than those required for bactericidal activity on planktonic bacteria. CSA-13 has little hemolytic activity which should allow testing its antibacterial efficacy in animal models.	[Moscoso, Miriam; Esteban-Torres, Maria; Garcia, Ernesto] CSIC, Ctr Invest Biol, Madrid, Spain; [Menendez, Margarita] CSIC, Inst Quim Fis Rocasolano, Dept Quim Fis Biol, Madrid, Spain; [Moscoso, Miriam; Esteban-Torres, Maria; Menendez, Margarita; Garcia, Ernesto] CIBER Enfermedades Resp CIBERES, Mallorca, Illes Balears, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Garcia, E (corresponding author), CSIC, Ctr Invest Biol, Madrid, Spain.	e.garcia@cib.csic.es	Esteban-Torres, Maria/AAA-8621-2020; Menendez, Margarita/M-1795-2014; Esteban-Torres, María/AAT-6046-2020	Menendez, Margarita/0000-0002-3267-4443; Esteban-Torres, María/0000-0001-8433-5729; Moscoso, Miriam/0000-0001-8977-3269; Partearroyo Lacaba, Olvido/0000-0002-1692-4481	Direccion General de Investigacion Cientifica y Tecnica [SAF2009-10824, BFU2009-10052, BFU2012-36825, SAF2012-39444-C02-01]; Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES)	Direccion General de Investigacion Cientifica y Tecnica(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES)	This work was supported by Direccion General de Investigacion Cientifica y Tecnica (grant numbers SAF2009-10824, BFU2009-10052, BFU2012-36825, and SAF2012-39444-C02-01) and Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES), which is an initiative of the ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbique JC, 2004, J CLIN MICROBIOL, V42, P4686, DOI 10.1128/JCM.42.10.4686-4696.2004; Berron S, 2005, J CLIN MICROBIOL, V43, P1694, DOI 10.1128/JCM.43.4.1694-1698.2005; Bozkurt-Guzel C, 2011, CHEMOTHERAPY, V57, P505, DOI 10.1159/000335588; Bucki R, 2007, J ANTIMICROB CHEMOTH, V60, P535, DOI 10.1093/jac/dkm218; Burnside K, 2011, J BIOL CHEM, V286, P44197, DOI 10.1074/jbc.M111.313486; Chin JN, 2008, J ANTIMICROB CHEMOTH, V61, P365, DOI 10.1093/jac/dkm457; Chin JN, 2007, ANTIMICROB AGENTS CH, V51, P1268, DOI 10.1128/AAC.01325-06; Clinical and Laboratory Standards Institute, 2006, M7A7 CLIN LAB STAND; Coates H, 2008, OTOLARYNG HEAD NECK, V138, P778, DOI 10.1016/j.otohns.2007.02.009; Diez-Martinez R, 2013, ANTIMICROB AGENTS CH, V57, P5355, DOI 10.1128/AAC.01372-13; Ding B, 2002, J MED CHEM, V45, P663, DOI 10.1021/jm0105070; Domenech M, 2013, INFECT IMMUN, V81, P2606, DOI 10.1128/IAI.00491-13; Domenech M, 2012, MICROB BIOTECHNOL, V5, P455, DOI 10.1111/j.1751-7915.2011.00294.x; Dufour D, 2013, J BACTERIOL, V195, P105, DOI 10.1128/JB.00926-12; Epand RF, 2007, BBA-BIOMEMBRANES, V1768, P2500, DOI 10.1016/j.bbamem.2007.05.023; Epand RM, 2008, DRUG NEWS PERSPECT, V21, P307, DOI 10.1358/dnp.2008.21.6.1246829; GARCIABUSTOS JF, 1987, J BIOL CHEM, V262, P15400; GOPPELTSTRUEBE M, 1995, CANCER CHEMOTH PHARM, V35, P519, DOI 10.1007/s002800050271; Hancock REW, 2005, LANCET INFECT DIS, V5, P209, DOI 10.1016/S1473-3099(05)70051-7; HOLTJE JV, 1975, P NATL ACAD SCI USA, V72, P1690, DOI 10.1073/pnas.72.5.1690; HOLTJE JV, 1976, J BIOL CHEM, V251, P4199; HORNE D, 1977, ANTIMICROB AGENTS CH, V11, P888, DOI 10.1128/AAC.11.5.888; HORNE D, 1977, J BACTERIOL, V132, P704, DOI 10.1128/JB.132.2.704-717.1977; Isogai E, 2009, ORAL MICROBIOL IMMUN, V24, P170, DOI 10.1111/j.1399-302X.2008.00464.x; Jensen PO, 2010, FEMS IMMUNOL MED MIC, V59, P292, DOI 10.1111/j.1574-695X.2010.00706.x; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; LACKS S, 1960, BIOCHIM BIOPHYS ACTA, V39, P508, DOI 10.1016/0006-3002(60)90205-5; Lai XZ, 2008, ACCOUNTS CHEM RES, V41, P1233, DOI 10.1021/ar700270t; Leszczynska K, 2011, J APPL MICROBIOL, V110, P229, DOI 10.1111/j.1365-2672.2010.04874.x; Lewis K, 2008, CURR TOP MICROBIOL, V322, P107; LIU HH, 1985, J INFECT DIS, V152, P365, DOI 10.1093/infdis/152.2.365; Liu YL, 2011, J BACTERIOL, V193, P2826, DOI 10.1128/JB.00056-11; Llull D, 2006, J CLIN MICROBIOL, V44, P1250, DOI 10.1128/JCM.44.4.1250-1256.2006; Llull D, 2007, ANTIMICROB AGENTS CH, V51, P1844, DOI 10.1128/AAC.01428-06; Lopez R, 2004, FEMS MICROBIOL REV, V28, P553, DOI 10.1016/j.femsre.2004.05.002; Lopez R, 2004, PNEUMOCCOCUS, P75; LOPEZ R, 1990, FEMS MICROBIOL LETT, V66, P317, DOI 10.1016/0378-1097(90)90305-A; LUND E, 1978, METHOD MICROBIOL, V12, P241; Maestro Beatriz, 2007, Recent Pat Antiinfect Drug Discov, V2, P188, DOI 10.2174/157489107782497290; Martin B, 2000, MOL MICROBIOL, V38, P867, DOI 10.1046/j.1365-2958.2000.02187.x; Medrano FJ, 1996, J BIOL CHEM, V271, P29152, DOI 10.1074/jbc.271.46.29152; Moscoso M, 2004, MOL MICROBIOL, V54, P783, DOI 10.1111/j.1365-2958.2004.04305.x; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; Moscoso M, 2010, MOL MICROBIOL, V77, P1052, DOI 10.1111/j.1365-2958.2010.07271.x; MOSSER JL, 1970, J BIOL CHEM, V245, P287; MUNOZ R, 1991, J INFECT DIS, V164, P302, DOI 10.1093/infdis/164.2.302; Nagant C, 2012, J APPL MICROBIOL, V112, P1173, DOI 10.1111/j.1365-2672.2012.05297.x; Nagant C, 2013, MICROBIOLOGYOPEN, V2, P318, DOI 10.1002/mbo3.77; Nagant C, 2010, APPL MICROBIOL BIOT, V88, P251, DOI 10.1007/s00253-010-2748-3; Obregon V, 2002, J CLIN MICROBIOL, V40, P2545, DOI 10.1128/JCM.40.7.2545-2554.2002; OTTOLENGHI E, 1962, J EXP MED, V116, P491, DOI 10.1084/jem.116.4.491; Papazafiri P, 2005, CANCER CHEMOTH PHARM, V56, P261, DOI 10.1007/s00280-004-0935-6; Polat ZA, 2011, J OCUL PHARMACOL TH, V27, P1, DOI 10.1089/jop.2010.0041; Pollard JE, 2012, J ANTIMICROB CHEMOTH, V67, P2665, DOI 10.1093/jac/dks276; RONDA C, 1988, MOL GEN GENET, V215, P53, DOI 10.1007/BF00331302; Sambrook J., 2001, MOL CLONING LAB MANU; SANCHEZPUELLES JM, 1992, EUR J BIOCHEM, V203, P153, DOI 10.1111/j.1432-1033.1992.tb19840.x; Soriano F, 2008, J ANTIMICROB CHEMOTH, V62, P1234, DOI 10.1093/jac/dkn392; Sung H, 2006, J CLIN MICROBIOL, V44, P3524, DOI 10.1128/JCM.00558-06; TOMASZ A, 1975, BIOCHEM BIOPH RES CO, V65, P1311, DOI 10.1016/S0006-291X(75)80373-1; Udekwu KI, 2009, J ANTIMICROB CHEMOTH, V63, P745, DOI 10.1093/jac/dkn554; [UNICEF WHO], 2006, PNEUM FORG KILL CHIL; Wolcott RD, 2008, JAMA-J AM MED ASSOC, V299, P2682, DOI 10.1001/jama.299.22.2682	63	17	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101037	10.1371/journal.pone.0101037	http://dx.doi.org/10.1371/journal.pone.0101037			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006964	Green Published, gold			2022-12-27	WOS:000339040600027
J	Sharma, K; Bayrakcismith, R; Tumursukh, L; Johansson, O; Sevger, P; McCarthy, T; Mishra, C				Sharma, Koustubh; Bayrakcismith, Rana; Tumursukh, Lkhagvasumberel; Johansson, Orjan; Sevger, Purevsuren; McCarthy, Tom; Mishra, Charudutt			Vigorous Dynamics Underlie a Stable Population of the Endangered Snow Leopard Panthera uncia in Tost Mountains, South Gobi, Mongolia	PLOS ONE			English	Article							TIGER DENSITIES; RECAPTURE; DISPERSAL; ABUNDANCE; TIGRIS; PARAMETERS; PANNA; INDIA	Population monitoring programmes and estimation of vital rates are key to understanding the mechanisms of population growth, decline or stability, and are important for effective conservation action. We report, for the first time, the population trends and vital rates of the endangered snow leopard based on camera trapping over four years in the Tost Mountains, South Gobi, Mongolia. We used robust design multi-season mark-recapture analysis to estimate the trends in abundance, sex ratio, survival probability and the probability of temporary emigration and immigration for adult and young snow leopards. The snow leopard population remained constant over most of the study period, with no apparent growth (lambda = 1.08+-20.25). Comparison of model results with the "known population'' of radio-collared snow leopards suggested high accuracy in our estimates. Although seemingly stable, vigorous underlying dynamics were evident in this population, with the adult sex ratio shifting from being male-biased to female-biased (1.67 to 0.38 males per female) during the study. Adult survival probability was 0.82 (SE+-0.08) and that of young was 0.83 (SE+-0.15) and 0.77 (SE+-0.2) respectively, before and after the age of 2 years. Young snow leopards showed a high probability of temporary emigration and immigration (0.6, SE +-0.19 and 0.68, SE +-0.32 before and after the age of 2 years) though not the adults (0.02 SE+-0.07). While the current female-bias in the population and the number of cubs born each year seemingly render the study population safe, the vigorous dynamics suggests that the situation can change quickly. The reduction in the proportion of male snow leopards may be indicative of continuing anthropogenic pressures. Our work reiterates the importance of monitoring both the abundance and population dynamics of species for effective conservation.	[Sharma, Koustubh; Tumursukh, Lkhagvasumberel; Johansson, Orjan; Sevger, Purevsuren; Mishra, Charudutt] Snow Leopard Trust, Seattle, WA 98103 USA; [Sharma, Koustubh; Mishra, Charudutt] Nat Conservat Fdn, Mysore, Karnataka, India; [Bayrakcismith, Rana; Johansson, Orjan; McCarthy, Tom] Panthera, New York, NY USA; [Tumursukh, Lkhagvasumberel; Sevger, Purevsuren] Snow Leopard Conservat Fdn, Ulaanbaatar, Mongolia; [Johansson, Orjan] Swedish Univ Agr Sci, Grimso Wildlife Res Stn, Uppsala, Sweden	Swedish University of Agricultural Sciences	Sharma, K (corresponding author), Snow Leopard Trust, Seattle, WA 98103 USA.	koustubhsharma@gmail.com			Whitley Fund For Nature; BBC Wildlife Fund; Kolmarden Zoo; AZA Conservation Endowment Fund; Disney, Worldwide Conservation Fund; David Shepherd Wildlife Foundation; Columbus Zoo and Aquarium; Nysether Family Foundation; Cheyenne Mountain zoos; Woodland Park Zoo	Whitley Fund For Nature; BBC Wildlife Fund; Kolmarden Zoo; AZA Conservation Endowment Fund; Disney, Worldwide Conservation Fund; David Shepherd Wildlife Foundation; Columbus Zoo and Aquarium; Nysether Family Foundation; Cheyenne Mountain zoos; Woodland Park Zoo	The authors are grateful to the Whitley Fund For Nature, BBC Wildlife Fund, Kolmarden Zoo, AZA Conservation Endowment Fund, Disney, Worldwide Conservation Fund, David Shepherd Wildlife Foundation, Woodland Park Zoo, Columbus Zoo and Aquarium, Nysether Family Foundation and Cheyenne Mountain zoos for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athreya V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057872; Bailey, 1993, AFRICAN LEOPARD ECOL; Balme G.A., 2004, ECOL J, V6, P1; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Caro TM, 2003, ANIM CONSERV, V6, P171, DOI 10.1017/S1367943003003214; Chundawat RS, 2009, PANNAS LAST TIGER; Cooch E., 2008, PROGRAM MARK GENTLE; GITTLEMAN JL, 1982, BEHAV ECOL SOCIOBIOL, V10, P57, DOI 10.1007/BF00296396; Goodrich JM, 2008, J ZOOL, V276, P323, DOI 10.1111/j.1469-7998.2008.00458.x; Gopal R, 2010, ORYX, V44, P383, DOI 10.1017/S0030605310000529; Gour DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066956; Jackson RM, 2006, WILDLIFE SOC B, V34, P772, DOI 10.2193/0091-7648(2006)34[772:ESLPAU]2.0.CO;2; Janecka JE, 2011, J MAMMAL, V92, P771, DOI 10.1644/10-MAMM-A-036.1; Johansson O, 2013, J WILDLIFE DIS, V49, P338, DOI 10.7589/2012-02-049; Karanth KU, 2006, ECOLOGY, V87, P2925, DOI 10.1890/0012-9658(2006)87[2925:ATPDUP]2.0.CO;2; Karanth KU, 2009, ORYX, V43, P1, DOI 10.1017/S003060530843106X; Karanth KU, 2004, ANIM CONSERV, V7, P285, DOI 10.1017/S1367943004001477; KARANTH KU, 1995, BIOL CONSERV, V71, P333, DOI 10.1016/0006-3207(94)00057-W; Karanth KU, 1998, ECOLOGY, V79, P2852; Kendall WL, 2001, BIOMETRICS, V57, P1113, DOI 10.1111/j.0006-341X.2001.01113.x; KENDALL WL, 1995, BIOMETRICS, V51, P293, DOI 10.2307/2533335; Kerley LL, 2003, J MAMMAL, V84, P288, DOI 10.1644/1545-1542(2003)084<0288:RPOWFA>2.0.CO;2; Lambert CMS, 2006, J WILDLIFE MANAGE, V70, P246, DOI 10.2193/0022-541X(2006)70[246:CPDAVI]2.0.CO;2; Maffei L, 2005, J TROP ECOL, V21, P349, DOI 10.1017/S0266467405002397; Maffei L, 2004, J ZOOL, V262, P295, DOI 10.1017/S0952836903004655; Marnewick K, 2008, S AFR J WILDL RES, V38, P59, DOI 10.3957/0379-4369-38.1.59; McCarthy KP, 2008, J WILDLIFE MANAGE, V72, P1826, DOI 10.2193/2008-040; McCarthy T, 2003, SNOW LEOPARD SURVIVA; Mills LS, 2000, ECOL APPL, V10, P283, DOI 10.2307/2641002; Nichols James D., 2002, P121; OTIS DL, 1978, WILDLIFE MONOGR, P1; Pradel R, 1996, BIOMETRICS, V52, P703, DOI 10.2307/2532908; Samelius G, 2012, J ZOOL, V286, P120, DOI 10.1111/j.1469-7998.2011.00857.x; Shehzad W, 2012, PLOS ONE, V7, P1, DOI DOI 10.1371/J0UMAL.P0NE.0032104; Silver S, 2004, WILDL CONSERV; SMITH JLD, 1993, BEHAVIOUR, V124, P165, DOI 10.1163/156853993X00560; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Trolle M, 2003, J MAMMAL, V84, P607, DOI 10.1644/1545-1542(2003)084<0607:EOODIT>2.0.CO;2; Vangen KM, 2001, CAN J ZOOL, V79, P1641, DOI 10.1139/cjz-79-9-1641; Wallace R. B., 2003, Mastozoologia Neotropical, V10, P133; Williams B. K., 2002, ANAL MANAGEMENT ANIM	41	43	47	1	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101319	10.1371/journal.pone.0101319	http://dx.doi.org/10.1371/journal.pone.0101319			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006879	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000339040600034
J	Hwang, SH; Cho, HK; Park, SH; Lee, W; Lee, HJ; Lee, DC; Oh, JH; Park, SH; Kim, TG; Sohn, HJ; Kang, JM; Kim, SW				Hwang, Se Hwan; Cho, Hye Kyung; Park, Sang Hi; Lee, WeonSun; Lee, Hee Jin; Lee, Dong Chang; Oh, Jeong Hoon; Park, Sun Hwa; Kim, Tai-Gyu; Sohn, Hyun-Jung; Kang, Jun Myung; Kim, Sung Won			Toll like Receptor 3 & 4 Responses of Human Turbinate Derived Mesenchymal Stem Cells: Stimulation by Double Stranded RNA and Lipopolysaccharide	PLOS ONE			English	Article							STROMAL CELLS; MULTIPOTENT	Background and objectives: Multipotent mesenchymal stromal cells (MSCs) represent a promising cell-based therapy for a number of inflammatory or autoimmune diseases. Herein, Toll like receptor (TLR) expression by MSCs and their immune regulatory roles are investigated. In this study, we investigated the influence of TLR on the immune response, proliferation, and differentiation potential of human turbinated MSC (hTMSC) cultures in vitro. Subjects and Methods: After isolating hTMSCs from discarded inferior turbinate tissue, FACS analysis was used to assess the expression of TLRs such as TLR2, TLR3, TLR4, and TLR5 in hTMSCs and cell proliferation was assessed using a cell counting kit (CCK)-8. Cytokine and chemokine secretions were analyzed with multiplex immunoassays for IL-1 alpha, IL-1 beta, IL-4, IL-6, IL-8, IL-10, IL-12, IP-10 (CXCL10), RANTES (CCL5), TNF-alpha, GM-CSF, and IFN-gamma. The differentiation potential of hTMSCs was evaluated in the osteogenic, chondogenic, and adipogeinc media and analyzed by histology and gene expression related to differentiation. Results: FACS analysis revealed that TLR3 and TLR4 expression consisted of a relatively high percentage of the surface proteins expressed by hTMSCs. The proliferation of hTMSCs was influenced and significantly increased by the presence of TLR4 agonists. In particular, hTMSCs produced a set of cytokines and chemokines and the expression of IL-6, IL-8, IL-12, IP-10 (CXCL10), RANTES (CCL5), TNF-alpha, and GM-CSF were up-regulated in response to the TLR4 agonist LPS. The osteogenic and adipogeinc differentiation potential of hTMSCs was not affected by TLR agonists. Conclusions: We conclude that TLR4 stimulation affects TLR expression, proliferation, and the immunomodulation potential of hTMSCs. Understanding the mechanism behind TLR's influence on hTMSCs and their immunomodulating properties would be useful for providing a novel target to exploit in the improvement of stem cell-based therapeutic strategies.	[Hwang, Se Hwan; Lee, Dong Chang; Oh, Jeong Hoon; Park, Sun Hwa; Kang, Jun Myung; Kim, Sung Won] Catholic Univ Korea, Dept Otolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea; [Cho, Hye Kyung] Gachon Univ, Grad Sch Med, Dept Pediat, Inchon, South Korea; [Park, Sang Hi; Lee, WeonSun; Lee, Hee Jin] Catholic Univ Korea, Inst Clin Med Res, Coll Med, Seoul, South Korea; [Park, Sun Hwa; Kim, Sung Won] Catholic Univ Korea, Dept Biomed Sci, Coll Med, Seoul, South Korea; [Kim, Tai-Gyu; Sohn, Hyun-Jung] Catholic Univ Korea, Catholic Hematopoiet Stem Cell Bank, Coll Med, Seoul, South Korea; [Kim, Tai-Gyu] Catholic Univ Korea, Dept Microbiol & Immunol, Coll Med, Seoul, South Korea	Catholic University of Korea; Gachon University; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Kang, JM (corresponding author), Catholic Univ Korea, Dept Otolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea.	entkjm@catholic.ac.kr; kswent@catholic.ac.kr		Hwang, Se Hwan/0000-0002-2838-7820	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2014R1A2A2A01004325]; Ministry of Education, Science and Technology [2010-0011249]; Research Fund of Seoul St. Mary's Hospital; Catholic Medical Center Research Foundation; Otorhinolaryngology Alumni Fund of the Catholic University of Korea	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Research Fund of Seoul St. Mary's Hospital; Catholic Medical Center Research Foundation; Otorhinolaryngology Alumni Fund of the Catholic University of Korea	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by by the Ministry of Science, ICT and Future Planning (2014R1A2A2A01004325) and the Ministry of Education, Science and Technology (2010-0011249), Research Fund of Seoul St. Mary's Hospital, The Catholic University of Korea, Catholic Institute of Cell Therapy in 2013, the Otorhinolaryngology Alumni Fund of the Catholic University of Korea made in the program year of 2013, 2012 Research Fund for the Colleague of Catholic University Medical College, the financial support of the Catholic Medical Center Research Foundation made in the program year of 2013, and the financial support of the Catholic Medical Center Research Foundation made in the program year of 2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auletta JJ, 2012, BLOOD, V119, P1801, DOI 10.1182/blood-2011-10-384354; Chen PM, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-49; Cho HH, 2006, STEM CELLS, V24, P2744, DOI 10.1634/stemcells.2006-0189; DelaRosa O, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00182; DelaRosa O, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/865601; Hwang SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074330; Hwang SH, 2012, OTOLARYNG HEAD NECK, V147, P568, DOI 10.1177/0194599812447172; Jakob M, 2010, STEM CELLS DEV, V19, P635, DOI 10.1089/scd.2009.0245; Law S, 2013, AM J STEM CELLS, V2, P22; Liang S, 2007, CHINESE MED J-PEKING, V120, P1685, DOI 10.1097/00029330-200710010-00008; Liotta F, 2008, STEM CELLS, V26, P279, DOI 10.1634/stemcells.2007-0454; Najar M, 2012, STEM CELL REV REP, V8, P1188, DOI 10.1007/s12015-012-9408-1; Opitz CA, 2009, STEM CELLS, V27, P909, DOI 10.1002/stem.7; Park HJ, 2012, ACTA OTO-LARYNGOL, V132, pS58, DOI 10.3109/00016489.2012.659756; Raicevic G, 2012, TISSUE ENG PT A, V18, P1410, DOI [10.1089/ten.tea.2011.0434, 10.1089/ten.TEA.2011.0434]; Raicevic G, 2011, CELL IMMUNOL, V270, P207, DOI 10.1016/j.cellimm.2011.05.010; Raicevic G, 2010, HUM IMMUNOL, V71, P235, DOI 10.1016/j.humimm.2009.12.005; Seo S, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/806891; Tomchuck SL, 2008, STEM CELLS, V26, P99, DOI 10.1634/stemcells.2007-0563; Wang XB, 2012, EXP CELL RES, V318, P196, DOI 10.1016/j.yexcr.2011.11.001; Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088	21	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101558	10.1371/journal.pone.0101558	http://dx.doi.org/10.1371/journal.pone.0101558			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004159	gold, Green Published, Green Submitted			2022-12-27	WOS:000339242700038
J	Kaniewski, D; Van Campo, E; Morhange, C; Guiot, J; Zviely, D; Le Burel, S; Otto, T; Artzy, M				Kaniewski, David; Van Campo, Elise; Morhange, Christophe; Guiot, Joel; Zviely, Dov; Le Burel, Sabine; Otto, Thierry; Artzy, Michal			Vulnerability of Mediterranean Ecosystems to Long-Term Changes along the Coast of Israel	PLOS ONE			English	Article							SEA-LEVEL RISE; HOLOCENE CLIMATE VARIABILITY; HAIFA BAY; SHORELINE MIGRATION; WATER AVAILABILITY; MIDDLE-EAST; FUTURE; FOREST; DROUGHT; FLORIDA	Although human activity is considered to be a major driving force affecting the distribution and dynamics of Mediterranean ecosystems, the full consequences of projected climate variability and relative sea-level changes on fragile coastal ecosystems for the next century are still unknown. It is unclear how these waterfront ecosystems can be sustained, as well as the services they provide, when relative sea-level rise and global warming are expected to exert even greater pressures in the near future (drought, habitat degradation and accelerated shoreline retreat). Haifa Bay, northern Israel, has recorded a landward sea invasion, with a maximum sea penetration 4,000 years ago, during an important period of urban development and climate instability. Here, we examine the cumulative pressure of climate shifts and relative sea-level changes in order to investigate the patterns and mechanisms behind forest replacement by an open-steppe. We provide a first comprehensive and integrative study for the southern Levant that shows that (i) human impact, through urbanization, has been the main driver behind ecological erosion in the past 4,000 years; (ii) climate pressures have reinforced this impact; and (iii) local coastal changes have played a decisive role in eroding ecosystem resilience. These three parameters, which have closely interacted during the last 4,000 years in Haifa Bay, clearly indicate that for an efficient management of the coastal habitats, anthropogenic pressures linked to urban development must be reduced in order to mitigate the predicted effects of Global Change.	[Kaniewski, David; Van Campo, Elise; Le Burel, Sabine; Otto, Thierry] Univ Toulouse 3, Lab Ecol Fonct & Environm EcoLab, F-31062 Toulouse, France; [Kaniewski, David; Van Campo, Elise; Le Burel, Sabine; Otto, Thierry] CNRS, Lab Ecol Fonct & Environm EcoLab, Toulouse, France; [Kaniewski, David; Morhange, Christophe] Inst Univ France, Paris, France; [Morhange, Christophe; Guiot, Joel] Aix Marseille Univ, Ctr Rech & Enseignement Geosci Environm CEREGE, CNRS, Unite Mixte 34, Aix En Provence, France; [Zviely, Dov; Artzy, Michal] Univ Haifa, Leon Recanati Inst Maritime Studies, IL-31999 Haifa, Israel; [Artzy, Michal] Univ Haifa, Hatter Lab, IL-31999 Haifa, Israel	Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Institut Universitaire de France; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Haifa; University of Haifa	Kaniewski, D (corresponding author), Univ Toulouse 3, Lab Ecol Fonct & Environm EcoLab, F-31062 Toulouse, France.	david.kaniewski@univ-tlse3.fr	Zviely, Dov/GPK-6194-2022; Kaniewski, David/AAT-2607-2021; Guiot, Joel/G-7818-2011	Kaniewski, David/0000-0001-6569-3184; Guiot, Joel/0000-0001-7345-4466; Otto, Thierry/0000-0003-2854-6454	Institut Universitaire de France; CLIMSORIENT; Geoarchaeology of ancient harbours projects; Mistrals-ENVIMED-GEOISRAEL program; Hatter Laboratory; Recanati Institute for Maritime Studies, University of Haifa; Investissements d'Avenir [ANR-11-LABEX-0061]; French Government project of the French National Research Agency (ANR) through the A*Midex project [ANR-11-IDEX-0001-02]	Institut Universitaire de France; CLIMSORIENT; Geoarchaeology of ancient harbours projects; Mistrals-ENVIMED-GEOISRAEL program; Hatter Laboratory; Recanati Institute for Maritime Studies, University of Haifa; Investissements d'Avenir(French National Research Agency (ANR)); French Government project of the French National Research Agency (ANR) through the A*Midex project(French National Research Agency (ANR))	Support was provided by the Institut Universitaire de France, CLIMSORIENT and Geoarchaeology of ancient harbours projects, the Mistrals-ENVIMED-GEOISRAEL program, and by the Hatter Laboratory, Recanati Institute for Maritime Studies, University of Haifa. This work is also a contribution to the Labex OT-Med (ANR-11-LABEX-0061) funded by the "Investissements d'Avenir", French Government project of the French National Research Agency (ANR) through the A*Midex project (ANR-11-IDEX-0001-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTHONY E. J, 2009, DEV MARINE GEOLOGY, V4; Bar-Matthews M, 2003, GEOCHIM COSMOCHIM AC, V67, P3181, DOI 10.1016/S0016-7037(02)01031-1; Bernhardt CE, 2012, GEOLOGY, V40, P615, DOI 10.1130/G33012.1; Cazenave A, 2001, GEOPHYS RES LETT, V28, P1607, DOI 10.1029/2000GL012628; Chen J, 2011, WATER RESOUR RES, V47, DOI [10.1029/2010WR010269, 10.1029/2011WR010602]; DANIN A, 1981, ANALES JARD BOT MADR, V37, P269; Desantis LRG, 2007, GLOBAL CHANGE BIOL, V13, P2349, DOI 10.1111/j.1365-2486.2007.01440.x; Evans JP, 2009, CLIMATIC CHANGE, V92, P417, DOI 10.1007/s10584-008-9438-5; Fiorentino G, 2008, PALAEOGEOGR PALAEOCL, V266, P51, DOI 10.1016/j.palaeo.2008.03.034; Grafe K.-U., 2003, SEPM SPECIAL PUBLICA, V75, P229; Guiot J, 2009, CLIM PAST, V5, P571, DOI 10.5194/cp-5-571-2009; Iversen J, 1989, J BIOGEOGR; Kafle HK, 2009, CLIMATIC CHANGE, V96, P63, DOI 10.1007/s10584-009-9578-2; Kaniewski D, 2008, P NATL ACAD SCI USA, V105, P13941, DOI 10.1073/pnas.0803533105; Kaniewski D, 2010, QUATERNARY RES, V74, P207, DOI 10.1016/j.yqres.2010.07.010; Kaniewski D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03540; Kaniewski D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071004; Kaplan JO, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002559; Langgut D, 2014, PALYNOLOGY, V38, P280, DOI 10.1080/01916122.2014.906001; Langgut D, 2013, TEL AVIV, V40, P149, DOI 10.1179/033443513X13753505864205; Lichter M, 2010, CELL ORIG LIFE EXTRE, V15, P3, DOI 10.1007/978-90-481-8569-6_1; Litt T, 2012, QUATERNARY SCI REV, V49, P95, DOI 10.1016/j.quascirev.2012.06.012; Marcos M, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2008JC004820; Milano M, 2013, WATER RESOURCES NATU, V26, P1; Milly PCD, 2005, NATURE, V438, P347, DOI 10.1038/nature04312; Nicholls RJ, 2007, CLIMATIC CHANGE 2007, P315, DOI 10.2134/jeq2008.0015br; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Porat Naomi, 2008, Israel Journal of Earth Sciences, V57, P21, DOI 10.1560/IJES.57.1.21; Rahmstorf S, 2007, SCIENCE, V315, P368, DOI 10.1126/science.1135456; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schilman B, 2001, PALAEOGEOGR PALAEOCL, V176, P157, DOI 10.1016/S0031-0182(01)00336-4; Schilman Bettina, 2002, Israel Journal of Earth Sciences, V51, P181, DOI 10.1560/504G-007U-5NKY-GUN1; Sellers PJ, 1996, J CLIMATE, V9, P706, DOI 10.1175/1520-0442(1996)009<0706:ARLSPF>2.0.CO;2; Soltani S, 2012, CLIMATIC CHANGE, V110, P187, DOI 10.1007/s10584-011-0146-1; Sowers J, 2011, CLIMATIC CHANGE, V104, P599, DOI 10.1007/s10584-010-9835-4; Sternberg M, 2001, ECOL RES, V16, P335, DOI 10.1046/j.1440-1703.2001.00393.x; Stewart I. S, 2009, PHYS GEOGRAPHY MEDIT, P385; Suppan P, 2008, ENVIRON SCI ENG, P47, DOI 10.1007/978-3-540-85047-2_5; Williams K, 2003, J COASTAL RES, V19, P1116; Williams K, 1999, ECOLOGY, V80, P2045, DOI 10.1890/0012-9658(1999)080[2045:SLRACF]2.0.CO;2; Zviely D, 2007, MAR GEOL, V238, P61, DOI 10.1016/j.margeo.2006.12.003; Zviely D, 2006, HOLOCENE, V16, P849, DOI 10.1191/0959683606hol977rp; Zviely D, 2009, GEO-MAR LETT, V29, P93, DOI 10.1007/s00367-008-0126-2	43	14	15	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e102090	10.1371/journal.pone.0102090	http://dx.doi.org/10.1371/journal.pone.0102090			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003703	Green Published, gold, Green Submitted			2022-12-27	WOS:000339242700106
J	Morais, DB; Barros, MS; Paula, TAR; Freitas, MBD; Gomes, MLM; Matta, SLP				Morais, Danielle B.; Barros, Mirlaine S.; Paula, Tarcizio A. R.; Freitas, Mariella B. D.; Gomes, Marcos L. M.; Matta, Sergio L. P.			Evaluation of the Cell Population of the Seminiferous Epithelium and Spermatic Indexes of the Bat Sturnira lilium (Chiroptera: Phyllostomidae)	PLOS ONE			English	Article							MONTANE ATLANTIC FOREST; HISTOMORPHOMETRIC EVALUATION; SPERMATOGENIC EFFICIENCY; SYNAPTONEMAL COMPLEX; TESTIS MORPHOMETRY; MOLOSSUS-MOLOSSUS; CYCLE LENGTH; DURATION; MAMMALIA; BRAZIL	Due to the scarcity of information about patterns of spermatogenesis in bats, this study aimed to provide information on the testicular activity of the bat Sturnira lilium along the annual seasons. Thus, a series of morphometrical and stereological analyses were made using the testes of adult S. lilium in order to achieve a better understanding of the sperm production dynamics. Light and transmission electron microscopy analyses were performed in testicular fragments of animals captured during dry and rainy seasons. The testes followed the pattern of organization described for other mammals, and there were no morphological differences between organs collected either in dry or in rainy seasons. Each tubular cross-section in stage 1 was made of 0.5 type-A spermatogonia, 4.4 primary spermatocytes in preleptotene/leptotene, 3.7 in zygotene, 11.9 in pachytene, 35.6 round spermatids and 8.5 Sertoli cells. The mitotic and meiotic indexes were 15.4 and 2.9 cells, respectively, while the spermatogenesis yield was 68.7 cells. The testicular sperm reserves was 37.61 x 10(6) cells, and daily sperm production per gram of testis averaged 209.68 x 10(6) cells, both highest averages occurring in the rainy season. S. lilium male bats have a continuous reproductive pattern, high spermatogenesis yield and low support capacity by the Sertoli cells.	[Morais, Danielle B.] Univ Fed Rio Grande do Norte, Dept Morphol, BR-59072970 Natal, RN, Brazil; [Barros, Mirlaine S.; Freitas, Mariella B. D.] Univ Fed Vicosa, Dept Anim Biol, Vicosa, MG, Brazil; [Paula, Tarcizio A. R.] Univ Fed Vicosa, Dept Vet, Vicosa, MG, Brazil; [Gomes, Marcos L. M.; Matta, Sergio L. P.] Univ Fed Vicosa, Dept Gen Biol, Vicosa, MG, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Vicosa	Matta, SLP (corresponding author), Univ Fed Vicosa, Dept Gen Biol, Vicosa, MG, Brazil.	smatta@ufv.br	Gomes, Marcos/L-5734-2019; Freitas, Mariella B/H-9512-2015	Gomes, Marcos/0000-0003-4397-4609; Freitas, Mariella/0000-0001-5132-242X; Morais, Danielle/0000-0003-3277-1857	FAPEMIG - Research Foundation of the State of Minas Gerais; CAPES - Coordination for the Improvement of Higher Level Personnel	FAPEMIG - Research Foundation of the State of Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES - Coordination for the Improvement of Higher Level Personnel(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The work was supported by the following: FAPEMIG - Research Foundation of the State of Minas Gerais, http://www.fapemig.br; and CAPES - Coordination for the Improvement of Higher Level Personnel, http://www.capes.gov.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Almeida FFL, 2006, BIOL REPROD, V75, P792, DOI 10.1095/biolreprod.106.053835; Altringham J D, 1996, BATS BIOL BEHAV, P2; Amann R.P., 1970, TESTIS, V1, P433, DOI DOI 10.1016/B978-0-12-386601-1.50013-5; AMANN RP, 1962, J DAIRY SCI, V45, P774, DOI 10.3168/jds.S0022-0302(62)89487-9; Baker J. R., 1938, P161; Balarini MK, 2012, THERIOGENOLOGY, V77, P873, DOI 10.1016/j.theriogenology.2011.09.011; Beguelini MR, 2011, MICRON, V42, P586, DOI 10.1016/j.micron.2011.02.004; Beguelini MR, 2009, J MORPHOL, V270, P943, DOI 10.1002/jmor.10731; Bernardi I. P., 2011, THESIS FEDERAL U PAR; BERNDTSON WE, 1977, J ANIM SCI, V44, P818, DOI 10.2527/jas1977.445818x; Bittencourt V. L., 2004, Revista Brasileira de Reproducao Animal, V28, P108; Bittencourt VL, 2007, REV CERES, V54, P329; Blanco-Rodriguez J, 1998, INT J ANDROL, V21, P236; Caldeira Bianca Cabral, 2010, Rev. Ceres, V57, P569; Costa KLC, 2011, ANIM REPROD SCI, V127, P202, DOI 10.1016/j.anireprosci.2011.07.016; Costa DS, 2007, ANIM REPROD SCI, V98, P322, DOI 10.1016/j.anireprosci.2006.03.014; Costa GMJ, 2008, THERIOGENOLOGY, V70, P1136, DOI 10.1016/j.theriogenology.2008.06.035; Costa GMJ, 2010, J ANDROL, V31, P489, DOI 10.2164/jandrol.109.009787; Couto D, 2005, ACTA ZOOL-STOCKHOLM, V86, P111, DOI 10.1111/j.1463-6395.2005.00191.x; Crichton E. G., 2000, LIFE HIST REPROD STR, P364; de Barros JBG, 2007, ANIM REPROD SCI, V102, P350, DOI 10.1016/j.anireprosci.2007.04.002; de Azevedo MHF, 2010, ANIM REPROD SCI, V118, P83, DOI 10.1016/j.anireprosci.2009.05.018; Franca LR, 2003, BIOL REPROD, V68, P1554, DOI 10.1095/biolreprod.102.010652; Franca LR, 1998, MALE REPROD MULTIDIS, V197, P219; Fraune J, 2012, EXP CELL RES, V318, P1340, DOI 10.1016/j.yexcr.2012.02.018; GOLFARI L., 1975, ZONEAMENTO ECOLOGICO; Guiao-Leite F. L., 2003, Revista Brasileira de Reproducao Animal, V27, P21; HAPPOLD DCD, 1990, J ZOOL, V222, P557, DOI 10.1111/j.1469-7998.1990.tb06014.x; HEIDEMAN PD, 1994, BIOL REPROD, V50, P607, DOI 10.1095/biolreprod50.3.607; HERNANDEZ CS, 1986, SOUTHWEST NAT, V31, P331, DOI 10.2307/3671837; Johnson L, 2000, ANIM REPROD SCI, V60, P471, DOI 10.1016/S0378-4320(00)00108-1; Kaku-Oliveira Nathalia Y., 2010, Chiroptera Neotropical, V16, P22; KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137; KENAGY GJ, 1986, J MAMMAL, V67, P1, DOI 10.2307/1380997; Kimura M, 2003, J ANDROL, V24, P185; KUNZ TH, 1982, J MAMMAL, V63, P23, DOI 10.2307/1380667; Leal MC, 2006, BIOL REPROD, V74, P616, DOI 10.1095/biolreprod.105.048074; MARINHOFILHO JS, 1991, J TROP ECOL, V7, P59, DOI 10.1017/S0266467400005083; Mascarenhas RM, 2006, REV CERES, V53, P107; MCGUCKIN MA, 1987, AUST J BIOL SCI, V40, P203; Mello MAR, 2009, CAN J ZOOL, V87, P239, DOI 10.1139/Z09-010; Mello MAR, 2008, J MAMMAL, V89, P485, DOI 10.1644/06-MAMM-A-411R.1; Melo FCSA, 2010, BIOL RES, V43, P445, DOI [/S0716-97602010000400009, 10.4067/S0716-97602010000400009]; Miranda D. C., 2012, THESIS FEDERAL U VIC; Morais DB, 2013, ANIM REPROD SCI, V140, P268, DOI 10.1016/j.anireprosci.2013.06.003; Morais DB, 2013, J ANAT, V222, P372, DOI 10.1111/joa.12016; Morais DB, 2012, ASIAN PAC J REPROD, V1, P303, DOI DOI 10.1016/S2305-0500(13)60097-4; Oliveira RL, 2009, GEN COMP ENDOCR, V161, P283, DOI 10.1016/j.ygcen.2009.01.019; Orsi Antonio Marcos, 1993, Revista Brasileira de Biologia, V53, P583; Passos Fernando C., 2003, Rev. Bras. Zool., V20, P511, DOI 10.1590/S0101-81752003000300024; Paula T.A.R., 2002, BIOSCI J, V18, P121; Paula TAR, 1999, TISSUE CELL, V31, P327, DOI 10.1054/tice.1999.0039; REIS N. R., 2007, SUBFAMILIA STERNODER; ROOSENRU.EC, 1973, J REPROD FERTIL, V35, P339; Russell L. D., 1993, SERTOLI CELL; RUSSELL LD, 1984, J REPROD FERTIL, V70, P635, DOI 10.1530/jrf.0.0700635; Russell LD, 1990, HISTOLOGICAL HISTOPA, P1; Saidapur S. K., 1992, Indian Journal of Experimental Biology, V30, P1037; Sazima M, 2003, ANN BOT-LONDON, V92, P725, DOI 10.1093/aob/mcg190; SINGWI MS, 1983, ACTA ANAT, V116, P136; TADDEI V A, 1976, Boletim de Zoologia, V1, P313; Wilson D.E., 1979, Texas Tech University Museum Special Publications, P317; Xie Wen-Jun, 2012, Yichuan, V34, P167, DOI 10.3724/SP.J.1005.2012.00167; Yang ZW, 1998, J CLIN ENDOCR METAB, V83, P1284; Zhengwei Y, 1997, J Androl, V18, P681; Zortea M, 2008, BIODIVERS CONSERV, V17, P1	67	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101759	10.1371/journal.pone.0101759	http://dx.doi.org/10.1371/journal.pone.0101759			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003782	Green Submitted, gold, Green Published			2022-12-27	WOS:000339242700062
J	Ponnuchamy, R; Bonhomme, V; Prasad, S; Das, L; Patel, P; Gaucherel, C; Pragasam, A; Anupama, K				Ponnuchamy, Raja; Bonhomme, Vincent; Prasad, Srinivasan; Das, Lipi; Patel, Prakash; Gaucherel, Cedric; Pragasam, Arunachalam; Anupama, Krishnamurthy			Honey Pollen: Using Melissopalynology to Understand Foraging Preferences of Bees in Tropical South India	PLOS ONE			English	Article							MULTIVARIATE-ANALYSIS; CONSERVATION; FORESTS; RESTORATION; POLLINATION; FREQUENCY; GRADIENT; PLANTS; TREES	The aim of the study was to use melissopalynology to delineate the foraging preferences of bees in tropical environs. This was done by comparing pollen spectra obtained from the same hives every three months for three years at four sampling locations (in two sites) within a confined landscape mosaic. If melissopalynology is highly replicable, the spatial variation of the pollen spectrum from the honey samples would be much more than the temporal (inter-annual) variations. In other words, given the three factors, Month, Year and Location, honey pollen from different Locations, in a given Year and Month, would be much less similar than samples from different Years, in a given Location and Month. We then determined how the factors, Month, Year and Location, influenced the pollen influx of honey. The pollen analyses of the 42 honey samples collected during the three years yielded 80 pollen taxa/types: 72 dicotyledonous and 8 monocotyledonous, encompassing 41 botanical families spread into seven life forms namely, trees, shrubs, epiphytes, herbs, climbers, grasses, and sedges. Our results showed that pollen spectra were equally comparable between Locations and between Months and Years; the importance of this result is that it helped to demonstrate the complexity of ecological/environmental phenomena involved in the process of foraging by bees in a heterogeneous and complex landscape.	[Ponnuchamy, Raja; Bonhomme, Vincent; Prasad, Srinivasan; Gaucherel, Cedric; Anupama, Krishnamurthy] UMIFRE 21 CNRS MAEE USR 3330, French Inst Pondicherry, Dept Ecol, Pondicherry, India; [Pragasam, Arunachalam] Kanchi Mamunivar Ctr Postgrad Studies, Dept Bot, Pondicherry, India; [Das, Lipi; Patel, Prakash] Sri Aurobindo Int Ctr Educ, Pondicherry, India	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Kanchi Mamunivar Government Institute for Post graduate Studies & Research	Anupama, K (corresponding author), UMIFRE 21 CNRS MAEE USR 3330, French Inst Pondicherry, Dept Ecol, Pondicherry, India.	anupama.k@ifpindia.org		Vincent, Bonhomme/0000-0002-2742-6349	French Institute of Pondicherry	French Institute of Pondicherry	Ms. Sieglind D'Arcy provided financial support through a donation that helped provide a Doctoral fellowship to the first author ( RP). She had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other funding is available for this project. Publication fee has been provided by The French Institute of Pondicherry.	Aronne G, 2010, PLANT BIOSYST, V144, P833, DOI 10.1080/11263504.2010.514125; Baldock KCR, 2011, ECOLOGY, V92, P687, DOI 10.1890/10-1110.1; Bawa KS, 2003, AM J BOT, V90, P877, DOI 10.3732/ajb.90.6.877; BAWA KS, 1990, ANNU REV ECOL SYST, V21, P399, DOI 10.1146/annurev.es.21.110190.002151; Bhargava HR., 2009, APIACTA, V44, P14; Bilisik A, 2008, GRANA, V47, P70, DOI 10.1080/00173130801923976; Bogdanov S, 2007, J APICULT RES, V46, P269, DOI 10.1080/00218839.2007.11101407; Borchert R, 2004, GLOBAL ECOL BIOGEOGR, V13, P409, DOI 10.1111/j.1466-822X.2004.00111.x; Bryant V. M., 2001, PALYNOLOGY, V25, P11, DOI DOI 10.1080/01916122.2001.9989554; Champion H. G., 1968, REVISED SURVEY FORES, P404; Corbella E, 2008, CHIL J AGR RES, V68, P102, DOI 10.4067/S0718-58392008000100010; Corlett RT, 2004, BIOL REV, V79, P497, DOI 10.1017/S1464793103006341; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; ERDTMAN G., 1960, SVENSK BOT TIDSKR, V54, P561; Erdtman G., 1969, HDB PALYNOLOGY MORPH; Grim EC, 1987, TILIA TILIA GRAPH; HERRERA CM, 1995, ECOLOGY, V76, P218, DOI 10.2307/1940644; Herrero B, 2002, CAN J PLANT SCI, V82, P75, DOI 10.4141/P00-187; Huang T. C., 1972, POLLEN FLORA TAIWAN; Iversen J, 1989, J BIOGEOGR; JATO MV, 1994, GRANA, V33, P260, DOI 10.1080/00173139409429008; Jens MO, 2008, ECOLOGY, V89, P1573, DOI DOI 10.1890/07-0451.1; JHANSI P, 1994, APIDOLOGIE, V25, P289, DOI 10.1051/apido:19940303; Jones Gretchen D., 1992, Palynology, V16, P63, DOI 10.1080/01916122.1992.9989407; Liow LH, 2001, J APPL ECOL, V38, P180, DOI 10.1046/j.1365-2664.2001.00582.x; LOUVEAUX J, 1978, BEE WORLD, V59, P139, DOI 10.1080/0005772X.1978.11097714; Maurizio A., 1975, HONEY A COMPREHENSIV, P240; Meher-Homji VM, 1966, INDIAN GEOGRAPHICAL, V41, P9; Meher- Homji VM, 1974, J ECOLOGY ENV SCI, V1, P19; MOAR NT, 1985, NEW ZEAL J AGR RES, V28, P39, DOI 10.1080/00288233.1985.10426997; Montenegro Gloria, 2010, Braz. J. Bot., V33, P615, DOI 10.1590/S0100-84042010000400010; Moore P.D., 1991, BLACKWELL SCI PUBLI; Nair PKK, 1964, J INDIAN BOT SOC, V43, P171; Nascimento DL, 2012, EXTREME EFFECTS SEAS, V2012, DOI [10.1155/2012/267361, DOI 10.1155/2012/267361]; Nayar TS., 1990, POLLEN FLORA MAHARAS; OKSANEN FJ, 2011, VEGAN COMMUNITY ECOL; Oldroyd BP, 2009, APIDOLOGIE, V40, P296, DOI 10.1051/apido/2009021; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Parthasarathy N, 2008, TROP CONSERV SCI, V1, P89, DOI 10.1177/194008290800100203; Pragasam A., 2013, CHECK LIST, V9, P555, DOI 10.15560/9.3.555; Punt W, 2007, REV PALAEOBOT PALYNO, V143, P1, DOI 10.1016/j.revpalbo.2006.06.008; Ramanujam C.C.K., 1992, Geophytology, V22, P261; Rands SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002007; Rivera G, 2001, TREE PHYSIOL, V21, P201, DOI 10.1093/treephys/21.4.201; Sajwani A, 2007, PALYNOLOGY, V31, P63, DOI 10.2113/gspalynol.31.1.63; Sajwani A, 2014, PALYNOLOGY, V38, P207, DOI 10.1080/01916122.2013.871652; Schemske DW, 2009, ANNU REV ECOL EVOL S, V40, P245, DOI 10.1146/annurev.ecolsys.39.110707.173430; Selva Singh Richard P, 2011, INDIAN FOR, V137, P962; SHARMA M, 1970, Grana, V10, P35, DOI 10.1080/00173137009429855; SIVARAJ N, 1989, VEGETATIO, V79, P85, DOI 10.1007/BF00044851; Song XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049545; Thomas SG, 2009, TROP ECOL, V50, P79; Tissot C., 1994, POLLEN WET EVERGREEN; Todd FE, 1942, J ECON ENTOMOL, V35, P728, DOI 10.1093/jee/35.5.728; Vasanthy G., 1976, POLLEN S INDIAN HILL; Venables WN., 2002, MODERN APPL STAT S 4; Waters R, 1915, J AGR, V11, P213; Winfree R, 2010, ANN NY ACAD SCI, V1195, P169, DOI 10.1111/j.1749-6632.2010.05449.x; Wodehouse RP., 1959, POLLEN GRAINS THEIR	59	21	31	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101618	10.1371/journal.pone.0101618	http://dx.doi.org/10.1371/journal.pone.0101618			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004103	gold, Green Published			2022-12-27	WOS:000339242700046
J	Teh, X; Khosravi, Y; Lee, WC; Leow, AHR; Loke, MF; Vadivelu, J; Goh, KL				Teh, Xinsheng; Khosravi, Yalda; Lee, Woon Ching; Leow, Alex Hwong Ruey; Loke, Mun Fai; Vadivelu, Jamuna; Goh, Khean Lee			Functional and Molecular Surveillance of Helicobacter pylori Antibiotic Resistance in Kuala Lumpur	PLOS ONE			English	Article							23S RIBOSOMAL-RNA; CLARITHROMYCIN RESISTANCE; FLUOROQUINOLONE RESISTANCE; POINT MUTATIONS; GYRA MUTATIONS; FRXA GENES; ERADICATION; METRONIDAZOLE; MANAGEMENT; QUADRUPLE	Background: Helicobacter pylori is the etiological agent for diseases ranging from chronic gastritis and peptic ulcer disease to gastric adenocarcinoma and primary gastric B-cell lymphoma. Emergence of resistance to antibiotics possesses a challenge to the effort to eradicate H. pylori using conventional antibiotic-based therapies. The molecular mechanisms that contribute to the resistance of these strains have yet to be identified and are important for understanding the evolutional pattern and selective pressure imposed by the environment. Methods and Findings: H. pylori was isolated from 102 patients diagnosed with gastrointestinal diseases, who underwent endoscopy at University Malaya Medical Centre (UMMC). The isolates were tested for their susceptibility on eleven antibiotics using Etest. Based on susceptibility test, 32.3% of the isolates were found to have primary metronidazole resistance; followed by clarithromycin (6.8%) and fluoroquinolones (6.8%). To further investigate the resistant strains, mutational patterns of gene rdxA, frxA, gyrA, gyrB, and 23S rRNA were studied. Consistent with the previous reports, metronidazole resistance was prevalent in the local population. However, clarithromycin, fluoroquinolone and multi-drug resistance were shown to be emerging. Molecular patterns correlated well with phenotypic data. Interestingly, multi-drug resistant (MDR) strains were found to be associated with higher minimum inhibitory concentration (MIC) than their single-drug resistant (SDR) counterparts. Most importantly, clarithromycin-resistant strains were suggested to have a higher incidence for developing multi-drug resistance. Conclusion: Data from this study highlighted the urgency to monitor closely the prevalence of antibiotic resistance in the Malaysian population; especially that of clarithromycin and multi-drug resistance. Further study is needed to understand the molecular association between clarithromycin resistance and multi-drug resistance in H. pylori. The report serves a reminder that a strict antibiotic usage policy is needed in Malaysia and other developing countries (especially those where H. pylori prevalence remained high).	[Teh, Xinsheng; Khosravi, Yalda; Lee, Woon Ching; Loke, Mun Fai; Vadivelu, Jamuna] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Leow, Alex Hwong Ruey; Goh, Khean Lee] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Vadivelu, J (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	jamuna@ummc.edu.my	Goh, Khean-Lee/B-6404-2009; Loke, Mun Fai/B-1060-2011; Leow, Alex HR/B-1626-2017; VADIVELU, JAMUNARANI S/B-8696-2010	Goh, Khean-Lee/0000-0002-9965-1561; Loke, Mun Fai/0000-0002-3554-5313; Leow, Alex HR/0000-0003-1752-0435; VADIVELU, JAMUNARANI S/0000-0001-7322-3676	University of Malaya - Ministry of Education (UM-MOE) High Impact Research (HIR) Grant [UM.C/625/1/HIR/MOE/CHAN/02]	University of Malaya - Ministry of Education (UM-MOE) High Impact Research (HIR) Grant	University of Malaya - Ministry of Education (UM-MOE) High Impact Research (HIR) Grant (UM.C/625/1/HIR/MOE/CHAN/02, HIR Account No: H-50001-A00014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo S, 2011, REV ESP QUIM, V24, P32; Ahmad N, 2011, HELICOBACTER, V16, P47, DOI 10.1111/j.1523-5378.2010.00816.x; Ahmad N, 2009, WORLD J GASTROENTERO, V15, P3161, DOI 10.3748/wjg.15.3161; Bago J, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-13; Baldwin CM, 2009, DRUGS, V69, P1373, DOI 10.2165/00003495-200969100-00007; Binh TT, 2013, J CLIN GASTROENTEROL, V47, P233, DOI 10.1097/MCG.0b013e3182676e2b; Chang WL, 2012, HELICOBACTER, V17, P210, DOI 10.1111/j.1523-5378.2012.00935.x; Corry JEL, 2003, HDB CULTURE MEDIA FO, Vxiv; Cuadrado-Lavin A, 2012, J ANTIMICROB CHEMOTH, V67, P170, DOI 10.1093/jac/dkr410; Dorer MS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000544; Dunn BE, 1997, CLIN MICROBIOL REV, V10, P720, DOI 10.1128/CMR.10.4.720; Farhana F, 2009, TROP BIOMED, V26, P262; Fischbach L, 2007, ALIMENT PHARM THER, V26, P343, DOI 10.1111/j.1365-2036.2007.03386.x; Gao W, 2010, HELICOBACTER, V15, P460, DOI 10.1111/j.1523-5378.2010.00788.x; Garcia M, 2012, ANTIMICROB AGENTS CH, V56, P550, DOI 10.1128/AAC.05243-11; Gerrits MM, 2004, J MED MICROBIOL, V53, P1123, DOI 10.1099/jmm.0.45701-0; GISBERT JP, 2008, GASTROENTEROLOGY S1, V134, pA333; Goh KL, 2012, ALIMENT PHARM THER, V35, P1486, DOI 10.1111/j.1365-2036.2012.05120.x; Goh KL, 2012, ALIMENT PHARM THER, V35, P1097, DOI 10.1111/j.1365-2036.2012.05054.x; Goh KL, 2011, HELICOBACTER, V16, P1, DOI 10.1111/j.1523-5378.2011.00874.x; Goh KL, 2011, HELICOBACTER, V16, P241, DOI 10.1111/j.1523-5378.2011.00841.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Han FC, 2007, RES MICROBIOL, V158, P38, DOI 10.1016/j.resmic.2006.10.001; Hansomburana Piyathida, 2012, J Med Assoc Thai, V95 Suppl 3, pS28; Hirata K, 2010, J GASTROEN HEPATOL, V25, pS75, DOI 10.1111/j.1440-1746.2009.06220.x; Ho SL, 2010, J DIGEST DIS, V11, P101, DOI 10.1111/j.1751-2980.2010.00423.x; Katelaris PH, 2002, GASTROENTEROLOGY, V123, P1763, DOI 10.1053/gast.2002.37051; Kese D, 2009, HEPATO-GASTROENTEROL, V56, P925; Khan R, 2004, ANTIMICROB AGENTS CH, V48, P3567, DOI 10.1128/AAC.48.9.3567-3569.2004; Kim N, 2011, GASTROENTEROLOGY, V140, pS881; Lee JH, 2005, ANTIMICROB AGENTS CH, V49, P1600, DOI 10.1128/AAC.49.4.1600-1603.2005; Lee JW, 2013, HELICOBACTER, V18, P206, DOI 10.1111/hel.12031; Liu ZQ, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-81; Lui SY, 2003, J CLIN MICROBIOL, V41, P5011, DOI 10.1128/JCM.41.11.5011-5014.2003; Malfertheiner P, 1997, EUR J GASTROEN HEPAT, V9, P1; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Megraud F, 2012, THER ADV GASTROENTER, V5, P103, DOI 10.1177/1756283X11432492; Nishizawa T, 2006, ANTIMICROB AGENTS CH, V50, P1538, DOI 10.1128/AAC.50.4.1538-1540.2006; Paul R, 2001, ANTIMICROB AGENTS CH, V45, P962, DOI 10.1128/AAC.45.3.962-965.2001; Qua CS, 2010, J DIGEST DIS, V11, P244, DOI 10.1111/j.1751-2980.2010.00445.x; Rimbara E, 2012, HELICOBACTER, V17, P36, DOI 10.1111/j.1523-5378.2011.00912.x; Saravolatz LD, 2003, CLIN INFECT DIS, V37, P1210, DOI 10.1086/378809; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan HJ, 2008, J DIGEST DIS, V9, P186, DOI 10.1111/j.1751-2980.2008.00344.x; Tangmankongworakoon Nathaya, 2003, Journal of the Medical Association of Thailand, V86, pS439; Tankovic J, 2003, ANTIMICROB AGENTS CH, V47, P3942, DOI 10.1128/AAC.47.12.3942-3944.2003; Wang LH, 2010, WORLD J GASTROENTERO, V16, P2272, DOI 10.3748/wjg.v16.i18.2272; [WHO] World Health Organization, 2011, AG CLASS IARC MON, V1-102; Wu CY, 2009, GASTROENTEROLOGY, V137, P1641, DOI 10.1053/j.gastro.2009.07.060; Wuppenhorst N, 2011, J ANTIMICROB CHEMOTH, V66, P222, DOI 10.1093/jac/dkq405; Zullo A, 2011, GUT, V60, P1604, DOI 10.1136/gut.2010.231233	51	42	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101481	10.1371/journal.pone.0101481	http://dx.doi.org/10.1371/journal.pone.0101481			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003707	Green Published, gold, Green Submitted			2022-12-27	WOS:000339242700034
J	Huang, HL; Kung, PT; Chiu, CF; Wang, YH; Tsai, WC				Huang, Hsiu-Ling; Kung, Pei-Tseng; Chiu, Chang-Fang; Wang, Yueh-Hsin; Tsai, Wen-Chen			Factors Associated with Lung Cancer Patients Refusing Treatment and Their Survival: A National Cohort Study under a Universal Health Insurance in Taiwan	PLOS ONE			English	Article							SEX-ASSOCIATED DIFFERENCES; BREAST-CANCER; STAGE; COMORBIDITY; PROGNOSIS; RESECTION; AUTONOMY; VALUES	Background: Lung cancer is the leading cause mortality among all cancers in Taiwan. Although Taiwan offers National Health Insurance (NHI), occasionally, patients refuse treatment. This study examined the patient characteristics and factors associated with lung cancer patients refusing cancer treatment in four months after cancer diagnosed and compared the survival differences between treated and non-treated patients. Methods: The study included 38584 newly diagnosed lung cancer patients between 2004 and 2008, collected from the Taiwan Cancer Registry, which was linked with NHI research database and Cause of Death data set. Logistic regression was conducted to analyze factors associated with treatment refusal. The Cox proportional hazards model was used to examine the effects of treatment and non-treatment on patient survival and the factors affecting non-treatment patient survival. Results: Among the newly diagnosed cancer patients, older adults, or those who had been diagnosed with other catastrophic illnesses, an increased pre-cancer Charlson Comorbidity Index (CCI) score, and advanced stage cancer exhibited an increased likelihood of refusing treatment. Compared with treated patients, non-treated patients showed an increased mortality risk of 2.09 folds. The 1-year survival rate of treated patients (53.32%) was greater than that of non-treated patients (21.44%). Among the non-treated patients, those who were older, resided in lowly urbanized areas, had other catastrophic illnesses, a CCI score of >= 4, advanced cancer, or had received a diagnosis from a private hospital exhibited an increased mortality risk. Conclusions: Despite Taiwan's NHI system, some lung cancer patients choose not to receive cancer treatment and the mortality rate for non-treated patients is significantly higher than that of patients who undergo treatment. Therefore, to increase the survival rate of cancer patients, treatment refusal should be addressed.	[Huang, Hsiu-Ling; Wang, Yueh-Hsin; Tsai, Wen-Chen] China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan; [Huang, Hsiu-Ling] Minist Hlth & Welf, Hosp & Social Welf Org Adm Commiss, Taipei, Taiwan; [Kung, Pei-Tseng] Asia Univ, Dept Healthcare Adm, Taichung, Taiwan; [Chiu, Chang-Fang] China Med Univ, Dept Internal Med, Taichung, Taiwan	China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan	Tsai, WC (corresponding author), China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan.	wtsai@mail.cmu.edu.tw	Tsai, Wen-Chen/O-3095-2015	Tsai, Wen-Chen/0000-0002-9684-0789; Wang, Yueh-Hsin/0000-0002-1282-5945	China Medical University [CMU100-ASIA-9, DOH101-HP-1501]; Asia University; Taiwan Health Promotion Administration	China Medical University(China Medical University); Asia University; Taiwan Health Promotion Administration	This study was supported by grants (CMU100-ASIA-9, DOH101-HP-1501) from China Medical University, Asia University, and the Taiwan Health Promotion Administration. The authors are grateful for use of the National Health Insurance Research Database and the Cancer Register Files provided by Statistic Center of Department of Health and Welfare, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. China Medical University's website: http://english.cmu.edu.tw/. Asia University's website: http://www.asia.edu.tw/EN/. Health Promotion Administration's website: http://www.hpa.gov.tw/English/Index.aspx.	Brown JS, 1996, THORAX, V51, P564, DOI 10.1136/thx.51.6.564; Chadha AS, 2005, ANTICANCER RES, V25, P3517; Chen CYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015939; Chi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035809; Chu F-YS, 2012, COMPLEMENTARY ALTERN; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Ferguson MK, 2000, ANN THORAC SURG, V69, P245, DOI 10.1016/S0003-4975(99)01078-4; FERGUSON MK, 1990, J CLIN ONCOL, V8, P1402, DOI 10.1200/JCO.1990.8.8.1402; Hedestig O, 2003, CANCER NURS, V26, P55, DOI 10.1097/00002820-200302000-00008; HUCHCROFT SA, 1993, CANCER CAUSE CONTROL, V4, P179; Huijer M, 2000, J MED ETHICS, V26, P358, DOI 10.1136/jme.26.5.358; Janssen-Heijnen MLG, 2004, THORAX, V59, P602, DOI 10.1136/thx.2003.018044; Khakwani A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089426; Konigsberg RD, 2011, TIME, V177, P77; Konigsberg Ruth Davis, 2011, Time, V177, P72; Kowalski LP, 2000, EUR J CANCER, V36, P1032, DOI 10.1016/S0959-8049(00)00054-X; Kutlay H, 2003, ACTA CHIR BELG, V103, P293; LEECHIONG TL, 1993, CLIN CHEST MED, V14, P453; Lin JH, 2011, CANCER PREV RES, V4, P1360, DOI 10.1158/1940-6207.CAPR-11-0380; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; Ma HX, 2011, LUNG CANCER, V74, P164, DOI 10.1016/j.lungcan.2011.03.005; Marshall CA, 2013, PSYCHO-ONCOLOGY, V22, P470, DOI 10.1002/pon.2108; Mystakidou K, 2007, INT J PSYCHIAT MED, V37, P201, DOI 10.2190/0509-7332-388N-566W; Ou SHI, 2008, CANCER-AM CANCER SOC, V112, P2011, DOI 10.1002/cncr.23397; Radley A, 2009, MORTALITY, V14, P309, DOI DOI 10.1080/13576270903257422; Sant M, 2003, INT J CANCER, V106, P416, DOI 10.1002/ijc.11226; Sensky T, 2002, BRIT MED J, V325, P175, DOI 10.1136/bmj.325.7357.175; Shubha R, 2007, J Psychosoc Nurs Ment Health Serv, V45, P24, DOI 10.3928/02793695-20070801-06; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Simon TG, 2012, EUROPEAN J RADIOLOGY; Taiwan Cancer Registry, 2008, CANC STAT; Taiwan National Health Insurance Administration MoHW, 2013, STAT SURVEYS; Tsai W-C, 2012, EXPLORING REASONS NO; Turner D, 2013, PSYCHO-ONCOLOGY, V22, P12, DOI 10.1002/pon.2050; van Kleffens T, 2004, SOC SCI MED, V58, P2325, DOI 10.1016/j.socscimed.2003.08.027; Walters S, 2013, THORAX, V68, P551, DOI 10.1136/thoraxjnl-2012-202297; Wang BY, 2013, J THORAC ONCOL, V8, P1128, DOI 10.1097/JTO.0b013e31829ceba4; Warnakulasuriya S, 2007, ORAL ONCOL, V43, P982, DOI 10.1016/j.oraloncology.2006.11.021; World Health Organization, 2008, CANC MORT MORB; Yim J, 2012, J EPIDEMIOL COMMUN H, V66, P37, DOI 10.1136/jech.2009.104554	40	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101731	10.1371/journal.pone.0101731	http://dx.doi.org/10.1371/journal.pone.0101731			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7WB	24999633	gold, Green Published, Green Submitted			2022-12-27	WOS:000338637300080
J	Zhang, X; Woolley, DG; Swinnen, SP; Feys, H; Meesen, R; Wenderoth, N				Zhang, Xue; Woolley, Daniel G.; Swinnen, Stephan P.; Feys, Hilde; Meesen, Raf; Wenderoth, Nicole			Changes in Corticomotor Excitability and Intracortical Inhibition of the Primary Motor Cortex Forearm Area Induced by Anodal tDCS	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; NONINVASIVE CORTICAL STIMULATION; STROKE PATIENTS; SILENT PERIOD; CORTICOCORTICAL INHIBITION; EFFECTIVE CONNECTIVITY; HUMANS; FACILITATION; MODULATION	Objective: Previous studies have investigated how tDCS over the primary motor cortex modulates excitability in the intrinsic hand muscles. Here, we tested if tDCS changes corticomotor excitability and/or cortical inhibition when measured in the extensor carpi radialis (ECR) and if these aftereffects can be successfully assessed during controlled muscle contraction. Methods: We implemented a double blind cross-over design in which participants (n = 16) completed two sessions where the aftereffects of 20 min of 1 mA (0.04 mA/cm(2)) anodal vs sham tDCS were tested in a resting muscle, and two more sessions where the aftereffects of anodal vs sham tDCS were tested in an active muscle. Results: Anodal tDCS increased corticomotor excitability in ECR when aftereffects were measured with a low-level controlled muscle contraction. Furthermore, anodal tDCS decreased short interval intracortical inhibition but only when measured at rest and after non-responders (n = 2) were removed. We found no changes in the cortical silent period. Conclusion: These findings suggest that targeting more proximal muscles in the upper limb with anodal tDCS is achievable and corticomotor excitability can be assessed in the presence of a low-level controlled contraction of the target muscle.	[Zhang, Xue; Woolley, Daniel G.; Swinnen, Stephan P.; Meesen, Raf; Wenderoth, Nicole] Katholieke Univ Leuven, Dept Kinesiol, Motor Control Lab, Movement Control & Neuroplast Res Grp, Leuven, Belgium; [Feys, Hilde] Katholieke Univ Leuven, Res Grp Neuromotor Rehabil, Dept Rehabil Sci, Leuven, Belgium; [Meesen, Raf] Hasselt Univ, Biomed Res Inst, REVAL Rehabil Res Ctr, Hasselt, Belgium; [Wenderoth, Nicole] ETH, Dept Hlth Sci & Technol, Neural Control Movement Lab, Zurich, Switzerland	KU Leuven; KU Leuven; Hasselt University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Wenderoth, N (corresponding author), Katholieke Univ Leuven, Dept Kinesiol, Motor Control Lab, Movement Control & Neuroplast Res Grp, Leuven, Belgium.	nicole.wenderoth@hest.ethz.ch	Cuypers, Koen/N-9918-2018; Wenderoth, Nicole/D-7262-2015; Meesen, Raf L/F-2582-2019	Wenderoth, Nicole/0000-0002-3246-9386; Meesen, Raf L/0000-0002-7938-3758	Flanders Fund for Scientific Research [G. 0758.10]	Flanders Fund for Scientific Research(FWO)	This work was funded by the Flanders Fund for Scientific Research (Project G. 0758.10). Xue Zhang is a pre-doctoral fellow of the Flanders Fund for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzese G, 1999, J PHYSIOL-LONDON, V514, P895, DOI 10.1111/j.1469-7793.1999.895ad.x; Antal A, 2007, EUR J NEUROSCI, V26, P2687, DOI 10.1111/j.1460-9568.2007.05896.x; Batsikadze G, 2013, J PHYSIOL-LONDON, V591, P1987, DOI 10.1113/jphysiol.2012.249730; Boggio PS, 2006, NEUROSCI LETT, V404, P232, DOI 10.1016/j.neulet.2006.05.051; Boros K, 2008, EUR J NEUROSCI, V27, P1292, DOI 10.1111/j.1460-9568.2008.06090.x; Bradnam LV, 2010, J NEUROPHYSIOL, V103, P2382, DOI 10.1152/jn.01046.2009; Byblow WD, 2012, PLOS ONE, V7, DOI [10.1371/journal.-pone.0033882, DOI 10.1371/JOURNAL.-PONE.0033882]; Cash RFH, 2013, J NEUROPHYSIOL, V109, P106, DOI 10.1152/jn.00584.2011; Cengiz B, 2013, EXP BRAIN RES, V225, P321, DOI 10.1007/s00221-012-3369-0; Chen R, 1998, J NEUROPHYSIOL, V80, P2870, DOI 10.1152/jn.1998.80.6.2870; Daskalakis ZJ, 2003, CLIN NEUROPHYSIOL, V114, P938, DOI 10.1016/S1388-2457(03)00038-5; Datta Abhishek, 2012, Front Psychiatry, V3, P91, DOI 10.3389/fpsyt.2012.00091; Di Lazzaro V, 1998, EXP BRAIN RES, V119, P265; Edwards DJ, 2009, RESTOR NEUROL NEUROS, V27, P199, DOI 10.3233/RNN-2009-0470; Fregni F, 2005, NEUROREPORT, V16, P1551, DOI 10.1097/01.wnr.0000177010.44602.5e; Furubayashi T, 2008, EXP BRAIN RES, V185, P279, DOI 10.1007/s00221-007-1149-z; Garvey MA, 2001, CLIN NEUROPHYSIOL, V112, P1451, DOI 10.1016/S1388-2457(01)00581-8; Hendy AM, 2013, MED SCI SPORT EXER, V45, P1721, DOI 10.1249/MSS.0b013e31828d2923; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; Hummel FC, 2010, NEUROBIOL AGING, V31, P2160, DOI 10.1016/j.neurobiolaging.2008.12.008; Ilic TV, 2002, J PHYSIOL-LONDON, V545, P153, DOI 10.1113/jphysiol.2002.030122; Jeffery DT, 2007, EXP BRAIN RES, V182, P281, DOI 10.1007/s00221-007-1093-y; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Lang N, 2004, EXP BRAIN RES, V156, P439, DOI 10.1007/s00221-003-1800-2; Liebetanz D, 2002, BRAIN, V125, P2238, DOI 10.1093/brain/awf238; Lindenberg R, 2010, NEUROLOGY, V75, P2176, DOI 10.1212/WNL.0b013e318202013a; Lopez-Alonso V, 2014, BRAIN STIMUL, V7, P372, DOI 10.1016/j.brs.2014.02.004; MacKinnon CD, 2005, ANN NEUROL, V58, P516, DOI 10.1002/ana.20599; Marquez CMS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027292; Martin PG, 2006, CLIN NEUROPHYSIOL, V117, P2684, DOI 10.1016/j.clinph.2006.08.008; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Miranda PC, 2006, CLIN NEUROPHYSIOL, V117, P1623, DOI 10.1016/j.clinph.2006.04.009; Nilsson J, 1997, J CLIN NEUROPHYSIOL, V14, P136, DOI 10.1097/00004691-199703000-00006; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2005, J PHYSIOL-LONDON, V568, P291, DOI 10.1113/jphysiol.2005.092429; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PALMER E, 1992, J PHYSIOL-LONDON, V448, P397, DOI 10.1113/jphysiol.1992.sp019048; Paulus W, 2008, BRAIN STIMUL, V1, P151, DOI 10.1016/j.brs.2008.06.002; Pennisi G, 1999, STROKE, V30, P2666, DOI 10.1161/01.STR.30.12.2666; Peurala SH, 2008, CLIN NEUROPHYSIOL, V119, P2291, DOI 10.1016/j.clinph.2008.05.031; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; RIDDING MC, 1995, J PHYSIOL-LONDON, V487, P541, DOI 10.1113/jphysiol.1995.sp020898; Rosanova M, 2012, BRAIN, V135, P1308, DOI 10.1093/brain/awr340; Rosenkranz K, 2003, J PHYSIOL-LONDON, V551, P649, DOI 10.1113/jphysiol.2003.043752; Rosenkranz K, 2005, BRAIN, V128, P918, DOI 10.1093/brain/awh402; Roshan L, 2003, EXP BRAIN RES, V151, P330, DOI 10.1007/s00221-003-1502-9; Rutiku R, 2013, EUR J NEUROSCI, V38, P3768, DOI 10.1111/ejn.12374; Sanger TD, 2001, J PHYSIOL-LONDON, V530, P307, DOI 10.1111/j.1469-7793.2001.0307l.x; Shimizu T, 1999, CLIN NEUROPHYSIOL, V110, P575, DOI 10.1016/S1388-2457(98)00081-9; Siebner HR, 1998, MUSCLE NERVE, V21, P1209, DOI 10.1002/(SICI)1097-4598(199809)21:9<1209::AID-MUS15>3.3.CO;2-O; Smith MJ, 2002, ANN NEUROL, V51, P599, DOI 10.1002/ana.10180; Squeri V, 2014, IEEE T NEUR SYS REH, V22, P312, DOI 10.1109/TNSRE.2013.2250521; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Stagg CJ, 2009, J NEUROSCI, V29, P5202, DOI 10.1523/JNEUROSCI.4432-08.2009; Stinear CM, 2004, MOVEMENT DISORD, V19, P1312, DOI 10.1002/mds.20160; Suzuki K, 2012, INT J NEUROSCI, V122, P675, DOI 10.3109/00207454.2012.707715; Uy J, 2003, J NEUROSCI METH, V127, P193, DOI 10.1016/S0165-0270(03)00142-0; WASSERMANN EM, 1992, ELECTROEN CLIN NEURO, V85, P1, DOI 10.1016/0168-5597(92)90094-R; Wiethoff S, 2014, BRAIN STIMUL, V7, P468, DOI 10.1016/j.brs.2014.02.003	60	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101496	10.1371/journal.pone.0101496	http://dx.doi.org/10.1371/journal.pone.0101496			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999827	gold, Green Published, Green Submitted			2022-12-27	WOS:000338637300050
J	Dale, G; Arnell, KM				Dale, Gillian; Arnell, Karen M.			Lost in the Forest, Stuck in the Trees: Dispositional Global/Local Bias Is Resistant to Exposure to High and Low Spatial Frequencies	PLOS ONE			English	Article							FACE RECOGNITION; NAVON LETTERS; BIG PICTURE; POSITIVE EMOTIONS; VISUAL-PERCEPTION; PROCESSING BIAS; ATTENTION; FEATURES; LEVEL; INFORMATION	Visual stimuli can be perceived at a broad, "global'' level, or at a more focused, "local'' level. While research has shown that many individuals demonstrate a preference for global information, there are large individual differences in the degree of global/local bias, such that some individuals show a large global bias, some show a large local bias, and others show no bias. The main purpose of the current study was to examine whether these dispositional differences in global/local bias could be altered through various manipulations of high/low spatial frequency. Through 5 experiments, we examined various measures of dispositional global/local bias and whether performance on these measures could be altered by manipulating previous exposure to high or low spatial frequency information (with high/low spatial frequency faces, gratings, and Navon letters). Ultimately, there was little evidence of change from pre-to-post manipulation on the dispositional measures, and dispositional global/local bias was highly reliable pre- to post-manipulation. The results provide evidence that individual differences in global/local bias or preference are relatively resistant to exposure to spatial frequency information, and suggest that the processing mechanisms underlying high/low spatial frequency use and global/local bias may be more independent than previously thought.	[Dale, Gillian; Arnell, Karen M.] Brock Univ, Dept Psychol, St Catharines, ON L2S 3A1, Canada	Brock University	Dale, G (corresponding author), Brock Univ, Dept Psychol, St Catharines, ON L2S 3A1, Canada.	Gillian.dale@brocku.ca		Dale, Gillian/0000-0002-8505-087X	National Sciences and Engineering Research Council of Canada (NSERC); Canadian Foundation for Innovation (CFI); Ontario Innovation Trust (OIT)	National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ontario Innovation Trust (OIT)	This work was funded by grants from the National Sciences and Engineering Research Council of Canada (NSERC) (http://www.nserc-crsng.gc.ca/index_eng.asp), the Canadian Foundation for Innovation (CFI) (http://www.innovation.ca/), and the Ontario Innovation Trust (OIT) (http://www.oit.on.ca/), to the second author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby FG, 1999, PSYCHOL REV, V106, P529, DOI 10.1037/0033-295X.106.3.529; Colzato LS, 2010, COGNITION, V117, P87, DOI 10.1016/j.cognition.2010.07.003; Dale G, 2013, ATTEN PERCEPT PSYCHO, V75, P394, DOI 10.3758/s13414-012-0416-7; Dale G, 2010, ATTEN PERCEPT PSYCHO, V72, P602, DOI 10.3758/APP.72.3.602; Davidoff J, 2008, COGNITION, V108, P702, DOI 10.1016/j.cognition.2008.06.004; Deruelle C, 2008, BRAIN COGNITION, V66, P115, DOI 10.1016/j.bandc.2007.06.001; Evans MA, 2000, NEUROPSYCHOLOGIA, V38, P225, DOI 10.1016/S0028-3932(99)00080-9; Finger K, 2002, APPL COGNITIVE PSYCH, V16, P887, DOI 10.1002/acp.922; Fink GR, 1997, P ROY SOC B-BIOL SCI, V264, P487, DOI 10.1098/rspb.1997.0070; Forster J, 2010, PSYCHOL INQ, V21, P257, DOI 10.1080/1047840X.2010.507989; Forster J, 2009, J EXP PSYCHOL GEN, V138, P88, DOI 10.1037/a0014484; Fredrickson BL, 2005, COGNITION EMOTION, V19, P313, DOI 10.1080/02699930441000238; Fredrickson BL, 2001, AM PSYCHOL, V56, P218, DOI 10.1037/0003-066X.56.3.218; Gable P, 2010, PSYCHOL SCI, V21, P211, DOI 10.1177/0956797609359622; Gable PA, 2008, PSYCHOL SCI, V19, P476, DOI 10.1111/j.1467-9280.2008.02112.x; Gao ZF, 2011, ATTEN PERCEPT PSYCHO, V73, P1477, DOI 10.3758/s13414-011-0109-7; Gasper K, 2002, PSYCHOL SCI, V13, P34, DOI 10.1111/1467-9280.00406; Hanif A, 2012, ACTA PSYCHOL, V139, P104, DOI 10.1016/j.actpsy.2011.09.010; Harmon-Jones E, 2012, SOC PERSONAL PSYCHOL, V6, P314, DOI 10.1111/j.1751-9004.2012.00432.x; Hills PJ, 2008, EUR J COGN PSYCHOL, V20, P561, DOI 10.1080/09541440701728524; Hills PJ, 2009, J EXP PSYCHOL HUMAN, V35, P1427, DOI 10.1037/a0015788; Hubner R, 2000, VIS COGN, V7, P465, DOI 10.1080/135062800394612; KIMCHI R, 1992, PSYCHOL BULL, V112, P24, DOI 10.1037/0033-2909.112.1.24; KIMCHI R, 1982, J EXP PSYCHOL HUMAN, V8, P521, DOI 10.1037/0096-1523.8.4.521; KINCHLA RA, 1979, PERCEPT PSYCHOPHYS, V25, P225, DOI 10.3758/BF03202991; LAMB MR, 1993, PERCEPT PSYCHOPHYS, V54, P773, DOI 10.3758/BF03211802; Lamb MR, 1998, PSYCHOL SCI, V9, P14, DOI 10.1111/1467-9280.00003; Lamb MR, 1996, PERCEPT PSYCHOPHYS, V58, P363, DOI 10.3758/BF03206812; Large ME, 2006, PERCEPT PSYCHOPHYS, V68, P845, DOI 10.3758/BF03193706; Lewis MB, 2009, EXP PSYCHOL, V56, P258, DOI 10.1027/1618-3169.56.4.258; Liberman N, 2009, COGNITIVE SCI, V33, P1330, DOI 10.1111/j.1551-6709.2009.01061.x; Macrae CN, 2002, PSYCHOL SCI, V13, P194, DOI 10.1111/1467-9280.00436; Marguc J, 2011, J PERS SOC PSYCHOL, V101, P883, DOI 10.1037/a0025013; Mathot S, 2010, ONLINE GABOR PATCH G; McKone E, 2010, VISION RES, V50, P1540, DOI 10.1016/j.visres.2010.05.010; Minear M, 2004, BEHAV RES METH INS C, V36, P630, DOI 10.3758/BF03206543; Moritz S, 2006, J INT NEUROPSYCH SOC, V12, P566, DOI 10.1017/S1355617706060577; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; NAVON D, 1981, PSYCHOL RES-PSYCH FO, V43, P1, DOI 10.1007/BF00309635; PAQUET L, 1984, CAN J PSYCHOL, V38, P45, DOI 10.1037/h0080783; Perfect TJ, 2003, PSYCHOL REP, V93, P393, DOI 10.2466/PR0.93.6.393-394; Robertson LC, 1996, J EXP PSYCHOL GEN, V125, P227, DOI 10.1037/0096-3445.125.3.227; Scherf KS, 2008, AUTISM RES, V1, P114, DOI 10.1002/aur.17; Scherf KS, 2009, CHILD DEV, V80, P162, DOI 10.1111/j.1467-8624.2008.01252.x; Shedden JM, 2003, VIS COGN, V10, P433, DOI 10.1080/13506280244000159; SHULMAN GL, 1986, PERCEPTION, V15, P259, DOI 10.1068/p150259; SHULMAN GL, 1987, PERCEPTION, V16, P89, DOI 10.1068/p160089; Sierra-Vazquez V, 2006, PERCEPTION, V35, P1583, DOI 10.1068/p5364; Stoesz BM, 2007, MUSIC PERCEPT, V25, P153, DOI 10.1525/MP.2007.25.2.153; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; VALENTINE T, 1988, BRIT J PSYCHOL, V79, P471, DOI 10.1111/j.2044-8295.1988.tb02747.x; WARD LM, 1982, J EXP PSYCHOL HUMAN, V8, P562, DOI 10.1037/0096-1523.8.4.562; Weston NJ, 2005, PSYCHON B REV, V12, P1038, DOI 10.3758/BF03206440; Woltin KA, 2012, J EXP SOC PSYCHOL, V48, P1179, DOI 10.1016/j.jesp.2012.03.004; Yovel G, 2001, J EXP PSYCHOL HUMAN, V27, P1369, DOI 10.1037/0096-1523.27.6.1369	55	17	17	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e98625	10.1371/journal.pone.0098625	http://dx.doi.org/10.1371/journal.pone.0098625			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3RT	24992321	Green Published, Green Submitted, gold			2022-12-27	WOS:000341253400005
J	Ruda, VM; Chandwani, R; Sehgal, A; Bogorad, RL; Akinc, A; Charisse, K; Tarakhovsky, A; Novobrantseva, TI; Koteliansky, V				Ruda, Vera M.; Chandwani, Rohit; Sehgal, Alfica; Bogorad, Roman L.; Akinc, Akin; Charisse, Klaus; Tarakhovsky, Alexander; Novobrantseva, Tatiana I.; Koteliansky, Victor			The Roles of Individual Mammalian Argonautes in RNA Interference In Vivo	PLOS ONE			English	Article							LIPID-LIKE MATERIALS; MICRORNA TARGETS; GENE-REGULATION; MESSENGER-RNAS; PROTEINS; SIRNAS; MIRNAS; THERAPEUTICS; DELIVERY; MECHANISMS	Argonaute 2 (Ago2) is the only mammalian Ago protein capable of mRNA cleavage. It has been reported that the activity of the short interfering RNA targeting coding sequence (CDS), but not 3' untranslated region (3'UTR) of an mRNA, is solely dependent on Ago2 in vitro. These studies utilized extremely high doses of siRNAs and overexpressed Ago proteins, as well as were directed at various highly expressed reporter transgenes. Here we report the effect of Ago2 in vivo on targeted knockdown of several endogenous genes by siRNAs, targeting both CDS and 39UTR. We show that siRNAs targeting CDS lose their activity in the absence of Ago2, whereas both Ago1 and Ago3 proteins contribute to residual 3'UTR-targeted siRNA-mediated knockdown observed in the absence of Ago2 in mouse liver. Our results provide mechanistic insight into two components mediating RNAi under physiological conditions: mRNA cleavage dependent and independent. In addition our results contribute a novel consideration for designing most efficacious siRNA molecules with the preference given to 3'UTR targeting as to harness the activity of several Ago proteins.	[Ruda, Vera M.; Bogorad, Roman L.; Koteliansky, Victor] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Sehgal, Alfica; Akinc, Akin; Charisse, Klaus; Novobrantseva, Tatiana I.] Alnylam Pharmaceut, Cambridge, MA 02139 USA; [Chandwani, Rohit; Tarakhovsky, Alexander] Rockefeller Univ, Lab Immune Cell Epigenet & Signaling, New York, NY 10021 USA	Massachusetts Institute of Technology (MIT); Rockefeller University	Ruda, VM (corresponding author), Novartis Pharma AG, Novartis Inst Biomed Res, Cambridge, MA 02139 USA.	rudavera@gmail.com; v.kotelianski@skolkovotech.ru		Chandwani, Rohit/0000-0003-4781-6069	Alnylam Pharmaceuticals	Alnylam Pharmaceuticals	This work was supported by Alnylam Pharmaceuticals. No additional funding was received for this study. Alnylam employees were collaborators on this project. Alnylam Pharmaceuticals had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BD, 2009, ENDOCRINOLOGY, V150, P14, DOI 10.1210/en.2008-0984; Akinc A, 2008, NAT BIOTECHNOL, V26, P561, DOI 10.1038/nbt1402; Akinc A, 2010, MOL THER, V18, P1357, DOI 10.1038/mt.2010.85; Akinc A, 2009, MOL THER, V17, P872, DOI 10.1038/mt.2009.36; Bartlett DW, 2006, NUCLEIC ACIDS RES, V34, P322, DOI 10.1093/nar/gkj439; Broderick JA, 2011, GENE THER, V18, P1104, DOI 10.1038/gt.2011.50; Burroughs AM, 2011, RNA BIOL, V8, P158, DOI 10.4161/rna.8.1.14300; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Cenik ES, 2011, CURR BIOL, V21, pR446, DOI 10.1016/j.cub.2011.05.020; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; De N, 2013, MOL CELL, V50, P344, DOI 10.1016/j.molcel.2013.04.001; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Ender C, 2010, J CELL SCI, V123, P1819, DOI 10.1242/jcs.055210; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Foster DJ, 2012, RNA, V18, P557, DOI 10.1261/rna.031120.111; Grimm D, 2010, J CLIN INVEST, V120, P3106, DOI 10.1172/JCI43565; Gu S, 2011, P NATL ACAD SCI USA, V108, P9208, DOI 10.1073/pnas.1018023108; Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552; Haussecker D, 2010, RNA, V16, P673, DOI 10.1261/rna.2000810; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Jayaraman M, 2012, ANGEW CHEM INT EDIT, V51, P8529, DOI 10.1002/anie.201203263; John M, 2007, NATURE, V449, P745, DOI 10.1038/nature06179; Kaelin WG, 2012, SCIENCE, V337, P421, DOI 10.1126/science.1225787; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Love KT, 2010, P NATL ACAD SCI USA, V107, P1864, DOI 10.1073/pnas.0910603106; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Mescalchin A, 2010, RNA, V16, P2529, DOI 10.1261/rna.2204610; Nakanishi K, 2012, NATURE, V486, P368, DOI 10.1038/nature11211; Nishihara T, 2013, NUCL ACIDS RES; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; Olejniczak SH, 2013, P NATL ACAD SCI USA, V110, P157, DOI 10.1073/pnas.1219958110; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Rettig GR, 2012, MOL THER, V20, P483, DOI 10.1038/mt.2011.263; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Semple SC, 2010, NAT BIOTECHNOL, V28, P172, DOI 10.1038/nbt.1602; Shi HF, 2007, RNA, V13, P1132, DOI 10.1261/rna.474707; Su H, 2009, GENE DEV, V23, P304, DOI 10.1101/gad.1749809; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vickers TA, 2009, NUCLEIC ACIDS RES, V37, P6927, DOI 10.1093/nar/gkp735; Wang BB, 2009, NAT STRUCT MOL BIOL, V16, P1259, DOI 10.1038/nsmb.1712; Wang DM, 2012, GENE DEV, V26, P693, DOI 10.1101/gad.182758.111; Wang HW, 2009, NAT STRUCT MOL BIOL, V16, P1148, DOI 10.1038/nsmb.1673; Wu LG, 2008, CURR BIOL, V18, P1327, DOI 10.1016/j.cub.2008.07.072; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Zeigerer A, 2012, NATURE, V485, P465, DOI 10.1038/nature11133	52	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101749	10.1371/journal.pone.0101749	http://dx.doi.org/10.1371/journal.pone.0101749			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992693	Green Published, Green Submitted, gold			2022-12-27	WOS:000341253400112
J	Xavier, FE; Blanco-Rivero, J; Sastre, E; Caracuel, L; Callejo, M; Balfagon, G				Xavier, Fabiano E.; Blanco-Rivero, Javier; Sastre, Esther; Caracuel, Laura; Callejo, Maria; Balfagon, Gloria			Tranilast Increases Vasodilator Response to Acetylcholine in Rat Mesenteric Resistance Arteries through Increased EDHF Participation	PLOS ONE			English	Article							OXIDE SYNTHASE EXPRESSION; VASCULAR SMOOTH-MUSCLE; NITRIC-OXIDE; ENDOTHELIAL DYSFUNCTION; K+ CHANNELS; MAST-CELLS; DEPENDENT RELAXATION; HYPERTENSIVE-RATS; SMALL-CONDUCTANCE; OXIDATIVE STRESS	Background and Purpose: Tranilast, in addition to its capacity to inhibit mast cell degranulation, has other biological effects, including inhibition of reactive oxygen species, cytokines, leukotrienes and prostaglandin release. In the current study, we analyzed whether tranilast could alter endothelial function in rat mesenteric resistance arteries (MRA). Experimental Approach: Acetylcholine-induced relaxation was analyzed in MRA (untreated and 1-hour tranilast treatment) from 6 month-old Wistar rats. To assess the possible participation of endothelial nitric oxide or prostanoids, acetylcholine-induced relaxation was analyzed in the presence of L-NAME or indomethacin. The participation of endothelium-derived hyperpolarizing factor (EDHF) in acetylcholine-induced response was analyzed by preincubation with TRAM-34 plus apamin or by precontraction with a high K+ solution. Nitric oxide (NO) and superoxide anion levels were measured, as well as vasomotor responses to NO donor DEA-NO and to large conductance calcium-activated potassium channel opener NS1619. Key Results: Acetylcholine-induced relaxation was greater in tranilast-incubated MRA. Acetylcholine-induced vasodilation was decreased by L-NAME in a similar manner in both experimental groups. Indomethacin did not modify vasodilation. Preincubation with a high K+ solution or TRAM-34 plus apamin reduced the vasodilation to ACh more markedly in tranilast-incubated segments. NO and superoxide anion production, and vasodilator responses to DEA-NO or NS1619 remained unmodified in the presence of tranilast. Conclusions and Implications: Tranilast increased the endothelium-dependent relaxation to acetylcholine in rat MRA. This effect is independent of the nitric oxide and cyclooxygenase pathways but involves EDHF, and is mediated by an increased role of small conductance calcium-activated K+ channels.	[Blanco-Rivero, Javier; Sastre, Esther; Caracuel, Laura; Callejo, Maria; Balfagon, Gloria] Univ Autonoma Madrid, Fac Med, Dept Fis, Madrid, Spain; [Blanco-Rivero, Javier; Sastre, Esther; Caracuel, Laura; Balfagon, Gloria] Inst Invest Sanitaria IdIPaz, Madrid, Spain; [Xavier, Fabiano E.] Univ Fed Pernambuco, Ctr Ciencias Biol, Dept Fisiol & Farmacol, Recife, PE, Brazil	Autonomous University of Madrid; Universidade Federal de Pernambuco	Balfagon, G (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Fis, Madrid, Spain.	gloria.balfagon@uam.es	Xavier, Fabiano Elias/G-1253-2012; Blanco-Rivero, Javier/J-6118-2014; Xavier, Fabiano/G-1253-2012	Xavier, Fabiano Elias/0000-0003-2028-2562; Blanco-Rivero, Javier/0000-0001-7232-2314; Xavier, Fabiano/0000-0002-1387-8491; Balfagon Calvo, Gloria/0000-0001-9477-7950	Ministerio de Ciencia e Innovacion [SAF 2009-10374]; Ministerio de Economia y Competitivida [SAF 2012-38530]; Fundacion Mapfre; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil)	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Economia y Competitivida; Fundacion Mapfre; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Ministerio de Ciencia e Innovacion (SAF 2009-10374), Ministerio de Economia y Competitivida (SAF 2012-38530), and Fundacion Mapfre. F.E. Xavier is recipient of research fellowship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aras-Lopez R, 2008, J PHYSIOL BIOCHEM, V64, P115, DOI 10.1007/BF03168239; AZUMA H, 1976, BRIT J PHARMACOL, V58, P483, DOI 10.1111/j.1476-5381.1976.tb08614.x; Bischoff SC, 2009, SEMIN IMMUNOPATHOL, V31, P185, DOI 10.1007/s00281-009-0165-4; Bot I, 2011, THROMB HAEMOSTASIS, V106, P820, DOI 10.1160/TH11-05-0291; Briones AM, 2000, BRIT J PHARMACOL, V131, P185, DOI 10.1038/sj.bjp.0703552; Cahill PA, 2001, PHARMACOL THERAPEUT, V89, P273, DOI 10.1016/S0163-7258(01)00128-0; COHEN RA, 1995, CIRCULATION, V92, P3337, DOI 10.1161/01.CIR.92.11.3337; Dalsgaard T, 2010, BRIT J PHARMACOL, V160, P1496, DOI 10.1111/j.1476-5381.2010.00803.x; Edwards G, 2010, PFLUG ARCH EUR J PHY, V459, P863, DOI 10.1007/s00424-010-0817-1; Feletou M, 2011, MORGAN CLAYPOOL LIFE; Feletou M, 2007, ANN MED, V39, P495, DOI 10.1080/07853890701491000; Feletou M, 2009, CLIN SCI, V117, P139, DOI 10.1042/CS20090096; Feng J, 2008, CIRCULATION, V118, pS46, DOI 10.1161/CIRCULATIONAHA.107.755827; Ferrer M, 1999, GEN PHARMACOL, V33, P35, DOI 10.1016/S0306-3623(98)00259-6; GARLAND CJ, 1992, BRIT J PHARMACOL, V105, P429, DOI 10.1111/j.1476-5381.1992.tb14270.x; Hishikawa K, 1996, J CARDIOVASC PHARM, V28, P200, DOI 10.1097/00005344-199608000-00004; HOJO M, 1994, ANN ALLERGY, V73, P21; HWA JJ, 1994, AM J PHYSIOL, V266, pH952, DOI 10.1152/ajpheart.1994.266.3.H952; Jain N, 2001, INDIAN J PEDIATR, V4, P31; Jones SE, 2004, J DIABETES COMPLICAT, V18, P309, DOI 10.1016/j.jdiacomp.2004.02.002; KHAN SA, 1993, J PHARMACOL EXP THER, V267, P1327; Konneh M, 1998, TRANILAST KISSEI PHA, V1, P141; Lagaud GJL, 1999, J PHARMACOL EXP THER, V290, P832; Loppnow H, 2008, INNATE IMMUN-LONDON, V14, P63, DOI 10.1177/1753425908091246; Luksha L, 2009, ATHEROSCLEROSIS, V202, P330, DOI 10.1016/j.atherosclerosis.2008.06.008; Mansouri K, 2011, MED HYPOTHESES, V76, P217, DOI 10.1016/j.mehy.2010.09.034; MIYACHI Y, 1987, J PHARMACOBIO-DYNAM, V10, P255, DOI 10.1248/bpb1978.10.255; MORI H, 1995, JPN J PHARMACOL, V67, P279, DOI 10.1254/jjp.67.279; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Onoue S, 2013, EUR J PHARM BIOPHARM; Pae HO, 2008, BIOCHEM BIOPH RES CO, V371, P361, DOI 10.1016/j.bbrc.2008.04.054; Platten M, 2003, BIOCHEM PHARMACOL, V66, P1263, DOI 10.1016/S0006-2952(03)00449-0; Ribatti D, 2012, CURR MED CHEM, V19, P955, DOI 10.2174/092986712799320655; Sastre E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073232; Sastre E, 2012, SHOCK, V38, P328, DOI 10.1097/SHK.0b013e31826240ba; Schemann M, 2013, GASTROENTEROLOGY, V144, P698, DOI 10.1053/j.gastro.2013.01.040; Shimokawa H, 1996, J CARDIOVASC PHARM, V28, P703, DOI 10.1097/00005344-199611000-00014; Shiota N, 2010, BRIT J PHARMACOL, V159, P626, DOI 10.1111/j.1476-5381.2009.00561.x; Takala J, 1996, BRIT J ANAESTH, V77, P50, DOI 10.1093/bja/77.1.50; Tan SM, 2011, NEPHROL DIAL TRANSPL, V26, P100, DOI 10.1093/ndt/gfq355; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; Triggle CR, 2012, CAN J PHYSIOL PHARM, V90, P713, DOI [10.1139/Y2012-073, 10.1139/y2012-073]; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; Vanhoutte PM, 2003, CIRC J, V67, P572; WALDRON GJ, 1994, BRIT J PHARMACOL, V112, P831, DOI 10.1111/j.1476-5381.1994.tb13154.x; Wenceslau CF, 2011, J VASC RES, V48, P316, DOI 10.1159/000322576; Wiggers GA, 2008, AM J PHYSIOL-HEART C, V295, pH1033, DOI 10.1152/ajpheart.00430.2008; Wulff H, 2013, J CARDIOVASC PHARM, V61, P102, DOI 10.1097/FJC.0b013e318279ba20; Xavier FE, 2008, BRIT J PHARMACOL, V154, P1225, DOI 10.1038/bjp.2008.200; Xavier FE, 2011, EUR J PHARMACOL, V654, P280, DOI 10.1016/j.ejphar.2011.01.007; Xavier FE, 2010, CLIN SCI, V119, P283, DOI 10.1042/CS20090536; Xavier FE, 2004, BRIT J PHARMACOL, V143, P215, DOI 10.1038/sj.bjp.0705919; Yang A, 2010, VASC PHARMACOL, V53, P122, DOI 10.1016/j.vph.2010.05.001; Yang X, 2014, J PHARMACOL SCI, V124, P18, DOI 10.1254/jphs.13151FP	54	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100356	10.1371/journal.pone.0100356	http://dx.doi.org/10.1371/journal.pone.0100356			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992476	gold, Green Published, Green Submitted			2022-12-27	WOS:000341253400022
J	Yi, ZA; Stunz, LL; Lin, WW; Bishop, GA				Yi, Zuoan; Stunz, Laura L.; Lin, Wai Wai; Bishop, Gail A.			TRAF3 Regulates Homeostasis of CD8(+) Central Memory T Cells	PLOS ONE			English	Article							RECEPTOR-ASSOCIATED FACTOR-3; B-INDUCING KINASE; PROTECTIVE IMMUNITY; DENDRITIC CELLS; ROLES; TOLERANCE; NAIVE	Our laboratory reported previously that TNF receptor associated factor 3 (TRAF3) is a positive regulator of TCR signaling and T cell function. In the current study, we present new findings that reveal differential roles for TRAF3 in the regulation of CD4(+) and CD8(+) T cells. In response to TCR stimulation in vitro, TRAF3 has greater impact in CD4+ T cells than in CD8(+) T cells. However, T cell-specific TRAF3 deficient mice (CD4(Cre) TRAF3(flox/flox); T-TRAF3(-/-)) have a greater number of CD4(+)CD44(hi) effector/memory T cells than littermate control (LMC) mice, possibly due to an inefficient suppressive effect of TRAF3 deficient Foxp3(+) regulatory T cells. In contrast, CD(8+)CD44(hi)CD62L(hi) central memory (Tcm) cells are markedly reduced in T-TRAF3(-/-) mice in comparison to LMC mice, although CD(8+)CD44(hi)CD62L(low) effector memory T (Tem) cells and naive T cells (CD(8+)CD44(low) CD62L(hi)) do not show significant differences in number. Importantly, TRAF3-deficient Tcm cells exhibit defective homeostasis due to impaired IL-15 signaling. These results indicate that the involvement of TRAF3 in IL-15 mediated signaling to T cells plays a previously unappreciated and critical role in CD(8+)Tcm cell regulation and maintenance.	[Yi, Zuoan; Stunz, Laura L.; Lin, Wai Wai; Bishop, Gail A.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Lin, Wai Wai; Bishop, Gail A.] Univ Iowa, Grad Program Immunol, Iowa City, IA 52242 USA; [Bishop, Gail A.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Bishop, Gail A.] VA Med Ctr, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Bishop, GA (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.	gail-bishop@uiowa.edu		Bishop, Gail/0000-0002-1291-5078	National Institutes of Health [P30CA086862, AI28847, T32 AI007260]; Veterans Administration Senior RCS Award; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007260, R29AI028847, R01AI028847, R56AI028847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001702] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration Senior RCS Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Veterans Affairs(US Department of Veterans Affairs)	National Institutes of Health (nih.gov): P30CA086862 (GAB), AI28847 (GAB), T32 AI007260 (ZY); Veterans Administration Senior RCS Award (Va.gov) (GAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Amsen D, 2013, ADV EXP MED BIOL, V785, P107, DOI 10.1007/978-1-4614-6217-0_12; Bishop GA, 2007, IMMUNOL RES, V39, P22, DOI 10.1007/s12026-007-0068-1; Bishop GA, 2013, J IMMUNOL, V191, P3483, DOI 10.4049/jimmunol.1390048; Boehm T, 2003, J EXP MED, V198, P757, DOI 10.1084/jem.20030794; Chang JH, 2014, J EXP MED, V211, P137, DOI 10.1084/jem.20131019; Gardam S, 2008, IMMUNITY, V28, P391, DOI 10.1016/j.immuni.2008.01.009; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hacker H, 2011, NAT REV IMMUNOL, V11, P457, DOI 10.1038/nri2998; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Hildebrand JM, 2011, IMMUNOL REV, V244, P55, DOI 10.1111/j.1600-065X.2011.01055.x; Hofmann J, 2011, J EXP MED, V208, P1917, DOI 10.1084/jem.20110128; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kajiura F, 2004, J IMMUNOL, V172, P2067, DOI 10.4049/jimmunol.172.4.2067; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Murray SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076216; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Rowe AM, 2013, J IMMUNOL, V191, P3663, DOI 10.4049/jimmunol.1301328; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Xie P, 2007, IMMUNITY, V27, P253, DOI 10.1016/j.immuni.2007.07.012; Xie P, 2011, J LEUKOCYTE BIOL, V90, P1149, DOI 10.1189/jlb.0111044; Xie P, 2011, J IMMUNOL, V186, P143, DOI 10.4049/jimmunol.1000290; Xu Y, 1996, IMMUNITY, V5, P407, DOI 10.1016/S1074-7613(00)80497-5; Yi ZA, 2014, CYTOKINE GROWTH F R, V25, P147, DOI 10.1016/j.cytogfr.2013.12.002; Yi ZA, 2013, J EXP MED, V210, P1079, DOI 10.1084/jem.20122135; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zhu MZ, 2006, J CLIN INVEST, V116, P2964, DOI 10.1172/JCI28326; Zhu S, 2010, J EXP MED, V207, P2647, DOI 10.1084/jem.20100703	35	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102120	10.1371/journal.pone.0102120	http://dx.doi.org/10.1371/journal.pone.0102120			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010048	Green Published, gold, Green Submitted			2022-12-27	WOS:000338763800070
J	Hass, M; Luttermann, C; Meyers, G				Hass, Maria; Luttermann, Christine; Meyers, Gregor			Feline Calicivirus Can Tolerate Gross Changes of Its Minor Capsid Protein Expression Levels Induced by Changing Translation Reinitiation Frequency or Use of a Separate VP2-Coding mRNA	PLOS ONE			English	Article							HEMORRHAGIC-DISEASE VIRUS; TRACT-BINDING-PROTEIN; RIBOSOME ENTRY SITE; OPEN READING FRAME; TERMINATION-REINITIATION; COUPLED TRANSLATION; SUBGENOMIC RNA; INTERNAL INITIATION; CDNA CONSTRUCTS; VP2 PROTEIN	Caliciviruses use reinitiation of translation governed by a 'termination upstream ribosomal binding site' (TURBS) for expression of their minor capsid protein VP2. Mutation analysis allowed to identify sequences surrounding the translational start/stop site of the feline calicivirus (FCV) that fine tune reinitiation frequency. A selection of these changes was introduced into the infectious FCV cDNA clone to check the influence of altered VP2 levels on virus replication. In addition, full length constructs were established that displayed a conformation, in which VP2 expression occurred under control of a duplicated subgenomic promoter. Viable viruses recovered from such constructs revealed a rather broad range of VP2 expression levels but comparable growth kinetics showing that caliciviruses can tolerate gross changes of the VP2 expression level.	[Hass, Maria; Luttermann, Christine; Meyers, Gregor] Friedrich Loeffler Inst, Inst Immunol, Tubingen, Germany	Friedrich Loeffler Institute	Meyers, G (corresponding author), Friedrich Loeffler Inst, Inst Immunol, Tubingen, Germany.	gregor.meyers@fli.bund.de	Luttermann, Christine/L-5440-2019	Luttermann, Christine/0000-0002-6977-9900	Deutsche Forschungsgemeinschaft [1367/3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grant Me 1367/3 from the Deutsche Forschungsgemeinschaft: http://www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian G, 2000, EMBO J, V19, P2681, DOI 10.1093/emboj/19.11.2681; Bertolotti-Ciarlet A, 2003, J VIROL, V77, P11603, DOI 10.1128/JVI.77.21.11603-11615.2003; Clarke I., 2012, CALICIVIRIDAE, P977; Clarke IN, 2000, J INFECT DIS, V181, pS309, DOI 10.1086/315575; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; Gould PS, 2014, RNA, V20, P373, DOI 10.1261/rna.041574.113; Gould PS, 2007, J VIROL, V81, P8488, DOI 10.1128/JVI.00457-07; Gould PS, 2005, J BIOL CHEM, V280, P21972, DOI 10.1074/jbc.M502276200; Herbert TP, 1997, J GEN VIROL, V78, P1033, DOI 10.1099/0022-1317-78-5-1033; HORVATH CM, 1990, EMBO J, V9, P2639, DOI 10.1002/j.1460-2075.1990.tb07446.x; Jackson RJ, 2005, BIOCHEM SOC T, V33, P1231, DOI 10.1042/BST0331231; Karakasiliotis I, 2006, J GEN VIROL, V87, P3339, DOI 10.1099/vir.0.82153-0; Karakasiliotis I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009562; Lancaster AM, 2006, RNA, V12, P894, DOI 10.1261/rna.2342306; Li H, 2011, J VIROL, V85, P7343, DOI 10.1128/JVI.00364-11; Lukavsky PJ, 2000, NAT STRUCT BIOL, V7, P1105; Luttermann C, 2007, J BIOL CHEM, V282, P7056, DOI 10.1074/jbc.M608948200; Luttermann C, 2010, CALICIVIRUSES: MOLECULAR AND CELLULAR VIROLOGY, P145; Luttermann C, 2009, GENE DEV, V23, P331, DOI 10.1101/gad.507609; Machin A, 2001, J BIOL CHEM, V276, P27787, DOI 10.1074/jbc.M100707200; McCormick CJ, 2008, J VIROL, V82, P8917, DOI 10.1128/JVI.02362-07; McFadden N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002413; Meyers G, 2000, VIROLOGY, V276, P349, DOI 10.1006/viro.2000.0545; Meyers G, 2003, J BIOL CHEM, V278, P34051, DOI 10.1074/jbc.M304874200; MEYERS G, 1991, VIROLOGY, V184, P677, DOI 10.1016/0042-6822(91)90437-G; Meyers G, 2007, J VIROL, V81, P9623, DOI 10.1128/JVI.00771-07; Morales M, 2004, J BIOL CHEM, V279, P17013, DOI 10.1074/jbc.M313674200; Napthine S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008390; Neill JD, 2002, VIRUS RES, V87, P89, DOI 10.1016/S0168-1702(02)00086-2; Pisarev AV, 2005, CR BIOL, V328, P589, DOI 10.1016/j.crvi.2005.02.004; Powell ML, 2008, RNA, V14, P2394, DOI 10.1261/rna.1231008; Powell ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016822; Poyry TAA, 2007, GENE DEV, V21, P3149, DOI 10.1101/gad.439507; PRASAD BVV, 1994, J MOL BIOL, V240, P256, DOI 10.1006/jmbi.1994.1439; Reusken CBEM, 2003, J GEN VIROL, V84, P1761, DOI 10.1099/vir.0.19063-0; REYNOLDS JE, 1995, EMBO J, V14, P6010, DOI 10.1002/j.1460-2075.1995.tb00289.x; Ryabova L, 2004, BIOCHEM SOC T, V32, P592, DOI 10.1042/BST0320592; Ryabova LA, 2006, VIRUS RES, V119, P52, DOI 10.1016/j.virusres.2005.10.017; SCHAFFER FL, 1980, J GEN VIROL, V47, P215, DOI 10.1099/0022-1317-47-1-215; SCHNELL MJ, 1994, EMBO J, V13, P4195, DOI 10.1002/j.1460-2075.1994.tb06739.x; Simmonds P, 2008, NUCLEIC ACIDS RES, V36, P2530, DOI 10.1093/nar/gkn096; Sosnovtsev SV, 2000, VIROLOGY, V277, P193, DOI 10.1006/viro.2000.0579; Sosnovtsev SV, 2005, J VIROL, V79, P4012, DOI 10.1128/JVI.79.7.4012-4024.2005; Sosnovtsev SV, 1998, J VIROL, V72, P3051, DOI 10.1128/JVI.72.4.3051-3059.1998; Subba-Reddy CV, 2012, J VIROL, V86, P10138, DOI 10.1128/JVI.01208-12; Thumfart JO, 2002, J VIROL, V76, P6398, DOI 10.1128/JVI.76.12.6398-6407.2002; Vongpunsawad S, 2013, J VIROL, V87, P4818, DOI 10.1128/JVI.03508-12; WYATT LS, 1995, VIROLOGY, V210, P202, DOI 10.1006/viro.1995.1332; Zhu S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003592	49	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102254	10.1371/journal.pone.0102254	http://dx.doi.org/10.1371/journal.pone.0102254			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007260	Green Published, gold			2022-12-27	WOS:000339040600110
J	Knowlden, SA; Capece, T; Popovic, M; Chapman, TJ; Rezaee, F; Kim, M; Georas, SN				Knowlden, Sara A.; Capece, Tara; Popovic, Milan; Chapman, Timothy J.; Rezaee, Fariba; Kim, Minsoo; Georas, Steve N.			Regulation of T Cell Motility In Vitro and In Vivo by LPA and LPA2	PLOS ONE			English	Article							LYSOPHOSPHATIDIC ACID RECEPTOR; PROTEIN-COUPLED RECEPTOR; HIGH ENDOTHELIAL VENULES; LUNG FIBROSIS; AUTOTAXIN EXPRESSION; LYSOPHOSPHOLIPASE-D; MOLECULAR-CLONING; PROMOTES; IDENTIFICATION; ACTIVATION	Lysophosphatidic acid (LPA) and the LPA-generating enzyme autotaxin (ATX) have been implicated in lymphocyte trafficking and the regulation of lymphocyte entry into lymph nodes. High local concentrations of LPA are thought to be present in lymph node high endothelial venules, suggesting a direct influence of LPA on cell migration. However, little is known about the mechanism of action of LPA, and more work is needed to define the expression and function of the six known G protein-coupled receptors (LPA 1-6) in T cells. We studied the effects of 18:1 and 16:0 LPA on naive CD4+ T cell migration and show that LPA induces CD4+ T cell chemorepulsion in a Transwell system, and also improves the quality of non-directed migration on ICAM-1 and CCL21 coated plates. Using intravital two-photon microscopy, lpa2-/- CD4+ T cells display a striking defect in early migratory behavior at HEVs and in lymph nodes. However, later homeostatic recirculation and LPA-directed migration in vitro were unaffected by loss of lpa2. Taken together, these data highlight a previously unsuspected and non-redundant role for LPA2 in intranodal T cell motility, and suggest that specific functions of LPA may be manipulated by targeting T cell LPA receptors.	[Knowlden, Sara A.; Capece, Tara; Popovic, Milan; Kim, Minsoo; Georas, Steve N.] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Chapman, Timothy J.; Georas, Steve N.] Univ Rochester, Med Ctr, Dept Med, Div Pulm & Crit Care Med, Rochester, NY 14642 USA; [Rezaee, Fariba] Univ Rochester, Med Ctr, Dept Pediat, Div Pediat Pulm Med, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Georas, SN (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	Steve_Georas@urmc.rochester.edu	Rezaee, Fariba/AAI-1437-2021	Rezaee, Fariba/0000-0002-7625-3341; Capece, Tara/0000-0001-9282-0273; Chapman, Timothy/0000-0002-2337-2136	NIH [R01 HL071933, P30 ES001247, HL018208, F32 HL110718, K12 HD068373, T32 AI007285]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD068373] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL110718, R01HL087088, R01HL071933, P01HL018208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The work was supported by the following funding sources: NIH R01 HL071933 and P30 ES001247 (SG); NIH HL018208 (MK); NIH F32 HL110718 (TC); NIH K12 HD068373 (FR); and T32 AI007285 (SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SZ, 1998, J BIOL CHEM, V273, P7906, DOI 10.1074/jbc.273.14.7906; An SZ, 1997, BIOCHEM BIOPH RES CO, V231, P619, DOI 10.1006/bbrc.1997.6150; Bai ZB, 2013, J IMMUNOL, V190, P2036, DOI 10.4049/jimmunol.1202025; Balazs L, 2001, AM J PHYSIOL-REG I, V280, pR466, DOI 10.1152/ajpregu.2001.280.2.R466; Bandoh K, 1999, J BIOL CHEM, V274, P27776, DOI 10.1074/jbc.274.39.27776; Cahalan MD, 2008, ANNU REV IMMUNOL, V26, P585, DOI 10.1146/annurev.immunol.24.021605.090620; Chen CG, 2012, ATHEROSCLEROSIS, V222, P74, DOI 10.1016/j.atherosclerosis.2012.02.010; Chen RJ, 2012, INT J CANCER, V131, P789, DOI 10.1002/ijc.26476; Chen SU, 2010, ENDOCRINOLOGY, V151, P369, DOI 10.1210/en.2009-0779; Clement CC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009863; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; Cui MZ, 2011, CLIN LIPIDOL, V6, P413, DOI 10.2217/CLP.11.38; Emo J, 2012, J IMMUNOL, V188, P3784, DOI 10.4049/jimmunol.1102956; Gan L, 2011, BIOCHEM BIOPH RES CO, V409, P7, DOI 10.1016/j.bbrc.2011.04.084; Goetzl EJ, 2000, J IMMUNOL, V164, P4996, DOI 10.4049/jimmunol.164.10.4996; Goldsmith Zachariah G, 2011, Genes Cancer, V2, P563, DOI 10.1177/1947601911419362; Guo H, 2013, ARCH GYNECOL OBSTET, V287, P131, DOI 10.1007/s00404-012-2479-z; Hayashi M, 2012, CANC LETT; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Hope JM, 2009, GYNECOL ONCOL, V112, P215, DOI 10.1016/j.ygyno.2008.09.019; Huang LS, 2013, AM J RESP CELL MOL B; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Jeong KJ, 2008, EXP MOL MED, V40, P607, DOI 10.3858/emm.2008.40.6.607; Kanda H, 2008, NAT IMMUNOL, V9, P415, DOI 10.1038/ni1573; Knowlden S GS, 2012, ATLAS GENET CYTOGENE; Knowlden S, 2014, J IMMUNOL, V192, P851, DOI 10.4049/jimmunol.1302831; Kotarsky K, 2006, J PHARMACOL EXP THER, V318, P619, DOI 10.1124/jpet.105.098848; Lai YJ, 2010, MOL CELL BIOL, V30, P5582, DOI 10.1128/MCB.00134-10; Lay MDH, 2009, J IMMUNOL, V182, P902, DOI 10.4049/jimmunol.182.2.902; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Lee SJ, 2011, GASTROENTEROLOGY, V140, P924, DOI 10.1053/j.gastro.2010.11.054; Leve F, 2011, EUR J PHARMACOL, V671, P7, DOI 10.1016/j.ejphar.2011.09.006; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Mionnet C, 2011, BLOOD, V118, P6115, DOI 10.1182/blood-2011-07-367409; Miyabe Y, 2013, ARTHRITIS RHEUM-US, V65, P2037, DOI 10.1002/art.37991; Nakasaki T, 2008, AM J PATHOL, V173, P1566, DOI 10.2353/ajpath.2008.071153; Nikitopoulou I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070941; Nikitopoulou I, 2012, J EXP MED, V209, P923, DOI 10.1084/jem.20112012; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; Oda SK, 2013, CANCER IMMUNOL RES, V1, P245, DOI 10.1158/2326-6066.CIR-13-0043-T; Oikonomou N, 2012, AM J RESP CELL MOL, V47, P566, DOI 10.1165/rcmb.2012-0004OC; Orosa B, 2014, ANN RHEUM DIS, V73, P298, DOI 10.1136/annrheumdis-2012-202832; Palmeri D, 2004, J LEUKOCYTE BIOL, V75, P910, DOI 10.1189/jlb.0903408; Park GY, 2013, AM J RESP CRIT CARE, V188, P928, DOI 10.1164/rccm.201306-1014OC; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Perrakis A, 2014, J LIPID RES; Ptaszynska MM, 2010, MOL CANCER RES, V8, P309, DOI 10.1158/1541-7786.MCR-09-0288; Ren B, 2011, BLOOD, V117, P6036, DOI 10.1182/blood-2010-12-326017; Rivera-Lopez CM, 2008, ANGIOGENESIS, V11, P301, DOI 10.1007/s10456-008-9113-5; Roozendaal R, 2009, IMMUNITY, V30, P264, DOI 10.1016/j.immuni.2008.12.014; Sevastou I, 2013, BBA-MOL CELL BIOL L, V1831, P42, DOI 10.1016/j.bbalip.2012.07.019; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Stam JC, 1998, EMBO J, V17, P4066, DOI 10.1093/emboj/17.14.4066; Swaney JS, 2010, BRIT J PHARMACOL, V160, P1699, DOI 10.1111/j.1476-5381.2010.00828.x; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Tang N, 2014, J CELL MOL MED, V18, P156, DOI 10.1111/jcmm.12178; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Xu J, 2004, J BIOL CHEM, V279, P10459, DOI 10.1074/jbc.M311891200; Yanagida K, 2009, J BIOL CHEM, V284, P17731, DOI 10.1074/jbc.M808506200; Ye XQ, 2011, FERTIL STERIL, V95, P2107, DOI 10.1016/j.fertnstert.2011.02.024; Zaslavsky A, 2006, BBA-MOL CELL BIOL L, V1761, P1200, DOI 10.1016/j.bbalip.2006.08.011; Zhang YF, 2012, J IMMUNOL, V189, P3914, DOI 10.4049/jimmunol.1201604; Zhao YT, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-114; Zheng YH, 2001, J IMMUNOL, V166, P2317, DOI 10.4049/jimmunol.166.4.2317; Zhou Z, 2011, CELL METAB, V13, P592, DOI 10.1016/j.cmet.2011.02.016	67	36	36	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101655	10.1371/journal.pone.0101655	http://dx.doi.org/10.1371/journal.pone.0101655			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003200	gold, Green Published, Green Submitted			2022-12-27	WOS:000339242700048
J	Watanabe, LA; Vallinoto, M; Neto, NA; Muriel-Cunha, J; Saint-Paul, U; Schneider, H; Sampaio, I				Watanabe, Luciana Almeida; Vallinoto, Marcelo; Neto, Nils Asp; Muriel-Cunha, Janice; Saint-Paul, Ulrich; Schneider, Horacio; Sampaio, Iracilda			The Past and Present of an Estuarine-Resident Fish, the "Four-Eyed Fish'' Anableps anableps (Cyprinodontiformes, Anablepidae), Revealed by mtDNA Sequences	PLOS ONE			English	Article							GENETIC-STRUCTURE; AMAZON BASIN; PERFORMANCE; DIVERGENCE; CONSERVATION; ALGORITHMS; SPECIATION; DISPERSAL; CLIMATE; MAXIMUM	Historical events, such as changes in sea level during the Pleistocene glacial cycles, had a strong impact on coastal habitats, limiting connectivity and promoting the genetic divergence of various species. In this study, we evaluated the influence of climate oscillations and the possibility of estuary function as a barrier to gene flow among populations of the four-eyed fish, Anableps anableps. This species is fully estuarine-resident, has internal fertilization, is viviparous and does not migrate across long distances. These features make the four-eyed fish an excellent model for the study of evolutionary processes related to genetic differentiation of species and populations in estuaries. The evolutionary history of A. anableps was inferred from phylogeographic and population analyses using sequences of the mitochondrial DNA Control Region of 13 populations distributed in the Amazon and Northeast Coast of Brazil from Calcoene (Amapa) to Parnaiba (Piaui). The 83 retrieved haplotypes show a pattern of four distinct mitochondrial lineages, with up to 3.4% nucleotide divergence among them. The evolutionary reconstruction suggests that these lineages diverged recently in the late Pleistocene/early Holocene after the Atlantic Ocean reaching current levels. Analysis of variability, neutrality and the genetic expansion pattern revealed that the lineages have distinct characteristics, which were shaped by the different geomorphological features of coastal regions combined with sea level oscillations over a very long period of time. Only few neighboring populations show a discreet gene flow. This study may also be helpful for designing new experiments to better understand the geomorphological evolutionary history of the estuaries of the Amazon and the Northeast Coast of Brazil using estuarine-resident species as a model.	[Watanabe, Luciana Almeida; Vallinoto, Marcelo; Muriel-Cunha, Janice; Schneider, Horacio; Sampaio, Iracilda] Univ Fed Para UFPA, Inst Estudos Costeiros, Lab Filogen & Bioinformat, Belem, Para, Brazil; [Neto, Nils Asp] Univ Fed Para UFPA, Inst Estudos Costeiros, Lab Geol Costeira, Belem, Para, Brazil; [Saint-Paul, Ulrich] Univ Bremen, Ctr Marine Trop Ecol, D-28359 Bremen, Germany	Universidade Federal do Para; Universidade Federal do Para; University of Bremen	Sampaio, I (corresponding author), Univ Fed Para UFPA, Inst Estudos Costeiros, Lab Filogen & Bioinformat, Campus Braganca, Belem, Para, Brazil.	ira@ufpa.br	Vallinoto, Marcelo/J-3086-2012; Asp, Nils/J-6226-2012; SAMPAIO, IRACILDA/J-6514-2012; Schneider, Horacio/J-7131-2012; Vallinoto, Marcelo/ABF-9834-2021	Vallinoto, Marcelo/0000-0002-3465-3830; Asp, Nils/0000-0002-6468-6158; SAMPAIO, IRACILDA/0000-0002-2137-4656; Schneider, Horacio/0000-0002-5987-6395; Vallinoto, Marcelo/0000-0002-3465-3830; Muriel-Cunha, Janice/0000-0002-8267-6068	CNPq [306233/2009-6, 473341/2010-7, 305645/2009-9]; DAAD/CAPES [BEX 11447/13-3]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); DAAD/CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by CNPq, grants 306233/2009-6 (to I.S.), 473341/2010-7 and 305645/2009-9 (to H.S.). www.cnpq.br; DAAD/CAPES, grant BEX 11447/13-3, www.capes.gov.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Beheregaray LB, 2001, MOL ECOL, V10, P2849, DOI 10.1046/j.1365-294X.2001.t01-1-01406.x; Benzie JAH, 2002, MOL ECOL, V11, P2553, DOI 10.1046/j.1365-294X.2002.01638.x; Bilton DT, 2002, ESTUAR COAST SHELF S, V55, P937, DOI 10.1006/ecss.2002.1037; Butler A.J., 1999, SEAGRASS AUSTR STRAT; Chenoweth SF, 2003, MOL ECOL, V12, P2387, DOI 10.1046/j.1365-294X.2003.01921.x; Chenoweth SF, 1998, P ROY SOC B-BIOL SCI, V265, P415, DOI 10.1098/rspb.1998.0310; Cohen Marcelo C. L., 2005, Wetlands Ecology and Management, V13, P433, DOI 10.1007/s11273-004-0413-2; Corander J, 2004, BIOINFORMATICS, V20, P2363, DOI 10.1093/bioinformatics/bth250; Domingues VS, 2007, MOL ECOL, V16, P3592, DOI 10.1111/j.1365-294X.2007.03405.x; Donaldson KA, 1999, MOL PHYLOGENET EVOL, V13, P208, DOI 10.1006/mpev.1999.0625; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Durand JD, 2005, MOL PHYLOGENET EVOL, V36, P277, DOI 10.1016/j.ympev.2005.01.019; El-Robrini E, 1992, REGISTRO OSCILACOES, P73; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Faulks LK, 2010, CONSERV GENET, V11, P921, DOI 10.1007/s10592-009-9936-7; Filho PWMS, 2006, J COASTAL RES, P306; Franzinelli E., 1992, EVOLUTION LITTORAUX, P203; Ghedotti MJ, 2003, CHECK LIST FRESHWATE, P582; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haberle SG, 1999, QUATERNARY RES, V51, P27, DOI 10.1006/qres.1998.2020; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Imbrie J, 1992, PALEOCEANOGRAPHY, V7, P701, DOI 10.1029/92PA02253; Imron, 2007, MOL ECOL, V16, P289, DOI 10.1111/j.1365-294X.2006.03141.x; Lambeck K, 2002, NATURE, V419, P199, DOI 10.1038/nature01089; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu JX, 2007, MOL ECOL, V16, P275, DOI 10.1111/j.1365-294X.2006.03140.x; Miranda L.B., 2012, PRINCIPIOS OCEANOGRA; Nascimento F.L., 2008, B MUSEU PARAENSE EMI, V3, P229; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Page TJ, 2010, J FISH BIOL, V77, P2093, DOI 10.1111/j.1095-8649.2010.02821.x; Rambaut A, 2009, TRACER; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Rossetti DF, 2008, HOLOCENE, V18, P923, DOI 10.1177/0959683608091798; SALATI E, 1984, SCIENCE, V225, P129, DOI 10.1126/science.225.4658.129; Salzburger W, 2011, MOL ECOL, V20, P1952, DOI 10.1111/j.1365-294X.2011.05066.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santa Brigida EL, 2007, J BRAZ BIOL, V67, P919; Schwab I R, 2001, Trans Am Ophthalmol Soc, V99, P145; SIVAK JG, 1976, VISION RES, V16, P531, DOI 10.1016/0042-6989(76)90035-3; Souza Filho P.W.M., 2005, REV BRAS GEOFISICA, V23, P427, DOI DOI 10.1590/S0102-261X2005000400006; Souza Filho PWM, 2000, REV BRASILEIRA GEOCI, V30, P527; Souza PWM, 2009, LECT NOTES EARTH SCI, V107, P347; Tanabe AS, 2007, MOL ECOL NOTES, V7, P962, DOI 10.1111/j.1471-8286.2007.01807.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torres AM, 2006, EROSAO PROGRADACAO L, P1; Turner CL, 1938, J MORPHOL, V62, P323, DOI 10.1002/jmor.1050620208; Waters JM, 2007, SYST BIOL, V56, P271, DOI 10.1080/10635150701313855; Worheide G, 2002, MOL ECOL, V11, P1753, DOI 10.1046/j.1365-294X.2002.01570.x; Yokoyama Y, 2000, NATURE, V406, P713, DOI 10.1038/35021035	51	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101727	10.1371/journal.pone.0101727	http://dx.doi.org/10.1371/journal.pone.0101727			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003185	Green Submitted, gold, Green Published			2022-12-27	WOS:000339242700057
J	Lin, TY; Chou, CF; Chung, HY; Chiang, CY; Li, CH; Wu, JL; Lin, HJ; Pai, TW; Hu, CH; Tzou, WS				Lin, Tzung-Yi; Chou, Chi-Fu; Chung, Hsin-Yu; Chiang, Chia-Yin; Li, Chung-Hao; Wu, Jen-Leih; Lin, Han-Jia; Pai, Tun-Wen; Hu, Chin-Hwa; Tzou, Wen-Shyong			Hypoxia-Inducible Factor 2 Alpha Is Essential for Hepatic Outgrowth and Functions via the Regulation of leg1 Transcription in the Zebrafish Embryo	PLOS ONE			English	Article							INDUCED GENE-EXPRESSION; HIPPEL-LINDAU PROTEIN; LIVER DEVELOPMENT; ENDODERM FORMATION; GROWTH-FACTOR; FACTOR-I; MESODERMAL SIGNALS; DIGESTIVE ORGANS; CELL-CYCLE; HOMEOSTASIS	The liver plays a vital role in metabolism, detoxification, digestion, and the maintenance of homeostasis. During development, the vertebrate embryonic liver undergoes a series of morphogenic processes known as hepatogenesis. Hepatogenesis can be separated into three interrelated processes: endoderm specification, hepatoblast differentiation, and hepatic outgrowth. Throughout this process, signaling molecules and transcription factors initiate and regulate the coordination of cell proliferation, apoptosis, differentiation, intercellular adhesion, and cell migration. Hifs are already recognized to be essential in embryonic development, but their role in hepatogenesis remains unknown. Using the zebrafish embryo as a model organism, we report that the lack of Hif2-alpha but not Hif1-alpha blocks hepatic outgrowth. While Hif2-alpha is not involved in hepatoblast specification, this transcription factor regulates hepatocyte cell proliferation during hepatic outgrowth. Furthermore, we demonstrated that the lack of Hif2-alpha can reduce the expression of liver-enriched gene 1 (leg1), which encodes a secretory protein essential for hepatic outgrowth. Additionally, exogenous mRNA expression of leg1 can rescue the small liver phenotype of hif2-alpha morphants. We also showed that Hif2-alpha directly binds to the promoter region of leg1 to control leg1 expression. Interestingly, we discovered overrepresented, high-density Hif-binding sites in the potential upstream regulatory sequences of leg1 in teleosts but not in terrestrial mammals. We concluded that hif2-alpha is a key factor required for hepatic outgrowth and regulates leg1 expression in zebrafish embryos. We also proposed that the hif2-alpha-leg1 axis in liver development may have resulted from the adaptation of teleosts to their environment.	[Lin, Tzung-Yi; Chou, Chi-Fu; Chung, Hsin-Yu; Chiang, Chia-Yin; Li, Chung-Hao; Lin, Han-Jia; Hu, Chin-Hwa] Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Keelung, Taiwan; [Wu, Jen-Leih] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Pai, Tun-Wen] Natl Taiwan Ocean Univ, Dept Comp Sci & Engn, Keelung, Taiwan; [Tzou, Wen-Shyong] Natl Taiwan Ocean Univ, Dept Life Sci, Keelung, Taiwan	National Taiwan Ocean University; Academia Sinica - Taiwan; National Taiwan Ocean University; National Taiwan Ocean University	Tzou, WS (corresponding author), Natl Taiwan Ocean Univ, Dept Life Sci, Keelung, Taiwan.	wstzou@ntou.edu.tw	Hu, Chin-Hwa/D-1178-2009; Tzou, Wen-Shyong/H-4517-2014	Hu, Chin-Hwa/0000-0001-9582-2303; Tzou, Wen-Shyong/0000-0002-6726-1390; Lin, Han-Jia/0000-0002-4929-6573	National Science Council, Taiwan, R.O.C. [NSC 95-2113-M-019-003, NSC 96-2627-B-019-002, NSC 97-2627-B-019-002, NSC 98-2627-B-019-002, NSC 98-2313-B-019-004-MY3, NSC 101-2311-B-019-001, NSC 102-2627-B-019-002-, NSC 102-2633-B-019-001]; Center of Excellence for the Oceans, National Taiwan Ocean University	National Science Council, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan); Center of Excellence for the Oceans, National Taiwan Ocean University	This work was supported by the National Science Council, Taiwan, R.O.C. (Grant Nos. NSC 95-2113-M-019-003, NSC 96-2627-B-019-002, NSC 97-2627-B-019-002, NSC 98-2627-B-019-002, NSC 98-2313-B-019-004-MY3, NSC 101-2311-B-019-001, NSC 102-2627-B-019-002-, NSC 102-2633-B-019-001) and the Center of Excellence for the Oceans, National Taiwan Ocean University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 1999, CURR BIOL, V9, P1147, DOI 10.1016/S0960-9822(00)80016-0; Allende ML, 1996, GENE DEV, V10, P3141, DOI 10.1101/gad.10.24.3141; Barriga EH, 2013, J CELL BIOL, V201, P759, DOI 10.1083/jcb.201212100; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Calmont A, 2006, DEV CELL, V11, P339, DOI 10.1016/j.devcel.2006.06.015; Chang CQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022910; Chang CT, 2013, TOXICOL APPL PHARM, V270, P174, DOI 10.1016/j.taap.2013.04.010; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Cheng W, 2006, DEV BIOL, V294, P482, DOI 10.1016/j.ydbio.2006.03.018; Chu J, 2009, HEPATOLOGY, V50, P1656, DOI 10.1002/hep.23157; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; Copple BL, 2009, LIVER INT, V29, P1010, DOI 10.1111/j.1478-3231.2009.02015.x; Costa RH, 2003, HEPATOLOGY, V38, P1331, DOI 10.1016/j.hep.2003.09.034; Covassin L, 2006, DEV BIOL, V299, P551, DOI 10.1016/j.ydbio.2006.08.020; Das SK, 2013, CANCER RES, V73, P844, DOI 10.1158/0008-5472.CAN-12-1681; Farooq M, 2008, DEV BIOL, V317, P336, DOI 10.1016/j.ydbio.2008.02.034; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Fradette C, 2003, BRIT J PHARMACOL, V140, P1146, DOI 10.1038/sj.bjp.0705543; Goessling W, 2008, DEV BIOL, V320, P161, DOI 10.1016/j.ydbio.2008.05.526; Gotea V, 2010, GENOME RES, V20, P565, DOI 10.1101/gr.104471.109; Holtzinger A, 2005, DEVELOPMENT, V132, P4005, DOI 10.1242/dev.01978; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huang H, 2008, DEVELOPMENT, V135, P3209, DOI 10.1242/dev.024406; Imanirad P, 2014, STEM CELL RES, V12, P24, DOI 10.1016/j.scr.2013.09.006; Ito K, 2012, CANCER METAST REV, V31, P763, DOI 10.1007/s10555-012-9388-2; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kajimura S, 2006, MOL CELL BIOL, V26, P1142, DOI 10.1128/MCB.26.3.1142-1155.2006; Kajimura S, 2005, P NATL ACAD SCI USA, V102, P1240, DOI 10.1073/pnas.0407443102; Kawasaki I, 2013, MOL CELLS, V36, P410, DOI 10.1007/s10059-013-0170-2; Ko CY, 2011, CELL DEATH DIFFER, V18, P1757, DOI 10.1038/cdd.2011.44; Korzh S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-84; Latimer AJ, 2008, DEV DYNAM, V237, P3904, DOI 10.1002/dvdy.21794; Lemaigre FP, 2009, GASTROENTEROLOGY, V137, P62, DOI 10.1053/j.gastro.2009.03.035; Lettice LA, 2012, DEV CELL, V22, P459, DOI 10.1016/j.devcel.2011.12.010; Li Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030186, 10.1371/journal.pone.0029003, 10.1371/journal.pone.0042558, 10.1371/journal.pone.0030835, 10.1371/journal.pone.0044441, 10.1371/journal.pone.0035543, 10.1371/journal.pone.0035122]; Li YH, 2010, J BIOL CHEM, V285, P41001, DOI 10.1074/jbc.M110.138743; Liao W, 2000, DEVELOPMENT, V127, P4303; Lifanov AP, 2003, GENOME RES, V13, P579, DOI 10.1101/gr.668403; Lu HQ, 2013, DEV CELL, V24, P543, DOI 10.1016/j.devcel.2013.01.021; Marneros AG, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003573; Mayer AN, 2003, DEVELOPMENT, V130, P3917, DOI 10.1242/dev.00600; Moorman C, 2006, P NATL ACAD SCI USA, V103, P12027, DOI 10.1073/pnas.0605003103; Nath B, 2012, HEPATOLOGY, V55, P622, DOI 10.1002/hep.25497; Nguyen AD, 2007, J BIOL CHEM, V282, P27436, DOI 10.1074/jbc.M704976200; Niu XB, 2010, SCI CHINA LIFE SCI, V53, P455, DOI 10.1007/s11427-010-0078-4; Ober EA, 2003, MECH DEVELOP, V120, P5, DOI 10.1016/S0925-4773(02)00327-1; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Park SK, 2003, MOL CELL BIOL, V23, P4959, DOI 10.1128/MCB.23.14.4959-4971.2003; Passeri MJ, 2009, HEPATOLOGY, V49, P443, DOI 10.1002/hep.22667; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Piret JP, 2002, ANN NY ACAD SCI, V973, P443, DOI 10.1111/j.1749-6632.2002.tb04680.x; Ramakrishnan SK, 2014, MOL CELL BIOL, V34, P1208, DOI 10.1128/MCB.01441-13; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Rankin EB, 2009, MOL CELL BIOL, V29, P4527, DOI 10.1128/MCB.00200-09; Reiter JF, 1999, GENE DEV, V13, P2983, DOI 10.1101/gad.13.22.2983; Reiter JF, 2001, DEVELOPMENT, V128, P125; Rossi JM, 2001, GENE DEV, V15, P1998, DOI 10.1101/gad.904601; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Sadler KC, 2007, P NATL ACAD SCI USA, V104, P1570, DOI 10.1073/pnas.0610774104; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Scortegagna M, 2005, BLOOD, V105, P3133, DOI 10.1182/blood-2004-05-1695; Shepard JL, 2004, METHOD CELL BIOL, V76, P109; Shin D, 2007, DEVELOPMENT, V134, P2041, DOI 10.1242/dev.000281; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Sun CF, 2011, GEN COMP ENDOCR, V172, P409, DOI 10.1016/j.ygcen.2011.04.005; Takahashi R, 2004, BIOCHEM BIOPH RES CO, V317, P84, DOI 10.1016/j.bbrc.2004.03.010; Tanimizu N, 2007, INT REV CYTOL, V259, P1, DOI 10.1016/S0074-7969(06)59001-1; Tao T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058858; Tao T, 2009, J GENET GENOMICS, V36, P325, DOI 10.1016/S1673-8527(08)60121-6; Thompson MD, 2007, HEPATOLOGY, V45, P1298, DOI 10.1002/hep.21651; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Tsai SM, 2013, TRANSGENIC RES, V22, P301, DOI 10.1007/s11248-012-9636-9; van Rooijen E, 2009, BLOOD, V113, P6449, DOI 10.1182/blood-2008-07-167890; Wallace KN, 2001, GENESIS, V30, P141, DOI 10.1002/gene.1050; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Westerfield M., 2000, GUIDE LAB USE ZEBRAF; Woollett LA, 2008, ANNU REV NUTR, V28, P97, DOI 10.1146/annurev.nutr.26.061505.111311; Yoon D, 2006, J BIOL CHEM, V281, P25703, DOI 10.1074/jbc.M602329200; Yu RMK, 2012, ENVIRON SCI TECHNOL, V46, P9112, DOI 10.1021/es301758c; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200; Zhang P, 2012, AM J PHYSIOL-REG I, V303, pR1165, DOI 10.1152/ajpregu.00340.2012; Zorn A. M., 2008, STEMBOOK	89	30	30	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101980	10.1371/journal.pone.0101980	http://dx.doi.org/10.1371/journal.pone.0101980			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000307	Green Submitted, Green Published, gold			2022-12-27	WOS:000338637300109
J	Ouyang, W; Chen, SY; Cai, GQ; Hao, FH				Ouyang, Wei; Chen, Siyang; Cai, Guanqing; Hao, Fanghua			Dryland Soil Hydrological Processes and Their Impacts on the Nitrogen Balance in a Soil-Maize System of a Freeze-Thawing Agricultural Area	PLOS ONE			English	Article							NONPOINT-SOURCE POLLUTION; USE EFFICIENCY; CROPPING SYSTEM; WINTER-WHEAT; WATER-USE; GROWTH; MODEL; DYNAMICS; CROPS; FERTILIZATION	Understanding the fates of soil hydrological processes and nitrogen (N) is essential for optimizing the water and N in a dryland crop system with the goal of obtaining a maximum yield. Few investigations have addressed the dynamics of dryland N and its association with the soil hydrological process in a freeze-thawing agricultural area. With the daily monitoring of soil water content and acquisition rates at 15, 30, 60 and 90 cm depths, the soil hydrological process with the influence of rainfall was identified. The temporal-vertical soil water storage analysis indicated the local albic soil texture provided a stable soil water condition for maize growth with the rainfall as the only water source. Soil storage water averages at 0-20, 20-40 and 40-60 cm were observed to be 490.2, 593.8, and 358 m(3) ha(-1), respectively, during the growing season. The evapo-transpiration (ET), rainfall, and water loss analysis demonstrated that these factors increased in same temporal pattern and provided necessary water conditions for maize growth in a short period. The dry weight and N concentration of maize organs (root, leaf, stem, tassel, and grain) demonstrated the N accumulation increased to a peak in the maturity period and that grain had the most N. The maximum N accumulative rate reached about 500 mg m(-2) d(-1) in leaves and grain. Over the entire growing season, the soil nitrate N decreased by amounts ranging from 48.9 kg N ha(-1) to 65.3 kg N ha(-1) over the 90 cm profile and the loss of ammonia-N ranged from 9.79 to 12.69 kg N ha(-1). With soil water loss and N balance calculation, the N usage efficiency (NUE) over the 0-90 cm soil profile was 43%. The soil hydrological process due to special soil texture and the temporal features of rainfall determined the maize growth in the freeze-thawing agricultural area.	[Ouyang, Wei; Cai, Guanqing; Hao, Fanghua] Beijing Normal Univ, State Key Lab Water Environm Simulat, Sch Environm, Beijing 100875, Peoples R China; [Chen, Siyang] Marine Monitoring & Forecasting Ctr Zhejiang, Hangzhou, Zhejiang, Peoples R China	Beijing Normal University	Ouyang, W (corresponding author), Beijing Normal Univ, State Key Lab Water Environm Simulat, Sch Environm, Beijing 100875, Peoples R China.	wei@itc.nl	Ou-Yang, Wei/AGS-1930-2022; ouyang, wei/AAM-8141-2020	wei, ouyang/0000-0002-5851-056X	National Natural Science Foundation of China [41371018, 51121003]; Supporting Program of the "Twelfth Five-year'' Plan for Sci & Tech Research of China [2012BAD15B05]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Supporting Program of the "Twelfth Five-year'' Plan for Sci & Tech Research of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	We are grateful for assistance with the data requirements of the Bawujiu Farm in Heilongjiang Province. The research discussed in this paper benefited from financial support provided by the National Natural Science Foundation of China (Grant No. 41371018, 51121003), the Supporting Program of the "Twelfth Five-year'' Plan for Sci & Tech Research of China (2012BAD15B05), and The Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asseng S, 2001, PLANT SOIL, V233, P127, DOI 10.1023/A:1010381602223; Binder DL, 2002, SOIL SCI SOC AM J, V66, P531, DOI 10.2136/sssaj2002.0531; Bonato O, 1999, ECOL MODEL, V124, P11, DOI 10.1016/S0304-3800(99)00146-5; Buckley C, 2013, ENVIRON SCI POLICY, V25, P118, DOI 10.1016/j.envsci.2012.10.002; Caliskan S, 2008, FIELD CROP RES, V108, P126, DOI 10.1016/j.fcr.2008.04.005; Dawson JC, 2008, FIELD CROP RES, V107, P89, DOI 10.1016/j.fcr.2008.01.001; Dorner J, 2009, SOIL TILL RES, V102, P225, DOI 10.1016/j.still.2008.07.004; DORIOZ JM, 1994, WATER RES, V28, P395, DOI 10.1016/0043-1354(94)90277-1; Fang QX, 2006, PLANT SOIL, V284, P335, DOI 10.1007/s11104-006-0055-7; Favaretto N, 2012, SOIL SCI SOC AM J, V76, P575, DOI 10.2136/sssaj2011.0223; Ferrant S, 2011, J HYDROL, V406, P1, DOI 10.1016/j.jhydrol.2011.05.026; Friend AD, 1997, ECOL MODEL, V95, P249, DOI 10.1016/S0304-3800(96)00034-8; Gheysari M, 2009, AGR WATER MANAGE, V96, P946, DOI 10.1016/j.agwat.2009.01.005; Grzebisz W, 2013, PLANT SOIL, V368, P23, DOI 10.1007/s11104-012-1574-z; Hall JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058188; Hao FH, 2013, J HYDROL, V486, P412, DOI 10.1016/j.jhydrol.2013.02.008; Hirel B, 2007, J EXP BOT, V58, P2369, DOI 10.1093/jxb/erm097; HUGGINS DR, 1993, AGRON J, V85, P898, DOI 10.2134/agronj1993.00021962008500040022x; Jackson JE, 1991, USERS GUIDE PRINCIPA; Katerji N, 2013, AGR WATER MANAGE, V130, P14, DOI 10.1016/j.agwat.2013.08.005; KEENEY DR, 1991, MANAGING NITROGEN FOR GROUNDWATER QUALITY AND FARM PROFITABILITY, P1; Kerbiriou PJ, 2013, PLANT SOIL, V371, P281, DOI 10.1007/s11104-013-1672-6; Kersebaum KC, 2003, PHYS CHEM EARTH, V28, P537, DOI 10.1016/S1474-7065(03)00090-1; Kim DG, 2012, BIOGEOSCIENCES, V9, P2459, DOI 10.5194/bg-9-2459-2012; Kovacs GJ, 2005, PHYS CHEM EARTH, V30, P209, DOI 10.1016/j.pce.2004.08.022; Lam QD, 2012, J HYDROL, V438, P137, DOI 10.1016/j.jhydrol.2012.03.011; Lewis DR, 2003, AGR SYST, V76, P159, DOI 10.1016/S0308-521X(02)00032-X; Lteif A, 2010, PLANT SOIL, V333, P105, DOI 10.1007/s11104-010-0326-1; Matejek B, 2010, PLANT SOIL, V337, P93, DOI 10.1007/s11104-010-0503-2; MEISINGER JJ, 1991, MANAGING NITROGEN FOR GROUNDWATER QUALITY AND FARM PROFITABILITY, P85; Moreau P, 2013, AGR SYST, V118, P41, DOI 10.1016/j.agsy.2013.02.007; Moroizumi T, 2009, AGR WATER MANAGE, V96, P160, DOI 10.1016/j.agwat.2008.07.007; Murungu FS, 2011, SOIL TILL RES, V112, P58, DOI 10.1016/j.still.2010.11.005; Nacry P, 2013, PLANT SOIL, V370, P1, DOI 10.1007/s11104-013-1645-9; Ouyang W, 2013, SCI TOTAL ENVIRON, V450, P129, DOI 10.1016/j.scitotenv.2013.02.016; Ouyang W, 2012, SCI TOTAL ENVIRON, V432, P412, DOI 10.1016/j.scitotenv.2012.06.017; Overman AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072810; Panda RK, 2003, J FOOD AGRIC ENVIRON, V1, P308; Pask AJD, 2012, FIELD CROP RES, V126, P104, DOI 10.1016/j.fcr.2011.09.021; Quemada M, 2013, AGR ECOSYST ENVIRON, V174, P1, DOI 10.1016/j.agee.2013.04.018; Razzaghi F, 2012, AGR WATER MANAGE, V109, P20, DOI 10.1016/j.agwat.2012.02.002; Schroder JL, 2011, SOIL SCI SOC AM J, V75, P957, DOI 10.2136/sssaj2010.0187; SHOJI S, 1991, SOIL SCI SOC AM J, V55, P1468, DOI 10.2136/sssaj1991.03615995005500050045x; Sierra J, 2003, PLANT SOIL, V256, P333, DOI 10.1023/A:1026106208320; Strullu L, 2011, FIELD CROP RES, V121, P381, DOI 10.1016/j.fcr.2011.01.005; Tanveer SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072140; Vazquez N, 2006, AGR ECOSYST ENVIRON, V112, P313, DOI 10.1016/j.agee.2005.07.009; Wang XB, 2010, AGR WATER MANAGE, V97, P1344, DOI 10.1016/j.agwat.2010.03.016; Wegehenkel M, 2006, ECOL MODEL, V190, P116, DOI 10.1016/j.ecolmodel.2005.02.020; Yang YG, 2011, J HYDROL, V409, P149, DOI 10.1016/j.jhydrol.2011.08.013	50	3	3	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101282	10.1371/journal.pone.0101282	http://dx.doi.org/10.1371/journal.pone.0101282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000400	gold, Green Published, Green Submitted			2022-12-27	WOS:000338637300029
J	Rieger, D; Assinger, A; Einfinger, K; Sokolikova, B; Geiger, M				Rieger, Daniela; Assinger, Alice; Einfinger, Katrin; Sokolikova, Barbora; Geiger, Margarethe			Protein C Inhibitor (PCI) Binds to Phosphatidylserine Exposing Cells with Implications in the Phagocytosis of Apoptotic Cells and Activated Platelets	PLOS ONE			English	Article							DIFFERENTIATION; EXPRESSION; SURFACE; INTERNALIZATION; LYMPHOCYTES; MACROPHAGES; NEUTROPHILS; MECHANISM; MONOCYTES; EXPOSURE	Protein C Inhibitor (PCI) is a secreted serine protease inhibitor, belonging to the family of serpins. In addition to activated protein C PCI inactivates several other proteases of the coagulation and fibrinolytic systems, suggesting a regulatory role in hemostasis. Glycosaminoglycans and certain negatively charged phospholipids, like phosphatidylserine, bind to PCI and modulate its activity. Phosphatidylerine (PS) is exposed on the surface of apoptotic cells and known as a phagocytosis marker. We hypothesized that PCI might bind to PS exposed on apoptotic cells and thereby influence their removal by phagocytosis. Using Jurkat T-lymphocytes and U937 myeloid cells, we show here that PCI binds to apoptotic cells to a similar extent at the same sites as Annexin V, but in a different manner as compared to live cells (defined spots on similar to 10-30% of cells). PCI dose dependently decreased phagocytosis of apoptotic Jurkat cells by U937 macrophages. Moreover, the phagocytosis of PS exposing, activated platelets by human blood derived monocytes declined in the presence of PCI. In U937 cells the expression of PCI as well as the surface binding of PCI increased with time of phorbol ester treatment/macrophage differentiation. The results of this study suggest a role of PCI not only for the function and/or maturation of macrophages, but also as a negative regulator of apoptotic cell and activated platelets removal.	[Rieger, Daniela; Einfinger, Katrin; Sokolikova, Barbora; Geiger, Margarethe] Med Univ Vienna, Ctr Physiol & Pharmacol, Dept Vasc Biol & Thrombosis Res, Vienna, Austria; [Assinger, Alice] Med Univ Vienna, Ctr Phsiol & Pharmacol, Dept Physiol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Geiger, M (corresponding author), Med Univ Vienna, Ctr Physiol & Pharmacol, Dept Vasc Biol & Thrombosis Res, Vienna, Austria.	margarethe.geiger@meduniwien.ac.at		Assinger, Alice/0000-0002-5670-5910; Geiger, Margarethe/0000-0003-2021-5319	Austrian Science Fund FWF [P 20248-B09, P 22792-B11]; Austrian Science Fund (FWF) [P 22792] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund FWF (www.fwf.ac.at) Projects P 20248-B09 and P 22792-B11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson HA, 2003, NAT IMMUNOL, V4, P87, DOI 10.1038/ni871; ANDREE HAM, 1990, J BIOL CHEM, V265, P4923; Assinger A, 2010, ATHEROSCLEROSIS, V212, P153, DOI 10.1016/j.atherosclerosis.2010.05.010; Badrnya S, 2014, ARTERIOSCL THROM VAS, V34, P571, DOI 10.1161/ATVBAHA.113.302919; Baumgartner P, 2007, J CELL BIOL, V179, P793, DOI 10.1083/jcb.200707165; BEVERS EM, 1983, BIOCHIM BIOPHYS ACTA, V736, P57, DOI 10.1016/0005-2736(83)90169-4; Callahan MK, 2003, J LEUKOCYTE BIOL, V74, P846, DOI 10.1189/jlb.0902433; Carroll VA, 1997, ARTERIOSCL THROM VAS, V17, P114, DOI 10.1161/01.ATV.17.1.114; Elliott JI, 2005, NAT CELL BIOL, V7, P808, DOI 10.1038/ncb1279; ESPANA F, 1989, THROMB RES, V55, P369, DOI 10.1016/0049-3848(89)90069-8; Fadok VA, 2001, J BIOL CHEM, V276, P1071, DOI 10.1074/jbc.M003649200; FADOK VA, 1992, J IMMUNOL, V148, P2207; Greenberg ME, 2006, J EXP MED, V203, P2613, DOI 10.1084/jem.20060370; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Huber J, 2002, ARTERIOSCL THROM VAS, V22, P581, DOI 10.1161/01.ATV.0000012782.59850.41; Kenis H, 2004, J BIOL CHEM, V279, P52623, DOI 10.1074/jbc.M409009200; Kenis H, 2006, EXP CELL RES, V312, P719, DOI 10.1016/j.yexcr.2005.11.023; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; Kuhn, 1990, ELUCIDATING STRUCTUR; Lemarie A, 2006, J PHARMACOL EXP THER, V316, P304, DOI 10.1124/jpet.105.092874; Liu G, 2008, J IMMUNOL, V181, P4240, DOI 10.4049/jimmunol.181.6.4240; Malleier JM, 2007, BLOOD, V109, P4769, DOI 10.1182/blood-2006-09-046953; Malmstrom E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000698; MARLAR RA, 1980, J CLIN INVEST, V66, P1186, DOI 10.1172/JCI109952; Maugeri N, 2009, BLOOD, V113, P5254, DOI 10.1182/blood-2008-09-180794; MEIJERS JCM, 1988, BIOCHEMISTRY-US, V27, P4231, DOI 10.1021/bi00412a005; Nilsson G, 2007, THROMB RES, V120, P237, DOI 10.1016/j.thromres.2006.10.004; Park YJ, 2008, P NATL ACAD SCI USA, V105, P11784, DOI 10.1073/pnas.0801394105; Rehault SM, 2005, BBA-PROTEINS PROTEOM, V1748, P57, DOI 10.1016/j.bbapap.2004.12.003; Schuster C, 2007, BIOCHEM PHARMACOL, V74, P1424, DOI 10.1016/j.bcp.2007.07.017; Shen L, 1999, THROMB HAEMOSTASIS, V82, P72, DOI 10.1055/s-0037-1614632; SHIRK RA, 1994, J BIOL CHEM, V269, P28690; SUZUKI K, 1987, J BIOL CHEM, V262, P611; SUZUKI K, 1984, J BIOCHEM, V95, P187, DOI 10.1093/oxfordjournals.jbchem.a134583; Watanabe R, 2000, AM J HEMATOL, V65, P35, DOI 10.1002/1096-8652(200009)65:1<35::AID-AJH6>3.0.CO;2-1; Zhang WJ, 2003, THROMB HAEMOSTASIS, V90, P904, DOI 10.1160/TH03-03-0136; Zhao KW, 2004, BLOOD, V104, P3731, DOI 10.1182/blood-2004-04-1630	37	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101794	10.1371/journal.pone.0101794	http://dx.doi.org/10.1371/journal.pone.0101794			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000564	Green Published, gold, Green Submitted			2022-12-27	WOS:000338637300087
J	Gavioli, M; Lara, A; Almeida, PWM; Lima, AM; Damasceno, DD; Rocha-Resende, C; Ladeira, M; Resende, RR; Martinelli, PM; Melo, MB; Brum, PC; Fontes, MAP; Santos, RAS; Prado, MAM; Guatimosim, S				Gavioli, Mariana; Lara, Aline; Almeida, Pedro W. M.; Lima, Augusto Martins; Damasceno, Denis D.; Rocha-Resende, Cibele; Ladeira, Marina; Resende, Rodrigo R.; Martinelli, Patricia M.; Melo, Marcos Barrouin; Brum, Patricia C.; Peliky Fontes, Marco Antonio; Souza Santos, Robson A.; Prado, Marco A. M.; Guatimosim, Silvia			Cholinergic Signaling Exerts Protective Effects in Models of Sympathetic Hyperactivity-Induced Cardiac Dysfunction	PLOS ONE			English	Article							VESICULAR ACETYLCHOLINE TRANSPORTER; PROTEIN EXPRESSION; HEART; SURVIVAL; HYPERTROPHY; CARVEDILOL; RECEPTORS; EXERCISE; DEFICITS; IMPROVES	Cholinergic control of the heart is exerted by two distinct branches; the autonomic component represented by the parasympathetic nervous system, and the recently described non-neuronal cardiomyocyte cholinergic machinery. Previous evidence has shown that reduced cholinergic function leads to deleterious effects on the myocardium. Yet, whether conditions of increased cholinergic signaling can offset the pathological remodeling induced by sympathetic hyperactivity, and its consequences for these two cholinergic axes are unknown. Here, we investigated two models of sympathetic hyperactivity: i) the chronic beta-adrenergic receptor stimulation evoked by isoproterenol (ISO), and ii) the alpha(2A)/alpha(2C)-drenergic receptor knockout (KO) mice that lack pre-synaptic adrenergic receptors. In both models, cholinergic signaling was increased by administration of the cholinesterase inhibitor, pyridostigmine. First, we observed that isoproterenol produces an autonomic imbalance characterized by increased sympathetic and reduced parasympathetic tone. Under this condition transcripts for cholinergic proteins were upregulated in ventricular myocytes, indicating that non-neuronal cholinergic machinery is activated during adrenergic overdrive. Pyridostigmine treatment prevented the effects of ISO on autonomic function and on the ventricular cholinergic machinery, and inhibited cardiac remodeling. alpha(2A)/alpha(2C)-KO mice presented reduced ventricular contraction when compared to wild-type mice, and this dysfunction was also reversed by cholinesterase inhibition. Thus, the cardiac parasympathetic system and non-neuronal cardiomyocyte cholinergic machinery are modulated in opposite directions under conditions of increased sympathetic drive or ACh availability. Moreover, our data support the idea that pyridostigmine by restoring ACh availability is beneficial in heart disease.	[Gavioli, Mariana; Lara, Aline; Almeida, Pedro W. M.; Lima, Augusto Martins; Damasceno, Denis D.; Rocha-Resende, Cibele; Ladeira, Marina; Melo, Marcos Barrouin; Peliky Fontes, Marco Antonio; Souza Santos, Robson A.; Guatimosim, Silvia] Univ Fed Minas Gerais, Inst Biol Sci, Dept Physiol & Biophys, Belo Horizonte, MG, Brazil; [Resende, Rodrigo R.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Biochem, Belo Horizonte, MG, Brazil; [Martinelli, Patricia M.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Morphol, Belo Horizonte, MG, Brazil; [Lima, Augusto Martins; Melo, Marcos Barrouin; Peliky Fontes, Marco Antonio; Souza Santos, Robson A.; Guatimosim, Silvia] Univ Fed Minas Gerais, Natl Inst Sci & Technol Nanobiopharmaceut, Belo Horizonte, MG, Brazil; [Brum, Patricia C.] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil; [Prado, Marco A. M.] Univ Western Ontario, Schulich Sch Med & Dent, Robarts Res Inst, Dept Anat & Cell Biol,Dept Physiol & Pharmacol, London, ON, Canada	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade de Sao Paulo; Western University (University of Western Ontario)	Guatimosim, S (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Dept Physiol & Biophys, Belo Horizonte, MG, Brazil.	guatimosim@icb.ufmg.br	Fontes, Marco Antônio Peliky/AAT-7570-2021; Rocha-Resende, Cibele/CAI-0845-2022; Brum, Patricia C/E-6605-2011; Rocha-Resende, Cibele/CAF-4462-2022; Prado, Marco Antonio Maximo/K-7638-2013; Martinelli, Patricia/H-6341-2014; Santos, Robson A S/C-9336-2011; Guatimosim, Silvia/AAN-7441-2021; Lima, Augusto Martins/D-7730-2015	Fontes, Marco Antônio Peliky/0000-0003-4525-3565; Brum, Patricia C/0000-0002-4750-6506; Prado, Marco Antonio Maximo/0000-0002-3028-5778; Santos, Robson A S/0000-0001-8738-5852; Guatimosim, Silvia/0000-0001-8386-3722; Gavioli, Mariana/0000-0001-9413-9019; Martins Lima, Augusto/0000-0002-0461-1226; Rocha-Resende, Cibele/0000-0002-5109-0654	NIH from the Fogarty International Center [R03TW008425]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, PRONEX [APQ-04334-10]; National Institute of Science and Technology in Nanobiopharmaceutics; Heart and Stroke Foundation of Ontario [NA6656]; CNPq; FOGARTY INTERNATIONAL CENTER [R03TW008425] Funding Source: NIH RePORTER	NIH from the Fogarty International Center; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, PRONEX; National Institute of Science and Technology in Nanobiopharmaceutics; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by grants from NIH R03TW008425 from the Fogarty International Center (Guatimosim S), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, PRONEX (APQ-04334-10) and National Institute of Science and Technology in Nanobiopharmaceutics. MAMP is supported by the Heart and Stroke Foundation of Ontario (Grant-in aid NA6656). Gavioli, M is recipient of CNPq PhD fellowship at the Post-graduation Program in Biological Science: Physiology and Pharmacology at UFMG. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartholomeu JB, 2008, J MOL CELL CARDIOL, V45, P240, DOI 10.1016/j.yjmcc.2008.05.011; De Angelis K, 2004, J APPL PHYSIOL, V96, P2174, DOI 10.1152/japplphysiol.00870.2003; de Castro BM, 2009, GENES BRAIN BEHAV, V8, P23, DOI 10.1111/j.1601-183X.2008.00439.x; de Castro CH, 2005, HYPERTENSION, V46, P937, DOI 10.1161/01.HYP.0000175813.04375.8a; Ferreira AJ, 2007, LIFE SCI, V81, P916, DOI 10.1016/j.lfs.2007.07.022; Freeling J, 2008, EXP PHYSIOL, V93, P75, DOI 10.1113/expphysiol.2007.039784; Gava E, 2012, REGUL PEPTIDES, V175, P30, DOI 10.1016/j.regpep.2012.01.001; Guatimosim S, 2001, AM J PHYSIOL-CELL PH, V280, pC1327, DOI 10.1152/ajpcell.2001.280.5.C1327; Guatimosim S, 2008, CELL CALCIUM, V44, P230, DOI 10.1016/j.ceca.2007.11.016; Handa T, 2009, J CARD FAIL, V15, P805, DOI 10.1016/j.cardfail.2009.05.008; Kakinuma Y, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004887; Kakinuma Y, 2009, FEBS J, V276, P5111, DOI 10.1111/j.1742-4658.2009.07208.x; Kanazawa H, 2010, J CLIN INVEST, V120, P408, DOI 10.1172/JCI39778; LaCroix C, 2008, AM J PHYSIOL-HEART C, V294, pH810, DOI 10.1152/ajpheart.00724.2007; Lara A, 2010, MOL CELL BIOL, V30, P1746, DOI 10.1128/MCB.00996-09; Lataro RM, 2013, AM J PHYSIOL-REG I, V305, pR908, DOI 10.1152/ajpregu.00102.2013; Marques FD, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/795452; Marques FD, 2011, HYPERTENSION, V57, P477, DOI 10.1161/HYPERTENSIONAHA.110.167346; NEGRAO CE, 1992, BRAZ J MED BIOL RES, V25, P1045; Nordstrom P, 2013, EUR HEART J, V34, P2585, DOI 10.1093/eurheartj/eht182; Okazaki Y, 2010, J PHYSIOL SCI, V60, P67, DOI 10.1007/s12576-009-0071-5; Oliveira EA, 2005, EUR J PHARMACOL, V520, P135, DOI 10.1016/j.ejphar.2005.07.026; Packer M, 2002, CIRCULATION, V106, P2194, DOI 10.1161/01.CIR.0000035653.72855.BF; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Prado VF, 2006, NEURON, V51, P601, DOI 10.1016/j.neuron.2006.08.005; Rana OR, 2010, AUTON NEUROSCI-BASIC, V156, P82, DOI 10.1016/j.autneu.2010.04.011; Rocha-Resende C, 2012, J MOL CELL CARDIOL, V53, P206, DOI 10.1016/j.yjmcc.2012.05.003; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Rolim NPL, 2007, PHYSIOL GENOMICS, V29, P246, DOI 10.1152/physiolgenomics.00188.2006; Roy A, 2013, FASEB J, V27, P5072, DOI 10.1096/fj.13-238279; Sabino JPJ, 2013, AUTON NEUROSCI-BASIC, V173, P58, DOI 10.1016/j.autneu.2012.11.007	31	34	35	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100179	10.1371/journal.pone.0100179	http://dx.doi.org/10.1371/journal.pone.0100179			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992197	Green Published, gold, Green Submitted			2022-12-27	WOS:000341253400020
J	Rotheram-Borus, MJ; Stein, JA; Rice, E				Rotheram-Borus, Mary Jane; Stein, Judith A.; Rice, Eric			Intervening on Conflict, Parental Bonds, and Sexual Risk Acts among Adolescent Children of Mothers Living with HIV	PLOS ONE			English	Article							PSYCHOLOGICAL DISTRESS; PSYCHOSOCIAL ADJUSTMENT; AFFECTED FAMILIES; SUBSTANCE USE; OUTCOMES; INSTRUMENT; WOMEN; AIDS; HIV/AIDS; BEHAVIOR	Objective: In 1993-1994, a psychosocial intervention conducted in New York City significantly improved outcomes for parents living with HIV and their adolescent children over six years. We examine if the intervention benefits are similar for adolescents of mothers living with HIV (MLH) in 2004-2005 in Los Angeles when MLH's survival had increased substantially. Methods: Adolescents of MLH in Los Angeles (N = 256) aged 12-20 years old were randomized with their MLH to either: 1) a standard care condition (n = 120 adolescent-MLH dyads); or 2) an intervention condition consisting of small group activities to build coping skills (n = 136 adolescent-MLH dyads, 78% attended the intervention). At 18 months, 94.7% of adolescents were reassessed. Longitudinal structural equation modeling examined if intervention participation impacted adolescents' relationships with parents and their sexual risk behaviors. Results: Compared to the standard care, adolescents in the intervention condition reported significantly more positive family bonds 18 months later. Greater participation by MLH predicted fewer family conflicts, and was indirectly associated with less adolescent sexual risk behavior at the 18 month follow-up assessment. Anticipated developmental patterns were observed - sexual risk acts increased with age. Reports were also consistent with anticipated gender roles; girls reported better bonds with their mothers at 18 months, compared to boys. Conclusions: Adolescents of MLH have better bonds with their mothers as a function of participating in a coping skills intervention and reduced sexual risk-taking as a function of MLH intervention involvement.	[Rotheram-Borus, Mary Jane; Stein, Judith A.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; [Rice, Eric] Univ So Calif, Sch Social Work, Los Angeles, CA 90089 USA	University of California System; University of California Los Angeles; University of Southern California	Rotheram-Borus, MJ (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA.	CCHPublications@mednet.ucla.edu			National Institute of Mental Health [MH-068194]; National Institute on Drug Abuse [DA-01070-38]; National Institutes of Health (NIH) [MH58107, 5P30AI028697, UL1TR000124]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068194, P30MH058107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA001070] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by Grant MH-068194 from the National Institute of Mental Health, and Grant DA-01070-38 from the National Institute on Drug Abuse. This work was supported by National Institutes of Health (NIH) grants MH58107, 5P30AI028697, and UL1TR000124. The content is solely the responsibility of the authors and does not necessarily represent the views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altice FL, 1998, ANN INTERN MED, V129, P503, DOI 10.7326/0003-4819-129-6-199809150-00015; [Anonymous], 1993, NEW YORK CITY AIDS S; Antonucci TC, 1994, ATTACHMENT ADULTS CL, P256; ARMISTEAD L, 1995, CLIN PSYCHOL-SCI PR, V2, P239, DOI 10.1111/j.1468-2850.1995.tb00042.x; Arnett JJ, 1999, AM PSYCHOL, V54, P317, DOI 10.1037/0003-066X.54.5.317; Barnard M, 2004, ADDICTION, V99, P552, DOI 10.1111/j.1360-0443.2003.00664.x; Bentler P.M., 2006, MULTIVARIATE SOFTWAR; Bretherton I, 1997, CHILD PSYCHIAT HUM D, V28, P33, DOI 10.1023/A:1025193002462; Catz SL, 2002, BEHAV MED, V28, P53, DOI 10.1080/08964280209596398; Center for HIV Identification Prevention and Treatment Services Website, TEENS AD LEARN COMM; Chambers JA, 2000, SOC PSYCH PSYCH EPID, V35, P318, DOI 10.1007/s001270050245; CHOU CP, 1990, MULTIVAR BEHAV RES, V25, P115, DOI 10.1207/s15327906mbr2501_13; Division of HIV and STD Programs LAC Department of Public Health, 2013, 2012 ANN HIV SURV RE; DOWNEY G, 1990, PSYCHOL BULL, V108, P50, DOI 10.1037/0033-2909.108.1.50; ELLERBROCK TV, 1991, JAMA-J AM MED ASSOC, V265, P2971, DOI 10.1001/jama.265.22.2971; FAUCI AS, 1992, ANN INTERN MED, V116, P85, DOI 10.7326/0003-4819-116-1-85; Forehand R, 1998, J CONSULT CLIN PSYCH, V66, P513, DOI 10.1037/0022-006X.66.3.513; Golder S., 2005, J CHILD FAM STUD, V14, P181, DOI [10.1007/s10826-005-5046-6, DOI 10.1007/S10826-005-5046-6]; Hackl KL, 1997, HEALTH SOC WORK, V22, P53, DOI 10.1093/hsw/22.1.53; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huebner AJ, 2003, J ADOLESCENT HEALTH, V33, P71, DOI 10.1016/S1054-139X(03)00141-1; JARLAIS DCD, 1994, JAMA-J AM MED ASSOC, V271, P121, DOI 10.1001/jama.271.2.121; Keigher S, 2005, CHILD YOUTH SERV REV, V27, P881, DOI 10.1016/j.childyouth.2004.12.010; Kendler KS, 2000, PSYCHOL MED, V30, P281, DOI 10.1017/S0033291799001889; KLIMIDIS S, 1992, COMPR PSYCHIAT, V33, P374, DOI 10.1016/0010-440X(92)90058-X; Kotchick BA, 2001, CLIN PSYCHOL REV, V21, P493, DOI 10.1016/S0272-7358(99)00070-7; Lee MB, 2002, CLIN CHILD PSYCHOL P, V7, P71, DOI DOI 10.1177/1359104502007001006; Lester P, 2010, J CLIN CHILD ADOLESC, V39, P328, DOI 10.1080/15374411003691677; Lizardi H, 2002, J NERV MENT DIS, V190, P619, DOI 10.1097/00005053-200209000-00007; MACCALLUM R, 1986, PSYCHOL BULL, V100, P107, DOI 10.1037/0033-2909.100.1.107; Matic S, 2006, HIV AIDS EUR MOV DEA; METZLER CW, 1994, J BEHAV MED, V17, P419, DOI 10.1007/BF01858012; Murphy DA, 2010, AIDS CARE, V22, P1449, DOI 10.1080/09540121.2010.487085; O'Leary A, 2008, HEALTH PSYCHOL, V27, pS180, DOI 10.1037/0278-6133.27.2(Suppl.).S180; PARKER G, 1979, BRIT J MED PSYCHOL, V52, P1, DOI 10.1111/j.2044-8341.1979.tb02487.x; PARKER G, 1990, SOC PSYCH PSYCH EPID, V25, P281, DOI 10.1007/BF00782881; Resnick MD, 1997, JAMA-J AM MED ASSOC, V278, P823, DOI 10.1001/jama.278.10.823; Rice E, 2010, J IMMIGR MINOR HEALT, V12, P875, DOI 10.1007/s10903-009-9279-y; Rice E, 2009, AIDS BEHAV, V13, P1005, DOI 10.1007/s10461-008-9417-x; Rigby K, 2007, J ADOLESCENCE, V30, P801, DOI 10.1016/j.adolescence.2006.09.008; Rotheram-Borus M., 2002, CLIN CHILD PSYCHOL P, V1, P115, DOI DOI 10.1177/1359104502007001009; Rotheram-Borus MJ, 2006, J ADOLESCENT HEALTH, V39, P174, DOI 10.1016/j.jadohealth.2006.02.014; Rotheram-Borus MJ, 2012, AIDS BEHAV, V16, P1265, DOI 10.1007/s10461-011-0075-z; Rotheram-Borus MJ, 1998, FAM PROCESS, V37, P83, DOI 10.1111/j.1545-5300.1998.00083.x; Rotheram-Borus MJ, 2006, J CONSULT CLIN PSYCH, V74, P622, DOI 10.1037/0022-006X.74.3.622; Rotheram-Borus MJ, 2004, ARCH PEDIAT ADOL MED, V158, P742, DOI 10.1001/archpedi.158.8.742; Rotheram-Borus MJ, 2001, AM J PUBLIC HEALTH, V91, P1294, DOI 10.2105/AJPH.91.8.1294; Rotherarn-Borus MJ, 2003, AIDS, V17, P1217, DOI 10.1097/01.aids.0000060337.12269.1d; Rubenstein J.L., 1993, J RES ADOLESCENCE, V3, P41, DOI [10.1207/s15327795jra0301_3, DOI 10.1111/1532-7795.EP11323961]; Serido J, 2004, J HEALTH SOC BEHAV, V45, P17, DOI 10.1177/002214650404500102; SIEGEL K, 1992, J AM ACAD CHILD PSY, V31, P327, DOI 10.1097/00004583-199203000-00022; Stein JA, 2004, PSYCHOL HEALTH, V19, P321, DOI 10.1080/0887044042000193479; Stein JA, 1999, FAM PROCESS, V38, P193, DOI 10.1111/j.1545-5300.1999.00193.x; Stein JA, 2007, FAM PROCESS, V46, P317, DOI 10.1111/j.1545-5300.2007.00214.x; Tompkins T. L., 2007, Journal of Child and Family Studies, V16, P108, DOI 10.1007/s10826-006-9072-7; Willinger U, 2005, BEHAV MED, V31, P63, DOI 10.3200/BMED.31.2.63-72; Yuan K.H., 1997, BEHAVIORMETRIKA, V24, P71, DOI [10.2333/bhmk.24.71, DOI 10.2333/BHMK.24.71, https://doi.org/10.2333/bhmk.24.71]	57	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101874	10.1371/journal.pone.0101874	http://dx.doi.org/10.1371/journal.pone.0101874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK9RG	25010119	Green Published, gold			2022-12-27	WOS:000338763800048
J	Ruberti, C; Barizza, E; Bodner, M; La Rocca, N; De Michele, R; Carimi, F; Lo Schiavo, F; Zottini, M				Ruberti, Cristina; Barizza, Elisabetta; Bodner, Martina; La Rocca, Nicoletta; De Michele, Roberto; Carimi, Francesco; Lo Schiavo, Fiorella; Zottini, Michela			Mitochondria Change Dynamics and Morphology during Grapevine Leaf Senescence	PLOS ONE			English	Article							CELL-DEATH; ARABIDOPSIS; LEAVES; GROWTH; EMBRYOGENESIS; CHLOROPLASTS; SEQUENCE; REVEALS; GENOME; ASSAYS	Leaf senescence is the last stage of development of an organ and is aimed to its ordered disassembly and nutrient reallocation. Whereas chlorophyll gradually degrades during senescence in leaves, mitochondria need to maintain active to sustain the energy demands of senescing cells. Here we analysed the motility and morphology of mitochondria in different stages of senescence in leaves of grapevine (Vitis vinifera), by stably expressing a GFP (green fluorescent protein) reporter targeted to these organelles. Results show that mitochondria were less dynamic and markedly changed morphology during senescence, passing from the elongated, branched structures found in mature leaves to enlarged and sparse organelles in senescent leaves. Progression of senescence in leaves was not synchronous, since changes in mitochondria from stomata were delayed. Mitochondrial morphology was also analysed in grapevine cell cultures. Mitochondria from cells at the end of their growth curve resembled those from senescing leaves, suggesting that cell cultures might represent a useful model system for senescence. Additionally, senescence-associated mitochondrial changes were observed in plants treated with high concentrations of cytokinins. Overall, morphology and dynamics of mitochondria might represent a reliable senescence marker for plant cells.	[Ruberti, Cristina; Barizza, Elisabetta; Bodner, Martina; La Rocca, Nicoletta; Lo Schiavo, Fiorella; Zottini, Michela] Univ Padua, Dipartimento Biol, Padua, Italy; [De Michele, Roberto; Carimi, Francesco] CNR, Ist Biosci & Biorisorse, IBBR, Palermo, Italy	University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR)	Zottini, M (corresponding author), Univ Padua, Dipartimento Biol, Padua, Italy.	michela.zottini@unipd.it	De Michele, Roberto/Z-4760-2019; Ruberti, Cristina/AAC-2135-2019; Zottini, Michela/Y-3763-2019; Bodner, Martina/AAK-2971-2020; La Rocca, Nicoletta/AAA-2241-2021; Carimi, Francesco/E-2954-2016; Carimi, Francesco/GYU-0312-2022; Ruberti, Cristina/W-5132-2018	De Michele, Roberto/0000-0002-8987-6599; Bodner, Martina/0000-0002-2753-9052; La Rocca, Nicoletta/0000-0003-4866-5952; Carimi, Francesco/0000-0002-7700-9527; zottini, michela/0000-0001-8930-2969; Ruberti, Cristina/0000-0002-9013-1412	University of Padova (PRAT); Veneto Region Innovation Grants [Mis. 124 PSR Veneto]; Vigoni-DAAD Project; Italian Ministry for University and Research (MIUR) [PON01 -02286];  [PRIN200920094CEKT4]	University of Padova (PRAT); Veneto Region Innovation Grants; Vigoni-DAAD Project; Italian Ministry for University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); 	This work was supported by University of Padova (PRAT 2012), Veneto Region Innovation Grants (Mis. 124 PSR Veneto), Vigoni-DAAD Project, by the Italian Ministry for University and Research (MIUR), Projec (PON01 -02286) 'Tecnologie e processi per il miglioramento della shelf-life dei prodotti del comparto agroalimentare attraverso l'uso di film edibili innovativi a base pectinica' and by the grant PRIN200920094CEKT4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2003, ANAL BIOCHEM, V314, P555; Breeze E, 2011, PLANT CELL, V23, P873, DOI 10.1105/tpc.111.083345; Carimi F, 2005, PLANT CELL ENVIRON, V28, P1171, DOI 10.1111/j.1365-3040.2005.01355.x; Carimi F, 2005, IN VITRO CELL DEV-PL, V41, P249, DOI 10.1079/IVP2004617; Carimi F, 2004, PLANT SCI, V166, P963, DOI 10.1016/j.plantsci.2003.12.016; Carimi F, 2003, PLANTA, V216, P413, DOI 10.1007/s00425-002-0862-x; Chang KT, 2011, P NATL ACAD SCI USA, V108, P15456, DOI 10.1073/pnas.1106862108; De Michele R, 2009, PLANT SIGNAL BEHAV, V4, P1; De Michele R, 2009, NEW PHYTOL, V181, P563, DOI 10.1111/j.1469-8137.2008.02684.x; De Michele R, 2014, INT J BIOCHEM CELL B, V48, P39, DOI 10.1016/j.biocel.2013.12.014; De Michele R, 2013, ELIFE, V2, DOI 10.7554/eLife.00800; DemmigAdams B, 1996, PHYSIOL PLANTARUM, V98, P253, DOI 10.1034/j.1399-3054.1996.980206.x; Duby G, 2001, PLANT J, V27, P539, DOI 10.1046/j.1365-313X.2001.01098.x; Espinoza C, 2007, J EXP BOT, V58, P3197, DOI 10.1093/jxb/erm165; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; Goremykin VV, 2009, MOL BIOL EVOL, V26, P99, DOI 10.1093/molbev/msn226; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Keech O, 2007, PLANT CELL ENVIRON, V30, P1523, DOI 10.1111/j.1365-3040.2007.01724.x; Keech O, 2010, PLANT PHYSIOL, V154, P1710, DOI 10.1104/pp.110.163402; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Logan DC, 2010, SEMIN CELL DEV BIOL, V21, P550, DOI 10.1016/j.semcdb.2009.12.010; Loro G, 2012, PLANT J, V71, P1, DOI 10.1111/j.1365-313X.2012.04968.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NITSCH JP, 1969, SCIENCE, V163, P85, DOI 10.1126/science.163.3862.85; OZUNA R, 1985, PLANT PHYSIOL, V79, P7, DOI 10.1104/pp.79.1.7; Piotrowska A, 2009, ACTA PHYSIOL PLANT, V31, P573, DOI 10.1007/s11738-008-0267-y; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Reape TJ, 2008, NEW PHYTOL, V180, P13, DOI 10.1111/j.1469-8137.2008.02549.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Scott I, 2008, NEW PHYTOL, V177, P90, DOI 10.1111/j.1469-8137.2007.02255.x; SIEDOW JN, 2000, BIOCH MOL BIOL PLANT, P676; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Vlckova A, 2006, PHYSIOL PLANTARUM, V126, P257, DOI 10.1111/j.1399-3054.2006.00593.x; Yamaoka S, 2008, PLANT CELL, V20, P589, DOI 10.1105/tpc.107.055756; Yoshida S, 2003, CURR OPIN PLANT BIOL, V6, P79, DOI 10.1016/S1369526602000092; ZEIGER E, 1982, SCIENCE, V218, P680, DOI 10.1126/science.218.4573.680; Zhao RM, 2000, PLANT CELL, V12, P535, DOI 10.1105/tpc.12.4.535; Zottini M, 2008, PLANT CELL REP, V27, P845, DOI 10.1007/s00299-008-0510-4; Zottini M, 2006, NEW PHYTOL, V172, P239, DOI 10.1111/j.1469-8137.2006.01830.x	39	22	25	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102012	10.1371/journal.pone.0102012	http://dx.doi.org/10.1371/journal.pone.0102012			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25009991	Green Submitted, Green Published, gold			2022-12-27	WOS:000338763800058
J	Allahverdyan, AE; Galstyan, A				Allahverdyan, Armen E.; Galstyan, Aram			Opinion Dynamics with Confirmation Bias	PLOS ONE			English	Article							ATTITUDE-CHANGE; PROBABILITY; PRIMACY; MODEL; COMMUNICATION; INFORMATION; BELIEFS	Background: Confirmation bias is the tendency to acquire or evaluate new information in a way that is consistent with one's preexisting beliefs. It is omnipresent in psychology, economics, and even scientific practices. Prior theoretical research of this phenomenon has mainly focused on its economic implications possibly missing its potential connections with broader notions of cognitive science. Methodology/Principal Findings: We formulate a (non-Bayesian) model for revising subjective probabilistic opinion of a confirmationally-biased agent in the light of a persuasive opinion. The revision rule ensures that the agent does not react to persuasion that is either far from his current opinion or coincides with it. We demonstrate that the model accounts for the basic phenomenology of the social judgment theory, and allows to study various phenomena such as cognitive dissonance and boomerang effect. The model also displays the order of presentation effect-when consecutively exposed to two opinions, the preference is given to the last opinion (recency) or the first opinion (primacy) -and relates recency to confirmation bias. Finally, we study the model in the case of repeated persuasion and analyze its convergence properties. Conclusions: The standard Bayesian approach to probabilistic opinion revision is inadequate for describing the observed phenomenology of persuasion process. The simple non-Bayesian model proposed here does agree with this phenomenology and is capable of reproducing a spectrum of effects observed in psychology: primacy-recency phenomenon, boomerang effect and cognitive dissonance. We point out several limitations of the model that should motivate its future development.	[Allahverdyan, Armen E.] Yerevan Phys Inst, Dept Theoret Phys, Yerevan 375036, Armenia; [Galstyan, Aram] USC Informat Sci Inst, Marina Del Rey, CA USA	Yerevan Physics Institute; University of Southern California	Allahverdyan, AE (corresponding author), Yerevan Phys Inst, Dept Theoret Phys, Yerevan 375036, Armenia.	armen.allahverdyan@gmail.com		Galstyan, Aram/0000-0003-4215-0886	DARPA [W911NF-12-1-0034]; AFOSR MURI [FA9550-10-1-0569]	DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); AFOSR MURI(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI)	This research was supported by DARPA grant No. W911NF-12-1-0034 and AFOSR MURI grant No. FA9550-10-1-0569. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELSON RP, 1986, J THEOR SOC BEHAV, V16, P223, DOI 10.1111/j.1468-5914.1986.tb00078.x; AKERLOF GA, 1982, AM ECON REV, V72, P307; ALCHOURRON CE, 1985, J SYMBOLIC LOGIC, V50, P510, DOI 10.2307/2274239; Allahverdyan AE, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.041117; Allakhverdov VM, 2010, INTEGR PSYCHOL BEHAV, V44, P340, DOI 10.1007/s12124-010-9133-8; ALLEN EH, 1976, PHILOS SCI, V43, P53, DOI 10.1086/288669; Anderson N. H., 1981, FDN INFORM INTEGRATI; ANDERSON NH, 1965, J PERS SOC PSYCHOL, V2, P1, DOI 10.1037/h0021966; ANDERSON NH, 1971, PSYCHOL REV, V78, P171, DOI 10.1037/h0030834; [Anonymous], 2008, THINKING DECIDING; Aronson E, 2007, SOCIAL ANIMAL; Atmanspacher H, 2012, J MATH PSYCHOL, V56, P274, DOI 10.1016/j.jmp.2012.06.003; Austerweil JL, 2011, COGNITIVE SCI, V35, P499, DOI 10.1111/j.1551-6709.2010.01161.x; BARTLETT MS, 1945, P CAMB PHILOS SOC, V41, P71, DOI 10.1017/S0305004100022398; BERNARDO JM, 1979, ANN STAT, V7, P686, DOI 10.1214/aos/1176344689; Bochner S, 1966, J PERS SOC PSYCHOL, V4, P133; Bonaccio S, 2006, ORG BEHAV HUMAN DECI, V101; Burgin M, 2012, WILMOTT MAGAZINE, V58, P6065; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Clemen RT, 1999, RISK ANAL, V19, P187, DOI 10.1023/A:1006917509560; COX RT, 1946, AM J PHYS, V14, P1, DOI 10.1119/1.1990764; Curtis JP, 2008, MATH COMPUT SCI ENG, P60; DARLEY JM, 1983, J PERS SOC PSYCHOL, V44, P20, DOI 10.1037/0022-3514.44.1.20; DIACONIS P, 1982, J AM STAT ASSOC, V77, P822, DOI 10.2307/2287313; Festinger L., 1957, THEORY COGNITIVE DIS, V2; FINK EL, 1983, COMMUN MONOGR, V50, P413, DOI 10.1080/03637758309390178; FRENCH S, 1980, J ROY STAT SOC A STA, V143, P43, DOI 10.2307/2981768; GENEST C, 1990, J FORECASTING, V9, P53, DOI 10.1002/for.3980090106; Genest C., 1986, STAT SCI, V1, P114, DOI [DOI 10.1214/SS/1177013825, DOI 10.1214/SS]; Gentzkow M, 2006, J POLIT ECON, V114, P280, DOI 10.1086/499414; Gibbs AL, 2002, INT STAT REV, V70, P419, DOI 10.2307/1403865; Graben Peter beim, 2006, MIND MATTER, V4, P169; HENDRICK C, 1970, J PERS SOC PSYCHOL, V15, P158, DOI 10.1037/h0029203; HOGARTH RM, 1992, COGNITIVE PSYCHOL, V24, P1, DOI 10.1016/0010-0285(92)90002-J; Hovland C. I., 1957, ORDER PRESENTATION P; Huhns M. N., 1997, IEEE Internet Computing, V1, P81, DOI 10.1109/4236.643942; JAYNES ET, 1968, IEEE T SYST SCI CYB, VSSC4, P227, DOI 10.1109/TSSC.1968.300117; Jeng M, 2006, AM J PHYS, V74, P578, DOI 10.1119/1.2186333; Jones M, 2001, THEOR DECIS, V50, P59, DOI 10.1023/A:1005296023424; Kaplowitz SA, 1997, PROGR COMMUNICATION; KELLER AM, 1985, IEEE T SOFTWARE ENG, V11, P620, DOI 10.1109/TSE.1985.232506; Khrennikov A, 2006, BIOSYSTEMS, V84, P225, DOI 10.1016/j.biosystems.2005.11.005; KLAYMAN J, 1987, PSYCHOL REV, V94, P211, DOI 10.1037/0033-295X.94.2.211; KOEHLER JJ, 1993, ORGAN BEHAV HUM DEC, V56, P28, DOI 10.1006/obhd.1993.1044; Kruglanski AW, 2007, SCOPE OF SOCIAL PSYCHOLOGY: THEORY AND APPLICATIONS, P107; LAROCHE M, 1977, BEHAV SCI, V22, P246, DOI 10.1002/bs.3830220403; Lazarsfeld P. F., 1948, PEOPLES CHOICE VOTER, V2nd; LINDLEY DV, 1979, J ROY STAT SOC A STA, V142, P146, DOI 10.2307/2345078; LORD CG, 1979, J PERS SOC PSYCHOL, V37, P2098, DOI 10.1037/0022-3514.37.11.2098; MILLER N, 1959, J ABNORM SOC PSYCH, V59, P1, DOI 10.1037/h0049330; Mullainathan S, 2005, AM ECON REV, V95, P1031, DOI 10.1257/0002828054825619; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; Nyhan B, 2010, POLIT BEHAV, V32, P303, DOI 10.1007/s11109-010-9112-2; OSKAMP S, 1965, J CONSULT PSYCHOL, V29, P261, DOI 10.1037/h0022125; PETERSON CR, 1967, J EXP PSYCHOL, V73, P61, DOI 10.1037/h0024139; Pothos EM, 2009, P ROY SOC B-BIOL SCI, V276, P2171, DOI 10.1098/rspb.2009.0121; Rabin M, 1999, Q J ECON, V114, P37, DOI 10.1162/003355399555945; Redlawsk DP, 2010, POLIT PSYCHOL, V31, P563, DOI 10.1111/j.1467-9221.2010.00772.x; Schreider YA, 1970, INTRO INFORM SCI, P24; Stauffer D, 2013, J STAT PHYS, V151, P9, DOI 10.1007/s10955-012-0604-9; STEWART RH, 1965, J PERS SOC PSYCHOL, V1, P161, DOI 10.1037/h0021641; Sutherland S, 1992, IRRATIONALITY ENEMY; Szekely G., 2005, WILMOTT MAGAZINE, V50, P66; Trueblood JS, 2011, COGNITIVE SCI, V35, P1518, DOI 10.1111/j.1551-6709.2011.01197.x; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; van der Maas HLJ, 2003, SOCIOL METHOD RES, V32, P125, DOI 10.1177/0049124103253773; WASON PC, 1960, Q J EXP PSYCHOL, V12, P129, DOI 10.1080/17470216008416717; Webster DM, 1996, J EXP SOC PSYCHOL, V32, P181, DOI 10.1006/jesp.1996.0009; WHITTAKER JO, 1963, PSYCHOL REP, V13, P763, DOI 10.2466/pr0.1963.13.3.763; WRIGHT AA, 1985, SCIENCE, V229, P287, DOI 10.1126/science.9304205; Yaniv I, 1997, ORG BEHAV HUMAN DECI, V69; Yariv L., 2002, 1352 COWL FDN	73	29	29	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e99557	10.1371/journal.pone.0099557	http://dx.doi.org/10.1371/journal.pone.0099557			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL3PK	25007078	Green Published, gold, Green Submitted			2022-12-27	WOS:000339040600008
J	Barua, S; Chadman, KK; Kuizon, S; Buenaventura, D; Stapley, NW; Ruocco, F; Begum, U; Guariglia, SR; Brown, WT; Junaid, MA				Barua, Subit; Chadman, Kathryn K.; Kuizon, Salomon; Buenaventura, Diego; Stapley, Nathan W.; Ruocco, Felicia; Begum, Umme; Guariglia, Sara R.; Brown, W. Ted; Junaid, Mohammed A.			Increasing Maternal or Post-Weaning Folic Acid Alters Gene Expression and Moderately Changes Behavior in the Offspring	PLOS ONE			English	Article							VESICULAR GLUTAMATE TRANSPORTER-1; GENOMIC DNA METHYLATION; NEURAL-TUBE DEFECTS; MOUSE MODEL; BIPOLAR DISORDER; UNITED-STATES; FOLATE STATUS; QUANTAL SIZE; MICE; VGLUT1	Background: Studies have indicated that altered maternal micronutrients and vitamins influence the development of newborns and altered nutrient exposure throughout the lifetime may have potential health effects and increased susceptibility to chronic diseases. In recent years, folic acid (FA) exposure has significantly increased as a result of mandatory FA fortification and supplementation during pregnancy. Since FA modulates DNA methylation and affects gene expression, we investigated whether the amount of FA ingested during gestation alters gene expression in the newborn cerebral hemisphere, and if the increased exposure to FA during gestation and throughout the lifetime alters behavior in C57BL/6J mice. Methods: Dams were fed FA either at 0.4 mg or 4 mg/kg diet throughout the pregnancy and the resulting pups were maintained on the diet throughout experimentation. Newborn pups brain cerebral hemispheres were used for microarray analysis. To confirm alteration of several genes, quantitative RT-PCR (qRT-PCR) and Western blot analyses were performed. In addition, various behavior assessments were conducted on neonatal and adult offspring. Results: Results from microarray analysis suggest that the higher dose of FA supplementation during gestation alters the expression of a number of genes in the newborns' cerebral hemispheres, including many involved in development. QRT-PCR confirmed alterations of nine genes including down-regulation of Cpn2, Htr4, Zfp353, Vgll2 and up-regulation of Xist, Nkx6-3, Leprel1, Nfix, Slc17a7. The alterations in the expression of Slc17a7 and Vgll2 were confirmed at the protein level. Pups exposed to the higher dose of FA exhibited increased ultrasonic vocalizations, greater anxiety-like behavior and hyperactivity. These findings suggest that although FA plays a significant role in mammalian cellular machinery, there may be a loss of benefit from higher amounts of FA. Unregulated high FA supplementation during pregnancy and throughout the life course may have lasting effects, with alterations in brain development resulting in changes in behavior.	[Barua, Subit; Kuizon, Salomon; Junaid, Mohammed A.] New York State Inst Basic Res Dev Disabil, Dept Dev Biochem, Staten Isl, NY 10314 USA; [Chadman, Kathryn K.; Buenaventura, Diego; Stapley, Nathan W.; Ruocco, Felicia; Begum, Umme] New York State Inst Basic Res Dev Disabil, Dept Dev Neurobiol, Staten Isl, NY 10314 USA; [Guariglia, Sara R.] Columbia Univ, Dept Environm Hlth Sci, New York, NY USA; [Brown, W. Ted] New York State Inst Basic Res Dev Disabil, Dept Human Genet, Staten Isl, NY 10314 USA; [Junaid, Mohammed A.] CUNY, Grad Ctr, Staten Isl, NY USA; [Junaid, Mohammed A.] CUNY Coll Staten Isl, Staten Isl, NY USA	Institute for Basic Research in Developmental Disabilities; Institute for Basic Research in Developmental Disabilities; Columbia University; Institute for Basic Research in Developmental Disabilities; City University of New York (CUNY) System; City University of New York (CUNY) System; College of Staten Island (CUNY)	Junaid, MA (corresponding author), New York State Inst Basic Res Dev Disabil, Dept Dev Biochem, 1050 Forest Hill Rd, Staten Isl, NY 10314 USA.	mohammed.junaid@opwdd.ny.gov	Brown, William/GXN-2777-2022	, Kathryn/0000-0002-2307-7225; Buenaventura, Diego/0000-0002-5430-1357	March of Dimes Research Foundation [12-FY12-170]; New York State Office for People with Developmental Disabilities	March of Dimes Research Foundation(March of Dimes); New York State Office for People with Developmental Disabilities	This study was supported by grant 12-FY12-170 from March of Dimes Research Foundation to KKC WTB MAJ and Institutional Funds from the New York State Office for People with Developmental Disabilities to KKC and MAJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achon M, 1999, J NUTR, V129, P1204, DOI 10.1093/jn/129.6.1204; Balschun D, 2010, CEREB CORTEX, V20, P684, DOI 10.1093/cercor/bhp133; Barua S, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-3; Callaerts-Vegh Z, 2013, BEHAV BRAIN RES, V245, P13, DOI 10.1016/j.bbr.2013.01.042; Calonge N, 2009, ANN INTERN MED, V150, P626, DOI 10.7326/0003-4819-150-9-200905050-00009; Chadman KK, 2011, PHARMACOL BIOCHEM BE, V97, P586, DOI 10.1016/j.pbb.2010.09.012; Chadman KK, 2008, AUTISM RES, V1, P147, DOI 10.1002/aur.22; Chen ZT, 2005, INT J DEV NEUROSCI, V23, P465, DOI 10.1016/j.ijdevneu.2005.05.007; Choumenkovitch SF, 2002, J NUTR, V132, P2792, DOI 10.1093/jn/132.9.2792; Chu PJ, 2006, J BIOL CHEM, V281, P365, DOI 10.1074/jbc.M508897200; Dewing P, 2003, MOL BRAIN RES, V118, P82, DOI 10.1016/S0169-328X(03)00339-5; Dietrich M, 2005, J AM COLL NUTR, V24, P266, DOI 10.1080/07315724.2005.10719474; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; Gilabert-Juan J, 2012, NEUROSCI LETT, V530, P97, DOI 10.1016/j.neulet.2012.09.032; Haberg SE, 2009, ARCH DIS CHILD, V94, P180, DOI 10.1136/adc.2008.142448; Hamilton SM, 2011, BEHAV BRAIN RES, V218, P29, DOI 10.1016/j.bbr.2010.11.026; HEID MK, 1992, J NUTR, V122, P888, DOI 10.1093/jn/122.4.888; Heng YH, 2012, CEREB CORTEX, V24, P261; Hu VW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019067; Iskandar BJ, 2010, J CLIN INVEST, V120, P1603, DOI 10.1172/JCI40000; Johnson CW, 2011, DEV BIOL, V357, P269, DOI 10.1016/j.ydbio.2011.06.034; Junaid MA, 2011, BIOCHEM BIOPH RES CO, V412, P688, DOI 10.1016/j.bbrc.2011.08.027; Ladd-Acosta C, 2014, MOL PSYCHIATR, V19, P862, DOI 10.1038/mp.2013.114; Ly A, 2011, CANCER RES, V71, P988, DOI 10.1158/0008-5472.CAN-10-2379; Mikael LG, 2013, BIRTH DEFECTS RES A, V97, P47, DOI 10.1002/bdra.23092; Miller JW, 2013, LANCET, V381, P974, DOI 10.1016/S0140-6736(13)60110-5; Muris P, 1998, J ANXIETY DISORD, V12, P387, DOI 10.1016/S0887-6185(98)00022-X; Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024; Ohtsuki T, 2002, MOL PSYCHIATR, V7, P954, DOI 10.1038/sj.mp.4001133; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Peng XJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-26; Pfaffl MW, 2004, A Z QUANTITATIVE PCR, P87; Pickell L, 2011, BIRTH DEFECTS RES A, V91, P8, DOI 10.1002/bdra.20754; Rampersaud GC, 2000, AM J CLIN NUTR, V72, P998; Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533; Roy S, 2012, BRAIN DEV-JPN, V34, P64, DOI 10.1016/j.braindev.2011.01.002; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Sie KKY, 2013, MOL NUTR FOOD RES, V57, P677, DOI 10.1002/mnfr.201200186; Silberberg G, 2010, AM J MED GENET B, V153B, P1318, DOI 10.1002/ajmg.b.31112; Simon R, 2007, CANCER INFORM, V3, P11; Sittig LJ, 2012, GENES BRAIN BEHAV, V11, P193, DOI 10.1111/j.1601-183X.2011.00749.x; Smith AD, 2008, AM J CLIN NUTR, V87, P517; Stanger O, 2002, CURR DRUG METAB, V3, P211, DOI 10.2174/1389200024605163; Stapley NW, 2013, NEUROSCI LETT, V549, P120, DOI 10.1016/j.neulet.2013.06.032; Suren P, 2013, JAMA-J AM MED ASSOC, V309, P570, DOI 10.1001/jama.2012.155925; Sweeney MR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-41; Sweeney MR, 2005, BRIT J NUTR, V94, P727, DOI 10.1079/BJN20051572; Vawter MP, 2007, AM J MED GENET B, V144B, P728, DOI 10.1002/ajmg.b.30454; Vincent JB, 2009, AM J MED GENET B, V150B, P817, DOI 10.1002/ajmg.b.30903; Whitrow MJ, 2009, AM J EPIDEMIOL, V170, P1486, DOI 10.1093/aje/kwp315; Wilson NR, 2005, J NEUROSCI, V25, P6221, DOI 10.1523/JNEUROSCI.3003-04.2005; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Wu GY, 2004, J NUTR, V134, P2169, DOI 10.1093/jn/134.9.2169; Yajnik CS, 2008, REV ENDOCR METAB DIS, V9, P203, DOI 10.1007/s11154-008-9087-z; Zhao XY, 2003, P NATL ACAD SCI USA, V100, P6777, DOI 10.1073/pnas.1131928100	57	55	58	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101674	10.1371/journal.pone.0101674	http://dx.doi.org/10.1371/journal.pone.0101674			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006883	Green Published, gold			2022-12-27	WOS:000339040600056
J	Chen, HL; Wu, SP; Lu, R; Zhang, YG; Zheng, YY; Sun, J				Chen, Honglei; Wu, Shaoping; Lu, Rong; Zhang, Yong-guo; Zheng, Yuanyuan; Sun, Jun			Pulmonary Permeability Assessed by Fluorescent-Labeled Dextran Instilled Intranasally into Mice with LPS-Induced Acute Lung Injury	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; EVANS BLUE-DYE; ALBUMIN CLEARANCE; VASCULAR LEAKAGE; NEUTROPHIL; JUNCTIONS; PROGRESS; MARKER; ALPHA	Background: Several different methods have been used to assess pulmonary permeability in response to acute lung injury (ALI). However, these methods often involve complicated procedures and algorithms that are difficult to precisely control. The purpose of the current study is to establish a feasible method to evaluate alterations in lung permeability by instilling fluorescently labeled dextran (FITC-Dextran) intranasally. Methods/Principal Findings: For the mouse model of direct ALI, lipopolysaccharide (LPS) was administered intranasally. FITC-Dextran was instilled intranasally one hour before the mice were euthanized. Plasma fluorescence intensities from the LPS group were significantly higher than in the control group. To determine the reliability and reproducibility of the procedure, we also measured the lung wet-to-dry weight ratio, the protein concentration of the bronchoalveolar lavage fluid, tight and adherens junction markers and pathological changes. Consistent results were observed when the LPS group was compared with the control group. Simultaneously, we found that the concentration of plasma FITC-Dextran was LPS dose-dependent. The concentration of plasma FITC-Dextran also increased with initial intranasal FITC-Dextran doses. Furthermore, increased fluorescence intensity of plasma FITC-Dextran was found in the intraperitoneally LPS-induced ALI model. Conclusion/Significance: In conclusion, the measurement of FITC-Dextran in plasma after intranasal instillation is a simple, reliable, and reproducible method to evaluate lung permeability alterations in vivo. The concentration of FITC-Dextran in the plasma may be useful as a potential peripheral biomarker of ALI in experimental clinical studies.	[Chen, Honglei; Wu, Shaoping; Lu, Rong; Zhang, Yong-guo; Zheng, Yuanyuan; Sun, Jun] Rush Univ, Dept Biochem, Chicago, IL 60612 USA	Rush University	Sun, J (corresponding author), Rush Univ, Dept Biochem, Chicago, IL 60612 USA.	jun_sun@rush.edu	Sun, Jun/S-7440-2019	Sun, Jun/0000-0001-7465-3133	NIDDK [KO1 DK075386, 1R03DK089010-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK089010, K01DK075386] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the NIDDK (KO1 DK075386 and 1R03DK089010-01) to Jun Sun. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett N, 2011, CRIT CARE CLIN, V27, P661, DOI 10.1016/j.ccc.2011.04.001; Bdeir K, 2010, AM J RESP CRIT CARE, V181, P935, DOI 10.1164/rccm.200907-1128OC; Ghosh CC, 2012, P NATL ACAD SCI USA, V109, P10024, DOI 10.1073/pnas.1120755109; Grommes J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038917; Hoff J, 2000, LAB ANIMAL, V29, P47; Matthay MA, 2005, AM J RESP CELL MOL, V33, P319, DOI 10.1165/rcmb.F305; Maus U, 2001, AM J RESP CRIT CARE, V164, P406, DOI 10.1164/ajrccm.164.3.2009055; Mayeux PR, 1997, J TOXICOL ENV HEALTH, V51, P415, DOI 10.1080/00984109708984034; Mazzon E, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-75; Moitra J, 2007, TRANSL RES, V150, P253, DOI 10.1016/j.trsl.2007.03.013; Niessen CM, 2007, J INVEST DERMATOL, V127, P2525, DOI 10.1038/sj.jid.5700865; Parasuraman S, 2010, J PHARMACOL PHARMACO, V1, P87, DOI 10.4103/0976-500X.72350; PATTERSON CE, 1992, J APPL PHYSIOL, V72, P865, DOI 10.1152/jappl.1992.72.3.865; Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Wagner EM, 2006, J APPL PHYSIOL, V100, P1224, DOI 10.1152/japplphysiol.01060.2005; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Zhang YG, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.23118; Zhao YY, 2006, J CLIN INVEST, V116, P2333, DOI 10.1172/JCI27154; Zhao YT, 2011, AM J RESP CELL MOL, V45, P426, DOI 10.1165/rcmb.2010-0422OC	21	31	32	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101925	10.1371/journal.pone.0101925	http://dx.doi.org/10.1371/journal.pone.0101925			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007191	gold, Green Submitted, Green Published			2022-12-27	WOS:000339040600080
J	Porwollik, S; Santiviago, CA; Cheng, P; Long, F; Desai, P; Fredlund, J; Srikumar, S; Silva, CA; Chu, WP; Chen, X; Canals, R; Reynolds, MM; Bogomolnaya, L; Shields, C; Cui, P; Guo, JB; Zheng, Y; Endicott-Yazdani, T; Yang, HJ; Maple, A; Ragoza, Y; Blondel, CJ; Valenzuela, C; Andrews-Polymenis, H; McClelland, M				Porwollik, Steffen; Santiviago, Carlos A.; Cheng, Pui; Long, Fred; Desai, Prerak; Fredlund, Jennifer; Srikumar, Shabarinath; Silva, Cecilia A.; Chu, Weiping; Chen, Xin; Canals, Rocio; Reynolds, M. Megan; Bogomolnaya, Lydia; Shields, Christine; Cui, Ping; Guo, Jinbai; Zheng, Yi; Endicott-Yazdani, Tiana; Yang, Hee-Jeong; Maple, Aimee; Ragoza, Yury; Blondel, Carlos J.; Valenzuela, Camila; Andrews-Polymenis, Helene; McClelland, Michael			Defined Single-Gene and Multi-Gene Deletion Mutant Collections in Salmonella enterica sv Typhimurium	PLOS ONE			English	Article							CONDITIONALLY ESSENTIAL GENES; HIGH-THROUGHPUT; GENOME; INSERTION; INFECTION; MUTAGENESIS; SEQUENCE; LIBRARY; FITNESS; PROTEIN	We constructed two collections of targeted single gene deletion (SGD) mutants and two collections of targeted multi-gene deletion (MGD) mutants in Salmonella enterica sv Typhimurium 14028s. The SGD mutant collections contain (1), 3517 mutants in which a single gene is replaced by a cassette containing a kanamycin resistance (Kan(R)) gene oriented in the sense direction (SGD-K), and (2), 3376 mutants with a chloramphenicol resistance gene (Cam(R)) oriented in the antisense direction (SGD-C). A combined total of 3773 individual genes were deleted across these SGD collections. The MGD collections contain mutants bearing deletions of contiguous regions of three or more genes and include (3), 198 mutants spanning 2543 genes replaced by a Kan(R) cassette (MGD-K), and (4), 251 mutants spanning 2799 genes replaced by a Cam(R) cassette (MGD-C). Overall, 3476 genes were deleted in at least one MGD collection. The collections with different antibiotic markers permit construction of all viable combinations of mutants in the same background. Together, the libraries allow hierarchical screening of MGDs for different phenotypic followed by screening of SGDs within the target MGD regions. The mutants of these collections are stored at BEI Resources (www.beiresources.org) and publicly available.	[Porwollik, Steffen; Cheng, Pui; Long, Fred; Desai, Prerak; Fredlund, Jennifer; Srikumar, Shabarinath; Silva, Cecilia A.; Chu, Weiping; Chen, Xin; Canals, Rocio; McClelland, Michael] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; [Santiviago, Carlos A.; Silva, Cecilia A.; Blondel, Carlos J.; Valenzuela, Camila] Univ Chile, Fac Ciencias Quim & Farmaceut, Santiago, Chile; [Reynolds, M. Megan; Bogomolnaya, Lydia; Shields, Christine; Cui, Ping; Guo, Jinbai; Zheng, Yi; Endicott-Yazdani, Tiana; Yang, Hee-Jeong; Maple, Aimee; Ragoza, Yury; Andrews-Polymenis, Helene] Texas A&M Univ, Dept Microbial Pathogenesis & Immunol, College Stn, TX 77843 USA	University of California System; University of California Irvine; Universidad de Chile; Texas A&M University System; Texas A&M University College Station	Andrews-Polymenis, H (corresponding author), Texas A&M Univ, Dept Microbial Pathogenesis & Immunol, College Stn, TX 77843 USA.	handrews@medicine.tamhsc.edu; mmcclell@uci.edu	Blondel, Carlos/X-7380-2019; Desai, Prerak/ABF-8529-2020; Silva, Cecilia A./E-1382-2015; Chen, Xin/ABA-3794-2020; Blondel, Carlos J/B-1287-2010; Valenzuela, Camila/ADU-5264-2022; Santiviago, Carlos/N-9991-2018	Blondel, Carlos/0000-0002-7099-6347; Silva, Cecilia A./0000-0003-1945-7767; Blondel, Carlos J/0000-0002-7099-6347; Valenzuela, Camila/0000-0002-5642-6188; Santiviago, Carlos/0000-0002-7043-7908; Bogomolnaya, Lydia/0000-0001-7041-1815; Srikumar, Shabarinath/0000-0003-3775-2831; McClelland, Michael/0000-0003-1788-9347; Yang, Hee-Jeong/0000-0002-7351-8404; Canals, Rocio/0000-0001-7079-7690	NIH [R01AI075093, R21AI083964, R01AI083646, R56AI077645]; NIAID [HHSN272200900040C]; Binational Agricultural Research Development Fund; Center for Produce Safety at UC Davis; AFRI CSRESS United States Department of Agriculture [2009-03579]; FONDECYT [1110172, 1140754]; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083646, R21AI083964, R56AI077645, R01AI075093] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Binational Agricultural Research Development Fund; Center for Produce Safety at UC Davis; AFRI CSRESS United States Department of Agriculture; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in part under NIH grant R01AI075093, and NIAID Contract No. HHSN272200900040C. The authors also acknowledge support from NIH grants R21AI083964, R01AI083646, R56AI077645, the Binational Agricultural Research Development Fund, the Center for Produce Safety at UC Davis, AFRI CSRESS United States Department of Agriculture grant 2009-03579, and FONDECYT grants 1110172 and 1140754. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Polymenis HL, 2004, J BACTERIOL, V186, P2619, DOI 10.1128/JB.186.9.2619-2628.2004; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barquist L, 2013, NUCLEIC ACIDS RES, V41, P4549, DOI 10.1093/nar/gkt148; Baumler AJ, 1996, INFECT IMMUN, V64, P61; Bolle C, 2013, PLANT J, V75, P157, DOI 10.1111/tpj.12197; Bowe F, 1998, INFECT IMMUN, V66, P3372, DOI 10.1128/IAI.66.7.3372-3377.1998; Butland G, 2008, NAT METHODS, V5, P789, DOI 10.1038/NMETH.1239; Cameron DE, 2008, P NATL ACAD SCI USA, V105, P8736, DOI 10.1073/pnas.0803281105; Canals R, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-212; Chaudhuri RR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003456; Chaudhuri RR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000529; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; Feinbaum RL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002813; Fey PD, 2013, MBIO, V4, DOI 10.1128/mBio.00537-12; Gallagher LA, 2013, MBIO, V4, DOI 10.1128/mBio.00604-13; Goodman AL, 2011, NAT PROTOC, V6, P1969, DOI 10.1038/nprot.2011.417; Gould LH, 2013, MMWR SURVEILL SUMM, V62, P1; Hashimoto M, 2005, MOL MICROBIOL, V55, P137, DOI 10.1111/j.1365-2958.2004.04386.x; Held K, 2012, J BACTERIOL, V194, P6387, DOI 10.1128/JB.01479-12; Huang TT, 2013, CARCINOGENESIS, DOI 10.1093/carcin/bgt112 23568951; IZAT AL, 1990, POULTRY SCI, V69, P1876, DOI 10.3382/ps.0691876; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; Kato JI, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100174; Katribe E, 2009, J BACTERIOL, V191, P2843, DOI 10.1128/JB.01223-08; Khatiwara A, 2012, APPL ENVIRON MICROB, V78, P3098, DOI 10.1128/AEM.06865-11; Kullas AL, 2012, CELL HOST MICROBE, V12, P791, DOI 10.1016/j.chom.2012.10.018; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r134; Langridge GC, 2009, GENOME RES, V19, P2308, DOI 10.1101/gr.097097.109; Lawley TD, 2006, PLOS PATHOG, V2, P87, DOI 10.1371/journal.ppat.0020011; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Makela P, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3129; Mazurkiewicz P, 2006, NAT REV GENET, V7, P929, DOI 10.1038/nrg1984; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Mulleder M, 2012, NAT BIOTECHNOL, V30, P1176, DOI 10.1038/nbt.2442; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Parsons DA, 2005, INFECT IMMUN, V73, P4338, DOI 10.1128/IAI.73.7.4338-4345.2005; Pezoa D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063917; Pickard D, 2013, J BACTERIOL, V195, P1320, DOI 10.1128/JB.01632-12; Reynolds MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015800; Sabbagh SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036643; Santiviago CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000477; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; Silva CA, 2012, INFECT IMMUN, V80, P839, DOI 10.1128/IAI.05497-11; Skurnik D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003582; Swearingen MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036043; Typas A, 2008, NAT METHODS, V5, P781, DOI 10.1038/NMETH.1240; van Opijnen T, 2013, NAT REV MICROBIOL, V11, DOI 10.1038/nrmicro3033; Varshney GK, 2013, NUCLEIC ACIDS RES, V41, pD861, DOI 10.1093/nar/gks946; WALDROUP AL, 1993, POULTRY SCI, V72, P643, DOI 10.3382/ps.0720643; Wang Y, 2009, COLD SPRING HARB PRO, V2009; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zheng Y, 2013, MOL MICROBIOL, V89, P403, DOI 10.1111/mmi.12284	54	87	87	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e99820	10.1371/journal.pone.0099820	http://dx.doi.org/10.1371/journal.pone.0099820			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007190	Green Published, gold			2022-12-27	WOS:000339040600009
J	Stanton, DWG; Hart, J; Galbusera, P; Helsen, P; Shephard, J; Kumpel, NF; Wang, JL; Ewen, JG; Bruford, MW				Stanton, David W. G.; Hart, John; Galbusera, Peter; Helsen, Philippe; Shephard, Jill; Kuempel, Noelle F.; Wang, Jinliang; Ewen, John G.; Bruford, Michael W.			Distinct and Diverse: Range-Wide Phylogeography Reveals Ancient Lineages and High Genetic Variation in the Endangered Okapi (Okapia johnstoni)	PLOS ONE			English	Article							POPULATION-GENETICS; COMPREHENSIVE ANALYSIS; CLIMATE-CHANGE; MITOCHONDRIAL; EVOLUTION; CONSERVATION; HISTORY; POLYMORPHISM; EXPANSION; REFUGIA	The okapi is an endangered, evolutionarily distinctive even-toed ungulate classified within the giraffidae family that is endemic to the Democratic Republic of Congo. The okapi is currently under major anthropogenic threat, yet to date nothing is known about its genetic structure and evolutionary history, information important for conservation management given the species' current plight. The distribution of the okapi, being confined to the Congo Basin and yet spanning the Congo River, also makes it an important species for testing general biogeographic hypotheses for Congo Basin fauna, a currently understudied area of research. Here we describe the evolutionary history and genetic structure of okapi, in the context of other African ungulates including the giraffe, and use this information to shed light on the biogeographic history of Congo Basin fauna in general. Using nuclear and mitochondrial DNA sequence analysis of mainly non-invasively collected samples, we show that the okapi is both highly genetically distinct and highly genetically diverse, an unusual combination of genetic traits for an endangered species, and feature a complex evolutionary history. Genetic data are consistent with repeated climatic cycles leading to multiple Plio-Pleistocene refugia in isolated forests in the Congo catchment but also imply historic gene flow across the Congo River.	[Stanton, David W. G.; Bruford, Michael W.] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Hart, John] Lukuru Fdn, Projet Tshuapa Lomami Lualaba TL2, Kinshasa, DEM REP CONGO; [Galbusera, Peter; Helsen, Philippe; Shephard, Jill] Royal Zool Soc Antwerp, Ctr Res & Conservat, Antwerp, Belgium; [Kuempel, Noelle F.] Zool Soc London, Conservat Programmes, London, England; [Wang, Jinliang; Ewen, John G.] Zool Soc London, Inst Zool, London NW1 4RY, England	Cardiff University; Zoological Society of London; Zoological Society of London	Stanton, DWG (corresponding author), Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales.	stantondw@cardiff.ac.uk	Bruford, Michael/Y-7463-2019; Bruford, Michael W/D-3750-2009; Helsen, Philippe/K-8660-2018; Galbusera, Peter HA/D-2188-2014	Bruford, Michael/0000-0001-6357-6080; Bruford, Michael W/0000-0001-6357-6080; Galbusera, Peter HA/0000-0001-9516-8196; Stanton, David/0000-0002-9753-3166; Shephard, Jill/0000-0002-4418-9891	UK Natural Environment Research Council (NERC); ZSL (ZSL as NERC CASE industry partner and via an Erasmus Darwin Barlow Expedition grant); GIC (the Okapi Conservation Project); US Fish and Wildlife Service; UK's Darwin Initiative; Mohamed bin Zayed Species Conservation Fund	UK Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ZSL (ZSL as NERC CASE industry partner and via an Erasmus Darwin Barlow Expedition grant); GIC (the Okapi Conservation Project); US Fish and Wildlife Service(US Fish & Wildlife Service); UK's Darwin Initiative; Mohamed bin Zayed Species Conservation Fund	This project was jointly funded by the UK Natural Environment Research Council (NERC) and ZSL (ZSL as NERC CASE industry partner and via an Erasmus Darwin Barlow Expedition grant). The authors also acknowledge the financial support provided by GIC (the Okapi Conservation Project), the US Fish and Wildlife Service, the UK's Darwin Initiative and the Mohamed bin Zayed Species Conservation Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken N, 2004, MOL ECOL, V13, P1423, DOI 10.1111/j.1365-294X.2004.02159.x; Alpers DL, 2004, MOL ECOL, V13, P1771, DOI 10.1111/j.1365-294X.2004.02204.x; Anka Z, 2009, TECTONOPHYSICS, V470, P42, DOI 10.1016/j.tecto.2008.04.009; Arctander P, 1999, MOL BIOL EVOL, V16, P1724, DOI 10.1093/oxfordjournals.molbev.a026085; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Born C, 2011, MOL ECOL, V20, P131, DOI 10.1111/j.1365-294X.2010.04919.x; Bowie RCK, 2006, MOL PHYLOGENET EVOL, V38, P171, DOI 10.1016/j.ympev.2005.06.001; BRAGA J, 1995, CR ACAD SCI II, V320, P1025; Bromham L, 2003, NAT REV GENET, V4, P216, DOI 10.1038/nrg1020; Brown DM, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-57; Caswell JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000057; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Clifford SL, 2004, MOL ECOL, V13, P1551, DOI 10.1111/j.1365-294X.2004.02140.x; Colinvaux PA, 2000, QUATERNARY SCI REV, V19, P141, DOI 10.1016/S0277-3791(99)00059-1; Cowling SA, 2008, GLOBAL CHANGE BIOL, V14, P827, DOI 10.1111/j.1365-2486.2007.01524.x; de Thoisy B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-278; deBonis L, 1997, PALAEONTOLOGY, V40, P121; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; Dietrich WO, 1942, PALAEONTOGR ABT A, V94, P3; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eriksson J, 2004, MOL ECOL, V13, P3425, DOI 10.1111/j.1365-294X.2004.02332.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fernandez MH, 2005, BIOL REV, V80, P269, DOI 10.1017/S1464793104006670; Fischer A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021605; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; GENTRY AW, 1990, J HUM EVOL, V19, P529, DOI 10.1016/0047-2484(90)90063-H; Graur D, 2004, TRENDS GENET, V20, P80, DOI 10.1016/j.tig.2003.12.003; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hamilton AC, 1975, PLANT ECOL, V30, P99; Harris J.M., 1991, P93; Harris John M., 2010, P797; HART JA, 1989, SYM ZOOL S, V61, P31; Hart JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044271; Hassanin A, 2012, CR BIOL, V335, P32, DOI 10.1016/j.crvi.2011.11.002; Hey J, 2010, MOL BIOL EVOL, V27, P921, DOI 10.1093/molbev/msp298; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Ho SYW, 2006, TRENDS GENET, V22, P79, DOI 10.1016/j.tig.2005.11.006; IUCN, 2008, IUCN 2013 IUCN RED L; Johnston AR, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-120; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kawamoto Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059660; Kennis J, 2011, ZOOL J LINN SOC-LOND, V163, P983, DOI 10.1111/j.1096-3642.2011.00733.x; Lankester E. R., 1901, Proceedings of the Zoological Society of London, Vii, P279; Lessa EP, 2003, P NATL ACAD SCI USA, V100, P10331, DOI 10.1073/pnas.1730921100; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LIVINGSTONE DA, 1975, ANNU REV ECOL SYST, V6, P249, DOI 10.1146/annurev.es.06.110175.001341; Lopes JS, 2009, BIOINFORMATICS, V25, P2747, DOI 10.1093/bioinformatics/btp487; Lorenzen ED, 2010, J BIOGEOGR, V37, P571, DOI 10.1111/j.1365-2699.2009.02207.x; MAGLIO VJ, 1973, T AM PHILOS SOC, V63, P5; Mallon D, 2013, IUCN 2013 IUCN RED L; Maslin MA, 2007, J HUM EVOL, V53, P443, DOI 10.1016/j.jhevol.2007.06.005; Mboumba JF, 2011, J ZOOL SYST EVOL RES, V49, P77, DOI 10.1111/j.1439-0469.2010.00579.x; Moodley Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000454; MORITZ C, 1994, MOL ECOL, V3, P401, DOI 10.1111/j.1365-294X.1994.tb00080.x; Muwanika VB, 2003, HEREDITY, V91, P361, DOI 10.1038/sj.hdy.6800341; Nersting LG, 2001, MOL ECOL, V10, P711, DOI 10.1046/j.1365-294x.2001.01205.x; Nicolas V, 2011, J BIOGEOGR, V38, P191, DOI 10.1111/j.1365-2699.2010.02399.x; Nixon S., 2008, CONSERVATION STATUS; Pickles RSA, 2011, MOL PHYLOGENET EVOL, V61, P616, DOI 10.1016/j.ympev.2011.08.017; Plana V, 2004, PHILOS T ROY SOC B, V359, P1585, DOI 10.1098/rstb.2004.1535; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Potts R, 2013, QUATERNARY SCI REV, V73, P1, DOI 10.1016/j.quascirev.2013.04.003; Querouil S, 2003, MOL PHYLOGENET EVOL, V28, P24, DOI 10.1016/S1055-7903(03)00027-7; Rambaut A., 2007, TRACER V1 5; Rohland N, 2005, MOL BIOL EVOL, V22, P2435, DOI 10.1093/molbev/msi244; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stuart C., 2017, STUARTS FIELD GUIDE; Uchida A, 1996, TRENDS ECOL EVOL, V11, P163, DOI 10.1016/0169-5347(96)10007-0; Van der Made J, 2012, ESTUD GEOL-MADRID, V67, P613; Van Hooft WF, 2002, MOL ECOL, V11, P267, DOI 10.1046/j.1365-294X.2002.01429.x; Willis KJ, 2000, SCIENCE, V287, P1406, DOI 10.1126/science.287.5457.1406; Won YJ, 2005, MOL BIOL EVOL, V22, P297, DOI 10.1093/molbev/msi017; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371	74	13	13	3	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101081	10.1371/journal.pone.0101081	http://dx.doi.org/10.1371/journal.pone.0101081			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007188	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000339040600029
J	de Jong, PA; Hellings, WE; Takx, RAP; Isgum, I; van Herwaarden, JA; Mali, WPTM				de Jong, Pim A.; Hellings, Willem E.; Takx, Richard A. P.; Isgum, Ivana; van Herwaarden, Joost A.; Mali, Willem P. Th M.			Computed Tomography of Aortic Wall Calcifications in Aortic Dissection Patients	PLOS ONE			English	Article							HUMAN THORACIC AORTA; ARTERIAL CALCIFICATION; CARDIOVASCULAR EVENTS; RISK-FACTORS; ATHEROSCLEROSIS; ARTERIOSCLEROSIS; MANAGEMENT; STENOSIS; BONE; CT	Objectives: To investigate the frequency of aortic calcifications at the outer edge of the false lumen and the frequency of fully circular aortic calcifications in a consecutive series of patients with aortic dissection who underwent contrast-enhanced CT. Methods: The study population compromised of 69 consecutive subjects aged 60 years and older with a contrast-enhanced CT scan demonstrating an aortic dissection. All CT scans were evaluated for the frequency of aortic calcifications at the outer edge of the false lumen and the frequency of fully circular aortic calcifications by two experienced observers. Between observer reliability was evaluated by using Cohen's Kappa. Differences between groups were tested using unpaired T test and Chi-square test. Results: Presumed media calcifications were observed in 22 (32%) patients of 60 years and older and were found more frequently in chronic aortic dissection (N = 12/23, 52%) than in acute aortic dissection (N = 10/46, 22%). Conclusion: As the intima has been torn away by the aortic dissection it is highly likely that CT scans can visualize the calcifications in the tunica media of the aorta.	[de Jong, Pim A.; Takx, Richard A. P.; Mali, Willem P. Th M.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Hellings, Willem E.; van Herwaarden, Joost A.] Univ Med Ctr Utrecht, Dept Vasc Surg, Utrecht, Netherlands; [Isgum, Ivana] Univ Med Ctr Utrecht, Images Sci Inst, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	de Jong, PA (corresponding author), Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands.	pimdejong@gmail.com	de Jong, Pim A/G-7220-2014; Takx, Richard/T-2852-2019; Isgum, Ivana/H-8659-2014	de Jong, Pim A/0000-0003-4840-6854; Takx, Richard/0000-0003-2252-3040; van Herwaarden, Joost/0000-0003-1165-5179; Isgum, Ivana/0000-0003-1869-5034				Allison MA, 2004, ARTERIOSCL THROM VAS, V24, P331, DOI 10.1161/01.ATV.0000110786.02097.0c; Blumenthal Herman T., 1944, AMER JOUR PATH, V20, P665; Dweck MR, 2013, EUR HEART J, V34, P1567, DOI 10.1093/eurheartj/eht034; ELLIOTT RJ, 1994, CALCIFIED TISSUE INT, V54, P268, DOI 10.1007/BF00295949; GOEBEL FD, 1983, DIABETOLOGIA, V24, P347; HACHIYA J, 1993, J COMPUT ASSIST TOMO, V17, P374, DOI 10.1097/00004728-199305000-00006; HICKLER RB, 1990, CLIN CARDIOL, V13, P317, DOI 10.1002/clc.4960130504; Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c; Iribarren C, 2007, J INTERN MED, V261, P235, DOI 10.1111/j.1365-2796.2007.01768.x; Itani Y, 2004, CIRC J, V68, P538, DOI 10.1253/circj.68.538; Jacobs PC, 2011, EUR RADIOL, V21, P1577, DOI 10.1007/s00330-011-2112-8; Jeffcoate WJ, 2009, DIABETOLOGIA, V52, P2478, DOI 10.1007/s00125-009-1521-6; Juraszek A, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-110; KANNEL WB, 1972, J PEDIATR-US, V80, P544, DOI 10.1016/S0022-3476(72)80049-0; Khan IA, 2002, CHEST, V122, P311, DOI 10.1378/chest.122.1.311; LACHMAN AS, 1977, AM J MED, V63, P615, DOI 10.1016/0002-9343(77)90207-8; LINDBOM A, 1950, Acta Radiol Suppl, V80, P1; MCCULLAGH KG, 1975, ATHEROSCLEROSIS, V21, P37, DOI 10.1016/0021-9150(75)90093-3; MEEMA HE, 1986, RADIOLOGY, V158, P671, DOI 10.1148/radiology.158.3.3945736; Monckeberg JG, 1903, VIRCHOWS ARCH A, V171, P141; Neven E, 2007, KIDNEY INT, V72, P574, DOI 10.1038/sj.ki.5002353; ORR DP, 1978, INVEST RADIOL, V13, P110, DOI 10.1097/00004424-197803000-00002; REID JM, 1982, THORAX, V37, P902, DOI 10.1136/thx.37.12.902; Sawabe M, 2010, GERIATR GERONTOL INT, V10, pS213, DOI 10.1111/j.1447-0594.2010.00603.x; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Strong JP, 1999, JAMA-J AM MED ASSOC, V281, P727, DOI 10.1001/jama.281.8.727; Subbotin VM, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-41; Tohno S, 1998, CELL MOL BIOL, V44, P1253; Tohno Y, 1996, BIOL TRACE ELEM RES, V54, P23, DOI 10.1007/BF02785317; Wallin R, 2001, MED RES REV, V21, P274, DOI 10.1002/med.1010.abs; Willoteaux S, 2004, EUR RADIOL, V14, P1999, DOI 10.1007/s00330-004-2441-y; Yamada S, 2014, EUR J RADIOL, V83, P957, DOI 10.1016/j.ejrad.2014.02.009	32	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e102036	10.1371/journal.pone.0102036	http://dx.doi.org/10.1371/journal.pone.0102036			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003993	Green Published, Green Submitted, gold			2022-12-27	WOS:000339242700100
J	Li, B; Flaveny, CA; Giambelli, C; Fei, DL; Han, L; Hang, BI; Bai, F; Pei, XH; Nose, V; Burlingame, O; Capobianco, AJ; Orton, D; Lee, E; Robbins, DJ				Li, Bin; Flaveny, Colin A.; Giambelli, Camilla; Fei, Dennis Liang; Han, Lu; Hang, Brian I.; Bai, Feng; Pei, Xin-Hai; Nose, Vania; Burlingame, Oname; Capobianco, Anthony J.; Orton, Darren; Lee, Ethan; Robbins, David J.			Repurposing the FDA-Approved Pinworm Drug Pyrvinium as a Novel Chemotherapeutic Agent for Intestinal Polyposis	PLOS ONE			English	Article							BETA-CATENIN; COLORECTAL-CANCER; ADENOMATOUS POLYPOSIS; DOWN-REGULATION; MURINE MODEL; E-CADHERIN; CYCLIN D1; APC GENE; COLON; PHOSPHORYLATION	Mutations in the WNT-pathway regulator ADENOMATOUS POLYPOSIS COLI (APC) promote aberrant activation of the WNT pathway that is responsible for APC-associated diseases such as Familial Adenomatous Polyposis (FAP) and 85% of spontaneous colorectal cancers (CRC). FAP is characterized by multiple intestinal adenomas, which inexorably result in CRC. Surprisingly, given their common occurrence, there are few effective chemotherapeutic drugs for FAP. Here we show that the FDA-approved, anti-helminthic drug Pyrvinium attenuates the growth of WNT-dependent CRC cells and does so via activation of CK1 alpha. Furthermore, we show that Pyrvinium can function as an in vivo inhibitor of WNT-signaling and polyposis in a mouse model of FAP: APC(min) mice. Oral administration of Pyrvinium, a CK1 alpha agonist, attenuated the levels of WNT-driven biomarkers and inhibited adenoma formation in APC(min) mice. Considering its well-documented safe use for treating enterobiasis in humans, our findings suggest that Pyrvinium could be repurposed for the clinical treatment of APC-associated polyposes.	[Li, Bin; Flaveny, Colin A.; Giambelli, Camilla; Fei, Dennis Liang; Han, Lu; Bai, Feng; Pei, Xin-Hai; Capobianco, Anthony J.; Robbins, David J.] Univ Miami, Mol Oncol Program, Dept Surg, Miami, FL 33152 USA; [Pei, Xin-Hai; Capobianco, Anthony J.; Robbins, David J.] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA; [Robbins, David J.] Univ Miami, Dept Biochem & Mol Biol, Miami, FL 33101 USA; [Nose, Vania] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA; [Burlingame, Oname] Univ Miami, Dept Pathol, Jackson Hlth Syst, Miami, FL USA; [Hang, Brian I.; Lee, Ethan] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA; [Orton, Darren] Stemsynergy Therapeut Inc, Miami, FL USA	University of Miami; University of Miami; University of Miami; University of Miami; University of Miami; Vanderbilt University	Robbins, DJ (corresponding author), Univ Miami, Mol Oncol Program, Dept Surg, Miami, FL 33152 USA.	drobbins@med.miami.edu	Pei, Xin-Hai/P-1812-2014	Li, Bin/0000-0001-9341-4672; Capobianco, Anthony/0000-0002-3706-6797; pei, xin-hai/0000-0001-6441-1691; Fei, Dennis Liang/0000-0002-1953-0584	NIH [5R01-CA-082628]; University of Miami Women's Cancer Association; Sylvester Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [R01CA082628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103926, R01GM081635] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Miami Women's Cancer Association; Sylvester Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funds from the NIH: 5R01-CA-082628, the University of Miami Women's Cancer Association, and the Sylvester Comprehensive Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed D, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.35; Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; AMBROZE WL, 1995, SEMIN SURG ONCOL, V11, P423, DOI 10.1002/ssu.2980110610; Arango D, 2001, CANCER RES, V61, P4910; Augenlicht LH, 1997, CANCER RES, V57, P1769; Baba S, 1998, Nihon Geka Gakkai Zasshi, V99, P336; BANDYOPADHYAY A K, 1966, Bulletin of the Calcutta School of Tropical Medicine, V14, P134; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; BLAIR LS, 1968, LAB ANIM CARE, V18, P314; Burn J, 2011, CANCER PREV RES, V4, P655, DOI 10.1158/1940-6207.CAPR-11-0106; CERDA AP, 1993, REV INVEST CLIN, V45, P493; Chan TA, 2002, P NATL ACAD SCI USA, V99, P8265, DOI 10.1073/pnas.082240999; Church JM, 1996, DIS COLON RECTUM, V39, P584, DOI 10.1007/BF02058717; Cohen B, 2010, EUR EARLY CHILD EDUC, V18, P1, DOI 10.1080/13502930903519993; Cunningham C, 1996, BRIT J SURG, V83, P321, DOI 10.1002/bjs.1800830309; de la Roche M, 2014, CANCER RES, V74, P1495, DOI 10.1158/0008-5472.CAN-13-2682; Elyada E, 2011, NATURE, V470, P409, DOI 10.1038/nature09673; Fan XS, 2010, INT J COLORECTAL DIS, V25, P583, DOI 10.1007/s00384-010-0903-z; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gerlier D, 1986, J IMMUNOLOGICAL METH; GOLDBERG MT, 1984, TOXICOL APPL PHARM, V74, P293, DOI 10.1016/0041-008X(84)90154-6; GRODEN J, 1993, AM J HUM GENET, V52, P263; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Herendeen JM, 2003, ANN PHARMACOTHER, V37, P1664, DOI 10.1345/aph.1C489; JAGELMAN DG, 1991, WORLD J SURG, V15, P47, DOI 10.1007/BF01658960; Kanwar SS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-212; Keller JJ, 2003, CANCER BIOL THER, V2, pS140; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Kita H, 2006, J GASTROENTEROL, V41, P1053, DOI 10.1007/s00535-006-1894-y; LAKE RS, 1982, J TOXICOL ENV HEALTH, V10, P255, DOI 10.1080/15287398209530248; Lee KH, 2010, P NATL ACAD SCI USA, V107, P69, DOI 10.1073/pnas.0909734107; Liu CM, 1999, P NATL ACAD SCI USA, V96, P6273, DOI 10.1073/pnas.96.11.6273; Mahmoud NN, 1998, SURGERY, V124, P225, DOI 10.1016/S0039-6060(98)70124-2; Mazaki T, 1996, INT J ONCOL, V9, P579; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; MORGAN GP, 1995, GUT, V36, P153, DOI 10.1136/gut.36.1.153-c; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Nakamura Y, 1991, Princess Takamatsu Symp, V22, P285; Okuno Scott, 2006, Curr Treat Options Oncol, V7, P438, DOI 10.1007/s11864-006-0019-4; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Paoni NF, 2003, PHYSL GENOMICS, P15; Paulsen JE, 2000, SCAND J GASTROENTERO, V35, P534; Prange W, 2003, J PATHOL, V201, P250, DOI 10.1002/path.1448; Ramsay RG, 2005, DNA CELL BIOL, V24, P21, DOI 10.1089/dna.2005.24.21; Rao CV, 2004, CURR CANCER DRUG TAR, V4, P29, DOI 10.2174/1568009043481632; Rice PL, 2003, MOL CANCER THER, V2, P885; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Santini D L, 1999, J Assoc Acad Minor Phys, V10, P68; Saraswati S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015521; Sinnberg T, 2010, CANCER RES, V70, P6999, DOI 10.1158/0008-5472.CAN-10-0645; SMITH TC, 1976, CLIN PHARMACOL THER, V19, P802; SPIRIO L, 1993, CELL, V75, P951, DOI 10.1016/0092-8674(93)90538-2; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Venerando A, 2013, BIOCHEM J, V452, P131, DOI 10.1042/BJ20121140; Wallace MH, 1998, BRIT J SURG, V85, P742; Wallace MH, 1999, ANN ONCOL, V10, P201, DOI 10.1023/A:1008323206601; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; Yu DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003951	60	42	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101969	10.1371/journal.pone.0101969	http://dx.doi.org/10.1371/journal.pone.0101969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003333	Green Published, gold, Green Submitted			2022-12-27	WOS:000339242700094
J	Rondeau, G; Abedinpour, P; Desai, P; Baron, VT; Borgstrom, P; Welsh, J				Rondeau, Gaelle; Abedinpour, Parisa; Desai, Prerak; Baron, Veronique T.; Borgstrom, Per; Welsh, John			Effects of Different Tissue Microenvironments on Gene Expression in Breast Cancer Cells	PLOS ONE			English	Article							RAT MAMMARY-TUMORS; ENDOPLASMIC-RETICULUM; MODEL; METASTASIS; MICE; DYNAMICS; STRESS	In metastasis, circulating tumor cells penetrate the walls of blood vessels and enter the metastatic target tissue, thereby becoming exposed to novel and relatively unsupportive microenvironments. In the new microenvironments, the tumor cells often remain in a dormant state indefinitely and must adapt before they are able to successfully colonize the tissue. Very little is known about this adaptive process. We studied temporal changes in gene expression when breast cancer cells adapt to survive and grow on brain, bone marrow, and lung tissue maintained in an in vivo culture system, as models of the metastatic colonization of these tissues. We observed the transient activation of genes typically associated with homeostasis and stress during the initial stages of adaptation, followed by the activation of genes that mediate more advanced functions, such as elaboration of cell morphology and cell division, as the cells adapted to thrive in the host tissue microenvironment. We also observed the temporary induction of genes characteristic of the host tissue, which was particularly evident when tumor cells were grown on brain tissue. These early transient gene expression events suggest potential points of therapeutic intervention that are not evident in data from well-established tumors.	[Rondeau, Gaelle; Abedinpour, Parisa; Desai, Prerak; Baron, Veronique T.; Borgstrom, Per; Welsh, John] Vaccine Res Inst San Diego, San Diego, CA 92121 USA		Welsh, J (corresponding author), Vaccine Res Inst San Diego, San Diego, CA 92121 USA.	jwelsh@sdibr.org	Desai, Prerak/ABF-8529-2020		California Breast Cancer Research Program [151B-0133]; DOD [W81XWH-09-1-0280]; NCI [1R21CA133638]; NATIONAL CANCER INSTITUTE [R21CA133638] Funding Source: NIH RePORTER	California Breast Cancer Research Program; DOD(United States Department of Defense); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the California Breast Cancer Research Program (151B-0133), the DOD (W81XWH-09-1-0280), and the NCI (1R21CA133638). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Astolfi A, 2005, AM J PATHOL, V166, P1205, DOI 10.1016/S0002-9440(10)62339-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benosman S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064256; Bonfanti P, 2010, NATURE, V466, P978, DOI 10.1038/nature09269; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Brochner CB, 2012, J HISTOCHEM CYTOCHEM, V60, P188, DOI 10.1369/0022155411433331; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; Chan MM, 2007, INT J CANCER, V121, P474, DOI 10.1002/ijc.22684; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Cuadros C, 2003, CANCER RES, V63, P5895; DULBECCO R, 1988, P NATL ACAD SCI USA, V85, P8659, DOI 10.1073/pnas.85.22.8659; Eilken HM, 2010, CURR OPIN CELL BIOL, V22, P617, DOI 10.1016/j.ceb.2010.08.010; Frost GI, 2005, MICROVASC RES, V69, P1, DOI 10.1016/j.mvr.2004.10.001; Funayama M, 2002, ANN NEUROL, V51, P296, DOI 10.1002/ana.10113; Giancotti FG, 2013, CELL, V155, P750, DOI 10.1016/j.cell.2013.10.029; Gros-Louis F, 2007, NAT GENET, V39, P80, DOI 10.1038/ng1927; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hagglund MGA, 2011, J BIOL CHEM, V286, P20500, DOI 10.1074/jbc.M110.162404; Han HX, 2011, ACTA PHARMACOL SIN, V32, P1327, DOI 10.1038/aps.2011.106; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Horiuchi Y, 2012, AM J MED GENET B, V159B, P30, DOI 10.1002/ajmg.b.31249; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johnston J, 2010, TRANSGENIC RES, V19, P1017, DOI 10.1007/s11248-010-9376-7; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Khoo MLM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019025; Kim SY, 2011, CELL ADHES MIGR, V5, P97, DOI 10.4161/cam.5.2.14374; Kobayashi K, 2003, DEVELOPMENT, V130, P5179, DOI 10.1242/dev.00732; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Lombard Z, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-30; Lu X, 2009, CELL CYCLE, V8, P3804, DOI 10.4161/cc.8.23.10104; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Metz M, 2011, J COMP NEUROL, V519, P1435, DOI 10.1002/cne.22610; Miles RR, 2000, ENDOCRINOLOGY, V141, P4533, DOI 10.1210/en.141.12.4533; Molinari F, 2002, SCIENCE, V298, P1779, DOI 10.1126/science.1076521; Moreira LO, 2008, CELL MICROBIOL, V10, P2067, DOI 10.1111/j.1462-5822.2008.01189.x; Oh P, 2007, NAT BIOTECHNOL, V25, P327, DOI 10.1038/nbt1292; Overgaard K, 1999, J PHYSIOL-LONDON, V518, P215, DOI 10.1111/j.1469-7793.1999.0215r.x; Palmieri D, 2009, CLIN CANCER RES, V15, P6148, DOI 10.1158/1078-0432.CCR-09-1039; Palmieri D, 2009, MOL CANCER RES, V7, P1438, DOI 10.1158/1541-7786.MCR-09-0234; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Perez-Llamas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019541; R Core Team, 2012, R LANG ENV STAT COMP; Rojas P, 2007, MOL PSYCHIATR, V12, P756, DOI 10.1038/sj.mp.4001993; Saadat L, 2010, GLIA, V58, P391, DOI 10.1002/glia.20930; Sabrautzki S, 2012, MAMM GENOME, V23, P416, DOI 10.1007/s00335-012-9397-z; Scheel C, 2007, CANCER RES, V67, P11476, DOI 10.1158/0008-5472.CAN-07-1653; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Straub C, 2011, J NEUROSCI, V31, P8078, DOI 10.1523/JNEUROSCI.0024-11.2011; Takahashi M, 1998, MOL CELL NEUROSCI, V12, P340, DOI 10.1006/mcne.1998.0721; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Velasco J, 2010, OSTEOPOROSIS INT, V21, P109, DOI 10.1007/s00198-009-0931-0; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486; Zhang P, 2011, ARTERIOSCL THROM VAS, V31, P890, DOI 10.1161/ATVBAHA.110.215640	57	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101160	10.1371/journal.pone.0101160	http://dx.doi.org/10.1371/journal.pone.0101160			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004123	gold, Green Published, Green Submitted			2022-12-27	WOS:000339242700019
J	Sala, R; Nguyen, QD; Patel, CBK; Mann, D; Steinke, JHG; Vilar, R; Aboagye, EO				Sala, Roberta; Quang-De Nguyen; Patel, Chirag B. K.; Mann, David; Steinke, Joachim H. G.; Vilar, Ramon; Aboagye, Eric O.			Phosphorylation Status of Thymidine Kinase 1 Following Antiproliferative Drug Treatment Mediates 3 '-Deoxy-3 '-[F-18]-Fluorothymidine Cellular Retention	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; IN-VIVO; BREAST-CANCER; 3'-DEOXY-3'-FLUOROTHYMIDINE PET; MITOTIC PHOSPHORYLATION; PROLIFERATION; TUMOR; CELLS; DEGRADATION; VALIDATION	Background: 3'-Deoxy-3'-[F-18]-fluorothymidine ([F-18] FLT) is being investigated as a Positron Emission Tomography (PET) proliferation biomarker. The mechanism of cellular [F-18] FLT retention has been assigned primarily to alteration of the strict transcriptionally regulated S-phase expression of thymidine kinase 1 (TK1). This, however, does not explain how anticancer agents acting primarily through G2/M arrest affect [F-18] FLT uptake. We investigated alternative mechanisms of [F-18] FLT cellular retention involving post-translational modification of TK1 during mitosis. Methods: [F-18] FLT cellular retention was assessed in cell lines having different TK1 expression. Drug-induced phosphorylation of TK1 protein was evaluated by MnCl2-phos-tag gel electrophoresis and correlated with [F-18] FLT cellular retention. We further elaborated the amino acid residues involved in TK1 phosphorylation by transient transfection of FLAG-pCMV2 plasmids encoding wild type or mutant variants of TK1 into TK1 negative cells. Results: Baseline [F-18] FLT cellular retention and TK1 protein expression were associated. S-phase and G2/M phase arrest caused greater than two-fold reduction in [F-18] FLT cellular retention in colon cancer HCT116 cells (p<0.001). G2/M cell cycle arrest increased TK1 phosphorylation as measured by induction of at least one phosphorylated form of the protein on MnCl2-phos-tag gels. Changes in [F-18] FLT cellular retention reflected TK1 phosphorylation and not expression of total protein, in keeping with the impact of phosphorylation on enzyme catalytic activity. Both Ser13 and Ser231 were shown to be involved in the TK1 phosphorylation-modulated [F-18] FLT cellular retention; although the data suggested involvement of other amino-acid residues. Conclusion: We have defined a regulatory role of TK1 phosphorylation in mediating [F-18] FLT cellular retention and hence reporting of antiproliferative activity, with implications especially for drugs that induce a G2/M cell cycle arrest.	[Sala, Roberta; Quang-De Nguyen; Aboagye, Eric O.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Comprehens Canc Imaging Ctr, London, England; [Patel, Chirag B. K.; Steinke, Joachim H. G.; Vilar, Ramon] Univ London Imperial Coll Sci Technol & Med, Dept Chem, Inst Chem Biol, London SW7 2AY, England; [Mann, David] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England	Imperial College London; Imperial College London; Imperial College London	Aboagye, EO (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Comprehens Canc Imaging Ctr, London, England.	eric.aboagye@imperial.ac.uk	Vilar, Ramon/U-3746-2019	Vilar, Ramon/0000-0003-2992-199X; ABOAGYE, Eric/0000-0003-2276-6771	Cancer Research UK - Engineering and Physical Sciences Research Council grant [C2536/A10337]; UK Medical Research Council [MC_US_A652_0030]; EPSRC [EP/K039946/1] Funding Source: UKRI; Cancer Research UK [10337] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/K039946/1] Funding Source: researchfish	Cancer Research UK - Engineering and Physical Sciences Research Council grant; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by Cancer Research UK - Engineering and Physical Sciences Research Council grant (in association with the Medical Research Council and Department of Health (England)) grant C2536/A10337. EOA's laboratory receives core funding from the UK Medical Research Council (MC_US_A652_0030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Bading JR, 2008, J NUCL MED, V49, p64S, DOI 10.2967/jnumed.107.046391; Barthel H, 2005, EUR J NUCL MED MOL I, V32, P257, DOI 10.1007/s00259-004-1611-0; Barthel H, 2003, CANCER RES, V63, P3791; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Brockenbrough J Scott, 2011, J Nucl Med, V52, P1181, DOI 10.2967/jnumed.111.089482; Chan F, 2007, MOL CANCER THER, V6, P3147, DOI 10.1158/1535-7163.MCT-07-2156; CHANG ZF, 1994, J BIOL CHEM, V269, P21249; Chang ZF, 1998, J BIOL CHEM, V273, P12095, DOI 10.1074/jbc.273.20.12095; CHANG ZF, 1993, J BIOL CHEM, V268, P1266; Contractor K, 2012, BIOMARK MED, V6, P231, DOI [10.2217/BMM.12.11, 10.2217/bmm.12.11]; Contractor KB, 2011, CLIN CANCER RES, V17, P7664, DOI 10.1158/1078-0432.CCR-11-0783; CRISSMAN HA, 1973, J CELL BIOL, V59, P766, DOI 10.1083/jcb.59.3.766; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dittmann H, 2002, EUR J NUCL MED MOL I, V29, P1462, DOI 10.1007/s00259-002-0925-z; Grierson JR, 2004, NUCL MED BIOL, V31, P829, DOI 10.1016/j.nucmedbio.2004.06.004; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hu CM, 2007, J BIOMED SCI, V14, P491, DOI 10.1007/s11373-007-9175-1; KAUFFMAN MG, 1991, MOL CELL BIOL, V11, P2538, DOI 10.1128/MCB.11.5.2538; Ke PY, 2004, MOL CELL BIOL, V24, P514, DOI 10.1128/MCB.24.2.514-526.2004; Ke PY, 2003, BIOCHEM J, V370, P265, DOI 10.1042/BJ20021335; Kenny LM, 2009, CLIN CANCER RES, V15, P6649, DOI 10.1158/1078-0432.CCR-09-1213; Kenny LM, 2005, CANCER RES, V65, P10104, DOI 10.1158/0008-5472.CAN-04-4297; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kinoshita E, 2005, J SEP SCI, V28, P155, DOI 10.1002/jssc.200401833; Kinoshita E, 2009, NAT PROTOC, V4, P1513, DOI 10.1038/nprot.2009.154; Leyton J, 2008, MOL CANCER THER, V7, P3112, DOI 10.1158/1535-7163.MCT-08-0264; Leyton J, 2006, CANCER RES, V66, P7621, DOI 10.1158/0008-5472.CAN-05-3962; Li CL, 2004, BIOCHEM BIOPH RES CO, V313, P587, DOI 10.1016/j.bbrc.2003.11.147; McKinley ET, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058938; Merrick KA, 2011, MOL CELL, V42, P624, DOI 10.1016/j.molcel.2011.03.031; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; MUNCHPETERSEN B, 1993, J BIOL CHEM, V268, P15621; MUNCHPETERSEN B, 1991, J BIOL CHEM, V266, P9032; Muzi M, 2005, J NUCL MED, V46, P274; Paproski RJ, 2008, MOL PHARMACOL, V74, P1372, DOI 10.1124/mol.108.048900; Pontarin G, 2003, P NATL ACAD SCI USA, V100, P12159, DOI 10.1073/pnas.1635259100; Rasey JS, 2002, J NUCL MED, V43, P1210; Alexander S, 2007, SEMIN NUCL MED, V37, P429, DOI 10.1053/j.semnuclmed.2007.08.001; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; SCHLOSSER CA, 1981, P NATL ACAD SCI-BIOL, V78, P1119, DOI 10.1073/pnas.78.2.1119; Seitz U, 2002, EUR J NUCL MED MOL I, V29, P1174, DOI 10.1007/s00259-002-0851-0; SHERLEY JL, 1988, J BIOL CHEM, V263, P8350; Shields AF, 2003, J NUCL MED, V44, P1432; Shields AF, 1998, NAT MED, V4, P1334, DOI 10.1038/3337; Shields AF, 2006, MOL IMAGING BIOL, V8, P141, DOI 10.1007/s11307-006-0039-2; Smith G, 2012, NUCL MED BIOL, V39, P652, DOI 10.1016/j.nucmedbio.2011.12.002; Tommasi S, 1997, J BIOL CHEM, V272, P30483, DOI 10.1074/jbc.272.48.30483; Toyohara J, 2002, NUCL MED BIOL, V29, P281, DOI 10.1016/S0969-8051(02)00286-X; Vesselle H, 2002, CLIN CANCER RES, V8, P3315; Welin M, 2004, P NATL ACAD SCI USA, V101, P17970, DOI 10.1073/pnas.0406332102; Wells P, 2004, BBA-REV CANCER, V1705, P91, DOI 10.1016/j.bbcan.2004.09.007; XU YZ, 1993, J BIOL CHEM, V268, P22363; Zhang CC, 2012, CLIN CANCER RES, V18, P1303, DOI 10.1158/1078-0432.CCR-11-1433	54	2	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101366	10.1371/journal.pone.0101366	http://dx.doi.org/10.1371/journal.pone.0101366			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003822	Green Published, Green Submitted, gold			2022-12-27	WOS:000339242700026
J	Martinez-Aquino, A; Ceccarelli, FS; Eguiarte, LE; Vazquez-Dominguez, E; de Leon, GPP				Martinez-Aquino, Andres; Sara Ceccarelli, Fadia; Eguiarte, Luis E.; Vazquez-Dominguez, Ella; Perez-Ponce de Leon, Gerardo			Do the Historical Biogeography and Evolutionary History of the Digenean Margotrema spp. across Central Mexico Mirror Those of Their Freshwater Fish Hosts (Goodeinae)?	PLOS ONE			English	Article							GEOGRAPHIC RANGE; PHYLOGENY; DIVERSIFICATION; PHYLOGEOGRAPHY; MITOCHONDRIAL; COSPECIATION; DISPERSAL; INFERENCE; PATTERNS; TREES	Host-parasite systems provide an ideal platform to study evolution at different levels, including codivergence in a historical biogeography context. In this study we aim to describe biogeographic and codivergent patterns and associated processes of the Goodeinae freshwater fish and their digenean parasite (Margotrema spp.) over the last 6.5 Ma (million years), identifying the main factors (host and/or hydrogeomorphology) that influenced the evolution of Margotrema. We obtained a species tree for Margotrema spp. using DNA sequence data from mitochondrial and nuclear molecular markers (COI and ITS1, respectively) and performed molecular dating to discern divergence events within the genus. The dispersal-extinction-cladogenesis (DEC) model was used to describe the historical biogeography of digeneans and applied to cophylogenetic analyses of Margotrema and their goodeine hosts. Our results showed that the evolutionary history of Margotrema has been shaped in close association with its geographic context, especially with the geological history of central Mexico during the Pleistocene. Host-specificity has been established at three levels of historical association: a) Species-Species, represented by Xenotaenia resolanae-M. resolanae exclusively found in the Cuzalapa River Basin; b) Species-Lineage, represented by Characodon audax-M. bravoae Lineage II, exclusive to the Upper and Middle Mezquital River Basin, and c) Tribe-Lineage, including two instances of historical associations among parasites and hosts at the taxonomical level of tribe, one represented by Ilyodontini-M. bravoae Lineage I (distributed across the Ayuquila and Balsas River Basins), and another comprised of Girardinichthyini/Chapalichthyini-M. bravoae Lineage III, found only in the Lerma River Basin. We show that the evolutionary history of the parasites is, on several occasions, in agreement with the phylogenetic and biogeographic history of their hosts. A series of biogeographic and host-parasite events explain the codivergence patterns observed, in which cospeciation and colonisation via host-switching and vicariant plus dispersal events are appreciated, at different times during the diversification history of both associates, particularly during the Pleistocene.	[Martinez-Aquino, Andres] Univ Nacl Autonoma Mexico, Mexico City 04510, DF, Mexico; [Martinez-Aquino, Andres; Perez-Ponce de Leon, Gerardo] Univ Nacl Autonoma Mexico, Inst Biol, Dept Zool, Mexico City 04510, DF, Mexico; [Sara Ceccarelli, Fadia] Museo Argentino Ciencias Nat Bernardino Rivadavia, Div Aracnol, Buenos Aires, DF, Argentina; [Eguiarte, Luis E.] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City 04510, DF, Mexico; [Vazquez-Dominguez, Ella] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Biodiversidad, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Martinez-Aquino, A (corresponding author), UNLP, FCNyM, Museo La Plata, Div Zool Invertebrados, La Plata, Buenos Aires, Argentina.	maandres_@hotmail.com	Ceccarelli, F. Sara/L-3208-2019; de León, Gerardo Pérez Ponce/U-3869-2017	de León, Gerardo Pérez Ponce/0000-0001-6472-5113; Vazquez-Dominguez, Ella/0000-0001-6131-2014; Ceccarelli, Fadia Sara/0000-0003-4117-7366	Consejo Nacional de Ciencia y Tecnologia (CONACyT) within Posgrado en Ciencias Biologicas, Universidad Nacional Autonoma de Mexico; CONACYT [207983]; Universidad Nacional Autonoma de Mexico (UNAM-DGAPA); Consejo Nacional de Ciencia y Tecnologia (CONACyT) [83043]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT-UNAM) [IN202111, IN204514]	Consejo Nacional de Ciencia y Tecnologia (CONACyT) within Posgrado en Ciencias Biologicas, Universidad Nacional Autonoma de Mexico; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Universidad Nacional Autonoma de Mexico (UNAM-DGAPA)(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT-UNAM)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico)	AMA was supported by a scholarship from Consejo Nacional de Ciencia y Tecnologia (CONACyT) to obtain his PhD degree within Posgrado en Ciencias Biologicas, Universidad Nacional Autonoma de Mexico, and actually his research is supported by a postdoctoral grant from CONACYT (# 207983). FSC was supported by a postdoctoral fellowships provided by Universidad Nacional Autonoma de Mexico (UNAM-DGAPA). GPPL was supported by grants from the Consejo Nacional de Ciencia y Tecnologia (CONACyT 83043) and Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT-UNAM IN 202111 and IN204514). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff DM, 2014, TRENDS ECOL EVOL, V29, P82, DOI 10.1016/j.tree.2013.11.003; alvarez Del Villar V. J., 1972, ANALES ESCUELA NACL, V19, P155; Caira JN, 2001, INT J PARASITOL, V31, P960, DOI 10.1016/S0020-7519(01)00206-5; Charleston MA, 2011, TREEMAP 3B; Charleston NA, 2006, J BIOMED INFORM, V39, P62, DOI 10.1016/j.jbi.2005.08.006; Choudhury A, 2002, J PARASITOL, V88, P1045, DOI 10.1645/0022-3395(2002)088[1045:VKHSAC]2.0.CO;2; Curran SS, 2011, J PARASITOL, V97, P661, DOI 10.1645/GE-2641.1; Dominguez-Dominguez O., 2010, VIVIPAROUS FISHES, P13; Dominguez-Dominguez O, 2006, J BIOGEOGR, V33, P1437, DOI 10.1111/j.1365-2699.2006.01526.x; Dominguez-Dominguez O, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-161; Drummond AJ, 2010, GENEIOUS V5 0 4; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Ferrari L, 1999, GEOLOGY, V27, P303, DOI 10.1130/0091-7613(1999)027<0303:STPOCA>2.3.CO;2; Ferrari L, 2004, GEOLOGY, V32, P77, DOI 10.1130/G19887.1; Froeschke G, 2014, ADV PARASIT, V84, P209, DOI 10.1016/B978-0-12-800099-1.00004-1; HAFNER MS, 1990, SYST ZOOL, V39, P192, DOI 10.2307/2992181; HAFNER MS, 1994, SCIENCE, V265, P1087, DOI 10.1126/science.8066445; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Heneghan C, 2011, DATA MED DEVICE RECA; Hijmans R.J., 2012, DIVA GIS; Hoberg E.P., 2000, Bulletin of the Scandinavian Society for Parasitology, V10, P19; HOBERG EP, 1992, CAN J ZOOL, V70, P703, DOI 10.1139/z92-105; Hoberg EP, 2008, J BIOGEOGR, V35, P1533, DOI 10.1111/j.1365-2699.2008.01951.x; Huyse T, 2003, INT J PARASITOL, V33, P1679, DOI 10.1016/S0020-7519(03)00253-4; Keller-Schmidt S, 2011, EVALUATION HOST PARA; Maddison WP, 2011, MESQUITE MODULAR SYS; Martinez-Aquino A, 2013, ZOOL J LINN SOC-LOND, V168, P1, DOI 10.1111/zoj.12027; Mateos M, 2002, EVOLUTION, V56, P972; Miller M.A., 2010, P GAT COMP ENV WORKS; Miller R.R., 1986, P487; Minckley W.L., 1986, P519; Morand S., 2010, BIOGEOGRAPHY HOST PA; Morrone JJ, 2006, ANNU REV ENTOMOL, V51, P467, DOI 10.1146/annurev.ento.50.071803.130447; Nieberding CM, 2008, MOL PHYLOGENET EVOL, V47, P538, DOI 10.1016/j.ympev.2008.01.028; Page RDM, 2003, TANGLED TREES: PHYLOGENY, COSPECIATION AND COEVOLUTION, P1; PAGE RDM, 1994, CLADISTICS, V10, P155, DOI 10.1006/clad.1994.1010; Page RDM, 1998, TRENDS ECOL EVOL, V13, P356, DOI 10.1016/S0169-5347(98)01438-4; Page RDM, 1996, SYST BIOL, V45, P151, DOI 10.2307/2413612; de Leon GPP, 2007, SYST PARASITOL, V68, P49, DOI 10.1007/s11230-006-9081-3; Perez-Ponce de Leon G, 2005, J BIOGEOGR, V32, P645, DOI 10.1111/j.1365-2699.2005.01218.x; Perez-Rodriguez R, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-223; Price P. W., 1980, EVOLUTIONARY BIOL PA; Rannala B, 2003, TANGLED TREES: PHYLOGENY, COSPECIATION AND COEVOLUTION, P120; Ree RH, 2005, EVOLUTION, V59, P2299; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Ronquist F, 2011, ANNU REV ECOL EVOL S, V42, P441, DOI 10.1146/annurev-ecolsys-102209-144710; Sanmartin I, 2008, J BIOGEOGR, V35, P428, DOI 10.1111/j.1365-2699.2008.01885.x; Sanmartin Isabel, 2012, Evolution Education and Outreach, V5, P555; Ceccarelli FS, 2013, MOL PHYLOGENET EVOL, V69, P142, DOI 10.1016/j.ympev.2013.05.001; Thompson J. N., 2005, INTERSPEC INTERACT	52	13	13	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101700	10.1371/journal.pone.0101700	http://dx.doi.org/10.1371/journal.pone.0101700			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999998	Green Submitted, Green Published, gold			2022-12-27	WOS:000338637300075
J	Nordberg, N; Olsson, I; Carlsson, M; Hu, GZ; Westholm, JO; Ronne, H				Nordberg, Niklas; Olsson, Ida; Carlsson, Mattias; Hu, Guo-Zhen; Westholm, Jakub Orzechowski; Ronne, Hans			The Histone Demethylase Activity of Rph1 is Not Essential for Its Role in the Transcriptional Response to Nutrient Signaling	PLOS ONE			English	Article							JMJC-DOMAIN; STRESS-RESPONSE; LIFE-SPAN; FAMILY; METHYLATION; YEAST; PROTEIN; H3K36; GIS1; TRIMETHYLATION	Rph1 and Gis1 are two related yeast zinc finger proteins that function as downstream effectors in the Ras/PKA, TOR and Sch9 nutrient signaling pathways. Both proteins also contain JmjC histone demethylase domains, but only Rph1 is known to be an active enzyme, demethylating lysine 36 of histone H3. We have studied to what extent the demethylase activity of Rph1 contributes to its role in nutrient signaling by performing gene expression microarray experiments on a yeast strain containing a catalytically inactive allele of RPH1. We find that the enzymatic activity of Rph1 is not essential for its role in growth phase dependent gene regulation. However, the ability of Rph1 to both activate and repress transcription is partially impaired in the active site mutant, indicating that the demethylase activity may enhance its function in vivo. Consistent with this, we find that the Rph1 mutation and a deletion of the histone H3 methylase Set2 affect the same target genes in opposite directions. Genes that are differentially expressed in the Rph1 mutant are also enriched for binding of Rpd3, a downstream effector in silencing, to their promoters. The expression of some subtelomeric genes and genes involved in sporulation and meiosis are also affected by the mutation, suggesting a role for Rph1-dependent demethylation in regulating these genes. A small set of genes are more strongly affected by the active site mutation, indicating a more pronounced role for the demethylase activity in their regulation by Rph1.	[Nordberg, Niklas; Olsson, Ida; Carlsson, Mattias; Hu, Guo-Zhen; Ronne, Hans] Swedish Univ Agr Sci, Dept Microbiol, Uppsala, Sweden; [Nordberg, Niklas; Westholm, Jakub Orzechowski] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden	Swedish University of Agricultural Sciences; Uppsala University	Ronne, H (corresponding author), Swedish Univ Agr Sci, Dept Microbiol, Uppsala, Sweden.	Hans.Ronne@slu.se		Westholm, Jakub/0000-0002-6849-6220; Ronne, Hans/0000-0002-1645-6091	Swedish Research Council VR [621-2007-5079, 521-2011-3157]; Swedish Cancer Society	Swedish Research Council VR(Swedish Research Council); Swedish Cancer Society(Swedish Cancer Society)	This work was supported by grants to HR from the Swedish Research Council VR (621-2007-5079, 521-2011-3157) and the Swedish Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejandro-Osorio AL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r57; Balciunas D, 2000, TRENDS BIOCHEM SCI, V25, P274, DOI 10.1016/S0968-0004(00)01593-0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Cameroni E, 2004, CELL CYCLE, V3, P462; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chang Y, 2010, BIOCHEM J, V433, P295; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Coluccio A, 2004, EUKARYOT CELL, V3, P1464, DOI 10.1128/EC.3.6.1464-1475.2004; Crona F, 2013, DEV BIOL, V373, P453, DOI 10.1016/j.ydbio.2012.11.011; Fang J, 2007, MOL CELL BIOL, V27, P5055, DOI 10.1128/MCB.00127-07; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Greer EL, 2010, NATURE, V466, P383, DOI 10.1038/nature09195; He J, 2008, NAT STRUCT MOL BIOL, V15, P1169, DOI 10.1038/nsmb.1499; Hsia DA, 2010, P NATL ACAD SCI USA, V107, P9671, DOI 10.1073/pnas.1000401107; Huang F, 2010, J BIOL CHEM, V285, P24548, DOI 10.1074/jbc.M110.117333; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Humphrey EL, 2004, CHEM BIOL, V11, P295, DOI 10.1016/j.chembiol.2004.03.001; Jang YK, 1999, MOL CELL BIOL, V19, P7630; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim T, 2007, J BIOL CHEM, V282, P20827, DOI 10.1074/jbc.M703034200; Klose RJ, 2007, MOL CELL BIOL, V27, P3951, DOI 10.1128/MCB.02180-06; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kurdistani SK, 2002, NAT GENET, V31, P248, DOI 10.1038/ng907; Kwon DW, 2011, BIOCHEM BIOPH RES CO, V410, P614, DOI 10.1016/j.bbrc.2011.06.039; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Liang CY, 2013, MOL BIOL CELL, V24, P3251, DOI 10.1091/mbc.E12-11-0820; Liang CY, 2011, NUCLEIC ACIDS RES, V39, P4151, DOI 10.1093/nar/gkr040; Lorbeck MT, 2010, GENE, V450, P8, DOI 10.1016/j.gene.2009.09.007; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; NEHLIN JO, 1989, GENE, V85, P313, DOI 10.1016/0378-1119(89)90423-X; Oshiro J, 2003, J BIOL CHEM, V278, P31495, DOI 10.1074/jbc.M305452200; Oyen M, 2004, CURR GENET, V45, P76, DOI 10.1007/s00294-003-0462-8; Pedersen MT, 2010, TRENDS CELL BIOL, V20, P662, DOI 10.1016/j.tcb.2010.08.011; Pedruzzi I, 2000, EMBO J, V19, P2569, DOI 10.1093/emboj/19.11.2569; Polytarchou C, 2008, MOL CELL BIOL, V28, P7451, DOI 10.1128/MCB.00688-08; Rohde JR, 2003, MOL CELL BIOL, V23, P629, DOI 10.1128/MCB.23.2.629-635.2003; Roosen J, 2005, MOL MICROBIOL, V55, P862, DOI 10.1111/j.1365-2958.2004.04429.x; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schroeder EA, 2013, CELL METAB, V17, P954, DOI 10.1016/j.cmet.2013.04.003; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; SIEBERT PD, 1992, NATURE, V359, P557, DOI 10.1038/359557a0; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; Tamaru H, 2010, GENE DEV, V24, P1465, DOI 10.1101/gad.1941010; Tanaka Y, 2010, EMBO J, V29, P1510, DOI 10.1038/emboj.2010.56; Teperino R, 2010, CELL METAB, V12, P321, DOI 10.1016/j.cmet.2010.09.004; Tompa R, 2007, GENETICS, V175, P585, DOI 10.1534/genetics.106.067751; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tu SJ, 2007, J BIOL CHEM, V282, P14262, DOI 10.1074/jbc.M609900200; Vandamme J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002647; Wei M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040013; Weiner A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001369; Westholm JO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031577; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wu ZJ, 2004, NAT BIOTECHNOL, V22, P656, DOI 10.1038/nbt0604-656b; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Yu Y, 2010, FEMS YEAST RES, V10, P793, DOI 10.1111/j.1567-1364.2010.00680.x; Zhang NS, 2010, J BIOL CHEM, V285, P6465, DOI 10.1074/jbc.M109.073288; Zhang NS, 2009, MICROBIOL-SGM, V155, P1690, DOI 10.1099/mic.0.026377-0; Zofall M, 2006, MOL CELL, V22, P681, DOI 10.1016/j.molcel.2006.05.010	73	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e95078	10.1371/journal.pone.0095078	http://dx.doi.org/10.1371/journal.pone.0095078			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999627	Green Published, gold, Green Submitted			2022-12-27	WOS:000338637300001
J	Rohlmann, A; Schwachmeyer, V; Graichen, F; Bergmann, G				Rohlmann, Antonius; Schwachmeyer, Verena; Graichen, Friedmar; Bergmann, Georg			Spinal Loads during Post-Operative Physiotherapeutic Exercises	PLOS ONE			English	Article							VERTEBRAL BODY REPLACEMENT; IN-VIVO; INTRADISCAL PRESSURE; MUSCLE FORCES; LUMBAR SPINE; IMPLANT	After spinal surgery, physiotherapeutic exercises are performed to achieve a rapid return to normal life. One important aim of treatment is to regain muscle strength, but it is known that muscle forces increase the spinal loads to potentially hazardous levels. It has not yet been clarified which exercises cause high spinal forces and thus endanger the surgical outcome. The loads on vertebral body replacements were measured in 5 patients during eleven physiotherapeutic exercises, performed in the supine, prone, or lateral position or on all fours (kneeling on the hands and knees). Low resultant forces on the vertebral body replacement were measured for the following exercises: lifting one straight leg in the supine position, abduction of the leg in the lateral position, outstretching one leg in the all-fours position, and hollowing the back in the all-fours position. From the biomechanical point of view, these exercises can be performed shortly after surgery. Implant forces similar or even greater than those for walking were measured during: lifting both legs, lifting the pelvis in the supine position, outstretching one arm with or without simultaneously outstretching the contralateral leg in the all-fours position, and arching the back in the all-fours position. These exercises should not be performed shortly after spine surgery.	[Rohlmann, Antonius; Schwachmeyer, Verena; Graichen, Friedmar; Bergmann, Georg] Charite, Julius Wolff Inst, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Rohlmann, A (corresponding author), Charite, Julius Wolff Inst, D-13353 Berlin, Germany.	antonius.rohlmann@charite.de	Rohlmann, Antonius/E-4778-2011; Schwachmeyer, Verena/O-6745-2014	Rohlmann, Antonius/0000-0002-0083-2793; 	Deutsche Forschungsgemeinschaft [Ro 581/18-1]; Deutsche Arthrose-Hilfe e.V., Frankfurt	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Arthrose-Hilfe e.V., Frankfurt	This study was funded by the Deutsche Forschungsgemeinschaft (project: Ro 581/18-1) and the Deutsche Arthrose-Hilfe e.V., Frankfurt. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmann G, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2898831; CAPPOZZO A, 1984, Journal of Orthopaedic Research, V1, P292; CHOLEWICKI J, 1994, J BIOMECH, V27, P1287, DOI 10.1016/0021-9290(94)90282-8; de Zee M, 2007, J BIOMECH, V40, P1219, DOI 10.1016/j.jbiomech.2006.05.030; Graichen F, 2007, IEEE T BIO-MED ENG, V54, P253, DOI 10.1109/TBME.2006.886857; Han KS, 2013, MED ENG PHYS, V35, P969, DOI 10.1016/j.medengphy.2012.09.009; MARRAS WS, 1984, SPINE, V9, P176, DOI 10.1097/00007632-198403000-00008; McGill SM, 2013, ERGONOMICS, V56, P293, DOI 10.1080/00140139.2012.752528; NACHEMSON AL, 1981, SPINE, V6, P93, DOI 10.1097/00007632-198101000-00020; Rohlmann A, 2014, GAIT POSTURE, V39, P750, DOI 10.1016/j.gaitpost.2013.10.010; Rohlmann A, 2013, EUR SPINE J, V22, P2575, DOI 10.1007/s00586-013-3057-1; Rohlmann A, 2012, CLIN BIOMECH, V27, P754, DOI 10.1016/j.clinbiomech.2012.04.006; Rohlmann A, 2002, PHYS THER, V82, P44, DOI 10.1093/ptj/82.1.44; Rohlmann A, 2008, SPINE, V33, P1170, DOI 10.1097/BRS.0b013e3181722d52; Rohlmann A, 2007, MED ENG PHYS, V29, P580, DOI 10.1016/j.medengphy.2006.06.012; Rohlmann A, 2014, EUR SPINE J, V23, P666, DOI 10.1007/s00586-013-3087-8; Rohlmann A, 2013, J BIOMECH, V46, P511, DOI 10.1016/j.jbiomech.2012.10.022; Rohlmann A, 2011, SPINE J, V11, P870, DOI 10.1016/j.spinee.2011.06.017; Rohlmann A, 2010, EUR SPINE J, V19, P1129, DOI 10.1007/s00586-010-1346-5; Rohlmann A, 2008, CLIN BIOMECH, V23, P147, DOI 10.1016/j.clinbiomech.2007.09.011; Sato K, 1999, SPINE, V24, P2468, DOI 10.1097/00007632-199912010-00008; Shirazi-Adl A, 2005, EUR SPINE J, V14, P381, DOI 10.1007/s00586-004-0779-0; Wilke HJ, 1999, SPINE, V24, P755, DOI 10.1097/00007632-199904150-00005; Wilke HJ, 2001, CLIN BIOMECH, V16, pS111, DOI 10.1016/S0268-0033(00)00103-0	24	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e102005	10.1371/journal.pone.0102005	http://dx.doi.org/10.1371/journal.pone.0102005			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999808	Green Submitted, Green Published, gold			2022-12-27	WOS:000338637300113
J	Sepehr, S; Rahmani-Badi, A; Babaie-Naiej, H				Sepehr, Shayesteh; Rahmani-Badi, Azadeh; Babaie-Naiej, Hamta			Unsaturated Fatty Acid, cis-2-Decenoic Acid, in Combination with Disinfectants or Antibiotics Removes Pre-Established Biofilms Formed by Food-Related Bacteria	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA BIOFILMS; IN-VITRO; MECHANISMS; PENETRATION; LIMITATION; RESISTANCE	Biofilm formation by food-related bacteria and food-related pathogenesis are significant problems in the food industry. Even though much disinfection and mechanical procedure exist for removal of biofilms, they may fail to eliminate preestablished biofilms. cis-2 decenoic acid (CDA), an unsaturated fatty acid messenger produced by Pseudomonas aeruginosa, is reportedly capable of inducing the dispersion of established biofilms by multiple types of microorganisms. However, whether CDA has potential to boost the actions of certain antimicrobials is unknown. Here, the activity of CDA as an inducer of pre-established biofilms dispersal, formed by four main food pathogens; Staphylococcus aureus, Bacillus cereus, Salmonella enterica and E. coli, was measured using both semi-batch and continuous cultures bioassays. To assess the ability of CDA combined biocides treatments to remove pre-established biofilms formed on stainless steel discs, CFU counts were performed for both treated and untreated cultures. Eradication of the biofilms by CDA combined antibiotics was evaluated using crystal violet staining. The effect of CDA combined treatments (antibiotics and disinfectants) on biofilm surface area and bacteria viability was evaluated using fluorescence microscopy, digital image analysis and LIVE/DEAD staining. MICs were also determined to assess the probable inhibitory effects of CDA combined treatments on the growth of tested microorganisms' planktonic cells. Treatment of pre-established biofilms with only 310 nM CDA resulted in at least two-fold increase in the number of planktonic cells in all cultures. While antibiotics or disinfectants alone exerted a trivial effect on CFU counts and percentage of surface area covered by the biofilms, combinational treatments with both 310 nM CDA and antibiotics or disinfectants led to approximate 80% reduction in biofilm biomass. These data suggests that combined treatments with CDA would pave the way toward developing new strategies to control biofilms with widespread applications in industry as well as medicine.	[Sepehr, Shayesteh; Rahmani-Badi, Azadeh; Babaie-Naiej, Hamta] Alzahra Univ, Dept Biol, Tehran, Iran	Alzahra University	Rahmani-Badi, A (corresponding author), Alzahra Univ, Dept Biol, Tehran, Iran.	a.rahmanibadi@gmail.com	Soudi, Mohammad Reza/T-8744-2019	Soudi, Mohammad Reza/0000-0002-5823-5465				Anderl JN, 2000, ANTIMICROB AGENTS CH, V44, P1818, DOI 10.1128/AAC.44.7.1818-1824.2000; [Anonymous], 1997, 1276 EN; Campanac C, 2002, ANTIMICROB AGENTS CH, V46, P1469, DOI 10.1128/AAC.46.5.1469-1474.2002; Chambers LD, 2006, SURF COAT TECH, V201, P3642, DOI 10.1016/j.surfcoat.2006.08.129; Clinical and Laboratory Standards Institute, 2006, M7A7 CLIN LAB STAND; Clinical and Laboratory Standards Institute, 2006, M100S16 CLIN LAB STA; Cloete TE, 1998, BIODEGRADATION, V9, P23, DOI 10.1023/A:1008216209206; Davies DG, 2009, J BACTERIOL, V191, P1393, DOI 10.1128/JB.01214-08; Desbois AP, 2010, APPL MICROBIOL BIOT, V85, P1629, DOI 10.1007/s00253-009-2355-3; Desbois AP, 2008, APPL MICROBIOL BIOT, V81, P755, DOI 10.1007/s00253-008-1714-9; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Gilbert P, 2002, J APPL MICROBIOL, V92, p98S, DOI 10.1046/j.1365-2672.92.5s1.5.x; Jennings JA, 2012, CLIN ORTHOP RELAT R, V470, P2663, DOI 10.1007/s11999-012-2388-2; Kenny JG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004344; Korstgens V, 2001, J MICROBIOL METH, V46, P9, DOI 10.1016/S0167-7012(01)00248-2; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Musk DJ, 2008, J APPL MICROBIOL, V105, P380, DOI 10.1111/j.1365-2672.2008.03751.x; Palmer J, 2007, J IND MICROBIOL BIOT, V34, P577, DOI 10.1007/s10295-007-0234-4; Poppele EH, 2003, J MICROBIOL METH, V55, P607, DOI 10.1016/S0167-7012(03)00198-2; Shi XM, 2009, TRENDS FOOD SCI TECH, V20, P407, DOI 10.1016/j.tifs.2009.01.054; Simoes M, 2005, WATER RES, V39, P5142, DOI 10.1016/j.watres.2005.09.028; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Takigawa H, 2005, DERMATOLOGY, V211, P240, DOI 10.1159/000087018; Verran J, 2008, ADV APPL MICROBIOL, V64, P223, DOI 10.1016/S0065-2164(08)00408-5; Walters MC, 2003, ANTIMICROB AGENTS CH, V47, P317, DOI 10.1128/AAC.47.1.317-323.2003; Yang L, 2012, FEMS IMMUNOL MED MIC, V65, P146, DOI 10.1111/j.1574-695X.2011.00858.x	26	36	36	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101677	10.1371/journal.pone.0101677	http://dx.doi.org/10.1371/journal.pone.0101677			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000301	Green Published, Green Submitted, gold			2022-12-27	WOS:000338637300069
J	Yadav, NS; Singh, VK; Singh, D; Jha, B				Yadav, Narendra Singh; Singh, Vijay Kumar; Singh, Dinkar; Jha, Bhavanath			A Novel Gene SbSI-2 Encoding Nuclear Protein from a Halophyte Confers Abiotic Stress Tolerance in E-coli and Tobacco	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; SALT-TOLERANCE; SALICORNIA-BRACHIATA; TRANSGENIC TOBACCO; EXTREME HALOPHYTE; RESPONSIVE GENE; ABSCISIC-ACID; THELLUNGIELLA-HALOPHILA; DEHYDRATION TOLERANCE; TRANSCRIPTION FACTORS	Salicornia brachiata is an extreme halophyte that grows luxuriantly in coastal marshes. Previously, we have reported isolation and characterization of ESTs from Salicornia with large number of novel/unknown salt-responsive gene sequences. In this study, we have selected a novel salt-inducible gene SbSI-2 (Salicornia brachiata salt-inducible-2) for functional characterization. Bioinformatics analysis revealed that SbSI-2 protein has predicted nuclear localization signals and a strong protein-protein interaction domain. Transient expression of the RFP: SbSI2 fusion protein confirmed that SbSI-2 is a nuclear localized protein. Genomic organization study showed that SbSI-2 is intronless and has a single copy in Salicornia genome. Quantitative RT-PCR analysis revealed higher SbSI-2 expression under salt stress and desiccation conditions. The SbSI-2 gene was transformed in E. coli and tobacco for functional characterization. pET28a-SbSI-2 recombinant E. coli cells showed higher tolerance to desiccation and salinity compared to vector alone. Transgenic tobacco plants overexpressing SbSI-2 have improved salt-and osmotic tolerance, accompanied by better growth parameters, higher relative water content, elevated accumulation of compatible osmolytes, lower Na+ and ROS accumulation and lesser electrolyte leakage than the wild-type. Overexpression of the SbSI-2 also enhanced transcript levels of ROS-scavenging genes and some stress-related transcription factors under salt and osmotic stresses. Taken together, these results demonstrate that SbSI-2 might play an important positive modulation role in abiotic stress tolerance. This identifies SbSI-2 as a novel determinant of salt/osmotic tolerance and suggests that it could be a potential bioresource for engineering abiotic stress tolerance in crop plants.	[Yadav, Narendra Singh; Singh, Vijay Kumar; Singh, Dinkar; Jha, Bhavanath] Cent Salt & Marine Chem Res Inst, CSIR, Discipline Marine Biotechnol & Ecol, Bhavnagar 364002, Gujarat, India; [Jha, Bhavanath] CSIR, Acad Sci & Innovat Res, New Delhi 110001, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Salt & Marine Chemical Research Institute (CSMCRI); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India	Jha, B (corresponding author), Cent Salt & Marine Chem Res Inst, CSIR, Discipline Marine Biotechnol & Ecol, Bhavnagar 364002, Gujarat, India.	bjha@csmcri.org	Singh, Vijay Kumar/G-6839-2013; Yadav, Narendra Singh/C-3330-2013	Singh, Vijay Kumar/0000-0003-4872-4545; Yadav, Narendra Singh/0000-0003-0122-173X	Council of Scientific and Industrial Research (CSIR), New Delhi [BSC0109]	Council of Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	The financial assistance received from Council of Scientific and Industrial Research (CSIR) (www.csir.res.in), New Delhi (BSC0109: SIMPLE) is duly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, PLANT MOL BIOL, V51, P363, DOI 10.1023/A:1022043000516; Agarwal PK, 2010, BIOL PLANTARUM, V54, P201, DOI 10.1007/s10535-010-0038-7; Agarwal PK, 2010, MOL BIOL REP, V37, P981, DOI 10.1007/s11033-009-9774-1; Amtmann A, 2005, PLANT PHYSIOL, V138, P127, DOI 10.1104/pp.105.059972; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Ashraf M, 2004, PLANT SCI, V166, P3, DOI 10.1016/j.plantsci.2003.10.024; Baisakh N, 2008, FUNCT INTEGR GENOMIC, V8, P287, DOI 10.1007/s10142-008-0075-x; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Boudsocq M, 2005, PLANT PHYSIOL, V138, P1185, DOI 10.1104/pp.105.061275; Chaurasia N, 2008, BIOCHEM BIOPH RES CO, V376, P225, DOI 10.1016/j.bbrc.2008.08.129; Chen SH, 2007, DNA SEQUENCE, V18, P61, DOI 10.1080/10425170601108555; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cvikrova M, 2012, PLANT SCI, V182, P49, DOI 10.1016/j.plantsci.2011.01.016; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Foyer CH, 2011, PLANT PHYSIOL, V155, P93, DOI 10.1104/pp.110.166181; Gong QQ, 2005, PLANT J, V44, P826, DOI 10.1111/j.1365-313X.2005.02587.x; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Gu LL, 2011, MOL BIOL REP, V38, P5285, DOI 10.1007/s11033-011-0678-5; Guo JL, 2012, PLANT CELL REP, V31, P1801, DOI 10.1007/s00299-012-1293-1; Guo XH, 2010, MOL BIOL REP, V37, P1183, DOI 10.1007/s11033-009-9484-8; Gupta K, 2010, PLANT CELL REP, V29, P1131, DOI 10.1007/s00299-010-0896-7; Hadiarto T, 2011, PLANT CELL REP, V30, P297, DOI 10.1007/s00299-010-0956-z; Hao YJ, 2011, PLANT J, V68, P302, DOI 10.1111/j.1365-313X.2011.04687.x; Harb A, 2010, PLANT PHYSIOL, V154, P1254, DOI 10.1104/pp.110.161752; He YA, 2012, J EXP BOT, V63, P1511, DOI 10.1093/jxb/err389; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huang GT, 2012, MOL BIOL REP, V39, P969, DOI 10.1007/s11033-011-0823-1; Huang XS, 2011, J EXP BOT, V62, P5191, DOI 10.1093/jxb/err229; Jha A, 2011, MOL BIOL REP, V38, P1965, DOI 10.1007/s11033-010-0318-5; Jha B, 2012, MAR BIOTECHNOL, V14, P782, DOI 10.1007/s10126-012-9442-7; Jha B, 2011, MOL BIOL REP, V38, P4823, DOI 10.1007/s11033-010-0625-x; Jha B, 2009, GENES GENET SYST, V84, P111, DOI 10.1266/ggs.84.111; Jin HC, 2010, MOL BIOL REP, V37, P745, DOI 10.1007/s11033-009-9590-7; Knowlton AA, 1996, J BIOSCIENCE, V21, P123, DOI 10.1007/BF02703103; Kong XP, 2011, PLANT CELL ENVIRON, V34, P1291, DOI 10.1111/j.1365-3040.2011.02329.x; Kore-eda S, 2004, GENE, V341, P83, DOI 10.1016/j.gene.2004.06.037; Li CL, 2010, PLANT PHYSIOL, V154, P211, DOI 10.1104/pp.110.161182; Li HY, 2009, GENE, V433, P65, DOI 10.1016/j.gene.2008.12.007; Li SO, 2010, PLANT CELL ENVIRON, V33, P117, DOI 10.1111/j.1365-3040.2009.02063.x; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Liu Y, 2005, BIOCHEM BIOPH RES CO, V331, P325, DOI 10.1016/j.bbrc.2005.03.165; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lutts S, 1996, ANN BOT-LONDON, V78, P389, DOI 10.1006/anbo.1996.0134; LYNCH J, 1984, PLANTA, V161, P295, DOI 10.1007/BF00398718; Maathuis FJM, 1999, ANN BOT-LONDON, V84, P123, DOI 10.1006/anbo.1999.0912; Mahajan S, 2008, ARCH BIOCHEM BIOPHYS, V471, P146, DOI 10.1016/j.abb.2008.01.010; Mehta PA, 2005, THEOR APPL GENET, V110, P416, DOI 10.1007/s00122-004-1801-y; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Munns R, 2006, J EXP BOT, V57, P1025, DOI 10.1093/jxb/erj100; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Niu CF, 2012, PLANT CELL ENVIRON, V35, P1156, DOI 10.1111/j.1365-3040.2012.02480.x; Pitzschke A, 2009, MOL PLANT, V2, P120, DOI 10.1093/mp/ssn079; Reddy PCO, 2008, PLANT SCI, V175, P372, DOI 10.1016/j.plantsci.2008.05.012; Reddy PS, 2010, MOL GENET GENOMICS, V283, P243, DOI 10.1007/s00438-010-0518-7; Rodriguez-Navarro A, 2006, J EXP BOT, V57, P1149, DOI 10.1093/jxb/erj068; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shi J, 2010, TREE PHYSIOL, V30, P914, DOI 10.1093/treephys/tpq030; Shukla PS, 2012, J PLANT GROWTH REGUL, V31, P195, DOI 10.1007/s00344-011-9231-y; Singh D, 2014, PLANT BIOTECHNOL REP, V8, P325, DOI 10.1007/s11816-014-0324-5; Szekely G, 2008, PLANT J, V53, P11, DOI 10.1111/j.1365-313X.2007.03318.x; TOPFER R, 1987, NUCLEIC ACIDS RES, V15, P5890, DOI 10.1093/nar/15.14.5890; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Verslues PE, 2007, PLANT MOL BIOL, V64, P205, DOI 10.1007/s11103-007-9145-z; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Wang ZI, 2004, PLANT SCI, V166, P609, DOI 10.1016/j.plantsci.2003.10.030; Xiang Y, 2008, PLANT PHYSIOL, V148, P1938, DOI 10.1104/pp.108.128199; Yadav NS, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-188; Yadav NS, 2012, MOL BIOL REP, V39, P1943, DOI 10.1007/s11033-011-0941-9; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yang A, 2012, J EXP BOT, V63, P2541, DOI 10.1093/jxb/err431; Zhang L, 2001, GENE, V267, P193, DOI 10.1016/S0378-1119(01)00403-6; Zhang L, 2012, J EXP BOT, V63, P3935, DOI 10.1093/jxb/ers086; Zhu NQ, 2001, J NAT PROD, V64, P627, DOI 10.1021/np000483k; Zou M, 2011, COMP FUNCT GENOM, DOI 10.1155/2011/680673; Zouari N, 2007, GENE, V404, P61, DOI 10.1016/j.gene.2007.08.021	80	14	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101926	10.1371/journal.pone.0101926	http://dx.doi.org/10.1371/journal.pone.0101926			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999628	Green Submitted, Green Published, gold			2022-12-27	WOS:000338637300104
J	Ibanez, F; Levy, J; Tamborindeguy, C				Ibanez, Freddy; Levy, Julien; Tamborindeguy, Cecilia			Transcriptome Analysis of "Candidatus Liberibacter solanacearum'' in Its Psyllid Vector, Bactericera cockerelli	PLOS ONE			English	Article							AFFECTED CARROTS; UNITED-STATES; ZEBRA CHIP; 1ST REPORT; GENOME; ENDOSYMBIONTS; SEQUENCE; DISEASE; POTATO; DNA	"Candidatus Liberibacter solanacearum'' (Lso) is an emergent pathogen of carrots in Europe and solanaceous plants in North and Central America and New Zealand. This bacterium is closely related to other pathogenic Candidatus Liberibacter spp., all vectored by psyllids. In order to understand the molecular interaction of this pathogen and its psyllid vector, Bactericera cockerelli, Illumina sequencing of psyllid harboring Lso was performed to determine if this approach could be used to assess the bacterial transcriptome in this association. Prior to sequencing, psyllid RNA was purified and insect and bacterial rRNA were removed. Mapping of reads to Lso genome revealed that over 92% of the bacterial genes were expressed in the vector, and that the COG categories Translation and Post-translational modification, protein turnover, chaperone functions were the most expressed functional categories. Expression levels of selected Lso genes were confirmed by RT-qPCR. The transcriptomic analysis also helped correct Lso genome annotation by identifying the expression of genes that were not predicted in the genome sequencing effort.	[Ibanez, Freddy; Tamborindeguy, Cecilia] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Levy, Julien] Texas A&M Univ, Dept Hort Sci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Tamborindeguy, C (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.	ctamborindeguy@ag.tamu.edu	levy, julien G./I-9904-2019	levy, julien G./0000-0002-1422-2195	NIFA-AFRI [2012-67013-19431]; Texas A&M University WSGI Catalyst; Texas A&M University-CONACYT: Collaborative Research Grant Program [9577]	NIFA-AFRI; Texas A&M University WSGI Catalyst; Texas A&M University-CONACYT: Collaborative Research Grant Program	Funding for this work was provided by NIFA-AFRI grant 2012-67013-19431, Texas A&M University 2012 WSGI Catalyst and 2011 Texas A&M University-CONACYT: Collaborative Research Grant Program Project No: 9577. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro-Fernandez A, 2012, PLANT DIS, V96, P581, DOI 10.1094/PDIS-10-11-0878-PDN; Bell JK, 2002, EUR J BIOCHEM, V269, P4176, DOI 10.1046/j.1432-1033.2002.03075.x; Bove JM, 2006, J PLANT PATHOL, V88, P7; Callaway E, 2008, NATURE, V452, P148, DOI 10.1038/452148a; Charles H, 1997, BIOCHEM BIOPH RES CO, V239, P769, DOI 10.1006/bbrc.1997.7552; Clark MA, 2000, EVOLUTION, V54, P517, DOI 10.1111/j.0014-3820.2000.tb00054.x; Crosslin J. M., 2010, PLANT HLTH PROG; Darby AC, 2012, GENOME RES, V22, P2467, DOI 10.1101/gr.138420.112; Douglas AE, 2006, J EXP BOT, V57, P747, DOI 10.1093/jxb/erj067; Graham MR, 2005, AM J PATHOL, V166, P455, DOI 10.1016/S0002-9440(10)62268-7; Hansen AK, 2008, APPL ENVIRON MICROB, V74, P5862, DOI 10.1128/AEM.01268-08; ISHIKAWA H, 1987, J MOL EVOL, V24, P205, DOI 10.1007/BF02111233; ISHIKAWA H, 1984, INSECT BIOCHEM, V14, P417, DOI 10.1016/0020-1790(84)90098-2; Liefting LW, 2008, PLANT DIS, V92, P1474, DOI 10.1094/PDIS-92-10-1474A; Lin H, 2012, EUR J PLANT PATHOL, V132, P297, DOI 10.1007/s10658-011-9874-3; Lin H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019135; Liu S, 2012, PLOS ONE, P7; MOLLER EM, 1992, NUCLEIC ACIDS RES, V20, P6115, DOI 10.1093/nar/20.22.6115; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Munyaneza JE, 2007, J ECON ENTOMOL, V100, P656, DOI 10.1603/0022-0493(2007)100[656:AOBCHP]2.0.CO;2; Munyaneza JE, 2010, PLANT DIS, V94, P639, DOI 10.1094/PDIS-94-5-0639A; Munyaneza JE, 2009, PLANT DIS, V93, P552, DOI 10.1094/PDIS-93-5-0552A; Munyaneza J. E., 2007, PLANT SCI, V59, P30; Munyaneza JE, 2010, J ECON ENTOMOL, V103, P1060, DOI 10.1603/EC10027; Nachappa P, 2012, MOL GENET GENOMICS, V287, P803, DOI 10.1007/s00438-012-0713-9; Nachappa P, 2011, CURR MICROBIOL, V62, P1510, DOI 10.1007/s00284-011-9885-5; Nakabachi A, 2006, SCIENCE, V314, P267, DOI 10.1126/science.1134196; Nelson WR, 2013, EUR J PLANT PATHOL, V135, P633, DOI 10.1007/s10658-012-0121-3; Nelson WR, 2011, EUR J PLANT PATHOL, V130, P5, DOI 10.1007/s10658-010-9737-3; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Reineke A, 1998, INSECT MOL BIOL, V7, P95, DOI 10.1046/j.1365-2583.1998.71048.x; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; SLAUGHTER JC, 1968, BIOCHEM J, V109, P749, DOI 10.1042/bj1090749; Sloan DB, 2012, MOL BIOL EVOL, V29, P3781, DOI 10.1093/molbev/mss180; Sorek R, 2010, NAT REV GENET, V11, P9, DOI 10.1038/nrg2695; Stoll S, 2009, ENVIRON MICROBIOL, V11, P877, DOI 10.1111/j.1462-2920.2008.01808.x; Thao ML, 2000, APPL ENVIRON MICROB, V66, P2898, DOI 10.1128/AEM.66.7.2898-2905.2000; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; TOBEY KL, 1986, J BIOL CHEM, V261, P2179; Tsuchida T, 2004, SCIENCE, V303, P1989, DOI 10.1126/science.1094611; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wang DP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-618; Wen AM, 2013, AM J POTATO RES, V90, P229, DOI 10.1007/s12230-012-9293-9; Wilson ACC, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-50; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Yan Q, 2013, MOL PLANT PATHOL	48	17	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100955	10.1371/journal.pone.0100955	http://dx.doi.org/10.1371/journal.pone.0100955			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992557	Green Submitted, Green Published, gold			2022-12-27	WOS:000341253400038
J	Jin, Y; Diaz, B; Colomer, M; Sebastian-Galles, N				Jin, Yu; Diaz, Begona; Colomer, Marc; Sebastian-Galles, Nuria			Oscillation Encoding of Individual Differences in Speech Perception	PLOS ONE			English	Article							AUDITORY CHANGE-DETECTION; MISMATCH NEGATIVITY MMN; THETA OSCILLATION; BRAIN POTENTIALS; SOUNDS; RESPONSES; MEMORY; ADULTS; REPRESENTATION; SCHIZOPHRENIA	Individual differences in second language (L2) phoneme perception (within the normal population) have been related to speech perception abilities, also observed in the native language, in studies assessing the electrophysiological response mismatch negativity (MMN). Here, we investigate the brain oscillatory dynamics in the theta band, the spectral correlate of the MMN, that underpin success in phoneme learning. Using previous data obtained in an MMN paradigm, the dynamics of cortical oscillations while perceiving native and unknown phonemes and nonlinguistic stimuli were studied in two groups of participants classified as good and poor perceivers (GPs and PPs), according to their L2 phoneme discrimination abilities. The results showed that for GPs, as compared to PPs, processing of a native phoneme change produced a significant increase in theta power. Stimulus time-locked analysis event-related spectral perturbation (ERSP) showed differences for the theta band within the MMN time window (between 70 and 240 ms) for the native deviant phoneme. No other significant difference between the two groups was observed for the other phoneme or nonlinguistic stimuli. The dynamic patterns in the theta-band may reflect early automatic change detection for familiar speech sounds in the brain. The behavioral differences between the two groups may reflect individual variations in activating brain circuits at a perceptual level.	[Jin, Yu; Diaz, Begona; Colomer, Marc; Sebastian-Galles, Nuria] Pompeu Fabra Univ, Ctr Brain & Cognit, Dept Technol, Speech Acquisit & Percept Grp, Barcelona, Spain	Pompeu Fabra University; University of Barcelona	Diaz, B (corresponding author), Pompeu Fabra Univ, Ctr Brain & Cognit, Dept Technol, Speech Acquisit & Percept Grp, Barcelona, Spain.	begona.diaz@upf.edu	Díaz, Begona/H-5854-2012; Sebastian-Galles, Nuria/A-4215-2008	Díaz, Begona/0000-0003-1628-4901; Sebastian-Galles, Nuria/0000-0001-6938-2498; Colomer, Marc/0000-0002-4337-0373	European Community's Seventh Framework Programme (FP7): ERG [323961]; Spanish Ministerio de Economia y Competitividad [PSI 2012 - 34071]; Catalan Government [SGR 2009-1521]; People Programme (Marie Curie Actions) of the European Union'sSeventh Framework Programme (FP7) under REA [328671]; Generalitat de Catalunya	European Community's Seventh Framework Programme (FP7): ERG; Spanish Ministerio de Economia y Competitividad(Spanish Government); Catalan Government; People Programme (Marie Curie Actions) of the European Union'sSeventh Framework Programme (FP7) under REA; Generalitat de Catalunya(Generalitat de Catalunya)	This research was supported by grants from the European Community's Seventh Framework Programme (FP7/2007-2013): ERG grant agreement number 323961, the Spanish Ministerio de Economia y Competitividad (PSI 2012 - 34071), and the Catalan Government (SGR 2009-1521) to N. Sebastian-Galles, and the People Programme (Marie Curie Actions) of the European Union'sSeventh Framework Programme (FP7/2007-2013) under REA grant agreement nu 328671 to B. Diaz. N. Sebastian-Galles received the "ICREA Academia'' Prize for Excellence in Research, funded by the Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTONEN O, 1987, BIOL PSYCHOL, V24, P197, DOI 10.1016/0301-0511(87)90002-0; AALTONEN O, 1993, BRAIN LANG, V44, P139, DOI 10.1006/brln.1993.1009; Alain C, 1998, BRAIN RES, V812, P23, DOI 10.1016/S0006-8993(98)00851-8; ALHO K, 1994, PSYCHOPHYSIOLOGY, V31, P469, DOI 10.1111/j.1469-8986.1994.tb01050.x; Amenedo E, 2000, EUR J NEUROSCI, V12, P2570, DOI 10.1046/j.1460-9568.2000.00114.x; Bishop DVM, 2010, PSYCHOPHYSIOLOGY, V47, P697, DOI 10.1111/j.1469-8986.2009.00970.x; DehaeneLambertz G, 1997, NEUROREPORT, V8, P919, DOI 10.1097/00001756-199703030-00021; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Diaz B, 2008, P NATL ACAD SCI USA, V105, P16083, DOI 10.1073/pnas.0805022105; Dima D, 2012, SCHIZOPHR RES, V135, P23, DOI 10.1016/j.schres.2011.12.024; Doeller CF, 2003, NEUROIMAGE, V20, P1270, DOI 10.1016/S1053-8119(03)00389-6; Flege JE, 1999, J MEM LANG, V41, P78, DOI 10.1006/jmla.1999.2638; Fuentemilla L, 2008, BRAIN RES, V1220, P93, DOI 10.1016/j.brainres.2007.07.079; Garrido MI, 2009, CLIN NEUROPHYSIOL, V120, P453, DOI 10.1016/j.clinph.2008.11.029; Golestani N, 2004, NEUROIMAGE, V21, P494, DOI 10.1016/j.neuroimage.2003.09.071; Golestani N, 2007, CEREB CORTEX, V17, P575, DOI 10.1093/cercor/bhk001; GUION S, 2007, 2 LANGUAGE SPEECH LE, P57; GUTHRIE D, 1991, PSYCHOPHYSIOLOGY, V28, P240, DOI 10.1111/j.1469-8986.1991.tb00417.x; HALGREN E, 1995, ELECTROEN CLIN NEURO, V94, P191, DOI 10.1016/0013-4694(94)00259-N; Harrington M., 1992, STUDIES 2 LANGUAGE A, V14, P25, DOI [10.1017/S0272263100010457, DOI 10.1017/S0272263100010457]; Hsiao FJ, 2009, BIOL PSYCHOL, V81, P58, DOI 10.1016/j.biopsycho.2009.01.007; Jakoby H, 2011, PSYCHOPHYSIOLOGY, V48, P1516, DOI 10.1111/j.1469-8986.2011.01227.x; Jemel B, 2002, BRAIN TOPOGR, V15, P13, DOI 10.1023/A:1019944805499; Klimesch W, 2006, NEUROIMAGE, V29, P808, DOI 10.1016/j.neuroimage.2005.08.041; Ko D, 2012, J CLIN NEUROL, V8, P35, DOI 10.3988/jcn.2012.8.1.35; Kraus N, 1996, SCIENCE, V273, P971, DOI 10.1126/science.273.5277.971; Liasis A, 2001, COGNITIVE BRAIN RES, V11, P227, DOI 10.1016/S0926-6410(00)00077-X; Majerus S, 2008, COGNITION, V107, P395, DOI 10.1016/j.cognition.2007.10.003; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Marco-Pallares J, 2005, NEUROIMAGE, V25, P471, DOI 10.1016/j.neuroimage.2004.11.028; Mei LL, 2008, NEUROREPORT, V19, P215, DOI 10.1097/WNR.0b013e3282f46ea9; Miyake A, 1998, FOREIGN LANGUAGE LEARNING, P339; Molholm S, 2005, CEREB CORTEX, V15, P545, DOI 10.1093/cercor/bhh155; Moyer A., 1999, STUD SECOND LANG ACQ, V21, P81, DOI [DOI 10.1017/S0272263199001035, https://doi.org/10.1017/S0272263199001035]; Muller BW, 2002, NEUROIMAGE, V17, P231, DOI 10.1006/nimg.2002.1176; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Naatanen R, 2001, PSYCHOPHYSIOLOGY, V38, P1, DOI 10.1017/S0048577201000208; Naatanen R., 1979, ORIENTING REFLEX HUM, P61; Oknina LB, 2005, SCHIZOPHR RES, V76, P25, DOI 10.1016/j.schres.2004.10.003; Opitz B, 2002, NEUROIMAGE, V15, P167, DOI 10.1006/nimg.2001.0970; Rinne T, 1999, NEUROIMAGE, V10, P620, DOI 10.1006/nimg.1999.0495; Sauseng P, 2007, NEUROSCIENCE, V146, P1435, DOI 10.1016/j.neuroscience.2007.03.014; Sauseng P, 2008, NEUROSCI BIOBEHAV R, V32, P1001, DOI 10.1016/j.neubiorev.2008.03.014; Sauseng P, 2010, NEUROSCI BIOBEHAV R, V34, P1015, DOI 10.1016/j.neubiorev.2009.12.006; Scherg M, 1989, J Cogn Neurosci, V1, P336, DOI 10.1162/jocn.1989.1.4.336; Sebastian-Galles N, 2005, TWENTY-FIRST CENTURY PSYCHOLINGUISTICS: FOUR CORNERSTONES, P279; Sebastian-Galles N, 2012, J NEUROLINGUIST, V25, P150, DOI 10.1016/j.jneuroling.2011.11.001; Sharma A, 1999, J ACOUST SOC AM, V106, P1078, DOI 10.1121/1.428048; Sharma A, 1994, J ACOUST SOC AM, V95, P3011; Takegata R, 2005, COGNITIVE BRAIN RES, V25, P169, DOI 10.1016/j.cogbrainres.2005.05.006; Ventura-Campos N, 2013, J NEUROSCI, V33, P9295, DOI 10.1523/JNEUROSCI.4655-12.2013; Waberski TD, 2001, NEUROSCI LETT, V308, P107, DOI 10.1016/S0304-3940(01)01988-7; Winkler I, 2005, J COGNITIVE NEUROSCI, V17, P320, DOI 10.1162/0898929053124866; Wong PCM, 2008, CEREB CORTEX, V18, P828, DOI 10.1093/cercor/bhm115; Wong PCM, 2007, HUM BRAIN MAPP, V28, P995, DOI 10.1002/hbm.20330; Yeung N, 2007, PSYCHOPHYSIOLOGY, V44, P39, DOI 10.1111/j.1469-8986.2006.00482.x	57	11	11	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100901	10.1371/journal.pone.0100901	http://dx.doi.org/10.1371/journal.pone.0100901			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992269	Green Published, Green Submitted, gold			2022-12-27	WOS:000341253400036
J	Park, S; Kim, JI; Lee, I; Lee, S; Hwang, MW; Bae, JY; Heo, J; Kim, D; Jang, SI; Kim, H; Cheong, HJ; Song, JW; Song, KJ; Baek, LJ; Park, MS				Park, Sehee; Kim, Jin Il; Lee, Ilseob; Lee, Sangmoo; Hwang, Min-Woong; Bae, Joon-Yong; Heo, Jun; Kim, Donghwan; Jang, Seok-Il; Kim, Hyejin; Cheong, Hee Jin; Song, Jin-Won; Song, Ki-Joon; Baek, Luck Ju; Park, Man-Seong			Combination Effects of Peramivir and Favipiravir against Oseltamivir-Resistant 2009 Pandemic Influenza A(H1N1) Infection in Mice	PLOS ONE			English	Article							H1N1 VIRUS-INFECTIONS; NEURAMINIDASE INHIBITOR RWJ-270201; IN-VITRO; A VIRUS; ANTIVIRAL THERAPY; CELL-CULTURE; MODEL; T-705; RIBAVIRIN; EFFICACY	Antiviral drugs are being used for therapeutic purposes against influenza illness in humans. However, antiviral-resistant variants often nullify the effectiveness of antivirals. Combined medications, as seen in the treatment of cancers and other infectious diseases, have been suggested as an option for the control of antiviral-resistant influenza viruses. Here, we evaluated the therapeutic value of combination therapy against oseltamivir-resistant 2009 pandemic influenza H1N1 virus infection in DBA/2 mice. Mice were treated for five days with favipiravir and peramivir starting 4 hours after lethal challenge. Compared with either monotherapy, combination therapy saved more mice from viral lethality and resulted in increased antiviral efficacy in the lungs of infected mice. Furthermore, the synergism between the two antivirals, which was consistent with the survival outcomes of combination therapy, indicated that favipiravir could serve as a critical agent of combination therapy for the control of oseltamivir-resistant strains. Our results provide new insight into the feasibility of favipiravir in combination therapy against oseltamivir-resistant influenza virus infection.	[Park, Sehee; Kim, Jin Il; Lee, Ilseob; Lee, Sangmoo; Hwang, Min-Woong; Bae, Joon-Yong; Heo, Jun; Kim, Hyejin; Song, Jin-Won; Song, Ki-Joon; Baek, Luck Ju; Park, Man-Seong] Korea Univ, Coll Med, Dept Microbiol, Seoul 136705, South Korea; [Park, Sehee; Kim, Jin Il; Lee, Ilseob; Lee, Sangmoo; Hwang, Min-Woong; Bae, Joon-Yong; Heo, Jun; Kim, Hyejin; Song, Jin-Won; Song, Ki-Joon; Baek, Luck Ju; Park, Man-Seong] Korea Univ, Inst Viral Dis, Seoul 136705, South Korea; [Park, Sehee; Kim, Jin Il; Lee, Ilseob; Lee, Sangmoo; Hwang, Min-Woong; Bae, Joon-Yong; Heo, Jun; Kim, Donghwan; Jang, Seok-Il; Park, Man-Seong] Hallym Univ, Coll Med, Dept Microbiol, Chunchon, Gangwon Do, South Korea; [Cheong, Hee Jin] Korea Univ, Coll Med, Guro Hosp, Div Infect Dis, Seoul 136705, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Hallym University; Korea University; Korea University Medicine (KU Medicine)	Park, MS (corresponding author), Korea Univ, Coll Med, Dept Microbiol, Seoul 136705, South Korea.	ms0392@korea.ac.kr	Kim, Young-jin/GSD-3168-2022; Song, Jin/HHS-8731-2022; Park, Man-Seong/AAF-1207-2020	Kim, Jin Il/0000-0001-8833-2138; Cheong, Hee Jin/0000-0002-2532-1463	Korea Healthcare Technology RAMP;D Project of the Ministry of Health Welfare [A103001]	Korea Healthcare Technology RAMP;D Project of the Ministry of Health Welfare	This study was supported by grant from the Korea Healthcare Technology R&D Project of the Ministry of Health & Welfare (Grant No. A103001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002431; Bantia S, 2010, ANTIVIR RES, V88, P276, DOI 10.1016/j.antiviral.2010.09.020; Baz M, 2010, J INFECT DIS, V201, P740, DOI 10.1086/650464; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Chao DL, 2013, INFLUENZA OTHER RESP, V7, P58, DOI 10.1111/irv.12043; Ferraris O, 2008, J CLIN VIROL, V41, P13, DOI 10.1016/j.jcv.2007.10.020; Furuta Y, 2005, ANTIMICROB AGENTS CH, V49, P981, DOI 10.1128/AAC.49.3.981-986.2005; Furuta Y, 2002, ANTIMICROB AGENTS CH, V46, P977, DOI 10.1128/AAC.46.4.977-981.2002; Govorkova EA, 2004, ANTIMICROB AGENTS CH, V48, P4855, DOI 10.1128/AAC.48.12.4855-4863.2004; Govorkova EA, 2010, VIRUSES-BASEL, V2, P1510, DOI 10.3390/v2081510; Gowen BB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003725; Gulick R, 1998, AIDS, V12, pS17; HELENIUS A, 1992, CELL, V69, P577, DOI 10.1016/0092-8674(92)90219-3; Huang P, 2013, EPIDEMIOL INFECT, V141, P1061, DOI 10.1017/S0950268812001318; Hurt AC, 2010, J VIROL, V84, P9427, DOI 10.1128/JVI.00373-10; 이일섭, 2013, Journal of Bacteriology and Virology, V43, P9, DOI 10.4167/jbv.2013.43.1.9; Ilyushina NA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000933; Jonges M, 2009, ANTIVIR RES, V83, P290, DOI 10.1016/j.antiviral.2009.07.003; Kim JI, 2013, J MICROBIOL, V51, P866, DOI 10.1007/s12275-013-3428-7; Kim JI, 2013, J VIROL, V87, P7539, DOI 10.1128/JVI.00373-13; Kiso M, 2011, J VIROL, V85, P4667, DOI 10.1128/JVI.00047-11; Kiso M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001079; Kiso M, 2010, P NATL ACAD SCI USA, V107, P882, DOI 10.1073/pnas.0909603107; Knipe DM., 2006, FIELDS VIROLOGY, V5th ed; Lee S, 2013, J MICROBIOL, V51, P676, DOI 10.1007/s12275-013-3384-2; Nguyen HT, 2010, ANTIMICROB AGENTS CH, V54, P3671, DOI 10.1128/AAC.00581-10; Nguyen JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009332; Park Sehee, 2012, Journal of Bacteriology and Virology, V42, P284, DOI 10.4167/jbv.2012.42.4.284; Park S, 2013, BIOCHEM BIOPH RES CO, V440, P14, DOI 10.1016/j.bbrc.2013.08.090; Park S, 2012, J MICROBIOL, V50, P1067, DOI 10.1007/s12275-012-2541-3; Pica N, 2011, J VIROL, V85, P12825, DOI 10.1128/JVI.05930-11; Pizzorno A, 2011, SEMIN RESP CRIT CARE, V32, P409, DOI 10.1055/s-0031-1283281; PRICHARD MN, 1990, ANTIVIR RES, V14, P181, DOI 10.1016/0166-3542(90)90001-N; Samson M, 2013, ANTIVIR RES, V98, P174, DOI 10.1016/j.antiviral.2013.03.014; Seibert CW, 2010, J VIROL, V84, P11219, DOI 10.1128/JVI.01424-10; Shetty AK, 2012, EXPERT REV ANTI-INFE, V10, P123, DOI [10.1586/eri.11.174, 10.1586/ERI.11.174]; Sidwell RW, 2001, ANTIMICROB AGENTS CH, V45, P749, DOI 10.1128/AAC.45.3.749-757.2001; Smee DF, 2002, CHEMOTHERAPY, V48, P88, DOI 10.1159/000057668; Smee DF, 2001, ANTIMICROB AGENTS CH, V45, P743, DOI 10.1128/AAC.45.3.743-748.2001; Smee DF, 2012, ANTIVIR RES, V96, P13, DOI 10.1016/j.antiviral.2012.07.002; Smee DF, 2010, ANTIVIR RES, V88, P38, DOI 10.1016/j.antiviral.2010.07.003; Smee DF, 2010, ANTIMICROB AGENTS CH, V54, P126, DOI 10.1128/AAC.00933-09; Smee DF, 2009, J ANTIMICROB CHEMOTH, V64, P741, DOI 10.1093/jac/dkp274; Sugaya N, 2012, ANTIMICROB AGENTS CH, V56, P369, DOI 10.1128/AAC.00132-11; Tarbet EB, 2012, ANTIVIR RES, V94, P103, DOI 10.1016/j.antiviral.2012.03.001; Tsiodras S, 2007, BMJ-BRIT MED J, V334, P293, DOI 10.1136/bmj.39105.428981.BE; van der Vries E, 2013, ADV PHARMACOL, V67, P217, DOI 10.1016/B978-0-12-405880-4.00006-8; von Itzstein M, 2007, NAT REV DRUG DISCOV, V6, P967, DOI 10.1038/nrd2400; Wong DDY, 2012, J VIROL, V86, P10558, DOI 10.1128/JVI.00985-12; Yun NE, 2008, VIROLOGY, V374, P198, DOI 10.1016/j.virol.2007.12.029	50	15	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101325	10.1371/journal.pone.0101325	http://dx.doi.org/10.1371/journal.pone.0101325			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992479	Green Published, gold, Green Submitted			2022-12-27	WOS:000341253400062
J	Bastos, EP; Brentani, H; Pasini, FS; Silva, ART; Torres, CH; Puga, RD; Olivieri, EHR; Piovezani, AR; Pereira, CAD; Machado-Lima, A; Carraro, DM; Brentani, MM				Bastos, Elen Pereira; Brentani, Helena; Pasini, Fatima Solange; Silva, Aderbal Ruy T.; Torres, Cesar Henrique; Puga, Renato David; Ribeiro Olivieri, Eloisa Helena; Piovezani, Amanda Rusiska; de Braganca Pereira, Carlos Alberto; Machado-Lima, Ariane; Carraro, Dirce Maria; Brentani, Maria Mitzi			MicroRNAs Discriminate Familial from Sporadic Non-BRCA1/2 Breast Carcinoma Arising in Patients <= 35 Years	PLOS ONE			English	Article							CANCER PATIENTS; MESSENGER-RNA; GENE-EXPRESSION; YOUNG; WOMEN; SURVIVAL; MUTATIONS; TARGETS; TUMORS; CELLS	The influence of genetic factors may contribute to the poor prognosis of breast cancer (BC) at a very young age. However BRCA1/2 mutations could not explain the majority of cases arising in these patients. MicroRNAs (miRs) have been implicated in biological processes associated with BC. Therefore, we investigated differences in miRs expression between tumors from young patients (<= 35 years) with sporadic or familial history and non-carriers of BRCA1/2 mutations. Thirty-six young Brazilian patients were divided into 2 groups: sporadic (NF-BC) or familial breast cancer (F-BC). Most of the samples were classified as luminal A and B and the frequency of subtypes did not differ between familial or sporadic cases. Using real time qPCR and discriminant function analysis, we identified 9 miRs whose expression levels rather than miR identity can discriminate between both patient groups. Candidate predicted targets were determined by combining results from miRWalk algorithms with mRNA expression profiles (n = 91 differently expressed genes). MiR/mRNA integrated analysis identified 91 candidate genes showing positive or negative correlation to at least 1 of the 9 miRs. Co-expression analysis of these genes with 9 miRs indicated that 49 differentially co-expressed miR-gene interactions changes in F-BC tumors as compared to those of NF-BC tumors. Out of 49, 17 (34.6%) of predicted miR-gene interactions showed an inverse correlation suggesting that miRs act as post-transcriptional regulators, whereas 14 (28.6%) miR-gene pairs tended to be co-expressed in the same direction indicating that the effects exerted by these miRs pointed to a complex level of target regulation. The remaining 18 pairs were not predicted by our criteria suggesting involvement of other regulators. MiR-mRNA co-expression analysis allowed us to identify changes in the miR-mRNA regulation that were able to distinguish tumors from familial and sporadic young BC patients non-carriers of BRCA mutations.	[Bastos, Elen Pereira; Pasini, Fatima Solange; Brentani, Maria Mitzi] Univ Sao Paulo, Sch Med, Lab Med Invest LIM 24 24, Oncol & Radiol Dept, Sao Paulo, Brazil; [Brentani, Helena; Silva, Aderbal Ruy T.; Torres, Cesar Henrique] Univ Sao Paulo, Sch Med, Inst & Dept Psychiat, Clin Pathol Lab,Lab Med Invest LIM 23 23, Sao Paulo, Brazil; [Puga, Renato David] HIAE, Clin Res Ctr, Sao Paulo, Brazil; [Ribeiro Olivieri, Eloisa Helena; Carraro, Dirce Maria] AC Camargo Canc Ctr, Res Ctr CIPE, Lab Genom & Mol Biol, Sao Paulo, Brazil; [Piovezani, Amanda Rusiska; de Braganca Pereira, Carlos Alberto] Univ Sao Paulo, Math & Stat Inst, Sao Paulo, Brazil; [Machado-Lima, Ariane] Univ Sao Paulo, Sch Arts Sci & Humanities, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Hospital Israelita Albert Einstein; A.C.Camargo Cancer Center; Universidade de Sao Paulo; Universidade de Sao Paulo	Bastos, EP (corresponding author), Univ Sao Paulo, Sch Med, Lab Med Invest LIM 24 24, Oncol & Radiol Dept, Sao Paulo, Brazil.	elenbastos@hotmail.com	Machado-Lima, Ariane/F-4245-2012; carraro, dirce/C-9179-2009; Pasini, Fatima/D-8966-2012; Pasini, Fatima Solange/AAA-2283-2019; Faria, Carolina Pereira de Morais/HHT-0142-2022; Brentani, Maria Mitzi/E-8017-2012; Brentani, Helena/G-6839-2011; Lima, Ariane Machado/O-1772-2019; Ruy T. Silva, Aderbal/K-6503-2012; Pereira, Carlos Alberto de Braganca/O-5022-2015	Machado-Lima, Ariane/0000-0002-5719-338X; carraro, dirce/0000-0001-5667-1418; Pasini, Fatima Solange/0000-0002-0361-7781; Brentani, Helena/0000-0001-5192-4682; Lima, Ariane Machado/0000-0002-5719-338X; Ruy T. Silva, Aderbal/0000-0003-1158-5617; Pereira, Carlos Alberto de Braganca/0000-0001-6315-7484	FAPESP [2009/10088-7]; CNPq	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by FAPESP (2009/10088-7) and CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An CH, 2012, HUM PATHOL, V43, P40, DOI 10.1016/j.humpath.2010.03.015; Anders CK, 2008, J CLIN ONCOL, V26, P3324, DOI 10.1200/JCO.2007.14.2471; Anders CK, 2011, J CLIN ONCOL, V29, pE18, DOI 10.1200/JCO.2010.28.9199; Azim HA, 2012, CLIN CANCER RES, V18, P1341, DOI 10.1158/1078-0432.CCR-11-2599; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Brinton LA, 2008, JNCI-J NATL CANCER I, V100, P1643, DOI 10.1093/jnci/djn344; Browne MW, 2000, J MATH PSYCHOL, V44, P108, DOI 10.1006/jmps.1999.1279; Buffa FM, 2011, CANCER RES, V71, P5635, DOI 10.1158/0008-5472.CAN-11-0489; Cancello G, 2013, BREAST, V22, P1046, DOI 10.1016/j.breast.2013.08.006; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Carraro DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057581; CHU G, 2001, SAM SIGNIFICANCE ANA; de Sanjose S, 2003, INT J CANCER, V106, P588, DOI 10.1002/ijc.11271; Dimitrakakis C, 2013, OBSTET GYNECOL, V121, P1235, DOI 10.1097/AOG.0b013e318291ef9a; Dmitriev P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-265; El Saghir NS, 2006, BMC CANCER, V20, P6; Fackenthal JD, 2007, NAT REV CANCER, V7, P937, DOI 10.1038/nrc2054; Farazi TA, 2011, CANCER RES, V71, P4443, DOI 10.1158/0008-5472.CAN-11-0608; Fernandez-Ramires R, 2011, INT J CANCER, V128, P2635, DOI 10.1002/ijc.25603; Ferracin M, 2011, SEMIN ONCOL, V38, P764, DOI 10.1053/j.seminoncol.2011.08.005; Fredholm H, 2009, PLOS ONE, V4, pA38, DOI 10.1371/journal.pone.0007695; Garrido P, 2013, ENDOCRINOLOGY, V154, P1979, DOI 10.1210/en.2012-1558; Haffty BG, 2009, ANN ONCOL, V20, P1653, DOI 10.1093/annonc/mdp051; Han W, 2010, BREAST CANCER RES TR, V119, P193, DOI 10.1007/s10549-009-0388-z; Hannafon BN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2839; Hung TC, 2013, J AM CHEM SOC, V135, P5934, DOI 10.1021/ja312210c; Kashimoto K, 2012, CANCER SCI, V103, P2021, DOI 10.1111/j.1349-7006.2012.02407.x; Keegan THM, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3556; Liang YJ, 2013, CARCINOGENESIS, V34, P713, DOI 10.1093/carcin/bgs383; Lieblein JC, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-302; Lin CH, 2011, J CLIN PATHOL, V64, P781, DOI 10.1136/jclinpath-2011-200064; Liu SL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002751; Lv Xiao-Bin, 2011, Chin J Cancer, V30, P821, DOI 10.5732/cjc.011.10289; Madaras L, 2013, PATHOL ONCOL RES, V19, P723, DOI 10.1007/s12253-013-9635-z; Estal RM, 2013, BREAST CANCER RES TR, V142, P19, DOI 10.1007/s10549-013-2723-7; Nunez-Iglesias J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008898; Paluch-Shimon S, 2011, AM J CLIN ONCOL-CANC, V34, P219, DOI 10.1097/COC.0b013e3181d6b500; Pastrello C, 2010, CARCINOGENESIS, V31, P2124, DOI 10.1093/carcin/bgq184; Pellegrini L, 2012, CELL DEATH DIFFER, V19, P1815, DOI 10.1038/cdd.2012.62; Peng RJ, 2011, BREAST, V20, P568, DOI 10.1016/j.breast.2011.07.012; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Shen J, 2008, CARCINOGENESIS, V29, P1963, DOI 10.1093/carcin/bgn172; Shi M, 2010, CANCER METAST REV, V29, P785, DOI 10.1007/s10555-010-9265-9; Silva ART, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048751; Siragam V, 2012, ONCOTARGET, V3, P1370, DOI 10.18632/oncotarget.717; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Tanic M, 2013, BRIT J CANCER, V109, P2724, DOI 10.1038/bjc.2013.612; Tichy JR, 2013, J NATL COMPR CANC NE, V11, P1060, DOI 10.6004/jnccn.2013.0128; Tompkins VS, 2007, J BIOL CHEM, V282, P1322, DOI 10.1074/jbc.M609612200; van Miltenburg MH, 2013, ONCOGENE IN PRESS, DOI [10.1038/onc.2013.219, DOI 10.1038/ONC.2013.219]; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Volinia S, 2013, P NATL ACAD SCI USA, V110, P7413, DOI 10.1073/pnas.1304977110; Wagner Kay-Uwe, 2011, J Carcinog, V10, P32, DOI 10.4103/1477-3163.90677; Wang C, 2012, J CANCER RES CLIN, V138, P2127, DOI 10.1007/s00432-012-1288-x; Yoshitaka T, 2013, J ORTHOP RES, V31, P1992, DOI 10.1002/jor.22457	55	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101656	10.1371/journal.pone.0101656	http://dx.doi.org/10.1371/journal.pone.0101656			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006670	Green Submitted, Green Published, gold			2022-12-27	WOS:000339040600053
J	de Montjoye, YA; Shmueli, E; Wang, SS; Pentland, AS				de Montjoye, Yves-Alexandre; Shmueli, Erez; Wang, Samuel S.; Pentland, Alex Sandy			openPDS: Protecting the Privacy of Metadata through SafeAnswers	PLOS ONE			English	Article							LOCATION PRIVACY; HUMAN MOBILITY; ANONYMIZATION; ANONYMITY; SYSTEMS; MODEL	The rise of smartphones and web services made possible the large-scale collection of personal metadata. Information about individuals' location, phone call logs, or web-searches, is collected and used intensively by organizations and big data researchers. Metadata has however yet to realize its full potential. Privacy and legal concerns, as well as the lack of technical solutions for personal metadata management is preventing metadata from being shared and reconciled under the control of the individual. This lack of access and control is furthermore fueling growing concerns, as it prevents individuals from understanding and managing the risks associated with the collection and use of their data. Our contribution is two-fold: (1) we describe openPDS, a personal metadata management framework that allows individuals to collect, store, and give fine-grained access to their metadata to third parties. It has been implemented in two field studies; (2) we introduce and analyze SafeAnswers, a new and practical way of protecting the privacy of metadata at an individual level. SafeAnswers turns a hard anonymization problem into a more tractable security one. It allows services to ask questions whose answers are calculated against the metadata instead of trying to anonymize individuals' metadata. The dimensionality of the data shared with the services is reduced from high-dimensional metadata to low-dimensional answers that are less likely to be re-identifiable and to contain sensitive information. These answers can then be directly shared individually or in aggregate. openPDS and SafeAnswers provide a new way of dynamically protecting personal metadata, thereby supporting the creation of smart data-driven services and data science research.	[de Montjoye, Yves-Alexandre; Shmueli, Erez; Pentland, Alex Sandy] MIT, Media Lab, Cambridge, MA 02139 USA; [Wang, Samuel S.] MIT, DIG CSAIL, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	de Montjoye, YA (corresponding author), MIT, Media Lab, Cambridge, MA 02139 USA.	yva@mit.edu			Army Research Laboratory [W911NF-09-2-0053]; Center for Complex Engineering Systems; Media Lab Consortium	Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); Center for Complex Engineering Systems; Media Lab Consortium	This research was partially sponsored by the Army Research Laboratory under Cooperative Agreement Number W911NF-09-2-0053, by the Center for Complex Engineering Systems, and by the Media Lab Consortium. The conclusions in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the sponsors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson Hal, 2008, BLOWN BITS YOUR LIFE; Aggarwal CC, 2008, ADV DATABASE SYST, V34, P1, DOI 10.1007/978-0-387-70992-5; Aggarwal Charu C., 2005, VLDB VANCOUVER, P901, DOI DOI 10.5555/1083592.1083696; Assad M, 2007, LECT NOTES COMPUT SC, V4480, P55; Baden R, 2009, ACM SIGCOMM COMP COM, V39, P135, DOI 10.1145/1594977.1592585; Bell G, 2001, COMMUN ACM, V44, P86, DOI 10.1145/357489.357513; Beresford AR, 2003, IEEE PERVAS COMPUT, V2, P46, DOI 10.1109/MPRV.2003.1186725; Blumberg A, 2009, LOCATIONAL PRIVACY A; Butler D, 2007, NATURE, V449, P644, DOI 10.1038/449644a; Byun JW, 2006, LECT NOTES COMPUT SC, V4165, P48; Caceres R, 2009, MOBIHELD 09, P37; Cao JN, 2011, VLDB J, V20, P59, DOI 10.1007/s00778-010-0191-9; de Montjoye Yves-Alexandre, 2013, Social Computing, Behavioral-Cultural Modeling and Prediction. 6th International Conference, SBP 2013. Proceedings, P48, DOI 10.1007/978-3-642-37210-0_6; de Montjoye YA, 2013, NATURE SREP, V3; de Montjoye YA, 2012, IEEE DATA ENG B, V35, P5; Dwork C, 2006, LECT NOTES COMPUT SC, V4052, P1; Eagle N, 2010, SCIENCE, V328, P1029, DOI 10.1126/science.1186605; Fung BCM, 2010, ACM COMPUT SURV, V42, DOI 10.1145/1749603.1749605; Gedik B, 2005, INT CON DISTR COMP S, P620, DOI 10.1109/ICDCS.2005.48; Gellman B, 2013, WASHINGTON POST 0606; Gentry C, 2009, FULLY HOMOMORPHIC EN; Goldreich O., 1998, SECURE MULTI PARTY C; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Greenwald G., 2013, GUARDIAN; Hammer-Lahav E, 2010, 5849 RFC IETF; Hong J, 2004, P 2 INT C MOB SYST A, P177; Josang A, 2007, DECIS SUPPORT SYST, V43, P618, DOI 10.1016/j.dss.2005.05.019; Kay J, 2012, ACM T INTERACT INTEL, V2, P24; Kearns M, 2007, ADV NEURAL INFORM PR, V20; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lederer S, 2003, CHI 03 HUM FACT COMP, P724, DOI DOI 10.1145/765891.765952; Li NH, 2010, IEEE T KNOWL DATA EN, V22, P943, DOI 10.1109/TKDE.2009.139; Mascetti S, 2011, VLDB J, V20, P541, DOI 10.1007/s00778-010-0213-7; Mir Darakhshan J., 2013, 2013 IEEE International Conference on Big Data, P580, DOI 10.1109/BigData.2013.6691626; Monreale A, 2010, TRANS DATA PRIV, V3, P91; Mui L., 2002, Proceedings of the 35th Annual Hawaii International Conference on System Sciences, P2431, DOI 10.1109/HICSS.2002.994181; Mun M, 2010, P 6 INT C, P17; Narayanan A, 2008, P IEEE S SECUR PRIV, P111, DOI 10.1109/SP.2008.33; Orlandi C, 2011, INT CONF ACOUST SPEE, P5848; Palfrey J, 2011, SCIENCE, V334, P1210, DOI 10.1126/science.1210737; Place RCAA S, 2013, 030113 COG CORP; Popa L, 2010, P 9 ACM SIGCOMM WORK, P7, DOI DOI 10.1145/1868447.1868454; Popa RA, 2011, SOSP 11: PROCEEDINGS OF THE TWENTY-THIRD ACM SYMPOSIUM ON OPERATING SYSTEMS PRINCIPLES, P85; Prasad NR, 2009, CMC-COMPUT MATER CON, V14, P1, DOI 10.1145/1541880.1541882; Reades J, 2010, J URBAN TECHNOL, V17, P29, DOI 10.1080/10630731003597314; Rubinstein IS, 2012, BIG DATA END PRIVACY; Schwab K., 2011, INITIATIVE WORLD EC; Schwartz PM, 2004, HARVARD LAW REV, V117, P2055; Shmueli E, 2014, COMPUTERS SECURITY; Shmueli E, 2012, INFORM SCIENCES, V191, P98, DOI 10.1016/j.ins.2011.12.020; Solomon A, 2012, P 2 ACM SIGHIT INT H, P523, DOI DOI 10.1145/2110363.2110422; Stopczynski A, 2014, ARXIV14035299; Sweeney L, 2002, INT J UNCERTAIN FUZZ, V10, P557, DOI 10.1142/S0218488502001648; Terrovitis M, 2008, PROC VLDB ENDOW, V1, P115, DOI 10.14778/1453856.1453874; Thurm S, 2014, WALL STREET J; Venkitasubramaniam M, 2006, 22 INT C DAT ENG ICD, P24, DOI [DOI 10.1109/ICDE.2006.1, DOI 10.1145/1217299.1217302]; Wang K., 2006, P 12 ACM SIGKDD INT, P414, DOI DOI 10.1145/1150402.1150449; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467; William S, 2008, COMPUTER SECURITY PR; Xiao X., 2007, P 2007 ACM SIGMOD IN, P689, DOI DOI 10.1145/1247480.1247556; Yarovoy R., 2009, EDBT, P72, DOI DOI 10.1145/1516360.1516370; Zhong G, 2007, LECT NOTES COMPUT SC, V4776, P62	62	104	103	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e98790	10.1371/journal.pone.0098790	http://dx.doi.org/10.1371/journal.pone.0098790			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007320	Green Submitted, Green Published, gold			2022-12-27	WOS:000339040600003
J	Klailova, M; Lee, PC				Klailova, Michelle; Lee, Phyllis C.			Wild Western Lowland Gorillas Signal Selectively Using Odor	PLOS ONE			English	Article							OLFACTORY DISCRIMINATION; REPRODUCTIVE SUCCESS; SCENT-MARKING; BODY ODOR; BEHAVIOR; SKIN; TESTOSTERONE; STRATEGIES; QUALITY; GLAND	Mammals communicate socially through visual, auditory and chemical signals. The chemical sense is the oldest sense and is shared by all organisms including bacteria. Despite mounting evidence for social chemo-signaling in humans, the extent to which it modulates behavior is debated and can benefit from comparative models of closely related hominoids. The use of odor cues in wild ape social communication has been only rarely explored. Apart from one study on wild chimpanzee sniffing, our understanding is limited to anecdotes. We present the first study of wild gorilla chemo-communication and the first analysis of olfactory signaling in relation to arousal levels and odor strength in wild apes. If gorilla scent is used as a signaling mechanism instead of only a sign of arousal or stress, odor emission should be context specific and capable of variation as a function of the relationships between the emitter and perceiver(s). Measured through a human pungency scale, we determined the factors that predicted extreme levels of silverback odor for one wild western lowland gorilla (Gorilla gorilla gorilla) group silverback. Extreme silverback odor was predicted by the presence and intensity of inter-unit interactions, silverback anger, distress and long-calling auditory rates, and the absence of close proximity between the silverback and mother of the youngest infant. Odor strength also varied according to the focal silverback's strategic responses during high intensity inter-unit interactions. Silverbacks appear to use odor as a modifiable form of communication; where odor acts as a highly flexible, context dependent signaling mechanism to group members and extragroup units. The importance of olfaction to ape social communication may be especially pertinent in Central African forests where limited visibility may necessitate increased reliance on other senses.	[Klailova, Michelle; Lee, Phyllis C.] Univ Stirling, Sch Nat Sci, Evolut & Res Grp, Div Psychol, Stirling FK9 4LA, Scotland; [Klailova, Michelle] Univ Lisbon, Inst Super Ciencias Sociais Polit, Ctr Adm Polit Publ, Dept Antropol, P-1699 Lisbon, Portugal; [Klailova, Michelle] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Tubney, Oxon, England	University of Stirling; Universidade de Lisboa; University of Oxford	Klailova, M (corresponding author), Univ Stirling, Sch Nat Sci, Evolut & Res Grp, Div Psychol, Stirling FK9 4LA, Scotland.	mk29@stir.ac.uk		Lee, Phyllis/0000-0002-4296-3513	Fundacao Para a Ciencia e Tecnologia, Bolsa de Pos-Doutoramento, Portugal; Division of Psychology, Behaviour and Evolution Research Group, School of Natural Sciences, University of Stirling, Stirling; Wildlife Conservation Research Unit, Department of Zoology, University of Oxford, UK; Toronto Zoo, Canada; Panton Trust, UK	Fundacao Para a Ciencia e Tecnologia, Bolsa de Pos-Doutoramento, Portugal; Division of Psychology, Behaviour and Evolution Research Group, School of Natural Sciences, University of Stirling, Stirling; Wildlife Conservation Research Unit, Department of Zoology, University of Oxford, UK; Toronto Zoo, Canada; Panton Trust, UK	This work received funding from Fundacao Para a Ciencia e Tecnologia, Bolsa de Pos-Doutoramento, Portugal (http://www.fct.pt); Division of Psychology, Behaviour and Evolution Research Group, School of Natural Sciences, University of Stirling, Stirling (http://www.stir.ac.uk); Wildlife Conservation Research Unit, Department of Zoology, University of Oxford, UK (http://www.wildcru.org); The Toronto Zoo, Canada (http://www.torontozoo.com); and The Panton Trust, UK (http://opencharities.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerl K, 2002, NEUROENDOCRINOL LETT, V23, P79; Adolph D, 2010, PHYSIOL BEHAV, V101, P666, DOI 10.1016/j.physbeh.2010.08.004; ALBERTS AC, 1992, AM NAT, V139, pS62, DOI 10.1086/285305; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 2007, BBC NEWS GORILLA NOV; Blackman TM, 1947, AM J PHYS ANTHROP-NE, V5, P283, DOI 10.1002/ajpa.1330050303; Breuer T, 2012, J HUM EVOL, V62, P466, DOI 10.1016/j.jhevol.2012.01.006; Caillaud D, 2008, AM J PHYS ANTHROPOL, V135, P379, DOI 10.1002/ajpa.20754; Charpentier MJE, 2008, MOL ECOL, V17, P3225, DOI 10.1111/j.1365-294X.2008.03831.x; Cousins D, 1990, MAGNIFICIENT GORILLA; DIXSON A. F., 1981, NATURAL HIST GORILLA; DONISTHORPE J. H., 1958, S AFRICAN JOUR SCI, V54, P195; DORAN DM, 2001, MOUNTAIN GORILLAS 3, P123, DOI DOI 10.1017/CBO9780511661631.006; DOTY RL, 1986, EXPERIENTIA, V42, P257, DOI 10.1007/BF01942506; Eisenegger C, 2011, TRENDS COGN SCI, V15, P263, DOI 10.1016/j.tics.2011.04.008; ELLIS RA, 1962, AM J PHYS ANTHROPOL, V20, P79, DOI 10.1002/ajpa.1330200210; Elsenberg J.F., 1972, Annual Rev Ecol Syst, V3, P1; FOSSEY D, 1972, ANIM BEHAV, V20, P36, DOI 10.1016/S0003-3472(72)80171-4; Fossey Diane, 1983, GORILLAS IN THE MIST; GILBERT AN, 1986, J COMP PSYCHOL, V100, P262, DOI 10.1037/0735-7036.100.3.262; Gosling LM, 2001, ADV STUD BEHAV, V30, P169, DOI 10.1016/S0065-3454(01)80007-3; Grammer K, 2005, EUR J OBSTET GYN R B, V118, P135, DOI 10.1016/j.ejogrb.2004.08.010; HARCOURT AH, 2001, MOUNTAIN GORILLAS 3, P241; Havlicek J, 2005, BIOL LETTERS, V1, P256, DOI 10.1098/rsbl.2005.0332; Havlicek J, 2010, VITAM HORM, V83, P47, DOI 10.1016/S0083-6729(10)83003-1; Hedwig D, 2014, BEHAVIOUR, V151, P1091, DOI 10.1163/1568539X-00003175; Hepper P, 2008, CHEM SIGNAL, V11, P103, DOI 10.1007/978-0-387-73945-8_9; Hepper PG, 2012, PRIMATES, V53, P121, DOI 10.1007/s10329-011-0291-1; Hepper PG, 2010, CHEM SENSES, V35, P263, DOI 10.1093/chemse/bjq015; Heymann EW, 2006, AM J PRIMATOL, V68, P650, DOI 10.1002/ajp.20258; Jeffery KJ, 2007, INTEGR ZOOL, V2, P111, DOI 10.1111/j.1749-4877.2007.00050.x; KING JE, 1974, J HUM EVOL, V3, P435, DOI 10.1016/0047-2484(74)90003-7; Klailova M, 2011, THESIS U STIRLING SC; Laska M, 2005, CHEM SENSES, V30, P505, DOI 10.1093/chemse/bji043; Macfie EJ, 2010, BEST PRACTICE GUIDEL; Matsumoto-Oda A, 2007, PRIMATES, V48, P81, DOI 10.1007/s10329-006-0006-1; MONTAGNA W, 1963, AM J PHYS ANTHROPOL, V21, P189, DOI 10.1002/ajpa.1330210211; MOORE AJ, 1995, ANIM BEHAV, V50, P191, DOI 10.1006/anbe.1995.0231; Moss C.J., 2011, AMBOSELI ELEPHANTS L, DOI DOI 10.7208/CHICAGO/9780226542263.001.0001; MULLERSCHWARZE D, 1984, J CHEM ECOL, V10, P1707, DOI 10.1007/BF00987357; Murray AK, 2013, THESIS U LIVERPOOL E; Oeda R, 2002, ANTHROPOL SCI, V110, P140; OWENS IPF, 1995, TRENDS ECOL EVOL, V10, P44, DOI 10.1016/S0169-5347(00)88967-3; Parnell RJ, 2002, AM J PRIMATOL, V56, P193, DOI 10.1002/ajp.1074; Parnell RJ, 2001, NATURE, V412, P294, DOI 10.1038/35085631; Rijksen HD, 1978, THESIS NETHERLANDS; Rikowski A, 1999, P ROY SOC B-BIOL SCI, V266, P869, DOI 10.1098/rspb.1999.0717; Robbins MM, 1997, AM J PRIMATOL, V43, P51, DOI 10.1002/(SICI)1098-2345(1997)43:1<51::AID-AJP4>3.0.CO;2-X; Roberts SC, 2011, ARCH SEX BEHAV, V40, P1111, DOI 10.1007/s10508-011-9803-8; Salmi R, 2013, ETHOLOGY, V119, P831, DOI 10.1111/eth.12122; Salvador A, 2005, NEUROSCI BIOBEHAV R, V29, P195, DOI 10.1016/j.neubiorev.2004.07.004; SAPOLSKY RM, 1991, PSYCHONEUROENDOCRINO, V16, P281, DOI 10.1016/0306-4530(91)90015-L; Saxton TK, 2008, CHEM SIGNAL, V11, P111, DOI 10.1007/978-0-387-73945-8_10; Schaller G.E., 1963, MOUNTAIN GORILLA ECO; Setchell JM, 2010, BIOESSAYS, V32, P940, DOI 10.1002/bies.201000066; Setchell JM, 2010, CHEM SENSES, V35, P205, DOI 10.1093/chemse/bjp105; Stephan H, 1970, THE PRIMATE BRAIN, P289; Stokes EJ, 2003, BEHAV ECOL SOCIOBIOL, V54, P329, DOI 10.1007/s00265-003-0630-3; Struthers EJ, 1996, MAD WISC 16 C INT PR, P762; Wells DL, 2007, APPL ANIM BEHAV SCI, V106, P155, DOI 10.1016/j.applanim.2006.07.010; Williams RJP, 1981, P R SOC LONDON, V213, P361; Wyatt T, 2003, PHEROMONES ANIMAL BE, P408; Wyatt TD, 2009, NATURE, V457, P262, DOI 10.1038/457262a; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zhou W, 2009, PSYCHOL SCI, V20, P177, DOI 10.1111/j.1467-9280.2009.02263.x; [No title captured]	66	18	18	35	370	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e99554	10.1371/journal.pone.0099554	http://dx.doi.org/10.1371/journal.pone.0099554			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006973	Green Submitted, Green Published, gold			2022-12-27	WOS:000339040600007
J	McMurray, MS; Amodeo, LR; Roitman, JD				McMurray, Matthew S.; Amodeo, Leslie R.; Roitman, Jamie D.			Effects of Voluntary Alcohol Intake on Risk Preference and Behavioral Flexibility during Rat Adolescence	PLOS ONE			English	Article							BRAIN REGIONAL VOLUMES; ETHANOL DRINKING; ADULT RATS; CONSUMPTION; ALTERS; EXPRESSION; EXPOSURE	Alcohol use is common in adolescence, with a large portion of intake occurring during episodes of binging. This pattern of alcohol consumption coincides with a critical period for neurocognitive development and may impact decision-making and reward processing. Prior studies have demonstrated alterations in adult decision-making following adolescent usage, but it remains to be seen if these alterations exist in adolescence, or are latent until adulthood. Here, using a translational model of voluntary binge alcohol consumption in adolescents, we assess the impact of alcohol intake on risk preference and behavioral flexibility during adolescence. During adolescence (postnatal day 30-50), rats were given 1-hour access to either a 10% alcohol gelatin mixture (EtOH) or a calorie equivalent gelatin (Control) at the onset of the dark cycle. EtOH consuming rats were classified as either High or Low consumers based on intake levels. Adolescent rats underwent behavioral testing once a day, with one group performing a risk preference task, and a second group performing a reversal-learning task during the 20-day period of gelatin access. EtOH-High rats showed increases in risk preference compared to Control rats, but not EtOH-Low animals. However, adolescent rats did a poor job of matching their behavior to optimize outcomes, suggesting that adolescents may adopt a response bias. In addition, adolescent ethanol exposure did not affect the animals' ability to flexibly adapt behavior to changing reward contingencies during reversal learning. These data support the view that adolescent alcohol consumption can have short-term detrimental effects on risk-taking when examined during adolescence, which does not seem to be attributable to an inability to flexibly encode reward contingencies on behavioral responses.	[McMurray, Matthew S.; Amodeo, Leslie R.; Roitman, Jamie D.] Univ Illinois, Dept Psychol, Chicago, IL 60680 USA; [Roitman, Jamie D.] Univ Illinois, Lab Integrat Neurosci, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Roitman, JD (corresponding author), Univ Illinois, Dept Psychol, Chicago, IL 60680 USA.	jroitman@uic.edu	McMurray, Matthew/AAO-5310-2021	McMurray, Matthew/0000-0002-1898-2933; Amodeo, Leslie/0000-0003-1787-0902	Brain Research Foundation	Brain Research Foundation	This work was supported by a Seed Grant from The Brain Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodeo DA, 2012, BEHAV BRAIN RES, V227, P64, DOI 10.1016/j.bbr.2011.10.032; Barron Susan, 2005, Alcohol Clin Exp Res, V29, P1720, DOI 10.1097/01.alc.0000179220.79356.e5; Bava S, 2010, NEUROPSYCHOL REV, V20, P398, DOI 10.1007/s11065-010-9146-6; Bell RL, 2011, PHARMACOL BIOCHEM BE, V100, P90, DOI 10.1016/j.pbb.2011.07.017; Bell RL, 2006, PHARMACOL BIOCHEM BE, V83, P35, DOI 10.1016/j.pbb.2005.12.004; Binakonsky J, 2011, SUBST USE MISUSE, V46, P828, DOI 10.3109/10826084.2010.538886; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Casey BJ, 2008, DEV REV, V28, P62, DOI [10.1016/j.dr.2007.08.003, 10.1196/annals.1440.010]; Chein J, 2011, DEVELOPMENTAL SCI, V14, pF1, DOI 10.1111/j.1467-7687.2010.01035.x; Clark JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037357; Coleman LG, 2011, ALCOHOL CLIN EXP RES, V35, P671, DOI 10.1111/j.1530-0277.2010.01385.x; Coleman LG, 2014, PHARMACOL BIOCHEM BE, V116, P142, DOI 10.1016/j.pbb.2013.11.021; Crews FT, 2000, ALCOHOL CLIN EXP RES, V24, P1712, DOI 10.1111/j.1530-0277.2000.tb01973.x; Crews FT, 2004, ALCOHOL CLIN EXP RES, V28, P350, DOI 10.1097/01.ALC.0000113416.65546.01; Crews FT, 2006, NEUROSCIENCE, V137, P437, DOI 10.1016/j.neuroscience.2005.08.090; Doremus-Fitzwater TL, 2010, BRAIN COGNITION, V72, P114, DOI 10.1016/j.bandc.2009.08.008; Eshel N, 2007, NEUROPSYCHOLOGIA, V45, P1270, DOI 10.1016/j.neuropsychologia.2006.10.004; Giga NM, 2011, AM J DRUG ALCOHOL AB, V37, P229, DOI 10.3109/00952990.2011.568558; Hall FS, 1998, CRIT REV NEUROBIOL, V12, P129, DOI 10.1615/CritRevNeurobiol.v12.i1-2.50; Kanny D., 2010, Morbidity and Mortality Weekly Report, V59, P1274; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; McCool BA, 2009, ALCOHOL CLIN EXP RES, V33, P273, DOI 10.1111/j.1530-0277.2008.00830.x; Monti PM, 2005, ALCOHOL CLIN EXP RES, V29, P207, DOI 10.1097/01.ALC.0000153551.11000.F3; Nasrallah NA, 2011, P NATL ACAD SCI USA, V108, P5466, DOI 10.1073/pnas.1017732108; Nasrallah NA, 2009, P NATL ACAD SCI USA, V106, P17600, DOI 10.1073/pnas.0906629106; National Institute on Alcohol Abuse and Alcoholism, 2004, NIAAA NEWSLETTER, V3, P3, DOI DOI 10.1037/E306662005-004; Peris J, 2006, PHARMACOL BIOCHEM BE, V85, P562, DOI 10.1016/j.pbb.2006.10.010; Perry JL, 2008, PSYCHOPHARMACOLOGY, V200, P1, DOI 10.1007/s00213-008-1173-0; Roitman JD, 2010, EUR J NEUROSCI, V31, P1492, DOI 10.1111/j.1460-9568.2010.07169.x; Semenova S, 2012, PSYCHOPHARMACOLOGY, V219, P433, DOI 10.1007/s00213-011-2458-2; Silvers JM, 2006, ALCOHOL, V39, P151, DOI 10.1016/j.alcohol.2006.09.001; Somerville LH, 2010, CURR OPIN NEUROBIOL, V20, P236, DOI 10.1016/j.conb.2010.01.006; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Substance Abuse and Mental Health Services Administration, 2012, HHS PUBL, V12-4681; Substance Abuse and Mental Health Services Administration, 2012, NSDUH SER H, VH- 44; Truxell EM, 2007, ALCOHOL CLIN EXP RES, V31, P755, DOI 10.1111/j.1530-0277.2007.00358.x; Tymula A, 2012, P NATL ACAD SCI USA, V109, P17135, DOI 10.1073/pnas.1207144109; Vetreno RP, 2012, NEUROSCIENCE, V226, P475, DOI 10.1016/j.neuroscience.2012.08.046; Vetter CS, 2007, ALCOHOL CLIN EXP RES, V31, P1159, DOI 10.1111/j.1530-0277.2007.00417.x	39	21	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e100697	10.1371/journal.pone.0100697	http://dx.doi.org/10.1371/journal.pone.0100697			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007338	gold, Green Published, Green Submitted			2022-12-27	WOS:000339040600018
J	Natsuka, S; Masuda, M; Sumiyoshi, W; Nakakita, S				Natsuka, Shunji; Masuda, Mayumi; Sumiyoshi, Wataru; Nakakita, Shin-ichi			Improved Method for Drawing of a Glycan Map, and the First Page of Glycan Atlas, Which Is a Compilation of Glycan Maps for a Whole Organism	PLOS ONE			English	Article							N-LINKED GLYCANS; PERFORMANCE LIQUID-CHROMATOGRAPHY; SUGAR CHAINS; STRUCTURAL-ANALYSIS; OLIGOSACCHARIDES; IDENTIFICATION; GLYCOPROTEINS; IGM	Glycan Atlas is a set of glycan maps over the whole body of an organism. The glycan map that includes data of glycan structure and quantity displays micro-heterogeneity of the glycans in a tissue, an organ, or cells. The two-dimensional glycan mapping is widely used for structure analysis of N-linked oligosaccharides on glycoproteins. In this study we developed a comprehensive method for the mapping of both N- and O-glycans with and without sialic acid. The mapping data of 150 standard pyridylaminated glycans were collected. The empirical additivity rule which was proposed in former reports was able to adapt for this extended glycan map. The adapted rule is that the elution time of pyridylamino glycans on high performance liquid chromatography (HPLC) is expected to be the simple sum of the partial elution times assigned to each monosaccharide residue. The comprehensive mapping method developed in this study is a powerful tool for describing the micro-heterogeneity of the glycans. Furthermore, we prepared 42 pyridylamino (PA-) glycans from human serum and were able to draw the map of human serum N- and O-glycans as an initial step of Glycan Atlas editing.	[Natsuka, Shunji; Masuda, Mayumi] Niigata Univ, Fac Sci, Dept Biol, Niigata 95021, Japan; [Sumiyoshi, Wataru; Nakakita, Shin-ichi] Kagawa Univ, Life Sci Res Ctr, Takamatsu, Kagawa 760, Japan	Niigata University; Kagawa University	Natsuka, S (corresponding author), Niigata Univ, Fac Sci, Dept Biol, Niigata 95021, Japan.	natsuka@bio.sc.niigata-u.ac.jp	Natsuka, Shunji/L-9330-2018	Natsuka, Shunji/0000-0003-1726-8946	Mizutani Foundation for Glycosciences	Mizutani Foundation for Glycosciences	This work was supported by the Mizutani Foundation for Glycosciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHAPMAN A, 1979, J BIOL CHEM, V254, P816; CUMMING DA, 1987, BIOCHEMISTRY-US, V26, P6655, DOI 10.1021/bi00395a015; HASE S, 1987, ANAL BIOCHEM, V167, P321, DOI 10.1016/0003-2697(87)90171-0; HASE S, 1978, BIOCHEM BIOPH RES CO, V85, P257, DOI 10.1016/S0006-291X(78)80037-0; HASE S, 1990, ANAL BIOCHEM, V184, P135, DOI 10.1016/0003-2697(90)90025-5; HASE S, 1985, J BIOCHEM-TOKYO, V98, P863, DOI 10.1093/oxfordjournals.jbchem.a135366; HASE S, 1982, J BIOCHEM-TOKYO, V91, P735, DOI 10.1093/oxfordjournals.jbchem.a133748; Kuraya N, 1996, ANAL BIOCHEM, V233, P205, DOI 10.1006/abio.1996.0029; LEE YC, 1990, ANAL BIOCHEM, V188, P259, DOI 10.1016/0003-2697(90)90603-7; Natsuka S, 2002, J BIOCHEM, V131, P807, DOI 10.1093/oxfordjournals.jbchem.a003169; Natsuka S, 1998, METH MOL B, V76, P101; Natsuka S, 2006, J BIOCHEM, V140, P87, DOI 10.1093/jb/mvj131; Natsuka S, 2011, FEBS J, V278, P452, DOI 10.1111/j.1742-4658.2010.07966.x; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; SHIBUYA N, 1988, ARCH BIOCHEM BIOPHYS, V267, P676, DOI 10.1016/0003-9861(88)90076-8; TOMIYA N, 1988, ANAL BIOCHEM, V171, P73, DOI 10.1016/0003-2697(88)90126-1; YAMAMOTO S, 1989, J BIOCHEM-TOKYO, V105, P547, DOI 10.1093/oxfordjournals.jbchem.a122703; Yanagida K, 1998, J CHROMATOGR A, V800, P187, DOI 10.1016/S0021-9673(97)01109-6	18	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102219	10.1371/journal.pone.0102219	http://dx.doi.org/10.1371/journal.pone.0102219			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006806	Green Submitted, gold, Green Published			2022-12-27	WOS:000339040600106
J	Onoa, B; Schneider, AR; Brooks, MD; Grob, P; Nogales, E; Geissler, PL; Niyogi, KK; Bustamante, C				Onoa, Bibiana; Schneider, Anna R.; Brooks, Matthew D.; Grob, Patricia; Nogales, Eva; Geissler, Phillip L.; Niyogi, Krishna K.; Bustamante, Carlos			Atomic Force Microscopy of Photosystem II and Its Unit Cell Clustering Quantitatively Delineate the Mesoscale Variability in Arabidopsis Thylakoids	PLOS ONE			English	Article							GRANA MEMBRANES; SUPRAMOLECULAR ORGANIZATION; MACRO-ORGANIZATION; PROTEINS; MACROSTRUCTURE; ACCLIMATION; ARRANGEMENT; COMPLEXES; SOFTWARE; SPINACH	Photoautotrophic organisms efficiently regulate absorption of light energy to sustain photochemistry while promoting photoprotection. Photoprotection is achieved in part by triggering a series of dissipative processes termed non-photochemical quenching (NPQ), which depend on the re-organization of photosystem (PS) II supercomplexes in thylakoid membranes. Using atomic force microscopy, we characterized the structural attributes of grana thylakoids from Arabidopsis thaliana to correlate differences in PSII organization with the role of SOQ1, a recently discovered thylakoid protein that prevents formation of a slowly reversible NPQ state. We developed a statistical image analysis suite to discriminate disordered from crystalline particles and classify crystalline arrays according to their unit cell properties. Through detailed analysis of the local organization of PSII supercomplexes in ordered and disordered phases, we found evidence that interactions among light-harvesting antenna complexes are weakened in the absence of SOQ1, inducing protein rearrangements that favor larger separations between PSII complexes in the majority (disordered) phase and reshaping the PSII crystallization landscape. The features we observe are distinct from known protein rearrangements associated with NPQ, providing further support for a role of SOQ1 in a novel NPQ pathway. The particle clustering and unit cell methodology developed here is generalizable to multiple types of microscopy and will enable unbiased analysis and comparison of large data sets.	[Onoa, Bibiana; Nogales, Eva; Geissler, Phillip L.; Bustamante, Carlos] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Schneider, Anna R.; Geissler, Phillip L.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Brooks, Matthew D.; Niyogi, Krishna K.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Brooks, Matthew D.; Grob, Patricia; Nogales, Eva; Niyogi, Krishna K.; Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Brooks, Matthew D.; Geissler, Phillip L.; Niyogi, Krishna K.; Bustamante, Carlos] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Nogales, Eva; Bustamante, Carlos] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Nogales, Eva] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Geissler, Phillip L.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Kavli Energy NanoSci Inst, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Bustamante, C (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA.	carlosb@berkeley.edu		Grob, Patricia/0000-0002-8330-8961; Bustamante, Carlos/0000-0002-2970-0073; Brooks, Matthew D./0000-0002-6081-6103	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, Office of Science, US Department of Energy; National Science Foundation Graduate Research Fellowship; Howard Hughes Medical; Institute and the Gordon and Betty Moore Foundation [GBMF3070]; National Science Foundation [MCB-1158555, CHE-7178966]	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, Office of Science, US Department of Energy(United States Department of Energy (DOE)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Howard Hughes Medical(Howard Hughes Medical Institute); Institute and the Gordon and Betty Moore Foundation; National Science Foundation(National Science Foundation (NSF))	BO MDB KKN CB EN and PLG were supported by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, Office of Science, US Department of Energy (Field work proposal SISGRKN). ARS was supported by National Science Foundation Graduate Research Fellowship. KKN CB EN PG were supported by Howard Hughes Medical. KKN was supported by the Institute and the Gordon and Betty Moore Foundation Grant GBMF3070. PLG was supported by National Science Foundation grants No. MCB-1158555 and CHE-7178966 "Functional Significance of Ultrastructural Changes in Photosynthesis Membranes for the Repair of Damaged Photosystem II". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betterle N, 2009, J BIOL CHEM, V284, P15255, DOI 10.1074/jbc.M808625200; Boekema EJ, 2000, J MOL BIOL, V301, P1123, DOI 10.1006/jmbi.2000.4037; Brooks MD, 2013, P NATL ACAD SCI USA, V110, pE2733, DOI 10.1073/pnas.1305443110; Caffarri S, 2009, EMBO J, V28, P3052, DOI 10.1038/emboj.2009.232; Damkjaer JT, 2009, PLANT CELL, V21, P3245, DOI 10.1105/tpc.108.064006; Daum B, 2010, PLANT CELL, V22, P1299, DOI 10.1105/tpc.109.071431; de Bianchi S, 2008, PLANT CELL, V20, P1012, DOI 10.1105/tpc.107.055749; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Goral TK, 2012, PLANT J, V69, P289, DOI 10.1111/j.1365-313X.2011.04790.x; Goral TK, 2010, PLANT J, V62, P948, DOI [10.1111/j.1365-313X.2010.04207.x, 10.1111/j.0960-7412.2010.04207.x]; Hankamer B, 2005, ADV PHOTO RESPIRAT, V22, P403; Hastie T., 2009, UNSUPERVISED LEARNIN; Horton P, 2008, FEBS J, V275, P1069, DOI 10.1111/j.1742-4658.2008.06263.x; Johnson MP, 2011, PLANT CELL, V23, P1468, DOI 10.1105/tpc.110.081646; Kereiche S, 2010, FEBS LETT, V584, P759, DOI 10.1016/j.febslet.2009.12.031; Keys AS, 2011, J COMPUT PHYS, V230, P6438, DOI 10.1016/j.jcp.2011.04.017; Keys AS, 2011, ANNU REV CONDEN MA P, V2, P263, DOI 10.1146/annurev-conmatphys-062910-140526; Kirchhoff H, 2004, BIOCHEMISTRY-US, V43, P9204, DOI 10.1021/bi0494626; Kirchhoff H, 2008, BIOCHEMISTRY-US, V47, P431, DOI 10.1021/bi7017877; Kirchhoff H, 2007, BIOCHEMISTRY-US, V46, P11169, DOI 10.1021/bi700748y; Kouril R, 2013, BBA-BIOENERGETICS, V1827, P411, DOI 10.1016/j.bbabio.2012.12.003; Kouril R, 2012, BBA-BIOENERGETICS, V1817, P2, DOI 10.1016/j.bbabio.2011.05.024; Kouril R, 2011, BBA-BIOENERGETICS, V1807, P368, DOI 10.1016/j.bbabio.2010.11.007; Kovacs L, 2006, PLANT CELL, V18, P3106, DOI 10.1105/tpc.106.045641; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Morosinotto T, 2006, FEBS J, V273, P4616, DOI 10.1111/j.1742-4658.2006.05465.x; Morosinotto T, 2010, J BIOENERG BIOMEMBR, V42, P37, DOI 10.1007/s10863-009-9261-3; Muh F, 2012, BBA-BIOENERGETICS, V1817, P1446, DOI 10.1016/j.bbabio.2012.02.016; Necas D, 2012, CENT EUR J PHYS, V10, P181, DOI 10.2478/s11534-011-0096-2; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Ruban AV, 2003, NATURE, V421, P648, DOI 10.1038/nature01344; Schneider AR, 2013, BIOPHYS J, V105, P1161, DOI 10.1016/j.bpj.2013.06.052; Schneider AR, 2013, ZENODO, DOI [10.5281/zenodo.10533, DOI 10.5281/ZENODO.10533]; SEMENOVA GA, 1995, CAN J BOT, V73, P1676, DOI 10.1139/b95-181; Sznee K, 2011, J BIOL CHEM, V286, P39164, DOI 10.1074/jbc.M111.284844; Tax DMJ, 2008, PATTERN RECOGN LETT, V29, P1565, DOI 10.1016/j.patrec.2008.03.010; van Oort B, 2011, PHYS CHEM CHEM PHYS, V13, P12614, DOI 10.1039/c1cp20331b; Yakushevska AE, 2003, BIOCHEMISTRY-US, V42, P608, DOI 10.1021/bi027109z	42	20	21	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101470	10.1371/journal.pone.0101470	http://dx.doi.org/10.1371/journal.pone.0101470			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007326	gold, Green Published			2022-12-27	WOS:000339040600038
J	Li, QG; Zhuo, CH; Cai, GX; Zheng, HT; Li, DW; Cai, SJ				Li, Qingguo; Zhuo, Changhua; Cai, Guoxiang; Zheng, Hongtu; Li, Dawei; Cai, SanJun			Pathological Features and Survival Outcomes of Young Patients with Operable Colon Cancer: Are They Homogeneous?	PLOS ONE			English	Article							COLORECTAL-CANCER; OLDER PATIENTS; ADULTS; ADENOCARCINOMA; PROGNOSIS; AGE; ADOLESCENTS; CARCINOMA; DIAGNOSIS; RATES	Objective: To compare the pathological features and survival outcomes at different age subgroups of young patients with colon cancer. Methods: Using Surveillance, Epidemiology, and End Results (SEER) population-based data, we identified 2,861 young patients with colon cancer diagnosed between 1988 and 2005 treated with surgery. Patients were divided into four groups: group 1 (below 25 years), group 2 (26-30 years), group 3 (31-35 years) and group 4 (36-40 years). Five-year cancer specific survival data were obtained. Kaplan-Meier methods were adopted and multivariable Cox regression models were built for the analysis of long-term survival outcomes and risk factors. Results: There were significant different among four groups in pathological grading, histological type, AJCC stage, current standard (>= 12 lymph nodes retrieval), mean number of lymph nodes examined and positive lymph nodes (p<0.001). The 5-year cause specific survival was 71.0% in group 1, 75.1% in group 2, 80.6% in group 3 and 82.5% in group 4, which had significant difference in both univariate (P = 0.002) and multivariate analysis (P = 0.041). Conclusions: Young patients with colon cancer at age 18-40 years are essentially a heterogeneous group. Patients at age 31-35, 36-40 subgroups have more favorable clinicopathologic characteristics and better cancer specific survival than below 30 years.	[Li, Qingguo; Zhuo, Changhua; Cai, Guoxiang; Zheng, Hongtu; Li, Dawei; Cai, SanJun] Fudan Univ, Dept Colorectal Surg, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Li, Qingguo; Zhuo, Changhua; Cai, Guoxiang; Zheng, Hongtu; Li, Dawei; Cai, SanJun] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Li, DW (corresponding author), Fudan Univ, Dept Colorectal Surg, Shanghai Canc Ctr, Shanghai 200433, Peoples R China.	18918298120@163.com; caisanjun_sh@163.com	ZHUO, CHANGHUA/H-7592-2012	ZHUO, CHANGHUA/0000-0002-5900-9048	National Natural Science Foundation of China [81001055, 81101586]; Shanghai Pujiang Program [13PJD008]; National High Technology Research and Development Program (863 Program) [2012AA02A506]; Shanghai Shenkang Program [SHDC12012120]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); National High Technology Research and Development Program (863 Program)(National High Technology Research and Development Program of China); Shanghai Shenkang Program	This study was supported by grants from the National Natural Science Foundation of China (No. 81001055; 81101586), Shanghai Pujiang Program (No. 13PJD008), National High Technology Research and Development Program (863 Program, No. 2012AA02A506) and Shanghai Shenkang Program (No. SHDC12012120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders CK, 2008, J CLIN ONCOL, V26, P3324, DOI 10.1200/JCO.2007.14.2471; Ben-Ishay O, 2013, ISR MED ASSOC J, V15, P284; Cusack JC, 1996, J AM COLL SURGEONS, V183, P105; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Gao P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035021; Golan T, 2013, CANCER-AM CANCER SOC, V119, P3084, DOI 10.1002/cncr.28143; Gondos A, 2013, INT J CANCER, V133, P2207, DOI 10.1002/ijc.28231; Kam M H, 2004, Colorectal Dis, V6, P191, DOI 10.1111/j.1463-1318.2004.00596.x; Kaplan MA, 2013, J PEDIAT HEMATOL ONC, V35, P83, DOI 10.1097/MPH.0b013e31827e7f20; Karsten B, 2008, AM SURGEON, V74, P973; Li M, 2011, J SURG RES, V167, P231, DOI 10.1016/j.jss.2010.10.040; Li Q, 2014, PLOS ONE, V9; MARBLE K, 1992, J SURG ONCOL, V51, P179, DOI 10.1002/jso.2930510311; Mitry E, 2001, DIS COLON RECTUM, V44, P380, DOI 10.1007/BF02234737; Neufeld D, 2009, TECH COLOPROCTOL, V13, P201, DOI 10.1007/s10151-009-0501-7; O'Connell JB, 2004, AM J SURG, V187, P343, DOI 10.1016/j.amjsurg.2003.12.020; O'Connell JB, 2003, AM SURGEON, V69, P866; Schellerer VS, 2012, INT J COLORECTAL DIS, V27, P71, DOI 10.1007/s00384-011-1291-8; TAYLOR MC, 1988, CAN J SURG, V31, P150; You YN, 2012, ARCH INTERN MED, V172, P287, DOI 10.1001/archinternmed.2011.602	20	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e102004	10.1371/journal.pone.0102004	http://dx.doi.org/10.1371/journal.pone.0102004			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003760	gold, Green Published, Green Submitted			2022-12-27	WOS:000339242700098
J	Wei, KF; Chen, YH; Lin, YN; Pan, YT				Wei, Kaifa; Chen, Yanhui; Lin, Yina; Pan, Yutian			Genetic Dynamic Analysis of the Influenza A H5N1 NS1 Gene in China	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL-3-KINASE PI3K; PHOSPHOINOSITIDE 3-KINASE; AIRBORNE TRANSMISSION; HEMAGGLUTININ GENE; STRUCTURAL BASIS; BETA-INTERFERON; RNA-BINDING; VIRUS; PROTEIN; VIRULENCE	The direct precursors of the A/Goose/Guangdong/1/1996 (GS/GD) virus lineage and its reassortants have been established geographically and ecologically. To investigate the variation and evolutionary dynamics of H5N1 viruses, whole-genome viral sequences (n = 164) were retrieved from the NCBI Influenza Virus Resource. Here, we present phylogenetic evidence for intrasubtype reassortments among H5N1 viruses isolated from China during 1996-2012. On the basis of phylogenetic analysis, we identified four major groups and further classified the reassortant viruses into three subgroups. Putative mosaic structures were mostly found in the viral ribonucleoprotein (vRNP) complexes and 91.0% (10/11) mosaics were obtained from terrestrial birds. Sequence variability and selection pressure analyses revealed that both surface glycoproteins (HA and NA) and nonstructural protein 1 (NS1) have higher dN/dS ratio and variability than other internal proteins. Furthermore, we detected 47 positively selected sites in genomic segments with the exception of PB2 and M1 genes. Hemagglutinin (HA) and neuraminidase (NA) are considered highly variable due to host immune pressure, however, it is not known what drives NS1 variability. Therefore, we performed a thorough analysis of the genetic variation and selective pressure of NS1 protein (462 available NS1 sequences). We found that most of positively selected sites and variable amino acids were located in the C-terminal effector domain (ED) of NS1. In addition, we focused on the NS1-RNA and NS1-protein interactions that were involved in viral replication mechanisms and host immune response. Transcriptomic analysis of H5N1-infected monkey lungs showed that certain PI3K-related genes were up-regulated.	[Wei, Kaifa; Lin, Yina] Minnan Normal Univ, Sch Biol Sci & Biotechnol, Zhangzhou, Peoples R China; [Chen, Yanhui] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Pan, Yutian] Minnan Normal Univ, Engn Technol Ctr Mushroom Ind, Zhangzhou, Peoples R China	MinNan Normal University; Tsinghua University; MinNan Normal University	Wei, KF (corresponding author), Minnan Normal Univ, Sch Biol Sci & Biotechnol, Zhangzhou, Peoples R China.	kaifa-wei@163.com; xmpyt@sina.com						AGUADE M, 1989, GENETICS, V122, P607; Aragon T, 2000, MOL CELL BIOL, V20, P6259, DOI 10.1128/MCB.20.17.6259-6268.2000; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Burgui I, 2003, J GEN VIROL, V84, P3263, DOI 10.1099/vir.0.19487-0; Carrillo B, 2014, J VIROL, V88, P4113, DOI 10.1128/JVI.03692-13; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Chen RB, 2006, MOL BIOL EVOL, V23, P2336, DOI 10.1093/molbev/msl102; Cheng A, 2009, CELL RES, V19, P187, DOI 10.1038/cr.2008.288; Das K, 2008, P NATL ACAD SCI USA, V105, P13093, DOI 10.1073/pnas.0805213105; Das K, 2010, NAT STRUCT MOL BIOL, V17, P530, DOI 10.1038/nsmb.1779; Donelan NR, 2003, J VIROL, V77, P13257, DOI 10.1128/JVI.77.24.13257-13266.2003; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fan SF, 2013, J VIROL, V87, P4861, DOI 10.1128/JVI.02608-12; GRIBSKOV M, 1986, NUCLEIC ACIDS RES, V14, P6745, DOI 10.1093/nar/14.16.6745; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; He CQ, 2009, MOL BIOL EVOL, V26, P177, DOI 10.1093/molbev/msn238; Heath L, 2006, J VIROL, V80, P11827, DOI 10.1128/JVI.01100-06; Heikkinen LS, 2008, J BIOL CHEM, V283, P5719, DOI 10.1074/jbc.M707195200; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Holmes E, 2003, J GEN VIROL, V84, P2691, DOI 10.1099/vir.0.19277-0; Hrincius ER, 2011, CELL MICROBIOL, V13, P1907, DOI 10.1111/j.1462-5822.2011.01680.x; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; Koyasu S, 2003, NAT IMMUNOL, V4, P313, DOI 10.1038/ni0403-313; Krug RM, 2003, VIROLOGY, V309, P181, DOI 10.1016/S0042-6822(03)00119-3; Kuo RL, 2009, J VIROL, V83, P1611, DOI 10.1128/JVI.01491-08; Lam TTY, 2013, INFECT GENET EVOL, V18, P367, DOI 10.1016/j.meegid.2013.03.015; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Li WZ, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-36; Li WF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-183; Li Y, 2008, J BIOL CHEM, V283, P23397, DOI 10.1074/jbc.M802737200; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Linster M, 2014, CELL, V157, DOI 10.1016/j.cell.2014.02.040; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matsuda M, 2010, BIOCHEM BIOPH RES CO, V395, P312, DOI 10.1016/j.bbrc.2010.03.166; Miled N, 2007, SCIENCE, V317, P239, DOI 10.1126/science.1135394; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; Munir M, 2011, J GEN VIROL, V92, P2111, DOI 10.1099/vir.0.031716-0; NEI M, 1986, MOL BIOL EVOL, V3, P418; Neumann G, 2010, CELL RES, V20, P51, DOI 10.1038/cr.2009.124; Neverov AD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004037; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rubio L, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00151; Shi WF, 2008, SCI CHINA SER C, V51, P987, DOI 10.1007/s11427-008-0131-8; Shin YK, 2007, J GEN VIROL, V88, P13, DOI 10.1099/vir.0.82419-0; Shinya K, 2012, J VIROL, V86, P6055, DOI 10.1128/JVI.00365-12; Simon-Loriere E, 2011, NAT REV MICROBIOL, V9, P617, DOI 10.1038/nrmicro2614; SIMONSEN KL, 1995, GENETICS, V141, P413; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tamuri AU, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000564; Ueki K, 2003, J BIOL CHEM, V278, P48453, DOI 10.1074/jbc.M305602200; Wang J, 2008, J Virol, V82, P3405, DOI 10.1128/JVI.02468-07; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wei KF, 2012, J CELL BIOCHEM, V113, P2576, DOI 10.1002/jcb.24133; Wei KF, 2013, VET MICROBIOL, V167, P383, DOI 10.1016/j.vetmic.2013.09.030; Wei KF, 2013, CHINESE J CANCER RES, V25, P430, DOI 10.3978/j.issn.1000-9604.2013.08.13; Wei KF, 2012, DNA RES, V19, P463, DOI 10.1093/dnares/dss026; Wei KF, 2012, VIRUS GENES, V44, P450, DOI 10.1007/s11262-012-0717-x; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zhang DG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-170; Zielecki F, 2010, J VIROL, V84, P10708, DOI 10.1128/JVI.00610-10	77	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101384	10.1371/journal.pone.0101384	http://dx.doi.org/10.1371/journal.pone.0101384			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003973	Green Published, Green Submitted, gold			2022-12-27	WOS:000339242700027
J	Abildgaard, J; Henstridge, DC; Pedersen, AT; Langley, KG; Scheele, C; Pedersen, BK; Lindegaard, B				Abildgaard, Julie; Henstridge, Darren C.; Pedersen, Anette T.; Langley, Katherine G.; Scheele, Camilla; Pedersen, Bente Klarlund; Lindegaard, Birgitte			In Vitro Palmitate Treatment of Myotubes from Postmenopausal Women Leads to Ceramide Accumulation, Inflammation and Affected Insulin Signaling	PLOS ONE			English	Article							SKELETAL-MUSCLE CELLS; ACTIVATED PROTEIN-KINASE; METABOLIC SYNDROME; ENERGY-EXPENDITURE; OXIDATIVE STRESS; FAT OXIDATION; CARDIOVASCULAR-DISEASE; LIPID DEPOSITION; GLUCOSE-UPTAKE; RESISTANCE	Menopause is associated with an increased incidence of insulin resistance and metabolic diseases. In a chronic palmitate treatment model, we investigated the role of skeletal muscle fatty acid exposure in relation to the metabolic deterioration observed with menopause. Human skeletal muscle satellite cells were isolated from premenopausal (n = 6) and postmenopausal (n = 5) women. In an in vitro model, the myotubes were treated with palmitate (300 mu M) for one-, two-or three days during differentiation. Effects on lipid accumulation, inflammation and insulin signaling were studied. Palmitate treatment led to a 108% (CI 95%: 50%; 267%) increase in intramyocellular ceramide in the myotubes from the postmenopausal women (post-myotubes) compared with a 26% (CI 95%: -57%; 96%) increase in myotubes from the premenopausal women (pre-myotubes), (p<0.05). Furthermore, post-myotubes had a 22% (CI 95%: 4%; 34%) increase in pJNK (p = 0.04) and a 114% (CI 95%: 50%; 177%) increase in Hsp70 protein expression (p = 0.03) after three days of palmitate treatment, compared with pre-myotubes, in which no increase in either pJNK (-12% (CI 95: -26%; 2%)) or Hsp70 (7% (CI 95: -78%; 91%)) was detected. Furthermore, post-myotubes showed a blunted insulin stimulated phosphorylation of AS160 in response to chronic palmitate treatment compared with pre-myotubes (p = 0.02). The increased intramyocellular ceramide content in the post-myotubes was associated with a significantly higher mRNA expression of Serine Palmitoyltransferase1 (SPT1) after one day of palmitate treatment (p = 0.03) in post-myotubes compared with pre-myotubes. Our findings indicate that post-myotubes are more prone to develop lipid accumulation and defective insulin signaling following chronic saturated fatty acid exposure as compared to pre-myotubes.	[Abildgaard, Julie; Scheele, Camilla; Pedersen, Bente Klarlund; Lindegaard, Birgitte] Ctr Inflammat & Metab, Copenhagen, Denmark; [Abildgaard, Julie; Scheele, Camilla; Pedersen, Bente Klarlund; Lindegaard, Birgitte] Ctr Phys Act Res, Dept Infect Dis, Copenhagen, Denmark; [Abildgaard, Julie; Scheele, Camilla; Pedersen, Bente Klarlund; Lindegaard, Birgitte] CMRC, Copenhagen, Denmark; [Henstridge, Darren C.; Langley, Katherine G.] Baker IDI Heart & Diabet Inst, Cellular & Mol Metab Lab, Melbourne, Vic, Australia; [Pedersen, Anette T.] Rigshosp, Dept Gynaecol, DK-2100 Copenhagen, Denmark	Baker Heart and Diabetes Institute; Rigshospitalet; University of Copenhagen	Lindegaard, B (corresponding author), Ctr Inflammat & Metab, Copenhagen, Denmark.	birgitte.lindegaard@rh.regionh.dk	Lindegaard, Birgitte/AGY-9629-2022; Pedersen, Bente Klarlund/AGR-3217-2022; Scheele, Camilla/S-6401-2017; Scheele, Camilla/AAA-3599-2020; Abildgaard, Julie/ABB-2325-2020	Pedersen, Bente Klarlund/0000-0001-6508-6288; Scheele, Camilla/0000-0002-6055-9709; Scheele, Camilla/0000-0002-6055-9709; Abildgaard, Julie/0000-0003-1317-7051; Lindegaard, Birgitte/0000-0002-5236-8427	Danish National Research Foundation [DNRF55]; Trygfonden; Augustinusfonden; Danish Ministry of Science, Technology, and Innovation; Danish Council for Strategic Research [09-067009, 09-075724]; Capital Region of Denmark	Danish National Research Foundation(Danmarks Grundforskningsfond); Trygfonden; Augustinusfonden; Danish Ministry of Science, Technology, and Innovation; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Capital Region of Denmark	The Centre of Inflammation and Metabolism (CIM) is supported by a grant from the Danish National Research Foundation (DNRF55). The Centre for Physical Activity Research is supported by a grant from Trygfonden. This study was further supported by grants from Augustinusfonden. CIM is part of the UNIK Project: Food, Fitness & Pharma for Health and Disease, supported by the Danish Ministry of Science, Technology, and Innovation. CIM is a member of DD2 - the Danish Center for Strategic Research in Type 2 Diabetes (the Danish Council for Strategic Research, grant no. 09-067009 and 09-075724). The Copenhagen Muscle Research Centre is supported by a grant from the Capital Region of Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abildgaard J, 2013, AM J PHYSIOL-ENDOC M, V304, pE1227, DOI 10.1152/ajpendo.00492.2012; Adams JM, 2004, DIABETES, V53, P25, DOI 10.2337/diabetes.53.1.25; Aguer C, 2010, DIABETOLOGIA, V53, P1151, DOI 10.1007/s00125-010-1708-x; Amati F, 2011, DIABETES, V60, P2588, DOI 10.2337/db10-1221; Atsma F, 2006, MENOPAUSE, V13, P265, DOI 10.1097/01.gme.0000218683.97338.ea; Austin RL, 2008, DIABETES, V57, P2066, DOI 10.2337/db07-0763; BARON AD, 1988, AM J PHYSIOL, V255, pE769, DOI 10.1152/ajpendo.1988.255.6.E769; Boon J, 2013, DIABETES, V62, P401, DOI 10.2337/db12-0686; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruce CR, 2003, DIABETES, V52, P2338, DOI 10.2337/diabetes.52.9.2338; Cavalcanti-de-Albuquerque JP, 2014, J APPL PHYSL, V00121; Choi CS, 2007, P NATL ACAD SCI USA, V104, P16480, DOI 10.1073/pnas.0706794104; Chung J, 2008, P NATL ACAD SCI USA, V105, P1739, DOI 10.1073/pnas.0705799105; Coll T, 2008, J BIOL CHEM, V283, P11107, DOI 10.1074/jbc.M708700200; Corcoran MP, 2007, AM J CLIN NUTR, V85, P662; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; Douchi T, 2003, J BONE MINER METAB, V21, P17, DOI 10.1007/s007740300003; Ellis S, 2000, J HISTOCHEM CYTOCHEM, V48, P321, DOI 10.1177/002215540004800302; Green CJ, 2011, DIABETES, V60, P2810, DOI 10.2337/db11-0263; Green CJ, 2013, J PHYSL; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Jackson KC, 2013, AM J PHYSIOL-REG I, V304, pR206, DOI 10.1152/ajpregu.00428.2012; Janssen I, 2008, ARCH INTERN MED, V168, P1568, DOI 10.1001/archinte.168.14.1568; Korytkowski MT, 2005, METABOLISM, V54, P1626, DOI 10.1016/j.metabol.2005.06.011; Lansey MN, 2012, AM J PHYSIOL-ENDOC M, V303, pE1273, DOI 10.1152/ajpendo.00316.2012; Lovejoy JC, 2008, INT J OBESITY, V32, P949, DOI 10.1038/ijo.2008.25; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; Matthews VB, 2010, DIABETOLOGIA, V53, P2431, DOI 10.1007/s00125-010-1865-y; Meriin AB, 1999, MOL CELL BIOL, V19, P2547; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Park YW, 2003, ARCH INTERN MED, V163, P427, DOI 10.1001/archinte.163.4.427; Pimenta AS, 2008, J CELL PHYSIOL, V217, P478, DOI 10.1002/jcp.21520; Powell DJ, 2004, BIOCHEM J, V382, P619, DOI 10.1042/BJ20040139; Prasannarong M, 2012, BBA-MOL BASIS DIS, V1822, P1051, DOI 10.1016/j.bbadis.2012.02.018; Ravussin E, 2002, ANN NY ACAD SCI, V967, P363; Reynolds CP, 2004, CANCER LETT, V206, P169, DOI 10.1016/j.canlet.2003.08.034; Rincon J, 1996, DIABETES, V45, P615, DOI 10.2337/diabetes.45.5.615; Roden M, 2000, DIABETES, V49, P701, DOI 10.2337/diabetes.49.5.701; Schrauwen P, 2010, BBA-MOL CELL BIOL L, V1801, P266, DOI 10.1016/j.bbalip.2009.09.011; Steinberg GR, 2006, CELL METAB, V4, P465, DOI 10.1016/j.cmet.2006.11.005; Stern MP, 2004, DIABETES CARE, V27, P2676, DOI 10.2337/diacare.27.11.2676; Straczkowski M, 2004, DIABETES, V53, P1215, DOI 10.2337/diabetes.53.5.1215; Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002; SVENDSEN OL, 1995, METABOLISM, V44, P369, DOI 10.1016/0026-0495(95)90168-X; Tang DL, 2007, J IMMUNOL, V178, P7376, DOI 10.4049/jimmunol.178.11.7376; Turpin SM, 2006, AM J PHYSIOL-ENDOC M, V291, pE1341, DOI 10.1152/ajpendo.00095.2006; Urakawa H, 2003, J CLIN ENDOCR METAB, V88, P4673, DOI 10.1210/jc.2003-030202; Ussher JR, 2010, DIABETES, V59, P2453, DOI 10.2337/db09-1293; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Wang HY, 2013, BIOCHEM J, V449, P479, DOI 10.1042/BJ20120702; Yuzefovych L, 2010, AM J PHYSIOL-ENDOC M, V299, pE1096, DOI 10.1152/ajpendo.00238.2010; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857; ZURLO F, 1990, AM J PHYSIOL, V259, pE650	54	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101555	10.1371/journal.pone.0101555	http://dx.doi.org/10.1371/journal.pone.0101555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000528	Green Published, Green Submitted, gold			2022-12-27	WOS:000338637300055
J	Melchior, C; Loeuillard, E; Marion-Letellier, R; Nicol, L; Mulder, P; Guerin, C; Bole-Feysot, C; Aziz, M; Dechelotte, P; Vera, P; Savoye, G; Savoye-Collet, C				Melchior, Chloe; Loeuillard, Emilien; Marion-Letellier, Rachel; Nicol, Lionel; Mulder, Paul; Guerin, Charlene; Bole-Feysot, Christine; Aziz, Moutaz; Dechelotte, Pierre; Vera, Pierre; Savoye, Guillaume; Savoye-Collet, Celine			Magnetic Resonance Colonography for Fibrosis Assessment in Rats with Chronic Colitis	PLOS ONE			English	Article							INTESTINAL FIBROSIS; CROHNS-DISEASE; INFLAMMATION; RESPONSES; COX-2; MODEL; MRI	Background: Magnetic resonance colonography (MRC) has been developed to assess inflammatory bowel diseases. We aimed to assess the feasibility of MRC in rats with TNBS-induced chronic colitis and to confront imaging results with fibrosis and stenosing features of the model. Materials and Methods: Chronic colitis was induced in 12 rats by weekly intra-rectal injection of increasing doses of TNBS for 6 weeks, while 8 control rats received the vehicle. At week 7, MRC was performed. Fibrosis scores were assessed and fibrosis mediators measured. Results: Chronic colitis was associated with significant body weight loss (p<0.0001) and higher colon weight/length compared to controls (p = 0.0004). Fibrosis mediators and histological scores were significantly higher in rats with TNBS than in controls: alpha-SMA expression (0.9 versus 0.61, p = 0.0311) and fibrosis score (p = 0.0308). Colon wall thickness was higher in rats with TNBS than in controls: maximal thickness (2.38 versus 0.74 mm, p<0.0001) and minimal thickness (1.33 versus 0.48 mm, p<0.0001). Wall signal intensity on T2w images was higher in rats with TNBS than in controls (9040 versus 6192, p = 0.0101) and correlated with fibrosis score (r = 0.5214; p = 0.04). Luminal narrowing was higher in rats with TNBS (50.08 versus 10.33%, p<0.0001) and correlated with a-SMA expression (r = 0.5618; p = 0.01). Stenosis was observed in 7/9 rats with TNBS and in no controls (p = 0.0053). Conclusions: MRC is feasible and easily distinguishes rats with colitis from controls. MRC signs correlated with fibrosis parameters. MRC evaluation may be part of a new anti-fibrosis drug assessment in experimental models of chronic colitis.	[Melchior, Chloe; Loeuillard, Emilien; Marion-Letellier, Rachel; Guerin, Charlene; Bole-Feysot, Christine; Dechelotte, Pierre; Savoye, Guillaume] Univ Rouen, Inst Biomed Res, INSERM, UMR 1073, Rouen, France; [Melchior, Chloe; Savoye, Guillaume] Rouen Univ Hosp, Dept Gastroenterol, Rouen, France; [Nicol, Lionel; Mulder, Paul] Univ Rouen, Inst Biomed Res, INSERM, U644, Rouen, France; [Aziz, Moutaz] Rouen Univ Hosp, Dept Pathol, Rouen, France; [Dechelotte, Pierre] Rouen Univ Hosp, Dept Nutr, Rouen, France; [Vera, Pierre; Savoye-Collet, Celine] Rouen Univ Hosp, Dept Radiol, Rouen, France; [Vera, Pierre; Savoye-Collet, Celine] Univ Rouen, QUANTIF LITIS EA 4108, Rouen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; CHU de Rouen; CHU de Rouen; CHU de Rouen; Universite de Rouen Normandie	Marion-Letellier, R (corresponding author), Univ Rouen, Inst Biomed Res, INSERM, UMR 1073, Rouen, France.	marion_rachel@hotmail.com	Marion-Letellier, Rachel/ABB-8213-2021	Marion-Letellier, Rachel/0000-0002-3006-5943; Mulder, Paul/0000-0002-5936-5704; Loeuillard, Emilien/0000-0002-3650-8100; Melchior, Chloe/0000-0002-8146-1540; Savoye, Guillaume/0000-0002-9200-2067	MSD (Merck Sharp and Dohme)	MSD (Merck Sharp and Dohme)(Merck & Company)	This work was supported by a grant from MSD (Merck Sharp and Dohme). The authors state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2013, INFLAMM BOWEL DIS, V19, P683, DOI 10.1097/MIB.0b013e3182802c32; Adler J, 2011, RADIOLOGY, V259, P127, DOI 10.1148/radiol.10091648; Breynaert C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068876; Burke JP, 2007, AM J GASTROENTEROL, V102, P439, DOI 10.1111/j.1572-0241.2006.01010.x; Charpentier C, 2012, INFLAMM BOWEL DIS, V18, P1940, DOI 10.1002/ibd.22897; Cosnes J, 2005, GUT, V54, P237, DOI 10.1136/gut.2004.045294; Cosnes Jacques, 2013, Gastroenterol Hepatol (N Y), V9, P103; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; Fiocchi C, 2011, AM J PHYSIOL-GASTR L, V300, pG677, DOI 10.1152/ajpgi.00104.2011; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Hassan A, 2010, J NUTR, V140, P1714, DOI 10.3945/jn.109.119768; Ibrahim A, 2011, CLIN NUTR, V30, P678, DOI 10.1016/j.clnu.2011.05.002; Kohnke T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/748160; Liu F, 2010, J CELL BIOL, V190, P693, DOI 10.1083/jcb.201004082; Mansson LE, 2012, AM J PHYSIOL-GASTR L, V303, pG311, DOI 10.1152/ajpgi.00038.2012; Mbodji K, 2013, J NUTR BIOCHEM, V24, P700, DOI 10.1016/j.jnutbio.2012.03.022; Michael S, 2013, INFLAMM BOWEL DIS, V19, P185, DOI 10.1002/ibd.23006; MORRIS GP, 1989, GASTROENTEROLOGY, V96, P795, DOI 10.1016/0016-5085(89)90904-9; Mustafi D, 2010, MAGN RESON MED, V63, P922, DOI 10.1002/mrm.22229; Ordas I, 2011, GASTROENTEROLOGY, V140, pS73; Panes J, 2011, ALIMENT PHARM THER, V34, P125, DOI 10.1111/j.1365-2036.2011.04710.x; Pariente B, 2011, INFLAMM BOWEL DIS, V17, P1415, DOI 10.1002/ibd.21506; Peyrin-Biroulet L, 2012, AM J GASTROENTEROL, V107, P1693, DOI 10.1038/ajg.2012.298; Richert ND, 1999, NEUROLOGY, V53, pS29; Rieder F, 2011, AM J PATHOL, V179, P2660, DOI 10.1016/j.ajpath.2011.07.042; Rieder F, 2009, NAT REV GASTRO HEPAT, V6, P228, DOI 10.1038/nrgastro.2009.31; Rimola J, 2009, GUT, V58, P1113, DOI 10.1136/gut.2008.167957; Rimola J, 2011, INFLAMM BOWEL DIS, V17, P1759, DOI 10.1002/ibd.21551; Savoye-Collet C, 2011, INFLAMM BOWEL DIS, V17, P1751, DOI 10.1002/ibd.21568; Stidham RW, 2011, GASTROENTEROLOGY, V141, P819, DOI 10.1053/j.gastro.2011.07.027	30	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e100921	10.1371/journal.pone.0100921	http://dx.doi.org/10.1371/journal.pone.0100921			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000184	Green Published, gold, Green Submitted			2022-12-27	WOS:000338637300019
J	Zambuzzi, WF; Bonfante, EA; Jimbo, R; Hayashi, M; Andersson, M; Alves, G; Takamori, ER; Beltrao, PJ; Coelho, PG; Granjeiro, JM				Zambuzzi, Willian F.; Bonfante, Estevam A.; Jimbo, Ryo; Hayashi, Mariko; Andersson, Martin; Alves, Gutemberg; Takamori, Esther R.; Beltrao, Paulo J.; Coelho, Paulo G.; Granjeiro, Jose M.			Nanometer Scale Titanium Surface Texturing Are Detected by Signaling Pathways Involving Transient FAK and Src Activations	PLOS ONE			English	Article							PHOSPHATE-COATED IMPLANTS; OSTEOBLAST ADHESION; IN-VIVO; ENHANCED OSSEOINTEGRATION; BONE INTEGRATION; BEHAVIOR; CELLS; DIFFERENTIATION; ORGANIZATION; FIBRONECTIN	Background: It is known that physico/chemical alterations on biomaterial surfaces have the capability to modulate cellular behavior, affecting early tissue repair. Such surface modifications are aimed to improve early healing response and, clinically, offer the possibility to shorten the time from implant placement to functional loading. Since FAK and Src are intracellular proteins able to predict the quality of osteoblast adhesion, this study evaluated the osteoblast behavior in response to nanometer scale titanium surface texturing by monitoring FAK and Src phosphorylations. Methodology: Four engineered titanium surfaces were used for the study: machined (M), dual acid-etched (DAA), resorbable media microblasted and acid-etched (MBAA), and acid-etch microblasted (AAMB). Surfaces were characterized by scanning electron microscopy, interferometry, atomic force microscopy, x-ray photoelectron spectroscopy and energy dispersive X-ray spectroscopy. Thereafter, those 4 samples were used to evaluate their cytotoxicity and interference on FAK and Src phosphorylations. Both Src and FAK were investigated by using specific antibody against specific phosphorylation sites. Principal Findings: The results showed that both FAK and Src activations were differently modulated as a function of titanium surfaces physico/chemical configuration and protein adsorption. Conclusions: It can be suggested that signaling pathways involving both FAK and Src could provide biomarkers to predict osteoblast adhesion onto different surfaces.	[Zambuzzi, Willian F.] Univ Estadual Paulista, UNESP, Inst Biociencias, Dept Quim & Bioquim, Sao Paulo, Brazil; [Bonfante, Estevam A.] Univ Sao Paulo, Fac Odontol Bauru, Sao Paulo, Brazil; [Jimbo, Ryo; Hayashi, Mariko] Malmo Univ, Fac Odontol, Dept Prosthodont, Malmo, Sweden; [Andersson, Martin] Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden; [Alves, Gutemberg] Univ Fed Fluminense, Dept Cell & Mol Biol, Inst Biol, Niteroi, RJ, Brazil; [Takamori, Esther R.] Excell Biomed Serv, Rio De Janeiro, Brazil; [Beltrao, Paulo J.; Granjeiro, Jose M.] Natl Inst Metrol Qual & Technol INMETRO, Rio De Janeiro, Brazil; [Coelho, Paulo G.] NYU, Coll Dent, Dept Biomat & Biomimet, New York, NY USA	Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade de Sao Paulo; Malmo University; Chalmers University of Technology; Universidade Federal Fluminense; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); New York University	Zambuzzi, WF (corresponding author), Univ Estadual Paulista, UNESP, Inst Biociencias, Dept Quim & Bioquim, Sao Paulo, Brazil.	wzambuzzi@ibb.unesp.br; jmgranjeiro@inmetro.gov.br	Bonfante, Estevam/F-7238-2012; Zambuzzi, Willian/ABD-8339-2020; Zambuzzi, Willian Fernando/F-9519-2012; Coelho, Paulo G/B-2999-2014; Alves, Gutemberg G/E-2742-2013; Granjeiro, Jose/D-8289-2012	Bonfante, Estevam/0000-0001-6867-8350; Zambuzzi, Willian Fernando/0000-0002-4149-5965; Coelho, Paulo G/0000-0001-8347-6124; Alves, Gutemberg G/0000-0003-0016-4809; , Martin/0000-0003-1523-4697; Granjeiro, Jose/0000-0002-8027-8293; Miranda da Silva Iwakami Beltrao, Paulo Jose/0000-0002-2449-248X	Fapesp; CNPq; Faperj	Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Faperj(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This study was funded by Fapesp, CNPq and Faperj. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertazzo S, 2009, CLIN ORAL IMPLAN RES, V20, P288, DOI 10.1111/j.1600-0501.2008.01642.x; Bertazzo S, 2010, CLIN ORAL IMPLAN RES, V21, P1411, DOI 10.1111/j.1600-0501.2010.01968.x; Chuang SK, 2006, J DENT RES, V85, P1147, DOI 10.1177/154405910608501216; Coelho PG, 2009, J BIOMED MATER RES B, V88B, P579, DOI 10.1002/jbm.b.31264; Cooper LF, 2006, BIOMATERIALS, V27, P926, DOI 10.1016/j.biomaterials.2005.07.009; Malaspina TSD, 2009, ARCH ORAL BIOL, V54, P642, DOI 10.1016/j.archoralbio.2009.03.011; Esposito M, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003815.pub3; Frojd V, 2008, INT J ORAL MAX SURG, V37, P561, DOI 10.1016/j.ijom.2008.01.020; Gemini-Piperni S, 2014, BIOTECHNOL BIOENG, V111, P1900, DOI 10.1002/bit.25246; Hoemann CD, 2009, PATHOL BIOL, V57, P318, DOI 10.1016/j.patbio.2008.06.004; Jimbo R, 2012, J DENT RES, V91, P1172, DOI 10.1177/0022034512463240; Jimbo R, 2011, J DENT RES, V90, P1422, DOI 10.1177/0022034511422911; Jimbo R, 2008, CLIN IMPLANT DENT R, V10, P55, DOI 10.1111/j.1708-8208.2007.00061.x; Jimbo R, 2007, BIOMATERIALS, V28, P3469, DOI 10.1016/j.biomaterials.2007.04.029; Jimbo R, 2011, ACTA BIOMATER, V7, P4229, DOI 10.1016/j.actbio.2011.07.017; Lamolle SF, 2009, BIOMATERIALS, V30, P736, DOI 10.1016/j.biomaterials.2008.10.052; Luthen F, 2005, BIOMATERIALS, V26, P2423, DOI 10.1016/j.biomaterials.2004.07.054; Marin C, 2012, CLIN ORAL IMPLAN RES, V23, P119, DOI 10.1111/j.1600-0501.2010.02155.x; Meirelles L, 2008, INT J ORAL MAX IMPL, V23, P641; Milani R, 2010, J CELL BIOCHEM, V109, P957, DOI 10.1002/jcb.22479; Monjo M, 2008, BIOMATERIALS, V29, P3771, DOI 10.1016/j.biomaterials.2008.06.001; Monjo M, 2012, INT J BIOMATER, V2012, DOI 10.1155/2012/181024; Raes F, 2012, CLIN ORAL IMPLAN RES, V23, P602, DOI 10.1111/j.1600-0501.2011.02178.x; Saruwatari L, 2005, J BONE MINER RES, V20, P2002, DOI 10.1359/JBMR.050703; Sawase T, 2008, CLIN ORAL IMPLAN RES, V19, P491, DOI 10.1111/j.1600-0501.2007.01509.x; Shapira L, 2009, CLIN ORAL IMPLAN RES, V20, P50, DOI 10.1111/j.1600-0501.2008.01594.x; Sommerfeldt DW, 2001, BIOCHEM BIOPH RES CO, V285, P355, DOI 10.1006/bbrc.2001.5198; Sul YT, 2010, INT J NANOMED, V5, P87; Wei JW, 2012, J CELL BIOL, V197, P509, DOI 10.1083/jcb.201201057; Wennerberg A, 2010, INT J ORAL MAX IMPL, V25, P63; Wennerberg A, 2009, ACTA ODONTOL SCAND, V67, P333, DOI 10.1080/00016350903188325; Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x; Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1; WLODARSKI KH, 1986, CALCIFIED TISSUE INT, V39, P382, DOI 10.1007/BF02555175; Yang Q, 2011, J BONE MINER RES, V26, P1188, DOI 10.1002/jbmr.337; Zambuzzi WF, 2011, J BIOMED MATER RES A, V97A, P193, DOI 10.1002/jbm.a.32933; Zambuzzi WF, 2010, BIOCHIMIE, V92, P327, DOI 10.1016/j.biochi.2010.01.002; Zambuzzi WF, 2009, J CELL BIOCHEM, V108, P134, DOI 10.1002/jcb.22236; Zhang WJ, 2013, BIOMATERIALS, V34, P3184, DOI 10.1016/j.biomaterials.2013.01.008	39	28	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e95662	10.1371/journal.pone.0095662	http://dx.doi.org/10.1371/journal.pone.0095662			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999733	gold, Green Published, Green Submitted			2022-12-27	WOS:000338637300002
J	Brooks, LR; Pals, HL; Enix, CL; Woolaver, RA; Paul, ED; Lowry, CA; Tsai, PS				Brooks, Leah R.; Pals, Heide L.; Enix, Courtney L.; Woolaver, Rachel A.; Paul, Evan D.; Lowry, Christopher A.; Tsai, Pei-San			Fibroblast Growth Factor 8 Deficiency Compromises the Functional Response of the Serotonergic System to Stress	PLOS ONE			English	Article							DORSAL RAPHE NUCLEUS; GONADOTROPIN-RELEASING-HORMONE; ANXIETY-LIKE BEHAVIOR; DIFFERENTIAL INVOLVEMENT; DEVELOPING MIDBRAIN; NEURONS; FGF8; MICE; EXPRESSION; RECEPTORS	Functionally heterogeneous populations of serotonergic neurons, located within the dorsal raphe nucleus (DR), play a role in stress-related behaviors and neuropsychiatric illnesses such as anxiety and depression. Abnormal development of these neurons may permanently alter their structure and connections, making the organism more susceptible to anxiety-related disorders. A factor that critically regulates the development of serotonergic neurons is fibroblast growth factor 8 (Fgf8). In this study, we used acute restraint stress followed by behavioral testing to examine whether Fgf8 signaling during development is important for establishing functional stress- and anxiety-related DR neurocircuits in adulthood. Wild-type and heterozygous male mice globally hypomorphic for Fgf8 were exposed to acute restraint stress and then tested for anxiety-like behavior on the elevated plus-maze. Further, we measured c-Fos immunostaining as a marker of serotonergic neuronal activation and tissue 5-hydroxyindoleacetic acid concentrations as a marker of serotonin functional output. Results showed that Fgf8 hypomorphs exhibited 1) an exaggerated response of DR anxiety-promoting circuits and 2) a blunted response of a DR panic-inhibiting circuit to stress, effects that together were associated with increased baseline anxiety-like behavior. Overall, our results provide a neural substrate upon which Fgf8 deficiency could affect stress response and support the hypothesis that developmental disruptions of serotonergic neurons affect their postnatal functional integrity.	[Brooks, Leah R.; Pals, Heide L.; Enix, Courtney L.; Woolaver, Rachel A.; Paul, Evan D.; Lowry, Christopher A.; Tsai, Pei-San] Univ Colorado, Integrat Physiol & Ctr Neurosci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Brooks, LR (corresponding author), Univ Colorado, Integrat Physiol & Ctr Neurosci, Boulder, CO 80309 USA.	leah.brooks@colorado.edu		Tsai, Pei-San/0000-0002-8650-647X; Paul, Evan/0000-0002-7011-8050	National Institutes of Health [R01 HD042634, R01 MH086539]; University of Colorado Boulder; Undergraduate Research Opportunities Program (UROP) Assistantship grants; Biological Undergraduate Research Skills & Training (BURST) grant from the Biological Sciences Initiative; UROP/Howard Hughes Medical Institute (HHMI) Individual Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado Boulder; Undergraduate Research Opportunities Program (UROP) Assistantship grants; Biological Undergraduate Research Skills & Training (BURST) grant from the Biological Sciences Initiative; UROP/Howard Hughes Medical Institute (HHMI) Individual Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health grants R01 HD042634 to PST and R01 MH086539 to CAL (http://www.nih.gov/). LRB was supported by a Sigma Xi Grants-in-Aid of Research (http://www.sigmaxi.org/programs/giar/) and a summer graduate school fellowship from the University of Colorado Boulder (http://www.colorado.edu/GraduateSchool/funding/). HLP, CLE, and RAW were supported by Undergraduate Research Opportunities Program (UROP) Assistantship grants (http://enrichment.colorado.edu/urop/). HLP was supported by a Biological Undergraduate Research Skills & Training (BURST) grant from the Biological Sciences Initiative, and CLE was supported by a UROP/Howard Hughes Medical Institute (HHMI) Individual Grant (http://enrichment.colorado.edu/urop/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams JK, 2005, NEUROSCIENCE, V133, P983, DOI 10.1016/j.neuroscience.2005.03.025; Bailey JD, 2006, J NEUROENDOCRINOL, V18, P1, DOI 10.1111/j.1365-2826.2005.01361.x; Bailey KR, 2007, PHARMACOL BIOCHEM BE, V86, P8, DOI 10.1016/j.pbb.2006.11.024; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Boxer AL, 1999, J NEUROPHYSIOL, V82, P3367, DOI 10.1152/jn.1999.82.6.3367; Brooks Leah R, 2014, Behav Brain Res, V264, P74, DOI 10.1016/j.bbr.2014.01.053; Brooks LR, 2010, ENDOCRINE, V38, P174, DOI 10.1007/s12020-010-9366-9; Celada P, 2001, J NEUROSCI, V21, P9917, DOI 10.1523/JNEUROSCI.21-24-09917.2001; Celada P, 2004, J PSYCHIATR NEUROSCI, V29, P252; Chi CL, 2003, DEVELOPMENT, V130, P2633, DOI 10.1242/dev.00487; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Evans AK, 2008, EUR J PHARMACOL, V590, P136, DOI 10.1016/j.ejphar.2008.06.014; Falardeau J, 2008, J CLIN INVEST, V118, P2822, DOI 10.1172/JCI34538; Ferrer I, 1996, MOL BRAIN RES, V38, P91, DOI 10.1016/0169-328X(95)00334-O; Forster GL, 2008, EUR J NEUROSCI, V28, P299, DOI 10.1111/j.1460-9568.2008.06333.x; Gardner KL, 2009, NEUROSCIENCE, V163, P991, DOI 10.1016/j.neuroscience.2009.07.055; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Grahn RE, 1999, BRAIN RES, V826, P35, DOI 10.1016/S0006-8993(99)01208-1; Greenwood BN, 2008, PSYCHOPHARMACOLOGY, V199, P209, DOI 10.1007/s00213-008-1167-y; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Hale MW, 2012, CELL MOL NEUROBIOL, V32, P695, DOI 10.1007/s10571-012-9827-1; Hale MW, 2011, J CHEM NEUROANAT, V41, P219, DOI 10.1016/j.jchemneu.2011.05.002; Hale MW, 2011, EXP NEUROL, V227, P264, DOI 10.1016/j.expneurol.2010.11.012; Hale MW, 2011, PSYCHOPHARMACOLOGY, V213, P243, DOI 10.1007/s00213-010-2089-z; HEINRICHS SC, 1994, NEUROPSYCHOPHARMACOL, V11, P179, DOI 10.1038/sj.npp.1380104; Huffman KJ, 2004, J NEUROSCI, V24, P8917, DOI 10.1523/JNEUROSCI.2086-04.2004; Iwata T, 2009, DEV GROWTH DIFFER, V51, P299, DOI 10.1111/j.1440-169X.2009.01104.x; JAMES MD, 1989, NEUROENDOCRINOLOGY, V49, P561, DOI 10.1159/000125169; Jankowski MP, 2004, J COMP NEUROL, V468, P518, DOI 10.1002/cne.10976; Johnson PL, 2008, J PSYCHOPHARMACOL, V22, P642, DOI 10.1177/0269881107082900; Johnson PL, 2005, J PSYCHOPHARMACOL, V19, P327, DOI 10.1177/0269881105053281; Johnson PL, 2004, ANN NY ACAD SCI, V1018, P58, DOI 10.1196/annals.1296.006; Jukkola T, 2006, DEV BIOL, V297, P141, DOI 10.1016/j.ydbio.2006.05.002; Kirby LG, 1997, BRAIN RES, V760, P218, DOI 10.1016/S0006-8993(97)00287-4; Korte SM, 2003, EUR J PHARMACOL, V463, P163, DOI 10.1016/S0014-2999(03)01279-2; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leonardo ED, 2008, NEUROPSYCHOPHARMACOL, V33, P134, DOI 10.1038/sj.npp.1301569; Lowry CA, 2005, STRESS, V8, P233, DOI 10.1080/10253890500492787; Lowry CA, 2008, ANN NY ACAD SCI, V1148, P86, DOI 10.1196/annals.1410.004; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Maier SF, 2005, NEUROSCI BIOBEHAV R, V29, P829, DOI 10.1016/j.neubiorev.2005.03.021; MATTSON MP, 1989, J NEUROSCI, V9, P3728; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Neufeld-Cohen A, 2010, MOL PSYCHIATR, V15, P426, DOI 10.1038/mp.2009.115; Partanen J, 2007, J NEUROCHEM, V101, P1185, DOI 10.1111/j.1471-4159.2007.04463.x; Paul ED, 2013, J PSYCHOPHARMACOL; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Petersen R.G., 1985, DESIGN ANAL EXPT; Saarimaki-Vire J, 2007, J NEUROSCI, V27, P8581, DOI 10.1523/JNEUROSCI.0192-07.2007; Sapolsky R, 2003, SCI AM, V289, P86, DOI 10.1038/scientificamerican0903-86; Singewald N, 2003, BIOL PSYCHIAT, V53, P275, DOI 10.1016/S0006-3223(02)01574-3; Sommer W, 2001, NEUROPSYCHOPHARMACOL, V24, P430, DOI 10.1016/S0893-133X(00)00210-4; Spannuth BM, 2011, NEUROSCIENCE, V179, P104, DOI 10.1016/j.neuroscience.2011.01.042; Spiacci A, 2012, NEUROSCIENCE, V227, P350, DOI 10.1016/j.neuroscience.2012.09.061; Stone EA, 1996, PHARMACOL BIOCHEM BE, V55, P215, DOI 10.1016/S0091-3057(96)00070-6; Storm EE, 2006, DEVELOPMENT, V133, P1831, DOI 10.1242/dev.02324; Tanaka M, 1983, Kurume Med J, V30, P35; Terauchi A, 2010, NATURE, V465, P783, DOI 10.1038/nature09041; Toyoda R, 2010, DEVELOPMENT, V137, P3439, DOI 10.1242/dev.055392; Voikar V, 2004, GENES BRAIN BEHAV, V3, P27, DOI 10.1046/j.1601-183X.2003.0044.x; WANG QP, 1992, BRAIN RES BULL, V29, P943; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3	63	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101420	10.1371/journal.pone.0101420	http://dx.doi.org/10.1371/journal.pone.0101420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992493	Green Submitted, gold, Green Published			2022-12-27	WOS:000341253400070
J	Cheng, YZ; Zhang, H; Chen, RP; Yang, F; Li, W; Chen, LS; Lin, SD; Liang, GX; Cai, DH; Chen, H				Cheng, Yanzhen; Zhang, Hua; Chen, Rongping; Yang, Fan; Li, Wei; Chen, Lishu; Lin, Shaoda; Liang, Ganxiong; Cai, Dehong; Chen, Hong			Cardiometabolic Risk Profiles Associated with Chronic Complications in Overweight and Obese Type 2 Diabetes Patients in South China	PLOS ONE			English	Article							BODY-MASS INDEX; METABOLIC SYNDROME; BLOOD-PRESSURE; PREVALENCE; MELLITUS; DISEASE; RETINOPATHY; DIAGNOSIS; STROKE; ADULTS	Background: Type 2 diabetes is often accompanied by altered cardiometabolic risk profiles, including abdominal obesity, hypertension, and dyslipidaemia. The association of altered cardiometabolic risk profiles with chronic complications of diabetes is not well investigated. Methods: We recruited 2954 type 2 diabetes patients with a body mass index >= 25 kg/m(2) who visited the diabetes clinics of 62 hospitals in 21 cities in Guangdong province of China from August 2011 to March 2012. Demographic characteristics, personal and family medical histories, and data on chronic complications of diabetes were collected. Clinical examinations and laboratory assessment were conducted. Results: Abdominal obesity was found in 91.6% of the study population, elevated blood pressure in 78.3%; elevated serum triacylglycerols in 57.8%, and reduced serum HDL-C in 55.9%. Among the cardiometabolic risk factors, elevated blood pressure was significantly associated with almost all the chronic complications of diabetes. After adjusting for age, gender, duration of diabetes, and HbA1c, elevated blood pressure was significantly associated with diabetic retinopathy (OR 1.63, 95% CI: 1.22-2.19), diabetic nephropathy (OR 3.16, 95% CI: 2.25-4.46), cardiovascular disease (OR 2.71, 95% CI: 1.70-4.32), and stroke (OR 1.90, 95% CI: 1.15-3.12). Abdominal adiposity was significantly associated with diabetic nephropathy (OR 1.39, 95% CI: 1.11-1.74). Elevated triacylglycerols was significantly associated with diabetic retinopathy (OR 1.29, 95% CI: 1.05-1.58) and diabetic nephropathy (OR 1.30, 95% CI: 1.05-1.58). Reduced HDL-C was significantly associated with stroke (OR 1.41, 95% CI: 1.05-1.88). Conclusions: Altered cardiometabolic risk profiles, and elevated blood pressure in particular, were significantly associated with chronic complications in overweight and obese patients with type 2 diabetes. Future studies on the prevention of chronic complications of diabetes might make lowering blood pressure a primary target.	[Cheng, Yanzhen; Zhang, Hua; Chen, Rongping; Yang, Fan; Cai, Dehong; Chen, Hong] Southern Med Univ, Zhujiang Hosp, Dept Endocrinol, Guangzhou, Guangdong, Peoples R China; [Yang, Fan] Gulin Med Univ, Affiliated Hosp, Dept Endocrinol, Guilin, Peoples R China; [Li, Wei] Wu Jing Zong Dui Hosp Guangdong Prov, Dept Endocrinol, Guangzhou, Guangdong, Peoples R China; [Chen, Lishu] Shantou Univ, Affiliated Hosp 2, Coll Med, Dept Endocrinol, Shantou, Peoples R China; [Lin, Shaoda] Shantou Univ, Affiliated Hosp 1, Coll Med, Dept Endocrinol, Shantou, Peoples R China; [Liang, Ganxiong] Peoples Hosp Zhongshan City, Dept Endocrinol, Zhongshan, Peoples R China	Southern Medical University - China; Shantou University; Shantou University	Chen, H (corresponding author), Southern Med Univ, Zhujiang Hosp, Dept Endocrinol, Guangzhou, Guangdong, Peoples R China.	rubychq@163.com			Diabetes Society of Guangdong Provincial Medical Association [2011-DM-01]	Diabetes Society of Guangdong Provincial Medical Association	This study was supported by the Diabetes Society of Guangdong Provincial Medical Association and a special grant for overweight and obese type 2 diabetic patients in Guangdong province (No. 2011-DM-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PLease update this information in the Financial Disclosure.	Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Bonora E, 2004, DIABETIC MED, V21, P52, DOI 10.1046/j.1464-5491.2003.01068.x; Cederholm J, 2010, J HYPERTENS, V28, P2026, DOI 10.1097/HJH.0b013e32833c8b75; Chiu M, 2011, DIABETES CARE, V34, P1741, DOI 10.2337/dc10-2300; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Costa LA, 2004, DIABETIC MED, V21, P252, DOI 10.1111/j.1464-5491.2004.01124.x; Ejerblad E, 2006, J AM SOC NEPHROL, V17, P1695, DOI 10.1681/ASN.2005060638; Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444; Gillow JT, 1999, BRIT J OPHTHALMOL, V83, P1083, DOI 10.1136/bjo.83.9.1083; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; Guo SD, 2014, J ENDOCRINOL, V220, pT1, DOI 10.1530/JOE-13-0327; Guo Shaodong, 2013, Drug Discov Today Dis Mech, V10, pe27; ISHIHARA M, 1987, DIABETES CARE, V10, P20, DOI 10.2337/diacare.10.1.20; Isomaa B, 2001, DIABETOLOGIA, V44, P1148, DOI 10.1007/s001250100615; Litwak L, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-57; Liu ZL, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-62; Meigs JB, 2006, J CLIN ENDOCR METAB, V91, P2906, DOI 10.1210/jc.2006-0594; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; World Medical Association, 2002, J Postgrad Med, V48, P206; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Zhang XL, 2009, STROKE, V40, P1098, DOI 10.1161/STROKEAHA.108.539692; Zhao WH, 2013, DIABETES CARE, V36, P3287, DOI 10.2337/dc13-0189; Zhao WH, 2013, J CLIN ENDOCR METAB, V98, P3653, DOI 10.1210/jc.2013-1757	26	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101289	10.1371/journal.pone.0101289	http://dx.doi.org/10.1371/journal.pone.0101289			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992024	Green Published, Green Submitted, gold			2022-12-27	WOS:000341253400059
J	Cossetti, C; Lugini, L; Astrologo, L; Saggio, I; Fais, S; Spadafora, C				Cossetti, Cristina; Lugini, Luana; Astrologo, Letizia; Saggio, Isabella; Fais, Stefano; Spadafora, Corrado			Soma-to-Germline Transmission of RNA in Mice Xenografted with Human Tumour Cells: Possible Transport by Exosomes	PLOS ONE			English	Article							GENE-TRANSFER; INHERITANCE; SPERMATOZOA; VESICLES; ORIGIN	Mendelian laws provide the universal founding paradigm for the mechanism of genetic inheritance through which characters are segregated and assorted. In recent years, however, parallel with the rapid growth of epigenetic studies, cases of inheritance deviating from Mendelian patterns have emerged. Growing studies underscore phenotypic variations and increased risk of pathologies that are transgenerationally inherited in a non-Mendelian fashion in the absence of any classically identifiable mutation or predisposing genetic lesion in the genome of individuals who develop the disease. Non-Mendelian inheritance is most often transmitted through the germline in consequence of primary events occurring in somatic cells, implying soma-to-germline transmission of information. While studies of sperm cells suggest that epigenetic variations can potentially underlie phenotypic alterations across generations, no instance of transmission of DNA-or RNA-mediated information from somatic to germ cells has been reported as yet. To address these issues, we have now generated a mouse model xenografted with human melanoma cells stably expressing EGFP-encoding plasmid. We find that EGFP RNA is released from the xenografted human cells into the bloodstream and eventually in spermatozoa of the mice. Tumor-released EGFP RNA is associated with an extracellular fraction processed for exosome purification and expressing exosomal markers, in all steps of the process, from the xenografted cancer cells to the spermatozoa of the recipient animals, strongly suggesting that exosomes are the carriers of a flow of information from somatic cells to gametes. Together, these results indicate that somatic RNA is transferred to sperm cells, which can therefore act as the final recipients of somatic cell-derived information.	[Cossetti, Cristina; Spadafora, Corrado] Ist Super Sanita, SBGSA, I-00161 Rome, Italy; [Lugini, Luana; Fais, Stefano] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, Unit Antitumor Drugs, I-00161 Rome, Italy; [Astrologo, Letizia; Saggio, Isabella] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, I-00185 Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Sapienza University Rome	Spadafora, C (corresponding author), Ist Super Sanita, SBGSA, Viale Regina Elena 299, I-00161 Rome, Italy.	cspadaf@tin.it	Lugini, Luana/J-8672-2016; Saggio, Isabella/H-2417-2015; Cossetti, Cristina/K-5034-2016; Fais, Stefano/J-8638-2016	Lugini, Luana/0000-0002-8778-2601; Cossetti, Cristina/0000-0002-8809-4149; Fais, Stefano/0000-0001-9060-2766; Spadafora, Corrado/0000-0002-5743-3224; saggio, isabella/0000-0002-9497-7415	Italian Ministry of Health "Endogenous Reverse Transcriptase as tumour marker and causative agent of tumour onset and progression"; Endogenous Reverse Transcriptase in tumour onset and progression and in tumour therapy	Italian Ministry of Health "Endogenous Reverse Transcriptase as tumour marker and causative agent of tumour onset and progression"; Endogenous Reverse Transcriptase in tumour onset and progression and in tumour therapy	This work was supported by grants from the Italian Ministry of Health "Endogenous Reverse Transcriptase as tumour marker and causative agent of tumour onset and progression", "Endogenous Reverse Transcriptase in tumour onset and progression and in tumour therapy" to CS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nedawi K, 2009, CELL CYCLE, V8, P2014, DOI 10.4161/cc.8.13.8988; Azmi AS, 2013, CANCER METAST REV, V32, P623, DOI 10.1007/s10555-013-9441-9; BACCETTI B, 1994, J CELL BIOL, V127, P903, DOI 10.1083/jcb.127.4.903; Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Bonduriansky R, 2009, ANNU REV ECOL EVOL S, V40, P103, DOI 10.1146/annurev.ecolsys.39.110707.173441; Caballero JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065364; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Cavalli G, 2006, DEVELOPMENT, V133, P2089, DOI 10.1242/dev.02402; Cheng RYS, 2004, MOL CARCINOGEN, V40, P1, DOI 10.1002/mc.20022; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Etheridge Alton, 2013, Frontiers in Genetics, V4, P115, DOI 10.3389/fgene.2013.00115; Gatti JL, 2005, BIOL REPROD, V72, P1452, DOI 10.1095/biolreprod.104.036426; Gluckman PD, 2007, BIOESSAYS, V29, P145, DOI 10.1002/bies.20522; Goodrich R, 2007, ARCH ANDROLOGY, V53, P161, DOI 10.1080/01485010701216526; Hamatani T, 2012, FERTIL STERIL, V97, P275, DOI 10.1016/j.fertnstert.2011.12.035; Henikoff S, 2004, TRENDS GENET, V20, P320, DOI 10.1016/j.tig.2004.05.004; Lim JP, 2013, TRENDS GENET, V29, P176, DOI 10.1016/j.tig.2012.12.008; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Lumey LH, 2007, INT J EPIDEMIOL, V36, P1196, DOI 10.1093/ije/dym126; Niu YD, 2008, J GENET GENOMICS, V35, P701, DOI 10.1016/S1673-8527(08)60225-8; Ostermeier GC, 2004, NATURE, V429, P154, DOI 10.1038/429154a; Piersanti S, 2006, CALCIFIED TISSUE INT, V78, P372, DOI 10.1007/s00223-006-0001-y; Pittoggi C, 2006, MOL REPROD DEV, V73, P1239, DOI 10.1002/mrd.20550; Poliakov A, 2009, PROSTATE, V69, P159, DOI 10.1002/pros.20860; Rando OJ, 2012, CELL, V151, P702, DOI 10.1016/j.cell.2012.10.020; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Sciamanna I, 2003, BIOCHEM BIOPH RES CO, V312, P1039, DOI 10.1016/j.bbrc.2003.11.024; Sciamanna I, 2009, GENE, V448, P180, DOI 10.1016/j.gene.2009.07.011; Sharma A, 2012, PROG BIOPH MOL BIOL, DOI [10.1016/j.pbiomolbio, DOI 10.1016/J.PBIOMOLBIO]; Smith K, 2005, BIOESSAYS, V27, P551, DOI 10.1002/bies.20211; Stoeger R, 2008, BIOESSAYS, V30, P156, DOI DOI 10.1002/bies.20700; Sullivan R, 2005, BLOOD CELL MOL DIS, V35, P1, DOI 10.1016/j.bcmd.2005.03.005; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van der Vaart M, 2008, ANN NY ACAD SCI, V1137, P18, DOI 10.1196/annals.1448.022; Wagner KD, 2008, DEV CELL, V14, P962, DOI 10.1016/j.devcel.2008.03.009; Weismann A, 1893, GERM PLASM THEORY HE; Yang CJ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/842849; Zaccagnini G, 1998, BIOL REPROD, V59, P1549, DOI 10.1095/biolreprod59.6.1549	41	95	100	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101629	10.1371/journal.pone.0101629	http://dx.doi.org/10.1371/journal.pone.0101629			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992257	Green Submitted, Green Published, gold			2022-12-27	WOS:000341253400100
J	Lu, XL; Lin, QA; Lin, M; Duan, P; Ye, LL; Chen, J; Chen, XM; Zhang, LF; Xue, XY				Lu, Xulian; Lin, Qiaoai; Lin, Mao; Duan, Ping; Ye, Lulu; Chen, Jun; Chen, Xiangmin; Zhang, Lifang; Xue, Xiangyang			Multiple-Integrations of HPV16 Genome and Altered Transcription of Viral Oncogenes and Cellular Genes Are Associated with the Development of Cervical Cancer	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; INTRAEPITHELIAL NEOPLASIA; UP-REGULATION; ANOGENITAL LESIONS; FUSION TRANSCRIPTS; CARCINOMA-CELLS; GENITAL TUMORS; MYC LOCUS; EXPRESSION; E6	The constitutive expression of the high-risk HPV E6 and E7 viral oncogenes is the major cause of cervical cancer. To comprehensively explore the composition of HPV16 early transcripts and their genomic annotation, cervical squamous epithelial tissues from 40 HPV16-infected patients were collected for analysis of papillomavirus oncogene transcripts (APOT). We observed different transcription patterns of HPV16 oncogenes in progression of cervical lesions to cervical cancer and identified one novel transcript. Multiple-integration events in the tissues of cervical carcinoma (CxCa) are significantly more often than those of low-grade squamous intraepithelial lesions (LSIL) and high-grade squamous intraepithelial lesions (HSIL). Moreover, most cellular genes within or near these integration sites are cancer-associated genes. Taken together, this study suggests that the multiple-integrations of HPV genome during persistent viral infection, which thereby alters the expression patterns of viral oncogenes and integration-related cellular genes, play a crucial role in progression of cervical lesions to cervix cancer.	[Lu, Xulian; Lin, Qiaoai; Lin, Mao; Chen, Jun; Zhang, Lifang] Wenzhou Med Univ, Dept Microbiol & Immunol, Wenzhou, Zhejiang, Peoples R China; [Ye, Lulu; Xue, Xiangyang] Wenzhou Med Univ, Inst Mol Virol & Immunol, Wenzhou, Zhejiang, Peoples R China; [Lu, Xulian] Zhuji Peoples Hosp Zhejiang Prov, Dept Pathol, Zhuji, Zhejiang, Peoples R China; [Lin, Mao] Jinan Univ, Fuda Canc Hosp Affiliated, Coll Med, Guangzhou, Guangdong, Peoples R China; [Duan, Ping] Wenzhou Med Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Wenzhou, Zhejiang, Peoples R China; [Chen, Xiangmin] Wenzhou Med Univ, Sch Lab Med & Life Sci, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Jinan University; Wenzhou Medical University; Wenzhou Medical University	Xue, XY (corresponding author), Wenzhou Med Univ, Inst Mol Virol & Immunol, Wenzhou, Zhejiang, Peoples R China.	wzxxy001@163.com			National Natural Science Foundation of China [81001343, 81172463]; Department of Education of Zhejiang Province [Y200907403]; Wenzhou Science and Technology Bureau [Y20090103, Y20100175, H20100063]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Education of Zhejiang Province; Wenzhou Science and Technology Bureau	This work is supported by grants from the National Natural Science Foundation of China (81001343, 81172463), the Department of Education of Zhejiang Province (Y200907403) and Wenzhou Science and Technology Bureau (Y20090103, Y20100175 and H20100063). These sponsors provided the funding for the experiments and the collection of specimens. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mahrouki AA, 2012, ULTRASOUND MED BIOL, V38, P1958, DOI 10.1016/j.ultrasmedbio.2012.07.009; Arias-Pulido H, 2006, J CLIN MICROBIOL, V44, P1755, DOI 10.1128/JCM.44.5.1755-1762.2006; Badaracco G, 2002, J MED VIROL, V67, P574, DOI 10.1002/jmv.10141; Borelli I, 2013, EUR J HUM GENET, V21, P154, DOI 10.1038/ejhg.2012.150; Choi YW, 2007, INT J GYNECOL CANCER, V17, P687, DOI 10.1111/j.1525-1438.2007.00834.x; CORNELISSEN MTE, 1990, J GEN VIROL, V71, P1243, DOI 10.1099/0022-1317-71-5-1243; Dall KL, 2008, CANCER RES, V68, P8249, DOI 10.1158/0008-5472.CAN-08-1741; Dictor M, 2011, INFECT AGENTS CANCER, V6, DOI 10.1186/1750-9378-6-1; DOEBERITZ MV, 1991, P NATL ACAD SCI USA, V88, P1411, DOI 10.1073/pnas.88.4.1411; Ferber MJ, 2003, ONCOGENE, V22, P7233, DOI 10.1038/sj.onc.1207006; Flohe Leopold, 2007, V44, P1; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Galvan SC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-580; Giaginis C, 2009, HISTOL HISTOPATHOL, V24, P761, DOI 10.14670/HH-24.761; Guzman VB, 2008, HUM MOL GENET, V17, P1838, DOI 10.1093/hmg/ddn077; HAUSEN HZ, 1991, VIROLOGY, V184, P9, DOI 10.1016/0042-6822(91)90816-T; He M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-170; Hopman AHN, 2004, J PATHOL, V202, P23, DOI 10.1002/path.1490; HSU EM, 1993, INT J CANCER, V55, P397, DOI 10.1002/ijc.2910550311; HUMMEL M, 1992, J VIROL, V66, P6070, DOI 10.1128/JVI.66.10.6070-6080.1992; Incassati A, 2006, ONCOGENE, V25, P2444, DOI 10.1038/sj.onc.1209276; JEON S, 1995, P NATL ACAD SCI USA, V92, P1654, DOI 10.1073/pnas.92.5.1654; JEON S, 1995, J VIROL, V69, P2989, DOI 10.1128/JVI.69.5.2989-2997.1995; Kelley ML, 2005, J VIROL, V79, P3737, DOI 10.1128/JVI.79.6.3737-3747.2005; Klaes R, 1999, CANCER RES, V59, P6132; Kraus I, 2008, CANCER RES, V68, P2514, DOI 10.1158/0008-5472.CAN-07-2776; Li BH, 2010, INT J GYNECOL CANCER, V20, P597, DOI 10.1111/IGC.0b013e3181d63170; Liu SS, 2008, TUMOR BIOL, V29, P105, DOI 10.1159/000135690; Luke-Glaser S, 2010, EMBO J, V29, P795, DOI 10.1038/emboj.2009.371; Martin LM, 2013, CANCER LETT, V335, P19, DOI 10.1016/j.canlet.2013.01.046; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nam DK, 2002, P NATL ACAD SCI USA, V99, P6152, DOI 10.1073/pnas.092140899; Nijhuis ER, 2007, J CLIN PATHOL, V60, P824, DOI 10.1136/jcp.2005.036038; Nishimura A, 2000, J VIROL, V74, P3752, DOI 10.1128/JVI.74.8.3752-3760.2000; Ordonez RM, 2004, J GEN VIROL, V85, P1433, DOI 10.1099/vir.0.19317-0; Ozbun MA, 1997, J VIROL, V71, P5161, DOI 10.1128/JVI.71.7.5161-5172.1997; Peter M, 2006, ONCOGENE, V25, P5985, DOI 10.1038/sj.onc.1209625; Poynton RA, 2014, BBA-GEN SUBJECTS, V1840, P906, DOI 10.1016/j.bbagen.2013.08.001; Reuter S, 1998, EMBO J, V17, P215, DOI 10.1093/emboj/17.1.215; ROMANCZUK H, 1990, J VIROL, V64, P2849, DOI 10.1128/JVI.64.6.2849-2859.1990; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Schmitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039632; SCHNEIDERGADICKE A, 1986, EMBO J, V5, P2285, DOI 10.1002/j.1460-2075.1986.tb04496.x; Schwab RA, 2010, EMBO J, V29, P806, DOI 10.1038/emboj.2009.385; Schwartz S, 2008, FRONT BIOSCI-LANDMRK, V13, P5880, DOI 10.2741/3123; SMOTKIN D, 1989, J VIROL, V63, P1441, DOI 10.1128/JVI.63.3.1441-1447.1989; SMOTKIN D, 1986, P NATL ACAD SCI USA, V83, P4680, DOI 10.1073/pnas.83.13.4680; Steger G, 1997, J VIROL, V71, P50, DOI 10.1128/JVI.71.1.50-58.1997; THIERRY F, 1987, J VIROL, V61, P134, DOI 10.1128/JVI.61.1.134-142.1987; Thorland EC, 2003, ONCOGENE, V22, P1225, DOI 10.1038/sj.onc.1206170; Van Tine BA, 2004, J VIROL, V78, P11172, DOI 10.1128/JVI.78.20.11172-11186.2004; Wang J, 2001, ONCOGENE, V20, P4740, DOI 10.1038/sj.onc.1204655; Wang XH, 2011, INT J CANCER, V129, P1362, DOI 10.1002/ijc.25800; Wang XH, 2011, J VIROL, V85, P8080, DOI 10.1128/JVI.00670-11; Wang X, 2009, RNA, V15, P637, DOI 10.1261/rna.1442309; Wentzensen N, 2002, ONCOGENE, V21, P419, DOI 10.1038/sj.onc.1205104; Xu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066693; Ying HQ, 2006, CELL CYCLE, V5, P506, DOI 10.4161/cc.5.5.2515; Zheng ZM, 2006, FRONT BIOSCI-LANDMRK, V11, P2286, DOI 10.2741/1971; Zheng ZM, 2011, BBA-GENE REGUL MECH, V1809, P668, DOI 10.1016/j.bbagrm.2011.05.005; Ziegert C, 2003, ONCOGENE, V22, P3977, DOI 10.1038/sj.onc.1206629	61	10	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e97588	10.1371/journal.pone.0097588	http://dx.doi.org/10.1371/journal.pone.0097588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992025	Green Published, Green Submitted, gold			2022-12-27	WOS:000341253400003
J	Miranda, JA; Shepard, KN; McClintock, SK; Liu, RC				Miranda, Jason A.; Shepard, Kathryn N.; McClintock, Shannon K.; Liu, Robert C.			Adult Plasticity in the Subcortical Auditory Pathway of the Maternal Mouse	PLOS ONE			English	Article							DORSAL COCHLEAR NUCLEUS; BRAIN-STEM RESPONSE; IN-HOUSE MICE; CORTICOFUGAL MODULATION; POSTMENOPAUSAL WOMEN; COMMUNICATION CALLS; INBRED STRAINS; TONOTOPIC MAP; FOOD-INTAKE; EXPERIENCE	Subcortical auditory nuclei were traditionally viewed as non-plastic in adulthood so that acoustic information could be stably conveyed to higher auditory areas. Studies in a variety of species, including humans, now suggest that prolonged acoustic training can drive long-lasting brainstem plasticity. The neurobiological mechanisms for such changes are not well understood in natural behavioral contexts due to a relative dearth of in vivo animal models in which to study this. Here, we demonstrate in a mouse model that a natural life experience with increased demands on the auditory system - motherhood - is associated with improved temporal processing in the subcortical auditory pathway. We measured the auditory brainstem response to test whether mothers and pup-naive virgin mice differed in temporal responses to both broadband and tone stimuli, including ultrasonic frequencies found in mouse pup vocalizations. Mothers had shorter latencies for early ABR peaks, indicating plasticity in the auditory nerve and the cochlear nucleus. Shorter interpeak latency between waves IV and V also suggest plasticity in the inferior colliculus. Hormone manipulations revealed that these cannot be explained solely by estrogen levels experienced during pregnancy and parturition in mothers. In contrast, we found that pup-care experience, independent of pregnancy and parturition, contributes to shortening auditory brainstem response latencies. These results suggest that acoustic experience in the maternal context imparts plasticity on early auditory processing that lasts beyond pup weaning. In addition to establishing an animal model for exploring adult auditory brainstem plasticity in a neuroethological context, our results have broader implications for models of perceptual, behavioral and neural changes that arise during maternity, where subcortical sensorineural plasticity has not previously been considered.	[Miranda, Jason A.; Shepard, Kathryn N.; Liu, Robert C.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Miranda, Jason A.; Shepard, Kathryn N.; Liu, Robert C.] Ctr Behav Neurosci, Atlanta, GA USA; [Shepard, Kathryn N.] Emory Univ, Grad Program Neurosci, Atlanta, GA 30322 USA; [McClintock, Shannon K.] Emory Univ, Inst Quantitat Theory & Methods, Atlanta, GA 30322 USA; [Liu, Robert C.] Ctr Translat Social Neurosci, Atlanta, GA USA	Emory University; Emory University; Emory University	Miranda, JA (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	jason.miranda2@pfizer.com	Liu, Robert/B-2339-2015; Miranda, Jason/B-8043-2009; Pileggi, Shannon/L-1320-2016	Liu, Robert/0000-0003-2450-8194; Miranda, Jason/0000-0002-1459-2022; Pileggi, Shannon/0000-0002-7732-4164	National Institute of Deafness and Communication Disorders [DC008343]; Center for Behavioral Neuroscience under the STC Program of the National Science Foundation [IBN-9876754]; NIH Institutional Research and Academic Career Development Award [K12 GM000680]; NIH National Research Service Award Institutional Research Training Grant [T32 GM08605-14]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008605, K12GM000680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008343] Funding Source: NIH RePORTER	National Institute of Deafness and Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Center for Behavioral Neuroscience under the STC Program of the National Science Foundation; NIH Institutional Research and Academic Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Research Service Award Institutional Research Training Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding for the authors' research was provided by the National Institute of Deafness and Communication Disorders Grant DC008343 (J.A.M. and R.C.L.), the Center for Behavioral Neuroscience under the STC Program of the National Science Foundation (IBN-9876754), the NIH Institutional Research and Academic Career Development Award K12 GM000680 (J.A.M.) and the NIH National Research Service Award Institutional Research Training Grant T32 GM08605-14 (K.N.S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mana D, 2008, NEUROSCIENCE, V153, P881, DOI 10.1016/j.neuroscience.2008.02.077; Allen PD, 2010, BEHAV NEUROSCI, V124, P265, DOI 10.1037/a0018913; Banerjee SB, 2013, FRONT NEUROENDOCRIN, V34, P300, DOI 10.1016/j.yfrne.2013.07.008; BARKLEY MS, 1979, BIOL REPROD, V20, P733, DOI 10.1095/biolreprod20.4.733; Brozoski TJ, 2002, J NEUROSCI, V22, P2383, DOI 10.1523/JNEUROSCI.22-06-02383.2002; Caruso S, 2003, FERTIL STERIL, V79, P556, DOI 10.1016/S0015-0282(02)04763-5; Caruso S, 2000, MENOPAUSE, V7, P178, DOI 10.1097/00042192-200007030-00008; Charitidi K, 2010, NEUROSCIENCE, V165, P923, DOI 10.1016/j.neuroscience.2009.11.020; Cohen L, 2011, NEURON, V72, P357, DOI 10.1016/j.neuron.2011.08.019; COLEMAN JR, 1994, HEARING RES, V80, P209, DOI 10.1016/0378-5955(94)90112-0; de Boer J, 2008, J NEUROSCI, V28, P4929, DOI 10.1523/JNEUROSCI.0902-08.2008; DUBUC PU, 1985, P SOC EXP BIOL MED, V180, P468; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Ehret G, 2005, BEHAV GENET, V35, P19, DOI 10.1007/s10519-004-0853-8; Ehret G, 2002, P NATL ACAD SCI USA, V99, P479, DOI 10.1073/pnas.012361999; EHRET G, 1989, ETHOLOGY, V80, P81; EHRET G, 1987, NATURWISSENSCHAFTEN, V74, P47, DOI 10.1007/BF00367047; EHRET G, 1982, J COMP PHYSIOL, V148, P245, DOI 10.1007/BF00619131; EHRET G, 1992, ANIM BEHAV, V43, P409, DOI 10.1016/S0003-3472(05)80101-0; EHRET G, 1994, J PHYSIOLOGY-PARIS, V88, P315, DOI 10.1016/0928-4257(94)90012-4; Ehret G, 2009, PHYSIOL BEHAV, V96, P428, DOI 10.1016/j.physbeh.2008.11.005; Frisina RD, 2001, HEARING RES, V158, P1, DOI 10.1016/S0378-5955(01)00296-9; Fritz JB, 2007, HEARING RES, V229, P186, DOI 10.1016/j.heares.2007.01.009; Galbraith GC, 2003, NEUROREPORT, V14, P735, DOI 10.1097/00001756-200304150-00015; Galindo-Leon EE, 2009, NEURON, V62, P705, DOI 10.1016/j.neuron.2009.05.001; Geissler DB, 2002, P NATL ACAD SCI USA, V99, P9021, DOI 10.1073/pnas.122606499; Gregg C, 2007, J NEUROSCI, V27, P1812, DOI 10.1523/JNEUROSCI.4441-06.2007; Guimaraes P, 2006, P NATL ACAD SCI USA, V103, P14246, DOI 10.1073/pnas.0606891103; Haack B., 1983, AUDITORY PSYCHOBIOLO, P57; HENRY KR, 1979, J AM AUDITORY SOC, V4, P173; HERNANDEZPEON R, 1956, SCIENCE, V123, P331, DOI 10.1126/science.123.3191.331; Hoormann J, 2004, NEUROREPORT, V15, P1539, DOI 10.1097/01.wnr.0000134932.89313.3b; Hultcrantz M, 2006, ACTA OTO-LARYNGOL, V126, P10, DOI 10.1080/00016480510038617; HUNTER KP, 1987, HEARING RES, V30, P207, DOI 10.1016/0378-5955(87)90137-7; JERGER J, 1980, ARCH OTOLARYNGOL, V106, P387; JEWETT DL, 1970, ELECTROEN CLIN NEURO, V28, P609, DOI 10.1016/0013-4694(70)90203-8; Ji WQ, 2007, J NEUROSCI, V27, P4910, DOI 10.1523/JNEUROSCI.5528-06.2007; Kaltenbach JA, 2000, HEARING RES, V147, P282, DOI 10.1016/S0378-5955(00)00138-6; Keuroghlian AS, 2007, PROG NEUROBIOL, V82, P109, DOI 10.1016/j.pneurobio.2007.03.005; Khaliq Farah, 2003, Indian Journal of Physiology and Pharmacology, V47, P393; King AJ, 2011, NEUROSCI BIOBEHAV R, V35, P2129, DOI 10.1016/j.neubiorev.2011.03.008; KOENIG HL, 1995, SCIENCE, V268, P1500, DOI 10.1126/science.7770777; Krishnan A, 2010, BRAIN LANG, V114, P193, DOI 10.1016/j.bandl.2010.05.004; Krishnan A, 2010, J NEUROLINGUIST, V23, P81, DOI 10.1016/j.jneuroling.2009.09.001; Levine RA, 1999, AM J OTOLARYNG, V20, P351, DOI 10.1016/S0196-0709(99)90074-1; Liu RC, 2003, J ACOUST SOC AM, V114, P3412, DOI 10.1121/1.1623787; Liu RC, 2006, EUR J NEUROSCI, V23, P3087, DOI 10.1111/j.1460-9568.2006.04840.x; Liu RC, 2007, PLOS BIOL, V5, P1426, DOI 10.1371/journal.pbio.0050173; Liu XP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013021; Luo F, 2008, J NEUROSCI, V28, P11615, DOI 10.1523/JNEUROSCI.3972-08.2008; Maison S, 2001, PSYCHOPHYSIOLOGY, V38, P35, DOI 10.1017/S0048577201990109; Maney DL, 2006, EUR J NEUROSCI, V23, P1523, DOI 10.1111/j.1460-9568.2006.04673.x; MCCORMACK JT, 1974, J ENDOCRINOL, V62, P101, DOI 10.1677/joe.0.0620101; McGinley MJ, 2012, J NEUROSCI, V32, P9301, DOI 10.1523/JNEUROSCI.0272-12.2012; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Miasnikov AA, 2008, NEUROBIOL LEARN MEM, V90, P443, DOI 10.1016/j.nlm.2008.05.010; Miranda JA, 2009, HEARING RES, V252, P21, DOI 10.1016/j.heares.2009.04.014; Newman JD, 2007, BEHAV BRAIN RES, V182, P155, DOI 10.1016/j.bbr.2007.02.011; Numan Michael, 2006, Behav Cogn Neurosci Rev, V5, P163, DOI 10.1177/1534582306288790; Oertel D, 1999, ANNU REV PHYSIOL, V61, P497, DOI 10.1146/annurev.physiol.61.1.497; Parham K, 2001, HANDBOOK OF MOUSE AUDITORY RESEARCH: FROM BEHAVIOR TO MOLECULAR BIOLOGY, P37; Pauli-Magnus D, 2007, NEUROSCIENCE, V149, P673, DOI 10.1016/j.neuroscience.2007.08.010; Radziwon KE, 2009, J COMP PHYSIOL A, V195, P961, DOI 10.1007/s00359-009-0472-1; Remage-Healey L, 2010, P NATL ACAD SCI USA, V107, P3852, DOI 10.1073/pnas.0906572107; ROSENBLATT JS, 1988, PSYCHONEUROENDOCRINO, V13, P29, DOI 10.1016/0306-4530(88)90005-4; Rothschild G, 2013, J NEUROSCI, V33, P12851, DOI 10.1523/JNEUROSCI.4656-12.2013; SANES DH, 1985, DEV BRAIN RES, V22, P255, DOI 10.1016/0165-3806(85)90177-4; SANES DH, 1985, J NEUROSCI, V5, P1152; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; Shepard KN, 2011, GENES BRAIN BEHAV, V10, P28, DOI 10.1111/j.1601-183X.2010.00580.x; Sisneros JA, 2004, SCIENCE, V305, P404, DOI 10.1126/science.1097218; Song JH, 2008, J COGNITIVE NEUROSCI, V20, P1892, DOI 10.1162/jocn.2008.20131; Strait DL, 2009, EUR J NEUROSCI, V29, P661, DOI 10.1111/j.1460-9568.2009.06617.x; Suga N, 2003, NAT REV NEUROSCI, V4, P783, DOI 10.1038/nrn1222; Suga N, 2012, NEUROSCI BIOBEHAV R, V36, P969, DOI 10.1016/j.neubiorev.2011.11.006; Swain JE, 2008, J CHILD PSYCHOL PSYC, V49, P1042, DOI 10.1111/j.1469-7610.2008.01963.x; Tremere LA, 2011, J NEUROSCI, V31, P3271, DOI 10.1523/JNEUROSCI.4355-10.2011; Tremere LA, 2009, J NEUROSCI, V29, P5949, DOI 10.1523/JNEUROSCI.0774-09.2009; Tzounopoulos T, 2009, NEURON, V62, P463, DOI 10.1016/j.neuron.2009.05.002; WADE GN, 1979, PHYSIOL BEHAV, V22, P583, DOI 10.1016/0031-9384(79)90028-3; Wang H, 2009, NEUROSCIENCE, V164, P747, DOI 10.1016/j.neuroscience.2009.08.026; Wang HN, 2011, HEARING RES, V279, P111, DOI 10.1016/j.heares.2011.04.004; Willott James F, 2006, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0821bs34; Wu SH, 2002, HEARING RES, V168, P43, DOI 10.1016/S0378-5955(02)00375-1; Yan J, 2001, NEUROREPORT, V12, P3313, DOI 10.1097/00001756-200110290-00033; Yan J, 2002, EUR J NEUROSCI, V16, P119, DOI 10.1046/j.1460-9568.2002.02046.x; YOVANOF S, 1983, NEUROSCI LETT, V36, P291, DOI 10.1016/0304-3940(83)90015-0; Yu X, 2007, P NATL ACAD SCI USA, V104, P12193, DOI 10.1073/pnas.0700960104; Zhang JS, 1998, NEUROSCI LETT, V250, P197, DOI 10.1016/S0304-3940(98)00482-0; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9; ZHOU RZ, 1995, HEARING RES, V88, P98, DOI 10.1016/0378-5955(95)00105-D; Zhou XM, 2006, BRAIN RES, V1091, P16, DOI 10.1016/j.brainres.2006.01.107	92	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101630	10.1371/journal.pone.0101630	http://dx.doi.org/10.1371/journal.pone.0101630			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992362	gold, Green Published, Green Submitted			2022-12-27	WOS:000341253400101
J	Mohamed, HJJ; Rowan, A; Fong, B; Loy, SL				Mohamed, Hamid Jan Jan; Rowan, Angela; Fong, Bertram; Loy, See-Ling			Maternal Serum and Breast Milk Vitamin D Levels: Findings from the Universiti Sains Malaysia Pregnancy Cohort Study	PLOS ONE			English	Article							PARATHYROID-HORMONE CONCENTRATIONS; D DEFICIENCY; 25-HYDROXYVITAMIN D-3; WOMEN; INFANTS; METAANALYSIS; ASSOCIATION; OUTCOMES; BONE; MASS	Background: Vitamin D deficiency has become a global health issue in pregnant women. This study aimed to assess the adequacy of maternal vitamin D status by measuring maternal serum and breast milk 25-hydroxyvitamin D [25(OH)D] levels and to determine the association between maternal serum and milk 25(OH)D levels. Methods: Data was obtained from the Universiti Sains Malaysia Pregnancy Cohort Study. This study was conducted from April 2010 to December 2012 in the state of Kelantan, Malaysia. Blood samples from pregnant women aged 19 to 40 years were drawn in the second and third trimesters of pregnancy, while breast milk samples at delivery, 2, 6 and 12 months postpartum were collected to analyze for 25(OH)D levels. A total of 102 pregnant women were included in the analysis. Results: Vitamin D deficiency [25(OH)D <50 nmol/L] was detected in 60% and 37% of women in the second and third trimesters of pregnancy, respectively. There were 6% and 23% of women who reached normal level of vitamin D status in the second trimester and the third trimester, respectively. Multivitamin intakes during pregnancy were significantly associated with higher serum 25(OH)D levels in the second trimester (beta = 9.16, p = 0.005) and the third trimester (beta = 13.65, p = 0.003). 25(OH)D levels in breast milk during the first year of lactation ranged from 1.01 to 1.26 nmol/L. Higher maternal serum 25(OH)D level in the second trimester of pregnancy was associated with an elevated level of 25(OH)D in breast milk at delivery (beta = 0.002, p = 0.026). Conclusions: This study shows that high proportions of Malay pregnant women are at risk of vitamin D deficiency. Maternal vitamin D status in the second trimester of pregnancy was found to influence vitamin D level in breast milk at delivery.	[Mohamed, Hamid Jan Jan; Loy, See-Ling] Univ Sains Malaysia, Sch Hlth Sci, Nutr Program, Kubang Kerian, Kelantan, Malaysia; [Rowan, Angela] Fonterra Cooperat Grp Ltd, Palmerston North, New Zealand; [Fong, Bertram] Fonterra Res & Dev Ctr, Palmerston North, New Zealand	Universiti Sains Malaysia; Fonterra; Fonterra	Mohamed, HJJ (corresponding author), Univ Sains Malaysia, Sch Hlth Sci, Nutr Program, Kubang Kerian, Kelantan, Malaysia.	hamidjan@usm.my	Loy, SeeLing/AGW-6714-2022		Universiti Sains Malaysia Research University Grant Scheme [1001/PPSK/811087]; Universiti Sains Malaysia Fellowship Scheme; New Zealand Primary Growth Partnerships post-farmgate dairy programme; Fonterra Co-operative group; NZ Ministry for Primary Industries (MPI)	Universiti Sains Malaysia Research University Grant Scheme(Universiti Sains Malaysia); Universiti Sains Malaysia Fellowship Scheme; New Zealand Primary Growth Partnerships post-farmgate dairy programme; Fonterra Co-operative group(Fonterra); NZ Ministry for Primary Industries (MPI)	This work was supported by Universiti Sains Malaysia Research University Grant Scheme (1001/PPSK/811087). See-Ling Loy was funded by Universiti Sains Malaysia Fellowship Scheme. Financial support for the analytical work was provided through the New Zealand Primary Growth Partnerships post-farmgate dairy programme, funded by Fonterra Co-operative group and the NZ Ministry for Primary Industries (MPI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajafari F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1169; Aloia JF, 2006, AM J CLIN NUTR, V84, P602, DOI 10.1093/ajcn/84.3.602; Amukele TK, 2013, ARCH DIS CHILD, V98, P180, DOI 10.1136/archdischild-2012-302377; [Anonymous], 2012, PEDIATRICS, DOI [DOI 10.1542/peds.2011-3289, 10.1542/peds.2011-3289]; Balasubramanian S, 2008, INDIAN J MED RES, V127, P250; Barrett H, 2010, BEST PRACT RES CL EN, V24, P527, DOI 10.1016/j.beem.2010.05.010; Charatcharoenwitthaya N, 2013, CLIN ENDOCRINOL, V78, P126, DOI 10.1111/j.1365-2265.2012.04470.x; Dawodu A, 2012, ADV NUTR, V3, P353, DOI 10.3945/an.111.000950; De-Regil LM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008873.pub2; Fahmida U, 2011, NUTR ASSESSMENT; Fernandez-Alonso AM, 2012, INT J GYNECOL OBSTET, V116, P6, DOI 10.1016/j.ijgo.2011.07.029; Green TJ, 2008, EUR J CLIN NUTR, V62, P373, DOI 10.1038/sj.ejcn.1602696; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hollis BW, 2004, AM J CLIN NUTR, V80, p1752S, DOI 10.1093/ajcn/80.6.1752S; HOLLIS BW, 1986, J CLIN ENDOCR METAB, V62, P41, DOI 10.1210/jcem-62-1-41; Institute of Medicine, 2011, DIETARY REFERENCE IN; IPAQ, 2005, GUIDELINES DATA PROC; Javaid MK, 2006, LANCET, V367, P36, DOI 10.1016/S0140-6736(06)67922-1; Lewis John G, 2008, Clin Chem, V54, P1931, DOI 10.1373/clinchem.2008.111526; Loy SL, 2014, HLTH ENV J, V5, P50; Lucas R, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1675; Maghbooli Zhila, 2007, BMC Pregnancy Childbirth, V7, P1, DOI 10.1186/1471-2393-7-1; Moy FM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-735; Nassar N, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.058; National Coordinating Committee On Food And Nutrition (NCCFN), 2005, REC NUTR INT MAL; Nurbazlin M, 2013, ASIA PAC J CLIN NUTR, V22, P391, DOI 10.6133/apjcn.2013.22.3.15; Perez-Lopez FR, 2007, GYNECOL ENDOCRINOL, V23, P13, DOI 10.1080/09513590601045629; Principi N, 2013, EUR J NUTR, V52, P859, DOI 10.1007/s00394-012-0476-4; Rahman SA, 2004, ASIA PAC J CLIN NUTR, V13, P255; REEVE LE, 1982, AM J CLIN NUTR, V36, P122, DOI 10.1093/ajcn/36.1.122; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Roth HJ, 2008, ANN CLIN BIOCHEM, V45, P153, DOI 10.1258/acb.2007.007091; Sahu M, 2009, CLIN ENDOCRINOL, V70, P680, DOI 10.1111/j.1365-2265.2008.03360.x; Song SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085081; SPECKER BL, 1985, AM J DIS CHILD, V139, P1134, DOI 10.1001/archpedi.1985.02140130072032; Specker BL, 2012, P NUTR SOC, V71, P38, DOI 10.1017/S0029665111003053; Suzana S., 2009, ATLAS FOOD EXCHANGES; Thorne-Lyman A, 2012, PAEDIATR PERINAT EP, V26, P75, DOI 10.1111/j.1365-3016.2012.01283.x; Whitehouse AJO, 2012, PEDIATRICS, V129, P485, DOI 10.1542/peds.2011-2644	39	34	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100705	10.1371/journal.pone.0100705	http://dx.doi.org/10.1371/journal.pone.0100705			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992199	Green Published, Green Submitted, gold			2022-12-27	WOS:000341253400028
J	Sadleir, KR; Eimer, WA; Kaufman, RJ; Osten, P; Vassar, R				Sadleir, Katherine R.; Eimer, William A.; Kaufman, Randal J.; Osten, Pavel; Vassar, Robert			Genetic Inhibition of Phosphorylation of the Translation Initiation Factor eIF2 alpha Does Not Block A beta-Dependent Elevation of BACE1 and APP Levels or Reduce Amyloid Pathology in a Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS VECTORS; UNFOLDED PROTEIN RESPONSE; PRECURSOR PROTEIN; SECRETASE ACTIVITY; PATHOGENIC MUTATION; CLEAVING ENZYME-1; MAMMALIAN-CELLS; TRANSGENIC MICE; UPSTREAM AUGS; SYNAPSE LOSS	beta-site amyloid precursor protein (APP) cleaving enzyme 1 (BACE1) initiates the production of beta-amyloid (A beta), the major constituent of amyloid plaques in Alzheimer's disease (AD). BACE1 is elevated similar to 2-3 fold in AD brain and is concentrated in dystrophic neurites near plaques, suggesting BACE1 elevation is A beta-dependent. Previously, we showed that phosphorylation of the translation initiation factor eIF2 alpha de-represses translation of BACE1 mRNA following stress such as energy deprivation. We hypothesized that stress induced by A beta might increase BACE1 levels by the same translational mechanism involving eIF2 alpha phosphorylation. To test this hypothesis, we used three different genetic strategies to determine the effects of reducing eIF2 alpha phosphorylation on A beta-dependent BACE1 elevation in vitro and in vivo: 1) a two-vector adeno-associated virus (AAV) system to express constitutively active GADD34, the regulatory subunit of PP1c eIF2 alpha phosphatase; 2) a non-phosphorylatable eIF2 alpha S51A knockin mutation; 3) a BACE1-YFP transgene lacking the BACE1 mRNA 59 untranslated region (UTR) required for eIF2 alpha translational regulation. The first two strategies were used in primary neurons and 5XFAD transgenic mice, while the third strategy was employed only in 5XFAD mice. Despite very effective reduction of eIF2 alpha phosphorylation in both primary neurons and 5XFAD brains, or elimination of eIF2 alpha-mediated regulation of BACE1-YFP mRNA translation in 5XFAD brains, A beta-dependent BACE1 elevation was not decreased. Additionally, robust inhibition of eIF2 alpha phosphorylation did not block A beta-dependent APP elevation in primary neurons, nor did it reduce amyloid pathology in 5XFAD mice. We conclude that amyloid-associated BACE1 elevation is not caused by translational derepression via eIF2 alpha phosphorylation, but instead appears to involve a post-translational mechanism. These definitive genetic results exclude a role for eIF2 alpha phosphorylation in A beta-dependent BACE1 and APP elevation. We suggest a vicious pathogenic cycle wherein Ab42 toxicity induces peri-plaque BACE1 and APP accumulation in dystrophic neurites leading to exacerbated A beta production and plaque progression.	[Sadleir, Katherine R.; Vassar, Robert] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Eimer, William A.] Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA; [Kaufman, Randal J.] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Osten, Pavel] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Northwestern University; Feinberg School of Medicine; Harvard University; Massachusetts General Hospital; Sanford Burnham Prebys Medical Discovery Institute; Cold Spring Harbor Laboratory	Vassar, R (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA.	r-vassar@northwestern.edu	Sadleir, Katherine R/N-1199-2019	Sadleir, Katherine R/0000-0001-8310-841X; Eimer, William/0000-0003-1067-9339	National Institutes of Health [R01 AG030142]; NIH [DK042394, DK088227, HL052173, 5T32AG00026]; NRSA [F32AG033445]; Northwestern University Cell Imaging Facility; Cancer Center [NCI CA060553]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088227, R01DK042394, R37DK042394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030142, F32AG033445] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northwestern University Cell Imaging Facility; Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health R01 AG030142 to Dr. Robert Vassar, NIH grants DK042394, DK088227 and HL052173 to Dr. Randal Kaufman, NRSA F32AG033445 to Dr. Katherine Sadleir, NIH training grant 5T32AG00026 to Dr. Katherine Sadleir, and the Northwestern University Cell Imaging Facility and a Cancer Center Support Grant (NCI CA060553). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	AKRAM A, 2007, NEUROBIOL AGING; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Boissonneault V, 2009, J BIOL CHEM, V284, P1971, DOI 10.1074/jbc.M807530200; Buggia-Prevot V, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-1; Calabrese B, 2007, MOL CELL NEUROSCI, V35, P183, DOI 10.1016/j.mcn.2007.02.006; Chami L, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-52; Chan CS, 2011, NAT NEUROSCI, V14, P85, DOI 10.1038/nn.2692; Chen GJ, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-3; Chu J, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-1; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Devi L, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.59; Devi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077335; Devi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012974; Eckman CB, 1997, HUM MOL GENET, V6, P2087, DOI 10.1093/hmg/6.12.2087; Eimer WA, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-2; Faghihi MA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r56; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Grimm D, 2003, MOL THER, V7, P839, DOI 10.1016/S1525-0016(03)00095-9; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; He B, 1996, J VIROL, V70, P84, DOI 10.1128/JVI.70.1.84-90.1996; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Yun SH, 2006, NEUROSCI LETT, V403, P162, DOI 10.1016/j.neulet.2006.04.065; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kandalepas PC, 2013, ACTA NEUROPATHOL, V126, P329, DOI 10.1007/s00401-013-1152-3; Kang EL, 2010, J BIOL CHEM, V285, P24108, DOI 10.1074/jbc.M109.092742; Kim JS, 2008, J NEUROSCI, V28, P6030, DOI 10.1523/JNEUROSCI.0891-08.2008; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lammich S, 2004, EMBO REP, V5, P620, DOI 10.1038/sj.embor.7400166; Levites Y, 2006, J NEUROSCI, V26, P11923, DOI 10.1523/JNEUROSCI.2795-06.2006; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Ma T, 2013, NAT NEUROSCI, V16, P1299, DOI 10.1038/nn.3486; Mayginnes JP, 2006, J VIROL METHODS, V137, P193, DOI 10.1016/j.jviromet.2006.06.011; Mihailovich M, 2007, NUCLEIC ACIDS RES, V35, P2975, DOI 10.1093/nar/gkm191; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Patterson KR, 2011, J BIOL CHEM, V286, P23063, DOI 10.1074/jbc.M111.237974; Reed SE, 2006, J VIROL METHODS, V138, P85, DOI 10.1016/j.jviromet.2006.07.024; Rogers GW, 2004, P NATL ACAD SCI USA, V101, P2794, DOI 10.1073/pnas.0308576101; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Sadleir KR, 2012, J BIOL CHEM, V287, P7224, DOI 10.1074/jbc.M111.333914; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Sleegers K, 2006, BRAIN, V129, P2977, DOI 10.1093/brain/awl203; Sorensen AT, 2008, HIPPOCAMPUS; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Sun X, 2006, P NATL ACAD SCI USA, V103, P18727, DOI 10.1073/pnas.0606298103; Tanzi RE, 2012, COLD SPRING HARB PER, V2; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Tonelli DD, 2004, NUCLEIC ACIDS RES, V32, P1808, DOI 10.1093/nar/gkh348; Tong Y, 2005, J NEURAL TRANSM, V112, P455, DOI 10.1007/s00702-004-0255-3; Tyler SJ, 2002, BIOCHEM BIOPH RES CO, V299, P373, DOI 10.1016/S0006-291X(02)02635-9; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Velliquette RA, 2005, J NEUROSCI, V25, P10874, DOI 10.1523/JNEUROSCI.2350-05.2005; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wen Y, 2004, BRAIN RES, V1009, P1, DOI 10.1016/j.brainres.2003.09.086; Wen Y, 2008, NEURON, V57, P680, DOI 10.1016/j.neuron.2008.02.024; Zempel H, 2012, NEURODEGENER DIS, V10, P64, DOI 10.1159/000332816; Zhang X, 2007, J BIOL CHEM, V282, P10873, DOI 10.1074/jbc.M608856200; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007; Zong YY, 2011, BRAIN RES, V1395, P108, DOI 10.1016/j.brainres.2011.04.035	72	28	28	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101643	10.1371/journal.pone.0101643	http://dx.doi.org/10.1371/journal.pone.0101643			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992504	Green Submitted, Green Published, gold			2022-12-27	WOS:000341253400102
J	Huang, Y; Shi, JQ; Tao, ZS; Zhang, LD; Liu, Q; Wang, XF; Yang, Q; Liu, GH; Wang, HZ				Huang, Yi; Shi, Jiaqin; Tao, Zhangsheng; Zhang, Lida; Liu, Qiong; Wang, Xinfa; Yang, Qing; Liu, Guihua; Wang, Hanzhong			Microarray Expression Analysis of the Main Inflorescence in Brassica napus	PLOS ONE			English	Article							GENE-EXPRESSION; ALLELIC VARIATION; ARABIDOPSIS-THALIANA; ARCHITECTURE; RICE; DIVERSITY; PROFILES; GENOME; QTL	The effect of the number of pods on the main inflorescence (NPMI) on seed yield in Brassica napus plants grown at high density is a topic of great economic and scientific interest. Here, we sought to identify patterns of gene expression that determine the NPMI during inflorescence differentiation. We monitored gene expression profiles in the main inflorescence of two B. napus F-6 RIL pools, each composed of nine lines with a low or high NPMI, and their parental lines, Zhongshuang 11 (ZS11) and 73290, using a Brassica 90K elements oligonucleotide array. We identified 4,805 genes that were differentially expressed (>= 1.5 fold-change) between the low- and high-NPMI samples. Of these, 82.8% had been annotated and 17.2% shared no significant homology with any known genes. About 31 enriched GO clusters were identified amongst the differentially expressed genes (DEGs), including those involved in hormone responses, development regulation, carbohydrate metabolism, signal transduction, and transcription regulation. Furthermore, 92.8% of the DEGs mapped to chromosomes that originated from B. rapa and B. oleracea, and 1.6% of the DEGs co-localized with two QTL intervals (PMI10 and PMI11) known to be associated with the NPMI. Overexpression of BnTPI, which co-localized with PMI10, in Arabidopsis suggested that this gene increases the NPMI. This study provides insight into the molecular factors underlying inflorescence architecture, NPMI determination and, consequently, seed yield in B. napus.	[Huang, Yi; Shi, Jiaqin; Tao, Zhangsheng; Liu, Qiong; Wang, Xinfa; Yang, Qing; Liu, Guihua; Wang, Hanzhong] Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Hubei, Peoples R China; [Zhang, Lida] Shanghai Jiao Tong Univ, Sch Agr & Biol, Plant Biotechnol Res Ctr, Shanghai 200030, Peoples R China; [Liu, Qiong] Hubei Univ, Sch Life Sci & Technol, Wuhan, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Shanghai Jiao Tong University; Hubei University	Wang, HZ (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Hubei, Peoples R China.	wanghz@oilcrops.cn			Hubei Provincial Key Natural Science Foundation [2011CDA073]; National High-tech RD Program [2012AA101107]; National System of Modern Technology for Rapeseed Industry in China [CARS-13]; Hubei Agricultural Science and Technology Innovation Center	Hubei Provincial Key Natural Science Foundation; National High-tech RD Program; National System of Modern Technology for Rapeseed Industry in China; Hubei Agricultural Science and Technology Innovation Center	This work was financially supported by grants from the Hubei Provincial Key Natural Science Foundation (No.: 2011CDA073), National High-tech R&D Program (No.: 2012AA101107), The National System of Modern Technology for Rapeseed Industry in China (No.: CARS-13), and Hubei Agricultural Science and Technology Innovation Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Abied M, 2012, PLANT J, V71, P787, DOI 10.1111/j.1365-313X.2012.05032.x; Benlloch R, 2007, ANN BOT-LONDON, V100, P659, DOI 10.1093/aob/mcm146; Carlsson J, 2007, PLANT J, V49, P452, DOI 10.1111/j.1365-313X.2006.02975.x; Cavell AC, 1998, GENOME, V41, P62, DOI 10.1139/gen-41-1-62; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Eveland AL, 2014, GENOME RES, V24, P431, DOI 10.1101/gr.166397.113; Harder LD, 2013, ANN BOT-LONDON, V112, P1477, DOI 10.1093/aob/mcs252; Hart T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-778; Hitzemann R, 2003, MAMM GENOME, V14, P733, DOI 10.1007/s00335-003-2277-9; Huang Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-256; Iwata T, 2012, NEW PHYTOL, V193, P196, DOI 10.1111/j.1469-8137.2011.03892.x; Jansen L, 2013, PLANT BIOTECHNOL J, V11, P1092, DOI 10.1111/pbi.12104; Jefferson RA, 1987, EMBO J, V6, P39001; Jiang YQ, 2010, PLANT CELL REP, V29, P327, DOI 10.1007/s00299-010-0824-x; Kawamura K, 2011, THEOR APPL GENET, V122, P661, DOI 10.1007/s00122-010-1476-5; Koes R, 2008, TRENDS PLANT SCI, V13, P1, DOI 10.1016/j.tplants.2007.11.004; Koia JH, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-240; Krouk G, 2010, DEV CELL, V18, P927, DOI 10.1016/j.devcel.2010.05.008; Larson SR, 2013, J HERED, V104, P678, DOI 10.1093/jhered/est033; Liu C, 2013, DEV CELL, V24, P612, DOI 10.1016/j.devcel.2013.02.013; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; MacAlister CA, 2012, NAT GENET, V44, P1393, DOI 10.1038/ng.2465; Oono Y, 2013, PLANT MOL BIOL, V83, P523, DOI 10.1007/s11103-013-0106-4; Park SJ, 2014, CURR OPIN PLANT BIOL, V17, P70, DOI 10.1016/j.pbi.2013.11.006; Provart NJ., 2003, CURRENT COMPUTER MOL, V2003, P271; Rodriguez-Suarez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019885; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Shao GN, 2012, THEOR APPL GENET, V125, P1303, DOI 10.1007/s00122-012-1914-7; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Sun MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047037; Teo ZWN, 2014, TRENDS PLANT SCI, V19, P158, DOI 10.1016/j.tplants.2013.11.001; Upadyayula N, 2006, THEOR APPL GENET, V112, P592, DOI 10.1007/s00122-005-0133-x; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Yan F, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-58; Zhu YN, 2012, THEOR APPL GENET, V124, P515, DOI 10.1007/s00122-011-1725-2; Zhu ZF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3200	37	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102024	10.1371/journal.pone.0102024	http://dx.doi.org/10.1371/journal.pone.0102024			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007212	Green Submitted, gold, Green Published			2022-12-27	WOS:000339040600087
J	Ioannidis, JPA; Boyack, KW; Klavans, R				Ioannidis, John P. A.; Boyack, Kevin W.; Klavans, Richard			Estimates of the Continuously Publishing Core in the Scientific Workforce	PLOS ONE			English	Article							PRODUCTIVITY; SCIENCE; LIFE	Background: The ability of a scientist to maintain a continuous stream of publication may be important, because research requires continuity of effort. However, there is no data on what proportion of scientists manages to publish each and every year over long periods of time. Methodology/Principal Findings: Using the entire Scopus database, we estimated that there are 15,153,100 publishing scientists (distinct author identifiers) in the period 1996-2011. However, only 150,608 (<1%) of them have published something in each and every year in this 16-year period (uninterrupted, continuous presence [UCP] in the literature). This small core of scientists with UCP are far more cited than others, and they account for 41.7% of all papers in the same period and 87.1% of all papers with >1000 citations in the same period. Skipping even a single year substantially affected the average citation impact. We also studied the birth and death dynamics of membership in this influential UCP core, by imputing and estimating UCP-births and UCP-deaths. We estimated that 16,877 scientists would qualify for UCP-birth in 1997 (no publication in 1996, UCP in 1997-2012) and 9,673 scientists had their UCP-death in 2010. The relative representation of authors with UCP was enriched in Medical Research, in the academic sector and in Europe/North America, while the relative representation of authors without UCP was enriched in the Social Sciences and Humanities, in industry, and in other continents. Conclusions: The proportion of the scientific workforce that maintains a continuous uninterrupted stream of publications each and every year over many years is very limited, but it accounts for the lion's share of researchers with high citation impact. This finding may have implications for the structure, stability and vulnerability of the scientific workforce.	[Ioannidis, John P. A.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Boyack, Kevin W.] SciTech Strategies Inc, Albuquerque, NM USA; [Klavans, Richard] SciTech Strategies Inc, Berwyn, PA USA	Stanford University; Stanford University; Stanford University	Ioannidis, JPA (corresponding author), Stanford Univ, Dept Med, Stanford, CA 94305 USA.	jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011	Boyack, Kevin/0000-0001-7814-8951				Adams JD, 2005, RES POLICY, V34, P259, DOI 10.1016/j.respol.2005.01.014; BLACKBURN RT, 1986, REV EDUC RES, V56, P265, DOI 10.3102/00346543056003265; Borner K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039464; Boyack KW, 2014, J ASSOC INF SCI TECH, V65, P670, DOI 10.1002/asi.22990; Boyack KW, 2013, EUR J CLIN INVEST, V43, P1339, DOI 10.1111/eci.12171; De Solla Price D. J., 1963, LITTLE SCI BIG SCI; DE SOLLA PRICE DEREK J., 1965, SCIENCE, V149, P510, DOI 10.1126/science.149.3683.510; Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90; Garfield E, 1996, SCIENTIST, V10, P13; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Ioannidis JPA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000005; Ioannidis JPA, 2011, NATURE, V477, P529, DOI 10.1038/477529a; LEVIN SG, 1991, AM ECON REV, V81, P114; Levin SG., 1992, STRIKING MOTHER LODE; LONG JS, 1981, AM SOCIOL REV, V46, P422, DOI 10.2307/2095262; Macleod MR, 2014, LANCET, V383, P101, DOI 10.1016/S0140-6736(13)62329-6; MADDOX GL, 1979, ANNU REV SOCIOL, V5, P113, DOI 10.1146/annurev.so.05.080179.000553; MCNAMEE SJ, 1994, KNOWLEDGE, V15, P396, DOI 10.1177/107554709401500403; Michels C, 2012, SCIENTOMETRICS, V93, P831, DOI 10.1007/s11192-012-0732-7; Nicholson JM, 2012, NATURE, V492, P34, DOI 10.1038/492034a; O'Brien TL, 2012, SCI TECHNOL HUM VAL, V37, P210, DOI 10.1177/0162243911406744; Oster SM, 1998, REV ECON STAT, V80, P154, DOI 10.1162/003465398557258; SIMONTON DK, 1988, PSYCHOL BULL, V104, P251, DOI 10.1037/0033-2909.104.2.251; Stephan PE, 2007, ECON INNOV NEW TECH, V16, P71, DOI 10.1080/10438590600982806; Wray KB, 2004, SCIENTOMETRICS, V61, P117, DOI 10.1023/B:SCIE.0000037367.99073.bb; Young NS, 2008, PLOS MED, V5, P1418, DOI 10.1371/journal.pmed.0050201	26	60	60	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101698	10.1371/journal.pone.0101698	http://dx.doi.org/10.1371/journal.pone.0101698			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL3PK	25007173	Green Published, gold, Green Submitted			2022-12-27	WOS:000339040600059
J	Palusinska-Szysz, M; Kania, M; Turska-Szewczuk, A; Danikiewicz, W; Russa, R; Fuchs, B				Palusinska-Szysz, Marta; Kania, Magdalena; Turska-Szewczuk, Anna; Danikiewicz, Witold; Russa, Ryszard; Fuchs, Beate			Identification of Unusual Phospholipid Fatty Acyl Compositions of Acanthamoeba castellanii	PLOS ONE			English	Article							P-31 NMR-SPECTROSCOPY; BIOLOGY; LIPIDS; BIOSYNTHESIS; PATHOGENESIS; SPP.	Acanthamoeba are opportunistic protozoan pathogens that may lead to sight-threatening keratitis and fatal granulomatous encephalitis. The successful prognosis requires early diagnosis and differentiation of pathogenic Acanthamoeba followed by aggressive treatment regimen. The plasma membrane of Acanthamoeba consists of 25% phospholipids (PL). The presence of C20 and, recently reported, 28- and 30-carbon fatty acyl residues is characteristic of amoeba PL. A detailed knowledge about this unusual PL composition could help to differentiate Acanthamoeba from other parasites, e.g. bacteria and develop more efficient treatment strategies. Therefore, the detailed PL composition of Acanthamoeba castellanii was investigated by P-31 nuclear magnetic resonance spectroscopy, thin-layer chromatography, gas chromatography, high performance liquid chromatography and liquid chromatography-mass spectrometry. Normal and reversed phase liquid chromatography coupled with mass spectrometric detection was used for detailed characterization of the fatty acyl composition of each detected PL. The most abundant fatty acyl residues in each PL class were octadecanoyl (18:0), octadecenoyl (18:1 Delta 9) and hexadecanoyl (16:0). However, some selected PLs contained also very long fatty acyl chains: the presence of 28- and 30-carbon fatty acyl residues was confirmed in phosphatidylethanolamine (PE), phosphatidylserine, phosphatidic acid and cardiolipin. The majority of these fatty acyl residues were also identified in PE that resulted in the following composition: 28:1/20:2, 30:2/18:1, 28:0/20:2, 30:2/20:4 and 30:3/20:3. The PL of amoebae are significantly different in comparison to other cells: we describe here for the first time unusual, very long chain fatty acids with Delta(5)-unsaturation (30:3(5,21,24)) and 30:2(21,24) localized exclusively in specific phospholipid classes of A. castellanii protozoa that could serve as specific biomarkers for the presence of these microorganisms.	[Palusinska-Szysz, Marta; Turska-Szewczuk, Anna; Russa, Ryszard] Marie Curie Sklodowska Univ, Dept Genet & Microbiol, Lublin, Poland; [Kania, Magdalena; Danikiewicz, Witold] Polish Acad Sci, Inst Organ Chem, Mass Spectrometry Grp, Warsaw, Poland; [Fuchs, Beate] Univ Leipzig, Fac Med, Inst Med Phys & Biophys, D-04109 Leipzig, Germany	Maria Curie-Sklodowska University; Polish Academy of Sciences; Institute of Organic Chemistry of the Polish Academy of Sciences; Leipzig University	Fuchs, B (corresponding author), Univ Leipzig, Fac Med, Inst Med Phys & Biophys, D-04109 Leipzig, Germany.	Beate.Fuchs@medizin.uni-leipzig.de	Danikiewicz, Witold/H-2257-2016	Danikiewicz, Witold/0000-0003-0484-2689; Turska-Szewczuk, Anna/0000-0002-2975-9593; Palusinska-Szysz, Marta/0000-0001-8540-3084	Deutsche Forschungsgemeinschaft (German Research Council) DFG [FU 771/1-2]	Deutsche Forschungsgemeinschaft (German Research Council) DFG(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (German Research Council) DFG: FU 771/1-2 (http://www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAND RN, 1959, J GEN MICROBIOL, V21, P80, DOI 10.1099/00221287-21-1-80; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOCHNER BR, 1981, ANAL BIOCHEM, V117, P81, DOI 10.1016/0003-2697(81)90695-3; Brindley N, 2009, EXP PARASITOL, V121, P254, DOI 10.1016/j.exppara.2008.11.009; Croft SL, 2003, MOL BIOCHEM PARASIT, V126, P165, DOI 10.1016/S0166-6851(02)00283-9; Fuchs B, 2012, MINI-REV MED CHEM, V12, P74, DOI 10.2174/138955712798868931; Fuchs B, 2007, CHEM PHYS LIPIDS, V150, P229, DOI 10.1016/j.chemphyslip.2007.08.005; Kates M, 1986, TECHNIQUES LIPIDOLOG, P232; Khan NA, 2001, CURR MICROBIOL, V43, P391, DOI 10.1007/s002840010325; Khan NA, 2006, FEMS MICROBIOL REV, V30, P564, DOI 10.1111/j.1574-6976.2006.00023.x; KORN ED, 1964, J BIOL CHEM, V239, P396; KUNSMAN JE, 1970, J BACTERIOL, V103, P104, DOI 10.1128/JB.103.1.104-110.1970; Lam SM, 2013, J GENET GENOMICS, V40, P375, DOI 10.1016/j.jgg.2013.06.007; Larsen A, 2005, MODERN METHODS LIPID; LITCHFIELD C, 1980, LIPIDS, V15, P200, DOI 10.1007/BF02540971; LONDON E, 1979, J LIPID RES, V20, P408; Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003; McBride J, 2007, J ANTIMICROB CHEMOTH, V60, P521, DOI 10.1093/jac/dkm245; Palusinska-Szysz M, 2009, ACTA PROTOZOOL, V48, P63; Pearce JM, 2000, MAGN RESON MED, V44, P215, DOI 10.1002/1522-2594(200008)44:2<215::AID-MRM8>3.0.CO;2-N; Rod'kina SA, 2005, RUSS J MAR BIOL, V31, P49; Sayanova O, 2006, J BIOL CHEM, V281, P36533, DOI 10.1074/jbc.M605158200; Schiller J, 2004, PROG LIPID RES, V43, P449, DOI 10.1016/j.plipres.2004.08.001; SCHILLER J, 2002, MED SCI MONITOR, V8, P205; Schiller J, 2000, ENCY ANAL CHEM, P559; Schiller J, 2007, CURR ANAL CHEM, V3, P283, DOI 10.2174/157341107782109635; Schiller J, 2007, FRONT BIOSCI-LANDMRK, V12, P2568, DOI 10.2741/2255; Siddiqui R, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-112; Siddiqui R, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-6; SMITH JD, 1993, PROG LIPID RES, V32, P47, DOI 10.1016/0163-7827(93)90004-G; ULSAMER AG, 1969, J CELL BIOL, V43, P105, DOI 10.1083/jcb.43.1.105; Visvesvara GS, 2007, FEMS IMMUNOL MED MIC, V50, P1, DOI 10.1111/j.1574-695X.2007.00232.x; Xu GY, 1996, MICROCHEM J, V53, P29, DOI 10.1006/mchj.1996.0005	33	12	12	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e01243	10.1371/journal.pone.0101243	http://dx.doi.org/10.1371/journal.pone.0101243			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007336	gold, Green Published, Green Submitted			2022-12-27	WOS:000339040600031
J	Morroni, C; Heartwell, S; Edwards, S; Zieman, M; Westhoff, C				Morroni, Chelsea; Heartwell, Stephen; Edwards, Sharon; Zieman, Mimi; Westhoff, Carolyn			The Impact of Oral Contraceptive Initiation on Young Women's Condom Use in 3 American Cities: Missed Opportunities for Intervention	PLOS ONE			English	Article							DUAL-METHOD USE; UNINTENDED PREGNANCY; UNITED-STATES; HIV; RISK; IMPLANTS; CONSISTENCY; DISPARITIES; PREVENTION; PATTERNS	Purpose: To describe women's condom use and assess predictors of consistent condom use and dual method use in the 6 months after the initiation of oral contraception (OC). Methods: We conducted a planned secondary cohort analysis among women less than 25 years of age initiating oral contraceptives at public family planning clinics in Atlanta, Dallas and New York City, USA, as part of a randomized trial. These clinics provide care to predominantly African American or Hispanic women of low socioeconomic status. Participants completed interviews at enrollment and at 6 months after OC start. We used multivariate logistic regression to assess factors associated with consistent condom and dual method use at 6 months. Results: 1281 participants met the inclusion criteria for this analysis. At enrollment prior to OC start, 28% were consistent condom users. In the six months after initiation of oral contraception, only 14% always used a condom and 4% always used dual methods. In multivariate analysis, receiving basic advice to always use a condom after OC initiation from a provider during the baseline clinic consultation was associated with a 50% increase in the odds of using condoms consistently. Only 28% of participants were given this condom use advice. Conclusions: This study documents a decline in women's condom consistent use subsequent to initiation of the oral contraceptive and suggests that opportunities for positive intervention around condom use among women starting hormonal methods are being missed. Basic condom use advice, which is neither time consuming nor resource dependent, was associated with increased consistent use and should be immediately implemented in all family planning services.	[Morroni, Chelsea] UCL, Inst Global Hlth, Inst Womens Hlth, London, England; [Heartwell, Stephen] Susan Thompson Buffet Fdn, Omaha, NE USA; [Edwards, Sharon] Mt Sinai Sch Med, Dept Pediat, New York, NY USA; [Zieman, Mimi] Emory Univ, Dept Gynecol & Obstet, Atlanta, GA 30322 USA; [Westhoff, Carolyn] Columbia Univ, Dept Obstet & Gynecol, New York, NY USA	University of London; University College London; Icahn School of Medicine at Mount Sinai; Emory University; Columbia University	Morroni, C (corresponding author), UCL, Inst Global Hlth, Inst Womens Hlth, London, England.	c.morroni@ucl.ac.uk		Morroni, Chelsea/0000-0002-2026-6039	National Institutes of Health (NIH) [HD42413]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this study was provided by the National Institutes of Health (NIH) Grant Number HD42413. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MM, 2004, B WORLD HEALTH ORGAN, V82, P180; Anderson JE, 2003, JAIDS-J ACQ IMM DEF, V34, P195, DOI 10.1097/00126334-200310010-00010; Bearinger LH, 2003, J ADOLESCENT HEALTH, V32, P340, DOI 10.1016/S1054-139X(03)00018-1; BERENSON AB, 1995, AM J OBSTET GYNECOL, V172, P1128, DOI 10.1016/0002-9378(95)91471-4; Centers for Disease Control, 2010, SEX TRANSM DIS SURV; Crosby RA, 2001, J ADOLESCENT HEALTH, V28, P410, DOI 10.1016/S1054-139X(00)00210-X; Cushman LF, 1998, FAM PLANN PERSPECT, V30, P240, DOI 10.2307/2991611; Darney PD, 1999, AM J OBSTET GYNECOL, V180, P929, DOI 10.1016/S0002-9378(99)70664-2; Eisenberg DL, 2012, INFECT DIS OBSTET GY; Ethier KA, 2003, SEX TRANSM INFECT, V79, P408, DOI 10.1136/sti.79.5.408; Finer LB, 2006, PERSPECT SEX REPRO H, V38, P90, DOI 10.1363/3809006; Finer LB, 2011, CONTRACEPTION, V84, P478, DOI 10.1016/j.contraception.2011.07.013; Ford CA, 2004, PERSPECT SEX REPRO H, V36, P258, DOI 10.1363/3625804; Frost JJ, 2007, PERSPECT SEX REPRO H, V39, P48, DOI 10.1363/3904807; Goldstein RL, 2012, J ADOLESCENT HEALTH, P1; HUMPHRIES HO, 1994, SEX TRANSM DIS, V21, P217, DOI 10.1097/00007435-199407000-00007; JONES J, 2012, CIVIL ENG, V82, P20; KU L, 1994, FAM PLANN PERSPECT, V26, P246, DOI 10.2307/2135889; Lopez LM, 2013, COCHRANE DB SYST REV, V10, DOI DOI 10.1002/14651858.CD010662.PUB2.REVIEW; Martinez Gladys, 2011, Vital Health Stat 23, P1; Morrison CS, 2012, LANCET INFECT DIS, V12, P2, DOI 10.1016/S1473-3099(11)70254-7; Mosher William D, 2004, Adv Data, P1; Mosher William D, 2010, Vital Health Stat 23, P1; Ott MA, 2002, PERSPECT SEX REPRO H, V34, P6, DOI 10.2307/3030227; Pazol K., 2011, Morbidity and Mortality Weekly Report, V60, P414; Pazol K, 2010, PUBLIC HEALTH REP, V125, P208, DOI 10.1177/003335491012500209; PLICHTA SB, 1992, J ADOLESCENT HEALTH, V13, P506, DOI 10.1016/1054-139X(92)90015-4; Polaneczky M, 1999, AM J OBSTET GYNECOL, V181, P1270, DOI 10.1016/S0002-9378(99)70121-3; Riehman KS, 1998, FAM PLANN PERSPECT, V30, P212, DOI 10.2307/2991606; Roye CF, 1998, J ADOLESCENT HEALTH, V23, P205, DOI 10.1016/S1054-139X(97)00264-4; Sangi-Haghpeykar H, 2005, PERSPECT SEX REPRO H, V37, P184, DOI 10.1363/3718405; SangiHaghpeykar H, 1997, FAM PLANN PERSPECT, V29, P67, DOI 10.2307/2953364; SANTELLI JS, 1995, FAM PLANN PERSPECT, V27, P74, DOI 10.2307/2135909; Sayegh MA, 2006, J ADOLESCENT HEALTH, V39, P388, DOI 10.1016/j.jadohealth.2005.12.027; Sieving Renee E, 2007, J Adolesc Health, V40, DOI 10.1016/j.jadohealth.2006.10.003; Trussell J, 2011, CONTRACEPTION, V83, P397, DOI 10.1016/j.contraception.2011.01.021; US. Department of Health and Human Services Office of Disease Prevention and Health Promotion, 2020, HLTH PEOPL 2020; Westhoff C, 2007, OBSTET GYNECOL, V109, P1270, DOI 10.1097/01.AOG.0000264550.41242.f2; WHO, 2012, HORM CONTR HIV TECHN; Wilson TE, 2003, SEX TRANSM DIS, V30, P809, DOI 10.1097/01.OLQ.0000086617.41012.14	40	14	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101804	10.1371/journal.pone.0101804	http://dx.doi.org/10.1371/journal.pone.0101804			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL6KZ	25003504	Green Published, gold, Green Submitted			2022-12-27	WOS:000339242700068
J	Panda, AC; Sahu, I; Kulkarni, SD; Martindale, JL; Abdelmohsen, K; Vindu, A; Joseph, J; Gorospe, M; Seshadri, V				Panda, Amaresh C.; Sahu, Itishri; Kulkarni, Shardul D.; Martindale, Jennifer L.; Abdelmohsen, Kotb; Vindu, Arya; Joseph, Jomon; Gorospe, Myriam; Seshadri, Vasudevan			miR-196b-Mediated Translation Regulation of Mouse Insulin2 via the 5 ' UTR	PLOS ONE			English	Article							MESSENGER-RNA; POSTTRANSCRIPTIONAL REGULATION; MICRORNA EXPRESSION; GLUCOSE; REPRESSION; RESISTANCE; PANCREAS; ISLETS; GENES; HUR	The 5' and the 3' untranslated regions (UTR) of the insulin genes are very well conserved across species. Although microRNAs (miRNAs) are known to regulate insulin secretion process, direct regulation of insulin biosynthesis by miRNA has not been reported. Here, we show that mouse microRNA miR-196b can specifically target the 5'UTR of the long insulin2 splice isoform. Using reporter assays we show that miR-196b specifically increases the translation of the reporter protein luciferase. We further show that this translation activation is abolished when Argonaute 2 levels are knocked down after transfection with an Argonaute 2-directed siRNA. Binding of miR-196b to the target sequence in insulin 5'UTR causes the removal of HuD (a 5'UTR-associated translation inhibitor), suggesting that both miR-196b and HuD bind to the same RNA element. We present data suggesting that the RNA-binding protein HuD, which represses insulin translation, is displaced by miR-196b. Together, our findings identify a mechanism of post-transcriptional regulation of insulin biosynthesis.	[Panda, Amaresh C.; Sahu, Itishri; Kulkarni, Shardul D.; Vindu, Arya; Joseph, Jomon; Seshadri, Vasudevan] Natl Ctr Cell Sci, Pune, Maharashtra, India; [Panda, Amaresh C.; Martindale, Jennifer L.; Abdelmohsen, Kotb; Gorospe, Myriam] NIA, Genet Lab, NIH, Baltimore, MD 21224 USA	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Seshadri, V (corresponding author), Natl Ctr Cell Sci, Pune, Maharashtra, India.	seshadriv@nccs.res.in	Joseph, Jomon/C-1397-2009; Martindale, Jennifer Luethy/AAD-1963-2022; Kulkarni, S/AAO-8388-2020; Vindu, Arya/GQP-2981-2022; Abdelmohsen, Kotb/AAX-4191-2020; Kulkarni, Shardul/AAD-2205-2020; Panda, Amaresh C./H-5459-2019	Martindale, Jennifer Luethy/0000-0002-3234-6861; Abdelmohsen, Kotb/0000-0001-6240-5810; Kulkarni, Shardul/0000-0003-3814-4432; Panda, Amaresh C./0000-0003-3189-8995; Joseph, Jomon/0000-0002-3042-6286; Sahu, Itishri/0000-0002-6069-656X; Vindu, Arya/0000-0001-8711-2037	Department of Biotechnology, India [BT/PR14109/BRB/10/812/2010]; intramural grant from National Centre for Cell Science, India; Council for scientific and industrial research, India; National Institute on Aging - Intramural Research Program, National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIAAG000394] Funding Source: NIH RePORTER	Department of Biotechnology, India(Department of Biotechnology (DBT) India); intramural grant from National Centre for Cell Science, India; Council for scientific and industrial research, India(Council of Scientific & Industrial Research (CSIR) - India); National Institute on Aging - Intramural Research Program, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grant (BT/PR14109/BRB/10/812/2010) from Department of Biotechnology, India, and intramural grant from National Centre for Cell Science, India, to VS. AV and SDK are supported by a fellowship from Council for scientific and industrial research, India. KA, JLM, and MG were supported by the National Institute on Aging - Intramural Research Program, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Baroukh N, 2007, J BIOL CHEM, V282, P19575, DOI 10.1074/jbc.M611841200; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; DOCHERTY K, 1994, FASEB J, V8, P20, DOI 10.1096/fasebj.8.1.8299887; Gao Y, 2011, NUCLEIC ACIDS RES, V39, P454, DOI 10.1093/nar/gkq782; Gauthier BR, 2006, NAT MED, V12, P36, DOI 10.1038/nm0106-36; He AB, 2007, MOL ENDOCRINOL, V21, P2785, DOI 10.1210/me.2007-0167; Huang B, 2009, ACTA BIOCH BIOPH SIN, V41, P472, DOI 10.1093/abbs/gmp035; ITOH N, 1978, FEBS LETT, V93, P343, DOI 10.1016/0014-5793(78)81136-3; Joglekar MV, 2009, GENE EXPR PATTERNS, V9, P109, DOI 10.1016/j.gep.2008.10.001; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Lee EK, 2010, ENDOCRINOLOGY, V151, P1403, DOI 10.1210/en.2009-1123; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Ling HY, 2009, CLIN EXP PHARM PHYSL; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; Minn AH, 2005, MOL ENDOCRINOL, V19, P794, DOI 10.1210/me.2004-0119; Muralidharan B, 2007, FEBS LETT, V581, P4103, DOI 10.1016/j.febslet.2007.07.050; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Panda AC, 2013, INT J MOL SCI, V14, P19202, DOI 10.3390/ijms140919202; Panda AC, 2010, FEBS LETT, V584, P1169, DOI 10.1016/j.febslet.2010.02.020; Phua SLC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025689; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Plaisance V, 2006, J BIOL CHEM, V281, P26932, DOI 10.1074/jbc.M601225200; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Srikantan S, 2012, CURR PROTEIN PEPT SC, V13, P372, DOI 10.2174/138920312801619394; Tsai NP, 2009, BIOCHEM J, V424, P411, DOI 10.1042/BJ20090915; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; WESSELLS NK, 1968, DEV BIOL, V17, P413, DOI 10.1016/0012-1606(68)90073-0; Wicksteed B, 2001, J BIOL CHEM, V276, P22553, DOI 10.1074/jbc.M011214200; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zhou X, 2009, GENETICA, V137, P159, DOI 10.1007/s10709-009-9378-7	32	25	28	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101084	10.1371/journal.pone.0101084	http://dx.doi.org/10.1371/journal.pone.0101084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003985	Green Submitted, Green Published, gold			2022-12-27	WOS:000339242700018
J	Polidori, C; Nieves-Aldrey, JL				Polidori, Carlo; Nieves-Aldrey, Jose L.			Diverse Filters to Sense: Great Variability of Antennal Morphology and Sensillar Equipment in Gall-Wasps (Hymenoptera: Cynipidae)	PLOS ONE			English	Article							MULTIPOROUS PLATE SENSILLA; SCANNING-ELECTRON-MICROSCOPY; 2 PARASITOID WASPS; FLAGELLAR SENSILLA; PHYLOGENETIC-RELATIONSHIPS; FUNCTIONAL-MORPHOLOGY; EVOLUTION; BRACONIDAE; ULTRASTRUCTURE; CHALCIDOIDEA	Comparative studies on antennal sensillar equipment in insects are largely lacking, despite their potential to provide insights into both ecological and phylogenetic relationships. Here we present the first comparative study on antennal morphology and sensillar equipment in female Cynipoidea (Hymenoptera), a large and diverse group of wasps, with special reference to the so-called gall-wasps (Cynipidae). A SEM analysis was conducted on 51 species from all extant cynipoid families and all cynipid tribes, and spanning all known life-histories in the superfamily (gall-inducers, gall-inquilines, and non-gall associated parasitoids). The generally filiform, rarely clavate, antennal flagellum of Cynipoidea harbours overall 12 types of sensilla: s. placoidea (SP), two types of s. coeloconica (SCo-A, SCo-B), s. campaniformia (SCa), s. basiconica (SB), five types of s. trichoidea (ST-A, B, C, D, E), large disc sensilla (LDS) and large volcano sensilla (LVS). We found a great variability in sensillar equipment both among and within lineages. However, few traits seem to be unique to specific cynipid tribes. Paraulacini are, for example, distinctive in having apical LVS; Pediaspidini are unique in having >= 3 rows of SP, each including 6-8 sensilla per flagellomere, and up to 7 SCo-A in a single flagellomere; Eschatocerini have by far the largest SCo-A. Overall, our data preliminarily suggest a tendency to decreased numbers of SP rows per flagellomere and increased relative size of SCo-A during cynipoid evolution. Furthermore, SCo-A size seems to be higher in species inducing galls in trees than in those inducing galls in herbs. On the other hand, ST seem to be more abundant on the antennae of herb-gallers than wood-gallers. The antennal morphology and sensillar equipment in Cynipoidea are the complex results of different interacting pressures that need further investigations to be clarified.	[Polidori, Carlo; Nieves-Aldrey, Jose L.] CSIC, Museo Nacl Ciencias Nat, Dept Biodiversidad & Biol Evolut, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Polidori, C (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Biodiversidad & Biol Evolut, E-28006 Madrid, Spain.	cpolidori@mncn.csic.es	Polidori, Carlo/G-4382-2010; Nieves-Aldrey, Jose Luis/K-2544-2012	Polidori, Carlo/0000-0003-4834-0752; Nieves-Aldrey, Jose Luis/0000-0002-4711-7455	Spanish Research Council (CSIC); European Social Fund; Spanish Ministry of Science and Innovation [CGL2005-01922/BOS, CGL2009-10111/BOS, CGL2010-15786/BOS]	Spanish Research Council (CSIC); European Social Fund(European Social Fund (ESF)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	CP was funded by a post-doctoral contract (Program JAE-Doc "Junta para la Ampliacion de Estudios'' funded by the Spanish Research Council (CSIC) and the European Social Fund). JLNA was supported in part by research projects CGL2005-01922/BOS, CGL2009-10111/BOS and CGL2010-15786/BOS by the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acs Z, 2010, MOL PHYLOGENET EVOL, V55, P210, DOI 10.1016/j.ympev.2009.12.004; AGREN L, 1978, INT J INSECT MORPHOL, V7, P73, DOI 10.1016/S0020-7322(78)80016-6; Agren L, 1996, APIDOLOGIE, V27, P433, DOI 10.1051/apido:19960601; Agren L., 1977, International J Insect Morph Embryol, V6, P137, DOI 10.1016/0020-7322(77)90002-2; Ahmed T, 2013, MICRON, V50, P35, DOI 10.1016/j.micron.2013.04.003; Altner H., 1980, International Review of Cytology, V67, P69, DOI 10.1016/S0074-7696(08)62427-4; Altner H., 1977, OLFACTION TASTE, V6, P295; Amornsak W, 1998, INT J INSECT MORPHOL, V27, P67, DOI 10.1016/S0020-7322(98)00003-8; Barbarossa IT, 1998, ITAL J ZOOL, V65, P367, DOI 10.1080/11250009809386775; BARLIN MR, 1981, INT J INSECT MORPHOL, V10, P29, DOI 10.1016/0020-7322(81)90011-8; Basibuyuk HH, 1999, ZOOL SCR, V28, P51, DOI 10.1046/j.1463-6409.1999.00007.x; Basibuyuk HH, 2000, ANN ENTOMOL SOC AM, V93, P625, DOI 10.1603/0013-8746(2000)093[0625:MASOTO]2.0.CO;2; Bin F., 1981, Redia, V64, P245; Bleeker MAK, 2004, MICROSC RES TECHNIQ, V63, P266, DOI 10.1002/jemt.20038; Bourdais D, 2006, MICROSC RES TECHNIQ, V69, P1005, DOI 10.1002/jemt.20378; Buffington ML, 2007, ZOOTAXA, P1; Buffington ML, 2007, CLADISTICS, V23, P403, DOI 10.1111/j.1096-0031.2007.00153.x; Buffington ML, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.202.2136; Buffington ML, 2011, P ENTOMOL SOC WASH, V113, P91, DOI 10.4289/0013-8797.113.2.91; BUTTERFIELD A, 1994, INT J INSECT MORPHOL, V23, P11, DOI 10.1016/0020-7322(94)90012-4; CALLAHAN P S, 1975, International Journal of Insect Morphology and Embryology, V4, P381, DOI 10.1016/0020-7322(75)90038-0; CAVE RD, 1987, INT J INSECT MORPHOL, V16, P27, DOI 10.1016/0020-7322(87)90054-7; Chapman RF, 2003, ANNU REV ENTOMOL, V48, P455, DOI 10.1146/annurev.ento.48.091801.112629; CHAPMAN RF, 1982, ADV INSECT PHYSIOL, V16, P247, DOI 10.1016/S0065-2806(08)60155-1; Csoka Gyorgy, 2005, P573; da Rocha L, 2007, NEOTROP ENTOMOL, V36, P721, DOI 10.1590/S1519-566X2007000500013; Das P, 2011, MICROSC RES TECHNIQ, V74, P900, DOI 10.1002/jemt.20974; Dicke M, 2001, ANNU REV ECOL SYST, V32, P1, DOI 10.1146/annurev.ecolsys.32.081501.113951; DIETZ A, 1971, ANN ENTOMOL SOC AM, V64, P919, DOI 10.1093/aesa/64.4.919; Dweck HKM, 2008, BIOCONTROL, V53, P841, DOI 10.1007/s10526-007-9145-6; Galvani GL, 2012, MICRON, V43, P673, DOI 10.1016/j.micron.2011.12.003; Gao Y, 2007, MICRON, V38, P684, DOI 10.1016/j.micron.2006.09.004; Gauld I. D., 1988, HYMENOPTERA; GIBSON GAP, 1986, CAN ENTOMOL, V118, P205, DOI 10.4039/Ent118205-3; Gibson GAP, 1999, ZOOL SCR, V28, P87, DOI 10.1046/j.1463-6409.1999.00016.x; Gibson GAP, 2007, J HYMENOPT RES, V16, P51; Goulet H., 1993, HYMENOPTERA WORLD ID, V1894E; Hartenstein V., 2005, P379; HASHIMOTO Y, 1990, APPL ENTOMOL ZOOL, V25, P491, DOI 10.1303/aez.25.491; Hicks JB, 1859, T LINN SOC LONDON ZO, V22, P141; Isidoro N, 1999, ZOOL SCR, V28, P165, DOI 10.1046/j.1463-6409.1999.00013.x; Isidoro N., 1996, Journal of Hymenoptera Research, V5, P206; Isidoro N, 2001, MICROSC RES TECHNIQ, V55, P350, DOI 10.1002/jemt.1183; Isidoro Nunzio, 1992, Redia, V75, P169; JOURDAN H, 1995, INT J INSECT MORPHOL, V24, P307, DOI 10.1016/0020-7322(95)98584-Z; Keil TA, 1997, MICROSC RES TECHNIQ, V39, P506, DOI 10.1002/(SICI)1097-0029(19971215)39:6<506::AID-JEMT5>3.0.CO;2-B; Keil Thomas A., 1999, P5; Klopfstein S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-218; LACHER V, 1964, Z VERGL PHYSIOL, V48, P587, DOI 10.1007/BF00333743; Li J, 2013, FLA ENTOMOL, V96, P1288, DOI 10.1653/024.096.0407; Li ZB, 2009, CAN ENTOMOL, V141, P463, DOI 10.4039/n09-011; Liljeblad J, 2011, ZOOTAXA, P35, DOI 10.11646/zootaxa.2806.1.3; Liljeblad J, 2008, ZOOTAXA, P1; Nieves-Aldrey JL, 2009, ZOOTAXA, P1; MARTINI R, 1986, TISSUE CELL, V18, P143, DOI 10.1016/0040-8166(86)90013-3; Meng ZJ, 2012, MICROSC RES TECHNIQ, V75, P1066, DOI 10.1002/jemt.22032; Merivee E, 2003, PHYSIOL ENTOMOL, V28, P88, DOI 10.1046/j.1365-3032.2003.00320.x; Meyhofer R, 1997, ANN ENTOMOL SOC AM, V90, P208, DOI 10.1093/aesa/90.2.208; Mottern JL, 2011, SYST ENTOMOL, V36, P267, DOI 10.1111/j.1365-3113.2010.00557.x; Navasero RC, 1991, P ENTOMOL SOC WASH, V93, P343; Nieves-Aldrey J. L., 2001, HYMENOPTERA CYNIPIDA, V16; NORTON W N, 1974, International Journal of Insect Morphology and Embryology, V3, P305, DOI 10.1016/0020-7322(74)90025-7; NYLANDER JAA, 2004, BAYESIAN PHYLOGENETI; Obonyo M, 2011, ANN SOC ENTOMOL FR, V47, P119, DOI 10.1080/00379271.2011.10697703; Ochieng SA, 2000, ARTHROPOD STRUCT DEV, V29, P231, DOI 10.1016/S1467-8039(01)00008-1; OLSON DM, 1993, INT J INSECT MORPHOL, V22, P507, DOI 10.1016/0020-7322(93)90037-2; Onagbola EO, 2008, MICRON, V39, P526, DOI 10.1016/j.micron.2007.08.001; Onagbola EO, 2009, ANN ENTOMOL SOC AM, V102, P523, DOI 10.1603/008.102.0324; Ozaki Mamiko, 1999, P143; Pettersson EM, 2001, J APPL ENTOMOL, V125, P293, DOI 10.1046/j.1439-0418.2001.00550.x; Polidori C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070529; Polidori C, 2012, CR BIOL, V335, P279, DOI 10.1016/j.crvi.2012.03.008; Romani Roberto, 2010, Atti della Accademia Nazionale Italiana di Entomologia Rendiconti, V58, P97; Romani R, 2010, PROG BIOL CONTROL, V9, P57, DOI 10.1007/978-1-4020-9110-0_3; RONQUIST F, 1994, EVOLUTION, V48, P241, DOI 10.1111/j.1558-5646.1994.tb01310.x; Ronquist F, 2001, EVOLUTION, V55, P2503; Ronquist F, 1999, ZOOL SCR, V28, P139, DOI 10.1046/j.1463-6409.1999.00022.x; Roux O, 2005, MICROSC RES TECHNIQ, V68, P36, DOI 10.1002/jemt.20220; Ruchty M, 2009, ARTHROPOD STRUCT DEV, V38, P195, DOI 10.1016/j.asd.2008.11.001; Sharkey MJ, 2012, CLADISTICS, V28, P80, DOI 10.1111/j.1096-0031.2011.00366.x; Spaethe J, 2007, NATURWISSENSCHAFTEN, V94, P733, DOI 10.1007/s00114-007-0251-1; Steinbrecht RA, 1997, INT J INSECT MORPHOL, V26, P229, DOI 10.1016/S0020-7322(97)00024-X; Stone GN, 2003, TRENDS ECOL EVOL, V18, P512, DOI 10.1016/S0169-5347(03)00247-7; Stone GN, 1998, P ROY SOC B-BIOL SCI, V265, P979, DOI 10.1098/rspb.1998.0387; Stone GN, 2002, ANNU REV ENTOMOL, V47, P633, DOI 10.1146/annurev.ento.47.091201.145247; Stone GN, 2009, EVOLUTION, V63, P854, DOI 10.1111/j.1558-5646.2008.00604.x; Symonds MRE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078297; Todd Julie L., 1999, P67; Tormos J, 2013, MICROSC MICROANAL, V19, P1475, DOI 10.1017/S1431927613013330; van Baaren J, 1999, ZOOMORPHOLOGY, V119, P1, DOI 10.1007/s004350050076; van Baaren J., 2007, MODERN RES ED TOPICS, VVolume 1, P345; vanBaaren J, 1996, CAN J ZOOL, V74, P710, DOI 10.1139/z96-080; VIGGIANI G, 1982, Bollettino del Laboratorio di Entomologia Agraria Filippo Silvestri, V39, P19; Villa L., 1992, Frustula Entomologica, V13, P9; VOEGELE J, 1975, Entomophaga, V20, P161, DOI 10.1007/BF02371656; WALTHER J R, 1983, Verhandlungen des Naturwissenschaftlichen Vereins in Hamburg, V26, P373; Wang XY, 2010, MICROSC RES TECHNIQ, V73, P560, DOI 10.1002/jemt.20795; WARE AB, 1992, P K NED AKAD WETENSC, V95, P275; WCISLO WT, 1995, INT J INSECT MORPHOL, V24, P63, DOI 10.1016/0020-7322(94)E0006-B; Xi YQ, 2011, MICROSC RES TECHNIQ, V74, P936, DOI 10.1002/jemt.20979; Yoder MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015991; Zacharuk R.Y., 1985, COMPREHENSIVE INSECT, P1; Zhou H, 2013, MICRON, V44, P365, DOI 10.1016/j.micron.2012.09.001; Zhou H, 2011, MICROSC RES TECHNIQ, V74, P1199, DOI 10.1002/jemt.21016	104	16	17	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101843	10.1371/journal.pone.0101843	http://dx.doi.org/10.1371/journal.pone.0101843			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003514	Green Published, Green Submitted, gold			2022-12-27	WOS:000339242700077
J	Santalla, M; Valverde, CA; Harnichar, E; Lacunza, E; Aguilar-Fuentes, J; Mattiazzi, A; Ferrero, P				Santalla, Manuela; Valverde, Carlos A.; Harnichar, Ezequiel; Lacunza, Ezequiel; Aguilar-Fuentes, Javier; Mattiazzi, Alicia; Ferrero, Paola			Aging and CaMKII Alter Intracellular Ca2+ Transients and Heart Rhythm in Drosophila melanogaster	PLOS ONE			English	Article							PROTEIN-KINASE-II; CARDIAC-HYPERTROPHY; RYANODINE RECEPTOR; PHOSPHORYLATION; AGE; ARRHYTHMIAS; INHIBITION; MUTATIONS; LOAD	Aging is associated to disrupted contractility and rhythmicity, among other cardiovascular alterations. Drosophila melanogaster shows a pattern of aging similar to human beings and recapitulates the arrhythmogenic conditions found in the human heart. Moreover, the kinase CaMKII has been characterized as an important regulator of heart function and an arrhythmogenic molecule that participate in Ca2+ handling. Using a genetically engineered expressed Ca2+ indicator, we report changes in cardiac Ca2+ handling at two different ages. Aging prolonged relaxation, reduced spontaneous heart rate (HR) and increased the occurrence of arrhythmias, ectopic beats and asystoles. Alignment between Drosophila melanogaster and human CaMKII showed a high degree of conservation and indicates that relevant phosphorylation sites in humans are also present in the fruit fly. Inhibition of CaMKII by KN-93 (CaMKII-specific inhibitor), reduced HR without significant changes in other parameters. By contrast, overexpression of CaMKII increased HR and reduced arrhythmias. Moreover, it increased fluorescence amplitude, maximal rate of rise of fluorescence and reduced time to peak fluorescence. These results suggest that CaMKII in Drosophila melanogaster acts directly on heart function and that increasing CaMKII expression levels could be beneficial to improve contractility.	[Santalla, Manuela; Valverde, Carlos A.; Harnichar, Ezequiel; Mattiazzi, Alicia; Ferrero, Paola] Univ Nacl La Plata, Fac Med, CONICET La Plata, Ctr Invest Cardiovasc, La Plata, Buenos Aires, Argentina; [Santalla, Manuela; Ferrero, Paola] Univ Nacl Noroeste Buenos Aires, Dept Ciencias Basicas & Expt, Buenos Aires, DF, Argentina; [Lacunza, Ezequiel] Univ Nacl La Plata, Ctr Invest Inmunol Basicas & Aplicadas, CONICET La Plata, Fac Med, La Plata, Buenos Aires, Argentina; [Aguilar-Fuentes, Javier] Univ Autonoma Chiapas, Ctr Mesoamer Estudios Salud Publ & Desastres, Lab Epigenet Neurodesarrollo & Neurobiol Mol, Tapachula, Chiapas, Mexico	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Universidad Nacional del Noroeste de la Provincia de Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Universidad Autonoma de Chiapas	Ferrero, P (corresponding author), Univ Nacl La Plata, Fac Med, CONICET La Plata, Ctr Invest Cardiovasc, La Plata, Buenos Aires, Argentina.	pferrero@unnoba.edu.ar	Mattiazzi, Alicia/L-1512-2019	Mattiazzi, Alicia/0000-0002-5166-5606; Ferrero, Paola/0000-0002-5582-642X; Harnichar, Alejandro Ezequiel/0000-0002-1308-9097; Santalla, Manuela/0000-0002-3590-9586	UNNOBA (SIB); CONICET [PIP-2010-00318]; PIP [2139]; MinCyT [PICT 1903]	UNNOBA (SIB); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); PIP; MinCyT	This work was supported by grants of UNNOBA (SIB 2013) and CONICET (PIP-2010-00318) to PF and PIP 2139 and MinCyT, PICT 1903, to AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai X, 2005, CIRC RES, V97, P1314, DOI 10.1161/01.RES.0000194329.41863.89; Anderson ME, 2009, J CLIN INVEST, V119, P1082, DOI 10.1172/JCI39262; Ashpole NM, 2012, J BIOL CHEM, V287, P19856, DOI 10.1074/jbc.M111.322537; Backs J, 2009, P NATL ACAD SCI USA, V106, P2342, DOI 10.1073/pnas.0813013106; Bodmer R, 1998, DEV GENET, V22, P181, DOI 10.1002/(SICI)1520-6408(1998)22:3<181::AID-DVG1>3.0.CO;2-2; Bodmer R., 2004, BIOTECHNIQUES, DOI [10.2144/04371st01, DOI 10.2144/04371ST01]; Cain BS, 1998, J AM COLL CARDIOL, V32, P458, DOI 10.1016/S0735-1097(98)00233-2; Cammarato A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018497; CHO KO, 1991, NEURON, V7, P439, DOI 10.1016/0896-6273(91)90296-C; Cripps RM, 2002, DEV BIOL, V246, P14, DOI 10.1006/dbio.2002.0666; Desai-Shah M., 2010, OPEN PHYSL J, V3, P16; Dulcis D, 2005, J NEUROSCI, V25, P271, DOI 10.1523/JNEUROSCI.2906-04.2005; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Fares E, 2010, CLIN EXP PHARMACOL P, V37, P1, DOI 10.1111/j.1440-1681.2009.05276.x; Ferrero P, 2007, J MOL CELL CARDIOL, V43, P281, DOI 10.1016/j.yjmcc.2007.05.022; Gaertner TR, 2004, J BIOL CHEM, V279, P12484, DOI 10.1074/jbc.M313597200; Gonano LA, 2011, CIRC-ARRHYTHMIA ELEC, V4, P947, DOI 10.1161/CIRCEP.111.964908; GRIFFITH LC, 1993, NEURON, V10, P501, DOI 10.1016/0896-6273(93)90337-Q; Guo T, 2006, CIRC RES, V99, P398, DOI 10.1161/01.RES.0000236756.06252.13; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Lin N, 2011, CIRC RES, V108, P1306, DOI 10.1161/CIRCRESAHA.110.238105; Ling HY, 2009, J CLIN INVEST, V119, P1230, DOI 10.1172/JCI38022; Luong N, 2006, CELL METAB, V4, P133, DOI 10.1016/j.cmet.2006.05.013; Maier LS, 2012, ADV EXP MED BIOL, V740, P685, DOI 10.1007/978-94-007-2888-2_30; Maier LS, 2003, CIRC RES, V92, P904, DOI 10.1161/01.RES.0000069685.20258.F1; MundinaWeilenmann C, 1996, J BIOL CHEM, V271, P33561, DOI 10.1074/jbc.271.52.33561; Ocorr K, 2007, P NATL ACAD SCI USA, V104, P3943, DOI 10.1073/pnas.0609278104; Paternostro G, 2001, CIRC RES, V88, P1053, DOI 10.1161/hh1001.090857; Said M, 2008, AM J PHYSIOL-HEART C, V295, pH1669, DOI 10.1152/ajpheart.00010.2008; Said M, 2011, J MOL CELL CARDIOL, V51, P936, DOI 10.1016/j.yjmcc.2011.08.010; Sanyal S, 2006, J COMP PHYSIOL B, V176, P253, DOI 10.1007/s00360-005-0046-7; Taghli-Lamallem O, 2008, AGING CELL, V7, P237, DOI 10.1111/j.1474-9726.2008.00367.x; Takamatsu Y, 2003, BRAIN RES, V974, P99, DOI 10.1016/S0006-8993(03)02562-9; Tang M, 2013, CIRC-CARDIOVASC GENE, V6, P472, DOI 10.1161/CIRCGENETICS.113.000253; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Vinogradova TM, 2000, CIRC RES, V87, P760, DOI 10.1161/01.RES.87.9.760; Vogler G, 2009, JOVE-J VIS EXP; Wang Z, 1998, J NEUROCHEM, V71, P378; Wessel RJ, 2004, BIOTECHNIQUES, V37, P58, DOI 10.2144/04371ST01; Wessells R, 2009, AGING CELL, V8, P542, DOI 10.1111/j.1474-9726.2009.00504.x; Wolf MJ, 2006, P NATL ACAD SCI USA, V103, P1394, DOI 10.1073/pnas.0507359103; Wu YJ, 2009, P NATL ACAD SCI USA, V106, P5972, DOI 10.1073/pnas.0806422106; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215	43	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101871	10.1371/journal.pone.0101871	http://dx.doi.org/10.1371/journal.pone.0101871			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003749	Green Published, Green Submitted, gold			2022-12-27	WOS:000339242700079
J	Devanathan, S; Whitehead, T; Schweitzer, GG; Fettig, N; Kovacs, A; Korach, KS; Finck, BN; Shoghi, KI				Devanathan, Sriram; Whitehead, Timothy; Schweitzer, George G.; Fettig, Nicole; Kovacs, Attila; Korach, Kenneth S.; Finck, Brian N.; Shoghi, Kooresh I.			An Animal Model with a Cardiomyocyte-Specific Deletion of Estrogen Receptor Alpha: Functional, Metabolic, and Differential Network Analysis	PLOS ONE			English	Article							ER-ALPHA; GLUCOSE-HOMEOSTASIS; TISSUE DISTRIBUTION; ADIPOSE-TISSUE; BETA; EXPRESSION; GENE; MUSCLE; PATHWAYS; CELLS	Estrogen exerts diverse biological effects in multiple tissues in both animals and humans. Much of the accumulated knowledge on the role of estrogen receptor (ER) in the heart has been obtained from studies using ovariectomized mice, whole body ER gene knock-out animal models, ex vivo heart studies, or from isolated cardiac myocytes. In light of the wide systemic influence of ER signaling in regulating a host of biological functions in multiple tissues, it is difficult to infer the direct role of ER on the heart. Therefore, we developed a mouse model with a cardiomyocyte-specific deletion of the ER alpha allele (cs-ER alpha(-/-)). Male and female cs-ER alpha(-/-) mice with age/sex-matched wild type controls were examined for differences in cardiac structure and function by echocardiogram and differential gene expression microarray analysis. Our study revealed sex-differences in structural parameters in the hearts of cs-ER alpha(-/-) mice, with minimal functional differences. Analysis of microarray data revealed differential variations in the expression of 208 genes affecting multiple transcriptional networks. Furthermore, we report sex-specific differences in the expression of 56 genes. Overall, we developed a mouse model with cardiac-specific deletion of ER alpha to characterize the role of ER alpha in the heart independent of systemic effects. Our results suggest that ER alpha is involved in controlling the expression of diverse genes and networks in the cardiomyocyte in a sex-dependent manner.	[Devanathan, Sriram; Whitehead, Timothy; Fettig, Nicole; Shoghi, Kooresh I.] Washington Univ, Dept Radiol, St Louis, MO 63130 USA; [Schweitzer, George G.; Finck, Brian N.] Washington Univ, Dept Med, Div Geriatr & Nutr Sci, St Louis, MO USA; [Kovacs, Attila] Washington Univ, Dept Med, Cardiovasc Res Ctr, St Louis, MO USA; [Korach, Kenneth S.] NIEHS, Lab Reprod & Dev Toxicol, Receptor Biol Sect, NIH, Res Triangle Pk, NC 27709 USA; [Shoghi, Kooresh I.] Washington Univ, Dept Biomed Engn, St Louis, MO USA; [Shoghi, Kooresh I.] Washington Univ, Div Biol & Biomed Sci, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Washington University (WUSTL); Washington University (WUSTL)	Shoghi, KI (corresponding author), Washington Univ, Dept Radiol, St Louis, MO 63130 USA.	shoghik@wustl.edu	Shoghi, Kooresh/H-7398-2014; devanathan, sriram/H-6519-2014	Shoghi, Kooresh/0000-0003-3204-457X; Finck, Brian/0000-0001-5411-3674; Korach, Kenneth/0000-0002-7765-418X	National Institutes of Health (NIH) [R01-EB012284]; NIH [R01-DK085298, Z01ES70065, T32-HL007275, P30-DK020579]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007081, R01HL119225, T32HL007275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, R01DK085298, P30DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES070065, Z01ES070065] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The work was partially supported by research funds from the National Institutes of Health (NIH, http://www.nih.gov) grant number R01-EB012284 to KIS, NIH grant number R01-DK085298 to KIS, intramural NIH research funding Z01ES70065 to KSK, and intramural funds available to KIS. GGS was supported by NIH training grant T32-HL007275. The work utilized core services available through the Washington University School of Medicine Diabetes Research Center (DRC) supported by NIH grant number P30-DK020579. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Loza PA, 2012, HYPERTENSION, V60, P1070, DOI 10.1161/HYPERTENSIONAHA.111.190389; Ascenzi Paolo, 2006, Molecular Aspects of Medicine, V27, P299, DOI 10.1016/j.mam.2006.07.001; Aslanidi G, 2007, AM J PHYSIOL-ENDOC M, V293, pE726, DOI 10.1152/ajpendo.00248.2007; Barros RPA, 2006, P NATL ACAD SCI USA, V103, P1605, DOI 10.1073/pnas.0510391103; Boj SF, 2012, CELL, V151, P1595, DOI 10.1016/j.cell.2012.10.053; Bryzgalova G, 2006, DIABETOLOGIA, V49, P588, DOI 10.1007/s00125-005-0105-3; CaulinGlaser T, 1997, CIRC RES, V81, P885; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Couse JF, 1997, ENDOCRINOLOGY, V138, P4613, DOI 10.1210/en.138.11.4613; Cui J, 2013, TRENDS MOL MED, V19, P197, DOI 10.1016/j.molmed.2012.12.007; Farhat MY, 1996, J PHARMACOL EXP THER, V276, P652; Gabel SA, 2005, J MOL CELLULAR CARDI, V38; Gorres BK, 2011, J APPL PHYSIOL, V110, P1046, DOI 10.1152/japplphysiol.00541.2010; Grohe C, 1997, FEBS LETT, V416, P107, DOI 10.1016/S0014-5793(97)01179-4; Grohe C, 1998, J ENDOCRINOL, V156, pR1, DOI 10.1677/joe.0.156R001; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Hewitt SC, 2010, FASEB J, V24, P4660, DOI 10.1096/fj.10-163428; Hewitt SC, 2009, MOL ENDOCRINOL, V23, P2111, DOI 10.1210/me.2009-0356; Konishi T, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S2-S6; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Levin ER, 2009, TRENDS ENDOCRIN MET, V20, P477, DOI 10.1016/j.tem.2009.06.009; Lodhi IJ, 2007, CELL METAB, V5, P59, DOI 10.1016/j.cmet.2006.12.006; Lundholm L, 2008, J ENDOCRINOL, V199, P275, DOI [10.1677/JOE-08-0192, 10.1530/JOE-08-0192e]; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Nathan L, 1997, ANNU REV PHARMACOL, V37, P477, DOI 10.1146/annurev.pharmtox.37.1.477; Nilsson S, 2002, CRIT REV BIOCHEM MOL, V37, P1, DOI 10.1080/10409230290771438; O'Malley BW, 2005, MOL ENDOCRINOL, V19, P1402, DOI 10.1210/me.2004-0480; Ohlsson C, 2000, BIOCHEM BIOPH RES CO, V278, P640, DOI 10.1006/bbrc.2000.3827; Riant E, 2009, ENDOCRINOLOGY, V150, P2109, DOI 10.1210/en.2008-0971; Ribas V, 2010, AM J PHYSIOL-ENDOC M, V298, pE304, DOI 10.1152/ajpendo.00504.2009; Skavdahl M, 2005, AM J PHYSIOL-HEART C, V288, pH469, DOI 10.1152/ajpheart.00723.2004; Srivastava RAK, 1997, J BIOL CHEM, V272, P33360, DOI 10.1074/jbc.272.52.33360; Tamhane AC, 2000, STAT DATA ANAL ELEME; Tsutsumi S, 2008, J ENDOCRINOL, V199, P267, DOI 10.1677/JOE-07-0292; Wang MJ, 2009, AM J PHYSIOL-REG I, V296, pR972, DOI 10.1152/ajpregu.00045.2009; Watters JJ, 1997, ENDOCRINOLOGY, V138, P4030, DOI 10.1210/en.138.9.4030; Wend K, 2013, J CELL BIOCHEM, V114, P1306, DOI 10.1002/jcb.24470	37	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101900	10.1371/journal.pone.0101900	http://dx.doi.org/10.1371/journal.pone.0101900			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000186	Green Published, gold, Green Submitted			2022-12-27	WOS:000338637300099
J	Kleine, M; Riemer, M; Krech, T; DeTemple, D; Jager, MD; Lehner, F; Manns, MP; Klempnauer, J; Borlak, J; Bektas, H; Vondran, FWR				Kleine, Moritz; Riemer, Marc; Krech, Till; DeTemple, Daphne; Jaeger, Mark D.; Lehner, Frank; Manns, Michael P.; Klempnauer, Juergen; Borlak, Juergen; Bektas, Hueseyin; Vondran, Florian W. R.			Explanted Diseased Livers - A Possible Source of Metabolic Competent Primary Human Hepatocytes	PLOS ONE			English	Article							CRYOPRESERVATION; TRANSPLANTATION; MODELS; OPTIMIZATION; CULTURES; TIME	Being an integral part of basic, translational and clinical research, the demand for primary human hepatocytes (PHH) is continuously growing while the availability of tissue resection material for the isolation of metabolically competent PHH remains limited. To overcome current shortcomings, this study evaluated the use of explanted diseased organs from liver transplantation patients as a potential source of PHH. Therefore, PHH were isolated from resected surgical specimens (Rx-group; n = 60) and explanted diseased livers obtained from graft recipients with low labMELD-score (Ex-group; n = 5). Using established protocols PHH were subsequently cultured for a period of 7 days. The viability and metabolic competence of cultured PHH was assessed by the following parameters: morphology and cell count (CyQuant assay), albumin synthesis, urea production, AST-leakage, and phase I and II metabolism. Both groups were compared in terms of cell yield and metabolic function, and results were correlated with clinical parameters of tissue donors. Notably, cellular yields and viabilities were comparable between the Rx- and Ex-group and were 5.3 +/- 0.5 and 2.9 +/- 0.7x10(6) cells/g liver tissue with 84.3 +/- 1.3 and 76.0 +/- 8.6% viability, respectively. Moreover, PHH isolated from the Rx- or Ex-group did not differ in regards to loss of cell number in culture, albumin synthesis, urea production, AST-leakage, and phase I and II metabolism (measured by the 7-ethoxycoumarin-O-deethylase and uracil-5'-diphosphate-glucuronyltransferase activity). Likewise, basal transcript expressions of the CYP monooxygenases 1A1, 2C8 and 3A4 were comparable as was their induction when treated with a cocktail that consisted of 3-methylcholantren, rifampicin and phenobarbital, with increased expression of CYP 1A1 and 3A4 mRNA while transcript expression of CYP 2C8 was only marginally changed. In conclusion, the use of explanted diseased livers obtained from recipients with low labMELD-score might represent a valuable source of metabolically competent PHH which are comparable in viability and function to cells obtained from specimens following partial liver resection.	[Kleine, Moritz; Riemer, Marc; DeTemple, Daphne; Jaeger, Mark D.; Lehner, Frank; Klempnauer, Juergen; Bektas, Hueseyin; Vondran, Florian W. R.] Hannover Med Sch, Dept Gen Visceral & Transplantat Surg, ReMediES, Hannover, Germany; [Krech, Till] Hannover Med Sch, Inst Pathol, Hannover, Germany; [Manns, Michael P.] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Manns, Michael P.; Vondran, Florian W. R.] German Ctr Infect Res DZIF, Hannover, Germany; [Borlak, Juergen] Hannover Med Sch, Ctr Pharmacol & Toxicol, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; German Center for Infection Research; Hannover Medical School	Vondran, FWR (corresponding author), Hannover Med Sch, Dept Gen Visceral & Transplantat Surg, ReMediES, Hannover, Germany.	Vondran.Florian@MH-Hannover.de			B. Braun-Stiftung (Melsungen, Germany); Else Kroner-Fresenius-Stiftung (Bad Homburg v.d.H., Germany) [2010_A49]; "Verein zur Forderung der Forschung und Lehre in der Allgemein Chirurgie'' (FULAC); German Virtual Liver Network [0316154]	B. Braun-Stiftung (Melsungen, Germany); Else Kroner-Fresenius-Stiftung (Bad Homburg v.d.H., Germany); "Verein zur Forderung der Forschung und Lehre in der Allgemein Chirurgie'' (FULAC); German Virtual Liver Network	This study partially was funded by B. Braun-Stiftung (Melsungen, Germany), Else Kroner-Fresenius-Stiftung (Bad Homburg v.d.H., Germany; 2010_A49) and "Verein zur Forderung der Forschung und Lehre in der Allgemein Chirurgie'' (FULAC). JB received funding from the German Virtual Liver Network (Grant 0316154) which is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre E., 2002, Cell and Tissue Banking, V3, P223; Bhogal RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018222; Borlak R, 2003, TOXICOL APPL PHARM, V188, P81, DOI 10.1016/S0041-008X(02)00075-3; Deurholt T, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-89; Dolle L, 2010, J HEPATOL, V52, P117, DOI 10.1016/j.jhep.2009.10.009; Freeman RB, 2006, LIVER TRANSPLANT, V12, pS128, DOI 10.1002/lt.20979; Fuller BJ, 2013, CRYOLETTERS, V34, P432; Gramignoli R, 2013, CELL TRANSP IN PRESS; Gramignoli R, 2013, STEM CELL RES, V11, P563, DOI 10.1016/j.scr.2013.03.002; GREENLEE WF, 1978, J PHARMACOL EXP THER, V205, P596; Guguen-Guillouzo C, 2010, METHODS MOL BIOL, V640, P1, DOI 10.1007/978-1-60761-688-7_1; Harring TR, 2011, CLIN LIVER DIS, V15, P879, DOI 10.1016/j.cld.2011.08.006; Hewitt NJ, 2010, METHODS MOL BIOL, V640, P83, DOI 10.1007/978-1-60761-688-7_4; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Katenz E, 2007, LIVER TRANSPLANT, V13, P38, DOI 10.1002/lt.20921; Kehr DC, 2012, TRANSPL P, V44, P999, DOI 10.1016/j.transproceed.2012.03.006; Kirchberg J, 2013, LANGENBECK ARCH SURG, V398, P931, DOI 10.1007/s00423-013-1117-y; Krause P, 2013, CELL TRANSP IN PRESS; LeCluyse EL, 2012, CRIT REV TOXICOL, V42, P501, DOI 10.3109/10408444.2012.682115; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lloyd T. D. R., 2004, Cell and Tissue Banking, V5, P81, DOI 10.1023/B:CATB.0000034079.10985.bd; Nguyen TH, 2009, CURR GENE THER, V9, P136, DOI 10.2174/156652309787909481; Quante M, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/264015; Ramboer E, 2013, DRUG METAB REV, V45, P196, DOI 10.3109/03602532.2012.756010; Rogue A, 2012, DRUG METAB DISPOS, V40, P151, DOI 10.1124/dmd.111.042028; Stephenne X, 2010, WORLD J GASTROENTERO, V16, P1, DOI 10.3748/wjg.v16.i1.1; Tariq H, 2012, INFECT GENET EVOL, V12, P13, DOI 10.1016/j.meegid.2011.10.009; Terry C, 2010, LIVER TRANSPLANT, V16, P229, DOI 10.1002/lt.21983; Vondran FWR, 2008, ARTIF ORGANS, V32, P205, DOI 10.1111/j.1525-1594.2007.00524.x	29	44	44	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101386	10.1371/journal.pone.0101386	http://dx.doi.org/10.1371/journal.pone.0101386			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999631	Green Published, gold, Green Submitted			2022-12-27	WOS:000338637300040
J	Roorkiwal, M; von Wettberg, EJ; Upadhyaya, HD; Warschefsky, E; Rathore, A; Varshney, RK				Roorkiwal, Manish; von Wettberg, Eric J.; Upadhyaya, Hari D.; Warschefsky, Emily; Rathore, Abhishek; Varshney, Rajeev K.			Exploring Germplasm Diversity to Understand the Domestication Process in Cicer spp. Using SNP and DArT Markers	PLOS ONE			English	Article							PLANT GENETIC-RESOURCES; CROP IMPROVEMENT; CHICKPEA; DISCOVERY; GENOMICS	To estimate genetic diversity within and between 10 interfertile Cicer species (94 genotypes) from the primary, secondary and tertiary gene pool, we analysed 5,257 DArT markers and 651 KASPar SNP markers. Based on successful allele calling in the tertiary gene pool, 2,763 DArT and 624 SNP markers that are polymorphic between genotypes from the gene pools were analyzed further. STRUCTURE analyses were consistent with 3 cultivated populations, representing kabuli, desi and pea-shaped seed types, with substantial admixture among these groups, while two wild populations were observed using DArT markers. AMOVA was used to partition variance among hierarchical sets of landraces and wild species at both the geographical and species level, with 61% of the variation found between species, and 39% within species. Molecular variance among the wild species was high (39%) compared to the variation present in cultivated material (10%). Observed heterozygosity was higher in wild species than the cultivated species for each linkage group. Our results support the Fertile Crescent both as the center of domestication and diversification of chickpea. The collection used in the present study covers all the three regions of historical chickpea cultivation, with the highest diversity in the Fertile Crescent region. Shared alleles between different gene pools suggest the possibility of gene flow among these species or incomplete lineage sorting and could indicate complicated patterns of divergence and fusion of wild chickpea taxa in the past.	[Roorkiwal, Manish; Upadhyaya, Hari D.; Rathore, Abhishek; Varshney, Rajeev K.] Int Crops Res Inst Semi Arid Trop, Hyderabad, Andhra Pradesh, India; [von Wettberg, Eric J.; Warschefsky, Emily] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [von Wettberg, Eric J.; Warschefsky, Emily] Fairchild Trop Bot Garden, Ctr Trop Plant Conservat, Miami, FL USA	CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); State University System of Florida; Florida International University	Varshney, RK (corresponding author), Int Crops Res Inst Semi Arid Trop, Hyderabad, Andhra Pradesh, India.	r.k.varshney@cgiar.org	Varshney, Rajeev K/C-5295-2014; Warschefsky, Emily/AAA-6146-2019; Updhayaya, Hari/C-4858-2014; von Wettberg, Eric/C-1115-2016; Roorkiwal, Manish/E-9822-2011	Varshney, Rajeev K/0000-0002-4562-9131; Warschefsky, Emily/0000-0003-3894-6662; Updhayaya, Hari/0000-0002-5166-6844; von Wettberg, Eric/0000-0002-2724-0317; Roorkiwal, Manish/0000-0001-6595-281X	Australian Indo Strategic Research Fund (AISRF) of Ministry of Science Technology; CGIAR Generation Challenge Programme (GCP), Mexico; HHMI [52006924]; USDA-NIFA-Hispanic Serving Institutions Grant [2011-38422-30804]; Fairchild Challenge of Fairchild Tropical Botanic Garden	Australian Indo Strategic Research Fund (AISRF) of Ministry of Science Technology(Australian GovernmentDepartment of Industry, Innovation and Science); CGIAR Generation Challenge Programme (GCP), Mexico; HHMI(Howard Hughes Medical Institute); USDA-NIFA-Hispanic Serving Institutions Grant; Fairchild Challenge of Fairchild Tropical Botanic Garden	This study was funded by grants from Australian Indo Strategic Research Fund (AISRF) of Ministry of Science & Technology and CGIAR Generation Challenge Programme (GCP), Mexico. This work has been undertaken as part of the CGIAR Research Program on Grain Legumes. ICRISAT is a member of CGIAR Consortium. Thanks are also due to several colleagues at ICRISAT and partners in collaborating centres. EvW received support from HHMI award #52006924 to FIU's discipline-based education research group, and USDA-NIFA-Hispanic Serving Institutions Grant 2011-38422-30804 to FIU's agroecology program. EW is supported by the Fairchild Challenge of Fairchild Tropical Botanic Garden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbo S, 2003, FUNCT PLANT BIOL, V30, P1081, DOI 10.1071/FP03084; Abbo S, 2009, Q REV BIOL, V84, P29, DOI 10.1086/596462; Akibode S, 2011, GLOBAL REGIONAL TREN; Albrechtsen A, 2010, MOL BIOL EVOL, V27, P2534, DOI 10.1093/molbev/msq148; Allen AM, 2011, PLANT BIOTECHNOL J, V9, P1086, DOI 10.1111/j.1467-7652.2011.00628.x; Berger J, 2003, CROP SCI, V43, P1076, DOI 10.2135/cropsci2003.1076; Berger JD, 2011, EUPHYTICA, V180, P1, DOI 10.1007/s10681-011-0391-4; Berger JD, 2013, CROP PASTURE SCI, V64, P300, DOI 10.1071/CP13023; Cortes AJ, 2011, THEOR APPL GENET, V123, P827, DOI 10.1007/s00122-011-1630-8; Cuc LM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-55; Dempewolf H, 2014, AGROECOL SUST FOOD, V38, P369, DOI 10.1080/21683565.2013.870629; Excoffier L, 2005, GENETICS, V169, P1727, DOI 10.1534/genetics.104.036236; EXCOFFIER L, 1992, GENETICS, V131, P479; Fu Yong-Bi, 2006, Plant Genetic Resources Characterization and Utilization, V4, P87, DOI [10.1079/PGR2005100, 10.1079/PGR2006116]; Gepts P, 2004, PLANT PHYSIOL, V134, P1295, DOI 10.1104/pp.103.038885; Gepts P, 2012, BIODIVERSITY IN AGRICULTURE: DOMESTICATION, EVOLUTION, AND SUSTAINABILITY, P1; Gowda CLL, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2013.05.0016; Gross BL, 2010, TRENDS PLANT SCI, V15, P529, DOI 10.1016/j.tplants.2010.05.008; Hajjar R, 2007, EUPHYTICA, V156, P1, DOI 10.1007/s10681-007-9363-0; HARLAN J R, 1971, Taxon, V20, P509, DOI 10.2307/1218252; Haussmann B. I. G., 2004, Plant Genetic Resources Characterization and Utilization, V2, P3, DOI 10.1079/PGR200430; Hillman G., 1975, P PREHIST SOC, V41, P70; Hiremath PJ, 2012, PLANT BIOTECHNOL J, V10, P716, DOI 10.1111/j.1467-7652.2012.00710.x; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Kassa MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039563; Lachance J, 2013, BIOESSAYS, V35, P780, DOI 10.1002/bies.201300014; LADIZINSKY G, 1985, ECON BOT, V39, P191, DOI 10.1007/BF02907844; LADIZINSKY G, 1976, THEOR APPL GENET, V48, P197, DOI 10.1007/BF00527371; Lev-Yadun S, 2000, SCIENCE, V288, P1602, DOI 10.1126/science.288.5471.1602; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Mallikarjuna N, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: LEGUME CROPS AND FORAGES, P63, DOI 10.1007/978-3-642-14387-8_4; McCouch S, 2013, NATURE, V499, P23, DOI 10.1038/499023a; Miflin B, 2000, J EXP BOT, V51, P1, DOI 10.1093/jexbot/51.342.1; Millan T, 2006, EUPHYTICA, V147, P81, DOI 10.1007/s10681-006-4261-4; MORENO MT, 1978, EUPHYTICA, V27, P465, DOI 10.1007/BF00043173; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard JK, 2000, GENETICS, V155, P945; Rao V. R., 2002, PLANT CELL TISSUE OR, V68, P1, DOI DOI 10.1023/A:1013359015812; Roorkiwal M, 2013, PLANT GEN, V6, P1, DOI DOI 10.3835/PLANTGENOME2013.05.0017; Roorkiwal M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00248; Saxena RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088568; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Singh M, 2013, ELSEV INSIGHT, P1; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Thudi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027275; VANDERMAESEN LJG, 1987, CHICKPEA, P139; Varshney RK, 2013, BIOTECHNOL ADV, V31, P1120, DOI 10.1016/j.biotechadv.2013.01.001; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Varshney RK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-523; Yadav SS, 2007, CHICKPEA BREEDING AND MANAGEMENT, P1, DOI 10.1079/9781845932138.000; Zohary D, 2000, DOMESTICATION PLANTS, DOI DOI 10.1006/ANBO.2001.1505	53	29	29	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102016	10.1371/journal.pone.0102016	http://dx.doi.org/10.1371/journal.pone.0102016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010059	Green Published, Green Submitted, gold			2022-12-27	WOS:000338763800059
J	Li, RH; Li, X; Ning, SW; Ye, JR; Han, L; Kang, CS; Li, X				Li, Ronghong; Li, Xiang; Ning, Shangwei; Ye, Jingrun; Han, Lei; Kang, Chunsheng; Li, Xia			Identification of a Core miRNA-Pathway Regulatory Network in Glioma by Therapeutically Targeting miR-181d, miR-21, miR-23b, beta-Catenin, CBP, and STAT3	PLOS ONE			English	Article							MALIGNANT GLIOMAS; WNT/BETA-CATENIN; DOWN-REGULATION; CANCER CELLS; IN-VIVO; MICRORNA; GLIOBLASTOMA; EXPRESSION; GENES; PROGRESSION	The application of microRNAs (miRNAs) in the therapeutics of glioma and other human diseases is an area of intense interest. However, it's still a great challenge to interpret the functional consequences of using miRNAs in glioma therapy. Here, we examined paired deep sequencing expression profiles of miRNAs and mRNAs from human glioma cell lines after manipulating the levels of miRNAs miR-181d, -21, and -23b, as well as transcriptional regulators beta-catenin, CBP, and STAT3. An integrated approach was used to identify functional miRNA-pathway regulatory networks (MPRNs) responding to each manipulation. MiRNAs were identified to regulate glioma related biological pathways collaboratively after manipulating the level of either post-transcriptional or transcriptional regulators, and functional synergy and crosstalk was observed between different MPRNs. MPRNs responsive to multiple interventions were found to occupy central positions in the comprehensive MPRN (cMPRN) generated by integrating all the six MPRNs. Finally, we identified a core module comprising 14 miRNAs and five pathways that could predict the survival of glioma patients and represent potential targets for glioma therapy. Our results provided novel insight into miRNA regulatory mechanisms implicated in therapeutic interventions and could offer more inspiration to miRNA-based glioma therapy.	[Li, Ronghong; Li, Xiang; Ning, Shangwei; Ye, Jingrun; Li, Xia] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; [Han, Lei; Kang, Chunsheng] Tianjin Med Univ, Lab Neurooncol,Dept Neurosurg, Tianjin Neurol Inst,Gen Hosp, Lab Neurotrauma Variat & Regenerat,Minist Educ, Tianjin, Peoples R China; [Han, Lei; Kang, Chunsheng] Tianjin Municipal Govt, Tianjin, Peoples R China	Harbin Medical University; Tianjin Medical University	Kang, CS (corresponding author), Tianjin Med Univ, Lab Neurooncol,Dept Neurosurg, Tianjin Neurol Inst,Gen Hosp, Lab Neurotrauma Variat & Regenerat,Minist Educ, Tianjin, Peoples R China.	kang97061@gmail.com; lixia@hrbmu.edu.cn	Ye, jingrun/GSJ-2822-2022; li, xia/HHZ-7468-2022; Kang, Chunsheng/AAM-5979-2021	Kang, Chunsheng/0000-0002-3255-3369	National High Technology Research and Development Program of China (863 Program) [2014AA021102]; National Natural Science Foundation of China [81272792, 61073136, 81171122, 61170154]; Undergraduate Innovation Funds of Harbin Medical University [YJSCX2012-206HLJ]; Foundation of Tianjin Municipal Science and Technology commission [12ZCDZSY17300]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Undergraduate Innovation Funds of Harbin Medical University; Foundation of Tianjin Municipal Science and Technology commission	This work was supported by the National High Technology Research and Development Program of China (863 Program, 2014AA021102), the National Natural Science Foundation of China (81272792, 61073136, 81171122 and 61170154), the Undergraduate Innovation Funds of Harbin Medical University (YJSCX2012-206HLJ), and Foundation of Tianjin Municipal Science and Technology commission (12ZCDZSY17300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay S, 2009, BIOINFORMATICS, V25, P2625, DOI 10.1093/bioinformatics/btp503; Beezhold KJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-134; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bottomly D, 2010, NUCLEIC ACIDS RES, V38, P5735, DOI 10.1093/nar/gkq363; Burel-Vandenbos F, 2013, NEURO-ONCOLOGY, V15, P1278, DOI 10.1093/neuonc/not094; Carcagno AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021938; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen LC, 2012, NEURO-ONCOLOGY, V14, P1026, DOI 10.1093/neuonc/nos122; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r127; Corsten MF, 2007, CANCER RES, V67, P8994, DOI 10.1158/0008-5472.CAN-07-1045; de Oliveira RL, 2011, MOL ASPECTS MED, V32, P71, DOI 10.1016/j.mam.2011.04.001; Dong CG, 2012, INT J ONCOL, V41, P1005, DOI 10.3892/ijo.2012.1542; Frohlich H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-166; Guardavaccaro D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002921; Han ZQ, 2009, CARCINOGENESIS, V30, P2014, DOI 10.1093/carcin/bgp249; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hollenhorst PC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000778; Hui Wang, 2013, PLoS One, V8, pe54932, DOI 10.1371/journal.pone.0054932; Hutchins AP, 2013, NUCLEIC ACIDS RES, V41, P2155, DOI 10.1093/nar/gks1300; Iwamaru A, 2007, ONCOGENE, V26, P2435, DOI 10.1038/sj.onc.1210031; Jhaveri K, 2012, BBA-MOL CELL RES, V1823, P742, DOI 10.1016/j.bbamcr.2011.10.008; Ji JF, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-4; Jia WT, 2010, INT J BIOCHEM CELL B, V42, P2019, DOI 10.1016/j.biocel.2010.09.003; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kwak HJ, 2011, ONCOGENE, V30, P2433, DOI 10.1038/onc.2010.620; Lazovic J, 2012, NEURO-ONCOLOGY, V14, P1465, DOI 10.1093/neuonc/nos258; Lerebours F, 2013, INT J CANCER, V133, P1614, DOI 10.1002/ijc.28171; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Malzkorn B, 2010, BRAIN PATHOL, V20, P539, DOI 10.1111/j.1750-3639.2009.00328.x; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Moller HG, 2013, MOL NEUROBIOL, V47, P131, DOI 10.1007/s12035-012-8349-7; Nazarov PV, 2013, NUCLEIC ACIDS RES, V41, P2817, DOI 10.1093/nar/gks1471; Nichane M, 2010, EMBO J, V29, P55, DOI 10.1038/emboj.2009.313; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Pio G, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S7-S8; Plaisier CL, 2012, GENOME RES, V22, P2302, DOI 10.1101/gr.133991.111; Plate KH, 2012, ACTA NEUROPATHOL, V124, P763, DOI 10.1007/s00401-012-1066-5; Rebocho AP, 2013, ONCOGENE, V32, P3207, DOI 10.1038/onc.2012.330; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rodriguez FJ, 2012, J NEUROPATH EXP NEUR, V71, P789, DOI 10.1097/NEN.0b013e3182656ef8; Rukov JL, 2011, TRENDS MOL MED, V17, P412, DOI 10.1016/j.molmed.2011.04.003; Sahm F, 2013, CANCER RES, V73, P3225, DOI 10.1158/0008-5472.CAN-12-3831; Sciaccaluga M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073426; Shahab SW, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-33; Shi ZD, 2012, J NEUROIMMUNE PHARM, V7, P892, DOI 10.1007/s11481-012-9354-3; Skuli N, 2006, CANCER RES, V66, P482, DOI 10.1158/0008-5472.CAN-05-2299; Somel M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001214; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Tan XC, 2012, P NATL ACAD SCI USA, V109, P15805, DOI 10.1073/pnas.1207787109; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Wang WX, 2011, ACTA NEUROPATHOL, V121, P193, DOI 10.1007/s00401-010-0756-0; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wang XF, 2012, J CANCER RES CLIN, V138, P573, DOI 10.1007/s00432-011-1114-x; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Williams EJB, 2004, GENOME RES, V14, P1060, DOI 10.1101/gr.2131104; Xu J, 2013, ONCOGENE, V32, P976, DOI 10.1038/onc.2012.121; Xu JA, 2011, NUCLEIC ACIDS RES, V39, P825, DOI 10.1093/nar/gkq832; Yang QQ, 2011, BIOINFORMATICS, V27, P3329, DOI 10.1093/bioinformatics/btr556; Yates LA, 2013, CELL, V153, P516, DOI 10.1016/j.cell.2013.04.003; Zhang AL, 2013, J NEURO-ONCOL, V112, P179, DOI 10.1007/s11060-013-1061-2; Zhang JX, 2011, NEURO-ONCOLOGY, V13, P600, DOI 10.1093/neuonc/nor034; Zhang QQ, 2012, NEURO-ONCOLOGY, V14, P278, DOI 10.1093/neuonc/nor216; Zhang W, 2012, NEURO-ONCOLOGY, V14, P712, DOI 10.1093/neuonc/nos089; Zhao LQ, 2012, CARCINOGENESIS, V33, P2220, DOI 10.1093/carcin/bgs235; Zhao SG, 2013, CANCER LETT, V333, P253, DOI 10.1016/j.canlet.2013.01.039; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707	77	12	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101903	10.1371/journal.pone.0101903	http://dx.doi.org/10.1371/journal.pone.0101903			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007077	Green Published, gold, Green Submitted			2022-12-27	WOS:000339040600079
J	Naude, CE; Schoonees, A; Senekal, M; Young, T; Garner, P; Volmink, J				Naude, Celeste E.; Schoonees, Anel; Senekal, Marjanne; Young, Taryn; Garner, Paul; Volmink, Jimmy			Low Carbohydrate versus Isoenergetic Balanced Diets for Reducing Weight and Cardiovascular Risk: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							LOW-FAT DIET; RANDOMIZED CONTROLLED-TRIAL; HIGH-MONOUNSATURATED-FAT; MEDITERRANEAN-STYLE DIET; ENERGY-RESTRICTED DIETS; CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; DENSITY-LIPOPROTEIN CHOLESTEROL; GLYCEMIC INDEX DIET; 2 HYPOCALORIC DIETS	Background: Some popular weight loss diets restricting carbohydrates (CHO) claim to be more effective, and have additional health benefits in preventing cardiovascular disease compared to balanced weight loss diets. Methods and Findings: We compared the effects of low CHO and isoenergetic balanced weight loss diets in overweight and obese adults assessed in randomised controlled trials (minimum follow-up of 12 weeks), and summarised the effects on weight, as well as cardiovascular and diabetes risk. Dietary criteria were derived from existing macronutrient recommendations. We searched Medline, EMBASE and CENTRAL (19 March 2014). Analysis was stratified by outcomes at 3-6 months and 1-2 years, and participants with diabetes were analysed separately. We evaluated dietary adherence and used GRADE to assess the quality of evidence. We calculated mean differences (MD) and performed random-effects meta-analysis. Nineteen trials were included (n = 3209); 3 had adequate allocation concealment. In non-diabetic participants, our analysis showed little or no difference in mean weight loss in the two groups at 3-6 months (MD 0.74 kg, 95% CI -1.49 to 0.01 kg; I-2 = 53%; n = 1745, 14 trials; moderate quality evidence) and 1-2 years (MD 0.48 kg, 95% CI -1.44 kg to 0.49 kg; I-2 = 12%; n = 1025; 7 trials, moderate quality evidence). Furthermore, little or no difference was detected at 3-6 months and 1-2 years for blood pressure, LDL, HDL and total cholesterol, triglycerides and fasting blood glucose (>914 participants). In diabetic participants, findings showed a similar pattern. Conclusions: Trials show weight loss in the short-term irrespective of whether the diet is low CHO or balanced. There is probably little or no difference in weight loss and changes in cardiovascular risk factors up to two years of follow-up when overweight and obese adults, with or without type 2 diabetes, are randomised to low CHO diets and isoenergetic balanced weight loss diets.	[Naude, Celeste E.; Schoonees, Anel; Young, Taryn; Volmink, Jimmy] Univ Stellenbosch, Fac Med & Hlth Sci, Ctr Evidence Based Hlth Care, Cape Town, South Africa; [Senekal, Marjanne] Univ Cape Town, Fac Hlth Sci, Dept Human Biol, Div Human Nutr, ZA-7925 Cape Town, South Africa; [Young, Taryn; Volmink, Jimmy] South African Med Res Council, South African Cochrane Ctr, Cape Town, South Africa; [Garner, Paul] Univ Liverpool, Liverpool Sch Trop Med, Dept Clin Sci, Effect Hlth Care Res Consortium, Liverpool L3 5QA, Merseyside, England	Stellenbosch University; University of Cape Town; South African Medical Research Council; Liverpool School of Tropical Medicine; University of Liverpool	Naude, CE (corresponding author), Univ Stellenbosch, Fac Med & Hlth Sci, Ctr Evidence Based Hlth Care, Cape Town, South Africa.	cenaude@sun.ac.za	Garner, Paul/HII-5856-2022; Garner, Paul/Y-8385-2019; Senekal, Marjanne/ABG-1478-2021	Garner, Paul/0000-0002-0607-6941; Senekal, Marjanne/0000-0002-9427-2319; Young, Taryn/0000-0003-2406-081X; Schoonees, Anel/0000-0001-8989-6891; Naude, Celeste/0000-0002-9114-1452	Effective Health Care Research Consortium; South African Medical Research Council; Centre for Evidence-based Health Care (CEBHC); CEBHC; University of Cape Town; Stellenbosch University; South African Cochrane Centre; University of Liverpool; Evidence Building and Synthesis Research Consortium; Department for International Development (DFID) [201400] Funding Source: researchfish	Effective Health Care Research Consortium; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Centre for Evidence-based Health Care (CEBHC); CEBHC; University of Cape Town; Stellenbosch University; South African Cochrane Centre; University of Liverpool; Evidence Building and Synthesis Research Consortium; Department for International Development (DFID)	This review was funded by the Effective Health Care Research Consortium and the South African Medical Research Council. CN is funded by the Centre for Evidence-based Health Care (CEBHC) and the South African Medical Research Council. AS and TY are funded by CEBHC. MS is funded by University of Cape Town. JV is funded by Stellenbosch University and the South African Cochrane Centre. PG is funded by the University of Liverpool and the Evidence Building and Synthesis Research Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Abete I, 2009, INT J FOOD SCI NUTR, V60, P1, DOI 10.1080/09637480802232625; Al-Sarraj T, 2010, NUTR METAB CARDIOVAS, V20, P720, DOI 10.1016/j.numecd.2009.06.004; Al-Sarraj T, 2009, J NUTR, V139, P1667, DOI 10.3945/jn.109.109603; Alhassan S, 2008, INT J OBESITY, V32, P985, DOI 10.1038/ijo.2008.8; [Anonymous], 2012, CIRCULATION, V125, pAP306; de Luis DA, 2012, DIABETES-METAB RES, V28, P663, DOI 10.1002/dmrr.2323; Aquilani R, 1999, EUR HEART J, V20, P1020, DOI 10.1053/euhj.1999.1402; Ashton EL, 2000, J AM DIET ASSOC, V100, P537, DOI 10.1016/S0002-8223(00)00167-X; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Aude YW, 2004, ARCH INTERN MED, V164, P2141, DOI 10.1001/archinte.164.19.2141; Australian National Health and Medical Research Council (NHMRC), 2006, NUTR REF VAL AUSTR N; Avenell A, 2004, HEALTH TECHNOL ASSES, V8, P1; Baba NH, 1999, INT J OBESITY, V23, P1202, DOI 10.1038/sj.ijo.0801064; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Barnett J., 2009, ZONE DIET EXPLAINED; BARON JA, 1986, AM J PUBLIC HEALTH, V76, P1293, DOI 10.2105/AJPH.76.11.1293; Becker W., 2004, Scandinavian Journal of Nutrition, V48, P178, DOI 10.1080/1102680410003794; Belobrajdic DP, 2010, EUR J ENDOCRINOL, V162, P1075, DOI 10.1530/EJE-10-0062; Ben-Avraham S, 2009, DIABETES RES CLIN PR, V86, pS41, DOI 10.1016/S0168-8227(09)70008-7; Berglund L, 1999, AM J CLIN NUTR, V70, P992; Bowden RG, 2007, J AM COLL HEALTH, V56, P147, DOI 10.3200/JACH.56.2.147-152; Bradley U, 2009, DIABETES, V58, P2741, DOI 10.2337/db09-0098; Brehm BJ, 2003, J CLIN ENDOCR METAB, V88, P1617, DOI 10.1210/jc.2002-021480; Brehm BJ, 2009, DIABETES CARE, V32, P215, DOI 10.2337/dc08-0687; Brinkworth GD, 2004, DIABETOLOGIA, V47, P1677, DOI 10.1007/s00125-004-1511-7; Brinkworth GD, 2009, AM J CLIN NUTR, V90, P23, DOI 10.3945/ajcn.2008.27326; British Dietetic Association, 2013, WEIGHT WIS EAT WELL; Buscemi S, 2009, EUR J CLIN INVEST, V39, P339, DOI 10.1111/j.1365-2362.2009.02091.x; Camhi SM, 2010, OBESITY, V18, P548, DOI 10.1038/oby.2009.304; Campbell DD, 2012, BRIT J NUTR, V108, P1658, DOI 10.1017/S0007114511007215; Campbell WW, 2010, J GERONTOL A-BIOL, V65, P1115, DOI 10.1093/gerona/glq083; Carter JD, 2006, OSTEOPOROSIS INT, V17, P1398, DOI 10.1007/s00198-006-0134-x; Carty CL, 2011, AM J CLIN NUTR, V93, P516, DOI 10.3945/ajcn.110.006395; CHEN YDI, 1995, DIABETES CARE, V18, P10, DOI 10.2337/diacare.18.1.10; Clifton PM, 2008, AM J CLIN NUTR, V87, P23, DOI 10.1093/ajcn/87.1.23; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Daly ME, 2006, DIABETIC MED, V23, P15, DOI 10.1111/j.1464-5491.2005.01760.x; Dansinger ML, 2005, JAMA-J AM MED ASSOC, V293, P43, DOI 10.1001/jama.293.1.43; Das SK, 2007, AM J CLIN NUTR, V85, P1023, DOI 10.1093/ajcn/85.4.1023; Davis NJ, 2009, DIABETES CARE, V32, P1147, DOI 10.2337/dc08-2108; de Luis DA, 2007, HORM RES, V67, P296, DOI 10.1159/000099329; de Luis DA, 2009, J DIABETES COMPLICAT, V23, P239, DOI 10.1016/j.jdiacomp.2007.12.006; De Natale C, 2009, DIABETES CARE, V32, P2168, DOI 10.2337/dc09-0266; Delbridge EA, 2009, AM J CLIN NUTR, V90, P1203, DOI 10.3945/ajcn.2008.27209; DELORGERIL M, 1994, LANCET, V343, P1454, DOI 10.1016/S0140-6736(94)92580-1; Djuric Z, 2002, J AM COLL NUTR, V21, P38, DOI 10.1080/07315724.2002.10719192; Donnelly JE, 2008, OBESITY, V16, P107, DOI 10.1038/oby.2007.33; Douketis JD, 2005, INT J OBESITY, V29, P1153, DOI 10.1038/sj.ijo.0802982; Dreon DM, 1999, AM J CLIN NUTR, V69, P411; Due A, 2004, INT J OBESITY, V28, P1283, DOI 10.1038/sj.ijo.0802767; Due A, 2008, AM J CLIN NUTR, V87, P855, DOI 10.1093/ajcn/87.4.855; Dyson PA, 2007, DIABETIC MED, V24, P1430, DOI 10.1111/j.1464-5491.2007.02290.x; Dyson PA, 2010, DIABETIC MED, V27, P363, DOI 10.1111/j.1464-5491.2010.02926.x; Ebbeling CB, 2007, JAMA-J AM MED ASSOC, V297, P2092, DOI 10.1001/jama.297.19.2092; EFSA Panel on Dietetic Products Nutrition and Allergies (NDA), 2010, DIET REF VAL PARM; Egert S, 2011, EUR J NUTR, V50, P71, DOI 10.1007/s00394-010-0116-9; Elhayany A, 2010, DIABETES OBES METAB, V12, P204, DOI 10.1111/j.1463-1326.2009.01151.x; Erlinger TP, 2003, CIRCULATION, V108, P150, DOI 10.1161/01.CIR.0000080288.30567.86; Esposito K, 2004, JAMA-J AM MED ASSOC, V292, P1440, DOI 10.1001/jama.292.12.1440; Esposito K, 2009, ANN INTERN MED, V151, P306, DOI 10.7326/0003-4819-151-5-200909010-00004; Estruch R, 2009, J EPIDEMIOL COMMUN H, V63, P582, DOI 10.1136/jech.2008.082214; Estruch R, 2006, ANN INTERN MED, V145, P1, DOI 10.7326/0003-4819-145-1-200607040-00004; Evangelista LS, 2009, J CARDIOVASC NURS, V24, P207, DOI 10.1097/JCN.0b013e31819846b9; Fabricatore AN, 2011, DIABETES RES CLIN PR, V92, P37, DOI 10.1016/j.diabres.2010.12.016; Farnsworth E, 2003, AM J CLIN NUTR, V78, P31, DOI 10.1093/ajcn/78.1.31; Ference BA, 2012, J AM COLL CARDIOL, V60, P2631, DOI 10.1016/j.jacc.2012.09.017; Fito M, 2007, ARCH INTERN MED, V167, P1195, DOI 10.1001/archinte.167.11.1195; Flechtner-Mors M, 2010, DIABETES-METAB RES, V26, P393, DOI 10.1002/dmrr.1097; Fleming Richard M, 2002, Prev Cardiol, V5, P110, DOI 10.1111/j.1520-037X.2002.01231.x; Foster GD, 2010, ANN INTERN MED, V153, P147, DOI 10.7326/0003-4819-153-3-201008030-00005; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; Frisch S, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-36; Galani C, 2007, INT J PUBLIC HEALTH, V52, P348, DOI 10.1007/s00038-007-7015-8; Gardner CD, 2007, JAMA-J AM MED ASSOC, V297, P969, DOI 10.1001/jama.297.9.969; Gerhard GT, 2004, AM J CLIN NUTR, V80, P668; Glenton C, 2010, MED DECIS MAKING, V30, P566, DOI 10.1177/0272989X10375853; GRADE Working Group, 2004, GRADEPROFILER GRADEP; Greenberg I, 2009, J AM COLL NUTR, V28, P159, DOI 10.1080/07315724.2009.10719767; Groeneveld IF, 2010, SCAND J WORK ENV HEA, V36, P202, DOI 10.5271/sjweh.2891; Guay V, 2012, METABOLISM, V61, P76, DOI 10.1016/j.metabol.2011.06.002; Guldbrand H, 2012, DIABETOLOGIA, V55, P2118, DOI 10.1007/s00125-012-2567-4; Gulseth HL, 2010, BRIT J NUTR, V104, P160, DOI 10.1017/S0007114510000565; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Halyburton AK, 2007, AM J CLIN NUTR, V86, P580, DOI 10.1093/ajcn/86.3.580; Hartwich J, 2009, CLIN NUTR, V28, P510, DOI 10.1016/j.clnu.2009.04.016; Haufe S, 2012, HYPERTENSION, V59, P70, DOI 10.1161/HYPERTENSIONAHA.111.178616; Haufe S, 2011, HEPATOLOGY, V53, P1504, DOI 10.1002/hep.24242; Hays NP, 2004, ARCH INTERN MED, V164, P210, DOI 10.1001/archinte.164.2.210; Higgins D, 2011, COCHRANE HDB SYSTEMA; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HOCKADAY TDR, 1978, BRIT J NUTR, V39, P357, DOI 10.1079/BJN19780045; Hodson L, 2010, J HUM HYPERTENS, V24, P312, DOI 10.1038/jhh.2009.65; Holloway CJ, 2011, AM J CLIN NUTR, V93, P748, DOI 10.3945/ajcn.110.002758; Howard BV, 2010, AM J CLIN NUTR, V91, P860, DOI 10.3945/ajcn.2009.28034; Howard BV, 2006, JAMA-J AM MED ASSOC, V295, P655, DOI 10.1001/jama.295.6.655; Hoy MK, 2009, J AM DIET ASSOC, V109, P688, DOI 10.1016/j.jada.2008.12.016; Hu T, 2013, CIRCULATION, V127, pAP167; Hu T, 2013, CIRCULATION, V127, pAP166; Hu T, 2013, CIRCULATION, V127, pAP165; Institute of Medicine Food and Nutrition Board, 2002, DIET REF INT EN CARB; Iqbal N, 2005, Eur Rev Med Pharmacol Sci, V9, P161; Iqbal N, 2010, OBESITY, V18, P1733, DOI 10.1038/oby.2009.460; Jakobsen MU, 2010, AM J CLIN NUTR, V91, P1764, DOI 10.3945/ajcn.2009.29099; Jakobsen MU, 2009, AM J CLIN NUTR, V89, P1425, DOI 10.3945/ajcn.2008.27124; Jebb SA, 2010, AM J CLIN NUTR, V92, P748, DOI 10.3945/ajcn.2009.29096; Jenkins DJA, 2009, ARCH INTERN MED, V169, P1046, DOI 10.1001/archinternmed.2009.115; Jensen M.D., 2013, 2013 AHA ACC TOS GUI, V01; Jeppesen J, 1997, AM J CLIN NUTR, V65, P1027, DOI 10.1093/ajcn/65.4.1027; Jimenez-Gomez Y, 2010, J NUTR, V140, P1595, DOI 10.3945/jn.109.120816; Johnston CS, 2006, AM J CLIN NUTR, V83, P1055, DOI 10.1093/ajcn/83.5.1055; Johnston CS, 2004, J NUTR, V134, P586, DOI 10.1093/jn/134.3.586; Johnstone AM, 2011, BRIT J NUTR, V106, P282, DOI 10.1017/S0007114511000092; KASIM SE, 1993, AM J CLIN NUTR, V57, P146, DOI 10.1093/ajcn/57.2.146; Kasim-Karakas SE, 2009, FERTIL STERIL, V92, P262, DOI 10.1016/j.fertnstert.2008.05.065; Keogh JB, 2008, AM J CLIN NUTR, V87, P567, DOI 10.1093/ajcn/87.3.567; Keogh JB, 2007, BRIT J NUTR, V98, P852, DOI 10.1017/S0007114507747815; Kleiner Rima E, 2006, MedGenMed, V8, P39; Klemsdal TO, 2010, NUTR METAB CARDIOVAS, V20, P195, DOI 10.1016/j.numecd.2009.03.010; Knopp RH, 1997, JAMA-J AM MED ASSOC, V278, P1509, DOI 10.1001/jama.278.18.1509; Knopp RH, 2000, P SOC EXP BIOL MED, V225, P191, DOI 10.1046/j.1525-1373.2000.22524.x; KRAUSS RM, 1995, AM J CLIN NUTR, V62, p478S, DOI 10.1093/ajcn/62.2.478S; Krauss RM, 2006, AM J CLIN NUTR, V83, P1025, DOI 10.1093/ajcn/83.5.1025; Krebs JD, 2012, DIABETOLOGIA, V55, P905, DOI 10.1007/s00125-012-2461-0; Labayen Idoia, 2003, Forum Nutr, V56, P168; Lagiou P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4026; Larsen RN, 2011, DIABETOLOGIA, V54, P731, DOI 10.1007/s00125-010-2027-y; Larsen TM, 2010, NEW ENGL J MED, V363, P2102, DOI 10.1056/NEJMoa1007137; Lasker DAW, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-30; Layman DK, 2005, J NUTR, V135, P1903, DOI 10.1093/jn/135.8.1903; Layman DK, 2003, J NUTR, V133, P411, DOI 10.1093/jn/133.2.411; Layman DK, 2009, J NUTR, V139, P514, DOI 10.3945/jn.108.099440; Lefevre M, 2005, AM J CLIN NUTR, V82, P957, DOI 10.1093/ajcn/82.5.957; Leidy HJ, 2007, OBESITY, V15, P421, DOI 10.1038/oby.2007.531; Lim SS, 2010, NUTR METAB CARDIOVAS, V20, P599, DOI 10.1016/j.numecd.2009.05.003; Lindeberg S, 2007, DIABETOLOGIA, V50, P1795, DOI 10.1007/s00125-007-0716-y; Louheranta AM, 2000, NUTR METAB CARDIOVAS, V10, P177; Luscombe ND, 2003, INT J OBESITY, V27, P582, DOI 10.1038/sj.ijo.0802270; Luscombe-Marsh ND, 2005, AM J CLIN NUTR, V81, P762, DOI 10.1093/ajcn/81.4.762; Mangravite LM, 2011, J NUTR, V141, P2180, DOI 10.3945/jn.111.139477; McAuley KA, 2006, INT J OBESITY, V30, P342, DOI 10.1038/sj.ijo.0803075; McAuley KA, 2005, DIABETOLOGIA, V48, P8, DOI 10.1007/s00125-004-1603-4; McClain AD, 2013, DIABETES OBES METAB, V15, P87, DOI 10.1111/j.1463-1326.2012.01668.x; McLaughlin T, 2007, DIABETES CARE, V30, P1877, DOI 10.2337/dc07-0301; McManus K, 2001, INT J OBESITY, V25, P1503, DOI 10.1038/sj.ijo.0801796; Meckling KA, 2004, J CLIN ENDOCR METAB, V89, P2717, DOI 10.1210/jc.2003-031606; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Miller M, 2009, J AM DIET ASSOC, V109, P713, DOI 10.1016/j.jada.2008.12.023; Mohler ER, 2013, OBESITY, V21, P504, DOI 10.1002/oby.20055; Monteiro CA, 2013, OBES REV, V14, P21, DOI 10.1111/obr.12107; Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3; Moore C, 2009, J NUTR, V139, P1534, DOI 10.3945/jn.108.103374; Moore SD, 2011, EAT BEHAV, V12, P60, DOI 10.1016/j.eatbeh.2010.08.007; Morenga LAT, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-40; Morgan LM, 2009, PUBLIC HEALTH NUTR, V12, P799, DOI 10.1017/S1368980008003236; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; Mueller C, 2010, NUTR CLIN PRACT, V25, P542, DOI 10.1177/0884533610379854; Neter JE, 2003, HYPERTENSION, V42, P878, DOI 10.1161/01.HYP.0000094221.86888.AE; Nielsen JV, 2005, UPSALA J MED SCI, V110, P69, DOI 10.3109/2000-1967-182; NNR Project Group, 2004, NORD NUTR REC NNR 20; Noakes M, 2005, AM J CLIN NUTR, V81, P1298; Noakes M, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-7; Noakes TD, 2013, SAMJ S AFR MED J, V103, P826, DOI [10.7196/samj.7302, 10.7196/SAMJ.7302]; Noto H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055030; Paniagua JA, 2011, ATHEROSCLEROSIS, V218, P443, DOI 10.1016/j.atherosclerosis.2011.07.003; Papakonstantinou E, 2010, EUR J CLIN NUTR, V64, P595, DOI 10.1038/ejcn.2010.29; Parker B, 2002, DIABETES CARE, V25, P425, DOI 10.2337/diacare.25.3.425; PASCALE RW, 1995, DIABETES CARE, V18, P1241, DOI 10.2337/diacare.18.9.1241; Patterson RE, 2004, J AM DIET ASSOC, V104, P654, DOI 10.1016/j.jada.2004.01.014; Pereira MA, 2004, JAMA-J AM MED ASSOC, V292, P2482, DOI 10.1001/jama.292.20.2482; Petersen M, 2006, INT J OBESITY, V30, P552, DOI 10.1038/sj.ijo.0803186; Phillips SA, 2008, HYPERTENSION, V51, P376, DOI 10.1161/HYPERTENSIONAHA.107.101824; Raatz SK, 2005, J NUTR, V135, P2387, DOI 10.1093/jn/135.10.2387; Rencher AC, 2002, METHODS MULTIVARIATE, P43; Rodriguez-Hernandez H, 2009, BRIT J NUTR, V102, P1847, DOI 10.1017/S0007114509991231; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Samaha FF, 2003, NEW ENGL J MED, V348, P2074, DOI 10.1056/NEJMoa022637; Sebregts EH, 2003, INT J BEHAV MED, V10, P315, DOI 10.1207/S15327558IJBM1004_3; Segal-Isaacson CJ, 2004, OBES RES, V12, p130S, DOI 10.1038/oby.2004.278; Seshadri P, 2004, AM J MED, V117, P398, DOI 10.1016/j.amjmed.2004.04.009; Seshadri Prakash, 2005, Endocr Pract, V11, P234; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; Sharman MJ, 2004, J NUTR, V134, P880, DOI 10.1093/jn/134.4.880; Shaw DI, 2009, BRIT J NUTR, V101, P750, DOI 10.1017/S0007114508039962; SHEPPARD L, 1991, AM J CLIN NUTR, V54, P821, DOI 10.1093/ajcn/54.5.821; Shikany JM, 2011, AM J CLIN NUTR, V94, P75, DOI 10.3945/ajcn.110.010843; SIMKINSILVERMAN L, 1995, PREV MED, V24, P509, DOI 10.1006/pmed.1995.1081; Simons-Morton DG, 2006, JAMA-J AM MED ASSOC, V295, P826, DOI 10.1001/jama.295.7.826; Sjogren P, 2010, AM J CLIN NUTR, V92, P967, DOI 10.3945/ajcn.2010.29345; Skov AR, 1999, INT J OBESITY, V23, P528, DOI 10.1038/sj.ijo.0800867; Sloth B, 2009, BRIT J NUTR, V101, P1846, DOI 10.1017/S0007114508137710; Soenen S, 2012, PHYSIOL BEHAV, V107, P374, DOI 10.1016/j.physbeh.2012.08.004; Stamets K, 2004, FERTIL STERIL, V81, P630, DOI 10.1016/j.fertnstert.2003.08.023; Stoernell CK, 2008, NUTR RES, V28, P443, DOI 10.1016/j.nutres.2008.03.013; Summer SS, 2011, OBESITY, V19, P2198, DOI 10.1038/oby.2011.60; Swinburn BA, 1999, J AM DIET ASSOC, V99, P1400, DOI 10.1016/S0002-8223(99)00339-9; Swinburn BA, 2001, DIABETES CARE, V24, P619, DOI 10.2337/diacare.24.4.619; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Tay J, 2008, J AM COLL CARDIOL, V51, P59, DOI 10.1016/j.jacc.2007.08.050; The Nordic Cochrane Centre The Cochrane Collaboration, 2011, REV MAN REVMAN 5 1; Tierney AC, 2011, INT J OBESITY, V35, P800, DOI 10.1038/ijo.2010.209; Torbay N, 2002, NUTR RES, V22, P587, DOI 10.1016/S0271-5317(02)00359-7; Treyzon L, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-23; Turley ML, 1998, EUR J CLIN NUTR, V52, P728, DOI 10.1038/sj.ejcn.1600634; Tuttle KR, 2008, AM J CARDIOL, V101, P1523, DOI 10.1016/j.amjcard.2008.01.038; Varady KA, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-8; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330; Volek JS, 2009, METABOLISM, V58, P1769, DOI 10.1016/j.metabol.2009.06.005; Volek JS, 2003, J NUTR, V133, P2756, DOI 10.1093/jn/133.9.2756; WALKER KZ, 1995, DIABETES CARE, V18, P401, DOI 10.2337/diacare.18.3.401; Wang YF, 2008, J HUM HYPERTENS, V22, P745, DOI 10.1038/jhh.2008.64; WebMD, 2012, ATK DIET; Westman EC, 2006, INT J CARDIOL, V110, P212, DOI 10.1016/j.ijcard.2005.08.034; WHO, 2010, GLOB STAT REP NONC D; Wolever TMS, 2008, DIABETOLOGIA, V51, P1607, DOI 10.1007/s00125-008-1093-x; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Health Organization, 1995, PHYS STAT US INT ANT; Wycherley TP, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.11; Wycherley TP, 2010, J INTERN MED, V267, P452, DOI 10.1111/j.1365-2796.2009.02174.x; Wycherley TP, 2010, DIABETES CARE, V33, P969, DOI 10.2337/dc09-1974; Yancy WS, 2007, EUR J CLIN NUTR, V61, P1416, DOI 10.1038/sj.ejcn.1602661; Yancy WS, 2004, ANN INTERN MED, V140, P769, DOI 10.7326/0003-4819-140-10-200405180-00006; Zatonski WA, 2005, BMJ-BRIT MED J, V331, P187, DOI 10.1136/bmj.331.7510.187	223	157	159	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e100652	10.1371/journal.pone.0100652	http://dx.doi.org/10.1371/journal.pone.0100652			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007189	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000339040600016
J	Singh, N; Eeda, SS; Gudapati, BK; Reddy, S; Kanade, P; Shantha, GPS; Rani, PK; Chakrabarti, S; Khanna, RC				Singh, Nakul; Eeda, Shiva Shankar; Gudapati, Bala Krishna; Reddy, Srinivasa; Kanade, Pushkar; Shantha, Ghanshyam Palamaner Subash; Rani, Padmaja Kumari; Chakrabarti, Subhabrata; Khanna, Rohit C.			Prevalence and Causes of Blindness and Visual Impairment and Their Associated Risk Factors, in Three Tribal Areas of Andhra Pradesh, India	PLOS ONE			English	Article							RAPID ASSESSMENT; AVOIDABLE BLINDNESS; CATARACT-SURGERY; OLDER-ADULTS; DISTRICT; PAKISTAN; VISION; NEPAL	Objective: To assess the prevalence of blindness and visual impairment (VI), their associated causes and underlying risk factors in three tribal areas of Andhra Pradesh, India and compare this data in conjunction with data from other countries with low and middle income settings. Methods: Using a validated Rapid Assessment of Avoidable Blindness methodology, a two stage sampling survey was performed in these areas involving probability proportionate to size sampling and compact segment sampling methods. Blindness, VI and severe visual impairment (SVI) were defined as per the WHO guidelines and Indian definitions. Results: Based on a prior enumeration, 7281 (97.1%) subjects were enrolled (mean age = 61.0+/27.9 years). Based on the presenting visual acuity (PVA), the prevalences of VI, SVI and blindness were 16.9% (95% CI: 15.7-18.1), 2.9% (95% CI: 2.5-3.4), and 2.3% (95% CI: 1.9-2.7), respectively. When based on the Pinhole corrected visual acuity (PCVA), the prevalences were lower in VI (6.2%, 95% CI: 5.4-6.9), SVI (1.5%, 95% CI: 1.2-1.9) and blindness (2.1%, 95% CI: 1.7-2.5). Refractive error was the major cause of VI (71.4%), whereas, cataract was the major cause of SVI and blindness (70.3%). Based on the PVA, the odds ratio (OR) of blindness increased in the age groups of 60-69 years (OR = 3.8, 95% CI: 2.8, 5.1), 70-79 years (OR = 10.6, 95% CI: 7.2, 15.5) and 80 years and above (OR = 30.7, 95% CI: 19.2, 49). The ORs were relatively higher in females (OR = 1.3, 95% CI: 1.0, 1.6) and illiterate subjects (OR = 4.3, 95% CI: 2.2, 8.5), but lower in those wearing glasses (OR = 0.2, 95% CI: 0.1, 0.4). Conclusions: This is perhaps the first study to assess the prevalence of blindness and VI in these tribal regions and the majority of the causes of blindness and SVI were avoidable (88.5%). These findings may be useful for planning eye care services in these underserved regions.	[Singh, Nakul] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Eeda, Shiva Shankar; Gudapati, Bala Krishna; Reddy, Srinivasa] Andhra Pradesh Right Sight Soc, Hyderabad, Andhra Pradesh, India; [Eeda, Shiva Shankar; Gudapati, Bala Krishna; Reddy, Srinivasa] Univ New S Wales, Sch Optometry & Vis Sci, Sydney, NSW, Australia; [Kanade, Pushkar] St Vincent Charity Med Ctr, Cleveland, OH USA; [Shantha, Ghanshyam Palamaner Subash] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Shantha, Ghanshyam Palamaner Subash] Wright Ctr Grad Med Educ, Dept Internal Med, Scranton, PA 18510 USA; [Rani, Padmaja Kumari; Chakrabarti, Subhabrata; Khanna, Rohit C.] LV Prasad Eye Inst, Brien Holden Eye Res Ctr, Hyderabad, Andhra Pradesh, India; [Rani, Padmaja Kumari; Khanna, Rohit C.] LV Prasad Eye Inst, GPR Int Ctr Adv Rural Eye Care, Allen Foster Res Ctr Community Eye Hlth, Hyderabad, Andhra Pradesh, India	Harvard University; Harvard T.H. Chan School of Public Health; University of New South Wales Sydney; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; L. V. Prasad Eye Institute; L. V. Prasad Eye Institute	Khanna, RC (corresponding author), LV Prasad Eye Inst, Brien Holden Eye Res Ctr, Banjara Hills, Hyderabad, Andhra Pradesh, India.	rohit@lvpei.org	pallerla, srinivasa r/F-4575-2014; Chakrabarti, Subhabrata/F-2468-2015	pallerla, srinivasa r/0000-0001-9126-1676; Chakrabarti, Subhabrata/0000-0003-3717-4963	Department for International Development (DFID) UK; Rose Traveling Fellowship	Department for International Development (DFID) UK; Rose Traveling Fellowship	Department for International Development (DFID) UK funded the study. The sponsor or funding organization had no role in the design or conduct of this research. In addition, Nakul Singh was supported by the Rose Traveling Fellowship, administered through the Harvard School of Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad K, 2005, OPHTHAL EPIDEMIOL, V12, P19, DOI 10.1080/09286580490921304; Anjum KM, 2006, BRIT J OPHTHALMOL, V90, P135, DOI 10.1136/bjo.2005.078527; Casson RJ, 2007, OPHTHALMOLOGY, V114, P2302, DOI 10.1016/j.ophtha.2007.02.004; Dulal S, 2012, NEPAL J OPHTHALMOL, V4, P282, DOI http://dx.doi.org/10.3126/nepjoph.v4i2.6545; Guruprasad BS, 2013, OPHTHAL EPIDEMIOL, V20, P89, DOI 10.3109/09286586.2012.759597; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Khandekar R, 2011, OMAN J OPHTHALMOLOGY, V4, P129; Khanna RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035701; Marmamula S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070120; Marmamula S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055924; Marmamula S, 2011, BMC OPHTHALMOL, V11, DOI 10.1186/1471-2415-11-26; Murthy GVS, 2010, OPHTHAL EPIDEMIOL, V17, P185, DOI 10.3109/09286586.2010.483751; Murthy GVS, 2001, OPHTHALMOLOGY, V108, P679, DOI 10.1016/S0161-6420(00)00579-0; Neena J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002867; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Sapkota YD, 2006, BRIT J OPHTHALMOL, V90, P411, DOI 10.1136/bjo.2005.082503; Sapkota YD, 2010, OPHTHAL EPIDEMIOL, V17, P82, DOI 10.3109/09286581003624947; Shaikh Sajida Parveen, 2005, J Coll Physicians Surg Pak, V15, P145; Sherchan A, 2010, BRIT J OPHTHALMOL, V94, P161, DOI 10.1136/bjo.2008.155408; StataCorp, 2009, STAT STAT SOFTW REL; Wadud Z, 2006, BRIT J OPHTHALMOL, V90, P1225, DOI 10.1136/bjo.2006.101287; Wu M, 2008, OPHTHALMOLOGY, V115, P969, DOI 10.1016/j.ophtha.2007.08.002; Zhao JL, 2010, OPHTHALMOLOGY, V117, P409, DOI 10.1016/j.ophtha.2009.11.023	23	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e100644	10.1371/journal.pone.0100644	http://dx.doi.org/10.1371/journal.pone.0100644			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007075	gold, Green Submitted, Green Published			2022-12-27	WOS:000339040600015
J	Vossius, C; Lotto, E; Lyanga, S; Mduma, E; Msemo, G; Perlman, J; Ersdal, HL				Vossius, Corinna; Lotto, Editha; Lyanga, Sara; Mduma, Estomih; Msemo, Georgina; Perlman, Jeffrey; Ersdal, Hege L.			Cost-Effectiveness of the "Helping Babies Breathe'' Program in a Missionary Hospital in Rural Tanzania	PLOS ONE			English	Article							CHILD-MORTALITY; COUNTRIES	Objective: The Helping Babies Breathe'' (HBB) program is an evidence-based curriculum in basic neonatal care and resuscitation, utilizing simulation-based training to educate large numbers of birth attendants in low-resource countries. We analyzed its cost-effectiveness at a faith-based Haydom Lutheran Hospital (HLH) in rural Tanzania. Methods: Data about early neonatal mortality and fresh stillbirth rates were drawn from a linked observational study during one year before and one year after full implementation of the HBB program. Cost data were provided by the Tanzanian Ministry of Health and Social Welfare (MOHSW), the research department at HLH, and the manufacturer of the training material Laerdal Global Health. Findings: Costs per life saved were USD 233, while they were USD 4.21 per life year gained. Costs for maintaining the program were USD 80 per life saved and USD 1.44 per life year gained. Costs per disease adjusted life year (DALY) averted ranged from International Dollars (ID; a virtual valuta corrected for purchasing power world-wide) 12 to 23, according to how DALYs were calculated. Conclusion: The HBB program is a low-cost intervention. Implementation in a very rural faith-based hospital like HLH has been highly cost-effective. To facilitate further global implementation of HBB a cost-effectiveness analysis including government owned institutions, urban hospitals and district facilities is desirable for a more diverse analysis to explore cost-driving factors and predictors of enhanced cost-effectiveness.	[Vossius, Corinna; Ersdal, Hege L.] Stavanger Univ Hosp, SAFER Stavanger Acute Med Fdn Educ & Res, Stavanger, Norway; [Lotto, Editha; Lyanga, Sara; Mduma, Estomih; Ersdal, Hege L.] Haydom Lutheran Hosp, Res Inst, Haydom, Tanzania; [Msemo, Georgina] Minist Hlth & Social Welf, Dar Es Salaam, Tanzania; [Perlman, Jeffrey] Weill Cornell Med Coll, Dept Pediat, New York, NY USA	Stavanger University Hospital; Cornell University	Vossius, C (corresponding author), Stavanger Univ Hosp, SAFER Stavanger Acute Med Fdn Educ & Res, Stavanger, Norway.	c.vossius@hotmail.com			Laerdal Foundation for Acute Medicine [40023]; municipaility of Stavanger, Norway; research department of Haydom Lutheran Hospital, Tanzania	Laerdal Foundation for Acute Medicine; municipaility of Stavanger, Norway; research department of Haydom Lutheran Hospital, Tanzania	The study was partly funded by the Laerdal Foundation for Acute Medicine (grant number 40023; http://www.laerdal.com/no/doc/311/Laerdals-Fond-for-Akuttmedisin), that provided travel expenses for Corinna Vossius and Hege L. Ersdal and a reserach grant for Hege L. Ersdal. Further, the research was funded by the municipaility of Stavanger, Norway and the research department of Haydom Lutheran Hospital, Tanzania. No funding bodies had any role in study design, data collection, decision or preparation of the manuscript.	Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Ersdal HL, 2013, RESUSCITATION, V84, P1422, DOI 10.1016/j.resuscitation.2013.04.005; Ersdal HL, 2012, RESUSCITATION, V83, P869, DOI 10.1016/j.resuscitation.2011.12.011; Ersdal HL, 2012, PEDIATRICS, V129, pE1238, DOI 10.1542/peds.2011-3134; Ersdal HL, 2013, PAS 2013; Johns B, 2003, PROGRAMME COSTS EC E; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Manasyan A, 2011, PEDIATRICS, V127, pE1176, DOI 10.1542/peds.2010-2158; Mduma E, 2013, PAS 2013; Msemo G, 2013, PEDIATRICS, V131, pE353, DOI 10.1542/peds.2012-1795; Oestergaard MZ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001080; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Save The Children, 2009, SIT AN NEWB HLTH TAN; UN, 1994, INT C POP DEV 5 13 S, P5; UNICEF, 2004, STAT WORLDS CHILDR R; UNICEF, 2011, UNICEF REP 2011 LEV; United Nations, 2013, BREAKTHR INN CAN SAV; United Nations Department of Economic and Social Affairs (UN DESA), 2011, POP DIV WORLD POP PR; WHO, 2009, NAT ROADM STRAT PLAN; World Health Organization, 2006, NEON PER MORT COUNTR; World Health Organization, 2005, CHOOS INT AR COST EF; World Health Organization, 2005, CHOSS INT ARE COST E; World Health Organization, 2006, WORK HLTH; World Health Organization, 2005, WORLD HLTH REP 2005	25	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102080	10.1371/journal.pone.0102080	http://dx.doi.org/10.1371/journal.pone.0102080			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006802	gold, Green Submitted, Green Published			2022-12-27	WOS:000339040600092
J	Andrade, K; Guerra, S; Debut, A				Andrade, Kleber; Guerra, Sara; Debut, Alexis			Fullerene-Based Symmetry in Hibiscus rosa-sinensis Pollen	PLOS ONE			English	Article								The fullerene molecule belongs to the so-called super materials. The compound is interesting due to its spherical configuration where atoms occupy positions forming a mechanically stable structure. We first demonstrate that pollen of Hibiscus rosa-sinensis has a strong symmetry regarding the distribution of its spines over the spherical grain. These spines form spherical hexagons and pentagons. The distance between atoms in fullerene is explained applying principles of flat, spherical, and spatial geometry, based on Euclid's "Elements'' book, as well as logic algorithms. Measurements of the pollen grain take into account that the true spine lengths, and consequently the real distances between them, are measured to the periphery of each grain. Algorithms are developed to recover the spatial effects lost in 2D photos. There is a clear correspondence between the position of atoms in the fullerene molecule and the position of spines in the pollen grain. In the fullerene the separation gives the idea of equal length bonds which implies perfectly distributed electron clouds while in the pollen grain we suggest that the spines being equally spaced carry an electrical charge originating in forces involved in the pollination process.	[Andrade, Kleber; Guerra, Sara; Debut, Alexis] Univ Fuerzas Armadas ESPE, Ctr Nanociencia & Nanotecnol, Sangolqui, Ecuador	Escuela Politecnica Superior del Ejercito	Andrade, K (corresponding author), Univ Fuerzas Armadas ESPE, Ctr Nanociencia & Nanotecnol, Sangolqui, Ecuador.	kgandrade@espe.edu.ec	Debut, Alexis/H-8424-2019	Debut, Alexis/0000-0002-8269-7619				Beers L, 1992, GROWING HIBISCUS; BOLICK MR, 1981, REV PALAEOBOT PALYNO, V35, P61, DOI 10.1016/0034-6667(81)90014-2; Bowker GE, 2007, ATMOS ENVIRON, V41, P1587, DOI 10.1016/j.atmosenv.2006.10.047; FOWLER PW, 1993, CHEM PHYS LETT, V202, P371, DOI 10.1016/0009-2614(93)90055-6; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Girling RD, 2013, SCI REP-UK, V3, DOI 10.1038/srep02779; Guerra S, 2013, ESPE CIENCIA TECNOLO, V4, P57; Jha S, 2013, EARTH SYSTEMS ENC SC, V4, P117; Karton A, 2013, J PHYS CHEM A, V117, P1834, DOI 10.1021/jp312585r; Kaya Y, 2013, REV PALAEOBOT PALYNO, V189, P50, DOI 10.1016/j.revpalbo.2012.11.004; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Lacourse T, 2012, REV PALAEOBOT PALYNO, V182, P55, DOI 10.1016/j.revpalbo.2012.06.007; Shaheen N, 2009, J MED PLANTS RES, V3, P921; Zhang JY, 2012, J MECH PHYS SOLIDS, V60, P1757, DOI 10.1016/j.jmps.2012.06.001	14	4	4	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e102123	10.1371/journal.pone.0102123	http://dx.doi.org/10.1371/journal.pone.0102123			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003375	Green Published, gold, Green Submitted			2022-12-27	WOS:000339242700113
J	Benitez, HA; Puschel, T; Lemic, D; Cacija, M; Kozina, A; Bazok, R				Benitez, Hugo A.; Pueschel, Thomas; Lemic, Darija; Cacija, Maja; Kozina, Antonela; Bazok, Renata			Ecomorphological Variation of the Wireworm Cephalic Capsule: Studying the Interaction of Environment and Geometric Shape	PLOS ONE			English	Article							DIABROTICA-VIRGIFERA-VIRGIFERA; FLUCTUATING ASYMMETRY; MORPHOLOGICAL INTEGRATION; CHARACTER DISPLACEMENT; LATITUDINAL GRADIENT; INDIVIDUAL VARIATION; AGRIOTES-USTULATUS; GENUS CEROGLOSSUS; SIZE DIMORPHISM; CARABID BEETLES	Studying the association between organismal morphology and environmental conditions has been very useful to test hypothesis regarding the influence of climate on shape. It has been long recognized that different environments produce dissimilar stress levels in insects, which can be reflected on the ability of an individual to overcome these pressures and spread further. Agriotes (Coleoptera: Elateridae) species infest agricultural fields in different parts of Croatia, inhabiting different climatic conditions. Previous biological studies have indicated that there is a relationship between some Agriotes biological parameters such as density and climatic conditions such as soil moisture and temperature. However, it is still unknown how these environmental properties influence the wireworm morphological structure. This is highly relevant because the head of this species is directly involved in the mobility in the soil, thus affecting the invasive capacity of this insect. Therefore the aim of this study was to assess the association between different climatic conditions and the morphological variation of Agriotes cephalic capsule. Advanced multivariate analysis and geometric morphometric tool were applied to study the covariation between shape and environmental variables. Partial Least Squares methods were used in order to analyse the association between the wireworm head shape and three different climatic conditions: soil type, temperature and rainfall. Our results showed that there is a high covariation between the wireworm head shape and the climatic conditions. It was suggested that the observed shape-environment association could be result of the high plasticity of this species in relation to its invasive capacity.	[Benitez, Hugo A.; Pueschel, Thomas] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Benitez, Hugo A.] Univ Tarapaca, Inst Alta Invest, Casilla, Arica, Chile; [Lemic, Darija; Cacija, Maja; Kozina, Antonela; Bazok, Renata] Univ Zagreb, Fac Agr, Dept Agr Zool, Zagreb 41000, Croatia	University of Manchester; Universidad de Tarapaca; University of Zagreb	Benitez, HA (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester, Lancs, England.	hugo.benitez@postgrad.manchester.ac.uk	Benítez, Hugo A/C-5077-2011; Čačija, Maja/K-3057-2018; Püschel, Thomas A/AAS-4535-2020; Bazok, Renata/G-8225-2012; Benitez, Hugo/AAI-1928-2019	Benítez, Hugo A/0000-0001-7553-9893; Čačija, Maja/0000-0001-9841-2721; Püschel, Thomas A/0000-0002-2231-2297; Bazok, Renata/0000-0003-1655-8140; Benitez, Hugo/0000-0001-7553-9893	Ministry of Science, Education and Sports of the Republic of Croatia by project: "The spatial distribution of economically important pests with the use of GIS'' [178-1782066-2065]	Ministry of Science, Education and Sports of the Republic of Croatia by project: "The spatial distribution of economically important pests with the use of GIS''	This research was supported by the Ministry of Science, Education and Sports of the Republic of Croatia by project: "The spatial distribution of economically important pests with the use of GIS'' (178-1782066-2065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2000, P NATL ACAD SCI USA, V97, P4106, DOI 10.1073/pnas.97.8.4106; Adams DC, 2013, HYSTRIX, V24, P7, DOI 10.4404/hystrix-24.1-6283; Alibert P, 2001, ZOOL SCR, V30, P299, DOI 10.1046/j.1463-6409.2001.00068.x; Arnqvist G, 1998, ACTA ZOOL ACAD SCI H, V44, P73; Bazok R., 2010, PHEROMONE APPL MAIZE; Bazok R, 2007, GLASILO BILJNE ZASTI, V5, P339; Benefer CM, 2013, J PEST SCI, V86, P19, DOI 10.1007/s10340-012-0454-x; Benefer CM, 2012, APPL SOIL ECOL, V53, P39, DOI 10.1016/j.apsoil.2011.11.004; Benitez H, 2008, GAYANA, V72, P131; Benitez HA, 2014, J INSECT SCI, V14, DOI 10.1673/031.014.11; Benitez HA, 2014, BIOL J LINN SOC, V111, P110, DOI 10.1111/bij.12194; Benitez HA, 2013, CURR ZOOL, V59, P769, DOI 10.1093/czoolo/59.6.769; Benitez HA, 2013, ZOOL SCI, V30, P289, DOI 10.2108/zsj.30.289; Bookstein FL, 2003, J HUM EVOL, V44, P167, DOI 10.1016/S0047-2484(02)00201-4; Bouyer J, 2007, J MED ENTOMOL, V44, P788, DOI 10.1603/0022-2585(2007)44[788:PSOGPG]2.0.CO;2; Bravi R, 2013, ACTA OECOL, V52, P57, DOI 10.1016/j.actao.2013.07.007; Brunner Nina, 2005, IOBC-WPRS Bulletin, V28, P117; CAMPBELL NA, 1981, SYST ZOOL, V30, P268, DOI 10.2307/2413249; Castaneda LE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058920; Clarke GM, 1998, AM NAT, V152, P762, DOI 10.1086/286207; COOK DF, 1990, ANIM BEHAV, V40, P428, DOI 10.1016/S0003-3472(05)80522-6; Corti M, 2001, BIOL J LINN SOC, V73, P99, DOI [10.1006/bijl.2001.0528, 10.1111/j.1095-8312.2001.tb01349.x]; DALY HV, 1985, ANNU REV ENTOMOL, V30, P415, DOI 10.1146/annurev.en.30.010185.002215; De Esteban-Trivigno S, 2011, AMEGHINIANA, V48, P381; De Esteban-Trivigno S, 2011, AMEGHINIANA, V48, P189, DOI 10.5710/AMGH.v48i2(313); Demirci B, 2012, J VECTOR ECOL, V37, P197, DOI 10.1111/j.1948-7134.2012.00217.x; Drake AG, 2008, P ROY SOC B-BIOL SCI, V275, P71, DOI 10.1098/rspb.2007.1169; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; Furlan L, 1998, J APPL ENTOMOL, V122, P71, DOI 10.1111/j.1439-0418.1998.tb01464.x; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; GOULD SJ, 1966, BIOL REV, V41, P587, DOI 10.1111/j.1469-185X.1966.tb01624.x; GROSS P, 1993, ANNU REV ENTOMOL, V38, P251, DOI 10.1146/annurev.en.38.010193.001343; Gurgel-GonCAlves R, MED VET ENTOMOLOGY, V25, P84; Haine ER, 2008, SCIENCE, V322, P1257, DOI 10.1126/science.1165265; Henderson A, 2006, BOT J LINN SOC, V151, P103, DOI 10.1111/j.1095-8339.2006.00526.x; Kaupp A, 1997, LARVEN KAFER MITTELE, P330; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2005, SYST BIOL, V54, P678, DOI 10.1080/10635150590947258; Klingenberg CP, 1996, BIOL J LINN SOC, V59, P143; Klingenberg CP, 1996, NATO ADV SCI INST SE, V284, P23; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Klingenberg CP, 1998, EVOLUTION, V52, P1363, DOI 10.1111/j.1558-5646.1998.tb02018.x; Klingenberg CP, 2001, AM NAT, V157, P11, DOI 10.1086/317002; Klingenberg CP, 2000, EVOLUTION, V54, P1273, DOI 10.1111/j.0014-3820.2000.tb00560.x; Kovacevic Z., 1960, PROBLEMATIKA ZEMLJIS, P567; Kozina A, 2012, FACTORS TEMPORAL SPA; Kozina A, 2013, INT J BIOMETEOROL, V57, P509, DOI 10.1007/s00484-012-0577-z; Laibner S., 2000, Elateridae. Ceske a Slovenske republiky.; LANDE R, 1985, J THEOR BIOL, V117, P651, DOI 10.1016/S0022-5193(85)80245-9; LAUDER GV, 1982, J THEOR BIOL, V97, P57, DOI 10.1016/0022-5193(82)90276-4; Legendre P, 2010, MOL ECOL RESOUR, V10, P831, DOI 10.1111/j.1755-0998.2010.02866.x; LIEBHOLD AM, 1993, ANNU REV ENTOMOL, V38, P303, DOI 10.1146/annurev.en.38.010193.001511; Maceljski M, 2002, POLJOPRIVREDNAENTOMO; McCullough EL, 2013, ANIM BEHAV, V86, P977, DOI 10.1016/j.anbehav.2013.08.017; Moczek AP, 2000, ANIM BEHAV, V59, P459, DOI 10.1006/anbe.1999.1342; Monteiro LR, 2010, EVOLUTION, V64, P724, DOI 10.1111/j.1558-5646.2009.00857.x; Monteiro LR, 2013, HYSTRIX, V24, P25, DOI 10.4404/hystrix-24.1-6282; Monteiro LR, 2003, J ZOOL, V261, P47, DOI 10.1017/S0952836903003893; Nijhout HF, 1998, P NATL ACAD SCI USA, V95, P3685, DOI 10.1073/pnas.95.7.3685; O'Higgins P, 2000, J ANAT, V197, P103, DOI 10.1046/j.1469-7580.2000.19710103.x; Parker WE, 2001, AGR FOREST ENTOMOL, V3, P85, DOI 10.1046/j.1461-9563.2001.00094.x; Parsons SMA, 2014, OECOLOGIA, V174, P379, DOI 10.1007/s00442-013-2785-6; PATON DC, 1989, AUST J ECOL, V14, P473, DOI 10.1111/j.1442-9993.1989.tb01457.x; Pfennig DW, 2010, TRENDS ECOL EVOL, V25, P459, DOI 10.1016/j.tree.2010.05.006; Piras P, 2010, BIOL J LINN SOC, V99, P632, DOI 10.1111/j.1095-8312.2009.01379.x; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Rohlf F.J., 2013, TPSDIG V 2 17; Rohlf FJ, 2000, SYST BIOL, V49, P740, DOI 10.1080/106351500750049806; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Roy D, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-135; Sanzana MJ, 2013, REV BRAS ENTOMOL, V57, P411, DOI 10.1590/S0085-56262013005000045; SCHLUTER D, 1988, AM NAT, V131, P799, DOI 10.1086/284823; Stone GN, 2003, TRENDS ECOL EVOL, V18, P512, DOI 10.1016/S0169-5347(03)00247-7; TABACHNICK RE, 1990, EVOLUTION, V44, P416, DOI 10.1111/j.1558-5646.1990.tb05209.x; Tellez TR, 2006, INT J PLANT SCI, V167, P321, DOI 10.1086/499613; Toepfer S, 2007, ENTOMOL EXP APPL, V124, P61, DOI 10.1111/j.1570-7458.2007.00549.x; Toth M, 2013, J PEST SCI, V86, P3, DOI 10.1007/s10340-012-0429-y; TOTH Z, 1984, ACTA PHYTOPATHOL HUN, V19, P13; Traugott M, 2008, SOIL BIOL BIOCHEM, V40, P342, DOI 10.1016/j.soilbio.2007.08.013; Villani MG, 1999, ANNU REV ENTOMOL, V44, P233, DOI 10.1146/annurev.ento.44.1.233; Vogelweith F, 2014, J INSECT PHYSIOL, V64, P54, DOI 10.1016/j.jinsphys.2014.03.009	82	18	18	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e102059	10.1371/journal.pone.0102059	http://dx.doi.org/10.1371/journal.pone.0102059			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003506	gold, Green Published			2022-12-27	WOS:000339242700104
J	Rosenberg, MS				Rosenberg, Michael S.			Contextual Cross-Referencing of Species Names for Fiddler Crabs (Genus Uca): An Experiment in Cyber-Taxonomy	PLOS ONE			English	Article							OCYPODIDAE	Cyber-taxonomy of name usage has focused primarily on producing authoritative lists of names or cross-linking names and data across disparate databases. A feature missing from much of this work is the recording and analysis of the context in which a name was used-context which can be critical for understanding not only what name an author used, but to which currently recognized species they actually refer. An experiment on recording contextual information associated with name usage was conducted for the fiddler crabs (genus Uca). Data from approximately one quarter of all publications that mention fiddler crabs, including 95% of those published prior to 1924 and 67% of those published prior to 1976, have currently been recorded in a database. Approaches and difficulties in recording and analyzing the context of name use are discussed. These results are not meant to be a full solution, rather to highlight problems which have not been previously investigated and may act as a springboard for broader approaches and discussion. Some data on the accessibility of the literature, including in particular electronic forms of publication, are also presented.	[Rosenberg, Michael S.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Rosenberg, Michael S.] Arizona State Univ, Ctr Evolutionary Med & Informat, Biodesign Inst, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Rosenberg, MS (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	msr@asu.edu	Rosenberg, Michael S/A-4621-2008	Rosenberg, Michael S/0000-0001-7882-2467				BOTT R, 1973, Senckenbergiana Biologica, V54, P311; Crane J., 1975, FIDDLER CRABS WORLD, V1st, DOI [10.1515/9781400867936, DOI 10.1515/9781400867936]; FIELDER DR, 1971, COMP BIOCHEM PHYSIOL, V39, P291, DOI 10.1016/0305-0491(71)90172-6; Franz NM, 2013, SYST BIODIVERS, V11, P209, DOI 10.1080/14772000.2013.806371; George R.W., 1982, Records of the Western Australian Museum Supplement, V14, P1; Gould A.A., 1841, REPORT INVERTEBRA MA; Hess W., 1865, ARCH NATURGESCH, VXXXI, P127; Hoffmann CK, 1874, CRUSTACEA; Holthuis L.B., 1979, Bulletin of Zoological Nomenclature, V35, P248; Huber R, 2009, COMPUT GEOSCI-UK, V35, P862, DOI 10.1016/j.cageo.2008.02.016; Kennedy JB, 2005, LECT NOTES COMPUT SC, V3615, P80; KING DS, 1969, NATURE, V221, P955, DOI 10.1038/221955a0; Kingsley JS, 1880, P ACAD NAT SCI PHILA, P135; Linnaeus C, 1758, SYSTEMA NATURAE; MACNAE W, 1966, AUST J BOT, V14, P67, DOI 10.1071/BT9660067; MARCGRAVI G., 1648, HIST NATURALIS BRASI, P1; Miller J, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-87; Nabout JC, 2010, IHERINGIA SER ZOOL, V100, P463, DOI 10.1590/S0073-47212010000400019; NOVAK A, 1974, Proceedings of the Biological Society of Washington, V87, P313; Page RDM, 2013, PEERJ, V1, DOI 10.7717/peerj.190; Rao K. R., 1968, Proceedings of the Louisiana Academy of Sciences, V31, P27; Rathbun M. J., 1897, P BIOL SOC WASH, V11, P153; Rathbun Mary J., 1914, Proceedings of the United States National Museum Smithsonian Institution Washington, V47; Rosenberg MS, 2013, ZOOTAXA, V3716, P494; Rumphius G.E., 1705, AMBOINSCHE RARITEITK; Shih HT, 2009, HYDROBIOLOGIA, V635, P373, DOI 10.1007/s10750-009-9930-6; Tavares Marcos S., 1993, V8, P7; VERNBERG FJ, 1966, PHYSIOL ZOOL, V39, P36, DOI 10.1086/physzool.39.1.30152765; VERWEY J., 1930, TREUBIA, V12, P167	29	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101704	10.1371/journal.pone.0101704	http://dx.doi.org/10.1371/journal.pone.0101704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004097	Green Published, gold, Green Submitted			2022-12-27	WOS:000339242700055
J	Widjaja, D; Caicedo, A; Vlemincx, E; Van Diest, I; Van Huffel, S				Widjaja, Devy; Caicedo, Alexander; Vlemincx, Elke; Van Diest, Ilse; Van Huffel, Sabine			Separation of Respiratory Influences from the Tachogram: A Methodological Evaluation	PLOS ONE			English	Article							RSA COMPONENT EXTRACTION; SINUS ARRHYTHMIA; BAROREFLEX GAIN; VARIABILITY; SIGNALS; MODEL; PCA	The variability of the heart rate (HRV) is widely studied as it contains information about the activity of the autonomic nervous system (ANS). However, HRV is influenced by breathing, independently of ANS activity. It is therefore important to include respiratory information in HRV analyses in order to correctly interpret the results. In this paper, we propose to record respiratory activity and use this information to separate the tachogram in two components: one which is related to breathing and one which contains all heart rate variations that are unrelated to respiration. Several algorithms to achieve this have been suggested in the literature, but no comparison between the methods has been performed yet. In this paper, we conduct two studies to evaluate the methods' performances to accurately decompose the tachogram in two components and to assess the robustness of the algorithms. The results show that orthogonal subspace projection and an ARMAX model yield the best performances over the two comparison studies. In addition, a real-life example of stress classification is presented to demonstrate that this approach to separate respiratory information in HRV studies can reveal changes in the heart rate variations that are otherwise masked by differing respiratory patterns.	[Widjaja, Devy; Caicedo, Alexander; Van Huffel, Sabine] Katholieke Univ Leuven, Dept Elect Engn, STADIUS Ctr Dynam Syst Signal Proc & Data Analyt, Leuven, Belgium; [Widjaja, Devy; Caicedo, Alexander; Van Huffel, Sabine] IMinds, Med Informat Technol Dept, Leuven, Belgium; [Vlemincx, Elke; Van Diest, Ilse] Katholieke Univ Leuven, Fac Psychol & Educ Sci Hlth Psychol, Leuven, Belgium	KU Leuven; IMEC; KU Leuven	Widjaja, D (corresponding author), Katholieke Univ Leuven, Dept Elect Engn, STADIUS Ctr Dynam Syst Signal Proc & Data Analyt, Leuven, Belgium.	devy.widjaja@esat.kuleuven.be	Dorado, Alexander Caicedo/ABG-9304-2020	Dorado, Alexander Caicedo/0000-0002-2073-8008; Van Diest, Ilse/0000-0002-0048-774X	Research Council KUL [CoE PFV/10/002 (OPTEC), GOA/10/09 MaNet]; FWO [G.0427.10N, G.0108.11, G.0869.12N, G.0A5513N]; IWT [TBM 080658-MRI, TBM 110697-NeoGuard]; IWT PhD Grant; iMinds Medical Information Technologies: SBO; ICON NXT_Sleep; Flanders Care Demonstratieproject Tele-Rehab III; Belgian Federal Science Policy Office [IUAP P7/19]; Belgian Foreign Affairs-Development Cooperation: VLIR UOS programs; EU RECAP 209G within INTERREG IVB NWE programme, EU MC ITN TRANSACT [316679]; ERC Advanced Grant BIOTENSORS [339804]; ERASMUS EQR Community service engineer [539642-LLP-1-2013]	Research Council KUL(KU Leuven); FWO(FWO); IWT(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); IWT PhD Grant; iMinds Medical Information Technologies: SBO; ICON NXT_Sleep; Flanders Care Demonstratieproject Tele-Rehab III; Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); Belgian Foreign Affairs-Development Cooperation: VLIR UOS programs; EU RECAP 209G within INTERREG IVB NWE programme, EU MC ITN TRANSACT; ERC Advanced Grant BIOTENSORS; ERASMUS EQR Community service engineer	Research supported by Research Council KUL: CoE PFV/10/002 (OPTEC), GOA/10/09 MaNet, PhD/Postdoc grants; FWO: PhD/Postdoc grants, G.0427.10N (Integrated EEG-fMRI), G.0108.11 (Compressed Sensing), G.0869.12N (Tumor imaging), G.0A5513N (Deep brain stimulation); IWT: PhD/Postdoc grants, TBM 080658-MRI (EEG-fMRI), TBM 110697-NeoGuard, D. Widjaja is supported by an IWT PhD Grant; iMinds Medical Information Technologies: SBO 2014, ICON NXT_Sleep; Flanders Care Demonstratieproject Tele-Rehab III (2012-2014); Belgian Federal Science Policy Office IUAP P7/19 (DYSCO,'Dynamical systems, control and optimization', 2012-2017); Belgian Foreign Affairs-Development Cooperation: VLIR UOS programs; EU RECAP 209G within INTERREG IVB NWE programme, EU MC ITN TRANSACT 2012 (no 316679), ERC Advanced Grant BIOTENSORS (no 339804), ERASMUS EQR Community service engineer (no 539642-LLP-1-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataee P, 2012, IEEE ENG MED BIO, P3805, DOI 10.1109/EMBC.2012.6346796; Bailon R, 2007, P ANN INT IEEE EMBS, P6675; Bakshi BR, 1998, AICHE J, V44, P1596, DOI 10.1002/aic.690440712; Bartsch RP, 2012, P NATL ACAD SCI USA, V109, P10181, DOI 10.1073/pnas.1204568109; BASELLI G, 1988, IEEE T BIO-MED ENG, V35, P1033, DOI 10.1109/10.8688; Bernardi L, 2000, J AM COLL CARDIOL, V35, P1462, DOI 10.1016/S0735-1097(00)00595-7; BERNTSON GG, 1993, PSYCHOPHYSIOLOGY, V30, P183, DOI 10.1111/j.1469-8986.1993.tb01731.x; BIANCHI AM, 1994, PROCEEDINGS OF THE 16TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY - ENGINEERING ADVANCES: NEW OPPORTUNITIES FOR BIOMEDICAL ENGINEERS, PTS 1&2, P121, DOI 10.1109/IEMBS.1994.412075; Brabanter J.D., 2002, LEAST SQUARES SUPPOR, DOI DOI 10.1142/9789812776655; BROWN TE, 1993, J APPL PHYSIOL, V75, P2310, DOI 10.1152/jappl.1993.75.5.2310; Caicedo A, 2013, IEEE ENG MED BIO, P2032, DOI 10.1109/EMBC.2013.6609930; Caicedo A, 2012, IEEE ENG MED BIO, P6153, DOI 10.1109/EMBC.2012.6347398; Camm AJ, 1996, EUR HEART J, V17, P354; Choi J, 2011, IEEE SENS J, V11, P2649, DOI 10.1109/JSEN.2011.2150746; Denver JW, 2007, BIOL PSYCHOL, V74, P286, DOI 10.1016/j.biopsycho.2005.09.005; Grossman P, 2007, BIOL PSYCHOL, V74, P263, DOI 10.1016/j.biopsycho.2005.11.014; Grossman P, 2006, BIOMED SCI INSTRUM, V42, P193; Hayano J, 1996, CIRCULATION, V94, P842, DOI 10.1161/01.CIR.94.4.842; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Lewis GF, 2012, BIOL PSYCHOL, V89, P349, DOI 10.1016/j.biopsycho.2011.11.009; MERRI M, 1990, IEEE T BIO-MED ENG, V37, P99, DOI 10.1109/10.43621; PAN J, 1985, IEEE T BIO-MED ENG, V32, P230, DOI 10.1109/TBME.1985.325532; Patton DJ, 1996, AM J PHYSIOL-HEART C, V270, pH1240, DOI 10.1152/ajpheart.1996.270.4.H1240; Porta A, 2000, AM J PHYSIOL-HEART C, V279, pH2558, DOI 10.1152/ajpheart.2000.279.5.H2558; Porta A, 2012, COMPUT BIOL MED, V42, P298, DOI 10.1016/j.compbiomed.2011.04.019; Ritz T, 2006, PSYCHOSOM MED, V68, P617, DOI 10.1097/01.psy.0000228010.96408.ed; Seidel H, 1995, MODELLING DYNAMICS B, P205, DOI DOI 10.1007/978-3-642-79290-8_11; Taelman J, 2011, EUR J APPL PHYSIOL, V111, P1497, DOI 10.1007/s00421-010-1776-0; Tiinanen S, 2009, COMPUT CARDIOL, V36, P161; Tiinanen S, 2008, IEEE T BIO-MED ENG, V55, P51, DOI 10.1109/TBME.2007.897840; Tiinanen S, 2010, COMPUT CARDIOL CONF, V37, P73; Vlemincx E, 2013, INT J PSYCHOPHYSIOL, V87, P147, DOI 10.1016/j.ijpsycho.2012.12.002; Vlemincx E, 2011, PSYCHOPHYSIOLOGY, V48, P117, DOI 10.1111/j.1469-8986.2010.01043.x; Widjaja D, 2012, 7 INT WORKSH BIOS IN, P299; Widjaja D, 2013, IEEE ENG MED BIO, P6123, DOI 10.1109/EMBC.2013.6610950; Yasuma F, 2004, CHEST, V125, P683, DOI 10.1378/chest.125.2.683	36	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101713	10.1371/journal.pone.0101713	http://dx.doi.org/10.1371/journal.pone.0101713			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004139	Green Published, Green Submitted, gold			2022-12-27	WOS:000339242700056
J	Yokota, M; Kobayashi, Y; Morita, J; Suzuki, H; Hashimoto, Y; Sasaki, Y; Akiyoshi, K; Moriyama, K				Yokota, Masako; Kobayashi, Yukiho; Morita, Jumpei; Suzuki, Hiroyuki; Hashimoto, Yoshihide; Sasaki, Yoshihiro; Akiyoshi, Kazunari; Moriyama, Keiji			Therapeutic Effect of Nanogel-Based Delivery of Soluble FGFR2 with S252W Mutation on Craniosynostosis	PLOS ONE			English	Article							FACTOR RECEPTOR-2 FGFR2; APERT-SYNDROME; MOUSE MODEL; SUSTAINED-RELEASE; IMMUNE-RESPONSES; BONE-DEVELOPMENT; CROUZON-SYNDROME; CALVARIAL BONE; GENE CAUSE; DIFFERENTIATION	Apert syndrome is an autosomal dominantly inherited disorder caused by missense mutations in fibroblast growth factor receptor 2 (FGFR2). Surgical procedures are frequently required to reduce morphological and functional defects in patients with Apert syndrome; therefore, the development of noninvasive procedures to treat Apert syndrome is critical. Here we aimed to clarify the etiological mechanisms of craniosynostosis in mouse models of Apert syndrome and verify the effects of purified soluble FGFR2 harboring the S252W mutation (sFGFR2IIIc(S252W)) on calvarial sutures in Apert syndrome mice in vitro. We observed increased expression of Fgf10, Esrp1, and Fgfr2IIIb, which are indispensable for epidermal development, in coronal sutures in Apert syndrome mice. Purified sFGFR2IIIc(S252W) exhibited binding affinity for fibroblast growth factor (Fgf)2 but also formed heterodimers with FGFR2IIIc, FGFR2IIIc(S252W), and FGFR2IIIb(S252W). Administration of sFGFR2IIIc(S252W) also inhibited Fgf2-dependent proliferation, phosphorylation of intracellular signaling molecules, and mineralization of FGFR2(S252W)-overexpressing MC3T3-E1 osteoblasts. sFGFR2IIIc(S252W) complexed with nanogels maintained the patency of coronal sutures, whereas synostosis was observed where the nanogel without sFGFR2(S252W) was applied. Thus, based on our current data, we suggest that increased Fgf10 and Fgfr2IIIb expression may induce the onset of craniosynostosis in patients with Apert syndrome and that the appropriate delivery of purified sFGFR2IIIc(S252W) could be effective for treating this disorder.	[Yokota, Masako; Kobayashi, Yukiho; Morita, Jumpei; Suzuki, Hiroyuki; Moriyama, Keiji] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Div Maxillofacial Neck Reconstruct, Dept Maxillofacial Reconstruct & Funct, Tokyo, Japan; [Kobayashi, Yukiho; Suzuki, Hiroyuki; Sasaki, Yoshihiro; Akiyoshi, Kazunari; Moriyama, Keiji] Tokyo Med & Dent Univ, Hard Tissue Genome Res Ctr, Tokyo, Japan; [Sasaki, Yoshihiro; Akiyoshi, Kazunari] Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Kyoto, Japan; [Hashimoto, Yoshihide; Akiyoshi, Kazunari] Japan Sci & Technol Agcy, ERATO, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Kyoto University; Japan Science & Technology Agency (JST)	Kobayashi, Y (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Div Maxillofacial Neck Reconstruct, Dept Maxillofacial Reconstruct & Funct, Tokyo, Japan.	yukiho-kobayashi.mort@tmd.ac.jp	HASHIMOTO, YOSHIHIDE/S-3056-2017; Moriyama, Keiji/AAC-3193-2019	HASHIMOTO, YOSHIHIDE/0000-0003-0537-8291; Moriyama, Keiji/0000-0003-0580-4510	Japan Society for the Promotion of Science, as well as the Global Center of Excellence Program at the Tokyo Medical and Dental University (TMDU), Japan [23390471, 23792418]	Japan Society for the Promotion of Science, as well as the Global Center of Excellence Program at the Tokyo Medical and Dental University (TMDU), Japan	This study was financially supported by a Grant-in-aid for Scientific Research (No. 23390471 to KM, http://www.jsps.go.jp/english/index.html) and Young Scientists (No. 23792418 to YK, http://www.jsps.go.jp/english/index.html) from Japan Society for the Promotion of Science, as well as the Global Center of Excellence Program at the Tokyo Medical and Dental University (TMDU), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behr B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070240; Biechele TL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002274; Chen L, 2003, BONE, V33, P169, DOI 10.1016/S8756-3282(03)00222-9; Chevrel G, 2002, ANN RHEUM DIS, V61, P730, DOI 10.1136/ard.61.8.730; Fong KD, 2004, PLAST RECONSTR SURG, V113, P2037, DOI 10.1097/01.PRS.0000121182.01199.C1; Fragale A, 1999, AM J PATHOL, V154, P1465, DOI 10.1016/S0002-9440(10)65401-6; Fujioka-Kobayashi M, 2012, BIOMATERIALS, V33, P7613, DOI 10.1016/j.biomaterials.2012.06.075; Hajihosseini MK, 2001, P NATL ACAD SCI USA, V98, P3855, DOI 10.1073/pnas.071586898; Hayashi C, 2009, J CELL PHYSIOL, V220, P1, DOI 10.1002/jcp.21760; Holmes G, 2009, DEV BIOL, V328, P273, DOI 10.1016/j.ydbio.2009.01.026; Ikuta Y, 2002, BLOOD, V99, P3717, DOI 10.1182/blood.V99.10.3717; JABS EW, 1994, NAT GENET, V8, P275, DOI 10.1038/ng1194-275; Johnson D, 2011, EUR J HUM GENET, V19, P369, DOI 10.1038/ejhg.2010.235; Kageyama S, 2008, CANCER SCI, V99, P601, DOI 10.1111/j.1349-7006.2007.00705.x; Kitano S, 2006, CLIN CANCER RES, V12, P7397, DOI 10.1158/1078-0432.CCR-06-1546; Lali FV, 2000, J BIOL CHEM, V275, P7395, DOI 10.1074/jbc.275.10.7395; Lamoureux F, 2008, MOL CANCER THER, V7, P3389, DOI 10.1158/1535-7163.MCT-08-0497; Lomri A, 1998, J CLIN INVEST, V101, P1310; Matsumoto K, 2002, SCAND J PLAST RECONS, V36, P368, DOI 10.1080/028443102321096375; Miralles F, 1999, P NATL ACAD SCI USA, V96, P6267, DOI 10.1073/pnas.96.11.6267; Miraoui H, 2009, J BIOL CHEM, V284, P4897, DOI 10.1074/jbc.M805432200; Morita J, 2014, DEV DYNAM, V243, P560, DOI 10.1002/dvdy.24099; Nochi T, 2010, NAT MATER, V9, P572, DOI [10.1038/NMAT2784, 10.1038/nmat2784]; Oldridge M, 1999, AM J HUM GENET, V64, P446, DOI 10.1086/302245; Przylepa KA, 1996, NAT GENET, V13, P492, DOI 10.1038/ng0896-492; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; Rice DPC, 1999, EUR J ORAL SCI, V107, P265, DOI 10.1046/j.0909-8836.1999.eos107406.x; Rice DPC, 2003, BONE, V33, P14, DOI 10.1016/S8756-3282(03)00163-7; Rice DPC, 2000, DEVELOPMENT, V127, P1845; RUTLAND P, 1995, NAT GENET, V9, P173, DOI 10.1038/ng0295-173; Sasaki Y, 2010, CHEM REC, V10, P366, DOI 10.1002/tcr.201000008; Shen K, 2009, ORTHOD CRANIOFAC RES, V12, P254, DOI 10.1111/j.1601-6343.2009.01460.x; Shimizu T, 2008, BIOCHEM BIOPH RES CO, V367, P330, DOI 10.1016/j.bbrc.2007.12.112; Shimoda A, 2012, COLLOID SURFACE B, V99, P38, DOI 10.1016/j.colsurfb.2011.09.025; Shukla V, 2007, NAT GENET, V39, P1145, DOI 10.1038/ng2096; Suzuki H, 2012, J CELL PHYSIOL, V227, P3267, DOI 10.1002/jcp.24021; Tanimoto Y, 2004, J BIOL CHEM, V279, P45926, DOI 10.1074/jbc.M404824200; TROWELL OA, 1954, EXP CELL RES, V6, P246, DOI 10.1016/0014-4827(54)90169-X; Veistinen L, 2009, J EXP ZOOL PART B, V312B, P351, DOI 10.1002/jez.b.21276; Wang YL, 2005, DEVELOPMENT, V132, P3537, DOI 10.1242/dev.01914; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Watanabe K, 2011, BIOMATERIALS, V32, P5900, DOI 10.1016/j.biomaterials.2011.04.058; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165; Yang F, 2008, BONE, V43, P55, DOI 10.1016/j.bone.2008.02.008; Yin L, 2008, BONE, V42, P631, DOI 10.1016/j.bone.2007.11.019; Yu K, 2000, P NATL ACAD SCI USA, V97, P14536, DOI 10.1073/pnas.97.26.14536	46	17	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101693	10.1371/journal.pone.0101693	http://dx.doi.org/10.1371/journal.pone.0101693			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003957	gold, Green Published, Green Submitted			2022-12-27	WOS:000339242700054
J	Assmann, A; Heke, M; Kropil, P; Ptok, L; Hafner, D; Ohmann, C; Martens, A; Karluss, A; Emmert, MY; Kutschka, I; Sievers, HH; Klein, HM				Assmann, Alexander; Heke, Michael; Kroepil, Patric; Ptok, Lena; Hafner, Dieter; Ohmann, Christian; Martens, Andreas; Karluss, Antje; Emmert, Maximilian Y.; Kutschka, Ingo; Sievers, Hans-Hinrich; Klein, Hans-Michael			Laser-Supported CD133+Cell Therapy in Patients with Ischemic Cardiomyopathy: Initial Results from a Prospective Phase I Multicenter Trial	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR MAGNETIC-RESONANCE; LEFT-VENTRICULAR FUNCTION; STEM-CELL THERAPY; BONE-MARROW-CELLS; TRANSMYOCARDIAL LASER; HEART-FAILURE; INTRACORONARY INJECTION; MONONUCLEAR-CELLS; HOLMIUM-YAG	Objectives: This study evaluates the safety, principal feasibility and restoration potential of laser-supported CD133+ intramyocardial cell transplantation in patients with ischemic cardiomyopathy. Methods: Forty-two patients with severe ischemic cardiomyopathy (left ventricular ejection fraction (LVEF) >15% and <35%) were included in this prospective multicenter phase I trial. They underwent coronary artery bypass grafting (CABG) with subsequent transepicardial low-energy laser treatment and autologous CD133+ cell transplantation, and were followed up for 12 months. To evaluate segmental myocardial contractility as well as perfusion and to identify the areas of scar tissue, cardiac MRI was performed at 6 months and compared to the preoperative baseline. In addition, clinical assessment comprising of CCS scoring, blood and physical examination was performed at 3, 6 and 12 months, respectively. Results: Intraoperative cell isolation resulted in a mean cell count of 9.7 +/- 1.2x10(6). Laser treatment and subsequent CD133+ cell therapy were successfully and safely carried out in all patients and no procedure-related complications occurred. At 6 months, the LVEF was significantly increased (29.7 +/- 1.9% versus 24.6 +/- 1.5% with p = 0.004). In addition, freedom from angina was achieved, and quality of life significantly improved after therapy (p<0.0001). Interestingly, an extended area of transmural delayed enhancement (>3 myocardial segments) determined in the preoperative MRI was inversely correlated with a LVEF increase after laser-supported cell therapy (p = 0.024). Conclusions: This multicenter trial demonstrates that laser-supported CD133+ cell transplantation is safe and feasible in patients with ischemic cardiomyopathy undergoing CABG, and in most cases, it appears to significantly improve the myocardial function. Importantly, our data show that the beneficial effect was significantly related to the extent of transmural delayed enhancement, suggesting that MRI-guided selection of patients is mandatory to ensure the effectiveness of the therapy.	[Assmann, Alexander; Heke, Michael; Ptok, Lena; Klein, Hans-Michael] Univ Dusseldorf, Dept Cardiovasc Surg, Fac Med, Dusseldorf, Germany; [Assmann, Alexander; Heke, Michael] Univ Dusseldorf, Res Grp Expt Surg, Fac Med, Dusseldorf, Germany; [Assmann, Alexander] Harvard Univ, Brigham & Womens Hosp, Ctr Biomed Engn, Dept Med,Med Sch, Boston, MA 02115 USA; [Assmann, Alexander] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Kroepil, Patric] Univ Dusseldorf, Dept Diagnost & Intervent Radiol, Fac Med, Dusseldorf, Germany; [Hafner, Dieter] Univ Dusseldorf, Inst Pharmacol & Clin Pharmacol, Fac Med, Dusseldorf, Germany; [Ohmann, Christian] Univ Dusseldorf, Coordinat Ctr Clin Trials, Fac Med, Dusseldorf, Germany; [Martens, Andreas; Kutschka, Ingo] Hannover Med Sch, Clin Cardiothorac Transplantat & Vasc Surg, Hannover, Germany; [Karluss, Antje; Sievers, Hans-Hinrich] Univ Hosp Schleswig Holstein, Dept Cardiac & Thorac Vasc Surg, Lubeck, Germany; [Emmert, Maximilian Y.] Univ Zurich Hosp, Clin Cardiac & Vasc Surg, CH-8091 Zurich, Switzerland	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Hannover Medical School; University of Kiel; Schleswig Holstein University Hospital; University of Zurich; University Zurich Hospital	Klein, HM (corresponding author), Univ Dusseldorf, Dept Cardiovasc Surg, Fac Med, Dusseldorf, Germany.	kleinhm@med.uni-duesseldorf.de	Ohmann, Christian/AAV-8608-2020; Martens, Andreas/AAG-2746-2020	Martens, Andreas/0000-0002-7953-2645	PLC Medical Systems Inc. (Milford, USA); Miltenyi Biotech Inc. (Bergisch Gladbach, Germany)	PLC Medical Systems Inc. (Milford, USA); Miltenyi Biotech Inc. (Bergisch Gladbach, Germany)	This work was supported by the study sponsors PLC Medical Systems Inc. (Milford, USA) and Miltenyi Biotech Inc. (Bergisch Gladbach, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Moreover, this funding situation does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Ang KL, 2008, NAT CLIN PRACT CARD, V5, P663, DOI 10.1038/ncpcardio1321; Assmus B, 2010, CIRC-HEART FAIL, V3, P89, DOI 10.1161/CIRCHEARTFAILURE.108.843243; Babin-Ebell J, 2010, THORAC CARDIOV SURG, V58, P11, DOI 10.1055/s-0029-1186199; Fuchs S, 2002, J CARDIAC SURG, V17, P413; Grothues F, 2002, AM J CARDIOL, V90, P29, DOI 10.1016/S0002-9149(02)02381-0; Hirsch A, 2011, EUR HEART J, V32, P1736, DOI 10.1093/eurheartj/ehq449; Horvath KA, 2008, J CARDIAC SURG, V23, P266, DOI 10.1111/j.1540-8191.2008.00579.x; Hughes GC, 2000, ANN THORAC SURG, V70, P504, DOI 10.1016/S0003-4975(00)01569-1; Hughes GC, 2002, J AM COLL CARDIOL, V39, P1220, DOI 10.1016/S0735-1097(02)01734-5; Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074; Klein C, 2002, CIRCULATION, V105, P162, DOI 10.1161/hc0202.102123; Klein HM, 2007, HEART SURG FORUM, V10, P28, DOI 10.1532/HSF98.20061054; Klein HM, 2004, HEART SURG FORUM, V7, pE416, DOI 10.1532/HSF98.20041095; Klein HM, 2010, MMCTS, P3947; Li W, 2003, AM J PHYSIOL-HEART C, V284, pH23, DOI 10.1152/ajpheart.00240.2002; Losordo DW, 2011, CIRC RES, V109, P428, DOI 10.1161/CIRCRESAHA.111.245993; Manginas A, 2007, CATHETER CARDIO INTE, V69, P773, DOI 10.1002/ccd.21023; Menasche P, 2008, J CARDIOVASC TRANSL, V1, P201, DOI 10.1007/s12265-008-9017-1; Meyer GP, 2009, EUR HEART J, V30, P2978, DOI 10.1093/eurheartj/ehp374; Nyolczas N, 2009, REGEN MED, V4, P407, DOI 10.2217/RME.09.14; Patel AN, 2007, CELL TRANSPLANT, V16, P899, DOI 10.3727/096368907783338253; Patila T, 2014, J HEART LUNG TRANSPL, V33, P567, DOI 10.1016/j.healun.2014.02.009; Pennell DJ, 2004, J CARDIOVASC MAGN R, V6, P727, DOI 10.1081/JCMR-200038581; Reyes G, 2009, EUR J CARDIO-THORAC, V36, P192, DOI 10.1016/j.ejcts.2009.03.022; Roncalli J, 2011, EUR HEART J, V32, P1748, DOI 10.1093/eurheartj/ehq455; Sanganalmath SK, 2013, CIRC RES, V113, P810, DOI 10.1161/CIRCRESAHA.113.300219; Schneider J, 2001, EUR J CARDIO-THORAC, V19, P164, DOI 10.1016/S1010-7940(00)00652-7; Stamm C, 2007, J THORAC CARDIOV SUR, V133, P717, DOI 10.1016/j.jtcvs.2006.08.077; Strauer BE, 2011, J AM COLL CARDIOL, V58, P1095, DOI 10.1016/j.jacc.2011.06.016; Strauer BE, 2010, EUR J HEART FAIL, V12, P721, DOI 10.1093/eurjhf/hfq095; Surder D, 2013, CIRCULATION, V127, P1968, DOI 10.1161/CIRCULATIONAHA.112.001035; Traverse JH, 2012, JAMA-J AM MED ASSOC, V308, P2380, DOI 10.1001/jama.2012.28726; Vogel-Claussen J, 2006, RADIOGRAPHICS, V26, P795, DOI 10.1148/rg.263055047; Yerebakan C, 2011, J THORAC CARDIOV SUR, V142, P1530, DOI 10.1016/j.jtcvs.2011.05.002	34	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101449	10.1371/journal.pone.0101449	http://dx.doi.org/10.1371/journal.pone.0101449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000346	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000338637300045
J	Manabe, YC; Nonyane, BAS; Nakiyingi, L; Mbabazi, O; Lubega, G; Shah, M; Moulton, LH; Joloba, M; Ellner, J; Dorman, SE				Manabe, Yukari C.; Nonyane, Bareng A. S.; Nakiyingi, Lydia; Mbabazi, Olive; Lubega, Gloria; Shah, Maunank; Moulton, Lawrence H.; Joloba, Moses; Ellner, Jerrold; Dorman, Susan E.			Point-of-Care Lateral Flow Assays for Tuberculosis and Cryptococcal Antigenuria Predict Death in HIV Infected Adults in Uganda	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; PULMONARY TUBERCULOSIS; ANTIRETROVIRAL THERAPY; HOSPITALIZED ADULTS; XPERT MTB/RIF; URINE ANTIGEN; SEVERE SEPSIS; LOW-COST; OUTCOMES; BURDEN	Background: Mortality in hospitalized, febrile patients in Sub-Saharan Africa is high due to HIV-infected, severely immunosuppressed patients with opportunistic co-infection, particularly disseminated tuberculosis (TB) and cryptococcal disease. We sought to determine if a positive lateral flow assay (LFA) result for urine lipoarabinomannan (LAM) and cryptococcal antigenuria was associated with mortality. Methods: 351 hospitalized, HIV-positive adults with symptoms consistent with TB and who were able to provide both urine and sputum specimens were prospectively enrolled at Mulago National Referral Hospital in Uganda as part of a prospective accuracy evaluation of the lateral flow Determine TB LAM test. Stored frozen urine was retrospectively tested for cryptococcal antigen (CRAG) using the LFA. We fitted a multinomial logistic regression model to analyze factors associated with death within 2 months after initial presentation. Results: The median CD4 of the participants was 57 (IQR: 14-179) cells/mu l and 41% (145) were microbiologically confirmed TB cases. LAM LFA was positive in 38% (134), 7% (25) were CRAG positive, and 43% (151) were positive for either test in urine. Overall, 21% (75) died within the first 2 months, and a total of 32% (114) were confirmed dead by 6 months. At 2 months, 30% of LAM or CRAG positive patients were confirmed dead compared to 15.0% of those who were negative. In an adjusted model, LAM or CRAG positive results were associated with an increased risk of death (RRR 2.29, 95% CI: 1.29, 4.05; P = 0.005). Conclusions: In hospitalized HIV-infected patients, LAM or CRAG LFA positivity was associated with subsequent death within 2 months. Further studies are warranted to examine the impact of POC diagnostic 'test and treat' approach on patient-centered outcomes.	[Manabe, Yukari C.; Nakiyingi, Lydia; Mbabazi, Olive; Lubega, Gloria] Makerere Univ, Infect Dis Inst, Coll Hlth Sci, Kampala, Uganda; [Manabe, Yukari C.; Shah, Maunank; Dorman, Susan E.] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA; [Nonyane, Bareng A. S.; Moulton, Lawrence H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Joloba, Moses] Makerere Univ, Dept Microbiol, Coll Hlth Sci, Kampala, Uganda; [Ellner, Jerrold] Boston Univ, Sch Med, Boston, MA 02118 USA; [Ellner, Jerrold] Boston Med Ctr, Boston, MA USA	Makerere University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Makerere University; Boston University; Boston Medical Center	Manabe, YC (corresponding author), Makerere Univ, Infect Dis Inst, Coll Hlth Sci, Kampala, Uganda.	ymanabe@jhmi.edu	Nakiyingi, Lydia/ABG-7669-2020; Nonyane, Bareng A.S./AAC-8118-2020	Nakiyingi, Lydia/0000-0001-7263-3198; Nonyane, Bareng A.S./0000-0001-5633-7487; Joloba, Moses/0000-0002-0334-9983; Moulton, Lawrence/0000-0001-7041-7387	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN2722000900050C]; Johns Hopkins University Center for AIDS Research (National Institute of Allergy And Infectious Diseases) [1P30AI094189]; FOGARTY INTERNATIONAL CENTER [D43TW009771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI104830, P30AI094189] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Johns Hopkins University Center for AIDS Research (National Institute of Allergy And Infectious Diseases); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project was funded with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under contract #HHSN2722000900050C, "TB Clinical Diagnostics Research Consortium.'' Additional Support was provided to YCM by the Johns Hopkins University Center for AIDS Research (Grant Number 1P30AI094189 from the National Institute of Allergy And Infectious Diseases). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaba PA, 2011, J INFECT DEV COUNTR, V5, P377, DOI 10.3855/jidc.1096; Andama AO, 2013, JAIDS-J ACQ IMM DEF, V63, P189, DOI 10.1097/QAI.0b013e3182926f95; Archibald LK, 1998, CLIN INFECT DIS, V26, P290, DOI 10.1086/516297; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; Cox JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033685; Crump JA, 2011, CLIN INFECT DIS, V52, P341, DOI 10.1093/cid/ciq103; Dorman S, 2012, CROI 2012 SEATTL; French N, 2002, AIDS, V16, P1031, DOI 10.1097/00002030-200205030-00009; Jacob ST, 2012, CRIT CARE MED, V40, P2050, DOI 10.1097/CCM.0b013e31824e65d7; Jacob ST, 2009, PLOS ONE, V4, pA115, DOI 10.1371/journal.pone.0007782; Jarvis JN, 2011, CLIN INFECT DIS, V53, P1019, DOI 10.1093/cid/cir613; Jarvis JN, 2009, AIDS, V23, P1182, DOI 10.1097/QAD.0b013e32832be0fc; Jarvis JN, 2009, CLIN INFECT DIS, V48, P856, DOI 10.1086/597262; Lawn SD, 2011, INT J TUBERC LUNG D, V15, P287; Lawn SD, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-407; Lawn SD, 2012, AIDS, V26, P1635, DOI 10.1097/QAD.0b013e3283553685; Lawn SD, 2012, CLIN INFECT DIS, V54, P1071, DOI 10.1093/cid/cir1039; Lawn SD, 2012, LANCET INFECT DIS, V12, P201, DOI 10.1016/S1473-3099(11)70251-1; Lewis DK, 2002, INT J TUBERC LUNG D, V6, P1067; Liechty CA, 2007, TROP MED INT HEALTH, V12, P929, DOI 10.1111/j.1365-3156.2007.01874.x; Martinson NA, 2007, AIDS, V21, P2043, DOI 10.1097/QAD.0b013e3282eea47f; McDonald LC, 1999, LANCET, V354, P1159, DOI 10.1016/S0140-6736(98)12325-5; Meya DB, 2010, CLIN INFECT DIS, V51, P448, DOI 10.1086/655143; Micol R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013856; Munseri PJ, 2011, SCAND J INFECT DIS, V43, P696, DOI 10.3109/00365548.2011.577802; Nakiyingi L, 2014, JAIDS-J ACQ IMM DEF, V66, P270, DOI 10.1097/QAI.0000000000000151; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Peeling RW, 2006, SEX TRANSM INFECT, V82, pV1, DOI 10.1136/sti.2006.024265; Albuquerque MDPM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-289; Peter JG, 2012, EUR RESPIR J, V40, P1211, DOI 10.1183/09031936.00201711; Rajasingham R, 2012, JAIDS-J ACQ IMM DEF, V59, pE85, DOI 10.1097/QAI.0b013e31824c837e; Saleri N, 2009, INFECTION, V37, P142, DOI 10.1007/s15010-008-7406-7; Shah M, 2009, J ACQ IMMUN DEF SYND; Shah M, 2014, AIDS; Ssali FN, 1998, J ACQ IMMUN DEF SYND, V19, P484, DOI 10.1097/00042560-199812150-00007; Talbot E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032876; Theron G, 2012, EUR RESPIR J, V40, P161, DOI 10.1183/09031936.00145511; Van Rie A, 2013, C RETR OPP INF ATL G; Wood R, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-47; Yoon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048599	40	37	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101459	10.1371/journal.pone.0101459	http://dx.doi.org/10.1371/journal.pone.0101459			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000489	Green Published, gold, Green Submitted			2022-12-27	WOS:000338637300046
J	Mondal, S; Pathak, BK; Ray, S; Barat, C				Mondal, Surojit; Pathak, Bani Kumar; Ray, Sutapa; Barat, Chandana			Impact of P-Site tRNA and Antibiotics on Ribosome Mediated Protein Folding: Studies Using the Escherichia coli Ribosome	PLOS ONE			English	Article							AMINOACYLATED TRANSFER-RNAS; IN-VITRO; TRANSLATION INITIATION; DOMAIN-V; STRUCTURAL BASIS; DISTINCT ROLES; MESSENGER-RNA; BLASTICIDIN-S; BINDING; SUBUNIT	Background: The ribosome, which acts as a platform for mRNA encoded polypeptide synthesis, is also capable of assisting in folding of polypeptide chains. The peptidyl transferase center (PTC) that catalyzes peptide bond formation resides in the domain V of the 23S rRNA of the bacterial ribosome. Proper positioning of the 3' -CCA ends of the A- and P-site tRNAs via specific interactions with the nucleotides of the PTC are crucial for peptidyl transferase activity. This RNA domain is also the center for ribosomal chaperoning activity. The unfolded polypeptide chains interact with the specific nucleotides of the PTC and are released in a folding competent form. In vitro transcribed RNA corresponding to this domain (bDV RNA) also displays chaperoning activity. Results: The present study explores the effects of tRNAs, antibiotics that are A- and P-site PTC substrate analogs (puromycin and blasticidin) and macrolide antibiotics (erythromycin and josamycin) on the chaperoning ability of the E. coli ribosome and bDV RNA. Our studies using mRNA programmed ribosomes show that a tRNA positioned at the P-site effectively inhibits the ribosome's chaperoning function. We also show that the antibiotic blasticidin (that mimics the interaction between 3'-CCA end of P/P-site tRNA with the PTC) is more effective in inhibiting ribosome and bDV RNA chaperoning ability than either puromycin or the macrolide antibiotics. Mutational studies of the bDV RNA could identify the nucleotides U2585 and G2252 (both of which interact with P-site tRNA) to be important for its chaperoning ability. Conclusion: Both protein synthesis and their proper folding are crucial for maintenance of a functional cellular proteome. The PTC of the ribosome is attributed with both these abilities. The silencing of the chaperoning ability of the ribosome in the presence of P-site bound tRNA might be a way to segregate these two important functions.	[Mondal, Surojit; Pathak, Bani Kumar; Barat, Chandana] St Xaviers Coll, Dept Biotechnol, Kolkata, W Bengal, India; [Ray, Sutapa] Univ Calcutta, Dr BC Guha Ctr Genet Engn, Kolkata, W Bengal, India; [Ray, Sutapa] Univ Calcutta, Dept Biotechnol, Kolkata, W Bengal, India	St. Xavier's College Kolkata; University of Calcutta; University of Calcutta	Barat, C (corresponding author), St Xaviers Coll, Dept Biotechnol, Kolkata, W Bengal, India.	chandanasgb@yahoo.com			Council of Scientific and Industrial Research [37(1334)/08/EMR-II]; Department of Science and Technology, Government of India [SERB/F/0643]	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was financially supported by the Council of Scientific and Industrial Research [Grant number 37(1334)/08/EMR-II] and Department of Science and Technology, Government of India funded research fellowship scheme [Grant number SERB/F/0643]. S.M. is a Department of Biotechnology, Government of West Bengal, India, funded research fellow and B.K.P. is a Department of Science and Technology, Government of India funded research fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal RK, 1999, J BIOL CHEM, V274, P8723, DOI 10.1074/jbc.274.13.8723; Amort M, 2007, NUCLEIC ACIDS RES, V35, P5130, DOI 10.1093/nar/gkm539; Argent RH, 2000, J BIOL CHEM, V275, P9263, DOI 10.1074/jbc.275.13.9263; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Basu A, 2008, BIOCHEM BIOPH RES CO, V366, P598, DOI 10.1016/j.bbrc.2007.11.143; BERA AK, 1994, CURR SCI INDIA, V66, P230; BISCHOF O, 1994, J BIOL CHEM, V269, P18315; Bocchetta M, 1998, P NATL ACAD SCI USA, V95, P3525, DOI 10.1073/pnas.95.7.3525; Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; CALOGERO RA, 1988, P NATL ACAD SCI USA, V85, P6427, DOI 10.1073/pnas.85.17.6427; Chowdhury S, 2002, NUCLEIC ACIDS RES, V30, P1278, DOI 10.1093/nar/30.5.1278; Das A, 2011, J BIOL CHEM, V286, P43771, DOI 10.1074/jbc.M111.263574; DAS B, 1992, BIOCHEM BIOPH RES CO, V183, P774, DOI 10.1016/0006-291X(92)90550-5; Das B, 1996, EUR J BIOCHEM, V235, P613, DOI 10.1111/j.1432-1033.1996.00613.x; Das D, 2012, J BIOL CHEM, V287, P37508, DOI 10.1074/jbc.M112.396127; Das Debasis, 2008, Biotechnology Journal, V3, P999, DOI 10.1002/biot.200800098; Di Giacco V, 2008, P NATL ACAD SCI USA, V105, P10715, DOI 10.1073/pnas.0801974105; Erlacher MD, 2006, J AM CHEM SOC, V128, P4453, DOI 10.1021/ja0588454; Fahlman RP, 2004, MOL CELL, V16, P799, DOI 10.1016/j.molcel.2004.10.030; Fahlman RP, 2004, BIOCHEMISTRY-US, V43, P7575, DOI 10.1021/bi0495836; Hansen JL, 2003, J MOL BIOL, V330, P1061, DOI 10.1016/S0022-2836(03)00668-5; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; KALPAXIS DL, 1986, EUR J BIOCHEM, V154, P267, DOI 10.1111/j.1432-1033.1986.tb09392.x; Kannan K, 2011, ANN NY ACAD SCI, V1241, P33, DOI 10.1111/j.1749-6632.2011.06315.x; KINOSHITA T, 1970, J ANTIBIOT, V23, P288, DOI 10.7164/antibiotics.23.288; Kudlicki W, 1997, FOLD DES, V2, P101, DOI 10.1016/S1359-0278(97)00014-X; LILL R, 1986, BIOCHEMISTRY-US, V25, P3245, DOI 10.1021/bi00359a025; Madore E, 1999, EUR J BIOCHEM, V266, P1128, DOI 10.1046/j.1432-1327.1999.00965.x; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Pal S, 1999, J BIOL CHEM, V274, P32771, DOI 10.1074/jbc.274.46.32771; Pang YH, 2013, J BIOL CHEM, V288, P19081, DOI 10.1074/jbc.M113.466748; Peske F, 2005, MOL CELL, V18, P403, DOI 10.1016/j.molcel.2005.04.009; Polacek N, 2005, CRIT REV BIOCHEM MOL, V40, P285, DOI 10.1080/10409230500326334; Polikanov YS, 2012, SCIENCE, V336, P915, DOI 10.1126/science.1218538; Rodriguez-Fonseca C, 2000, RNA, V6, P744, DOI 10.1017/S1355838200000091; Samanta D, 2008, J BACTERIOL, V190, P3344, DOI 10.1128/JB.01800-07; SARKAR S, 1968, P NATL ACAD SCI USA, V60, P1479, DOI 10.1073/pnas.60.4.1479; Schafer MA, 2002, J BIOL CHEM, V277, P19095, DOI 10.1074/jbc.M108902200; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Shoji S, 2009, NUCLEIC ACIDS RES, V37, P4033, DOI 10.1093/nar/gkp296; Tribouillard-Tanvier D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001981; Uesono Y, 2002, J BIOL CHEM, V277, P13848, DOI 10.1074/jbc.M108848200; van den Elzen AMG, 2014, EMBO J, V33, P265, DOI 10.1002/embj.201386123; Walker SE, 2008, METHODS, V44, P81, DOI 10.1016/j.ymeth.2007.09.003; Wegrzyn RD, 2005, CELL MOL LIFE SCI, V62, P2727, DOI 10.1007/s00018-005-5292-z; Xiong LQ, 2005, ANTIMICROB AGENTS CH, V49, P281, DOI 10.1128/AAC.49.1.281-288.2005; Yan K, 2005, ANTIMICROB AGENTS CH, V49, P3367, DOI 10.1128/AAC.49.8.3367-3372.2005; Youngman EM, 2004, CELL, V117, P589, DOI 10.1016/S0092-8674(04)00411-8; Zaman S, 2007, MOL MICROBIOL, V66, P1039, DOI 10.1111/j.1365-2958.2007.05975.x	51	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101293	10.1371/journal.pone.0101293	http://dx.doi.org/10.1371/journal.pone.0101293			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000563	Green Published, Green Submitted, gold			2022-12-27	WOS:000338637300031
J	Priotto, G; Rguig, A; Ziani, M; Berger, A; Nabeth, P				Priotto, Gerardo; Rguig, Ahmed; Ziani, Moncef; Berger, Anouk; Nabeth, Pierre			Needs Assessment for Performance Improvement of Personnel in Charge of Epidemiological Surveillance in Morocco	PLOS ONE			English	Article								Background: In line with the International Health Regulations (IHR 2005), the Morocco health surveillance system has been reinforced via infrastructure strengthening and decentralization in its regions. To plan for personnel capacity reinforcement actions, a national workforce needs assessment was conducted by the National Epidemiological Surveillance Service and the World Health Organization. Methods: The assessment used an ad-hoc method comprising two stages: (1) A survey via a standardized electronic questionnaire, administered to all staff in regional and provincial surveillance teams. Data collected included demographics, basic qualification, complementary training, perceived training needs, and preferred training modalities. Individuals were asked to grade, on a nine-point scale, their perception of importance of a given list of tasks and of their capacity to perform them. The gap between perceptions was quantified and described. (2) Field visits to national, regional and provincial sites for direct observation and opinion gathering on broader issues such as motivators, barriers, and training needs from the local perspective. Results: Questionnaire respondents were 122/158 agents at 78 surveillance units countrywide. Mean age was 43.6 years and job longevity 5.7 years. Only 53% (65/122) had epidemiology training, posted in 62% (48/78) of the structures. Self-assessed capacity varied by basic qualification and by structure level (regional vs. provincial). The gap between the importance granted to a task and the perceived capacity to perform it was sizable, showing an uneven distribution across competency domains, regions, surveillance level and staff's basic qualification. From the opinions gathered, a problem of staff demotivation and high turnover emerged clearly. Conclusions: Our method was successful in revealing specific details of the training needs countrywide. A national strategy is needed to ensure rational planning of training, personnel motivation and long-term sustainability. In terms of training, an innovative program should target the specific needs per group and per region.	[Priotto, Gerardo; Berger, Anouk; Nabeth, Pierre] WHO, Lyon, France; [Rguig, Ahmed; Ziani, Moncef] WHO, Lyon, France; [Ziani, Moncef] Univ Mohammed V Souissi, Fac Med & Pharm, Ctr Hosp Univ Ibn Sina, Serv Pediat, Rabat, Morocco	World Health Organization; World Health Organization; Mohammed First University of Oujda; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat	Priotto, G (corresponding author), WHO, Lyon, France.	priottog@who.int	Nabeth, Pierre/AAI-9461-2021; Nabeth, Pierre/GLU-1262-2022; Priotto, Gerardo/AAS-9027-2021	Nabeth, Pierre/0000-0002-1567-6252; 	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Borders Stephen, 2006, Hum Resour Health, V4, P18, DOI 10.1186/1478-4491-4-18; Chauvin S W, 2001, J Public Health Manag Pract, V7, P23; Chevalier R, 2003, PERFORMANCE IMPROVEM, V42, P9, DOI [DOI 10.1002/PFI.4930420504, 10.1002/pfi.4930420504]; Fritzen SA, 2007, HUM RESOUR HEALTH, V5, P4; Harrison LM, 2005, PUBLIC HEALTH REP, V120, P28, DOI 10.1177/00333549051200S107; Kolehmainen-Aitken Riitta-Liisa, 2004, Hum Resour Health, V2, P5, DOI 10.1186/1478-4491-2-5; National Council for Voluntary Organisations, 2010, GUID COND TRAIN NEED; World Health Organization, 2008, INT HLTH REG 2005, V2nd	8	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101594	10.1371/journal.pone.0101594	http://dx.doi.org/10.1371/journal.pone.0101594			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000499	Green Published, Green Submitted, gold			2022-12-27	WOS:000338637300062
J	Aveyard, ME				Aveyard, Mark E.			A Call to Honesty: Extending Religious Priming of Moral Behavior to Middle Eastern Muslims	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; GOD; OMISSION; PROSOCIALITY; PEOPLE; COGNITION; BIAS	Two experiments with Middle Eastern participants explored the generalizability of prior research on religious priming and moral behavior to a novel cultural and religious context. Participants in Experiment 1 completed a sentence unscrambling task with religious or non-religious content (in Arabic) before taking an unsupervised math test on which cheating was possible and incentivized. No difference in honesty rates emerged between the two groups, failing to extend findings from previous research with similar stimuli. Experiment 2 tested the effects of the athan, the Islamic call to prayer, using the same design. This naturalistic religious prime produced higher rates of honesty (68%) compared to controls who did not hear the call to prayer (53%). These results raise the possibility that the psychological mechanisms used by religion to influence moral behavior might differ between religions and cultures, highlighting an avenue of exploration for future research. The experiments here also address two growing concerns in psychological science: that the absence of replications casts doubt on the reliability of original research findings, and that the Westernized state of psychological science casts doubt on the generalizability of such work.	Amer Univ Sharjah, Dept Int Studies, Sharjah, U Arab Emirates	American University of Sharjah	Aveyard, ME (corresponding author), Amer Univ Sharjah, Dept Int Studies, Sharjah, U Arab Emirates.	maveyard@aus.edu	Aveyard, Mark/ABD-2297-2020					Arnett JJ, 2008, AM PSYCHOL, V63, P602, DOI 10.1037/0003-066X.63.7.602; Baron J, 2004, ORGAN BEHAV HUM DEC, V94, P74, DOI 10.1016/j.obhdp.2004.03.003; Bering JM, 2005, HUM NATURE-INT BIOS, V16, P360, DOI 10.1007/s12110-005-1015-2; Bloom PBN, 2013, INT J PUBLIC OPIN R, V25, P368, DOI 10.1093/ijpor/eds030; Bushman BJ, 2007, PSYCHOL SCI, V18, P204, DOI 10.1111/j.1467-9280.2007.01873.x; Dear BF, 2011, J PAIN, V12, P625, DOI 10.1016/j.jpain.2010.11.010; DeScioli P, 2011, EVOL HUM BEHAV, V32, P204, DOI 10.1016/j.evolhumbehav.2011.01.003; DeScioli P, 2011, PSYCHOL SCI, V22, P442, DOI 10.1177/0956797611400616; Dijksterhuis A, 2008, J EXP SOC PSYCHOL, V44, P2, DOI 10.1016/j.jesp.2007.01.003; Francis G, 2012, PSYCHON B REV, V19, P151, DOI 10.3758/s13423-012-0227-9; Gervais WM, 2012, J EXP SOC PSYCHOL, V48, P298, DOI 10.1016/j.jesp.2011.09.006; Graham J, 2010, PERS SOC PSYCHOL REV, V14, P140, DOI 10.1177/1088868309353415; Harris CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072467; Harrison J.M.D., 2013, J ARTICLES SUPPORT N, V10, P25; Hartshorne H, 1928, STUDIES NATURE CHARA, V1; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Johnson MK, 2010, SOC PSYCHOL PERS SCI, V1, P119, DOI 10.1177/1948550609357246; Kantowitz B.H., 2014, EXP PSYCHOL; LaBouff JP, 2011, THESIS; Lee TS, 1999, ETHNOMUSICOLOGY, V43, P86, DOI 10.2307/852695; Makel MC, 2012, PERSPECT PSYCHOL SCI, V7, P537, DOI 10.1177/1745691612460688; Mazar N, 2008, J MARKETING RES, V45, P633, DOI 10.1509/jmkr.45.6.633; Norenzayan A, 2013, BIG GODS RELIG TRANS, P23; Norenzayan A, 2008, SCIENCE, V322, P58, DOI 10.1126/science.1158757; Nussbaum D., 2012, PSYCHOLOGIST, V25, P350; Perrin RD, 2000, REV RELIG RES, V41, P534, DOI 10.2307/3512319; Pichon I, 2007, EUR J SOC PSYCHOL, V37, P1032, DOI 10.1002/ejsp.416; Preston JL, 2013, PERS SOC PSYCHOL B, V39, P1471, DOI 10.1177/0146167213499937; Preston JL, 2010, SOC PERSONAL PSYCHOL, V4, P574, DOI 10.1111/j.1751-9004.2010.00286.x; Randolph-Seng Brandon, 2007, INT J PSYCHOL RELIG, V17, P303, DOI [DOI 10.1080/10508610701572812, 10.1080/10508610701572812]; Rounding K, 2012, PSYCHOL SCI, V23, P635, DOI 10.1177/0956797611431987; Saroglou V, 2009, INT J PSYCHOL RELIG, V19, P143, DOI 10.1080/10508610902880063; Shariff AF, 2007, PSYCHOL SCI, V18, P803, DOI 10.1111/j.1467-9280.2007.01983.x; Shariff AF, 2011, INT J PSYCHOL RELIG, V21, P85, DOI 10.1080/10508619.2011.556990; SPRANCA M, 1991, J EXP SOC PSYCHOL, V27, P76, DOI 10.1016/0022-1031(91)90011-T; Toburen T, 2010, J SOC CLIN PSYCHOL, V29, P127, DOI 10.1521/jscp.2010.29.2.127; Vohs KD, 2008, PSYCHOL SCI, V19, P49, DOI 10.1111/j.1467-9280.2008.02045.x; von Hippel W, 2005, PERS SOC PSYCHOL B, V31, P1347, DOI 10.1177/0146167205274899; Weisbuch-Remington M, 2005, PERS SOC PSYCHOL B, V31, P1203, DOI 10.1177/0146167205274448; Wolff P, 2011, WIRES COGN SCI, V2, P253, DOI 10.1002/wcs.104; Zemack-Rugar Y, 2007, J PERS SOC PSYCHOL, V93, P927, DOI 10.1037/0022-3514.93.6.927	41	40	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e99447	10.1371/journal.pone.0099447	http://dx.doi.org/10.1371/journal.pone.0099447			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AO3RT	24992091	Green Submitted, Green Published, gold			2022-12-27	WOS:000341253400011
J	Barret, M; Pratico, CA; Camus, M; Beuvon, F; Jarraya, M; Nicco, C; Mangialavori, L; Chaussade, S; Batteux, F; Prat, F				Barret, Maximilien; Pratico, Carlos Alberto; Camus, Marine; Beuvon, Frederic; Jarraya, Mohamed; Nicco, Carole; Mangialavori, Luigi; Chaussade, Stanislas; Batteux, Frederic; Prat, Frederic			Amniotic Membrane Grafts for the Prevention of Esophageal Stricture after Circumferential Endoscopic Submucosal Dissection	PLOS ONE			English	Article							HIGH-GRADE DYSPLASIA; MUCOSAL RESECTION; BARRETTS-ESOPHAGUS; RADIOFREQUENCY ABLATION; SURFACE RECONSTRUCTION; GROWTH-FACTOR; TRANSPLANTATION; MUCOSECTOMY; THERAPY; CANCER	Background and Aims: The prevention of esophageal strictures following circumferential mucosal resection remains a major clinical challenge. Human amniotic membrane (AM) is an easily available material, which is widely used in ophthalmology due to its wound healing, anti-inflammatory and anti-fibrotic properties. We studied the effect of AM grafts in the prevention of esophageal stricture after endoscopic submucosal dissection (ESD) in a swine model. Animals and Methods: In this prospective, randomized controlled trial, 20 swine underwent a 5 cm-long circumferential ESD of the lower esophagus. In the AM Group (n = 10), amniotic membrane grafts were placed on esophageal stents; a subgroup of 5 swine (AM 1 group) was sacrificed on day 14, whereas the other 5 animals (AM 2 group) were kept alive. The esophageal stent (ES) group (n = 5) had ES placement alone after ESD. Another 5 animals served as a control group with only ESD. Results: The prevalence of symptomatic strictures at day 14 was significantly reduced in the AM group and ES groups vs. the control group (33%, 40% and 100%, respectively, p = 0.03); mean esophageal diameter was 5.8 +/- 3.6 mm, 6.8 +/- 3.3 mm, and 2.6 +/- 1.7 mm for AM, ES, and control groups, respectively. Median (range) esophageal fibrosis thickness was 0.87 mm (0.78-1.72), 1.19 mm (0.28-1.95), and 1.65 mm (0.7-1.79) for AM 1, ES, and control groups, respectively. All animals had developed esophageal strictures by day 35. Conclusions: The anti-fibrotic effect of AM on esophageal wound healing after ESD delayed the development of esophageal stricture in our model. However, this benefit was of limited duration in the conditions of our study.	[Barret, Maximilien; Pratico, Carlos Alberto; Camus, Marine; Mangialavori, Luigi; Chaussade, Stanislas; Prat, Frederic] Cochin Hosp, Dept Gastroenterol, Paris, France; [Barret, Maximilien; Pratico, Carlos Alberto; Camus, Marine; Beuvon, Frederic; Nicco, Carole; Chaussade, Stanislas; Batteux, Frederic; Prat, Frederic] Fac Paris Descartes, Paris, France; [Beuvon, Frederic] Cochin Hosp, Dept Pathol, Paris, France; [Jarraya, Mohamed] St Louis Hosp, Paris, France; [Nicco, Carole; Batteux, Frederic] Cochin Hosp, Dept Immunol, Paris, France; [Nicco, Carole; Batteux, Frederic] Cochin Hosp, EA 1833, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Prat, F (corresponding author), Cochin Hosp, Dept Gastroenterol, Paris, France.	frederic.prat@cch.aphp.fr	Coriat, Romain/O-7902-2017; Camus, Marine/O-8570-2017; Barret, Maximilien/O-8341-2017; Nicco, Carole/X-6726-2019; Nicco, Carole/O-8169-2017; Batteux, Frederic/O-7889-2017	Camus, Marine/0000-0003-2566-3866; Nicco, Carole/0000-0001-8211-2556; Nicco, Carole/0000-0001-8211-2556; Batteux, Frederic/0000-0002-1265-7996; Barret, Maximilien/0000-0002-0566-7870	Fondation de l'Avenir, Paris, France [ET9-553]	Fondation de l'Avenir, Paris, France	The study received funding from the Fondation de l'Avenir, Paris, France (grant number ET9-553), www.fondationdelavenir.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, METHOD ENZYMOL, V6, P105, DOI DOI 10.1016/S0076-6879(84)05016-3; AKLE CA, 1981, LANCET, V2, P1003; Apaydin BB, 2001, EUR SURG RES, V33, P225, DOI 10.1159/000049710; Badylak SF, 2011, TISSUE ENG PT A, V17, P1643, DOI 10.1089/ten.tea.2010.0739; Barret M, 2013, SURG LAPARO ENDO PER, V23, pE182, DOI 10.1097/SLE.0b013e31828b8328; Barret M, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-8; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Bennett C, 2012, GASTROENTEROLOGY, V143, P336, DOI 10.1053/j.gastro.2012.04.032; Chennat J, 2009, AM J GASTROENTEROL, V104, P2684, DOI 10.1038/ajg.2009.465; Choi TH, 2001, CORNEA, V20, P197, DOI 10.1097/00003226-200103000-00019; Ezoe Y, 2011, J CLIN GASTROENTEROL, V45, P222, DOI 10.1097/MCG.0b013e3181f39f4e; Fernandes M, 2005, CORNEA, V24, P643, DOI 10.1097/01.ico.0000151501.80952.c5; Fraser JF, 2009, BURNS, V35, P998, DOI 10.1016/j.burns.2009.01.003; GEHANNO P, 1981, ARCH OTOLARYNGOL, V107, P145; Gunel E, 2002, PEDIATR SURG INT, V18, P24, DOI 10.1007/s003830200005; Hanaoka N, 2012, ENDOSCOPY, V44, P1007, DOI 10.1055/s-0032-1310107; Hao YX, 2000, CORNEA, V19, P348, DOI 10.1097/00003226-200005000-00018; Hashimoto S, 2011, GASTROINTEST ENDOSC, V74, P1389, DOI 10.1016/j.gie.2011.07.070; Katada C, 2003, GASTROINTEST ENDOSC, V57, P165, DOI 10.1067/mge.2003.73; KIM JC, 1995, CORNEA, V14, P473; Koizumi N, 2000, CURR EYE RES, V20, P173, DOI 10.1076/0271-3683(200003)20:3;1-9;FT173; Koltuksuz U, 2001, J PEDIATR SURG, V36, P1504, DOI 10.1053/jpsu.2001.27032; Lee SB, 2000, CURR EYE RES, V20, P325, DOI 10.1076/0271-3683(200004)20:4;1-5;FT325; Mizutani T, 2010, HEPATO-GASTROENTEROL, V57, P1150; Muraine M, 2006, J FR OPHTALMOL, V29, P1070, DOI 10.1016/S0181-5512(06)73902-X; Nieponice A, 2009, GASTROINTEST ENDOSC, V69, P289, DOI 10.1016/j.gie.2008.04.022; Ohki T, 2012, GASTROENTEROLOGY, V143, P582, DOI 10.1053/j.gastro.2012.04.050; Ozcelik MF, 2004, AM J SURG, V187, P257, DOI 10.1016/j.amjsurg.2003.11.008; Prat F, 2006, ESOPHAGEAL CIRCUMFER; Rajan E, 2005, ENDOSCOPY, V37, P1111, DOI 10.1055/s-2005-870531; Roland L, 2010, PLACENTA, V31, P392, DOI 10.1016/j.placenta.2010.02.007; Sato H, 2013, GASTROINTEST ENDOSC, V78, P250, DOI 10.1016/j.gie.2013.01.008; Seewald S, 2006, ENDOSCOPY, V38, P1029, DOI 10.1055/s-2006-944527; Shaheen NJ, 2011, GASTROENTEROLOGY, V141, P460, DOI 10.1053/j.gastro.2011.04.061; Shaheen NJ, 2009, LANCET, V373, P850, DOI 10.1016/S0140-6736(09)60487-6; Titi M, 2012, GASTROENTEROLOGY, V143, P564, DOI 10.1053/j.gastro.2012.04.051; Turkyilmaz Z, 2005, J SURG RES, V123, P182, DOI 10.1006/j.jss.2004.08.009; Willingham FF, 2009, GASTROINTEST ENDOSC, V69, P147, DOI 10.1016/j.gie.2008.09.010; WitkoSarsat V, 1996, KIDNEY INT, V49, P1304, DOI 10.1038/ki.1996.186; Witteman BPL, 2009, J GASTROINTEST SURG, V13, P2104, DOI 10.1007/s11605-009-1053-x; Wu Y, 2014, SURG ENDOSC, V28, P447, DOI 10.1007/s00464-013-3210-2; Zuercher BF, 2013, SURG ENDOSC, V27, P1022, DOI 10.1007/s00464-012-2509-8	42	25	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100236	10.1371/journal.pone.0100236	http://dx.doi.org/10.1371/journal.pone.0100236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992335	Green Submitted, Green Published, gold			2022-12-27	WOS:000341253400021
J	Domingue, BW; Belsky, DW; Harris, KM; Smolen, A; McQueen, MB; Boardman, JD				Domingue, Benjamin W.; Belsky, Daniel W.; Harris, Kathleen Mullan; Smolen, Andrew; McQueen, Matthew B.; Boardman, Jason D.			Polygenic Risk Predicts Obesity in Both White and Black Young Adults	PLOS ONE			English	Article							TO-HEIGHT RATIO; POPULATION STRATIFICATION; GENETIC RISK; ADIPOSITY; LOCI; INDIVIDUALS; ASSOCIATION; VARIANTS; GENOMICS; GROWTH	Objective: To test transethnic replication of a genetic risk score for obesity in white and black young adults using a national sample with longitudinal data. Design and Methods: A prospective longitudinal study using the National Longitudinal Study of Adolescent Health Sibling Pairs (n = 1,303). Obesity phenotypes were measured from anthropometric assessments when study members were aged 18-26 and again when they were 24-32. Genetic risk scores were computed based on published genome-wide association study discoveries for obesity. Analyses tested genetic associations with body-mass index (BMI), waist-height ratio, obesity, and change in BMI over time. Results: White and black young adults with higher genetic risk scores had higher BMI and waist-height ratio and were more likely to be obese compared to lower genetic risk age-peers. Sibling analyses revealed that the genetic risk score was predictive of BMI net of risk factors shared by siblings. In white young adults only, higher genetic risk predicted increased risk of becoming obese during the study period. In black young adults, genetic risk scores constructed using loci identified in European and African American samples had similar predictive power. Conclusion: Cumulative information across the human genome can be used to characterize individual level risk for obesity. Measured genetic risk accounts for only a small amount of total variation in BMI among white and black young adults. Future research is needed to identify modifiable environmental exposures that amplify or mitigate genetic risk for elevated BMI.	[Domingue, Benjamin W.; Boardman, Jason D.] Univ Colorado, Inst Behav Sci, Boulder, CO 80309 USA; [Belsky, Daniel W.] Duke Univ, Med Ctr, Ctr Study Aging & Human Dev, Durham, NC USA; [Harris, Kathleen Mullan] Univ N Carolina, Dept Sociol, Chapel Hill, NC USA; [Harris, Kathleen Mullan] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA; [Smolen, Andrew] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; [McQueen, Matthew B.] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Boardman, JD (corresponding author), Univ Colorado, Inst Behav Sci, Boulder, CO 80309 USA.	boardman@colorado.edu	McQueen, Matthew/X-5845-2019; Belsky, Daniel/AAB-4785-2021; Belsky, Daniel/HDN-5118-2022	Belsky, Daniel/0000-0001-5463-2212; Domingue, Ben/0000-0002-3894-9049	Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01-HD31921]; NIH/NICHD [R01HD060726]; CU Population Center [R24HD066613];  [T32-AG000029]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD031921, R24HD066613, R01HD060726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000029] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); CU Population Center; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Add Health is funded by grant P01-HD31921 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, with cooperative funding from 23 other federal agencies and foundations. Genotyping of the Sibling Pairs data was funded by the NIH/NICHD (R01HD060726). Additional research funds were provided by the NIH/NICHD funded CU Population Center (R24HD066613). DWB is supported in part by T32-AG000029. JDB had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Belsky DW, 2013, AM J PUBLIC HEALTH, V103, P73, DOI 10.2105/AJPH.2012.301139; Belsky DW, 2013, BIODEMOGR SOC BIOL, V59, P85, DOI 10.1080/19485565.2013.774628; Belsky DW, 2012, ARCH PEDIAT ADOL MED, V166, P515, DOI 10.1001/archpediatrics.2012.131; Boardman JD, 2014, DEMOGRAPHY, V51, P119, DOI 10.1007/s13524-013-0259-4; Boardman JD, 2013, AM J PUBLIC HEALTH, V103, P64, DOI 10.2105/AJPH.2013.301355; Boardman JD, 2011, DEMOGRAPHY, V48, P1517, DOI 10.1007/s13524-011-0057-9; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Demerath EW, 2013, HUM HERED, V75, P175, DOI 10.1159/000351742; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Elks CE, 2012, AM J CLIN NUTR, V95, P1150, DOI 10.3945/ajcn.111.027870; Elks CE, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000284; Entzel P., 2009, ADD HLTH WAVE 4 DOCU, DOI 10.17615/C6HM11; Fernandez JR, 2012, INT J OBESITY, V36, P479, DOI 10.1038/ijo.2011.236; Garnett SP, 2008, INT J OBESITY, V32, P1028, DOI 10.1038/ijo.2008.51; Harris KM, 2013, TWIN RES HUM GENET, V16, P391, DOI 10.1017/thg.2012.137; Hester JM, 2012, INT J OBESITY, V36, P465, DOI 10.1038/ijo.2011.131; Ioannidis JPA, 2011, JAMA-J AM MED ASSOC, V305, P2200, DOI 10.1001/jama.2011.713; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Khoury MJ, 2012, AM J PUBLIC HEALTH, V102, P34, DOI 10.2105/AJPH.2011.300299; Li SX, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000332; Llewellyn CH, 2013, JAMA PEDIAT IN PRESS; Loos RJF, 2012, BEST PRACT RES CL EN, V26, P211, DOI 10.1016/j.beem.2011.11.003; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Monda KL, 2013, NAT GENET, V45, P690, DOI 10.1038/ng.2608; Moustafa JSES, 2013, NAT REV ENDOCRINOL, V9, P402, DOI 10.1038/nrendo.2013.57; Plomin R, 2009, NAT REV GENET, V10, P872, DOI 10.1038/nrg2670; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039; Ramachandrappa S, 2011, J CLIN INVEST, V121, P2080, DOI 10.1172/JCI46044; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Schneider HJ, 2010, J CLIN ENDOCR METAB, V95, P1777, DOI 10.1210/jc.2009-1584; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Xing JC, 2009, GENOME RES, V19, P815, DOI 10.1101/gr.085589.108	35	41	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101596	10.1371/journal.pone.0101596	http://dx.doi.org/10.1371/journal.pone.0101596			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992585	Green Submitted, Green Published, gold			2022-12-27	WOS:000341253400095
J	Jelsbak, L; Hartman, H; Schroll, C; Rosenkrantz, JT; Lemire, S; Wallrodt, I; Thomsen, LE; Poolman, M; Kilstrup, M; Jensen, PR; Olsen, JE				Jelsbak, Lotte; Hartman, Hassan; Schroll, Casper; Rosenkrantz, Jesper T.; Lemire, Sebastien; Wallrodt, Inke; Thomsen, Line E.; Poolman, Mark; Kilstrup, Mogens; Jensen, Peter R.; Olsen, John E.			Identification of Metabolic Pathways Essential for Fitness of Salmonella Typhimurium In Vivo	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; ESCHERICHIA-COLI; INFECTION; MACROPHAGES; EXPRESSION; VIRULENCE; REQUIRES; BIOLOGY; MODELS; GROWTH	Bacterial infections remain a threat to human and animal health worldwide, and there is an urgent need to find novel targets for intervention. In the current study we used a computer model of the metabolic network of Salmonella enterica serovar Typhimurium and identified pairs of reactions (cut sets) predicted to be required for growth in vivo. We termed such cut sets synthetic auxotrophic pairs. We tested whether these would reveal possible combined targets for new antibiotics by analyzing the performance of selected single and double mutants in systemic mouse infections. One hundred and two cut sets were identified. Sixty-three of these included only pathways encoded by fully annotated genes, and from this subset we selected five cut sets involved in amino acid or polyamine biosynthesis. One cut set (asnA/asnB) demonstrated redundancy in vitro and in vivo and showed that asparagine is essential for S. Typhimurium during infection. trpB/trpA as well as single mutants were attenuated for growth in vitro, while only the double mutant was a cut set in vivo, underlining previous observations that tryptophan is essential for successful outcome of infection. speB/speF, speC was not affected in vitro but was attenuated during infection showing that polyamines are essential for virulence apparently in a growth independent manner. The serA/glyA cut-set was found to be growth attenuated as predicted by the model. However, not only the double mutant, but also the glyA mutant, were found to be attenuated for virulence. This adds glycine production or conversion of glycine to THF to the list of essential reactions during infection. One pair (thrC/kbl) showed true redundancy in vitro but not in vivo demonstrating that threonine is available to the bacterium during infection. These data add to the existing knowledge of available nutrients in the intra-host environment, and have identified possible new targets for antibiotics.	[Jelsbak, Lotte; Schroll, Casper; Rosenkrantz, Jesper T.; Wallrodt, Inke; Thomsen, Line E.; Olsen, John E.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg, Denmark; [Hartman, Hassan; Poolman, Mark] Oxford Brookes Univ, Fac Hlth & Life Sci, Dept Med & Biol Sci, Oxford OX3 0BP, England; [Lemire, Sebastien; Kilstrup, Mogens; Jensen, Peter R.] Tech Univ Denmark, Ctr Syst Microbiol, Dept Syst Biol, DK-2800 Lyngby, Denmark	University of Copenhagen; Oxford Brookes University; Technical University of Denmark	Olsen, JE (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg, Denmark.	jeo@sund.ku.dk	Kilstrup, Mogens/AAV-2030-2021; Olsen, John Elmerdahl/N-9271-2019; jensen, Peter Ruhdal/AAC-4891-2019	Kilstrup, Mogens/0000-0002-3900-723X; Jensen, Peter Ruhdal/0000-0003-2080-2070; Thomsen, Line Elnif/0000-0001-5460-9178; Jelsbak, Lotte/0000-0002-6642-7424; Olsen, John Elmerdahl/0000-0001-6225-6587	Danish Research Council for Technology and Production [274-07-0328]	Danish Research Council for Technology and Production	The Danish Research Council for Technology and Production supported this study through grant number 274-07-0328. The funder had no role in the study design, data collation and analysis, decision to publish or preparation of the manuscript.	Barbagallo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027226; Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; Bogard RW, 2012, MBIO, V3, DOI 10.1128/mBio.00236-12; Bowden SD, 2009, INFECT IMMUN, V77, P3117, DOI 10.1128/IAI.00093-09; Bumann D, 2008, CURR OPIN MICROBIOL, V11, P387, DOI 10.1016/j.mib.2008.08.002; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Cersini A, 1998, INFECT IMMUN, V66, P549, DOI 10.1128/IAI.66.2.549-557.1998; Chaudhuri RR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000529; CHEN J, 1990, J BACTERIOL, V172, P5686, DOI 10.1128/jb.172.10.5686-5689.1990; Chico-Calero I, 2002, P NATL ACAD SCI USA, V99, P431, DOI 10.1073/pnas.012363899; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Durot M, 2009, FEMS MICROBIOL REV, V33, P164, DOI 10.1111/j.1574-6976.2008.00146.x; ENOMOTO M, 1974, VIROLOGY, V60, P503, DOI 10.1016/0042-6822(74)90344-4; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; FELL DA, 1986, BIOCHEM J, V238, P781, DOI 10.1042/bj2380781; Furst P, 2004, J NUTR, V134, p1558S, DOI 10.1093/jn/134.6.1558S; GLANVILLE EV, 1960, GENETICS, V45, P1359; Gotz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010586; Gorke B, 2008, NAT REV MICROBIOL, V6, P275; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hartman HB, 2014, MICROBIOL-SGM, V160, P1252, DOI 10.1099/mic.0.076091-0; Hautefort I, 2008, CELL MICROBIOL, V10, P958, DOI 10.1111/j.1462-5822.2007.01099.x; He M, 2013, NAT GENET, V45, P109, DOI 10.1038/ng.2478; Henry T, 2005, MOL MICROBIOL, V56, P252, DOI 10.1111/j.1365-2958.2005.04540.x; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Hove-Jensen B, 1988, J BAC, V170, P1448; Jamshidi N, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.8; Jelsbak L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036149; KIRSCHNER K, 1991, BIOCHEMISTRY-US, V30, P472, DOI 10.1021/bi00216a024; Klamt S, 2004, BIOINFORMATICS, V20, P226, DOI 10.1093/bioinformatics/btg395; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; Nasrallah GK, 2011, J BACTERIOL, V193, P4346, DOI 10.1128/JB.01506-10; O'Connor TJ, 2012, SCIENCE, V338, P1440, DOI 10.1126/science.1229556; Papp B, 2011, NAT REV GENET, V12, P591, DOI 10.1038/nrg3033; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; PIZER LI, 1964, J BACTERIOL, V88, P611, DOI 10.1128/JB.88.3.611-619.1964; Poolman MG, 2006, IEE P SYST BIOL, V153, P375, DOI 10.1049/ip-syb:20060010; Portillo FGD, 2001, MICROBES INFECT, V3, P1305, DOI 10.1016/S1286-4579(01)01491-5; Raghunathan A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-38; SIGWART DF, 1989, INFECT IMMUN, V57, P1858, DOI 10.1128/IAI.57.6.1858-1861.1989; Smallbone K, 2007, FEBS J, V274, P5576, DOI 10.1111/j.1742-4658.2007.06076.x; STAUFFER GV, 1989, MOL GEN GENET, V220, P154, DOI 10.1007/BF00260870; Steeb B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003301; Thiele I, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-8; VARMA A, 1993, J THEOR BIOL, V165, P477, DOI 10.1006/jtbi.1993.1202; WALLIS TS, 1995, INFECT IMMUN, V63, P2755, DOI 10.1128/IAI.63.7.2755-2761.1995	48	27	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101869	10.1371/journal.pone.0101869	http://dx.doi.org/10.1371/journal.pone.0101869			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992475	Green Published, gold, Green Submitted			2022-12-27	WOS:000341253400126
J	Tallman, M; Amenta, N; Delson, E; Frost, SR; Ghosh, D; Klukkert, ZS; Morrow, A; Sawyer, GJ				Tallman, Melissa; Amenta, Nina; Delson, Eric; Frost, Stephen R.; Ghosh, Deboshmita; Klukkert, Zachary S.; Morrow, Andrea; Sawyer, Gary J.			Evaluation of a New Method of Fossil Retrodeformation by Algorithmic Symmetrization: Crania of Papionins (Primates, Cercopithecidae) as a Test Case	PLOS ONE			English	Article							VIRTUAL RECONSTRUCTION; BILATERAL SYMMETRY; DEFORMATION	Diagenetic distortion can be a major obstacle to collecting quantitative shape data on paleontological specimens, especially for three-dimensional geometric morphometric analysis. Here we utilize the recently -published algorithmic symmetrization method of fossil reconstruction and compare it to the more traditional reflection & averaging approach. In order to have an objective test of this method, five casts of a female cranium of Papio hamadryas kindae were manually deformed while the plaster hardened. These were subsequently "retrodeformed" using both algorithmic symmetrization and reflection & averaging and then compared to the original, undeformed specimen. We found that in all cases, algorithmic retrodeformation improved the shape of the deformed cranium and in four out of five cases, the algorithmically symmetrized crania were more similar in shape to the original crania than the reflected & averaged reconstructions. In three out of five cases, the difference between the algorithmically symmetrized crania and the original cranium could be contained within the magnitude of variation among individuals in a single subspecies of Papio. Instances of asymmetric distortion, such as breakage on one side, or bending in the axis of symmetry, were well handled, whereas symmetrical distortion remained uncorrected. This technique was further tested on a naturally deformed and fossilized cranium of Paradolichopithecus arvernensis. Results, based on a principal components analysis and Procrustes distances, showed that the algorithmically symmetrized Paradolichopithecus cranium was more similar to other, less-deformed crania from the same species than was the original. These results illustrate the efficacy of this method of retrodeformation by algorithmic symmetrization for the correction of asymmetrical distortion in fossils. Symmetrical distortion remains a problem for all currently developed methods of retrodeformation.	[Tallman, Melissa] Grand Valley State Univ, Dept Biomed Sci, Allendale, MI 49401 USA; [Tallman, Melissa; Delson, Eric; Frost, Stephen R.; Klukkert, Zachary S.] New York Consortium Evolutionary Primatol, Morphometr Grp, New York, NY USA; [Amenta, Nina; Ghosh, Deboshmita] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA; [Delson, Eric] CUNY Herbert H Lehman Coll, Dept Anthropol, Bronx, NY 10468 USA; [Delson, Eric; Klukkert, Zachary S.] New York Consortium Evolutionary Primatol, New York, NY USA; [Delson, Eric; Klukkert, Zachary S.] CUNY, Grad Ctr, PhD Program Anthropol, New York, NY USA; [Delson, Eric] Amer Museum Nat Hist, Dept Vertebrate Paleontol, New York, NY 10024 USA; [Frost, Stephen R.] Univ Oregon, Dept Anthropol, Eugene, OR 97403 USA; [Ghosh, Deboshmita] Stratovan Corp, Sacramento, CA USA; [Morrow, Andrea] Grand Valley State Univ, Dept Biol, Allendale, MI 49401 USA; [Sawyer, Gary J.] Amer Museum Nat Hist, Dept Anthropol, New York, NY 10024 USA	Grand Valley State University; University of California System; University of California Davis; City University of New York (CUNY) System; Lehman College (CUNY); City University of New York (CUNY) System; American Museum of Natural History (AMNH); University of Oregon; Grand Valley State University; American Museum of Natural History (AMNH)	Tallman, M (corresponding author), Grand Valley State Univ, Dept Biomed Sci, Allendale, MI 49401 USA.	tallmame@gvsu.edu	Klukkert, Zachary S./Y-7788-2019; Tallman, Melissa/H-3189-2019	Klukkert, Zachary S./0000-0001-5006-8810; Tallman, Melissa/0000-0003-3747-5600; Delson, Eric/0000-0002-4062-7567	National Science Foundation [05-13894, 11-17663, 99-82351, 05-13660, 11-16921]; Professional Staff Congress-City University of New York Faculty Research Award Program [669381, 664333, 665407]; National Science Foundation Integrative Graduate Education and Research Traineeship [03-33415, 09-66166]	National Science Foundation(National Science Foundation (NSF)); Professional Staff Congress-City University of New York Faculty Research Award Program; National Science Foundation Integrative Graduate Education and Research Traineeship(National Science Foundation (NSF))	This research was supported, in part, by National Science Foundation grants 05-13894 and 11-17663 (to N.A.), 99-82351, 05-13660 and 11-16921 (to E.D.); Professional Staff Congress-City University of New York Faculty Research Award Program grants 669381, 664333 and 665407 (to E.D.); and National Science Foundation Integrative Graduate Education and Research Traineeship grants 03-33415 and 09-66166 (to E.D. for NYCEP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala F, 2014, VERTEBR PALEOBIOL PA, P209, DOI 10.1007/978-94-007-6841-3_13; Angielczyk KD, 2007, PALEOBIOLOGY, V33, P125, DOI 10.1666/06007.1; Benazzi S, 2014, AM J PHYS ANTHROPOL, V153, P154, DOI 10.1002/ajpa.22376; Bookstein F L, 1997, Med Image Anal, V1, P225; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Delson E., 1975, 6 P C REG COMN MED N, P91; Frost SR, 2003, ANAT REC PART A, V275A, P1048, DOI 10.1002/ar.a.10112; Ghosh D, 2010, COMPUT GRAPH FORUM, V29, P1681, DOI 10.1111/j.1467-8659.2010.01777.x; Golovinskiy A, 2009, LECT NOTES COMPUT SC, V5654, P170, DOI 10.1007/978-3-642-03596-8_10; Guipert G, 2014, CR PALEVOL, V13, P51, DOI 10.1016/j.crpv.2013.07.004; Gunz P, 2009, J HUM EVOL, V57, P48, DOI 10.1016/j.jhevol.2009.04.004; Harvati K, 2004, P NATL ACAD SCI USA, V101, P1147, DOI 10.1073/pnas.0308085100; Kazhdan M., 2009, P 21 ANN CANADIAN C, P37; Keith A, 1914, J R ANTHROPOL INST G, V44, P12, DOI 10.2307/2843529; Mardia KV, 2000, BIOMETRIKA, V87, P285, DOI 10.1093/biomet/87.2.285; Mitra NJ, 2007, ACM T GRAPHIC, V26, DOI 10.1145/1239451.1239514; Motani R, 1997, LETHAIA, V30, P221; Ogihara N, 2006, AM J PHYS ANTHROPOL, V130, P1, DOI 10.1002/ajpa.20332; Shultz AH, 1960, Z MORPHOL ANTHROPOL, V19, P149; Singleton M, 2002, J HUM EVOL, V42, P547, DOI 10.1006/jhev.2001.0539; Spencer Frank, 1990, PILTDOWN SCI FORGERY; Subsol G, 2013, AM J PHYS ANTHROPOL, V150, P266; Tschopp E, 2013, PALEONTOLOGIA ELECT; Wiley D. F., 2005, P IEEE VIS C, P1; Williams BA, 2012, AM J PHYS ANTHROPOL, V149, P1, DOI 10.1002/ajpa.22093; Williams S.H., 1990, CONTRIBUTIONS PALAEO, P46; Zollikofer C.P.E., 2005, VIRTUAL RECONSTRUCTI; Zollikofer CPE, 2005, NATURE, V434, P755, DOI 10.1038/nature03397; 1948, NATURE, V162, P688	30	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100833	10.1371/journal.pone.0100833	http://dx.doi.org/10.1371/journal.pone.0100833			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992483	Green Published, gold			2022-12-27	WOS:000341253400030
J	Cristofari, C; Guitton, MJ				Cristofari, Cecile; Guitton, Matthieu J.			Surviving at Any Cost: Guilt Expression Following Extreme Ethical Conflicts in a Virtual Setting	PLOS ONE			English	Article							MORAL DILEMMAS; HUMAN-BEHAVIOR; EMOTION; JUDGMENT; REAL; DISGUST	Studying human behavior in response to large-scale catastrophic events, particularly how moral challenges would be undertaken under extreme conditions, is an important preoccupation for contemporary scientists and decision leaders. However, researching this issue was hindered by the lack of readily available models. Immersive virtual worlds could represent a solution, by providing ways to test human behavior in controlled life-threatening situations. Using a massively multi-player zombie apocalypse setting, we analysed spontaneously reported feelings of guilt following ethically questionable actions related to survival. The occurrence and magnitude of guilt depended on the nature of the consequences of the action. Furthermore, feelings of guilt predicted long-lasting changes in behavior, displayed as compensatory actions. Finally, actions inflicting immediate harm to others appeared mostly prompted by panic and were more commonly regretted. Thus, extreme conditions trigger a reduction of the impact of ethical norms in decision making, although awareness of ethicality is retained to a surprising extent.	[Cristofari, Cecile; Guitton, Matthieu J.] Inst Univ Sante Mentale Quebec, Quebec City, PQ, Canada; [Cristofari, Cecile; Guitton, Matthieu J.] Univ Laval, Fac Med, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University	Guitton, MJ (corresponding author), Inst Univ Sante Mentale Quebec, Quebec City, PQ, Canada.	matthieu.guitton@fmed.ulaval.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [371644]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	MJG holds a Career Grant from the "Fonds de Recherche du Quebec - Sante'' (FRQS). This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC - grant number 371644). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bainbridge WS, 2007, SCIENCE, V317, P472, DOI 10.1126/science.1146930; Blascovich J, 2002, PSYCHOL INQ, V13, P103, DOI 10.1207/S15327965PLI1302_01; Bostrom N., 2002, J EVOL TECHNOL, V9; Christensen JF, 2012, NEUROSCI BIOBEHAV R, V36, P1249, DOI 10.1016/j.neubiorev.2012.02.008; Cummins DD, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00328; Eisenberg N, 2000, ANNU REV PSYCHOL, V51, P665, DOI 10.1146/annurev.psych.51.1.665; FeldmanHall O, 2012, COGNITION, V123, P434, DOI 10.1016/j.cognition.2012.02.001; Frith U, 2005, CONSCIOUS COGN, V14, P719, DOI 10.1016/j.concog.2005.04.006; Gillath O, 2008, MEDIA PSYCHOL, V11, P259, DOI 10.1080/15213260801906489; Gollwitzer M, 2012, J EXP SOC PSYCHOL, V48, P1356, DOI 10.1016/j.jesp.2012.07.001; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Guitton MJ, 2014, J PUBLIC HEALTH MAN, V20, P375, DOI 10.1097/PHH.0000000000000043; Guitton MJ, 2013, SCIENCE, V342, P559, DOI 10.1126/science.342.6158.559-c; Guitton MJ, 2013, COMPUT HUM BEHAV, V29, P2756, DOI 10.1016/j.chb.2013.07.027; Guitton MJ, 2012, COMPUT HUM BEHAV, V28, P1681, DOI 10.1016/j.chb.2012.04.006; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Huebner B, 2009, TRENDS COGN SCI, V13, P1, DOI 10.1016/j.tics.2008.09.006; Lofgren ET, 2007, LANCET INFECT DIS, V7, P625, DOI 10.1016/S1473-3099(07)70212-8; Manfrinati A, 2013, COGNITION EMOTION, V27, P1276, DOI 10.1080/02699931.2013.785388; Nadelhoffer T, 2008, NEUROETHICS-NETH, V1, P133, DOI 10.1007/s12152-008-9015-7; Navarrete CD, 2012, EMOTION, V12, P364, DOI 10.1037/a0025561; Nichols S, 2006, COGNITION, V100, P530, DOI 10.1016/j.cognition.2005.07.005; O'Neill P, 1998, EVOL HUM BEHAV, V19, P349, DOI 10.1016/S1090-5138(98)00030-0; Patil I, 2014, SOC NEUROSCI-UK, V9, P94, DOI 10.1080/17470919.2013.870091; Rappuoli R, 2012, SCIENCE, V336, P1531, DOI 10.1126/science.1221466; Rees M, 2013, SCIENCE, V339, P1123, DOI 10.1126/science.1236756; Rovira A, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.059.2009; Schnall S, 2008, PERS SOC PSYCHOL B, V34, P1096, DOI 10.1177/0146167208317771; Slater M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000039; Sood S, 2005, ORGAN BEHAV HUM DEC, V98, P144, DOI 10.1016/j.obhdp.2005.05.005; Tassy S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00250; Teper R, 2011, PSYCHOL SCI, V22, P553, DOI 10.1177/0956797611402513; THOMSON JJ, 1976, MONIST, V59, P205; Ugazio G, 2012, EMOTION, V12, P579, DOI 10.1037/a0024611; Valdesolo P, 2006, PSYCHOL SCI, V17, P476, DOI 10.1111/j.1467-9280.2006.01731.x; Wheatley T, 2005, PSYCHOL SCI, V16, P780, DOI 10.1111/j.1467-9280.2005.01614.x; Young G, 2010, COMPUT HUM BEHAV, V26, P1228, DOI 10.1016/j.chb.2010.03.023; Young G, 2010, PHILOS PSYCHOL, V23, P1, DOI 10.1080/09515080903532274	39	3	3	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101711	10.1371/journal.pone.0101711	http://dx.doi.org/10.1371/journal.pone.0101711			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL3PK	25007261	Green Published, Green Submitted, gold			2022-12-27	WOS:000339040600060
J	de Boer, M; Ramrattan, MA; Boeker, EB; Kuks, PFM; Boermeester, MA; Lie-A-Huen, L				de Boer, Monica; Ramrattan, Maya A.; Boeker, Eveline B.; Kuks, Paul F. M.; Boermeester, Marja A.; Lie-A-Huen, Loraine			Quality of Pharmaceutical Care in Surgical Patients	PLOS ONE			English	Article							ADVERSE DRUG EVENTS; VULNERABLE ELDERS; MEDICATION ERRORS; HOSPITAL-CARE; TRIGGER TOOL; HEALTH-CARE; INDICATORS; PHARMACISTS; AGREEMENT; HARM	Background: Surgical patients are at risk for preventable adverse drug events (ADEs) during hospitalization. Usually, preventable ADEs are measured as an outcome parameter of quality of pharmaceutical care. However, process measures such as QIs are more efficient to assess the quality of care and provide more information about potential quality improvements. Objective: To assess the quality of pharmaceutical care of medication-related processes in surgical wards with quality indicators, in order to detect targets for quality improvements. Methods: For this observational cohort study, quality indicators were composed, validated, tested, and applied on a surgical cohort. Three surgical wards of an academic hospital in the Netherlands (Academic Medical Centre, Amsterdam) participated. Consecutive elective surgical patients with a hospital stay longer than 48 hours were included from April until June 2009. To assess the quality of pharmaceutical care, the set of quality indicators was applied to 252 medical records of surgical patients. Results: Thirty-four quality indicators were composed and tested on acceptability and content- and face-validity. The selected 28 candidate quality indicators were tested for feasibility and 'sensitivity to change'. This resulted in a final set of 27 quality indicators, of which inter-rater agreements were calculated (kappa 0.92 for eligibility, 0.74 for pass-rate). The quality of pharmaceutical care was assessed in 252 surgical patients. Nearly half of the surgical patients passed the quality indicators for pharmaceutical care (overall pass rate 49.8%). Improvements should be predominantly targeted to medication care related processes in surgical patients with gastro-intestinal problems (domain pass rate 29.4%). Conclusions: This quality indicator set can be used to measure quality of pharmaceutical care and detect targets for quality improvements. With these results medication safety in surgical patients can be enhanced.	[de Boer, Monica; Ramrattan, Maya A.; Kuks, Paul F. M.; Lie-A-Huen, Loraine] Univ Amsterdam, Acad Med Ctr, Dept Hosp Pharm, NL-1105 AZ Amsterdam, Netherlands; [Boeker, Eveline B.; Boermeester, Marja A.] Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	de Boer, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Hosp Pharm, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.deboer@amc.nl		Boermeester, Marja/0000-0003-3890-8105	Dutch Organization for Health Research and Development [170882706]	Dutch Organization for Health Research and Development	This work was supported by funding of ZonMw, The Dutch Organization for Health Research and Development [grant number 170882706]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, SURG SAF CHECKL; Arora VM, 2007, J AM GERIATR SOC, V55, P1705, DOI 10.1111/j.1532-5415.2007.01444.x; Boeker EB, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-364; Campbell SM, 2003, BRIT MED J, V326, P816, DOI 10.1136/bmj.326.7393.816; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; de Boer M, 2013, J EVAL CLIN PRACT, V19, P1073, DOI 10.1111/jep.12033; de Boer M, 2013, INT J CLIN PHARM-NET, V35, P744, DOI 10.1007/s11096-013-9797-5; De Vos M, 2009, INT J QUAL HEALTH C, V21, P119, DOI 10.1093/intqhc/mzn059; de Vries EN, 2008, QUAL SAF HEALTH CARE, V17, P216, DOI 10.1136/qshc.2007.023622; de Vries EN, 2010, NEW ENGL J MED, V363, P1928, DOI 10.1056/NEJMsa0911535; Evans SM, 2009, INTERN MED J, V39, P648, DOI 10.1111/j.1445-5994.2008.01733.x; Handler Steven M, 2010, Ann Longterm Care, V18, P17; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Higashi T, 2004, ANN INTERN MED, V140, P714, DOI 10.7326/0003-4819-140-9-200405040-00011; Kaboli PJ, 2006, ARCH INTERN MED, V166, P955, DOI 10.1001/archinte.166.9.955; Kristensen S, 2009, INT J QUAL HEALTH C, V21, P169, DOI 10.1093/intqhc/mzp015; Kucukarslan SN, 2003, ARCH INTERN MED, V163, P2014, DOI 10.1001/archinte.163.17.2014; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Lawrence M., 1997, EUR J GEN PRACT, V3, P103, DOI DOI 10.3109/13814789709160336; Leape LL, 1999, JAMA-J AM MED ASSOC, V282, P267, DOI 10.1001/jama.282.3.267; McGory ML, 2009, ANN SURG, V250, P338, DOI 10.1097/SLA.0b013e3181ae575a; Meyer-Massetti C, 2011, AM J HEALTH-SYST PH, V68, P227, DOI 10.2146/ajhp100019; Morimoto T, 2004, QUAL SAF HEALTH CARE, V13, P306, DOI 10.1136/qshc.2004.010611; Rozich JD, 2003, QUAL SAF HEALTH CARE, V12, P194, DOI 10.1136/qhc.12.3.194; Rubin HR, 2001, INT J QUAL HEALTH C, V13, P489, DOI 10.1093/intqhc/13.6.489; Rubin HR, 2001, INT J QUAL HEALTH C, V13, P469, DOI 10.1093/intqhc/13.6.469; Seynaeve S, 2011, AM J CRIT CARE, V20, pE131, DOI 10.4037/ajcc2011818; Shekelle PG, 2001, ANN INTERN MED, V135, P647, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00003; Singh R, 2009, QUAL SAF HEALTH CARE, V18, P199, DOI 10.1136/qshc.2007.024406; Takata GS, 2008, PEDIATRICS, V121, pE927, DOI 10.1542/peds.2007-1779; van Doormaal JE, 2009, QUAL SAF HEALTH CARE, V18, P22, DOI 10.1136/qshc.2007.023812; Verdaasdonk EGG, 2009, SURG ENDOSC, V23, P715, DOI 10.1007/s00464-008-0044-4; Wenger NS, 2001, ANN INTERN MED, V135, P642, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00002; Wierenga PC, 2011, DRUG AGING, V28, P295, DOI 10.2165/11587700-000000000-00000	34	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101573	10.1371/journal.pone.0101573	http://dx.doi.org/10.1371/journal.pone.0101573			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL3PK	25006676	Green Published, gold, Green Submitted			2022-12-27	WOS:000339040600046
J	Mosesson, Y; Voichek, Y; Barkai, N				Mosesson, Yaron; Voichek, Yoav; Barkai, Naama			Divergence and Selectivity of Expression-Coupled Histone Modifications in Budding Yeasts	PLOS ONE			English	Article							GENE-EXPRESSION; GENOME-WIDE; SACCHAROMYCES-CEREVISIAE; SAGA COMPLEX; TRANSCRIPTIONAL ELONGATION; H3 ACETYLATION; METHYLATION; NUCLEOSOME; CHROMATIN; RECRUITMENT	Various histone modifications are widely associated with gene expression, but their functional selectivity at individual genes remains to be characterized. Here, we identify widespread differences between genome-wide patterns of two prominent marks, H3K9ac and H3K4me3, in budding yeasts. As well as characteristic gene profiles, relative modification levels vary significantly amongst genes, irrespective of expression. Interestingly, we show that these differences couple to contrasting features: higher methylation to essential, periodically expressed, 'DPN' (Depleted Proximal Nucleosome) genes, and higher acetylation to non-essential, responsive, 'OPN' (Occupied Proximal Nucleosome) genes. Thus, H3K4me3 may generally associate with expression stability, and H3K9ac, with variability. To evaluate this notion, we examine their association with expression divergence between the closely related species, S. cerevisiae and S. paradoxus. Although individually well conserved at orthologous genes, changes between modifications are mostly uncorrelated, indicating largely non-overlapping regulatory mechanisms. Notably, we find that inter-species differences in methylation, but not acetylation, are well correlated with expression changes, thereby proposing H3K4me3 as a candidate regulator of expression divergence. Taken together, our results suggest distinct evolutionary roles for expression-linked modifications, wherein H3K4me3 may contribute to stabilize average expression, whilst H3K9ac associates with more indirect aspects such as responsiveness.	[Mosesson, Yaron; Voichek, Yoav; Barkai, Naama] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Barkai, N (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	naama.barkai@weizmann.ac.il		Voichek, Yoav/0000-0001-8460-7018	ERC; Israel Science Foundation; Helen and Martin Kimmel award for Innovative Investigations	ERC(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation); Helen and Martin Kimmel award for Innovative Investigations	This work was supported by the ERC, the Israel Science Foundation, and the Helen and Martin Kimmel award for Innovative Investigations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejandro-Osorio AL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r57; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Barth TK, 2010, TRENDS BIOCHEM SCI, V35, P618, DOI 10.1016/j.tibs.2010.05.006; Bian CB, 2011, EMBO J, V30, P2829, DOI 10.1038/emboj.2011.193; Carey M, 2006, MOL CELL, V24, P481, DOI 10.1016/j.molcel.2006.09.012; Choi JK, 2008, NAT GENET, V40, P141, DOI 10.1038/ng.2007.58; Choi JK, 2009, NAT GENET, V41, P498, DOI 10.1038/ng.319; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Jiang CZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r109; Katan-Khaykovich Y, 2002, GENE DEV, V16, P743, DOI 10.1101/gad.967302; Koutelou E, 2010, CURR OPIN CELL BIOL, V22, P374, DOI 10.1016/j.ceb.2010.03.005; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larson DR, 2011, CURR OPIN GENET DEV, V21, P591, DOI 10.1016/j.gde.2011.07.010; Le Martelot G, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001442; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Lee SI, 2006, P NATL ACAD SCI USA, V103, P14062, DOI 10.1073/pnas.0601852103; Lenstra TL, 2011, MOL CELL, V42, P536, DOI 10.1016/j.molcel.2011.03.026; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Maltby VE, 2012, P NATL ACAD SCI USA, V109, P18505, DOI 10.1073/pnas.1202070109; Margaritis T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002952; Morillon A, 2005, MOL CELL, V18, P723, DOI 10.1016/j.molcel.2005.05.009; Muramoto T, 2010, CURR BIOL, V20, P397, DOI 10.1016/j.cub.2010.01.017; Nagarajan M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000913; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng RK, 2008, NAT CELL BIOL, V10, P102, DOI 10.1038/ncb1674; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Pramila T, 2006, GENE DEV, V20, P2266, DOI 10.1101/gad.1450606; Protacio RU, 2000, MOL CELL BIOL, V20, P8866, DOI 10.1128/MCB.20.23.8866-8878.2000; Radman-Livaja M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002811; Robert F, 2004, MOL CELL, V16, P199, DOI 10.1016/j.molcel.2004.09.021; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Shivaswamy S, 2008, PLOS BIOL, V6, P618, DOI 10.1371/journal.pbio.0060065; Smolle M, 2013, BBA-GENE REGUL MECH, V1829, P84, DOI 10.1016/j.bbagrm.2012.08.008; Sommermeyer V, 2013, MOL CELL, V49, P43, DOI 10.1016/j.molcel.2012.11.008; Stein AB, 2011, J CLIN INVEST, V121, P2641, DOI 10.1172/JCI44641; Thompson DA, 2009, FEBS LETT, V583, P3959, DOI 10.1016/j.febslet.2009.11.032; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; Tirosh I, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.20; Tirosh I, 2009, SCIENCE, V324, P659, DOI 10.1126/science.1169766; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; Wang A, 2002, SCIENCE, V298, P1412, DOI 10.1126/science.1077790; Weake VM, 2012, TRENDS CELL BIOL, V22, P177, DOI 10.1016/j.tcb.2011.11.005; Weake VM, 2011, GENE DEV, V25, P1499, DOI 10.1101/gad.2046211; Weinberger L, 2012, MOL CELL, V47, P193, DOI 10.1016/j.molcel.2012.05.008; Weiner A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001369; Zhang LY, 2011, GENOME RES, V21, P875, DOI 10.1101/gr.117465.110; Zhang ZQ, 2004, TRENDS GENET, V20, P403, DOI 10.1016/j.tig.2004.07.006; Zhou BO, 2011, J BIOL CHEM, V286, P34770, DOI 10.1074/jbc.M111.273128	60	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101538	10.1371/journal.pone.0101538	http://dx.doi.org/10.1371/journal.pone.0101538			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007273	Green Published, Green Submitted, gold			2022-12-27	WOS:000339040600044
J	Quintela, M; Johansson, MP; Kristjansson, BK; Barreiro, R; Laurila, A				Quintela, Maria; Johansson, Magnus P.; Kristjansson, Bjarni K.; Barreiro, Rodolfo; Laurila, Anssi			AFLPs and Mitochondrial Haplotypes Reveal Local Adaptation to Extreme Thermal Environments in a Freshwater Gastropod	PLOS ONE			English	Article							GRAYLING THYMALLUS-THYMALLUS; ADAPTIVE GENETIC-DIVERGENCE; MULTILOCUS GENOTYPE DATA; DETECT CANDIDATE LOCI; CYTOCHROME-C-OXIDASE; POPULATION-STRUCTURE; LITTORINA-SAXATILIS; NATURAL-SELECTION; SPATIAL-ANALYSIS; GENOME-SCAN	The way environmental variation shapes neutral and adaptive genetic variation in natural populations is a key issue in evolutionary biology. Genome scans allow the identification of the genetic basis of local adaptation without previous knowledge of genetic variation or traits under selection. Candidate loci for divergent adaptation are expected to show higher F-ST than neutral loci influenced solely by random genetic drift, migration and mutation. The comparison of spatial patterns of neutral markers and loci under selection may help disentangle the effects of gene flow, genetic drift and selection among populations living in contrasting environments. Using the gastropod Radix balthica as a system, we analyzed 376 AFLP markers and 25 mtDNA COI haplotypes for candidate loci and associations with local adaptation among contrasting thermal environments in Lake Myvatn, a volcanic lake in northern Iceland. We found that 2% of the analysed AFLP markers were under directional selection and 12% of the mitochondrial haplotypes correlated with differing thermal habitats. The genetic networks were concordant for AFLP markers and mitochondrial haplotypes, depicting distinct topologies at neutral and candidate loci. Neutral topologies were characterized by intense gene flow revealed by dense nets with edges connecting contrasting thermal habitats, whereas the connections at candidate loci were mostly restricted to populations within each thermal habitat and the number of edges decreased with temperature. Our results suggest microgeographic adaptation within Lake Myvatn and highlight the utility of genome scans in detecting adaptive divergence.	[Quintela, Maria; Barreiro, Rodolfo] Univ A Coruna, Fac Sci, Dept Anim Biol Plant Biol & Ecol, La Coruna, Spain; [Quintela, Maria; Johansson, Magnus P.; Laurila, Anssi] Uppsala Univ, Evolutionary Biol Ctr, Dept Ecol & Genet, Uppsala, Sweden; [Kristjansson, Bjarni K.] Holar Univ Coll, Dept Aquaculture & Fish Biol, Sauoarkrokur, Iceland	Universidade da Coruna; Uppsala University	Quintela, M (corresponding author), Univ A Coruna, Fac Sci, Dept Anim Biol Plant Biol & Ecol, La Coruna, Spain.	m.quintelas@udc.es	Barreiro, Rodolfo/B-1005-2008; Kristjánsson, Bjarni K./B-4349-2013	Barreiro, Rodolfo/0000-0002-6049-5215; Kristjánsson, Bjarni K./0000-0001-6984-5771	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding for this study was provided by the Swedish Research Council (to AL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Antao T, 2011, BIOINFORMATICS, V27, P1717, DOI 10.1093/bioinformatics/btr253; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Baumann H, 2011, P ROY SOC B-BIOL SCI, V278, P2265, DOI 10.1098/rspb.2010.2479; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Blier PU, 2001, J COMP PHYSIOL B, V171, P247, DOI 10.1007/s003600000169; Blier PU, 2001, TRENDS GENET, V17, P400, DOI 10.1016/S0168-9525(01)02338-1; Bonin A, 2006, MOL BIOL EVOL, V23, P773, DOI 10.1093/molbev/msj087; Bronmark C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021773; Caballero A, 2008, GENETICS, V179, P539, DOI 10.1534/genetics.107.083246; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Cheviron ZA, 2009, EVOLUTION, V63, P1593, DOI 10.1111/j.1558-5646.2009.00644.x; Collin H, 2011, MOL ECOL, V20, P4490, DOI 10.1111/j.1365-294X.2011.05284.x; Conover DO, 2006, J FISH BIOL, V69, P21, DOI 10.1111/j.1095-8649.2006.01274.x; Coutellec-Vreto MA, 1998, EVOLUTION, V52, P1635, DOI [10.2307/2411337, 10.1111/j.1558-5646.1998.tb02244.x]; Dalesman S, 2007, ECOLOGY, V88, P2462, DOI 10.1890/07-0403.1; Dalesman S, 2007, FRESHWATER BIOL, V52, P2134, DOI 10.1111/j.1365-2427.2007.01843.x; Dillon ME, 2010, NATURE, V467, P704, DOI 10.1038/nature09407; Dowling DK, 2008, TRENDS ECOL EVOL, V23, P546, DOI 10.1016/j.tree.2008.05.011; Dyer RJ, 2004, MOL ECOL, V13, P1713, DOI 10.1111/j.1365-294X.2004.02177.x; Dyer RJ, 2010, MOL ECOL, V19, P3746, DOI 10.1111/j.1365-294X.2010.04748.x; Dyer RJ, 2009, MOL ECOL RESOUR, V9, P110, DOI 10.1111/j.1755-0998.2008.02384.x; Eckert AJ, 2010, GENETICS, V185, P969, DOI 10.1534/genetics.110.115543; Einarsson A, 2004, AQUAT ECOL, V38, P111, DOI 10.1023/B:AECO.0000032091.58691.45; EINARSSON A, 1982, FRESHWATER BIOL, V12, P63, DOI 10.1111/j.1365-2427.1982.tb00603.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Foll M, 2008, GENETICS, V179, P927, DOI 10.1534/genetics.107.084541; Foll M, 2006, GENETICS, V174, P875, DOI 10.1534/genetics.106.059451; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Galindo J, 2009, MOL ECOL, V18, P919, DOI 10.1111/j.1365-294X.2008.04076.x; Garant D, 2007, FUNCT ECOL, V21, P434, DOI 10.1111/j.1365-2435.2006.01228.x; GarciaRamos G, 1997, EVOLUTION, V51, P21, DOI 10.2307/2410956; Garroway CJ, 2008, EVOL APPL, V1, P620, DOI 10.1111/j.1752-4571.2008.00047.x; Gebremedhin B, 2009, ANIM CONSERV, V12, P89, DOI 10.1111/j.1469-1795.2009.00238.x; Giordano AR, 2007, MOL ECOL, V16, P1625, DOI 10.1111/j.1365-294X.2006.03223.x; HALL T, 1999, BIOEDIT 7 0 9 0; Hendry AP, 1999, EVOLUTION, V53, P1637, DOI 10.1111/j.1558-5646.1999.tb04550.x; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Hoffmann AA, 2003, SCIENCE, V301, P100, DOI 10.1126/science.1084296; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jorger KM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-323; Joost S, 2007, MOL ECOL, V16, P3955, DOI 10.1111/j.1365-294X.2007.03442.x; Joost S, 2008, MOL ECOL RESOUR, V8, P957, DOI 10.1111/j.1755-0998.2008.02162.x; Junge C, 2011, HEREDITY, V106, P460, DOI 10.1038/hdy.2010.160; Kane NC, 2007, GENETICS, V175, P1823, DOI 10.1534/genetics.106.067728; Kavanagh KD, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-350; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kingsolver JG, 2009, EVOLUTION, V63, P537, DOI 10.1111/j.1558-5646.2008.00568.x; Kinnison MT, 2001, GENETICA, V112, P145, DOI 10.1023/A:1013375419520; KIRBY RR, 1994, BIOL J LINN SOC, V53, P255; Koskinen MT, 2002, ECOL LETT, V5, P193, DOI 10.1046/j.1461-0248.2002.00302.x; Kristmannsdottir H, 2004, AQUAT ECOL, V38, P115, DOI 10.1023/B:AECO.0000032067.47495.71; Kuo ESL, 2009, MAR ECOL PROG SER, V388, P137, DOI 10.3354/meps08102; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; Lowry DB, 2010, BIOL LETTERS, V6, P502, DOI 10.1098/rsbl.2009.0969; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Luikart G, 2008, BIOL LETTERS, V4, P228, DOI 10.1098/rsbl.2007.0633; MANTEL N, 1967, CANCER RES, V27, P209; Minor ES, 2007, ECOL APPL, V17, P1771, DOI 10.1890/06-1073.1; Morelissen B, 2007, J EXP MAR BIOL ECOL, V348, P162, DOI 10.1016/j.jembe.2007.04.006; NIEWIAROWSKI PH, 1993, ECOLOGY, V74, P1992, DOI 10.2307/1940842; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Nunes VL, 2011, MOL ECOL, V20, P193, DOI 10.1111/j.1365-294X.2010.04936.x; Okland J., 1990, LAKES SNAILS ENV GAS; Pardo LM, 2005, MAR ECOL PROG SER, V296, P229, DOI 10.3354/meps296229; Parsons KE, 1997, EVOLUTION, V51, P784, DOI 10.1111/j.1558-5646.1997.tb03661.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P7495, DOI 10.1073/pnas.0811117106; Perez-Figueroa A, 2010, J EVOLUTION BIOL, V23, P2267, DOI 10.1111/j.1420-9101.2010.02093.x; Portner HO, 2007, PHILOS T R SOC B, V362, P2233, DOI 10.1098/rstb.2006.1947; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Rand DM, 2004, TRENDS ECOL EVOL, V19, P645, DOI 10.1016/j.tree.2004.10.003; Ribeiro AM, 2011, EVOLUTION, V65, P3499, DOI 10.1111/j.1558-5646.2011.01397.x; Richter-Boix A, 2011, MOL ECOL, V20, P1582, DOI 10.1111/j.1365-294X.2011.05025.x; Rosenberg MS, 2011, METHODS ECOL EVOL, V2, P229, DOI 10.1111/j.2041-210X.2010.00081.x; Rosenberg NA, 2001, GENETICS, V159, P699; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sanford E, 2011, ANNU REV MAR SCI, V3, P509, DOI 10.1146/annurev-marine-120709-142756; Schwartz MK, 2010, SPATIAL COMPLEXITY, INFORMATICS, AND WILDLIFE CONSERVATION, P165, DOI 10.1007/978-4-431-87771-4_9; SINERVO B, 1989, OECOLOGIA, V78, P411, DOI 10.1007/BF00379118; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Sokolova IM, 2001, MAR BIOL, V139, P113; Somero GN, 2002, INTEGR COMP BIOL, V42, P780, DOI 10.1093/icb/42.4.780; Sorensen JG, 2005, J EVOLUTION BIOL, V18, P829, DOI 10.1111/j.1420-9101.2004.00876.x; Steiner CC, 2007, PLOS BIOL, V5, P1880, DOI 10.1371/journal.pbio.0050219; Stinchcombe JR, 2007, HEREDITY; Storz JF, 2008, GENETICS, V180, P367, DOI 10.1534/genetics.108.088732; Tobler M, 2008, EVOLUTION, V62, P2643, DOI 10.1111/j.1558-5646.2008.00466.x; Trussell GC, 2000, EVOLUTION, V54, P151, DOI 10.1111/j.0014-3820.2000.tb00016.x; VEKEMANS X, 2002, AFLP SURV VERSION 1; Vignal A, 2002, GENET SEL EVOL, V34, P275, DOI [10.1186/1297-9686-34-3-275, 10.1051/gse:2002009]; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Welter-Schulte F, 2009, SPECIES SUMMARY OMPH; Wilding CS, 2001, J EVOLUTION BIOL, V14, P611, DOI 10.1046/j.1420-9101.2001.00304.x; WILLIAM J, 1995, TRENDS ECOL EVOL, V10, P485, DOI 10.1016/S0169-5347(00)89195-8; YAMADA SB, 1989, MAR BIOL, V103, P403, DOI 10.1007/BF00397275; Yeaman S, 2006, P ROY SOC B-BIOL SCI, V273, P1587, DOI 10.1098/rspb.2006.3498; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x	108	20	20	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101821	10.1371/journal.pone.0101821	http://dx.doi.org/10.1371/journal.pone.0101821			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007329	gold, Green Submitted, Green Published			2022-12-27	WOS:000339040600068
J	Sim, JH; Himmel, NJ; Redd, SK; Pulous, FE; Rogers, RT; Black, LN; Hong, SM; von Bergen, TN; Blount, MA				Sim, Jae H.; Himmel, Nathaniel J.; Redd, Sara K.; Pulous, Fadi E.; Rogers, Richard T.; Black, Lauren N.; Hong, Seongun M.; von Bergen, Tobias N.; Blount, Mitsi A.			Absence of PKC-Alpha Attenuates Lithium-Induced Nephrogenic Diabetes Insipidus	PLOS ONE			English	Article							CALCIUM-SENSING RECEPTOR; RENAL COLLECTING DUCT; INDUCED AQUAPORIN-2 TRAFFICKING; ENHANCER-BINDING PROTEIN; KINASE-C-ALPHA; PRINCIPAL CELLS; DOWN-REGULATION; URINE CONCENTRATION; UREA TRANSPORTER; HYPERCALCEMIC RATS	Lithium, an effective antipsychotic, induces nephrogenic diabetes insipidus (NDI) in similar to 40% of patients. The decreased capacity to concentrate urine is likely due to lithium acutely disrupting the cAMP pathway and chronically reducing urea transporter (UT-A1) and water channel (AQP2) expression in the inner medulla. Targeting an alternative signaling pathway, such as PKC-mediated signaling, may be an effective method of treating lithium-induced polyuria. PKC-alpha null mice (PKC alpha KO) and strain-matched wild type (WT) controls were treated with lithium for 0, 3 or 5 days. WT mice had increased urine output and lowered urine osmolality after 3 and 5 days of treatment whereas PKC alpha KO mice had no change in urine output or concentration. Western blot analysis revealed that AQP2 expression in medullary tissues was lowered after 3 and 5 days in WT mice; however, AQP2 was unchanged in PKC alpha KO. Similar results were observed with UT-A1 expression. Animals were also treated with lithium for 6 weeks. Lithium-treated WT mice had 19-fold increased urine output whereas treated PKC alpha KO animals had a 4-fold increase in output. AQP2 and UT-A1 expression was lowered in 6 week lithium-treated WT animals whereas in treated PKC alpha KO mice, AQP2 was only reduced by 2-fold and UT-A1 expression was unaffected. Urinary sodium, potassium and calcium were elevated in lithium-fed WT but not in lithium-fed PKC alpha KO mice. Our data show that ablation of PKC alpha preserves AQP2 and UT-A1 protein expression and localization in lithium-induced NDI, and prevents the development of the severe polyuria associated with lithium therapy.	[Sim, Jae H.; Himmel, Nathaniel J.; Redd, Sara K.; Pulous, Fadi E.; Rogers, Richard T.; Black, Lauren N.; Hong, Seongun M.; von Bergen, Tobias N.; Blount, Mitsi A.] Emory Univ, Sch Med, Dept Med, Div Renal, Atlanta, GA 30322 USA; [Blount, Mitsi A.] Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA	Emory University; Emory University	Blount, MA (corresponding author), Emory Univ, Sch Med, Dept Med, Div Renal, Atlanta, GA 30322 USA.	mabloun@emory.edu	Himmel, Nathaniel J./AAC-2463-2020	Himmel, Nathaniel J./0000-0001-7876-6960; Sim, Jae/0000-0002-3851-5689; Redd, Sara/0000-0002-2422-8937; Pulous, Fadi/0000-0002-0794-8078	American Society of Nephrology Medical Student Scholar Grant [K01-DK082733, R03-DK091501]; Satellite Dialysis - Norman S. Coplon Extramural Grant Program; Emory University Research Committee; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK082733, R03DK091501] Funding Source: NIH RePORTER	American Society of Nephrology Medical Student Scholar Grant; Satellite Dialysis - Norman S. Coplon Extramural Grant Program; Emory University Research Committee; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the following sources: American Society of Nephrology Medical Student Scholar Grant (J.H.S.), K01-DK082733 (M.A.B.), R03-DK091501 (M.A.B.), Satellite Dialysis - Norman S. Coplon Extramural Grant Program (M.A.B.), and support from the Emory University Research Committee (M. A. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blount MA, 2008, AM J PHYSIOL-RENAL, V295, pF295, DOI 10.1152/ajprenal.00102.2008; Blount MA, 2010, AM J PHYSIOL-RENAL, V298, pF601, DOI 10.1152/ajprenal.00424.2009; Boone M, 2010, NEPHROL DIAL TRANSPL, V25, P48, DOI 10.1093/ndt/gfp409; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Bustamante M, 2008, J AM SOC NEPHROL, V19, P109, DOI 10.1681/ASN.2007010092; Chen GP, 2006, J BIOL CHEM, V281, P27436, DOI 10.1074/jbc.M605525200; Chiu CT, 2013, PHARMACOL REV, V65, P105, DOI 10.1124/pr.111.005512; Christensen BM, 2011, J AM SOC NEPHROL, V22, P253, DOI 10.1681/ASN.2010070734; de Groot T, 2014, J AM SOC NEPHROL, V25, P501, DOI 10.1681/ASN.2013090988; Earm JH, 1998, J AM SOC NEPHROL, V9, P2181; Fenton RA, 2013, CURR OPIN NEPHROL HY, V22, P551, DOI 10.1097/MNH.0b013e328364000d; Grandjean EM, 2009, CNS DRUGS, V23, P331, DOI 10.2165/00023210-200923040-00005; Grunfeld JP, 2009, NAT REV NEPHROL, V5, P270, DOI 10.1038/nrneph.2009.43; Hasler U, 2006, AM J PHYSIOL-RENAL, V290, pF177, DOI 10.1152/ajprenal.00056.2005; Hasler U, 2006, J AM SOC NEPHROL, V17, P1521, DOI 10.1681/ASN.2005121317; Hoffert JD, 2006, P NATL ACAD SCI USA, V103, P7159, DOI 10.1073/pnas.0600895103; Hryciw DH, 2005, AM J PHYSIOL-RENAL, V288, pF1227, DOI 10.1152/ajprenal.00428.2003; Jeon US, 2007, AM J PHYSIOL-RENAL, V293, pF408, DOI 10.1152/ajprenal.00502.2006; Kamsteeg EJ, 2006, P NATL ACAD SCI USA, V103, P18344, DOI 10.1073/pnas.0604073103; Kishore BK, 2013, AM J PHYSIOL-RENAL, V304, pF1139, DOI 10.1152/ajprenal.00718.2012; Klein JD, 2012, PFLUG ARCH EUR J PHY, V464, P561, DOI 10.1007/s00424-012-1157-0; LAU K, 1978, AM J PHYSIOL, V234, pE294, DOI 10.1152/ajpendo.1978.234.3.E294; Li CL, 2003, AM J PHYSIOL-RENAL, V284, pF1066, DOI 10.1152/ajprenal.00090.2002; Li YD, 2006, J AM SOC NEPHROL, V17, P1063, DOI 10.1681/ASN.2005080884; Lim SW, 2007, J AM SOC NEPHROL, V18, P421, DOI 10.1681/ASN.2006060664; Mann L, 2008, INT J NEUROPSYCHOPH, V11, P533, DOI 10.1017/S1461145707008395; Naruse M, 1997, J AM SOC NEPHROL, V8, P517; Nielsen J, 2008, P NATL ACAD SCI USA, V105, P3634, DOI 10.1073/pnas.0800001105; Olesen ETB, 2013, J AM SOC NEPHROL, V24, P169, DOI 10.1681/ASN.2012020217; Procino G, 2004, KIDNEY INT, V66, P2245, DOI 10.1111/j.1523-1755.2004.66036.x; Procino G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033145; Quiroz JA, 2004, MOL INTERV, V4, P259, DOI 10.1124/mi.4.5.6; Rao R, 2005, AM J PHYSIOL-RENAL, V288, pF642, DOI 10.1152/ajprenal.00287.2004; Rao R, 2012, CURR OPIN NEPHROL HY, V21, P541, DOI 10.1097/MNH.0b013e32835571d4; Rej S, 2012, J GERIATR PSYCH NEUR, V25, P51, DOI 10.1177/0891988712436690; Renkema KY, 2009, J AM SOC NEPHROL, V20, P1705, DOI 10.1681/ASN.2008111195; Riccardi D, 2010, AM J PHYSIOL-RENAL, V298, pF485, DOI 10.1152/ajprenal.00608.2009; SAMADIAN T, 1993, HISTOL HISTOPATHOL, V8, P139; Sands Jeff M, 2011, Trans Am Clin Climatol Assoc, V122, P82; Sands JM, 1998, AM J PHYSIOL-RENAL, V274, pF978, DOI 10.1152/ajprenal.1998.274.5.F978; Schrier RW, 2006, J AM SOC NEPHROL, V17, P1820, DOI 10.1681/ASN.2006030240; Stone K A, 1999, J Am Board Fam Pract, V12, P43; Terris J, 1996, AM J PHYSIOL-RENAL, V271, pF414, DOI 10.1152/ajprenal.1996.271.2.F414; Thomsen K, 2006, NEPHROL DIAL TRANSPL, V21, P869, DOI 10.1093/ndt/gfk029; Timmer RT, 1999, J AM SOC NEPHROL, V10, P666; Valenti G, 2000, J AM SOC NEPHROL, V11, P1873, DOI 10.1681/ASN.V11101873; van Balkom BWM, 2002, J BIOL CHEM, V277, P41473, DOI 10.1074/jbc.M207525200; von Bergen TN, 2012, AM J PHYSIOL-RENAL, V303, pF900, DOI 10.1152/ajprenal.00547.2011; Vossenkamper A, 2007, AM J PHYSIOL-CELL PH, V293, pC1129, DOI 10.1152/ajpcell.00628.2006; Wang WD, 2002, AM J PHYSIOL-RENAL, V283, pF1313, DOI 10.1152/ajprenal.00040.2002; Wang Y, 2013, AM J PHYSIOL-RENAL, V304, pF233, DOI 10.1152/ajprenal.00484.2012; WILSON DM, 1993, AM J CLIN PATHOL, V100, P419, DOI 10.1093/ajcp/100.4.419; YAMAKI M, 1991, AM J PHYSIOL, V261, pF505, DOI 10.1152/ajprenal.1991.261.3.F505; Yao LJ, 2004, AM J PHYSIOL-RENAL, V287, pF299, DOI 10.1152/ajprenal.00274.2003; Yasui M, 1997, AM J PHYSIOL-RENAL, V272, pF443, DOI 10.1152/ajprenal.1997.272.4.F443; Yu MJ, 2009, P NATL ACAD SCI USA, V106, P2441, DOI 10.1073/pnas.0813002106; Zhang Y, 2013, AM J PHYSIOL-RENAL, V305, pF407, DOI 10.1152/ajprenal.00464.2012; Zhang Y, 2008, AM J PHYSIOL-RENAL, V295, pF1715, DOI 10.1152/ajprenal.90311.2008; Zhao H, 2012, ACTA PHARMACOL SIN, V33, P230, DOI 10.1038/aps.2011.160	59	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101753	10.1371/journal.pone.0101753	http://dx.doi.org/10.1371/journal.pone.0101753			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006961	Green Published, gold, Green Submitted			2022-12-27	WOS:000339040600064
J	Timeus, F; Crescenzio, N; Longoni, D; Doria, A; Foglia, L; Pagliano, S; Vallero, S; Decimi, V; Svahn, J; Palumbo, G; Ruggiero, A; Martire, B; Pillon, M; Marra, N; Dufour, C; Ramenghi, U; Saracco, P				Timeus, Fabio; Crescenzio, Nicoletta; Longoni, Daniela; Doria, Alessandra; Foglia, Luiselda; Pagliano, Sara; Vallero, Stefano; Decimi, Valentina; Svahn, Johanna; Palumbo, Giuseppe; Ruggiero, Antonio; Martire, Baldassarre; Pillon, Marta; Marra, Nicoletta; Dufour, Carlo; Ramenghi, Ugo; Saracco, Paola			Paroxysmal Nocturnal Hemoglobinuria Clones in Children with Acquired Aplastic Anemia: A Multicentre Study	PLOS ONE			English	Article							MINOR POPULATION; CELLS; DIAGNOSIS; DEFICIENT	A multicentre study evaluating the presence of glycosil phosphatidyl-inositol (GPI)-negative populations was performed in 85 children with acquired aplastic anemia (AA). A GPI-negative population was observed in 41% of patients at diagnosis, 48% during immune-suppressive therapy (IST), and 45% in patients off-therapy. No association was found between the presence of a GPI-negative population at diagnosis and the response to IST. In addition, the response rate to IST did not differ between the patients who were GPI-positive at diagnosis and later developed GPI-negative populations and the 11 patients who remained GPI-positive. Two patients with a GPI-negative population >10%, and laboratory signs of hemolysis without hemoglobinuria were considered affected by paroxysmal nocturnal hemoglobinuria (PNH) secondary to AA; no thrombotic event was reported. Excluding the 2 patients with a GPI-negative population greater than 10%, we did not observe a significant correlation between LDH levels and GPI-negative population size. In this study monitoring for laboratory signs of hemolysis was sufficient to diagnose PNH in AA patients. The presence of minor GPI-negative populations at diagnosis in our series did not influence the therapeutic response. As occasionally the appearance of a GPI-negative population was observed at cyclosporine (CSA) tapering or AA relapse, a possible role of GPI-negative population monitoring during IST modulation may need further investigation.	[Timeus, Fabio; Vallero, Stefano] Regina Margherita Childrens Hosp, Turin, Italy; [Timeus, Fabio; Crescenzio, Nicoletta; Doria, Alessandra; Foglia, Luiselda; Pagliano, Sara; Ramenghi, Ugo; Saracco, Paola] Univ Turin, Turin, Italy; [Longoni, Daniela; Decimi, Valentina] MBBM Fdn S Gerardo Hosp, Dept Pediat, Monza, Italy; [Svahn, Johanna; Dufour, Carlo] G Gaslini Childrens Hosp, Hematol Unit, Genoa, Italy; [Palumbo, Giuseppe] Bambin Gesu Childrens Hosp, Pediat Oncohematol Dept, Rome, Italy; [Ruggiero, Antonio] Policlin Gemelli, Rome, Italy; [Martire, Baldassarre] Univ Bari, Dept Pediat, Bari, Italy; [Pillon, Marta] Univ Hosp Padua, Pediat Oncohematol Unit, Padua, Italy; [Marra, Nicoletta] Santobono Pausilipon Hosp, Dept Pediat Haematooncol, Naples, Italy	A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; IRCCS Bambino Gesu; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Universita degli Studi di Bari Aldo Moro; University of Padua; Azienda Ospedaliera - Universita di Padova	Timeus, F (corresponding author), Regina Margherita Childrens Hosp, Turin, Italy.	fabio.timeus@unito.it	Ruggiero, Antonio/M-7849-2018; Dufour, Carlo/AAB-1000-2021; Palumbo, Giuseppe/AAB-5305-2020; VALLERO, STEFANO GABRIELE/AAA-4131-2019; Pillon, Marta/AAB-9581-2022	Ruggiero, Antonio/0000-0002-6052-3511; Pillon, Marta/0000-0002-1190-3198; Svahn, Johanna/0000-0002-7135-9171; PALUMBO, GIUSEPPE/0000-0002-1010-2946	DBA Italia Onlus	DBA Italia Onlus	This work was supported by a grant from DBA Italia Onlus (www.diamondblackfanitalia.org) for a fellowship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araten DJ, 1999, P NATL ACAD SCI USA, V96, P5209, DOI 10.1073/pnas.96.9.5209; Bellido M, 2012, ANN HEMATOL, V91, P1969, DOI 10.1007/s00277-012-1511-5; Borowitz MJ, 2010, CYTOM PART B-CLIN CY, V78B, P211, DOI 10.1002/cyto.b.20525; Brodsky RA, 2000, AM J CLIN PATHOL, V114, P459, DOI 10.1093/ajcp/114.3.459; Curran KJ, 2012, PEDIATR BLOOD CANCER, V59, P525, DOI 10.1002/pbc.23410; Hall SE, 1996, BLOOD, V87, P5332, DOI 10.1182/blood.V87.12.5332.bloodjournal87125332; Hu R, 2005, BLOOD, V105, P3848, DOI 10.1182/blood-2004-04-1472; Ishiyama K, 2003, BLOOD, V102, P1211, DOI 10.1182/blood-2002-12-3706; Karadimitris A, 2000, BLOOD, V96, P2613, DOI 10.1182/blood.V96.7.2613.h8002613_2613_2620; Kumar KS, 2000, DIGEST DIS SCI, V45, P2238, DOI 10.1023/A:1026467219850; Maciejewski JP, 2001, BLOOD, V98, P3513, DOI 10.1182/blood.V98.13.3513; Murakami Y, 2012, BRIT J HAEMATOL, V156, P383, DOI 10.1111/j.1365-2141.2011.08914.x; Parker C, 2005, BLOOD, V106, P3699, DOI 10.1182/blood-2005-04-1717; Scheinberg P, 2010, HAEMATOL-HEMATOL J, V95, P1075, DOI 10.3324/haematol.2009.017889; Sugimori C, 2006, BLOOD, V107, P1308, DOI 10.1182/blood-2005-06-2485; Sugimori C, 2009, BRIT J HAEMATOL, V147, P102, DOI 10.1111/j.1365-2141.2009.07822.x; Sutton KS, 2013, PEDIATR BLOOD CANCER, V60, P455, DOI 10.1002/pbc.24247; Timeus F, 2010, BRIT J HAEMATOL, V150, P483, DOI 10.1111/j.1365-2141.2010.08219.x; van den Heuvel-Eibrink MM, 2005, BRIT J HAEMATOL, V128, P571, DOI 10.1111/j.1365-2141.2004.05337.x; Yoshida N, 2008, BRIT J HAEMATOL, V142, P427, DOI 10.1111/j.1365-2141.2008.07182.x	20	22	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101948	10.1371/journal.pone.0101948	http://dx.doi.org/10.1371/journal.pone.0101948			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007335	Green Published, Green Submitted, gold			2022-12-27	WOS:000339040600082
J	Tobe, T; Yen, H; Takahashi, H; Kagayama, Y; Ogasawara, N; Oshima, T				Tobe, Toru; Yen, Hilo; Takahashi, Hiroki; Kagayama, Yoko; Ogasawara, Naotake; Oshima, Taku			Antisense Transcription Regulates the Expression of the Enterohemorrhagic Escherichia coli Virulence Regulatory Gene ler in Response to the Intracellular Iron Concentration	PLOS ONE			English	Article							ENTEROCYTE EFFACEMENT LEE; PATHOGENICITY ISLAND; DNA-DAMAGE; SMALL RNAS; LOCUS; O157-H7; SEQUENCE; K-12; HOMEOSTASIS; TRANSPORT	Enteric pathogens, such as enterohemorrhagic E. coli (EHEC) O157:H7, encounter varying concentrations of iron during their life cycle. In the gastrointestinal tract, the amount of available free iron is limited because of absorption by host factors. EHEC and other enteric pathogens have developed sophisticated iron-responsive systems to utilize limited iron resources, and these systems are primarily regulated by the Fur repressor protein. The iron concentration could be a signal that controls gene expression in the intestines. In this study, we explored the role of iron in LEE (locus for enterocyte effacement) virulence gene expression in EHEC. In contrast to the expression of Fur-regulated genes, the expression of LEE genes was greatly reduced in fur mutants irrespective of the iron concentration. The expression of the ler gene, the LEE-encoded master regulator, was affected at a post-transcription step by fur mutation. Further analysis showed that the loss of Fur affected the translation of the ler gene by increasing the intracellular concentration of free iron, and the transcription of the antisense strand was necessary for regulation. The results indicate that LEE gene expression is closely linked to the control of intracellular free iron homeostasis.	[Tobe, Toru] Osaka Univ, Dept Biomed Informat, Grad Sch Med, Suita, Osaka, Japan; [Yen, Hilo] Osaka Univ, Grad Sch Med, Dept Microbiol & Immunol, Suita, Osaka, Japan; [Takahashi, Hiroki] Chiba Univ, Med Mycol Res Ctr, Chiba, Japan; [Kagayama, Yoko; Ogasawara, Naotake; Oshima, Taku] Nara Inst Sci & Technol, Grad Sch Informat Sci, Ikoma, Nara 6300101, Japan	Osaka University; Osaka University; Chiba University; Nara Institute of Science & Technology	Tobe, T (corresponding author), Osaka Univ, Dept Biomed Informat, Grad Sch Med, Suita, Osaka, Japan.	torutobe@sahs.med.osaka-u.ac.jp	Takahashi, Hiroki/M-9169-2015	Takahashi, Hiroki/0000-0001-5627-1035	Ministry of Education, Culture, Sports, Science, and Technology of Japan [22590389]; Institute for Fermentation Osaka; Biotechnology and Biological Sciences Research Council [BB/H531586/1] Funding Source: researchfish; BBSRC [BB/H531586/1] Funding Source: UKRI	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Institute for Fermentation Osaka(Institute for Fermentation (IFO)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grant 22590389 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and a grant from the Institute for Fermentation Osaka. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2002, INFECT IMMUN, V70, P3500, DOI 10.1128/IAI.70.7.3500-3509.2002; Abe H, 2008, DNA RES, V15, P25, DOI 10.1093/dnares/dsm033; Ahmad R, 2009, PROTEINS, V75, P373, DOI 10.1002/prot.22247; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Burton NA, 2010, J MOL BIOL, V401, P726, DOI 10.1016/j.jmb.2010.06.054; CALDERWOOD SB, 1987, J BACTERIOL, V169, P4759, DOI 10.1128/jb.169.10.4759-4764.1987; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DEGRANDIS S, 1987, J BACTERIOL, V169, P4313, DOI 10.1128/jb.169.9.4313-4319.1987; Ellermeier JR, 2008, J BACTERIOL, V190, P476, DOI 10.1128/JB.00926-07; Elliott SJ, 1998, MOL MICROBIOL, V28, P1, DOI 10.1046/j.1365-2958.1998.00783.x; Gottesman S, 2010, COLD SPRING HARBOR P, V3; GUERINOT ML, 1994, ANNU REV MICROBIOL, V48, P743, DOI 10.1146/annurev.micro.48.1.743; HANTKE K, 1981, MOL GEN GENET, V182, P288, DOI 10.1007/BF00269672; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; Iyoda S, 2004, MICROBIOL-SGM, V150, P2357, DOI 10.1099/mic.0.27100-0; Jacques JF, 2006, MOL MICROBIOL, V62, P1181, DOI 10.1111/j.1365-2958.2006.05439.x; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; KNUTTON S, 1987, INFECT IMMUN, V55, P69, DOI 10.1128/IAI.55.1.69-77.1987; Koo JT, 2011, P NATL ACAD SCI USA, V108, pE709, DOI 10.1073/pnas.1101655108; Kroger C, 2012, P NATL ACAD SCI USA, V109, pE1277, DOI 10.1073/pnas.1201061109; Lasa I, 2011, P NATL ACAD SCI USA, V108, P20172, DOI 10.1073/pnas.1113521108; LITWIN CM, 1993, CLIN MICROBIOL REV, V6, P137, DOI 10.1128/CMR.6.2.137-149.1993; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; Mellies JL, 2007, INFECT IMMUN, V75, P4199, DOI 10.1128/IAI.01927-06; Nachin L, 2001, MOL MICROBIOL, V39, P960, DOI 10.1046/j.1365-2958.2001.02288.x; Nakanishi N, 2006, MOL MICROBIOL, V61, P194, DOI 10.1111/j.1365-2958.2006.05217.x; Nakanishi N, 2009, MICROBIOL-SGM, V155, P521, DOI 10.1099/mic.0.023499-0; Perna NT, 1998, INFECT IMMUN, V66, P3810, DOI 10.1128/IAI.66.8.3810-3817.1998; Porter ME, 2005, J BACTERIOL, V187, P458, DOI 10.1128/JB.187.2.458-472.2005; Salvail H, 2010, P NATL ACAD SCI USA, V107, P15223, DOI 10.1073/pnas.1007805107; Sesto N, 2013, NAT REV MICROBIOL, V11, P75, DOI 10.1038/nrmicro2934; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Soutourina OA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003493; Teixido L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019711; Tobe T, 2005, MOL MICROBIOL, V58, P320, DOI 10.1111/j.1365-2958.2005.04828.x	38	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101582	10.1371/journal.pone.0101582	http://dx.doi.org/10.1371/journal.pone.0101582			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006810	Green Published, Green Submitted, gold			2022-12-27	WOS:000339040600047
J	Dong, B; Han, RM; Wang, GX; Cao, X				Dong, Bin; Han, Ruiming; Wang, Guoxiang; Cao, Xun			O-2, pH, and Redox Potential Microprofiles around Potamogeton malaianus Measured Using Microsensors	PLOS ONE			English	Article							SUBMERGED MACROPHYTE; BOUNDARY-LAYERS; LAKE TAIHU; OXYGEN; EPIPHYTE; PHOTOSYNTHESIS; SHALLOW; PERIPHYTON; ALGAE; PHYTOPLANKTON	This study aimed to elucidate the effects of periphyton on the microprofiles of oxygen (O-2), pH, and oxidation-reduction potential around the stems and leaves of a submerged macrophyte Potamogeton malaianus and on the plant growth in the eutrophic shallow Taihu Lake, China. The microprofiles were measured using a motorized microprofiling system equipped with microsensors. The leaf age of the macrophyte and periphyton exerted significant effects on the microprofiles of O-2, pH, and oxidation-reduction potential. O-2 concentration and pH increased whereas the oxidation-reduction potential decreased with decreasing distance to the stem/leaf surface. The fluctuation amplitudes of O-2, pH, and oxidation-reduction potential were the largest in the microprofiles of mature leaves and the lowest in senescent leaves. The periphyton increased the thickness of the broad diffusive boundary layer and fluctuation amplitudes of O-2, pH, and oxidation-reduction potential. When the periphyton was removed, the thickness of the broad diffusive boundary layer in the microprofiles of stems, senescent leaves, and mature leaves reduced by 29.0%, 49.72%, and 70.34%, and the O-2, pH, and oxidation-reduction potential fluctuation amplitudes also declined accordingly. Our results suggest that a thick periphyton exerted negative effects on the growth of macrophytes by providing extensive shading and creating a barrier that hindered the transport of dissolved substances such as O-2, and led to premature decline in macrophytes in the eutrophic Taihu Lake. The consequent implications can help to elucidate the control mechanism of the broad diffusive boundary layer around macrophytes on nutrient cycling in eutrophic waters and to better understand the role of this layer in the Taihu Lake and other similar eutrophic waters.	[Dong, Bin; Han, Ruiming; Wang, Guoxiang; Cao, Xun] Nanjing Normal Univ, Sch Geog Sci, Jiangsu Key Lab Environm Change & Ecol Construct, Nanjing, Jiangsu, Peoples R China; [Dong, Bin] Linyi Univ, Sch Resource & Environm, Linyi, Peoples R China	Nanjing Normal University; Linyi University	Wang, GX (corresponding author), Nanjing Normal Univ, Sch Geog Sci, Jiangsu Key Lab Environm Change & Ecol Construct, Nanjing, Jiangsu, Peoples R China.	wangguoxiang@njnu.edu.cn			National Natural Science Foundation of China [41173078]; National Water Pollution Control and Management Technology Major Projects [2012ZX07101-008-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Water Pollution Control and Management Technology Major Projects	This study was supported by the National Natural Science Foundation of China (41173078), National Water Pollution Control and Management Technology Major Projects (2012ZX07101-008-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardon M, 2007, FRESHWATER BIOL, V52, P1762, DOI 10.1111/j.1365-2427.2007.01807.x; Asaeda T, 2004, ENVIRON EXP BOT, V52, P225, DOI 10.1016/j.envexpbot.2004.02.001; Boros G, 2011, HYDROBIOLOGIA, V665, P117, DOI 10.1007/s10750-011-0609-4; Cai XL, 2013, J BASIC MICROB, V53, P828, DOI 10.1002/jobm.201200220; China EPA, 2002, MON AN METH WAT WAST; Demarty M, 2009, CAN J FISH AQUAT SCI, V66, P1522, DOI 10.1139/F09-099; Dong Bin, 2013, Hupo Kexue, V25, P359; Fang F, 2013, J APPL PHYCOL, V25, P1; Greve TM, 2003, LIMNOL OCEANOGR, V48, P210, DOI 10.4319/lo.2003.48.1.0210; Hart DD, 2013, FRESHWATER BIOL, V58, P1588, DOI 10.1111/fwb.12147; He Feng, 2002, Acta Hydrobiologica Sinica, V26, P421; Herrmann M, 2011, APPL ENVIRON MICROB, V77, P1896, DOI 10.1128/AEM.02879-10; Ji Haiting, 2013, Hupo Kexue, V25, P163; Jones JI, 2000, AQUAT BOT, V67, P191; JORGENSEN BB, 1985, LIMNOL OCEANOGR, V30, P111, DOI 10.4319/lo.1985.30.1.0111; Korschgen CE, 1997, AQUAT BOT, V58, P1, DOI 10.1016/S0304-3770(97)00014-4; Li YL, 2013, PLANT SOIL, V365, P115, DOI 10.1007/s11104-012-1378-1; Liboriussen L, 2003, FRESHWATER BIOL, V48, P418, DOI 10.1046/j.1365-2427.2003.01018.x; [刘伟龙 LIU WeiLong], 2007, [生态学报, Acta Ecologica Sinica], V27, P3324; Ozkan K, 2010, FRESHWATER BIOL, V55, P463, DOI 10.1111/j.1365-2427.2009.02297.x; PHILLIPS GL, 1978, AQUAT BOT, V4, P103, DOI 10.1016/0304-3770(78)90012-8; PIP E, 1984, Hydrobiological Bulletin, V18, P109, DOI 10.1007/BF02257050; Pomazkina G, 2012, LIMNOLOGICAL REV, V12, P19, DOI DOI 10.2478/v10194-011-0041-1; [钱宝 Qian Bao], 2013, [水利学报, Journal of Hydraulic Engineering], V44, P295; Qin BQ, 2006, SCI CHINA SER C, V49, P597, DOI 10.1007/s11427-006-2025-y; Qin BQ, 2013, CHINESE SCI BULL, V58, P961, DOI 10.1007/s11434-012-5560-x; Qin BQ, 2004, CHINESE SCI BULL, V49, P54, DOI 10.1360/03wd0174; Revsbech NP, 1999, BIOL FERT SOILS, V29, P379, DOI 10.1007/s003740050568; ROGERS KH, 1981, MICROBIAL ECOL, V7, P351, DOI 10.1007/BF02341430; Romanow M, 2011, OCEANOL HYDROBIOL ST, V40, P64, DOI 10.2478/s13545-011-0042-3; SANDJENSEN K, 1985, MAR BIOL, V89, P55, DOI 10.1007/BF00392877; SANDJENSEN K, 1987, LIMNOL OCEANOGR, V32, P452, DOI 10.4319/lo.1987.32.2.0452; SANDJENSEN K, 1989, AQUAT BOT, V34, P5, DOI 10.1016/0304-3770(89)90048-X; SANDJENSEN K, 1990, FOLIA GEOBOT PHYTOTX, V25, P315, DOI 10.1007/BF02913033; Santegoeds CM, 1998, BIODEGRADATION, V9, P159, DOI 10.1023/A:1008302622946; Schreiber L, 2005, NEW PHYTOL, V166, P589, DOI 10.1111/j.1469-8137.2005.01343.x; Schreiber U, 1997, PLANT CELL PHYSIOL, V38, P945, DOI 10.1093/oxfordjournals.pcp.a029256; SIMPSON PS, 1986, AQUAT BOT, V24, P1, DOI 10.1016/0304-3770(86)90112-9; Song Yu-zhi, 2007, Yingyong Shengtai Xuebao, V18, P928; Song Yuzhi, 2010, Hupo Kexue, V22, P935; Spilling K, 2010, J PHYCOL, V46, P1350, DOI 10.1111/j.1529-8817.2010.00894.x; Stevens CL, 1997, HYDROBIOLOGIA, V346, P119, DOI 10.1023/A:1002914015683; Toth VR, 2013, AQUAT SCI, V75, P523, DOI 10.1007/s00027-013-0297-4; Vermaire JC, 2013, J PALEOLIMNOL, V50, P447, DOI 10.1007/s10933-013-9737-3; Wahl A, 2005, GALVANOTECHTNIK, V96, P1820; Wang WL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098457; Wang YongPing, 2013, China Environmental Science, V33, P132; Wang ZJ, 2013, BIORESOURCE TECHNOL, V132, P387, DOI 10.1016/j.biortech.2012.11.026; Wang Zhi, 2013, China Environmental Science, V33, P328; Wieland A, 2006, FEMS MICROBIOL ECOL, V55, P195, DOI 10.1111/j.1574-6941.2005.00031.x; Xie D, 2013, CHEMOSPHERE, V93, P1301, DOI [10.1016/j.chemosphere.2013.07.008, 10.1016/j.chemosphere.2013.04.098]; Zhao DY, 2013, CAN J MICROBIOL, V59, P237, DOI 10.1139/cjm-2012-0554	52	10	12	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101825	10.1371/journal.pone.0101825	http://dx.doi.org/10.1371/journal.pone.0101825			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004129	Green Submitted, Green Published, gold			2022-12-27	WOS:000339242700073
J	Ikumi, N; Soto-Faraco, S				Ikumi, Nara; Soto-Faraco, Salvador			Selective Attention Modulates the Direction of Audio-Visual Temporal Recalibration	PLOS ONE			English	Article							MULTISENSORY INTEGRATION; ORDER JUDGMENTS; SIMULTANEITY JUDGMENTS; SUPERIOR COLLICULUS; SPEECH-PERCEPTION; PRIOR ENTRY; SYNCHRONY; VENTRILOQUISM; TUTORIAL; TIME	Temporal recalibration of cross-modal synchrony has been proposed as a mechanism to compensate for timing differences between sensory modalities. However, far from the rich complexity of everyday life sensory environments, most studies to date have examined recalibration on isolated cross-modal pairings. Here, we hypothesize that selective attention might provide an effective filter to help resolve which stimuli are selected when multiple events compete for recalibration. We addressed this question by testing audio-visual recalibration following an adaptation phase where two opposing audio-visual asynchronies were present. The direction of voluntary visual attention, and therefore to one of the two possible asynchronies (flash leading or flash lagging), was manipulated using colour as a selection criterion. We found a shift in the point of subjective audio-visual simultaneity as a function of whether the observer had focused attention to audio-then-flash or to flash-then-audio groupings during the adaptation phase. A baseline adaptation condition revealed that this effect of endogenous attention was only effective toward the lagging flash. This hints at the role of exogenous capture and/or additional endogenous effects producing an asymmetry toward the leading flash. We conclude that selective attention helps promote selected audio-visual pairings to be combined and subsequently adjusted in time but, stimulus organization exerts a strong impact on recalibration. We tentatively hypothesize that the resolution of recalibration in complex scenarios involves the orchestration of top-down selection mechanisms and stimulus-driven processes.	[Ikumi, Nara; Soto-Faraco, Salvador] Univ Pompeu Fabra, Dept Tecnol Informacio & Comunicac, Barcelona, Spain; [Soto-Faraco, Salvador] ICREA, Barcelona, Spain	Pompeu Fabra University; ICREA	Soto-Faraco, S (corresponding author), Univ Pompeu Fabra, Dept Tecnol Informacio & Comunicac, Barcelona, Spain.	salvador.soto@icrea.cat	Ikumi, Nara/AAB-1181-2019; SOTO-FARACO, SALVADOR/B-8400-2011	Ikumi, Nara/0000-0002-0617-9879; SOTO-FARACO, SALVADOR/0000-0002-4799-3762	Spanish Ministry of Science and Innovation [PSI2010-15426]; Comissionat per a Universitats i Recerca del DIUE-Generalitat de Catalunya [SRG2009-092]; European Research Council [StG-2010 263145]; ICREA Funding Source: Custom	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comissionat per a Universitats i Recerca del DIUE-Generalitat de Catalunya(Generalitat de Catalunya); European Research Council(European Research Council (ERC)European Commission); ICREA(ICREA)	This research was supported by the Spanish Ministry of Science and Innovation (PSI2010-15426), Comissionat per a Universitats i Recerca del DIUE-Generalitat de Catalunya (SRG2009-092), and the European Research Council (StG-2010 263145). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CAVANAGH P, 1987, J OPT SOC AM A, V4, P1428, DOI 10.1364/JOSAA.4.001428; Chen LH, 2013, ATTEN PERCEPT PSYCHO, V75, P244, DOI [10.3758/s13414-012-0395-8, 10.3758/s13414-013-0475-4]; Di Luca M, 2009, J VISION, V9, DOI 10.1167/9.12.7; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Fujisaki W, 2010, P ROY SOC B-BIOL SCI, V277, P2281, DOI 10.1098/rspb.2010.0243; Heron J, 2012, EXP BRAIN RES, V218, P477, DOI 10.1007/s00221-012-3038-3; Heron J, 2010, EUR J NEUROSCI, V31, P1755, DOI 10.1111/j.1460-9568.2010.07194.x; Jaekl P, 2012, EXP BRAIN RES, V216, P457, DOI 10.1007/s00221-011-2948-9; Keetels M, 2005, EXP BRAIN RES, V167, P635, DOI 10.1007/s00221-005-0067-1; Keetels M, 2007, EXP BRAIN RES, V180, P449, DOI 10.1007/s00221-007-0881-8; King AJ, 2005, CURR BIOL, V15, pR339, DOI 10.1016/j.cub.2005.04.022; KING AJ, 1985, EXP BRAIN RES, V60, P492; Kosem A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040936; Lewald J, 2003, COGNITIVE BRAIN RES, V16, P468, DOI 10.1016/S0926-6410(03)00074-0; Love SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054798; Machulla TK, 2012, EXP BRAIN RES, V217, P89, DOI 10.1007/s00221-011-2976-5; MEREDITH MA, 1987, J NEUROSCI, V7, P3215; Morein-Zamir S, 2003, COGNITIVE BRAIN RES, V17, P154, DOI 10.1016/S0926-6410(03)00089-2; Myung IJ, 2003, J MATH PSYCHOL, V47, P90, DOI 10.1016/S0022-2496(02)00028-7; Navarra J, 2005, COGNITIVE BRAIN RES, V25, P499, DOI 10.1016/j.cogbrainres.2005.07.009; Navarra J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084278; Navarra Jordi, 2012, Front Psychol, V3, P152, DOI 10.3389/fpsyg.2012.00152; Roseboom W, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00189; Roseboom W, 2011, PSYCHOL SCI, V22, P872, DOI 10.1177/0956797611413293; Schroeder CE, 2005, CURR OPIN NEUROBIOL, V15, P454, DOI 10.1016/j.conb.2005.06.008; Soto-Faraco S, 2009, J EXP PSYCHOL HUMAN, V35, P580, DOI 10.1037/a0013483; Spence C, 2003, CURR BIOL, V13, pR519, DOI 10.1016/S0960-9822(03)00445-7; Spence C, 2001, J EXP PSYCHOL GEN, V130, P799, DOI 10.1037//0096-3445.130.4.799; Talsma D, 2010, TRENDS COGN SCI, V14, P400, DOI 10.1016/j.tics.2010.06.008; Titchener E. B., 1908, LECT ELEMENTARY PSYC, DOI 10.1037/10867-000; Van der Burg E, 2013, J NEUROSCI, V33, P14633, DOI 10.1523/JNEUROSCI.1182-13.2013; van Eijk RLJ, 2008, PERCEPT PSYCHOPHYS, V70, P955, DOI 10.3758/PP.70.6.955; van Wassenhove V, 2007, NEUROPSYCHOLOGIA, V45, P598, DOI 10.1016/j.neuropsychologia.2006.01.001; Vatakis A, 2008, EXP BRAIN RES, V185, P521, DOI 10.1007/s00221-007-1168-9; Vatakis A, 2007, EXP BRAIN RES, V181, P173, DOI 10.1007/s00221-007-0918-z; Vatakis A, 2006, BRAIN RES, V1111, P134, DOI 10.1016/j.brainres.2006.05.078; Vroomen J, 2004, COGNITIVE BRAIN RES, V22, P32, DOI 10.1016/j.cogbrainres.2004.07.003; Vroomen J, 2004, J EXP PSYCHOL HUMAN, V30, P513, DOI 10.1037/0096-1523.30.3.513; Vroomen J, 2010, ATTEN PERCEPT PSYCHO, V72, P871, DOI 10.3758/APP.72.4.871; Wilbiks JMP, 2013, ATTEN PERCEPT PSYCHO, V75, P1883, DOI 10.3758/s13414-013-0527-9; Yarrow K, 2011, J EXP PSYCHOL HUMAN, V37, P1657, DOI 10.1037/a0024235; Zampini M, 2005, PERCEPT PSYCHOPHYS, V67, P531, DOI 10.3758/BF03193329; Zampini M, 2005, NEUROSCI LETT, V381, P217, DOI 10.1016/j.neulet.2005.01.085; Zampini M, 2003, EXP BRAIN RES, V152, P198, DOI 10.1007/s00221-003-1536-z	44	12	12	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e99311	10.1371/journal.pone.0099311	http://dx.doi.org/10.1371/journal.pone.0099311			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004132	gold, Green Submitted, Green Published			2022-12-27	WOS:000339242700002
J	Kiwelu, IE; Novitsky, V; Kituma, E; Margolin, L; Baca, J; Manongi, R; Sam, N; Shao, J; McLane, MF; Kapiga, SH; Essex, M				Kiwelu, Ireen E.; Novitsky, Vladimir; Kituma, Elimsaada; Margolin, Lauren; Baca, Jeannie; Manongi, Rachel; Sam, Noel; Shao, John; McLane, Mary F.; Kapiga, Saidi H.; Essex, M.			HIV-1 pol Diversity among Female Bar and Hotel Workers in Northern Tanzania	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DRUG-RESISTANCE MUTATIONS; REVERSE-TRANSCRIPTASE; TYPE-1 SUBTYPES; ANTIRETROVIRAL THERAPY; VIROLOGICAL FAILURE; CROSS-RESISTANCE; MBEYA REGION; CLADE-C; PROTEASE	A national ART program was launched in Tanzania in October 2004. Due to the existence of multiple HIV-1 subtypes and recombinant viruses co-circulating in Tanzania, it is important to monitor rates of drug resistance. The present study determined the prevalence of HIV-1 drug resistance mutations among ART-naive female bar and hotel workers, a high-risk population for HIV-1 infection in Moshi, Tanzania. A partial HIV-1 pol gene was analyzed by single-genome amplification and sequencing in 45 subjects (622 pol sequences total; median number of sequences per subject, 13; IQR 5-20) in samples collected in 2005. The prevalence of HIV-1 subtypes A1, C, and D, and inter-subtype recombinant viruses, was 36%, 29%, 9% and 27%, respectively. Thirteen different recombination patterns included D/A1/D, C/A1, A1/C/A1, A1/U/A1, C/U/A1, C/A1, U/D/U, D/A1/D, A1/C, A1/C, A2/C/A2, CRF10_CD/C/CRF10_CD and CRF35_AD/A1/CRF35_AD. CRF35_AD was identified in Tanzania for the first time. All recombinant viruses in this study were unique, suggesting ongoing recombination processes among circulating HIV-1 variants. The prevalence of multiple infections in this population was 16% (n=7). Primary HIV-1 drug resistance mutations to RT inhibitors were identified in three (7%) subjects (K65R plus Y181C; N60D; and V106M). In some subjects, polymorphisms were observed at the RT positions 41, 69, 75, 98, 101, 179, 190, and 215. Secondary mutations associated with NNRTIs were observed at the RT positions 90 (7%) and 138 (6%). In the protease gene, three subjects (7%) had M46I/L mutations. All subjects in this study had HIV-1 subtype-specific natural polymorphisms at positions 36, 69, 89 and 93 that are associated with drug resistance in HIV-1 subtype B. These results suggested that HIV-1 drug resistance mutations and natural polymorphisms existed in this population before the initiation of the national ART program. With increasing use of ARV, these results highlight the importance of drug resistance monitoring in Tanzania.	[Kiwelu, Ireen E.; Kituma, Elimsaada; Manongi, Rachel; Sam, Noel; Shao, John] Tumaini Univ, Kilimanjaro Christian Med Ctr & Coll, Moshi, Tanzania; [Kiwelu, Ireen E.; Novitsky, Vladimir; Margolin, Lauren; Baca, Jeannie; McLane, Mary F.; Essex, M.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Kapiga, Saidi H.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Kituma, Elimsaada; Manongi, Rachel; Sam, Noel; Kapiga, Saidi H.] Kilimanjaro Reprod Hlth Program, Moshi, Tanzania	Harvard University; Harvard T.H. Chan School of Public Health; University of London; London School of Hygiene & Tropical Medicine	Essex, M (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	messex@hsph.harvard.edu	shao, jianfu/N-2447-2018	shao, jianfu/0000-0002-6632-8207; Kapiga, Saidi/0000-0003-1753-4060	International Partnership for Microbicides; NIH Fogarty International Center AIDS International Training and Research Program [D43 TW000004]; Fogarty International Center Scholars and Fellows Program; FOGARTY INTERNATIONAL CENTER [D43TW000004] Funding Source: NIH RePORTER	International Partnership for Microbicides; NIH Fogarty International Center AIDS International Training and Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Fogarty International Center Scholars and Fellows Program; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by a grant from the International Partnership for Microbicides (SHK), the NIH Fogarty International Center AIDS International Training and Research Program grant D43 TW000004 (IEK), and the Fogarty International Center Scholars and Fellows Program (IEK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Ao TTH, 2011, AIDS BEHAV, V15, P330, DOI 10.1007/s10461-010-9849-y; Ao TTH, 2006, SEX TRANSM DIS, V33, P163, DOI 10.1097/01.olq.0000187204.57006.b3; Apetrei C, 1998, J VIROL, V72, P3534, DOI 10.1128/JVI.72.5.3534-3538.1998; Arroyo MA, 2004, AIDS RES HUM RETROV, V20, P895, DOI 10.1089/0889222041725235; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Becker-Pergola G, 2000, AIDS RES HUM RETROV, V16, P807, DOI 10.1089/088922200308800; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Birk M, 1998, AIDS, V12, P2369, DOI 10.1097/00002030-199818000-00005; Brenner B, 2003, AIDS, V17, pF1, DOI 10.1097/00002030-200301030-00001; Brindeiro R, 1999, ANTIMICROB AGENTS CH, V43, P1674, DOI 10.1128/AAC.43.7.1674; Chan DJ, 2009, CURR HIV RES, V7, P231, DOI 10.2174/157016209787581463; de Oliveira T, 2006, REGA HIV 1 SUBTYPING; Deeks SG, 2008, PLOS MED, V5, P1014, DOI 10.1371/journal.pmed.0050164; Descamps D, 1998, AIDS, V12, P1109; Dugan KA, 2002, J FORENSIC SCI, V47, P811; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erickson JW, 1999, AIDS, V13, pS189; Eshleman SH, 2002, AIDS RES HUM RETROV, V18, P507, DOI 10.1089/088922202317406655; Grossman Z, 2001, AIDS, V15, P1453, DOI 10.1097/00002030-200108170-00001; GU ZX, 1995, J GEN VIROL, V76, P2601, DOI 10.1099/0022-1317-76-10-2601; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Herbinger KH, 2006, AIDS RES HUM RETROV, V22, P599, DOI 10.1089/aid.2006.22.599; Hickman M, 1999, SEX TRANSM INFECT, V75, P385, DOI 10.1136/sti.75.6.385; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hirsch MS, 1998, JAMA-J AM MED ASSOC, V279, P1984, DOI 10.1001/jama.279.24.1984; *HIV, HIV SEQ DAT; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Hoelscher M, 2002, AIDS, V16, P2055, DOI 10.1097/00002030-200210180-00011; HolmHansen C, 1996, APMIS, V104, P459, DOI 10.1111/j.1699-0463.1996.tb00742.x; Hue S, 2012, AIDS RES HUM RETROV, V28, P220, DOI 10.1089/aid.2011.0048; Jetzt AE, 2000, J VIROL, V74, P1234, DOI 10.1128/JVI.74.3.1234-1240.2000; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Kahle EM, 2014, JAIDS-J ACQ IMM DEF, V65, pE90, DOI 10.1097/QAI.0b013e3182a2db02; Kanki PJ, 1999, J INFECT DIS, V179, P68, DOI 10.1086/314557; Kantor R, 2005, PLOS MED, V2, P325, DOI 10.1371/journal.pmed.0020112; Kantor R, 2004, J CLIN VIROL, V29, P152, DOI 10.1016/S1386-6532(03)00115-X; Kapiga SH, 2002, J ACQ IMMUN DEF SYND, V29, P409, DOI 10.1097/00126334-200204010-00013; Kasang C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023091; Kijak GH, 2004, AIDS REV, V6, P54; Kiwelu IE, 2005, AIDS RES HUM RETROV, V21, P897, DOI 10.1089/aid.2005.21.897; Kiwelu IE, 2003, AIDS RES HUM RETROV, V19, P57, DOI 10.1089/08892220360473970; Kiwelu IE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071131; Kiwelu IE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047605; Koulinska IN, 2001, AIDS RES HUM RETROV, V17, P423, DOI 10.1089/088922201750102508; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Liu SL, 1996, SCIENCE, V273, P415, DOI 10.1126/science.273.5274.415; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Martinez-Picado J, 2000, VIROLOGY, V275, P318, DOI 10.1006/viro.2000.0527; Mosha F, 2011, AIDS RES HUM RETROV, V27, P377, DOI 10.1089/aid.2010.0113; National AIDS Control Programme, 2007, HIV AIDS STI SURV RE; Novitsky V, 2007, AIDS RES HUM RETROV, V23, P868, DOI 10.1089/aid.2006.0298; Nucleotide Blast, BLAST BAS LOG AL SEA; Nyombi BM, 2008, AIDS RES HUM RETROV, V24, P761, DOI 10.1089/aid.2007.0311; Nyombi Balthazar M, 2008, AIDS Res Ther, V5, P13, DOI 10.1186/1742-6405-5-13; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; Palmer S, 1998, AIDS RES HUM RETROV, V14, P157, DOI 10.1089/aid.1998.14.157; Pernas M, 2006, JAIDS-J ACQ IMM DEF, V42, P12, DOI 10.1097/01.qai.0000214810.65292.73; Perno CF, 2001, J INFECT DIS, V184, P983, DOI 10.1086/323604; Piantadosi A, 2008, AIDS RES HUM RETROV, V24, P1221, DOI 10.1089/aid.2008.0100; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; Quesnel-Vallieres M, 2011, EMERG INFECT DIS, V17, P271, DOI 10.3201/eid1702.100629; Rambaut A, 2010, FIGTREE V131; Renjifo B, 1998, AIDS RES HUM RETROV, V14, P635, DOI 10.1089/aid.1998.14.635; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Rusine J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042557; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Sanders-Buell E, 2007, AIDS RES HUM RETROV, V23, P834, DOI 10.1089/aid.2006.0299; Shafer RW, 2008, AIDS REV, V10, P67; Shekelle Paul, 2007, Evid Rep Technol Assess (Full Rep), P1; SIWKA W, 1994, AIDS RES HUM RETROV, V10, P1753, DOI 10.1089/aid.1994.10.1753; Soheilli ZS, 2009, AIDS RES HUM RETROV, V25, P123, DOI 10.1089/aid.2008.0199; Somi GR, 2008, ANTIVIR THER, V13, P77; Ssemwanga D, 2011, VIROLOGY, V411, P113, DOI 10.1016/j.virol.2010.12.025; TACAIDS/Tanzania ZAC/Tanzania NBS/Tanzania OCGS/Tanzania and Macro International, 2008, TANZ HIV AIDS MAL IN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vandamme AM, 2011, AIDS REV, V13, P77; Vergne L, 2000, J CLIN MICROBIOL, V38, P3919, DOI 10.1128/JCM.38.11.3919-3925.2000; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Whitman S, 2000, ARCH INTERN MED, V160, P365, DOI 10.1001/archinte.160.3.365; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9	83	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e102258	10.1371/journal.pone.0102258	http://dx.doi.org/10.1371/journal.pone.0102258			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003939	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000339242700117
J	Lingappan, K; Srinivasan, C; Jiang, WW; Wang, LH; Couroucli, XI; Moorthy, B				Lingappan, Krithika; Srinivasan, Chandra; Jiang, Weiwu; Wang, Lihua; Couroucli, Xanthi I.; Moorthy, Bhagavatula			Analysis of the Transcriptome in Hyperoxic Lung Injury and Sex-Specific Alterations in Gene Expression	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; NF-KAPPA-B; CELL-DEATH; OXYGEN-TOXICITY; MOUSE LUNG; PULMONARY-FIBROSIS; GENDER-DIFFERENCES; OXIDATIVE-STRESS; UNITED-STATES; DISEASE	Exposure to high concentration of oxygen (hyperoxia) leads to lung injury in experimental animal models and plays a role in the pathogenesis of diseases such as Acute Respiratory Distress Syndrome (ARDS) and Bronchopulmonary dysplasia (BPD) in humans. The mechanisms responsible for sex differences in the susceptibility towards hyperoxic lung injury remain largely unknown. The major goal of this study was to characterize the changes in the pulmonary transcriptome following hyperoxia exposure and further elucidate the sex-specific changes. Male and female (8-10 wk) wild type (WT) (C57BL/6J) mice were exposed to hyperoxia (FiO(2)>0.95) and gene expression in lung tissues was studied at 48 h. A combination of fold change >= 1.4 and false discovery rate (FDR) <5% was used to define differentially expressed genes (DEGs). Overrepresentation of gene ontology terms representing biological processes and signaling pathway impact analysis (SPIA) was performed. Comparison of DEG profiles identified 327 genes unique to females, 585 unique to males and 1882 common genes. The major new findings of this study are the identification of new candidate genes of interest and the sex-specific transcriptomic changes in hyperoxic lung injury. We also identified DEGs involved in signaling pathways like MAP kinase and NF-kappa B which may explain the differences in sex-specific susceptibility to hyperoxic lung injury. These findings highlight changes in the pulmonary transcriptome and sex-specific differences in hyperoxic lung injury, and suggest new pathways, whose components could serve as sex-specific biomarkers and possible therapeutic targets for acute lung injury (ALI)/acute respiratory distress (ARDS) in humans.	[Lingappan, Krithika; Jiang, Weiwu; Wang, Lihua; Couroucli, Xanthi I.; Moorthy, Bhagavatula] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Sect Neonatol, Houston, TX 77030 USA; [Srinivasan, Chandra] Univ Texas Med Sch Houston, Dept Pediat, Div Pediat Cardiol, Houston, TX USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Lingappan, K (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Sect Neonatol, Houston, TX 77030 USA.	lingappa@bcm.edu			National Institutes of Health (NIH) [ES-019689, ES-001932, HL-087174, HL-112516, HL-088343]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112516, R01HL087174, R01HL088343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019689, R01ES009132, P30ES023512] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by the National Institutes of Health (NIH) ES-019689, ES-001932, HL-087174, and HL-112516 to B. M. and HL-088343 to X. C. (www.nih.gov).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2006, CHEST, V130, P724, DOI 10.1378/chest.130.3.724; Ambalavanan N, 2011, PEDIATRICS, V128, pE1216, DOI 10.1542/peds.2011-1142; BANNAI S, 1989, J BIOL CHEM, V264, P18480; Barazzone C, 1998, AM J RESP CELL MOL, V19, P573, DOI 10.1165/ajrcmb.19.4.3173; Barazzone C, 1996, J CLIN INVEST, V98, P2666, DOI 10.1172/JCI119089; Barinaga M, 1996, SCIENCE, V274, P724, DOI 10.1126/science.274.5288.724; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bhattacharya S, 2012, AM J RESP CRIT CARE, V186, P349, DOI 10.1164/rccm.201203-0406OC; BRYAN CL, 1988, CLIN CHEST MED, V9, P141; Buczynski BW, 2013, SEMIN PERINATOL, V37, P69, DOI 10.1053/j.semperi.2013.01.002; Budinger GRS, 2011, AM J RESP CRIT CARE, V183, P1043, DOI 10.1164/rccm.201002-0181OC; Card JW, 2006, J IMMUNOL, V177, P621, DOI 10.4049/jimmunol.177.1.621; Carey MA, 2007, TRENDS ENDOCRIN MET, V18, P308, DOI 10.1016/j.tem.2007.08.003; Carey MA, 2007, AM J PHYSIOL-LUNG C, V293, pL272, DOI 10.1152/ajplung.00174.2007; Chevet E, 2013, ONCOGENE, V32, P2499, DOI 10.1038/onc.2012.346; Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501; Cho HY, 2007, FREE RADICAL BIO MED, V42, P433, DOI 10.1016/j.freeradbiomed.2006.11.021; Cho HY, 2012, ANTIOXID REDOX SIGN, V17, P1066, DOI 10.1089/ars.2011.4288; CLARK JM, 1971, PHARMACOL REV, V23, P37; Ding LH, 2009, J CLIN INVEST, V119, P349, DOI 10.1172/JCI35930; FREEMAN BA, 1981, J BIOL CHEM, V256, P986; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GONDER JC, 1985, P NATL ACAD SCI USA, V82, P6315, DOI 10.1073/pnas.82.18.6315; Gribbin J, 2006, THORAX, V61, P980, DOI 10.1136/thx.2006.062836; Hamon I, 2011, ARCH PEDIATRIE, V18, P247, DOI 10.1016/j.arcped.2010.12.004; Han W, 2013, J CLIN INVEST, V123, P2103, DOI 10.1172/JCI61820; Hilgendorff A, 2014, AM J RESP CELL MOL, V50, P233, DOI 10.1165/rcmb.2013-0014TR; Horowitz S, 1999, CHEST, V116, p64S, DOI 10.1378/chest.116.suppl_1.64S; Howden R, 2012, AM J RESP CELL MOL, V46, P470, DOI 10.1165/rcmb.2011-0204OC; Hubbi ME, 2012, J BIOL CHEM, V287, P6139, DOI 10.1074/jbc.M111.278630; HUDAK BB, 1993, PHARMACOGENETICS, V3, P135, DOI 10.1097/00008571-199306000-00003; Jacobson JR, 2009, TRANSL RES, V154, P219, DOI 10.1016/j.trsl.2009.07.012; Johannessen M, 2006, CELL MOL LIFE SCI, V63, P268, DOI 10.1007/s00018-005-5438-z; Kallet RH, 2013, RESP CARE, V58, P123, DOI 10.4187/respcare.01963; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Kobayashi S, 2012, FREE RADICAL BIO MED, V53, P2197, DOI 10.1016/j.freeradbiomed.2012.09.040; KRAYBILL EN, 1989, J PEDIATR-US, V115, P115, DOI 10.1016/S0022-3476(89)80345-2; Li LF, 2007, CRIT CARE, V11, DOI 10.1186/cc5704; Lingappan K, 2013, TOXICOL APPL PHARM, V272, P281, DOI 10.1016/j.taap.2013.06.007; Liu YY, 2009, TRANSL RES, V154, P228, DOI 10.1016/j.trsl.2009.06.006; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Michiels C, 2002, FREE RADICAL BIO MED, V33, P1231, DOI 10.1016/S0891-5849(02)01045-6; Miron M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-333; Moss M, 2002, CRIT CARE MED, V30, P1679, DOI 10.1097/00003246-200208000-00001; Natarajan G, 2012, EARLY HUM DEV, V88, P509, DOI 10.1016/j.earlhumdev.2011.12.013; O'Reilly MA, 1998, AM J RESP CELL MOL, V18, P43, DOI 10.1165/ajrcmb.18.1.2950m; O'Reilly MA, 2001, AM J PHYSIOL-LUNG C, V281, pL291, DOI 10.1152/ajplung.2001.281.2.L291; Olson AL, 2007, AM J RESP CRIT CARE, V176, P277, DOI 10.1164/rccm.200701-044OC; Park HS, 2009, RESPIROLOGY, V14, P27, DOI 10.1111/j.1440-1843.2008.01447.x; Park HS, 2013, AM J RESP CELL MOL, V48, P105, DOI 10.1165/rcmb.2012-0043OC; Penaloza C, 2009, FASEB J, V23, P1869, DOI 10.1096/fj.08-119388; Perkowski S, 2003, AM J RESP CELL MOL, V28, P682, DOI 10.1165/rcmb.4692; Popescu CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082421; Prakash Ys, 2010, Expert Rev Respir Med, V4, P395, DOI 10.1586/ers.10.29; Prows DR, 2007, PHYSIOL GENOMICS, V30, P271, DOI 10.1152/physiolgenomics.00038.2007; R Core Team, 2021, R LANGUAGE ENV STAT; Reddy AJ, 2009, J CELL MOL MED, V13, P1784, DOI 10.1111/j.1582-4934.2008.00581.x; Rhodes L, 2005, J ASTHMA, V42, P777, DOI 10.1080/02770900500308387; Romashko J, 2003, FREE RADICAL BIO MED, V35, P978, DOI 10.1016/S0891-5849(03)00494-5; Shaw GM, 2013, SEMIN PERINATOL, V37, P85, DOI 10.1053/j.semperi.2013.01.004; Slaughter JL, 2011, J PERINATOL, V31, P635, DOI 10.1038/jp.2010.213; Speyer CL, 2005, AM J PHYSIOL-CELL PH, V288, pC881, DOI 10.1152/ajpcell.00467.2004; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Vento M, 2009, ANTIOXID REDOX SIGN, V11, P2945, DOI 10.1089/ars.2009.2671; WARE LB, 2000, NEW ENGL J MED, V342, P1334, DOI [DOI 10.1056/NEJM200005043421806, 10.1056/NEJM200005043421806]; Yao Q, 2005, AM J PHYSIOL-LUNG C, V289, pL307, DOI 10.1152/ajplung.00030.2005	66	18	18	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101581	10.1371/journal.pone.0101581	http://dx.doi.org/10.1371/journal.pone.0101581			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003466	gold, Green Published, Green Submitted			2022-12-27	WOS:000339242700041
J	Ming, Y; Hu, XN; Song, Y; Liu, ZG; Li, JB; Gao, RF; Zhang, YY; Mei, H; Guo, TW; Xiao, L; Wang, BC; Wu, CD; Xiao, XQ				Ming, Yue; Hu, Xiangnan; Song, Ying; Liu, Zhiguo; Li, Jibin; Gao, Rufei; Zhang, Yuyao; Mei, Hu; Guo, Tingwang; Xiao, Ling; Wang, Bochu; Wu, Chaodong; Xiao, Xiaoqiu			CMHX008, a Novel Peroxisome Proliferator-Activated Receptor gamma Partial Agonist, Enhances Insulin Sensitivity In Vitro and In Vivo	PLOS ONE			English	Article							PPAR-GAMMA; ADIPOSE-TISSUE; MYOCARDIAL-INFARCTION; ANTIDIABETIC THIAZOLIDINEDIONE; SELECTIVE MODULATOR; ROSIGLITAZONE; OBESITY; SENSITIZATION; METABOLISM; MECHANISMS	The peroxisome proliferator-activated receptor gamma (PPAR gamma) plays an important role in adipocyte differentiation and insulin sensitivity. Its ligand rosiglitazone has anti-diabetic effect but is frequently accompanied with some severe unwanted effects. The aim of the current study was to compare the anti-diabetic effect of CMHX008, a novel thiazolidinedione-derivative, with rosiglitazone. A luciferase assay was used to evaluate in vitro PPAR gamma activation. 3T3-L1 cells were used to examine adipocyte differentiation. High fat diet (HFD) mice were used to examine in vivo insulin sensitivity. The mRNA levels were evaluated by real-time RT-PCR. Serum biochemical and hormonal variables were assessed using a clinical chemistry analyser. CMHX008 displayed a moderate PPAR gamma agonist activity, and promoted 3T3-L1 preadipocyte differentiation with lower activity than rosiglitazone. CMHX008 regulated the expression of PPAR gamma target genes in a different manner from rosiglitazone. CMHX008 increased the expression and secretion of adiponectin with the similar efficacy as rosiglitazone, but only 25% as potent as rosiglitazone for the induction of adipocyte fatty acid binding protein. Treatment of CMHX008 and rosiglitazone protected mice from high fat diet (HFD)-induced glucose intolerance, hyperinsulinemia and inflammation. CMHX008 reduced the mRNA expression of M1 macrophage markers, and significantly increased the expressions of M2 markers. In conclusion, CMHX008 shared the comparable insulin-sensitizing effects as rosiglitazone with lower adipogenic capacity and might potentially be developed into an effective agent for the treatment of diabetes and metabolic disorders.	[Ming, Yue; Liu, Zhiguo; Gao, Rufei; Zhang, Yuyao; Xiao, Xiaoqiu] Chongqing Med Univ, Affiliated Hosp 1, Lab Lipid & Glucose Metab, Chongqing, Peoples R China; [Hu, Xiangnan] Chongqing Med Univ, Coll Pharm, Chongqing, Peoples R China; [Song, Ying; Gao, Rufei; Xiao, Xiaoqiu] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrine, Chongqing, Peoples R China; [Li, Jibin] Chongqing Med Univ, Sch Publ Hlth & Management, Dept Nutr & Food Hyg, Chongqing, Peoples R China; [Mei, Hu; Guo, Tingwang; Xiao, Ling; Wang, Bochu] Chongqing Univ, Coll Bioengn, Chongqing 630044, Peoples R China; [Wu, Chaodong] Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX USA	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing University; Texas A&M University System; Texas A&M University College Station	Xiao, XQ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Lab Lipid & Glucose Metab, Chongqing, Peoples R China.	xiaoxq@cqmu.edu.cn	Xiao, Xiaoqiu/K-7672-2019; Li, Jibin/ABF-6006-2021; Wang, Bo/AAU-1329-2021	Xiao, Xiaoqiu/0000-0002-4568-8772; Li, Jibin/0000-0001-9160-4093; Wang, Bo/0000-0001-8947-8526	National Program on Key Basic Research Project of China [2012CB517505]; National Natural Science Foundation of China [81270947]; Doctoral Fund of Ministry of Education of China [20115503110008]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095828] Funding Source: NIH RePORTER	National Program on Key Basic Research Project of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Program on Key Basic Research Project of China (http://www.most.gov.cn, 2012CB517505, to Xiaoqiu Xiao), National Natural Science Foundation of China (http://www.nsfc.gov.cn, 81270947, to Xiaoqiu Xiao) and Doctoral Fund of Ministry of Education of China (http://www.moe.edu.cn, 20115503110008, to Xiaoqiu Xiao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 2012, MINI-REV MED CHEM, V12, P87, DOI 10.2174/138955712798995048; Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Amato AA, 2012, J BIOL CHEM, V287, P28169, DOI 10.1074/jbc.M111.332106; Berger JP, 2003, MOL ENDOCRINOL, V17, P662, DOI 10.1210/me.2002-0217; Bhalla K, 2011, J BIOL CHEM, V286, P41626, DOI 10.1074/jbc.M111.257915; Brun RP, 1997, J ENDOCRINOL, V155, P217, DOI 10.1677/joe.0.1550217; Cock TA, 2004, EMBO REP, V5, P142, DOI 10.1038/sj.embor.7400082; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; DeFronzo RA, 2011, NEW ENGL J MED, V364, P1104, DOI 10.1056/NEJMoa1010949; Dunn FL, 2011, J DIABETES COMPLICAT, V25, P151, DOI 10.1016/j.jdiacomp.2010.06.006; Goto T, 2011, BIOCHEM J, V438, P111, DOI 10.1042/BJ20101939; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Grey A, 2007, J CLIN ENDOCR METAB, V92, P1305, DOI 10.1210/jc.2006-2646; Halade GV, 2011, PHARMACOL RES, V63, P300, DOI 10.1016/j.phrs.2010.12.012; Hemmeryckx B, 2013, EUR J PHARMACOL, V700, P23, DOI 10.1016/j.ejphar.2012.11.062; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h; Ji YW, 2012, J BIOL CHEM, V287, P24378, DOI 10.1074/jbc.M112.371807; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kubo M, 2014, J PHARMACOL SCI, V124, P276, DOI 10.1254/jphs.13236FP; Kubo M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00275; Lago RM, 2007, LANCET, V370, P1129, DOI 10.1016/S0140-6736(07)61514-1; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Li PP, 2010, J BIOL CHEM, V285, P15333, DOI 10.1074/jbc.M110.100263; Lu CJ, 2013, CEREBROVASC DIS, V36, P145, DOI 10.1159/000353679; MacDonald MR, 2011, DIABETES CARE, V34, P1394, DOI 10.2337/dc10-2398; Mendez R, 2013, AM J TRANSL RES, V5, P224; Miles PDG, 2000, J CLIN INVEST, V105, P287, DOI 10.1172/JCI8538; Misra P, 2003, J PHARMACOL EXP THER, V306, P763, DOI 10.1124/jpet.103.049791; Mitka M, 2013, JAMA-J AM MED ASSOC, V310, P246, DOI 10.1001/jama.2013.8141; Miyazaki Y, 2004, J CLIN ENDOCR METAB, V89, P4312, DOI 10.1210/jc.2004-0190; Motani A, 2009, J MOL BIOL, V386, P1301, DOI 10.1016/j.jmb.2009.01.025; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Nissen SE, 2010, ARCH INTERN MED, V170, P1191, DOI 10.1001/archinternmed.2010.207; Nugent C, 2001, MOL ENDOCRINOL, V15, P1729, DOI 10.1210/me.15.10.1729; Ohashi K, 2012, BIOCHIMIE, V94, P2137, DOI 10.1016/j.biochi.2012.06.008; Okamoto Y, 2006, CLIN SCI, V110, P267, DOI 10.1042/CS20050182; Olefsky JM, 2000, TRENDS ENDOCRIN MET, V11, P362, DOI 10.1016/S1043-2760(00)00306-4; Prieur X, 2011, DIABETES, V60, P797, DOI 10.2337/db10-0705; Rival Y, 2004, J PHARMACOL EXP THER, V311, P467, DOI 10.1124/jpet.104.068254; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Sharma AM, 2007, J CLIN ENDOCR METAB, V92, P386, DOI 10.1210/jc.2006-1268; Sugii S, 2009, P NATL ACAD SCI USA, V106, P22504, DOI 10.1073/pnas.0912487106; Sun SY, 2012, ANNU REV NUTR, V32, P261, DOI 10.1146/annurev-nutr-071811-150623; Takasawa K, 2008, ENDOCR J, V55, P767, DOI 10.1507/endocrj.K08E-018; Taygerly JP, 2013, BIOORGAN MED CHEM, V21, P979, DOI 10.1016/j.bmc.2012.11.058; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yamauchi T, 2001, J CLIN INVEST, V108, P1001, DOI 10.1172/JCI12864; Yamauchi T, 2001, J BIOL CHEM, V276, P41245, DOI 10.1074/jbc.M103241200	51	10	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e102102	10.1371/journal.pone.0102102	http://dx.doi.org/10.1371/journal.pone.0102102			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004107	Green Submitted, gold, Green Published			2022-12-27	WOS:000339242700109
J	Verma, SK; Alim, A				Verma, Sushant Kumar; Alim, Abdul			Differential Activity of Stanniocalcin in Male and Female Fresh Water Teleost Mastacembelus armatus (Lacepede) during Gonadal Maturation	PLOS ONE			English	Article							HETEROPNEUSTES-FOSSILIS BLOCH; SERUM-CALCIUM LEVEL; BREAM SPARUS-AURATA; SEASONAL-CHANGES; REPRODUCTIVE-CYCLE; INORGANIC-PHOSPHATE; STANNIUS CORPUSCLES; PIMEPHALES-PROMELAS; MOLECULAR-CLONING; PLASMA CALCIUM	The present study was carried out to analyze the differences in the activity of hormone stanniocalcin (STC) between male and female fishes of Mastacembelus armatus during their gonadal cycle. A large variation in nuclear diameter of cells of corpuscles of Stannius (CS) were recorded in relation to testicular cycle as well as ovarian cycle which indicates that the cellular activity varied with different phases of reproductive cycle in both male and female fish. Similar changes in nuclear diameter of CS cells were also observed after 17alpha-methyltestosterone administration in males and 17 beta-estradiol administrations in females. A positive correlation was observed between plasma STC levels, gonadosomatic index (GSI) and the sex steroids in both sexes, suggesting that STC has a role in the processes involved in gonadal development. In addition females showed remarkable changes in plasma calcium level during gonadal cycle while no such change for males were observed. In females the plasma calcium level estimated during different phases of reproductive cycle indicates positive correlation between plasma level of calcium and gonad growth. Thus hyperactivity of CS cells was noted in both male and female fishes during gonadal cycle along with the differences in the activity of STC as well. In female it may act as hypocalcemic factor and bring the level of calcium to normal which increases during preparatory and pre spawning phases to fulfill the increased demand of calcium for vitellogenesis. However data of male fishes indicated that plasma STC concentration varied widely during gonadal cycle but showed no consistent relationship to plasma calcium level.	[Verma, Sushant Kumar; Alim, Abdul] Ranchi Univ, Cooperat Coll, Ranchi, Jharkhand, India	Ranchi University	Verma, SK (corresponding author), Ranchi Univ, Cooperat Coll, Ranchi, Jharkhand, India.	vermasushant2008@gmail.com	Verma, Sushant/AAU-1890-2020					Adebiyi FA, 2013, FISH PHYSIOL BIOCHEM, V39, P547, DOI 10.1007/s10695-012-9718-x; AHMAD N, 1990, ARCH BIOL, V101, P285; BALBONTIN F, 1978, COMP BIOCHEM PHYS A, V61, P617, DOI 10.1016/0300-9629(78)90138-X; Bedjargi PRC, 2014, INT J RES FISH AQUA, V4, P63; BJORNSSON BT, 1985, J COMP PHYSIOL B, V155, P347, DOI 10.1007/BF00687477; Clark MS, 2002, J MOL ENDOCRINOL, V28, P111, DOI 10.1677/jme.0.0280111; Filby AL, 2005, BIOL REPROD, V73, P648, DOI 10.1095/biolreprod.105.039701; FONTAINE M, 1964, CR HEBD ACAD SCI, V259, P875; Fuentes J, 2007, AM J PHYSIOL-REG I, V293, pR956, DOI 10.1152/ajpregu.00111.2007; Gillespie DK, 2004, ECOTOX ENVIRON SAFE, V58, P90, DOI 10.1016/j.ecoenv.2003.09.005; Guerreiro PM, 2002, J ENDOCRINOL, V173, P377, DOI 10.1677/joe.0.1730377; Guerreiro PM, 2001, AM J PHYSIOL-REG I, V281, pR855, DOI 10.1152/ajpregu.2001.281.3.R855; Guerriero G, 2005, ZOOL STUD, V44, P228; Guerriero G, 1998, ITAL J ZOOL, V65, P223, DOI 10.1080/11250009809386818; Hang XM, 2005, GEN COMP ENDOCR, V144, P188, DOI 10.1016/j.ygcen.2005.05.008; Hiroi O, 1970, B FAC FISH HOKKAIDO, V2, P179; Istria M, 1974, STEROIDS LIPID RES, V5, P42; JOHNSON DW, 1972, GEN COMP ENDOCR, V19, P7, DOI 10.1016/0016-6480(72)90002-0; Jones C, 1996, J ENDOCRINOL, V34, P393; LAFEBER FPJG, 1988, GEN COMP ENDOCR, V69, P19, DOI 10.1016/0016-6480(88)90048-2; Lee WK, 2002, AQUACULTURE, V207, P169, DOI 10.1016/S0044-8486(01)00728-1; Li Wei-guo, 1999, Zoological Research, V20, P147; LU MQ, 1994, AM J PHYSIOL-REG I, V267, pR1356, DOI 10.1152/ajpregu.1994.267.5.R1356; Luo CW, 2005, ENDOCRINOLOGY, V146, P469, DOI 10.1210/en.2004-1197; MAYERGOSTAN N, 1992, GEN COMP ENDOCR, V86, P10, DOI 10.1016/0016-6480(92)90120-9; NATH P, 1992, Indian Journal of Experimental Biology, V30, P464; Oguri M, 1967, B JAPAN SOC SCI FISH, V33, P161; PANDEY AC, 1988, GEN COMP ENDOCR, V69, P467, DOI 10.1016/0016-6480(88)90039-1; POLZONETTI A, 1983, GEN COMP ENDOCR, V54, P372; Shin J, 2008, ZOOL SCI, V25, P728, DOI 10.2108/zsj.25.728; Singh S., 1990, Boletim de Fisiologia Animal (Sao Paulo), V14, P81; SO YP, 1979, GEN COMP ENDOCR, V37, P143, DOI 10.1016/0016-6480(79)90101-1; Srivastav AK, 1996, GEN COMP ENDOCR, V104, P37, DOI 10.1006/gcen.1996.0138; Srivastav SK, 1998, BRAZ J MED BIOL RES, V31, P1069, DOI 10.1590/S0100-879X1998000800006; SRIVASTAVA SJ, 1994, ANN ENDOCRINOL-PARIS, V55, P197; SUBHEDAR N, 1979, Z MIKROSK ANAT FORSC, V93, P74; SUNDELL K, 1992, J COMP PHYSIOL B, V162, P489; SWARUP K, 1986, ZOOL ANZ, V217, P402; Swarup K, 1985, RECENT ADV ZOOLOGY, P89; URASA FM, 1985, CELL TISSUE RES, V241, P219, DOI 10.1007/BF00214644; Verma SK, 2010, J THREAT TAXA, V2, P992, DOI DOI 10.11609/JOTT.O2223.992-3; Verma SK, 2013, IND STR RES J, DOI [10.9780/22307850, DOI 10.9780/22307850]; Wagner GF, 1998, AM J PHYSIOL-REG I, V274, pR1177, DOI 10.1152/ajpregu.1998.274.4.R1177; Wagner GF, 2006, J EXP ZOOL PART A, V305A, P769, DOI 10.1002/jez.a.313; Wang DS, 2005, FISH PHYSIOL BIOCHEM, V31, P255, DOI 10.1007/s10695-006-0033-2; WOODHEAD PM, 1968, J MAR BIOL ASSOC UK, V48, P81, DOI 10.1017/S0025315400032434; Woodhead PMJ, 1964, IONAF ENV S SER, V117-175	47	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101439	10.1371/journal.pone.0101439	http://dx.doi.org/10.1371/journal.pone.0101439			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003342	Green Submitted, gold, Green Published			2022-12-27	WOS:000339242700031
J	Ahmed, S; Salim, M; Chauhan, BS				Ahmed, Sharif; Salim, Muhammad; Chauhan, Bhagirath S.			Effect of Weed Management and Seed Rate on Crop Growth under Direct Dry Seeded Rice Systems in Bangladesh	PLOS ONE			English	Article							SUPPRESSION; DENSITY; COMPETITION; WHEAT	Weeds are a major constraint to the success of dry-seeded rice (DSR). The main means of managing these in a DSR system is through chemical weed control using herbicides. However, the use of herbicides alone may not be sustainable in the long term. Approaches that aim for high crop competitiveness therefore need to be exploited. One such approach is the use of high rice seeding rates. Experiments were conducted in the aman (wet) seasons of 2012 and 2013 in Bangladesh to evaluate the effect of weed infestation level (partially-weedy and weed-free) and rice seeding rate (20, 40, 60, 80, and 100 kg ha(-1)) on weed and crop growth in DSR. Under weed-free conditions, higher crop yields (5.1 and 5.2 t ha(-1) in the 2012 and 2013 seasons, respectively) were obtained at the seeding rate of 40 kg ha(-1) and thereafter, yield decreased slightly beyond 40 kg seed ha(-1). Under partially-weedy conditions, yield increased by 30 to 33% (2.0-2.2 and 2.9-3.2 t ha(-1) in the 2012 and 2013 seasons, respectively) with increase in seeding rate from 20 to 100 kg ha(-1). In the partially-weedy plots, weed biomass decreased by 41-60% and 54-56% at 35 days after sowing and at crop anthesis, respectively, when seeding rate increased from 20 to 100 kg ha(-1). Results from our study suggest that increasing seeding rates in DSR can suppress weed growth and reduce grain yield losses from weed competition.	[Ahmed, Sharif] Int Rice Res Inst, Crop & Environm Sci Div, Los Banos, Philippines; [Ahmed, Sharif; Salim, Muhammad] Bangladesh Agr Univ, Div Agron, Mymensingh, Bangladesh; [Chauhan, Bhagirath S.] Univ Queensland, Queensland Alliance Agr & Food Innovat, Toowoomba, Qld, Australia	CGIAR; International Rice Research Institute (IRRI); Bangladesh Agricultural University (BAU); University of Queensland	Ahmed, S (corresponding author), Int Rice Res Inst, Crop & Environm Sci Div, Los Banos, Philippines.	s.ahmed@irri.org	Ahmed, Sharif/L-8113-2017; Chauhan, Bhagirath/G-8892-2014	Ahmed, Sharif/0000-0003-3678-3345; Chauhan, Bhagirath/0000-0003-1540-4668	International Fund for Agricultural Development (IFAD); Cereal Systems Initiative for South Asia (CSISA, Bangladesh)	International Fund for Agricultural Development (IFAD); Cereal Systems Initiative for South Asia (CSISA, Bangladesh)	International Fund for Agricultural Development (IFAD) and Cereal Systems Initiative for South Asia (CSISA, Bangladesh). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul Khaliq, 2012, Pakistan Journal of Weed Science Research, V18, P167; Anwar P, 2011, AFR J BIOTECHNOL, V10, P15259, DOI 10.5897/AJB11.060; Arce GD, 2009, WEED TECHNOL, V23, P17, DOI 10.1614/WT-08-060.1; Azmi M., 2005, Rice is life: scientific perspectives for the 21st century. Proceedings of the World Rice Research Conference held in Tsukuba, Japan, 4-7 November 2004, P196; Buhler DD, 2000, WEED SCI, V48, P274, DOI 10.1614/0043-1745(2000)048[0274:TAPCTA]2.0.CO;2; Chauhan BS, 2012, WEED TECHNOL, V26, P1, DOI 10.1614/WT-D-11-00105.1; Chauhan BS, 2011, FIELD CROP RES, V121, P226, DOI 10.1016/j.fcr.2010.12.008; Chauhan BS, 2011, FIELD CROP RES, V121, P105, DOI 10.1016/j.fcr.2010.11.019; Chauhan BS, 2010, FIELD CROP RES, V117, P177, DOI 10.1016/j.fcr.2010.02.014; Chauhan BS, 2012, CROP PROT, V38, P57, DOI 10.1016/j.cropro.2012.03.010; Choudhury BU, 2009, FIELD CROPS RES, V100, P229; Fischer AJ, 2000, WEED SCI, V48, P225, DOI 10.1614/0043-1745(2000)048[0225:HREOAE]2.0.CO;2; Gibson KD, 2002, WEED RES, V42, P351, DOI 10.1046/j.1365-3180.2002.00295.x; Kirkland KJ, 2000, WEED TECHNOL, V14, P692, DOI 10.1614/0890-037X(2000)014[0692:ACSRWH]2.0.CO;2; Kristensen L, 2008, WEED SCI, V56, P97, DOI 10.1614/WS-07-065.1; Lemerle D, 2004, J AGR SCI-CAMBRIDGE, V142, P395, DOI 10.1017/S002185960400454X; Mortensen D.A., 1998, INTEGRATED WEED SOIL, P293; Ni HW, 2004, WEED SCI, V52, P142, DOI 10.1614/P2002-148; O'Donovan JT, 2001, WEED SCI, V49, P746, DOI 10.1614/0043-1745(2001)049[0746:BSRITE]2.0.CO;2; Olsen J, 2005, WEED RES, V45, P316, DOI 10.1111/j.1365-3180.2005.00456.x; Phuong LT, 2005, J AGRON CROP SCI, V191, P185, DOI 10.1111/j.1439-037X.2005.00151.x; Place GT, 2009, WEED TECHNOL, V23, P497, DOI 10.1614/WT-08-134.1; Rao AN, 2007, ADV AGRON, V93, P153, DOI 10.1016/S0065-2113(06)93004-1; Shamsudduha M, 2009, HYDROL EARTH SYST SC, V13, P2373, DOI 10.5194/hess-13-2373-2009; Singh S, 2008, CROP PROT, V27, P660, DOI 10.1016/j.cropro.2007.09.012; Singh Y, 2008, DIRECT SEEDING RICE; Tuong TP, 2003, COMP ASSESS WAT MAN, V1, P53, DOI 10.1079/9780851996691.0053; Weiner J, 2001, J APPL ECOL, V38, P784, DOI 10.1046/j.1365-2664.2001.00634.x; Zhao DL, 2007, FIELD CROP RES, V100, P327, DOI 10.1016/j.fcr.2006.08.007	29	28	28	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101919	10.1371/journal.pone.0101919	http://dx.doi.org/10.1371/journal.pone.0101919			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000520	Green Submitted, gold, Green Published			2022-12-27	WOS:000338637300102
J	Chen, Y; Yang, LL; Liu, Y; Yang, HS; Wang, XW; Chen, DY				Chen, Yu; Yang, Lili; Liu, Yang; Yang, Haisong; Wang, Xinwei; Chen, Deyu			Surgical Results and Prognostic Factors of Anterior Cervical Corpectomy and Fusion for Ossification of the Posterior Longitudinal Ligament	PLOS ONE			English	Article							OPEN-DOOR LAMINOPLASTY; FLOATING METHOD; FOLLOW-UP; SPINE; MYELOPATHY; DECOMPRESSION; COMPLICATIONS; SURGERY	Background: Mechanism of ossification of the posterior longitudinal ligament (OPLL) has not been elucidated clearly. Surgical decompression is usually necessary for the patients with neurological symptoms. Anterior decompression and resection of OPLL seems to be a radical surgical option, because the spinal cord is compressed from the anterior direction. Methods: Among 229 patients who underwent ACF for OPLL between January 2001 and December 2007 in our hospital, a total of 133 patients responded to the invitation and made return visits, with a follow-up rate of 58.1%. For these patients, clinical data were collected from medical and operative records. Neurological status were evaluated by using the Japanese Orthopedic Association (JOA) scoring system. Radiological evaluations including C2-7 lordotic angle, sagittal vertical axis (SVA), occupying rate of OPLL, double-layer sign and high-intensity zone were obtained from all the patients. Complications and causes of revision surgery were also investigated. Correlations between the long-term surgical outcome and various prognostic factors were statistically analyzed. Findings: Eighty-four males and forty-nine females completed the follow-up, with a mean age at operation of 56.8 years. The overall average JOA score significantly increased, with a mean recovery rate of 64.1% 614.2%. The mean C2-7 lordotic angle and SVA were also significantly improved, and fusion rate was satisfactory. The incidence of complications was consistent to the previous reports and most of them were controllable by suitable treatments. Multiple regression analysis showed that number of corpectmies and preoperative JOA score were important predictors of surgical outcome. Conclusions: ACF is a reliable and effective method for treating OPLL patients in terms of neurological recovery, maintenance of radiological parameters, fusion rate and complications. Number of corpectomies and preoperative JOA score are important predictors for the clinical outcome when this procedure is used.	[Chen, Yu; Yang, Lili; Liu, Yang; Yang, Haisong; Wang, Xinwei; Chen, Deyu] Second Mil Med Univ, Changzheng Hosp, Dept Spine Surg, Shanghai, Peoples R China	Naval Medical University	Wang, XW (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Spine Surg, Shanghai, Peoples R China.	wxwspine@126.com; surgchenyu@163.com						Cardoso MJ, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.1.FOCUS10278; Chen Y. J., 2013, 2013 IEEE 15th International Symposium and Exhibition on Advanced Packaging Materials (APM 2013), P102, DOI 10.1109/ISAPM.2013.6510393; Chen Y, 2009, EUR SPINE J, V18, P1541, DOI 10.1007/s00586-009-1029-2; Chen Y, 2009, INT ORTHOP, V33, P477, DOI 10.1007/s00264-008-0542-y; Choi S, 2005, J SPINAL DISORD TECH, V18, P309, DOI 10.1097/01.bsd.0000161236.94894.fc; Fujimura Y, 1998, ARCH ORTHOP TRAUM SU, V117, P471, DOI 10.1007/s004020050296; Harker RJ, 2000, SPINE, V25, P2646; Hida Kazutoshi, 1997, Neurologia Medico-Chirurgica, V37, P173, DOI 10.2176/nmc.37.173; HIRABAYASHI K, 1981, SPINE, V6, P354, DOI 10.1097/00007632-198107000-00005; Inamasu J, 2006, NEUROSURGERY, V58, P1027, DOI 10.1227/01.NEU.0000215867.87770.73; Iwasaki M, 2002, J NEUROSURG, V96, P180, DOI 10.3171/spi.2002.96.2.0180; Iwasaki M, 2007, SPINE, V32, P654, DOI 10.1097/01.brs.0000257566.91177.cb; IZAWA K, 1980, Journal of the Japanese Orthopaedic Association, V54, P461; Jain SK, 2005, NEUROL INDIA, V53, P283; Li H, 2008, EUR SPINE J, V17, P1277, DOI 10.1007/s00586-008-0740-8; Li H, 2011, SPINE J, V11, P1049, DOI 10.1016/j.spinee.2011.09.008; LIU K-C, 1990, Journal of the Japanese Orthopaedic Association, V64, P401; Masaki Y, 2007, J SPINAL DISORD TECH, V20, P7, DOI 10.1097/01.bsd.0000211260.28497.35; Matsunaga S, 1999, SPINE, V24, P937, DOI 10.1097/00007632-199905150-00002; Matsuoka T, 2001, SPINE, V26, P241, DOI 10.1097/00007632-200102010-00008; Mizuno J, 2001, Neurosurg Focus, V10, pE6; Nakamura M, 1998, SPINE, V23, P38, DOI 10.1097/00007632-199801010-00008; Odate S, 2012, J SPINAL DISORD TECH, V25, P133, DOI 10.1097/BSD.0b013e318211fc35; Ogawa Y, 2004, J NEUROSURG-SPINE, V1, P168, DOI 10.3171/spi.2004.1.2.0168; Okamoto K, 2004, J BONE MINER METAB, V22, P612, DOI 10.1007/s00774-004-0531-1; Sakai K, 2012, SPINE, V37, P367, DOI 10.1097/BRS.0b013e31821f4a51; Sakou T, 2000, J Orthop Sci, V5, P310, DOI 10.1007/s007760050169; Shin JH, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2010.12.FOCUS10270; TAKETOMI E, 1992, SPINE, V17, pS55; Tani T, 2002, SPINE, V27, P2491, DOI 10.1097/00007632-200211150-00013; Terayama K, 1984, EPIDEMIOLOGICAL STUD, P55; Tomita T, 1994, EPIDEMIOLOGICAL STUD, P101; Tsukimoto H., 1960, ARCH JPN CHIR, V29, P1003; Yamaura I, 1999, CLIN ORTHOP RELAT R, P27, DOI 10.1097/00003086-199902000-00004	34	22	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e102008	10.1371/journal.pone.0102008	http://dx.doi.org/10.1371/journal.pone.0102008			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000183	gold, Green Submitted, Green Published			2022-12-27	WOS:000338637300115
J	Chiu, CH; Chao, A				Chiu, Chun-Huo; Chao, Anne			Distance-Based Functional Diversity Measures and Their Decomposition: A Framework Based on Hill Numbers	PLOS ONE			English	Article							RAOS QUADRATIC ENTROPY; PHYLOGENETIC DIVERSITY; PARTITIONING DIVERSITY; ECOSYSTEM-FUNCTION; BIODIVERSITY; COMMUNITIES; PATTERNS; EVENNESS; INDEXES; DISSIMILARITIES	Hill numbers (or the "effective number of species'') are increasingly used to characterize species diversity of an assemblage. This work extends Hill numbers to incorporate species pairwise functional distances calculated from species traits. We derive a parametric class of functional Hill numbers, which quantify "the effective number of equally abundant and (functionally) equally distinct species'' in an assemblage. We also propose a class of mean functional diversity (per species), which quantifies the effective sum of functional distances between a fixed species to all other species. The product of the functional Hill number and the mean functional diversity thus quantifies the (total) functional diversity, i.e., the effective total distance between species of the assemblage. The three measures (functional Hill numbers, mean functional diversity and total functional diversity) quantify different aspects of species trait space, and all are based on species abundance and species pairwise functional distances. When all species are equally distinct, our functional Hill numbers reduce to ordinary Hill numbers. When species abundances are not considered or species are equally abundant, our total functional diversity reduces to the sum of all pairwise distances between species of an assemblage. The functional Hill numbers and the mean functional diversity both satisfy a replication principle, implying the total functional diversity satisfies a quadratic replication principle. When there are multiple assemblages defined by the investigator, each of the three measures of the pooled assemblage (gamma) can be multiplicatively decomposed into alpha and beta components, and the two components are independent. The resulting beta component measures pure functional differentiation among assemblages and can be further transformed to obtain several classes of normalized functional similarity (or differentiation) measures, including N-assemblage functional generalizations of the classic Jaccard, Sorensen, Horn and Morisita-Horn similarity indices. The proposed measures are applied to artificial and real data for illustration.	[Chiu, Chun-Huo; Chao, Anne] Natl Tsing Hua Univ, Inst Stat, Hsinchu, Taiwan	National Tsing Hua University	Chao, A (corresponding author), Natl Tsing Hua Univ, Inst Stat, Hsinchu, Taiwan.	chao@stat.nthu.edu.tw		CHIU, CHUN-HUO/0000-0002-7096-2278	National Tsing Hua University, Taiwan; National Science Council, Taiwan [100-2118-M007-006-MY3]	National Tsing Hua University, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	National Science Council, Taiwan. Contract number: 100-2118-M007-006-MY3 (http://web1.nsc.gov.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, INT J ECOL, DOI DOI 10.1155/2012/478728; Bernard-Verdier M, 2013, J VEG SCI, V24, P877, DOI 10.1111/jvs.12048; Botta-Dukat Z, 2005, J VEG SCI, V16, P533, DOI 10.1111/j.1654-1103.2005.tb02393.x; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Carboni M, 2010, J PLANT ECOL, V3, P139, DOI 10.1093/jpe/rtp037; Carboni M, 2013, J VEG SCI, V24, P932, DOI 10.1111/jvs.12095; Carboni M, 2011, J VEG SCI, V22, P751, DOI 10.1111/j.1654-1103.2011.01303.x; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Champely S, 2002, ENVIRON ECOL STAT, V9, P167, DOI 10.1023/A:1015170104476; Chao A, 2014, ANN REV ECO IN PRESS; Chao A, 2008, BIOMETRICS, V64, P1178, DOI 10.1111/j.1541-0420.2008.01010.x; Chao A, 2014, ECOL MONOGR, V84, P45, DOI 10.1890/13-0133.1; Chao A, 2012, ECOLOGY, V93, P2037, DOI 10.1890/11-1817.1; Chao A, 2010, PHILOS T R SOC B, V365, P3599, DOI 10.1098/rstb.2010.0272; Chiu CH, 2014, ECOL MONOGR, V84, P21, DOI 10.1890/12-0960.1; de Bello F, 2011, METHODS ECOL EVOL, V2, P163, DOI 10.1111/j.2041-210X.2010.00071.x; de Bello F, 2010, J VEG SCI, V21, P992, DOI 10.1111/j.1654-1103.2010.01195.x; Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Dukes JS, 2001, OIKOS, V94, P468, DOI 10.1034/j.1600-0706.2001.940309.x; Ellison AM, 2010, ECOLOGY, V91, P1962, DOI 10.1890/09-1692.1; Escalas A, 2013, ENVIRON MICROBIOL, V15, P2642, DOI 10.1111/1462-2920.12156; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Guiasu RC, 2011, NAT SCI, V3, P795, DOI DOI 10.4236/NS.2011.39104; Hardy OJ, 2008, J ECOL, V96, P849, DOI 10.1111/j.1365-2745.2008.01423.x; Hardy OJ, 2007, J ECOL, V95, P493, DOI 10.1111/j.1365-2745.2007.01222.x; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; HORN HS, 1966, AM NAT, V100, P419, DOI 10.1086/282436; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; JOST L, 2010, DIVERSITY-BASEL, V2, P207, DOI [DOI 10.3390/d2020207, 10.3390/d2020207]; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Jost L, 2010, DIVERS DISTRIB, V16, P65, DOI 10.1111/j.1472-4642.2009.00626.x; Kosman E, 1996, PHYTOPATHOLOGY, V86, P1152; Kosman E, 2014, EUR J PLANT PATHOL, V138, P467, DOI 10.1007/s10658-013-0323-3; Kosman E, 2007, NEW PHYTOL, V174, P683, DOI 10.1111/j.1469-8137.2007.02031.x; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Leinster T, 2012, ECOLOGY, V93, P477, DOI 10.1890/10-2402.1; MacArthur R.H., 1972, pvii; MACARTHUR RH, 1965, BIOL REV, V40, P510, DOI 10.1111/j.1469-185X.1965.tb00815.x; Marshall A.M., 1979, INEQUALITIES THEORY; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; Mason NWH, 2003, J VEG SCI, V14, P571, DOI 10.1111/j.1654-1103.2003.tb02184.x; Morisita M., 1959, MEM FS KYUSHU U    E, V3, P65, DOI DOI 10.18960/SEITAI.11.6_252_4; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Mouillot D, 2013, TRENDS ECOL EVOL, V28, P167, DOI 10.1016/j.tree.2012.10.004; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Norberg J, 2001, P NATL ACAD SCI USA, V98, P11376, DOI 10.1073/pnas.171315998; Pavoine S, 2005, THEOR POPUL BIOL, V67, P231, DOI 10.1016/j.tpb.2005.01.004; Pavoine S, 2004, J THEOR BIOL, V228, P523, DOI 10.1016/j.jtbi.2004.02.014; Pavoine S, 2009, OIKOS, V118, P391, DOI 10.1111/j.1600-0706.2008.16668.x; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petchey OL, 2007, OIKOS, V116, P1422, DOI 10.1111/j.2007.0030-1299.15894.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Petchey OL, 2009, OIKOS, V118, P1118, DOI 10.1111/j.1600-0706.2009.17403.x; Pla L., 2012, FUNCTIONAL DIVERSITY, P27, DOI 10.1007/978-94-007-2648-2_3; Podani J, 2007, OIKOS, V116, P1427, DOI 10.1111/j.2007.0030-1299.16160.x; Podani J, 2006, OIKOS, V115, P179, DOI 10.1111/j.2006.0030-1299.15048.x; Poos MS, 2009, ECOLOGY, V90, P341, DOI 10.1890/08-1638.1; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Reeve R, 2014, ARXIV14046520 CORN U; Ricotta C, 2005, BASIC APPL ECOL, V6, P479, DOI 10.1016/j.baae.2005.02.008; Ricotta C, 2006, THEOR POPUL BIOL, V70, P237, DOI 10.1016/j.tpb.2006.06.003; Ricotta C, 2012, METHODS ECOL EVOL, V3, P519, DOI 10.1111/j.2041-210X.2011.00178.x; Ricotta C, 2009, THEOR POPUL BIOL, V76, P299, DOI 10.1016/j.tpb.2009.10.001; ROUTLEDGE RD, 1979, J THEOR BIOL, V76, P503, DOI 10.1016/0022-5193(79)90015-8; Scheiner SM, 2012, OIKOS, V121, P1191, DOI 10.1111/j.1600-0706.2012.20607.x; Schmera D, 2009, AQUAT ECOL, V43, P157, DOI 10.1007/s10452-007-9152-9; Stegen JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020906; Stuart-Smith RD, 2013, NATURE, V501, P539, DOI 10.1038/nature12529; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Swenson NG, 2012, ECOLOGY, V93, pS112, DOI 10.1890/11-0402.1; Swenson NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021264; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 2001, ENCY BIODIVERSITY, V3, P109, DOI [DOI 10.1016/B0-12-226865-2/00132-2, 10.1006/rwbd.1999.0154]; TOTHMERESZ B, 1995, J VEG SCI, V6, P283, DOI 10.2307/3236223; Vile D, 2006, ECOL LETT, V9, P1061, DOI 10.1111/j.1461-0248.2006.00958.x; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Villeger S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040679; Walker B, 1999, ECOSYSTEMS, V2, P95, DOI 10.1007/s100219900062; Weiher Evan, 2011, P175; Weikard HP, 2006, DIVERS DISTRIB, V12, P215, DOI 10.1111/j.1366-9516.2006.00234.x; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190	87	92	93	5	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e100014	10.1371/journal.pone.0100014	http://dx.doi.org/10.1371/journal.pone.0100014			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000299	Green Submitted, Green Published, gold			2022-12-27	WOS:000338637300006
J	Krellman, JW; Ruiz, HH; Marciano, VA; Mondrow, B; Croll, SD				Krellman, Jason W.; Ruiz, Henry H.; Marciano, Veronica A.; Mondrow, Bracha; Croll, Susan D.			Behavioral and Neuroanatomical Abnormalities in Pleiotrophin Knockout Mice	PLOS ONE			English	Article							GROWTH-ASSOCIATED MOLECULE; LONG-TERM POTENTIATION; HB-GAM; ENTORHINAL CORTEX; SYNAPTIC-TRANSMISSION; BINDING PROTEIN; HIPPOCAMPAL LTP; TEST BATTERIES; EXPRESSION; MOUSE	Pleiotrophin (PTN) is an extracellular matrix-associated protein with neurotrophic and neuroprotective effects that is involved in a variety of neurodevelopmental processes. Data regarding the cognitive-behavioral and neuroanatomical phenotype of pleiotrophin knockout (KO) mice is limited. The purpose of this study was to more fully characterize this phenotype, with emphasis on the domains of learning and memory, cognitive-behavioral flexibility, exploratory behavior and anxiety, social behavior, and the neuronal and vascular microstructure of the lateral entorhinal cortex (EC). PTN KOs exhibited cognitive rigidity, heightened anxiety, behavioral reticence in novel contexts and novel social interactions suggestive of neophobia, and lamina-specific decreases in neuronal area and increases in neuronal density in the lateral EC. Initial learning of spatial and other associative tasks, as well as vascular density in the lateral EC, was normal in the KOs. These data suggest that the absence of PTN in vivo is associated with disruption of specific cognitive and affective processes, raising the possibility that further study of PTN KOs might have implications for the study of human disorders with similar features.	[Krellman, Jason W.] CUNY, Grad Ctr, Neuropsychol Doctoral Subprogram, New York, NY USA; [Croll, Susan D.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Ruiz, Henry H.; Marciano, Veronica A.; Mondrow, Bracha; Croll, Susan D.] CUNY Queens Coll, Dept Psychol, Flushing, NY 11367 USA; [Croll, Susan D.] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Queens College NY (CUNY); Regeneron	Krellman, JW (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.	jason.krellman@mountsinai.org	Ruiz, Henry H./AAA-1872-2020	Ruiz, Henry H./0000-0002-0213-6759; Croll, Susan/0000-0002-3949-1877	CUNY	CUNY	This work was funded in part by a CUNY doctoral student research grant paid directly to the applicant (JWK). Remaining funding came from faculty start-up funds provided by CUNY and paid to the doctoral faculty member (SDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Amet LEA, 2001, MOL CELL NEUROSCI, V17, P1014, DOI 10.1006/mcne.2001.0998; Birrell JM, 2000, J NEUROSCI, V20, P4320; Christman KL, 2005, BIOCHEM BIOPH RES CO, V332, P1146, DOI 10.1016/j.bbrc.2005.04.174; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; Crawley JN, 2008, NEURON, V57, P809, DOI 10.1016/j.neuron.2008.03.001; Crawley JN, 2004, MENT RETARD DEV D R, V10, P248, DOI 10.1002/mrdd.20039; Crawley JN, 2007, BEHAV PHENOTYPING TR, DOI [10.1002/0470119055, DOI 10.1002/0470119055]; Croll SD, 2004, EXP NEUROL, V187, P388, DOI 10.1016/j.expneurol.2004.02.010; Dai ZS, 1996, SEMIN NEUROSCI, V8, P97, DOI 10.1006/smns.1996.0013; de Curtis M, 2004, PROG NEUROBIOL, V74, P101, DOI 10.1016/j.pneurobio.2004.08.005; del Olmo N, 2009, GROWTH FACTORS, V27, P189, DOI 10.1080/08977190902906859; DiCicco-Bloom E, 2006, J NEUROSCI, V26, P6897, DOI 10.1523/JNEUROSCI.1712-06.2006; Gombash SE, 2012, MOL THER, V20, P544, DOI 10.1038/mt.2011.216; Gramage E, 2013, ADDICT BIOL, V18, P19, DOI 10.1111/j.1369-1600.2011.00362.x; Gramage E, 2010, ADDICT BIOL, V15, P403, DOI 10.1111/j.1369-1600.2009.00202.x; HAMPTON BS, 1992, MOL BIOL CELL, V3, P85, DOI 10.1091/mbc.3.1.85; Hardman R, 1997, BRAIN RES, V758, P187, DOI 10.1016/S0006-8993(97)00223-0; Hienola A, 2004, MOL CELL NEUROSCI, V26, P75, DOI 10.1016/j.mcn.2004.01.018; Hoistad M, 2008, NEUROIMAGE, V40, P1016, DOI 10.1016/j.neuroimage.2007.12.043; Huang CC, 2001, REV NEUROSCIENCE, V12, P51; Kalueff AV, 2005, BEHAV BRAIN RES, V160, P1, DOI 10.1016/j.bbr.2004.11.010; Kana RK, 2007, BIOL PSYCHIAT, V62, P198, DOI 10.1016/j.biopsych.2006.08.004; KOCH M, 1991, BEHAV BRAIN RES, V42, P99, DOI 10.1016/S0166-4328(05)80044-0; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Lauri SE, 1998, EUR J NEUROSCI, V10, P188; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; Marchionini DM, 2007, BRAIN RES, V1147, P77, DOI 10.1016/j.brainres.2007.02.028; McIlwain KL, 2001, PHYSIOL BEHAV, V73, P705, DOI 10.1016/S0031-9384(01)00528-5; Meunier M, 2006, J NEUROSCI, V26, P7718, DOI 10.1523/JNEUROSCI.1949-06.2006; Mi RF, 2007, P NATL ACAD SCI USA, V104, P4664, DOI 10.1073/pnas.0603243104; Miao JY, 2012, NEUROSCI RES, V74, P269, DOI 10.1016/j.neures.2012.09.001; MILNER PG, 1989, BIOCHEM BIOPH RES CO, V165, P1096, DOI 10.1016/0006-291X(89)92715-0; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; MULLER D, 1995, NEURON, V14, P599, DOI 10.1016/0896-6273(95)90316-X; Nakamura E, 1998, GENES CELLS, V3, P811, DOI 10.1046/j.1365-2443.1998.00231.x; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Pavlov I, 2006, NEUROSCIENCE, V139, P505, DOI 10.1016/j.neuroscience.2005.11.070; Pavlov I, 2002, MOL CELL NEUROSCI, V20, P330, DOI 10.1006/mcne.2002.1104; Paylor R, 2006, PHYSIOL BEHAV, V87, P95, DOI 10.1016/j.physbeh.2005.09.002; PENG HB, 1995, J NEUROSCI, V15, P3027; Ploghaus A, 2001, J NEUROSCI, V21, P9896, DOI 10.1523/JNEUROSCI.21-24-09896.2001; RAULO E, 1992, J BIOL CHEM, V267, P11408; Rauvala H, 2000, MATRIX BIOL, V19, P377, DOI 10.1016/S0945-053X(00)00084-6; RAUVALA H, 1989, EMBO J, V8, P2933, DOI 10.1002/j.1460-2075.1989.tb08443.x; Rauvala H, 1997, PROG NEUROBIOL, V52, P127, DOI 10.1016/S0301-0082(97)00007-5; Sadamatsu Miyuki, 2006, Congenital Anomalies, V46, P1, DOI 10.1111/j.1741-4520.2006.00094.x; Stork O, 1999, J NEUROBIOL, V40, P343, DOI 10.1002/(SICI)1097-4695(19990905)40:3<343::AID-NEU6>3.0.CO;2-S; Szabat E, 1996, DEV BIOL, V178, P77, DOI 10.1006/dbio.1996.0199; TAKEDA A, 1995, NEUROSCIENCE, V68, P57, DOI 10.1016/0306-4522(95)00110-5; Taravini IRE, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-40; Teng H, 2008, J CEREBR BLOOD F MET, V28, P764, DOI 10.1038/sj.jcbfm.9600573; van Groen T, 2003, HIPPOCAMPUS, V13, P133, DOI 10.1002/hipo.10037; WANAKA A, 1993, DEV BRAIN RES, V72, P133, DOI 10.1016/0165-3806(93)90166-8; WATSON RE, 1986, PEPTIDES, V7, P155, DOI 10.1016/0196-9781(86)90076-8; WITTER MP, 1991, J COMP NEUROL, V307, P437, DOI 10.1002/cne.903070308; Xu CY, 2014, BIOL PHARM BULL, V37, P511, DOI 10.1248/bpb.b13-00845; Yang S, 2013, NEUROSCI LETT, V539, P86, DOI 10.1016/j.neulet.2013.01.046; Yeh HJ, 1998, J NEUROSCI, V18, P3699; ZOLAMORGAN S, 1989, J NEUROSCI, V9, P4355	64	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e100597	10.1371/journal.pone.0100597	http://dx.doi.org/10.1371/journal.pone.0100597			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000129	Green Published, gold			2022-12-27	WOS:000338637300011
J	Li, N; Sun, CY; Zhou, B; Xing, H; Ma, D; Chen, G; Weng, DH				Li, Na; Sun, Chaoyang; Zhou, Bo; Xing, Hui; Ma, Ding; Chen, Gang; Weng, Danhui			Low Concentration of Quercetin Antagonizes the Cytotoxic Effects of Anti-Neoplastic Drugs in Ovarian Cancer	PLOS ONE			English	Article							CISPLATIN-INDUCED APOPTOSIS; HUMAN HEPATOMA-CELLS; DNA; INHIBITION; 8-OHDG; RISK	Objective: The role of Quercetin in ovarian cancer treatment remains controversial, and the mechanism is unknown. The aim of this study was to investigate the therapeutic effects of Quercetin in combination with Cisplatin and other antineoplastic drugs in ovarian cancer cells both in vitro and in vivo, along with the molecular mechanism of action. Methods: Quercetin treatment at various concentrations was examined in combination with Cisplatin, taxol, Pirarubicin and 5-Fu in human epithelial ovarian cancer C13* and SKOV3 cells. CCK8 assay and Annexin V assay were for cell viability and apoptosis analysis, immunofluorescence assay, DCFDA staining and realtime PCR were used for reactive oxygen species (ROS)-induced injury detection and endogenous antioxidant enzymes expression. Athymic BALB/c-nu nude mice were injected with C13*cells to obtain a xenograft model for in vivo studies. Immunohistochemical analysis was carried out to evaluate the ROS-induced injury and SOD1 activity of xenograft tumors. Results: Contrary to the pro-apoptotic effect of high concentration (40 mu M-100 mu M) of Quercetin, low concentrations (5 mu M-30 mu M) of Quercetin resulted in varying degrees of attenuation of cytotoxicity of Cisplatin treatment when combined with Cisplatin. Similar anti-apoptotic effects were observed when Quercetin was combined with other anti-neoplastic agents: Taxol, Pirarubicin and 5-Fluorouracil (5-Fu). Low concentrations of Quercetin were observed to suppress ROS-induced injury, reduce intracellular ROS level and increase the expression of endogenous antioxidant enzymes, suggesting a ROS-mediated mechanism of attenuating anti-neoplastic drugs. In xenogeneic model, Quercetin led to a substantial reduction of therapeutic efficacy of Cisplatin along with enhancing the endogenous antioxidant enzyme expression and reducing ROS-induced damage in xenograft tumor tissue. Conclusion: Taken together, these data suggest that Quercetin at low concentrations attenuate the therapeutic effects of Cisplatin and other anti-neoplastic drugs in ovarian cancer cells by reducing ROS damage. Quercetin supplementation during ovarian cancer treatment may detrimentally affect therapeutic response.	[Li, Na; Sun, Chaoyang; Zhou, Bo; Ma, Ding; Chen, Gang; Weng, Danhui] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Canc Biol Res Ctr, Wuhan 430074, Hubei, Peoples R China; [Xing, Hui] Hubei Univ Arts & Sci, Affiliated Hosp 1, Xiangyang Cent Hosp, Dept Obstet & Gynecol, Xiangyang, Hubei, Peoples R China	Huazhong University of Science & Technology; Hubei University of Arts & Science	Chen, G (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Canc Biol Res Ctr, Wuhan 430074, Hubei, Peoples R China.	gumpc@126.com; weng.dh@gmail.com			National Basic Research Program of China (973 Program) [2009CB521808]; National Nature and Science Foundation of China [81230038, 81272859, 81025011, 81090414, 81000979, 81101962]; Nature and Science Foundation of Hubei Province [2011CBD542]; Fundamental Research Funds for the Central Universities [HUST: 2012TS058]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Nature and Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature and Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Basic Research Program of China (973 Program, 2009CB521808); National Nature and Science Foundation of China (81230038; 81272859; 81025011; 81090414; 81000979; 81101962); Nature and Science Foundation of Hubei Province (2011CBD542); Fundamental Research Funds for the Central Universities (HUST: 2012TS058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselin E, 2001, CANCER RES, V61, P1862; Chang YF, 2006, NUTR CANCER, V55, P201, DOI 10.1207/s15327914nc5502_12; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Egert S, 2008, J NUTR, V138, P1615, DOI 10.1093/jn/138.9.1615; Formica JV, 1995, FOOD CHEM TOXICOL, V33, P1061, DOI 10.1016/0278-6915(95)00077-1; Gao S, 2013, CANCER LETT, V333, P36, DOI 10.1016/j.canlet.2012.12.029; Gates MA, 2009, INT J CANCER, V124, P1918, DOI 10.1002/ijc.24151; GUGLER R, 1975, EUR J CLIN PHARMACOL, V9, P229, DOI 10.1007/BF00614022; Heaney ML, 2008, CANCER RES, V68, P8031, DOI 10.1158/0008-5472.CAN-08-1490; Hollman PCH, 1997, CANCER LETT, V114, P139, DOI 10.1016/S0304-3835(97)04644-2; Kim JY, 2008, J CELL BIOCHEM, V105, P1386, DOI 10.1002/jcb.21958; Lu P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088918; Nessa MU, 2011, ANTICANCER RES, V31, P3789; Pylvas M, 2011, ANTICANCER RES, V31, P1411; Ramos AM, 2008, BIOCHEM PHARMACOL, V75, P1912, DOI 10.1016/j.bcp.2008.02.007; Robaszkiewicz A, 2007, CELL BIOL INT, V31, P1245, DOI 10.1016/j.cellbi.2007.04.009; Samuel T, 2012, ANTICANCER RES, V32, P61; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Staedler D, 2011, CANCER CHEMOTH PHARM, V68, P1161, DOI 10.1007/s00280-011-1596-x; Sun CY, 2013, JNCI-J NATL CANCER I, V105, P1750, DOI 10.1093/jnci/djt302; Wu LL, 2004, CLIN CHIM ACTA, V339, P1, DOI 10.1016/j.cccn.2003.09.010	21	53	54	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e100314	10.1371/journal.pone.0100314	http://dx.doi.org/10.1371/journal.pone.0100314			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999622	Green Published, Green Submitted, gold			2022-12-27	WOS:000338637300008
J	Meng, HY; Jiang, L; Xu, BS; Guo, WZ; Li, JL; Zhu, XQ; Qi, XQ; Duan, LX; Meng, XB; Fan, YL; Zhang, CY				Meng, Hongyan; Jiang, Ling; Xu, Bosi; Guo, Wenzhu; Li, Jinglai; Zhu, Xiuqing; Qi, Xiaoquan; Duan, Lixin; Meng, Xianbin; Fan, Yunliu; Zhang, Chunyi			Arabidopsis Plastidial Folylpolyglutamate Synthetase Is Required for Seed Reserve Accumulation and Seedling Establishment in Darkness	PLOS ONE			English	Article							ONE-CARBON METABOLISM; PISUM-SATIVUM-L; HIGHER-PLANTS; TETRAHYDROFOLATE BIOSYNTHESIS; FOLATE POLYGLUTAMYLATION; CELL ELONGATION; GERMINATION; THALIANA; GROWTH; ACID	Interactions among metabolic pathways are important in plant biology. At present, not much is known about how folate metabolism affects other metabolic pathways in plants. Here we report a T-DNA insertion mutant (atdfb-3) of the plastidial folylpolyglutamate synthetase gene (AtDFB) was defective in seed reserves and skotomorphogenesis. Lower carbon (C) and higher nitrogen (N) content in the mutant seeds than that of the wild type were indicative of an altered C and N partitioning capacity. Higher levels of organic acids and sugars were detected in the mutant seeds compared with the wild type. Further analysis revealed that atdfb-3 seeds contained less total amino acids and individual Asn and Glu as well as NO3-. These results indicate significant changes in seed storage in the mutant. Defects in hypocotyl elongation were observed in atdfb-3 in darkness under sufficient NO3- conditions, and further enhanced under NO3- limited conditions. The strong expression of AtDFB in cotyledons and hypocotyl during early developmental stage was consistent with the mutant sensitivity to limited NO3- during a narrow developmental window. Exogenous 5-formyl-tetrahydrofolate completely restored the hypocotyl length in atdfb-3 seedlings with NO3- as the sole N source. Further study demonstrated that folate profiling and N metabolism were perturbed in atdfb-3 etiolated seedlings. The activity of enzymes involved in N reduction and assimilation was altered in atdfb-3. Taken together, these results indicate that AtDFB is required for seed reserves, hypocotyl elongation and N metabolism in darkness, providing novel insights into potential associations of folate metabolism with seed reserve accumulation, N metabolism and hypocotyl development in Arabidopsis.	[Meng, Hongyan; Jiang, Ling; Xu, Bosi; Fan, Yunliu; Zhang, Chunyi] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China; [Jiang, Ling; Fan, Yunliu; Zhang, Chunyi] Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China; [Guo, Wenzhu] Huazhong Agr Univ, Wuhan, Peoples R China; [Li, Jinglai; Zhu, Xiuqing] Beijing Inst Pharmacol & Toxicol, Beijing, Peoples R China; [Qi, Xiaoquan; Duan, Lixin; Meng, Xianbin] Chinese Acad Sci, Inst Bot, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Huazhong Agricultural University; Academy of Military Medical Sciences - China; Chinese Academy of Sciences; Institute of Botany, CAS	Zhang, CY (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China.	zhangchunyi@caas.cn	Qi, Xiaoquan/G-1545-2010	Qi, Xiaoquan/0000-0001-7175-115X	National Basic Research Program of China [2013CB127003]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China (grant no. 2013CB127003 to C.Z.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar TA, 2010, PLANT J, V64, P256, DOI 10.1111/j.1365-313X.2010.04330.x; Andre C, 2007, PLANT PHYSIOL, V145, P1670, DOI 10.1104/pp.107.108340; ANDREW KN, 1995, ANAL CHIM ACTA, V314, P33, DOI 10.1016/0003-2670(95)00269-6; Anguera MC, 2003, J BIOL CHEM, V278, P29856, DOI 10.1074/jbc.M302883200; Baud S, 2002, PLANT PHYSIOL BIOCH, V40, P151, DOI 10.1016/S0981-9428(01)01350-X; Baud Sebastien, 2008, Arabidopsis Book, V6, pe0113, DOI 10.1199/tab.0113; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Blochl A, 2007, J PLANT PHYSIOL, V164, P1093, DOI 10.1016/j.jplph.2006.10.010; Canas RA, 2006, PLANTA, V224, P83, DOI 10.1007/s00425-005-0196-6; Cernac A, 2006, PLANT PHYSIOL, V141, P745, DOI 10.1104/pp.106.079574; CHAN PY, 1986, PLANT CELL PHYSIOL, V27, P431; Chen M, 2010, PLANT CELL, V22, P77, DOI 10.1105/tpc.109.071837; Collakova E, 2008, PLANT CELL, V20, P1818, DOI 10.1105/tpc.108.058701; Conklin PL, 2013, J EXP BOT, V64, P2793, DOI 10.1093/jxb/ert140; Cowling RJ, 1999, J EXP BOT, V50, P1351, DOI 10.1093/jexbot/50.337.1351; Eastmond PJ, 2000, P NATL ACAD SCI USA, V97, P5669, DOI 10.1073/pnas.97.10.5669; Eastmond PJ, 2006, PLANT CELL, V18, P665, DOI 10.1105/tpc.105.040543; Fait A, 2006, PLANT PHYSIOL, V142, P839, DOI 10.1104/pp.106.086694; Fait A, 2011, PLANT PHYSIOL, V157, P1026, DOI 10.1104/pp.111.179986; Foster J, 2012, PLANT CELL, V24, P1217, DOI 10.1105/tpc.112.096032; Franceschi VR, 2005, ANNU REV PLANT BIOL, V56, P41, DOI 10.1146/annurev.arplant.56.032604.144106; Francisco P, 2010, J PLANT PHYSIOL, V167, P890, DOI 10.1016/j.jplph.2010.01.006; Gambonnet B, 2001, J SCI FOOD AGR, V81, P835, DOI 10.1002/jsfa.870; Graham IA, 2008, ANNU REV PLANT BIOL, V59, P115, DOI 10.1146/annurev.arplant.59.032607.092938; Hanson AD, 2002, CURR OPIN PLANT BIOL, V5, P244, DOI 10.1016/S1369-5266(02)00249-2; Hanson AD, 2001, ANNU REV PLANT PHYS, V52, P119, DOI 10.1146/annurev.arplant.52.1.119; Hanson AD, 2011, ANNU REV PLANT BIOL, V62, P105, DOI 10.1146/annurev-arplant-042110-103819; HEATH JD, 1986, PLANTA, V169, P304, DOI 10.1007/BF00392124; Ishikawa T, 2003, PLANT J, V33, P235, DOI 10.1046/j.1365-313X.2003.01621.x; Jabrin S, 2003, PLANT PHYSIOL, V131, P1431, DOI 10.1104/pp.016915; Jiang L, 2013, PLANT PHYSIOL, V161, P971, DOI 10.1104/pp.112.203430; Josse EM, 2008, CURR BIOL, V18, pR1144, DOI 10.1016/j.cub.2008.10.034; Lancien M, 2002, PLANT J, V29, P347, DOI 10.1046/j.1365-313X.2002.01218.x; LEMIEUX B, 1990, THEOR APPL GENET, V80, P234, DOI 10.1007/BF00224392; Li JJ, 2011, PLANT CELL, V23, P4411, DOI 10.1105/tpc.111.092684; Mehrshahi P, 2010, PLANT J, V64, P267, DOI 10.1111/j.1365-313X.2010.04336.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; O'Neill CM, 2003, PHYTOCHEMISTRY, V64, P1077, DOI 10.1016/S0031-9422(03)00351-0; ONEAL D, 1973, ARCH BIOCHEM BIOPHYS, V159, P113, DOI 10.1016/0003-9861(73)90435-9; Penfield S, 2005, BIOCHEM SOC T, V33, P380, DOI 10.1042/BST0330380; Penfield S, 2004, PLANT CELL, V16, P2705, DOI 10.1105/tpc.104.024711; Ravanel S, 2004, J BIOL CHEM, V279, P22548, DOI 10.1074/jbc.M313250200; Ravanel S, 2001, P NATL ACAD SCI USA, V98, P15360, DOI 10.1073/pnas.261585098; REED LS, 1979, J AGR FOOD CHEM, V27, P995, DOI 10.1021/jf60225a048; Renault H, 2011, PLANT CELL PHYSIOL, V52, P894, DOI 10.1093/pcp/pcr041; Roessner U, 2001, PLANT CELL, V13, P11, DOI 10.1105/tpc.13.1.11; Roje S, 2002, J BIOL CHEM, V277, P42748, DOI 10.1074/jbc.M205632200; ROOS AJ, 1971, BIOCHEM J, V125, P17, DOI 10.1042/bj1250017; Sahr T, 2005, BIOCHEM SOC T, V33, P758, DOI 10.1042/BST0330758; Srivastava AC, 2011, PLANT PHYSIOL, V155, P1237, DOI 10.1104/pp.110.168278; Takahashi M, 2001, PLANT PHYSIOL, V126, P731, DOI 10.1104/pp.126.2.731; To Jennifer P C, 2002, BMC Plant Biol, V2, P4, DOI 10.1186/1471-2229-2-4; Van Wilder V, 2009, NEW PHYTOL, V182, P137, DOI 10.1111/j.1469-8137.2008.02707.x; Weber H, 2005, ANNU REV PLANT BIOL, V56, P253, DOI 10.1146/annurev.arplant.56.032604.144201; Wei ZY, 2013, ARCH BIOCHEM BIOPHYS, V536, P87, DOI 10.1016/j.abb.2013.06.004; Yu L, 2010, J EXP BOT, V61, P1625, DOI 10.1093/jxb/erq028	56	14	16	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101905	10.1371/journal.pone.0101905	http://dx.doi.org/10.1371/journal.pone.0101905			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000295	Green Published, Green Submitted, gold			2022-12-27	WOS:000338637300100
J	Monzen, S; Hosoda, M; Osanai, M; Tokonami, S				Monzen, Satoru; Hosoda, Masahiro; Osanai, Minoru; Tokonami, Shinji			Radiation Dose Reduction Efficiency of Buildings after the Accident at the Fukushima Daiichi Nuclear Power Station	PLOS ONE			English	Article							EVACUEES; CS-137	Numerous radionuclides were released from the Fukushima Daiichi Nuclear Power Station (F1-NPS) in Japan following the magnitude 9.0 earthquake and tsunami on March 11, 2011. Local residents have been eager to calculate their individual radiation exposure. Thus, absorbed dose rates in the indoor and outdoor air at evacuation sites in the Fukushima Prefecture were measured using a gamma-ray measuring devices, and individual radiation exposure was calculated by assessing the radiation dose reduction efficiency (defined as the ratio of absorbed dose rate in the indoor air to the absorbed dose rate in the outdoor air) of wood, aluminum, and reinforced concrete buildings. Between March 2011 and July 2011, dose reduction efficiencies of wood, aluminum, and reinforced concrete buildings were 0.55 +/- 0.04, 0.15 +/- 0.02, and 0.19 +/- 0.04, respectively. The reduction efficiency of wood structures was 1.4 times higher than that reported by the International Atomic Energy Agency. The efficiency of reinforced concrete was similar to previously reported values, whereas that of aluminum structures has not been previously reported. Dose reduction efficiency increased in proportion to the distance from F1-NPS at 8 of the 18 evacuation sites. Time variations did not reflect dose reduction efficiencies at evacuation sites although absorbed dose rates in the outdoor air decreased. These data suggest that dose reduction efficiency depends on structure types, levels of contamination, and evacuee behaviors at evacuation sites.	[Monzen, Satoru; Hosoda, Masahiro; Osanai, Minoru] Hirosaki Univ, Grad Sch Hlth Sci, Div Med Life Sci, Dept Radiol Life Sci, Hirosaki, Aomori, Japan; [Tokonami, Shinji] Hirosaki Univ, Res Inst Radiat Emergency Med, Hirosaki, Aomori, Japan	Hirosaki University; Hirosaki University	Monzen, S (corresponding author), Hirosaki Univ, Grad Sch Hlth Sci, Div Med Life Sci, Dept Radiol Life Sci, Hirosaki, Aomori, Japan.	monzens@cc.hirosaki-u.ac.jp	Tokonami, Shinji/AAH-6042-2020; Monzen, Satoru/AAF-9870-2021; monzen, satoru/F-1468-2013	Monzen, Satoru/0000-0003-2436-8048; monzen, satoru/0000-0003-2436-8048; Tokonami, Shinji/0000-0002-6617-7402	Education Program for Professionals in Radiation Emergency Medicine in Hirosaki University; Hirosaki University Institutional Research	Education Program for Professionals in Radiation Emergency Medicine in Hirosaki University; Hirosaki University Institutional Research	This study was supported by a Grant for Education Program for Professionals in Radiation Emergency Medicine in Hirosaki University (2011-2012), Grant for Hirosaki University Institutional Research (2011-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE S, 1981, J NUCL SCI TECHNOL, V18, P21, DOI 10.3327/jnst.18.21; Akahane K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01670; Hosoda M, 2013, ENVIRON INT, V61, P73, DOI 10.1016/j.envint.2013.09.013; Hosoda M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02283; Hosoda M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00087; IAEA, 1979, IAEATECDOC225, pP 53; International Atomic Energy Agency, 2000, IAEATECODC1162; Katata G, 2012, J ENVIRON RADIOACTIV, V111, P2, DOI 10.1016/j.jenvrad.2011.09.011; Machart P, 2007, J ENVIRON RADIOACTIV, V97, P70, DOI 10.1016/j.jenvrad.2007.05.003; Minato S., 1978, REP GOV IND RES I NA, V27, P384; Monzen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027761; Prohl G, 2006, J ENVIRON RADIOACTIV, V91, P41, DOI 10.1016/j.jenvrad.2006.08.004; Tokonami S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00507; Tsukada H, 2008, J ENVIRON RADIOACTIV, V99, P875, DOI 10.1016/j.jenvrad.2007.11.014; Yoshida-Ohuchi H, 2013, RADIAT PROT DOSIM, V154, P385, DOI 10.1093/rpd/ncs245	15	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101650	10.1371/journal.pone.0101650	http://dx.doi.org/10.1371/journal.pone.0101650			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999992	Green Published, Green Submitted, gold			2022-12-27	WOS:000338637300067
J	Wang, Y; Chen, F; Le, B; Stepp, DW; Fulton, DJR				Wang, Yusi; Chen, Feng; Le, Brian; Stepp, David W.; Fulton, David J. R.			Impact of Nox5 Polymorphisms on Basal and Stimulus-Dependent ROS Generation	PLOS ONE			English	Article							OXIDASE 5 NOX5; NADPH OXIDASE; NOX1-DEFICIENT MICE; OXIDATIVE STRESS; REACTIVE OXYGEN; BLOOD-VESSELS; CANCER CELLS; EXPRESSION; DISEASE; HYPERTENSION	Nox5 is an EF-hand containing, calcium-dependent isoform of the NADPH oxidase family of reactive oxygen species (ROS) generating enzymes. Altered expression and activity of Nox5 has been reported in cardiovascular diseases and cancers but the absence of Nox5 in rodents has precluded a greater understanding of its physiological and pathophysiological roles. Multiple polymorphisms have been identified within the coding sequence of human Nox5, but whether this translates into altered enzyme function is unknown. Herein, we have generated 15 novel mutants of Nox5 beta to evaluate the effect of exonic SNPs on basal and stimulated enzyme activity. Compared to the WT enzyme, ROS production was unchanged or slightly modified in the majority of mutants, but significantly decreased in 7. Focusing on M77K, Nox5 activity was dramatically reduced in unstimulated cells and following challenge with both calcium- and phosphorylation-dependent stimuli despite equivalent levels of expression. The M77K mutation did not influence the Nox5 phosphorylation or the ability to bind Hsp90, but in cell-free assays with excess co-factors and calcium, ROS production was dramatically reduced. A more conservative substitution M77V arising from another SNP yielded a different profile of enzyme activity and suggests a critical role of M77 in calcium-dependent ROS production. Two C-terminal mutants, R530H and G542R, were observed that had little to no activity and relatively high minor allele frequency (MAF). In conclusion, we have identified 7 missense SNPs in Nox5 that result in little or no enzyme activity. Whether humans with dysfunctional Nox5 variants have altered physiology or disease remains to be determined.	[Wang, Yusi; Chen, Feng; Le, Brian; Stepp, David W.; Fulton, David J. R.] Georgia Regents Univ, Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA; [Chen, Feng] Nanjing Med Univ, Dept Forens Med, Nanjing, Jiangsu, Peoples R China; [Stepp, David W.] Georgia Regents Univ, Dept Physiol, Augusta, GA USA; [Fulton, David J. R.] Georgia Regents Univ, Dept Pharmacol, Augusta, GA USA	University System of Georgia; Augusta University; Nanjing Medical University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Fulton, DJR (corresponding author), Georgia Regents Univ, Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA.	dfulton@gru.edu	Chen, Feng/E-1133-2011		National Institutes of Health [P01 HL101902-01A1, R01HL092446]; AHA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092446, P01HL101902] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health P01 HL101902-01A1 (DF), R01HL092446 (DS, DF), and by a Postdoctoral Fellowship from the AHA (FC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Balog EM, 2006, AM J PHYSIOL-HEART C, V290, pH794, DOI 10.1152/ajpheart.00706.2005; Banfi B, 2004, J BIOL CHEM, V279, P46065, DOI 10.1074/jbc.M403046200; Bedard K, 2012, FREE RADICAL BIO MED, V52, P725, DOI 10.1016/j.freeradbiomed.2011.11.023; Brar SS, 2003, AM J PHYSIOL-CELL PH, V285, pC353, DOI 10.1152/ajpcell.00525.2002; Chen F, 2012, ARTERIOSCL THROM VAS, V32, P2989, DOI 10.1161/ATVBAHA.112.300361; Chen F, 2011, ANTIOXID REDOX SIGN, V14, P2107, DOI 10.1089/ars.2010.3669; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Chu AY, 2012, CIRC-CARDIOVASC GENE, V5, P676, DOI 10.1161/CIRCGENETICS.112.963314; Chua PJ, 2009, EXP BIOL MED, V234, P1086, DOI 10.3181/0903-RM-98; Comuzzie AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051954; Deffert C, 2012, J PATHOL, V228, P341, DOI 10.1002/path.4061; Dikalova A, 2005, CIRCULATION, V112, P2668, DOI 10.1161/CIRCULATIONAHA.105.538934; Fu XY, 2006, J BIOL CHEM, V281, P20368, DOI 10.1074/jbc.M603353200; Fulton DJR, 2009, ANTIOXID REDOX SIGN, V11, P2443, DOI [10.1089/ars.2009.2587, 10.1089/ARS.2009.2587]; Gavazzi G, 2006, FEBS LETT, V580, P497, DOI 10.1016/j.febslet.2005.12.049; Gray SP, 2013, CIRCULATION, V127, P1888, DOI 10.1161/CIRCULATIONAHA.112.132159; Guzik TJ, 2008, J AM COLL CARDIOL, V52, P1803, DOI 10.1016/j.jacc.2008.07.063; Hahn NE, 2012, AM J PATHOL, V180, P2222, DOI 10.1016/j.ajpath.2012.02.018; Holterman CE, 2014, J AM SOC NEPHROL, V25, P784, DOI 10.1681/ASN.2013040371; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; Jagnandan D, 2007, J BIOL CHEM, V282, P6494, DOI 10.1074/jbc.M608966200; Jay DB, 2008, FREE RADICAL BIO MED, V45, P329, DOI 10.1016/j.freeradbiomed.2008.04.024; Kamiguti AS, 2005, J IMMUNOL, V175, P8424, DOI 10.4049/jimmunol.175.12.8424; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee MY, 2009, ARTERIOSCL THROM VAS, V29, P480, DOI 10.1161/ATVBAHA.108.181925; Lim SC, 2009, DIABETOLOGIA, V52, P1343, DOI 10.1007/s00125-009-1368-x; Matsuno K, 2005, CIRCULATION, V112, P2677, DOI 10.1161/CIRCULATIONAHA.105.573709; Montezano AC, 2010, CIRC RES, V106, P1363, DOI 10.1161/CIRCRESAHA.109.216036; Nielsen R, 2010, NATURE, V467, P1050, DOI 10.1038/4671050a; Paffenholz R, 2004, GENE DEV, V18, P486, DOI 10.1101/gad.1172504; Pandey D, 2012, AM J PHYSIOL-HEART C, V302, pH1919, DOI 10.1152/ajpheart.00910.2011; Qian J, 2012, FREE RADICAL BIO MED, V52, P1806, DOI 10.1016/j.freeradbiomed.2012.02.029; Qian WF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002603; Rada Balazs, 2008, V15, P164, DOI 10.1159/000136357; Stergachis AB, 2013, SCIENCE, V342, P1367, DOI 10.1126/science.1243490; Touyz RM, 2012, CIRC RES, V110, P1159, DOI 10.1161/CIRCRESAHA.112.269068; Zhang Q, 2008, ARTERIOSCL THROM VAS, V28, P1627, DOI 10.1161/ATVBAHA.108.168278	39	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100102	10.1371/journal.pone.0100102	http://dx.doi.org/10.1371/journal.pone.0100102			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992705	Green Published, Green Submitted, gold			2022-12-27	WOS:000341253400016
J	Zhou, QY; Gui, SY; Zhou, Q; Wang, Y				Zhou, Qiaoyun; Gui, Shuyu; Zhou, Qing; Wang, Yuan			Melatonin Inhibits the Migration of Human Lung Adenocarcinoma A549 Cell Lines Involving JNK/MAPK Pathway	PLOS ONE			English	Article							BREAST-CANCER CELLS; LIGHT-CHAIN KINASE; JUNCTION-ASSOCIATED PROTEIN; RHO-ASSOCIATED KINASE; PLASMA OSTEOPONTIN; OCCLUDIN EXPRESSION; SIGNAL-TRANSDUCTION; PROSTATE-CANCER; COLON-CANCER; IN-VITRO	Objective: Melatonin, an indolamine produced and secreted predominately by the pineal gland, exhibits a variety of physiological functions, possesses antioxidant and antitumor properties. But, the mechanisms for the anti-cancer effects are unknown. The present study explored the effects of melatonin on the migration of human lung adenocarcinoma A549 cells and its mechanism. Methods: MTT assay was employed to measure the viability of A549 cells treated with different concentrations of melatonin. The effect of melatonin on the migration of A549 cells was analyzed by wound healing assay. Occludin location was observed by immunofluorescence. The expression of occludin, osteopontin (OPN), myosin light chain kinase (MLCK) and phosphorylation of myosin light chain (MLC), JNK were detected by western blots. Results: After A549 cells were treated with melatonin, the viability and migration of the cells were inhibited significantly. The relative migration rate of A549 cells treated with melatonin was only about 20% at 24 h. The expression level of OPN, MLCK and phosphorylation of MLC of A549 cells were reduced, while the expression of occludin was conversely elevated, and occludin located on the cell surface was obviously increased. The phosphorylation status of JNK in A549 cells was also reduced when cells were treated by melatonin. Conclusions: Melatonin significantly inhibits the migration of A549 cells, and this may be associated with the down-regulation of the expression of OPN, MLCK, phosphorylation of MLC, and up-regulation of the expression of occludin involving JNK/MAPK pathway.	[Zhou, Qiaoyun; Gui, Shuyu] Anhui Med Univ, Affiliated Hosp 1, Dept Resp Med, Hefei, Anhui, Peoples R China; [Zhou, Qing; Wang, Yuan] Anhui Med Univ, Mol Biol Lab, Hefei, Anhui, Peoples R China; [Zhou, Qing; Wang, Yuan] Anhui Med Univ, Dept Biochem, Hefei, Anhui, Peoples R China; [Gui, Shuyu; Zhou, Qing; Wang, Yuan] Anhui Med Univ, Key Lab Gene Res Anhui Prov, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University	Gui, SY (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Resp Med, Hefei, Anhui, Peoples R China.	guishuyu@126.com; wangyuan@ahmu.edu.cn			National Natural Science Foundation of China [81272399]; Natural Science Foundation of Anhui Province [90413116]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province)	This study was supported by National Natural Science Foundation of China (No. 81272399) and Natural Science Foundation of Anhui Province (No. 90413116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSHENBEL IF, 1954, CANCER, V71, P1954, DOI DOI 10.1002/1097-0142(19930315)71:6; AndoAkatsuka Y, 1996, J CELL BIOL, V133, P43, DOI 10.1083/jcb.133.1.43; Bellon A, 2007, J PINEAL RES, V42, P214, DOI 10.1111/j.1600-079X.2006.00408.x; Benitez-King G, 2009, HISTOL HISTOPATHOL, V24, P789, DOI 10.14670/HH-24.789; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Bonnefont-Rousselot D, 2011, J PINEAL RES, V50, P328, DOI 10.1111/j.1600-079X.2010.00847.x; Bramwell VHC, 2005, CANCER BIOL THER, V4, P1336, DOI 10.4161/cbt.4.12.2166; Bramwell VHC, 2006, CLIN CANCER RES, V12, P3337, DOI 10.1158/1078-0432.CCR-05-2354; CHAMBERS AF, 1992, ANTICANCER RES, V12, P43; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chew TL, 2002, J CELL BIOL, V156, P543, DOI 10.1083/jcb.200110161; Cos S, 1998, CANCER RES, V58, P4383; Dai M, 2008, J PINEAL RES, V44, P121, DOI 10.1111/j.1600-079X.2007.00498.x; Davies DC, 2002, J ANAT, V200, P639, DOI 10.1046/j.1469-7580.2002.00065.x; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; Dominguez-Rodriguez A, 2011, INT J CARDIOL, V149, P382, DOI 10.1016/j.ijcard.2011.02.070; Dziadziuszko R, 2008, CLIN LUNG CANCER, V9, P78, DOI 10.3816/CLC.2008.n.012; Fedarko NS, 2001, CLIN CANCER RES, V7, P4060; Fornas O, 2000, HORM RES, V53, P251, DOI 10.1159/000023575; FUJIMOTO K, 1995, J CELL SCI, V108, P3443; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; Garcia-Navarro A, 2007, J PINEAL RES, V43, P195, DOI 10.1111/j.1600-079X.2007.00463.x; Gonzalez A, 2011, J PINEAL RES, V50, P250, DOI 10.1111/j.1600-079X.2010.00834.x; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Grant SG, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000982; Hill SM, 2011, J MAMMARY GLAND BIOL, V16, P235, DOI 10.1007/s10911-011-9222-4; Hoover KB, 1998, AM J PATHOL, V153, P1767, DOI 10.1016/S0002-9440(10)65691-X; Hotte SJ, 2002, CANCER-AM CANCER SOC, V95, P506, DOI 10.1002/cncr.10709; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Jung-Hynes B, 2010, J PINEAL RES, V48, P9, DOI 10.1111/j.1600-079X.2009.00729.x; Kim JH, 2002, JAMA-J AM MED ASSOC, V287, P1671, DOI 10.1001/jama.287.13.1671; Kimura Y, 1997, AM J PATHOL, V151, P45; Kishi H, 2000, J BIOL CHEM, V275, P1414, DOI 10.1074/jbc.275.2.1414; Kolega J, 2003, MOL BIOL CELL, V14, P4745, DOI 10.1091/mbc.E03-04-0205; Korkmaz A, 2009, MOL MED, V15, P43, DOI 10.2119/molmed.2008.00117; Mao LL, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2794; Martinez-Campa CM, 2008, CANCER LETT, V268, P272, DOI 10.1016/j.canlet.2008.04.001; Mediavilla MD, 1999, LIFE SCI, V65, P415, DOI 10.1016/S0024-3205(99)00262-3; Messina G, 2010, J RES MED SCI, V15, P225; Minamiya Y, 2005, TUMOR BIOL, V26, P153, DOI 10.1159/000086487; Oates AJ, 1996, ONCOGENE, V13, P97; Ortiz-Lopez L, 2009, J PINEAL RES, V46, P15, DOI 10.1111/j.1600-079X.2008.00600.x; Padillo FJ, 2010, J PINEAL RES, V49, P264, DOI 10.1111/j.1600-079X.2010.00791.x; Papadopoulos MC, 2001, NEUROPATH APPL NEURO, V27, P384, DOI 10.1046/j.0305-1846.2001.00341.x; Petty RD, 2004, CLIN CANCER RES, V10, P3237, DOI 10.1158/1078-0432.CCR-03-0503; POEGGELER B, 1993, J PINEAL RES, V14, P151, DOI 10.1111/j.1600-079X.1993.tb00498.x; Proietti S, 2011, J PINEAL RES, V50, P150, DOI 10.1111/j.1600-079X.2010.00824.x; Ramankulov A, 2007, PROSTATE, V67, P330, DOI 10.1002/pros.20540; Ramirez-Rodriguez G, 2007, J PINEAL RES, V42, P180, DOI 10.1111/j.1600-079X.2006.00404.x; REITER RJ, 1994, ANN NY ACAD SCI, V719, P1, DOI 10.1111/j.1749-6632.1994.tb56817.x; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; Srinivasan V, 2008, INTEGR CANCER THER, V7, P189, DOI 10.1177/1534735408322846; Tam CW, 2007, J PINEAL RES, V42, P191, DOI 10.1111/j.1600-079X.2006.00406.x; Tobioka H, 2004, VIRCHOWS ARCH, V445, P472, DOI 10.1007/s00428-004-1054-9; Tobioka H, 2004, HUM PATHOL, V35, P159, DOI 10.1016/j.humpath.2003.09.013; Tohtong R, 2003, PROSTATE CANCER P D, V6, P212, DOI 10.1038/sj.pcan.4500663; Tuck AB, 2003, ONCOGENE, V22, P1198, DOI 10.1038/sj.onc.1206209; Um HJ, 2011, J PINEAL RES, V50, P359, DOI 10.1111/j.1600-079X.2010.00851.x; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Yang R, 2008, CLIN CANCER RES, V14, P6396, DOI 10.1158/1078-0432.CCR-07-5113	63	55	57	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101132	10.1371/journal.pone.0101132	http://dx.doi.org/10.1371/journal.pone.0101132			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992189	gold, Green Published, Green Submitted			2022-12-27	WOS:000341253400044
J	Jiang, QJ; Ding, SF; Wu, JX; Liu, X; Wu, ZG				Jiang, Qijun; Ding, Shifang; Wu, Jianxiang; Liu, Xing; Wu, Zonggui			Norepinephrine Stimulates Mobilization of Endothelial Progenitor Cells after Limb Ischemia	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; BONE-MARROW; ANGIOGENESIS; GROWTH; SYSTEM; NEOANGIOGENESIS; CATECHOLAMINES; AKT/ENOS; STRESS; VEGF	Objective: During several pathological processes such as cancer progression, thermal injury, wound healing and hindlimb ischemia, the mobilization of endothelial progenitor cells (EPCs) mobilization was enhanced with an increase of sympathetic nerve activity and norepinephrine (NE) secretion, yet the cellular and molecular mechanisms involved in the effects of NE on EPCs has less been investigated. Methods and Results: EPCs from BMs, peripheral circulation and spleens, the VEGF concentration in BM, skeletal muscle, peripheral circulation and spleen and angiogenesis in ischemic gastrocnemius were quantified in mice with hindlimbs ischemia. Systemic treatment of NE significantly increased EPCs number in BM, peripheral circulation and spleen, VEGF concentration in BM and skeletal muscle and angiogenesis in ischemic gastrocnemius in mice with hind limb ischemia, but did not affair VEGF concentration in peripheral circulation and spleen. EPCs isolated from healthy adults were cultured with NE in vitro to evaluate proliferation potential, migration capacity and phosphorylations of Akt and eNOS signal moleculars. Treatment of NE induced a significant increase in number of EPCs in the S-phase in a dose-dependent manner, as well as migrative activity of EPCs in vitro (p<0.05). The co-treatment of Phentolamine, I127, LY294002 and L-NAME with NE blocked the effects of NE on EPCs proliferation and migration. Treatment with NE significantly increased phosphorylation of Akt and eNOS of EPCs. Addition of phentolamine and I127 attenuated the activation of Akt/eNOS pathway, but metoprolol could not. Pretreatment of mice with either Phentolamine or I127 significantly attenuated the effects of NE on EPCs in vivo, VEGF concentration in BM, skeletal muscle and angiogenesis in ischemic gastrocnemius, but Metoprolol did not. Conclusion: These results unravel that sympathetic nervous system regulate EPCs mobilization and their pro-angiogenic capacity via alpha adrenoceptor, beta 2 adrenoceptor and meanwhile Akt/eNOS signaling pathway.	[Jiang, Qijun; Ding, Shifang] Wuhan Gen Hosp Guangzhou Mil, Dept Cardiol, Wuhan, Hubei, Peoples R China; [Jiang, Qijun; Wu, Jianxiang; Liu, Xing; Wu, Zonggui] Second Mil Med Univ, Changzheng Hosp, Dept Cardiol, Shanghai, Peoples R China	Naval Medical University	Ding, SF (corresponding author), Wuhan Gen Hosp Guangzhou Mil, Dept Cardiol, Wuhan, Hubei, Peoples R China.	DingSFMD@gmail.com			Major National Basic Research Development Program of People's Republic of China [2005CB523309]	Major National Basic Research Development Program of People's Republic of China	This work was supported by the Major National Basic Research Development Program of People's Republic of China (2005CB523309). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 2003, CIRCULATION, V107, P2134, DOI 10.1161/01.CIR.0000062649.63838.C9; Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Bernal-Mizrachi E, 2004, J CLIN INVEST, V114, P928, DOI 10.1172/JCI200420016; Busik JV, 2009, J EXP MED, V206, P2897, DOI 10.1084/jem.20090889; Catoire M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051066; Chalothorn D, 2005, AM J PHYSIOL-HEART C, V289, pH947, DOI 10.1152/ajpheart.00952.2004; Engler H, 2004, J NEUROIMMUNOL, V148, P106, DOI 10.1016/j.jneuroim.2003.11.011; Erami C, 2005, AM J PHYSIOL-HEART C, V289, pH744, DOI 10.1152/ajpheart.00129.2005; Fox A, 2008, BRIT J SURG, V95, P244, DOI 10.1002/bjs.5913; Galasso G, 2013, CIRC RES, V112, P1026, DOI 10.1161/CIRCRESAHA.111.300152; Iaccarino G, 2005, CIRC RES, V97, P1182, DOI 10.1161/01.RES.0000191541.06788.bb; Iwaguro H, 2002, CIRCULATION, V105, P732, DOI 10.1161/hc0602.103673; Lee JH, 2013, ARTERIOSCL THROM VAS, V33, P1622, DOI 10.1161/ATVBAHA.112.301052; Lee SH, 2013, ARTERIOSCL THROM VAS, V33, P2407, DOI 10.1161/ATVBAHA.113.301931; Liang C, 2009, BRIT J PHARMACOL, V158, P1865, DOI 10.1111/j.1476-5381.2009.00450.x; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Park SY, 2011, INT J CANCER, V128, P2306, DOI 10.1002/ijc.25589; Peng XQ, 2003, HYPERTENSION, V41, P378, DOI 10.1161/01.HYP.0000049624.99844.3D; Qijun J, 2013, MED HYPOTHESES, V80, P778; Ramcharan SK, 2013, EUR J CLIN INVEST, V43, P801, DOI 10.1111/eci.12108; Recalde A, 2012, ARTERIOSCL THROM VAS, V32, P643, DOI 10.1161/ATVBAHA.111.244392; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; Sun CB, 2009, BASIC RES CARDIOL, V104, P42, DOI 10.1007/s00395-008-0738-8; Sun CK, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt181; Tabarowski Z, 1996, ACTA HISTOCHEM, V98, P453, DOI 10.1016/S0065-1281(96)80013-4; Tanaka R, 2013, DIABETES, V62, P3207, DOI 10.2337/db12-1621; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Turgeon J, 2013, ATHEROSCLEROSIS, V229, P295, DOI 10.1016/j.atherosclerosis.2013.05.020; Zhang H, 2004, AM J PHYSIOL-HEART C, V287, pH2106, DOI 10.1152/ajpheart.00290.2004	29	27	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101774	10.1371/journal.pone.0101774	http://dx.doi.org/10.1371/journal.pone.0101774			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007164	gold, Green Published, Green Submitted			2022-12-27	WOS:000339040600066
J	Peugnet, P; Wimel, L; Duchamp, G; Sandersen, C; Camous, S; Guillaume, D; Dahirel, M; Dubois, C; Jouneau, L; Reigner, F; Berthelot, V; Chaffaux, S; Tarrade, A; Serteyn, D; Chavatte-Palmer, P				Peugnet, Pauline; Wimel, Laurence; Duchamp, Guy; Sandersen, Charlotte; Camous, Sylvaine; Guillaume, Daniel; Dahirel, Michele; Dubois, Cedric; Jouneau, Luc; Reigner, Fabrice; Berthelot, Valerie; Chaffaux, Stephane; Tarrade, Anne; Serteyn, Didier; Chavatte-Palmer, Pascale			Enhanced or Reduced Fetal Growth Induced by Embryo Transfer into Smaller or Larger Breeds Alters Post-Natal Growth and Metabolism in Pre-Weaning Horses	PLOS ONE			English	Article							CATCH-UP GROWTH; INSULIN SENSITIVITY; PLACENTAL RESTRICTION; BIRTH-WEIGHT; DEVELOPMENTAL ORIGINS; PRENATAL EXPOSURE; GLUCOSE-TOLERANCE; THYROID-HORMONE; MATERNAL SIZE; BODY-WEIGHT	In equids, placentation is diffuse and nutrient supply to the fetus is determined by uterine size. This correlates with maternal size and affects intra-uterine development and subsequent post-natal growth, as well as insulin sensitivity in the newborn. Long-term effects remain to be described. In this study, fetal growth was enhanced or restricted through ET using pony (P), saddlebred (S) and draft (D) horses. Control P-P (n = 21) and S-S (n = 28) pregnancies were obtained by AI. Enhanced and restricted pregnancies were obtained by transferring P or S embryos into D mares (P-D, n = 6 and S-D, n = 8) or S embryos into P mares (S-P, n = 6), respectively. Control and experimental foals were raised by their dams and recipient mothers, respectively. Weight gain, growth hormones and glucose homeostasis were investigated in the foals from birth to weaning. Fetal growth was enhanced in P-D and these foals remained consistently heavier, with reduced T-3 concentrations until weaning compared to P-P. P-D had lower fasting glucose from days 30 to 200 and higher insulin secretion than P-P after IVGTT on day 3. Euglycemic clamps in the immediate post-weaning period revealed no difference in insulin sensitivity between P-D and P-P. Fetal growth was restricted in S-P and these foals remained consistently lighter until weaning compared to S-D, with elevated T-3 concentrations in the newborn compared to S-S. S-P exhibited higher fasting glycemia than S-S and S-D from days 30 to 200. They had higher maximum increment in plasma glucose than S-D after IVGTT on day 3 and clamps on day 200 demonstrated higher insulin sensitivity compared to S-D. Neither the restricted nor the enhanced fetal environment affected IGF-1 concentrations. Thus, enhanced and restricted fetal and post-natal environments had combined effects that persisted until weaning. They induced different adaptive responses in post-natal glucose metabolism: an early insulin-resistance was induced in enhanced P-D, while S-P developed increased insulin sensitivity.	[Peugnet, Pauline; Camous, Sylvaine; Dahirel, Michele; Jouneau, Luc; Chaffaux, Stephane; Tarrade, Anne; Chavatte-Palmer, Pascale] INRA, Biol Dev & Reprod UMR1198, Jouy En Josas, France; [Peugnet, Pauline; Camous, Sylvaine; Dahirel, Michele; Jouneau, Luc; Chaffaux, Stephane; Tarrade, Anne; Chavatte-Palmer, Pascale] ENVA, Maisons Alfort, France; [Wimel, Laurence; Dubois, Cedric] IFCE, Stn Expt Valade, Chamberet, France; [Duchamp, Guy; Reigner, Fabrice] INRA, UE1293, F-37380 Nouzilly, France; [Sandersen, Charlotte; Serteyn, Didier] Univ Liege, CORD, Fac Med Vet, Clin Equine, Liege, Belgium; [Guillaume, Daniel] INRA, UMR85, F-37380 Nouzilly, France; [Guillaume, Daniel] CNRS, UMR7247, Nouzilly, France; [Guillaume, Daniel] Univ Tours, Tours, France; [Guillaume, Daniel] IFCE, Nouzilly, France; [Berthelot, Valerie] INRA, Modelisat Syst Appl Ruminants UMR791, Paris, France; [Berthelot, Valerie] AgroParis Tech, Paris, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; University of Liege; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Tours; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech	Chavatte-Palmer, P (corresponding author), INRA, Biol Dev & Reprod UMR1198, Jouy En Josas, France.	pascale.chavatte@jouy.inra.fr	Chavatte-Palmer, Pascale/K-7349-2012; Jouneau, Luc/AAC-4711-2020	Chavatte-Palmer, Pascale/0000-0002-4581-6092; Couturier-Tarrade, Anne/0000-0003-1559-5476; Sandersen, charlotte/0000-0002-3404-2757	Institut Francais du Cheval et de l'Equitation (IFCE) under the "FOETALIM''; INRA Dept of Physiology and Breeding Systems	Institut Francais du Cheval et de l'Equitation (IFCE) under the "FOETALIM''; INRA Dept of Physiology and Breeding Systems	This work was funded through a grant from the Institut Francais du Cheval et de l'Equitation (IFCE) under the grant name "FOETALIM'' and through funding from INRA Dept of Physiology and Breeding Systems. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WR, 2004, REPRODUCTION, V127, P67, DOI 10.1530/rep.1.00024; Allen WR, 2002, REPRODUCTION, V123, P445, DOI 10.1530/rep.0.1230445; Ansari T, 1998, PILOT INVESTIGATIONS, P15; Arnaud G, 2000, NOTATION ETAT CORPOR; Bamford NJ, 2013, DOMEST ANIM IN PRESS; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; BARKER DJP, 1989, LANCET, V2, P577; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Ben XM, 2001, CHINESE MED J-PEKING, V114, P636; Berends LM, 2013, INT J OBESITY, V37, P1051, DOI 10.1038/ijo.2012.196; Berg EL, 2007, J ANIM SCI, V85, P1660, DOI 10.2527/jas.2006-771; Buff PR, 2002, J ANIM SCI, V80, P2942; Clifton VL, 2010, PLACENTA, V31, pS33, DOI 10.1016/j.placenta.2009.11.010; Cymbaluk NF, 1996, DOMEST ANIM ENDOCRIN, V13, P197, DOI 10.1016/0739-7240(96)00014-8; De Blasio MJ, 2007, AM J PHYSIOL-REG I, V292, pR875, DOI 10.1152/ajpregu.00430.2006; De Blasio MJ, 2007, ENDOCRINOLOGY, V148, P1350, DOI 10.1210/en.2006-0653; De Blasio MJ, 2012, ENDOCRINOLOGY, V153, P2142, DOI 10.1210/en.2011-1955; Donjacour A, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.113134; DOREAU M, 1989, LIVEST PROD SCI, V22, P213, DOI 10.1016/0301-6226(89)90057-2; Elliott C, 2009, THERIOGENOLOGY, V71, P683, DOI 10.1016/j.theriogenology.2008.09.041; Firshman AM, 2007, EQUINE VET J, V39, P567, DOI 10.2746/042516407X238512; Forhead AJ, 2000, J PHYSIOL-LONDON, V526, P167, DOI 10.1111/j.1469-7793.2000.00167.x; Forhead AJ, 2004, J ENDOCRINOL, V181, P459, DOI 10.1677/joe.0.1810459; Fowden AL, 2006, PHYSIOLOGY, V21, P29, DOI 10.1152/physiol.00050.2005; FOWDEN AL, 1984, EQUINE VET J, V16, P286, DOI 10.1111/j.2042-3306.1984.tb01928.x; Frank N, 2014, EQUINE VET J, V46, P103, DOI 10.1111/evj.12169; Frank N, 2010, J VET INTERN MED, V24, P467, DOI 10.1111/j.1939-1676.2010.0503.x; Gatford KL, 2008, ENDOCRINOLOGY, V149, P5118, DOI 10.1210/en.2008-0233; Geor R, 2009, VET IMMUNOL IMMUNOP, V129, P151, DOI 10.1016/j.vetimm.2008.11.012; Giussani DA, 2003, J PHYSIOL-LONDON, V547, P67, DOI 10.1113/jphysiol.2002.027409; Gonzalez-Bulnes A, 2012, REPRODUCTION, V144, P269, DOI 10.1530/REP-12-0105; Hanson M, 2011, AM J CLIN NUTR, V94, p1754S, DOI 10.3945/ajcn.110.001206; Heidler B, 2004, THERIOGENOLOGY, V61, P883, DOI 10.1016/S0093-691X(03)00279-6; Hemkemeyer SA, 2014, HUM REPROD, V29, P220, DOI 10.1093/humrep/det411; HESSDUDAN F, 1994, EQUINE VET J, V26, P134, DOI 10.1111/j.2042-3306.1994.tb04352.x; Hoffman RM, 2003, J ANIM SCI, V81, P2333; Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430; IRVINE CHG, 1975, J REPROD FERTIL, P709; Jakimiuk AJ, 2003, GYNECOL ENDOCRINOL, V17, P311, DOI 10.1080/713603295; JEFFCOTT LB, 1986, EQUINE VET J, V18, P97, DOI 10.1111/j.2042-3306.1986.tb03556.x; Johnson PJ, 2002, VET CLIN N AM-EQUINE, V18, P271, DOI 10.1016/S0749-0739(02)00006-8; Kawai M, 1997, BIOCHEM BIOPH RES CO, V240, P798, DOI 10.1006/bbrc.1997.7750; Kim B, 2008, THYROID, V18, P141, DOI 10.1089/thy.2007.0266; Klein I, 2001, NEW ENGL J MED, V344, P501, DOI 10.1056/NEJM200102153440707; Larsen PR, 1998, WILLIAMS TXB ENDOCRI, P389; Levin BE, 2006, PHILOS T R SOC B, V361, P1107, DOI 10.1098/rstb.2006.1851; Lim K, 2011, PEDIATR RES, V70, P339, DOI 10.1203/PDR.0b013e31822a65a3; Malinowski K, 1996, J ANIM SCI, V74, P1936; Market-Velker BA, 2010, BIOL REPROD, V83, P938, DOI 10.1095/biolreprod.110.085480; McMullen S, 2009, P NUTR SOC, V68, P306, DOI 10.1017/S0029665109001396; Noguchi K, 2012, J STAT SOFTW, V50, P1, DOI 10.18637/jss.v050.i12; Ogilvy-Stuart AL, 2002, ARCH DIS CHILD-FETAL, V87, P165, DOI 10.1136/fn.87.3.F165; Ohkawa N, 2010, ACTA PAEDIATR, V99, P37, DOI 10.1111/j.1651-2227.2009.01516.x; Owens JA, 2007, AM J PHYSIOL-ENDOC M, V292, pE1879, DOI 10.1152/ajpendo.00706.2006; Panzani S, 2012, THERIOGENOLOGY, V77, P1167, DOI 10.1016/j.theriogenology.2011.10.023; Pardo CE, 2013, ANIMAL, V7, P1884, DOI 10.1017/S1751731113001419; Poore KR, 2003, J PHYSIOL-LONDON, V547, P107, DOI 10.1113/jphysiol.2002.024349; Poore KR, 2002, DIABETOLOGIA, V45, P1247, DOI 10.1007/s00125-002-0849-y; Powell DM, 2002, EQUINE VET J, V34, P81; Radin MJ, 2009, VET CLIN PATH, V38, P136, DOI 10.1111/j.1939-165X.2009.00133.x; Ravelli ACJ, 1999, AM J CLIN NUTR, V70, P811; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; Rijnen KEPM, 2003, AM J VET RES, V64, P1260, DOI 10.2460/ajvr.2003.64.1260; Romagnoli U, 2007, ANIM REPROD SCI, V97, P180, DOI 10.1016/j.anireprosci.2006.02.004; Roseboom TJ, 2001, MOL CELL ENDOCRINOL, V185, P93, DOI 10.1016/S0303-7207(01)00721-3; Rossdale PD, 2002, EQUINE VET EDUC, V14, P98, DOI 10.1111/j.2042-3292.2002.tb00148.x; ROSSDALE PD, 1976, P ROY SOC MED, V69, P631, DOI 10.1177/003591577606900901; Sainsbury A, 2012, OBES REV, V13, P234, DOI 10.1111/j.1467-789X.2011.00948.x; Salazar-Ortiz J, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-130; Salimei E, 2002, REPROD NUTR DEV, V42, P65, DOI 10.1051/rnd:2002007; SILVER M, 1991, J REPROD FERTIL, P619; Slebodzinski AB, 1998, REPROD NUTR DEV, V38, P235, DOI 10.1051/rnd:19980303; Stettler N, 2002, PEDIATRICS, V109, P194, DOI 10.1542/peds.109.2.194; Symonds ME, 2010, ANIMAL, V4, P1075, DOI 10.1017/S1751731110000479; Thomas C R, 2001, Int J Exp Diabetes Res, V2, P113, DOI 10.1155/EDR.2001.113; Thomas L, 2001, J ENDOCRINOL, V169, P465, DOI 10.1677/joe.0.1690465; Vander Heyden L, 2013, VET REC, V172, P68, DOI 10.1136/vr.101034; Vick MM, 2006, REPROD FERT DEVELOP, V18, P609, DOI 10.1071/RD06016; Walton A, 1938, PROC R SOC SER B-BIO, V125, P311, DOI 10.1098/rspb.1938.0029; Wang C, 2005, ENDOCRINE, V27, P75, DOI 10.1385/ENDO:27:1:075; Watkins A J, 2010, J Dev Orig Health Dis, V1, P87, DOI 10.1017/S2040174409990195; Watkins AJ, 2007, P NATL ACAD SCI USA, V104, P5449, DOI 10.1073/pnas.0610317104; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156	83	33	33	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102044	10.1371/journal.pone.0102044	http://dx.doi.org/10.1371/journal.pone.0102044			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006665	Green Submitted, gold, Green Published			2022-12-27	WOS:000339040600090
J	Pickering, JW; Endre, ZH				Pickering, John W.; Endre, Zoltan H.			Acute Kidney Injury Urinary Biomarker Time-Courses	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; LINE RENAL-FUNCTION; CARDIAC-SURGERY; CREATININE; AKI; ESTABLISHMENT; PERFORMANCE; ADAPTATION; KINETICS; ABLATION	Factors which modify the excretion profiles of acute kidney injury biomarkers are difficult to measure. To facilitate biomarker choice and interpretation we modelled key modifying factors: extent of hyperfiltration or reduced glomerular filtration rate, structural damage, and reduced nephron number. The time-courses of pre-formed, induced (upregulated), and filtered biomarker concentrations were modelled in single nephrons, then combined to construct three multiple-nephron models: a healthy kidney with normal nephron number, a non-diabetic hyperfiltering kidney with reduced nephron number but maintained total glomerular filtration rate, and a chronic kidney disease kidney with reduced nephron number and reduced glomerular filtration rate. Time-courses for each model were derived for acute kidney injury scenarios of structural damage and/or reduced nephron number. The model predicted that pre-formed biomarkers would respond quickest to injury with a brief period of elevation, which would be easily missed in clinical scenarios. Induced biomarker time-courses would be influenced by biomarker-specific physiology and the balance between insult severity (which increased single nephron excretion), the number of remaining nephrons (reduced total excretion), and the extent of glomerular filtration rate reduction (increased concentration). Filtered biomarkers have the longest time-course because plasma levels increased following glomerular filtration rate decrease. Peak concentration and profile depended on the extent of damage to the reabsorption mechanism and recovery rate. Rapid recovery may be detected through a rapid reduction in urinary concentration. For all biomarkers, impaired hyperfiltration substantially increased concentration, especially with chronic kidney disease. For clinical validation of these model-derived predictions the clinical biomarker of choice will depend on timing in relation to renal insult and interpretation will require the pre-insult nephron number (renal mass) and detection of hyperfiltration.	[Pickering, John W.] Univ Otago, Dept Med, Christchurch, New Zealand; [Endre, Zoltan H.] Univ New S Wales, Prince Wales Clin Sch, Dept Nephrol, Sydney, NSW, Australia	University of Otago; University of New South Wales Sydney	Pickering, JW (corresponding author), Univ Otago, Dept Med, Christchurch, New Zealand.	john.pickering@otago.ac.nz	Pickering, John/ABC-8089-2021; Pickering, John W/A-9453-2009; Endre, Zoltan/A-3331-2009	Pickering, John/0000-0001-9475-0344; Pickering, John W/0000-0001-9475-0344; Endre, Zoltan/0000-0002-4782-8695	Royal Society of New Zealand [UOO1020]; University of Otago Research Grant	Royal Society of New Zealand(Royal Society of New Zealand); University of Otago Research Grant	1. Marsden Grant UOO1020 administered by the Royal Society of New Zealand. 2. University of Otago Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELSSON L, 1995, SCAND J CLIN LAB INV, V55, P577, DOI 10.3109/00365519509110257; Bakonska-Pacon E, 2003, BIOL SPORT, V20, P69; Blankenberg S, 2003, CIRCULATION, V108, P2453, DOI 10.1161/01.CIR.0000099509.76044.A2; Bolignano D, 2009, REJUV RES, V12, P7, DOI 10.1089/rej.2008.0803; Bonventre JV, 2009, NEPHROL DIAL TRANSPL, V24, P3265, DOI 10.1093/ndt/gfp010; BRENNER BM, 1985, AM J PHYSIOL, V249, pF324, DOI 10.1152/ajprenal.1985.249.3.F324; Cullen MR, 2012, ANN CLIN BIOCHEM, V49, P190, DOI 10.1258/acb.2011.011105; Endre ZH, 2011, AM J PHYSIOL-RENAL, V301, pF697, DOI 10.1152/ajprenal.00448.2010; Endre ZH, 2011, KIDNEY INT, V79, P1119, DOI 10.1038/ki.2010.555; Haase M, 2011, J AM COLL CARDIOL, V57, P1752, DOI 10.1016/j.jacc.2010.11.051; Han M, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-25; Han WK, 2009, CLIN J AM SOC NEPHRO, V4, P873, DOI 10.2215/CJN.04810908; Helal I, 2012, NAT REV NEPHROL, V8, P293, DOI 10.1038/nrneph.2012.19; Hvidberg V, 2005, FEBS LETT, V579, P773, DOI 10.1016/j.febslet.2004.12.031; JONES RL, 1980, J EXP MED, V151, P418, DOI 10.1084/jem.151.2.418; KAUFMAN JM, 1975, CIRC RES, V36, P286, DOI 10.1161/01.RES.36.2.286; Ko GJ, 2010, AM J PHYSIOL-RENAL, V298, pF1472, DOI 10.1152/ajprenal.00619.2009; Koyner JL, 2010, CLIN J AM SOC NEPHRO, V5, P2154, DOI 10.2215/CJN.00740110; Krawczeski CD, 2011, J AM COLL CARDIOL, V58, P2301, DOI 10.1016/j.jacc.2011.08.017; McIlroy DR, 2010, CLIN J AM SOC NEPHRO, V5, P211, DOI 10.2215/CJN.04240609; Metcalfe W, 2007, NEPHROL DIAL TRANSPL, V22, P26, DOI 10.1093/ndt/gfm446; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Molnar AO, 2012, CLIN J AM SOC NEPHRO, V7, P1749, DOI 10.2215/CJN.13421211; MORAN SM, 1985, KIDNEY INT, V27, P928, DOI 10.1038/ki.1985.101; Nejat M, 2012, NEPHROL DIAL TRANSPL, V27, P96, DOI 10.1093/ndt/gfr222; Pennemans V, 2013, CLIN CHEM LAB MED, V51, P1795, DOI 10.1515/cclm-2013-0157; Pickering JW, 2013, BLOOD PURIFICAT, V35, P295, DOI 10.1159/000351542; Pickering JW, 2013, CRIT CARE, V17, DOI 10.1186/cc11931; Pickering JW, 2009, LANCET, V373, P1318, DOI 10.1016/S0140-6736(09)60751-0; Ralib AM, 2012, J AM SOC NEPHROL, V23, P322, DOI 10.1681/ASN.2011040325; Schmidt-Ott KM, 2007, J AM SOC NEPHROL, V18, P407, DOI 10.1681/ASN.2006080882; Waikar SS, 2010, KIDNEY INT, V78, P486, DOI 10.1038/ki.2010.165; Westhuyzen J, 2003, NEPHROL DIAL TRANSPL, V18, P543, DOI 10.1093/ndt/18.3.543	34	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101288	10.1371/journal.pone.0101288	http://dx.doi.org/10.1371/journal.pone.0101288			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006799	Green Submitted, Green Published, gold			2022-12-27	WOS:000339040600033
J	Li, S; Zeng, XT; Ruan, XL; Weng, H; Liu, TZ; Wang, X; Zhang, C; Meng, Z; Wang, XH				Li, Sheng; Zeng, Xian-Tao; Ruan, Xiao-Lan; Weng, Hong; Liu, Tong-Zu; Wang, Xiao; Zhang, Chao; Meng, Zhe; Wang, Xing-Huan			Holmium Laser Enucleation versus Transurethral Resection in Patients with Benign Prostate Hyperplasia: An Updated Systematic Review with Meta-Analysis and Trial Sequential Analysis	PLOS ONE			English	Article							RANDOMIZED PROSPECTIVE TRIAL; INFORMATION SIZE; FOLLOW-UP; BOUNDARIES; 2-CENTER; HOLEP; TURP	Background: Holmium laser enucleation (HoLEP) in surgical treatment of benign prostate hyperplasia (BPH) potentially offers advantages over transurethral resection of the prostate (TURP). Methods: Published randomized controlled trials (RCTs) were identified from PubMed, EMBASE, Science Citation Index, and the Cochrane Library up to October 10, 2013 (updated on February 5, 2014). After methodological quality assessment and data extraction, meta-analysis was performed using STATA 12.0 and Trial Sequential Analysis (TSA) 0.9 software. Results: Fifteen studies including 8 RCTs involving 855 patients met the criteria. The results of meta-analysis showed that: a) efficacy indicators: there was no significant difference in quality of life between the two groups (P>0.05), but compared with the TURP group, Qmax was better at 3 months and 12 months, PVR was less at 6, 12 months, and IPSS was lower at 12 months in the HoLEP, b) safety indicators: compared with the TURP, HoLEP had less blood transfusion (RR 0.17, 95% CI 0.06 to 0.47), but there was no significant difference in early and late postoperative complications (P>0.05), and c) perioperative indicators: HoLEP was associated with longer operation time (WMD 14.19 min, 95% CI 6.30 to 22.08 min), shorter catheterization time (WMD -19.97 h, 95% CI -24.24 to -15.70 h) and hospital stay (WMD -25.25 h, 95% CI -29.81 to -20.68 h). Conclusions: In conventional meta-analyses, there is no clinically relevant difference in early and late postoperative complications between the two techniques, but HoLEP is preferable due to advantage in the curative effect, less blood transfusion rate, shorter catheterization duration time and hospital stay. However, trial sequential analysis does not allow us to draw any solid conclusion in overall clinical benefit comparison between the two approaches. Further large, well-designed, multicentre/international RCTs with long-term data and the comparison between the two approaches remain open.	[Li, Sheng; Liu, Tong-Zu; Wang, Xiao; Meng, Zhe; Wang, Xing-Huan] Wuhan Univ, Dept Urol, Zhongnan Hosp, Wuhan 430072, Peoples R China; [Zeng, Xian-Tao; Weng, Hong; Zhang, Chao] Hubei Univ Med, Taihe Hosp, Ctr Evidence Based Med & Clin Res, Shiyan, Peoples R China; [Ruan, Xiao-Lan] Huazhong Univ Sci & Technol, Dept & Inst Hematol, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China	Wuhan University; Hubei University of Medicine; Huazhong University of Science & Technology	Wang, XH (corresponding author), Wuhan Univ, Dept Urol, Zhongnan Hosp, Wuhan 430072, Peoples R China.	wangxinghuan1965@gmail.com	Wang, Xinghuan/AAB-3192-2021; Weng, Hong/I-6590-2019	Wang, Xinghuan/0000-0003-3497-0024; Weng, Hong/0000-0001-7795-5671; Li, Sheng/0000-0003-4070-7345; Zeng, Xian-Tao/0000-0003-1262-725X				Ahyai SA, 2007, EUR UROL, V52, P1456, DOI 10.1016/j.eururo.2007.04.053; Ahyai SA, 2010, EUR UROL, V58, P384, DOI 10.1016/j.eururo.2010.06.005; Briganti A, 2006, J UROLOGY, V175, P1817, DOI 10.1016/S0022-5347(05)00983-3; Brok J, 2009, INT J EPIDEMIOL, V38, P287, DOI 10.1093/ije/dyn188; Brok J, 2008, J CLIN EPIDEMIOL, V61, P763, DOI 10.1016/j.jclinepi.2007.10.007; Eltabey MA, 2010, CAN J UROL, V17, P5447; Fraundorfer MR, 2001, UROLOGY, V57, P454, DOI 10.1016/S0090-4295(00)00987-0; Gilling P, 1997, J UROLOGY, V157, p149A; Gilling PJ, 2008, EUR UROL, V53, P744, DOI 10.1016/j.eururo.2007.04.052; Gilling PJ, 2012, BJU INT, V109, P408, DOI 10.1111/j.1464-410X.2011.10359.x; Gilling PJ, 1999, J UROLOGY, V162, P1640, DOI 10.1016/S0022-5347(05)68186-4; Gupta N, 2006, BJU INT, V97, P85, DOI 10.1111/j.1464-410X.2006.05862.x; Hemmingsen B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1771; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Higgins JPT, 2011, STAT MED, V30, P903, DOI 10.1002/sim.4088; Kabalin JN, 1997, J ENDOUROL, V11, P291, DOI 10.1089/end.1997.11.291; Kim SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084938; Kuntz RM, 2004, J UROLOGY, V172, P1012, DOI 10.1097/01.ju.0000136218.11998.9e; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Mavuduru RM, 2009, UROL INT, V82, P130, DOI 10.1159/000200786; McVary KT, 2011, J UROLOGY, V185, P1793, DOI 10.1016/j.juro.2011.01.074; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Montorsi F, 2004, J UROLOGY, V172, P1926, DOI 10.1097/01.ju.0000140501.68841.a1; Oelke M, 2013, EUR UROL, V64, P118, DOI 10.1016/j.eururo.2013.03.004; Rigatti L, 2006, UROLOGY, V67, P1193, DOI 10.1016/j.urology.2005.12.036; Sun N, 2014, INT UROL NEPHROL; Tan A, 2007, BRIT J SURG, V94, P1201, DOI 10.1002/bjs.5916; Tan AHH, 2003, J UROLOGY, V170, P1270, DOI 10.1097/01.ju.0000086948.55973.00; Thorlund K., 2011, USER MANUAL TRIAL SE; Thorlund K, 2009, INT J EPIDEMIOL, V38, P276, DOI 10.1093/ije/dyn179; Thorlund K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025491; Westenberg A, 2004, J UROLOGY, V172, P616, DOI 10.1097/01.ju.0000132739.57555.d8; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013; Wetterslev J, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-86; Wilson LC, 2006, EUR UROL, V50, P569, DOI 10.1016/j.eururo.2006.04.002; Yin L, 2013, J ENDOUROL, V27, P604, DOI 10.1089/end.2012.0505	37	48	50	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101615	10.1371/journal.pone.0101615	http://dx.doi.org/10.1371/journal.pone.0101615			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003963	Green Published, Green Submitted, gold			2022-12-27	WOS:000339242700045
J	Miller, JC				Miller, Joel C.			Epidemics on Networks with Large Initial Conditions or Changing Structure	PLOS ONE			English	Article							SIR DYNAMICS; MODELS	In this paper we extend previous work deriving dynamic equations governing infectious disease spread on networks. The previous work has implicitly assumed that the disease is initialized by an infinitesimally small proportion of the population. Our modifications allow us to account for an arbitrarily large initial proportion infected. This helps resolve an apparent paradox in earlier work whereby the number of susceptible individuals could increase if too many individuals were initially infected. It also helps explain an apparent small deviation that has been observed between simulation and theory. An advantage of this modification is that it allows us to account for changes in the structure or behavior of the population during the epidemic.	[Miller, Joel C.] Monash Univ, Sch Biol Sci, Sch Math Sci, Melbourne, Vic 3004, Australia; [Miller, Joel C.] Monash Univ, Monash Acad Cross & Interdisciplinary Math, Melbourne, Vic 3004, Australia	Monash University; Monash University	Miller, JC (corresponding author), Monash Univ, Sch Biol Sci, Sch Math Sci, Melbourne, Vic 3004, Australia.	joel.c.miller.research@gmail.com	Miller, Joel C./C-4229-2015	Miller, Joel C./0000-0003-4426-0405	Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health; Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard School of Public Health from the National Institute Of General Medical Sciences [U54GM088558]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard School of Public Health from the National Institute Of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	JCM was supported in part by 1) the Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, Department of Homeland Security and the Fogarty International Center, National Institutes of Health, and 2) the Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard School of Public Health under Award Number U54GM088558 from the National Institute Of General Medical Sciences. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health. The funders had no role in study design,data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Ball F, 2008, MATH BIOSCI, V212, P69, DOI 10.1016/j.mbs.2008.01.001; Bansal S, 2007, J R SOC INTERFACE, V4, P879, DOI 10.1098/rsif.2007.1100; Decreusefond L, 2012, ANN APPL PROBAB, V22, P541, DOI 10.1214/11-AAP773; Eames KTD, 2002, P NATL ACAD SCI USA, V99, P13330, DOI 10.1073/pnas.202244299; House T, 2011, J R SOC INTERFACE, V8, P67, DOI 10.1098/rsif.2010.0179; Janson S, 2013, ARXIV13085493; Kiss I, 2012, P ROYAL SOC A; Lindquist J, 2011, J MATH BIOL, V62, P143, DOI 10.1007/s00285-010-0331-2; MAY RM, 1988, PHILOS T ROY SOC B, V321, P565, DOI 10.1098/rstb.1988.0108; May RM, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.066112; Meyers LA, 2005, J THEOR BIOL, V232, P71, DOI 10.1016/j.jtbi.2004.07.026; Meyers LA, 2006, J THEOR BIOL, V240, P400, DOI 10.1016/j.jtbi.2005.10.004; Miller JC, 2014, MATH MODELLING NATUR; Miller JC, 2008, J APPL PROBAB, V45, P498, DOI 10.1239/jap/1214950363; Miller JC, 2013, J MATH BIOL, V67, P869, DOI 10.1007/s00285-012-0572-3; Miller JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069162; Miller JC, 2012, B MATH BIOL, V74, P2125, DOI 10.1007/s11538-012-9749-6; Miller JC, 2012, J R SOC INTERFACE, V9, P890, DOI 10.1098/rsif.2011.0403; Miller JC, 2011, J MATH BIOL, V62, P349, DOI 10.1007/s00285-010-0337-9; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Moreno Y, 2002, EUR PHYS J B, V26, P521, DOI 10.1140/epjb/e20020122; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Noel PA, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.031118; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Volz E, 2008, J MATH BIOL, V56, P293, DOI 10.1007/s00285-007-0116-4	26	23	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101421	10.1371/journal.pone.0101421	http://dx.doi.org/10.1371/journal.pone.0101421			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004149	Green Submitted, Green Published, gold			2022-12-27	WOS:000339242700029
J	Costa, L; Rodrigues, MS; Benseny-Cases, N; Mayeux, V; Chevrier, J; Comin, F				Costa, Luca; Rodrigues, Mario S.; Benseny-Cases, Nuria; Mayeux, Veronique; Chevrier, Joel; Comin, Fabio			Spectroscopic Investigation of Local Mechanical Impedance of Living Cells	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; NANOMECHANICAL PROPERTIES; FIBROBLASTS; AFM	We studied nanoscale mechanical properties of PC12 living cells with a Force Feedback Microscope using two experimental approaches. The first one consists in measuring the local mechanical impedance of the cell membrane while simultaneously mapping the cell morphology at constant force. As the interaction force is increased, we observe the appearance of the submembrane cytoskeleton. We compare our findings with the outcome of other techniques. The second experimental approach consists in a spectroscopic investigation of the cell while varying the tip indentation into the membrane and consequently the applied force. At variance with conventional dynamic Atomic Force Microscopy techniques, here it is not mandatory to work at the first oscillation eigenmode of the cantilever: the excitation frequency of the tip can be chosen arbitrary leading then to new spectroscopic AFM techniques. We found in this way that the mechanical response of the PC12 cell membrane is found to be frequency dependent in the 1 kHz - 10 kHz range. In particular, we observe that the damping coefficient consistently decreases when the excitation frequency is increased.	[Costa, Luca; Comin, Fabio] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Costa, Luca] Univ Grenoble 1, Grenoble, France; [Rodrigues, Mario S.] Univ Lisbon, Fac Ciencia, Ctr Fis Mat Condensada, Dept Fis, P-1699 Lisbon, Portugal; [Benseny-Cases, Nuria; Mayeux, Veronique] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England; [Chevrier, Joel] CNRS, Inst NEEL, Grenoble, France; [Chevrier, Joel] Univ Grenoble Alpes, Inst NEEL, Grenoble, France	European Synchrotron Radiation Facility (ESRF); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universidade de Lisboa; University of Leeds; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Costa, L (corresponding author), European Synchrotron Radiat Facil, BP 220, F-38043 Grenoble, France.	luca.costa@esrf.fr	Benseny-Cases, Nuria/M-6443-2018; Rodrigues, Mario S/C-1151-2013; Costa, Luca/K-6429-2014	Benseny-Cases, Nuria/0000-0003-4603-6829; Rodrigues, Mario S/0000-0002-0468-1910; Costa, Luca/0000-0002-4527-0034; Chevrier, Joel/0000-0001-5609-6863	Fundacao para a Ciencia e Tecnologia [SFRH/BPD/69201/2010. COST Action TD 1002]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	Funding provided by Fundacao para a Ciencia e Tecnologia SFRH/BPD/69201/2010. COST Action TD 1002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz J, 2003, BIOPHYS J, V84, P2071, DOI 10.1016/S0006-3495(03)75014-0; Andre S, 2003, J NEUROPHYSIOL, V90, P3764, DOI 10.1152/jn.00449.2003; BILODEAU GG, 1992, J APPL MECH-T ASME, V59, P519, DOI 10.1115/1.2893754; Braet F, 1998, APPL PHYS A-MATER, V66, pS575, DOI 10.1007/s003390051204; Brown AEX, 2009, BIOPHYS J, V96, P1952, DOI 10.1016/j.bpj.2008.11.032; Cartagena A, 2014, BIOPHYS J, V106, P1033, DOI 10.1016/j.bpj.2013.12.037; Chang CT, 2012, J MECH MED BIOL, V12, DOI 10.1142/S0219519412500327; Costa L, 2014, ARXIV14045277; Costa L, 2013, J MOL RECOGNIT, V26, P689, DOI 10.1002/jmr.2328; de Beer S, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/32/325703; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Gaboriaud F, 2007, COLLOID SURFACE B, V54, P10, DOI 10.1016/j.colsurfb.2006.09.014; Garcia R, 2012, NAT NANOTECHNOL, V7, P217, DOI [10.1038/nnano.2012.38, 10.1038/NNANO.2012.38]; Guzman HV, 2013, ACS NANO, V7, P3198, DOI 10.1021/nn4012835; Haga H, 2000, ULTRAMICROSCOPY, V82, P253, DOI 10.1016/S0304-3991(99)00157-6; Hofmann UG, 1997, J STRUCT BIOL, V119, P84, DOI 10.1006/jsbi.1997.3868; Iyer S, 2009, NAT NANOTECHNOL, V4, P389, DOI [10.1038/nnano.2009.77, 10.1038/NNANO.2009.77]; KASAS S, 1995, BIOPHYS J, V68, P1678, DOI 10.1016/S0006-3495(95)80344-9; Kiracofe D, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/48/485502; Le Grimellec C, 1998, BIOPHYS J, V75, P695, DOI 10.1016/S0006-3495(98)77559-9; Li JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050292; Luque T, 2013, ACTA BIOMATER, V9, P6852, DOI 10.1016/j.actbio.2013.02.044; Martinez-Martin D, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.198101; Muller DJ, 2008, NAT NANOTECHNOL, V3, P261, DOI 10.1038/nnano.2008.100; Plodinec M, 2012, NAT NANOTECHNOL, V7, P757, DOI [10.1038/nnano.2012.167, 10.1038/NNANO.2012.167]; RADMACHER M, 1993, BIOPHYS J, V64, P735, DOI 10.1016/S0006-3495(93)81433-4; Raman A, 2011, NAT NANOTECHNOL, V6, P809, DOI [10.1038/nnano.2011.186, 10.1038/NNANO.2011.186]; Rico F, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.021914; Rodrigues MS, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4766172; Rodrigues MS, 2013, J APPL PHYS IN PRESS; Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8; Sokolov I, 2013, METHODS, V60, P202, DOI 10.1016/j.ymeth.2013.03.037; Viero C, 2006, CELL CALCIUM, V40, P383, DOI 10.1016/j.ceca.2006.04.007	35	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101687	10.1371/journal.pone.0101687	http://dx.doi.org/10.1371/journal.pone.0101687			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999625	Green Submitted, Green Published, gold			2022-12-27	WOS:000338637300072
J	Heindorf, M; Kadari, M; Heider, C; Skiebe, E; Wilharm, G				Heindorf, Magdalena; Kadari, Mahendar; Heider, Christine; Skiebe, Evelyn; Wilharm, Gottfried			Impact of Acinetobacter baumannii Superoxide Dismutase on Motility, Virulence, Oxidative Stress Resistance and Susceptibility to Antibiotics	PLOS ONE			English	Article							BIOFILM FORMATION; BACTERICIDAL ANTIBIOTICS; ESCHERICHIA-COLI; DEATH PATHWAY; GALLERIA-MELLONELLA; ABIOTIC SURFACES; CELL-DEATH; PATHOGENESIS; INFECTION; INVOLVEMENT	Acinetobacter baumannii is a Gram-negative bacterium appearing as an opportunistic pathogen in hospital settings. Superoxide dismutase (SOD) contributes to virulence in several pathogenic bacteria by detoxifying reactive oxygen species released in the course of host defense reactions. However, the biological role of SODs in A. baumannii has not yet been elucidated. Here, we inactivated in A. baumannii ATCC 17978 gene A1S_2343, encoding a putative SOD of the Fe-Mn type by transposon insertion, resulting in mutant ATCC 17978 sod2343::Km. The mutation was also introduced in two naturally competent A. baumannii isolates by transformation with chromosomal DNA derived from mutant ATCC 17978 sod2343::Km. We demonstrate that inactivation of sod2343 leads to significant motility defects in all three A. baumannii strains. The mutant strains were more susceptible to oxidative stress compared to their parental strains. Susceptibility to colistin and tetracycline was increased in all mutant strains while susceptibility of the mutants to gentamicin, levofloxacin and imipenem was strain-dependent. In the Galleria mellonella infection model the mutant strains were significantly attenuated. In conclusion, sod2343 plays an important role in motility, resistance to oxidative stress, susceptibility to antibiotics and virulence in A. baumannii.	[Heindorf, Magdalena; Kadari, Mahendar; Heider, Christine; Skiebe, Evelyn; Wilharm, Gottfried] Robert Koch Inst, Wernigerode Branch, Wernigerode, Germany	Robert Koch Institute	Wilharm, G (corresponding author), Robert Koch Inst, Wernigerode Branch, Wernigerode, Germany.	wilharmg@rki.de		Wilharm, Gottfried/0000-0002-1771-6799	Lund University, Sweden; Robert Koch-Institute, Germany	Lund University, Sweden; Robert Koch-Institute, Germany	Mahendar Kadari was supported by an ERASMUS stipend of Lund University, Sweden, and Magdalena Heindorf was supported by a PhD stipend of the Robert Koch-Institute, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsan Marcella, 2010, J Clin Outcomes Manag, V17, P363; Alvarez-Lerma F, 2012, DRUGS, V72, P447, DOI 10.2165/11599520-000000000-00000; Baquero F, 2011, ANTIMICROB AGENTS CH, V55, P3649, DOI 10.1128/AAC.00013-11; Browne N, 2013, VIRULENCE, V4, P597, DOI 10.4161/viru.25906; Brynildsen MP, 2013, NAT BIOTECHNOL, V31, P160, DOI 10.1038/nbt.2458; Burger RM, 2009, J INORG BIOCHEM, V103, P1273, DOI 10.1016/j.jinorgbio.2009.07.009; Canvin J, 1996, FEMS MICROBIOL LETT, V136, P215, DOI 10.1016/0378-1097(96)84203-0; Cerqueira GM, 2011, IUBMB LIFE, V63, P1055, DOI 10.1002/iub.533; Champion OL, 2009, MICROBIOL-SGM, V155, P1516, DOI 10.1099/mic.0.026823-0; Chatti A, 2012, WORLD J MICROB BIOT, V28, P129, DOI 10.1007/s11274-011-0801-8; Dupont CL, 2008, ENVIRON MICROBIOL, V10, P1831, DOI 10.1111/j.1462-2920.2008.01604.x; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Ezraty B, 2013, SCIENCE, V340, P1583, DOI 10.1126/science.1238328; Fajardo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001619; Farrant JL, 1997, MOL MICROBIOL, V25, P785, DOI 10.1046/j.1365-2958.1997.5151877.x; Feld L, 2012, APPL ENVIRON MICROB, V78, P4353, DOI 10.1128/AEM.00324-12; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; Giannouli M, 2013, BMC INFECT DIS, V13, DOI [10.1186/1471-2334-13-470, 10.1186/1471-2334-13-282]; HASSETT DJ, 1989, FASEB J, V3, P2574, DOI 10.1096/fasebj.3.14.2556311; Howard A, 2012, VIRULENCE, V3, P243, DOI 10.4161/viru.19700; HUNGER M, 1990, GENE, V87, P45, DOI 10.1016/0378-1119(90)90494-C; Hwang S, 2013, J ANTIBIOT, V66, P351, DOI 10.1038/ja.2013.20; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; LANGFORD PR, 1992, J GEN MICROBIOL, V138, P517, DOI 10.1099/00221287-138-3-517; Lebreton F, 2011, J MOL MICROB BIOTECH, V21, P191, DOI 10.1159/000332737; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Lynch M, 2000, MICROBES INFECT, V2, P1245, DOI 10.1016/S1286-4579(00)01278-8; McConnell MJ, 2013, FEMS MICROBIOL REV, V37, P130, DOI 10.1111/j.1574-6976.2012.00344.x; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; McNamara M, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-45; Mendez JA, 2012, J PROTEOME RES, V11, P5678, DOI 10.1021/pr300496c; Miller RA, 1997, CLIN MICROBIOL REV, V10, P1; Mortensen BL, 2012, CELL MICROBIOL, V14, P1336, DOI 10.1111/j.1462-5822.2012.01817.x; Nwugo CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051936; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Pour NK, 2011, FEMS IMMUNOL MED MIC, V62, P328, DOI 10.1111/j.1574-695X.2011.00818.x; Pournaras S, 2014, ANTIMICROB AGENTS CH, V58, P828, DOI 10.1128/AAC.01439-13; Poyart C, 2001, INFECT IMMUN, V69, P5098, DOI 10.1128/IAI.69.8.5098-5106.2001; Qiu HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040019; Qiu HY, 2009, INFECT IMMUN, V77, P1015, DOI 10.1128/IAI.01029-08; Sampson TR, 2012, ANTIMICROB AGENTS CH, V56, P5642, DOI 10.1128/AAC.00756-12; Sanjay MK, 2011, INDIAN J MICROBIOL, V51, P326, DOI 10.1007/s12088-011-0074-9; SCOTT MD, 1987, J BIOL CHEM, V262, P3640; Shin BJ, 2008, J MICROBIOL, V46, P300, DOI 10.1007/s12275-007-0212-6; Silva JP, 2010, DRUG DISCOV THER, V4, P144; Skiebe E, 2012, INT J MED MICROBIOL, V302, P117, DOI 10.1016/j.ijmm.2012.03.003; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; SMITH MW, 1992, J MOL EVOL, V34, P175; STABEL TJ, 1994, VET MICROBIOL, V38, P307, DOI 10.1016/0378-1135(94)90149-X; Tang YL, 2012, VET MICROBIOL, V158, P360, DOI 10.1016/j.vetmic.2012.02.028; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Vidal R, 1996, MICROBIOS, V86, P49; Vila J, 2012, EXPERT OPIN PHARMACO, V13, P2319, DOI 10.1517/14656566.2012.729820; Wang XH, 2009, ANTIMICROB AGENTS CH, V53, P1395, DOI 10.1128/AAC.01087-08; Wilharm G, 2013, J BACTERIOL, V195, P4146, DOI 10.1128/JB.00754-13	56	52	56	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101033	10.1371/journal.pone.0101033	http://dx.doi.org/10.1371/journal.pone.0101033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000585	Green Published, Green Submitted, gold			2022-12-27	WOS:000338637300023
J	Yamashita, S; Ogawa, K; Ikei, T; Fujiki, T; Katakura, Y				Yamashita, Shuntaro; Ogawa, Kaori; Ikei, Takahiro; Fujiki, Tsukasa; Katakura, Yoshinori			FOXO3a Potentiates hTERT Gene Expression by Activating c-MYC and Extends the Replicative Life-Span of Human Fibroblast	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE GENE; CELLULAR SENESCENCE; SIRT1; TELOMERASE; CELLS; PATHWAY; BINDING; CANCER; IDENTIFICATION; TUMORIGENESIS	In our previous studies, we reported that SIRT1 prevents cellular senescence in human fibroblast, and that SIRT1-induced inhibition of cellular senescence is due to enhanced hTERT gene expression. In this study, we investigate the molecular mechanisms behind SIRT1-induced potentiation of hTERT transcription and show that FOXO3a functions downstream of SIRT1 and prevents the induction of cellular senescence by enhancing hTERT gene expression. Furthermore, we found that FOXO3a-induced potentiation of hTERT gene expression is regulated in a c-MYC/E-box dependent manner. In addition, we found that FOXO3a binds to the novel binding element in the c-MYC promoter, and this interaction activates the transcription of the c-MYC gene. The resulting increase in c-MYC leads to higher levels of c-MYC recruited to the hTERT promoter and, in turn, activates hTERT gene expression. Taken together, this pathway might constitute the molecular basis for the anti-senescence effects of SIRT1 and FOXO3a.	[Yamashita, Shuntaro; Katakura, Yoshinori] Kyushu Univ, Grad Sch Syst Life Sci, Higashi Ku, Fukuoka 812, Japan; [Ogawa, Kaori; Ikei, Takahiro; Katakura, Yoshinori] Kyushu Univ, Grad Sch Bioresources & Bioenvironm Sci, Higashi Ku, Fukuoka 812, Japan; [Fujiki, Tsukasa; Katakura, Yoshinori] Kyushu Univ, Fac Agr, Higashi Ku, Fukuoka 812, Japan	Kyushu University; Kyushu University; Kyushu University	Katakura, Y (corresponding author), Kyushu Univ, Grad Sch Syst Life Sci, Higashi Ku, Fukuoka 812, Japan.	katakura@grt.kyushu-u.ac.jp			JSPS KAKENHI [24580190, 25.4465]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers 24580190, 25.4465. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baur JA, 2012, NAT REV DRUG DISCOV, V11, P443, DOI 10.1038/nrd3738; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chandramohan V, 2004, J IMMUNOL, V172, P5522, DOI 10.4049/jimmunol.172.9.5522; Daniel M, 2012, GENE, V498, P135, DOI 10.1016/j.gene.2012.01.095; Delpuech O, 2007, MOL CELL BIOL, V27, P4917, DOI 10.1128/MCB.01789-06; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Fujiki T, 2007, ONCOGENE, V26, P5258, DOI 10.1038/sj.onc.1210331; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gan BY, 2010, CANCER CELL, V18, P472, DOI 10.1016/j.ccr.2010.10.019; Giannakou ME, 2004, TRENDS CELL BIOL, V14, P408, DOI 10.1016/j.tcb.2004.07.006; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Huang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001710; Jensen KS, 2011, EMBO J, V30, P4554, DOI 10.1038/emboj.2011.323; Katakura Y, 2009, J BIOCHEM, V146, P87, DOI 10.1093/jb/mvp046; Kim HK, 2005, J GERONTOL A-BIOL, V60, P4, DOI 10.1093/gerona/60.1.4; Kress TR, 2011, MOL CELL, V41, P445, DOI 10.1016/j.molcel.2011.01.023; Kyo S, 2008, CANCER SCI, V99, P1528, DOI 10.1111/j.1349-7006.2008.00878.x; Lavu S, 2008, NAT REV DRUG DISCOV, V7, P841, DOI 10.1038/nrd2665; Lees SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC1238, DOI 10.1152/ajpcell.00349.2008; Madonna R, 2011, EUR HEART J, V32, P1190, DOI 10.1093/eurheartj/ehq450; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Tomas-Loba A, 2008, CELL, V135, P609, DOI 10.1016/j.cell.2008.09.034; Yamashita S, 2012, BIOCHEM BIOPH RES CO, V417, P630, DOI 10.1016/j.bbrc.2011.12.021	29	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101864	10.1371/journal.pone.0101864	http://dx.doi.org/10.1371/journal.pone.0101864			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000517	Green Submitted, gold, Green Published			2022-12-27	WOS:000338637300094
J	Kapur, A; Schneider, JA; Heard, D; Mukherjee, S; Schumm, P; Oruganti, G; Laumann, EO				Kapur, Abhinav; Schneider, John A.; Heard, Daniel; Mukherjee, Sayan; Schumm, Phil; Oruganti, Ganesh; Laumann, Edward O.			A Digital Network Approach to Infer Sex Behavior in Emerging HIV Epidemics	PLOS ONE			English	Article							INDIAN MEN; RISK; PREVENTION; TRANSMISSION; METAANALYSIS; PARTNERS; POSITION	Purpose: Improve the ability to infer sex behaviors more accurately using network data. Methods: A hybrid network analytic approach was utilized to integrate: (1) the plurality of reports from others tied to individual(s) of interest; and (2) structural features of the network generated from those ties. Network data was generated from digitally extracted cell-phone contact lists of a purposeful sample of 241 high-risk men in India. These data were integrated with interview responses to describe the corresponding individuals in the contact lists and the ties between them. HIV serostatus was collected for each respondent and served as an internal validation of the model's predictions of sex behavior. Results: We found that network-based model predictions of sex behavior and self-reported sex behavior had limited correlation (54% agreement). Additionally, when respondent sex behaviors were re-classified to network model predictions from self-reported data, there was a 30.7% decrease in HIV seroprevalence among groups of men with lower risk behavior, which is consistent with HIV transmission biology. Conclusion: Combining the relative completeness and objectivity of digital network data with the substantive details of classical interview and HIV biomarker data permitted new analyses and insights into the accuracy of self-reported sex behavior.	[Kapur, Abhinav] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; [Schneider, John A.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Schneider, John A.; Schumm, Phil] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Heard, Daniel; Mukherjee, Sayan] Duke Univ, Dept Stat Sci, Durham, NC USA; [Oruganti, Ganesh] SHARE India, Publ Hlth Management Inst, Hyderabad, Andhra Pradesh, India; [Laumann, Edward O.] Univ Chicago, Dept Sociol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; Duke University; University of Chicago	Schneider, JA (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	jschnei1@medicine.bsd.uchicago.edu		Schumm, Phil/0000-0002-3050-2429; Mukherjee, Sayan/0000-0002-6715-3920	National Institutes of Health [R21HD068352, R21AI098599-01]; American Foundation for AIDS Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD068352] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI098599] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1209155] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Foundation for AIDS Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was funded in part by the National Institutes of Health (R21HD068352 and R21AI098599-01) and the American Foundation for AIDS Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adafruit, 2012, SIM READ; Adams J, 2007, SOC NETWORKS, V29, P44, DOI 10.1016/j.socnet.2005.11.009; Airoldi EM, 2008, J MACH LEARN RES, V9, P1981; Aral SO, 2002, SEX TRANSM DIS, V29, P530, DOI 10.1097/00007435-200209000-00006; Asthana S, 2001, SOC SCI MED, V52, P707, DOI 10.1016/S0277-9536(00)00167-2; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Bates D., 2009, LME4 LINEAR MIXED EF; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Borgatti SP, 2003, J APPL BEHAV SCI, V39, P337, DOI DOI 10.1177/0021886303258111; Brewer DD, 2006, SEX TRANSM DIS, V33, P277, DOI 10.1097/01.olq.0000204746.58160.c1; Brewer DD, 2005, SEX TRANSM DIS, V32, P189, DOI 10.1097/01.olq.0000154492.98350.90; Dandona L, 2005, AIDS, V19, P611, DOI 10.1097/01.aids.0000163938.01188.e4; Dandona L, 2006, BMC MED, V4, P1, DOI DOI 10.1186/1741-7015-4-7; Des Jarlais DC, 1999, LANCET, V353, P1657, DOI 10.1016/S0140-6736(98)07026-3; Diaz RM, 2001, AM J PUBLIC HEALTH, V91, P927, DOI 10.2105/AJPH.91.6.927; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Helleringer S, 2011, AIDS, V25, P503, DOI 10.1097/QAD.0b013e3283434485; Hemmige V, 2011, AIDS PATIENT CARE ST, V25, P725, DOI 10.1089/apc.2011.0079; Hoff PD, 2003, DYNAMIC SOCIAL NETWORK MODELING AND ANALYSIS, P303; IANNOTTI RJ, 1992, J YOUTH ADOLESCENCE, V21, P375, DOI 10.1007/BF01537024; Kadushin C, 2005, SOC NETWORKS, V27, P139, DOI 10.1016/j.socnet.2005.01.005; Kossinets G, 2006, SCIENCE, V311, P88, DOI 10.1126/science.1116869; KRACKHARDT D, 1987, SOC NETWORKS, V9, P109, DOI 10.1016/0378-8733(87)90009-8; Marsden P.V., 2005, STRUCTURAL ANAL SOCI, P8, DOI DOI 10.1017/CBO9780511811395.002; Medley A, 2009, AIDS EDUC PREV, V21, P181, DOI 10.1521/aeap.2009.21.3.181; Minnis AM, 2009, AM J EPIDEMIOL, V170, P918, DOI 10.1093/aje/kwp219; Morrison DM, 2007, PREV SCI, V8, P274, DOI 10.1007/s11121-007-0075-4; NACO Minsitry of Health and Family Welfare, 2007, NACO GUIDL HIV TEST; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Pequegnat W, 2000, SEX TRANSM DIS, V27, P127, DOI 10.1097/00007435-200003000-00001; Peterman TA, 2000, SEX TRANSM DIS, V27, P446, DOI 10.1097/00007435-200009000-00004; Schneider JA, 2012, SOC SCI MED, V75, P1192, DOI 10.1016/j.socscimed.2012.05.022; Schneider JA, 2012, AIDS BEHAV, V16, P350, DOI 10.1007/s10461-011-9982-2; Simoni JM, 2011, AIDS BEHAV, V15, P1589, DOI 10.1007/s10461-011-9963-5; Snyder H, 2012, AIDS EDUC PREV, V24, P309, DOI 10.1521/aeap.2012.24.4.309; Valente TW, 2010, SOC NETWORKS, V32, P212, DOI 10.1016/j.socnet.2010.03.003; Valente TW, 1997, SOC SCI MED, V45, P677, DOI 10.1016/S0277-9536(96)00385-1; Valente TW, 2010, SOCIAL NETWORKS HLTH, DOI DOI 10.1093/ACPROF:OSO/9780195301014.001.0001/ACPROF-9780195301014; Valleroy LA, 2000, JAMA-J AM MED ASSOC, V284, P198, DOI 10.1001/jama.284.2.198	41	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101416	10.1371/journal.pone.0101416	http://dx.doi.org/10.1371/journal.pone.0101416			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3RT	24992340	Green Published, Green Submitted, gold			2022-12-27	WOS:000341253400069
J	Hiratani, N; Fukai, T				Hiratani, Naoki; Fukai, Tomoki			Interplay between Short- and Long-Term Plasticity in Cell-Assembly Formation	PLOS ONE			English	Article							TIMING-DEPENDENT PLASTICITY; IRREGULAR PERSISTENT ACTIVITY; SYNAPTIC PLASTICITY; PYRAMIDAL NEURONS; MEMORY RETENTION; WORKING-MEMORY; AMYLOID-BETA; SPIKE; NETWORKS; MODULATION	Various hippocampal and neocortical synapses of mammalian brain show both short-term plasticity and long-term plasticity, which are considered to underlie learning and memory by the brain. According to Hebb's postulate, synaptic plasticity encodes memory traces of past experiences into cell assemblies in cortical circuits. However, it remains unclear how the various forms of long-term and short-term synaptic plasticity cooperatively create and reorganize such cell assemblies. Here, we investigate the mechanism in which the three forms of synaptic plasticity known in cortical circuits, i.e., spike-timing-dependent plasticity (STDP), short-term depression (STD) and homeostatic plasticity, cooperatively generate, retain and reorganize cell assemblies in a recurrent neuronal network model. We show that multiple cell assemblies generated by external stimuli can survive noisy spontaneous network activity for an adequate range of the strength of STD. Furthermore, our model predicts that a symmetric temporal window of STDP, such as observed in dopaminergic modulations on hippocampal neurons, is crucial for the retention and integration of multiple cell assemblies. These results may have implications for the understanding of cortical memory processes.	[Hiratani, Naoki; Fukai, Tomoki] Univ Tokyo, Dept Complex Sci & Engn, Kashiwa, Chiba, Japan; [Fukai, Tomoki] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Hiratani, Naoki; Fukai, Tomoki] RIKEN, Brain Sci Inst, Lab Neural Circuit Theory, Wako, Saitama, Japan; [Fukai, Tomoki] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama, Japan	University of Tokyo; Japan Society for the Promotion of Science; RIKEN; Japan Science & Technology Agency (JST)	Fukai, T (corresponding author), Univ Tokyo, Dept Complex Sci & Engn, Kashiwa, Chiba, Japan.	tfukai@riken.jp	Fukai, Tomoki/A-3936-2015	Fukai, Tomoki/0000-0001-6977-5638	Junior Research Associate Program of RIKEN;  [22115013]	Junior Research Associate Program of RIKEN; 	This work was partly supported by Grants-in-Aid for Scientific Research on Innovative Areas (no. 22115013, http://www.jsps.go.jp/english/e-grants/index.html). NH was supported by Junior Research Associate Program of RIKEN (http://www.riken.jp/en/careers/programs/jra/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; Barbieri F, 2007, FRONT COMPUT NEUROSC, V1, DOI 10.3389/neuro.10.005.2007; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Billings G, 2009, J NEUROPHYSIOL, V101, P2775, DOI 10.1152/jn.91007.2008; Bush D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000839; Buzsaki G, 2014, NAT REV NEUROSCI, V15, P264, DOI 10.1038/nrn3687; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Cassenaer S, 2012, NATURE, V482, P47, DOI 10.1038/nature10776; Cheetham CEJ, 2010, J NEUROSCI, V30, P12566, DOI 10.1523/JNEUROSCI.2544-10.2010; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; Del Giudice P, 2001, NEUROCOMPUTING, V38, P1175, DOI 10.1016/S0925-2312(01)00557-4; Diekelmann S, 2010, BEHAV BRAIN RES, V208, P425, DOI 10.1016/j.bbr.2009.12.021; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; El Boustani S, 2012, J NEUROSCI, V32, P194, DOI 10.1523/JNEUROSCI.2496-11.2012; Ellenbogen JM, 2007, P NATL ACAD SCI USA, V104, P7723, DOI 10.1073/pnas.0700094104; Fiete IR, 2010, NEURON, V65, P563, DOI 10.1016/j.neuron.2010.02.003; Fukai T, 2001, BIOL CYBERN, V85, P107, DOI 10.1007/PL00007998; Gilson M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025339; Gilson M, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00023; Gilson M, 2010, BIOL CYBERN, V103, P365, DOI 10.1007/s00422-010-0405-7; Gilson M, 2009, BIOL CYBERN, V101, P427, DOI 10.1007/s00422-009-0346-1; Hansel D, 2013, J NEUROSCI, V33, P133, DOI 10.1523/JNEUROSCI.3455-12.2013; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hiratani N, 2013, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00102; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Itami C, 2012, J NEUROSCI, V32, P15000, DOI 10.1523/JNEUROSCI.2506-12.2012; Izhikevich EM, 2004, CEREB CORTEX, V14, P933, DOI 10.1093/cercor/bhh053; Karst H, 2005, P NATL ACAD SCI USA, V102, P19204, DOI 10.1073/pnas.0507572102; Klampfl S, 2013, J NEUROSCI, V33, P11515, DOI 10.1523/JNEUROSCI.5044-12.2013; Lengyel M, 2005, NAT NEUROSCI, V8, P1677, DOI 10.1038/nn1561; Levy N, 2001, NEURAL NETWORKS, V14, P815, DOI 10.1016/S0893-6080(01)00044-2; Lewis PA, 2011, TRENDS COGN SCI, V15, P343, DOI 10.1016/j.tics.2011.06.004; Litwin-Kumar A, 2012, NAT NEUROSCI, V15, P1498, DOI 10.1038/nn.3220; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Marro J, 2007, NEURAL NETWORKS, V20, P230, DOI 10.1016/j.neunet.2006.11.005; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Morrison A, 2007, NEURAL COMPUT, V19, P1437, DOI 10.1162/neco.2007.19.6.1437; O'Neill J, 2010, TRENDS NEUROSCI, V33, P220, DOI 10.1016/j.tins.2010.01.006; Oswald AMM, 2008, J NEUROPHYSIOL, V99, P2998, DOI 10.1152/jn.01160.2007; Pantic L, 2002, NEURAL COMPUT, V14, P2903, DOI 10.1162/089976602760805331; Redondo RL, 2011, NAT REV NEUROSCI, V12, P17, DOI 10.1038/nrn2963; Romani S, 2006, J COMPUT NEUROSCI, V20, P201, DOI 10.1007/s10827-006-6308-x; Sandi C, 2011, TRENDS NEUROSCI, V34, P165, DOI 10.1016/j.tins.2011.01.006; Seol GH, 2007, NEURON, V55, P919, DOI 10.1016/j.neuron.2007.08.013; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Tan DP, 2006, P NATL ACAD SCI USA, V103, P5125, DOI 10.1073/pnas.0601043103; Teramae J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00485; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; van Vreeswijk C, 1998, NEURAL COMPUT, V10, P1321, DOI 10.1162/089976698300017214; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; York LC, 2009, J COMPUT NEUROSCI, V27, P607, DOI 10.1007/s10827-009-0172-4; Zenke F, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003330; Zhang JC, 2009, P NATL ACAD SCI USA, V106, P13028, DOI 10.1073/pnas.0900546106; Zheng PS, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002848	59	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101535	10.1371/journal.pone.0101535	http://dx.doi.org/10.1371/journal.pone.0101535			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007209	gold, Green Submitted, Green Published			2022-12-27	WOS:000339040600043
J	Noratto, GD; Garcia-Mazcorro, JF; Markel, M; Martino, HS; Minamoto, Y; Steiner, JM; Byrne, D; Suchodolski, JS; Mertens-Talcott, SU				Noratto, Giuliana D.; Garcia-Mazcorro, Jose F.; Markel, Melissa; Martino, Hercia S.; Minamoto, Yasushi; Steiner, Joerg M.; Byrne, David; Suchodolski, Jan S.; Mertens-Talcott, Susanne U.			Carbohydrate-Free Peach (Prunus persica) and Plum (Prunus domestica) Juice Affects Fecal Microbial Ecology in an Obese Animal Model	PLOS ONE			English	Article							EUTERPE-OLERACEA MART.; DIET-INDUCED OBESITY; GUT MICROBIOTA; IN-VITRO; INTESTINAL MICROBIOTA; BACTERIAL MICROBIOTA; TEA POLYPHENOLS; METABOLIC-FATE; RIBOSOMAL-RNA; RED WINE	Background: Growing evidence shows the potential of nutritional interventions to treat obesity but most investigations have utilized non-digestible carbohydrates only. Peach and plum contain high amounts of polyphenols, compounds with demonstrated anti-obesity effects. The underlying process of successfully treating obesity using polyphenols may involve an alteration of the intestinal microbiota. However, this phenomenon is not well understood. Methodology/Principal Findings: Obese Zucker rats were assigned to three groups (peach, plum, and control, n = 10 each), wild-type group was named lean (n = 10). Carbohydrates in the fruit juices were eliminated using enzymatic hydrolysis. Fecal samples were obtained after 11 weeks of fruit or control juice administration. Real-time PCR and 454-pyrosequencing were used to evaluate changes in fecal microbiota. Over 1,500 different Operational Taxonomic Units at 97% similarity were detected in all rats. Several bacterial groups (e. g. Lactobacillus and members of Ruminococcacea) were found to be more abundant in the peach but especially in the plum group (plum juice contained 3 times more total polyphenolics compared to peach juice). Principal coordinate analysis based on Unifrac-based unweighted distance matrices revealed a distinct separation between the microbiota of control and treatment groups. These changes in fecal microbiota occurred simultaneously with differences in fecal short-chain acids concentrations between the control and treatment groups as well as a significant decrease in body weight in the plum group. Conclusions: This study suggests that consumption of carbohydrate-free peach and plum juice has the potential to modify fecal microbial ecology in an obese animal model. The separate contribution of polyphenols and non-polyphenols compounds (vitamins and minerals) to the observed changes is unknown.	[Noratto, Giuliana D.; Martino, Hercia S.; Mertens-Talcott, Susanne U.] Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX 77843 USA; [Garcia-Mazcorro, Jose F.] Univ Autonoma Nuevo Leon, Fac Med Vet & Zootecnia, Nuevo Leon, Mexico; [Markel, Melissa; Minamoto, Yasushi; Steiner, Joerg M.; Suchodolski, Jan S.] Texas A&M Univ, Gastrointestinal Lab, College Stn, TX USA; [Byrne, David] Texas A&M Univ, Dept Hort Sci, College Stn, TX 77843 USA; [Mertens-Talcott, Susanne U.] Texas A&M Univ, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Universidad Autonoma de Nuevo Leon; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Mertens-Talcott, SU (corresponding author), Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX 77843 USA.	SMTalcott@tamu.edu	Noratto, Giuliana/AAS-8959-2020; Byrne, David/AAF-6262-2021; Garcia-Mazcorro, Jose F./O-5799-2018	Garcia-Mazcorro, Jose F./0000-0001-6047-4361; Stampini Duarte Martino, Hercia/0000-0002-8565-8439; Noratto, Giuliana/0000-0003-1831-7172; Suchodolski, Jan/0000-0002-2176-6932; Mertens-Talcott, Susanne/0000-0003-2828-4044	Vegetable and Fruit Improvement Center at Texas AM University; National Counsel of Technological and Scientific Development (CNPq-Brazil) [200382/2011-0]; CONACYT (Mexico) through the National System of Researchers program	Vegetable and Fruit Improvement Center at Texas AM University; National Counsel of Technological and Scientific Development (CNPq-Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CONACYT (Mexico) through the National System of Researchers program	This research was supported by the Vegetable and Fruit Improvement Center (http://vfic.tamu.edu/) at Texas A&M University. Hercia S. Martino thanks the National Counsel of Technological and Scientific Development (CNPq-Brazil) for the scholarship (reference number: 200382/2011-0). Jose F Garcia-Mazcorro is financially supported by CONACYT (Mexico) through the National System of Researchers (SNI, for initials in Spanish) program (http://www.conacyt.mx/index.php/el-conacyt/sistema-nacional-de-investigadores). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YJ, 1998, J APPL MICROBIOL, V84, P439, DOI 10.1046/j.1365-2672.1998.00363.x; Albrecht M, 2004, J MED FOOD, V7, P274, DOI 10.1089/1096620041938704; Bialonska D, 2010, INT J FOOD MICROBIOL, V140, P175, DOI 10.1016/j.ijfoodmicro.2010.03.038; Bolca S, 2013, CURR OPIN BIOTECH, V24, P220, DOI 10.1016/j.copbio.2012.09.009; Bravo L, 1998, NUTR REV, V56, P317, DOI 10.1111/j.1753-4887.1998.tb01670.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chiva-Blanch G, 2012, J BERRY RES, V2, P63, DOI 10.3233/JBR-2012-028; Coccia A, 2012, INT J FOOD SCI TECH, V47, P1620, DOI 10.1111/j.1365-2621.2012.03012.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; Cueva C, 2013, FEMS MICROBIOL ECOL, V83, P792, DOI 10.1111/1574-6941.12037; Delzenne NM, 2011, ANNU REV NUTR, V31, P15, DOI 10.1146/annurev-nutr-072610-145146; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Gallagher EJ, 2010, MT SINAI J MED, V77, P511, DOI 10.1002/msj.20212; Garcia-Mazcorro JF, 2012, FEMS MICROBIOL ECOL, V80, P624, DOI 10.1111/j.1574-6941.2012.01331.x; LeBlanc JG, 2013, CURR OPIN BIOTECH, V24, P160, DOI 10.1016/j.copbio.2012.08.005; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hidalgo M, 2012, J AGR FOOD CHEM, V60, P3882, DOI 10.1021/jf3002153; Holvoet P, 2008, Verh K Acad Geneeskd Belg, V70, P193; Hunter DC, 2012, PHYTOCHEMICALS NUTRA, P225; Ikeda I, 2005, J NUTR, V135, P155, DOI 10.1093/jn/135.2.155; Queipo-Ortuno MI, 2012, AM J CLIN NUTR, V95, P1323, DOI 10.3945/ajcn.111.027847; Jellinger Paul S, 2007, Clin Cornerstone, V8 Suppl 7, pS30, DOI 10.1016/S1098-3597(07)80019-6; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926; Lacombe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067497; Lee HC, 2006, RES MICROBIOL, V157, P876, DOI 10.1016/j.resmic.2006.07.004; Lei F, 2007, INT J OBESITY, V31, P1023, DOI 10.1038/sj.ijo.0803502; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lin JK, 2006, MOL NUTR FOOD RES, V50, P211, DOI 10.1002/mnfr.200500138; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Ly NP, 2011, J ALLERGY CLIN IMMUN, V127, P1087, DOI 10.1016/j.jaci.2011.02.015; Malinen E, 2005, AM J GASTROENTEROL, V100, P373, DOI 10.1111/j.1572-0241.2005.40312.x; Mertens-Talcott SU, 2008, J AGR FOOD CHEM, V56, P7796, DOI 10.1021/jf8007037; Meydani M, 2010, NUTRIENTS, V2, P737, DOI 10.3390/nu2070737; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Moreau NM, 2003, J CHROMATOGR B, V784, P395, DOI 10.1016/S1570-0232(02)00827-9; Muhling M, 2008, ISME J, V2, P379; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nakai M, 2005, J AGR FOOD CHEM, V53, P4593, DOI 10.1021/jf047814+; Niswender KD, 2011, POSTGRAD MED, V123, P27, DOI 10.3810/pgm.2011.07.2301; Pacheco-Palencia LA, 2008, J AGR FOOD CHEM, V56, P3593, DOI 10.1021/jf8001608; Parkar SG, 2008, INT J FOOD MICROBIOL, V124, P295, DOI 10.1016/j.ijfoodmicro.2008.03.017; Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281; Presley LL, 2010, APPL ENVIRON MICROB, V76, P936, DOI 10.1128/AEM.01561-09; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051907; Suchodolski JS, 2010, VET MICROBIOL, V142, P394, DOI 10.1016/j.vetmic.2009.11.002; SWAIN T., 1959, Journal of the Science of Food and Agriculture, V10, P63, DOI 10.1002/jsfa.2740100110; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Tzounis X, 2008, BRIT J NUTR, V99, P782, DOI 10.1017/S0007114507853384; Tzounis X, 2011, AM J CLIN NUTR, V93, P62, DOI 10.3945/ajcn.110.000075; van Baarlen P, 2011, P NATL ACAD SCI USA, V108, P4562, DOI 10.1073/pnas.1000079107; van Dorsten FA, 2010, MOL NUTR FOOD RES, V54, P897, DOI 10.1002/mnfr.200900212; van Duynhoven J, 2011, P NATL ACAD SCI USA, V108, P4531, DOI 10.1073/pnas.1000098107; Waldram A, 2009, J PROTEOME RES, V8, P2361, DOI 10.1021/pr8009885	61	32	34	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101723	10.1371/journal.pone.0101723	http://dx.doi.org/10.1371/journal.pone.0101723			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007331	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000339040600061
J	Zou, X; Wang, HJ; Cai, LL; Li, KL; Zhang, W; Ding, Y; Si, QJ				Zou, Xiao; Wang, Haijun; Cai, Lili; Li, Kailiang; Zhang, Wei; Ding, Yu; Si, Quanjin			Effects of Serum Lipid Smoothness on the Progression and Vulnerability of Atherosclerotic Plaques in Rabbits	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; C-REACTIVE PROTEIN; MATRIX METALLOPROTEINASES; ENDOTHELIAL DYSFUNCTION; MYOCARDIAL-INFARCTION; INFLAMMATION; RUPTURE; LOX-1; CELLS; RISK	Objective: We aimed to explore the effects of lipid smoothness on the progression and vulnerability of atherosclerotic plaques. Approach: 24 rabbits were divided into three groups randomly. Group 1 was given standard chow diet; group 2 was fed with cholesterol-rich diet; for group 3, subjects were planned to take cholesterol-rich diet at the first phase for 12 weeks and during the second phase, low-fat and cholesterol-rich diet was then applied alternately every three weeks till the end of the experiment. Lipid profiles, inflammatory factors, endothelium functions, pathological and histological changes were examined. Expressions of matrix metalloproteinase-9 and lectin-like oxidized LDL receptor-1 were measured by immunohistochemical staining. Results: According to data collected during the whole experiment, lipid smoothness index of group 3 was the lowest. Compared with group 2, statistics of the group 3 indicated that: the development of plaques progressed faster; the plaque area and plaque thickness (53.53[22.6]% vs 33.90[24.91]%, 800.38[98.25]mu m vs 675.00[109.67]mu m) were higher while the fibrous cap thickness (103.50[45.66]mu m vs 295.83[97.90] mm) was lower; hs-CRP (0.53[0.07] mg/dL vs 0.45[0.06] mg/dL), interleukin-18 (186.01[8.41]ng/L vs 158.08[2.37]ng/L), OX-LDL (177.15[5.93]mu g/L vs 139.57[2.35] mu g/L) and endothelin-1 (164.66[9.54] ng/L vs 131.52[4.39]ng/L) were higher while nitric-oxide (22.41[1.69]mu mol/L vs 27.23[1.36]mu mol/L) was lower; expressions of matrix metalloproteinase-9 (IOD: 37375.87[5634.52] vs 20956.57[4616.93]) and lectin-like oxidized LDL receptor-1 (IOD: 45213.04[16653.81] vs 21921.68[6142.32]) were higher. Conclusions: Lipids fluctuation could accelerate the progression and vulnerability of atherosclerotic plaques through worsening arterial endothelium dysfunction and inflammatory reactions.	[Zou, Xiao; Wang, Haijun; Li, Kailiang; Zhang, Wei; Ding, Yu; Si, Quanjin] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol 1, Beijing, Peoples R China; [Cai, Lili] Chinese Peoples Liberat Army Gen Hosp, Clin Lab Nanlou, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Si, QJ (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol 1, Beijing, Peoples R China.	quanjin2004@sohu.com						Bea F, 2002, ARTERIOSCL THROM VAS, V22, P1832, DOI 10.1161/01.ATV.0000036081.01231.16; Blankenberg S, 2003, CIRCULATION, V108, P2453, DOI 10.1161/01.CIR.0000099509.76044.A2; Calabro P, 2009, SEMIN IMMUNOPATHOL, V31, P79, DOI 10.1007/s00281-009-0149-4; Funk SD, 2013, PHARMACOL RES, V67, P42, DOI 10.1016/j.phrs.2012.10.008; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hayashida K, 2002, FEBS LETT, V511, P133, DOI 10.1016/S0014-5793(01)03297-5; Heo SH, 2011, J CLIN NEUROL, V7, P69, DOI 10.3988/jcn.2011.7.2.69; Itabe H, 1998, PROG LIPID RES, V37, P181, DOI 10.1016/S0163-7827(98)00009-5; Juhel C, 2000, BRIT J NUTR, V83, P549; Li D, 2010, CIRC-CARDIOVASC IMAG, V3, P464, DOI 10.1161/CIRCIMAGING.109.896654; Li DY, 2003, CIRCULATION, V107, P612, DOI 10.1161/01.CIR.0000047276.52039.FB; Li TT, 2011, TOHOKU J EXP MED, V225, P23, DOI 10.1620/tjem.225.23; Libby P, 2005, J AM COLL CARDIOL, V45, P1600, DOI 10.1016/j.jacc.2005.02.058; Libby P, 2002, NAT MED, V8, P1257, DOI 10.1038/nm1102-1257; Mauriello A, 2005, J AM COLL CARDIOL, V45, P1585, DOI 10.1016/j.jacc.2005.01.054; Moreno PR, 2002, CIRCULATION, V105, P923, DOI 10.1161/hc0802.104291; Nadzhafov RN, 2010, KARDIOLOGIIA, V50, P88; Ortiz AF, 1999, REV ESP CARDIOL, V52, P3; Rai S, 2009, INT J EXP PATHOL, V90, P598, DOI 10.1111/j.1365-2613.2009.00668.x; Razavian M, 2011, J NUCL MED, V52, P1795, DOI 10.2967/jnumed.111.092379; Ross JS, 2001, ANN NY ACAD SCI, V947, P271; Silva D, 2012, REV PORT CARDIOL, V31, P733, DOI 10.1016/j.repc.2012.02.018; Silvello D, 2013, BIOMARKERS; Steinberg D, 2005, MOL NUTR FOOD RES, V49, P995, DOI 10.1002/mnfr.200500081; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Wilbert-Lampen U, 2007, ENDOTHELIUM-J ENDOTH, V14, P65, DOI 10.1080/10623320701346585; Wu G, 2013, CHEM PHARM BULL, V61, P121, DOI 10.1248/cpb.c12-00462; Yu MM, 2010, INT J CARDIOL, V145, P57, DOI 10.1016/j.ijcard.2009.04.018; Yu Q, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/506159; Zhao SH, 2008, THROMB RES, V123, P281, DOI 10.1016/j.thromres.2008.04.011	32	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e93686	10.1371/journal.pone.0093686	http://dx.doi.org/10.1371/journal.pone.0093686			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007151	Green Published, Green Submitted, gold			2022-12-27	WOS:000339040600001
J	Meng, Y; Lin, S; Liu, SF; Fan, X; Li, GR; Meng, YF				Meng, Yao; Lin, Sen; Liu, Shuangfeng; Fan, Xiang; Li, Gangrui; Meng, Yanfa			A Novel Method for Simultaneous Production of Two Ribosome-Inactivating Proteins, alpha-MMC and MAP30, from Momordica charantia L.	PLOS ONE			English	Article							IN-VITRO; ANTITUMOR; INHIBITION; EXPRESSION; APOPTOSIS; PROGRESS; SEEDS	Alpha-momorcharin (alpha-MMC) and momordica anti-HIV protein (MAP30) from Momordica charantia L. have been confirmed to possess anti-tumor and anti-virus activities. Traditional purification methods of these two ribosome-inactivating proteins (RIPs) were separate which was time consuming and cost effective as well as low efficient. In order to obtain sufficient samples for researches, a strategy combining ion-exchange and gel filtration chromatography was developed and optimized in this study. Using this novel purification method, averagely 1162 mg of alpha-MMC and 535 mg of MAP30 were obtained from 400 g of Momordica charantia L seeds. The homogeneities of them were assessed by electrophoresis analysis. Determination of molecular weights of alpha-MMC and MAP30 were 28.585 kDa and 29.094 kDa by MALDI-TOF/TOF and pl were 9.02 and 9.12, respectively. The single glycoproteins were identified by Periodate-Schiff's base (PAS) and the saccharide content was tested to be 1.25% and 1.1% by anthrone-sulfuric acid method. Biological activities were evidenced by their ability to inhibit proliferation of lung adenocarcinoma A549 cell and to convert supercoiled plasmid pUC18 into relaxed forms. Finally, we also found that both two RIPs exhibited no superoxide dismutase (SOD) activity.	[Meng, Yao; Liu, Shuangfeng] Chengdu Med Coll, Sch Med Lab Sci, Chengdu, Peoples R China; [Lin, Sen] Chengdu Med Coll, Dept Histol & Embryol & Neurobiol, Dev & Regenerat Key Lab Sichuan Prov, Chengdu, Peoples R China; [Fan, Xiang; Li, Gangrui; Meng, Yanfa] Sichuan Univ, Key Lab Bioresources & Ecoenvironm, Minist Educ,Coll Life Sci, Anim Dis Prevent & Food Safety Key Lab Sichuan Pr, Chengdu 610064, Peoples R China	Chengdu Medical College; Chengdu Medical College; Sichuan University	Meng, YF (corresponding author), Sichuan Univ, Key Lab Bioresources & Ecoenvironm, Minist Educ,Coll Life Sci, Anim Dis Prevent & Food Safety Key Lab Sichuan Pr, Chengdu 610064, Peoples R China.	yfmeng0902@scu.edu.cn			Sichuan provincial department of education [13ZB0091, 201313705020]; Sichuan province health department [130301]	Sichuan provincial department of education; Sichuan province health department	This work was financially supported by Sichuan provincial department of education (Grant No. 13ZB0091, No. 201313705020) and Sichuan province health department (Grant No. 130301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Bian XX, 2010, BIOTECHNOL LETT, V32, P883, DOI 10.1007/s10529-010-0242-8; Bourinbaiar AS, 1996, BIOCHEM BIOPH RES CO; Budilova J, 2006, J SEP SCI, V29, P1613, DOI 10.1002/jssc.200500458; de Virgilio M, 2010, TOXINS, V2, P2699, DOI 10.3390/toxins2112699; DOERNER KC, 1990, ANAL BIOCHEM, V187, P147, DOI 10.1016/0003-2697(90)90433-A; Fan J, 2009, MOL BIOL REP, V36, P381, DOI 10.1007/s11033-007-9191-2; Fan JM, 2008, MOL BIOTECHNOL, V39, P79, DOI 10.1007/s12033-008-9034-y; Fang EF, 2011, CURR MED CHEM, V18, P4410; Fang EF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041592; Fang EF, 2012, CANCER LETT, V324, P66, DOI 10.1016/j.canlet.2012.05.005; Fong WP, 1996, LIFE SCI, V59, P901, DOI 10.1016/0024-3205(96)00388-8; GRAHAM D, 1965, ANAL BIOCHEM, V11, P246, DOI 10.1016/0003-2697(65)90012-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee K, 2009, J SEP SCI, V32, P1237, DOI 10.1002/jssc.200800672; Lee-Huang S, 2000, ANTICANCER RES, V20, P653; LEEHUANG S, 1990, FEBS LETT, V272, P12, DOI 10.1016/0014-5793(90)80438-O; Li ME, 2009, ACTA BIOCH BIOPH SIN, V41, P792, DOI 10.1093/abbs/gmp068; Li XD, 1997, PROTEIN EXPRES PURIF, V10, P27, DOI 10.1006/prep.1996.0706; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Meng Y, 2012, INT J NANOMED, V7, P3133, DOI 10.2147/IJN.S30631; Mukherjee P, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-207; Niepmann M, 2006, ELECTROPHORESIS, V27, P3949, DOI 10.1002/elps.200600172; Park SW, 2004, PLANTA, V219, P1093, DOI 10.1007/s00425-004-1357-8; Schreiber CA, 1999, FERTIL STERIL, V72, P686, DOI 10.1016/S0015-0282(99)00302-7; Stirpe F, 2006, CELL MOL LIFE SCI, V63, P1850, DOI 10.1007/s00018-006-6078-7; Stirpe F, 2004, TOXICON, V44, P371, DOI 10.1016/j.toxicon.2004.05.004; Sun YT, 2001, BIOCHEM BIOPH RES CO, V287, P983, DOI 10.1006/bbrc.2001.5689; Tumer NE, 2012, CURR TOP MICROBIOL, V357, P1, DOI 10.1007/82_2011_174	30	13	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101998	10.1371/journal.pone.0101998	http://dx.doi.org/10.1371/journal.pone.0101998			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003606	gold, Green Submitted, Green Published			2022-12-27	WOS:000339242700097
J	Patel, SA; Narayan, KMV; Ali, MK; Mehta, NK				Patel, Shivani A.; Narayan, K. M. Venkat; Ali, Mohammed K.; Mehta, Neil K.			Interstate Variation in Modifiable Risk Factors and Cardiovascular Mortality in the United States	PLOS ONE			English	Article							LEADING CAUSES; HEART-DISEASE; HEALTH; PREVALENCE; VALIDITY; DEATHS; IMPACT	Objective: We investigated the role of state-level differences in modifiable cardiovascular (CV) risk factors in contributing to state disparities in cardiovascular mortality rates in the US. Methods: Adults aged 45-74 in 2010 were examined. We constructed a CV risk index summarizing state-level exposure to current smoking, obesity, physical inactivity, alcohol abstinence, hypertension, elevated cholesterol, and diabetes using the Behavioral Risk Factor Surveillance System. Outcomes were cardiovascular, coronary heart disease, and stroke mortality. Linear regression was used to estimate associations between the CV risk index and mortality outcomes. Models accounted for state-level socioeconomic characteristics and other potential confounders. Results: Risk factors were highly correlated at the state-level (Cronbach's alpha 0.85 (men) and 0.92 (women). Each + 1SD difference in the cardiovascular risk index was associated with higher adjusted cardiovascular mortality rates by 41.0 (95% CI = 26.3, 55.7) and 33.3 (95% CI = 24.4, 42.2) deaths per 100,000 for men and women, respectively. The index accounted for 8% (men) and 11% (women) of the variation in state-level cardiovascular mortality. Comparable associations were also observed for coronary heart disease and stroke mortality. Conclusions: CV risk factors were highly correlated at the state-level and were independently associated with state CV mortality, suggesting the utility of generalized CV risk reduction.	[Patel, Shivani A.; Narayan, K. M. Venkat; Ali, Mohammed K.; Mehta, Neil K.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health	Patel, SA (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.	s.a.patel@emory.edu	Narayan, K.M. Venkat/J-9819-2012; Ali, Mohammed K/N-9833-2013	Narayan, K.M. Venkat/0000-0001-8621-5405; Patel, Shivani/0000-0003-0082-5857; Ali, Mohammed/0000-0001-7266-2503	Robert Wood Johnson Foundation [70769]; NATIONAL INSTITUTE ON AGING [R01AG040212] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a grant from the Robert Wood Johnson Foundation (http://www.rwjf.org; grant #: 70769). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOWLIN SJ, 1993, J CLIN EPIDEMIOL, V46, P561, DOI 10.1016/0895-4356(93)90129-O; Bowlin SJ, 1996, J CLIN EPIDEMIOL, V49, P511, DOI 10.1016/0895-4356(96)00010-8; Byers T, 1998, PREV MED, V27, P311, DOI 10.1006/pmed.1998.0303; Fang Jing, 2011, Morbidity and Mortality Weekly Report, V60, P1377; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Ford ES, 2011, ANNU REV PUBL HEALTH, V32, P5, DOI 10.1146/annurev-publhealth-031210-101211; Ford ES, 2005, OBES RES, V13, P118, DOI 10.1038/oby.2005.15; Hahn R A, 1998, MMWR CDC Surveill Summ, V47, P35; Howard G, 2009, PREV MED, V49, P129, DOI 10.1016/j.ypmed.2009.03.004; Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; Li CY, 2012, PREV MED, V54, P381, DOI 10.1016/j.ypmed.2012.04.003; Lipsitch M, 2010, EPIDEMIOLOGY, V21, P383, DOI 10.1097/EDE.0b013e3181d61eeb; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Martin LM, 2000, AM J PREV MED, V18, P215, DOI 10.1016/S0749-3797(99)00158-0; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WILLIAMS DR, 1995, ANNU REV SOCIOL, V21, P349, DOI 10.1146/annurev.so.21.080195.002025; Yoon PW, 2014, MMWR-MORBID MORTAL W, V63, P369; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	21	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101531	10.1371/journal.pone.0101531	http://dx.doi.org/10.1371/journal.pone.0101531			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL6KZ	25003975	Green Published, Green Submitted, gold			2022-12-27	WOS:000339242700036
J	Penn, LA; Qian, M; Zhang, EH; Ng, E; Shao, YZ; Berwick, M; Lazovich, D; Polsky, D				Penn, Lauren A.; Qian, Meng; Zhang, Enhan; Ng, Elise; Shao, Yongzhao; Berwick, Marianne; Lazovich, DeAnn; Polsky, David			Development of a Melanoma Risk Prediction Model Incorporating MC1R Genotype and Indoor Tanning Exposure: Impact of Mole Phenotype on Model Performance	PLOS ONE			English	Article							DIVERGENT PATHWAY HYPOTHESIS; GENOME-WIDE ASSOCIATION; COMMON GENETIC-VARIANTS; BREAST-CANCER RISK; CUTANEOUS MELANOMA; IDENTIFYING INDIVIDUALS; MELANOCYTIC NEVI; PROSTATE-CANCER; FAMILY-HISTORY; SUN EXPOSURE	Background: Identifying individuals at increased risk for melanoma could potentially improve public health through targeted surveillance and early detection. Studies have separately demonstrated significant associations between melanoma risk, melanocortin receptor (MC1R) polymorphisms, and indoor ultraviolet light (UV) exposure. Existing melanoma risk prediction models do not include these factors; therefore, we investigated their potential to improve the performance of a risk model. Methods: Using 875 melanoma cases and 765 controls from the population-based Minnesota Skin Health Study we compared the predictive ability of a clinical melanoma risk model (Model A) to an enhanced model (Model F) using receiver operating characteristic (ROC) curves. Model A used self-reported conventional risk factors including mole phenotype categorized as "none'', "few'', "some'' or "many'' moles. Model F added MC1R genotype and measures of indoor and outdoor UV exposure to Model A. We also assessed the predictive ability of these models in subgroups stratified by mole phenotype (e.g. nevus-resistant ("none'' and "few'' moles) and nevus-prone ("some'' and "many'' moles)). Results: Model A (the reference model) yielded an area under the ROC curve (AUC) of 0.72 (95% CI = 0.69, 0.74). Model F was improved with an AUC = 0.74 (95% CI = 0.71-0.76, p<0.01). We also observed substantial variations in the AUCs of Models A & F when examined in the nevus-prone and nevus-resistant subgroups. Conclusions: These results demonstrate that adding genotypic information and environmental exposure data can increase the predictive ability of a clinical melanoma risk model, especially among nevus-prone individuals.	[Penn, Lauren A.; Ng, Elise; Polsky, David] NYU, Sch Med, Ronald O Perelman Dept Dermatol, New York, NY 10012 USA; [Qian, Meng; Zhang, Enhan; Shao, Yongzhao] NYU, Sch Med, Dept Populat Hlth & Environm Med, New York, NY USA; [Berwick, Marianne] Univ New Mexico, Ctr Canc, Dept Internal Med, Div Epidemiol & Biostat, Albuquerque, NM 87131 USA; [Lazovich, DeAnn] Univ Minnesota, Sch Publ Hlth, Masonic Med Ctr, Div Epidemiol & Community Hlth, Minneapolis, MN USA	New York University; New York University; University of New Mexico; University of Minnesota System; University of Minnesota Twin Cities	Polsky, D (corresponding author), NYU, Sch Med, Ronald O Perelman Dept Dermatol, New York, NY 10012 USA.	David.Polsky@nyumc.org	Polsky, David/AAO-6254-2020	Polsky, David/0000-0001-9554-5289; Berwick, Marianne/0000-0001-5062-2180	Live4Life foundation; Marc Jacobs Campaign; American Cancer Society [RSGPB-04-083-01-CCE]; National Cancer Institute [5R01CA106807]; NATIONAL CANCER INSTITUTE [R01CA106807, P30CA016087] Funding Source: NIH RePORTER	Live4Life foundation; Marc Jacobs Campaign; American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the following sources of funding: 1. Live4Life foundation; 2. Marc Jacobs Campaign to Support Melanoma Research; 3. American Cancer Society (RSGPB-04-083-01-CCE); and 4. The National Cancer Institute (5R01CA106807). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boniol M, 2012, CUTANEOUS MELANOMA A, V345, pe8503; Boniol M, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4757; Chatterjee N, 2011, CANCER EPIDEM BIOMAR, V20, P3, DOI 10.1158/1055-9965.EPI-10-1022; Cho E, 2005, J CLIN ONCOL, V23, P2669, DOI 10.1200/JCO.2005.11.108; Cust AE, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-406; Elfakir A, 2010, J INVEST DERMATOL, V130, P1107, DOI 10.1038/jid.2009.366; Falchi M, 2009, NAT GENET, V41, P915, DOI 10.1038/ng.410; Fang SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085642; Fargnoli MC, 2010, EUR J CANCER, V46, P1413, DOI 10.1016/j.ejca.2010.01.027; Fears TR, 2006, J CLIN ONCOL, V24, P3590, DOI 10.1200/JCO.2005.04.1277; Folsom AR, 2006, ARCH INTERN MED, V166, P1368, DOI 10.1001/archinte.166.13.1368; Fortes C, 2010, EUR J CANCER PREV, V19, P393, DOI 10.1097/CEJ.0b013e32833b492f; Gail MH, 2008, J NATL CANCER I, V100, P1037, DOI 10.1093/jnci/djn180; Gandini S, 2005, EUR J CANCER, V41, P2040, DOI 10.1016/j.ejca.2005.03.034; Gandini S, 2005, EUR J CANCER, V41, P28, DOI 10.1016/j.ejca.2004.10.015; Gimotty PA, 2007, J CLIN ONCOL, V25, P1129, DOI 10.1200/JCO.2006.08.1463; Guy GP, 2013, JAMA INTERN MED, V173, P1920, DOI 10.1001/jamainternmed.2013.10013; Hill VK, 2013, ANNU REV GENOM HUM G, V14, P257, DOI 10.1146/annurev-genom-091212-153429; Ibarrola-Villava M, 2012, EUR J CANC; Kanetsky PA, 2010, CANCER-AM CANCER SOC, V116, P2416, DOI 10.1002/cncr.24994; Katalinic A, 2012, CANCER; Kricker A, 2005, CANCER EPIDEM BIOMAR, V14, P2427, DOI 10.1158/1055-9965.EPI-05-0265; Lazovich D, 2010, CANCER EPIDEM BIOMAR, V19, P1557, DOI 10.1158/1055-9965.EPI-09-1249; Lindstrom S, 2012, CANCER EPIDEM BIOMAR, V21, P437, DOI 10.1158/1055-9965.EPI-11-1038; MacInnis RJ, 2011, GENET EPIDEMIOL, V35, P549, DOI 10.1002/gepi.20605; Mar V, 2011, AUSTRALAS J DERMATOL, V52, P109, DOI 10.1111/j.1440-0960.2010.00727.x; Mealiffe ME, 2010, JNCI-J NATL CANCER I, V102, P1618, DOI 10.1093/jnci/djq388; Newton-Bishop JA, 2010, CANCER EPIDEM BIOMAR, V19, P2043, DOI 10.1158/1055-9965.EPI-10-0233; Olsen CM, 2009, INT J CANCER, V124, P937, DOI 10.1002/ijc.24011; Raimondi S, 2008, INT J CANCER, V122, P2753, DOI 10.1002/ijc.23396; Ranucci M, 2010, EUR J CARDIO-THORAC, V37, P724, DOI 10.1016/j.ejcts.2009.08.033; Ries L MD, 2008, SEER CANC STAT REV 1; Sestini P, 2011, NEW ENGL J MED, V365, P2037, DOI 10.1056/NEJMc1110293; Smith RA, 2009, CA-CANCER J CLIN, V59, P27, DOI 10.3322/caac.20008; Stefanaki I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055712; Tucker MA, 1997, JAMA-J AM MED ASSOC, V277, P1439, DOI 10.1001/jama.277.18.1439; Udayakumar D, 2009, GENOME MED, V1, DOI 10.1186/gm95; Vickers AJ, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-13; Whiteman DC, 2011, PIGM CELL MELANOMA R, V24, P879, DOI 10.1111/j.1755-148X.2011.00880.x; Whiteman DC, 2010, EXPERT REV ANTICANC, V10, P615, DOI 10.1586/ERA.10.42; Whiteman DC, 2005, CANCER EPIDEM BIOMAR, V14, P761, DOI 10.1158/1055-9965.EPI-14-4-ED; Whiteman DC, 2005, J AM ACAD DERMATOL, V52, P40, DOI 10.1016/j.jaad.2004.07.053; Williams PF, 2011, INT J CANCER, V129, P1730, DOI 10.1002/ijc.25804; Wong SS, 2012, J INVEST DERMATOL, V132, P1452, DOI 10.1038/jid.2011.473	44	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101507	10.1371/journal.pone.0101507	http://dx.doi.org/10.1371/journal.pone.0101507			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003831	Green Submitted, Green Published, gold			2022-12-27	WOS:000339242700035
J	Quilodran, CS; Currat, M; Montoya-Burgos, JI				Quilodran, Claudio S.; Currat, Mathias; Montoya-Burgos, Juan I.			A General Model of Distant Hybridization Reveals the Conditions for Extinction in Atlantic Salmon and Brown Trout	PLOS ONE			English	Article							INTERSPECIFIC HYBRIDIZATION; CLONAL REPRODUCTION; TRUTTA L.; SALAR L.; HYBRIDS; INTROGRESSION; FISH; REPLACEMENT; POLYPLOIDY; ESCULENTA	Interspecific hybridization is common in nature but can be increased in frequency or even originated by human actions, such as species introduction or habitat modification, which may threaten species persistence. When hybridization occurs between distantly related species, referred to as "distant hybridization,'' the resulting hybrids are generally infertile or fertile but do not undergo chromosomal recombination during gametogenesis. Here, we present a model describing this frequent but poorly studied interspecific hybridization to assess its consequences on parental species and to anticipate the conditions under which they can reach extinction. Our general model fully incorporates three important processes: density-dependent competition, dominance/recessivity inheritance of traits and assortative mating. We demonstrate its use and flexibility by assessing population extinction risk between Atlantic salmon and brown trout in Norway, whose interbreeding has recently increased due to farmed fish releases into the wild. We identified the set of conditions under which hybridization may threaten salmonid species. Thanks to the flexibility of our model, we evaluated the effect of an additional risk factor, a parasitic disease, and showed that the cumulative effects dramatically increase the extinction risk. The consequences of distant hybridization are not genetically, but demographically mediated. Our general model is useful to better comprehend the evolution of such hybrid systems and we demonstrated its importance in the field of conservation biology to set up management recommendations when this increasingly frequent type of hybridization is in action.	[Quilodran, Claudio S.; Currat, Mathias] Univ Geneva, Dept Genet & Evolut, Lab Anthropol Genet & Peopling Hist AGP, Geneva, Switzerland; [Quilodran, Claudio S.; Montoya-Burgos, Juan I.] Univ Geneva, Lab Mol Phylogeny & Evolut Vertebrates, Dept Genet & Evolut, Geneva, Switzerland	University of Geneva; University of Geneva	Currat, M (corresponding author), Univ Geneva, Dept Genet & Evolut, Lab Anthropol Genet & Peopling Hist AGP, Geneva, Switzerland.	mathias.currat@unige.ch		Quilodran, Claudio/0000-0001-7197-9154; Montoya-Burgos, Juan I./0000-0001-9080-9820	CADMOS; SNSF; Canton de Geneve; G. and A. Claraz donation; CONICYT-Becas Chile; iGE3 student salary award	CADMOS; SNSF(Swiss National Science Foundation (SNSF)); Canton de Geneve; G. and A. Claraz donation; CONICYT-Becas Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); iGE3 student salary award	This study was financed by a fellowship from CADMOS granted to JIMB and MC and partly supported by grants from the SNSF, the Canton de Geneve and the G. and A. Claraz donation to JIMB. CSQ acknowledges support from CONICYT-Becas Chile and from the iGE3 student salary award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Alvarez D, 2011, CAN J FISH AQUAT SCI, V68, P953, DOI [10.1139/F2011-004, 10.1139/F11-004, 10.1139/f2011-004]; Armstrong JD, 2003, FISH RES, V62, P143, DOI 10.1016/S0165-7836(02)00160-1; Arnold ML, 2010, TRENDS ECOL EVOL, V25, P530, DOI 10.1016/j.tree.2010.06.005; Bakke TA, 1999, PARASITOLOGY, V119, P467, DOI 10.1017/S0031182099004990; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Birkhead TR, 2007, TRENDS ECOL EVOL, V22, P266, DOI 10.1016/j.tree.2007.02.004; Castillo AGF, 2007, MOL ECOL, V16, P1741, DOI 10.1111/j.1365-294X.2007.03257.x; Castillo AGF, 2008, AQUACULTURE, V278, P31, DOI 10.1016/j.aquaculture.2008.03.029; Crespo-Lopez ME, 2006, ZOOLOGY, V109, P277, DOI 10.1016/j.zool.2006.03.008; Currat M, 2004, PLOS BIOL, V2, P2264, DOI 10.1371/journal.pbio.0020421; Currat M, 2008, EVOLUTION, V62, P1908, DOI 10.1111/j.1558-5646.2008.00413.x; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; DAWLEY RM, 1987, COPEIA, P275, DOI 10.2307/1445762; Ferdy JB, 2002, AM NAT, V160, P74, DOI 10.1086/340606; Galbreath PF, 1995, AQUACULTURE, V137, P299, DOI 10.1016/0044-8486(95)01115-3; Garcia-Vazquez E, 2004, AQUACULTURE, V234, P77, DOI 10.1016/j.aquaculture.2004.01.017; Garcia-Vazquez E, 2003, FRESHWATER BIOL, V48, P1100, DOI 10.1046/j.1365-2427.2003.01068.x; GRAY AK, 1993, AQUACULTURE, V112, P125, DOI 10.1016/0044-8486(93)90439-6; Gugsa L, 2006, PLANT CELL REP, V25, P1287, DOI 10.1007/s00299-006-0200-z; Heggenes J, 2007, J FISH BIOL, V71, P1069, DOI 10.1111/j.1095-8649.2007.01573.x; Henson SM, 2001, SCIENCE, V294, P602, DOI 10.1126/science.1063358; HINDAR K, 1994, CONSERV BIOL, V8, P881, DOI 10.1046/j.1523-1739.1994.08030863-10.x; Horreo JL, 2011, J HERED, V102, P237, DOI 10.1093/jhered/esq130; HUBBS CL, 1955, SYST ZOOL, V4, P1, DOI 10.2307/2411933; Jansson H, 1997, CAN J FISH AQUAT SCI, V54, P2033, DOI 10.1139/cjfas-54-9-2033; JOHNSEN BO, 1991, AQUACULTURE, V98, P289, DOI 10.1016/0044-8486(91)90393-L; Jonsson B, 2011, FISH FISH SER, V33, P1, DOI 10.1007/978-94-007-1189-1; Jonsson B, 2009, J FISH BIOL, V75, P2381, DOI 10.1111/j.1095-8649.2009.02380.x; Jonsson N, 2003, J APPL ECOL, V40, P900, DOI 10.1046/j.1365-2664.2003.00851.x; Kierzkowski P, 2011, ANN ZOOL FENN, V48, P56, DOI 10.5735/086.048.0106; Konishi M, 2004, CONSERV GENET, V5, P463, DOI 10.1023/B:COGE.0000041027.64785.77; Krysanov, 2000, J ICHTHYOL, V40, P298; Lampert KP, 2009, FUND APPL LIMNOL, V174, P245, DOI 10.1127/1863-9135/2009/0174-0245; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; Liu SJ, 2010, SCI CHINA LIFE SCI, V53, P416, DOI 10.1007/s11427-010-0057-9; Lode T, 2001, J ZOOL SYST EVOL RES, V39, P91; MaCCulloch RD, 1995, GENOME, V38, P1057, DOI 10.1139/g95-141; MANTOVANI B, 1992, EVOLUTION, V46, P783, DOI 10.2307/2409646; McDevitt AD, 2009, MOL ECOL, V18, P665, DOI 10.1111/j.1365-294X.2008.04050.x; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Rodriguez DJ, 1996, J THEOR BIOL, V180, P189, DOI 10.1006/jtbi.1996.0095; Rozhnov V.V., 1993, Lutreola (Moscow), V1, P10; Satake A, 2012, THEOR ECOL-NETH, V5, P283, DOI 10.1007/s12080-011-0128-y; Som C, 2006, EVOL ECOL RES, V8, P1235; Urke HA, 2010, FISH PHYSIOL BIOCHEM, V36, P845, DOI 10.1007/s10695-009-9359-x; Verhulst P. F., 1838, CORRES MATH PHYS, V10, P113, DOI DOI 10.1007/BF02309004; Wilbur Henry M., 1996, P75; WILBUR HM, 1976, ECOLOGY, V57, P1289, DOI 10.2307/1935053; YOUNGSON AF, 1993, CAN J FISH AQUAT SCI, V50, P1986, DOI 10.1139/f93-221	50	10	10	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101736	10.1371/journal.pone.0101736	http://dx.doi.org/10.1371/journal.pone.0101736			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003336	gold, Green Published, Green Submitted			2022-12-27	WOS:000339242700058
J	Chu, SC; Hsieh, YS; Yu, CC; Lai, YY; Chen, PN				Chu, Shu-Chen; Hsieh, Yih-Shou; Yu, Cheng-Chia; Lai, Yi-Yeh; Chen, Pei-Ni			Thymoquinone Induces Cell Death in Human Squamous Carcinoma Cells via Caspase Activation-Dependent Apoptosis and LC3-II Activation-Dependent Autophagy	PLOS ONE			English	Article							ORAL-CANCER CELLS; CYCLE ARREST; TUMOR-GROWTH; IN-VITRO; INDUCTION; INVASION; HEAD; GENERATION; TIGAR; A549	Background: Thymoquinone (TQ), an active component of Nigella sativa or black cumin, elicits cytotoxic effects on various cancer cell lines. However, the anti-cancer effects of TQ on head and neck squamous cell carcinoma (HNSCC) remain unclear. Methodology/Principal Findings: In this study, TQ elicited a strong cytotoxic effect on SASVO3, a highly malignant HNSCC cell line. The mechanisms of this cytotoxic effect were concentration dependent. TQ also induced apoptotic cell death in SASVO3 cells as indicated by an increase in Bax expression and caspase-9 activation. Apoptosis was possibly caspase-9 dependent because the exposure of cells to a caspase-9 inhibitor partially prevented cell death. The exposed cells also showed increased levels of autophagic vacuoles and LC3-II proteins, which are specific autophagy markers. Cell viability assay results further revealed that bafilomycin-A1, an autophagy inhibitor, enhanced TQ cytotoxicity; by comparison, Annexin V and propidium-iodide staining assay results showed that this inhibitor did not promote apoptosis. TQ treatment also increased the accumulation of autophagosomes. Using a lentivirus-shRNA system for LC3 silencing, we found that cell viability was eradicated in autophagy-defective cells. An in vivo BALB/c nude mouse xenograft model further showed that TQ administered by oral gavage reduced tumor growth via induced autophagy and apoptosis. Conclusions: These findings indicated that TQ induced cell death in oral cancer cells via two distinct anti-neoplastic activities that can induce apoptosis and autophagy. Therefore, TQ is a promising candidate in phytochemical-based, mechanistic, and pathway-targeted cancer prevention strategies.	[Chu, Shu-Chen] Cent Taiwan Univ Sci & Technol, Inst & Dept Food Sci, Taichung, Taiwan; [Yu, Cheng-Chia] Chung Shan Med Univ Hosp, Inst Oral Sci, Sch Dent, Taichung, Taiwan; [Hsieh, Yih-Shou; Lai, Yi-Yeh; Chen, Pei-Ni] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan; [Hsieh, Yih-Shou; Chen, Pei-Ni] Chung Shan Med Univ Hosp, Clin Lab, Taichung, Taiwan; [Yu, Cheng-Chia] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan	Central Taiwan University Science & Technology; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital	Chen, PN (corresponding author), Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan.	peini@csmu.edu.tw			National Science Council, Republic of China [NSC 98-2313-B-040-004-MY3]	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan)	This study was supported by grants of National Science Council, Republic of China (NSC 98-2313-B-040-004-MY3). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel-Salam BKA, 2012, ALLERGOL IMMUNOPATH, V40, P336, DOI 10.1016/j.aller.2011.07.002; Ahamed M, 2010, TOXICOL APPL PHARM, V242, P263, DOI 10.1016/j.taap.2009.10.016; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bensaad K, 2009, EMBO J, V28, P3015, DOI 10.1038/emboj.2009.242; BOXENBAUM H, 1995, J CLIN PHARMACOL, V35, P957, DOI 10.1002/j.1552-4604.1995.tb04011.x; Chen CY, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-100; Chen PN, 2006, CHEM-BIOL INTERACT, V163, P218, DOI 10.1016/j.cbi.2006.08.003; Chen PN, 2005, NUTR CANCER, V53, P232, DOI 10.1207/s15327914nc5302_12; Chen PN, 2011, J AGR FOOD CHEM, V59, P3836, DOI 10.1021/jf1049408; Chen PN, 2006, J DENT RES, V85, P220, DOI 10.1177/154405910608500303; Chen S, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048747, 10.1371/journal.pone.0046703, 10.1371/journal.pone.0029579, 10.1371/journal.pone.0050850]; Chen YQ, 2008, AUTOPHAGY, V4, P246, DOI 10.4161/auto.5432; Das S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046641; Gewirtz DA, 2013, AUTOPHAGY, V9, P1263, DOI 10.4161/auto.25233; Ho YS, 2001, INT J CANCER, V91, P393, DOI 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1070&gt;3.0.CO;2-#; Hsieh YS, 2013, FOOD CHEM TOXICOL, V62, P908, DOI 10.1016/j.fct.2013.10.021; Hsin IL, 2011, AUTOPHAGY, V7, P873, DOI 10.4161/auto.7.8.15698; Hu FW, 2012, MOL NUTR FOOD RES, V56, P1247, DOI 10.1002/mnfr.201200150; Huang AC, 2013, INT J ONCOL, V43, P485, DOI 10.3892/ijo.2013.1952; INGS RMJ, 1990, XENOBIOTICA, V20, P1201, DOI 10.3109/00498259009046839; Jafri SH, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-87; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kasten F H, 1990, Int J Periodontics Restorative Dent, V10, P68; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Mantena SK, 2006, MOL CANCER THER, V5, P296, DOI 10.1158/1535-7163.MCT-05-0448; Mohammadzadeh M, 2013, INTEGR CANCER THER, V12, P496, DOI 10.1177/1534735413485417; Park SH, 2012, TOXICOL LETT, V212, P252, DOI 10.1016/j.toxlet.2012.06.007; Racoma IO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072882; Raghavan D, 1997, EUR J CANCER, V33, P566, DOI 10.1016/S0959-8049(96)00510-2; Speirs CK, 2011, AM J CANCER RES, V1, P43; Stumm S, 2004, ONCOLOGY-BASEL, V66, P101, DOI 10.1159/000077435; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Thiriet C, 2005, MOL CELL, V18, P617, DOI 10.1016/j.molcel.2005.05.008; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tseng HH, 2012, INTEGR CANCER THER, V11, P267, DOI 10.1177/1534735411417128; WONG DYK, 1990, J ORAL MAXIL SURG, V48, P385, DOI 10.1016/0278-2391(90)90436-6; Woo CC, 2012, BIOCHEM PHARMACOL, V83, P443, DOI 10.1016/j.bcp.2011.09.029; Xu MY, 2013, FOOD CHEM TOXICOL, V59, P703, DOI 10.1016/j.fct.2013.06.059; Yang F, 2012, J PHARMACOL SCI, V119, P214, DOI 10.1254/jphs.11235FP; Yang WL, 2012, J SURG ONCOL, V106, P680, DOI 10.1002/jso.23184; Yi TF, 2008, MOL CANCER THER, V7, P1789, DOI 10.1158/1535-7163.MCT-08-0124	42	49	50	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101579	10.1371/journal.pone.0101579	http://dx.doi.org/10.1371/journal.pone.0101579			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000169	Green Published, gold, Green Submitted			2022-12-27	WOS:000338637300059
J	Corbani, AC; Hachey, MH; Desrochers, A				Corbani, Aude Catherine; Hachey, Marie-Helene; Desrochers, Andre			Food Provisioning and Parental Status in Songbirds: Can Occupancy Models Be Used to Estimate Nesting Performance?	PLOS ONE			English	Article							OVENBIRD SEIURUS-AUROCAPILLUS; THROATED BLUE WARBLERS; EXTRA-PAIR PATERNITY; BOREAL FOREST; HABITAT FRAGMENTATION; REPRODUCTIVE INDEX; BREEDING SUCCESS; JYNX-TORQUILLA; MOBBING CALLS; BIRDS	Indirect methods to estimate parental status, such as the observation of parental provisioning, have been problematic due to potential biases associated with imperfect detection. We developed a method to evaluate parental status based on a novel combination of parental provisioning observations and hierarchical modeling. In the summers of 2009 to 2011, we surveyed 393 sites, each on three to four consecutive days at Foret Montmorency, Quebec, Canada. We assessed parental status of 2331 adult songbirds based on parental food provisioning. To account for imperfect detection of parental status, we applied MacKenzie et al.'s (2002) two-state hierarchical model to obtain unbiased estimates of the proportion of sites with successfully nesting birds, and the proportion of adults with offspring. To obtain an independent evaluation of detection probability, we monitored 16 active nests in 2010 and conducted parental provisioning observations away from them. The probability of detecting food provisioning was 0.31 when using nest monitoring, a value within the 0.11 to 0.38 range that was estimated by two-state models. The proportion of adults or sites with broods approached 0.90 and varied depending on date during the sampling season and year, exemplifying the role of eastern boreal forests as highly productive nesting grounds for songbirds. This study offers a simple and effective sampling design for studying avian reproductive performance that could be implemented in national surveys such as breeding bird atlases.	[Corbani, Aude Catherine; Hachey, Marie-Helene; Desrochers, Andre] Univ Laval, Ctr Etud Foret, Quebec City, PQ, Canada	Laval University	Corbani, AC (corresponding author), Univ Laval, Ctr Etud Foret, Quebec City, PQ, Canada.	audecorbani@yahoo.fr			NSERC (Natural Sciences and Engineering Research Council of Canada)	NSERC (Natural Sciences and Engineering Research Council of Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by NSERC (Natural Sciences and Engineering Research Council of Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Arlettaz R, 2010, J ORNITHOL, V151, P889, DOI 10.1007/s10336-010-0527-7; Ball JR, 2012, AUK, V129, P438, DOI 10.1525/auk.2012.11224; Barba E, 2009, BIRD STUDY, V56, P187, DOI 10.1080/00063650902792049; Bayne EM, 2001, AUK, V118, P380, DOI 10.1642/0004-8038(2001)118[0380:EOHFOP]2.0.CO;2; Beauchesne P, 1991, THESIS U LAVAL QUEBE; Belisle M, 2002, LANDSCAPE ECOL, V17, P219, DOI 10.1023/A:1020260326889; BEST LB, 1977, AUK, V94, P308; Betts MG, 2005, ETHOLOGY, V111, P821, DOI 10.1111/j.1439-0310.2005.01109.x; Blancher P., 2005, BOREAL FOREST REGION; BRADLEY DW, 1985, AUK, V102, P493, DOI 10.1093/auk/102.3.493; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Cresswell W, 2008, IBIS, V150, P3, DOI 10.1111/j.1474-919X.2007.00793.x; Dalley KL, 2008, CAN J ZOOL, V86, P1203, DOI 10.1139/Z08-104; Dalley KL, 2009, CONDOR, V111, P314, DOI 10.1525/cond.2009.080104; Darveau M, 1997, ECOL APPL, V7, P572, DOI 10.1890/1051-0761(1997)007[0572:FPATRO]2.0.CO;2; Desrochers A, 2002, ANIM BEHAV, V64, P709, DOI 10.1006/anbe.2002.4013; Donovan TM, 2002, J FIELD ORNITHOL, V73, P329, DOI 10.1648/0273-8570-73.4.329; Doran PJ, 2005, J FIELD ORNITHOL, V76, P227, DOI 10.1648/0273-8570-76.3.227; Environment Canada, 2012, CAN CLIM NORM 1971 2; ESRI, 2009, ARCGIS 9 3 1; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Freitag A, 2001, BIRD STUDY, V48, P102, DOI 10.1080/00063650109461207; Gauthier J., 1996, BREEDING BIRDS QUEBE; Geiser S, 2008, J ORNITHOL, V149, P597, DOI 10.1007/s10336-008-0305-y; Goodbred CO, 1996, WILSON BULL, V108, P467; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Gunn JS, 2000, J FIELD ORNITHOL, V71, P472, DOI 10.1648/0273-8570-71.3.472; HINDE RA, 1954, PROC R SOC SER B-BIO, V142, P331, DOI 10.1098/rspb.1954.0029; Ibarzabal J, 2005, CAN J FOREST RES, V35, P374, DOI 10.1139/X04-169; Ibarzabal J, 2001, CAN J FOREST RES, V31, P117, DOI 10.1139/cjfr-31-1-117; JOHNSON EJ, 1982, AUK, V99, P148, DOI 10.2307/4086031; Jones SL, 2007, MAYFIELD MEASUREMENT; KNAPTON RW, 1984, WILSON BULL, V96, P594; Laberge G, 2010, POSSIBILITE FORESTIE; Lack D., 1966, POPULATION STUDIES B; LACK DAVID, 1940, AUK, V57, P169; Link WA, 2006, ECOLOGY, V87, P2626, DOI 10.1890/0012-9658(2006)87[2626:MWATFO]2.0.CO;2; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; MARTIN TE, 1993, J FIELD ORNITHOL, V64, P507; MAYFIELD HAROLD, 1961, WILSON BULL, V73, P255; Mazerolle MJ, 2006, AMPHIBIA-REPTILIA, V27, P169, DOI 10.1163/156853806777239922; Morgan MR, 2010, AUK, V127, P86, DOI 10.1525/auk.2009.09132; Newton I, 1989, LIFETIME REPROD BIRD; Orians G.H., 1979, P155; OTIS DL, 1978, WILDLIFE MONOGR, P1; Otis DL., 1982, CAPTURE RECAPTURE RE; PINKOWSKI BC, 1978, WILSON BULL, V90, P84; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rangen SA, 2000, WILDLIFE SOC B, V28, P110; Reed LP, 2007, WILSON J ORNITHOL, V119, P350, DOI 10.1676/06-050.1; ROBBINS CS, 1981, STUDIES AVIAN BIOL, V6, P275; ROBBINS CS, 1981, STUD AVIAN BIOL, V6, P301; ROBINSON SK, 1995, SCIENCE, V267, P1987, DOI 10.1126/science.267.5206.1987; Robinson SK, 2001, CONSERV BIOL, V15, P1763, DOI 10.1046/j.1523-1739.2001.00226.x; RODENHOUSE NL, 1992, ECOLOGY, V73, P357, DOI 10.2307/1938747; Rodewald AD, 2001, AUK, V118, P1018, DOI 10.1642/0004-8038(2001)118[1018:ANSIFL]2.0.CO;2; Rota CT, 2009, J APPL ECOL, V46, P1173, DOI 10.1111/j.1365-2664.2009.01734.x; Sallabanks R, 2000, WILDLIFE SOC B, V28, P1144; Schmiegelow FKA, 2002, ECOL APPL, V12, P375; Seagle SW, 2005, ECOLOGY, V86, P1531, DOI 10.1890/03-0770; Stephens SE, 2004, BIOL CONSERV, V115, P101, DOI 10.1016/S0006-3207(03)00098-3; Tewksbury JJ, 1998, ECOLOGY, V79, P2890, DOI 10.1890/0012-9658(1998)079[2890:BPDNDW]2.0.CO;2; Vatka E, 2011, GLOBAL CHANGE BIOL, V17, P3002, DOI 10.1111/j.1365-2486.2011.02430.x; VICKERY PD, 1992, AUK, V109, P697, DOI 10.2307/4088145; VILLARD MA, 1993, AUK, V110, P759; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439	69	2	2	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101765	10.1371/journal.pone.0101765	http://dx.doi.org/10.1371/journal.pone.0101765			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999969	Green Published, Green Submitted, gold			2022-12-27	WOS:000338637300082
J	Cox, R; Korjoukov, I; de Boer, M; Talamini, LM				Cox, Roy; Korjoukov, Ilia; de Boer, Marieke; Talamini, Lucia M.			Sound Asleep: Processing and Retention of Slow Oscillation Phase-Targeted Stimuli	PLOS ONE			English	Article							EVOKED-POTENTIALS; BRAIN ACTIVITY; K-COMPLEX; SLEEP; MEMORY; EEG; SPINDLES; REPETITION; SHIFTS; WAVES	The sleeping brain retains some residual information processing capacity. Although direct evidence is scarce, a substantial literature suggests the phase of slow oscillations during deep sleep to be an important determinant for stimulus processing. Here, we introduce an algorithm for predicting slow oscillations in real-time. Using this approach to present stimuli directed at both oscillatory up and down states, we show neural stimulus processing depends importantly on the slow oscillation phase. During ensuing wakefulness, however, we did not observe differential brain or behavioral responses to these stimulus categories, suggesting no enduring memories were formed. We speculate that while simpler forms of learning may occur during sleep, neocortically based memories are not readily established during deep sleep.	[Cox, Roy; de Boer, Marieke; Talamini, Lucia M.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Cox, Roy; de Boer, Marieke; Talamini, Lucia M.] Univ Amsterdam, Amsterdam Brain & Cognit, Amsterdam, Netherlands; [Korjoukov, Ilia] Okazolab Ltd, London, England	University of Amsterdam; University of Amsterdam	Cox, R (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	r.cox@uva.nl	Cox, Roy/I-1753-2019	Cox, Roy/0000-0002-3667-9049	Dutch National Science Foundation (NWO) [452-08-013]	Dutch National Science Foundation (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Dutch National Science Foundation (NWO - www.nwo.nl), grant 452-08-013 to LMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amzica F, 2002, SLEEP MED REV, V6, P139, DOI 10.1053/smrv.2001.0181; Arzi A, 2012, NAT NEUROSCI; Bastuji H, 1999, SLEEP MED REV, V3, P23, DOI 10.1016/S1087-0792(99)90012-6; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Bergmann TO, 2012, J NEUROSCI, V32, P243, DOI 10.1523/JNEUROSCI.4792-11.2012; Bourquin NMP, 2012, NEUROIMAGE, V62, P1800, DOI 10.1016/j.neuroimage.2012.04.055; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Cash SS, 2009, SCIENCE, V324, P1084, DOI 10.1126/science.1169626; Cote KA, 2000, J SLEEP RES, V9, P19, DOI 10.1046/j.1365-2869.2000.00188.x; Cox R, 2014, NEUROIMAGE, V99, P103, DOI 10.1016/j.neuroimage.2014.05.028; Cox R, 2012, LEARN MEMORY, V19, P264, DOI 10.1101/lm.026252.112; Czisch M, 2004, EUR J NEUROSCI, V20, P566, DOI 10.1111/j.1460-9568.2004.03518.x; Deffenbacher KA, 1981, AM J PSYCHOL; Elton M, 1997, J SLEEP RES, V6, P78, DOI 10.1046/j.1365-2869.1997.00033.x; EMMONS WH, 1956, AM J PSYCHOL, V69, P76, DOI 10.2307/1418117; FOX BH, 1952, J EXP PSYCHOL, V43, P75, DOI 10.1037/h0057555; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Gruber T, 2004, EUR J NEUROSCI, V19, P1073, DOI 10.1111/j.0953-816X.2004.03176.x; Halasz P, 2005, SLEEP MED REV, V9, P391, DOI 10.1016/j.smrv.2005.04.003; Hauner KK, 2013, NAT NEUROSCI; Iber C., 2007, AASM MANUAL SCORING; Leaver AM, 2010, J NEUROSCI, V30, P7604, DOI 10.1523/JNEUROSCI.0296-10.2010; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; Massimini M, 2003, J NEUROPHYSIOL, V89, P1205, DOI 10.1152/jn.00373.2002; Menicucci D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007601; Molle M, 2011, SLEEP, V34, P1411, DOI 10.5665/SLEEP.1290; Molle M, 2002, J NEUROSCI, V22, P10941; Murphy M, 2009, P NATL ACAD SCI USA, V106, P1608, DOI 10.1073/pnas.0807933106; Ngo HVV, 2013, NEURON, V78, P545, DOI 10.1016/j.neuron.2013.03.006; Nir Y, 2011, NEURON, V70, P153, DOI 10.1016/j.neuron.2011.02.043; Oudiette D, 2013, TRENDS COGN SCI REGU; Peyrache A, 2009, NAT NEUROSCI, V12, P919, DOI 10.1038/nn.2337; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rasch B, 2013, PHYSIOL REV, V93, P681, DOI 10.1152/physrev.00032.2012; Rasch BH, 2006, J COGNITIVE NEUROSCI, V18, P793, DOI 10.1162/jocn.2006.18.5.793; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Rudoy JD, 2009, SCIENCE, V326, P1079, DOI 10.1126/science.1179013; Schabus M, 2006, EUR J NEUROSCI, V23, P1738, DOI 10.1111/j.1460-9568.2006.04694.x; Schabus M, 2004, SLEEP, V27, P1479, DOI 10.1093/sleep/27.7.1479; Schabus M, 2012, FRONTIERS NEUROLOGY, V3; Stickgold R, 2013, NAT NEUROSCI, V16, P139, DOI 10.1038/nn.3303; Dang-Vu TT, 2011, P NATL ACAD SCI USA, V108, P15438, DOI 10.1073/pnas.1112503108; UJSZASZI J, 1988, ELECTROEN CLIN NEURO, V69, P516, DOI 10.1016/0013-4694(88)90163-0; Valderrama M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033477; van Ast VA, 2014, PSYCHONEUROENDOCRINO, V41, P97, DOI 10.1016/j.psyneuen.2013.12.007; van Dongen EV, 2012, P NATL ACAD SCI USA, V109, P10575, DOI 10.1073/pnas.1201072109; WOOD JM, 1992, PSYCHOL SCI, V3, P236, DOI 10.1111/j.1467-9280.1992.tb00035.x	50	41	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101567	10.1371/journal.pone.0101567	http://dx.doi.org/10.1371/journal.pone.0101567			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7WB	24999803	gold, Green Published			2022-12-27	WOS:000338637300057
J	de la Vega, R; Miro, J				de la Vega, Rocio; Miro, Jordi			mHealth: A Strategic Field without a Solid Scientific Soul. A Systematic Review of Pain-Related Apps	PLOS ONE			English	Review							ELECTRONIC DIARY ASSESSMENT; PERSONAL DIGITAL ASSISTANT; LOW-BACK-PAIN; TEMPOROMANDIBULAR DISORDER PAIN; CHRONIC WIDESPREAD PAIN; MOMENTARY ASSESSMENT; WIRELESS TECHNOLOGY; MOBILE PHONE; MANAGEMENT; ADOLESCENTS	Background: Mobile health (mHealth) has undergone exponential growth in recent years. Patients and healthcare professionals are increasingly using health-related applications, at the same time as concerns about ethical issues, bias, conflicts of interest and privacy are emerging. The general aim of this paper is to provide an overview of the current state of development of mHealth. Methods and Findings: To exemplify the issues, we made a systematic review of the pain-related apps available in scientific databases (Medline, Web of Science, Gale, Psycinfo, etc.) and the main application shops (App Store, Blackberry App World, Google Play, Nokia Store and Windows Phone Store). Only applications (designed for both patients and clinicians) focused on pain education, assessment and treatment were included. Of the 47 papers published on 34 apps in scientific databases, none were available in the app shops. A total of 283 pain-related apps were found in the five shops searched, but no articles have been published on these apps. The main limitation of this review is that we did not look at all stores in all countries. Conclusions: There is a huge gap between the scientific and commercial faces of mHealth. Specific efforts are needed to facilitate knowledge translation and regulate commercial health-related apps.	[Miro, Jordi] Univ Rovira & Virgili, Dept Psychol, Res Ctr Behav Assessment, Unit Study & Treatment Pain ALGOS, E-43007 Tarragona, Spain; Univ Rovira & Virgili, Inst Invest Sanitaria Pere Virgili, E-43007 Tarragona, Spain	Universitat Rovira i Virgili; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV)	Miro, J (corresponding author), Univ Rovira & Virgili, Dept Psychol, Res Ctr Behav Assessment, Unit Study & Treatment Pain ALGOS, E-43007 Tarragona, Spain.	jordi.miro@urv.cat	de la Vega, Rocio/I-8281-2019; Miró, Jordi/F-9080-2019	de la Vega, Rocio/0000-0002-2517-6948; Miró, Jordi/0000-0002-1998-6653	AGAUR [2009 SGR 434]; PFR-URV;  [PSI2009-12193PSIC-MICINN];  [PSI2012-32471]	AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); PFR-URV; ; 	This work was partly funded by grants PSI2009-12193PSIC-MICINN, PSI2012-32471, AGAUR (2009 SGR 434) and PFR-URV. RdlV is supported by a doctoral grant from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron LA, 2006, J OROFAC PAIN, V20, P125; Aaron LA, 2005, J PAIN, V6, P107, DOI 10.1016/j.jpain.2004.11.003; Affleck G, 1996, PAIN, V68, P363, DOI 10.1016/S0304-3959(96)03226-5; Alfven G, 2010, ACTA PAEDIATR, V99, P1047, DOI 10.1111/j.1651-2227.2010.01735.x; Allena M, 2012, J HEADACHE PAIN, V13, P537, DOI 10.1007/s10194-012-0473-2; Andalusian Quality Agency, 2013, DIST APPSALUDABLE CA; [Anonymous], 2013, PATIENT PRIVACY MOBI; Bender JL, 2011, PAIN, V152, P1740, DOI 10.1016/j.pain.2011.02.012; Castarlenas E, CLIN J PAIN IN PRESS; Center for Devices and Radiological Health, 2013, MOB MED APPL; Chan SSM, 2004, ANAESTH INTENS CARE, V32, P81, DOI 10.1177/0310057X0403200113; Connelly M, 2012, J PEDIATR PSYCHOL, V37, P43, DOI 10.1093/jpepsy/jsr088; Connelly M, 2010, HEADACHE, V50, P779, DOI 10.1111/j.1526-4610.2009.01586.x; Connelly M, 2010, J PAIN SYMPTOM MANAG, V39, P579, DOI 10.1016/j.jpainsymman.2009.07.013; De La Vega R, 2013, INT S PED PAIN STOCK; De la Vega R, 2013, TESTING PAINOMETER A; Duggan M., 2013, CELL INTERNET USE 20; European Commission, 2014, DIGITAL AGENDA EUROP; Evans SR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000551; Ferrero Alvarez Rementeria J, 2013, EUR J EPRACTICE, V20; Gaertner J, 2004, J PAIN SYMPTOM MANAG, V28, P259, DOI 10.1016/j.jpainsymman.2003.12.017; Ghinea G, 2008, IEEE T INF TECHNOL B, V12, P27, DOI 10.1109/TITB.2007.903266; Goldberg DS, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-770; Goldberg J, 2007, HEADACHE, V47, P384, DOI 10.1111/j.1526-4610.2006.00441.x; Goldstein H S, 2003, Hernia, V7, P25; Goyal S, 2013, QJM-INT J MED, V106, P1067, DOI 10.1093/qjmed/hct203; Group TBC, 2012, SOC IMP MOB HLTH; Gulur P, 2009, J PAIN, V10, P173, DOI 10.1016/j.jpain.2008.08.005; Heiberg T, 2007, ARTHRIT RHEUM-ARTHR, V57, P454, DOI 10.1002/art.22613; Hogan NM, 2012, PATIENT EDUC COUNS, V89, P360, DOI 10.1016/j.pec.2012.07.016; International Telecommunication Union (ITU), 2013, UN SPEC AG INF COMM; Jacob E, 2013, J AM ACAD NURSE PRAC, V25, P42, DOI 10.1111/j.1745-7599.2012.00754.x; Jacob E, 2012, J PEDIAT HEMATOL ONC, V34, P326, DOI 10.1097/MPH.0b013e318257a13c; Jahns R-G, 2013, MARKET MHEALTH APP S; Jamison RN, 2006, J PAIN, V7, P192, DOI 10.1016/j.jpain.2005.10.006; Jamison RN, 2002, PAIN, V99, P341, DOI 10.1016/S0304-3959(02)00178-1; Jamison RN, 2001, PAIN, V91, P277, DOI 10.1016/S0304-3959(00)00450-4; Jibb L, 2012, J PAIN, V13; Junker U, 2008, PAPER VERSUS ELECT R; Kleiboer A, 2009, TELEMED J E-HEALTH, V15, P682, DOI 10.1089/tmj.2009.0014; Krieger WH, 2013, PERSPECT BIOL MED, V56, P259, DOI 10.1353/pbm.2013.0013; Kristjansdottir OB, 2013, J MED INTERNET RES, V15, P152, DOI 10.2196/jmir.2442; Kristjansdottir OB, 2013, J MED INTERNET RES, V15, P41, DOI 10.2196/jmir.2249; Kristjansdottir OB, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-51; Lewandowski AS, 2009, CLIN J PAIN, V25, P299, DOI 10.1097/AJP.0b013e3181965578; Luckmann R, 2010, J BIOMED INFORM, V43, pS32, DOI 10.1016/j.jbi.2010.05.005; Madden M., 2013, TEENS TECHNOLOGY 201; Madelin R, 2013, EUROPEAN DIRECTORY H; Marceau LD, 2010, J PAIN SYMPTOM MANAG, V40, P391, DOI 10.1016/j.jpainsymman.2009.12.021; Martinez-Perez B, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.2779; Martinez-Perez B, 2013, JMIR MHEALTH UHEALTH, V1, DOI 10.2196/mhealth.2737; McClellan CB, 2009, J PEDIATR PSYCHOL, V34, P564, DOI 10.1093/jpepsy/jsn121; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Palermo TA, 2004, PAIN, V107, P213, DOI 10.1016/j.pain.2003.10.005; Patel B, 2013, MOBILE MED APPL GUID; Peters ML, 2000, PAIN, V84, P181, DOI 10.1016/S0304-3959(99)00206-7; Rideout, 2013, ZERO 8 CHILDRENS MED; Roelofs J, 2004, PAIN, V112, P335, DOI 10.1016/j.pain.2004.09.016; Roelofs J, 2006, BRIT J HEALTH PSYCH, V11, P595, DOI 10.1348/135910705X74819; Rosser BA, 2011, J TELEMED TELECARE, V17, P308, DOI 10.1258/jtt.2011.101102; Sifferlin A, 2013, TIME; Sigman A, 2012, IMPACT SCREEN MEDIA; Sorbi MJ, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.5.e38; Sorbi MJ, 2006, CLIN J PAIN, V22, P55, DOI 10.1097/01.ajp.0000148624.46756.fa; Sorbi MJ, 2006, CLIN J PAIN, V22, P67, DOI 10.1097/01.ajp.0000148625.84874.48; Stinson JN, 2008, PAIN, V136, P281, DOI 10.1016/j.pain.2007.07.002; Stinson JN, 2013, J MED INTERNET RES, V15, P137, DOI 10.2196/jmir.2350; Stinson JN, 2008, PAIN RES MANAG, V13, P375, DOI 10.1155/2008/326389; Stinson JN, 2006, CLIN J PAIN, V22, P295, DOI 10.1097/01.ajp.0000173371.54579.31; Stone AA, 2003, PAIN, V104, P343, DOI 10.1016/S0304-3959(03)00040-X; Stylianou A, 2013, ED APPL MHEALTH SOL; Turner JA, 2005, PAIN, V117, P377, DOI 10.1016/j.pain.2005.06.025; VanDenKerkhof EG, 2003, CAN J ANAESTH, V50, P368, DOI 10.1007/BF03021034; Walker LS, 2002, J PEDIATR PSYCHOL, V27, P303, DOI 10.1093/jpepsy/27.3.303; West D., 2012, ISSUES TECHNOL INNOV, V18, P1, DOI DOI 10.1158/1078-0432.CCR-12-0578; Whitehouse D, 2013, EDITORIAL MHEALTH RE; Williams DA, 2011, CURR RHEUMATOL REP, V13, P543, DOI 10.1007/s11926-011-0212-8; Wiltfong J, 2013, ONE Q 26 GLOBALLY WH; Wong C, 2013, PAIN SQUAD APP GAMIF; Wood C, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-87	80	115	115	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101312	10.1371/journal.pone.0101312	http://dx.doi.org/10.1371/journal.pone.0101312			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7WB	24999983	Green Published, Green Submitted, gold			2022-12-27	WOS:000338637300034
J	Esposito, S; Zampiero, A; Pugni, L; Tabano, S; Pelucchi, C; Ghirardi, B; Terranova, L; Miozzo, M; Mosca, F; Principi, N				Esposito, Susanna; Zampiero, Alberto; Pugni, Lorenza; Tabano, Silvia; Pelucchi, Claudio; Ghirardi, Beatrice; Terranova, Leonardo; Miozzo, Monica; Mosca, Fabio; Principi, Nicola			Genetic Polymorphisms and Sepsis in Premature Neonates	PLOS ONE			English	Article							EXPRESSION PROFILES; INCREASING PROTEIN; INNATE IMMUNITY; INTERLEUKIN-1; INFECTION; VARIANTS; NEWBORN; VIRUS; ZINC; METALLOPROTEINASES	Identifying single nucleotide polymorphisms (SNPs) in the genes involved in sepsis may help to clarify the pathophysiology of neonatal sepsis. The aim of this study was to evaluate the relationships between sepsis in pre-term neonates and genes potentially involved in the response to invasion by infectious agents. The study involved 101 pre-term neonates born between June 2008 and May 2012 with a diagnosis of microbiologically confirmed sepsis, 98 pre-term neonates with clinical sepsis and 100 randomly selected, otherwise healthy pre-term neonates born during the study period. During the study, 47 SNPs in 18 candidate genes were genotyped on Guthrie cards using an ABI PRISM 7900 HT Fast real-time and MAssARRAY for nucleic acids instruments. Genotypes CT and TT of rs1143643 (the IL1 beta gene) and genotype GG of rs2664349GG (the MMP-16 gene) were associated with a significantly increased overall risk of developing sepsis (p = 0.03, p = 0.05 and p = 0.03), whereas genotypes AG of rs4358188 (the BPI gene) and CT of rs1799946 (the DEF beta 1 gene) were associated with a significantly reduced risk of developing sepsis (p = 0.05 for both). Among the patients with bacteriologically confirmed sepsis, only genotype GG of rs2664349 (the MMP-16 gene) showed a significant association with an increased risk (p = 0.02). Genotypes GG of rs2569190 (the CD14 gene) and AT of rs4073 (the IL8 gene) were associated with a significantly increased risk of developing severe sepsis (p = 0.05 and p = 0.01). Genotype AG of rs1800629 (the LTA gene) and genotypes CC and CT of rs1341023 (the BPI gene) were associated with a significantly increased risk of developing Gram-negative sepsis (p = 0.04, p = 0.04 and p = 0.03). These results show that genetic variability seems to play a role in sepsis in pre-term neonates by influencing susceptibility to and the severity of the disease, as well as the risk of having disease due to specific pathogens.	[Esposito, Susanna; Zampiero, Alberto; Terranova, Leonardo; Principi, Nicola] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Pediat Highly Intens Care Unit, Milan, Italy; [Pugni, Lorenza; Ghirardi, Beatrice; Mosca, Fabio] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Clin Sci & Community Hlth, Neonatal Intens Care Unit, Milan, Italy; [Tabano, Silvia; Miozzo, Monica] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Genet Unit, Milan, Italy; [Pelucchi, Claudio] IRCCS, Mario Negri Inst Pharmacol Res, Dept Epidemiol Unit, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Esposito, S (corresponding author), Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Pediat Highly Intens Care Unit, Milan, Italy.	susanna.esposito@unimi.it	Miozzo, Monica Rosa/AAC-6401-2022; Mosca, Fabio/C-5826-2017; Terranova, Leonardo/C-4348-2017; Tabano, Silvia/P-1498-2017; Esposito, Susanna/K-3475-2016	Miozzo, Monica Rosa/0000-0002-6523-4575; Mosca, Fabio/0000-0001-6477-0299; Terranova, Leonardo/0000-0003-3596-104X; Esposito, Susanna/0000-0003-4103-2837; Pelucchi, Claudio/0000-0003-1425-8945; Tabano, Silvia Maria/0000-0002-5260-6691	Italian Ministry of Health (Bando Giovani Ricercatori)	Italian Ministry of Health (Bando Giovani Ricercatori)(Ministry of Health, Italy)	Italian Ministry of Health (Bando Giovani Ricercatori 2009). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Maziad A, 2010, PEDIATR RES, V68, P323, DOI 10.1203/00006450-201011001-00632; Bellamy R., 1998, Tubercle and Lung Disease, V79, P83, DOI 10.1054/tuld.1998.0009; Bochud PY, 2007, LANCET INFECT DIS, V7, P531, DOI 10.1016/S1473-3099(07)70185-8; Casabonne D, 2011, HAEMATOL-HEMATOL J, V96, P323, DOI 10.3324/haematol.2010.031161; Chauhan M, 2008, ARCH DIS CHILD-FETAL, V93, P1427, DOI 10.1136/adc.2007.134205; Chen Q, 2009, CRIT CARE S1, V13, P354; Chen QX, 2007, GENES IMMUN, V8, P439, DOI 10.1038/sj.gene.6364401; Chirico G, 2009, J MATERN-FETAL NEO M, V22, P46, DOI 10.1080/14767050903192192; Chung LP, 2011, CRIT REV CL LAB SCI, V48, P250, DOI 10.3109/10408363.2011.641517; Cvijanovich N, 2008, PHYSIOL GENOMICS, V34, P127, DOI 10.1152/physiolgenomics.00025.2008; DINARELLO CA, 1993, NEW ENGL J MED, V328, P106; Elkington PTG, 2005, CLIN EXP IMMUNOL, V142, P12, DOI 10.1111/j.1365-2249.2005.02840.X; European Medicines Agency, 2010, M NEON PAED SEPS EMA; Fang XM, 1999, CRIT CARE MED, V27, P1330, DOI 10.1097/00003246-199907000-00024; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Hadchouel A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003188; Hull J, 2000, THORAX, V55, P1023, DOI 10.1136/thorax.55.12.1023; Jabandziev P, 2014, CRIT CARE, V18, DOI 10.1186/cc13174; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; Lee HM, 2004, J PERIODONTOL, V75, P453, DOI 10.1902/jop.2004.75.3.453; Levy O, 2005, J ENDOTOXIN RES, V11, P113, DOI 10.1179/096805105X37376; Levy O, 1999, PEDIATRICS, V104, P1327, DOI 10.1542/peds.104.6.1327; Ma PG, 2002, CRIT CARE MED, V30, P1046, DOI 10.1097/00003246-200205000-00015; Mehta K, 2013, INDIAN PEDIATR, V50, P390, DOI 10.1007/s13312-013-0120-2; Michalek J, 2007, INTENS CARE MED, V33, P2158, DOI 10.1007/s00134-007-0860-3; Morales-Garcia G, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-299; Namath A, 2009, CRIT CARE CLIN, V25, P835, DOI 10.1016/j.ccc.2009.06.004; NOAH TL, 1995, J INFECT DIS, V171, P584, DOI 10.1093/infdis/171.3.584; Nupponen I, 2002, PEDIATR RES, V51, P670, DOI 10.1203/01.PDR.0000017477.64723.9D; Prasad AS, 2007, J NUTR, V137, P1345, DOI 10.1093/jn/137.5.1345; Ranoa DRE, 2013, J BIOL CHEM, V288, P9729, DOI 10.1074/jbc.M113.453266; Read RC, 2003, ANN INTERN MED, V138, P534, DOI 10.7326/0003-4819-138-7-200304010-00009; Sastre JBL, 2002, J PERINAT MED, V30, P149; Shanley TP, 2007, MOL MED, V13, P495, DOI 10.2119/2007-00065.Shanley; Shu Q, 2006, SHOCK, V26, P365, DOI 10.1097/01.shk.0000224722.65929.58; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; *VERM OXF NETW, 1993, VERM OXF NETW DAT MA; Watanabe E, 2010, CRIT CARE MED, V38, P181, DOI 10.1097/CCM.0b013e3181bc805d; Weitkamp JH, 2000, INFECTION, V28, P92, DOI 10.1007/s150100050053; Wilson N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081329; Woessner JF, 1999, ANN NY ACAD SCI, V878, P388, DOI 10.1111/j.1749-6632.1999.tb07697.x; Wong HR, 2007, PHYSIOL GENOMICS, V30, P146, DOI 10.1152/physiolgenomics.00024.2007; Wong HR, 2012, CRIT CARE MED, V40, P1618, DOI 10.1097/CCM.0b013e318246b546; Wong HR, 2010, PEDIATR CRIT CARE ME, V11, P349, DOI 10.1097/PCC.0b013e3181c519b4; Wong HR, 2009, CRIT CARE MED, V37, P1558, DOI 10.1097/CCM.0b013e31819fcc08; Zhang AQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071237	46	32	38	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101248	10.1371/journal.pone.0101248	http://dx.doi.org/10.1371/journal.pone.0101248			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000179	Green Submitted, Green Published, gold			2022-12-27	WOS:000338637300027
J	Chandra, S; Narang, R; Sreenivas, V; Bhatia, J; Saluja, D; Srivastava, K				Chandra, Sudhir; Narang, Rajiv; Sreenivas, Vishnubhatla; Bhatia, Jagriti; Saluja, Daman; Srivastava, Kamna			Association of Angiotensin II Type 1 Receptor (A1166C) Gene Polymorphism and Its Increased Expression in Essential Hypertension: A Case-Control Study	PLOS ONE			English	Article							BLOOD-PRESSURE; MYOCARDIAL-INFARCTION; UP-REGULATION; RISK; SYSTEM; AT(1); EPIDEMIOLOGY; METAANALYSIS; KIDNEY	Objectives: Hypertension is one of the major cardiovascular diseases. It affects nearly 1.56 billion people worldwide. The present study is about a particular genetic polymorphism (A1166C), gene expression and protein expression of the angiotensin II type I receptor (AT1R) (SNP ID: rs5186) and its association with essential hypertension in a Northern Indian population. Methods: We analyzed the A1166C polymorphism and expression of AT1R gene in 250 patients with essential hypertension and 250 normal healthy controls. Results: A significant association was found in the AT1R genotypes (AC+CC) with essential hypertension (chi(2) = 22.48, p = 0.0001). Individuals with CC genotypes were at 2.4 times higher odds (p = 0.0001) to develop essential hypertension than individuals with AC and AA genotypes. The statistically significant intergenotypic variation in the systolic blood pressure was found higher in the patients with CC (169.4 +/- 36.3 mmHg) as compared to that of AA (143.5 +/- 28.1 mmHg) and AC (153.9 +/- 30.5 mmHg) genotypes (p = 0.0001). We found a significant difference in the average delta-CT value (p = 0.0001) wherein an upregulated gene expression (approximately 16 fold) was observed in case of patients as compared to controls. Furthermore, higher expression of AT1R gene was observed in patients with CC genotype than with AC and AA genotypes. A significant difference (p = 0.0001) in the protein expression of angiotensin II Type 1 receptor was also observed in the plasma of patients (1.49 +/- 0.27) as compared to controls (0.80 +/- 0.24). Conclusion: Our findings suggest that C allele of A1166C polymorphism in the angiotensin II type 1 receptor gene is associated with essential hypertension and its upregulation could play an important role in essential hypertension.	[Chandra, Sudhir; Saluja, Daman; Srivastava, Kamna] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India; [Narang, Rajiv] All India Inst Med Sci, Dept Cardiol, New Delhi, India; [Sreenivas, Vishnubhatla] All India Inst Med Sci, Dept Biostat, New Delhi, India; [Bhatia, Jagriti] All India Inst Med Sci, Dept Pharmacol, New Delhi, India	University of Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Srivastava, K (corresponding author), Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India.	kamna_srivastava@hotmail.com		Srivastava, Kamna/0000-0003-4318-9483	B R Ambedkar Centre for Biomedical Research, University of Delhi, India	B R Ambedkar Centre for Biomedical Research, University of Delhi, India	This work was supported by Departmental grant, DR. B R Ambedkar Centre for Biomedical Research, University of Delhi, India to Dr. Kamna Srivastava and Prof. Daman Saluja. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agachan B, 2003, EXP MOL MED, V35, P545, DOI 10.1038/emm.2003.71; Allen AM, 2000, AM J HYPERTENS, V13, p31S, DOI 10.1016/S0895-7061(99)00249-6; Behravan Javad, 2006, DARU-Journal of Pharmaceutical Sciences, V14, P82; BONNARDEAUX A, 1994, HYPERTENSION, V24, P63, DOI 10.1161/01.HYP.24.1.63; Ceolotto G, 2011, AM J HYPERTENS, V24, P241, DOI 10.1038/ajh.2010.211; Dampney RAL, 2002, CLIN EXP PHARMACOL P, V29, P467, DOI 10.1046/j.1440-1681.2002.03658.x; Devi N, 2012, IOSR J DENT MED SCI, V2, P11; Farrag W, 2011, MOL CELL BIOCHEM, V351, P13, DOI 10.1007/s11010-010-0706-0; GUO DF, 1994, BIOCHEM BIOPH RES CO, V200, P313, DOI 10.1006/bbrc.1994.1450; Gupta R, 1996, J HUM HYPERTENS, V10, P465; Gupta R, 2004, J HUM HYPERTENS, V18, P73, DOI 10.1038/sj.jhh.1001633; Gupta R, 1997, J INDIAN MED ASSOC, V97, P74; Hu J, 2009, CLIN EXP HYPERTENS, V31, P49, DOI 10.1080/10641960802409788; Irijanto F, 2009, MAJ KEDOKT INDON, V59, P357; Jiang ZN, 2001, CHINESE MED J-PEKING, V114, P1249; Kainulainen K, 1999, HYPERTENSION, V33, P844, DOI 10.1161/01.HYP.33.3.844; Kannel WB, 2003, HYPERTENSION, V42, P453, DOI 10.1161/01.HYP.0000093382.69464.C4; Katovich MJ, 1999, AM J PHYSIOL-HEART C, V277, pH1260, DOI 10.1152/ajpheart.1999.277.3.H1260; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kikuya M, 2003, HYPERTENS RES, V26, P141, DOI 10.1291/hypres.26.141; Kooffreh Mary Esien, 2013, Indian J Hum Genet, V19, P213, DOI 10.4103/0971-6866.116120; Li NF, 2010, HEART, V96, pA8, DOI 10.1136/hrt.2010.208967.23; Li X, 2001, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V18, P292; Liang MY, 2009, AM J PHYSIOL-RENAL, V297, pF553, DOI 10.1152/ajprenal.00045.2009; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; LIFTON RP, 1992, NATURE, V355, P262, DOI 10.1038/355262a0; Liu Y, 2002, HYPERTENS RES, V25, P515; Mehri S, 2012, MOL BIOL REP, V39, P4059, DOI 10.1007/s11033-011-1187-2; Mehri S, 2011, J RENIN-ANGIO-ALDO S, V12, P595, DOI 10.1177/1470320310391833; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Messerli FH, 2007, LANCET, V370, P591, DOI 10.1016/S0140-6736(07)61299-9; Nickenig G, 1997, CIRCULATION, V95, P473; Nickenig G, 1997, AM J PHYSIOL-HEART C, V272, pH2701, DOI 10.1152/ajpheart.1997.272.6.H2701; Niu WQ, 2010, HYPERTENS RES, V33, P1137, DOI 10.1038/hr.2010.156; Pende A, 2008, CELL BIOCHEM FUNCT, V26, P493, DOI 10.1002/cbf.1472; Poch E, 2001, HYPERTENSION, V38, P1204, DOI 10.1161/hy1101.099479; Poirier O, 1998, J HYPERTENS, V16, P1443, DOI 10.1097/00004872-199816100-00007; Qureshi AI, 2002, STROKE, V33, P2781, DOI 10.1161/01.STR.0000039402.05613.0F; RAIZADA MK, 1993, J NEUROCHEM, V60, P1949, DOI 10.1111/j.1471-4159.1993.tb13426.x; Ramu P, 2011, INT J HUM GENET, V11, P31, DOI 10.1080/09723757.2011.11886120; Reja V, 2006, CLIN EXP PHARMACOL P, V33, P690, DOI 10.1111/j.1440-1681.2006.04420.x; Rodgers Anthony, 2000, Journal of Hypertension, V18, pS3; Srivastava K, 2012, J PHARM PHARM SCI, V15, P399, DOI 10.18433/J3KW3B; Srivastava K, 2012, GENET TEST MOL BIOMA, V16, P174, DOI 10.1089/gtmb.2011.0155; Sugimoto K, 2004, HYPERTENS RES, V27, P551, DOI 10.1291/hypres.27.551; Tabara Y, 2002, J HYPERTENS, V20, P651, DOI 10.1097/00004872-200204000-00022; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Wang JG, 2010, MAGNETIC FRINGE FIELDS AND INTERFERENCE IN HIGH INTENSITY ACCELERATORS, P1; Wang WYS, 1997, CLIN GENET, V51, P31; Wassmann S, 2004, CIRCULATION, V110, P3062, DOI 10.1161/01.CIR.0000137970.47771.AF; WATT GCM, 1992, J HYPERTENS, V10, P473, DOI 10.1097/00004872-199205000-00011; Zhu YC, 2003, CLIN EXP PHARMACOL P, V30, P911, DOI 10.1111/j.1440-1681.2003.03942.x	52	37	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101502	10.1371/journal.pone.0101502	http://dx.doi.org/10.1371/journal.pone.0101502			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992666	Green Published, Green Submitted, gold			2022-12-27	WOS:000341253400080
J	Gratton, C; Lee, TG; Nomura, EM; D'Esposito, M				Gratton, Caterina; Lee, Taraz G.; Nomura, Emi M.; D'Esposito, Mark			Perfusion MRI Indexes Variability in the Functional Brain Effects of Theta-Burst Transcranial Magnetic Stimulation	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; PRIMARY MOTOR CORTEX; INTERINDIVIDUAL VARIABILITY; CORTICAL PLASTICITY; REPETITIVE TMS; NETWORK DYNAMICS; FREQUENCY; CONNECTIVITY; RESONANCE; RESPONSES	Transcranial Magnetic Stimulation (TMS) is an important tool for testing causal relationships in cognitive neuroscience research. However, the efficacy of TMS can be variable across individuals and difficult to measure. This variability is especially a challenge when TMS is applied to regions without well-characterized behavioral effects, such as in studies using TMS on multi-modal areas in intrinsic networks. Here, we examined whether perfusion fMRI recordings of Cerebral Blood Flow (CBF), a quantitative measure sensitive to slow functional changes, reliably index variability in the effects of stimulation. Twenty-seven participants each completed four combined TMS-fMRI sessions during which both resting state Blood Oxygen Level Dependent (BOLD) and perfusion Arterial Spin Labeling (ASL) scans were recorded. In each session after the first baseline day, continuous theta-burst TMS (TBS) was applied to one of three locations: left dorsolateral prefrontal cortex (L dlPFC), left anterior insula/frontal operculum (L aI/fO), or left primary somatosensory cortex (L S1). The two frontal targets are components of intrinsic networks and L S1 was used as an experimental control. CBF changes were measured both before and after TMS on each day from a series of interleaved resting state and perfusion scans. Although TBS led to weak selective increases under the coil in CBF measurements across the group, individual subjects showed wide variability in their responses. TBS-induced changes in rCBF were related to TBS-induced changes in functional connectivity of the relevant intrinsic networks measured during separate resting-state BOLD scans. This relationship was selective: CBF and functional connectivity of these networks were not related before TBS or after TBS to the experimental control region (S1). Furthermore, subject groups with different directions of CBF change after TBS showed distinct modulations in the functional interactions of targeted networks. These results suggest that CBF is a marker of individual differences in the effects of TBS.	[Gratton, Caterina] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Gratton, C (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	cgratton@berkeley.edu		Lee, Taraz/0000-0002-3186-8625	National Institutes of Health [NIH MH63901, NS79698]; Department of Defense (NDSEG fellowship); NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079698] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense (NDSEG fellowship)(United States Department of Defense); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (NIH MH63901 and NS79698) and the Department of Defense (NDSEG fellowship to CG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 2005, INT REV NEUROBIOL, V66, P213, DOI 10.1016/S0074-7742(05)66007-2; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Baudewig J, 2001, NEUROREPORT, V12, P3543, DOI 10.1097/00001756-200111160-00034; Benali A, 2011, J NEUROSCI, V31, P1193, DOI 10.1523/JNEUROSCI.1379-10.2011; Bestmann S, 2003, NEUROIMAGE, V20, P1685, DOI 10.1016/j.neuroimage.2003.07.028; Bestmann S, 2005, NEUROIMAGE, V28, P22, DOI 10.1016/j.neuroimage.2005.05.027; Bestmann S, 2004, EUR J NEUROSCI, V19, P1950, DOI 10.1111/j.1460-9568.2004.03277.x; Bestmann S, 2008, EXP BRAIN RES, V191, P383, DOI 10.1007/s00221-008-1601-8; Bestmann S, 2008, CEREB CORTEX, V18, P1281, DOI 10.1093/cercor/bhm159; Buxton RB, 1998, MAGNET RESON MED, V40, P383, DOI 10.1002/mrm.1910400308; Cardenas-Morales L, 2010, BRAIN TOPOGR, V22, P294, DOI 10.1007/s10548-009-0084-7; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; Cheeran B, 2008, J PHYSIOL-LONDON, V586, P5717, DOI 10.1113/jphysiol.2008.159905; Chen AC, 2013, P NATL ACAD SCI USA, V110, P19944, DOI 10.1073/pnas.1311772110; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Dayan E, 2013, NAT NEUROSCI, V16, P838, DOI 10.1038/nn.3422; Di Lazzaro V, 2005, J PHYSIOL-LONDON, V565, P945, DOI 10.1113/jphysiol.2005.087288; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Driver J, 2009, TRENDS COGN SCI, V13, P319, DOI 10.1016/j.tics.2009.04.007; Eldaief MC, 2011, P NATL ACAD SCI USA, V108, P21229, DOI 10.1073/pnas.1113103109; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2013, NEUROIMAGE, V66, P151, DOI 10.1016/j.neuroimage.2012.10.082; Fox MD, 2012, NEUROIMAGE, V62, P2232, DOI 10.1016/j.neuroimage.2012.03.035; Fox P, 1997, NEUROREPORT, V8, P2787, DOI 10.1097/00001756-199708180-00027; Franca M, 2006, CLIN NEUROPHYSIOL, V117, P1808, DOI 10.1016/j.clinph.2006.03.019; Gangitano M, 2002, CLIN NEUROPHYSIOL, V113, P1249, DOI 10.1016/S1388-2457(02)00109-8; Gentner R, 2008, CEREB CORTEX, V18, P2046, DOI 10.1093/cercor/bhm239; Gratton C, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00124; Gratton C, 2012, J COGNITIVE NEUROSCI, V24, P1275, DOI 10.1162/jocn_a_00222; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Hamada M, 2013, CEREB CORTEX, V23, P1593, DOI 10.1093/cercor/bhs147; Hamidi M, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.014.2009; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Higo T, 2011, P NATL ACAD SCI USA, V108, P4230, DOI 10.1073/pnas.1013361108; Hoogendam JM, 2010, BRAIN STIMUL, V3, P95, DOI 10.1016/j.brs.2009.10.005; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Hubl D, 2008, NEUROSCIENCE, V151, P921, DOI 10.1016/j.neuroscience.2007.10.049; Inghilleri M, 2004, CLIN NEUROPHYSIOL, V115, P1063, DOI 10.1016/j.clinph.2003.12.003; Ishikawa S, 2007, CLIN NEUROPHYSIOL, V118, P1033, DOI 10.1016/j.clinph.2007.02.003; Johnson JS, 2012, J NEUROPHYSIOL, V107, P2383, DOI 10.1152/jn.00707.2011; Johnson JS, 2010, BRAIN TOPOGR, V22, P281, DOI 10.1007/s10548-009-0118-1; Kemna LJ, 2003, NEUROSCI LETT, V336, P85, DOI 10.1016/S0304-3940(02)01195-3; Knoch D, 2006, NEUROIMAGE, V31, P641, DOI 10.1016/j.neuroimage.2005.12.025; Kozel FA, 2000, J NEUROPSYCH CLIN N, V12, P376, DOI 10.1176/appi.neuropsych.12.3.376; Krivanekova L, 2013, BRAIN STIMUL, V6, P330, DOI 10.1016/j.brs.2012.06.004; Lauritzen M, 2001, J CEREBR BLOOD F MET, V21, P1367, DOI 10.1097/00004647-200112000-00001; Lee L, 2003, J NEUROSCI, V23, P5308; Li XB, 2004, BIOL PSYCHIAT, V55, P882, DOI 10.1016/j.biopsych.2004.01.017; Liang Z, 2013, NEUROIMAGE; Maeda F, 2000, EXP BRAIN RES, V133, P425, DOI 10.1007/s002210000432; Martin PG, 2006, CLIN NEUROPHYSIOL, V117, P2684, DOI 10.1016/j.clinph.2006.08.008; Moisa M, 2010, NEUROIMAGE, V49, P612, DOI 10.1016/j.neuroimage.2009.07.010; Muller-Dahlhaus JFM, 2008, EXP BRAIN RES, V187, P467, DOI 10.1007/s00221-008-1319-7; Myers L., 2004, ENCY STAT SCI, DOI [10.1002/0471667196.ess5050, DOI 10.1002/0471667196.ESS5050]; Nomura EM, 2010, P NATL ACAD SCI USA, V107, P12017, DOI 10.1073/pnas.1002431107; Nyffeler T, 2006, NEUROSCI LETT, V409, P57, DOI 10.1016/j.neulet.2006.09.011; O'Shea J, 2007, NEURON, V54, P479, DOI 10.1016/j.neuron.2007.04.021; Orosz A, 2012, NEUROIMAGE, V61, P599, DOI 10.1016/j.neuroimage.2012.03.084; Pleger B, 2006, J NEUROSCI, V26, P1945, DOI 10.1523/JNEUROSCI.4097-05.2006; Rahnev D, 2013, J NEUROPHYSIOL, V110, P1811, DOI 10.1152/jn.00209.2013; Reithler J, 2011, PROG NEUROBIOL, V94, P149, DOI 10.1016/j.pneurobio.2011.04.004; Ridding MC, 2010, J PHYSIOL-LONDON, V588, P2291, DOI 10.1113/jphysiol.2010.190314; Rounis E, 2005, NEUROIMAGE, V26, P164, DOI 10.1016/j.neuroimage.2005.01.037; Rounis E, 2006, J NEUROSCI, V26, P9629, DOI 10.1523/JNEUROSCI.2657-06.2006; Sack AT, 2007, CEREB CORTEX, V17, P2841, DOI 10.1093/cercor/bhm013; Sadaghiani S, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00020; Sale MV, 2008, J NEUROSCI, V28, P8285, DOI 10.1523/JNEUROSCI.1963-08.2008; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Siebner HR, 2003, BRAIN, V126, P2710, DOI 10.1093/brain/awg282; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sommer M, 2002, CLIN NEUROPHYSIOL, V113, P265, DOI 10.1016/S1388-2457(01)00726-X; Stagg CJ, 2009, J NEUROPHYSIOL, V101, P2872, DOI 10.1152/jn.91060.2008; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Strafella AP, 2001, J NEUROPHYSIOL, V85, P2624, DOI 10.1152/jn.2001.85.6.2624; Thut G, 2010, BRAIN TOPOGR, V22, P219, DOI 10.1007/s10548-009-0115-4; van der Werf YD, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-145; Vercammen A, 2010, J PSYCHIATR RES, V44, P725, DOI 10.1016/j.jpsychires.2009.12.011; Wagner T, 2009, CORTEX, V45, P1025, DOI 10.1016/j.cortex.2008.10.002; Wang JJ, 2005, RADIOLOGY, V235, P218, DOI 10.1148/radiol.2351031663; Watanabe T, 2013, HUMAN BRAIN MAPPING; Wig GS, 2005, NAT NEUROSCI, V8, P1228, DOI 10.1038/nn1515; Wu WC, 2007, MAGN RESON MED, V58, P1020, DOI 10.1002/mrm.21403; Yoo WK, 2008, NEUROIMAGE, V39, P1886, DOI 10.1016/j.neuroimage.2007.10.035; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198	87	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101430	10.1371/journal.pone.0101430	http://dx.doi.org/10.1371/journal.pone.0101430			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992641	Green Published, gold, Green Submitted			2022-12-27	WOS:000341253400071
J	Hendricks, JM; Lowe, DC; Hardy, ME				Hendricks, Jay M.; Lowe, Diana C.; Hardy, Michele E.			Differential Induction of Isolated Lymphoid Follicles in the Gut by 18 beta-Glycyrrhetinic Acid	PLOS ONE			English	Article							NF-KAPPA-B; ARYL-HYDROCARBON RECEPTOR; GLYCYRRHIZIN; MATURATION; PATHWAYS; CELLS; ACTIVATION; EXPRESSION; MICROBIOTA; IMMUNITY	18 beta-glycyrrhetinic acid (GRA) is a pharmacologically active component of licorice root with documented immunomodulatory properties. We reported that GRA administered orally to mice induces B cell recruitment to isolated lymphoid follicles (ILF) in the small intestine and shortens the duration of rotavirus antigen shedding. ILF are dynamic lymphoid tissues in the gut acquired post-natally upon colonization with commensal bacteria and mature through B cell recruitment to the follicles, resulting in up-regulation of IgA synthesis in response to changes in the composition of microbiota. In this study, we investigated potential mechanisms by which GRA induces ILF maturation in the ileum and the colon using mice depleted of enteric bacteria and a select group of mice genetically deficient in pattern recognition receptors. The data show GRA was unable to induce ILF maturation in ileums of mice devoid of commensal bacteria, MyD88(-/-) or NOD2(-/-) mice, but differentially induced ILF in colons. Increased expression of chemokine and chemokine receptor genes that modulate B and T cell recruitment to the mucosa were in part dependent on NOD2, TLR, and signaling adaptor protein MyD88. Together the results suggest GRA induces ILF through cooperative signals provided by bacterial ligands under normal conditions to induce B cell recruitment to ILF to the gut, but that the relative contribution of these signals differ between ileum and colon.	[Hendricks, Jay M.; Hardy, Michele E.] Washington State Univ, Coll Vet Med, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Lowe, Diana C.] Montana State Univ, Bozeman, MT 59717 USA	Washington State University; Montana State University System; Montana State University Bozeman	Hardy, ME (corresponding author), Washington State Univ, Coll Vet Med, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA.	mhardy@vetmed.wsu.edu			Public Health Service [AT004986]; National Center for Research Resources (Montana State University) Washington State University [RR020185-09]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P01AT004986] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020185] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Center for Research Resources (Montana State University) Washington State University; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was funded by Public Health Service grant AT004986 to MEH and National Center for Research Resources RR020185-09 (Montana State University) Washington State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, J INFECT DIS, V187, pS356, DOI 10.1086/374749; Asl MN, 2008, PHYTOTHER RES, V22, P709, DOI 10.1002/ptr.2362; Baptista AP, 2013, MUCOSAL IMMUNOL, V6, P511, DOI 10.1038/mi.2012.90; Biswas A, 2012, J MOL MED, V90, P15, DOI 10.1007/s00109-011-0802-y; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bordbar N, 2012, CELL IMMUNOL, V280, P44, DOI 10.1016/j.cellimm.2012.11.013; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Chang YL, 2010, ACTA PHARMACOL SIN, V31, P546, DOI 10.1038/aps.2010.34; Chen GY, 2009, CURR BIOL, V19, pR171, DOI 10.1016/j.cub.2008.12.027; Eberl G, 2010, TRENDS IMMUNOL, V31, P50, DOI 10.1016/j.it.2009.11.004; Fiore C, 2008, PHYTOTHER RES, V22, P141, DOI 10.1002/ptr.2295; Glaysher BR, 2007, IMMUNOLOGY, V120, P336, DOI 10.1111/j.1365-2567.2006.02508.x; Hamada H, 2002, J IMMUNOL, V168, P57, DOI 10.4049/jimmunol.168.1.57; Hardy ME, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-96; HATTORI M, 1983, PLANTA MED, V48, P38, DOI 10.1055/s-2007-969875; Hendricks JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049491; Hooper LV, 2011, CELL, V147, P486, DOI 10.1016/j.cell.2011.10.004; Hua H, 2012, INT IMMUNOPHARMACOL, V12, P518, DOI 10.1016/j.intimp.2012.01.006; Ikeda K, 2006, DIGEST DIS SCI, V51, P603, DOI 10.1007/s10620-006-3177-0; Kao TC, 2010, J AGR FOOD CHEM, V58, P8623, DOI 10.1021/jf101841r; Kim J, 2013, PHYTOMEDICINE, V20, P951, DOI 10.1016/j.phymed.2013.04.008; Kiss EA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00124; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Knoop KA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00084; Knoop KA, 2011, AM J PATHOL, V179, P1861, DOI 10.1016/j.ajpath.2011.06.004; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Lorenz RG, 2003, J IMMUNOL, V170, P5475, DOI 10.4049/jimmunol.170.11.5475; Marchesi F, 2009, MUCOSAL IMMUNOL, V2, P486, DOI 10.1038/mi.2009.113; McDonald KG, 2010, AM J PATHOL, V176, P2367, DOI 10.2353/ajpath.2010.090723; Pabst O, 2005, EUR J IMMUNOL, V35, P98, DOI 10.1002/eji.200425432; Pan QL, 2006, INFECT IMMUN, V74, P2121, DOI 10.1128/IAI.74.4.2121-2127.2006; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Robertson SJ, 2013, GUT MICROBES, V4, P222, DOI 10.4161/gmic.24373; Shaw MH, 2008, CURR OPIN IMMUNOL, V20, P377, DOI 10.1016/j.coi.2008.06.001; Soulier A, 2013, BLOOD, V122, P3288, DOI 10.1182/blood-2013-03-489138; Ukil A, 2005, J IMMUNOL, V175, P1161, DOI 10.4049/jimmunol.175.2.1161; Ukil A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029062; Van Rossum TGJ, 1998, ALIMENT PHARM THER, V12, P199; Velaga S, 2009, J IMMUNOL, V182, P2610, DOI 10.4049/jimmunol.0801141; Wang CY, 2011, J AGR FOOD CHEM, V59, P7726, DOI 10.1021/jf2013265; Williams A, 2010, CURR OPIN IMMUNOL, V22, P34, DOI 10.1016/j.coi.2010.01.004; Williams IR, 2006, ANN NY ACAD SCI, V1072, P52, DOI 10.1196/annals.1326.036	42	0	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100878	10.1371/journal.pone.0100878	http://dx.doi.org/10.1371/journal.pone.0100878			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992099	Green Published, Green Submitted, gold			2022-12-27	WOS:000341253400035
J	Hong, SW; Choi, EB; Min, TK; Kim, JH; Kim, MH; Jeon, SG; Lee, BJ; Gho, YS; Jee, YK; Pyun, BY; Kim, YK				Hong, Sung-Wook; Choi, Eun-Byul; Min, Taek-Ki; Kim, Ji-Hyun; Kim, Min-Hye; Jeon, Seong Gyu; Lee, Byung-Jae; Gho, Yong Song; Jee, Young-Koo; Pyun, Bok-Yang; Kim, Yoon-Keun			An Important Role of alpha-Hemolysin in Extracellular Vesicles on the Development of Atopic Dermatitis Induced by Staphylococcus aureus	PLOS ONE			English	Article							OUTER-MEMBRANE VESICLES; KERATINOCYTE APOPTOSIS; METHICILLIN-RESISTANT; EPITHELIAL-CELLS; DEATH PATHWAY; TOXIN; SKIN; DISEASE; INFLAMMATION; MECHANISMS	Skin barrier disruption and dermal inflammation are key phenotypes of atopic dermatitis (AD). Staphylococcus aureus secretes extracellular vesicles (EVs), which are involved in AD pathogenesis. Here, we evaluated the role of EVs-associated alpha-hemolysin derived from S. aureus in AD pathogenesis. alpha-hemolysin production from S. aureus was detected using western blot analyses. The cytotoxic activity of alpha-hemolysin on HaCaT keratinocytes was evaluated by measuring cell viability after treating cells with soluble and EVs-associated alpha-hemolysin. To determine the type of cell death, HaCaT keratinocytes were stained with annexin V and 7-AAD. The in vivo effects of alpha-hemolysin were evaluated by application of soluble and EV-associated alpha-hemolysin on the mouse skin. The present study showed that increased alpha-hemolysin was produced by S. aureus colonized on AD patients compared to healthy subjects. alpha-hemolysin production was also related to AD severity. In addition, EV-associated alpha-hemolysin was more cytotoxic to HaCaT keratinocytes than soluble alpha-hemolysin, and alpha-hemolysin-negative EVs did not induce keratinocyte death. EV-associated alpha-hemolysin induced necrosis, but soluble alpha-hemolysin induced apoptosis of keratinocytes. In vivo, skin barrier disruption and epidermal hyperplasia were induced by soluble and EV-associated alpha-hemolysin. However, AD-like dermal inflammation was only caused by EV-associated alpha-hemolysin. Moreover, neither skin barrier disruption nor AD-like skin inflammation was induced by alpha-hemolysin-negative EVs. Taken together, alpha-Hemolysin secreted from S. aureus, particularly the EV-associated form, induces both skin barrier disruption and AD-like skin inflammation, suggesting that EV-associated alpha-hemolysin is a novel diagnostic and therapeutic target for the control of AD.	[Hong, Sung-Wook; Choi, Eun-Byul; Kim, Ji-Hyun; Jeon, Seong Gyu; Gho, Yong Song] Pohang Univ Sci & Technol, POSTECH, Dept Life Sci, Pohang, South Korea; [Min, Taek-Ki; Pyun, Bok-Yang] Sooncheonhyang Univ, Coll Med, Dept Pediat, Seoul, South Korea; [Kim, Min-Hye; Kim, Yoon-Keun] Ewha Womans Med Ctr, Dept Med, Seoul, South Korea; [Kim, Min-Hye; Kim, Yoon-Keun] Ewha Womans Med Ctr, Inst Convergence Med, Seoul, South Korea; [Lee, Byung-Jae] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Allergy & Clin Immunol, Seoul, South Korea; [Jee, Young-Koo] Dankook Univ, Coll Med, Dept Internal Med, Cheonan, South Korea	Pohang University of Science & Technology (POSTECH); Soonchunhyang University; Ewha Womans University; Ewha Womans University; Sungkyunkwan University (SKKU); Samsung Medical Center; Dankook University	Pyun, BY (corresponding author), Sooncheonhyang Univ, Coll Med, Dept Pediat, Seoul, South Korea.	bypyun@hosp.sch.ac.kr; juinea@ewha.ac.kr		Jee, Young-Koo/0000-0001-5800-8038	Korea Ministry of Health & Welfare, Republic of Korea [HI 13C 0040-010013]	Korea Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by grants from the Korea Ministry of Health & Welfare, Republic of Korea (HI 13C 0040-010013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bantel H, 2001, J CELL BIOL, V155, P637, DOI 10.1083/jcb.200105081; Bayles KW, 1998, INFECT IMMUN, V66, P336, DOI 10.1128/IAI.66.1.336-342.1998; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Bin LH, 2012, J ALLERGY CLIN IMMUN, V130, P683, DOI 10.1016/j.jaci.2012.06.019; Boguniewicz M, 2011, IMMUNOL REV, V242, P233, DOI 10.1111/j.1600-065X.2011.01027.x; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; Brauweiler AM, 2013, J ALLERGY CLIN IMMUN, V131, P421, DOI 10.1016/j.jaci.2012.10.030; Cork MJ, 2009, J INVEST DERMATOL, V129, P1892, DOI 10.1038/jid.2009.133; Elias PM, 2008, J ALLERGY CLIN IMMUN, V121, P1337, DOI 10.1016/j.jaci.2008.01.022; Gurung M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027958; Haslinger B, 2003, CELL MICROBIOL, V5, P729, DOI 10.1046/j.1462-5822.2003.00317.x; Hong SW, 2011, ALLERGY, V66, P351, DOI 10.1111/j.1398-9995.2010.02483.x; Huang JT, 2009, PEDIATRICS, V123, pE808, DOI 10.1542/peds.2008-2217; Jin JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017027; Kim MR, 2012, ALLERGY, V67, P1271, DOI 10.1111/all.12001; Kim YR, 2010, BIOCHEM BIOPH RES CO, V399, P607, DOI 10.1016/j.bbrc.2010.07.122; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Lee EY, 2009, PROTEOMICS, V9, P5425, DOI 10.1002/pmic.200900338; MORFELDT E, 1995, EMBO J, V14, P4569, DOI 10.1002/j.1460-2075.1995.tb00136.x; O'Regan GM, 2009, J ALLERGY CLIN IMMUN, V124, pR2, DOI 10.1016/j.jaci.2009.07.013; Ohlsen K, 1998, ANTIMICROB AGENTS CH, V42, P2817, DOI 10.1128/AAC.42.11.2817; Ohlsen K, 1997, INFECT IMMUN, V65, P3606, DOI 10.1128/IAI.65.9.3606-3614.1997; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Parker H, 2010, INFECT IMMUN, V78, P5054, DOI 10.1128/IAI.00299-10; Prince LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031506; Radjainia M, 2010, P NATL ACAD SCI USA, V107, P14070, DOI 10.1073/pnas.1006473107; Rebane A, 2012, J ALLERGY CLIN IMMUN, V129, P1297, DOI 10.1016/j.jaci.2012.02.020; SATO H, 1987, INFECT IMMUN, V55, P909, DOI 10.1128/IAI.55.4.909-915.1987; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schlievert PM, 2010, J ALLERGY CLIN IMMUN, V125, P39, DOI 10.1016/j.jaci.2009.10.039; Semic-Jusufagic A, 2007, J ALLERGY CLIN IMMUN, V119, P930, DOI 10.1016/j.jaci.2006.12.639; Thay B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054661; Trautmann A, 2000, J CLIN INVEST, V106, P25, DOI 10.1172/JCI9199; WALEV I, 1993, INFECT IMMUN, V61, P4972, DOI 10.1128/IAI.61.12.4972-4979.1993; Wichmann K, 2009, BRIT J DERMATOL, V161, P300, DOI 10.1111/j.1365-2133.2009.09229.x; Zimmermann M, 2011, J ALLERGY CLIN IMMUN, V127, P200, DOI 10.1016/j.jaci.2010.11.005	36	54	57	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100499	10.1371/journal.pone.0100499	http://dx.doi.org/10.1371/journal.pone.0100499			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992681	gold, Green Published, Green Submitted			2022-12-27	WOS:000341253400024
J	Shen, Y; Wang, J; Wu, JW; Qu, WK; Wang, CX; Gao, X; Zhou, Y; Wang, AX; Wu, SL; Zhao, XQ				Shen, Yuan; Wang, Jing; Wu, Jianwei; Qu, Weikai; Wang, Chunxue; Gao, Xiang; Zhou, Yong; Wang, Anxin; Wu, Shouling; Zhao, Xingquan			Elevated Plasma Total Cholesterol Level Is Associated with the Risk of Asymptomatic Intracranial Arterial Stenosis	PLOS ONE			English	Article							TRANSIENT ISCHEMIC ATTACK; TRANSCRANIAL DOPPLER; CEREBRAL ATHEROSCLEROSIS; STROKE; SEVERITY; THERAPY; DISEASE	Background: Intracranial arterial stenosis (ICAS) is one of the most common causes of stroke, and dyslipidemia was one of the most common risk factors related to ICAS. However, the correlation between the plasma total cholesterol level (PTC) and ICAS, especially asymptomatic ICAS (AICAS) is not clear. Materials and Methods: 5,300 participants were enrolled in this study. The diagnosis of AICAS was made by transcranial Doppler ultrasonography. The participants were then divided into 5 essentially equal-sized groups based on their PTC levels. The multivariate logistic regression was used to analyze the correlation between the PTC level and the prevalence of AICAS. Results: 13.0% of the participants were diagnosed with AICAS. The prevalence of AICAS gradually increased with the increasing PTC level. After adjusted by the possible confounding factors, the Odds Ratios (OR) of the AICAS prevalence between the 1st quintile group and the other 4 groups were 1.13, 1.23, 1.63 and 1.75 with 95% confident intervals (CI) of 0.84-1.52, 0.91-1.66, 1.20-2.22 and 1.23-2.47, respectively. The further subgroup analysis revealed that the PTC level was stronger for males (OR 1.42 95% CI 1.23-1.64), regarding the prevalence of AICAS. Conclusions: In this large community-based study, the prevalence of AICAS is 13.0%, subjects with higher PTC levels showed a mild increase in the prevalence of AICAS. The PTC level is an independent risk factor of AICAS. Males seem to be significantly more vulnerable to the risk of AICAS.	[Shen, Yuan; Wang, Jing; Wu, Jianwei; Wang, Chunxue; Zhou, Yong; Wang, Anxin; Zhao, Xingquan] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Qu, Weikai] Univ Toledo, Med Ctr, Dept Surg, Toledo, OH 43606 USA; [Gao, Xiang] Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp,Channing Lab, Boston, MA USA; [Gao, Xiang] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Wu, Shouling] Hebei United Univ, Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China	Capital Medical University; University System of Ohio; University of Toledo; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; North China University of Science & Technology	Wu, SL (corresponding author), Hebei United Univ, Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China.	drwusl@163.com; zxq@vip.163.com	Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; , Xiang/0000-0003-2617-6509; Wu, Jian/0000-0002-3394-1507	Ministry of Science and Technology; Ministry of Health of the People's Republic of China [2008BAI52B03]; National Natural Science Foundation of China [81202279]; Beijing Municipal ST Commission [D101107049310005, Z121100005512016]; National Science and Technology Major Project of China [2011BAI08B02]; Capital Health research and Development of Special [2011-2004-03]; 12th Five-Year Plan for "New Drugs Innovation and Development'' National Science and Technology Major Project: Clinical Resource Biobank Construction [2011ZX09307-001-06]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health of the People's Republic of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal ST Commission; National Science and Technology Major Project of China; Capital Health research and Development of Special; 12th Five-Year Plan for "New Drugs Innovation and Development'' National Science and Technology Major Project: Clinical Resource Biobank Construction	This work is supported by grants from the Ministry of Science and Technology and the Ministry of Health of the People's Republic of China (No. 2008BAI52B03), the National Natural Science Foundation of China (No. 81202279), Beijing Municipal S&T Commission (D101107049310005, Z121100005512016), National Science and Technology Major Project of China (2011BAI08B02), the Capital Health research and Development of Special (No. Capital 2011-2004-03) and the 12th Five-Year Plan for "New Drugs Innovation and Development'' National Science and Technology Major Project: Clinical Resource Biobank Construction (2011ZX09307-001-06). Beijing Municipal Science & Technology Commission (No. D111107003111007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babikian VL, 2000, J NEUROIMAGING, V10, P101, DOI 10.1111/jon2000102101; Chimowitz MI, 2011, NEW ENGL J MED, V365, P993, DOI 10.1056/NEJMoa1105335; Famakin BM, 2009, STROKE, V40, P1999, DOI 10.1161/STROKEAHA.108.546150; FELDMANN E, 1990, NEUROLOGY, V40, P1541, DOI 10.1212/wnl.40.10.1540; Feldmann E, 2007, NEUROLOGY, V68, P2099, DOI 10.1212/01.wnl.0000261488.05906.c1; Gao S, 2002, J NEUROIMAGING, V12, P213, DOI 10.1177/10528402012003001; ITOH T, 1993, STROKE, V24, P1192, DOI 10.1161/01.STR.24.8.1192; Kim BS, 2010, ATHEROSCLEROSIS, V212, P682, DOI 10.1016/j.atherosclerosis.2010.07.007; Kim YS, 2011, GENDER MED, V8, P14, DOI 10.1016/j.genm.2011.01.001; Meseguer E, 2010, ANN NEUROL, V68, P9, DOI 10.1002/ana.21921; Papadakis JA, 1998, CARDIOVASC RES, V40, P265, DOI 10.1016/S0008-6363(98)00222-3; Pu YH, 2013, STROKE, V44, P2109, DOI 10.1161/STROKEAHA.113.001522; Rajkumar C, 1997, J AM COLL CARDIOL, V30, P350, DOI 10.1016/S0735-1097(97)00191-5; Sirimarco G, 2011, STROKE, V42, P2131, DOI 10.1161/STROKEAHA.110.609727; Turan TN, 2010, STROKE, V41, P1636, DOI 10.1161/STROKEAHA.110.584672; Wityk RJ, 1996, STROKE, V27, P1974, DOI 10.1161/01.STR.27.11.1974; Wong KS, 2003, STROKE, V34, P2361, DOI 10.1161/01.STR.0000089017.90037.7A; Wong KS, 2000, STROKE, V31, P2641, DOI 10.1161/01.STR.31.11.2641; Wu JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065229; Xu L, 2010, METABOLISM, V59, P367, DOI 10.1016/j.metabol.2009.08.004; Zhang Q, 2013, STROKE, V44, P2451, DOI 10.1161/STROKEAHA.113.678839	21	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101232	10.1371/journal.pone.0101232	http://dx.doi.org/10.1371/journal.pone.0101232			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992466	Green Published, Green Submitted, gold			2022-12-27	WOS:000341253400054
J	Xu, SQ; Wu, HJ; Nie, H; Yue, L; Jiang, HD; Xiao, S; Li, Y				Xu, Shengqiang; Wu, Hongjin; Nie, Huan; Yue, Lei; Jiang, Huadong; Xiao, Sheng; Li, Yu			AIF Downregulation and Its Interaction with STK3 in Renal Cell Carcinoma	PLOS ONE			English	Article							APOPTOSIS-INDUCING FACTOR; NON-CPG METHYLATION; CASPASE-INDEPENDENT DEATH; MITOCHONDRIAL RELEASE; NUCLEAR TRANSLOCATION; SIGNALING PATHWAY; HISTONE H2B; STRESS; MST; PHOSPHORYLATION	Apoptosis-inducing factor (AIF) plays a crucial role in caspase-independent programmed cell death by triggering chromatin condensation and DNA fragmentation. Therefore, it might be involved in cell homeostasis and tumor development. In this study, we report significant AIF downregulation in the majority of renal cell carcinomas (RCC). In a group of RCC specimens, 84% (43 out of 51) had AIF downregulation by immunohistochemistry stain. Additional 10 kidney tumors, including an oxyphilic adenoma, also had significant AIF downregulation by Northern blot analysis. The mechanisms of the AIF downregulation included both AIF deletion and its promoter methylation. Forced expression of AIF in RCC cell lines induced massive apoptosis. Further analysis revealed that AIF interacted with STK3, a known regulator of apoptosis, and enhanced its phosphorylation at Thr180. These results suggest that AIF downregulation is a common event in kidney tumor development. AIF loss may lead to decreased STK3 activity, defective apoptosis and malignant transformation.	[Xu, Shengqiang; Wu, Hongjin; Nie, Huan; Yue, Lei; Jiang, Huadong; Li, Yu] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150006, Peoples R China; [Xu, Shengqiang; Xiao, Sheng] Harvard Univ, Sch Med, Dept Pathol, Brigham & Womens Hosp, Boston, MA 02115 USA	Harbin Institute of Technology; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Xiao, S (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Brigham & Womens Hosp, Boston, MA 02115 USA.	sxiao@rics.bwh.harvard.edu; liyugene@hit.edu.cn	Wu, Hongjin/AAF-6122-2019	Wu, Hongjin/0000-0002-2053-7441	Heilongjiang Province Department of Education in China; Heilongjiang Province Department of Science and Technology [LC04C02]; China Scholarship Council	Heilongjiang Province Department of Education in China; Heilongjiang Province Department of Science and Technology; China Scholarship Council(China Scholarship Council)	This work was financed by grants from Heilongjiang Province Department of Education in China (http://www.hlje.net/), and LC04C02 Returned Overseas Personnel Fund from Heilongjiang Province Department of Science and Technology (http://www.hljkjt.gov.cn/) and Support from China Scholarship Council (http://www.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; Aron M, 2008, EUR UROL, V54, P133, DOI 10.1016/j.eururo.2007.12.001; Artus C, 2010, EMBO J, V29, P1585, DOI 10.1038/emboj.2010.43; Baritaud M, 2010, CELL CYCLE, V9, P3166, DOI 10.4161/cc.9.16.12552; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; Cabon L, 2012, CELL DEATH DIFFER, V19, P245, DOI 10.1038/cdd.2011.91; Cande C, 2002, BIOCHIMIE, V84, P215, DOI 10.1016/S0300-9084(02)01374-3; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Cheville JC, 2003, AM J SURG PATHOL, V27, P612, DOI 10.1097/00000478-200305000-00005; Creasy CL, 1995, GENE, V167, P303, DOI 10.1016/0378-1119(95)00653-2; Daugas E, 2000, FEBS LETT, V476, P118, DOI 10.1016/S0014-5793(00)01731-2; Daugas E, 2000, FASEB J, V14, P729, DOI 10.1096/fasebj.14.5.729; Davison JM, 1998, AM J PATHOL, V153, P1401, DOI 10.1016/S0002-9440(10)65727-6; De Souza PM, 2002, BLOOD, V99, P3432, DOI 10.1182/blood.V99.9.3432; Gupta K, 2008, CANCER TREAT REV, V34, P193, DOI 10.1016/j.ctrv.2007.12.001; Haines TR, 2001, DEV BIOL, V240, P585, DOI 10.1006/dbio.2001.0504; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeong EG, 2006, APMIS, V114, P867, DOI 10.1111/j.1600-0463.2006.apm_502.x; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Kook SH, 2007, APOPTOSIS, V12, P1289, DOI 10.1007/s10495-007-0056-x; Lee KK, 2001, J BIOL CHEM, V276, P19276, DOI 10.1074/jbc.M005109200; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Liu SS, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-58; Lohse CM, 2002, AM J CLIN PATHOL, V118, P877, DOI 10.1092/5PWP08HKHX0LY56L; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Miramar MD, 2001, J BIOL CHEM, V276, P16391, DOI 10.1074/jbc.M010498200; Onishi T, 2002, BJU INT, V90, P32, DOI 10.1046/j.1464-410X.2002.02798.x; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Seth R, 2005, J BIOL CHEM, V280, P31230, DOI 10.1074/jbc.M503305200; Skyrlas A, 2011, EXP DERMATOL, V20, P674, DOI 10.1111/j.1600-0625.2011.01249.x; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Susin SA, 1997, EXP CELL RES, V236, P397, DOI 10.1006/excr.1997.3733; Susin SA, 1996, J EXP MED, V184, P1331, DOI 10.1084/jem.184.4.1331; Urbano A, 2005, EMBO J, V24, P2815, DOI 10.1038/sj.emboj.7600746; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; Wang S, 2009, CANCER LETT, V282, P77, DOI 10.1016/j.canlet.2009.03.008; Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194; Wen WH, 2010, J BIOL CHEM, V285, P39108, DOI 10.1074/jbc.M110.151753; Yuste VJ, 2005, CELL DEATH DIFFER, V12, P1445, DOI 10.1038/sj.cdd.4401687; Zeng FL, 2011, MOL CELLS, V31, P267, DOI 10.1007/s10059-011-0037-3	44	9	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100824	10.1371/journal.pone.0100824	http://dx.doi.org/10.1371/journal.pone.0100824			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992339	Green Published, gold, Green Submitted			2022-12-27	WOS:000341253400029
J	Hennessy, E; O'Callaghan, J; Mooij, MJ; Legendre, C; Camacho-Vanegas, O; Camacho, SC; Adams, C; Martignetti, JA; O'Gara, F				Hennessy, Emma; O'Callaghan, Julie; Mooij, Marlies J.; Legendre, Claire; Camacho-Vanegas, Olga; Camacho, Sandra C.; Adams, Claire; Martignetti, John A.; O'Gara, Fergal			The Impact of Simvastatin on Pulmonary Effectors of Pseudomonas aeruginosa Infection	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; KRUPPEL-LIKE FACTOR-2; COA REDUCTASE INHIBITORS; TUMOR-SUPPRESSOR GENE; EPITHELIAL-CELLS; IN-VITRO; TRANSCRIPTION FACTOR; ENDOTHELIAL-CELLS; PROSTATE-CANCER; HEPATOCELLULAR-CARCINOMA	The statin family of cholesterol-lowering drugs is known to have pleiotropic properties which include anti-inflammatory and immunomodulatory effects. Statins exert their pleiotropic effects by altering expression of human immune regulators including pro-inflammatory cytokines. Previously we found that statins modulate virulence phenotypes of the human pathogen Pseudomonas aeruginosa, and sought to investigate if simvastatin could alter the host response to this organism in lung epithelial cells. Simvastatin increased the expression of the P. aeruginosa target genes KLF2, KLF6, IL-8 and CCL20. Furthermore, both simvastatin and P. aeruginosa induced alternative splicing of KLF6. The novel effect of simvastatin on wtKLF6 expression was found to be responsible for induction of the KLF6 regulated genes CCL20 and iNOS. Simvastatin also increased the adhesion of P. aeruginosa to host cells, without altering invasion or cytotoxicity. This study demonstrated that simvastatin had several novel effects on the pulmonary cellular immune response.	[Hennessy, Emma; O'Callaghan, Julie; Mooij, Marlies J.; Legendre, Claire; Adams, Claire; O'Gara, Fergal] Natl Univ Ireland, Sch Microbiol, BIOMERIT Res Ctr, Cork, Ireland; [Camacho-Vanegas, Olga; Camacho, Sandra C.; Martignetti, John A.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [O'Gara, Fergal] Curtin Univ, Sch Biomed Sci, Perth, WA 6845, Australia	University College Cork; Icahn School of Medicine at Mount Sinai; Curtin University	O'Gara, F (corresponding author), Natl Univ Ireland, Sch Microbiol, BIOMERIT Res Ctr, Cork, Ireland.	f.ogara@ucc.ie		O'Gara, Fergal/0000-0002-2659-0673; Hennessy, Emma/0000-0003-0511-0797; Claire, LEGENDRE/0000-0003-0248-1111	European Commission [607786, CP-TP-312184, 311975, 287589, 256596]; Science Foundation Ireland [SSPC-2, 07/IN.1/B948, 12/TIDA/B2411, 12/TIDA/B2405, 09/RFP/BMT2350]; Department of Agriculture and Food (FIRM/RSF/CoFoRD) [FIRM 08/RDC/629]; Irish Research Council for Science, Engineering and Technology [PD/2011/2414, RS/2010/2413]; Health Research Board [RP/2006/271, RP/2007/290, HRA/2009/146]; Environmental Protection Agency [EPA2006-PhD-S-21, EPA2008-PhD-S-2]; Marine Institute [C2CRA 2007/082]; Higher Education Authority of Ireland [PRTLI4]; Society For General Microbiology President's Fund for Research Visits	European Commission(European CommissionEuropean Commission Joint Research Centre); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Department of Agriculture and Food (FIRM/RSF/CoFoRD); Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR); Health Research Board; Environmental Protection Agency(United States Environmental Protection Agency); Marine Institute; Higher Education Authority of Ireland; Society For General Microbiology President's Fund for Research Visits	This research was supported in part by grants awarded by the European Commission (http://ec.europa.eu/index_en.htm)(FP7-PEOPLE-2013-ITN, 607786; FP7-KBBE-2012-6, CP-TP-312184; FP7-KBBE-2012-6, 311975; OCEAN 2011-2, 287589; Marie Curie 256596), Science Foundation Ireland (www.sfi.ie)(SSPC-2; 07/IN.1/B948; 12/TIDA/B2411; 12/TIDA/B2405; 09/RFP/BMT2350), the Department of Agriculture and Food (www.agriculture.gov.ie/) (FIRM/RSF/CoFoRD; FIRM 08/RDC/629), the Irish Research Council for Science, Engineering and Technology (www.research.ie/) (PD/2011/2414; RS/2010/2413), the Health Research Board (www.hrb.ie)(RP/2006/271; RP/2007/290; HRA/2009/146), the Environmental Protection Agency (www.epa.ie) (EPA2006-PhD-S-21; EPA2008-PhD-S-2), the Marine Institute (https://www.marine.ie) (Beaufort award C2CRA 2007/082) Teagasc (www.teagasc.ie) (Walsh Fellowship 2013), the Higher Education Authority of Ireland (www.hea.ie)(PRTLI4) and the Society For General Microbiology President's Fund for Research Visits (www.sgm.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almog Y, 2004, CIRCULATION, V110, P880, DOI 10.1161/01.CIR.0000138932.17956.F1; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Bove PF, 2006, FREE RADICAL BIO MED, V41, P515, DOI 10.1016/j.freeradbiomed.2006.05.011; Burns JL, 1996, INFECT IMMUN, V64, P4054, DOI 10.1128/IAI.64.10.4054-4059.1996; Chalmers JD, 2008, AM J MED, V121, P1002, DOI 10.1016/j.amjmed.2008.06.030; Coward WR, 2006, J IMMUNOL, V176, P5284, DOI 10.4049/jimmunol.176.9.5284; Dach K, 2009, INFECT IMMUN, V77, P5583, DOI 10.1128/IAI.00121-09; Darling KEA, 2003, INFECT IMMUN, V71, P2341, DOI 10.1128/IAI.71.5.2341-2349.2003; Das H, 2006, P NATL ACAD SCI USA, V103, P6653, DOI 10.1073/pnas.0508235103; Difeo A, 2008, CANCER RES, V68, P965, DOI 10.1158/0008-5472.CAN-07-2604; Difeo A, 2006, CLIN CANCER RES, V12, P3730, DOI 10.1158/1078-0432.CCR-06-0054; Difeo A, 2009, DRUG RESIST UPDATE, V12, P1, DOI 10.1016/j.drup.2008.11.001; Dulak J, 2005, CURR CANCER DRUG TAR, V5, P579, DOI 10.2174/156800905774932824; Edwards LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027030; Erkkila L, 2005, ANTIMICROB AGENTS CH, V49, P3959, DOI 10.1128/AAC.49.9.3959-3962.2005; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hennessy E, 2013, J ANTIBIOT, V66, P99, DOI 10.1038/ja.2012.95; Hernandez-Perera O, 1998, J CLIN INVEST, V101, P2711, DOI 10.1172/JCI1500; HOLLOWAY BW, 1979, MICROBIOL REV, V43, P73, DOI 10.1128/MMBR.43.1.73-102.1979; Ito G, 2004, CANCER RES, V64, P3838, DOI 10.1158/0008-5472.CAN-04-0185; Iwata A, 2012, CLIN EXP IMMUNOL, V168, P234, DOI 10.1111/j.1365-2249.2012.04564.x; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Jendrossek V, 2001, INFECT IMMUN, V69, P2675, DOI 10.1128/IAI.69.4.2675-2683.2001; Jouneau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022655; Khan MA, 2008, INFECT IMMUN, V76, P1410, DOI 10.1128/IAI.01141-07; Kiener PA, 2001, INT IMMUNOPHARMACOL, V1, P105, DOI 10.1016/S0162-3109(00)00272-1; Kim TG, 2011, EXP DERMATOL, V20, P855, DOI 10.1111/j.1600-0625.2011.01343.x; Kouroumichakis I, 2011, EUR J INTERN MED, V22, P125, DOI 10.1016/j.ejim.2010.12.004; Kremer-Tal S, 2007, J HEPATOL, V46, P645, DOI 10.1016/j.jhep.2006.10.012; LAW RE, 1992, MOL CELL BIOL, V12, P103, DOI 10.1128/MCB.12.1.103; Lee VT, 2005, INFECT IMMUN, V73, P1695, DOI 10.1128/IAI.73.3.1695-1705.2005; LEONARD S, 1990, J BIOL CHEM, V265, P5157; Li CB, 2012, CLIN EXP PHARMACOL P, V39, P759, DOI 10.1111/j.1440-1681.2012.05730.x; Lin TJ, 2003, INFECT IMMUN, V71, P365, DOI 10.1128/IAI.71.1.365-373.2003; Mahabeleshwar GH, 2011, IMMUNITY, V34, P715, DOI 10.1016/j.immuni.2011.04.014; Masamura K, 2003, ARTERIOSCL THROM VAS, V23, P512, DOI 10.1161/01.ATV.0000060461.64771.F0; MASSION PP, 1994, J CLIN INVEST, V93, P26, DOI 10.1172/JCI116954; Matsuda N, 2006, J PHARMACOL EXP THER, V319, P1348, DOI 10.1124/jpet.106.109785; McGuffie EM, 1998, INFECT IMMUN, V66, P2607, DOI 10.1128/IAI.66.6.2607-2613.1998; Mermis JD, 2012, CURR INFECT DIS REP, V14, P484, DOI 10.1007/s11908-012-0277-1; Mgbemena V, 2013, CELL IMMUNOL, V283, P1, DOI 10.1016/j.cellimm.2013.06.002; Mgbemena V, 2012, J IMMUNOL, V189, P606, DOI 10.4049/jimmunol.1102742; Moreilhon C, 2005, PHYSIOL GENOMICS, V20, P244, DOI 10.1152/physiolgenomics.00135.2004; Narla G, 2005, CANCER RES, V65, P5761, DOI 10.1158/0008-5472.CAN-05-0217; Narla G, 2005, CANCER RES, V65, P1213, DOI 10.1158/0008-5472.CAN-04-4249; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; O'Grady E, 2007, NAT REV MICROBIOL, V5, P337, DOI 10.1038/nrmicro1641; O'Grady EP, 2006, INFECT IMMUN, V74, P5893, DOI 10.1128/IAI.00489-06; Parihar SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075490; Park JH, 2005, BBA-GENE STRUCT EXPR, V1732, P82, DOI 10.1016/j.bbaexp.2006.01.002; Parker D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059932; Qi WE, 2011, INT J BIOCHEM CELL B, V43, P383, DOI 10.1016/j.biocel.2010.11.008; Quist-Paulsen P, 2010, CURR OPIN CARDIOL, V25, P399, DOI 10.1097/HCO.0b013e3283398e53; Sauvonnet N, 2002, J BIOL CHEM, V277, P25133, DOI 10.1074/jbc.M203239200; Schlienger RG, 2007, PHARMACOTHERAPY, V27, P325, DOI 10.1592/phco.27.3.325; Sen-Banerjee S, 2005, CIRCULATION, V112, P720, DOI 10.1161/CIRCULATIONAHA.104.525774; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Tuomisto TT, 2008, CARDIOVASC RES, V78, P175, DOI 10.1093/cvr/cvn007; Urtasun R, 2012, ALCOHOL CLIN EXP RES, V36, P1851, DOI 10.1111/j.1530-0277.2012.01798.x; Vetter D, 2012, HEPATOLOGY, V56, P1361, DOI 10.1002/hep.25810; Warke VG, 2003, J BIOL CHEM, V278, P14812, DOI 10.1074/jbc.M300787200; Yea S, 2008, GASTROENTEROLOGY, V134, P1521, DOI 10.1053/j.gastro.2008.02.015; Zhang J, 2003, INVEST OPHTH VIS SCI, V44, P4247, DOI 10.1167/iovs.03-0219	65	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102200	10.1371/journal.pone.0102200	http://dx.doi.org/10.1371/journal.pone.0102200			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010049	Green Submitted, Green Published, gold			2022-12-27	WOS:000338763800081
J	Parkes-Ratanshi, R; Elbireer, A; Mbambu, B; Mayanja, F; Coutinho, A; Merry, C				Parkes-Ratanshi, Rosalind; Elbireer, Ali; Mbambu, Betty; Mayanja, Faridah; Coutinho, Alex; Merry, Concepta			Ebola Outbreak Response; Experience and Development of Screening Tools for Viral Haemorrhagic Fever (VHF) in a HIV Center of Excellence Near to VHF Epicentres	PLOS ONE			English	Article							UGANDA; MARBURG; DIAGNOSIS; VIRUS; TIME	Introduction: There have been 3 outbreaks of viral hemorrhagic fever (VHF) in Uganda in the last 2 years. VHF often starts with non-specific symptoms prior to the onset of haemorrhagic signs. HIV clinics in VHF outbreak countries such as Uganda see large numbers of patients with HIV 1/2 infection presenting with non-specific symptoms every day. Whilst there are good screening tools for general health care facilities expecting VHF suspects, we were unable to find tools for use in HIV or other non-acute clinics. Methods: We designed tools to help with communication to staff, infection control and screening of HIV patients with nonspecific symptoms in a large HIV clinic during the outbreaks in Uganda. We describe our experiences in using these tools in 2 Ebola Virus Disease outbreaks in Uganda. Results: During the Ebola Virus Disease (EVD) outbreaks, enhanced infection control and communication procedures were implemented within 24 hours of the WHO/Ministry of Health announcement of the outbreaks. During course of these outbreaks the clinic saw 12,544 patients with HIV 1/2 infection, of whom 3,713 attended without an appointment, suggesting new symptoms. Of these 4 were considered at risk of EVD and seen with full infection procedures; 3 were sent home after further investigation. One patient was referred to the National Referral Hospital VHF unit, but discharged on the same day. One additional VHF suspect was identified outside of a VHF outbreak; he was transferred to the National Referral Hospital and placed in isolation within 2 hours of arriving at the HIV clinic. Discussion: Use of simple screening tools can be helpful in managing large numbers of symptomatic patients attending for routine and non-routine medical care (including HIV care) within a country experiencing a VHF outbreak, and can raise medical staff awareness of VHF outside of the epidemics.	[Parkes-Ratanshi, Rosalind; Elbireer, Ali; Mbambu, Betty; Mayanja, Faridah; Coutinho, Alex; Merry, Concepta] Makerere Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Elbireer, Ali] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Merry, Concepta] Univ Ireland Trinity Coll, Dublin, Ireland; [Merry, Concepta] Northwestern Univ, Chicago, IL 60611 USA	Johns Hopkins University; Trinity College Dublin; Northwestern University	Parkes-Ratanshi, R (corresponding author), Makerere Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda.	rratanshi@idi.co.ug	Parkes-Ratanshi, Rosalind/AAR-5409-2020; Merry, Concepta/AAM-7887-2021	Parkes-Ratanshi, Rosalind/0000-0001-9297-1311; Elbireer, Ali/0000-0002-2513-3497				Bitekyerezo M, 2002, TROP DOCT, V32, P10, DOI 10.1177/004947550203200107; Borchert M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-357; Control CfD, 2009, EB HEM FEV INF PACK; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Green A, 2012, LANCET, V380, P1726, DOI 10.1016/S0140-6736(12)61973-4; Hewlett Bonnie L, 2005, J Transcult Nurs, V16, P289, DOI 10.1177/1043659605278935; Jeffs B, 2006, TROP DOCT, V36, P1, DOI 10.1258/004947506775598914; Kinsman J, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-15; Locsin RC, 2002, J ADV NURS, V37, P173, DOI 10.1046/j.1365-2648.2002.02069.x; Mbonye Anthony K, 2010, Int J Adolesc Med Health, V22, P257, DOI 10.1515/IJAMH.2010.22.2.257; Mupere E, 2001, Afr Health Sci, V1, P60; Mwesiga A, 2011, PAN AFR MED J, V9; Ndyomugyenyi R, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-39; Raabe VN, 2010, T ROY SOC TROP MED H, V104, P48, DOI 10.1016/j.trstmh.2009.07.011; Roddy P, 2009, T ROY SOC TROP MED H, V103, P200, DOI 10.1016/j.trstmh.2008.09.001; Roddy P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052986; SANCHEZ A, 1995, EMERG INFECT DIS, V1, P96, DOI 10.3201/eid0103.950307; Shoemaker T, 2012, EMERG INFECT DIS, V18, P1480, DOI 10.3201/eid1809.111536; UNAIDS, 2013, UG AIDSINFO; Wakeham K, 2010, J PALLIAT MED, V13, P375, DOI 10.1089/jpm.2009.0259; WHO CfDCa, 1998, INF CONTR VIR HAEM F	22	20	22	0	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e100333	10.1371/journal.pone.0100333	http://dx.doi.org/10.1371/journal.pone.0100333			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007269	Green Published, Green Submitted, gold			2022-12-27	WOS:000339040600010
J	Sanchez-Alvarez, M; Finger, F; Arias-Garcia, MD; Bousgouni, V; Pascual-Vargas, P; Bakal, C				Sanchez-Alvarez, Miguel; Finger, Fabian; Arias-Garcia, Maria del Mar; Bousgouni, Vicky; Pascual-Vargas, Patricia; Bakal, Chris			Signaling Networks Converge on TORC1-SREBP Activity to Promote Endoplasmic Reticulum Homeostasis	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; MTOR COMPLEX 1; CELL-GROWTH; CAENORHABDITIS-ELEGANS; TRANSLATIONAL CONTROL; SREBP PATHWAY; STRESS; DROSOPHILA; GENE; BIOSYNTHESIS	The function and capacity of the endoplasmic reticulum (ER) is determined by multiple processes ranging from the local regulation of peptide translation, translocation, and folding, to global changes in lipid composition. ER homeostasis thus requires complex interactions amongst numerous cellular components. However, describing the networks that maintain ER function during changes in cell behavior and environmental fluctuations has, to date, proven difficult. Here we perform a systems-level analysis of ER homeostasis, and find that although signaling networks that regulate ER function have a largely modular architecture, the TORC1-SREBP signaling axis is a central node that integrates signals emanating from different sub-networks. TORC1-SREBP promotes ER homeostasis by regulating phospholipid biosynthesis and driving changes in ER morphology. In particular, our network model shows TORC1-SREBP serves to integrate signals promoting growth and G1-S progression in order to maintain ER function during cell proliferation.	[Sanchez-Alvarez, Miguel; Finger, Fabian; Arias-Garcia, Maria del Mar; Bousgouni, Vicky; Pascual-Vargas, Patricia; Bakal, Chris] Inst Canc Res, Chester Beatty Labs, Div Canc Biol, London, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Bakal, C (corresponding author), Inst Canc Res, Chester Beatty Labs, Div Canc Biol, London, England.	cbakal@icr.ac.uk	SÁNCHEZ-ÁLVAREZ, MIGUEL/AAA-4507-2019	SÁNCHEZ-ÁLVAREZ, MIGUEL/0000-0001-5287-1420; Finger, Fabian/0000-0002-0763-6250; Mar Arias-Garcia, M/0000-0003-0130-1107; Bakal, Chris/0000-0002-0413-6744	Biotechnology and Biological Sciences Research Council [BB/I002510/1]; BBSRC [BB/I002510/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Biotechnology and Biological Sciences Research Council: Grant BB/I002510/1. CB is a Research Career Development Fellow of the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007526; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bicknell AA, 2007, J CELL BIOL, V177, P1017, DOI 10.1083/jcb.200702101; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Gardner BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013169; Glimcher LH, 2010, ANN RHEUM DIS, V69, P67, DOI 10.1136/ard.2009.119388; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Henry KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012732; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Iwaki T, 2003, BIOTECHNIQUES, V35, P482, DOI 10.2144/03353bm08; Iwawaki T, 2009, P NATL ACAD SCI USA, V106, P16657, DOI 10.1073/pnas.0903775106; Kidani Y, 2013, NAT IMMUNOL, V14, P489, DOI 10.1038/ni.2570; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Krahmer N, 2011, CELL METAB, V14, P504, DOI 10.1016/j.cmet.2011.07.013; Kunte AS, 2006, CELL METAB, V3, P439, DOI 10.1016/j.cmet.2006.04.011; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Laplante M, 2010, P NATL ACAD SCI USA, V107, P3281, DOI 10.1073/pnas.1000323107; Lewis CA, 2011, BIOCHEM SOC T, V39, P495, DOI 10.1042/BST0390495; Li H, 2010, P NATL ACAD SCI USA, V107, P16113, DOI 10.1073/pnas.1010580107; Liang B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009869; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Merksamer PI, 2008, CELL, V135, P933, DOI 10.1016/j.cell.2008.10.011; Neumann FR, 2007, J CELL BIOL, V179, P593, DOI 10.1083/jcb.200708054; Okazaki H, 2010, J BIOL CHEM, V285, P6801, DOI 10.1074/jbc.M109.079459; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Porstmann T, 2005, ONCOGENE, V24, P6465, DOI 10.1038/sj.onc.1208802; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Qin L, 2010, AUTOPHAGY, V6, P239, DOI 10.4161/auto.6.2.11062; Ramadan N, 2007, NAT PROTOC, V2, P2245, DOI 10.1038/nprot.2007.250; Richardson CE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002391; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Royzman I, 1997, GENE DEV, V11, P1999, DOI 10.1101/gad.11.15.1999; Rubio C, 2011, J CELL BIOL, V193, P171, DOI 10.1083/jcb.201007077; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; Seegmiller AC, 2002, DEV CELL, V2, P229, DOI 10.1016/S1534-5807(01)00119-8; Snijder B, 2013, NAT METHODS, V10, P1089, DOI [10.1038/NMETH.2655, 10.1038/nmeth.2655]; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Sriburi R, 2007, J BIOL CHEM, V282, P7024, DOI 10.1074/jbc.M609490200; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tapon N, 2001, CURR OPIN CELL BIOL, V13, P731, DOI 10.1016/S0955-0674(00)00284-2; Taylor RC, 2013, CELL, V153, P1435, DOI 10.1016/j.cell.2013.05.042; Thibault G, 2012, MOL CELL, V48, P16, DOI 10.1016/j.molcel.2012.08.016; van Anken E, 2003, IMMUNITY, V18, P243, DOI 10.1016/S1074-7613(03)00024-4; Volmer R, 2013, P NATL ACAD SCI USA, V110, P4628, DOI 10.1073/pnas.1217611110; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038	57	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101164	10.1371/journal.pone.0101164	http://dx.doi.org/10.1371/journal.pone.0101164			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007267	Green Submitted, Green Published, gold			2022-12-27	WOS:000339040600030
J	Zelaya, JE; Goenezen, S; Dargon, PT; Azarbal, AF; Rugonyi, S				Zelaya, Jaime E.; Goenezen, Sevan; Dargon, Phong T.; Azarbal, Amir-Farzin; Rugonyi, Sandra			Improving the Efficiency of Abdominal Aortic Aneurysm Wall Stress Computations	PLOS ONE			English	Article							HUMAN CAROTID BIFURCATION; FINITE-ELEMENT-ANALYSIS; INTRALUMINAL THROMBUS; COMPUTED-TOMOGRAPHY; RUPTURE RISK; MECHANICS; THICKNESS; BEHAVIOR; ATHEROGENESIS; PREDICTION	An abdominal aortic aneurysm is a pathological dilation of the abdominal aorta, which carries a high mortality rate if ruptured. The most commonly used surrogate marker of rupture risk is the maximal transverse diameter of the aneurysm. More recent studies suggest that wall stress from models of patient-specific aneurysm geometries extracted, for instance, from computed tomography images may be a more accurate predictor of rupture risk and an important factor in AAA size progression. However, quantification of wall stress is typically computationally intensive and time-consuming, mainly due to the nonlinear mechanical behavior of the abdominal aortic aneurysm walls. These difficulties have limited the potential of computational models in clinical practice. To facilitate computation of wall stresses, we propose to use a linear approach that ensures equilibrium of wall stresses in the aneurysms. This proposed linear model approach is easy to implement and eliminates the burden of nonlinear computations. To assess the accuracy of our proposed approach to compute wall stresses, results from idealized and patient-specific model simulations were compared to those obtained using conventional approaches and to those of a hypothetical, reference abdominal aortic aneurysm model. For the reference model, wall mechanical properties and the initial unloaded and unstressed configuration were assumed to be known, and the resulting wall stresses were used as reference for comparison. Our proposed linear approach accurately approximates wall stresses for varying model geometries and wall material properties. Our findings suggest that the proposed linear approach could be used as an effective, efficient, easy-to-use clinical tool to estimate patient-specific wall stresses.	[Zelaya, Jaime E.; Rugonyi, Sandra] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Goenezen, Sevan] Texas A&M Univ, Dept Mech Engn, College Stn, TX 77843 USA; [Dargon, Phong T.; Azarbal, Amir-Farzin] Oregon Hlth & Sci Univ, Dept Surg, Div Vasc Surg, Portland, OR 97201 USA	Oregon Health & Science University; Texas A&M University System; Texas A&M University College Station; Oregon Health & Science University	Rugonyi, S (corresponding author), Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA.	rugonyis@ohsu.edu	Rugonyi, Sandra/AAF-9269-2020		NSF [DBI-1052688]; Oregon Clinical and Translational Research Institute (OCTRI); National Center for Advancing Translational Sciences (NCATS) NIH [TL1TR000129]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000129] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [1052688] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Oregon Clinical and Translational Research Institute (OCTRI); National Center for Advancing Translational Sciences (NCATS) NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the NSF DBI-1052688 grant and a grant from the Oregon Clinical and Translational Research Institute (OCTRI), National Center for Advancing Translational Sciences (NCATS) NIH TL1TR000129. The content is solely the responsibility of the authors and does not necessarily represent the official views of grant giving bodies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atar E, 2006, AM J ROENTGENOL, V186, P386, DOI 10.2214/AJR.04.0449; Bathe K-J, 1996, FINITE ELEMENT PROCE, P291; Bauchau OA, 2009, STRUCTURAL ANAL APPL, P117; DARLING RC, 1977, CIRCULATION, V56, P161; de Putter S, 2007, J BIOMECH, V40, P1081, DOI 10.1016/j.jbiomech.2006.04.019; Di Achille P, 2011, J BIOMECH, V44, P2418, DOI 10.1016/j.jbiomech.2011.06.029; Di Martino ES, 2003, ANN BIOMED ENG, V31, P804, DOI 10.1114/1.1581880; Fillinger MF, 2003, J VASC SURG, V37, P724, DOI 10.1067/mva.2003.213; FUNG YC, 1991, ANN BIOMED ENG, V19, P237, DOI 10.1007/BF02584301; Gee MW, 2010, INT J NUMER METH BIO, V26, P52, DOI 10.1002/cnm.1236; Geest JPV, 2006, J BIOMECH, V39, P1324, DOI 10.1016/j.jbiomech.2005.03.003; HE CM, 1994, J VASC SURG, V20, P6, DOI 10.1016/0741-5214(94)90169-4; Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564; Humphrey JD, 2012, J BIOMECH, V45, P805, DOI 10.1016/j.jbiomech.2011.11.021; Kaazempur-Mofrad MR, 2003, J ENG MATH, V47, P299, DOI 10.1023/B:ENGI.0000007974.82115.16; Li ZY, 2010, CIRCULATION, V122, P1815, DOI 10.1161/CIRCULATIONAHA.110.939819; Lu J, 2007, J BIOMECH, V40, P693, DOI 10.1016/j.jbiomech.2006.01.015; Martufi G, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3127256; McGloughlin TM, 2010, ARTERIOSCL THROM VAS, V30, P1687, DOI 10.1161/ATVBAHA.110.204529; Molacek J, 2011, ANN VASC SURG, V25, P1036, DOI 10.1016/j.avsg.2011.05.034; Mower WR, 1997, J VASC SURG, V26, P602, DOI 10.1016/S0741-5214(97)70058-2; Nicholls SC, 1998, J VASC SURG, V28, P884, DOI 10.1016/S0741-5214(98)70065-5; Polzer S, 2013, MED ENG PHYS, V35, P1282, DOI 10.1016/j.medengphy.2013.01.008; Rachev A, 2003, CISM COURSES LECT, P221; Rachev A, 2003, J BIOMECH, V36, P661, DOI 10.1016/S0021-9290(02)00444-X; Raghavan ML, 2006, ANN BIOMED ENG, V34, P1414, DOI 10.1007/s10439-006-9115-7; Raghavan ML, 2006, J BIOMECH, V39, P3010, DOI 10.1016/j.jbiomech.2005.10.021; Raghavan ML, 2000, J BIOMECH, V33, P475, DOI 10.1016/S0021-9290(99)00201-8; Raut SS, 2013, J BIOMECH ENG, V135; RODRIGUEZ EK, 1994, J BIOMECH, V27, P455, DOI 10.1016/0021-9290(94)90021-3; Rodriguez JF, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2898830; Roy D, 2012, COMPUT MATH METHOD M, V2012, P1; Scotti CM, 2008, COMPUT METHOD BIOMEC, V11, P301, DOI 10.1080/10255840701827412; Shum J, 2010, MED PHYS, V37, P638, DOI 10.1118/1.3284976; Speelman L, 2009, J BIOMECH, V42, P1713, DOI 10.1016/j.jbiomech.2009.04.020; Speelman L, 2010, J VASC SURG, V51, P19, DOI 10.1016/j.jvs.2009.08.075; STRINGFELLOW MM, 1987, J SURG RES, V42, P425, DOI 10.1016/0022-4804(87)90178-8; Taber LA, 2001, J BIOMECH ENG-T ASME, V123, P528, DOI 10.1115/1.1412451; Teutelink A, 2007, J ENDOVASC THER, V14, P44, DOI 10.1583/06-1976.1; Thubrikar MJ, 2001, ANN VASC SURG, V15, P355, DOI 10.1007/s100160010080; Tong J, 2011, EUR J VASC ENDOVASC, V42, P207, DOI 10.1016/j.ejvs.2011.02.017; Venkatasubramaniam AK, 2004, EUR J VASC ENDOVASC, V28, P168, DOI 10.1016/j.ejvs.2004.03.029; Vorp DA, 2005, ARTERIOSCL THROM VAS, V25, P1558, DOI 10.1161/01.ATV.0000174129.77391.55; Vorp DA, 2007, J BIOMECH, V40, P1887, DOI 10.1016/j.jbiomech.2006.09.003; Wang DHJ, 2002, J VASC SURG, V36, P598, DOI 10.1067/mva.2002.126087; Younis HF, 2004, BIOMECH MODEL MECHAN, V3, P17, DOI 10.1007/s10237-004-0046-7	46	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101353	10.1371/journal.pone.0101353	http://dx.doi.org/10.1371/journal.pone.0101353			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007052	Green Published, gold			2022-12-27	WOS:000339040600035
J	Gao, HT; Ai, ZR; Yu, HL; Wu, HY; Liu, XH				Gao, Haitao; Ai, Zhengrong; Yu, Hailiang; Wu, Hongyan; Liu, Xianghua			Analysis of Internal Crack Healing Mechanism under Rolling Deformation	PLOS ONE			English	Article							EVOLUTION; IRON; FEM	A new experimental method, called the 'hole filling method', is proposed to simulate the healing of internal cracks in rolled workpieces. Based on the experimental results, the evolution in the microstructure, in terms of diffusion, nucleation and recrystallisation were used to analyze the crack healing mechanism. We also validated the phenomenon of segmented healing. Internal crack healing involves plastic deformation, heat transfer and an increase in the free energy introduced by the cracks. It is proposed that internal cracks heal better under high plastic deformation followed by slow cooling after rolling. Crack healing is controlled by diffusion of atoms from the matrix to the crack surface, and also by the nucleation and growth of ferrite grain on the crack surface. The diffusion mechanism is used to explain the source of material needed for crack healing. The recrystallisation mechanism is used to explain grain nucleation and growth, accompanied by atomic migration to the crack surface.	[Gao, Haitao; Ai, Zhengrong; Wu, Hongyan; Liu, Xianghua] Northeastern Univ, State Key Lab Rolling & Automat, Shenyang, Peoples R China; [Yu, Hailiang] Univ Wollongong, Sch Mech Mat & Mechatron Engn, Wollongong, NSW 2522, Australia; [Yu, Hailiang] Shenyang Univ, Sch Mech Engn, Shenyang, Peoples R China	Northeastern University - China; University of Wollongong; Shenyang University	Yu, HL (corresponding author), Univ Wollongong, Sch Mech Mat & Mechatron Engn, Wollongong, NSW 2522, Australia.	hailiang@uow.edu.au	YU, Hailiang/B-5977-2009	YU, Hailiang/0000-0001-7959-0717; Gao, Haitao/0000-0001-6224-0032	Vice-Chancellor's Fellowship Grant; URC small grant at the University of Wollongong; National Natural Science Foundation of China [51105071]	Vice-Chancellor's Fellowship Grant; URC small grant at the University of Wollongong; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Vice-Chancellor's Fellowship Grant and URC small grant at the University of Wollongong, and the National Natural Science Foundation of China through Grant 51105071. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Li XG., 2002, ACTA METALL SIN-ENGL, V15, P385; Liu Xiang-hua, 2009, Journal of Iron and Steel Research, V21, P36; Liu XH, 2010, MATER MANUF PROCESS, V25, P161, DOI 10.1080/10426910903158256; [孟凡莹 Meng Fanying], 2010, [塑性工程学报, Journal of Plasticity Engineering], V17, P136; Wei D, 2006, J MATER PROCESS TECH, V177, P233, DOI 10.1016/j.jmatprotec.2006.04.067; Wei DB, 2004, SCRIPTA MATER, V51, P583, DOI 10.1016/j.scriptamat.2004.05.032; Wei DB, 2013, COMP MATER SCI, V69, P270, DOI 10.1016/j.commatsci.2012.11.043; [肖亚航 XIAO Yahang], 2008, [机械工程材料, Materials for Mechanical Engineering], V32, P13; Yu HL, 2013, INT J ADV MANUF TECH, V67, P1161, DOI 10.1007/s00170-012-4556-7; Yu HL, 2009, J MATER PROCESS TECH, V209, P2876, DOI 10.1016/j.jmatprotec.2008.06.045; Yu HL, 2009, MATER MANUF PROCESS, V24, P570, DOI 10.1080/10426910902746895; Yu HL, 2014, METALL MATER TRANS A, V45A, P1001, DOI 10.1007/s11661-013-2049-4; [袁朝龙 YUAN Chaolong], 2006, [塑性工程学报, Journal of plasticity engineering], V13, P53; Zhang HL, 2004, MAT SCI ENG A-STRUCT, V382, P171, DOI 10.1016/j.msea.2004.04.069; [张永军 ZHANG Yongjun], 2008, [塑性工程学报, Journal of Plasticity Engineering], V15, P122; Zhao XP, 1996, CHIN J MAT RES, V10, P101; Zheng XG, 2013, MAT SCI ENG A-STRUCT, V561, P52, DOI 10.1016/j.msea.2012.10.080; Zhou YZ, 2004, MATER LETT, V58, P1732, DOI 10.1016/j.matlet.2003.10.049; 周本濂, 1997, 材料研究学报, V11, P576	19	8	9	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101907	10.1371/journal.pone.0101907	http://dx.doi.org/10.1371/journal.pone.0101907			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003518	Green Published, Green Submitted, gold			2022-12-27	WOS:000339242700087
J	Trojanowicz, B; Ulrich, C; Seibert, E; Fiedler, R; Girndt, M				Trojanowicz, Bogusz; Ulrich, Christof; Seibert, Eric; Fiedler, Roman; Girndt, Matthias			Uremic Conditions Drive Human Monocytes to Pro-Atherogenic Differentiation via an Angiotensin-Dependent Mechanism	PLOS ONE			English	Article							CONVERTING-ENZYME-INHIBITOR; II-INDUCED ATHEROSCLEROSIS; CHEMOATTRACTANT PROTEIN-1; CARDIOVASCULAR-DISEASE; VASCULAR INFLAMMATION; CHRONIC-HEMODIALYSIS; RENAL-FAILURE; HUMAN PLASMA; MACROPHAGES; EXPRESSION	Aims: Elevated expression levels of monocytic-ACE have been found in haemodialysis patients. They are not only epidemiologically linked with increased mortality and cardiovascular disease, but may also directly participate in the initial steps of atherosclerosis. To further address this question we tested the role of monocytic-ACE in promotion of atherosclerotic events in vitro under conditions mimicking those of chronic renal failure. Methods and Results: Treatment of human primary monocytes or THP-1 cells with uremic serum as well as PMA-induced differentiation led to significantly up-regulated expression of ACE, further increased by additional treatment with LPS. Functionally, these monocytes revealed significantly increased adhesion and transmigration through endothelial monolayers. Overexpression of ACE in transfected monocytes or THP-1 cells led to development of more differentiated, macrophage-like phenotype with up-regulated expression of Arg1, MCSF, MCP-1 and CCR2. Expression of pro-inflammatory cytokines TNF alpha and IL-6 were also noticeably up-regulated. ACE overexpression resulted in significantly increased adhesion and transmigration properties. Transcriptional screening of ACE-overexpressing monocytes revealed noticeably increased expression of Angiotensin II receptors and adhesion-as well as atherosclerosis-related ICAM-1 and VCAM1. Inhibition of monocyte ACE or AngII-receptor signalling led to decreased adhesion potential of ACE-overexpressing cells. Conclusions: Taken together, these data demonstrate that uremia induced expression of monocytic-ACE mediates the development of highly pro-atherogenic cells via an AngII-dependent mechanism.	[Trojanowicz, Bogusz; Ulrich, Christof; Seibert, Eric; Fiedler, Roman; Girndt, Matthias] Univ Halle Wittenberg, Dept Internal Med 2, Halle, Germany	Martin Luther University Halle Wittenberg	Trojanowicz, B (corresponding author), Univ Halle Wittenberg, Dept Internal Med 2, Halle, Germany.	bogusz.trojanowicz@uk-halle.de	Trojanowicz, Bogusz/I-3042-2019; Girndt, Matthias/M-1436-2019	Trojanowicz, Bogusz/0000-0001-7429-381X; Girndt, Matthias/0000-0003-2823-0847	University Halle (Saale)	University Halle (Saale)	This work was supported by intramural funding of the University Halle (Saale). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardi S, 2011, NEPHROL DIAL TRANSPL, V26, P832, DOI 10.1093/ndt/gfq524; Blankenberg S, 2003, ATHEROSCLEROSIS, V170, P191, DOI 10.1016/S0021-9150(03)00097-2; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Chen XF, 2013, ARTERIOSCL THROM VAS, V33, P2075, DOI 10.1161/ATVBAHA.113.301777; Cheung AK, 2000, KIDNEY INT, V58, P353, DOI 10.1046/j.1523-1755.2000.00173.x; da Cunha V, 2005, ATHEROSCLEROSIS, V178, P9, DOI 10.1016/j.atherosclerosis.2004.08.023; Dawson TC, 1999, ATHEROSCLEROSIS, V143, P205; De Meyer I, 2012, BRIT J CLIN PHARMACO, V74, P246, DOI 10.1111/j.1365-2125.2012.04211.x; Diet F, 1996, CIRCULATION, V94, P2756, DOI 10.1161/01.CIR.94.11.2756; Finch JL, 2012, AM J PHYSIOL-RENAL, V302, pF141, DOI 10.1152/ajprenal.00293.2011; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Gratchev A, 2005, SCAND J IMMUNOL, V61, P10, DOI 10.1111/j.0300-9475.2005.01524.x; Guerin AP, 2001, CIRCULATION, V103, P987; Ishibashi M, 2004, CIRC RES, V94, P1203, DOI 10.1161/01.RES.0000126924.23467.A3; Ito S, 2010, J BIOL CHEM, V285, P38869, DOI 10.1074/jbc.M110.166686; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; KITAZONO T, 1995, CIRCULATION, V91, P1129, DOI 10.1161/01.CIR.91.4.1129; Kogai J, 2008, HYPERTENS RES, V31, P1791, DOI 10.1291/hypres.31.1791; Kohlstedt K, 2011, BASIC RES CARDIOL, V106, P205, DOI 10.1007/s00395-010-0137-9; Kojima C, 2007, J PHARMACOL EXP THER, V323, P855, DOI 10.1124/jpet.107.127944; Lal Hind, 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P109, DOI 10.2174/187152507780363223; Libby P, 1996, CURR OPIN LIPIDOL, V7, P330, DOI 10.1097/00041433-199610000-00012; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Metzger R, 2011, MICROVASC RES, V81, P206, DOI 10.1016/j.mvr.2010.12.003; Mizobuchi M, 2011, AM J NEPHROL, V34, P256, DOI 10.1159/000330188; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; NELKEN NA, 1991, J CLIN INVEST, V88, P1121, DOI 10.1172/JCI115411; Ni WH, 2004, ARTERIOSCL THROM VAS, V24, P534, DOI 10.1161/01.ATV.0000118275.60121.2b; O'Brien KD, 2002, CIRCULATION, V106, P2224, DOI 10.1161/01.CIR.0000035655.45453.D2; Okumoto S, 2009, THER APHER DIAL, V13, P205, DOI 10.1111/j.1744-9987.2009.00658.x; Ouimet T, 2012, MOL PHARMACEUT, V9, P850, DOI 10.1021/mp2003863; Pello OM, 2011, IMMUNOBIOLOGY, V216, P1172, DOI 10.1016/j.imbio.2011.05.010; Petrov MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049290; Pletinck A, 2013, J AM SOC NEPHROL, V24, P1981, DOI 10.1681/ASN.2012030281; Pourcet B, 2013, TRENDS CARDIOVAS MED, V23, P143, DOI 10.1016/j.tcm.2012.10.003; Rafatian N, 2013, AM J PHYSIOL-HEART C, V305, pH1309, DOI 10.1152/ajpheart.00826.2012; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Schepers E, 2007, NEPHROL DIAL TRANSPL, V22, P592, DOI 10.1093/ndt/gfl584; Schieffer B, 2000, CIRCULATION, V101, P1372, DOI 10.1161/01.CIR.101.12.1372; Shen XZ, 2011, NAT IMMUNOL, V12, P1078, DOI 10.1038/ni.2107; Shimizu H, 2013, AM J PHYSIOL-CELL PH, V304, pC685, DOI 10.1152/ajpcell.00236.2012; Simolin MA, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-10; Steinberg D, 2002, NAT MED, V8, P1211, DOI 10.1038/nm1102-1211; Stoger JL, 2012, ATHEROSCLEROSIS, V225, P461, DOI 10.1016/j.atherosclerosis.2012.09.013; Sun CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034026; Tuttolomondo A, 2012, CURR PHARM DESIGN, V18, P4266, DOI 10.2174/138161212802481237; Tyralla K, 2003, KIDNEY INT, V63, pS80, DOI 10.1046/j.1523-1755.63.s84.1.x; Ulrich C, 2006, NEPHROL DIAL TRANSPL, V21, P1596, DOI 10.1093/ndt/gfl008; Ulrich C, 2011, CLIN J AM SOC NEPHRO, V6, P505, DOI 10.2215/CJN.06870810; Ulrich C, 2010, NEPHROL DIAL TRANSPL, V25, P2265, DOI 10.1093/ndt/gfq012; van Tits LJH, 2011, ATHEROSCLEROSIS, V214, P345, DOI 10.1016/j.atherosclerosis.2010.11.018; Vanholder R, 2005, NEPHROL DIAL TRANSPL, V20, P1048, DOI 10.1093/ndt/gfh813; Vanholder R., 2014, J AM SOC NEPHROL; Wiesner P, 2013, J LIPID RES, V54, P1877, DOI 10.1194/jlr.M036343; Xu W, 2006, BLOOD, V107, P4930, DOI 10.1182/blood-2005-10-4144; Yusuf S, 2000, NEW ENGL J MED, V342, P145	57	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e102137	10.1371/journal.pone.0102137	http://dx.doi.org/10.1371/journal.pone.0102137			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003524	Green Published, gold, Green Submitted			2022-12-27	WOS:000339242700114
J	Tsertsvadze, A; Grove, A; Freeman, K; Court, R; Johnson, S; Connock, M; Clarke, A; Sutcliffe, P				Tsertsvadze, Alexander; Grove, Amy; Freeman, Karoline; Court, Rachel; Johnson, Samantha; Connock, Martin; Clarke, Aileen; Sutcliffe, Paul			Total Hip Replacement for the Treatment of End Stage Arthritis of the Hip: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							CROSS-LINKED POLYETHYLENE; PATIENT-REPORTED OUTCOMES; ALUMINA CERAMIC BEARINGS; RANDOMIZED-TRIALS; FOLLOW-UP; ARTHROPLASTY; CEMENT; OSTEOARTHRITIS; QUESTIONNAIRE; DISLOCATION	Background: Evolvements in the design, fixation methods, size, and bearing surface of implants for total hip replacement (THR) have led to a variety of options for healthcare professionals to consider. The need to determine the most optimal combinations of THR implant is warranted. This systematic review evaluated the clinical effectiveness of different types of THR used for the treatment of end stage arthritis of the hip. Methods: A comprehensive literature search was undertaken in major health databases. Randomised controlled trials (RCTs) and systematic reviews published from 2008 onwards comparing different types of primary THR in patients with end stage arthritis of the hip were included. Results: Fourteen RCTs and five systematic reviews were included. Patients experienced significant post-THR improvements in Harris Hip scores, but this did not differ between impact types. There was a reduced risk of implant dislocation after receiving a larger femoral head size (36 mm vs. 28 mm; RR = 0.17, 95% CI: 0.04, 0.78) or cemented cup (vs. cementless cup; pooled odds ratio: 0.34, 95% CI: 0.13, 0.89). Recipients of cross-linked vs. conventional polyethylene cup liners experienced reduced femoral head penetration and revision. There was no impact of femoral stem fixation and cup shell design on implant survival rates. Evidence on mortality and complications (aseptic loosening, femoral fracture) was inconclusive. Conclusions: The majority of evidence was inconclusive due to poor reporting, missing data, or uncertainty in treatment estimates. The findings warrant cautious interpretation given the risk of bias (blinding, attrition), methodological limitations (small sample size, low event counts, short follow-up), and poor reporting. Long-term pragmatic RCTs are needed to allow for more definitive conclusions. Authors are encouraged to specify the minimal clinically important difference and power calculation for their primary outcome(s) as well CONSORT, PRISMA and STROBE guidelines to ensure better reporting and more reliable production and assessment of evidence.	[Tsertsvadze, Alexander; Grove, Amy; Freeman, Karoline; Court, Rachel; Johnson, Samantha; Connock, Martin; Clarke, Aileen; Sutcliffe, Paul] Univ Warwick, Warwick Med Sch, Div Hlth Sci, Warwick Evidence, Coventry CV4 7AL, W Midlands, England	University of Warwick	Grove, A (corresponding author), Univ Warwick, Warwick Med Sch, Div Hlth Sci, Warwick Evidence, Coventry CV4 7AL, W Midlands, England.	A.L.Grove@Warwick.ac.uk	Sutcliffe, Paul/AAB-7325-2020; Clarke, Aileen/I-5679-2012; Johnson, Samantha/D-4736-2014	Clarke, Aileen/0000-0001-8299-3146; Johnson, Samantha/0000-0002-4716-1229; Freeman, Karoline/0000-0002-9963-2918; Grove, Prof Amy/0000-0002-8027-7274; Court, Rachel/0000-0002-4567-2586	National Institute for Health Research, Health Technology Assessment Programme [11/118]; National Institute for Health Research (NIHR) [DRF-2013-06-064]; Care West Midlands at University Hospitals Birmingham NHS Foundation Trust	National Institute for Health Research, Health Technology Assessment Programme(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Care West Midlands at University Hospitals Birmingham NHS Foundation Trust	This project was commissioned by the National Institute for Health Research, Health Technology Assessment Programme (project number 11/118). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. Prof Aileen Clarke is also supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care West Midlands at University Hospitals Birmingham NHS Foundation Trust. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. Amy Grove is funded by the National Institute for Health Research (NIHR) Doctoral Fellowship Programme (DRF-2013-06-064). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkarim A, 2013, ORTHOP REV, V5, P34, DOI 10.4081/or.2013.e8; Achten J, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-8; Amanatullah DF, 2011, J ARTHROPLASTY, V26, P72, DOI 10.1016/j.arth.2011.04.032; Angadi DS, 2012, J BONE JOINT SURG BR, V94B, P1604, DOI 10.1302/0301-620X.94B12.28060; Bascarevic Z, 2010, INT ORTHOP, V34, P1129, DOI 10.1007/s00264-009-0899-6; Bellamy N, 2010, INTERN MED J, V40, P6; Bjorgul K, 2010, ORTHOP TRAUMATOL-SUR, V96, P97, DOI [10.1016/j.otsr.2009.11.002, 10.1016/j.rcot.2010.02.009]; Bjorgul K, 2010, J ORTHOP TRAUMATOL, V11, P37, DOI 10.1007/s10195-010-0082-2; Bourne Robert B, 2010, Orthopedics, V33, P638, DOI 10.3928/01477447-20100722-24; Boutron I, 2003, JAMA-J AM MED ASSOC, V290, P1062, DOI 10.1001/jama.290.8.1062; Boutron I, 2008, ANN INTERN MED, V148, pW60, DOI 10.7326/0003-4819-148-4-200802190-00008-w1; Calvert M, 2013, JAMA-J AM MED ASSOC, V309, P814, DOI 10.1001/jama.2013.879; Capello WN, 2008, J ARTHROPLASTY, V23, P39, DOI 10.1016/j.arth.2008.06.003; Clement ND, 2012, ARCH ORTHOP TRAUM SU, V132, P411, DOI 10.1007/s00402-011-1422-2; Corten K, 2011, J BONE JOINT SURG AM, V93A, P1335, DOI [10.2106/JBJSJ.00448, 10.2106/JBJS.K.00308, 10.2106/JBJS.J.00448]; Corten K, 2011, CLIN ORTHOP RELAT R, V469, P209, DOI 10.1007/s11999-010-1459-5; D'Antonio J, 2005, CLIN ORTHOP RELAT R, P164, DOI 10.1097/01.blo.0000162995.50971.39; D'Antonio J, 2003, ORTHOPEDICS, V26, P39; DAUBIGNE RM, 1954, J BONE JOINT SURG AM, V36-A, P451, DOI 10.2106/00004623-195436030-00001; Dawson J, 1996, J BONE JOINT SURG BR, V78B, P185, DOI 10.1302/0301-620X.78B2.0780185; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Engh CA, 2006, J ARTHROPLASTY, V21, P17, DOI 10.1016/j.arth.2006.05.002; Engh CA, 2012, J ARTHROPLASTY, V27, P2, DOI 10.1016/j.arth.2012.03.048; Ergina PL, 2009, LANCET, V374, P1097, DOI 10.1016/S0140-6736(09)61086-2; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; HARRIS WH, 1969, J BONE JOINT SURG AM, VA 51, P737, DOI 10.2106/00004623-196951040-00012; Healy WL, 2009, J ARTHROPLASTY, V24, P831, DOI 10.1016/j.arth.2008.06.035; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Howie DW, 2012, J BONE JOINT SURG AM, V94A, P1095, DOI 10.2106/JBJS.K.00570; Issa K, 2013, LANCET, V382, P1074, DOI 10.1016/S0140-6736(13)61891-7; Kadar T, 2011, J ORTHOP RES, V29, P1222, DOI 10.1002/jor.21389; Kalairajah Y, 2005, J ARTHROPLASTY, V20, P1037, DOI 10.1016/j.arth.2005.04.017; Kim YH, 2011, J BONE JOINT SURG BR, V93B, P449, DOI 10.1302/0301-620X.93B4.26149; Kim YH, 2011, J ARTHROPLASTY, V26, P931, DOI 10.1016/j.arth.2010.10.001; Kraemer HC, 1998, PSYCHOL METHODS, V3, P23, DOI 10.1037/1082-989X.3.1.23; Laupacis A, 2002, J BONE JOINT SURG AM, V84A, P1823, DOI 10.2106/00004623-200210000-00013; Lewis PM, 2008, ORTHOPEDICS S2, V31, P37183; Lewis PM, 2008, ORTHOPEDICS, V31, P371; Li SZ, 2013, INT J SURG, V11, P477, DOI 10.1016/j.ijsu.2013.04.003; Lie SA, 2002, ACTA ORTHOP SCAND, V73, P392, DOI 10.1080/00016470216312; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; McCalden RW, 2009, J BONE JOINT SURG AM, V91A, P773, DOI 10.2106/JBJS.H.00244; McCulloch P, 2002, BRIT MED J, V324, P1448, DOI 10.1136/bmj.324.7351.1448; McLeod RS, 1999, WORLD J SURG, V23, P1210, DOI 10.1007/s002689900649; Mesko JW, 2011, J ARTHROPLASTY, V26, P172, DOI 10.1016/j.arth.2010.04.029; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; National Institute for Health and Clinical Excellence, 2000, GUID US LIQ BAS CYT, V2, P1; National Joint Registry for England, 2013, 10 ANN REP 2013 NAT; Nuesch E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3515; Pakvis D, 2011, INT ORTHOP, V35, P1109, DOI 10.1007/s00264-011-1234-6; Pivec R, 2012, LANCET, V380, P1768, DOI 10.1016/S0140-6736(12)60607-2; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Sedrakyan A, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7434; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Smith MA, 2012, ORTHOP NURS, V31, P296, DOI 10.1097/NOR.0b013e31826649b6; Stanley TD, 2010, AM STAT, V64, P70, DOI 10.1198/tast.2009.08205; Tubach F, 2005, ANN RHEUM DIS, V64, P29, DOI 10.1136/ard.2004.022905; Turner RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059202; VANDERLINDEN W, 1980, SURGERY, V87, P258; Verhoeven AC, 2000, J RHEUMATOL, V27, P2801; Voigt JD, 2012, J ARTHROPLASTY, V27, P1544, DOI 10.1016/j.arth.2011.12.008; Voleti PB, 2012, J ARTHROPLASTY, V27, P1844, DOI 10.1016/j.arth.2012.05.023; Walters SJ, 2005, QUAL LIFE RES, V14, P1523, DOI 10.1007/s11136-004-7713-0; Yoshitomi H, 2009, CLIN ORTHOP RELAT R, V467, P2349, DOI 10.1007/s11999-009-0709-x; Zahiri CA, 1998, J ARTHROPLASTY, V13, P890, DOI 10.1016/S0883-5403(98)90195-4	66	23	23	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e99804	10.1371/journal.pone.0099804	http://dx.doi.org/10.1371/journal.pone.0099804			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003202	Green Submitted, Green Published, gold			2022-12-27	WOS:000339242700003
J	Michinaga, S; Nagase, M; Matsuyama, E; Yamanaka, D; Seno, N; Fuka, M; Yamamoto, Y; Koyama, Y				Michinaga, Shotaro; Nagase, Marina; Matsuyama, Emi; Yamanaka, Daisuke; Seno, Naoki; Fuka, Mayu; Yamamoto, Yui; Koyama, Yutaka			Amelioration of Cold Injury-Induced Cortical Brain Edema Formation by Selective Endothelin ETB Receptor Antagonists in Mice	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; GROWTH-FACTOR; BARRIER BREAKDOWN; ASTROCYTES; EXPRESSION; ISCHEMIA; AGONIST; ACTIVATION; STROKE; MATRIX-METALLOPROTEINASE-9	Brain edema is a potentially fatal pathological condition that often occurs in stroke and head trauma. Following brain insults, endothelins (ETs) are increased and promote several pathophysiological responses. This study examined the effects of ETB antagonists on brain edema formation and disruption of the blood-brain barrier in a mouse cold injury model (Five-to six-week-old male ddY mice). Cold injury increased the water content of the injured cerebrum, and promoted extravasation of both Evans blue and endogenous albumin. In the injury area, expression of prepro-ET-1 mRNA and ET-1 peptide increased. Intracerebroventricular (ICV) administration of BQ788 (ETB antagonist), IRL-2500 (ETB antagonist), or FR139317 (ETA antagonist) prior to cold injury significantly attenuated the increase in brain water content. Bolus administration of BQ788, IRL-2500, or FR139317 also inhibited the cold injury-induced extravasation of Evans blue and albumin. Repeated administration of BQ788 and IRL-2500 beginning at 24 h after cold injury attenuated both the increase in brain water content and extravasation of markers. In contrast, FR139317 had no effect on edema formation when administrated after cold injury. Cold injury stimulated induction of glial fibrillary acidic protein-positive reactive astrocytes in the injured cerebrum. Induction of reactive astrocytes after cold injury was attenuated by ICV administration of BQ788 or IRL-2500. These results suggest that ETB receptor antagonists may be an effective approach to ameliorate brain edema formation following brain insults.	[Michinaga, Shotaro; Nagase, Marina; Matsuyama, Emi; Yamanaka, Daisuke; Seno, Naoki; Fuka, Mayu; Yamamoto, Yui; Koyama, Yutaka] Osaka Ohtani Univ, Fac Pharm, Pharmacol Lab, Tonda Bayashi, Osaka, Japan		Koyama, Y (corresponding author), Osaka Ohtani Univ, Fac Pharm, Pharmacol Lab, Tonda Bayashi, Osaka, Japan.	koyamay@osaka-ohtani.ac.jp		Michinaga, Shotaro/0000-0002-4052-7507	JPSP [21590108]	JPSP	This work was supported by a Grant-in-Aid for Scientific Research (C) from the JPSP (http://www.jsps.go.jp/english/e-grants/index.html) (grant No. 21590108). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Argaw AT, 2012, J CLIN INVEST, V122, P2454, DOI 10.1172/JCI60842; Barone FC, 2000, J CARDIOVASC PHARM, V36, pS357, DOI 10.1097/00005344-200036051-00104; Gadea A, 2008, J NEUROSCI, V28, P2394, DOI 10.1523/JNEUROSCI.5652-07.2008; Hama H, 1997, J NEUROSCI RES, V47, P590, DOI 10.1002/(SICI)1097-4547(19970315)47:6<590::AID-JNR4>3.0.CO;2-8; Hayashi T, 1997, STROKE, V28, P2039, DOI 10.1161/01.STR.28.10.2039; Ishikawa N, 1997, EUR J NEUROSCI, V9, P895, DOI 10.1111/j.1460-9568.1997.tb01440.x; Kaundal RK, 2012, DRUG DISCOV TODAY, V17, P793, DOI 10.1016/j.drudis.2012.02.017; Kimbler DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041229; Kimura R, 2005, STROKE, V36, P1259, DOI 10.1161/01.STR.0000165925.20413.14; Koyama Y, 2012, MAPAN-J METROL SOC I, V27, P1, DOI 10.1007/s12647-012-0009-x; Koyama Y, 2011, NEUROSCIENCE, V192, P689, DOI 10.1016/j.neuroscience.2011.05.058; Koyama Y, 2003, EUR J NEUROSCI, V18, P887, DOI 10.1046/j.1460-9568.2003.02797.x; Koyama Y, 1999, GLIA, V26, P268, DOI 10.1002/(SICI)1098-1136(199905)26:3<268::AID-GLIA8>3.0.CO;2-G; Koyama Y, 2012, J PHARMACOL SCI, V118, P401, DOI 10.1254/jphs.11R13CP; Koyama Y, 2010, J PHARMACOL SCI, V114, P433, DOI 10.1254/jphs.10195FP; Leonard MG, 2012, BRAIN RES, V1464, P14, DOI 10.1016/j.brainres.2012.05.005; Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4; Matsuo Y, 2001, STROKE, V32, P2143, DOI 10.1161/hs0901.94259; Moldes O, 2012, NEUROPHARMACOLOGY, V63, P1279, DOI 10.1016/j.neuropharm.2012.08.019; Murakami K, 1999, PROG NEUROBIOL, V57, P289, DOI 10.1016/S0301-0082(98)00047-1; Nag S, 1997, J NEUROPATH EXP NEUR, V56, P912, DOI 10.1097/00005072-199708000-00009; Nag S, 1996, J NEUROPATH EXP NEUR, V55, P880, DOI 10.1097/00005072-199608000-00003; Nag S, 2009, ACTA NEUROPATHOL, V118, P197, DOI 10.1007/s00401-009-0541-0; Ostrow LW, 2005, BRAIN RES REV, V48, P488, DOI 10.1016/j.brainresrev.2004.09.005; OURY TD, 1993, J BIOL CHEM, V268, P15394; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Peters CM, 2003, EXP NEUROL, V180, P1, DOI 10.1016/S0014-4886(02)00023-7; Rabinstein AA, 2006, NEUROLOGIST, V12, P59, DOI 10.1097/01.nrl.0000186810.62736.f0; ROBERTS WG, 1995, J CELL SCI, V108, P2369; Rogers SD, 2003, GLIA, V41, P180, DOI 10.1002/glia.10173; Rosenberg GA, 1996, J CEREBR BLOOD F MET, V16, P360, DOI 10.1097/00004647-199605000-00002; Schinelli S, 2006, CURR MED CHEM, V13, P627, DOI 10.2174/092986706776055652; Shields J, 2011, TRANSL STROKE RES, V2, P633, DOI 10.1007/s12975-011-0129-6; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sood RR, 2008, J CEREBR BLOOD F MET, V28, P431, DOI 10.1038/sj.jcbfm.9600534; Tejima E, 2007, J CEREBR BLOOD F MET, V27, P460, DOI 10.1038/sj.jcbfm.9600354; van Bruggen N, 1999, J CLIN INVEST, V104, P1613, DOI 10.1172/JCI8218; Wajima D, 2013, BRAIN RES, V1519, P127, DOI 10.1016/j.brainres.2013.05.002; Walcott BP, 2012, NEUROTHERAPEUTICS, V9, P65, DOI 10.1007/s13311-011-0087-4; Wang J, 2005, BRAIN, V128, P1622, DOI 10.1093/brain/awh489; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Watts LT, 2013, J NEUROTRAUM, V30, P55, DOI 10.1089/neu.2012.2488; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Wolburg H, 2009, CELL TISSUE RES, V335, P75, DOI 10.1007/s00441-008-0658-9; Yang Y, 2011, STROKE, V42, P3323, DOI 10.1161/STROKEAHA.110.608257	47	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e102009	10.1371/journal.pone.0102009	http://dx.doi.org/10.1371/journal.pone.0102009			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000290	Green Submitted, gold, Green Published			2022-12-27	WOS:000338637300116
J	Ma, B; Yu, XL; Ma, F; Li, ZB; Wu, FQ				Ma, Bo; Yu, Xiaoling; Ma, Fan; Li, Zhanbin; Wu, Faqi			Effects of Crop Canopies on Rain Splash Detachment	PLOS ONE			English	Article							COVERS	Crops are one of the main factors affecting soil erosion in sloping fields. To determine the characteristics of splash erosion under crop canopies, corn, soybean, millet, and winter wheat were collected, and the relationship among splash erosion, rainfall intensity, and throughfall intensity under different crop canopies was analyzed through artificial rainfall experiments. The results showed that, the mean splash detachment rate on the ground surface was 390.12g/m(2).h, which was lower by 67.81% than that on bare land. The inhibiting effects of crops on splash erosion increased as the crops grew, and the ability of the four crops to inhibit splash erosion was in the order of winter wheat>corn>soybeans>millet. An increase in rainfall intensity could significantly enhance the occurrence of splash erosion, but the ability of crops to inhibit splash erosion was 13% greater in cases of higher rainfall intensity. The throughfall intensity under crop canopies was positively related to the splash detachment rate, and this relationship was more significant when the rainfall intensity was 40 mm/h. Splash erosion tended to occur intensively in the central row of croplands as the crop grew, and the non-uniformity of splash erosion was substantial, with splash erosion occurring mainly between the rows and in the region directly under the leaf margin. This study has provided a theoretical basis for describing the erosion mechanisms of cropland and for assisting soil erosion prediction as well as irrigation and fertilizer management in cultivated fields.	[Ma, Bo; Li, Zhanbin] Northwest A&F Univ, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China; [Ma, Bo; Yu, Xiaoling; Wu, Faqi] Northwest A&F Univ, Coll Resources & Environm, Yangling, Shaanxi, Peoples R China; [Ma, Fan] Ningxia Acad Agr & Forestry Sci, Inst Desertificat Control, Yinchuan, Ningxia Hui Aut, Peoples R China	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; Northwest A&F University - China	Wu, FQ (corresponding author), Northwest A&F Univ, Coll Resources & Environm, Yangling, Shaanxi, Peoples R China.	wufaqi@263.net			National Basic Research Program of China (973 Program) [2007CB407201-5]; National Natural Science Foundation of China [41330858]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research for this thesis has been supported by the National Basic Research Program of China (973 Program, 2007CB407201-5) and the National Natural Science Foundation of China under Grant No. 41330858. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, CHINA SOIL SYSTEMIC; ARMSTRONG CL, 1987, T ASAE, V30, P688; Ellison W. D., 1944, AGRIC ENGINEERING, V25, P131; ELLISON W. D., 1947, Agric. Engng., V28, P197; FINNEY HJ, 1984, J AGR ENG RES, V29, P337, DOI 10.1016/0021-8634(84)90089-1; HAYNES J. L., 1940, JOUR AMER SOC AGRON, V32, P176; Jin K, 2008, CATENA, V75, P191, DOI 10.1016/j.catena.2008.06.002; JQ Xie, 2005, SLOPE LAND CHINA; Lamm RF, 2000, T ASABE, V43, P909; Ma F., 2009, EFFECTS CROP COVER S; [苗全安 Miao Quan'an], 2011, [中国水土保持科学, Science of Soil and Water Conservation], V9, P11; MORGAN RPC, 1982, T ASAE, V25, P987; MORGAN RPC, 1985, T ASAE, V28, P1135; MOSS AJ, 1987, AUST J SOIL RES, V25, P9, DOI 10.1071/SR9870009; Myneni RB, 2002, REMOTE SENS ENVIRON, V83, P214, DOI 10.1016/S0034-4257(02)00074-3; QUINN NW, 1983, T ASAE, V26, P1445; SREENIVAS L., 1947, SOIL SCI SOC AMER PROC, V12, P471; Tang K., 2004, SOIL WATER CONSERVAT; Wu FQ, 2001, DYNAMIC MECH EROSION	19	21	21	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e99717	10.1371/journal.pone.0099717	http://dx.doi.org/10.1371/journal.pone.0099717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992386	Green Published, Green Submitted			2022-12-27	WOS:000341253400013
J	Nault, BA; Kain, WC; Wang, P				Nault, Brian A.; Kain, Wendy C.; Wang, Ping			Seasonal Changes in Thrips tabaci Population Structure in Two Cultivated Hosts	PLOS ONE			English	Article							CYTOCHROME-OXIDASE I; ONION THRIPS; THYSANOPTERA THRIPIDAE; LINDEMAN THYSANOPTERA; PHYLOGENETIC ANALYSIS; REPRODUCTIVE FORMS; DIFFERENTIATION; RESISTANCE; SEQUENCES; FIELDS	Thrips tabaci is a major pest of high-value vegetable crops and understanding its population genetics will advance our knowledge about its ecology and management. Mitochondrial cytochrome oxidase subunit I (COI) gene sequence was used as a molecular marker to analyze T. tabaci populations from onion and cabbage fields in New York. Eight COI haplotypes were identified in 565 T. tabaci individuals collected from these fields. All T. tabaci were thelytokous and genetically similar to those originating from hosts representing seven plant families spanning five continents. The most dominant haplotype was NY-HT1, accounting for 92 and 88% of the total individuals collected from onion fields in mid-summer in 2005 and 2007, respectively, and 100 and 96% of the total in early fall in 2005 and 2007, respectively. In contrast, T. tabaci collected from cabbage fields showed a dynamic change in population structure from mid-summer to early fall. In mid-summer, haplotype NY-HT2 was highly abundant, accounting for 58 and 52% of the total in 2005 and 2007, respectively, but in early fall it decreased drastically to 15 and 7% of the total in 2005 and 2007, respectively. Haplotype NY-HT1 accounted for 12 and 46% of the total in cabbage fields in mid-summer of 2005 and 2007, respectively, but became the dominant haplotype in early fall accounting for 81 and 66% of the total in 2005 and 2007, respectively. Despite the relative proximity of onion and cabbage fields in the western New York landscape, T. tabaci populations differed seasonally within each cropping system. Differences may have been attributed to better establishment of certain genotypes on specific hosts or differing colonization patterns within these cropping systems. Future studies investigating temporal changes in T. tabaci populations on their major hosts in these ecosystems are needed to better understand host-plant utilization and implications for population management.	[Nault, Brian A.; Kain, Wendy C.; Wang, Ping] Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA	Cornell University	Nault, BA (corresponding author), Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA.	ban6@cornell.edu						ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Brunner PC, 2004, HEREDITY, V93, P364, DOI 10.1038/sj.hdy.6800512; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dorit RL, 2001, CURR PROTOC MOL BIOL, V56; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Jacobson AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054484; Jenser G., 2001, Acta Phytopathologica et Entomologica Hungarica, V36, P365; JUKES T H, 1969, P21; Kadirvel P, 2013, J ECON ENTOMOL, V106, P408, DOI 10.1603/EC12119; Kennedy GG, 2000, ANNU REV ENTOMOL, V45, P467, DOI 10.1146/annurev.ento.45.1.467; Kobayashi K, 2013, SCI REP-UK, V3, DOI 10.1038/srep03286; Kobayashi K, 2012, J ECON ENTOMOL, V105, P555, DOI 10.1603/EC11320; Larentzaki E, 2007, J ECON ENTOMOL, V100, P1194, DOI 10.1603/0022-0493(2007)100[1194:OLAHFO]2.0.CO;2; MORISON G. D., 1957, TRANS ROY ENT SOC LONDON, V109, P467; Nault BA, 2008, ARTHROPOD MANAGEMENT, V33, pE19; Nault BA, 2006, ARTHROPOD MANAGEMENT, V31, pE39; NAULT BA, 2010, ARTHROPOD MANAGEMENT, V35, pE13; Nault BA, 2006, ENVIRON ENTOMOL, V35, P1264, DOI 10.1603/0046-225X(2006)35[1264:RMIOTT]2.0.CO;2; NORTH RC, 1986, ENVIRON ENTOMOL, V15, P520, DOI 10.1093/ee/15.3.520; Parrella Michael P., 1997, P595; Shelton AM, 2008, J ECON ENTOMOL, V101, P438, DOI 10.1603/0022-0493(2008)101[438:AICOOT]2.0.CO;2; Shelton AM, 2006, J ECON ENTOMOL, V99, P1798, DOI 10.1603/0022-0493-99.5.1798; Shelton AM, 2003, J ECON ENTOMOL, V96, P1843, DOI 10.1603/0022-0493-96.6.1843; Smith EA, 2011, ENVIRON ENTOMOL, V40, P194, DOI 10.1603/EN10246; Srinivasan R, 2011, J ENTOMOL SCI, V46, P191, DOI 10.18474/0749-8004-46.3.191; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TEMPLETON AR, 1992, GENETICS, V132, P619; Tiewsiri K, 2011, P NATL ACAD SCI USA, V108, P14037, DOI 10.1073/pnas.1102555108; Toda S, 2007, APPL ENTOMOL ZOOL, V42, P309, DOI 10.1303/aez.2007.309; Westmore GC, 2013, HEREDITY, V111, P210, DOI 10.1038/hdy.2013.39; Zawirska I., 1976, Archiv fur Phytopathologie und Pflanzenschutz, V12, P411, DOI 10.1080/03235407609431780	33	15	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101791	10.1371/journal.pone.0101791	http://dx.doi.org/10.1371/journal.pone.0101791			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992484	Green Submitted, Green Published, gold			2022-12-27	WOS:000341253400118
J	Tan, XQ; Cheng, XL; Zhang, L; Wu, BW; Liu, QH; Meng, J; Xu, HY; Cao, JM				Tan, Xiao-Qiu; Cheng, Xiu-Li; Zhang, Li; Wu, Bo-Wei; Liu, Qing-Hua; Meng, Jie; Xu, Hai-Yan; Cao, Ji-Min			Multi-Walled Carbon Nanotubes Impair Kv4.2/4.3 Channel Activities, Delay Membrane Repolarization and Induce Bradyarrhythmias in the Rat	PLOS ONE			English	Article							POTASSIUM CHANNELS; ATRIAL-FIBRILLATION; K+ CHANNELS; IN-VITRO; MECHANISMS; SUBUNITS; KCHIP2; NANOTOXICOLOGY; INACTIVATION; ARRHYTHMIAS	Purpose: The potential hazardous effects of multi-walled carbon nanotubes (MWCNTs) on cardiac electrophysiology are seldom evaluated. This study aimed to investigate the impacts of MWCNTs on the Kv4/I-to channel, action potential and heart rhythm and the underlying mechanisms. Methods: HEK293 cells were engineered to express Kv4.2 or Kv4.3 with or without KChIP2 expression. A series of approaches were introduced to analyze the effects of MWCNTs on Kv4/I-to channel kinetics, current densities, expression and trafficking. Transmission electron microscopy was performed to observe the internalization of MWCNTs in HEK293 cells and rat cardiomyocytes. Current clamp was employed to record the action potentials of isolated rat cardiomyocytes. Surface ECG and epicardial monophasic action potentials were recorded to monitor heart rhythm in rats in vivo. Vagal nerve discharge monitoring and H&E staining were also performed. Results: Induction of MWCNTs into the cytosole through pipette solution soon accelerated the decay of I-Kv4 in HEK293 cells expressing Kv4.2/4.3 and KChIP2, and promoted the recovery from inactivation when Kv4.2 or Kv4.3 was expressed alone. Longer exposure (6 h) to MWCNTs decreased the I-Kv4.2 density, Kv4.2/Kv4.3 (but not KChIP2) expression and trafficking towards the plasma membrane in HEK293 cells. In acutely isolated rat ventricular myocytes, pipette MWCNTs also quickly accelerated the decay of I-Kv4 and prolonged the action potential duration (APD). Intravenous infusion of MWCNTs (2 mg/rat) induced atrioventricular (AV) block and even cardiac asystole. No tachyarrhythmia was observed after MWCNTs administration. MWCNTs did not cause coronary clot but induced myocardial inflammation and increased vagus discharge. Conclusions: MWCNTs suppress Kv4/I-to channel activities likely at the intracellular side of plasma membrane, delay membrane repolarization and induce bradyarrhythmia. The delayed repolarization, increased vagus output and focal myocardial inflammation may partially underlie the occurrence of bradyarrhythmias induced by MWCNTs. The study warns that MWCNTs are hazardous to cardiac electrophysiology.	[Tan, Xiao-Qiu; Cheng, Xiu-Li; Cao, Ji-Min] Chinese Acad Med Sci, Peking Union Med Coll, Sch Basic Med, Inst Basic Med Sci,Dept Physiol, Beijing 100730, Peoples R China; [Zhang, Li; Wu, Bo-Wei] Shanxi Med Univ, Dept Physiol, Taiyuan, Peoples R China; [Liu, Qing-Hua] Shanxi Med Univ, Dept Pathophysiol, Taiyuan, Peoples R China; [Meng, Jie; Xu, Hai-Yan] Chinese Acad Med Sci, Peking Union Med Coll, Sch Basic Med, Inst Basic Med Sci,Dept Biomed Engn, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Shanxi Medical University; Shanxi Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Cao, JM (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Sch Basic Med, Inst Basic Med Sci,Dept Physiol, Beijing 100730, Peoples R China.	caojimin@126.com	Liu, Qinghua/HCH-3099-2022		(973 program) from the Ministry of Science and Technology (MOST) of China [2011CB93350]; Natural Science Foundation of China (NSFC) [81071072, 31171088]	(973 program) from the Ministry of Science and Technology (MOST) of China; Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by grants 2011CB93350 (973 program) from the Ministry of Science and Technology (MOST) of China, 81071072 and 31171088 from the Natural Science Foundation of China (NSFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akar FG, 2004, AM J PHYSIOL-HEART C, V286, pH602, DOI 10.1152/ajpheart.00673.2003; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Bahring R, 2001, J BIOL CHEM, V276, P23888, DOI 10.1074/jbc.M101320200; Bahring R, 2001, J PHYSIOL-LONDON, V535, P65, DOI 10.1111/j.1469-7793.2001.00065.x; Bosch RF, 1999, CARDIOVASC RES, V44, P121, DOI 10.1016/S0008-6363(99)00178-9; Carmeliet E, 1999, PHYSIOL REV, V79, P917, DOI 10.1152/physrev.1999.79.3.917; De Volder MFL, 2013, SCIENCE, V339, P535, DOI 10.1126/science.1222453; Foeger NC, 2010, J BIOL CHEM, V285, P33413, DOI 10.1074/jbc.M110.145185; Gavello D, 2012, NANOTOXICOLOGY, V6, P47, DOI 10.3109/17435390.2011.553294; Hubbs AF, 2011, TOXICOL PATHOL, V39, P301, DOI 10.1177/0192623310390705; Inoue K, 2008, EXP BIOL MED, V233, P1583, DOI 10.3181/0805-RM-179; IRISAWA H, 1964, JPN J PHYSIOL, V14, P165; Johnston HJ, 2010, NANOTOXICOLOGY, V4, P207, DOI 10.3109/17435390903569639; Kahru A, 2010, TOXICOLOGY, V269, P105, DOI 10.1016/j.tox.2009.08.016; Liu QH, 2012, J CARDIOVASC PHARM, V59, P37, DOI 10.1097/FJC.0b013e3182350bcc; Meng J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038995; Nabauer M, 1998, CARDIOVASC RES, V37, P324, DOI 10.1016/S0008-6363(97)00274-5; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Nesti E, 2004, MOL BIOL CELL, V15, P4073, DOI 10.1091/mbc.E03-11-0788; Norris AJ, 2010, J NEUROSCI, V30, P13644, DOI 10.1523/JNEUROSCI.2487-10.2010; Ohya S, 1997, FEBS LETT, V420, P47, DOI 10.1016/S0014-5793(97)01483-X; Olesen MS, 2013, CARDIOVASC RES, V98, P488, DOI 10.1093/cvr/cvt028; Patel SP, 2005, J PHYSIOL-LONDON, V569, P7, DOI 10.1113/jphysiol.2005.086223; Patel SP, 2002, J PHYSIOL-LONDON, V545, P5, DOI 10.1113/jphysiol.2002.031856; Pongs O, 2010, PHYSIOL REV, V90, P755, DOI 10.1152/physrev.00020.2009; Scannevin RH, 2004, NEURON, V41, P587, DOI 10.1016/S0896-6273(04)00049-2; Schultz JH, 2005, J MOL CELL CARDIOL, V39, P269, DOI 10.1016/j.yjmcc.2005.02.025; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; Tang SX, 2012, J APPL TOXICOL, V32, P900, DOI 10.1002/jat.2748; Wako K, 2010, J TOXICOL SCI, V35, P437, DOI 10.2131/jts.35.437; Xu HF, 2010, J NANOSCI NANOTECHNO, V10, P7406, DOI 10.1166/jnn.2010.2830; Xu HF, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/28/285102; Zagha E, 2005, J BIOL CHEM, V280, P18853, DOI 10.1074/jbc.M410613200; Zhao YL, 2008, NAT NANOTECHNOL, V3, P191, DOI 10.1038/nnano.2008.77	34	7	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101545	10.1371/journal.pone.0101545	http://dx.doi.org/10.1371/journal.pone.0101545			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992664	Green Submitted, Green Published, gold			2022-12-27	WOS:000341253400087
J	Young, AM; Halgin, DS; DiClemente, RJ; Sterk, CE; Havens, JR				Young, April M.; Halgin, Daniel S.; DiClemente, Ralph J.; Sterk, Claire E.; Havens, Jennifer R.			Will HIV Vaccination Reshape HIV Risk Behavior Networks? A Social Network Analysis of Drug Users' Anticipated Risk Compensation	PLOS ONE			English	Article							EFFICACY TRIAL; INFECTIOUS-DISEASE; IMPACT; ACCEPTABILITY; VACCINES; SEX; PARTICIPANTS; PERCEPTIONS; PREVENTION; EPIDEMIC	Background: An HIV vaccine could substantially impact the epidemic. However, risk compensation (RC), or post-vaccination increase in risk behavior, could present a major challenge. The methodology used in previous studies of risk compensation has been almost exclusively individual-level in focus, and has not explored how increased risk behavior could affect the connectivity of risk networks. This study examined the impact of anticipated HIV vaccine-related RC on the structure of high-risk drug users' sexual and injection risk network. Methods: A sample of 433 rural drug users in the US provided data on their risk relationships (i.e., those involving recent unprotected sex and/or injection equipment sharing). Dyad-specific data were collected on likelihood of increasing/initiating risk behavior if they, their partner, or they and their partner received an HIV vaccine. Using these data and social network analysis, a "post-vaccination network" was constructed and compared to the current network on measures relevant to HIV transmission, including network size, cohesiveness (e.g., diameter, component structure, density), and centrality. Results: Participants reported 488 risk relationships. Few reported an intention to decrease condom use or increase equipment sharing (4% and 1%, respectively). RC intent was reported in 30 existing risk relationships and vaccination was anticipated to elicit the formation of five new relationships. RC resulted in a 5% increase in risk network size (n = 142 to n = 149) and a significant increase in network density. The initiation of risk relationships resulted in the connection of otherwise disconnected network components, with the largest doubling in size from five to ten. Conclusions: This study demonstrates a new methodological approach to studying RC and reveals that behavior change following HIV vaccination could potentially impact risk network connectivity. These data will be valuable in parameterizing future network models that can determine if network-level change precipitated by RC would appreciably impact the vaccine's population-level effectiveness.	[Young, April M.] Univ Kentucky, Dept Epidemiol, Lexington, KY 40506 USA; [Young, April M.; Havens, Jennifer R.] Univ Kentucky, Ctr Drug & Alcohol Res, Lexington, KY USA; [Halgin, Daniel S.] Univ Kentucky, Gatton Coll Business & Econ, LINKS Ctr Social Network Anal, Lexington, KY USA; [DiClemente, Ralph J.; Sterk, Claire E.] Emory Univ, Dept Behav Sci & Hlth Educ, Atlanta, GA 30322 USA	University of Kentucky; University of Kentucky; University of Kentucky; Emory University	Young, AM (corresponding author), Univ Kentucky, Dept Epidemiol, Lexington, KY 40506 USA.	april.young@uky.edu	Young, April/I-9518-2012; Halgin, Daniel/AHE-6070-2022	Young, April/0000-0003-3969-3249; Havens, Jennifer/0000-0002-1753-7280	National Institute on Drug Abuse [R01DA024598, R01DA033862]; National Center for Research Resources and the National Center for Advancing Translational Sciences at the National Institutes of Health [UL1TR000117]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024598, R01DA033862] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Center for Research Resources and the National Center for Advancing Translational Sciences at the National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute on Drug Abuse (Grant numbers R01DA024598, R01DA033862; http://www.drugabuse.gov/) and the National Center for Research Resources and the National Center for Advancing Translational Sciences at the National Institutes of Health (Grant number UL1TR000117; http://www.ncats.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2013, AM J PUBLIC HEALTH, V103, P322, DOI 10.2105/AJPH.2012.300908; Andersson KM, 2007, JAIDS-J ACQ IMM DEF, V46, P78; Andersson KM, 2011, VACCINE, V29, P6107, DOI 10.1016/j.vaccine.2011.06.076; Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; Barrington C, 2008, CULT HEALTH SEX, V10, P391, DOI 10.1080/13691050801898877; Bartholow BN, 2005, JAIDS-J ACQ IMM DEF, V39, P90, DOI 10.1097/01.qai.0000143600.41363.78; Bearman PS, 2004, AM J SOCIOL, V110, P44, DOI 10.1086/386272; Blower S., 2003, AIDS Reviews, V5, P113; BLOWER SM, 1994, SCIENCE, V265, P1451, DOI 10.1126/science.8073289; Bogard E, 2002, J ACQ IMMUN DEF SYND, V29, P132, DOI 10.1097/00042560-200202010-00004; Borgatti S.P., 2002, UCINET 6 WINDOWS SOF; Borgatti S.P., 2002, NETDRAW NETWORK VISU; Chesney MA, 1997, J ACQ IMMUN DEF SYND, V16, P266, DOI 10.1097/00042560-199712010-00007; Coyle S, 1998, PUBLIC HLTH REP, V113, P20; Crosby RA, 2006, INT J STD AIDS, V17, P180, DOI 10.1258/095646206775809204; De P, 2004, SEX TRANSM INFECT, V80, P280, DOI 10.1136/sti.2003.007187; De P, 2007, ADDICTION, V102, P1730, DOI 10.1111/j.1360-0443.2007.01936.x; Dombrowski Kirk, 2013, World J AIDS, V3, P1; Dombrowski K, 2013, SUBST USE MISUSE, V48, P1485, DOI 10.3109/10826084.2013.796987; Fonseca MGP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011736; Francis DP, 2003, AIDS, V17, P147, DOI 10.1097/00002030-200301240-00003; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Friedman SR, 1997, AM J PUBLIC HEALTH, V87, P1289, DOI 10.2105/AJPH.87.8.1289; Goodreau SM, 2012, AIDS BEHAV, V16, P312, DOI 10.1007/s10461-010-9858-x; Gray RH, 2003, AIDS, V17, P1941, DOI 10.1097/00002030-200309050-00013; Guest G, 2005, AIDS CARE, V17, P46, DOI 10.1080/09540120412331305124; Hanneman R.A., 2005, INTRO SOCIAL NETWORK; Havens Jennifer R, 2013, Am J Public Health, V103, pe44, DOI 10.2105/AJPH.2012.300874; Helleringer S, 2009, DEMOGR RES, V21, P428, DOI 10.4054/DemRes.2009.21.15; Hogben M, 2008, SEX TRANSM DIS, V35, P1009, DOI 10.1097/OLQ.0b013e31818eb752; Jenkins RA, 2005, JAIDS-J ACQ IMM DEF, V40, P592, DOI 10.1097/01.qai.0000171725.09812.a5; Kentucky Cabinet for Health and Human Services, 2010, INT EP PROF HIV AIDS; KLOVDAHL AS, 1994, SOC SCI MED, V38, P79, DOI 10.1016/0277-9536(94)90302-6; Koniak-Griffin D, 2007, J HEALTH CARE POOR U, V18, P687, DOI 10.1353/hpu.2007.0061; Lampinen TM, 2005, CAN MED ASSOC J, V172, P479, DOI 10.1503/cmaj.1031785; Latkin CA, 2013, JAIDS-J ACQ IMM DEF, V63, pS54, DOI 10.1097/QAI.0b013e3182928e2a; MacPhail CL, 2012, QUAL HEALTH RES, V22, P668, DOI 10.1177/1049732311431944; Martin M, 2010, INT J DRUG POLICY, V21, P296, DOI 10.1016/j.drugpo.2009.12.002; MEYERS K, 1994, AM J PUBLIC HEALTH, V84, P761, DOI 10.2105/AJPH.84.5.761; Morris M, 2009, AM J PUBLIC HEALTH, V99, P1023, DOI 10.2105/AJPH.2008.147835; Newman PA, 2004, VACCINE, V22, P1954, DOI 10.1016/j.vaccine.2003.10.031; Newman PA, 2012, GLOB PUBLIC HEALTH, V7, P1009, DOI 10.1080/17441692.2012.692388; Newman PA, 2010, VACCINE, V28, P958, DOI 10.1016/j.vaccine.2009.10.142; Newman PA, 2009, HEALTH SERV RES, V44, P2167, DOI 10.1111/j.1475-6773.2009.01039.x; O'Connell JM, 2002, JAIDS-J ACQ IMM DEF, V31, P521, DOI 10.1097/00126334-200212150-00010; Olin J, 2006, CULT HEALTH SEX, V8, P529, DOI 10.1080/13691050600888434; Potterat JJ, 1999, INT J STD AIDS, V10, P182, DOI 10.1258/0956462991913853; Robb ML, 2012, LANCET INFECT DIS, V12, P531, DOI 10.1016/S1473-3099(12)70088-9; Rothenberg RB, 1998, SEX TRANSM DIS, V25, P154, DOI 10.1097/00007435-199803000-00009; Rothenberg RB, 1998, AIDS, V12, P1529, DOI 10.1097/00002030-199812000-00016; Valente TW, 2010, SOCIAL NETWORKS HLTH, DOI DOI 10.1093/ACPROF:OSO/9780195301014.001.0001/ACPROF-9780195301014; van Griensven F, 2004, AIDS, V18, P295, DOI 10.1097/00002030-200401230-00020; Wang KD, 2011, AIDS BEHAV, V15, P1298, DOI 10.1007/s10461-011-0020-1; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Webb PM, 1999, J ADOLESCENT HEALTH, V25, P320, DOI 10.1016/S1054-139X(99)00066-X; Webb TL, 2006, PSYCHOL BULL, V132, P249, DOI 10.1037/0033-2909.132.2.249; Young AM, 2013, AIDS BEHAV, V17, P2341, DOI 10.1007/s10461-012-0371-2	57	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101047	10.1371/journal.pone.0101047	http://dx.doi.org/10.1371/journal.pone.0101047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3RT	24992659	Green Published, gold, Green Submitted			2022-12-27	WOS:000341253400039
J	Zhao, SR				Zhao, Shanrong			Assessment of the Impact of Using a Reference Transcriptome in Mapping Short RNA-Seq Reads	PLOS ONE			English	Article							DIFFERENTIAL GENE-EXPRESSION; ACCURATE ALIGNMENT; MICROARRAYS; ALGORITHMS; TOOL	RNA-Seq has become increasingly popular in transcriptome profiling. The major challenge in RNA-Seq data analysis is the accurate mapping of junction reads to their genomic origins. To detect splicing sites in short reads, many RNA-Seq aligners use reference transcriptome to inform placement of junction reads. However, no systematic evaluation has been performed to assess or quantify the benefits of incorporating reference transcriptome in mapping RNA-Seq reads. In this paper, we have studied the impact of reference transcriptome on mapping RNA-Seq reads, especially on junction ones. The same dataset were analysed with and without RefGene transcriptome, respectively. Then a Perl script was developed to analyse and compare the mapping results. It was found that about 50-55% junction reads can be mapped to the same genomic regions regardless of the usage of RefGene model. More than one-third of reads fail to be mapped without the help of a reference transcriptome. For "Alternatively" mapped reads, i.e., those reads mapped differently with and without RefGene model, the mappings without RefGene model are usually worse than their corresponding alignments with RefGene model. For junction reads that span more than two exons, it is less likely to align them correctly without the assistance of reference transcriptome. As the sequencing technology evolves, the read length is becoming longer and longer. When reads become longer, they are more likely to span multiple exons, and thus the mapping of long junction reads is actually becoming more and more challenging without the assistance of reference transcriptome. Therefore, the advantages of using reference transcriptome in the mapping demonstrated in this study are becoming more evident for longer reads. In addition, the effect of the completeness of reference transcriptome on mapping of RNA-Seq reads is discussed.	[Zhao, Shanrong] Janssen Res & Dev LLC, Syst Pharmacol & Biomarkers, San Diego, CA USA	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Zhao, SR (corresponding author), Pfizer Worldwide Res & Dev, BioTherapeut Clin R&D, Clin Genet & Bioinformat, Cambridge, MA 02140 USA.	Shanrong.Zhao@pfizer.com						Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Borozan I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076935; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Engstrom PG, 2013, NAT METHODS, V10, P1185, DOI [10.1038/NMETH.2722, 10.1038/nmeth.2722]; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grant GR, 2011, BIOINFORMATICS, V27, P2518, DOI 10.1093/bioinformatics/btr427; Hu J, 2012, BIOINFORMATICS, V28, P1933, DOI 10.1093/bioinformatics/bts294; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Knowles DG, 2013, BIOINFORMATICS, V29, P614, DOI 10.1093/bioinformatics/btt016; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; McIntyre LM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-293; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mutz KO, 2013, CURR OPIN BIOTECH, V24, P22, DOI 10.1016/j.copbio.2012.09.004; Nagalakshmi Ugrappa, 2010, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0411s89; Nookaew I, 2012, NUCLEIC ACIDS RES, V40, P10084, DOI 10.1093/nar/gks804; Oshlack A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-220; Pyrkosz A.B., 2013, ARXIV13032411V1; Seok J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031440; Stein LD, 2011, CURR PROTOC BIOINFOR; Twine NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016266; Vijay N, 2013, MOL ECOL, V22, P620, DOI 10.1111/mec.12014; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhao S, 2013, ISRN BIOINFORMATICS, V2013; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644	30	15	15	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101374	10.1371/journal.pone.0101374	http://dx.doi.org/10.1371/journal.pone.0101374			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992027	Green Submitted, Green Published, gold			2022-12-27	WOS:000341253400067
J	Bose, A; Majot, AT; Bidwai, AP				Bose, Anasua; Majot, Adam T.; Bidwai, Ashok P.			The Ser/Thr Phosphatase PP2A Regulatory Subunit Widerborst Inhibits Notch Signaling	PLOS ONE			English	Article							LOOP-HELIX PROTEINS; CASEIN KINASE-II; DROSOPHILA CIRCADIAN CLOCK; PERIPHERAL NERVOUS-SYSTEM; ACHAETE-SCUTE EXPRESSION; CELL FATE DECISIONS; OF-SPLIT COMPLEX; LATERAL-INHIBITION; NEURAL DEVELOPMENT; SENSORY ORGAN	Drosophila Enhancer of split M8, an effector of Notch signaling, is regulated by protein kinase CK2. The phosphatase PP2A is thought to play an opposing (inhibitory) role, but the identity of the regulatory subunit was unknown. The studies described here reveal a role for the PP2A regulatory subunit widerborst (wdb) in three developmental contexts; the bristle, wing and the R8 photoreceptors of the eye. wdb overexpression elicits bristle and wing defects akin to reduced Notch signaling, whereas hypomorphic mutations in this PP2A subunit elicit opposite effects. We have also evaluated wdb functions using mutations in Notch and E(spl) that affect the eye. We find that the eye and R8 defects of the well-known N-spl mutation are enhanced by a hypomorphic allele of wdb, whereas they are strongly rescued by wdb overexpression. Similarly, ectopic wdb rescues the eye and R8 defects of the E(spl) D mutation, which affects the m8 gene. In addition, wdb overexpression also rescues the bristle defects of ectopically expressed M8, or the eye and R8 defects of its CK2 phosphomimetic variant M8-S159D. The latter finding suggests that PP2A may target M8 at highly conserved residues in the vicinity of the CK2 site, whose phosphorylation controls repression of Atonal and the R8 fate. Together, the studies identify PP2A-Wdb as a participant in Notch signaling, and suggest that M8 activity is controlled by phosphorylation and dephosphorylation. The conservation of the phosphorylation sites between Drosophila E(spl) and the HES/HER proteins from mammals, reptiles, amphibians, birds and fish raises the prospect that this mode of regulation is widespread.	[Bose, Anasua; Majot, Adam T.; Bidwai, Ashok P.] W Virginia Univ, Dept Biol, Morgantown, WV 26506 USA	West Virginia University	Bidwai, AP (corresponding author), W Virginia Univ, Dept Biol, Morgantown, WV 26506 USA.	abidwai@wvu.edu		Bidwai, Ashok/0000-0002-4297-5629	National Institutes of Health (NIH) [EY015718]; Eberly Family Foundation [3V-235]; NATIONAL EYE INSTITUTE [R01EY015718] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eberly Family Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health (NIH) (EY015718) and a grant from the Eberly Family Foundation (3V-235). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of manuscript.	Abdelilah-Seyfried S, 2000, GENETICS, V155, P733; Akten B, 2003, NAT NEUROSCI, V6, P251, DOI 10.1038/nn1007; Alifragis P, 1997, P NATL ACAD SCI USA, V94, P13099, DOI 10.1073/pnas.94.24.13099; Artayanis-Tsakonas S, 2010, CURR TOP DEV BIOL, V92, P1, DOI 10.1016/S0070-2153(10)92001-2; Axelrod JD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3145pe38; Bae SK, 2000, DEVELOPMENT, V127, P2933; Baker NE, 2004, DEV CELL, V7, P632, DOI 10.1016/j.devcel.2004.10.010; Banreti A, 2012, AUTOPHAGY, V8, P623, DOI 10.4161/auto.19081; Belanger-Jasmin S, 2007, J NEUROCHEM, V103, P2022, DOI 10.1111/j.1471-4159.2007.04902.x; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Blau J, 2003, NAT NEUROSCI, V6, P208, DOI 10.1038/nn0303-208; Bose A, 2006, MECH DEVELOP, V123, P649, DOI 10.1016/j.mod.2006.07.003; Brand M, 1990, DEV GENES EVOL, V198, P275, DOI DOI 10.1007/BF00377394; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Bray SJ, 1997, PERSPECT DEV NEUROBI, V4, P313; Calleja M, 2002, GENE, V292, P1, DOI 10.1016/S0378-1119(02)00628-5; CAMPOS AR, 1987, EMBO J, V6, P425, DOI 10.1002/j.1460-2075.1987.tb04772.x; Campos-Ortega JA, 1998, INT J DEV BIOL, V42, P291; Castro B, 2005, DEVELOPMENT, V132, P3333, DOI 10.1242/dev.01920; Chiu JC, 2008, GENE DEV, V22, P1758, DOI 10.1101/gad.1682708; Cooper MTD, 2000, DEV BIOL, V221, P390, DOI 10.1006/dbio.2000.9691; CUBAS P, 1991, GENE DEV, V5, P996, DOI 10.1101/gad.5.6.996; Dambly-Chaudiere C, 1998, INT J DEV BIOL, V42, P269; DAWSON SR, 1995, MOL CELL BIOL, V15, P6923; deCelis JF, 1996, DEVELOPMENT, V122, P2719; DELIDAKIS C, 1992, P NATL ACAD SCI USA, V89, P8731, DOI 10.1073/pnas.89.18.8731; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Duvall LB, 2011, CURR BIOL, V21, pR305, DOI 10.1016/j.cub.2011.04.005; Ehebauer M, 2006, SCIENCE, V314, P1414, DOI 10.1126/science.1134042; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Fisher A, 1998, BIOESSAYS, V20, P298, DOI 10.1002/(SICI)1521-1878(199804)20:4&lt;298::AID-BIES6&gt;3.0.CO;2-M; Frankfort BJ, 2001, NEURON, V32, P403, DOI 10.1016/S0896-6273(01)00480-9; Garza AS, 2009, LIFE SCI, V84, P189, DOI 10.1016/j.lfs.2008.12.002; GHYSEN A, 1979, DEV BIOL, V70, P438, DOI 10.1016/0012-1606(79)90037-X; Giagtzoglou N, 2003, DEVELOPMENT, V130, P259, DOI 10.1242/dev.00206; Giebel B, 1997, P NATL ACAD SCI USA, V94, P6250, DOI 10.1073/pnas.94.12.6250; Gratton MO, 2003, MOL CELL BIOL, V23, P6922, DOI 10.1128/MCB.23.19.6922-6935.2003; Hannus M, 2002, DEVELOPMENT, V129, P3493; Heitzler P, 1996, DEVELOPMENT, V122, P161; HINZ U, 1994, CELL, V76, P77, DOI 10.1016/0092-8674(94)90174-0; Hsiung F, 2002, HUM MOL GENET, V11, P1207, DOI 10.1093/hmg/11.10.1207; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; JARMAN AP, 1994, NATURE, V369, P398, DOI 10.1038/369398a0; JENNINGS B, 1994, DEVELOPMENT, V120, P3537; Jennings BH, 1999, MOL CELL BIOL, V19, P4600; Jhas S, 2006, J NEUROSCI, V26, P11061, DOI 10.1523/JNEUROSCI.1358-06.2006; Jimenez G, 1997, MOL CELL BIOL, V17, P4355, DOI 10.1128/MCB.17.8.4355; Jones C, 2006, GENETICS, V173, P793, DOI 10.1534/genetics.106.056762; Kahali B, 2010, GENESIS, V48, P44, DOI 10.1002/dvg.20581; Kahali B, 2009, GENESIS, V47, P456, DOI 10.1002/dvg.20521; Karandikar UC, 2004, MECH DEVELOP, V121, P273, DOI 10.1016/j.mod.2004.01.008; Kiefer JC, 2005, DEV DYNAM, V234, P808, DOI 10.1002/dvdy.20522; KLAMBT C, 1989, EMBO J, V8, P203, DOI 10.1002/j.1460-2075.1989.tb03365.x; KNUST E, 1987, DEV BIOL, V122, P262, DOI 10.1016/0012-1606(87)90351-4; KNUST E, 1992, GENETICS, V132, P505; Ko HW, 2002, NATURE, V420, P673, DOI 10.1038/nature01272; Koyano-Nakagawa N, 2000, DEVELOPMENT, V127, P4203; KUENZEL EA, 1985, P NATL ACAD SCI USA, V82, P737, DOI 10.1073/pnas.82.3.737; KUENZEL EA, 1987, J BIOL CHEM, V262, P9136; Kumar JP, 2012, DEV DYNAM, V241, P136, DOI 10.1002/dvdy.23707; Kunttas-Tatli E, 2009, GENESIS, V47, P647, DOI 10.1002/dvg.20543; Li YX, 2003, DEVELOPMENT, V130, P2829, DOI 10.1242/dev.00498; Ligoxygakis P, 1998, DEVELOPMENT, V125, P2893; Lin JM, 2002, NATURE, V420, P816, DOI 10.1038/nature01235; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Lubensky DK, 2011, P NATL ACAD SCI USA, V108, P11145, DOI 10.1073/pnas.1015302108; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Modolell J, 1998, INT J DEV BIOL, V42, P275; Mumby M, 2007, ACS CHEM BIOL, V2, P99, DOI 10.1021/cb700021z; Nagel AC, 1999, DEV BIOL, V208, P406, DOI 10.1006/dbio.1999.9203; Nagel AC, 1999, DEV GENET, V25, P168, DOI 10.1002/(SICI)1520-6408(1999)25:2<168::AID-DVG11>3.0.CO;2-0; Nakao K, 1996, NEURON, V16, P275, DOI 10.1016/S0896-6273(00)80046-X; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; OELLERS N, 1994, MOL GEN GENET, V244, P465, DOI 10.1007/BF00583897; Powell LM, 2004, MOL CELL BIOL, V24, P9517, DOI 10.1128/MCB.24.21.9517-9526.2004; PREISS A, 1988, EMBO J, V7, P3917, DOI 10.1002/j.1460-2075.1988.tb03278.x; Preuss F, 2004, MOL CELL BIOL, V24, P886, DOI 10.1128/MCB.24.2.886-898.2004; Querfurth C, 2011, MOL CELL, V43, P713, DOI 10.1016/j.molcel.2011.06.033; Salvi M, 2009, BBA-MOL CELL RES, V1793, P847, DOI 10.1016/j.bbamcr.2009.01.013; Sathyanarayanan S, 2004, CELL, V116, P603, DOI 10.1016/S0092-8674(04)00128-X; SCHRONS H, 1992, GENETICS, V132, P481; SCHWEISGUTH F, 1995, DEVELOPMENT, V121, P1875; SCHWEISGUTH F, 1992, CELL, V69, P1199, DOI 10.1016/0092-8674(92)90641-O; Seugnet L, 2011, CURR BIOL; SHEPARD SB, 1989, GENETICS, V122, P429; SIMPSON P, 1990, DEVELOPMENT, V109, P509; SKEATH JB, 1991, GENE DEV, V5, P984, DOI 10.1101/gad.5.6.984; Sun H., 2007, TRANSL ONCOGENOM, V2, P105; Sun Y, 1998, DEVELOPMENT, V125, P3731; Tien AC, 2009, J CELL BIOL, V184, P621, DOI 10.1083/jcb.200811141; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Trott RL, 2001, J BIOL CHEM, V276, P2159, DOI 10.1074/jbc.M005996200; Vilas-Boas F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015459; Wech I, 1999, DEV GENES EVOL, V209, P370, DOI 10.1007/s004270050266; White NM, 2000, DEVELOPMENT, V127, P1681; WOLFF T, 1991, DEVELOPMENT, V113, P825; Wu MN, 2011, CURR BIOL, V21, pR397, DOI 10.1016/j.cub.2011.04.014; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; ZIEMER A, 1988, GENETICS, V119, P63	100	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101884	10.1371/journal.pone.0101884	http://dx.doi.org/10.1371/journal.pone.0101884			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006677	Green Published, Green Submitted, gold			2022-12-27	WOS:000339040600076
J	Hodges, JL; Vilchez, SM; Asmussen, H; Whitmore, LA; Horwitz, AR				Hodges, Jennifer L.; Vilchez, Samuel Martin; Asmussen, Hannelore; Whitmore, Leanna A.; Horwitz, Alan Rick			alpha-Actinin-2 Mediates Spine Morphology and Assembly of the Post-Synaptic Density in Hippocampal Neurons	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ALPHA-ACTININ; DENDRITIC SPINES; NMDA RECEPTOR; AMPA RECEPTORS; MENTAL-RETARDATION; MASS-SPECTROMETRY; PROTEIN; DYNAMICS; SYNAPSE	Dendritic spines are micron-sized protrusions that constitute the primary post-synaptic sites of excitatory neurotransmission in the brain. Spines mature from a filopodia-like protrusion into a mushroom-shaped morphology with a post-synaptic density (PSD) at its tip. Modulation of the actin cytoskeleton drives these morphological changes as well as the spine dynamics that underlie learning and memory. Several PSD molecules respond to glutamate receptor activation and relay signals to the underlying actin cytoskeleton to regulate the structural changes in spine and PSD morphology. alpha-Actinin-2 is an actin filament cross-linker, which localizes to dendritic spines, enriched within the post-synaptic density, and implicated in actin organization. We show that loss of alpha-actinin-2 in rat hippocampal neurons creates an increased density of immature, filopodia-like protrusions that fail to mature into a mushroom-shaped spine during development. alpha-Actinin-2 knockdown also prevents the recruitment and stabilization of the PSD in the spine, resulting in failure of synapse formation, and an inability to structurally respond to chemical stimulation of the N-methyl-D-aspartate (NMDA)-type glutamate receptor. The Ca2+-insensitive EF-hand motif in alpha-actinin-2 is necessary for the molecule's function in regulating spine morphology and PSD assembly, since exchanging it for the similar but Ca2+-sensitive domain from alpha-actinin-4, another alpha-actinin isoform, inhibits its function. Furthermore, when the Ca2+-insensitive domain from alpha-actinin-2 is inserted into alpha-actinin-4 and expressed in neurons, it creates mature spines. These observations support a model whereby alpha-actinin-2, partially through its Ca2+-insensitive EF-hand motif, nucleates PSD formation via F-actin organization and modulates spine maturation to mediate synaptogenesis.	[Hodges, Jennifer L.; Vilchez, Samuel Martin; Asmussen, Hannelore; Whitmore, Leanna A.; Horwitz, Alan Rick] Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA	University of Virginia	Hodges, JL (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	jlh3ke@virginia.edu; horwitz@virginia.edu	Martin-Vilchez, Samuel/AFV-2112-2022	Martin-Vilchez, Samuel/0000-0003-0557-7653	National Institutes of Health (NIH) [GM23244, T32-GM008136]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008136, R37GM023244, R01GM023244] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant (GM23244) and by the Cell and Molecular Biology training grant from the NIH (T32-GM008136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; Allison DW, 2000, J NEUROSCI, V20, P4545, DOI 10.1523/JNEUROSCI.20-12-04545.2000; Benson DL, 2012, HIPPOCAMPUS, V22, P954, DOI 10.1002/hipo.20872; Broderick MJF, 2005, ADV PROTEIN CHEM, V70, P203, DOI 10.1016/S0065-3233(04)70007-8; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Brunig I, 2004, NEUROPHARMACOLOGY, V47, P669, DOI 10.1016/j.neuropharm.2004.07.038; BURRIDGE K, 1981, NATURE, V294, P565, DOI 10.1038/294565a0; Burridge K, 2013, J CELL BIOL, V200, P9, DOI 10.1083/jcb.201210090; Chen XB, 2008, P NATL ACAD SCI USA, V105, P4453, DOI 10.1073/pnas.0800897105; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Dandapani SV, 2007, J BIOL CHEM, V282, P467, DOI 10.1074/jbc.M605024200; Dixson JD, 2003, J MOL EVOL, V56, P1, DOI 10.1007/s00239-002-2374-5; Djinovic-Carugo K, 1999, CELL, V98, P537, DOI 10.1016/S0092-8674(00)81981-9; Dunah AW, 2000, MOL BRAIN RES, V79, P77, DOI 10.1016/S0169-328X(00)00102-9; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Gray NW, 2006, PLOS BIOL, V4, P2065, DOI 10.1371/journal.pbio.0040370; Hall DD, 2013, NEURON, V78, P483, DOI 10.1016/j.neuron.2013.02.032; Harris KM, 2003, PHILOS T R SOC B, V358, P745, DOI 10.1098/rstb.2002.1254; Hayashi K, 1999, J NEUROSCI, V19, P3918; Hodges JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024149; Hoe HS, 2009, BIOCHEM BIOPH RES CO, V384, P55, DOI 10.1016/j.bbrc.2009.04.069; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Jalan-Sakrikar N, 2012, J BIOL CHEM, V287, P15275, DOI 10.1074/jbc.M112.351817; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kay L, 2011, NAT NEUROSCI, V14, P688, DOI 10.1038/nn.2826; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; KNUDSEN KA, 1995, J CELL BIOL, V130, P67, DOI 10.1083/jcb.130.1.67; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Krupp JJ, 1999, J NEUROSCI, V19, P1165; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; Lin H, 2004, BIOCHEM BIOPH RES CO, V316, P501, DOI 10.1016/j.bbrc.2004.02.086; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Lucido AL, 2009, J NEUROSCI, V29, P12449, DOI 10.1523/JNEUROSCI.1381-09.2009; Michailidis IE, 2007, J NEUROSCI, V27, P5523, DOI 10.1523/JNEUROSCI.4378-06.2007; Murthy VN, 1998, NATURE, V392, P497, DOI 10.1038/33152; Nakagawa T, 2004, NEUROPHARMACOLOGY, V47, P734, DOI 10.1016/j.neuropharm.2004.07.022; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; OTEY CA, 1990, J CELL BIOL, V111, P721, DOI 10.1083/jcb.111.2.721; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Robison AJ, 2005, J BIOL CHEM, V280, P35329, DOI 10.1074/jbc.M502191200; Schnizler MK, 2009, J BIOL CHEM, V284, P2697, DOI 10.1074/jbc.M805110200; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Tang VW, 2012, J CELL BIOL, V196, P115, DOI 10.1083/jcb.201103116; Walikonis RS, 2000, J NEUROSCI, V20, P4069; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Wyszynski M, 1998, J NEUROSCI, V18, P1383; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zhang HY, 2003, J CELL BIOL, V161, P131, DOI 10.1083/jcb.200211002	61	29	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101770	10.1371/journal.pone.0101770	http://dx.doi.org/10.1371/journal.pone.0101770			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007055	gold, Green Submitted, Green Published			2022-12-27	WOS:000339040600065
J	Lahouaoui, H; Coutanson, C; Cooper, HM; Bennis, M; Dkhissi-Benyahya, O				Lahouaoui, Hasna; Coutanson, Christine; Cooper, Howard M.; Bennis, Mohamed; Dkhissi-Benyahya, Ouria			Clock Genes and Behavioral Responses to Light Are Altered in a Mouse Model of Diabetic Retinopathy	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; SUPRACHIASMATIC NUCLEUS; ENTRAINMENT FUNCTION; CIRCADIAN RESPONSES; VISUAL DYSFUNCTION; INS2(AKITA) MOUSE; MELANOPSIN; EXPRESSION; RAT; APOPTOSIS	There is increasing evidence that melanopsin-expressing ganglion cells (ipRGCs) are altered in retinal pathologies. Using a streptozotocin-induced (STZ) model of diabetes, we investigated the impact of diabetic retinopathy on non-visual functions by analyzing ipRGCs morphology and light-induced c-Fos and Period 1-2 clock genes in the central clock (SCN). The ability of STZ-diabetic mice to entrain to light was challenged by exposure animals to 1) successive light/dark (LD) cycle of decreasing or increasing light intensities during the light phase and 2) 6-h advance of the LD cycle. Our results show that diabetes induces morphological changes of ipRGCs, including soma swelling and dendritic varicosities, with no reduction in their total number, associated with decreased c-Fos and clock genes induction by light in the SCN at 12 weeks post-onset of diabetes. In addition, STZ-diabetic mice exhibited a reduction of overall locomotor activity, a decrease of circadian sensitivity to light at low intensities, and a delay in the time to re-entrain after a phase advance of the LD cycle. These novel findings demonstrate that diabetes alters clock genes and behavioral responses of the circadian timing system to light and suggest that diabetic patients may show an increased propensity for circadian disturbances, in particular when they are exposed to chronobiological challenges.	[Lahouaoui, Hasna; Coutanson, Christine; Cooper, Howard M.; Dkhissi-Benyahya, Ouria] INSERM, Stem Cell & Brain Res Inst, Dept Chronobiol, U846, F-69500 Bron, France; [Lahouaoui, Hasna; Coutanson, Christine; Cooper, Howard M.; Dkhissi-Benyahya, Ouria] Univ Lyon 1, UMR S 846, F-69365 Lyon, France; [Lahouaoui, Hasna; Bennis, Mohamed] Univ Cadi Ayyad, Lab Pharmacol Neurobiol & Behav, URAC 37, Marrakech, Morocco	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Cadi Ayyad University of Marrakech	Dkhissi-Benyahya, O (corresponding author), INSERM, Stem Cell & Brain Res Inst, Dept Chronobiol, U846, F-69500 Bron, France.	ouria.benyahya@inserm.fr	Dkhissi-Benyahya, Ouria/M-5665-2014; COOPER, HOWARD/M-7304-2014	Dkhissi-Benyahya, Ouria/0000-0001-9168-3801; 	Rhone-Alpes CMIRA; GDRI-Neuro (CNRST/INSERM/CNRS); CNRST-INSERM; ARC Handicap Vieillissement Neurosciences	Rhone-Alpes CMIRA(Region Auvergne-Rhone-Alpes); GDRI-Neuro (CNRST/INSERM/CNRS); CNRST-INSERM; ARC Handicap Vieillissement Neurosciences	This research was supported by Rhone-Alpes CMIRA, GDRI-Neuro (CNRST/INSERM/CNRS), CNRST-INSERM PA/RN/2013, ARC Handicap Vieillissement Neurosciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu El-Asrar AM, 2004, INVEST OPHTH VIS SCI, V45, P2760, DOI 10.1167/iovs.03-1392; Akimov NP, 2012, BEHAV BRAIN RES, V226, P601, DOI 10.1016/j.bbr.2011.09.030; Antonetti DA, 2006, DIABETES, V55, P2401, DOI 10.2337/db05-1635; Asnaghi V, 2003, DIABETES, V52, P506, DOI 10.2337/diabetes.52.2.506; Aung MH, 2014, J NEUROSCI, V34, P726, DOI 10.1523/JNEUROSCI.3483-13.2014; Barber AJ, 2005, INVEST OPHTH VIS SCI, V46, P2210, DOI 10.1167/iovs.04-1340; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; Berson DM, 2010, J COMP NEUROL, V518, P2405, DOI 10.1002/cne.22381; Challet E, 1999, AM J PHYSIOL-REG I, V276, pR1063, DOI 10.1152/ajpregu.1999.276.4.R1063; Chang AM, 2011, J PHYSIOL-LONDON, V589, P1095, DOI 10.1113/jphysiol.2010.201194; Davidson E, 2009, EXP DIABETES RES, DOI 10.1155/2009/431980; de Faria JML, 2002, BRIT J OPHTHALMOL, V86, P725; de Zavalia N, 2011, J NEUROCHEM, V117, P904, DOI 10.1111/j.1471-4159.2011.07260.x; Dkhissi-Benyahya O, 2007, NEURON, V53, P677, DOI 10.1016/j.neuron.2007.02.005; Dkhissi-Benyahya O, 2013, CELL MOL LIFE SCI, V70, P3435, DOI 10.1007/s00018-013-1338-9; Dollet A, 2010, CHRONOBIOL INT, V27, P768, DOI 10.3109/07420521003695704; Drouyer E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003931; Esquiva G, 2013, INVEST OPHTH VIS SCI, V54, P4605, DOI 10.1167/iovs.13-12120; Feigl B, 2012, ACTA OPHTHALMOL, V90, pe230, DOI 10.1111/j.1755-3768.2011.02226.x; Fernandez DC, 2013, CHRONOBIOL INT, V30, P583, DOI 10.3109/07420528.2012.754453; Fernandez DC, 2012, AM J PATHOL, V180, P303, DOI 10.1016/j.ajpath.2011.09.018; Gastinger MJ, 2008, INVEST OPHTH VIS SCI, V49, P2635, DOI 10.1167/iovs.07-0683; Gastinger MJ, 2006, INVEST OPHTH VIS SCI, V47, P3143, DOI 10.1167/iovs.05-1376; Gastinger MJ, 2001, INVEST OPHTH VIS SCI, V42, P2679; Goz D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003153; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hall AC, 1997, J BIOL RHYTHM, V12, P388, DOI 10.1177/074873049701200501; Hancock HA, 2004, INVEST OPHTH VIS SCI, V45, P1002, DOI 10.1167/iovs.03-1080; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Herichova I, 2005, MOL CELL BIOCHEM, V270, P223, DOI 10.1007/s11010-005-5323-y; Jackson GR, 2003, NEUROL CLIN, V21, P709, DOI 10.1016/S0733-8619(02)00107-X; Kankipati L, 2011, INVEST OPHTH VIS SCI, V52, P2287, DOI 10.1167/iovs.10-6023; Kirwin SJ, 2011, INVEST OPHTH VIS SCI, V52, P7654, DOI 10.1167/iovs.10-6609; Kirwin SJ, 2009, INVEST OPHTH VIS SCI, V50, P5396, DOI 10.1167/iovs.09-3474; Kumar S, 2011, EXP EYE RES, V92, P164, DOI 10.1016/j.exer.2011.01.005; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Martin PM, 2004, INVEST OPHTH VIS SCI, V45, P3330, DOI 10.1167/iovs.04-0247; Mistlberger RE, 1998, APPETITE, V30, P255, DOI 10.1006/appe.1997.0134; Mohr S, 2002, DIABETES, V51, P1172, DOI 10.2337/diabetes.51.4.1172; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Oishi K, 2004, THROMB RES, V114, P129, DOI 10.1016/j.thromres.2004.05.011; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Park SH, 2003, DIABETOLOGIA, V46, P1260, DOI 10.1007/s00125-003-1177-6; Porta M, 2002, DIABETOLOGIA, V45, P1617, DOI 10.1007/s00125-002-0990-7; Schmidt TM, 2011, J NEUROSCI, V31, P16094, DOI 10.1523/JNEUROSCI.4132-11.2011; Shimazoe T, 1999, JPN J PHARMACOL, V80, P85, DOI 10.1254/jjp.80.85; Shimazoe T, 2000, JPN J PHARMACOL, V83, P355, DOI 10.1254/jjp.83.355; SHIMOMURA Y, 1990, PHYSIOL BEHAV, V47, P1153, DOI 10.1016/0031-9384(90)90366-C; Shirao Y, 1998, PROG RETIN EYE RES, V17, P59, DOI 10.1016/S1350-9462(97)00005-0; Stitt AW, 2013, CLIN SCI, V125, P1, DOI 10.1042/CS20120588; Tsai JW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000125; VARMA SD, 1974, EXP EYE RES, V19, P577, DOI 10.1016/0014-4835(74)90095-5; VELASCO A, 1988, CHRONOBIOL INT, V5, P127, DOI 10.3109/07420528809079553; Wang HZ, 2008, CHINESE MED J-PEKING, V121, P1015, DOI 10.1097/00029330-200806010-00010; Wong KY, 2005, NEURON, V48, P1001, DOI 10.1016/j.neuron.2005.11.016; Yamanouchi S, 1997, NEUROSCI LETT, V227, P103, DOI 10.1016/S0304-3940(97)00324-8; Young ME, 2002, J MOL CELL CARDIOL, V34, P223, DOI 10.1006/jmcc.2001.1504	60	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101584	10.1371/journal.pone.0101584	http://dx.doi.org/10.1371/journal.pone.0101584			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006976	gold, Green Published, Green Submitted			2022-12-27	WOS:000339040600048
J	Baudet, A; Morisset, C; d'Athis, P; Maillefert, JF; Casillas, JM; Ornetti, P; Laroche, D				Baudet, Audrey; Morisset, Claire; d'Athis, Philippe; Maillefert, Jean-Francis; Casillas, Jean-Marie; Ornetti, Paul; Laroche, Davy			Cross-Talk Correction Method for Knee Kinematics in Gait Analysis Using Principal Component Analysis (PCA): A New Proposal	PLOS ONE			English	Article							JOINT KINEMATICS; 3-DIMENSIONAL KINEMATICS; AXIS MISALIGNMENT; ANATOMICAL FRAME; FORMAL METHODS; MOVEMENT; MOTION; STANDARDIZATION; CALIBRATION; DEFINITION	Background: In 3D gait analysis, the knee joint is usually described by the Eulerian way. It consists in breaking down the motion between the articulating bones of the knee into three rotations around three axes: flexion/extension, abduction/adduction and internal/external rotation. However, the definition of these axes is prone to error, such as the "cross-talk'' effect, due to difficult positioning of anatomical landmarks. This paper proposes a correction method, principal component analysis (PCA), based on an objective kinematic criterion for standardization, in order to improve knee joint kinematic analysis. Methods: The method was applied to the 3D gait data of two different groups (twenty healthy subjects and four with knee osteoarthritis). Then, this method was evaluated with respect to three main criteria: (1) the deletion of knee joint angle cross-talk (2) the reduction of variance in the varus/valgus kinematic profile (3) the posture trial varus/valgus deformation matching the X-ray value for patients with knee osteoarthritis. The effect of the correction method was tested statistically on variabilities and cross-talk during gait. Results: Cross-talk was lower (p<0.05) after correction (the correlation between the flexion-extension and varus-valgus kinematic profiles being annihilated). Additionally, the variance in the kinematic profile for knee varus/valgus and knee flexion/extension was found to be lower and higher (p<0.05), respectively, after correction for both the left and right side. Moreover, after correction, the posture trial varus/valgus angles were much closer to x-ray grading. Conclusion: The results show that the PCA correction applied to the knee joint eliminates the cross-talk effect, and does not alter the radiological varus/valgus deformation for patients with knee osteoarthritis. These findings suggest that the proposed correction method produces new rotational axes that better fit true knee motion.	[Baudet, Audrey; Morisset, Claire; Casillas, Jean-Marie; Laroche, Davy] Dijon Univ Hosp, Ctr Invest Clin INSERM 1432, Dijon, France; [Morisset, Claire; Maillefert, Jean-Francis; Casillas, Jean-Marie; Ornetti, Paul; Laroche, Davy] INSERM, U1093, Dijon, France; [d'Athis, Philippe] Dijon Univ Hosp, Dept Med Informat, Dijon, France; [Maillefert, Jean-Francis; Casillas, Jean-Marie; Ornetti, Paul] Univ Burgundy, Dijon, France; [Maillefert, Jean-Francis; Ornetti, Paul] Dijon Univ Hosp, Dept Rheumatol, Dijon, France; [Casillas, Jean-Marie] Dijon Univ Hosp, Dept Phys Med, Dijon, France	CHU Dijon Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; CHU Dijon Bourgogne; Universite de Bourgogne; CHU Dijon Bourgogne; CHU Dijon Bourgogne	Laroche, D (corresponding author), Dijon Univ Hosp, Ctr Invest Clin INSERM 1432, Dijon, France.	davy.laroche@chu-dijon.fr	Laroche, Davy/K-4298-2015	Laroche, Davy/0000-0003-1599-4258; Casillas, Jean-Marie/0000-0003-0962-4699; Morisset, Christophe/0000-0001-5801-6724				Baker R, 1999, HUM MOVEMENT SCI, V18, P655, DOI 10.1016/S0167-9457(99)00027-5; Ball KA, 2008, J BIOMECH, V41, P1599, DOI 10.1016/j.jbiomech.2008.02.033; BLANKEVOORT L, 1988, J BIOMECH, V21, P705, DOI 10.1016/0021-9290(88)90280-1; CAPPOZZO A, 1995, CLIN BIOMECH, V10, P171, DOI 10.1016/0268-0033(95)91394-T; Cheze L, 2000, J BIOMECH, V33, P1695, DOI 10.1016/S0021-9290(00)00146-9; DAVIS RB, 1991, HUM MOVEMENT SCI, V10, P575, DOI 10.1016/0167-9457(91)90046-Z; Della Croce U, 1999, MED BIOL ENG COMPUT, V37, P155, DOI 10.1007/BF02513282; Della Croce U, 2003, MED ENG PHYS, V25, P425, DOI 10.1016/S1350-4533(03)00032-8; Donati M, 2007, GAIT POSTURE, V26, P179, DOI 10.1016/j.gaitpost.2007.04.009; Ehrig RM, 2007, J BIOMECH, V40, P2150, DOI 10.1016/j.jbiomech.2006.10.026; Ferrari A, 2008, GAIT POSTURE, V28, P207, DOI 10.1016/j.gaitpost.2007.11.009; Freeman MAR, 2005, J BIOMECH, V38, P197, DOI 10.1016/j.jbiomech.2004.02.006; GROOD ES, 1983, J BIOMECH ENG-T ASME, V105, P136, DOI 10.1115/1.3138397; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Ishii Y, 1997, CLIN ORTHOP RELAT R, P144; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; LAFORTUNE MA, 1992, J BIOMECH, V25, P347, DOI 10.1016/0021-9290(92)90254-X; Laroche D, 2011, OSTEOARTHR CARTILAGE, V19, P194, DOI 10.1016/j.joca.2010.10.024; Marin F, 2003, HUM MOVEMENT SCI, V22, P285, DOI 10.1016/S0167-9457(03)00036-8; McGinley JL, 2009, GAIT POSTURE, V29, P360, DOI 10.1016/j.gaitpost.2008.09.003; Moglo KE, 2005, J BIOMECH, V38, P1075, DOI 10.1016/j.jbiomech.2004.05.033; Most E, 2004, J BIOMECH, V37, P1743, DOI 10.1016/j.jbiomech.2004.01.025; Noonan KJ, 2003, J PEDIATR ORTHOPED, V23, P279, DOI 10.1097/00004694-200305000-00001; Pearson K, 1901, LINES PLANES CLOSEST; Piazza SJ, 2000, J BIOMECH, V33, P1029, DOI 10.1016/S0021-9290(00)00056-7; RAMAKRISHNAN HK, 1991, J BIOMECH, V24, P969, DOI 10.1016/0021-9290(91)90175-M; Ramsey DK, 1999, CLIN BIOMECH, V14, P595, DOI 10.1016/S0268-0033(99)00015-7; Reinschmidt C, 1997, GAIT POSTURE, V6, P98, DOI 10.1016/S0966-6362(97)01110-7; Rivest LP, 2005, J BIOMECH, V38, P1604, DOI 10.1016/j.jbiomech.2004.07.031; Robinson MA, 2012, J BIOMECH, V45, P1941, DOI 10.1016/j.jbiomech.2012.05.017; Sangeux M, 2014, GAIT POSTURE, V40, P20, DOI 10.1016/j.gaitpost.2014.01.024; Schache AG, 2006, GAIT POSTURE, V24, P100, DOI 10.1016/j.gaitpost.2005.08.002; Schwartz MH, 2004, GAIT POSTURE, V20, P196, DOI 10.1016/j.gaitpost.2003.09.011; Szczerbik E, 2011, ACTA BIOENG BIOMECH, V13, P43; TUPLING SJ, 1987, MED BIOL ENG COMPUT, V25, P527, DOI 10.1007/BF02441745; Upadhyaya S, 2013, APCBEE PROC, V7, P27, DOI 10.1016/j.apcbee.2013.08.007; WOLTRING HJ, 1986, ADV ENG SOFTW WORKST, V8, P104, DOI 10.1016/0141-1195(86)90098-7; WOLTRING HJ, 1994, J BIOMECH, V27, P1399, DOI 10.1016/0021-9290(94)90191-0; WU G, 1995, J BIOMECH, V28, P1257, DOI 10.1016/0021-9290(95)00017-C; Zeni JA, 2008, GAIT POSTURE, V27, P710, DOI 10.1016/j.gaitpost.2007.07.007	43	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e102098	10.1371/journal.pone.0102098	http://dx.doi.org/10.1371/journal.pone.0102098			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003974	gold, Green Published, Green Submitted			2022-12-27	WOS:000339242700108
J	Humair, F; Kueffer, C; Siegrist, M				Humair, Franziska; Kueffer, Christoph; Siegrist, Michael			Are Non-Native Plants Perceived to Be More Risky? Factors Influencing Horticulturists' Risk Perceptions of Ornamental Plant Species	PLOS ONE			English	Article							INTRODUCTIONS; ATTITUDES; PATHWAYS; NURSERY; TRADE	Horticultural trade is recognized as an important vector in promoting the introduction and dispersal of harmful non-native plant species. Understanding horticulturists' perceptions of biotic invasions is therefore important for effective species risk management. We conducted a large-scale survey among horticulturists in Switzerland (N = 625) to reveal horticulturists' risk and benefit perceptions from ornamental plant species, their attitudes towards the regulation of non-native species, as well as the factors decisive for environmental risk perceptions and horticulturists' willingness to engage in risk mitigation behavior. Our results suggest that perceived familiarity with a plant species had a mitigating effect on risk perceptions, while perceptions of risk increased if a species was perceived to be non-native. However, perceptions of the non-native origin of ornamental plant species were often not congruent with scientific classifications. Horticulturists displayed positive attitudes towards mandatory trade regulations, particularly towards those targeted against known invasive species. Participants also expressed their willingness to engage in risk mitigation behavior. Yet, positive effects of risk perceptions on the willingness to engage in risk mitigation behavior were counteracted by perceptions of benefits from selling non-native ornamental species. Our results indicate that the prevalent practice in risk communication to emphasize the non-native origin of invasive species can be ineffective, especially in the case of species of high importance to local industries and people. This is because familiarity with these plants can reduce risk perceptions and be in conflict with scientific concepts of non-nativeness. In these cases, it might be more effective to focus communication on well-documented environmental impacts of harmful species.	[Humair, Franziska; Siegrist, Michael] ETH, Swiss Fed Inst Technol, Inst Environm Decis Consumer Behav, Zurich, Switzerland; [Kueffer, Christoph] ETH, Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Humair, F (corresponding author), ETH, Swiss Fed Inst Technol, Inst Environm Decis Consumer Behav, Zurich, Switzerland.	fhumair@ethz.ch	Kueffer, Christoph/H-6091-2013; Siegrist, Michael/A-1032-2008	Kueffer, Christoph/0000-0001-6701-0703; Siegrist, Michael/0000-0002-6139-7190				[Anonymous], 2005, EC HUM WELL BEING SY; Baan P.J., 2004, INT J RIVER BASIN MA, V2, P113, DOI [10.1080/15715124.2004.9635226, DOI 10.1080/15715124.2004.9635226]; Barbier EB, 2013, BIOSCIENCE, V63, P132, DOI 10.1525/bio.2013.63.2.9; Baskin Y, 2002, BIOSCIENCE, V52, P464, DOI 10.1641/0006-3568(2002)052[0464:TGOHNC]2.0.CO;2; Bradley BA, 2012, FRONT ECOL ENVIRON, V10, P20, DOI 10.1890/110145; Brunel S., 2013, LATE LESSONS EARLY W, P518; Burt JW, 2007, BIOL INVASIONS, V9, P909, DOI 10.1007/s10530-007-9090-4; Chung JB, 2008, RISK ANAL, V28, P1021, DOI 10.1111/j.1539-6924.2008.01074.x; Coats VC, 2011, INVAS PLANT SCI MANA, V4, P378, DOI 10.1614/IPSM-D-10-00086.1; Conedera M, 2014, SCHWEIZERISCHE Z FOR, P6; Dehnen-Schmutz K, 2007, DIVERS DISTRIB, V13, P527, DOI 10.1111/j.1472-4642.2007.00359.x; Dehnen-Schmutz K, 2010, SCI HORTIC-AMSTERDAM, V125, P1, DOI 10.1016/j.scienta.2010.02.017; Drew J, 2010, BIOL INVASIONS, V12, P2837, DOI 10.1007/s10530-010-9689-8; Fischer A, 2007, BIOL CONSERV, V135, P256, DOI 10.1016/j.biocon.2006.10.026; FISCHHOFF B, 1978, POLICY SCI, V9, P127, DOI 10.1007/BF00143739; FISCHHOFF B, 1995, RISK ANAL, V15, P137, DOI 10.1111/j.1539-6924.1995.tb00308.x; Gagliardi JA, 2007, HORTTECHNOLOGY, V17, P39, DOI 10.21273/HORTTECH.17.1.39; Halford M., 2013, PERCEPTION INVASIVE, P31; Hobbs R.J., 2013, NOVEL ECOSYSTEMS INT, V1st ed.; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Humair F., 2014, NeoBiota, P1; Humair F, 2014, B OEPP EPPO IN PRESS, V44; Info Flora, 2014, CTR NAT DONN INF FLO; [JardinSuisse JardinSuisse UGS], 2012, PFLANZEN UNSERRE GAR; Joinson A, 1999, BEHAV RES METH INS C, V31, P433, DOI 10.3758/BF03200723; Kowarik Ingo, 2007, V193, P29; Kueffer C., 2013, BIODIVERSITY SOC PAC, P71; Kueffer C, 2014, BIOSCIENCE IN PRESS; Landolt E., 2010, FLORA INDICATIVA; Leung B, 2002, P ROY SOC B-BIOL SCI, V269, P2407, DOI 10.1098/rspb.2002.2179; Mack RN, 2005, HORTSCIENCE, V40, P1168, DOI 10.21273/HORTSCI.40.5.1168; Mack RN, 2002, ANN MO BOT GARD, V89, P176, DOI 10.2307/3298562; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; McDaniels T, 1996, GLOBAL ENVIRON CHANG, V6, P159, DOI 10.1016/0959-3780(96)00006-4; McNeely JA, 2006, EUPHYTICA, V148, P5, DOI 10.1007/s10681-006-5937-5; Peters WL, 2006, EUPHYTICA, V148, P75, DOI 10.1007/s10681-006-5942-8; Pysek P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024890; Reichard SH, 2001, BIOSCIENCE, V51, P103, DOI 10.1641/0006-3568(2001)051[0103:HAAPOI]2.0.CO;2; Ruiz G. M, 2003, INVASIVE SPECIES VEC; Selge S, 2011, BIOL CONSERV, V144, P3089, DOI 10.1016/j.biocon.2011.09.014; Selge S, 2011, J COMMUNITY APPL SOC, V21, P297, DOI 10.1002/casp.1075; SFC - Swiss Federal Council, 2008, ORD HANDL ORG ENV; Siegrist M, 2005, RISK ANAL, V25, P211, DOI 10.1111/j.0272-4332.2005.00580.x; Siegrist M, 2013, RISK ANAL, V33, P50, DOI 10.1111/j.1539-6924.2012.01941.x; Slovic P, 2004, RISK ANAL, V24, P311, DOI 10.1111/j.0272-4332.2004.00433.x; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; SLOVIC P, 1991, CAN J PUBLIC HEALTH, V82, pS15; Starfinger Uwe, 2003, Biological Invasions, V5, P323, DOI 10.1023/B:BINV.0000005573.14800.07; Stromberg JC, 2009, RESTOR ECOL, V17, P177, DOI 10.1111/j.1526-100X.2008.00514.x; Vanderhoeven S, 2011, ENVIRON MANAGE, V47, P425, DOI 10.1007/s00267-011-9621-8; Vila M, 2010, FRONT ECOL ENVIRON, V8, P135, DOI 10.1890/080083; Wang M, 2011, J BEHAV FINANC, V12, P9, DOI 10.1080/15427560.2011.548760; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848	53	22	23	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e102121	10.1371/journal.pone.0102121	http://dx.doi.org/10.1371/journal.pone.0102121			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003195	Green Published, Green Submitted, gold			2022-12-27	WOS:000339242700111
J	Nie, DC; Zhang, ZK; Zhou, JL; Fu, Y; Zhang, K				Nie, Da-Cheng; Zhang, Zi-Ke; Zhou, Jun-Lin; Fu, Yan; Zhang, Kui			Information Filtering on Coupled Social Networks	PLOS ONE			English	Article							OF-THE-ART; RECOMMENDER SYSTEMS; RANDOM-WALK; ALGORITHM	In this paper, based on the coupled social networks (CSN), we propose a hybrid algorithm to nonlinearly integrate both social and behavior information of online users. Filtering algorithm, based on the coupled social networks, considers the effects of both social similarity and personalized preference. Experimental results based on two real datasets, Epinions and Friendfeed, show that the hybrid pattern can not only provide more accurate recommendations, but also enlarge the recommendation coverage while adopting global metric. Further empirical analyses demonstrate that the mutual reinforcement and rich-club phenomenon can also be found in coupled social networks where the identical individuals occupy the core position of the online system. This work may shed some light on the in-depth understanding of the structure and function of coupled social networks.	[Nie, Da-Cheng; Zhou, Jun-Lin; Fu, Yan] Univ Elect Sci & Technol China, Sch Comp Sci & Engn, Web Sci Ctr, Chengdu 610054, Peoples R China; [Zhang, Zi-Ke; Zhang, Kui] Chongqing Univ, Coll Commun Engn, Chongqing 630044, Peoples R China; [Zhang, Zi-Ke] Hangzhou Normal Univ, Alibaba Res Ctr Complex Sci, Hangzhou, Zhejiang, Peoples R China; [Zhang, Zi-Ke] Alibaba Res Inst, Hangzhou, Zhejiang, Peoples R China	University of Electronic Science & Technology of China; Chongqing University; Hangzhou Normal University; Alibaba Group	Zhang, ZK (corresponding author), Chongqing Univ, Coll Commun Engn, Chongqing 630044, Peoples R China.	zhangzike@gmail.com			NSFC [11105024, 61103109, 1147015, 11301490, 11305043]; Zhejiang Talents Project [QJC1302001]; Zhejiang Provincial Natural Science Foundation of China [LY14A050001]; EU [611272]	NSFC(National Natural Science Foundation of China (NSFC)); Zhejiang Talents Project; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); EU(European Commission)	NSFC: 11105024, 61103109, 1147015, 11301490 and 11305043; Zhejiang Talents Project: QJC1302001, Zhejiang Provincial Natural Science Foundation of China (No. LY14A050001), EU FP7 Project: 611272 (GROWTHCOM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Rahman A., 2000, P 33 INT C SYST SCI, P4, DOI DOI 10.1109/HICCS.2000.926814; Abu-Mostafa Y., 2012, LEARNING DATA; Adomavicius G, 2005, IEEE T KNOWL DATA EN, V17, P734, DOI 10.1109/TKDE.2005.99; Anderberg M. R., 1973, CLUSTER ANAL APPL; [Anonymous], 2006, P ECAI WORKSHOP RECO; Bhuiyan Touhid, 2010, Journal of Emerging Technologies in Web Intelligence, V2, P291, DOI 10.4304/jetwi.2.4.291-299; Boulos MNK, 2007, HEALTH INFO LIBR J, V24, P2, DOI 10.1111/j.1471-1842.2007.00701.x; Breese J., 1998, P 14 C UNC ART INT M, P43; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Burke R, 2002, USER MODEL USER-ADAP, V12, P331, DOI 10.1023/A:1021240730564; Celli F, 2010, LECT NOTES COMPUT SC, V6007, P346, DOI 10.1007/978-3-642-12079-4_43; Chen G, 2012, ARXIV12052822; Crandall David, 2008, P 14 ACM SIGKDD INT, P160, DOI DOI 10.1145/1401890.1401914; Esslimani I, 2009, 2009 INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING, P143, DOI 10.1109/ASONAM.2009.30; Faloutsos M, 1999, COMP COMM R, V29, P251, DOI 10.1145/316194.316229; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Froomkin AM, 1995, J LAW COMMERCE, V15, P395; Fu F, 2008, PHYSICA A, V387, P675, DOI 10.1016/j.physa.2007.10.006; Gao JX, 2012, NAT PHYS, V8, P40, DOI 10.1038/nphys2180; Givoni M, 2006, TRANSPORT POLICY, V13, P386, DOI 10.1016/j.tranpol.2006.02.001; Guha R., 2004, P 13 INT C WORLD WID, P403, DOI [10.1145/988672.988727, DOI 10.1145/988672.988727]; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Herlocker JL, 2004, ACM T INFORM SYST, V22, P5, DOI 10.1145/963770.963772; Huang Z, 2004, ACM T INFORM SYST, V22, P116, DOI 10.1145/963770.963775; Josang A., 1998, P 21 NIST NCSC NAT I, P16; Kautz H, 1997, COMMUN ACM, V40, P63, DOI 10.1145/245108.245123; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Krestel R., 2009, ACM C RECOMMENDER SY, P61, DOI [10.1145/1639714.1639726, DOI 10.1145/1639714.1639726]; Kumar R, 1998, ANN IEEE SYMP FOUND, P664, DOI 10.1109/SFCS.1998.743517; Lee D, 2008, P SIGIR 2008 WORKSH, P7; Leicht EA, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.026120; Linden G, 2003, IEEE INTERNET COMPUT, V7, P76, DOI 10.1109/MIC.2003.1167344; Liu CJ, 2014, PATTERN RECOGN, V47, P359, DOI 10.1016/j.patcog.2013.06.023; Liu JG, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.016118; Liu JG, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.037101; Liu JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091070; Lu LY, 2012, PHYS REP, V519, P1, DOI 10.1016/j.physrep.2012.02.006; Lu LY, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066119; Lu LY, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046122; Massa P, 2004, LECT NOTES COMPUT SC, V3290, P492, DOI 10.1007/978-3-540-30468-5_31; Massa P, 2007, RECSYS 07: PROCEEDINGS OF THE 2007 ACM CONFERENCE ON RECOMMENDER SYSTEMS, P17; Mednick SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009775; Mild A, 2002, J RETAIL CONSUM SERV, V10, P123; Morita M., 1994, SIGIR '94. Proceedings of the Seventeenth Annual International ACM-SIGIR Conference on Research and Development in Information Retrieval, P272; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Pazzani M. J., 2007, The Adaptive Web. Methods and Strategies of Web Personalization, P325; Qiu T, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/58003; RESNICK P, 1994, 1994 ACM C COMPUTER, P175, DOI [DOI 10.1145/192844.192905, 10.1145/192844.192905]; Sarwar B., 2001, P 10 INT C WORLD WID, P285, DOI [DOI 10.1145/371920.372071, 10.1145/371920.372071]; Sarwar B, 2000, ACM WEBKDD 2000 WEB; Shang MS, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/68008; Sun D, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.017101; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Tong HH, 2006, IEEE DATA MINING, P613; Walter FE, 2008, AUTON AGENT MULTI-AG, V16, P57, DOI 10.1007/s10458-007-9021-x; Wang FG, 2001, PHYS REV LETT, V86, P2050, DOI 10.1103/PhysRevLett.86.2050; Yu AW, 2014, PROC VLDB ENDOW, V7, P401, DOI 10.14778/2732269.2732276; Zeng A, 2014, EPL-EUROPHYS LETT, V105, DOI 10.1209/0295-5075/105/58002; Zeng W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079354; Zeng W, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40258-1; Zhang YC, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.154301; Zhang ZK, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/10/P10005; Zhang ZK, 2011, J COMPUT SCI TECH-CH, V26, P767, DOI 10.1007/s11390-011-0176-1; Zhang ZK, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/28002; Zhang ZK, 2010, PHYSICA A, V389, P179, DOI 10.1016/j.physa.2009.08.036; Zhou S, 2004, IEEE COMMUN LETT, V8, P180, DOI 10.1109/LCOMM.2004.823426; Zhou T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046115; Zhou T, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/12/123008; Ziegler CN, 2013, SOCIALWEB ARTIFACTS, P11	75	14	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101675	10.1371/journal.pone.0101675	http://dx.doi.org/10.1371/journal.pone.0101675			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003525	gold, Green Submitted, Green Published			2022-12-27	WOS:000339242700051
J	Wensing, M; Huntink, E; van Lieshout, J; Godycki-Cwirko, M; Kowalczyk, A; Jager, C; Steinhauser, J; Aakhus, E; Flottorp, S; Eccles, M; Baker, R				Wensing, Michel; Huntink, Elke; van Lieshout, Jan; Godycki-Cwirko, Maciek; Kowalczyk, Anna; Jager, Cornelia; Steinhauser, Jost; Aakhus, Eivind; Flottorp, Signe; Eccles, Martin; Baker, Richard			Tailored Implementation of Evidence-Based Practice for Patients with Chronic Diseases	PLOS ONE			English	Article							HEALTH-CARE; INTERVENTIONS; BEHAVIOR; IMPROVEMENTS; INNOVATIONS; CHECKLIST; QUALITY	Background: When designing interventions and policies to implement evidence based healthcare, tailoring strategies to the targeted individuals and organizations has been recommended. We aimed to gather insights into the ideas of a variety of people for implementing evidence-based practice for patients with chronic diseases, which were generated in five European countries. Methods: A qualitative study in five countries (Germany, Netherlands, Norway, Poland, United Kingdom) was done, involving overall 115 individuals. A purposeful sample of four categories of stakeholders (healthcare professionals, quality improvement officers, healthcare purchasers and authorities, and health researchers) was involved in group interviews in each of the countries to generate items for improving healthcare in different chronic conditions per country: chronic obstructive pulmonary disease, cardiovascular disease, depression in elderly people, multi-morbidity, obesity. A disease-specific standardized list of determinants of practice in these conditions provided the starting point for these groups. The content of the suggested items was categorized in a pre-defined framework of 7 domains and specific themes in the items were identified within each domain. Results: The 115 individuals involved in the study generated 812 items, of which 586 addressed determinants of practice. These largely mapped onto three domains: individual health professional factors, patient factors, and professional interactions. Few items addressed guideline factors, incentives and resources, capacity of organizational change, or social, political and legal factors. The relative numbers of items in the different domains were largely similar across stakeholder categories within each of the countries. The analysis identified 29 specific themes in the suggested items across countries. Conclusion: The type of suggestions for improving healthcare practice was largely similar across different stakeholder groups, mainly addressing healthcare professionals, patient factors and professional interactions. As this study is one of the first of its kind, it is important that more research is done on tailored implementation strategies.	[Wensing, Michel; Huntink, Elke; van Lieshout, Jan] Radboud Univ Nijmegen Med Ctr, Nijmegen, Netherlands; [Godycki-Cwirko, Maciek; Kowalczyk, Anna] Med Univ Lodz, Lodz, Poland; [Jager, Cornelia; Steinhauser, Jost] Univ Heidelberg Hosp, Heidelberg, Germany; [Aakhus, Eivind; Flottorp, Signe] Norwegian Knowledge Ctr Hlth Serv, Oslo, Norway; [Eccles, Martin] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Baker, Richard] Univ Leicester, Leicester, Leics, England	Radboud University Nijmegen; Medical University Lodz; Ruprecht Karls University Heidelberg; Norwegian Knowledge Centre for Health Services; Newcastle University - UK; University of Leicester	Wensing, M (corresponding author), Radboud Univ Nijmegen Med Ctr, Nijmegen, Netherlands.	Michel.Wensing@radboudumc.nl	Loskamp-Huntink, Elke/F-3120-2016; Van Lieshout, J./L-4490-2015; Eccles, Martin P/AAD-4029-2020; Wensing, Michel/H-8113-2014; Aakhus, Eivind/AGO-7668-2022	Wensing, Michel/0000-0001-6569-8137; Godycki-Cwirko, Maciej/0000-0002-9204-5518; Flottorp, Signe/0000-0003-2961-7461; Kowalczyk, Anna/0000-0002-7524-2085	European Union [258837]; Netherlands Organization for Health Research (ZonMW) [200310011]; National Institute for Health Research [NF-SI-0510-10025] Funding Source: researchfish	European Union(European Commission); Netherlands Organization for Health Research (ZonMW)(Netherlands Organization for Health Research and Development); National Institute for Health Research(National Institute for Health Research (NIHR))	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no 258837. The Netherlands Organization for Health Research (ZonMW) provided additional funding under grant 200310011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker R, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005470.pub2; Bosch M, 2007, J EVAL CLIN PRACT, V13, P161, DOI 10.1111/j.1365-2753.2006.00660.x; Bosch M, 2009, MED CARE RES REV, V66, p5S, DOI 10.1177/1077558709343295; Cheetham G., 2001, J EUR IND TRAIN, V25, P247, DOI DOI 10.1108/03090590110395870; Eccles M, 2005, J CLIN EPIDEMIOL, V58, P107, DOI 10.1016/j.jclinepi.2004.09.002; Flottorp SA, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-35; Fowler JH, 2010, P NATL ACAD SCI USA, V107, P5334, DOI 10.1073/pnas.0913149107; Gagliardi AR, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-26; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Grimshaw JM, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-50; Grol RPTM, 2007, MILBANK Q, V85, P93, DOI 10.1111/j.1468-0009.2007.00478.x; Harden RM, 2000, MED TEACH, V22, P334; Ludt S, 2012, EUR J PREV CARD 0921; May C, 2013, SOC SCI MED, V78, P26, DOI 10.1016/j.socscimed.2012.11.021; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Mitchell AJ, 2009, LANCET, V374, P609, DOI 10.1016/S0140-6736(09)60879-5; Noordman J, 2012, PATIENT EDUC COUNS, V89, P227, DOI 10.1016/j.pec.2012.07.006; Schuster MA, 2005, MILBANK Q, V83, P843, DOI 10.1111/j.1468-0009.2005.00403.x; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Treweek S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-16; Weiner BJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-67; Wensing M, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-2; Wensing M, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-103; Wensing M, 2010, CAN MED ASSOC J, V182, pE85, DOI 10.1503/cmaj.081233; World Health Organization, 2011, NONCOMMUNICABLE DIS	25	34	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101981	10.1371/journal.pone.0101981	http://dx.doi.org/10.1371/journal.pone.0101981			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL6KZ	25003371	Green Published, Green Submitted, gold			2022-12-27	WOS:000339242700095
J	Yu, DW; Zhang, SF; Du, WH; Zhang, JX; Fan, ZX; Hao, HS; Liu, Y; Zhao, XM; Qin, T; Zhu, HB				Yu, Dawei; Zhang, Shoufeng; Du, Weihua; Zhang, Jinxia; Fan, Zongxing; Hao, Haisheng; Liu, Yan; Zhao, Xueming; Qin, Tong; Zhu, Huabin			Expression of Intracellular Interferon-Alpha Confers Antiviral Properties in Transfected Bovine Fetal Fibroblasts and Does Not Affect the Full Development of SCNT Embryos	PLOS ONE			English	Article							MOUTH-DISEASE; GENE-EXPRESSION; I INTERFERONS; GAMMA; ACTIVATION; VITRO; LEADS	Foot-and-mouth disease, one of the most significant diseases of dairy herds, has substantial effects on farm economics, and currently, disease control measures are limited. In this study, we constructed a vector with a human interferon-alpha (hIFN-alpha) (without secretory signal sequence) gene cassette containing the immediate early promoter of human cytomegalovirus. Stably transfected bovine fetal fibroblasts were obtained by G418 selection, and hIFN-alpha transgenic embryos were produced by somatic cell nuclear transfer (SCNT). Forty-six transgenic embryos were transplanted into surrogate cows, and five cows (10.9%) became pregnant. Two male cloned calves were born. Expression of hIFN-alpha was detected in transfected bovine fetal fibroblasts, transgenic SCNT embryos, and different tissues from a transgenic SCNT calf at two days old. In transfected bovine fetal fibroblasts, expression of intracellular IFN-alpha induced resistance to vesicular stomatitis virus infection, increased apoptosis, and induced the expression of double-stranded RNA-activated protein kinase gene (PKR) and the 2'-5'-oligoadenylate synthetase gene (29-59 OAS), which are IFN-inducible genes with antiviral activity. Analysis by qRT-PCR showed that the mRNA expression levels of PKR, 29-59 OAS, and P53 were significantly increased in wild-type bovine fetal fibroblasts stimulated with extracellular recombinant human IFN-alpha-2b, showing that intracellular IFN-alpha induces biological functions similar to extracellular IFN-alpha. In conclusion, expression of intracellular hIFN-alpha conferred antiviral properties in transfected bovine fetal fibroblasts and did not significantly affect the full development of SCNT embryos. Thus, IFN-alpha transgenic technology may provide a revolutionary way to achieve elite breeding of livestock.	[Yu, Dawei; Du, Weihua; Fan, Zongxing; Hao, Haisheng; Liu, Yan; Zhao, Xueming; Qin, Tong; Zhu, Huabin] Chinese Acad Agr Sci, Inst Anim Sci, Embryo Biotechnol & Reprod Lab, Beijing 100193, Peoples R China; [Zhang, Shoufeng; Zhang, Jinxia] Acad Mil Med Sci, Inst Mil Vet, Changchun, Peoples R China; [Yu, Dawei] China Agr Univ, Coll Biol Sci, State Key Labs Agrobiotechnol, Beijing 100094, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Academy of Military Medical Sciences - China; China Agricultural University	Du, WH (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Embryo Biotechnol & Reprod Lab, Beijing 100193, Peoples R China.	dwh@iascaas.net.cn	Yu, Dawei/J-3492-2013	Yu, Dawei/0000-0002-1105-4077	Agricultural Science and Technology Innovation Program [ASTIP-IAS06]; State Major Project of Transgenic [2009ZX08007-007B]	Agricultural Science and Technology Innovation Program; State Major Project of Transgenic	This work was partially supported by grants from the Agricultural Science and Technology Innovation Program (ASTIP-IAS06 to WHD), State Major Project of Transgenic (2009ZX08007-007B to WHD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed CMI, 2001, J INTERF CYTOK RES, V21, P399, DOI 10.1089/107999001750277871; Bauersachs S, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094771; Chen WZ, 2006, J VIROL, V80, P3559, DOI 10.1128/JVI.80.7.3559-3566.2006; Fujisawa M, 1998, ARCH ANDROLOGY, V40, P211, DOI 10.3109/01485019808987944; Grubman Marvin J, 2003, Expert Rev Anti Infect Ther, V1, P579, DOI 10.1586/14787210.1.4.579; Haneji T, 2013, INT J ONCOL, V42, P1904, DOI 10.3892/ijo.2013.1911; HEKMAN ACP, 1988, J BIOL CHEM, V263, P12151; Isakari Y, 2007, INT J PHARMACEUT, V338, P157, DOI 10.1016/j.ijpharm.2007.01.042; Knowles NJ, 2001, VET REC, V148, P258; Laible G, 2009, COMP IMMUNOL MICROB, V32, P123, DOI 10.1016/j.cimid.2007.11.012; Li L, 2014, J BIOTECHNOL, V171, P17, DOI 10.1016/j.jbiotec.2013.11.022; Malireddi RKS, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00077; Matoba S, 2011, P NATL ACAD SCI USA, V108, P20621, DOI 10.1073/pnas.1112664108; Moraes MP, 2003, VACCINE, V22, P268, DOI 10.1016/S0264-410X(03)00560-7; Oritani K, 2001, CYTOKINE GROWTH F R, V12, P337, DOI 10.1016/S1359-6101(01)00009-0; Park JH, 2013, CLIN EXP VACCINE RES, V2, P8, DOI 10.7774/cevr.2013.2.1.8; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pindel A, 2011, J INTERF CYTOK RES, V31, P59, DOI 10.1089/jir.2010.0099; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Satie AP, 2011, J BIOL CHEM, V286, P23280, DOI 10.1074/jbc.M111.229120; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shin-Ya M, 2005, BIOCHEM BIOPH RES CO, V329, P1139, DOI 10.1016/j.bbrc.2005.02.088; Takahashi M, 2003, J REPROD DEVELOP, V49, P297; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; Vajta G, 2003, BIOL REPROD, V68, P571, DOI 10.1095/biolreprod.102.008771; Vajta G, 2000, MOL REPROD DEV, V55, P256, DOI 10.1002/(SICI)1098-2795(200003)55:3&lt;256::AID-MRD3&gt;3.0.CO;2-7; Will A, 1996, J IMMUNOL, V157, P4576; Zhang JX, 2007, J DAIRY SCI, V90, P5218, DOI 10.3168/jds.2007-0301; Zhang JinXia, 2008, Chinese Journal of Veterinary Science, V28, P1433	30	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e94444	10.1371/journal.pone.0094444	http://dx.doi.org/10.1371/journal.pone.0094444			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004008	Green Published, gold, Green Submitted			2022-12-27	WOS:000339242700001
J	Aldrin-Kirk, P; Davidsson, M; Holmqvist, S; Li, JY; Bjorklund, T				Aldrin-Kirk, Patrick; Davidsson, Marcus; Holmqvist, Staffan; Li, Jia-Yi; Bjorklund, Tomas			Novel AAV-Based Rat Model of Forebrain Synucleinopathy Shows Extensive Pathologies and Progressive Loss of Cholinergic Interneurons	PLOS ONE			English	Article							HUMAN ALPHA-SYNUCLEIN; LEWY BODY DISEASE; ADENOASSOCIATED VIRAL VECTORS; PARKINSONS-DISEASE; MOUSE MODEL; NEURODEGENERATIVE DISEASES; ALZHEIMERS-DISEASE; DOPAMINE RELEASE; SUBSTANTIA-NIGRA; NEURONS	Synucleinopathies, characterized by intracellular aggregation of alpha-synuclein protein, share a number of features in pathology and disease progression. However, the vulnerable cell population differs significantly between the disorders, despite being caused by the same protein. While the vulnerability of dopamine cells in the substantia nigra to alpha-synuclein over-expression, and its link to Parkinson's disease, is well studied, animal models recapitulating the cortical degeneration in dementia with Lewy-bodies (DLB) are much less mature. The aim of this study was to develop a first rat model of widespread progressive synucleinopathy throughout the forebrain using adeno-associated viral (AAV) vector mediated gene delivery. Through bilateral injection of an AAV6 vector expressing human wild-type alpha-synuclein into the forebrain of neonatal rats, we were able to achieve widespread, robust alpha-synuclein expression with preferential expression in the frontal cortex. These animals displayed a progressive emergence of hyper-locomotion and dysregulated response to the dopaminergic agonist apomorphine. The animals receiving the alpha-synuclein vector displayed significant alpha-synuclein pathology including intra-cellular inclusion bodies, axonal pathology and elevated levels of phosphorylated alpha-synuclein, accompanied by significant loss of cortical neurons and a progressive reduction in both cortical and striatal ChAT positive interneurons. Furthermore, we found evidence of alpha-synuclein sequestered by IBA-1 positive microglia, which was coupled with a distinct change in morphology. In areas of most prominent pathology, the total alpha-synuclein levels were increased to, on average, two-fold, which is similar to the levels observed in patients with SNCA gene triplication, associated with cortical Lewy body pathology. This study provides a novel rat model of progressive cortical synucleinopathy, showing for the first time that cholinergic interneurons are vulnerable to alpha-synuclein over-expression. This animal model provides a powerful new tool for studies of neuronal degeneration in conditions of widespread cortical alpha-synuclein pathology, such as DLB, as well an attractive model for the exploration of novel biomarkers.	[Aldrin-Kirk, Patrick; Davidsson, Marcus; Holmqvist, Staffan; Li, Jia-Yi; Bjorklund, Tomas] Lund Univ, Wallenberg Neurosci Ctr, Lund, Sweden	Lund University	Bjorklund, T (corresponding author), Lund Univ, Wallenberg Neurosci Ctr, Lund, Sweden.	tomas.bjorklund@med.lu.se	Holmqvist, Staffan/AAD-4667-2020; Bjorklund, Tomas/S-7034-2019; Bjorklund, Tomas/F-5117-2013	Holmqvist, Staffan/0000-0001-6709-6666; Bjorklund, Tomas/0000-0001-7968-0034; Bjorklund, Tomas/0000-0001-7968-0034; Li, Jia-Yi/0000-0002-7770-7376; Aldrin-Kirk, Patrick/0000-0001-9163-4882; Davidsson, Marcus/0000-0003-0233-0516	Multipark; Swedish Alzheimer foundation; Swedish Parkinson's foundation; Crafoord foundation; Ahlen foundation; Kock foundation; Thuring foundation; Segerfalk foundation; Royal physiographic foundation	Multipark; Swedish Alzheimer foundation; Swedish Parkinson's foundation; Crafoord foundation; Ahlen foundation; Kock foundation; Thuring foundation; Segerfalk foundation; Royal physiographic foundation	Financial support for this study is provided by the strong research environment Multipark as well as the following foundations: The Swedish Alzheimer foundation, Swedish Parkinson's foundation, Crafoord foundation, Ahlen foundation, Kock foundation, Thuring foundation, Segerfalk foundation and the Royal physiographic foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Aurnhammer C, 2012, HUM GENE THER METHOD, V23, P18, DOI 10.1089/hgtb.2011.034; Ballard C, 2006, NEUROLOGY, V67, P1931, DOI 10.1212/01.wnl.0000249130.63615.cc; Bandeira F, 2009, P NATL ACAD SCI USA, V106, P14108, DOI 10.1073/pnas.0804650106; Basso E, 2013, MOL NEUROBIOL, V48, P854, DOI 10.1007/s12035-013-8473-z; Bjorklund A, 2010, PROG BRAIN RES, V184, P53, DOI 10.1016/S0079-6123(10)84004-X; Brown MTC, 2012, NATURE, V492, P452, DOI 10.1038/nature11657; Caccamo A, 2013, AGING CELL, V12, P370, DOI 10.1111/acel.12057; Cachope R, 2012, CELL REP, V2, P33, DOI 10.1016/j.celrep.2012.05.011; CHANG HT, 1992, BRAIN RES, V574, P307, DOI 10.1016/0006-8993(92)90830-3; Choubey V, 2011, J BIOL CHEM, V286, P10814, DOI 10.1074/jbc.M110.132514; Crews L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009313; Daher JPL, 2012, HUM MOL GENET, V21, P2420, DOI 10.1093/hmg/dds057; Decressac M, 2013, P NATL ACAD SCI USA, V110, pE1817, DOI 10.1073/pnas.1305623110; Decressac M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004676; Ding YM, 2011, P NATL ACAD SCI USA, V108, P840, DOI 10.1073/pnas.1006511108; Eslamboli A, 2007, BRAIN, V130, P799, DOI 10.1093/brain/awl382; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Gabery S, 2012, EUR J NEUROSCI, V36, P2789, DOI 10.1111/j.1460-9568.2012.08193.x; Games D, 2013, AM J PATHOL, V182, P940, DOI 10.1016/j.ajpath.2012.11.018; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Gorbatyuk MS, 2012, MOL THER, V20, P1327, DOI 10.1038/mt.2012.28; Gorbatyuk OS, 2008, P NATL ACAD SCI USA, V105, P763, DOI 10.1073/pnas.0711053105; Hall H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064844; Hansen C, 2013, NEUROBIOL DIS, V56, P145, DOI 10.1016/j.nbd.2013.04.017; Heidebrink JL, 2002, J GERIATR PSYCH NEUR, V15, P182, DOI 10.1177/089198870201500402; Herculano-Houzel S, 2005, J NEUROSCI, V25, P2518, DOI 10.1523/JNEUROSCI.4526-04.2005; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Klein RL, 2002, HUM GENE THER, V13, P605, DOI 10.1089/10430340252837206; Kontopoulos E, 2006, HUM MOL GENET, V15, P3012, DOI 10.1093/hmg/ddl243; Kornum BR, 2010, EXP NEUROL, V222, P70, DOI 10.1016/j.expneurol.2009.12.009; Kosaka K, 1996, NEUROPATHOLOGY, V16, P32, DOI 10.1111/j.1440-1789.1996.tb00152.x; Kugler S, 2003, GENE THER, V10, P337, DOI 10.1038/sj.gt.3301905; Lippa CF, 1999, J NEURAL TRANSM, V106, P525, DOI 10.1007/s007020050176; Lo Bianco C, 2002, P NATL ACAD SCI USA, V99, P10813, DOI 10.1073/pnas.152339799; Lundblad M, 2012, P NATL ACAD SCI USA, V109, P3213, DOI 10.1073/pnas.1200575109; Mackenzie IRA, 2000, NEUROLOGY, V55, P132, DOI 10.1212/WNL.55.1.132; Magen I, 2012, EUR J NEUROSCI, V35, P870, DOI 10.1111/j.1460-9568.2012.08012.x; Maries E, 2003, NAT REV NEUROSCI, V4, P727, DOI 10.1038/nrn1199; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Oliveras-Salva M, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-44; Oueslati A, 2013, P NATL ACAD SCI USA, V110, pE3945, DOI 10.1073/pnas.1309991110; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; PERRY EK, 1985, J NEUROL NEUROSUR PS, V48, P413, DOI 10.1136/jnnp.48.5.413; Pisani A, 2007, TRENDS NEUROSCI, V30, P545, DOI 10.1016/j.tins.2007.07.008; Prots I, 2013, J BIOL CHEM, V288, P21742, DOI 10.1074/jbc.M113.451815; Richmond MA, 1999, BEHAV NEUROSCI, V113, P1189, DOI 10.1037/0735-7044.113.6.1189; Saha AR, 2004, J CELL SCI, V117, P1017, DOI 10.1242/jcs.00967; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Suzuki M, 2002, NEUROLOGY, V58, P1013, DOI 10.1212/WNL.58.7.1013; Threlfell S, 2012, NEURON, V75, P58, DOI 10.1016/j.neuron.2012.04.038; Tinsley RB, 2010, J NEUROSCI RES, V88, P2693, DOI 10.1002/jnr.22417; Tiraboschi P, 2000, NEUROLOGY, V54, P407, DOI 10.1212/WNL.54.2.407; Ulusoy A, 2012, NEUROBIOL DIS, V47, P367, DOI 10.1016/j.nbd.2012.05.012; Wakamatsu M, 2007, J NEUROSCI RES, V85, P1819, DOI 10.1002/jnr.21310; Warner-Schmidt JL, 2012, P NATL ACAD SCI USA, V109, P11360, DOI 10.1073/pnas.1209293109; Wei J, 2007, J BIOL CHEM, V282, P28904, DOI 10.1074/jbc.M703711200; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Yu S, 2007, NEUROSCIENCE, V145, P539, DOI 10.1016/j.neuroscience.2006.12.028; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	63	25	25	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e100869	10.1371/journal.pone.0100869	http://dx.doi.org/10.1371/journal.pone.0100869			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999658	Green Published, gold, Green Submitted			2022-12-27	WOS:000338637300016
J	Garner, C; Ahn, R; Ding, YC; Steele, L; Stoven, S; Green, PH; Fasano, A; Murray, JA; Neuhausen, SL				Garner, Chad; Ahn, Richard; Ding, Yuan Chun; Steele, Linda; Stoven, Samantha; Green, Peter H.; Fasano, Alessio; Murray, Joseph A.; Neuhausen, Susan L.			Genome-Wide Association Study of Celiac Disease in North America Confirms FRMD4B as New Celiac Locus	PLOS ONE			English	Article							CROHNS-DISEASE; MICROSCOPIC COLITIS; RISK VARIANTS; UNITED-STATES; INFLAMMATION; PREVALENCE; AUTOPHAGY; ANTIGENS; GENES	We performed a genome-wide association study (GWAS) of 1550 North American celiac disease cases and 3084 controls. Twelve SNPs, distributed across four regions (3p21.31, 4q27, 6q15, 6q25), were significantly associated with disease (p-value < 1.0x10(-7)), and a further seven SNPs, across four additional regions (1q24.3, 10p15.1, 6q22.31, 17q21.32) had suggestive evidence (1.0x10(-7) < p-value < 1.0x10(-6)). This study replicated a previous suggestive association within FRMD4B (3p14.1), confirming it as a celiac disease locus. All four regions with significant associations and two regions with suggestive results (1q24.3, 10p15.1) were known disease loci. The 6q22.31 and 10p11.23 regions were not replicated. A total of 410 SNPs distributed across the eight significant and suggestive regions were tested for association with dermatitis herpetiformis and microscopic colitis. Preliminary, suggestive statistical evidence for association with the two traits was found at chromosomes 3p21.31, 6q15, 6q25, 1q24.3 and 10p11.23, with future studies being required to validate the reported associations.	[Garner, Chad; Ahn, Richard] Univ Calif Irvine, Sch Med, Dept Epidemiol, Irvine, CA 92717 USA; [Ding, Yuan Chun; Steele, Linda; Neuhausen, Susan L.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA USA; [Green, Peter H.] Columbia Univ, Celiac Dis Ctr, New York, NY USA; [Fasano, Alessio] MassGen Hosp Children, Ctr Celiac Res, Boston, MA USA; [Stoven, Samantha; Murray, Joseph A.] Mayo Clin, Dept Immunol, Div Gastroenterol & Hepatol, Rochester, MN USA	University of California System; University of California Irvine; City of Hope; Beckman Research Institute of City of Hope; Columbia University; Harvard University; Massachusetts General Hospital; Mayo Clinic	Garner, C (corresponding author), Univ Calif Irvine, Sch Med, Dept Epidemiol, Irvine, CA 92717 USA.	cgarner@uci.edu	Fasano, Alessio/K-5486-2016	Fasano, Alessio/0000-0002-2134-0261; Ahn, Richard/0000-0002-9698-2752	National Institutes of Health [DK081645, R01 DK057892]; Center for Celiac Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081645, R01DK057892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Celiac Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	SN and CG were funded by National Institutes of Health Grant DK081645 (www.nih.gov). JAM was also supported in part by National Institutes of Health Grant R01 DK057892 (www.nih.gov). AF was supported by funds from the Center for Celiac Research (www.celiacdiseasecenter.columbia.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bonciani D, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/239691; Brinar M, 2012, J CROHNS COLITIS, V6, P43, DOI 10.1016/j.crohns.2011.06.008; Christodoulou K, 2013, GUT, V62, P977, DOI 10.1136/gutjnl-2011-301833; Diegelmann J, 2010, INFLAMM BOWEL DIS, V16, P1871, DOI 10.1002/ibd.21306; Dubois PCA, 2010, NAT GENET; FALCHUK ZM, 1972, LANCET, V2, P1310; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; Fernandez-Banares F, 2005, EUR J GASTROEN HEPAT, V17, P1333, DOI 10.1097/00042737-200512000-00011; Garner C, 2006, HUM HERED, V61, P22, DOI 10.1159/000091833; Garner CP, 2009, HUM MOL GENET; Green PHR, 2009, CLIN GASTROENTEROL H, V7, P1210, DOI 10.1016/j.cgh.2009.07.011; Nguyen HTT, 2013, J INNATE IMMUN, V5, P434, DOI 10.1159/000345129; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Katz KD, 2011, AM J GASTROENTEROL, V106, P1333, DOI 10.1038/ajg.2011.21; Koskela RM, 2008, EUR J GASTROEN HEPAT, V20, P276, DOI 10.1097/MEG.0b013e3282f2468d; Ma J, 2014, J IMMUNOL, V192, P1356, DOI 10.4049/jimmunol.1302835; Murray JA, 2003, CLIN GASTROENTEROL H, V1, P19, DOI 10.1053/jcgh.2003.50004; Parmar AS, 2012, GENES IMMUN, V13, P474, DOI 10.1038/gene.2012.21; Rubio-Tapia A, 2012, AM J GASTROENTEROL, V107, P1538, DOI 10.1038/ajg.2012.219; STOKES PL, 1972, LANCET, V2, P162; TOSI R, 1983, CLIN IMMUNOL IMMUNOP, V28, P395, DOI 10.1016/0090-1229(83)90106-X; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Uza N, 2011, GUT, V60, P1494, DOI 10.1136/gut.2010.221879; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Walker MM, 2011, HISTOPATHOLOGY, V59, P166, DOI 10.1111/j.1365-2559.2010.03680.x	26	39	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101428	10.1371/journal.pone.0101428	http://dx.doi.org/10.1371/journal.pone.0101428			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999842	Green Published, gold			2022-12-27	WOS:000338637300042
J	Mertl, J; Kirchnawy, C; Osorio, V; Grininger, A; Richter, A; Bergmair, J; Pyerin, M; Washuttl, M; Tacker, M				Mertl, Johannes; Kirchnawy, Christian; Osorio, Veronica; Grininger, Angelika; Richter, Alexander; Bergmair, Johannes; Pyerin, Michael; Washuettl, Michael; Tacker, Manfred			Characterization of Estrogen and Androgen Activity of Food Contact Materials by Different In Vitro Bioassays (YES, YAS, ER alpha and AR CALUX) and Chromatographic Analysis (GC-MS, HPLC-MS)	PLOS ONE			English	Article							ENDOCRINE DISRUPTORS; STYRENE OLIGOMERS; CHEMICALS; ASSAYS; PREVALIDATION; OPTIMIZATION; EXPOSURE; SCREEN; CELLS; WATER	Endocrine active substances (EAS) show structural similarities to natural hormones and are suspected to affect the human endocrine system by inducing hormone dependent effects. Recent studies with in vitro tests suggest that EAS can leach from packaging into food and may therefore pose a risk to human health. Sample migrates from food contact materials were tested for estrogen and androgen agonists and antagonists with different commonly used in vitro tests. Additionally, chemical trace analysis by GC-MS and HPLC-MS was used to identify potential hormone active substances in sample migrates. A GC-MS method to screen migrates for 29 known or potential endocrine active substances was established and validated. Samples were migrated according to EC 10/2011, concentrated by solid phase extraction and tested with estrogen and androgen responsive reporter gene assays based on yeast cells (YES and YAS) or human osteoblast cells (ER alpha and AR CALUX). A high level of agreement between the different bioassays could be observed by screening for estrogen agonists. Four out of 18 samples tested showed an estrogen activity in a similar range in both, YES and ER alpha CALUX. Two more samples tested positive in ER alpha CALUX due to the lower limits of detection in this assay. Androgen agonists could not be detected in any of the tested samples, neither with YAS nor with AR CALUX. When testing for antagonists, significant differences between yeast and human cell-based bioassays were noticed. Using YES and YAS many samples showed a strong antagonistic activity which was not observed using human cell-based CALUX assays. By GC-MS, some known or supposed EAS were identified in sample migrates that showed a biological activity in the in vitro tests. However, no firm conclusions about the sources of the observed hormone activity could be obtained from the chemical results.	[Mertl, Johannes; Kirchnawy, Christian; Osorio, Veronica; Grininger, Angelika; Richter, Alexander; Bergmair, Johannes; Pyerin, Michael; Washuettl, Michael; Tacker, Manfred] OFI Austrian Res Inst Chem & Technol, Vienna, Austria		Mertl, J (corresponding author), OFI Austrian Res Inst Chem & Technol, Vienna, Austria.	johannes.mertl@ofi.at; christian.kirchnawy@ofi.at		Bergmair, Johannes/0000-0002-4279-5281	Osterreichische Forschungsforderungsgesellschaft mbH [826796]	Osterreichische Forschungsforderungsgesellschaft mbH	This study was financed by the Osterreichische Forschungsforderungsgesellschaft mbH, in the context of the project "Xeno'' (Project 826796). The funding source was not involved in study design, collection, analysis or interpretation of data. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Bohmler G., 2006, Journal fur Verbraucherschutz und Lebensmittelsicherheit, V1, P325, DOI 10.1007/s00003-006-0055-9; Bradley E., 2007, INVESTIGATION REACTI; CHONG YK, 1983, J AM CHEM SOC, V105, P7761, DOI 10.1021/ja00364a058; Della Seta D, 2006, HORM BEHAV, V50, P301, DOI 10.1016/j.yhbeh.2006.03.015; European Commission, 1998, FIN REP; Evans R., 2011, STATE ART ASSESSMENT; Gelmann EP, 1996, J NATL CANCER I, V88, P224, DOI 10.1093/jnci/88.5.224; Gray J, 2008, STATE EVIDENCE CONNE; Gray Jr LE, 2004, USE LAB RAT MODEL EN; Hecker Markus, 2011, Environmental Sciences Europe, V23, P15, DOI 10.1186/2190-4715-23-15; Jacobs JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082573; JOBLING S, 1995, ENVIRON HEALTH PERSP, V103, P582, DOI 10.2307/3432434; Kanako S, 2007, FOODS FOOD INGREDIEN, V212; Kirchnawy C, 2013, DET IDENTIF IN PRESS; Kitamura S, 2003, ENVIRON HEALTH PERSP, V111, P329, DOI 10.1289/ehp.5723; Kralli A, 1996, J BIOL CHEM, V271, P17152, DOI 10.1074/jbc.271.29.17152; Legler J, 2002, SCI TOTAL ENVIRON, V293, P69, DOI 10.1016/S0048-9697(01)01146-9; McGovern V, 2006, ENVIRON HEALTH PERSP, V114, pA368, DOI 10.1289/ehp.114-a368b; Muncke J, 2009, SCI TOTAL ENVIRON, V407, P4549, DOI 10.1016/j.scitotenv.2009.05.006; Muncke J, 2011, J STEROID BIOCHEM, V127, P118, DOI 10.1016/j.jsbmb.2010.10.004; OECD, 2002, SER TEST ASS; Ohyama K, 2001, ENVIRON HEALTH PERSP, V109, P699, DOI 10.2307/3454786; Pinto B, 2009, INT J HYG ENVIR HEAL, V212, P228, DOI 10.1016/j.ijheh.2008.06.004; Plotan M, 2013, FOOD CHEM, V136, P1590, DOI 10.1016/j.foodchem.2012.01.115; Routledge EJ, 1996, ENVIRON TOXICOL CHEM, V15, P241, DOI 10.1002/etc.5620150303; Scrimshaw MD, 2004, ANAL BIOANAL CHEM, V378, P576, DOI 10.1007/s00216-003-2227-0; Segner H, 2009, COMP BIOCHEM PHYS C, V149, P187, DOI 10.1016/j.cbpc.2008.10.099; Sikka SC, 2008, ASIAN J ANDROL, V10, P134, DOI 10.1111/j.1745-7262.2008.00370.x; Sohoni P, 1998, J ENDOCRINOL, V158, P327, DOI 10.1677/joe.0.1580327; Sonnenschein C, 1998, J STEROID BIOCHEM, V65, P143, DOI 10.1016/S0960-0760(98)00027-2; Sonneveld E, 2006, TOXICOL SCI, V89, P173, DOI 10.1093/toxsci/kfj009; Sonneveld E, 2005, TOXICOL SCI, V83, P136, DOI 10.1093/toxsci/kfi005; SOTO AM, 1995, ENVIRON HEALTH PERSP, V103, P113, DOI 10.1289/ehp.95103s7113; Svobodova K, 2010, APPL MICROBIOL BIOT, V88, P839, DOI 10.1007/s00253-010-2833-7; Swiss Federal Office of Public Health, 2011, BULLETIN, V14, P311; Tabb MM, 2006, MOL ENDOCRINOL, V20, P475, DOI 10.1210/me.2004-0513; Tollefsen KE, 2008, ECOTOX ENVIRON SAFE, V71, P370, DOI 10.1016/j.ecoenv.2007.10.006; van der Burg B, 2010, REPROD TOXICOL, V30, P18, DOI 10.1016/j.reprotox.2010.04.012; van der Burg B, 2010, REPROD TOXICOL, V30, P73, DOI 10.1016/j.reprotox.2010.04.007; Van der Linden SC, 2008, ENVIRON SCI TECHNOL, V42, P5814, DOI 10.1021/es702897y; VANDERBURG B, 1988, J CELL PHYSIOL, V134, P101, DOI 10.1002/jcp.1041340112; Wagner M, 2011, UMWELTBUNDESAMT, V84; Wagner M, 2011, J STEROID BIOCHEM, V127, P128, DOI 10.1016/j.jsbmb.2010.10.007; Wagner M, 2009, ENVIRON SCI POLLUT R, V16, P278, DOI 10.1007/s11356-009-0107-7; Yang CZ, 2011, ENVIRON HEALTH PERSP, V119, P989, DOI 10.1289/ehp.1003220; Zacharewski T, 1998, ENVIRON HEALTH PERSP, V106, P577, DOI 10.2307/3433808	46	39	41	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e100952	10.1371/journal.pone.0100952	http://dx.doi.org/10.1371/journal.pone.0100952			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000404	Green Submitted, gold, Green Published			2022-12-27	WOS:000338637300021
J	Winter, PS; Bowman, CE; Villani, PJ; Dolan, TE; Hauck, NR				Winter, Peter S.; Bowman, Collin E.; Villani, Philip J.; Dolan, Thomas E.; Hauck, Nathanael R.			Systemic Acquired Resistance in Moss: Further Evidence for Conserved Defense Mechanisms in Plants	PLOS ONE			English	Article							PHYSCOMITRELLA-PATENS; DISEASE RESISTANCE; ARABIDOPSIS; INFECTION; RESPONSES; IMMUNITY	Vascular plants possess multiple mechanisms for defending themselves against pathogens. One well-characterized defense mechanism is systemic acquired resistance (SAR). In SAR, a plant detects the presence of a pathogen and transmits a signal throughout the plant, inducing changes in the expression of various pathogenesis-related (PR) genes. Once SAR is established, the plant is capable of mounting rapid responses to subsequent pathogen attacks. SAR has been characterized in numerous angiosperm and gymnosperm species; however, despite several pieces of evidence suggesting SAR may also exist in non-vascular plants 6-8, its presence in non-vascular plants has not been conclusively demonstrated, in part due to the lack of an appropriate culture system. Here, we describe and use a novel culture system to demonstrate that the moss species Amblystegium serpens does initiate a SAR-like reaction upon inoculation with Pythium irregulare, a common soilborne oomycete. Infection of A. serpens gametophores by P. irregulare is characterized by localized cytoplasmic shrinkage within 34 h and chlorosis and necrosis within 7 d of inoculation. Within 24 h of a primary inoculation (induction), moss gametophores grown in culture became highly resistant to infection following subsequent inoculation (challenge) by the same pathogen. This increased resistance was a response to the pathogen itself and not to physical wounding. Treatment with beta-1,3 glucan, a structural component of oomycete cell walls, was equally effective at triggering SAR. Our results demonstrate, for the first time, that this important defense mechanism exists in a non-vascular plant, and, together with previous studies, suggest that SAR arose prior to the divergence of vascular and non-vascular plants. In addition, this novel moss - pathogen culture system will be valuable for future characterization of the mechanism of SAR in moss, which is necessary for a better understanding of the evolutionary history of SAR in plants.	[Winter, Peter S.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC USA; [Bowman, Collin E.] Indiana Univ, Sch Med, Muncie, IN USA; [Villani, Philip J.; Dolan, Thomas E.; Hauck, Nathanael R.] Butler Univ, Dept Biol Sci, Indianapolis, IN 46208 USA	Duke University; Indiana University System; Butler University	Hauck, NR (corresponding author), Butler Univ, Dept Biol Sci, Indianapolis, IN 46208 USA.	nhauck@butler.edu			Butler University Holcomb Awards Committee Faculty	Butler University Holcomb Awards Committee Faculty	This work was supported by a Butler University Holcomb Awards Committee Faculty Research Grant to N. Hauck. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Robert A., 2005, Journal of General Plant Pathology, V71, P23, DOI 10.1007/s10327-004-0154-3; Bell P. R., 1992, GREEN PLANTS THEIR O; Conrath U, 2006, PLANT SIGNAL BEHAV, V1, P179, DOI 10.4161/psb.1.4.3221; Cuming AC, 2009, NEW PHYTOL, V183, P237, DOI 10.1111/j.1469-8137.2009.02931.x; de Leon IP, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-52; Eklund DM, 2010, J EXP BOT, V61, P1917, DOI 10.1093/jxb/erq080; FARMER EE, 1990, P NATL ACAD SCI USA, V87, P7713, DOI 10.1073/pnas.87.19.7713; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Heil M, 2008, TRENDS PLANT SCI, V13, P264, DOI 10.1016/j.tplants.2008.03.005; KESSMANN H, 1994, ANNU REV PHYTOPATHOL, V32, P439, DOI 10.1146/annurev.py.32.090194.002255; KOCH E, 1990, PLANT CELL, V2, P437, DOI 10.1105/tpc.2.5.437; Krokene P, 1999, PLANT PHYSIOL, V121, P565, DOI 10.1104/pp.121.2.565; Lang D, 2008, TRENDS PLANT SCI, V13, P542, DOI 10.1016/j.tplants.2008.07.002; Lehtonen MT, 2009, NEW PHYTOL, V183, P432, DOI 10.1111/j.1469-8137.2009.02864.x; Liu PP, 2011, PLANT PHYSIOL, V155, P1762, DOI 10.1104/pp.110.171694; MARTIN J. T., 1964, ANN REV PHYTO PATHOL, V2, P81, DOI 10.1146/annurev.py.02.090164.000501; Moore JW, 2011, PLANT CELL, V23, P2809, DOI 10.1105/tpc.111.087346; NICHOLSON RL, 1992, ANNU REV PHYTOPATHOL, V30, P369, DOI 10.1146/annurev.py.30.090192.002101; Osbourn AE, 1996, PLANT CELL, V8, P1821, DOI 10.1105/tpc.8.10.1821; Oliver JP, 2009, PLANTA, V230, P569, DOI 10.1007/s00425-009-0969-4; Redman RS, 1999, PLANT PHYSIOL, V119, P795, DOI 10.1104/pp.119.2.795; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; Schumaker KS, 1998, ANNU REV PLANT PHYS, V49, P501, DOI 10.1146/annurev.arplant.49.1.501; Truman W, 2007, P NATL ACAD SCI USA, V104, P1075, DOI 10.1073/pnas.0605423104; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Wang PH, 2003, LETT APPL MICROBIOL, V37, P127, DOI 10.1046/j.1472-765X.2003.01353.x; WARD ER, 1991, PLANT CELL, V3, P1085, DOI 10.1105/tpc.3.10.1085	27	12	15	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101880	10.1371/journal.pone.0101880	http://dx.doi.org/10.1371/journal.pone.0101880			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000589	Green Published, Green Submitted, gold			2022-12-27	WOS:000338637300095
J	Guo, TC; Johansson, DX; Haugland, O; Liljestrom, P; Evensen, O				Guo, Tz-Chun; Johansson, Daniel X.; Haugland, Oyvind; Liljestrom, Peter; Evensen, Oystein			A 6K-Deletion Variant of Salmonid Alphavirus Is Non-Viable but Can Be Rescued through RNA Recombination	PLOS ONE			English	Article							HEPATITIS-C VIRUS; SEMLIKI-FOREST-VIRUS; PANCREAS DISEASE VIRUS; FARMED ATLANTIC SALMON; SINDBIS VIRUS; SLEEPING-DISEASE; RAINBOW-TROUT; SALAR L.; ONCORHYNCHUS-MYKISS; MEMBRANE-PROTEINS	Pancreas disease (PD) of Atlantic salmon is an emerging disease caused by Salmonid alphavirus (SAV) which mainly affects salmonid aquaculture in Western Europe. Although genome structure of SAV has been characterized and each individual viral protein has been identified, the role of 6K protein in viral replication and infectivity remains undefined. The 6K protein of alphaviruses is a small and hydrophobic protein which is involved in membrane permeabilization, protein processing and virus budding. Because these common features are shared across many viral species, they have been named viroporins. In the present study, we applied reverse genetics to generate SAV3 6K-deleted (Delta 6K) variant and investigate the role of 6K protein. Our findings show that the 6K-deletion variant of salmonid alphavirus is non-viable. Despite viral proteins of Delta 6K variant are detected in the cytoplasm by immunostaining, they are not found on the cell surface. Further, analysis of viral proteins produced in Delta 6K cDNA clone transfected cells using radioimmunoprecipitation (RIPA) and western blot showed a protein band of larger size than E2 of wild-type SAV3. When Delta 6K cDNA was co-transfected with SAV3 helper cDNA encoding the whole structural genes including 6K, the infectivity was rescued. The development of CPE after co-transfection and resolved genome sequence of rescued virus confirmed full-length viral genome being generated through RNA recombination. The discovery of the important role of the 6K protein in virus production provides a new possibility for the development of antiviral intervention which is highly needed to control SAV infection in salmonids.	[Guo, Tz-Chun; Haugland, Oyvind; Evensen, Oystein] Norwegian Univ Life Sci, Dept Basic Sci & Aquat Med, Oslo, Norway; [Johansson, Daniel X.; Liljestrom, Peter] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden	Norwegian University of Life Sciences; Karolinska Institutet	Evensen, O (corresponding author), Norwegian Univ Life Sci, Dept Basic Sci & Aquat Med, Oslo, Norway.	oystein.evensen@nmbu.no	Evensen, Øystein/O-3011-2015	Evensen, Øystein/0000-0002-4856-3043; Liljestrom, Peter/0000-0002-2132-0981	Norwegian Research Council [182035, 183204]; Swedish Research Council	Norwegian Research Council(Research Council of NorwayEuropean Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was carried out with financial support to OE from the Norwegian Research Council, projects no. 182035 Immunisation strategies against viral pathogens of Atlantic salmon and no. 183204 Indo-Norwegian platform on fish and shellfish vaccine development, and from the Swedish Research Council to PL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoine AF, 2007, J MEMBRANE BIOL, V215, P37, DOI 10.1007/s00232-007-9003-6; ATKINS GJ, 1979, J GEN VIROL, V45, P201, DOI 10.1099/0022-1317-45-1-201; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Fringuelli E, 2008, J FISH DIS, V31, P811, DOI 10.1111/j.1365-2761.2008.00944.x; Frolova EI, 2002, J VIROL, V76, P11254, DOI 10.1128/JVI.76.22.11254-11264.2002; GIRON DJ, 1969, APPL MICROBIOL, V18, P584, DOI 10.1128/AEM.18.4.584-588.1969; Gonzalez ME, 2003, FEBS LETT, V552, P28, DOI 10.1016/S0014-5793(03)00780-4; Graham DA, 2007, DIS AQUAT ORGAN, V74, P191, DOI 10.3354/dao074191; Griffin SDC, 2003, FEBS LETT, V535, P34, DOI 10.1016/S0014-5793(02)03851-6; Griffin S, 2010, CURR OPIN INVEST DR, V11, P175; HAHN CS, 1988, P NATL ACAD SCI USA, V85, P5997, DOI 10.1073/pnas.85.16.5997; Herath T, 2009, ICELAND AGR SCI, V22, P19; Hill KR, 1997, J VIROL, V71, P2693, DOI 10.1128/JVI.71.4.2693-2704.1997; Hjortaas MJ, 2013, J FISH DIS, V36, P71, DOI 10.1111/j.1365-2761.2012.01445.x; Hodneland K, 2005, DIS AQUAT ORGAN, V66, P113, DOI 10.3354/dao066113; Hofmann K., 1993, BIOL CHEM H-S, P374; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; Jose J, 2009, FUTURE MICROBIOL, V4, P837, DOI [10.2217/fmb.09.59, 10.2217/FMB.09.59]; Karlsen M, 2014, J GEN VIROL, V95, P52, DOI 10.1099/vir.0.057455-0; Knudsen ML, 2012, J VIROL, V86, P4082, DOI 10.1128/JVI.06535-11; LAI MMC, 1992, MICROBIOL REV, V56, P61, DOI 10.1128/MMBR.56.1.61-79.1992; LILJESTROM P, 1991, J VIROL, V65, P4107; LILJESTROM P, 1991, J VIROL, V65, P147; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOEWY A, 1995, J VIROL, V69, P469, DOI 10.1128/JVI.69.1.469-475.1995; Madan V, 2005, VIROLOGY, V332, P307, DOI 10.1016/j.virol.2004.11.001; McLoughlin MF, 2007, J FISH DIS, V30, P511, DOI 10.1111/j.1365-2761.2007.00848.x; Melton JV, 2002, J BIOL CHEM, V277, P46923, DOI 10.1074/jbc.M207847200; Miller J, 2001, PERCEPT PSYCHOPHYS, V63, P1399, DOI 10.3758/BF03194551; Moriette C, 2006, J VIROL, V80, P4088, DOI 10.1128/JVI.80.8.4088-4098.2006; Moriette C, 2005, J GEN VIROL, V86, P3119, DOI 10.1099/vir.0.81030-0; Nordstrom EKL, 2005, J GEN VIROL, V86, P349, DOI 10.1099/vir.0.80481-0; Petterson E, 2013, J GEN VIROL, V94, P1945, DOI 10.1099/vir.0.052563-0; RAJU R, 1995, J VIROL, V69, P7391, DOI 10.1128/JVI.69.12.7391-7401.1995; Rheme C, 2005, EXP PHYSIOL, V90, P45, DOI 10.1113/expphysiol.2004.028142; Ronn R, 2008, CURR TOP MED CHEM, V8, P533, DOI 10.2174/156802608783955647; Roos AK, 2009, MOL THER, V17, P1637, DOI 10.1038/mt.2009.120; Sakai A, 2003, P NATL ACAD SCI USA, V100, P11646, DOI 10.1073/pnas.1834545100; SaMJS Schlesinger, 2001, FUNDAMENTAL VIROLOGY; Sanz MA, 2005, PROTEIN REV, V1, P233; Sanz MA, 2001, J VIROL, V75, P7778, DOI 10.1128/JVI.75.16.7778-7784.2001; SCHLESINGER MJ, 1993, VIROLOGY, V193, P424, DOI 10.1006/viro.1993.1139; Simon-Loriere E, 2011, NAT REV MICROBIOL, V9, P617, DOI 10.1038/nrmicro2614; Skoging U, 1996, STRUCTURE, V4, P519, DOI 10.1016/S0969-2126(96)00058-5; Steinmann E, 2007, PLOS PATHOG, V3, P962, DOI 10.1371/journal.ppat.0030103; StGelais C, 2007, ANTIVIR RES, V76, P48, DOI 10.1016/j.antiviral.2007.05.001; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Taksdal T, 2007, J FISH DIS, V30, P545, DOI 10.1111/j.1365-2761.2007.00845.x; WEISS BG, 1991, J VIROL, V65, P4017, DOI 10.1128/JVI.65.8.4017-4025.1991; Weston J, 2002, J VIROL, V76, P6155, DOI 10.1128/JVI.76.12.6155-6163.2002; Weston JH, 1999, VIROLOGY, V256, P188, DOI 10.1006/viro.1999.9654; Xu C, 2010, J VIROL, V84, P8903, DOI 10.1128/JVI.00851-10	52	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e100184	10.1371/journal.pone.0100184	http://dx.doi.org/10.1371/journal.pone.0100184			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25009976	Green Published, gold, Green Submitted			2022-12-27	WOS:000338763800003
J	Kong, XJ; Liu, JH				Kong, Xiangjin; Liu, Junhai			Influence of Alumina Binder Content on Catalytic Performance of Ni/HZSM-5 for Hydrodeoxygenation of Cyclohexanone	PLOS ONE			English	Article							PTSNNA/ZSM-5 CATALYST	The influence of the amount of alumina binders on the catalytic performance of Ni/HZSM-5 for hydrodeoxygenation of cyclohexanone was investigated in a fixed-bed reactor. N-2 sorption, X-ray diffraction, H-2-chemisorption and temperature-programmed desorption of ammonia were used to characterize the catalysts. It can be observed that the Ni/HZSM-5 catalyst bound with 30 wt.% alumina binder exhibited the best catalytic performance. The high catalytic performance may be due to relatively good Ni metal dispersion, moderate mesoporosity, and proper acidity of the catalyst.	[Kong, Xiangjin; Liu, Junhai] Liaocheng Univ, Sch Chem & Chem Engn, Shandong Prov Key Lab Chem Energy Storage & Novel, Liaocheng, Peoples R China	Liaocheng University	Kong, XJ (corresponding author), Liaocheng Univ, Sch Chem & Chem Engn, Shandong Prov Key Lab Chem Energy Storage & Novel, Liaocheng, Peoples R China.	kongxjin@163.com; jhliu@lcu.edu.cn			Doctoral Foundation of Liaocheng University [318051329]	Doctoral Foundation of Liaocheng University	This work is supported by Doctoral Foundation of Liaocheng University (Under Grant No.318051329). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ F, 1994, J MOL CATAL, V92, P67, DOI 10.1016/0304-5102(94)00052-2; Consul JMD, 2006, J MOL CATAL A-CHEM, V246, P33, DOI 10.1016/j.molcata.2005.10.011; Du XB, 2014, CATAL COMMUN, V45, P109, DOI 10.1016/j.catcom.2013.10.042; Duan YZ, 2012, MICROPOR MESOPOR MAT, V161, P33, DOI 10.1016/j.micromeso.2012.05.016; Jin F, 2009, IND ENG CHEM RES, V48, P1873, DOI 10.1021/ie8014457; Kim SD, 2006, APPL CATAL A-GEN, V309, P139, DOI 10.1016/j.apcata.2006.05.008; Kong XJ, 2014, APPL CATAL A-GEN, V476, P34, DOI 10.1016/j.apcata.2014.02.011; Kong XJ, 2013, CHEMCATCHEM, V5, P2009, DOI 10.1002/cctc.201200824; Liu H, 2008, IND ENG CHEM RES, V47, P8142, DOI 10.1021/ie800693t; Liu SA, 2011, APPL CATAL A-GEN, V400, P99, DOI 10.1016/j.apcata.2011.04.020; Sanchez P, 2007, J MOL CATAL A-CHEM, V273, P109, DOI 10.1016/j.molcata.2007.03.076; Sun XY, 2010, APPL CATAL A-GEN, V377, P134, DOI 10.1016/j.apcata.2010.01.029; Zhang YW, 2006, IND ENG CHEM RES, V45, P2213, DOI 10.1021/ie051166h	13	22	23	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101744	10.1371/journal.pone.0101744	http://dx.doi.org/10.1371/journal.pone.0101744			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25009974	gold, Green Submitted, Green Published			2022-12-27	WOS:000338763800036
J	Hoffmann, J; Symul, L; Shostak, A; Fischer, T; Naef, F; Brunner, M				Hoffmann, Julia; Symul, Laura; Shostak, Anton; Fischer, Tamas; Naef, Felix; Brunner, Michael			Non-Circadian Expression Masking Clock-Driven Weak Transcription Rhythms in U2OS Cells	PLOS ONE			English	Article							REV-ERB; GENE-EXPRESSION; PROTEIN; REVEALS; OSCILLATIONS; COMPONENT; TARGET; MOUSE; LOOP; LIMB	U2OS cells harbor a circadian clock but express only a few rhythmic genes in constant conditions. We identified 3040 binding sites of the circadian regulators BMAL1, CLOCK and CRY1 in the U2OS genome. Most binding sites even in promoters do not correlate with detectable rhythmic transcript levels. Luciferase fusions reveal that the circadian clock supports robust but low amplitude transcription rhythms of representative promoters. However, rhythmic transcription of these potentially clock-controlled genes is masked by non-circadian transcription that overwrites the weaker contribution of the clock in constant conditions. Our data suggest that U2OS cells harbor an intrinsically rather weak circadian oscillator. The oscillator has the potential to regulate a large number of genes. The contribution of circadian versus non-circadian transcription is dependent on the metabolic state of the cell and may determine the apparent complexity of the circadian transcriptome.	[Hoffmann, Julia; Shostak, Anton; Fischer, Tamas; Brunner, Michael] Heidelberg Univ, Biochem Ctr, Heidelberg, Germany; [Symul, Laura; Naef, Felix] Ecole Polytech Fed Lausanne, Inst Bioengn, Lausanne, Switzerland	Ruprecht Karls University Heidelberg; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Brunner, M (corresponding author), Heidelberg Univ, Biochem Ctr, Heidelberg, Germany.	michael.brunner@bzh.uni-heidelberg.de	Fischer, Tamas/A-7729-2016; Symul, Laura/O-9586-2017	Fischer, Tamas/0000-0002-7996-4042; Symul, Laura/0000-0001-9286-0590; Brunner, Michael/0000-0001-9798-3047; Shostak, Anton/0000-0002-9621-741X; Naef, Felix/0000-0001-9786-3037	CycliX; Swiss National Science Foundation; Ecole Polytechique Federale de Lausanne (EPFL)	CycliX; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ecole Polytechique Federale de Lausanne (EPFL)	LS and FN were funded by CycliX, a grant from the Swiss SystemsX.ch (www.systemsx.ch) initiative evaluated by the Swiss National Science Foundation, and by the Ecole Polytechique Federale de Lausanne (EPFL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Crumbley C, 2010, J BIOL CHEM, V285, P35386, DOI 10.1074/jbc.M110.129288; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kojima S, 2012, GENE DEV, V26, P2724, DOI 10.1101/gad.208306.112; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lamia KA, 2011, NATURE, V480, P552, DOI 10.1038/nature10700; Le Martelot G, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001442; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Lucas RJ, 2001, BEHAV BRAIN RES, V125, P97, DOI 10.1016/S0166-4328(01)00274-1; Maier B, 2009, GENE DEV, V23, P708, DOI 10.1101/gad.512209; Menet JS, 2012, ELIFE, V1, DOI 10.7554/eLife.00011; Morf J, 2012, SCIENCE, V338, P379, DOI 10.1126/science.1217726; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reddy AB, 2007, HEPATOLOGY, V45, P1478, DOI 10.1002/hep.21571; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Stratmann M, 2006, J BIOL RHYTHM, V21, P494, DOI 10.1177/0748730406293889; Ukai-Tadenuma M, 2011, CELL, V144, P268, DOI 10.1016/j.cell.2010.12.019; Vollmers C, 2012, CELL METAB, V16, P833, DOI 10.1016/j.cmet.2012.11.004; Vollmers C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003457; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	34	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102238	10.1371/journal.pone.0102238	http://dx.doi.org/10.1371/journal.pone.0102238			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007071	Green Submitted, Green Published, gold			2022-12-27	WOS:000339040600108
J	Huang, JC; Wei, SY; Chen, SC; Chang, JM; Hung, CC; Su, HM; Hwang, SJ; Chen, HC				Huang, Jiun-Chi; Wei, Shu-Yi; Chen, Szu-Chia; Chang, Jer-Ming; Hung, Chi-Chih; Su, Ho-Ming; Hwang, Shang-Jyh; Chen, Hung-Chun			P Wave Dispersion and Maximum P Wave Duration Are Associated with Renal Outcomes in Chronic Kidney Disease	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; ATRIAL-FIBRILLATION; FUNCTION DECLINE; MORTALITY RISK; DYSFUNCTION; PROGRESSION; CREATININE; PREDICTION; DIALYSIS; IMPACT	P wave parameters measured by 12-lead electrocardiogram (ECG) are commonly used as a noninvasive tool to evaluate left atrial enlargement. This study was designed to assess whether P wave parameters were associated with renal outcomes in chronic kidney disease (CKD) patients. This longitudinal study enrolled 439 patients with CKD stages 3-5. Renal end points were defined as the commencement of dialysis or death. Change in renal function was measured using the estimated glomerular filtration rate (eGFR) slope. We measured two ECG P wave parameters corrected for heart rate, i.e., corrected P wave dispersion and corrected maximum P wave duration. The values of P wave dispersion and maximum P wave duration were 88.8 +/- 21.7 ms and 153.3 +/- 21.7 ms, respectively. During the follow-up period (mean, 25.2 months), 95 patients (21.6%) started hemodialysis and 30 deaths (6.8%) were recorded. Multivariate Cox regression analysis identified that increased P wave dispersion [hazard ratio (HR), 1.020; 95% confidence interval (CI), 1.009-1.032; P < 0.001] and maximum P wave duration (HR, 1.013; 95% CI, 1.003-1.024; P = 0.012) were associated with progression to renal end points. Furthermore, increased P wave dispersion (unstandardized coefficient beta = -0.016; P = 0.037) and maximum P wave duration (unstandardized coefficient beta = -0.014; P = 0.040) were negatively associated with the eGFR slope. We demonstrated that increased P wave dispersion and maximum P wave duration were associated with progression to the renal end points of dialysis or death and faster renal function decline in CKD patients. Screening CKD patients on the basis of P wave dispersion and maximum P wave duration may help identify patients at high risk for worse renal outcomes.	[Huang, Jiun-Chi; Chen, Szu-Chia; Chang, Jer-Ming; Hung, Chi-Chih; Hwang, Shang-Jyh; Chen, Hung-Chun] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan; [Su, Ho-Ming] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan; [Huang, Jiun-Chi; Chen, Szu-Chia; Chang, Jer-Ming; Su, Ho-Ming] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Szu-Chia; Chang, Jer-Ming; Hung, Chi-Chih; Su, Ho-Ming] Kaohsiung Med Univ, Fac Med, Coll Med, Kaohsiung, Taiwan; [Hwang, Shang-Jyh; Chen, Hung-Chun] Kaohsiung Med Univ, Fac Renal Care, Coll Med, Kaohsiung, Taiwan; [Wei, Shu-Yi] Kaohsiung Municipal United Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Wei, Shu-Yi] Yuh Ing Jr Coll Hlth Care Management, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Su, HM (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan.	cobeshm@seed.net.tw	蘇, 河名/AAE-9843-2019; Huang, Jiun-Chi/AAI-2494-2021	Huang, Jiun-Chi/0000-0002-5897-2860; Su, Ho-Ming/0000-0003-0247-3250				ALPERT MA, 1989, ARCH INTERN MED, V149, P1161, DOI 10.1001/archinte.149.5.1161; Bazett HC, 1920, J PHYSIOL-LONDON, V53, P320, DOI 10.1113/jphysiol.1920.sp001881; Birkbeck JP, 2006, J ELECTROCARDIOL, V39, P225, DOI 10.1016/j.jelectrocard.2005.06.109; Bock JS, 2010, CIRCULATION, V121, P2592, DOI 10.1161/CIRCULATIONAHA.109.886473; BUXTON AE, 1981, CHEST, V80, P68, DOI 10.1378/chest.80.1.68; Chen SC, 2011, CLIN J AM SOC NEPHRO, V6, P2750, DOI 10.2215/CJN.04660511; Chen SC, 2012, EXP DIABETES RES, DOI 10.1155/2012/789325; Chen SC, 2011, HYPERTENS RES, V34, P1052, DOI 10.1038/hr.2011.95; Dagli N, 2008, CLIN RES CARDIOL, V97, P98, DOI 10.1007/s00392-007-0587-8; Dilaveris PE, 1998, AM HEART J, V135, P733, DOI 10.1016/S0002-8703(98)70030-4; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Furukawa M, 2011, NEPHRON CLIN PRACT, V117, pC341, DOI 10.1159/000321512; Glowinska Irena, 2008, Pol Arch Med Wewn, V118, P404; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gunduz H, 2005, TEX HEART I J, V32, P163; Kovesdy CP, 2010, J AM SOC NEPHROL, V21, P1814, DOI 10.1681/ASN.2010090954; Koz C, 2008, SOUTH MED J, V101, P246, DOI 10.1097/SMJ.0b013e3181647071; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin A, 1999, AM J KIDNEY DIS, V34, P125, DOI 10.1016/S0272-6386(99)70118-6; Levin A, 1996, AM J KIDNEY DIS, V27, P347, DOI 10.1016/S0272-6386(96)90357-1; Magnani JW, 2011, AM J CARDIOL, V107, P917, DOI 10.1016/j.amjcard.2010.10.075; Mataradzija A, 2010, BOSNIAN J BASIC MED, V10, pS44; Paoletti E, 2011, NEPHROL DIAL TRANSPL, V26, P670, DOI 10.1093/ndt/gfq409; Perkins RM, 2011, CLIN J AM SOC NEPHRO, V6, P1879, DOI 10.2215/CJN.00470111; Ritz E, 2006, AM J MED, V119, p31S, DOI 10.1016/j.amjmed.2006.01.012; Ritz E, 2006, SAUDI J KIDNEY DIS T, V17, P481; Ronco C, 2010, CONTRIB NEPHROL, V164, P33, DOI 10.1159/000313718; Shlipak MG, 2009, J AM SOC NEPHROL, V20, P2625, DOI 10.1681/ASN.2009050546; SOKOLOW M, 1949, AM HEART J, V37, P161, DOI 10.1016/0002-8703(49)90562-1; Soliman EZ, 2009, STROKE, V40, P1204, DOI 10.1161/STROKEAHA.108.534735; Su HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042815; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Truong QA, 2011, J ELECTROCARDIOL, V44, P257, DOI 10.1016/j.jelectrocard.2010.04.011; Veves A, 1998, DIABETES, V47, P457, DOI 10.2337/diabetes.47.3.457; Vickery S, 2006, NEPHROL DIAL TRANSPL, V21, P2439, DOI 10.1093/ndt/gfl249; Yilmaz R, 2004, ANN NONINVAS ELECTRO, V9, P330, DOI 10.1111/j.1542-474X.2004.94568.x; Yjrn DH, 2007, YONSEI MED J, V48, P810, DOI 10.3349/ymj.2007.48.5.810	37	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101962	10.1371/journal.pone.0101962	http://dx.doi.org/10.1371/journal.pone.0101962			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006682	gold, Green Published, Green Submitted			2022-12-27	WOS:000339040600083
J	Chagnon-Choquet, J; Fontaine, J; Poudrier, J; Roger, M				Chagnon-Choquet, Josiane; Fontaine, Julie; Poudrier, Johanne; Roger, Michel		Montreal Primary HIV Infect Grp; Slow Progressor Study Grp	IL-10 and Lymphotoxin-alpha Expression Profiles within Marginal Zone-Like B-Cell Populations Are Associated with Control of HIV-1 Disease Progression	PLOS ONE			English	Article							LYMPHOCYTE STIMULATOR BLYS; AIDS-LIKE DISEASE; DENDRITIC CELLS; TRANSGENIC MICE; CD4(+); BAFF; INFECTION; RESPONSES; EFFECTOR; INCREASE	Understanding how the immune system facilitates or controls HIV-1 disease progression has important implications for the design of effective interventions. We report that although B-cell dysregulations associated with HIV-1 disease progression are accompanied by an overall decrease in the percentage of total blood B-cells, we observe an increase in relative frequencies of cells presenting characteristics of both transitional immature and first-line marginal zone (MZ) B-cell populations, we designated as precursor MZ-like B-cells. B-cells with similar attributes have been associated with IL-10 expression and "regulatory" potential. As such, the relative frequencies of precursor MZ-like B-cells expressing IL-10 are increased in the blood of viremic HIV-1-infected individuals when compared to HIV-negative subjects. Importantly, in aviremic HIV-1 Elite-Controllers (EC), we found unaltered relative percentages of precursor MZ-like B-cells which presented normal IL-10 expression patterns. Furthermore, EC had increased relative frequencies of blood MZ-like B-cells expressing LT-alpha. Thus in contrast to viremic HIV-1-infected individuals, EC present MZ-like B-cell populations which IL-10 and LT-alpha expression profiles may favour homeostasis of immune responses and lymphoid microenvironments.	[Chagnon-Choquet, Josiane; Fontaine, Julie; Poudrier, Johanne; Roger, Michel] CRCHUM, Lab Immunogenet, Montreal, PQ, Canada; [Chagnon-Choquet, Josiane; Fontaine, Julie; Poudrier, Johanne; Roger, Michel] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	Poudrier, J (corresponding author), CRCHUM, Lab Immunogenet, Montreal, PQ, Canada.	johanne.poudrier@crchum.qc.ca; michel.roger@ssss.gouv.qc.ca			Canadian Institutes of Health Research (CIHR) [CHR-126633]; Reseau SIDA from the Fonds de Recherche du Quebec en Sante (FRQS); Fondation Gabriel Marquis; Alberta Innovates [201201140] Funding Source: researchfish	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Reseau SIDA from the Fonds de Recherche du Quebec en Sante (FRQS); Fondation Gabriel Marquis; Alberta Innovates	This work was supported by grant # CHR-126633 from the Canadian Institutes of Health Research (CIHR) and by the Reseau SIDA from the Fonds de Recherche du Quebec en Sante (FRQS). Josiane Chagnon-Choquet holds a Studentship from the Fondation Gabriel Marquis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Bar-Or A, 2010, ANN NEUROL, V67, P452, DOI 10.1002/ana.21939; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Borrow P, 2011, CURR OPIN HIV AIDS, V6, P353, DOI 10.1097/COH.0b013e3283495996; Cagigi A, 2008, BLOOD, V112, P4401, DOI 10.1182/blood-2008-02-140426; Calmon-Hamaty F, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3376; Cancro MP, 2009, J CLIN INVEST, V119, P1066, DOI 10.1172/JCI38010; Cerutti A, 2013, NAT REV IMMUNOL, V13, P118, DOI 10.1038/nri3383; Cerutti A, 2011, TRENDS IMMUNOL, V32, P202, DOI 10.1016/j.it.2011.02.004; Das A, 2012, J IMMUNOL, V189, P3925, DOI 10.4049/jimmunol.1103139; Dosenovic P, 2012, J IMMUNOL, V188, P6018, DOI 10.4049/jimmunol.1200466; Fontaine J, 2011, BLOOD, V117, P145, DOI 10.1182/blood-2010-08-301887; Fontaine J, 2009, J INFECT DIS, V199, P1007, DOI 10.1086/597278; Gray D, 2010, EUR J IMMUNOL, V40, P2677, DOI 10.1002/eji.201040961; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Hassler S, 2006, BLOOD, V108, P1941, DOI 10.1182/blood-2006-04-019679; Klatt NR, 2013, TRENDS MICROBIOL, V21, P6, DOI 10.1016/j.tim.2012.09.001; Lindh E, 2008, P NATL ACAD SCI USA, V105, P18466, DOI 10.1073/pnas.0808205105; Liu Z, 2011, TRENDS IMMUNOL, V32, P388, DOI 10.1016/j.it.2011.06.004; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Mackay F, 2010, IMMUNOL REV, V237, P205, DOI 10.1111/j.1600-065X.2010.00944.x; MacPherson G, 1999, IMMUNOL REV, V172, P325, DOI 10.1111/j.1600-065X.1999.tb01376.x; Malaspina A, 2007, BLOOD, V109, P2086, DOI 10.1182/blood-2006-06-031385; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; Mercier F, 2008, CLIN EXP IMMUNOL, V152, P72, DOI 10.1111/j.1365-2249.2008.03610.x; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Poudrier J, 2003, J VIROL, V77, P11733, DOI 10.1128/JVI.77.21.11733-11744.2003; Poudrier J, 2001, IMMUNITY, V15, P173, DOI 10.1016/S1074-7613(01)00177-7; Poudrier J., 2012, CLIN DEV IMMUNOL, V2012, DOI [10.1155/2012/592187, DOI 10.1155/2012/592187]; Poudrier J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002154; Pujanauski LM, 2013, P NATL ACAD SCI USA, V110, P1422, DOI 10.1073/pnas.1213713110; Rodriguez B, 2003, AIDS, V17, P1983, DOI 10.1097/00002030-200309050-00018; Siewe B, 2013, J LEUKOCYTE BIOL, V93, P811, DOI 10.1189/jlb.0912436; Stohl W, 2002, CLIN IMMUNOL, V104, P115, DOI 10.1006/clim.2002.5238; Tangye SG, 2006, SEMIN IMMUNOL, V18, P305, DOI 10.1016/j.smim.2006.04.004; Thien M, 2004, IMMUNITY, V20, P785, DOI 10.1016/j.immuni.2004.05.010; Varin MM, 2010, AUTOIMMUN REV, V9, P604, DOI 10.1016/j.autrev.2010.05.006; Weill JC, 2009, ANNU REV IMMUNOL, V27, P267, DOI 10.1146/annurev.immunol.021908.132607; Weller S, 2012, BLOOD, V120, P4992, DOI 10.1182/blood-2012-07-440776; Yates NL, 2013, MUCOSAL IMMUNOL, V6, P692, DOI 10.1038/mi.2012.107; Yehudai D, 2012, SCAND J IMMUNOL, V76, P371, DOI 10.1111/j.1365-3083.2012.02752.x; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	42	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101949	10.1371/journal.pone.0101949	http://dx.doi.org/10.1371/journal.pone.0101949			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003989	Green Submitted, Green Published, gold			2022-12-27	WOS:000339242700091
J	Edmondson, JL; O'Sullivan, OS; Inger, R; Potter, J; McHugh, N; Gaston, KJ; Leake, JR				Edmondson, Jill L.; O'Sullivan, Odhran S.; Inger, Richard; Potter, Jonathan; McHugh, Nicola; Gaston, Kevin J.; Leake, Jonathan R.			Urban Tree Effects on Soil Organic Carbon	PLOS ONE			English	Article							FRAXINUS-EXCELSIOR; BIOMASS; STOCKS; ECOSYSTEMS; MECHANISMS; NITROGEN; CLIMATE; MATTER; SHADE; GRASS	Urban trees sequester carbon into biomass and provide many ecosystem service benefits aboveground leading to worldwide tree planting schemes. Since soils hold similar to 75% of ecosystem organic carbon, understanding the effect of urban trees on soil organic carbon (SOC) and soil properties that underpin belowground ecosystem services is vital. We use an observational study to investigate effects of three important tree genera and mixed-species woodlands on soil properties (to 1 m depth) compared to adjacent urban grasslands. Aboveground biomass and belowground ecosystem service provision by urban trees are found not to be directly coupled. Indeed, SOC enhancement relative to urban grasslands is genus-specific being highest under Fraxinus excelsior and Acer spp., but similar to grasslands under Quercus robur and mixed woodland. Tree cover type does not influence soil bulk density or C:N ratio, properties which indicate the ability of soils to provide regulating ecosystem services such as nutrient cycling and flood mitigation. The trends observed in this study suggest that genus selection is important to maximise long-term SOC storage under urban trees, but emerging threats from genus-specific pathogens must also be considered.	[Edmondson, Jill L.; O'Sullivan, Odhran S.; Potter, Jonathan; McHugh, Nicola; Leake, Jonathan R.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Inger, Richard; Gaston, Kevin J.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England	University of Sheffield; University of Exeter	Edmondson, JL (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	j.edmondson@sheffield.ac.uk	Inger, Richard/D-3445-2009	Inger, Richard/0000-0003-1660-3706; Edmondson, Jill/0000-0002-3623-4816; Gaston, Kevin J./0000-0002-7235-7928; Leake, Jonathan/0000-0001-8364-7616	U.K. Engineering and Physical Sciences Research Council Sustainable Urban Environments Thematic grants [EP/F007604/1, EP/I002154/1]	U.K. Engineering and Physical Sciences Research Council Sustainable Urban Environments Thematic grants	This work was supported by the U.K. Engineering and Physical Sciences Research Council (http://www.epsrc.ac.uk/) Sustainable Urban Environments Thematic grants EP/F007604/1 and EP/I002154/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari H, 2002, ENVIRON POLLUT, V116, pS119, DOI 10.1016/S0269-7491(01)00264-0; Armson D, 2012, URBAN FOR URBAN GREE, V11, P245, DOI 10.1016/j.ufug.2012.05.002; Batjes NH, 2014, EUR J SOIL SCI, V65, P10, DOI 10.1111/ejss.12114_2; Berthrong ST, 2009, ECOL APPL, V19, P2228, DOI 10.1890/08-1730.1; Bradley RI, 2005, SOIL USE MANAGE, V21, P363, DOI 10.1079/SUM2005351; Carey P.D., 2008, COUNTRYSIDE SURVEY U; Davies ZG, 2011, J APPL ECOL, V48, P1125, DOI 10.1111/j.1365-2664.2011.02021.x; Day Susan D., 2010, Arboriculture & Urban Forestry, V36, P193; DEFRA, 2013, CHAL MAN PLAN; DEFRA, 2014, BIG TREE PLANT; Dungait JAJ, 2012, SCI TOTAL ENVIRON, V434, P39, DOI 10.1016/j.scitotenv.2012.04.029; Edmondson JL, 2014, SCI TOTAL ENVIRON, V472, P444, DOI 10.1016/j.scitotenv.2013.11.025; Edmondson JL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00963; Edmondson JL, 2011, BIOL LETTERS, V7, P771, DOI 10.1098/rsbl.2011.0260; Forestry Commission, BLEED CANK HORS CHES; Franzluebbers AJ, 2002, SOIL TILL RES, V66, P95, DOI 10.1016/S0167-1987(02)00018-1; Gaston KJ, 2013, J APPL ECOL, V50, P830, DOI 10.1111/1365-2664.12087; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Hamada S, 2010, URBAN FOR URBAN GREE, V9, P15, DOI 10.1016/j.ufug.2009.10.002; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Jouraeva VA, 2002, ENVIRON POLLUT, V120, P331, DOI 10.1016/S0269-7491(02)00121-5; Kerr G, 2004, FOREST ECOL MANAG, V188, P225, DOI 10.1016/j.foreco.2003.07.016; Krull ES, 2003, FUNCT PLANT BIOL, V30, P207, DOI 10.1071/FP02085; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lal R, 2008, PHILOS T R SOC B, V363, P815, DOI 10.1098/rstb.2007.2185; Leicester City Council, POP LEIC 1801 2011; Lemoine D, 2001, ANN FOR SCI, V58, P723, DOI 10.1051/forest:2001159; Maleki K., 2011, Annals of Environmental Science, V5, P13; Maskell L., 2013, DISTRIBUTION ASH TRE; McHale M. R., 2009, Urban Ecosystems, V12, P95, DOI 10.1007/s11252-009-0081-3; McPherson E. G., 1997, Urban Ecosystems, V1, P49, DOI 10.1023/A:1014350822458; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nowak David J., 2006, Urban Forestry & Urban Greening, V5, P93, DOI [10.1016/j.ufug.2006.04.002, 10.1016/j.ufug.2006.01.007]; Nowak DJ, 2012, URBAN FOR URBAN GREE, V11, P21, DOI 10.1016/j.ufug.2011.11.005; Nowak David J., 2008, Arboriculture & Urban Forestry, V34, P347; Pouyat Richard V., 2009, Urban Ecosystems, V12, P45, DOI 10.1007/s11252-008-0059-6; R Core Team, 2012, R LANG ENV STAT COMP; Rasse DP, 2005, PLANT SOIL, V269, P341, DOI 10.1007/s11104-004-0907-y; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Snorrason Arnor, 2006, Icelandic Agricultural Sciences, V19, P15; Tallis M, 2011, LANDSCAPE URBAN PLAN, V103, P129, DOI 10.1016/j.landurbplan.2011.07.003; TerMikaelian MT, 1997, FOREST ECOL MANAG, V97, P1, DOI 10.1016/S0378-1127(97)00019-4; Tiwary A, 2009, INTEGRATED TOOL ASSE; Tree Health and Plant Biosecurity Taskforce, 2013, TREE HLTH PLANT BIOS; White MP, 2013, PSYCHOL SCI, V24, P920, DOI 10.1177/0956797612464659; Zianis D., 2005, Silva Fennica Monographs, P1	46	20	25	3	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101872	10.1371/journal.pone.0101872	http://dx.doi.org/10.1371/journal.pone.0101872			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003872	gold, Green Published, Green Accepted			2022-12-27	WOS:000339242700080
J	Karimkhani, C; Boyers, LN; Margolis, DJ; Naghavi, M; Hay, RJ; Williams, HC; Naldi, L; Coffeng, LE; Weinstock, MA; Dunnick, CA; Pederson, H; Vos, T; Murray, CJL; Dellavalle, RP				Karimkhani, Chante; Boyers, Lindsay N.; Margolis, David J.; Naghavi, Mohsen; Hay, Roderick J.; Williams, Hywel C.; Naldi, Luigi; Coffeng, Luc E.; Weinstock, Martin A.; Dunnick, Cory A.; Pederson, Hannah; Vos, Theo; Murray, Christopher J. L.; Dellavalle, Robert P.			Comparing Cutaneous Research Funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases with 2010 Global Burden of Disease Results	PLOS ONE			English	Article							RESEARCH PRIORITIES; LEPROSY; HEALTH; ASSOCIATION; PSORIASIS	Importance: Disease burden data helps guide research prioritization. Objective: To determine the extent to which grants issued by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) reflect disease burden, measured by disability-adjusted life years (DALYs) from Global Burden of Disease (GBD) 2010 project. Design: Two investigators independently assessed 15 skin conditions studied by GBD 2010 in the NIAMS database for grants issued in 2013. The 15 skin diseases were matched to their respective DALYs from GBD 2010. Setting: The United States NIAMS database and GBD 2010 skin condition disability data. Main Outcome(s) and Measure(s): Relationship of NIAMS grant database topic funding with percent total GBD 2010 DALY and DALY rank for 15 skin conditions. Results: During fiscal year 2013, 1,443 NIAMS grants were issued at a total value of $424 million. Of these grants, 17.7% covered skin topics. Of the total skin disease funding, 82%(91 grants) were categorized as "general cutaneous research.'' Psoriasis, leprosy, and "other skin and subcutaneous diseases'' (ie; immunobullous disorders, vitiligo, and hidradenitis suppurativa) were over-represented when funding was compared with disability. Conversely, cellulitis, decubitus ulcer, urticaria, acne vulgaris, viral skin diseases, fungal skin diseases, scabies, and melanoma were under-represented. Conditions for which disability and funding appeared well-matched were dermatitis, squamous and basal cell carcinoma, pruritus, bacterial skin diseases, and alopecia areata. Conclusions and Relevance: Degree of representation in NIAMS is partly correlated with DALY metrics. Grant funding was well-matched with disability metrics for five of the 15 studied skin diseases, while two skin diseases were over-represented and seven were under-represented. Global burden estimates provide increasingly transparent and important information for investigating and prioritizing national research funding allocations.	[Karimkhani, Chante] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Boyers, Lindsay N.] Georgetown Univ, Sch Med, Washington, DC USA; [Margolis, David J.] Univ Penn, Dept Biostat & Epidemiol & Dermatol, Philadelphia, PA 19104 USA; [Naghavi, Mohsen; Coffeng, Luc E.; Vos, Theo; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Hay, Roderick J.] Kings Coll Hosp NHS Trust, Dept Dermatol, London, England; [Williams, Hywel C.] Univ Nottingham, Ctr Evidence Based Dermatol, Nottingham NG7 2RD, England; [Naldi, Luigi] Azienda Osped Papa Giovanni XXIII, Dept Dermatol, Bergamo, Italy; [Weinstock, Martin A.] Vet Affairs Med Ctr, Dermatoepidemiol Unit, Providence, RI USA; [Weinstock, Martin A.] Rode Isl Hosp, Dept Dermatol, Providence, RI USA; [Weinstock, Martin A.] Brown Univ, Dept Dermatol, Providence, RI 02912 USA; [Weinstock, Martin A.] Brown Univ, Dept Epidemiol, Providence, RI 02912 USA; [Dunnick, Cory A.; Dellavalle, Robert P.] Univ Colorado, Dept Dermatol, Aurora, CO 80045 USA; [Dunnick, Cory A.; Dellavalle, Robert P.] Eastern Colorado Hlth Care Syst, Dermatol Serv, US Dept Vet Affairs, Denver, CO USA; [Pederson, Hannah] Univ Colorado, Sch Med, Aurora, CO USA; [Dellavalle, Robert P.] Univ Colorado, Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA	Columbia University; Georgetown University; University of Pennsylvania; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; King's College Hospital NHS Foundation Trust; King's College Hospital; University of Nottingham; ASST Papa Giovanni XXIII; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Brown University; Brown University; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Dellavalle, RP (corresponding author), Univ Colorado, Dept Dermatol, Anschutz Med Campus, Aurora, CO 80045 USA.	robert.dellavalle@ucdenver.edu	Coffeng, Luc/AAL-6631-2021; Naldi, Luigi/K-6343-2016; Naldi, Luigi/AFM-8982-2022	Coffeng, Luc/0000-0002-4425-2264; Naldi, Luigi/0000-0002-3160-2835; Naldi, Luigi/0000-0002-3160-2835; williams, hywel/0000-0002-5646-3093	Bill and Melinda Gates Foundation; US Department of Veterans Affairs; National Institute for Health Research [NF-SI-0611-10246] Funding Source: researchfish	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); US Department of Veterans Affairs(US Department of Veterans Affairs); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported in part by the Bill and Melinda Gates Foundation (PI: Christoper Murray) and the US Department of Veterans Affairs (salary for Drs. Dellavalle, Dunnick, Weinstock). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Dermatology, BUDG CUTS CHALL RES; Armstrong AW, 2013, J AM ACAD DERMATOL, V68, P654, DOI 10.1016/j.jaad.2012.08.015; Bickers DR, 2006, J AM ACAD DERMATOL, V55, P490, DOI 10.1016/j.jaad.2006.05.048; Clavisi O, 2013, J CLIN EPIDEMIOL, V66, P496, DOI 10.1016/j.jclinepi.2012.04.002; Fleurence RL, 2004, HEALTH POLICY, V69, P1, DOI 10.1016/j.healthpol.2003.11.002; Gross CP, 1999, NEW ENGL J MED, V340, P1881, DOI 10.1056/NEJM199906173402406; Hay RJ, 2014, J INVEST DERMATOL, V134, P1527, DOI 10.1038/jid.2013.446; Horn EJ, 2007, J AM ACAD DERMATOL, V57, P963, DOI 10.1016/j.jaad.2007.07.023; Institute for Health Metrics and Evaluation, GBD COMP; Knutsen-Larson S, 2012, DERMATOL CLIN, V30, P99, DOI 10.1016/j.det.2011.09.001; Lockwood DNJ, 2005, B WORLD HEALTH ORGAN, V83, P230; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Luchtefeld William, 2013, Nurse Pract, V38, P10, DOI 10.1097/01.NPR.0000425834.98059.ae; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; National Cancer Institute, CANC RES FUND; National Institute of Arthritis and Musculoskeletal and Skin Diseases, FREQ ASK QUEST; National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIAMS LONG RANG PLAN; National Institute of Arthritis and Musculoskeletal and Skin Diseases, IMM IMM DIS SKIN PRO; National Institute of Arthritis and Musculoskeletal and Skin Diseases, BUDG REQ FY 2014; National Institute of Health, NIAMS CEL TURN 25; National Psoriasis Foundation, STATISTICS; Ranson K, 2010, SOC SCI MED, V70, P1933, DOI 10.1016/j.socscimed.2010.01.051; Reidpath DD, 2003, HEALTH POLICY PLANN, V18, P351, DOI 10.1093/heapol/czg043; Rodrigues LC, 2011, LANCET INFECT DIS, V11, P464, DOI 10.1016/S1473-3099(11)70006-8; Sellheyer K, 2005, INT J DERMATOL, V44, P535, DOI 10.1111/j.1365-4632.2004.02536.x; Sivamani Raja K, 2010, Indian J Dermatol, V55, P161, DOI 10.4103/0019-5154.62754; U.S. Department of Health and Human Services, HANS DIS DAT STAT; Varmus H, 1999, NEW ENGL J MED, V340, P1914, DOI 10.1056/NEJM199906173402411; World Health Organization, LEPROSY; World Health Organization, LEPR EL	32	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e102122	10.1371/journal.pone.0102122	http://dx.doi.org/10.1371/journal.pone.0102122			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL6KZ	25003335	Green Submitted, Green Published, gold			2022-12-27	WOS:000339242700112
J	Shi, YZ; Xiang, YT; Wu, SL; Zhang, N; Zhou, J; Bai, Y; Wang, S; Wang, YL; Zhao, XQ; Ungvari, GS; Chiu, HFK; Wang, YJ; Wang, CX				Shi, Yu-Zhi; Xiang, Yu-Tao; Wu, Shuo-Lin; Zhang, Ning; Zhou, Juan; Bai, Ying; Wang, Shuo; Wang, Yi-Long; Zhao, Xing-Quan; Ungvari, Gabor S.; Chiu, Helen F. K.; Wang, Yong-Jun; Wang, Chun-Xue			The Relationship between Frontal Lobe Lesions, Course of Post-Stroke Depression, and 1-year Prognosis in Patients with First-Ever Ischemic Stroke	PLOS ONE			English	Article							FUNCTIONAL RECOVERY; ANTIDEPRESSANT THERAPY; CELL-DEATH; FOLLOW-UP; LOCATION; SYMPTOMS; METAANALYSIS; MECHANISMS; PREVENTION; CIRCUITS	Background and Purpose: Most studies on post-stroke depression (PSD) have focused on a certain time point after stroke instead of the time course of PSD. The aim of this study was to determine the relationship between frontal lobe lesions, course of PSD over a year following the stroke onset, and the 1-year prognosis in patients with first-ever ischemic stroke. Methods: A total of 1067 patients from the prospective cohort study on the incidence and outcome of patients with post stroke depression in China who were diagnosed with first-ever ischemic stroke and attended 4 follow-up visits at 14 +/- 2 days, 3 months, 6 months, and 1 year after stroke onset, were enrolled in the study. PSD was diagnosed according to DSM-IV. The course of PSD was divided into the following two categories: persistent/recurrent depression and no/transient depression. Patients with any ischemic lesion responsible for the indexed stroke event located in the frontal lobe were defined as patients with frontal lobe lesions. Modified Rankin Scale (mRS) >= 2 at 1-year was considered to be poor prognosis. Results: There were 109 patients with and 958 patients without frontal lobe lesions that formed the frontal lobe (FL) and no-frontal lobe (NFL) groups, respectively. After adjusting for confounding variables, frontal lobe lesion was significantly associated with persistent/recurrent PSD (OR 2.025, 95% CI 1.039-3.949). Overall, 32.7% of patients in the FL group had poor prognosis at 1-year compared with 22.7% in the NFL group (P = 0.021). Compared with no/transient depression, persistent/recurrent depression was found to be an independent predictor of poor prognosis at 1-year both in FL and NFL groups. Conclusions: Long-term and periodical screening, evaluation and treatment are needed for PSD after the onset of ischemic stroke, particularly for patients with frontal lobe infarction.	[Shi, Yu-Zhi; Wu, Shuo-Lin; Zhang, Ning; Wang, Shuo; Wang, Yi-Long; Zhao, Xing-Quan; Wang, Yong-Jun; Wang, Chun-Xue] Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurol, Beijing, Peoples R China; [Shi, Yu-Zhi; Wu, Shuo-Lin; Zhang, Ning; Wang, Shuo; Wang, Yi-Long; Zhao, Xing-Quan; Wang, Yong-Jun; Wang, Chun-Xue] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China; [Shi, Yu-Zhi; Wu, Shuo-Lin; Zhang, Ning; Wang, Shuo; Wang, Yi-Long; Zhao, Xing-Quan; Wang, Yong-Jun; Wang, Chun-Xue] Beijing Inst Brain Disorders, Ctr Stroke, Beijing, Peoples R China; [Shi, Yu-Zhi; Wu, Shuo-Lin; Zhang, Ning; Wang, Shuo; Wang, Yi-Long; Zhao, Xing-Quan; Wang, Yong-Jun; Wang, Chun-Xue] Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China; [Xiang, Yu-Tao] Univ Macau, Fac Hlth Sci, Taipa, Macao, Peoples R China; [Xiang, Yu-Tao; Chiu, Helen F. K.] Chinese Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Xiang, Yu-Tao] Capital Med Univ, Beijing Anding Hosp, Mood Disorders Ctr, Beijing, Peoples R China; [Zhou, Juan] Capital Med Univ, Beijing Daxing Dist Hosp, Dept Neurol, Beijing, Peoples R China; [Bai, Ying] Xinjiang Prod & Construct Corps 13 Div Red Star H, Xinjiang, Peoples R China; [Ungvari, Gabor S.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia; [Ungvari, Gabor S.] Univ Notre Dame Australia, Marian Ctr, Perth, WA, Australia	Capital Medical University; University of Macau; Chinese University of Hong Kong; Capital Medical University; Capital Medical University; University of Western Australia; University of Notre Dame Australia	Wang, CX (corresponding author), Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurol, Beijing, Peoples R China.	snowsen@126.com		Shi, YuZhi/0000-0002-4018-6984	Beijing Science and Technology Committee [7102050]; National Science Foundation [81071115]	Beijing Science and Technology Committee; National Science Foundation(National Science Foundation (NSF))	This study was funded jointly by the Beijing Science and Technology Committee (grant no. 7102050, www.bjkw.gov.cn), and the National Science Foundation (grant no. 81071115, www.nsfc.gov.cn). This does not alter the authors' adherence to all the policies about sharing data and materials. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Association A.P., 1994, DIAGN STAT MAN MENT, V4th; Ayerbe L, 2013, J NEUROL NEUROSURG P; Ayerbe L, 2013, BRIT J PSYCHIAT, V202, P14, DOI 10.1192/bjp.bp.111.107664; Bhogal SK, 2004, STROKE, V35, P794, DOI 10.1161/01.STR.0000117237.98749.26; Bilge C, 2008, EUR J PHYS REHAB MED, V44, P13; Bour A, 2010, J NUTR HEALTH AGING, V14, P488; Carson AJ, 2000, LANCET, V356, P122, DOI 10.1016/S0140-6736(00)02448-X; de Bilbao F, 2000, EUR J NEUROSCI, V12, P921, DOI 10.1046/j.1460-9568.2000.00984.x; Dihne M, 2002, STROKE, V33, P3006, DOI 10.1161/01.STR.0000039406.64644.CB; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Eker C, 2010, WORLD J BIOL PSYCHIA, V11, P19, DOI [10.1080/15622970902737998, 10.3109/15622970902737998]; Eriksson M, 2004, STROKE, V35, P936, DOI 10.1161/01.STR.0000121643.86762.9a; Glodzik-Sobanska L, 2006, PSYCHIAT RES-NEUROIM, V148, P111, DOI 10.1016/j.pscychresns.2006.08.004; Hackett ML, 2005, STROKE, V36, P1330, DOI 10.1161/01.STR.0000165928.19135.35; Hadidi N, 2009, HEART LUNG, V38, P151, DOI 10.1016/j.hrtlng.2008.05.002; Hama S, 2007, INT J GERIATR PSYCH, V22, P1046, DOI 10.1002/gps.1866; Hama S, 2011, PSYCHOGERIATRICS, V11, P68, DOI 10.1111/j.1479-8301.2011.00358.x; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Lorenzetti V, 2009, J AFFECT DISORDERS, V117, P1, DOI 10.1016/j.jad.2008.11.021; MacHale SM, 1998, J NEUROL NEUROSUR PS, V64, P371, DOI 10.1136/jnnp.64.3.371; Meyer JH, 2012, CLIN PHARMACOL THER, V91, P201, DOI 10.1038/clpt.2011.285; Mikami K, 2011, AM J GERIAT PSYCHIAT, V19, P1007, DOI 10.1097/JGP.0b013e31821181b0; Nys GMS, 2005, J NEUROL SCI, V228, P27, DOI 10.1016/j.jns.2004.09.031; Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282; Santos M, 2009, J NEUROL SCI, V283, P158, DOI 10.1016/j.jns.2009.02.334; Saxena SK, 2007, ACTA NEUROL SCAND, V115, P339, DOI 10.1111/j.1600-0404.2006.00751.x; Schmid AA, 2011, NEUROLOGY, V76, P1000, DOI 10.1212/WNL.0b013e318210435e; Shimoda K, 1999, BIOL PSYCHIAT, V45, P187, DOI 10.1016/S0006-3223(98)00178-4; Singh A, 2000, STROKE, V31, P637, DOI 10.1161/01.STR.31.3.637; Starkstein SE, 2008, EXPERT OPIN PHARMACO, V9, P1291, DOI 10.1517/14656566.9.8.1291 ; Tang WK, 2011, J GERIATR PSYCH NEUR, V24, P44, DOI 10.1177/0891988710392375; Terroni L, 2011, WORLD J BIOL PSYCHIA, V12, P539, DOI 10.3109/15622975.2011.562242; Vataja R, 2001, ARCH GEN PSYCHIAT, V58, P925, DOI 10.1001/archpsyc.58.10.925; Vataja R, 2004, J NEUROPSYCH CLIN N, V16, P156, DOI 10.1176/appi.neuropsych.16.2.156; White CL, 2011, CEREBROVASC DIS, V32, P354, DOI 10.1159/000330350; Whyte EM, 2004, J AM GERIATR SOC, V52, P774, DOI 10.1111/j.1532-5415.2004.52217.x; Yan TT, 2010, NEUROCHEM INT, V56, P529, DOI 10.1016/j.neuint.2010.01.013; Zhang LS, 2013, EUR NEUROL, V69, P336, DOI 10.1159/000345374; Zhang N, 2012, CNS NEUROSCI THER, V18, P475, DOI 10.1111/j.1755-5949.2012.00312.x	40	13	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e100456	10.1371/journal.pone.0100456	http://dx.doi.org/10.1371/journal.pone.0100456			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003990	Green Submitted, Green Published, gold			2022-12-27	WOS:000339242700009
J	Cole, AJ; de Nys, R; Paul, NA				Cole, Andrew J.; de Nys, Rocky; Paul, Nicholas A.			Removing Constraints on the Biomass Production of Freshwater Macroalgae by Manipulating Water Exchange to Manage Nutrient Flux	PLOS ONE			English	Article							MARINE FISHPOND EFFLUENTS; ULVA-LACTUCA BIOFILTERS; INORGANIC CARBON; CRUDE PROTEIN; ASPARAGOPSIS-ARMATA; MANURE NUTRIENTS; GROWTH-RATE; DRY-MATTER; ALGAE; EUTROPHICATION	Freshwater macroalgae represent a largely overlooked group of phototrophic organisms that could play an important role within an industrial ecology context in both utilising waste nutrients and water and supplying biomass for animal feeds and renewable chemicals and fuels. This study used water from the intensive aquaculture of freshwater fish (Barramundi) to examine how the biomass production rate and protein content of the freshwater macroalga Oedogonium responds to increasing the flux of nutrients and carbon, by either increasing water exchange rates or through the addition of supplementary nitrogen and CO2. Biomass production rates were highest at low flow rates (0.1-1 vol.day(-1)) using raw pond water. The addition of CO2 to cultures increased biomass production rates by between 2 and 25% with this effect strongest at low water exchange rates. Paradoxically, the addition of nitrogen to cultures decreased productivity, especially at low water exchange rates. The optimal culture of Oedogonium occurred at flow rates of between 0.5-1 vol.day(-1), where uptake rates peaked at 1.09 g.m(-2).day(-1) for nitrogen and 0.13 g.m(-2).day(-1) for phosphorous. At these flow rates Oedogonium biomass had uptake efficiencies of 75.2% for nitrogen and 22.1% for phosphorous. In this study a nitrogen flux of 1.45 g.m(-2).day(-1) and a phosphorous flux of 0.6 g.m(-2).day(-1) was the minimum required to maintain the growth of Oedogonium at 16-17 g DW.m(-2).day(-1) and a crude protein content of 25%. A simple model of minimum inputs shows that for every gram of dry weight biomass production (g DW.m(-2).day(-1)), Oedogonium requires 0.09 g.m(-2).day(-1) of nitrogen and 0.04 g.m(-2).day(-1) of phosphorous to maintain growth without nutrient limitation whilst simultaneously maintaining a high-nutrient uptake rate and efficiency. As such the integrated culture of freshwater macroalgae with aquaculture for the purposes of nutrient recovery is a feasible solution for the bioremediation of wastewater and the supply of a protein resource.	[Cole, Andrew J.] James Cook Univ, MACRO Ctr Macroalgal Resources & Biotechnol, Townsville, Qld 4811, Australia; James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Cole, AJ (corresponding author), James Cook Univ, MACRO Ctr Macroalgal Resources & Biotechnol, Townsville, Qld 4811, Australia.	andrew.cole3@jcu.edu.au	Paul, Nicholas/B-6496-2009; Cole, Andrew/G-5220-2011; de Nys, Rocky/D-6741-2012; cole, andrew J/L-5764-2013	de Nys, Rocky/0000-0003-3869-4928; Paul, Nicholas/0000-0002-9275-1535	Australian Government through the Australian Renewable Energy Agency (ARENA); Advanced Manufacturing Cooperative Research Centre (AMCRC), through the Australian Government's Cooperative Research Centre Scheme	Australian Government through the Australian Renewable Energy Agency (ARENA)(Australian Renewable Energy Agency (ARENA)); Advanced Manufacturing Cooperative Research Centre (AMCRC), through the Australian Government's Cooperative Research Centre Scheme(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This research project is supported by the Australian Government through the Australian Renewable Energy Agency (ARENA), and the Advanced Manufacturing Cooperative Research Centre (AMCRC), funded through the Australian Government's Cooperative Research Centre Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELIOVICH A, 1976, APPL ENVIRON MICROB, V31, P801, DOI 10.1128/AEM.31.6.801-806.1976; Aiking H, 2011, TRENDS FOOD SCI TECH, V22, P112, DOI 10.1016/j.tifs.2010.04.005; Angell AR, 2014, J PHYCOL, V50, P216, DOI 10.1111/jpy.12154; Aye P. A., 2013, Agriculture and Biology Journal of North America, V4, P71, DOI 10.5251/abjna.2013.4.1.71.77; Batajoo KK, 1998, ANIM FEED SCI TECH, V71, P165, DOI 10.1016/S0377-8401(97)00132-6; Becker EW, 2007, BIOTECHNOL ADV, V25, P207, DOI 10.1016/j.biotechadv.2006.11.002; Bianchi TS, 2010, SCI TOTAL ENVIRON, V408, P1471, DOI 10.1016/j.scitotenv.2009.11.047; Biller P, 2011, BIORESOURCE TECHNOL, V102, P215, DOI 10.1016/j.biortech.2010.06.028; Boland M. J., 2012, TRENDS FOOD SCI TECH; Borowitzka MA, 1999, J BIOTECHNOL, V70, P313, DOI 10.1016/S0168-1656(99)00083-8; Bouwman L., 2011, P NATL ACAD SCI US; COHEN I, 1991, BOT MAR, V34, P475, DOI 10.1515/botm.1991.34.6.475; Cole AJ, 2014, GCB BIOENERGY, V6, P637, DOI 10.1111/gcbb.12097; Conley DJ, 2009, SCIENCE, V323, P1014, DOI 10.1126/science.1167755; Craggs RJ, 1996, ECOL ENG, V6, P149, DOI 10.1016/0925-8574(95)00056-9; Craggs R, 2012, J APPL PHYCOL, V24, P329, DOI 10.1007/s10811-012-9810-8; Craigie JS, 2011, J APPL PHYCOL, V23, P371, DOI 10.1007/s10811-010-9560-4; Demetropoulos CL, 2004, AQUACULTURE, V235, P457, DOI 10.1016/j.aquaculture.2003.09.011; Dierick N, 2010, LIVEST SCI, V133, P154, DOI 10.1016/j.livsci.2010.06.051; EMERSON K, 1975, J FISH RES BOARD CAN, V32, P2379, DOI 10.1139/f75-274; FROSCH RA, 1992, P NATL ACAD SCI USA, V89, P800, DOI 10.1073/pnas.89.3.800; Gardiner GE, 2008, ANIM FEED SCI TECH, V141, P259, DOI 10.1016/j.anifeedsci.2007.06.011; Greenwell HC, 2010, J R SOC INTERFACE, V7, P703, DOI 10.1098/rsif.2009.0322; Grieshop CM, 2001, J AGR FOOD CHEM, V49, P2669, DOI 10.1021/jf0014009; HERRERASALDANA RE, 1990, J DAIRY SCI, V73, P2386, DOI 10.3168/jds.S0022-0302(90)78922-9; HILLMAN WS, 1978, AM SCI, V66, P442; Israel A, 1999, J APPL PHYCOL, V11, P447, DOI 10.1023/A:1008122306268; Kebede-Westhead E, 2003, J PHYCOL, V39, P1275, DOI 10.1111/j.0022-3646.2003.02-159.x; Kebede-Westhead E, 2006, J APPL PHYCOL, V18, P41, DOI 10.1007/s10811-005-9012-8; Korner S, 2001, AQUAT BOT, V71, P71, DOI 10.1016/S0304-3770(01)00158-9; Lawton RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064168; Lewis E., 1998, PROGRAM DEV CO2 SYST; Liu DY, 2009, MAR POLLUT BULL, V58, P888, DOI 10.1016/j.marpolbul.2009.01.013; Liu SM, 2005, PROG OCEANOGR, V66, P66, DOI 10.1016/j.pocean.2005.03.009; Lowe E.A., 1995, J CLEAN PROD, V3, P47, DOI DOI 10.1016/0959-6526(95)00045-G; Mata L, 2007, J PHYCOL, V43, P1252, DOI 10.1111/j.1529-8817.2007.00421.x; Mata L, 2012, J PHYCOL, V48, P248, DOI 10.1111/j.1529-8817.2011.01083.x; Mata L, 2010, J APPL PHYCOL, V22, P639, DOI 10.1007/s10811-010-9504-z; Mendieta-Araica B, 2011, LIVEST SCI, V137, P10, DOI 10.1016/j.livsci.2010.09.021; Michalak I, 2008, J SCI FOOD AGR, V88, P1178, DOI 10.1002/jsfa.3195; MOSSE J, 1983, QUAL PLANT, V32, P225, DOI 10.1007/BF01091188; Mulbry W, 2008, BIORESOURCE TECHNOL, V99, P8137, DOI 10.1016/j.biortech.2008.03.073; Mulbry WW, 2001, J APPL PHYCOL, V13, P301, DOI 10.1023/A:1017545116317; Neori A, 2003, J APPL PHYCOL, V15, P543, DOI 10.1023/B:JAPH.0000004382.89142.2d; NEORI A, 1991, BOT MAR, V34, P483, DOI 10.1515/botm.1991.34.6.483; Neveux N, 2014, BIORESOURCE TECHNOL, V155, P334, DOI 10.1016/j.biortech.2013.12.083; Neveux N, 2015, GCB BIOENERGY, V7, P673, DOI 10.1111/gcbb.12171; Nielsen MM, 2012, J APPL PHYCOL, V24, P449, DOI 10.1007/s10811-011-9767-z; Nzihou A, 2010, J IND ECOL, V14, P196, DOI 10.1111/j.1530-9290.2010.00242.x; O'Doherty JV, 2010, ANIM FEED SCI TECH, V157, P173, DOI 10.1016/j.anifeedsci.2010.03.004; Papadopoulos G, 2002, J DAIRY RES, V69, P357, DOI 10.1017/S0022029902005599; Pizarro C, 2002, J APPL PHYCOL, V14, P469, DOI 10.1023/A:1022338722952; PRICE PB, 1975, J AM OIL CHEM SOC, V52, P490, DOI 10.1007/BF02640738; Rabalais NN, 2007, ECOL APPL, V17, pS129, DOI 10.1890/06-0644.1; Rabalais NN, 2009, ICES J MAR SCI, V66, P1528, DOI 10.1093/icesjms/fsp047; Ragaee S, 2006, FOOD CHEM, V98, P32, DOI 10.1016/j.foodchem.2005.04.039; Roberts DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081631; Saunders RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036470; Schuenhoff A, 2006, AQUACULTURE, V252, P3, DOI 10.1016/j.aquaculture.2005.11.044; Scott SA, 2010, CURR OPIN BIOTECH, V21, P277, DOI 10.1016/j.copbio.2010.03.005; Singh AP, 2004, J DAIRY RES, V71, P66, DOI 10.1017/S0022029903006642; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Tokusoglu O, 2003, J FOOD SCI, V68, P1144, DOI 10.1111/j.1365-2621.2003.tb09615.x; Webber C. L. III, 1993, Industrial Crops and Products, V2, P27, DOI 10.1016/0926-6690(93)90007-V; Wilkie AC, 2002, BIORESOURCE TECHNOL, V84, P81, DOI 10.1016/S0960-8524(02)00003-2; WRIGLEY TJ, 1990, WATER RES, V24, P83, DOI 10.1016/0043-1354(90)90068-H; YOUNG VR, 1994, AM J CLIN NUTR, V59, p1203S, DOI 10.1093/ajcn/59.5.1203S; Zhang EL, 2010, J LIMNOL, V69, P235, DOI 10.4081/jlimnol.2010.235	68	33	36	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101284	10.1371/journal.pone.0101284	http://dx.doi.org/10.1371/journal.pone.0101284			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000501	Green Published, gold, Green Accepted			2022-12-27	WOS:000338637300030
J	Di Franco, A; Bulleri, F; Pennetta, A; De Benedetto, G; Clarke, KR; Guidetti, P				Di Franco, Antonio; Bulleri, Fabio; Pennetta, Antonio; De Benedetto, Giuseppe; Clarke, K. Robert; Guidetti, Paolo			Within-Otolith Variability in Chemical Fingerprints: Implications for Sampling Designs and Possible Environmental Interpretation	PLOS ONE			English	Article							MEDITERRANEAN COASTAL FISH; LASER-ABLATION ICPMS; EARLY-LIFE TRAITS; REEF FISH; ELEMENTAL CHEMISTRY; SPATIAL VARIATION; LARVAL RETENTION; MARINE FISH; INNER-EAR; PATTERNS	Largely used as a natural biological tag in studies of dispersal/connectivity of fish, otolith elemental fingerprinting is usually analyzed by laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS). LA-ICP-MS produces an elemental fingerprint at a discrete time-point in the life of a fish and can generate data on within-otolith variability of that fingerprint. The presence of within-otolith variability has been previously acknowledged but not incorporated into experimental designs on the presumed, but untested, grounds of both its negligibility compared to among-otolith variability and of spatial autocorrelation among multiple ablations within an otolith. Here, using a hierarchical sampling design of spatial variation at multiple scales in otolith chemical fingerprints for two Mediterranean coastal fishes, we explore: 1) whether multiple ablations within an otolith can be used as independent replicates for significance tests among otoliths, and 2) the implications of incorporating within-otolith variability when assessing spatial variability in otolith chemistry at a hierarchy of spatial scales (different fish, from different sites, at different locations on the Apulian Adriatic coast). We find that multiple ablations along the same daily rings do not necessarily exhibit spatial dependency within the otolith and can be used to estimate residual variability in a hierarchical sampling design. Inclusion of within-otolith measurements reveals that individuals at the same site can show significant variability in elemental uptake. Within-otolith variability examined across the spatial hierarchy identifies differences between the two fish species investigated, and this finding leads to discussion of the potential for within-otolith variability to be used as a marker for fish exposure to stressful conditions. We also demonstrate that a 'cost'-optimal allocation of sampling effort should typically include some level of within-otolith replication in the experimental design. Our findings provide novel evidence to aid the design of future sampling programs and improve our general understanding of the mechanisms regulating elemental fingerprints.	[Di Franco, Antonio; Guidetti, Paolo] Univ Nice Sophia Antipolis, Fac Sci, EA ECOMERS 4228, F-06189 Nice, France; [Di Franco, Antonio; Guidetti, Paolo] Univ Salento, CoNISMa Consorzio Nazl Interuniv Sci Mare, Dipartimento Sci & Tecnol Biol & Ambientali DiSTe, Lab Conservat & Management Marine & Coastal Resou, Lecce, Italy; [Bulleri, Fabio] Univ Pisa, Dept Biol, Pisa, Italy; [Pennetta, Antonio; De Benedetto, Giuseppe] Univ Salento, Dipartimento Beni Culturali, Lab Spettrometria Massa Analit & Isotop, Lecce, Italy; [Clarke, K. Robert] Plymouth Marine Lab, Plymouth, Devon, England	UDICE-French Research Universities; Universite Cote d'Azur; University of Salento; University of Pisa; University of Salento; Plymouth Marine Laboratory	Di Franco, A (corresponding author), Univ Nice Sophia Antipolis, Fac Sci, EA ECOMERS 4228, F-06189 Nice, France.	difry@libero.it	De Benedetto, Giuseppe Egidio/G-9470-2012; Clarke, K Robert/A-5934-2012; Di Franco, Antonio/A-8796-2010	De Benedetto, Giuseppe Egidio/0000-0002-0832-5470; Pennetta, Antonio/0000-0002-6760-9393; Bulleri, Fabio/0000-0002-7335-6791; Di Franco, Antonio/0000-0003-3411-7015; Guidetti, Paolo/0000-0002-7983-8775	Total Foundation; Italian MIUR [2008E7KBAE]; NERC [pml010004] Funding Source: UKRI; Natural Environment Research Council [pml010004] Funding Source: researchfish	Total Foundation(Total SA); Italian MIUR(Ministry of Education, Universities and Research (MIUR)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by Total Foundation (http://foundation.total.com/foundation/total-foundation-200090.html) and the Italian MIUR (PRIN Project: protocol no. 2008E7KBAE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; ANDREW NL, 1987, OCEANOGR MAR BIOL, V25, P39; Artegiani A, 1997, J PHYS OCEANOGR, V27, P1515, DOI 10.1175/1520-0485(1997)027<1515:TASGCP>2.0.CO;2; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; CAMPANA SE, 1994, CAN J FISH AQUAT SCI, V51, P1942, DOI 10.1139/f94-196; Chang MY, 2013, FISH FISH, V14, P458, DOI 10.1111/j.1467-2979.2012.00482.x; CLARKE KR, 1988, MAR ECOL PROG SER, V46, P213, DOI 10.3354/meps046213; CLARKE KR, 1993, MAR ECOL PROG SER, V102, P153, DOI 10.3354/meps102153; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Di Franco A, 2013, J SEA RES, V76, P73, DOI 10.1016/j.seares.2012.11.006; Di Franco A, 2011, ITAL J ZOOL, V78, P182, DOI 10.1080/11250003.2011.566227; Di Franco A, 2013, MAR ECOL PROG SER, V476, P227, DOI 10.3354/meps10117; Di Franco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031681; Di Franco A, 2011, BIOL LETTERS, V7, P454, DOI 10.1098/rsbl.2010.1149; Elsdon TS, 2008, OCEANOGR MAR BIOL, V46, P297, DOI 10.1201/9781420065756.ch7; Fablet R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027055; Gagliano M, 2004, MAR ECOL PROG SER, V278, P291, DOI 10.3354/meps278291; Garcia-Charton JA, 2001, MAR BIOL, V138, P917, DOI 10.1007/s002270000524; Gillanders BM, 1996, MAR ECOL PROG SER, V141, P13, DOI 10.3354/meps141013; Gillanders BM, 2005, ESTUAR COAST SHELF S, V64, P47, DOI 10.1016/j.ecss.2005.02.005; Gillanders BM, 2002, MAR ECOL PROG SER, V240, P215, DOI 10.3354/meps240215; Gorley C.K., 2006, GETTING STARTED PRIM; Gray CA, 2009, FISH RES, V96, P58, DOI 10.1016/j.fishres.2008.09.011; Green BS, 2009, REV-METHODS TECHNOL, V11, P1, DOI 10.1007/978-1-4020-5775-5; Hamer PA, 2003, MAR ECOL PROG SER, V263, P261, DOI 10.3354/meps263261; Hedges KJ, 2004, J FISH BIOL, V64, P923, DOI 10.1111/j.1095-8649.2004.00353.x; Hoover RR, 2013, MAR ECOL PROG SER, V486, P247, DOI 10.3354/meps10328; Jackson JR, 2007, FISHERIES, V32, P321, DOI 10.1577/1548-8446(2007)32[321:ERTADO]2.0.CO;2; Jolivet A, 2008, ANAL BIOANAL CHEM, V392, P551, DOI 10.1007/s00216-008-2273-8; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Limburg KE, 2007, X-RAY SPECTROM, V36, P336, DOI 10.1002/xrs.980; Limburg KE, 2010, ENVIRON BIOL FISH, V89, P427, DOI 10.1007/s10641-010-9660-7; Limburg KE, 2010, CAN J FISH AQUAT SCI, V67, P597, DOI 10.1139/F10-014; MANTEL N, 1967, CANCER RES, V27, P209; Mastronuzzi G, 2003, FIELD GUID PUGL 2003, V5, P184; Mateos C, 2008, ANIM BEHAV, V75, P1629, DOI 10.1016/j.anbehav.2007.10.016; Milton DA, 1998, J FISH BIOL, V53, P785, DOI 10.1006/jfbi.1998.0745; MORRISEY DJ, 1992, MAR ECOL PROG SER, V81, P197, DOI 10.3354/meps081197; Munday PL, 2011, BIOGEOSCIENCES, V8, P1631, DOI 10.5194/bg-8-1631-2011; Papetti C, 2013, ICES J MAR SCI, V70, P387, DOI 10.1093/icesjms/fss201; Patterson HM, 1999, CORAL REEFS, V18, P171, DOI 10.1007/s003380050176; Payan P, 2004, CAN J FISH AQUAT SCI, V61, P1247, DOI 10.1139/F04-059; Payan P, 1999, AM J PHYSIOL-REG I, V277, pR123, DOI 10.1152/ajpregu.1999.277.1.R123; Ruttenberg BI, 2005, MAR ECOL PROG SER, V297, P273, DOI 10.3354/meps297273; Sturrock AM, 2012, J FISH BIOL, V81, P766, DOI 10.1111/j.1095-8649.2012.03372.x; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Terlizzi A, 2007, MAR ECOL PROG SER, V332, P25, DOI 10.3354/meps332025; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, P524; Underwood AJ, 2000, J EXP MAR BIOL ECOL, V250, P97, DOI 10.1016/S0022-0981(00)00181-7; Walther BD, 2006, MAR ECOL PROG SER, V311, P125, DOI 10.3354/meps311125; Wu D, 2011, DEV CELL, V20, P271, DOI 10.1016/j.devcel.2010.12.006; Zakharov VM, 1992, ACTA ZOOL FENN, V19, P7	54	17	17	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101701	10.1371/journal.pone.0101701	http://dx.doi.org/10.1371/journal.pone.0101701			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000202	gold, Green Submitted, Green Published			2022-12-27	WOS:000338637300076
J	Fu, XL; Xiao, W; Wang, DL; Chen, M; Tan, QP; Li, L; Chen, XD; Gao, DS				Fu, Xi Ling; Xiao, Wei; Wang, Dong Ling; Chen, Min; Tan, Qiu Ping; Li, Ling; Chen, Xiu De; Gao, Dong Sheng			Roles of Endoplasmic Reticulum Stress and Unfolded Protein Response Associated Genes in Seed Stratification and Bud Endodormancy during Chilling Accumulation in Prunus persica	PLOS ONE			English	Article							SUPPRESSION SUBTRACTIVE HYBRIDIZATION; TRANSCRIPTION-FACTOR; ARABIDOPSIS-THALIANA; BINDING-PROTEIN; DORMANCY INDUCTION; JAPANESE APRICOT; VEGETATIVE BUDS; BIP; EXPRESSION; RELEASE	Dormancy mechanisms in seeds and buds arrest growth until environmental conditions are optimal for development. A genotype-specific period of chilling is usually required to release dormancy, but the underlying molecular mechanisms are still not fully understood. To discover transcriptional pathways associated with dormancy release common to seed stratification and bud endodormancy, we explored the chilling-dependent expression of 11 genes involved in endoplasmic reticulum stress and the unfolded protein response signal pathways. We propose that endoplasmic reticulum stress and the unfolded protein response impact on seed as well as bud germination and development by chilling-dependent mechanisms. The emerging discovery of similarities between seed stratification and bud endodormancy status indicate that these two processes are probably regulated by common endoplasmic reticulum stress and unfolded protein response signalling pathways. Clarification of regulatory pathways common to both seed and bud dormancy may enhance understanding of the mechanisms underlying dormancy and breeding programs may benefit from earlier prediction of chilling requirements for uniform blooming of novel genotypes of deciduous fruit tree species.	[Fu, Xi Ling; Xiao, Wei; Wang, Dong Ling; Chen, Min; Tan, Qiu Ping; Li, Ling; Chen, Xiu De; Gao, Dong Sheng] Shandong Agr Univ, Natl Res Ctr Apple Engn & Technol, Tai An, Shandong, Peoples R China; [Fu, Xi Ling; Xiao, Wei; Wang, Dong Ling; Chen, Min; Tan, Qiu Ping; Li, Ling; Chen, Xiu De; Gao, Dong Sheng] Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Fu, Xi Ling; Xiao, Wei; Wang, Dong Ling; Chen, Min; Tan, Qiu Ping; Li, Ling; Chen, Xiu De; Gao, Dong Sheng] Shandong Agr Univ, Coll Hort Sci & Engn, Tai An, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University; Shandong Agricultural University	Gao, DS (corresponding author), Shandong Agr Univ, Natl Res Ctr Apple Engn & Technol, Tai An, Shandong, Peoples R China.	dsgao@sdau.edu.cn			National Natural Science Foundation of China [31372050]; Agriculture Science Technology Achievement Transformation Fund [2012GB2C600248]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agriculture Science Technology Achievement Transformation Fund	This work was supported by the National Natural Science Foundation of China (31372050) and the Agriculture Science Technology Achievement Transformation Fund (2012GB2C600248). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvim FC, 2001, PLANT PHYSIOL, V126, P1042, DOI 10.1104/pp.126.3.1042; Anderson JV, 2001, WEED SCI, V49, P581, DOI 10.1614/0043-1745(2001)049[0581:RCROTR]2.0.CO;2; Arora R, 2003, HORTSCIENCE, V38, P911, DOI 10.21273/HORTSCI.38.5.911; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Che P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001140; Chibani K, 2006, PLANT PHYSIOL, V142, P1493, DOI 10.1104/pp.106.087452; Cooke JEK, 2012, PLANT CELL ENVIRON, V35, P1707, DOI 10.1111/j.1365-3040.2012.02552.x; Deng Y, 2011, P NATL ACAD SCI USA, V108, P7247, DOI 10.1073/pnas.1102117108; Fujita M, 2007, BIOCHEM BIOPH RES CO, V364, P250, DOI 10.1016/j.bbrc.2007.09.124; Gao HB, 2008, P NATL ACAD SCI USA, V105, P16398, DOI 10.1073/pnas.0808463105; Heide OM, 2005, TREE PHYSIOL, V25, P109, DOI 10.1093/treephys/25.1.109; Horvath DP, 2003, TRENDS PLANT SCI, V8, P534, DOI 10.1016/j.tplants.2003.09.013; Humbert S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039023; Iwata Y, 2010, PLANT BIOTECHNOL, V27, P161, DOI 10.5511/plantbiotechnology.27.161; Iwata Y, 2008, PLANT CELL, V20, P3107, DOI 10.1105/tpc.108.061002; Jia XY, 2008, J EXP BOT, V59, P739, DOI 10.1093/jxb/erm369; Jimenez S, 2010, PLANT MOL BIOL, V73, P157, DOI 10.1007/s11103-010-9608-5; Katz E, 2007, PLANTA, V226, P989, DOI 10.1007/s00425-007-0545-8; Koiwa H, 2003, PLANT CELL, V15, P2273, DOI 10.1105/tpc.013862; Leborgne-Castel N, 1999, PLANT CELL, V11, P459, DOI 10.1105/tpc.11.3.459; Leida C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035777; Leida C, 2010, TREE PHYSIOL, V30, P655, DOI 10.1093/treephys/tpq008; Liu JX, 2007, PLANT CELL, V19, P4111, DOI 10.1105/tpc.106.050021; Liu JX, 2007, PLANT J, V51, P897, DOI 10.1111/j.1365-313X.2007.03195.x; Liu JX, 2010, PLANT CELL, V22, P2930, DOI 10.1105/tpc.110.078154; Liu JX, 2010, PLANT CELL, V22, P782, DOI 10.1105/tpc.109.072173; Liu YM, 2012, PLANT CELL, V24, P4635, DOI 10.1105/tpc.112.101535; Martinez IM, 2003, PLANT CELL, V15, P561, DOI 10.1105/tpc.007609; Mazzitelli L, 2007, J EXP BOT, V58, P1035, DOI 10.1093/jxb/erl266; MEHLENBACHER SA, 1991, J AM SOC HORTIC SCI, V116, P565, DOI 10.21273/JASHS.116.3.565; Noh SJ, 2003, GENE, V311, P81, DOI 10.1016/S0378-1119(03)00559-6; Otero JH, 2010, SEMIN CELL DEV BIOL, V21, P472, DOI 10.1016/j.semcdb.2009.12.008; Reis PAA, 2011, PLANT PHYSIOL, V157, P1853, DOI 10.1104/pp.111.179697; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ruttink T, 2007, PLANT CELL, V19, P2370, DOI 10.1105/tpc.107.052811; Sreekantan L, 2010, PLANT MOL BIOL, V73, P191, DOI 10.1007/s11103-010-9611-x; Srivastava R, 2013, PLANT CELL, V25, P1416, DOI 10.1105/tpc.113.110684; Valente MAS, 2009, J EXP BOT, V60, P533, DOI 10.1093/jxb/ern296; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Yamane H, 2008, J AM SOC HORTIC SCI, V133, P708, DOI 10.21273/JASHS.133.5.708; Zhuang WB, 2013, PLANT BIOLOGY, V15, P233, DOI 10.1111/j.1438-8677.2012.00589.x	41	11	13	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101808	10.1371/journal.pone.0101808	http://dx.doi.org/10.1371/journal.pone.0101808			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999812	Green Submitted, Green Published, gold			2022-12-27	WOS:000338637300089
J	Guo, R; Zhang, M; Xi, Y; Ma, YF; Liang, S; Shi, S; Miao, Y; Li, B				Guo, Rui; Zhang, M.; Xi, Yun; Ma, Yufei; Liang, Sheng; Shi, Shuo; Miao, Ying; Li, Biao			Theranostic Studies of Human Sodium Iodide Symporter Imaging and Therapy Using Re-188: A Human Glioma Study in Mice	PLOS ONE			English	Article							CONCENTRATOR GENE-THERAPY; MEDIATED TRANSFER; TUMOR-CELLS; TARGETED RADIOTHERAPY; RADIONUCLIDE THERAPY; BREAST-CANCER; LINE; NIS; ESTABLISHMENT; EXPRESSION	Objective: To investigate the role of Re-188 in human sodium iodide symporter (hNIS) theranostic gene-mediated human glioma imaging and therapy in model mice. Methods: The human glioma cell line U87 was transfected with recombinant lentivirus encoding the hNIS gene under the control of cytomegalovirus promoter (U87-hNIS). The uptake and efflux of Re-188 were determined after incubating the cells with 188 Re. Re-188 uptake experiments in the presence of various concentrations of sodium perchlorate were carried out. In vitro cell killing tests with Re-188 were performed. U87-hNIS mediated Re-188 distribution, imaging and therapy in nude mice were also tested. Results: U87-hNIS cell line was successfully established. The uptake of Re-188 in U87-hNIS cells increased up to 26-fold compared to control cells, but was released rapidly with a half-life of approximately 4 minutes. Sodium perchlorate reduced hNIS-mediated Re-188 uptake to levels of control cell lines. U87-hNIS cells were selectively killed following exposure to 188 Re, with a survival of 21.4%, while control cells had a survival of 92.1%. Unlike in vitro studies, U87-hNIS tumor showed a markedly increased Re-188 retention even 48 hours after Re-188 injection. In the therapy study, there was a significant difference in tumor size between U87-hNIS mice (317667 mm 3) and control mice (8616153 mm 3) treated with Re-188 for 4 weeks (P < 0.01). Conclusion: The results indicate that inserting the hNIS gene into U87 cells is sufficient to induce specific Re-188 uptake, which has a cell killing effect both in vitro and in vivo. Moreover, our study, based on the function of hNIS as a theranostic gene allowing noninvasive imaging of hNIS expression by Re-188 scintigraphy, provides detailed characterization of in vivo vector biodistribution and level, localization, essential prerequisites for precise planning and monitoring of clinical gene therapy that aims to individualize gene therapy concept.	[Guo, Rui; Zhang, M.; Xi, Yun; Shi, Shuo; Miao, Ying; Li, Biao] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Nucl Med, Shanghai 200030, Peoples R China; [Ma, Yufei; Liang, Sheng] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Nucl Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Li, B (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Nucl Med, Shanghai 200030, Peoples R China.	lb10363@rjh.com.cn			National Natural Science Foundation of China [81101071, 81271610, 81101066]; Medical Engineering (Science) Cross Foundation of Shanghai Jiaotong University [YG2013MS27]; Training Young Teachers in Colleges and Universities in Shanghai	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Engineering (Science) Cross Foundation of Shanghai Jiaotong University; Training Young Teachers in Colleges and Universities in Shanghai	This work was supported by grants from the National Natural Science Foundation of China (Nos. 81101071, 81271610, and 81101066), http://www.nsfc. gov.cn/publish/portal0/default. htm, the Medical Engineering (Science) Cross Foundation of Shanghai Jiaotong University (YG2013MS27), http://en.sjtu.edu.cn/, the Funding Scheme for Training Young Teachers in Colleges and Universities in Shanghai, http://www. studyshanghai. org/controller. asp?action = index_en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BC, 2014, J DRUG TARGET, V22, P295, DOI 10.3109/1061186X.2013.878940; Boland A, 2000, CANCER RES, V60, P3484; Boland A, 2002, THYROID, V12, P19, DOI 10.1089/105072502753451922; Carlin S, 2000, CANCER GENE THER, V7, P1529, DOI 10.1038/sj.cgt.7700264; Chen LB, 2006, NUCL MED BIOL, V33, P575, DOI 10.1016/j.nucmedbio.2006.01.011; Cho JY, 2000, GENE THER, V7, P740, DOI 10.1038/sj.gt.3301170; Dadachova E, 2002, NUCL MED BIOL, V29, P13, DOI 10.1016/S0969-8051(01)00279-7; Darrouzet E, 2014, BBA-BIOMEMBRANES, V1838, P244, DOI 10.1016/j.bbamem.2013.08.013; Dingli D, 2004, BIOCHEM BIOPH RES CO, V325, P157, DOI 10.1016/j.bbrc.2004.09.219; Dingli D, 2003, BLOOD, V102, P489, DOI 10.1182/blood-2002-11-3390; Dohan O, 2003, ENDOCR REV, V24, P48, DOI 10.1210/er.2001-0029; Gao XF, 2014, ASIAN J ANDROL, V16, P120, DOI 10.4103/1008-682X.122354; Grunwald GK, 2013, J NUCL MED, V54, P1450, DOI 10.2967/jnumed.112.115493; Guo R, 2011, NUCL MED COMMUN, V32, P402, DOI 10.1097/MNM.0b013e328344a1ad; Guo R, 2011, NUCL MED BIOL, V38, P599, DOI 10.1016/j.nucmedbio.2010.11.005; Guo R, 2010, NUCL MED COMMUN, V31, P916, DOI 10.1097/MNM.0b013e32833dedd7; Kang JH, 2004, J NUCL MED, V45, P1571; Lambert B, 2006, NUCL MED COMMUN, V27, P223, DOI 10.1097/00006231-200603000-00004; Mallick UK, 2004, NUCL MED COMMUN, V25, P873, DOI 10.1097/00006231-200409000-00003; Mandell RB, 1999, CANCER RES, V59, P661; Nakamoto Y, 2000, J NUCL MED, V41, P1898; ODONOGHUE JA, 1995, J NUCL MED, V36, P1902; Prados Michael D., 2000, Seminars in Oncology, V27, P1; Tazebay UH, 2000, NAT MED, V6, P871, DOI 10.1038/78630; WEISS SJ, 1984, ENDOCRINOLOGY, V114, P1090, DOI 10.1210/endo-114-4-1090; Yin HY, 2010, WORLD J GASTROENTERO, V16, P5367, DOI 10.3748/wjg.v16.i42.5367; Zuckier LS, 2004, J NUCL MED, V45, P500	27	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e102011	10.1371/journal.pone.0102011	http://dx.doi.org/10.1371/journal.pone.0102011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000403	Green Published, gold, Green Submitted			2022-12-27	WOS:000338637300117
J	Vage, S; Storesund, JE; Giske, J; Thingstad, TF				Vage, Selina; Storesund, Julia E.; Giske, Jarl; Thingstad, T. Frede			Optimal Defense Strategies in an Idealized Microbial Food Web under Trade-Off between Competition and Defense	PLOS ONE			English	Article							COD GADUS-MORHUA; NUTRIENT LIMITATION; RESISTANCE; MODEL; EVOLUTION; DIVERSITY; PREDATION; PATTERNS; SIZE; COMMUNITY	Trophic mechanisms that can generate biodiversity in food webs include bottom-up (growth rate regulating) and top-down (biomass regulating) factors. The top-down control has traditionally been analyzed using the concepts of "Keystone Predation'' (KP) and "Killing-the-Winner'' (KtW), predominately occuring in discussions of macro- and micro-biological ecology, respectively. Here we combine the classical diamond-shaped food web structure frequently discussed in KP analyses and the KtW concept by introducing a defense strategist capable of partial defense. A formalized description of a trade-off between the defense-strategist's competitive and defensive ability is included. The analysis reveals a complex topology of the steady state solution with strong relationships between food web structure and the combination of trade-off, defense strategy and the system's nutrient content. Among the results is a difference in defense strategies corresponding to maximum biomass, production, or net growth rate of invading individuals. The analysis thus summons awareness that biomass or production, parameters typically measured in field studies to infer success of particular biota, are not directly acted upon by natural selection. Under coexistence with a competition specialist, a balance of competitive and defensive ability of the defense strategist was found to be evolutionarily stable, whereas stronger defense was optimal under increased nutrient levels in the absence of the pure competition specialist. The findings of success of different defense strategies are discussed with respect to SAR11, a highly successful bacterial clade in the pelagic ocean.	[Vage, Selina; Storesund, Julia E.; Giske, Jarl; Thingstad, T. Frede] Univ Bergen, Dept Biol, Hjort Ctr Marine Ecosyst Dynam, Bergen, Norway	University of Bergen	Vage, S (corresponding author), Univ Bergen, Dept Biol, Hjort Ctr Marine Ecosyst Dynam, Bergen, Norway.	Selina.Vage@bio.uib.no	Thingstad, Tron Frede/B-2254-2008; Giske, Jarl/A-2402-2010; Våge, Selina/ABE-3106-2020	Thingstad, Tron Frede/0000-0002-5593-819X; Giske, Jarl/0000-0001-5034-8177; Storesund, Julia E./0000-0003-4618-2324	European Research Council [250254]	European Research Council(European Research Council (ERC)European Commission)	The work was financed by the European Research Council through grant 250254 MINOS to T. Frede Thingstad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 2002, AM NAT, V160, P692, DOI 10.1086/342822; AKSNES DL, 1993, ECOL MODEL, V67, P233, DOI 10.1016/0304-3800(93)90007-F; Aranguiz-Acuna A, 2011, J PLANKTON RES, V33, P469, DOI 10.1093/plankt/fbq134; ARMSTRONG RA, 1994, LIMNOL OCEANOGR, V39, P597, DOI 10.4319/lo.1994.39.3.0597; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barton AD, 2010, SCIENCE, V327, P1509, DOI 10.1126/science.1184961; Becker S, 2012, FEMS MICROBIOL ECOL, V80, P488, DOI 10.1111/j.1574-6941.2012.01316.x; Bohannan BJM, 2000, AM NAT, V156, P329, DOI 10.1086/303393; Boots M, 1999, AM NAT, V153, P359, DOI 10.1086/303181; Boots M, 2011, AM NAT, V178, P214, DOI 10.1086/660833; Bouvier T, 2007, ENVIRON MICROBIOL, V9, P287, DOI 10.1111/j.1462-2920.2006.01137.x; Bowers RG, 2001, J THEOR BIOL, V212, P315, DOI 10.1006/jtbi.2001.2378; Carlson CA, 2009, ISME J, V3, P283, DOI 10.1038/ismej.2008.117; Chisholm S. W., 1992, PRIMARY PRODUCTIVITY; Ducklow HW, 1999, FEMS MICROBIOL ECOL, V30, P1, DOI 10.1111/j.1574-6941.1999.tb00630.x; Eiler A, 2009, ENVIRON MICROBIOL, V11, P2291, DOI 10.1111/j.1462-2920.2009.01954.x; Erken M, 2011, FEMS MICROBIOL ECOL, V76, P504, DOI 10.1111/j.1574-6941.2011.01067.x; Ersel H, 2004, DEFENCE PEACE ECON, V15, P133, DOI 10.1080/1024269032000110513; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Fiksen O, 2011, MAR ECOL PROG SER, V432, P207, DOI 10.3354/meps09148; Fisher RA, 1930, GENETICAL THEORY NAT; Folkvord A, 2005, CAN J FISH AQUAT SCI, V62, P1037, DOI 10.1139/F05-008; Follows MJ, 2011, ANNU REV MAR SCI, V3, P427, DOI 10.1146/annurev-marine-120709-142848; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; GISKE J, 1995, J THEOR BIOL, V173, P41, DOI 10.1016/S0022-5193(05)80003-7; Grote J, 2012, MBIO, V3, DOI 10.1128/mBio.00252-12; Grover JP, 1998, J THEOR BIOL, V191, P353, DOI 10.1006/jtbi.1997.0562; GROVER JP, 1995, AM NAT, V145, P746, DOI 10.1086/285766; Hahn MW, 1999, APPL ENVIRON MICROB, V65, P4863; HOLT RD, 1994, AM NAT, V144, P741, DOI 10.1086/285705; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Irigoien X, 2004, NATURE, V429, P863, DOI 10.1038/nature02593; Joint I, 2008, ISME J, V2, P455, DOI 10.1038/ismej.2008.30; Kirchman DL, 2013, NATURE, V494, P320, DOI 10.1038/nature11951; Kraaijeveld AR, 1997, NATURE, V389, P278, DOI 10.1038/38483; KRETZSCHMAR M, 1993, THEOR POPUL BIOL, V44, P32, DOI 10.1006/tpbi.1993.1017; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Leibold MA, 1996, AM NAT, V147, P784, DOI 10.1086/285879; LEVIN SA, 1970, AM NAT, V104, P413, DOI 10.1086/282676; Loeuille N, 2004, THEOR POPUL BIOL, V65, P285, DOI 10.1016/j.tpb.2003.12.004; Malmstrom RR, 2004, APPL ENVIRON MICROB, V70, P4129, DOI 10.1128/AEM.70.7.4129-4135.2004; Matz C, 2003, MICROB ECOL, V45, P384, DOI 10.1007/s00248-003-2000-0; MCCAULEY E, 1979, LIMNOL OCEANOGR, V24, P243, DOI 10.4319/lo.1979.24.2.0243; Michod RE, 2005, BIOL PHILOS, V20, P967, DOI 10.1007/s10539-005-9018-2; Michod RE, 2006, J THEOR BIOL, V239, P257, DOI 10.1016/j.jtbi.2005.08.043; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Mou XZ, 2008, NATURE, V451, P708, DOI 10.1038/nature06513; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; PENGERUD B, 1987, MAR ECOL PROG SER, V35, P111, DOI 10.3354/meps035111; Pennisi E, 2013, SCIENCE, V342, P790, DOI 10.1126/science.342.6160.790; Poulin FJ, 2010, J PLANKTON RES, V32, P1121, DOI 10.1093/plankt/fbp145; Rappe MS, 2002, NATURE, V418, P630, DOI 10.1038/nature00917; REYNOLDS CS, 1993, HYDROBIOLOGIA, V249, P183, DOI 10.1007/BF00008853; Rivkin RB, 1997, LIMNOL OCEANOGR, V42, P730, DOI 10.4319/lo.1997.42.4.0730; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Schattenhofer M, 2009, ENVIRON MICROBIOL, V11, P2078, DOI 10.1111/j.1462-2920.2009.01929.x; SHERR BF, 1992, APPL ENVIRON MICROB, V58, P2381, DOI 10.1128/AEM.58.8.2381-2385.1992; Siemens DH, 2003, EVOL ECOL, V17, P247, DOI 10.1023/A:1025517229934; Steiner CF, 2003, OIKOS, V101, P569, DOI 10.1034/j.1600-0706.2003.12309.x; SUTHERS IM, 1993, ICES J MAR SCI, V50, P261, DOI 10.1006/jmsc.1993.1028; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Thingstad TF, 1996, ECOLOGY, V77, P2108, DOI 10.2307/2265705; THINGSTAD TF, 1985, MAR ECOL PROG SER, V21, P47, DOI 10.3354/meps021047; Thingstad TF, 2005, ECOL LETT, V8, P675, DOI 10.1111/j.1461-0248.2005.00768.x; Thingstad TF, 1997, AQUAT MICROB ECOL, V13, P19, DOI 10.3354/ame013019; Thingstad TF, 2000, LIMNOL OCEANOGR, V45, P1320, DOI 10.4319/lo.2000.45.6.1320; Tripp HJ, 2009, ENVIRON MICROBIOL, V11, P230, DOI 10.1111/j.1462-2920.2008.01758.x; Vage S, 2013, NATURE, V499, pE3, DOI 10.1038/nature12387; Vage S, 2013, ENVIRON MICROBIOL, V15, P1842, DOI 10.1111/1462-2920.12077; Van Donk E, 2011, HYDROBIOLOGIA, V668, P3, DOI 10.1007/s10750-010-0395-4; VANCE RR, 1978, AM NAT, V112, P797, DOI 10.1086/283324; Visser AW, 2009, J PLANKTON RES, V31, P121, DOI 10.1093/plankt/fbn109; Ward BA, 2012, LIMNOL OCEANOGR, V57, P1877, DOI 10.4319/lo.2012.57.6.1877; Ward BA, 2014, J PLANKTON RES, V36, P31, DOI 10.1093/plankt/fbt097; Weitz JS, 2005, P NATL ACAD SCI USA, V102, P9535, DOI 10.1073/pnas.0504062102; Winter C, 2010, MICROBIOL MOL BIOL R, V74, P42, DOI 10.1128/MMBR.00034-09; Wiser MJ, 2013, SCIENCE, V342, P1364, DOI 10.1126/science.1243357; Zhao YL, 2013, NATURE, V494, P357, DOI 10.1038/nature11921; Zhou YX, 2012, FEMS MICROBIOL ECOL, V81, P230, DOI 10.1111/j.1574-6941.2012.01371.x; Zohary T, 1998, LIMNOL OCEANOGR, V43, P387, DOI 10.4319/lo.1998.43.3.0387	80	24	24	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101415	10.1371/journal.pone.0101415	http://dx.doi.org/10.1371/journal.pone.0101415			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999739	Green Published, Green Submitted, gold			2022-12-27	WOS:000338637300041
J	Zhang, Q; Zhuo, CJ; Lang, X; Li, HB; Qin, W; Yu, CS				Zhang, Quan; Zhuo, Chuanjun; Lang, Xu; Li, Huabing; Qin, Wen; Yu, Chunshui			Structural Impairments of Hippocampus in Coal Mine Gas Explosion-Related Posttraumatic Stress Disorder	PLOS ONE			English	Article							AMYGDALA VOLUME; MATTER VOLUME; PREDICTS; SURVIVORS; MEMORY; ADULTS; VETERANS; DURATION; WOMEN; MRI	Investigations on hippocampal and amygdalar volume have revealed inconsistent results in patients with posttraumatic stress disorder (PTSD). Little is known about the structural covariance alterations between the hippocampus and amygdala in PTSD. In this study, we evaluated the alteration in the hippocampal and amygdalar volume and their structural covariance in the coal mine gas explosion related PTSD. High resolution T1-weighted magnetic resonance imaging (MRI) was performed on coal mine gas explosion related PTSD male patients (n = 14) and non-traumatized coalminers without PTSD (n = 25). The voxel-based morphometry (VBM) method was used to test the inter-group differences in hippocampal and amygdalar volume as well as the inter-group differences in structural covariance between the ipsilateral hippocampus and amygdala. PTSD patients exhibited decreased gray matter volume (GMV) in the bilateral hippocampi compared to controls (p<0.05, FDR corrected). GMV covariances between the ipsilateral hippocampus and amygdala were significantly reduced in PTSD patients compared with controls (p<0.05, FDR corrected). The coalminers with gas explosion related PTSD had decreased hippocampal volume and structural covariance with the ipsilateral amygdala, suggesting that the structural impairment of the hippocampus may implicate in the pathophysiology of PTSD.	[Zhang, Quan; Lang, Xu; Qin, Wen; Yu, Chunshui] Tianjin Med Univ, Gen Hosp, Dept Radiol, Tianjin, Peoples R China; [Zhang, Quan; Lang, Xu; Qin, Wen; Yu, Chunshui] Tianjin Med Univ, Gen Hosp, Tianjin Key Lab Funct Imaging, Tianjin, Peoples R China; [Zhuo, Chuanjun] Anning Hosp Tianjin City, Dept Psychiat, Tianjin, Peoples R China; [Li, Huabing] Jinmei Grp Gen Hosp, Dept Radiol, Jincheng, Shanxi, Peoples R China	Tianjin Medical University; Tianjin Medical University	Yu, CS (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Radiol, Tianjin, Peoples R China.	chunshuiyu@tijmu.edu.cn	QIN, WEN/F-3783-2015	QIN, WEN/0000-0002-9121-8296; Yu, Chunshui/0000-0001-5648-5199	National Basic Research Program of China (973 program) [2010CB732506]; International Cooperation and Exchanges NSFC [81061120533]; National Key Clinical Program on Radiology	National Basic Research Program of China (973 program)(National Basic Research Program of China); International Cooperation and Exchanges NSFC; National Key Clinical Program on Radiology	This work was supported by the National Basic Research Program of China (973 program, No. 2010CB732506), the International Cooperation and Exchanges NSFC (No. 81061120533), and the National Key Clinical Program on Radiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander-Bloch A, 2013, NAT REV NEUROSCI, V14, P322, DOI 10.1038/nrn3465; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Bohbot VD, 2007, J NEUROSCI, V27, P10078, DOI 10.1523/JNEUROSCI.1763-07.2007; Bonne O, 2001, AM J PSYCHIAT, V158, P1248, DOI 10.1176/appi.ajp.158.8.1248; Bonne O, 2008, J CLIN PSYCHIAT, V69, P1087, DOI 10.4088/JCP.v69n0707; Bremner JD, 2003, AM J PSYCHIAT, V160, P924, DOI 10.1176/appi.ajp.160.5.924; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Carrion VG, 2007, PEDIATRICS, V119, P509, DOI 10.1542/peds.2006-2028; Chen SL, 2006, PSYCHIAT RES-NEUROIM, V146, P65, DOI 10.1016/j.pscychresns.2005.09.006; Dolcos F, 2004, NEURON, V42, P855, DOI 10.1016/S0896-6273(04)00289-2; Emdad R, 2006, PSYCHOTHER PSYCHOSOM, V75, P122, DOI 10.1159/000090897; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Felmingham K, 2009, NEUROREPORT, V20, P1402, DOI 10.1097/WNR.0b013e3283300fbc; Fennema-Notestine C, 2002, BIOL PSYCHIAT, V52, P1089, DOI 10.1016/S0006-3223(02)01413-0; Ghosh S, 2013, J NEUROSCI, V33, P7234, DOI 10.1523/JNEUROSCI.0638-13.2013; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Golier JA, 2005, PSYCHIAT RES-NEUROIM, V139, P53, DOI 10.1016/j.pscychresns.2005.02.007; Golub Y, 2011, J PSYCHIATR RES, V45, P650, DOI 10.1016/j.jpsychires.2010.10.014; Hughes KC, 2011, EXPERT REV NEUROTHER, V11, P275, DOI 10.1586/ERN.10.198; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Kim JJ, 2001, J NEUROSCI, V21, P5222, DOI 10.1523/JNEUROSCI.21-14-05222.2001; Kishi T, 2006, J COMP NEUROL, V496, P349, DOI 10.1002/cne.20919; Kitayama N, 2005, J AFFECT DISORDERS, V88, P79, DOI 10.1016/j.jad.2005.05.014; Kuhn S, 2013, BIOL PSYCHIAT, V73, P70, DOI 10.1016/j.biopsych.2012.06.029; Kuo JR, 2012, ARCH GEN PSYCHIAT, V69, P1080, DOI 10.1001/archgenpsychiatry.2012.73; Liberzon I, 2007, PROG BRAIN RES, V167, P151, DOI 10.1016/S0079-6123(07)67011-3; Lindauer RJL, 2004, BIOL PSYCHIAT, V56, P356, DOI 10.1016/j.biopsych.2004.05.021; Liu W, 2011, PSYCHIAT RES-NEUROIM, V194, P385, DOI 10.1016/j.pscychresns.2011.02.007; LUINE V, 1994, BRAIN RES, V639, P167, DOI 10.1016/0006-8993(94)91778-7; Mechelli A, 2005, J NEUROSCI, V25, P8303, DOI 10.1523/JNEUROSCI.0357-05.2005; Mitra R, 2005, P NATL ACAD SCI USA, V102, P9371, DOI 10.1073/pnas.0504011102; Morey RA, 2012, ARCH GEN PSYCHIAT, V69, P1169, DOI 10.1001/archgenpsychiatry.2012.50; Nemeroff CB, 2006, J PSYCHIATR RES, V40, P1, DOI 10.1016/j.jpsychires.2005.07.005; Pavic L, 2007, PSYCHIAT RES-NEUROIM, V154, P191, DOI 10.1016/j.pscychresns.2006.08.005; Pederson CL, 2004, J TRAUMA STRESS, V17, P37, DOI 10.1023/B:JOTS.0000014674.84517.46; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Rogers MA, 2009, PSYCHIAT RES-NEUROIM, V174, P210, DOI 10.1016/j.pscychresns.2009.06.001; Sheline YI, 1999, J NEUROSCI, V19, P5034; Shin LM, 2004, HIPPOCAMPUS, V14, P292, DOI 10.1002/hipo.10183; Shu XJ, 2013, PSYCHIAT RES-NEUROIM, V212, P237, DOI 10.1016/j.pscychresns.2012.04.009; Smith APR, 2006, NEURON, V49, P631, DOI 10.1016/j.neuron.2005.12.025; Smith ME, 2005, HIPPOCAMPUS, V15, P798, DOI 10.1002/hipo.20102; Thomaes K, 2010, J CLIN PSYCHIAT, V71, P1636, DOI 10.4088/JCP.08m04754blu; UNO H, 1994, HORM BEHAV, V28, P336, DOI 10.1006/hbeh.1994.1030; Vaisvaser S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00313; Villarreal G, 2002, BIOL PSYCHIAT, V52, P119, DOI 10.1016/S0006-3223(02)01359-8; Vyas A, 2004, NEUROSCIENCE, V128, P667, DOI 10.1016/j.neuroscience.2004.07.013; Vythilingam M, 2005, PSYCHIAT RES-NEUROIM, V139, P89, DOI 10.1016/j.pscychresns.2005.04.003; Wang HH, 2010, J PSYCHIATR RES, V44, P385, DOI 10.1016/j.jpsychires.2009.10.001; Wang Z, 2010, ARCH GEN PSYCHIAT, V67, P296, DOI 10.1001/archgenpsychiatry.2009.205; Wignall EL, 2004, BIOL PSYCHIAT, V56, P832, DOI 10.1016/j.biopsych.2004.09.015; Woon FL, 2008, HIPPOCAMPUS, V18, P729, DOI 10.1002/hipo.20437; Woon FL, 2009, J NEUROPSYCH CLIN N, V21, P5, DOI 10.1176/appi.neuropsych.21.1.5; Woon FL, 2010, PROG NEURO-PSYCHOPH, V34, P1181, DOI 10.1016/j.pnpbp.2010.06.016; Yehuda R, 2007, J PSYCHIATR RES, V41, P435, DOI 10.1016/j.jpsychires.2005.12.002; Zhang J, 2011, PSYCHIAT RES-NEUROIM, V192, P84, DOI 10.1016/j.pscychresns.2010.09.001	57	6	6	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e102042	10.1371/journal.pone.0102042	http://dx.doi.org/10.1371/journal.pone.0102042			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000505	Green Published, gold			2022-12-27	WOS:000338637300118
J	Jiang, JH; Miyata, M; Chan, C; Ngoh, SY; Liew, WC; Saju, JM; Ng, KS; Wong, FS; Lee, YS; Chang, SF; Orban, L				Jiang, Junhui; Miyata, Masato; Chan, Candy; Ngoh, Si Yan; Liew, Woei Chang; Saju, Jolly M.; Ng, Kah Sing; Wong, Fong Sian; Lee, Yeng Sheng; Chang, Siow Foong; Orban, Laszlo			Differential Transcriptomic Response in the Spleen and Head Kidney Following Vaccination and Infection of Asian Seabass with Streptococcus iniae	PLOS ONE			English	Article							NF-KAPPA-B; TROUT ONCORHYNCHUS-MYKISS; BARRAMUNDI LATES-CALCARIFER; HATCHERY-PRODUCED LARVAE; IMMUNE-RELATED GENES; RAINBOW-TROUT; YERSINIA-RUCKERI; EXPRESSION; INNATE; PATHWAY	Vaccination is an important strategy in the protection of aquaculture species from major diseases. However, we still do not have a good understanding of the mechanisms underlying vaccine-induced disease resistance. This is further complicated by the presence of several lymphoid organs that play different roles when mounting an immune response. In this study, we attempt to elucidate some of these mechanisms using a microarray-based approach. Asian seabass (Lates calcarifer) were vaccinated against Streptococcus iniae and the transcriptomic changes within the spleen and head kidney at one and seven days post-vaccination were profiled. We subsequently challenged the seabass at three weeks post-vaccination with live S. iniae and similarly profiled the transcriptomes of the two organs after the challenge. We found that vaccination induced an early, but transient transcriptomic change in the spleens and a delayed response in the head kidneys, which became more similar to one another compared to un-vaccinated ones. When challenged with the pathogen, the spleen, but not the head kidneys, responded transcriptomically at 25-29 hours post-challenge. A unique set of genes, in particular those involved in the activation of NF-kappa B signaling, was up-regulated in the vaccinated spleens upon pathogen challenge but not in the unvaccinated spleens. A semi-quantitative PCR detection of S. iniae using metagenomic DNA extracted from the water containing the seabass also revealed that vaccination resulted in reduction of pathogen shedding. This result indicated that vaccination not only led to a successful immune defense against the infection, but also reduced the chances for horizontal transmission of the pathogen. In conclusion, we have provided a transcriptomic analysis of how the teleost spleen and head kidneys responded to vaccination and subsequent infection. The different responses from the two organs are suggestive of their unique roles in establishing a vaccine-induced disease resistance.	[Jiang, Junhui; Chan, Candy; Ngoh, Si Yan; Liew, Woei Chang; Saju, Jolly M.; Orban, Laszlo] Natl Univ Singapore, Temasek Life Sci Lab, Reprod Genom Grp, Strateg Res Program, Singapore 117548, Singapore; [Jiang, Junhui] Agrifood & Vet Author Singapore, Singapore, Singapore; [Jiang, Junhui] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Miyata, Masato; Ng, Kah Sing; Wong, Fong Sian; Lee, Yeng Sheng; Chang, Siow Foong] MSD Anim Hlth Innovat, Singapore, Singapore; [Ngoh, Si Yan; Liew, Woei Chang] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Orban, Laszlo] Univ Pannonia, Georgikon Fac, Dept Anim Sci & Anim Husb, Keszthely, Hungary; [Orban, Laszlo] Murdoch Univ, Ctr Comparat Genom, Murdoch, WA 6150, Australia	National University of Singapore; National University of Singapore; Merck & Company; Intervet International B.V.; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Pannonia; Murdoch University	Chang, SF (corresponding author), MSD Anim Hlth Innovat, Singapore, Singapore.	siow.foong.chang@merck.com; laszlo@tll.org.sg	Orbán, László/A-3030-2009	Orbán, László/0000-0001-5435-5948; Jiang, Junhui/0000-0003-1319-8813; Liew, Woei Chang/0000-0001-9354-1647	National Research Foundation of Singapore [NRF-CRP7-2010-01]; Strategic Research Program of Temasek Life Sciences Laboratory	National Research Foundation of Singapore(National Research Foundation, Singapore); Strategic Research Program of Temasek Life Sciences Laboratory(National University of Singapore)	This study was supported by the National Research Foundation of Singapore under its Competitive Research Programme (award No: NRF-CRP7-2010-01) and the Strategic Research Program of Temasek Life Sciences Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azad I.S., 2009, Asian Fisheries Science, V22, P901; Azad IS, 2005, DIS AQUAT ORGAN, V63, P113, DOI 10.3354/dao063113; Berridge BR, 1998, J CLIN MICROBIOL, V36, P2778, DOI 10.1128/JCM.36.9.2778-2781.1998; Bhuju S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003077; Bridle AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040841; Bromage ES, 1999, DIS AQUAT ORGAN, V36, P177, DOI 10.3354/dao036177; Bromage ES, 2002, DIS AQUAT ORGAN, V52, P199, DOI 10.3354/dao052199; Campbell JJ, 2001, J IMMUNOL, V166, P877, DOI 10.4049/jimmunol.166.2.877; Colorni A, 2002, DIS AQUAT ORGAN, V49, P165, DOI 10.3354/dao049165; Cortes EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011319; Creeper JH, 2006, AUST VET J, V84, P408, DOI 10.1111/j.1751-0813.2006.00058.x; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Fuller CL, 2007, MOL IMMUNOL, V44, P3173, DOI 10.1016/j.molimm.2007.01.037; Furman D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.15; Gibson-Kueh S, 2004, J FISH DIS, V27, P731, DOI 10.1111/j.1365-2761.2004.00594.x; Gibson-Kueh S, 2012, J FISH DIS, V35, P19, DOI 10.1111/j.1365-2761.2011.01319.x; Gibson-Kueh S, 2011, VET PARASITOL, V181, P106, DOI 10.1016/j.vetpar.2011.04.040; Harun NO, 2011, VACCINE, V29, P4388, DOI 10.1016/j.vaccine.2011.04.003; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hich Tran Vi, 2013, International Journal of Aquatic Science, V4, P3; Ishii M, 2008, EUR J IMMUNOL, V38, P2290, DOI 10.1002/eji.200838360; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kennedy RB, 2013, GENES IMMUN, V14, P277, DOI 10.1038/gene.2013.14; Krasnov A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-130; Kurobe T, 2005, DEV COMP IMMUNOL, V29, P515, DOI 10.1016/j.dci.2004.10.005; Livolsi A, 2001, EUR J BIOCHEM, V268, P1508, DOI 10.1046/j.1432-1327.2001.02028.x; Ma CY, 2013, EUR J IMMUNOL, V43, P360, DOI 10.1002/eji.201242570; Madetoja J, 2000, DIS AQUAT ORGAN, V43, P27, DOI 10.3354/dao043027; McKibben CL, 1999, DIS AQUAT ORGAN, V38, P75, DOI 10.3354/dao038075; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Morra M, 2005, P NATL ACAD SCI USA, V102, P4819, DOI 10.1073/pnas.0408681102; Munoz N, 2010, INFECT IMMUN, V78, P4226, DOI 10.1128/IAI.00224-10; Ness TL, 2006, J IMMUNOL, V177, P7531, DOI 10.4049/jimmunol.177.11.7531; Osuna-Jimenez I, 2009, FISH SHELLFISH IMMUN, V26, P699, DOI 10.1016/j.fsi.2009.02.020; Perez-Sanchez T, 2011, FISH SHELLFISH IMMUN, V31, P196, DOI 10.1016/j.fsi.2011.05.005; Prado GN, 2007, BIOCHEMISTRY-US, V46, P8961, DOI 10.1021/bi7004043; Purcell MK, 2006, MOL IMMUNOL, V43, P2089, DOI 10.1016/j.molimm.2005.12.005; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Raida MK, 2008, VACCINE, V26, P1050, DOI 10.1016/j.vaccine.2007.12.029; Raida MK, 2008, FISH SHELLFISH IMMUN, V25, P533, DOI 10.1016/j.fsi.2008.07.008; Raida MK, 2009, DEV COMP IMMUNOL, V33, P35, DOI 10.1016/j.dci.2008.07.001; Ransangan J, 2010, VET MICROBIOL, V145, P153, DOI 10.1016/j.vetmic.2010.03.016; Regnstrom K, 2003, VACCINE, V21, P2307, DOI 10.1016/S0264-410X(03)00103-8; Sandford E, 2011, BMC GENOMICS, V12, P1; Shoemaker CA, 2012, AQUACULTURE, V354, P45, DOI 10.1016/j.aquaculture.2012.04.033; Siebenlist U, 2005, NAT REV IMMUNOL, V5, P435, DOI 10.1038/nri1629; Suanyuk N., 2010, Songklanakarin Journal of Science and Technology, V32, P341; Sumegi J, 2002, LEUKEMIA LYMPHOMA, V43, P1189, DOI 10.1080/10428190290026240; Sun Y, 2012, LETT APPL MICROBIOL, V55, P420, DOI 10.1111/j.1472-765X.2012.03307.x; Sun Y, 2012, FISH SHELLFISH IMMUN, V33, P1303, DOI 10.1016/j.fsi.2012.10.004; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tergaonkar V, 2006, INT J BIOCHEM CELL B, V38, P1647, DOI 10.1016/j.biocel.2006.03.023; Tipping PG, 2006, J AM SOC NEPHROL, V17, P1769, DOI 10.1681/ASN.2006050489; Toze S, 1999, WATER RES, V33, P3545, DOI 10.1016/S0043-1354(99)00071-8; Traeger T, 2008, INFECT IMMUN, V76, P5285, DOI 10.1128/IAI.00310-08; Vitiello M, 2012, MOL BIOSYST, V8, P1108, DOI 10.1039/c2mb05335g; Yang DH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-319; Yoon SI, 2012, SCIENCE, V335, P859, DOI 10.1126/science.1215584	65	26	26	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e99128	10.1371/journal.pone.0099128	http://dx.doi.org/10.1371/journal.pone.0099128			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992587	Green Published, gold			2022-12-27	WOS:000341253400007
J	Sampathkumar, R; Peters, HO; Mendoza, L; Bielawny, T; Ngugi, E; Kimani, J; Wachihi, C; Plummer, FA; Luo, M				Sampathkumar, Raghavan; Peters, Harold O.; Mendoza, Lillian; Bielawny, Thomas; Ngugi, Elizabeth; Kimani, Joshua; Wachihi, Charles; Plummer, Francis A.; Luo, Ma			Influence of HLA Class I Haplotypes on HIV-1 Seroconversion and Disease Progression in Pumwani Sex Worker Cohort	PLOS ONE			English	Article							IMMUNE CONTROL; EXON-2 DNA; INFECTION; ASSOCIATIONS; RESISTANCE; PROSTITUTES; PROTECTION; ALLELES; SUSCEPTIBILITY; GENOTYPE	We examined the effect of HLA class I haplotypes on HIV-1 seroconversion and disease progression in the Pumwani sex worker cohort. This study included 595 HIV-1 positive patients and 176 HIV negative individuals. HLA-A, -B, and -C were typed to 4-digit resolution using sequence-based typing method. HLA class I haplotype frequencies were estimated using PyPop 32-0.6.0. The influence of haplotypes on time to seroconversion and CD4+ T cell decline to <200 cells/mm(3) were analyzed by Kaplan-Meier analysis using SPSS 13.0. Before corrections for multiple comparisons, three 2-loci haplotypes were significantly associated with faster seroconversion, including A*23:01-C*02:02 (p = 0.014, log rank(LR) = 6.06, false-discovery rate (FDR) = 0.056), B*42:01-C*17:01 (p = 0.01, LR = 6.60, FDR = 0.08) and B*07:02-C*07:02 (p = 0.013, LR = 6.14, FDR = 0.069). Two A*74:01 containing haplotypes, A*74:01-B*15:03 (p = 0.047, LR = 3.942, FDR = 0.068) and A*74:01-B*15:03C* 02:02 (p = 0.045, LR = 4.01, FDR = 0.072) and B*14:02-C*08:02 (p = 0.021, LR = 5.36, FDR = 0.056) were associated with slower disease progression. Five haplotypes, including A*30:02-B*45:01 (p = 0.0008, LR = 11.183, FDR = 0.013), A*30:02-C* 16:01 (p = 0.015, LR = 5.97, FDR = 0.048), B*53:01-C*04:01 (p = 0.010, LR = 6.61, FDR = 0.08), B*15:10-C*03:04 (p = 0.031, LR = 4.65, FDR = 0.062), and B*58:01-C*03:02 (p = 0.037, LR = 4.35, FDR = 0.066) were associated with faster progression to AIDS. After FDR corrections, only the associations of A*30:02-B*45:01 and A*30:02-C*16:01 with faster disease progression remained significant. Cox regression and deconstructed Kaplan-Meier survival analysis showed that the associations of haplotypes of A*23:01-C*02:02, B*07:02-C*07:02, A*74:01-B*15:03, A*74:01-B*15:03-C*02:02, B*14:02-C*08:02 and B*58:01-C*03:02 with differential seroconversion or disease progression are due to the dominant effect of a single allele within the haplotypes. The true haplotype effect was observed with A*30:02-B*45:01, A*30:02-C*16:02, B*53:01-C*04:01 B*15:10-C*03:04, and B*42:01-C*17:01. In these cases, the presence of both alleles accelerated the disease progression or seroconversion than any of the single allele within the haplotypes. Our study showed that the true effects of HLA class I haplotypes on HIV seroconversion and disease progression exist and the associations of HLA class I haplotype can also be due to the dominant effect of a single allele within the haplotype.	[Sampathkumar, Raghavan; Kimani, Joshua; Plummer, Francis A.; Luo, Ma] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Ngugi, Elizabeth; Kimani, Joshua; Wachihi, Charles] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Sampathkumar, Raghavan; Peters, Harold O.; Mendoza, Lillian; Bielawny, Thomas; Plummer, Francis A.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada	University of Manitoba; University of Nairobi; Public Health Agency of Canada	Luo, M (corresponding author), Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada.	Ma.Luo@phac-aspc.gc.ca		Sampathkumar, Raghavan/0000-0003-3500-9083	National Institutes of Health; Canadian Institutes of Health Research; Bill and Melinda Gates Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the National Institutes of Health, Canadian Institutes of Health Research and the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allcock RJN, 2002, TISSUE ANTIGENS, V59, P520, DOI 10.1034/j.1399-0039.2002.590609.x; An P, 2010, TRENDS GENET, V26, P119, DOI 10.1016/j.tig.2010.01.002; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Flores-Villanueva PO, 2003, J IMMUNOL, V170, P1925, DOI 10.4049/jimmunol.170.4.1925; Fowke KR, 1996, LANCET, V348, P1347, DOI 10.1016/S0140-6736(95)12269-2; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Hardie RA, 2008, AIDS, V22, P2038, DOI 10.1097/QAD.0b013e328311d1a0; Hardie RA, 2008, AIDS, V22, P807, DOI 10.1097/QAD.0b013e3282f51b71; Heidari S, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18608; Jeffery KJM, 2000, MICROBES INFECT, V2, P1335, DOI 10.1016/S1286-4579(00)01287-9; Johnston MI, 2011, NEW ENGL J MED, V365, P873, DOI 10.1056/NEJMp1107621; Klein J, 2000, NEW ENGL J MED, V343, P702, DOI 10.1056/NEJM200009073431006; Koehler RN, 2010, J INFECT DIS, V202, P1562, DOI 10.1086/656913; Lacap PA, 2008, AIDS, V22, P1029, DOI 10.1097/QAD.0b013e3282ffb3db; Lancaster AK, 2007, TISSUE ANTIGENS, V69, P192, DOI 10.1111/j.1399-0039.2006.00769.x; Leslie A, 2010, J VIROL, V84, P9879, DOI 10.1128/JVI.00320-10; Li S, 2007, JAIDS-J ACQ IMM DEF, V44, P121, DOI 10.1097/01.qai.0000248355.40877.2a; Luo M, 1999, TISSUE ANTIGENS, V54, P69, DOI 10.1034/j.1399-0039.1999.540108.x; Luo M, 2001, HUM IMMUNOL, V62, P1294, DOI 10.1016/S0198-8859(01)00339-1; Luo M, 2012, MODELS OF PROTECTION AGAINST HIV/SIV: AVOIDING AIDS IN HUMANS AND MONKEYS, P169, DOI 10.1016/B978-0-12-387715-4.00006-X; Luo M, 2012, J VIROL, V86, P1166, DOI 10.1128/JVI.05721-11; Mackelprang RD, 2010, J INFECT DIS, V202, P1273, DOI 10.1086/656318; Martin MP, 2013, IMMUNOL REV, V254, P245, DOI 10.1111/imr.12071; Matthews PC, 2011, J IMMUNOL, V186, P5675, DOI 10.4049/jimmunol.1003711; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Peterson TA, 2013, TISSUE ANTIGENS, V81, P93, DOI 10.1111/tan.12051; Plummer FA, 1999, IMMUNOL LETT, V66, P27, DOI 10.1016/S0165-2478(98)00182-5; Price P, 2001, HUM IMMUNOL, V62, P157, DOI 10.1016/S0198-8859(00)00239-1; Rowland-Jones SL, 1998, J CLIN INVEST, V102, P1758, DOI 10.1172/JCI4314; SIMONSEN JN, 1990, AIDS, V4, P139, DOI 10.1097/00002030-199002000-00007; Sriwanthana B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041696; Trachtenberg EA, 2001, HIV MOL IMMUNOLOGY D; UNAIDS, 2012, GLOBAL REPORT UNAIDS; WARD FE, 1995, HIV MOL IMMUNOLOGY D, P10	35	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101475	10.1371/journal.pone.0101475	http://dx.doi.org/10.1371/journal.pone.0101475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992306	Green Published, Green Submitted, gold			2022-12-27	WOS:000341253400077
J	Zhang, T; Luo, XJ; Sai, WB; Yu, MF; Li, WE; Ma, YF; Chen, WW; Zhai, K; Qin, GJ; Guo, DL; Zheng, YM; Wang, YX; Shen, JH; Ji, GJ; Liu, QH				Zhang, Ting; Luo, Xiao-Jing; Sai, Wen-Bo; Yu, Meng-Fei; Li, Wen-Er; Ma, Yun-Fei; Chen, Weiwei; Zhai, Kui; Qin, Gangjian; Guo, Donglin; Zheng, Yun-Min; Wang, Yong-Xiao; Shen, Jin-Hua; Ji, Guangju; Liu, Qing-Hua			Non-Selective Cation Channels Mediate Chloroquine-Induced Relaxation in Precontracted Mouse Airway Smooth Muscle	PLOS ONE			English	Article							TASTANT-INDUCED BRONCHODILATION; PORTAL-VEIN MYOCYTES; BK CHANNELS; CELLS; ACTIVATION; CALCIUM; RECEPTORS; EXPRESSION; CURRENTS; SIGNALS	Bitter tastants can induce relaxation in precontracted airway smooth muscle by activating big-conductance potassium channels (BKs) or by inactivating voltage-dependent L-type Ca2+ channels (VDLCCs). In this study, a new pathway for bitter tastant-induced relaxation was defined and investigated. We found nifedipine-insensitive and bitter tastant chloroquine-sensitive relaxation in epithelium-denuded mouse tracheal rings (TRs) precontracted with acetylcholine (ACH). In the presence of nifedipine (10 mu M), ACH induced cytosolic Ca2+ elevation and cell shortening in single airway smooth muscle cells (ASMCs), and these changes were inhibited by chloroquine. In TRs, ACH triggered a transient contraction under Ca2+ -free conditions, and, following a restoration of Ca2+, a strong contraction occurred, which was inhibited by chloroquine. Moreover, the ACH-activated whole-cell and single channel currents of non-selective cation channels (NSCCs) were blocked by chloroquine. Pyrazole 3 (Pyr3), an inhibitor of transient receptor potential C3 (TRPC3) channels, partially inhibited ACH-induced contraction, intracellular Ca2+ elevation, and NSCC currents. These results demonstrate that NSCCs play a role in bitter tastant-induced relaxation in precontracted airway smooth muscle.	[Zhang, Ting; Luo, Xiao-Jing; Sai, Wen-Bo; Yu, Meng-Fei; Li, Wen-Er; Ma, Yun-Fei; Chen, Weiwei; Guo, Donglin; Shen, Jin-Hua; Liu, Qing-Hua] South Cent Univ Natl, Inst Med Biol, Wuhan, Peoples R China; [Zhang, Ting; Luo, Xiao-Jing; Sai, Wen-Bo; Yu, Meng-Fei; Li, Wen-Er; Ma, Yun-Fei; Chen, Weiwei; Guo, Donglin; Shen, Jin-Hua; Liu, Qing-Hua] South Cent Univ Natl, Hubei Prov Key Lab Protect & Applicat Special Pla, Wuhan, Peoples R China; [Zhai, Kui; Ji, Guangju] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Qin, Gangjian] Northwestern Univ Feinberg, Sch Med, Feinberg Cardiovasc Res Inst, Dept Med Cardiol, Chicago, IL USA; [Guo, Donglin] Lankenau Inst Med Res, Wynnewood, PA USA; [Guo, Donglin] Main Line Hlth Heart Ctr, Wynnewood, PA USA; [Zheng, Yun-Min; Wang, Yong-Xiao] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY USA	South Central Minzu University; South Central Minzu University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Northwestern University; Feinberg School of Medicine; Lankenau Medical Center; Lankenau Institute for Medical Research; Albany Medical College	Ji, GJ (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	gj28@sun5.ibp.ac.cn; liu258q@yahoo.com	Li, Wener/AAW-5655-2020	Li, Wener/0000-0002-1753-6245; Zhai, Kui/0000-0003-4725-190X; Ji, Guangju/0000-0001-8626-3490	Ministry of Science and Technology of China [2011CB809100]; National Natural Science Foundation of China [31140087, 30971514]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122865, R01HL108232] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support was provided by: contract grant sponsor: Ministry of Science and Technology of China (http://www.most.gov.cn/eng/), contract grant number: 2011CB809100 to QHL and GJ; contract grant sponsor: National Natural Science Foundation of China (http://www.nsfc.gov.cn/), contract grant numbers: 31140087 and 30971514 to QHL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz J, 2009, FASEB J, V23, P297, DOI 10.1096/fj.08-119495; Albert AP, 2002, J PHYSIOL-LONDON, V538, P717, DOI 10.1113/jphysiol.2001.013101; Albert AP, 2001, J PHYSIOL-LONDON, V536, P409, DOI 10.1111/j.1469-7793.2001.0409c.xd; An SS, 2012, AM J PHYSIOL-LUNG C, V303, pL304, DOI 10.1152/ajplung.00126.2012; An SS, 2012, NAT MED, V18, P650, DOI 10.1038/nm.2734; Belvisi MG, 2011, NAT MED, V17, P776, DOI [10.1038/nm0711-776a, 10.1038/nm0711-776b]; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; EHARA T, 1988, J PHYSIOL-LONDON, V403, P117, DOI 10.1113/jphysiol.1988.sp017242; Fleischmann BK, 1997, AM J PHYSIOL-CELL PH, V272, pC341, DOI 10.1152/ajpcell.1997.272.1.C341; Fujiyama R, 1998, FEBS LETT, V434, P47, DOI 10.1016/S0014-5793(98)00949-1; Grassin-Delyle S, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-134; He BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085188; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; Lee RJ, 2012, J CLIN INVEST, V122, P4145, DOI 10.1172/JCI64240; Liu QH, 2002, J EXP MED, V196, P897, DOI 10.1084/jem.20020381; Liu QH, 2009, P NATL ACAD SCI USA, V106, P11418, DOI 10.1073/pnas.0813307106; Liu QH, 2009, AM J RESP CELL MOL, V40, P663, DOI 10.1165/rcmb.2008-0323OC; Prandi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082820; Pulkkinen V, 2012, AM J PHYSIOL-LUNG C, V303, pL956, DOI 10.1152/ajplung.00205.2012; Rueda A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053321; Schleifer H, 2012, BRIT J PHARMACOL, V167, P1712, DOI 10.1111/j.1476-5381.2012.02126.x; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; Torrey TW, 1931, P NATL ACAD SCI USA, V17, P591, DOI 10.1073/pnas.17.11.591; Wang YX, 1997, AM J PHYSIOL-CELL PH, V273, pC500, DOI 10.1152/ajpcell.1997.273.2.C500; Zhang CH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001501; Zhang CH, 2012, NAT MED, V18, P648, DOI 10.1038/nm.2733; Zheng YM, 2008, J VASC RES, V45, P469, DOI 10.1159/000127438	29	33	36	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101578	10.1371/journal.pone.0101578	http://dx.doi.org/10.1371/journal.pone.0101578			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992312	gold, Green Published, Green Submitted			2022-12-27	WOS:000341253400093
J	Celiku, O; Johnson, S; Zhao, SP; Camphausen, K; Shankavaram, U				Celiku, Orieta; Johnson, Seth; Zhao, Shuping; Camphausen, Kevin; Shankavaram, Uma			Visualizing Molecular Profiles of Glioblastoma with GBM-BioDP	PLOS ONE			English	Article							CANCER GENOMICS DATA; TEMOZOLOMIDE; EXPRESSION; BROWSER; GENES	Validation of clinical biomarkers and response to therapy is a challenging topic in cancer research. An important source of information for virtual validation is the datasets generated from multi-center cancer research projects such as The Cancer Genome Atlas project (TCGA). These data enable investigation of genetic and epigenetic changes responsible for cancer onset and progression, response to cancer therapies, and discovery of the molecular profiles of various cancers. However, these analyses often require bulk download of data and substantial bioinformatics expertise, which can be intimidating for investigators. Here, we report on the development of a new resource available to scientists: a data base called Glioblastoma Bio Discovery Portal (GBM-BioDP). GBM-BioDP is a free web-accessible resource that hosts a subset of the glioblastoma TCGA data and enables an intuitive query and interactive display of the resultant data. This resource provides visualization tools for the exploration of gene, miRNA, and protein expression, differential expression within the subtypes of GBM, and potential associations with clinical outcome, which are useful for virtual biological validation. The tool may also enable generation of hypotheses on how therapies impact GBM molecular profiles, which can help in personalization of treatment for optimal outcome. The resource can be accessed freely at http://gbm-biodp.nci.nih.gov (a tutorial is included).	[Celiku, Orieta; Johnson, Seth; Zhao, Shuping; Camphausen, Kevin; Shankavaram, Uma] NCI, Radiat Oncol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Shankavaram, U (corresponding author), NCI, Radiat Oncol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	uma@mail.nih.gov		Celiku, Orieta/0000-0002-0500-1032; Johnson, Seth/0000-0001-5957-2052	National Institutes of Health, National Cancer Institute, Center for Cancer Research	National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addeo R, 2011, J NEURO-ONCOL, V102, P417, DOI 10.1007/s11060-010-0329-z; Addeo R, 2009, CANCER CHEMOTH PHARM, V64, P863, DOI 10.1007/s00280-009-1086-6; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cline MS, 2013, SCI REP-UK, V3, DOI 10.1038/srep02652; Fiume M, 2012, NUCLEIC ACIDS RES, V40, pW615, DOI 10.1093/nar/gks427; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Genovese G, 2012, CANCER DISCOV, V2, P736, DOI 10.1158/2159-8290.CD-12-0111; Hammoud MA, 1996, J NEURO-ONCOL, V27, P65, DOI 10.1007/BF00146086; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lex A, 2012, COMPUT GRAPH FORUM, V31, P1175, DOI 10.1111/j.1467-8659.2012.03110.x; Olar A, 2014, J PATHOL, V232, P165, DOI 10.1002/path.4282; Perez-Llamas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019541; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Raza SM, 2004, CLIN CANCER RES, V10, P212, DOI 10.1158/1078-0432.CCR-0155-3; RCore Team, 2020, R LANG ENV STAT COMP; Sanborn JZ, 2011, NUCLEIC ACIDS RES, V39, pD951, DOI 10.1093/nar/gkq1113; Sasaki A, 2012, ANTICANCER RES, V32, P4709; Schroeder MP, 2013, GENOME MED, V5, DOI 10.1186/gm413; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shannon PT, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-217; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Weller M, 2009, J CLIN ONCOL, V27, P5743, DOI 10.1200/JCO.2009.23.0805	29	36	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101239	10.1371/journal.pone.0101239	http://dx.doi.org/10.1371/journal.pone.0101239			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010047	gold, Green Submitted, Green Published			2022-12-27	WOS:000338763800015
J	Wang, ZR; Hou, XM; Qu, B; Wang, J; Gao, XJ; Li, QZ				Wang, Zhuoran; Hou, Xiaoming; Qu, Bo; Wang, Jie; Gao, Xuejun; Li, Qingzhang			Pten Regulates Development and Lactation in the Mammary Glands of Dairy Cows	PLOS ONE			English	Article							TISSUE-SPECIFIC REGULATION; GENE-EXPRESSION; EPITHELIAL-CELLS; AKT; PROLACTIN; PATHWAY; ACTIVATION; CANCER; MILK; OVEREXPRESSION	Pten is a tumor suppressor gene regulating many cellular processes, including growth, adhesion, and apoptosis. In the aim of investigating the role of Pten during mammary gland development and lactation of dairy cows, we analyzed Pten expression levels in the mammary glands of dairy cows by using western blotting, immunohistochemistry, and quantitative polymerase chain reaction (qPCR) assays. Dairy cow mammary epithelial cells (DCMECs) were used to study the function of Pten in vitro. We determined concentrations of beta-casein, triglyceride, and lactose in the culture medium following Pten overexpression and siRNA inhibition. To determine whether Pten affected DCMEC viability and proliferation, cells were analyzed by CASY-TT and flow cytometry. Genes involved in lactation-related signaling pathways were detected. Pten expression was also assessed by adding prolactin and glucose to cell cultures. When Pten was overexpressed, proliferation of DCMECs and concentrations for beta-casein, triglyceride, and lactose were significantly decreased. Overexpression of Pten down-regulated expression of MAPK, CYCLIN D1, AKT, MTOR, S6K1, STAT5, SREBP1, PPAR gamma, PRLR, and GLUT1, but up-regulated 4EBP1 in DCMECs. The Pten siRNA inhibition experiments revealed results that opposed those from the gene overexpression experiments. Introduction of prolactin (PRL) increased secretion of beta-casein, triglyceride, and lactose, but decreased Pten expression levels. Introduction of glucose also increased beta-casein and triglyceride concentrations, but did not significantly alter Pten expression levels. The Pten mRNA and protein expression levels were decreased 0.3- and 0.4-fold in mammary glands of lactating cows producing high quality milk (milk protein >3.0%, milk fat >3.5%), compared with those cows producing low quality milk (milk protein <3.0%, milk fat <3.5%). In conclusion, Pten functions as an inhibitor during mammary gland development and lactation in dairy cows. It can down-regulate DCMECs secretion of beta-casein, triglyceride, and lactose, and plays a critical role in lactation related signaling pathways.	[Wang, Zhuoran; Hou, Xiaoming; Qu, Bo; Wang, Jie; Gao, Xuejun; Li, Qingzhang] Northeast Agr Univ, Educ Minist, Key Lab Dairy Sci, Harbin, Heilongjiang, Peoples R China	Northeast Agricultural University - China	Li, QZ (corresponding author), Northeast Agr Univ, Educ Minist, Key Lab Dairy Sci, Harbin, Heilongjiang, Peoples R China.	qzli@neau.edu.cn			Major State Basic Research Development Program of China (973 Program) [2011CB 100804]; National High Technology Research and Development Program of China (863 Program) [2006AA10Z1A4]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This study was financially supported by the Major State Basic Research Development Program of China (973 Program, No. 2011CB 100804), and the National High Technology Research and Development Program of China (863 Program, 2006AA10Z1A4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn J, 2002, J PHARMACOL EXP THER, V303, P487, DOI 10.1124/jpet.102.038315; Anderson SM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1653; Ben-Jonathan N, 2006, TRENDS ENDOCRIN MET, V17, P110, DOI 10.1016/j.tem.2006.02.005; Bian CX, 2010, BIOCHEM BIOPH RES CO, V398, P395, DOI 10.1016/j.bbrc.2010.06.080; Blagosklonny MV, 2013, AGING-US, V5, P490, DOI 10.18632/aging.100580; Blanco AC, 2010, PLOS ONE, V5, P1; Boutinaud M, 2004, REPROD NUTR DEV, V44, P499, DOI 10.1051/rnd:2004054; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Carver KC, 2009, MOL CELL ENDOCRINOL, V307, P1, DOI 10.1016/j.mce.2009.03.014; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chan GK, 2013, PLOS ONE, V8, P1; Chen CC, 2012, GENE DEV, V26, P2154, DOI 10.1101/gad.197343.112; Chen CC, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2640; Cui W, 2011, MOL CELL BIOCHEM, V355, P17, DOI 10.1007/s11010-011-0834-1; Dai XJ, 2007, J INVEST DERMATOL, V127, P1728, DOI 10.1038/sj.jid.5700758; Dong YS, 2012, J BIOL CHEM, V287, P32172, DOI 10.1074/jbc.M112.393462; Dupont J, 2002, J CLIN INVEST, V110, P815, DOI [10.1172/JCI200213829, 10.1172/JCI0213829]; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Goo CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045806; GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x; Harris J, 2006, MOL ENDOCRINOL, V20, P1177, DOI 10.1210/me.2005-0473; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Hou T, 2014, INT J CLIN EXP PATHO, V7, P280; Hu H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007636; Jeurink PV, 2013, BENEF MICROBES, V4, P17, DOI 10.3920/BM2012.0040; Kark T, 2008, MOL PHARMACOL, V73, P1405, DOI 10.1124/mol.107.043323; Lee HJ, 2012, TRENDS ENDOCRIN MET, V23, P292, DOI 10.1016/j.tem.2012.02.006; Li HM, 2012, MOLECULES, V17, P12037, DOI 10.3390/molecules171012037; Liu HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066092; Liu JL, 2005, MOL CELL BIOL, V25, P6211, DOI 10.1128/MCB.25.14.6211-6224.2005; Liu XF, 2012, IN VITRO CELL DEV-AN, V48, P554, DOI 10.1007/s11626-012-9545-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macheda ML, 2003, CELL TISSUE RES, V311, P91, DOI 10.1007/s00441-002-0661-5; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mao J, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290073; Moon SH, 2013, INT J ONCOL, V42, P921, DOI 10.3892/ijo.2013.1765; Nilsson J, 2006, MOL CELL BIOL, V26, P5663, DOI 10.1128/MCB.02095-05; Ortega-Molina A, 2013, TRENDS ENDOCRIN MET, V24, P184, DOI 10.1016/j.tem.2012.11.002; Porstmann T, 2005, ONCOGENE, V24, P6465, DOI 10.1038/sj.onc.1208802; Qi XF, 2013, MOL IMMUNOL, V54, P327, DOI 10.1016/j.molimm.2013.01.001; Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093; Santos SJ, 2009, J STEROID BIOCHEM, V115, P161, DOI 10.1016/j.jsbmb.2009.04.001; Saqcena M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074157; SCHMITT-NEY M, 1991, MOL CELL BIOL, V11, P3745, DOI 10.1128/MCB.11.7.3745; Simpson L, 2001, EXP CELL RES, V264, P29, DOI 10.1006/excr.2000.5130; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Stephane P, 2008, J CLIN INVEST, V118, P1765; Tanaka T, 2009, DIFFERENTIATION, V77, P181, DOI 10.1016/j.diff.2008.10.001; Trott JF, 2009, J ENDOCRINOL, V202, P153, DOI 10.1677/JOE-08-0486; Weng LP, 2001, HUM MOL GENET, V10, P599, DOI 10.1093/hmg/10.6.599; Zhao K, 2010, CELL BIOL INT, V34, P717, DOI 10.1042/CBI20100023; Zhou BR, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-156; Zhu GY, 2013, BIOCHEM BIOPH RES CO, V433, P526, DOI 10.1016/j.bbrc.2013.03.018	54	21	28	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102118	10.1371/journal.pone.0102118	http://dx.doi.org/10.1371/journal.pone.0102118			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25009983	Green Submitted, Green Published, gold			2022-12-27	WOS:000338763800069
J	Batres, C; Perrett, DI				Batres, Carlota; Perrett, David I.			The Influence of the Digital Divide on Face Preferences in El Salvador: People without Internet Access Prefer More Feminine Men, More Masculine Women, and Women with Higher Adiposity	PLOS ONE			English	Article							SEXUAL-DIMORPHISM; MATE PREFERENCES; PREDICTS; CUES	Previous studies on face preferences have found that online and laboratory experiments yield similar results with samples from developed countries, where the majority of the population has internet access. No study has yet explored whether the same holds true in developing countries, where the majority of the population does not have internet access. This gap in the literature has become increasingly important given that several online studies are now using cross-country comparisons. We therefore sought to determine if an online sample is representative of the population in the developing country of El Salvador. In studies of Hispanic men and women aged 18-25, we tested facial masculinity and adiposity preferences by collecting data in person as well as online. Our results showed that there were no differences in preferences between people who reported having internet access, whether they were tested online or in person. This provides evidence that testing style does not bias preferences among the same population. On the other hand, our results showed multiple differences in preferences between people who reported having internet access and people who reported not having internet access. More specifically, we found that people without internet access preferred more feminine men, more masculine women, and women with higher adiposity than people with internet access. We also found that people without internet access had fewer resources (e.g. running water) than people with internet access, suggesting that harshness in the environment may be influencing face preferences. These findings suggest that online studies may provide a distorted perspective of the populations in developing countries.	[Batres, Carlota; Perrett, David I.] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland	University of St Andrews	Batres, C (corresponding author), Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland.	jcb23@st-andrews.ac.uk	Perrett, David/AAA-6264-2020; Batres, Carlota/J-2294-2015	Perrett, David/0000-0002-6025-0939; Batres, Carlota/0000-0002-3833-7667	Russell Trust	Russell Trust	CB received funding from the Russell Trust to support this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, DEF REC EL SALV SEG; [Anonymous], 2013, PERC IND US INT; Becker A, 2004, CULT MED PSYCHIAT, V28, P533, DOI 10.1007/s11013-004-1067-5; Brooks R, 2011, P ROY SOC B-BIOL SCI, V278, P810, DOI 10.1098/rspb.2010.0964; BROWN PJ, 1987, ANN NY ACAD SCI, V499, P29, DOI 10.1111/j.1749-6632.1987.tb36195.x; Censo de Poblacion y Vivienda, 2008, CENS POBL VIV; Coetzee V, 2009, PERCEPTION, V38, P1700, DOI 10.1068/p6423; de Barra M, 2013, EVOL HUM BEHAV, V34, P384, DOI 10.1016/j.evolhumbehav.2013.07.001; DeBruine LM, 2011, P ROY SOC B-BIOL SCI, V278, P813, DOI 10.1098/rspb.2010.2200; DeBruine LM, 2010, P ROY SOC B-BIOL SCI, V277, P2405, DOI 10.1098/rspb.2009.2184; DiMaggio P, 2001, ANNU REV SOCIOL, V27, P307, DOI 10.1146/annurev.soc.27.1.307; Furnham A, 2002, PERS INDIV DIFFER, V32, P729, DOI 10.1016/S0191-8869(01)00073-3; Germine L, 2012, PSYCHON B REV, V19, P847, DOI 10.3758/s13423-012-0296-9; Hargittai Eszter, 2002, 1 MONDAY; Harris J., 2002, International Review for the Sociology of Sport, V37, P397, DOI 10.1177/1012690202037004024; Hoerger M, 2011, PSYCHOL ASSESSMENT, V23, P725, DOI 10.1037/a0023286; Jones BC, 2007, EVOL HUM BEHAV, V28, P439, DOI 10.1016/j.evolhumbehav.2007.07.006; Lee AJ, 2011, BIOL LETTERS, V7, P892, DOI 10.1098/rsbl.2011.0454; Little AC, 2007, BEHAV ECOL SOCIOBIOL, V61, P967, DOI 10.1007/s00265-006-0325-7; Moore FR, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0050; Mueller U, 1996, SOC FORCES, V74, P823, DOI 10.2307/2580383; Penton-Voak IS, 2004, EVOL HUM BEHAV, V25, P355, DOI 10.1016/j.evolhumbehav.2004.06.002; Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005; Rantala MJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2495; Re DE, 2013, EVOL PSYCHOL-US, V11, P89, DOI 10.1177/147470491301100109; Re DE, 2013, Q J EXPT PSYCHOL; Rhodes G, 2003, P ROY SOC B-BIOL SCI, V270, pS93, DOI 10.1098/rsbl.2003.0023; Roberts ML, 2004, ANIM BEHAV, V68, P227, DOI 10.1016/j.anbehav.2004.05.001; ROWLAND DA, 1995, IEEE COMPUT GRAPH, V15, P70, DOI 10.1109/38.403830; Schramm, 1964, MASS MEDIA NATL DEV; Swami V., 2007, J EVOLUTIONARY PSYCH, V5, P149, DOI [10.1556/JEP.2007.1005, DOI 10.1556/JEP.2007.1005]; Swami Viren, 2005, Body Image, V2, P115, DOI 10.1016/j.bodyim.2005.02.002; Thornhill R, 2006, EVOL HUM BEHAV, V27, P131, DOI 10.1016/j.evolhumbehav.2005.06.001; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; Tinlin RM, 2013, BRIT J PSYCHOL, V104, P235, DOI 10.1111/j.2044-8295.2012.02117.x; Voracek M, 2006, ARCH SEX BEHAV, V35, P297, DOI 10.1007/s10508-006-9021-y	36	32	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e100966	10.1371/journal.pone.0100966	http://dx.doi.org/10.1371/journal.pone.0100966			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL3PK	25006801	Green Published, Green Submitted, gold			2022-12-27	WOS:000339040600026
J	Bishop, FL; Aizlewood, L; Adams, AEM				Bishop, Felicity L.; Aizlewood, Lizzi; Adams, Alison E. M.			When and Why Placebo-Prescribing Is Acceptable and Unacceptable: A Focus Group Study of Patients' Views	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; CLINICAL-PRACTICE; QUALITATIVE RESEARCH; INTERVENTIONS; ETHICS; OSTEOARTHRITIS; PARTICIPANTS; PHYSICIANS; ATTITUDES; COMMUNICATION	Background: Surveys of doctors suggest that they use placebos and placebo effects clinically to help patients. However, patients' views are not well-understood. We aimed to identify when and why placebo-prescribing in primary care might be acceptable and unacceptable to patients. Methods: A purposive diverse sample of 58 English-speaking adults (18 men; aged 19-80 years) participated in 11 focus groups. Vignettes describing doctors prescribing placebos in primary care were used to initiate discussions. Data were analyzed inductively. Results: Participants discussed diverse harms and benefits of placebo-prescribing for individual patients, carers, healthcare providers, and society. Two perspectives on placebo-prescribing were identified. First, the "consequentialist'' perspective focused on the potential for beneficial outcomes of placebo-prescribing. Here, some participants thought placebos are beneficial and should be used clinically; they often invoked the power of the mind or mind-body interactions. Others saw placebos as ineffective and therefore a waste of time and money. Second, the "respecting autonomy'' perspective emphasized the harms caused by the deceptive processes thought necessary for placebo-prescribing. Here, participants judged placebo-prescribing unacceptable because placebo-prescribers deceive patients, thus a doctor who prescribes placebos cannot be trusted and patients' autonomy is compromised. They also saw placebo-responders as gullible, which deterred them from trying placebos themselves. Overall, the word "placebo'' was often thought to imply "ineffective''; some participants suggested alternative carefully chosen language that could enable doctors to prescribe placebos without directly lying to patients. Conclusions: Negative views of placebos derive from beliefs that placebos do not work and/or that they require deception by the doctor. Positive views are pragmatic in that if placebos work then any associated processes (e.g. mechanisms, deception) are deemed unimportant. Public education about placebos and their effects is warranted and research to identify optimal ways of harnessing placebo effects in clinical practice is needed.	[Bishop, Felicity L.; Aizlewood, Lizzi] Univ Southampton, Ctr Applicat Hlth Psychol, Southampton, Hants, England; [Adams, Alison E. M.] No Arizona Univ, Dept Biol, Flagstaff, AZ 86011 USA	University of Southampton; Northern Arizona University	Bishop, FL (corresponding author), Univ Southampton, Ctr Applicat Hlth Psychol, Southampton, Hants, England.	F.L.Bishop@southampton.ac.uk		Bishop, Felicity/0000-0002-8737-6662	Primary Care and Population Sciences, University of Southampton	Primary Care and Population Sciences, University of Southampton	This study was supported by an internal grant from Primary Care and Population Sciences, University of Southampton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai A, 2013, BIOETHICS, V27, P186, DOI 10.1111/j.1467-8519.2011.01943.x; Barrett B, 2011, ANN FAM MED, V9, P312, DOI 10.1370/afm.1250; Benedetti F, 2011, PATIENT EDUC COUNS, V84, P413, DOI 10.1016/j.pec.2011.04.034; Benedetti F, 2008, ANNU REV PHARMACOL, V48, P33, DOI 10.1146/annurev.pharmtox.48.113006.094711; Berthelot JM, 2001, JOINT BONE SPINE, V68, P65, DOI 10.1016/S1297-319X(00)00225-6; Bishop FL, 2012, QUAL HEALTH RES, V22, P1138, DOI 10.1177/1049732312448544; Bishop FL, 2012, SOC SCI MED, V74, P767, DOI 10.1016/j.socscimed.2011.11.020; BOK S, 1974, SCI AM, V231, P17, DOI 10.1038/scientificamerican1174-17; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brody H, 2000, J FAM PRACTICE, V49, P649; BRODY H, 1982, ANN INTERN MED, V97, P112, DOI 10.7326/0003-4819-97-1-112; Chassany O, 2006, J RHEUMATOL, V33, P1827; Chen GF, 2009, NEW ZEAL MED J, V122, P35; COMAROFF J, 1976, SOCIOL REV, V24, P79, DOI 10.1111/j.1467-954X.1976.tb00574.x; Fassler M, 2011, BRIT J GEN PRACT, V61, P101, DOI 10.3399/bjgp11X556209; Fassler M, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-15; Fassler M, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-144; Golomb BA, 2010, ANN INTERN MED, V153, P532, DOI 10.7326/0003-4819-153-8-201010190-00010; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Howick J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058247; Hull SC, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f3757; Jonas WB, 2011, PHILOS T R SOC B, V366, P1896, DOI 10.1098/rstb.2010.0405; Kaptchuk TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015591; Kaptchuk TJ, 1998, LANCET, V351, P1722, DOI 10.1016/S0140-6736(97)10111-8; Kelley JM, 2012, PSYCHOTHER PSYCHOSOM, V81, P312, DOI 10.1159/000337053; Kirsch I., 1998, PREVENTION TREATMENT, V1, DOI 10.1037/1522-3736.1.1.12a; Kisaalita NR, 2012, J PAIN, V13, P891, DOI 10.1016/j.jpain.2012.06.003; Kisaalita NR, 2011, J PAIN, V12, P920, DOI 10.1016/j.jpain.2011.02.353; KITZINGER J, 1994, SOCIOL HEALTH ILL, V16, P103, DOI 10.1111/1467-9566.ep11347023; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Lichtenberg P, 2004, J MED ETHICS, V30, P551, DOI 10.1136/jme.2002.002832; Linde K, 2013, COMPLEMENT THER MED, V21, P109, DOI 10.1016/j.ctim.2012.11.010; Linde K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092938; Linde K, 2011, PHILOS T R SOC B, V366, P1905, DOI 10.1098/rstb.2010.0383; LYNOE N, 1993, SOC SCI MED, V36, P767, DOI 10.1016/0277-9536(93)90037-5; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; Meissner K, 2012, FAM PRACT, V29, P79, DOI 10.1093/fampra/cmr045; Moerman DE, 2002, ANN INTERN MED, V136, P471, DOI 10.7326/0003-4819-136-6-200203190-00011; Patel SM, 2005, NEUROGASTROENT MOTIL, V17, P332, DOI 10.1111/j.1365-2982.2005.00650.x; Patton M. Q., 2001, QUALITATIVE RES EVAL; Suarez-Almazor ME, 2010, ARTHRIT CARE RES, V62, P1229, DOI 10.1002/acr.20225; Thomas DR, 2006, AM J EVAL, V27, P237, DOI 10.1177/1098214005283748; Tilburt JC, 2008, BMJ-BRIT MED J, V337, P1097, DOI DOI 10.1136/BMJ.A1938; Vase L, 2011, PHILOS T R SOC B, V366, P1913, DOI 10.1098/rstb.2010.0402; Verheul W, 2010, PATIENT EDUC COUNS, V80, P300, DOI 10.1016/j.pec.2010.06.017; White P, 2012, PAIN, V153, P455, DOI 10.1016/j.pain.2011.11.007; Yardley L., 1999, PSYCHOL HEALTH, V15, P1; Zhang W, 2008, ANN RHEUM DIS, V67, P1716, DOI 10.1136/ard.2008.092015	48	29	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101822	10.1371/journal.pone.0101822	http://dx.doi.org/10.1371/journal.pone.0101822			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL3PK	25006673	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000339040600069
J	Dolny, A; Harabis, F; Mizicova, H				Dolny, Ales; Harabis, Filip; Mizicova, Hana			Home Range, Movement, and Distribution Patterns of the Threatened Dragonfly Sympetrum depressiusculum (Odonata: Libellulidae): A Thousand Times Greater Territory to Protect?	PLOS ONE			English	Article							FRESH-WATER; LANDSCAPE STRUCTURE; SPECIES-DIVERSITY; MALE HARASSMENT; MARKED ANIMALS; RAIN-FOREST; HABITAT USE; DISPERSAL; MANAGEMENT; SURVIVAL	Dragonflies are good indicators of environmental health and biodiversity. Most studies addressing dragonfly ecology have focused on the importance of aquatic habitats, while the value of surrounding terrestrial habitats has often been overlooked. However, species associated with temporary aquatic habitats must persist in terrestrial environments for long periods. Little is known about the importance of terrestrial habitat patches for dragonflies, or about other factors that initiate or influence dispersal behaviour. The aim of this study was to reveal the relationship between population dynamics of the threatened dragonfly species Sympetrum depressiusculum at its natal site and its dispersal behaviour or routine movements within its terrestrial home range. We used a mark-release-recapture method (marking 2,881 adults) and exuviae collection with the Jolly-Seber model and generalized linear models to analyse seasonal and spatial patterns of routine movement in a heterogeneous Central European landscape. Our results show that utilisation of terrestrial habitat patches by adult dragonflies is not random and may be relatively long term (approximately 3 mo). Adult dragonflies were present only in areas with dense vegetation that provided sufficient resources; the insects were absent from active agricultural patches (p = 0.019). These findings demonstrate that even a species tightly linked to its natal site utilises an area that is several orders of magnitude larger than the natal site. Therefore, negative trends in the occurrence of various dragonfly species may be associated not only with disturbances to their aquatic habitats, but also with changes in the surrounding terrestrial landscape.	[Dolny, Ales; Mizicova, Hana] Univ Ostrava, Fac Sci, Inst Environm Technol, Dept Biol & Ecol, CZ-70103 Ostrava, Czech Republic; [Harabis, Filip] Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic	University of Ostrava; Czech University of Life Sciences Prague	Dolny, A (corresponding author), Univ Ostrava, Fac Sci, Inst Environm Technol, Dept Biol & Ecol, CZ-70103 Ostrava, Czech Republic.	ales.dolny@osu.cz	Dolny, Ales/ABA-5480-2020; Harabiš, Filip/AAD-1887-2019; Sigutova, Hana/AGX-5626-2022	Dolny, Ales/0000-0002-6245-8442; Harabis, Filip/0000-0002-2936-8218; Sigutova, Hana/0000-0003-1134-248X	Research and Development for Innovations Operational Programme - Structural Funds of the European Union; state budget of the Czech Republic; National Feasibility Programme I [LO1208]; Internal Grant Agency of Czech University of Life Sciences Prague [42110/1312/3118]	Research and Development for Innovations Operational Programme - Structural Funds of the European Union; state budget of the Czech Republic; National Feasibility Programme I; Internal Grant Agency of Czech University of Life Sciences Prague	The work was funded by the Research and Development for Innovations Operational Programme financed by the Structural Funds of the European Union, the state budget of the Czech Republic, and by project LO1208 of the National Feasibility Programme I. This study was supported by Grant GA FZP No. 42110/1312/3118 from the Internal Grant Agency of Czech University of Life Sciences Prague. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock J., 2009, ANIMAL BEHAV; Anderson D, 2004, MODEL SELECTION MULT, V2nd; Anholt BR, 2001, CAN J ZOOL, V79, P895, DOI 10.1139/cjz-79-5-895; Benard MF, 2008, AM NAT, V171, P553, DOI 10.1086/587072; Benton TG, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P41; Bernath B, 2002, FRESHWATER BIOL, V47, P1707, DOI 10.1046/j.1365-2427.2002.00931.x; Bohonak AJ, 2003, ECOL LETT, V6, P783, DOI 10.1046/j.1461-0248.2003.00486.x; Bretz F., 2010, MULTIPLE COMP USING; Calcagno V, 2010, J STAT SOFTW, V34, P1; Chaput-Bardy A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010694; Clark TE, 1996, J APPL ECOL, V33, P1001, DOI 10.2307/2404681; Cooch E., 2012, PROGRAM MARK ANAL DA; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; Crawley M.J., 2007, R BOOK; Darden SK, 2008, BIOL LETTERS, V4, P449, DOI 10.1098/rsbl.2008.0308; Davidowitz G, 1998, J BIOGEOGR, V25, P553, DOI 10.1046/j.1365-2699.1998.2530553.x; Dijkstra K.-D.B., 2006, FIELD GUIDE DRAGONFL; Dolny A, 2013, J INSECT CONSERV, V17, P821, DOI 10.1007/s10841-013-9564-x; Dolny A, 2012, TROP ZOOL, V25, P141, DOI 10.1080/03946975.2012.717480; Dover J, 2009, J INSECT CONSERV, V13, P3, DOI 10.1007/s10841-008-9135-8; Flick T, 2012, AGR ECOSYST ENVIRON, V156, P123, DOI 10.1016/j.agee.2012.05.006; Foote AL, 2005, ECOL ENTOMOL, V30, P273, DOI 10.1111/j.0307-6946.2005.00701.x; Fric Z, 2007, BASIC APPL ECOL, V8, P377, DOI 10.1016/j.baae.2006.06.005; Gerken B., 1999, EXUVIEN EUROPAISCHER; Gerlach J, 2013, J INSECT CONSERV, V17, P831, DOI 10.1007/s10841-013-9565-9; Hamasaki K, 2009, ECOL RES, V24, P597, DOI 10.1007/s11284-008-0531-z; Harabis F, 2011, ODONATOLOGICA, V40, P17; Harabis F, 2013, ECOL ENG, V55, P51, DOI 10.1016/j.ecoleng.2013.02.007; Hassall C, 2011, BIODIVERS CONSERV, V20, P3189, DOI 10.1007/s10531-011-0142-9; Jonsen ID, 2000, OIKOS, V88, P553, DOI 10.1034/j.1600-0706.2000.880312.x; Kalkman VJ, 2008, HYDROBIOLOGIA, V595, P351, DOI 10.1007/s10750-007-9029-x; Kalkman VJ, 2010, IUCN PUBLICATIONS OF, V38; Knight TM, 2005, NATURE, V437, P880, DOI 10.1038/nature03962; Koch Kamilla, 2006, International Journal of Odonatology, V9, P71; KOENIG WD, 1990, J ANIM ECOL, V59, P317, DOI 10.2307/5175; Konvicka M, 2008, J INSECT CONSERV, V12, P549, DOI 10.1007/s10841-007-9087-4; Kutcher TE, 2014, ECOL INDIC, V38, P31, DOI 10.1016/j.ecolind.2013.10.028; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; McCauley SJ, 2010, ECOL ENTOMOL, V35, P377, DOI 10.1111/j.1365-2311.2010.01191.x; MICHIELS NK, 1991, ECOL ENTOMOL, V16, P449, DOI 10.1111/j.1365-2311.1991.tb00238.x; New TR, 2005, ECOL BIODIVERS CONS, P1, DOI 10.1017/CBO9780511542114; Oertli Beat, 2008, P79; Oliver T, 2010, ECOL LETT, V13, P473, DOI 10.1111/j.1461-0248.2010.01441.x; Oppel Steffen, 2006, International Journal of Odonatology, V9, P89; Purse BV, 2003, J APPL ECOL, V40, P716, DOI 10.1046/j.1365-2664.2003.00829.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Raebel EM, 2010, J INSECT CONSERV, V14, P523, DOI 10.1007/s10841-010-9281-7; Remsburg AJ, 2009, J N AM BENTHOL SOC, V28, P44, DOI 10.1899/08-004.1; Sahlen Goran, 2004, International Journal of Odonatology, V7, P385; Samways MJ, 1996, BIOL CONSERV, V78, P279, DOI 10.1016/S0006-3207(96)00032-8; Sang A, 2011, INSECT CONSERV DIVER, V4, P257, DOI 10.1111/j.1752-4598.2011.00134.x; Seifert LI, 2012, FRESHWATER BIOL, V57, P1449, DOI 10.1111/j.1365-2427.2012.02807.x; Sirot LK, 2001, ANIM BEHAV, V61, P415, DOI 10.1006/anbe.2000.1605; STERNBERG K., 2000, LIBELLEN BADEN WURTT, V2; Stoks R, 2012, ANNU REV ENTOMOL, V57, P249, DOI 10.1146/annurev-ento-120710-100557; Suhonen J, 2010, CONSERV BIOL, V24, P1148, DOI 10.1111/j.1523-1739.2010.01504.x; TAYLOR PD, 1995, OIKOS, V73, P43, DOI 10.2307/3545723; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Van Dyck H, 2005, BASIC APPL ECOL, V6, P535, DOI 10.1016/j.baae.2005.03.005; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wildermuth H., 1994, Advances in Odonatology, V6, P223	61	43	47	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e100408	10.1371/journal.pone.0100408	http://dx.doi.org/10.1371/journal.pone.0100408			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006671	gold, Green Submitted, Green Published			2022-12-27	WOS:000339040600012
J	Dreyer, G; Tucker, AT; Harwood, SM; Pearse, RM; Raftery, MJ; Yaqoob, MM				Dreyer, Gavin; Tucker, Arthur T.; Harwood, Steven M.; Pearse, Rupert M.; Raftery, Martin J.; Yaqoob, Muhammad M.			Ergocalciferol and Microcirculatory Function in Chronic Kidney Disease and Concomitant Vitamin D Deficiency: An Exploratory, Double Blind, Randomised Controlled Trial	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; NITRIC-OXIDE; SKIN MICROCIRCULATION; SODIUM-NITROPRUSSIDE; MORTALITY RISK; ENDOTHELIAL DYSFUNCTION; 25-HYDROXYVITAMIN D; REACTIVE HYPEREMIA; D SUPPLEMENTATION; RESPONSES	Background and Objectives: Vitamin D deficiency and endothelial dysfunction are non-traditional risk factors for cardiovascular events in chronic kidney disease. Previous studies in chronic kidney disease have failed to demonstrate a beneficial effect of vitamin D on arterial stiffness, left ventricular mass and inflammation but none have assessed the effect of vitamin D on microcirculatory endothelial function. Study Design: We conducted a randomised controlled trial of 38 patients with non diabetic chronic kidney disease stage 3-4 and concomitant vitamin D deficiency (<16 ng/dl) who received oral ergocalciferol (50,000 IU weekly for one month followed by 50,000 IU monthly) or placebo over 6 months. The primary outcome was change in microcirculatory function measured by laser Doppler flowmetry after iontophoresis of acetylcholine. Secondary endpoints were tissue advanced glycation end products, sublingual functional capillary density and flow index as well as macrovascular parameters. Parallel in vitro experiments were conducted to determine the effect of ergocalciferol on cultured human endothelial cells. Results: Twenty patients received ergocalciferol and 18 patients received placebo. After 6 months, there was a significant improvement in the ergocalciferol group in both endothelium dependent microcirculatory vasodilatation after iontophoresis of acetylcholine (p = 0.03) and a reduction in tissue advanced glycation end products (p = 0.03). There were no changes in sublingual microcirculatory parameters. Pulse pressure (p = 0.01) but not aortic pulse wave velocity was reduced. There were no significant changes in bone mineral parameters, blood pressure or left ventricular mass index suggesting that ergocalciferol improved endothelial function independently of these parameters. In parallel experiments, expression of endothelial nitric oxide synthase and activity were increased in human endothelial cells in a dose dependent manner. Conclusions: Ergocalciferol improved microcirculatory endothelial function in patients with chronic kidney disease and concomitant vitamin D deficiency. This process may be mediated through enhanced expression and activity of endothelial nitric oxide synthase.	[Dreyer, Gavin; Raftery, Martin J.; Yaqoob, Muhammad M.] Barts Hlth NHS Trust, Dept Renal Med, London, England; [Pearse, Rupert M.] Barts Hlth NHS Trust, Dept Crit Care Med, London, England; [Dreyer, Gavin; Harwood, Steven M.; Yaqoob, Muhammad M.] Queen Mary Univ London, Dept Translat Med & Therapeut, London, England; [Tucker, Arthur T.] Barts Hlth NHS Trust, Ernest Cooke Microvasc Unit, London, England	Barts Health NHS Trust; Barts Health NHS Trust; University of London; Queen Mary University London; Barts Health NHS Trust	Yaqoob, MM (corresponding author), Barts Hlth NHS Trust, Dept Renal Med, London, England.	m.m.yaqoob@qmul.ac.uk	Pearse, Rupert/H-5426-2011	Pearse, Rupert/0000-0002-4373-5934	British Renal Society [BRS 09/010]; Barts; London charitable Trust (Barts and the London charitable Trust); National Institute for Health Research [CS/08/08/17, RP_2014-04-022] Funding Source: researchfish	British Renal Society; Barts; London charitable Trust (Barts and the London charitable Trust); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by grants from the British Renal Society (www.britishrenal.org) (Grant number BRS 09/010) and the Barts and the London charitable Trust (Barts and the London charitable Trust). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andress DL, 2006, KIDNEY INT, V69, P33, DOI 10.1038/sj.ki.5000045; ARESE M, 1995, NEPHROL DIAL TRANSPL, V10, P1386; Assimon MM, 2012, NEPHROLOGY, V17, P237, DOI 10.1111/j.1440-1797.2011.01555.x; Blair D, 2008, J RENAL NUTR, V18, P375, DOI 10.1053/j.jrn.2008.04.008; Borges ACR, 1999, HYPERTENSION, V34, P897, DOI 10.1161/01.HYP.34.4.897; Chitalia N, 2012, ATHEROSCLEROSIS, V220, P265, DOI 10.1016/j.atherosclerosis.2011.10.023; Clough G, 2012, MICROCIRCULATION, V19, P1, DOI 10.1111/j.1549-8719.2011.00142.x; Cohn JN, 2004, CIRCULATION, V109, P31, DOI 10.1161/01.CIR.0000133442.99186.39; Cupisti A, 2000, NEPHRON, V85, P114, DOI 10.1159/000045643; Cupisti A, 2000, INT J CLIN LAB RES, V30, P157, DOI 10.1007/s005990070015; De Backer D, 2007, CRIT CARE, V11, DOI 10.1186/cc6118; de Boer IH, 2008, KIDNEY INT, V74, P985, DOI 10.1038/ki.2008.419; de Boer IH, 2007, AM J KIDNEY DIS, V50, P69, DOI 10.1053/j.ajkd.2007.04.015; de Boer IH, 2011, CLIN J AM SOC NEPHRO, V6, P2141, DOI 10.2215/CJN.02640311; de Boer IH, 2009, J AM SOC NEPHROL, V20, P1805, DOI 10.1681/ASN.2008111157; de Zeeuw D, 2010, LANCET, V376, P1543, DOI 10.1016/S0140-6736(10)61032-X; Droog EJ, 2004, MICROVASC RES, V67, P197, DOI 10.1016/j.mvr.2003.12.003; Economides PA, 2004, METABOLISM, V53, P222, DOI 10.1016/j.metabol.2003.09.019; Eknoyan G, 2003, AM J KIDNEY DIS, V41, pS1, DOI 10.1016/S0272-6386(03)00111-2; Feehally J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1618; Gerrits EG, 2009, NEPHROL DIAL TRANSPL, V24, P710, DOI 10.1093/ndt/gfn634; Hobbs DA, 2013, J NUTR, V143, P1399, DOI 10.3945/jn.113.175778; IGNARRO LJ, 1993, P NATL ACAD SCI USA, V90, P8103, DOI 10.1073/pnas.90.17.8103; Jung F, 2001, MICROVASC RES, V62, P154, DOI 10.1006/mvre.2001.2325; Kaiser SE, 2013, MICROCIRCULATION; LaClair RE, 2005, AM J KIDNEY DIS, V45, P1026, DOI 10.1053/j.ajkd.2005.02.029; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Marckmann P, 2012, NEPHROL DIAL TRANSPL; McIntyre CW, 2008, CLIN KIDNEY J, V1, P383, DOI 10.1093/ndtplus/sfn146; Molina P, 2013, NEPHROL DIAL TRANSPL; MORRIS SJ, 1995, DIABETOLOGIA, V38, P1337, DOI 10.1007/BF00401767; MULLER K, 1992, CYTOKINE, V4, P506, DOI 10.1016/1043-4666(92)90012-G; Pannier B, 2000, KIDNEY INT, V57, P1091, DOI 10.1046/j.1523-1755.2000.00936.x; Pellegatta F, 2006, INT J MOL MED, V17, P203; Pignocchino P, 1994, Cardiologia, V39, P193; Pilz S, 2011, AM J KIDNEY DIS, V58, P374, DOI 10.1053/j.ajkd.2011.03.020; Rashid G, 2004, KIDNEY INT, V66, P1099, DOI 10.1111/j.1523-1755.2004.00860.x; Recio-Mayoral A, 2011, ATHEROSCLEROSIS, V216, P446, DOI 10.1016/j.atherosclerosis.2011.02.017; Santoro D, 2011, RENAL FAILURE, V33, P184, DOI 10.3109/0886022X.2011.553303; Shab-Bidar S, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-125; Shamim-Uzzaman QA, 2002, CLIN SCI, V103, P267, DOI 10.1042/cs1030267; Shoben AB, 2008, J AM SOC NEPHROL, V19, P1613, DOI 10.1681/ASN.2007111164; Sugden JA, 2008, DIABETIC MED, V25, P320, DOI 10.1111/j.1464-5491.2007.02360.x; Talmor Y, 2008, AM J PHYSIOL-RENAL, V294, pF1059, DOI 10.1152/ajprenal.00051.2008; Tarcin O, 2009, J CLIN ENDOCR METAB, V94, P4023, DOI 10.1210/jc.2008-1212; Tatematsu S, 2007, J AM SOC NEPHROL, V18, P741, DOI 10.1681/ASN.2006040367; Tehrani S, 2013, DIABETES VASC DIS RE, V10, P483, DOI 10.1177/1479164113491275; Teng M, 2005, J AM SOC NEPHROL, V16, P1115, DOI 10.1681/ASN.2004070573; Tentori F, 2006, KIDNEY INT, V70, P1858, DOI 10.1038/sj.ki.5001868; Thadhani R, 2012, JAMA-J AM MED ASSOC, V307, P674, DOI 10.1001/jama.2012.120; TUR E, 1991, DIABETES CARE, V14, P958, DOI 10.2337/diacare.14.11.958; Witham MD, 2013, ATHEROSCLEROSIS, V230, P293, DOI 10.1016/j.atherosclerosis.2013.08.005; Wolf M, 2007, J STEROID BIOCHEM, V103, P487, DOI 10.1016/j.jsbmb.2006.11.009; Wong MSK, 2008, AM J PHYSIOL-HEART C, V295, pH289, DOI 10.1152/ajpheart.00116.2008	55	50	50	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e99461	10.1371/journal.pone.0099461	http://dx.doi.org/10.1371/journal.pone.0099461			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006678	Green Published, Green Submitted, gold			2022-12-27	WOS:000339040600005
J	Songstad, NT; Serrano, MC; Sitras, V; Johansen, D; Ytrehus, K; Acharya, G				Songstad, Nils Thomas; Serrano, Maria C.; Sitras, Vasilis; Johansen, Davis; Ytrehus, Kirsti; Acharya, Ganesh			Coronary Flow Reserve in Pregnant Rats with Increased Left Ventricular Afterload	PLOS ONE			English	Article							COLOR DOPPLER-ECHOCARDIOGRAPHY; BLOOD-FLOW; VELOCITY RESERVE; HEART-DISEASE; ENDOTHELIAL DYSFUNCTION; NONINVASIVE ASSESSMENT; MEDIATED DILATATION; VASOMOTOR FUNCTION; ARTERY; ULTRASOUND	Background: Coronary flow reserve (CFR) is used as a measure of coronary endothelial function. We investigated the effect of increased afterload on CFR of pregnant and non-pregnant rats. Methods: Afterload increase in Wister rats (both pregnant and non-pregnant) was achieved by the infusion of angiotensin II (Ang II) for similar to 10 days or by subjecting them to transverse aortic constriction (TAC) for similar to 14 days. Control groups were infused with 0.9% NaCl or had sham surgery, respectively. In pregnant rats, the experiments were performed close to term gestation. Doppler velocity waveforms of the left main coronary artery were recorded using a high resolution ultrasound imaging system (Vevo 770, VisualSonics, Canada) at baseline while the animals were anesthetized with 1.5% inhaled isoflurane, and during maximal coronary dilatation obtained by the inhalation of 3.5% of isoflurane. CFR was calculated as the ratio between the peak coronary flow velocities (CFRpeak) and the velocity-time integrals (CFRVTI) recorded at hyperemia and at baseline. Results: CFR could be calculated in 60 of 75 (80%) animals. There were no differences in CFR between intervention and control groups irrespective of whether afterload was increased by Ang II or TAC. In the TAC-study CFRpeak (1.54 +/- 0.07 vs 1.85 +/- 0.17; p = 0.03) was decreased in pregnant compared to non-pregnant shams. When sham animals from both studies were pooled together both CFRpeak (1.42 +/- 0.07 vs 1.86 +/- 0.16; p = 0.005) as well as CFRVTI (1.45 +/- 0.07 vs 1.78 +/- 0.12; p = 0.03) were significantly lower in pregnant rats compared to non-pregnant. Conclusions: CFR can be measured non-invasively in rats using Doppler echocardiography and high concentrations of inhaled isoflurane as a coronary vasodilator. In pregnant rats, CFR is reduced close to term. CFR is not affected by increased left ventricular afterload caused by chronic Ang II infusion or TAC.	[Songstad, Nils Thomas; Sitras, Vasilis; Acharya, Ganesh] UiT Arctic Univ Norway, Fac Hlth Sci, Inst Clin Med, Womens Hlth & Perinatol Res Grp, Tromso, Norway; [Songstad, Nils Thomas] Univ Hosp Northern Norway, Dept Pediat, Tromso, Norway; [Serrano, Maria C.] Univ Miami, Jackson Mem Hosp, Dept Pediat, Div Pediat Cardiol, Miami, FL 33136 USA; [Sitras, Vasilis; Acharya, Ganesh] Univ Hosp Northern Norway, Dept Obstet & Gynecol, Tromso, Norway; [Johansen, Davis; Ytrehus, Kirsti] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Med Biol, Cardiovasc Res Grp, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; University of Miami; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso	Songstad, NT (corresponding author), UiT Arctic Univ Norway, Fac Hlth Sci, Inst Clin Med, Womens Hlth & Perinatol Res Grp, Tromso, Norway.	Nils.songstad@unn.no	Sitras, Vasilis/R-1287-2018	Sitras, Vasilis/0000-0003-3264-3302	Northern Norway Regional Health Authority [1411, 1668, 2038]	Northern Norway Regional Health Authority	This work was supported by research grants from the Northern Norway Regional Health Authority, grant numbers 1411, 1668 and 2038 (http://www.helse-nord.no/about-helse-nord/category5770.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya G, 2009, NORSK EPIDEMIOLOGI, V19; Al Suwaidi J, 2000, CIRCULATION, V101, P948, DOI 10.1161/01.CIR.101.9.948; Aljabri MB, 2011, ACTA PHYSIOL, V201, P445, DOI 10.1111/j.1748-1716.2010.02234.x; Baumgart D, 1998, AM HEART J, V136, P136, DOI 10.1016/S0002-8703(98)70194-2; Blanco PG, 2011, VET J, V190, P154, DOI 10.1016/j.tvjl.2010.08.013; Bottcher M, 2001, CIRCULATION, V103, P1109; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; Dorup I, 1999, AM J PHYSIOL-HEART C, V276, pH821; Gan LM, 2013, J CARDIOVASC TRANSL, V6, P715, DOI 10.1007/s12265-013-9497-5; Hagg U, 2005, CLIN SCI, V109, P325, DOI 10.1042/CS20050052; Hartley CJ, 2008, ULTRASOUND MED BIOL, V34, P892, DOI 10.1016/j.ultrasmedbio.2007.11.019; Hartley CJ, 2007, ULTRASOUND MED BIOL, V33, P512, DOI 10.1016/j.ultrasmedbio.2006.11.002; Hirata K, 2004, CLIN SCI, V107, P449, DOI 10.1042/CS20040226; Hirata K, 2001, J AM COLL CARDIOL, V38, P1879, DOI 10.1016/S0735-1097(01)01658-8; Hirata K, 2007, ARTHRITIS RHEUM-US, V56, P1904, DOI 10.1002/art.22702; HITTINGER L, 1989, CIRC RES, V65, P971, DOI 10.1161/01.RES.65.4.971; HOFFMAN JIE, 1984, CIRCULATION, V70, P153, DOI 10.1161/01.CIR.70.2.153; HOFFMAN JIE, 1990, PHYSIOL REV, V70, P331, DOI 10.1152/physrev.1990.70.2.331; Hozumi T, 1998, CIRCULATION, V97, P1557, DOI 10.1161/01.CIR.97.16.1557; Huusom LD, 2011, BJOG-INT J OBSTET GY, V118, P1, DOI 10.1111/j.1471-0528.2010.02782.x; Khan F, 2008, CLIN SCI, V115, P295, DOI 10.1042/CS20070431; Kinzler WL, 2004, OBSTET GYNECOL, V104, P362, DOI 10.1097/01.AOG.0000134787.24959.9b; LANG RM, 1991, AM HEART J, V121, P1768, DOI 10.1016/0002-8703(91)90024-C; Lethen H, 2003, AM J CARDIOL, V91, P412, DOI 10.1016/S0002-9149(02)03235-6; MARCUS ML, 1982, NEW ENGL J MED, V307, P1362, DOI 10.1056/NEJM198211253072202; Pieper PG, 2013, CIRCULATION, V128, P2478, DOI 10.1161/CIRCULATIONAHA.113.002810; Quinton AE, 2007, HYPERTENS PREGNANCY, V26, P273, DOI 10.1080/10641950701366841; Roos-Hesselink JW, 2013, EUR HEART J, V34, P657, DOI 10.1093/eurheartj/ehs270; Saarelainen H, 2006, CIRC J, V70, P768, DOI 10.1253/circj.70.768; Savvidou MD, 2000, ULTRASOUND OBST GYN, V15, P502, DOI 10.1046/j.1469-0705.2000.00131.x; Schachinger V, 2000, CIRCULATION, V101, P1899, DOI 10.1161/01.CIR.101.16.1899; Seeliger C, 2012, Ultraschall Med, V33, pE126, DOI 10.1055/s-0031-1273488; Sierra-Laguado J, 2006, INT J GYNECOL OBSTET, V93, P60, DOI 10.1016/j.ijgo.2006.01.015; Songstad NT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089559; Valensise H, 2000, ULTRASOUND OBST GYN, V15, P487, DOI 10.1046/j.1469-0705.2000.00135.x; WILSON RF, 1985, CIRCULATION, V72, P82, DOI 10.1161/01.CIR.72.1.82; Wold LE, 2012, CIRC-HEART FAIL, V5, P452, DOI 10.1161/CIRCHEARTFAILURE.112.966580	37	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102147	10.1371/journal.pone.0102147	http://dx.doi.org/10.1371/journal.pone.0102147			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007056	Green Published, Green Submitted, gold			2022-12-27	WOS:000339040600101
J	Huang, R; Zhang, L; Gu, Q; Zhou, YH; Hao, YY; Zhang, K; Liu, Y; Dong, DJ; Wang, SX; Huang, ZH; Lu, S; Wu, C				Huang, Rui; Zhang, Lu; Gu, Qin; Zhou, Yi-Hua; Hao, Yingying; Zhang, Kui; Liu, Yong; Dong, Danjiang; Wang, Shixia; Huang, Zuhu; Lu, Shan; Wu, Chao			Profiles of Acute Cytokine and Antibody Responses in Patients Infected with Avian Influenza A H7N9	PLOS ONE			English	Article							C-VIRUS-INFECTION; RECEPTOR-BINDING; IP-10 PREDICTS; VIRAL RESPONSE; A(H7N9) VIRUS; T-CELLS; CHINA; FERRETS; TRANSMISSION; IMMUNIZATION	The influenza A H7N9 virus outbreak in Eastern China in the spring of 2013 represented a novel, emerging avian influenza transmission to humans. While clinical and microbiological features of H7N9 infection have been reported in the literature, the current study investigated acute cytokine and antibody responses in acute H7N9 infection. Between March 27, 2013 and April 23, 2013, six patients with confirmed H7N9 influenza infection were admitted to Drum Tower Hospital, Nanjing, China. Acute phase serum cytokine profiles were determined using a high-throughput multiplex assay. Daily H7 hemagglutinin (HA)-specific IgG, IgM, and IgA responses were monitored by ELISA. Neutralizing antibodies specific for H7N9 viruses were determined against a pseudotyped virus expressing the novel H7 subtype HA antigen. Five cytokines (IL-6, IP-10, IL-10, IFN gamma, and TNF alpha) were significantly elevated in H7N9-infected patients when compared to healthy volunteers. Serum H7 HA-specific IgG, as well as IgM and IgA responses, were detected within 8 days of disease onset and increased in a similar pattern during acute infection. Neutralizing antibodies developed shortly after the appearance of binding antibody responses and showed similar kinetics as a fraction of the total H7 HA-specific IgG responses. H7N9 infection resulted in hallmark serum cytokine increases, which correlated with fever and disease persistence. The novel finding of simultaneous development of IgG, IgM, and IgA responses in acute H7N9 infection points to the potential for live influenza viruses to elicit fast and potent protective antibodies to limit the infection.	[Huang, Rui; Zhou, Yi-Hua; Wu, Chao] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Infect Dis, Nanjing 210008, Jiangsu, Peoples R China; [Gu, Qin; Hao, Yingying; Dong, Danjiang] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Intens Care Units, Nanjing 210008, Jiangsu, Peoples R China; [Zhou, Yi-Hua; Zhang, Kui; Liu, Yong] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Lab Med, Nanjing 210008, Jiangsu, Peoples R China; [Zhou, Yi-Hua; Liu, Yong] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Jiangsu Key Lab Mol Med, Nanjing 210008, Jiangsu, Peoples R China; [Huang, Rui] Nanjing Univ Chinese Med, Clin Coll Tradit Chinese & Western Med, Nanjing, Jiangsu, Peoples R China; [Zhang, Lu; Huang, Zuhu] Nanjing Med Univ, Dept Infect Dis, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Zhang, Lu; Wang, Shixia; Huang, Zuhu; Lu, Shan] Nanjing Med Univ, Affiliated Hosp 1, China US Vaccine Res Ctr, Nanjing, Jiangsu, Peoples R China; [Wang, Shixia; Lu, Shan] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA	Nanjing University; Nanjing University; Nanjing University; Nanjing University; Nanjing University of Chinese Medicine; Nanjing Medical University; Nanjing Medical University; University of Massachusetts System; University of Massachusetts Worcester	Lu, S (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, China US Vaccine Res Ctr, Nanjing, Jiangsu, Peoples R China.	shan.lu@umassmed.edu; wuchao1962@163.com	Wu, Chao/H-3195-2019; Liu, Yong/GWQ-6163-2022; liu, yong/AAD-1467-2019		National Institutes of Health [5U01AI078073-04]; Jiangsu Province's Outstanding Medical Academic Leader Program [LJ201154]; Jiangsu Science and Technology Department [BL2012034]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI078073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jiangsu Province's Outstanding Medical Academic Leader Program; Jiangsu Science and Technology Department; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health [5U01AI078073-04] to [SL], Jiangsu Province's Outstanding Medical Academic Leader Program [LJ201154] to [CW], and a Special Grant from Jiangsu Science and Technology Department [BL2012034] to [CW]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almansour I, 2013, HUM VACCIN IMMUNOTHE, V9; Bai T, 2013, NEW ENGL J MED, V368, P2339, DOI 10.1056/NEJMc1305865; Belser JA, 2013, NATURE, V501, P556, DOI 10.1038/nature12391; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Chi Y, 2013, J INFECT DIS, V208, P1962, DOI 10.1093/infdis/jit440; Falconer K, 2010, SCAND J INFECT DIS, V42, P896, DOI 10.3109/00365548.2010.498019; Fouchier RAM, 2013, NATURE, V500, P150, DOI 10.1038/500150a; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Hagau N, 2010, CRIT CARE, V14, DOI 10.1186/cc9324; Han J, 2014, MICROBES INFECT; Han JK, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.28; Hvistendahl M, 2013, SCIENCE, V340, P414, DOI 10.1126/science.340.6131.414; Koopmans M, 2013, LANCET, V381, P1882, DOI 10.1016/S0140-6736(13)60936-8; Korn T, 2007, SEMIN IMMUNOL, V19, P362, DOI 10.1016/j.smim.2007.10.007; Lagging M, 2006, HEPATOLOGY, V44, P1617, DOI 10.1002/hep.21407; Lam TTY, 2013, NATURE, V502, P241, DOI 10.1038/nature12515; Liu XD, 2013, J NEUROSURG-SPINE, V19, P2; Middleton D, 2009, J VIROL, V83, P7770, DOI 10.1128/JVI.00241-09; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Mok CKP, 2013, MBIO, V4, DOI 10.1128/mBio.00362-13; Paquette SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038214; Qiu C, 2013, EMERG INFECT DIS, V19, P1685, DOI 10.3201/eid1910.130728; Richard M, 2013, NATURE, V501, P560, DOI 10.1038/nature12476; Romero AI, 2006, J INFECT DIS, V194, P895, DOI 10.1086/507307; Shen Z, 2013, CLIN MICROBIOL INFEC; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N; Tomaras GD, 2013, P NATL ACAD SCI; Wang SX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028757; Wang Y, 2013, AM J RESP CRIT CARE, V188, P115, DOI 10.1164/rccm.201305-0936LE; Wang ZF, 2014, P NATL ACAD SCI USA, V111, P769, DOI 10.1073/pnas.1321748111; Watanabe T, 2013, NATURE, V501, P551, DOI 10.1038/nature12392; Wen YM, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.18; WHO, 2013, HUM INF AV INFL A H7; Wu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082613; Wu H, 2013, N ENGL J MED; Wu SQ, 2013, LANCET, V381, P1539, DOI 10.1016/S0140-6736(13)60767-9; Xiong XL, 2013, NATURE, V499, P496, DOI 10.1038/nature12372; Yang FF, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.22; Yang S, 2013, J INFECT DIS; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165; Yates NL, 2011, AIDS, V25, P2089, DOI 10.1097/QAD.0b013e32834b348e; Yu HJ, 2013, LANCET, V382, P138, DOI 10.1016/S0140-6736(13)61207-6; Yu L, 2013, CLIN INFECT DIS, V57, P1449, DOI 10.1093/cid/cit541; Yu XL, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.41; Yu XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028680; Zhang L, 2014, HUM VACCIN IMMUNOTHE, V10; Zhao GY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092987; Zhou JF, 2013, NATURE, V499, P500, DOI 10.1038/nature12379; Zhu ZQ, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.50	50	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101788	10.1371/journal.pone.0101788	http://dx.doi.org/10.1371/journal.pone.0101788			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003343	Green Submitted, gold, Green Published			2022-12-27	WOS:000339242700067
J	Riemer, S; Muller, C; Viranyi, Z; Huber, L; Range, F				Riemer, Stefanie; Mueller, Corsin; Viranyi, Zsofia; Huber, Ludwig; Range, Friederike			The Predictive Value of Early Behavioural Assessments in Pet Dogs - A Longitudinal Study from Neonates to Adults	PLOS ONE			English	Article							GERMAN-SHEPHERD DOGS; PRINCIPAL-COMPONENTS-ANALYSIS; POTENTIAL GUIDE DOGS; INDIVIDUAL-DIFFERENCES; INFANT TEMPERAMENT; CANIS-LUPUS; PARUS-MAJOR; GREAT TITS; PERSONALITY; STABILITY	Studies on behavioural development in domestic dogs are of relevance for matching puppies with the right families, identifying predispositions for behavioural problems at an early stage, and predicting suitability for service dog work, police or military service. The literature is, however, inconsistent regarding the predictive value of tests performed during the socialisation period. Additionally, some practitioners use tests with neonates to complement later assessments for selecting puppies as working dogs, but these have not been validated. We here present longitudinal data on a cohort of Border collies, followed up from neonate age until adulthood. A neonate test was conducted with 99 Border collie puppies aged 2-10 days to assess activity, vocalisations when isolated and sucking force. At the age of 40-50 days, 134 puppies (including 93 tested as neonates) were tested in a puppy test at their breeders' homes. All dogs were adopted as pet dogs and 50 of them participated in a behavioural test at the age of 1.5 to 2 years with their owners. Linear mixed models found little correspondence between individuals' behaviour in the neonate, puppy and adult test. Exploratory activity was the only behaviour that was significantly correlated between the puppy and the adult test. We conclude that the predictive validity of early tests for predicting specific behavioural traits in adult pet dogs is limited.	[Riemer, Stefanie; Mueller, Corsin; Viranyi, Zsofia; Huber, Ludwig; Range, Friederike] Med Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Clever Dog Lab, Vienna, Austria; [Riemer, Stefanie; Mueller, Corsin; Viranyi, Zsofia; Huber, Ludwig; Range, Friederike] Univ Vienna, Vienna, Austria; [Riemer, Stefanie; Mueller, Corsin] Univ Vienna, Dept Cognit Biol, Vienna, Austria	Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna; University of Vienna	Riemer, S (corresponding author), Med Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Clever Dog Lab, Vienna, Austria.	riemer.stefanie@gmail.com		Range, Friederike/0000-0003-3127-5536; Riemer, Stefanie/0000-0001-8008-5291; Huber, Ludwig/0000-0002-0217-136X	Austrian Science Fund (FWF) [P21418]; FWF DK CogCom Programme; FWF [P21244-B17]; WWTF [CS11-005, CS11-026]; Austrian Science Fund (FWF) [P 21418] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); FWF DK CogCom Programme; FWF(Austrian Science Fund (FWF)); WWTF; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund (FWF) grant P21418 to L.H. and F.R.; FWF DK CogCom Programme to S.R.; FWF grant P21244-B17 to F.R. www.fwf.ac.at; WWTF grant CS11-005 to L.H.; WWTF grant CS11-026 to Zs.V., www.wwtf.at. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleby DL, 2002, VET REC, V150, P434, DOI 10.1136/vr.150.14.434; Asher L, 2013, J VET BEHAV, V8, P431, DOI 10.1016/j.jveb.2013.08.004; BEAUDET R, 1994, APPL ANIM BEHAV SCI, V40, P273, DOI 10.1016/0168-1591(94)90068-X; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Carere C, 2004, PHYSIOL BEHAV, V82, P905, DOI 10.1016/j.physbeh.2004.07.009; Carere C, 2005, ANIM BEHAV, V70, P795, DOI 10.1016/j.anbehav.2005.01.003; Costa PT, 2000, ASSESSMENT, V7, P365, DOI 10.1177/107319110000700405; CROCKENBERG SB, 1982, INFANT BEHAV DEV, V5, P105, DOI 10.1016/S0163-6383(82)80021-0; Foyer P, 2014, APPL ANIM B IN PRESS; Foyer P, 2013, APPL ANIM BEHAV SCI, V146, P79, DOI 10.1016/j.applanim.2013.03.013; FRANCIS RC, 1990, ETHOLOGY, V86, P311, DOI 10.1111/j.1439-0310.1990.tb00439.x; Fratkin JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054907; FREEDMAN DG, 1961, SCIENCE, V133, P1016, DOI 10.1126/science.133.3457.1016; GODDARD ME, 1982, THEOR APPL GENET, V62, P97, DOI 10.1007/BF00293339; GODDARD ME, 1986, APPL ANIM BEHAV SCI, V15, P247, DOI 10.1016/0168-1591(86)90095-X; GODDARD ME, 1984, APPL ANIM BEHAV SCI, V12, P253, DOI 10.1016/0168-1591(84)90118-7; Goddard ME, 1986, EARLY PREDICTION ADU; Heath-Lange S, 1999, AM J PRIMATOL, V47, P43, DOI 10.1002/(SICI)1098-2345(1999)47:1<43::AID-AJP5>3.0.CO;2-M; HOLM S, 1979, SCAND J STAT, V6, P65; HUBERT NC, 1982, CHILD DEV, V53, P571, DOI 10.2307/1129370; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; KORNER AF, 1971, AM J ORTHOPSYCHIAT, V41, P608, DOI 10.1111/j.1939-0025.1971.tb03220.x; Korner AF, 2010, AM J ORTHOPSYCHIAT, V41, P608; Kubinyi E, 2009, BEHAV PROCESS, V81, P392, DOI 10.1016/j.beproc.2009.04.004; Lansade L, 2008, APPL ANIM BEHAV SCI, V115, P182, DOI 10.1016/j.applanim.2008.06.011; Lehmann J, 2002, PHARMACOL BIOCHEM BE, V73, P141, DOI 10.1016/S0091-3057(02)00788-8; Lindsay S. R., 2000, HDB APPL DOG BEHAV T, V1; Linting M, 2007, PSYCHOL METHODS, V12, P336, DOI 10.1037/1082-989X.12.3.336; Linting M, 2012, J PERS ASSESS, V94, P12, DOI 10.1080/00223891.2011.627965; LOEHLIN JC, 1989, CHILD DEV, V60, P993, DOI 10.2307/1131039; Lord K, 2013, ETHOLOGY, V119, P110, DOI 10.1111/eth.12044; Lower SE, 2001, ANIM BEHAV, V61, P231, DOI 10.1006/anbe.2000.1545; MACDONALD K, 1983, J COMP PSYCHOL, V97, P99; MATHENY AP, 1985, DEV PSYCHOL, V21, P486, DOI 10.1037/0012-1649.21.3.486; McCrae RR, 2000, J PERS SOC PSYCHOL, V78, P173, DOI 10.1037/0022-3514.78.1.173; Miklosi A., 2009, DOG BEHAV EVOLUTION; MIRZA SN, 1990, APPL ANIM BEHAV SCI, V28, P255, DOI 10.1016/0168-1591(90)90104-L; Overall KL, 2005, ILAR J, V46, P202, DOI 10.1093/ilar.46.2.202; Pinheiro J., 2013, R PACKAGE3, P1; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Riemer S, 2013, APPL ANIM BEHAV SCI, V149, P36, DOI 10.1016/j.applanim.2013.09.006; Roberts BW, 2000, PSYCHOL BULL, V126, P3, DOI 10.1037/0033-2909.126.1.3; Romeo RD, 2003, J NEUROENDOCRINOL, V15, P1185, DOI 10.1111/j.1365-2826.2003.01106.x; Rooney NJ, 2011, APPL ANIM BEHAV SCI, V132, P169, DOI 10.1016/j.applanim.2011.03.007; Rooney NJ, 2004, APPL ANIM BEHAV SCI, V86, P123, DOI 10.1016/j.applanim.2003.12.007; Rothbart M.K., 1994, TEMPERAMENT INDIVIDU, P83, DOI DOI 10.1037/10149-003; Sachser N, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0344; Saetre P, 2006, GENES BRAIN BEHAV, V5, P240, DOI 10.1111/j.1601-183X.2005.00155.x; Schoberl I, 2012, ANTHROZOOS, V25, P199, DOI 10.2752/175303712X13316289505422; Schulz KM, 2009, HORM BEHAV, V55, P597, DOI 10.1016/j.yhbeh.2009.03.010; Scott J., 1976, GUIDE DOGS BLIND THE, P39; Scott JP., 1965, GENETICS SOCIAL BEHA; Sinn DL, 2010, APPL ANIM BEHAV SCI, V127, P51, DOI 10.1016/j.applanim.2010.08.007; Slabbert JM, 1999, APPL ANIM BEHAV SCI, V64, P269, DOI 10.1016/S0168-1591(99)00038-6; Stamps J, 2010, BIOL REV, V85, P301, DOI 10.1111/j.1469-185X.2009.00103.x; STEVENSON-HINDE J, 1980, Primates, V21, P66, DOI 10.1007/BF02383825; Strandberg E, 2005, LIVEST PROD SCI, V93, P33, DOI 10.1016/j.livprodsci.2004.11.004; Sussman A, 2011, DEV PSYCHOL, V47, P781, DOI 10.1037/a0022999; Svobodova I, 2008, APPL ANIM BEHAV SCI, V113, P139, DOI 10.1016/j.applanim.2007.09.010; Taylor KD, 2006, J VET BEHAV, V1, P94, DOI 10.1016/j.jveb.2006.09.002; van der Waaij EH, 2008, J ANIM SCI, V86, P2853, DOI 10.2527/jas.2007-0616; Visser EK, 2001, APPL ANIM BEHAV SCI, V74, P241, DOI 10.1016/S0168-1591(01)00177-0; Webster SD, 1997, P 1 INT C VET BEH ME, P20; Weinstein TAR, 2008, ANIM BEHAV, V76, P455, DOI 10.1016/j.anbehav.2008.01.024; Wilsson E, 1998, APPL ANIM BEHAV SCI, V58, P151, DOI 10.1016/S0168-1591(97)00093-2; Wilsson E, 1997, APPL ANIM BEHAV SCI, V53, P279, DOI 10.1016/S0168-1591(96)01174-4; WOROBEY J, 1989, DEV PSYCHOL, V25, P257, DOI 10.1037/0012-1649.25.2.257	67	33	33	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101237	10.1371/journal.pone.0101237	http://dx.doi.org/10.1371/journal.pone.0101237			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003341	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000339242700022
J	Cesari, M; Demougeot, L; Boccalon, H; Guyonnet, S; Van Kan, GA; Vellas, B; Andrieu, S				Cesari, Matteo; Demougeot, Laurent; Boccalon, Henri; Guyonnet, Sophie; Van Kan, Gabor Abellan; Vellas, Bruno; Andrieu, Sandrine			A Self-Reported Screening Tool for Detecting Community-Dwelling Older Persons with Frailty Syndrome in the Absence of Mobility Disability: The FiND Questionnaire	PLOS ONE			English	Article							LIFE-STYLE INTERVENTIONS; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; CLINICAL-PRACTICE; INDEPENDENCE; MORTALITY; PERFORMANCE; LIMITATION; CONSENSUS; VALIDITY	Background: The "frailty syndrome'' (a geriatric multidimensional condition characterized by decreased reserve and diminished resistance to stressors) represents a promising target of preventive interventions against disability in elders. Available screening tools for the identification of frailty in the absence of disability present major limitations. In particular, they have to be administered by a trained assessor, require special equipment, and/or do not discriminate between frail and disabled individuals. Aim of this study is to verify the agreement of a novel self-reported questionnaire (the "Frail Non-Disabled'' [FiND] instrument) designed for detecting non-mobility disabled frail older persons with results from reference tools. Methodology/Principal Findings: Data are from 45 community-dwelling individuals aged >= 60 years. Participants were asked to complete the FiND questionnaire separately exploring the frailty and disability domains. Then, a blinded assessor objectively measured the frailty status (using the phenotype proposed by Fried and colleagues) and mobility disability (using the 400-meter walk test). Cohen's kappa coefficients were calculated to determine the agreement between the FiND questionnaire with the reference instruments. Mean age of participants (women 62.2%) was 72.5 (standard deviation 8.2) years. Seven (15.6%) participants presented mobility disability as being unable to complete the 400-meter walk test. According to the frailty phenotype criteria, 25 (55.6%) participants were pre-frail or frail, and 13 (28.9%) were robust. Overall, a substantial agreement of the instrument with the reference tools (kappa = 0.748, quadratic weighted kappa = 0.836, both p values<0.001) was reported with only 7 (15.6%) participants incorrectly categorized. The agreement between results of the FiND disability domain and the 400-meter walk test was excellent (kappa = 0.920, p<0.001). Conclusions/Significance: The FiND questionnaire presents a very good capacity to correctly identify frail older persons without mobility disability living in the community. This screening tool may represent an opportunity for diffusing awareness about frailty and disability and supporting specific preventive campaigns.	[Cesari, Matteo; Demougeot, Laurent; Boccalon, Henri; Guyonnet, Sophie; Van Kan, Gabor Abellan; Vellas, Bruno; Andrieu, Sandrine] Ctr Hosp Univ Toulouse, Gerontopole, Inst Vieillissement, Toulouse, France; [Cesari, Matteo; Van Kan, Gabor Abellan; Vellas, Bruno; Andrieu, Sandrine] Univ Toulouse 3, INSERM, UMR1027, F-31062 Toulouse, France	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Cesari, M (corresponding author), Ctr Hosp Univ Toulouse, Gerontopole, Inst Vieillissement, Toulouse, France.	macesari@gmail.com	Cesari, Matteo/A-4649-2008; ANDRIEU, Sandrine/G-1343-2018; van Kan, Gabor Abellan/AAD-1411-2020	Cesari, Matteo/0000-0002-0348-3664; ANDRIEU, Sandrine/0000-0002-1142-770X; 	MINDED project	MINDED project	The MINDED project is funded as a Chair of Excellence of the Agence Nationale de Recherche assigned to Dr. Cesari. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Ensrud KE, 2008, ARCH INTERN MED, V168, P382, DOI 10.1001/archinternmed.2007.113; Ferrucci L, 2004, J AM GERIATR SOC, V52, P625, DOI 10.1111/j.1532-5415.2004.52174.x; Fielding RA, 2011, J GERONTOL A-BIOL, V66, P1226, DOI 10.1093/gerona/glr123; FLACK VF, 1988, PSYCHOMETRIKA, V53, P321, DOI 10.1007/BF02294215; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Hardy SE, 2011, J GEN INTERN MED, V26, P130, DOI 10.1007/s11606-010-1543-2; Hebert R, 1996, AGE AGEING, V25, P159; Hebert R, 2010, J GERONTOL B-PSYCHOL, V65, P107, DOI 10.1093/geronb/gbp027; Hirvensalo M, 2000, J AM GERIATR SOC, V48, P493, DOI 10.1111/j.1532-5415.2000.tb04994.x; Hoogendijk EO, 2013, AGE AGEING, V42, P262, DOI 10.1093/ageing/afs163; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; Martin MY, 2006, J AGING PHYS ACTIV, V14, P392, DOI 10.1123/japa.14.4.392; Morley JE, 2012, J NUTR HEALTH AGING, V16, P601, DOI 10.1007/s12603-012-0084-2; Morley JE, 2013, J AM MED DIR ASSOC, V14, P392, DOI 10.1016/j.jamda.2013.03.022; Newman AB, 2006, JAMA-J AM MED ASSOC, V295, P2018, DOI 10.1001/jama.295.17.2018; ORME JG, 1986, J CLIN PSYCHOL, V42, P28, DOI 10.1002/1097-4679(198601)42:1<28::AID-JCLP2270420104>3.0.CO;2-T; Pahor M, 2006, J GERONTOL A-BIOL, V61, P1157; RAPHAEL D, 1995, CAN J PUBLIC HEALTH, V86, P224; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Rodriguez-Manas L, 2013, J GERONTOL A-BIOL, V68, P62, DOI 10.1093/gerona/gls119; Rolland YM, 2004, J AM GERIATR SOC, V52, P972, DOI 10.1111/j.1532-5415.2004.52267.x; Santos-Eggimann B, 2009, J GERONTOL A-BIOL, V64, P675, DOI 10.1093/gerona/glp012; Siscovick DS, 1997, AM J EPIDEMIOL, V145, P977; Subra J, 2012, J NUTR HEALTH AGING, V16, P714, DOI 10.1007/s12603-012-0391-7; TAYLOR HL, 1978, J CHRON DIS, V31, P741, DOI 10.1016/0021-9681(78)90058-9; Vellas B, 2013, J NUTR HEALTH AGING, V17, P629, DOI 10.1007/s12603-013-0363-6; Vellas B, 2012, J NUTR HEALTH AGING, V16, P599, DOI 10.1007/s12603-012-0096-y	29	51	53	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101745	10.1371/journal.pone.0101745	http://dx.doi.org/10.1371/journal.pone.0101745			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7WB	24999805	Green Published, Green Submitted, gold			2022-12-27	WOS:000338637300081
J	Ciucci, A; Meco, D; De Stefano, I; Travaglia, D; Zannoni, GF; Scambia, G; Riccardi, R; Saran, A; Mancuso, M; Gallo, D				Ciucci, Alessandra; Meco, Daniela; De Stefano, Ilaria; Travaglia, Daniele; Zannoni, Gian Franco; Scambia, Giovanni; Riccardi, Riccardo; Saran, Anna; Mancuso, Mariateresa; Gallo, Daniela			Gender Effect in Experimental Models of Human Medulloblastoma: Does the Estrogen Receptor beta Signaling Play a Role?	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; CANCER CELL-PROLIFERATION; ALPHA ER-ALPHA; DNA-REPAIR; EXPRESSION; GROWTH; ER-BETA-2; CHILDREN; SURVIVAL; NUCLEAR	Background: The male-to-female sex ratio for medulloblastoma (MB) is approximately 1.5:1, female gender being also a favorable prognostic factor. This study aimed at evaluating the impact of gender on MB tumorigenesis. Methods: In vitro activity of 17 beta-estradiol (E-2), DPN [2,3-bis(4-hydroxyphenyl)-propionitrile, a selective estrogen receptor beta (ER beta)-agonist], PPT [4,4',4 ''-(4-Propyl-[1H]-pyrazole-1,3,5-triyl) trisphenol, a selective ER alpha-agonist] or DHT (5 alpha-dihydrotestosterone) was evaluated in three human MB cell lines. D283 Med cells were transplanted into athymic mice. Results: A significant expression of ERb, with little or no ER alpha, and low AR (androgen receptor) was found in MB cell lines. The compounds tested did not affect cell proliferation. In vivo, we observed a significantly lower growth of D283 Med in nude female mice compared to males. At microscopic examination, tumors from females showed a shift towards differentiation, as evaluated by lower nestin, and higher NSE (neuron-specific enolase) and GFAP (glial fibrillary acidic protein) expression compared to males. Tumors from females also showed lower Ki67 and p53 expression. The wild-type ER beta protein (ER beta 1) was lost in male tumors, while it was a permanent feature in females, and a strong negative correlation was found between Ki67 and ER beta 1 expression. Conversely, tumor levels of ER beta 2 and ER beta 5 did not significantly differ between genders. Increased levels of cyclin-dependent kinase inhibitor p21 were observed in females, suggesting that estrogen may decrease tumor growth through blocking cell cycle progression. An inhibition of the insulin-like growth factor I (IGF-I) signaling was also evident in females. Conclusion: We provides mechanistic evidence supporting the idea that ERb1 signaling may have pro-differentiation and tumor suppressive function in medulloblastomas.	[Ciucci, Alessandra; Travaglia, Daniele; Scambia, Giovanni; Gallo, Daniela] Univ Cattolica Sacro Cuore, Dept Obstet & Gynecol, I-00168 Rome, Italy; [Meco, Daniela; Riccardi, Riccardo] Univ Cattolica Sacro Cuore, Div Pediat Oncol, I-00168 Rome, Italy; [De Stefano, Ilaria] Univ Guglielmo Marconi, Dept Radiat Phys, Rome, Italy; [Zannoni, Gian Franco] Univ Cattolica Sacro Cuore, Dept Histopathol, I-00168 Rome, Italy; [Saran, Anna; Mancuso, Mariateresa] CR Casaccia, Agenzia Nazl Nuove Tecnol Energia & Sviluppo Econ, Lab Radiat Biol & Biomed, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Guglielmo Marconi University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Italian National Agency New Technical Energy & Sustainable Economics Development	Gallo, D (corresponding author), Univ Cattolica Sacro Cuore, Dept Obstet & Gynecol, Largo A Gemelli 8, I-00168 Rome, Italy.	d.gallo@rm.unicatt.it	Zannoni, Gian Franco/AAC-4754-2020; Gallo, Daniela/K-2518-2018	Zannoni, Gian Franco/0000-0002-4473-7560; Gallo, Daniela/0000-0002-1918-1054; Saran, Anna/0000-0002-5587-064X; Meco, Daniela/0000-0003-3488-4185; RICCARDI, RICCARDO/0000-0001-7515-6622				Ajeawung NF, 2012, CLIN INVEST MED, V35, pE246; Arai H, 2012, BRAIN TUMOR PATHOL, V29, P160, DOI 10.1007/s10014-012-0081-5; Barone TA, 2009, J NEURO-ONCOL, V95, P37, DOI 10.1007/s11060-009-9904-6; Belcher SM, 2009, ENDOCRINOLOGY, V150, P1112, DOI 10.1210/en.2008-1363; Bielecki A, 2011, NUTR CANCER, V63, P139, DOI 10.1080/01635581.2010.516867; Brandes AA, 2004, CRIT REV ONCOL HEMAT, V50, P121, DOI 10.1016/j.critrevonc.2003.08.005; Brandes AA, 2009, CRIT REV ONCOL HEMAT, V71, P165, DOI 10.1016/j.critrevonc.2009.02.002; Cardona-Gomez GP, 2001, BRAIN RES REV, V37, P320, DOI 10.1016/S0165-0173(01)00137-0; Chen S, 1999, ENDOCR-RELAT CANCER, V6, P149, DOI 10.1677/erc.0.0060149; Ciucci A, 2014, GYNECOL ONCOL, V132, P351, DOI 10.1016/j.ygyno.2013.12.027; Collins F, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-330; Corbert T., 1997, ANTICANCER DRUG DEV, P75; Curran EK, 2009, PEDIATR BLOOD CANCER, V52, P60, DOI 10.1002/pbc.21832; de Bont JM, 2008, INT J CANCER, V123, P594, DOI 10.1002/ijc.23558; De Stefano I, 2009, BIOCHEM PHARMACOL, V78, P1374, DOI 10.1016/j.bcp.2009.07.011; Dean SL, 2008, CEREBELLUM, V7, P38, DOI 10.1007/s12311-008-0003-6; Dey P, 2012, MOL ENDOCRINOL, V26, P1991, DOI 10.1210/me.2012.1227; Eberhart CG, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-19; Gallo D, 2008, J NUTR, V138, P1360, DOI 10.1093/jn/138.7.1360; Gallo D, 2012, CURR PHARM DESIGN, V18, P2734, DOI 10.2174/138161212800626139; Hall JM, 1999, ENDOCRINOLOGY, V140, P5566, DOI 10.1210/en.140.12.5566; Hartman J, 2009, CANCER RES, V69, P6100, DOI 10.1158/0008-5472.CAN-09-0506; HAYASHI K, 1987, ACTA PATHOL JAPON, V37, P85; Hayat MA, 2002, MICROSCOPY IMMUNOHIS, P276; Hedges VL, 2012, FRONT NEUROENDOCRIN, V33, P403, DOI 10.1016/j.yfrne.2012.08.005; Jakab RL, 2001, J COMP NEUROL, V430, P396, DOI 10.1002/1096-9861(20010212)430:3<396::AID-CNE1039>3.0.CO;2-0; Kabat GC, 2010, CANCER EPIDEM BIOMAR, V19, P2421, DOI 10.1158/1055-9965.EPI-10-0658; Kefalopoulou Z, 2012, J NEURO-ONCOL, V106, P23, DOI 10.1007/s11060-011-0637-y; Keles GE, 1995, ONCOL RES, V7, P493; KUMANISHI T, 1985, ACTA NEUROPATHOL, V67, P1, DOI 10.1007/BF00688118; Leung YK, 2006, P NATL ACAD SCI USA, V103, P13162, DOI 10.1073/pnas.0605676103; Lin HY, 2009, J STEROID BIOCHEM, V113, P182, DOI 10.1016/j.jsbmb.2008.12.010; Lindgren PR, 2004, MOL CELL ENDOCRINOL, V221, P97, DOI 10.1016/j.mce.2004.02.020; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Majid S, 2008, CANCER RES, V68, P2736, DOI 10.1158/0008-5472.CAN-07-2290; Mancuso M, 2011, CANCER LETT, V308, P197, DOI 10.1016/j.canlet.2011.05.004; Mancuso M, 2010, INT J CANCER, V127, P2749, DOI 10.1002/ijc.25293; Mendoza RA, 2011, J ENDOCRINOL, V208, P1, DOI 10.1677/JOE-10-0235; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; Plunkett RJ, 1999, J NEUROSURG, V90, P1072, DOI 10.3171/jns.1999.90.6.1072; PRADOS MD, 1995, INT J RADIAT ONCOL, V32, P1145, DOI 10.1016/0360-3016(94)00476-2; PRESTONMARTIN S, 1993, NEUROEPIDEMIOLOGY, V12, P270, DOI 10.1159/000110328; Ray A, 2004, CLIN CANCER RES, V10, P7613, DOI 10.1158/1078-0432.CCR-04-0499; Roger P, 2001, CANCER RES, V61, P2537; Saran A, 2009, CURR MOL MED, V9, P1046, DOI 10.2174/156652409789839080; Sareddy GR, 2012, MOL CANCER THER, V11, P1174, DOI 10.1158/1535-7163.MCT-11-0960; Saunders PTK, 2002, BRIT J CANCER, V86, P250, DOI 10.1038/sj/bjc/6600035; Saunders PTK, 2002, J CLIN ENDOCR METAB, V87, P2706, DOI 10.1210/jc.87.6.2706; Shaaban AM, 2008, CLIN CANCER RES, V14, P5228, DOI 10.1158/1078-0432.CCR-07-4528; Sime P J, 1989, Br J Neurosurg, V3, P89, DOI 10.3109/02688698909001030; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Skliris GP, 2006, BRIT J CANCER, V95, P616, DOI 10.1038/sj.bjc.6603295; Sonne-Hansen K, 2005, J STEROID BIOCHEM, V93, P25, DOI 10.1016/j.jsbmb.2004.11.005; Sun T, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-3; Tabori U, 2010, J CLIN ONCOL, V28, P1345, DOI 10.1200/JCO.2009.23.5952; Treeck O, 2008, BREAST CANCER RES TR, V110, P507, DOI 10.1007/s10549-007-9749-7; Treeck O, 2010, BREAST CANCER RES TR, V120, P557, DOI 10.1007/s10549-009-0413-2; Urbanska K, 2009, J CELL PHYSIOL, V219, P392, DOI 10.1002/jcp.21683; Warfel NA, 2013, CURR OPIN ONCOL, V25, P52, DOI 10.1097/CCO.0b013e32835b639e; Weil MD, 1998, JAMA-J AM MED ASSOC, V279, P1474, DOI 10.1001/jama.279.18.1474; Wong NACS, 2005, J PATHOL, V207, P53, DOI 10.1002/path.1807; Workman P, 1998, BRIT J CANCER, V77, P1; Wu XL, 2012, J CELL BIOCHEM, V113, P711, DOI 10.1002/jcb.23443; Wu XL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2844; Yan M, 2011, BREAST CANCER RES TR, V126, P395, DOI 10.1007/s10549-010-0941-9; Zannoni GF, 2013, HUM PATHOL, V44, P1047, DOI 10.1016/j.humpath.2012.09.007	67	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101623	10.1371/journal.pone.0101623	http://dx.doi.org/10.1371/journal.pone.0101623			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000562	Green Published, gold, Green Submitted			2022-12-27	WOS:000338637300063
J	Greenbaum, BD; Kumar, P; Libchaber, A				Greenbaum, Benjamin D.; Kumar, Pradeep; Libchaber, Albert			Using First Passage Statistics to Extract Environmentally Dependent Amino Acid Correlations	PLOS ONE			English	Article							SALT BRIDGES; PROTEINS; BIOTECHNOLOGY; PROKARYOTES; DISULFIDES; PATTERNS	In this work, we study the first passage statistics of amino acid primary sequences, that is the probability of observing an amino acid for the first time at a certain number of residues away from a fixed amino acid. By using this rich mathematical framework, we are able to capture the background distribution for an organism, and infer lengths at which the first passage has a probability that differs from what is expected. While many features of an organism's genome are due to natural selection, others are related to amino acid chemistry and the environment in which an organism lives, constraining the randomness of genomes upon which selection can further act. We therefore use this approach to infer amino acid correlations, and then study how these correlations vary across a wide range of organisms under a wide range of optimal growth temperatures. We find a nearly universal exponential background distribution, consistent with the idea that most amino acids are globally uncorrelated from other amino acids in genomes. When we are able to extract significant correlations, these correlations are reliably dependent on optimal growth temperature, across phylogenetic boundaries. Some of the correlations we extract, such as the enhanced probability of finding, for the first time, a cysteine three residues away from a cysteine or glutamic acid two residues away from an arginine, likely relate to thermal stability. However, other correlations, likely appearing on alpha helical surfaces, have a less clear physiochemical interpretation and may relate to thermal stability or unusual metabolic properties of organisms that live in a high temperature environment.	[Greenbaum, Benjamin D.] Icahn Sch Med Mt Sinai, Dept Med, Div Hematol & Med Oncol & Pathol, New York, NY 10029 USA; [Greenbaum, Benjamin D.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Greenbaum, Benjamin D.; Libchaber, Albert] Simons Ctr Syst Biol, Inst Adv Study, Princeton, NJ USA; [Kumar, Pradeep; Libchaber, Albert] Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10021 USA; [Kumar, Pradeep] Univ Arkansas, Dept Phys, Little Rock, AR 72204 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Institute for Advanced Study - USA; Rockefeller University; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock	Greenbaum, BD (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, Div Hematol & Med Oncol & Pathol, New York, NY 10029 USA.	benjamin.greenbaum@mssm.edu		Kumar, Pradeep/0000-0002-7417-9467	Simons Center for Systems Biology at the Institute for Advanced Study	Simons Center for Systems Biology at the Institute for Advanced Study	The work was supported by the Simons Center for Systems Biology at the Institute for Advanced Study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDOUS D, 1983, LECT NOTES MATH, V986, P243; Aldous DJ., 1982, STOCHASTIC PROCESS A, V13, P305, DOI [10.1016/0304-4149(82)90016-3, DOI 10.1016/0304-4149(82)90016-3]; Barton LL, 2009, ADV APPL MICROBIOL, V68, P41, DOI 10.1016/S0065-2164(09)01202-7; Beeby M, 2005, PLOS BIOL, V3, P1549, DOI 10.1371/journal.pbio.0030309; Bosshard HR, 2004, J MOL RECOGNIT, V17, P1, DOI 10.1002/jmr.657; Bragg JG, 2006, P ROY SOC B-BIOL SCI, V273, P1293, DOI 10.1098/rspb.2005.3441; BURGE C, 1992, P NATL ACAD SCI USA, V89, P1358, DOI 10.1073/pnas.89.4.1358; Chakravarty S, 2002, BIOCHEMISTRY-US, V41, P8152, DOI 10.1021/bi025523t; Chan CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021624; Chung K.L, 1967, MARKOV CHAINS STATIO; de Farias ST, 2002, GENOME BIOL, V3; Dokmanic I, 2008, ACTA CRYSTALLOGR D, V64, P257, DOI 10.1107/S090744490706595X; Dudev T, 2008, ANNU REV BIOPHYS, V37, P97, DOI 10.1146/annurev.biophys.37.032807.125811; Feller W., 2008, INTRO PROBABILITY TH, V2; Greenbaum B, 2013, ARXIV13094761; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Horikoshi K., 2011, EXTREMOPHILES HDB; Keilson J., 1979, MARKOV CHAIN MODELS; Klipcan L, 2006, FEBS LETT, V580, P1672, DOI 10.1016/j.febslet.2006.02.013; Kumar P, 2013, BIOPHYS J IN PRESS; Kumar S, 2000, PROTEINS, V38, P368, DOI 10.1002/(SICI)1097-0134(20000301)38:4<368::AID-PROT3>3.0.CO;2-R; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Ladenstein R, 2008, EXTREMOPHILES, V12, P29, DOI 10.1007/s00792-007-0076-z; Ladenstein R, 2006, FEBS J, V273, P4170, DOI 10.1111/j.1742-4658.2006.05421.x; Liang HK, 2005, PROTEINS, V59, P58, DOI 10.1002/prot.20386; Marino SM, 2012, J BIOL CHEM, V287, P4419, DOI 10.1074/jbc.R111.275578; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Muyzer G, 2008, NAT REV MICROBIOL, V6, P441, DOI 10.1038/nrmicro1892; Rietsch A, 1998, ANNU REV GENET, V32, P163, DOI 10.1146/annurev.genet.32.1.163; Rosato V, 2002, TRENDS GENET, V18, P278, DOI 10.1016/S0168-9525(02)02691-4; Rosenzweig AC, 2002, CHEM BIOL, V9, P673, DOI 10.1016/S1074-5521(02)00156-4; Schneider KL, 2006, NUCLEIC ACIDS RES, V34, pD407, DOI 10.1093/nar/gkj134; Singer GAC, 2003, GENE, V317, P39, DOI 10.1016/S0378-1119(03)00660-7; Suhre K, 2003, J BIOL CHEM, V19, P513; Wouters MA, 2010, ANTIOXID REDOX SIGN, V12, P53, DOI [10.1089/ars.2009.2510, 10.1089/ARS.2009.2510]; Zeldovich KB, 2007, PLOS COMPUT BIOL, V3, P62, DOI 10.1371/journal.pcbi.0030005; Zhou XX, 2008, AMINO ACIDS, V34, P25, DOI 10.1007/s00726-007-0589-x	38	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101665	10.1371/journal.pone.0101665	http://dx.doi.org/10.1371/journal.pone.0101665			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000191	Green Published, Green Submitted, gold			2022-12-27	WOS:000338637300068
J	Hinchliff, CE; Smith, SA				Hinchliff, Cody E.; Smith, Stephen Andrew			Some Limitations of Public Sequence Data for Phylogenetic Inference (in Plants)	PLOS ONE			English	Article							NUCLEOTIDE-SEQUENCES; SPARSE SUPERMATRICES; ROGUE TAXA; DIVERSIFICATION; LIKELIHOOD; GENES; LIFE; TREE; MITOCHONDRIAL; HISTORY	The GenBank database contains essentially all of the nucleotide sequence data generated for published molecular systematic studies, but for the majority of taxa these data remain sparse. GenBank has value for phylogenetic methods that leverage data-mining and rapidly improving computational methods, but the limits imposed by the sparse structure of the data are not well understood. Here we present a tree representing 13,093 land plant genera-an estimated 80% of extant plant diversity-to illustrate the potential of public sequence data for broad phylogenetic inference in plants, and we explore the limits to inference imposed by the structure of these data using theoretical foundations from phylogenetic data decisiveness. We find that despite very high levels of missing data (over 96%), the present data retain the potential to inform over 86.3% of all possible phylogenetic relationships. Most of these relationships, however, are informed by small amounts of data-approximately half are informed by fewer than four loci, and more than 99% are informed by fewer than fifteen. We also apply an information theoretic measure of branch support to assess the strength of phylogenetic signal in the data, revealing many poorly supported branches concentrated near the tips of the tree, where data are sparse and the limiting effects of this sparseness are stronger. We argue that limits to phylogenetic inference and signal imposed by low data coverage may pose significant challenges for comprehensive phylogenetic inference at the species level. Computational requirements provide additional limits for large reconstructions, but these may be overcome by methodological advances, whereas insufficient data coverage can only be remedied by additional sampling effort. We conclude that public databases have exceptional value for modern systematics and evolutionary biology, and that a continued emphasis on expanding taxonomic and genomic coverage will play a critical role in developing these resources to their full potential.	[Hinchliff, Cody E.; Smith, Stephen Andrew] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Hinchliff, CE (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	cody.hinchliff@gmail.com	Smith, Stephen/AAE-8623-2019	Smith, Stephen/0000-0003-2035-9531	National Science Foundation [DEB 1207915]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation (http://www.nsf.gov/) award DEB 1207915 to S. A. Smith. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberer AJ, 2013, SYST BIOL, V62, P162, DOI 10.1093/sysbio/sys078; Aliscioni S, 2012, NEW PHYTOL, V193, P304, DOI 10.1111/j.1469-8137.2011.03972.x; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Chang Y, 2011, AM J BOT, V98, P839, DOI 10.3732/ajb.0900384; CHASE MW, 1993, ANN MO BOT GARD, V80, P528, DOI 10.2307/2399846; Chase MW, 2004, AM J BOT, V91, P1645, DOI 10.3732/ajb.91.10.1645; Chesters D, 2013, SYST BIOL; Dress AWM, 2012, MATH BIOL, V105, P65; Driskell AC, 2004, SCIENCE, V306, P1172, DOI 10.1126/science.1102036; Edwards EJ, 2010, P NATL ACAD SCI USA, V107, P2532, DOI 10.1073/pnas.0909672107; Finet C, 2010, CURR BIOL, V20, P2217, DOI 10.1016/j.cub.2010.11.035; Govaerts R, 2003, TAXON, V52, P583, DOI 10.2307/3647457; Hilu KW, 2003, AM J BOT, V90, P1758, DOI 10.3732/ajb.90.12.1758; Hinchliff CE, 2013, SYST BIOL, V62, P205, DOI 10.1093/sysbio/sys088; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Leslie AB, 2012, P NATL ACAD SCI USA, V109, P16217, DOI 10.1073/pnas.1213621109; Lewis LA, 2004, AM J BOT, V91, P1535, DOI 10.3732/ajb.91.10.1535; Magallon S, 2013, AM J BOT, V100, P556, DOI 10.3732/ajb.1200416; Misof B, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-348; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001127; National Center for Biotechnology Information, 2013, TAX STAT; Olmstead RG, 2001, AM J BOT, V88, P348, DOI 10.2307/2657024; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Qiu YL, 2007, INT J PLANT SCI, V168, P691, DOI 10.1086/513474; Qiu YL, 1999, NATURE, V402, P404, DOI 10.1038/46536; Rambaut A, 2012, FIGTREE 1 4; Salichos L, 2014, MOL BIOL EVOL; Sanderson MJ, 2008, SCIENCE, V321, P121, DOI 10.1126/science.1154449; Sanderson MJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-155; Smith SA, 2014, PHYX; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Smith SA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003223; Smith SA, 2012, BIOINFORMATICS, V28, P2689, DOI 10.1093/bioinformatics/bts492; Smith SA, 2011, AM J BOT, V98, P404, DOI 10.3732/ajb.1000481; Smith SA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-37; Soltis DE, 1997, ANN MO BOT GARD, V84, P1, DOI 10.2307/2399952; Soltis DE, 2000, BOT J LINN SOC, V133, P381, DOI 10.1006/bojl.2000.0380; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Soltis DE, 2010, ANN MO BOT GARD, V97, P514, DOI 10.3417/2009136; Soltis PS, 1999, NATURE, V402, P402, DOI 10.1038/46528; Stamatakis A, 2012, BIOINFORMATICS, V28, P2064, DOI 10.1093/bioinformatics/bts309; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steel M, 2010, APPL MATH LETT, V23, P82, DOI 10.1016/j.aml.2009.08.009; Thomson RC, 2010, SYST BIOL, V59, P42, DOI 10.1093/sysbio/syp075; Timme RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029696; Treleaven N, 2012, GEANY	48	31	31	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e98986	10.1371/journal.pone.0098986	http://dx.doi.org/10.1371/journal.pone.0098986			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999823	Green Published, Green Submitted, gold			2022-12-27	WOS:000338637300003
J	Jacquin, L; Mori, Q; Pause, M; Steffen, M; Medoc, V				Jacquin, Lisa; Mori, Quentin; Pause, Mickael; Steffen, Melanie; Medoc, Vincent			Non-Specific Manipulation of Gammarid Behaviour by P-minutus Parasite Enhances Their Predation by Definitive Bird Hosts	PLOS ONE			English	Article							2 ACANTHOCEPHALAN PARASITES; POLYMORPHUS-MINUTUS; NONHOST PREDATOR; ANTIPREDATOR BEHAVIOR; ADAPTIVE-CHANGES; FISH PREDATORS; FIELD EVIDENCE; MULTIDIMENSIONALITY; INFECTION; VULNERABILITY	Trophically-transmitted parasites often change the phenotype of their intermediate hosts in ways that increase their vulnerability to definitive hosts, hence favouring transmission. As a "collateral damage'', manipulated hosts can also become easy prey for non-host predators that are dead ends for the parasite, and which are supposed to play no role in transmission strategies. Interestingly, infection with the acanthocephalan parasite Polymorphus minutus has been shown to reduce the vulnerability of its gammarid intermediate hosts to non-host predators, whose presence triggered the behavioural alterations expected to favour trophic transmission to bird definitive hosts. Whilst the behavioural response of infected gammarids to the presence of definitive hosts remains to be investigated, this suggests that trophic transmission might be promoted by non-host predation risk. We conducted microcosm experiments to test whether the behaviour of P. minutus-infected gammarids was specific to the type of predator (i.e. mallard as definitive host and fish as non-host), and mesocosm experiments to test whether trophic transmission to bird hosts was influenced by non-host predation risk. Based on the behaviours we investigated (predator avoidance, activity, geotaxis, conspecific attraction), we found no evidence for a specific fine-tuned response in infected gammarids, which behaved similarly whatever the type of predator (mallard or fish). During predation tests, fish predation risk did not influence the differential predation of mallards that over-consumed infected gammarids compared to uninfected individuals. Overall, our results bring support for a less sophisticated scenario of manipulation than previously expected, combining chronic behavioural alterations with phasic behavioural alterations triggered by the chemical and physical cues coming from any type of predator. Given the wide dispersal range of waterbirds (the definitive hosts of P. minutus), such a manipulation whose efficiency does not depend on the biotic context is likely to facilitate its trophic transmission in a wide range of aquatic environments.	[Jacquin, Lisa; Mori, Quentin; Pause, Mickael; Steffen, Melanie; Medoc, Vincent] Univ Paris 06, Inst Ecol & Environm Sci, iEES, CNRS,UMR 7618, Paris, France; [Jacquin, Lisa] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Jacquin, Lisa] McGill Univ, Redpath Museum, Montreal, PQ H3A 2K6, Canada	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; Institut de Recherche pour le Developpement (IRD); Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); McGill University; McGill University	Jacquin, L (corresponding author), Univ Paris 06, Inst Ecol & Environm Sci, iEES, CNRS,UMR 7618, Paris, France.	jacquin.lisa@gmail.com	Jacquin, Lisa/H-6878-2019	Jacquin, Lisa/0000-0002-0521-6113	Pierre & Marie Curie University; Versailles-St-Quentin University; Fyssen foundation	Pierre & Marie Curie University; Versailles-St-Quentin University; Fyssen foundation	This work was funded by a grant to VM and LJ from the Pierre & Marie Curie University. LJ was funded by an ATER fellowship from the Versailles-St-Quentin University (2011-2012), and by the Fyssen foundation (2012-2013). Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RA, 1999, P ROY SOC B-BIOL SCI, V266, P1729, DOI 10.1098/rspb.1999.0839; Baldauf SA, 2007, INT J PARASITOL, V37, P61, DOI 10.1016/j.ijpara.2006.09.003; Barber I, 2010, PHILOS T R SOC B, V365, P4077, DOI 10.1098/rstb.2010.0182; Bauer A, 2005, J ZOOL, V267, P39, DOI 10.1017/S0952836905007223; Beisel JN, 2010, ETHOL ECOL EVOL, V22, P265, DOI 10.1080/03949370.2010.502321; Berdoy M, 2000, P ROY SOC B-BIOL SCI, V267, P1591, DOI 10.1098/rspb.2000.1182; Bollache L, 2006, ANIM BEHAV, V72, P627, DOI 10.1016/j.anbehav.2005.11.020; Cezilly F, 2005, BEHAV PROCESS, V68, P223, DOI 10.1016/j.beproc.2004.08.013; Cezilly F, 2000, PARASITOLOGY, V120, P625, DOI 10.1017/S0031182099005910; Cezilly F, 2013, J EXP BIOL, V216, P27, DOI 10.1242/jeb.074005; Cezilly F, 2010, OIKOS, V119, P1224, DOI 10.1111/j.1600-0706.2010.18579.x; Cezilly F, 2010, TRENDS PARASITOL, V26, P311, DOI 10.1016/j.pt.2010.03.009; CHESSON J, 1983, ECOLOGY, V64, P1297, DOI 10.2307/1937838; Coats J, 2010, BEHAVIOUR, V147, P367, DOI 10.1163/000579509X12574307194101; Dianne L, 2011, EVOLUTION, V65, P2692, DOI 10.1111/j.1558-5646.2011.01330.x; Durieux R, 2012, BEHAV PROCESS, V91, P207, DOI 10.1016/j.beproc.2012.08.002; Evans SR, 2007, ANIM BEHAV, V74, P1691, DOI 10.1016/j.anbehav.2007.03.017; Guler Y, 2010, AQUAT TOXICOL, V99, P397, DOI 10.1016/j.aquatox.2010.05.019; Hammerschmidt K, 2009, EVOLUTION, V63, P1976, DOI 10.1111/j.1558-5646.2009.00687.x; Hammond-Tooke CA, 2012, BEHAVIOUR, V149, P601, DOI 10.1163/156853912X648903; Helluy S, 2013, J EXP BIOL, V216, P67, DOI 10.1242/jeb.073213; Jacquin L, 2013, PARASITOLOGY, V140, P1310, DOI 10.1017/S0031182013000760; Kaldonski N, 2008, PARASITOLOGY, V135, P627, DOI 10.1017/S003118200800423X; Kaldonski N, 2007, ANIM BEHAV, V74, P1311, DOI 10.1016/j.anbehav.2007.02.027; Kaldonski N, 2009, P ROY SOC B-BIOL SCI, V276, P169, DOI 10.1098/rspb.2008.0798; Kortet R, 2010, ECOL LETT, V13, P1449, DOI 10.1111/j.1461-0248.2010.01536.x; Lafferty KD, 2013, J EXP BIOL, V216, P56, DOI 10.1242/jeb.073668; Lagrue C, 2007, ECOLOGY, V88, P2839, DOI 10.1890/06-2105.1; Lefevre T, 2008, TRENDS PARASITOL, V24, P435, DOI 10.1016/j.pt.2008.06.006; Lukacsovics F., 1959, Annales Instituti Biologici (Tihany) Hungaricae Academiae Scientiarum, V26, P31; MANLY BFJ, 1974, BIOMETRICS, V30, P281, DOI 10.2307/2529649; Maure F, 2013, J EXP BIOL, V216, P36, DOI 10.1242/jeb.073130; Medoc V, 2008, PARASITOLOGY, V135, P977, DOI 10.1017/S0031182008004447; Medoc V, 2011, PARASITOLOGY, V138, P537, DOI 10.1017/S0031182010001617; Medoc V, 2006, INT J PARASITOL, V36, P1351, DOI 10.1016/j.ijpara.2006.07.001; Medoc V, 2011, OIKOS, V120, P1452, DOI 10.1111/j.1600-0706.2011.19585.x; Medoc V, 2009, NATURWISSENSCHAFTEN, V96, P513, DOI 10.1007/s00114-008-0503-8; Medoc V, 2009, ANIM BEHAV, V77, P1235, DOI 10.1016/j.anbehav.2009.01.029; Moore J., 2002, PARASITES BEHAV ANIM; Mouritsen KN, 2003, INT J PARASITOL, V33, P1043, DOI 10.1016/S0020-7519(03)00178-4; Ness JH, 1999, OIKOS, V85, P127, DOI 10.2307/3546798; Parker GA, 2009, EVOLUTION, V63, P448, DOI 10.1111/j.1558-5646.2008.00565.x; Perrot-Minnot MJ, 2007, INT J PARASITOL, V37, P645, DOI 10.1016/j.ijpara.2006.12.005; Perrot-Minnot MJ, 2013, J EXP BIOL, V216, P134, DOI 10.1242/jeb.074146; Poulin R, 1995, INT J PARASITOL, V25, P1371, DOI 10.1016/0020-7519(95)00100-X; Poulin R, 2013, J EXP BIOL, V216, P18, DOI 10.1242/jeb.073353; Poulin R, 2010, ADV STUD BEHAV, V41, P151, DOI 10.1016/S0065-3454(10)41005-0; RUMPUS AE, 1974, PARASITOLOGY, V68, P271, DOI 10.1017/S0031182000045789; Seppala O, 2008, BIOL LETTERS, V4, P663, DOI 10.1098/rsbl.2008.0335; Seppala O, 2008, P ROY SOC B-BIOL SCI, V275, P1611, DOI 10.1098/rspb.2008.0152; Tain L, 2006, P ROY SOC B-BIOL SCI, V273, P3039, DOI 10.1098/rspb.2006.3618; Thomas F, 2010, OIKOS, V119, P1230, DOI 10.1111/j.1600-0706.2010.18975.x; Thunken T, 2010, HYDROBIOLOGIA, V654, P137, DOI 10.1007/s10750-010-0377-6; Wudkevich K, 1997, J CHEM ECOL, V23, P1163, DOI 10.1023/B:JOEC.0000006393.92013.36; Zuur Alain F., 2009, P1	55	23	23	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101684	10.1371/journal.pone.0101684	http://dx.doi.org/10.1371/journal.pone.0101684			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000519	Green Published, gold, Green Submitted			2022-12-27	WOS:000338637300071
J	Nickerson, KP; Homer, CR; Kessler, SP; Dixon, LJ; Kabi, A; Gordon, IO; Johnson, EE; de la Motte, CA; McDonald, C				Nickerson, Kourtney P.; Homer, Craig R.; Kessler, Sean P.; Dixon, Laura J.; Kabi, Amrita; Gordon, Ilyssa O.; Johnson, Erin E.; de la Motte, Carol A.; McDonald, Christine			The Dietary Polysaccharide Maltodextrin Promotes Salmonella Survival and Mucosal Colonization in Mice	PLOS ONE			English	Article							NECROTIZING ENTEROCOLITIS; DISEASE; MACROPHAGES; HOST; MECHANISMS; GROWTH; COHORT; FEEDS; RISK; PIGS	In the latter half of the 20th century, societal and technological changes led to a shift in the composition of the American diet to include a greater proportion of processed, pre-packaged foods high in fat and carbohydrates, and low in dietary fiber (a "Western diet''). Over the same time period, there have been parallel increases in Salmonella gastroenteritis cases and a broad range of chronic inflammatory diseases associated with intestinal dysbiosis. Several polysaccharide food additives are linked to bacterially-driven intestinal inflammation and may contribute to the pathogenic effects of a Western diet. Therefore, we examined the effect of a ubiquitous polysaccharide food additive, maltodextrin (MDX), on clearance of the enteric pathogen Salmonella using both in vitro and in vivo infection models. When examined in vitro, murine bone marrow-derived macrophages exposed to MDX had altered vesicular trafficking, suppressed NAPDH oxidase expression, and reduced recruitment of NADPH oxidase to Salmonella-containing vesicles, which resulted in persistence of Salmonella in enlarged Rab(7+) late endosomal vesicles. In vivo, mice consuming MDX-supplemented water had a breakdown of the anti-microbial mucous layer separating gut bacteria from the intestinal epithelium surface. Additionally, oral infection of these mice with Salmonella resulted in increased cecal bacterial loads and enrichment of lamina propria cells harboring large Rab(7+) vesicles. These findings indicate that consumption of processed foods containing the polysaccharide MDX contributes to suppression of intestinal anti-microbial defense mechanisms and may be an environmental priming factor for the development of chronic inflammatory disease.	[Nickerson, Kourtney P.; Homer, Craig R.; Kessler, Sean P.; Dixon, Laura J.; Kabi, Amrita; de la Motte, Carol A.; McDonald, Christine] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44106 USA; [Nickerson, Kourtney P.; de la Motte, Carol A.; McDonald, Christine] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH 44106 USA; [Gordon, Ilyssa O.] Cleveland Clin, Robert J Tomsich Pathol & Lab Med Inst, Dept Anat Pathol, Cleveland, OH 44106 USA; [Johnson, Erin E.] John Carroll Univ, Dept Biol, University Hts, PA USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation	McDonald, C (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44106 USA.	mcdonac2@ccf.org		Nickerson, Kourtney/0000-0001-7852-593X; McDonald, Christine/0000-0002-6745-9487	National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health; Howard Hughes Medical Institute "Med into Grad'' Initiative;  [R01DK050984];  [R01DK082437];  [R01HD061918];  [UL1TR000439]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061918] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082437, R01DK050984] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Howard Hughes Medical Institute "Med into Grad'' Initiative(Howard Hughes Medical Institute); ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by R01DK050984, R01DK082437 (to C.M.), R01HD061918 (to C. A. de la M.), UL1TR000439, National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health, the Howard Hughes Medical Institute "Med into Grad'' Initiative, and the financial support of Gerald and Nancy Goldberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbaraly T, 2013, AM J MED, V126, P411, DOI 10.1016/j.amjmed.2012.10.028; ALPUCHEARANDA CM, 1995, INFECT IMMUN, V63, P4456, DOI 10.1128/IAI.63.11.4456-4462.1995; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Beal J, 2012, J PEDIATR-US, V161, P354, DOI 10.1016/j.jpeds.2012.03.054; Cani PD, 2009, CURR OPIN PHARMACOL, V9, P737, DOI 10.1016/j.coph.2009.06.016; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; Chronakis IS, 1998, CRIT REV FOOD SCI, V38, P599, DOI 10.1080/10408699891274327; Clarke P, 2004, ARCH DIS CHILD-FETAL, V89, pF280, DOI 10.1136/adc.2003.036392; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; de Oliveira EB, 2011, SCAND J IMMUNOL, V73, P420, DOI 10.1111/j.1365-3083.2010.02501.x; Gould LH, 2013, MMWR SURVEILL SUMM, V62, P1; Gradel KO, 2009, GASTROENTEROLOGY, V137, P495, DOI 10.1053/j.gastro.2009.04.001; Heidemann C, 2008, CIRCULATION, V118, P230, DOI 10.1161/CIRCULATIONAHA.108.771881; Holden DW, 2002, TRAFFIC, V3, P161, DOI 10.1034/j.1600-0854.2002.030301.x; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Korn L.L., 2014, MUCOSAL IMMUNOL; Martinez-Medina M, 2013, GUT; McDonald DE, 2001, BRIT J NUTR, V86, P487, DOI 10.1079/BJN2001416; MERCIER JC, 1984, ARCH FR PEDIATR, V41, P709; Meresse S, 1999, EMBO J, V18, P4394, DOI 10.1093/emboj/18.16.4394; Montagne L, 2004, J ANIM SCI, V82, P2364; Moran AP, 2011, GUT, V60, P1412, DOI 10.1136/gut.2010.212704; Nickerson KP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052132; Quezada-Calvillo R, 2007, J NUTR, V137, P1725, DOI 10.1093/jn/137.7.1725; Quezada-Calvillo R, 2007, J PEDIATR GASTR NUTR, V45, P32, DOI 10.1097/MPG.0b013e31804216fc; Rosenberger CM, 2003, NAT REV MOL CELL BIO, V4, P385, DOI 10.1038/nrm1104; Rowan NJ, 1997, APPL ENVIRON MICROB, V63, P1182, DOI 10.1128/AEM.63.3.1182-1184.1997; Ruby T, 2012, FEMS MICROBIOL REV, V36, P600, DOI 10.1111/j.1574-6976.2012.00332.x; Sachdev AH, 2013, THER ADV CHRONIC DIS, V4, P223, DOI 10.1177/2040622313496126; Shen XJ, 2010, GUT MICROBES, V1, P138, DOI 10.4161/gmic.1.3.12360; STEWARTPHILLIPS JL, 1991, INT J IMMUNOPHARMACO, V13, P325, DOI 10.1016/0192-0561(91)90001-N; Suskind DL, 2014, J PEDIATR GASTR NUTR, V58, P87, DOI 10.1097/MPG.0000000000000103; Swidsinski A, 2009, INFLAMM BOWEL DIS, V15, P359, DOI 10.1002/ibd.20763; Ten Bruggencate SJM, 2004, GUT, V53, P530, DOI 10.1136/gut.2003.023499; Thymann T, 2009, AM J PHYSIOL-GASTR L, V297, pG1115, DOI 10.1152/ajpgi.00261.2009; Tobacman JK, 2001, ENVIRON HEALTH PERSP, V109, P983, DOI 10.2307/3454951; Woods CW, 2012, J PERINATOL, V32, P150, DOI 10.1038/jp.2011.105; Zhou QD, 2009, P NATL ACAD SCI USA, V106, P10740, DOI 10.1073/pnas.0904412106	38	43	43	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101789	10.1371/journal.pone.0101789	http://dx.doi.org/10.1371/journal.pone.0101789			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000398	Green Published, gold, Green Submitted			2022-12-27	WOS:000338637300085
J	Tam, J; Cordier, GA; Borbely, JS; Alvarez, AS; Lakadamyali, M				Tam, Johnny; Alan Cordier, Guillaume; Steven Borbely, Joseph; Sandoval Alvarez, Angel; Lakadamyali, Melike			Cross-Talk-Free Multi-Color STORM Imaging Using a Single Fluorophore	PLOS ONE			English	Article							OPTICAL RECONSTRUCTION MICROSCOPY; FLUORESCENT-PROBES; SUPERRESOLUTION MICROSCOPY; LIVE-CELL; LOCALIZATION MICROSCOPY; DIFFRACTION-LIMIT; ULTRASTRUCTURE; TOMOGRAPHY; GFP	Multi-color stochastic optical reconstruction microscopy (STORM) is routinely performed; however, the various approaches for achieving multiple colors have important caveats. Color cross-talk, limited availability of spectrally distinct fluorophores with optimal brightness and duty cycle, incompatibility of imaging buffers for different fluorophores, and chromatic aberrations impact the spatial resolution and ultimately the number of colors that can be achieved. We overcome these complexities and develop a simple approach for multi-color STORM imaging using a single fluorophore and sequential labelling. In addition, we present a simple and versatile method to locate the same region of interest on different days and even on different microscopes. In combination, these approaches enable cross-talk-free multi-color imaging of sub-cellular structures.	[Tam, Johnny; Alan Cordier, Guillaume; Steven Borbely, Joseph; Sandoval Alvarez, Angel; Lakadamyali, Melike] ICFO Inst Ciencies Foton, Barcelona, Spain	Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO)	Lakadamyali, M (corresponding author), ICFO Inst Ciencies Foton, Mediterranean Technol Pk, Barcelona, Spain.	melike.lakadamyali@icfo.es	Tam, Johnny/AHD-6065-2022	Tam, Johnny/0000-0003-2300-0567; Borbely, Joseph/0000-0001-8618-1145	Fundacio CELLEX Barcelona; Systems Microscopy Network of Excellence consortium [FP-7-HEALTH.2010.2.1.2.2]; ERC-Starting grant [337191-MOTORS]; Whitaker International Fellows and Scholars Program	Fundacio CELLEX Barcelona(Foundation CELLEXEuropean Commission); Systems Microscopy Network of Excellence consortium; ERC-Starting grant(European Research Council (ERC)); Whitaker International Fellows and Scholars Program	This work was financially supported by Fundacio CELLEX Barcelona (M.L.), the Systems Microscopy Network of Excellence consortium (call identifier number FP-7-HEALTH.2010.2.1.2.2) (M.L.), ERC-Starting grant (grant agreement number 337191-MOTORS) (M.L.), and the Whitaker International Fellows and Scholars Program (J.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annibale P, 2012, OPT NANOSC, V1, P1, DOI DOI 10.1186/2192-2853-1-9; Balint S, 2013, P NATL ACAD SCI USA, V110, P3375, DOI 10.1073/pnas.1219206110; Bates M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108101; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Bates M, 2012, CHEMPHYSCHEM, V13, P99, DOI 10.1002/cphc.201100735; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Endesfelder U, 2011, MOLECULES, V16, P3106, DOI 10.3390/molecules16043106; Fernandez-Suarez M, 2008, NAT REV MOL CELL BIO, V9, P929, DOI 10.1038/nrm2531; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang F, 2013, NAT METHODS, V10, P653, DOI [10.1038/NMETH.2488, 10.1038/nmeth.2488]; Huang F, 2011, BIOMED OPT EXPRESS, V2, P1377, DOI 10.1364/BOE.2.001377; Jones SA, 2011, NAT METHODS, V8, P499, DOI [10.1038/NMETH.1605, 10.1038/nmeth.1605]; Jungmann R, 2014, NAT METHODS; Kamiyama D, 2012, DEV CELL, V23, P1103, DOI 10.1016/j.devcel.2012.10.003; Lakadamyali M, 2012, J MICROSC-OXFORD, V248, P111, DOI 10.1111/j.1365-2818.2012.03638.x; Lampe A, 2012, BIOL CELL, V104, P229, DOI 10.1111/boc.201100011; Lippincott-Schwartz J, 2009, TRENDS CELL BIOL, V19, P555, DOI 10.1016/j.tcb.2009.09.003; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; Marsh BJ, 2013, METHOD CELL BIOL, V118, P259, DOI 10.1016/B978-0-12-417164-0.00016-1; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pavani SRP, 2009, P NATL ACAD SCI USA, V106, P2995, DOI 10.1073/pnas.0900245106; Ries J, 2012, NAT METHODS, V9, P582, DOI [10.1038/NMETH.1991, 10.1038/nmeth.1991]; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schwartz CL, 2007, J MICROSC-OXFORD, V227, P98, DOI 10.1111/j.1365-2818.2007.01794.x; Shtengel G, 2009, P NATL ACAD SCI USA, V106, P3125, DOI 10.1073/pnas.0813131106; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; van de Linde S, 2011, NAT PROTOC, V6, P991, DOI 10.1038/nprot.2011.336; Wombacher R, 2010, NAT METHODS, V7, P717, DOI [10.1038/NMETH.1489, 10.1038/nmeth.1489]; Xu K, 2012, NAT METHODS, V9, P185, DOI [10.1038/NMETH.1841, 10.1038/nmeth.1841]; Yildiz A, 2005, ACCOUNTS CHEM RES, V38, P574, DOI 10.1021/ar040136s; Zanacchi FC, 2011, NAT METHODS, V8, P1047, DOI [10.1038/NMETH.1744, 10.1038/nmeth.1744]; Zhu L, 2012, NAT METHODS, V9, P721, DOI [10.1038/NMETH.1978, 10.1038/nmeth.1978]	35	54	56	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101772	10.1371/journal.pone.0101772	http://dx.doi.org/10.1371/journal.pone.0101772			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000286	Green Published, gold, Green Submitted			2022-12-27	WOS:000338637300084
J	Hong, DF; Su, J; Hong, QG; Pan, ZK; Wang, GD				Hong, Danfeng; Su, Jian; Hong, Qinggen; Pan, Zhenkuan; Wang, Guodong			Blurred Palmprint Recognition Based on Stable-Feature Extraction Using a Vese-Osher Decomposition Model	PLOS ONE			English	Article							FINGERPRINT; ALGORITHM	As palmprints are captured using non-contact devices, image blur is inevitably generated because of the defocused status. This degrades the recognition performance of the system. To solve this problem, we propose a stable-feature extraction method based on a Vese-Osher (VO) decomposition model to recognize blurred palmprints effectively. A Gaussian defocus degradation model is first established to simulate image blur. With different degrees of blurring, stable features are found to exist in the image which can be investigated by analyzing the blur theoretically. Then, a VO decomposition model is used to obtain structure and texture layers of the blurred palmprint images. The structure layer is stable for different degrees of blurring (this is a theoretical conclusion that needs to be further proved via experiment). Next, an algorithm based on weighted robustness histogram of oriented gradients (WRHOG) is designed to extract the stable features from the structure layer of the blurred palmprint image. Finally, a normalized correlation coefficient is introduced to measure the similarity in the palmprint features. We also designed and performed a series of experiments to show the benefits of the proposed method. The experimental results are used to demonstrate the theoretical conclusion that the structure layer is stable for different blurring scales. The WRHOG method also proves to be an advanced and robust method of distinguishing blurred palmprints. The recognition results obtained using the proposed method and data from two palmprint databases (PolyU and Blurred-PolyU) are stable and superior in comparison to previous high-performance methods (the equal error rate is only 0.132%). In addition, the authentication time is less than 1.3 s, which is fast enough to meet real-time demands. Therefore, the proposed method is a feasible way of implementing blurred palmprint recognition.	[Hong, Danfeng; Pan, Zhenkuan; Wang, Guodong] Qingdao Univ, Coll Informat Engn, Qingdao 266071, Peoples R China; [Su, Jian] Univ Elect Sci & Technol China, Sch Commun & Informat Engn, Chengdu 610054, Peoples R China; [Hong, Qinggen] Naval Aeronaut & Astronaut Univ, Res Inst Higher Educ, Training Dept, Yantai, Peoples R China	Qingdao University; University of Electronic Science & Technology of China	Hong, DF (corresponding author), Qingdao Univ, Coll Informat Engn, Qingdao 266071, Peoples R China.	hongdanfeng1989@gmail.com	su, jian/ABI-7927-2020; Hong, Danfeng/U-6082-2019	Hong, Danfeng/0000-0002-3212-9584	National Nature Science Committee of China [61170106, 61305045]	National Nature Science Committee of China	This paper was supported by National Nature Science Committee of China under grant number 61170106 and grant number 61305045. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choras M, 2012, PATTERN ANAL APPL, V15, P73, DOI 10.1007/s10044-011-0248-4; Dalal N., 2005, IEEE COMPUTER SOC C, V1, P886, DOI DOI 10.1109/CVPR.2005.177; Daugman J, 2003, PATTERN RECOGN, V36, P279, DOI 10.1016/S0031-3203(02)00030-4; Guo XM, 2014, NEUROCOMPUTING, V127, P152, DOI 10.1016/j.neucom.2013.08.027; He YL, 2006, IEEE T PATTERN ANAL, V28, P850, DOI 10.1109/TPAMI.2006.119; He YL, 2003, PATTERN RECOGN LETT, V24, P1349, DOI 10.1016/S0167-8655(02)00376-8; Jain A, 1997, IEEE T PATTERN ANAL, V19, P302, DOI 10.1109/34.587996; Jia W, 2008, PATTERN RECOGN, V41, P1504, DOI 10.1016/j.patcog.2007.10.011; Kang BJ, 2007, IEEE T SYST MAN CY B, V37, P1555, DOI 10.1109/TSMCB.2007.907042; Kanhangad V, 2011, IEEE T INF FOREN SEC, V6, P1014, DOI 10.1109/TIFS.2011.2121062; Kong A, 2006, PATTERN RECOGN, V39, P478, DOI 10.1016/j.patcog.2005.08.014; Kong A, 2009, PATTERN RECOGN, V42, P1408, DOI 10.1016/j.patcog.2009.01.018; Lin Sen, 2013, Optics and Precision Engineering, V21, P734, DOI 10.3788/OPE.20132103.0734; [林森 Lin Sen], 2012, [光电子·激光, Journal of Optoelectronics·Laser], V23, P2200; Liu EY, 2013, IEEE T PATTERN ANAL, V35, P2307, DOI 10.1109/TPAMI.2013.39; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; MANDELBROT BB, 1984, NATURE, V308, P721, DOI 10.1038/308721a0; [梅园 Mei Yuan], 2007, [计算机研究与发展, Journal of Computer Research and Development], V44, P1022, DOI 10.1360/crad20070615; Meyer Y, 2001, AM MATH SOC LEWIS ME, V22; Mi JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059430; Sang HF, 2009, 2009 INTERNATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND COMPUTATIONAL INTELLIGENCE, VOL I, PROCEEDINGS, P611, DOI 10.1109/AICI.2009.106; SARKAR N, 1994, IEEE T SYST MAN CYB, V24, P115, DOI 10.1109/21.259692; Tao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036234; Vese LA, 2003, J SCI COMPUT, V19, P553, DOI 10.1023/A:1025384832106; Wang JZ, 2010, AS PAC C INF THEOR, P64; [魏伟波 Wei Weibo], 2012, [仪器仪表学报, Chinese Journal of Scientific Instrument], V33, P2279; Weiqi Yuan, 2011, ACTA OPT SINICA, V31; Xue ML, 2013, NEURAL COMPUT APPL, V22, P1531, DOI 10.1007/s00521-012-0962-x; Yin YL, 2004, EURASIP J APPL SIG P, V2004, P495, DOI 10.1155/S1110865704310103; Zhai Y P, 2011, ACTA OPT SIN, V31; Zhang D, 2003, IEEE T PATTERN ANAL, V25, P1041, DOI 10.1109/TPAMI.2003.1227981; Zhang D, 2010, IEEE T INSTRUM MEAS, V59, P480, DOI 10.1109/TIM.2009.2028772; Zhu Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070370	33	6	9	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101866	10.1371/journal.pone.0101866	http://dx.doi.org/10.1371/journal.pone.0101866			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992328	gold, Green Published, Green Submitted			2022-12-27	WOS:000341253400125
J	Lin, H; Yang, Y; Chen, JJ; Zhong, XJ; Liu, ZC; Lin, ZL; Chen, W; Luo, LX; Qu, B; Zhang, XY; Zheng, DY; Zhan, J; Wu, HF; Wang, ZR; Geng, Y; Xiang, W; Chen, WR; Liu, YZ				Lin, Haotian; Yang, Ye; Chen, Jingjing; Zhong, Xiaojian; Liu, Zhaochuan; Lin, Zhuoling; Chen, Wan; Luo, Lixia; Qu, Bo; Zhang, Xinyu; Zheng, Danying; Zhan, Jiao; Wu, Hanfu; Wang, Zhirong; Geng, Yu; Xiang, Wu; Chen, Weirong; Liu, Yizhi		CCPMOH Study Grp	Congenital Cataract: Prevalence and Surgery Age at Zhongshan Ophthalmic Center (ZOC)	PLOS ONE			English	Article							INFANTILE CATARACT; UNITED-KINGDOM; EYE DISEASES; CHILDREN; EPIDEMIOLOGY; CHILDHOOD	Congenital cataract (CC) is the primary cause of treatable childhood blindness. Population-based assessments of prevalence and surgery age of CC, which are critical for improving management strategies, have been unavailable in China until now. We conducted a hospital-based, cross-sectional study of the hospital charts of CC patients younger than 18 years old from January 2005 to December 2010 at Zhongshan Ophthalmic Center (ZOC) in Guangzhou, China. Residence, gender, age at surgery, hospitalization time, and the presence of other ocular abnormalities were extracted and statistically analyzed in different subgroups. The search identified 1314 patients diagnosed with CC from a total of 136154 hospitalizations, which accounted for 2.39% of all the cataract in-patients and 1.06% of the total in-patients over the six-year study period. Of the identified CC patients, 9.2% had >= 2 hospitalizations due to the necessity of additional surgeries, with a total ratio of boys to girls of 1.75:1. Based on a subgroup analysis according to age, patients 2-6 years old constituted the highest proportion (29.22%) of all hospitalized CC patients, and those 13-18 years old constituted the lowest proportion (13.47%) of the total number. The average age at surgery was 27.62 +/- 23.36 months, but CC patients <= 6 years old (especially <= 6 months old) became increasingly prevalent throughout the 6-year study period. A total of 276 cases (20.93%) of CC were associated with one or more other ocular abnormalities, the highest incidence rates were observed for exotropia (6.24%), nystagmus (6.16%), and refractive error (3.65%). In conclusion, CC patients accounted for 2.39% of all cataract in-patients in a review of 6 years of hospitalization charts from ZOC. The age at the time of surgery decreased over the 6-year study period, which probably reflects the continuing improvement of public awareness of children's eye care in China.	[Lin, Haotian; Yang, Ye; Chen, Jingjing; Zhong, Xiaojian; Liu, Zhaochuan; Lin, Zhuoling; Chen, Wan; Luo, Lixia; Qu, Bo; Zhang, Xinyu; Zheng, Danying; Zhan, Jiao; Wu, Hanfu; Wang, Zhirong; Geng, Yu; Xiang, Wu; Chen, Weirong; Liu, Yizhi; CCPMOH Study Grp] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Chen, WR (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	chenwr_q@aliyun.com; yizhi_liu@aliyun.com	Zhong, Xiaojian/J-9727-2016; Chen, Wei/GZK-7348-2022; liu, yi/GXE-9662-2022	Zhong, Xiaojian/0000-0002-4201-0747; 	Key Projects for Hospital Clinical Disciplines of the Ministry of Health of China [175]; Pearl River Science and Technology New Star Project of Guangzhou City [2014J2200060]; Sun Yat-sen University of the Fundamental Research Funds for the Central Universities [12ykpy61]	Key Projects for Hospital Clinical Disciplines of the Ministry of Health of China; Pearl River Science and Technology New Star Project of Guangzhou City; Sun Yat-sen University of the Fundamental Research Funds for the Central Universities	This study was funded by the Key Projects for Hospital Clinical Disciplines of the Ministry of Health of China in 2010-2012 (Project No. 175 in Document 439 of the Planning and Finance Secretary of the Ministry of Health), the Pearl River Science and Technology New Star (2014J2200060) Project of Guangzhou City, and the Cultivation Projects for Young Teaching Staff of Sun Yat-sen University (12ykpy61) of the Fundamental Research Funds for the Central Universities. The sponsors of the study had no role in the design of the original study protocol, data collection, data analysis, data interpretation, writing of the report, or decision to submit the manuscript for publication.	Bhatti TR, 2003, ARCH PEDIAT ADOL MED, V157, P341, DOI 10.1001/archpedi.157.4.341; Birch EE, 2009, J AAPOS, V13, P67, DOI 10.1016/j.jaapos.2008.07.010; Bronsard A, 2008, OPHTHAL EPIDEMIOL, V15, P383, DOI 10.1080/09286580802488624; Chak M, 2006, INVEST OPHTH VIS SCI, V47, P4262, DOI 10.1167/iovs.05-1160; Chen W, 2013, PLOS ONE, V28; Fallaha N, 2001, Ophthalmol Clin North Am, V14, P479, DOI 10.1016/S0896-1549(05)70246-7; Foster A, 1997, J CATARACT REFR SURG, V23, P601, DOI 10.1016/S0886-3350(97)80040-5; France T D, 1984, J Pediatr Ophthalmol Strabismus, V21, P223; Garza-Reyes M, 2000, ARCH MED RES, V31, P500, DOI 10.1016/S0188-4409(00)00101-6; Haargaard B, 2004, OPHTHALMOLOGY, V111, P2292, DOI 10.1016/j.ophtha.2004.06.024; HILES D A, 1977, International Ophthalmology Clinics, V17, P193, DOI 10.1097/00004397-197701740-00020; HU DN, 1987, J MED GENET, V24, P584, DOI 10.1136/jmg.24.10.584; Lin H, 2013, PLOS ONE, V29; Lin HT, 2012, INT J OPHTHALMOL-CHI, V5, P638, DOI 10.3980/j.issn.2222-3959.2012.05.19; Lin HT, 2012, OPHTHALMOLOGY, V119, P2463, DOI 10.1016/j.ophtha.2012.06.046; Luo L, 2013, PLOS ONE, V24; Muir KW, 2013, JAMA OPHTHALMOL, V131, P119, DOI 10.1001/jamaophthalmol.2013.577; Nie Wen-ying, 2008, Zhonghua Yan Ke Za Zhi, V44, P497; Pi LH, 2012, J EPIDEMIOL, V22, P37, DOI 10.2188/jea.JE20110063; Rahi JS, 1999, BRIT MED J, V318, P362, DOI 10.1136/bmj.318.7180.362; Rahi JS, 2000, INVEST OPHTH VIS SCI, V41, P2108; Randrianotahina HCL, 2014, NIGER J CLIN PRACT, V17, P14, DOI 10.4103/1119-3077.122824; Robin AL, 2012, ARCH OPHTHALMOL-CHIC, V130, P1452, DOI 10.1001/jamaophthalmol.2013.765; Ruddle JB, 2013, CLIN EXP OPHTHALMOL, V41, P653, DOI 10.1111/ceo.12067; Shah MA, 2014, EUR J OPHTHALMOL, V24, P76, DOI 10.5301/ejo.5000309; Sisk RA, 2010, OPHTHALMOLOGY, V117, P2178, DOI 10.1016/j.ophtha.2010.03.062; Skalicky SE, 2013, JAMA OPHTHALMOL, V131, P1517, DOI 10.1001/jamaophthalmol.2013.5305; Trumler AA, 2011, CURR OPIN OPHTHALMOL, V22, P365, DOI 10.1097/ICU.0b013e32834994dc; You CY, 2011, OPHTHALMOLOGY, V118, P17, DOI 10.1016/j.ophtha.2010.04.014; Zhu JF, 2012, CHINESE MED J-PEKING, V125, P3654, DOI 10.3760/cma.j.issn.0366-6999.2012.20.010	30	22	23	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101781	10.1371/journal.pone.0101781	http://dx.doi.org/10.1371/journal.pone.0101781			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992190	Green Published, Green Submitted, gold			2022-12-27	WOS:000341253400116
J	Ang, M; Chong, W; Huang, HQ; Wong, TY; He, MG; Aung, T; Mehta, JS				Ang, Marcus; Chong, Wesley; Huang, Huiqi; Wong, Tien Yin; He, Ming-Guang; Aung, Tin; Mehta, Jodhbir S.			Determinants of Posterior Corneal Biometric Measurements in a Multi-Ethnic Asian Population	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; IN-SITU KERATOMILEUSIS; AUTOMATED ENDOTHELIAL KERATOPLASTY; LENS POWER CALCULATION; ANTERIOR SEGMENT OCT; ANGLE-CLOSURE; ULTRASOUND BIOMICROSCOPY; REFRACTIVE SURGERY; ASSESSMENT PROGRAM; CHINESE EYES	Purpose: To describe the corneal and anterior segment determinants of posterior corneal arc length (PCAL) and posterior corneal curvature (PCC). Methods: Cross-sectional, population-based study of 1069 subjects (1069 eyes) aged 40-80 years, from three major Asian ethnic groups. All underwent anterior segment optical coherence tomography imaging and analysis with Zhongshan Angle Assessment Program. Our main outcome measures were determinants of PCAL and PCC using adjusted, multivariate linear regression analysis, adjusted for confounders to obtain the estimated marginal means (EMM) with standard error (SE). Results: The overall mean (+/- SD) of PCC was: 6.51 +/- 0.39 mm; and PCAL was: 12.52 +/- 0.59 mm. Malays had a relatively longer PCAL (EMM = 12.74 mm, SE = 0.04 mm) than Chinese (EMM = 12.48 mm, SE = 0.03 mm, P<0.001), and Indians (EMM = 12.42 mm, SE = 0.03 mm, P<0.001). Anterior segment parameters had weak-moderate correlations with PCAL, which included: anterior chamber depth (ACD) (r = 0.55, P<0.001), PCC (r = 0.27, P<0.001), anterior corneal curvature (ACC) (r = 0.14, P<0.001) and central corneal thickness (CCT) (r = -0.07, P = 0.023). In multivariate analysis, anterior segment parameters explained only 37.6% of the variance of PCAL, with ACD being the most important determinant (partial R-2 = 0.300; P<0.001). The determinants of PCC included ACC, PCAL and CCT (explaining 72.1% variation of PCC), with ACC being the most important determinant (partial R-2 = 0.683; P<0.001). Conclusion: There was moderate correlation of PCAL with ACD, but anterior segment parameters accounted for only a small proportion of the variation in PCAL. The significant differences in PCAL and PCC amongst different Asian ethnic groups suggests that there is a need to consider this factor when planning for anterior segment surgeries such as endothelial keratoplasty.	[Ang, Marcus; Chong, Wesley; Wong, Tien Yin; Aung, Tin; Mehta, Jodhbir S.] Singapore Natl Eye Ctr, Singapore, Singapore; [Ang, Marcus; Huang, Huiqi; Wong, Tien Yin; Aung, Tin; Mehta, Jodhbir S.] Singapore Eye Res Inst, Singapore, Singapore; [Wong, Tien Yin; Aung, Tin] Natl Univ Singapore, Dept Ophthalmol, Singapore 117548, Singapore; [Wong, Tien Yin; Mehta, Jodhbir S.] Duke Natl Univ Singapore, Grad Sch Med, Off Clin Sci, Singapore, Singapore; [He, Ming-Guang] Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China	Singapore National Eye Center; National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore	Mehta, JS (corresponding author), Singapore Natl Eye Ctr, Singapore, Singapore.	jodmehta@gmail.com	He, Mingguang/AAY-5239-2020; Wong, Tien Yin/AAC-9724-2020	He, Mingguang/0000-0002-6912-2810; Wong, Tien Yin/0000-0002-8448-1264	National Research Foundation Translational and Clinical Research Programme [TCR: R621/42/2008]	National Research Foundation Translational and Clinical Research Programme	National Research Foundation Translational and Clinical Research Programme Grant (TCR: R621/42/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSBIRK PH, 1978, ACTA OPHTHALMOL, V56, P95; ALSBIRK PH, 1978, ACTA OPHTHALMOL, V56, P105; Ang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065559; Ang M, 2012, INVEST OPHTH VIS SCI, V53, P120, DOI 10.1167/iovs.11-8386; [Anonymous], 2002, OPHTHALMOLOGY, V109, P651; [Anonymous], 2000, J REFRACT SURG, V16, P349; Avila M, 2006, J CATARACT REFR SURG, V32, P1836, DOI 10.1016/j.jcrs.2006.07.015; Brandt JD, 2001, OPHTHALMOLOGY, V108, P1779, DOI 10.1016/S0161-6420(01)00760-6; Chan JB, 2011, INVEST OPHTH VIS SCI, V52, P8884, DOI 10.1167/iovs.10-6411; Cheng LS, 2011, ACTA OPHTHALMOL, V89, P417, DOI 10.1111/j.1755-3768.2009.01732.x; Congdon NG, 1997, OPHTHALMOLOGY, V104, P1489, DOI 10.1016/S0161-6420(97)30112-2; Console JW, 2008, BRIT J OPHTHALMOL, V92, P1612, DOI 10.1136/bjo.2007.129932; Dada T, 2007, J CATARACT REFR SURG, V33, P837, DOI 10.1016/j.jcrs.2007.01.021; Dorairaj S, 2007, T AM OPHTHAL SOC, V105, P108; Dorairaj Syril, 2007, Trans Am Ophthalmol Soc, V105, P99; Dubbelman M, 2006, VISION RES, V46, P993, DOI 10.1016/j.visres.2005.09.021; Goldsmith JA, 2005, OPHTHALMOLOGY, V112, P238, DOI 10.1016/j.ophtha.2004.09.019; Hall RC, 2011, J CATARACT REFR SURG, V37, P544, DOI 10.1016/j.jcrs.2010.10.037; Hosny M, 2000, J REFRACT SURG, V16, P336; Jin HY, 2012, J CATARACT REFR SURG, V38, P1749, DOI 10.1016/j.jcrs.2012.06.048; Jonas JB, 2009, AM J OPHTHALMOL, V148, P760, DOI 10.1016/j.ajo.2009.06.024; Kim SW, 2009, J REFRACT SURG, V25, P285, DOI 10.3928/1081597X-20090301-08; Koch DD, 2013, J CATARACT REFR SURG, V39, P1803, DOI 10.1016/j.jcrs.2013.06.027; Lavanya R, 2009, OPHTHAL EPIDEMIOL, V16, P325, DOI 10.3109/09286580903144738; Leung CK, 2010, BRIT J OPHTHALMOL, V94, P1184, DOI 10.1136/bjo.2009.167296; Nangia V, 2010, OPHTHALMOLOGY, V117, P705, DOI 10.1016/j.ophtha.2009.09.003; Nolan WP, 2006, AM J OPHTHALMOL, V141, P896, DOI 10.1016/j.ajo.2005.12.008; Prasher P, 2010, J CATARACT REFR SURG, V36, P1358, DOI 10.1016/j.jcrs.2010.01.032; Qin B, 2012, OPHTHAL SURG LAS IM, P1; Radhakrishnan S, 2005, ARCH OPHTHALMOL-CHIC, V123, P1053, DOI 10.1001/archopht.123.8.1053; Sakata LM, 2008, ARCH OPHTHALMOL-CHIC, V126, P181, DOI 10.1001/archophthalmol.2007.46; Su DHW, 2008, BRIT J OPHTHALMOL, V92, P103, DOI 10.1136/bjo.2007.122572; Tan DTH, 2012, LANCET, V379, P1749, DOI 10.1016/S0140-6736(12)60437-1; Tan GS, 2012, BMC MED IMAGING, V12, DOI 10.1186/1471-2342-12-19; Vijaya L, 2010, OPHTHALMOLOGY, V117, P700, DOI 10.1016/j.ophtha.2009.09.025; Yamaguchi T, 2011, INVEST OPHTH VIS SCI, V52, P6222, DOI 10.1167/iovs.11-7647; Yuen LH, 2010, INVEST OPHTH VIS SCI, V51, P3433, DOI 10.1167/iovs.09-4307; Zheng YF, 2011, OPHTHALMOLOGY	38	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101483	10.1371/journal.pone.0101483	http://dx.doi.org/10.1371/journal.pone.0101483			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006679	Green Published, gold			2022-12-27	WOS:000339040600039
J	Kleimann, A; Toto, S; Eberlein, CK; Kielstein, JT; Bleich, S; Frieling, H; Sieberer, M				Kleimann, Alexandra; Toto, Sermin; Eberlein, Christian K.; Kielstein, Jan T.; Bleich, Stefan; Frieling, Helge; Sieberer, Marcel			Psychiatric Symptoms in Patients with Shiga Toxin-Producing E-coli O104:H4 Induced Haemolytic-Uraemic Syndrome	PLOS ONE			English	Article							THERAPEUTIC PLASMA-EXCHANGE; MANIFESTATIONS; INVENTORY; INFECTION	Background: In May 2011 an outbreak of Shiga toxin-producing enterohaemorrhagic E. coli (STEC) O104:H4 in Northern Germany led to a high number of in-patients, suffering from post-enteritis haemolytic-uraemic syndrome (HUS) and often severe affection of the central nervous system. To our knowledge so far only neurological manifestations have been described systematically in literature. Aim: To examine psychiatric symptoms over time and search for specific symptom clusters in affected patients. Methods: 31 in-patients suffering from E. coli O104:H4 associated HUS, were examined and followed up a week during the acute hospital stay. Psychopathology was assessed by clinical interview based on the AMDP Scale, the Brief Symptom Inventory and the Clinical Global Impressions Scale. Results: At baseline mental disorder due to known physiological condition (ICD-10 F06.8) was present in 58% of the examined patients. Patients suffered from various manifestations of cognitive impairment (n = 27) and hallucinations (n = 4). Disturbances of affect (n = 28) included severe panic attacks (n = 9). Psychiatric disorder was significantly associated with higher age (p<0.0001), higher levels of C-reactive protein (p<0.05), and positive family history of heart disease (p<0.05). Even within the acute hospital stay with a median follow up of 7 days, symptoms improved markedly over time (p <0.0001). Conclusions: Aside from severe neurological symptoms the pathology in E. coli O104:H4 associated HUS frequently includes particular psychiatric disturbances. Long term follow up has to clarify whether or not these symptoms subside.	[Kleimann, Alexandra; Toto, Sermin; Eberlein, Christian K.; Bleich, Stefan; Frieling, Helge; Sieberer, Marcel] Hannover Med Sch, Dept Psychiat Social Psychiat & Psychotherapy, Hannover, Germany; [Kielstein, Jan T.] Hannover Med Sch, Dept Hypertens & Nephrol, Hannover, Germany	Hannover Medical School; Hannover Medical School	Kleimann, A (corresponding author), Hannover Med Sch, Dept Psychiat Social Psychiat & Psychotherapy, Hannover, Germany.	kleimann.alexandra@mh-hannover.de	Bleich, Stefan/ABC-1796-2020; Frieling, Helge/C-5299-2015; Kielstein, Jan T./I-2956-2019	Frieling, Helge/0000-0001-5146-9720; Kielstein, Jan T./0000-0001-8110-9064; Neyazi, Alexandra/0000-0003-0882-631X	Department of Psychiatry, Socialpsychiatry and Psychotherapy, Hannover Medical School, Hannover, Germany	Department of Psychiatry, Socialpsychiatry and Psychotherapy, Hannover Medical School, Hannover, Germany	This work was funded by the research budget of the Department of Psychiatry, Socialpsychiatry and Psychotherapy, Hannover Medical School, Hannover, Germany. The funding department as an institution had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoli SP, 2002, PEDIATR NEPHROL, V17, P293, DOI 10.1007/s00467-001-0783-0; Dankbaar JW, 2009, J NEURORADIOLOGY, V36, P219, DOI 10.1016/j.neurad.2009.01.001; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Donnerstag F, 2012, EUR RADIOL, V22, P506, DOI 10.1007/s00330-011-2286-0; Duivis HE, 2010, J AM COLL CARDIOL, V29, P31; Dundas S, 1999, LANCET, V354, P1327, DOI 10.1016/S0140-6736(99)01251-9; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Franke H., 2000, BSI BRIEF SYMPTOM IN; Greinacher A, 2011, LANCET, V378, P1166, DOI 10.1016/S0140-6736(11)61253-1; Gross CT, 2012, NAT REV NEUROSCI, V13, P651, DOI 10.1038/nrn3301; Guy W, 1976, ECDEU ASSESSMENT MAN; HAMANO S, 1993, ACTA PAEDIATR, V82, P454, DOI 10.1111/j.1651-2227.1993.tb12721.x; Kielstein JT, 2012, NEPHROL DIAL TRANSPL, V27, P3807, DOI 10.1093/ndt/gfs394; Kielstein JT, 2011, NEPHROL DIAL TRANSPL, V26, P2723, DOI 10.1093/ndt/gfr462; Lorenzen JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047215; Magnus T, 2012, BRAIN, V135, P1850, DOI 10.1093/brain/aws090; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Meuth SG, 2012, ANN NEUROL; Moller HJ, 2009, WORLD J BIOL PSYCHIA, V10, P6, DOI 10.1080/15622970802264606; Nathanson S, 2010, CLIN J AM SOC NEPHRO, V5, P1218, DOI 10.2215/CJN.08921209; Nemeroff CB, 2012, NAT REV CARDIOL, V9, P526, DOI 10.1038/nrcardio.2012.91; Obata F, 2008, J INFECT DIS, V198, P1398, DOI 10.1086/591911; PIERSMA HL, 1994, J CLIN PSYCHOL, V50, P555, DOI 10.1002/1097-4679(199407)50:4<555::AID-JCLP2270500410>3.0.CO;2-G; Pietzcker A, 1983, Mod Probl Pharmacopsychiatry, V20, P88; Proulx F, 2001, PEDIATR RES, V50, P163, DOI 10.1203/00006450-200108000-00002; Recklitis CJ, 2007, PSYCHO-ONCOLOGY, V16, P429, DOI 10.1002/pon.1069; Renfordt E, 1983, Mod Probl Pharmacopsychiatry, V20, P125; Robert-Koch-Institut, 2011, AUSBR FALLD EHEC HUS; SIEGLER RL, 1994, PEDIATRICS, V94, P35; Skripuletz T, 2013, BRAIN, V136, DOI 10.1093/brain/aws361; Lucero MS, 2012, MICROB PATHOGENESIS, V53, P87, DOI 10.1016/j.micpath.2012.05.005; Teramoto T, 2009, PEDIATR INT, V51, P107, DOI 10.1111/j.1442-200X.2008.02672.x; Tironi-Farinati C, 2010, J NEUROIMMUNOL, V222, P48, DOI 10.1016/j.jneuroim.2010.03.001; Weissenborn K, 2012, NEUROLOGY, V79, P1466, DOI 10.1212/WNL.0b013e31826d5f26; WHO, 1992, WHO ICD 10 CLASS MEN; ZOJA C, 1992, J LAB CLIN MED, V120, P229	38	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101839	10.1371/journal.pone.0101839	http://dx.doi.org/10.1371/journal.pone.0101839			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007072	Green Submitted, Green Published, gold			2022-12-27	WOS:000339040600072
J	Lambeth, LS; Ohnesorg, T; Cummins, DM; Sinclair, AH; Smith, CA				Lambeth, Luke S.; Ohnesorg, Thomas; Cummins, David M.; Sinclair, Andrew H.; Smith, Craig A.			Development of Retroviral Vectors for Tissue-Restricted Expression in Chicken Embryonic Gonads	PLOS ONE			English	Article							ROUS-SARCOMA-VIRUS; ESTROGEN-RECEPTOR; SEX DETERMINATION; OVO ELECTROPORATION; AROMATASE GENES; MESSENGER-RNA; GERM-CELLS; DMRT1; PROMOTER; ENHANCER	The chicken embryo has long been a useful model organism for studying development, including sex determination and gonadal differentiation. However, manipulating gene expression specifically in the embryonic avian gonad has been difficult. The viral vector RCASBP can be readily used for embryo-wide transgene expression; however global mis-expression using this method can cause deleterious off-target effects and embryo-lethality. In an attempt to develop vectors for the over-expression of sequences in chicken embryonic urogenital tissues, the viral vector RCANBP was engineered to contain predicted promoter sequences of gonadal-expressed genes. Several promoters were analysed and it was found that although the SF1 promoter produced a tissue-restricted expression pattern that was highest in the mesonephros and liver, it was also higher in the gonads compared to the rest of the body. The location of EGFP expression from the SF1 promoter overlapped with several key gonad-expressed sex development genes; however expression was generally low-level and was not seen in all gonadal cells. To further validate this sequence the key testis determinant DMRT1 was over-expressed in female embryos, which due to insufficient levels had no effect on gonad development. The female gene aromatase was then over-expressed in male embryos, which disrupted the testis pathway as demonstrated by a reduction in AMH protein. Taken together, although these data showed that the SF1 promoter can be used for functional studies in ovo, a stronger promoter sequence would likely be required for the functional analysis of gonad genes that require high-level expression.	[Lambeth, Luke S.; Ohnesorg, Thomas; Sinclair, Andrew H.; Smith, Craig A.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Sinclair, Andrew H.; Smith, Craig A.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Lambeth, Luke S.; Sinclair, Andrew H.; Smith, Craig A.] Poultry Cooperat Res Ctr, Armidale, NSW, Australia; [Cummins, David M.] CSIRO Anim Food & Hlth Sci, Australian Anim Hlth Lab, Geelong, Vic, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Lambeth, LS (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.	luke.lambeth@mcri.edu.au	Sinclair, Andrew H/A-3598-2010	Sinclair, Andrew H/0000-0003-2741-7992; Smith, Craig/0000-0002-1670-5545; Ohnesorg, Thomas/0000-0001-9225-8911	Australian Research Council (ARC) Future Fellowship; National Health and Medical Research Council [1031214]	Australian Research Council (ARC) Future Fellowship(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by an Australian Research Council (ARC) Future Fellowship awarded to CAS and The National Health and Medical Research Council (Project Grant # 1031214) awarded to TO. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JE, 1997, GEN COMP ENDOCR, V108, P182, DOI 10.1006/gcen.1997.6978; BOERKOEL CF, 1993, VIROLOGY, V195, P669, DOI 10.1006/viro.1993.1418; Busygina TV, 2003, BIOCHEMISTRY-MOSCOW+, V68, P377, DOI 10.1023/A:1023687527201; Carmona R, 2001, CELL TISSUE RES, V303, P173, DOI 10.1007/s004410000307; Chue J, 2011, FEBS J, V278, P1027, DOI 10.1111/j.1742-4658.2011.08032.x; Clinton M, 2001, BRIT POULTRY SCI, V42, P134, DOI 10.1080/713655025; COPELAND NG, 1981, CELL, V23, P51, DOI 10.1016/0092-8674(81)90269-5; Davey MG, 2007, CYTOGENET GENOME RES, V117, P231, DOI 10.1159/000103184; Farley EK, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-17; Fisher GH, 1999, ONCOGENE, V18, P5253, DOI 10.1038/sj.onc.1203087; FRAIZER GC, 1994, J BIOL CHEM, V269, P8892; Giering JC, 2008, MOL THER, V16, P1630, DOI 10.1038/mt.2008.144; Guioli S, 2007, DEVELOPMENT, V134, P4199, DOI 10.1242/dev.010249; Horard B, 2003, J MOL ENDOCRINOL, V31, P349, DOI 10.1677/jme.0.0310349; HUGHES SH, 1987, J VIROL, V61, P3004, DOI 10.1128/JVI.61.10.3004-3012.1987; Islam MM, 2012, JOVE-J VIS EXP, DOI 10.3791/3792; Kolle G, 2003, DEV DYNAM, V226, P107, DOI 10.1002/dvdy.10204; Krentz AD, 2009, P NATL ACAD SCI USA, V106, P22323, DOI 10.1073/pnas.0905431106; Kudo T, 1999, GENE, V231, P33, DOI 10.1016/S0378-1119(99)00097-9; Lambeth LS, 2014, DEV BIOL, V389, P160, DOI 10.1016/j.ydbio.2014.02.012; Lambeth LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068362; LERNER TL, 1981, J VIROL, V40, P421, DOI 10.1128/JVI.40.2.421-430.1981; Matson CK, 2010, DEV CELL, V19, P612, DOI 10.1016/j.devcel.2010.09.010; MATSUMINE H, 1991, J BIOL CHEM, V266, P19900; Nishikimi H, 2000, MOL REPROD DEV, V55, P20, DOI 10.1002/(SICI)1098-2795(200001)55:1&lt;20::AID-MRD4&gt;3.0.CO;2-E; Oreal E, 1998, DEV DYNAM, V212, P522, DOI 10.1002/(SICI)1097-0177(199808)212:4<522::AID-AJA5>3.0.CO;2-J; PETROPOULOS CJ, 1991, J VIROL, V65, P3728, DOI 10.1128/JVI.65.7.3728-3737.1991; Sato N, 2002, J VIROL, V76, P1980, DOI 10.1128/JVI.76.4.1980-1985.2002; Scaal M, 2004, DEV DYNAM, V229, P643, DOI 10.1002/dvdy.10433; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Shima Y, 2005, MOL ENDOCRINOL, V19, P2812, DOI 10.1210/me.2004-0431; Smith CA, 2004, BIOESSAYS, V26, P120, DOI 10.1002/bies.10400; Smith CA, 2003, BIOL REPROD, V68, P560, DOI 10.1095/biolreprod.102.007294; Smith CA, 1999, GENE, V234, P395, DOI 10.1016/S0378-1119(99)00179-1; Smith CA, 1997, J STEROID BIOCHEM, V60, P295, DOI 10.1016/S0960-0760(96)00196-3; Smith CA, 2009, DIFFERENTIATION, V77, P473, DOI 10.1016/j.diff.2009.02.001; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298; Stallings NR, 2002, MOL ENDOCRINOL, V16, P2360, DOI 10.1210/me.2002-0003; Swartz M, 2001, DEV BIOL, V233, P13, DOI 10.1006/dbio.2001.0181; Tyack SG, 2013, TRANSGENIC RES, V22, P1257, DOI 10.1007/s11248-013-9727-2; Wilhelm D, 2002, GENE DEV, V16, P1839, DOI 10.1101/gad.220102; Wilson NH, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr628	42	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101811	10.1371/journal.pone.0101811	http://dx.doi.org/10.1371/journal.pone.0101811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003592	gold, Green Published			2022-12-27	WOS:000339242700069
J	Uttervall, K; Duru, AD; Lund, J; Liwing, J; Gahrton, G; Holmberg, E; Aschan, J; Alici, E; Nahi, H				Uttervall, Katarina; Duru, Adil D.; Lund, Johan; Liwing, Johan; Gahrton, Gosta; Holmberg, Erik; Aschan, Johan; Alici, Evren; Nahi, Hareth			The Use of Novel Drugs Can Effectively Improve Response, Delay Relapse and Enhance Overall Survival in Multiple Myeloma Patients with Renal Impairment	PLOS ONE			English	Article							PROTEASOME INHIBITOR BORTEZOMIB; LENALIDOMIDE; FAILURE; PHARMACOKINETICS; IDENTIFICATION; DEXAMETHASONE; REVERSIBILITY; PATHOGENESIS; METABOLISM; REGIMENS	Background: Renal impairment is a common feature in multiple myeloma and is considered a poor prognostic factor. Aim: To determine the impact of novel drugs (i.e. bortezomib, lenalidomide and thalidomide) in the treatment of myeloma patients with renal impairment. The primary endpoint was overall survival and secondary endpoints were time to next treatment and response. Methods: The study population included all patients diagnosed with treatment-demanding multiple myeloma January 2000 to June 2011 at 15 Swedish hospitals. Renal impairment was defined as an estimated glomerular filtration rate under 60 mL/min/1.73 m(2). Result: The study population consisted of 1538 patients, of which 680 had renal impairment at diagnosis. The median overall survival in patients with renal impairment was 33 months, which was significantly shorter than 52 months in patients with normal renal function (P<0.001). Novel agents in first line improved overall survival (median 60 months) in non-high-dose treated patients with renal impairment (n = 143) as compared to those treated with conventional cytotoxic drugs (n = 411) (median 27 months) (P<0.001). In the multivariate analysis up front treatment with bortezomib was an independent factor for better overall survival in non-high-dose treated renally impaired patients. High-dose treated renally impaired patients had significantly better median overall survival than non-high-dose ones (74 versus 26 months) and novel drugs did not significantly improve survival further in these patients. Patients with renal impairment had both a shorter median time to next treatment and a lower response rate than those with normal renal function. However, novel drugs and high dose treatment lead to a significantly longer time to next treatment and the use of novel agents significantly improved the response rate of these patients. Conclusion: High dose treatment and novel drugs, especially bortezomib, can effectively overcome the negative impact of renal impairment in patients with multiple myeloma.	[Uttervall, Katarina; Duru, Adil D.; Lund, Johan; Liwing, Johan; Gahrton, Gosta; Alici, Evren; Nahi, Hareth] Karolinska Inst Huddinge, Dept Med, Stockholm, Sweden; [Uttervall, Katarina; Lund, Johan; Alici, Evren; Nahi, Hareth] Karolinska Univ, Huddinge Hosp, Hematol Ctr, Stockholm, Sweden; [Holmberg, Erik] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Oncol, Gothenburg, Sweden; [Aschan, Johan] Janssen Cilag AB, Sollentuna, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Gothenburg; Johnson & Johnson	Uttervall, K (corresponding author), Karolinska Inst Huddinge, Dept Med, Stockholm, Sweden.	katarina.uttervall@ki.se	nahi, hareth/AAA-3445-2020; Alici, Evren/A-4696-2010	Alici, Evren/0000-0001-5307-6648; Holmberg, Erik/0000-0001-5107-4550; Duru, Adil/0000-0002-5844-913X; nahi, hareth/0000-0003-4711-5094	Swedish cancer society; Swedish Research Council; Cancer Foundation in Sweden; Janssen-Cilag AB; Celgene lifetime achievement award	Swedish cancer society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancer Foundation in Sweden; Janssen-Cilag AB; Celgene lifetime achievement award(Bristol-Myers SquibbCelgene Corporation)	Swedish cancer society, Swedish Research Council, Cancer Foundation in Sweden, Janssen-Cilag AB, Celgene lifetime achievement award. The funder provided support in the form of salaries for authors Johan Liwing and Johan Aschan, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abbott KC, 2001, CLIN NEPHROL, V56, P207; ALEXANIAN R, 1990, Archives of Internal Medicine, V150, P1693, DOI 10.1001/archinte.150.8.1693; [Anonymous], 2002, AM J KIDNEY DIS OFFI, V39, pS46; Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Blade Joan, 1998, British Journal of Haematology, V102, P1115, DOI 10.1046/j.1365-2141.1998.00930.x; Chanan-Khan AA, 2010, J CLIN ONCOL, V28, P2612, DOI 10.1200/JCO.2009.25.4250; Chang DH, 2006, BLOOD, V108, P618, DOI 10.1182/blood-2005-10-4184; Chen N, 2007, J CLIN PHARMACOL, V47, P1466, DOI 10.1177/0091270007309563; Dimopoulos MA, 2008, LEUKEMIA, V22, P1485, DOI 10.1038/leu.2008.131; Dimopoulos MA, 2014, ANN ONCOL, V25, P195, DOI 10.1093/annonc/mdt483; Dimopoulos MA, 2013, LEUKEMIA, V27, P423, DOI 10.1038/leu.2012.182; Dimopoulos MA, 2010, J CLIN ONCOL, V28, P4976, DOI 10.1200/JCO.2010.30.8791; Dimopoulos MA, 2009, J CLIN ONCOL, V27, P6086, DOI 10.1200/JCO.2009.22.2232; Dimopoulos MA, 2009, CLIN LYMPHOMA MYELOM, V9, P302, DOI 10.3816/CLM.2009.n.059; Dingli D, 2007, J CLIN ONCOL, V25, P4933, DOI 10.1200/JCO.2007.11.7879; Eleftherakis-Papapiakovou E, 2011, LEUKEMIA LYMPHOMA, V52, P2299, DOI 10.3109/10428194.2011.597906; Eriksson T, 2003, J PHARM PHARMACOL, V55, P1701, DOI 10.1211/0022357022241; Harousseau JL, 2004, MULTIPLE MYELOMA HEM, P237; Laubach J, 2011, NAT REV CLIN ONCOL, V8, P8, DOI [10.1038/nrclinonc.2010.201, 10.1038/nrclinonc.2010.200]; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Ludwig H, 2010, J CLIN ONCOL, V28, P4635, DOI 10.1200/JCO.2010.28.1238; Pekol T, 2005, DRUG METAB DISPOS, V33, P771, DOI 10.1124/dmd.104.002956; RAYNER HC, 1991, Q J MED, V79, P517; Roussou M, 2010, LEUKEMIA RES, V34, P1395, DOI 10.1016/j.leukres.2010.04.024; Uttamsingh V, 2005, DRUG METAB DISPOS, V33, P1723, DOI 10.1124/dmd.105.005710; Wu L, 2008, CLIN CANCER RES, V14, P4650, DOI 10.1158/1078-0432.CCR-07-4405	26	37	39	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101819	10.1371/journal.pone.0101819	http://dx.doi.org/10.1371/journal.pone.0101819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003848	Green Published, Green Submitted, gold			2022-12-27	WOS:000339242700071
J	Wan, L; Zhang, FJ; He, QL; Tsang, WP; Lu, L; Li, QN; Wu, ZH; Qiu, GX; Zhou, GQ; Wan, C				Wan, Lin; Zhang, Fengjie; He, Qiling; Tsang, Wing Pui; Lu, Li; Li, Qingnan; Wu, Zhihong; Qiu, Guixing; Zhou, Guangqian; Wan, Chao			EPO Promotes Bone Repair through Enhanced Cartilaginous Callus Formation and Angiogenesis	PLOS ONE			English	Article							ERYTHROPOIETIN RECEPTOR; SKELETAL DEVELOPMENT; FRACTURE; EXPRESSION; MICE; OSTEOGENESIS; REGENERATION; PATHWAY; NONUNION; ISCHEMIA	Erythropoietin (EPO)/erythropoietin receptor (EPOR) signaling is involved in the development and regeneration of several non-hematopoietic tissues including the skeleton. EPO is identified as a downstream target of the hypoxia inducible factor-alpha (HIF-alpha) pathway. It is shown that EPO exerts a positive role in bone repair, however, the underlying cellular and molecular mechanisms remain unclear. In the present study we show that EPO and EPOR are expressed in the proliferating, pre-hypertrophic and hypertrophic zone of the developing mouse growth plates as well as in the cartilaginous callus of the healing bone. The proliferation rate of chondrocytes is increased under EPO treatment, while this effect is decreased following siRNA mediated knockdown of EPOR in chondrocytes. EPO treatment increases biosynthesis of proteoglycan, accompanied by up-regulation of chondrogenic marker genes including SOX9, SOX5, SOX6, collagen type 2, and aggrecan. The effects are inhibited by knockdown of EPOR. Blockage of the endogenous EPO in chondrocytes also impaired the chondrogenic differentiation. In addition, EPO promotes metatarsal endothelial sprouting in vitro. This coincides with the in vivo data that local delivery of EPO increases vascularity at the mid-stage of bone healing (day 14). In a mouse femoral fracture model, EPO promotes cartilaginous callus formation at days 7 and 14, and enhances bone healing at day 28 indexed by improved X-ray score and micro-CT analysis of microstructure of new bone regenerates, which results in improved biomechanical properties. Our results indicate that EPO enhances chondrogenic and angiogenic responses during bone repair. EPO's function on chondrocyte proliferation and differentiation is at least partially mediated by its receptor EPOR. EPO may serve as a therapeutic agent to facilitate skeletal regeneration.	[Wan, Lin; Zhang, Fengjie; Tsang, Wing Pui; Lu, Li; Wan, Chao] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Minist Educ,Key Lab Regenerat Med, Hong Kong, Hong Kong, Peoples R China; [Zhang, Fengjie; Tsang, Wing Pui; Wan, Chao] Chinese Univ Hong Kong, Shenzhen Res Inst, Sch Biomed Sci, Core Lab, Shenzhen, Peoples R China; [He, Qiling] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [He, Qiling] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Lu, Li; Li, Qingnan] Guangdong Pharmaceut Univ, Guangdong Key Lab Pharmaceut Bioact Subst, New Drug Funct Res Ctr, Sch Life Sci & Biopharm, Guangzhou, Guangdong, Peoples R China; [Wu, Zhihong; Qiu, Guixing] Peking Union Med Coll, Dept Orthopaed, Peking Union Med Coll Hosp, Beijing 100021, Peoples R China; [Wu, Zhihong; Qiu, Guixing] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Zhou, Guangqian] Shenzhen Univ, Ctr Antiageing & Regenerat Med, Sch Med, Shenzhen, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Guangdong Pharmaceutical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Shenzhen University	Wan, C (corresponding author), Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Minist Educ,Key Lab Regenerat Med, Hong Kong, Hong Kong, Peoples R China.	cwan@cuhk.edu.hk	wu, zhi/GXH-3041-2022; Wan, Chao/J-9277-2013	Wan, Chao/0000-0001-6780-2006; Qiu, Guixing/0000-0002-4597-9350	Hong Kong Research Grant Council General Research Fund [RGC GRF 475910]; National Natural Science Foundation of China [NSFC 81130034]; NSFC-RGC Joint Research Scheme [CUHK445/10]	Hong Kong Research Grant Council General Research Fund(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC-RGC Joint Research Scheme(National Natural Science Foundation of China (NSFC))	This work was supported by Hong Kong Research Grant Council General Research Fund (RGC GRF 475910), National Natural Science Foundation of China (NSFC 81130034), and NSFC-RGC Joint Research Scheme (CUHK445/10) to CW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson A, 2007, PHYSIOL BEHAV, V91, P579, DOI 10.1016/j.physbeh.2007.03.020; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2011, J BONE MINER METAB, V29, P390, DOI 10.1007/s00774-011-0273-9; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Brandi ML, 2013, EXPERT OPIN PHARMACO, V14, P1441, DOI 10.1517/14656566.2013.801959; Brines M, 2006, KIDNEY INT, V70, P246, DOI 10.1038/sj.ki.5001546; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Cackowski FC, 2010, BLOOD, V115, P140, DOI 10.1182/blood-2009-08-237628; Casazza K, 2013, WORLD J DIABETES, V4, P145, DOI 10.4239/wjd.v4.i4.145; Cianferotti L, 2014, ENDOCRINE, V45, P165, DOI 10.1007/s12020-013-0026-8; De Spiegelaere W, 2010, MOL CELL BIOCHEM, V337, P287, DOI 10.1007/s11010-009-0310-3; Deckers M, 2001, LAB INVEST, V81, P5, DOI 10.1038/labinvest.3780207; Derks M, 2013, CELLS TISSUES ORGANS, V198, P179, DOI 10.1159/000354897; EINHORN TA, 1995, J BONE JOINT SURG AM, V77A, P940, DOI 10.2106/00004623-199506000-00016; Enobakhare BO, 1996, ANAL BIOCHEM, V243, P189, DOI 10.1006/abio.1996.0502; Fassbender M, 2011, EUR CELLS MATER, V22, P1; Ferguson C, 1999, MECH DEVELOP, V87, P57, DOI 10.1016/S0925-4773(99)00142-2; Fisher JW, 1997, P SOC EXP BIOL MED, V216, P358; Garcia P, 2011, J ORTHOP RES, V29, P165, DOI 10.1002/jor.21219; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Haigh JJ, 2000, DEVELOPMENT, V127, P1445; Hak DJ, 2014, INJURY, V45, pS3, DOI 10.1016/j.injury.2014.04.002; Hak DJ, 2006, J ORTHOP RES, V24, P11, DOI 10.1002/jor.20022; Holstein JH, 2007, LIFE SCI, V80, P893, DOI 10.1016/j.lfs.2006.11.023; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08; Kertesz N, 2004, DEV BIOL, V276, P101, DOI 10.1016/j.ydbio.2004.08.025; Kigami R, 2013, IMPLANT DENT, V22, P422, DOI 10.1097/ID.0b013e31829d19f0; Kolar P, 2011, CLIN ORTHOP RELAT R, V469, P3118, DOI 10.1007/s11999-011-1865-3; Kumral A, 2011, BRAIN DEV-JPN, V33, P632, DOI 10.1016/j.braindev.2010.10.014; LANE JM, 1987, ORTHOP CLIN N AM, V18, P213; LEE MY, 1991, BLOOD, V77, P2135; Lee YJ, 2008, J KOREAN NEUROSURG S, V43, P149, DOI 10.3340/jkns.2008.43.3.149; MCKIBBIN B, 1978, J BONE JOINT SURG BR, V60, P150, DOI 10.1302/0301-620X.60B2.350882; Mihmanli A, 2009, J ORAL MAXIL SURG, V67, P2337, DOI 10.1016/j.joms.2008.06.082; Ovchinnikov D., 2009, COLD SPRING HARB PRO, V2009, pt5170, DOI 10.1101/pdb.prot5170; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Sheng Matilda H C, 2014, J Bone Metab, V21, P41, DOI 10.11005/jbm.2014.21.1.41; Shiozawa Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010853; Siddiqui NA, 2013, CURR STEM CELL RES T, V8, P192; Singbrant S, 2011, BLOOD, V117, P5631, DOI 10.1182/blood-2010-11-320564; Solomon DH, 2014, J BONE MINER RES; Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099; Sugawa M, 2002, NEUROSCI RES, V44, P391, DOI 10.1016/S0168-0102(02)00161-X; Sun HL, 2012, TISSUE ENG PT A, V18, P2095, DOI [10.1089/ten.tea.2011.0742, 10.1089/ten.TEA.2011.0742]; Tada H, 2006, CARDIOVASC RES, V71, P466, DOI 10.1016/j.cardiores.2006.05.010; Takenaka Tsuneo, 2003, International Urology and Nephrology, V35, P407, DOI 10.1023/B:UROL.0000022950.00626.e4; TAN CC, 1991, KIDNEY INT, V40, P69, DOI 10.1038/ki.1991.181; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; Wan C, 2008, P NATL ACAD SCI USA, V105, P686, DOI 10.1073/pnas.0708474105; Wan C, 2010, ANN NY ACAD SCI, V1192, P322, DOI 10.1111/j.1749-6632.2009.05238.x; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Warren SM, 2001, J SURG RES, V99, P147, DOI 10.1006/jsre.2001.6128; Wright GL, 2004, FASEB J, V18, P1031, DOI 10.1096/fj.03-1289fje; WU H, 1995, NATURE, V377, P242, DOI 10.1038/377242a0; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Yi CL, 2012, INJURY, V43, P402, DOI 10.1016/j.injury.2010.12.011; Zelzer E, 2002, DEVELOPMENT, V129, P1893	59	50	60	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e102010	10.1371/journal.pone.0102010	http://dx.doi.org/10.1371/journal.pone.0102010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003898	gold, Green Published, Green Submitted			2022-12-27	WOS:000339242700099
J	Zhen, YM; Qin, GR; Luo, C; Jiang, HL; Yu, KQ; Chen, GH				Zhen, Yunmei; Qin, Guangrong; Luo, Cheng; Jiang, Hualiang; Yu, Kunqian; Chen, Guanghui			Exploring the RING-Catalyzed Ubiquitin Transfer Mechanism by MD and QM/MM Calculations	PLOS ONE			English	Article							E3 LIGASE ACTIVITY; MOLECULAR-DYNAMICS; DNA-DAMAGE; MASS-SPECTROMETRY; DRUG TARGETS; RESP MODEL; SUMO; RNF4; COMPLEX; CONJUGATION	Ubiquitylation is a universal mechanism for controlling cellular functions. A large family of ubiquitin E3 ligases (E3) mediates Ubiquitin (Ub) modification. To facilitate Ub transfer, RING E3 ligases bind both the substrate and ubiquitin E2 conjugating enzyme (E2) linked to Ub via a thioester bond to form a catalytic complex. The mechanism of Ub transfer catalyzed by RING E3 remains elusive. By employing a combined computational approach including molecular modeling, molecular dynamics (MD) simulations, and quantum mechanics/molecular mechanics (QM/MM) calculations, we characterized this catalytic mechanism in detail. The three-dimensional model of dimeric RING E3 ligase RNF4 RING, E2 ligase UbcH5A, Ub and the substrate SUMO2 shows close contact between the substrate and Ub transfer catalytic center. Deprotonation of the substrate lysine by D117 on UbcH5A occurs with almost no energy barrier as calculated by MD and QM/MM calculations. Then, the side chain of the activated lysine gets close to the thioester bond via a conformation change. The Ub transfer pathway begins with a nucleophilic addition that forms an oxyanion intermediate of a 4.23 kcal/mol energy barrier followed by nucleophilic elimination, resulting in a Ub modified substrate by a 5.65 kcal/mol energy barrier. These results provide insight into the mechanism of RING-catalyzed Ub transfer guiding the discovery of Ub system inhibitors.	[Zhen, Yunmei] Shantou Univ, Dept Biol, Shantou, Guangdong, Peoples R China; [Zhen, Yunmei; Qin, Guangrong; Luo, Cheng; Jiang, Hualiang; Yu, Kunqian] Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 200031, Peoples R China; [Chen, Guanghui] Shantou Univ, Dept Chem, Shantou, Guangdong, Peoples R China	Shantou University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shantou University	Yu, KQ (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 200031, Peoples R China.	kqyu@mail.shcnc.ac.cn; ghchen@stu.edu.cn		QIN, GUANGRONG/0000-0001-8836-1246	National High Technology Research and Development Program of China (863 Program) [2012AA020301, 2012AA01A305]; National Natural Science Foundation of China [81230076, 21210003]; Chinese Academy of Sciences [KSZD-EW-L09-4]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from the National High Technology Research and Development Program of China (863 Program) (No. 2012AA020301 and 2012AA01A305), the National Natural Science Foundation of China grants (81230076 and 21210003), Chinese Academy of Sciences (Project KSZD-EW-L09-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Benjamin WC, 2012, BIOCHEM J, V445, P167; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Budhidarmo R, 2012, TRENDS BIOCHEM SCI, V37, P58, DOI 10.1016/j.tibs.2011.11.001; Calabrese MF, 2011, NAT STRUCT MOL BIOL, V18, P947, DOI 10.1038/nsmb.2086; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cohen P, 2010, CELL, V143, P686, DOI 10.1016/j.cell.2010.11.016; Cornell WD, 1996, J AM CHEM SOC, V118, P2309, DOI 10.1021/ja955032e; Danielsen JMR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003590; Dapprich S, 1999, J MOL STRUC-THEOCHEM, V461, P1, DOI 10.1016/S0166-1280(98)00475-8; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; FIELD MJ, 1990, J COMPUT CHEM, V11, P700, DOI 10.1002/jcc.540110605; Frisch G. W., 2013, GAUSSIAN 09; Fryrear KA, 2012, BLOOD, V119, P1173, DOI 10.1182/blood-2011-06-358564; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Gareau JR, 2012, J BIOL CHEM, V287, P4740, DOI 10.1074/jbc.M111.321141; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Grabbe C, 2011, NAT REV MOL CELL BIO, V12, P295, DOI 10.1038/nrm3099; Guzzo CM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003485; HAAS AL, 1982, J BIOL CHEM, V257, P329; Hakli M, 2004, FEBS LETT, V560, P56, DOI 10.1016/S0014-5793(04)00070-5; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hehre WJ, 1986, AB INITIO MOL ORBITA; Heideker J, 2009, DNA REPAIR, V8, P517, DOI 10.1016/j.dnarep.2009.01.010; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kosoy A, 2007, J BIOL CHEM, V282, P20388, DOI 10.1074/jbc.M702652200; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Liew CW, 2010, BIOCHEM J, V431, P23, DOI 10.1042/BJ20100957; Lima CD, 2012, NATURE, V489, P43, DOI 10.1038/489043a; Luo KT, 2012, EMBO J, V31, P3008, DOI 10.1038/emboj.2012.158; Markin CJ, 2010, J AM CHEM SOC, V132, P17775, DOI 10.1021/ja105267w; Mastrandrea LD, 1999, J BIOL CHEM, V274, P27299, DOI 10.1074/jbc.274.38.27299; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Metzger MB, 2013, MOL CELL, V50, P516, DOI 10.1016/j.molcel.2013.04.004; Metzger MB, 2012, J CELL SCI, V125, P531, DOI 10.1242/jcs.091777; Micel LN, 2013, J CLIN ONCOL, V31, P1231, DOI 10.1200/JCO.2012.44.0958; Mukhopadhyay D, 2010, J CELL BIOL, V188, P681, DOI 10.1083/jcb.200909008; Olsen SK, 2013, MOL CELL, V49, P884, DOI 10.1016/j.molcel.2013.01.013; Osula O, 2012, J MASS SPECTROM, V47, P644, DOI 10.1002/jms.2959; Parker JL, 2012, NUCL ACIDS RES; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Peters MB, 2010, J CHEM THEORY COMPUT, V6, P2935, DOI 10.1021/ct1002626; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Plechanovova A, 2011, NAT STRUCT MOL BIOL, V18, P1052, DOI 10.1038/nsmb.2108; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Pruneda JN, 2012, MOL CELL; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Svensson M, 1996, J PHYS CHEM-US, V100, P19357, DOI 10.1021/jp962071j; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; van Hagen M, 2010, NUCLEIC ACIDS RES, V38, P1922, DOI 10.1093/nar/gkp1157; Vucic D, 2011, NAT REV MOL CELL BIO, V12, P439, DOI 10.1038/nrm3143; Vyas R, 2012, CELL DEATH DIFFERENT; Wan J, 2012, CURR PROTEIN PEPT SC, V13, P467, DOI 10.2174/138920312802430563; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Wu PY, 2007, EMBO J, V26, P4051, DOI 10.1038/sj.emboj.7601829; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Yin YL, 2012, GENE DEV, V26, P1196, DOI 10.1101/gad.189274.112; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	74	7	7	5	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101663	10.1371/journal.pone.0101663	http://dx.doi.org/10.1371/journal.pone.0101663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003393	gold, Green Published, Green Submitted			2022-12-27	WOS:000339242700050
J	Gandhi, K; Thera, MA; Coulibaly, D; Traore, K; Guindo, AB; Ouattara, A; Takala-Harrison, S; Berry, AA; Doumbo, OK; Plowe, CV				Gandhi, Kavita; Thera, Mahamadou A.; Coulibaly, Drissa; Traore, Karim; Guindo, Ando B.; Ouattara, Amed; Takala-Harrison, Shannon; Berry, Andrea A.; Doumbo, Ogobara K.; Plowe, Christopher V.			Variation in the Circumsporozoite Protein of Plasmodium falciparum: Vaccine Development Implications	PLOS ONE			English	Article							STAGE MALARIA VACCINE; T-CELL EPITOPES; GENETIC DIVERSITY; AFRICAN CHILDREN; PHASE-3 TRIAL; EFFICACY; PARASITE; CANDIDATE; INFECTION; SELECTION	The malaria vaccine candidate RTS,S/AS01 is based on immunogenic regions of Plasmodium falciparum circumsporozoite protein (CSP) from the 3D7 reference strain and has shown modest efficacy against clinical disease in African children. It remains unclear what aspect(s) of the immune response elicited by this vaccine are protective. The goals of this study were to measure diversity in immunogenic regions of CSP, and to identify associations between polymorphism in CSP and the risk of P. falciparum infection and clinical disease. The present study includes data and samples from a prospective cohort study designed to measure incidence of malaria infection and disease in children in Bandiagara, Mali. A total of 769 parasite-positive blood samples corresponding to both acute clinical malaria episodes and asymptomatic infections experienced by 100 children were included in the study. Non-synonymous SNP data were generated by 454 sequencing for the T-cell epitopes, and repeat length data were generated for the B-cell epitopes of the cs gene. Cox proportional hazards models were used to determine the effect of sequence variation in consecutive infections occurring within individuals on the time to new infection and new clinical malaria episode. Diversity in the T-cell epitope-encoding regions Th2R and Th3R remained stable throughout seasons, between age groups and between clinical and asymptomatic infections with the exception of a higher proportion of 3D7 haplotypes found in the oldest age group. No associations between sequence variation and hazard of infection or clinical malaria were detected. The lack of association between sequence variation and hazard of infection or clinical malaria suggests that naturally acquired immunity to CSP may not be allele-specific.	[Gandhi, Kavita; Ouattara, Amed; Takala-Harrison, Shannon; Berry, Andrea A.; Plowe, Christopher V.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Howard Hughes Med Inst, Baltimore, MD 21201 USA; [Thera, Mahamadou A.; Coulibaly, Drissa; Traore, Karim; Guindo, Ando B.; Doumbo, Ogobara K.] Univ Sci Tech & Technol, Malaria Res & Training Ctr, Bamako, Mali	Howard Hughes Medical Institute; University System of Maryland; University of Maryland Baltimore; University of Science & Technology of Bamako	Plowe, CV (corresponding author), Univ Maryland, Sch Med, Ctr Vaccine Dev, Howard Hughes Med Inst, Baltimore, MD 21201 USA.	cplowe@medicine.umaryland.edu		Traore, Karim/0000-0002-9553-6611; Thera, Mahamadou A/0000-0002-2679-035X; Ouattara, Amed/0000-0003-1964-7130; Takala-Harrison, Shannon/0000-0003-4674-8500; Berry, Andrea/0000-0003-3140-3868	National Institute of Allergy and Infectious Diseases (NIAID) [N01AI85346, U19AI065683]; Fogarty International Center [D43TW001589]; National Institutes of Health; U.S. Department of Defense [W81XWH-06-1-0427]; U.S. Agency for International Development; Doris Duke Charitable Foundation; Howard Hughes Medical Institute; University of Maryland Multidisciplinary Clinical Research Career Development Program (NIH) [K12RR023250]; FOGARTY INTERNATIONAL CENTER [D43TW001589] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR023250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI085346, U19AI065683] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense); U.S. Agency for International Development(United States Agency for International Development (USAID)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); University of Maryland Multidisciplinary Clinical Research Career Development Program (NIH); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by contract N01AI85346 and cooperative agreement U19AI065683 from the National Institute of Allergy and Infectious Diseases (NIAID), grant D43TW001589 from the Fogarty International Center, National Institutes of Health, and contract W81XWH-06-1-0427 from the U.S. Department of Defense and the U.S. Agency for International Development. CVP was supported by a Distinguished Clinical Scientist Award from the Doris Duke Charitable Foundation and by the Howard Hughes Medical Institute. STH was supported by the University of Maryland Multidisciplinary Clinical Research Career Development Program (NIH grant K12RR023250). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Alloueche A, 2003, AM J TROP MED HYG, V68, P97, DOI 10.4269/ajtmh.2003.68.97; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Chenet SM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-93; Coulibaly D, 2002, AM J TROP MED HYG, V67, P604; de GA, 1989, J IMMUNOL, V142, P4000; Doolan DL, 2000, J IMMUNOL, V165, P1123, DOI 10.4049/jimmunol.165.2.1123; Doolan DL, 1997, IMMUNITY, V7, P97, DOI 10.1016/S1074-7613(00)80513-0; EGAN JE, 1993, AM J TROP MED HYG, V49, P166, DOI 10.4269/ajtmh.1993.49.166; Enosse S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010005; Escalante AA, 2002, MOL BIOCHEM PARASIT, V125, P83, DOI 10.1016/S0166-6851(02)00216-5; Gandhi K, 2012, AM J TROP MED HYG, V86, P775, DOI 10.4269/ajtmh.2012.11-0478; Gilbert SC, 1998, SCIENCE, V279, P1173, DOI 10.1126/science.279.5354.1173; Jalloh A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-120; Kumkhaek C, 2005, J IMMUNOL, V175, P3935, DOI 10.4049/jimmunol.175.6.3935; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; NARDIN EH, 1979, SCIENCE, V206, P597, DOI 10.1126/science.386511; Ochola LI, 2010, MOL BIOL EVOL, V27, P2344, DOI 10.1093/molbev/msq119; Ouattara A, 2013, J INFECT DIS, V207, P511, DOI 10.1093/infdis/jis709; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; SCHOFIELD L, 1990, B WORLD HEALTH ORGAN, V68, P66; Takala SL, 2009, PARASITE IMMUNOL, V31, P560, DOI 10.1111/j.1365-3024.2009.01138.x; Takala SL, 2007, PLOS MED, V4, P523, DOI 10.1371/journal.pmed.0040093; Takala SL, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000257; Thera MA, 2011, NEW ENGL J MED, V365, P1004, DOI 10.1056/NEJMoa1008115; Waitumbi JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007849; Weedall GD, 2007, INT J PARASITOL, V37, P77, DOI 10.1016/j.ijpara.2006.09.001; Williams R, 2006, NAT METHODS, V3, P545, DOI 10.1038/NMETH896	31	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101783	10.1371/journal.pone.0101783	http://dx.doi.org/10.1371/journal.pone.0101783			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992338	Green Submitted, gold, Green Published			2022-12-27	WOS:000341253400117
J	Wang, MTM; Gamble, G; Bolland, MJ; Grey, A				Wang, Michael T. M.; Gamble, Greg; Bolland, Mark J.; Grey, Andrew			Press Releases Issued by Supplements Industry Organisations and Non-Industry Organisations in Response to Publication of Clinical Research Findings: A Case-Control Study	PLOS ONE			English	Article							VITAMIN-D SUPPLEMENTATION; CARDIOVASCULAR-DISEASE; FOLIC-ACID; CALCIUM SUPPLEMENTATION; PHYSICIANS HEALTH; WOMENS-HEALTH; CANCER-RISK; ANTIOXIDANT SUPPLEMENTS; MYOCARDIAL-INFARCTION; DOCOSAHEXAENOIC ACID	Background: Dietary supplement use is increasing despite lack of evidence of benefits, or evidence of harm. Press releases issued by the supplements industry might contribute to this situation by using 'spin' (strategies to hype or denigrate findings) to distort the results of clinical studies. We assessed press releases issued in response to publication of clinical studies on dietary supplements. Methods and Findings: We analyzed 47 supplements industry press releases and 91 non-industry press releases and news stories, generated in response to 46 clinical studies of dietary supplements published between 1/1/2005 and 5/31/2013. The primary outcome was 'spin' content and direction. We also assessed disposition towards use of dietary supplements, reporting of study information, and dissemination of industry press releases. More supplements industry press releases (100%) contained 'spin' than non-industry media documents (55%, P<0.001). Hyping 'spin' scores were higher in industry than non-industry media documents for studies reporting benefit of supplements (median 'spin' score 3.3, 95% CI 1.0-5.5 vs 0.5, 0-1.0; P<0.001). Denigratory 'spin' scores were higher in industry than non-industry media documents for studies reporting no effect (6.0, 5.0-7.0 vs 0, 0-0; P<0.001) or harm (6.0, 5.5-7.5 vs 0, 0-0.5; P<0.001) from a supplement. Industry press releases advocated supplement use in response to >90% of studies that reported no benefit, or harm, of the supplement. Industry press releases less frequently reported study outcomes, sample size, and estimates of effect size than non-industry media documents (all P<0.001), particularly for studies that reported no benefit of supplements. Industry press releases were referenced by 148 news stories on the websites of 6 organizations that inform manufacturers, retailers and consumers of supplements. Conclusions: Dietary supplements industry press releases issued in response to clinical research findings are characterized by 'spin' that hypes results that are favourable to supplement use and denigrates results that are not.	[Wang, Michael T. M.; Gamble, Greg; Bolland, Mark J.; Grey, Andrew] Univ Auckland, Dept Med, Auckland, New Zealand	University of Auckland	Grey, A (corresponding author), Univ Auckland, Dept Med, Auckland, New Zealand.	a.grey@auckland.ac.nz	Wang, Michael T. M./X-4197-2019; Bolland, Mark J/A-7554-2008	Wang, Michael T. M./0000-0001-8334-3911; Bolland, Mark J/0000-0003-0465-2674; Gamble, Greg/0000-0003-0412-3203	University of Auckland; Health Research Council of New Zealand	University of Auckland; Health Research Council of New Zealand(Health Research Council of New Zealand)	Michael Wang is the recipient of a University of Auckland summer studentship to conduct this work. Mark Bolland is the recipient of a Hercus Fellowship from the Health Research Council of New Zealand (http://www.hrc.govt.nz/). Neither funder had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5463; Albertazzi P, 2002, CLIMACTERIC, V5, P374, DOI 10.1080/713605304; Armitage JM, 2010, JAMA-J AM MED ASSOC, V303, P2486, DOI 10.1001/jama.2010.840; Bacon CJ, 2011, NEW ZEAL MED J, V124, P55; Bailey RL, 2013, JAMA INTERN MED, V173, P355, DOI 10.1001/jamainternmed.2013.2299; Barry MJ, 2011, JAMA-J AM MED ASSOC, V306, P1344, DOI 10.1001/jama.2011.1364; Bent S, 2006, NEW ENGL J MED, V354, P557, DOI 10.1056/NEJMoa053085; Bischoff-Ferrari HA, 2012, NEW ENGL J MED, V367, P40, DOI 10.1056/NEJMoa1109617; Bjelakovic G, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007176; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; Bjelakovic G, 2013, JAMA-J AM MED ASSOC, V310, P1178, DOI 10.1001/jama.2013.277028; Blendon RJ, 2013, JAMA INTERN MED, V173, P74, DOI 10.1001/2013.jamainternmed.311; Bolland MJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3691; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Boutron I, 2010, JAMA-J AM MED ASSOC, V303, P2058, DOI 10.1001/jama.2010.651; Chew EY, 2013, JAMA-J AM MED ASSOC, V309, P2005, DOI 10.1001/jama.2013.4997; Chew EY, 2013, JAMA OPHTHALMOL, P1; Christen WG, 2009, ARCH INTERN MED, V169, P335, DOI 10.1001/archinternmed.2008.574; Clarke R, 2010, ARCH INTERN MED, V170, P1622, DOI 10.1001/archinternmed.2010.348; Clegg DO, 2006, NEW ENGL J MED, V354, P795, DOI 10.1056/NEJMoa052771; Cole BF, 2007, JAMA-J AM MED ASSOC, V297, P2351, DOI 10.1001/jama.297.21.2351; de Vet HCW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2125; Denison HJ, 2012, J NUTR HEALTH AGING, V16, P307, DOI 10.1007/s12603-012-0016-1; Ebbing M, 2009, JAMA-J AM MED ASSOC, V302, P2119, DOI 10.1001/jama.2009.1622; Gaziano JM, 2012, JAMA-J AM MED ASSOC, V308, P1871, DOI 10.1001/jama.2012.14641; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; Grey A, 2014, JAMA INTERN MED, V174, P460, DOI 10.1001/jamainternmed.2013.12765; Grilli R., 2002, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD000389; Haas JS, 2004, ANN INTERN MED, V140, P184, DOI 10.7326/0003-4819-140-3-200402030-00009; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Kramer H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047458; Kuriya B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002828; Kwak SM, 2012, ARCH INTERN MED, V172, P686, DOI 10.1001/archinternmed.2012.262; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Li KR, 2012, HEART, V98, P920, DOI 10.1136/heartjnl-2011-301345; Lin J, 2009, JNCI-J NATL CANCER I, V101, P14, DOI 10.1093/jnci/djn438; Lin J, 2007, ARCH INTERN MED, V167, P1050, DOI 10.1001/archinte.167.10.1050; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Lonn E, 2005, JAMA-J AM MED ASSOC, V293, P1338, DOI 10.1001/jama.293.11.1338; Makrides M, 2010, JAMA-J AM MED ASSOC, V304, P1675, DOI 10.1001/jama.2010.1507; Michaelsson K, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f228; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; Murdoch DR, 2012, JAMA-J AM MED ASSOC, V308, P1333, DOI 10.1001/jama.2012.12505; Mursu J, 2011, ARCH INTERN MED, V171, P1625, DOI 10.1001/archinternmed.2011.445; Neuhouser ML, 2009, ARCH INTERN MED, V169, P294, DOI 10.1001/archinternmed.2008.540; Park Y, 2009, ARCH INTERN MED, V169, P391, DOI 10.1001/archinternmed.2008.578; Prasad V, 2012, JAMA-J AM MED ASSOC, V307, P37, DOI 10.1001/jama.2011.1960; Prince RL, 2006, ARCH INTERN MED, V166, P869, DOI 10.1001/archinte.166.8.869; Quinn JF, 2010, JAMA-J AM MED ASSOC, V304, P1903, DOI 10.1001/jama.2010.1510; Reichenbach S, 2007, ANN INTERN MED, V146, P580, DOI 10.7326/0003-4819-146-8-200704170-00009; Rizos EC, 2012, JAMA-J AM MED ASSOC, V308, P1024, DOI 10.1001/2012.jama.11374; Sawitzke AD, 2008, ARTHRITIS RHEUM, V58, P3183, DOI 10.1002/art.23973; Schwartz LM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8164; Schwartz LM, 2004, ANN INTERN MED, V140, P226, DOI 10.7326/0003-4819-140-3-200402030-00015; Sesso HD, 2008, JAMA-J AM MED ASSOC, V300, P2123, DOI 10.1001/jama.2008.600; Sesso HD, 2012, JAMA-J AM MED ASSOC, V308, P1751, DOI 10.1001/jama.2012.14805; Shah SA, 2007, LANCET INFECT DIS, V7, P473, DOI 10.1016/S1473-3099(07)70160-3; Snitz BE, 2009, JAMA-J AM MED ASSOC, V302, P2663, DOI 10.1001/jama.2009.1913; Tatsioni A, 2007, JAMA-J AM MED ASSOC, V298, P2517, DOI 10.1001/jama.298.21.2517; Wactawski-Wende J, 2006, NEW ENGL J MED, V354, P684, DOI 10.1056/NEJMoa055222; Wandel S, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4675; Woloshin S, 2009, ANN INTERN MED, V150, P613, DOI 10.7326/0003-4819-150-9-200905050-00007; Xiao Q, 2013, JAMA INTERN MED, V173, P639, DOI 10.1001/jamainternmed.2013.3283; Yavchitz A, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001308	67	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101533	10.1371/journal.pone.0101533	http://dx.doi.org/10.1371/journal.pone.0101533			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992571	Green Published, gold, Green Submitted			2022-12-27	WOS:000341253400086
J	Tryon, RC; Johnson, SL				Tryon, Robert C.; Johnson, Stephen L.			Clonal Analysis of kit ligand a Functional Expression Reveals Lineage-Specific Competence to Promote Melanocyte Rescue in the Mutant Regenerating Caudal Fin	PLOS ONE			English	Article							ZEBRAFISH; PROLIFERATION; DEDIFFERENTIATION; DIFFERENTIATION; MORPHOGENESIS; REQUIREMENTS; TISSUE; ROLES; CELLS	The study of regeneration in an in vivo vertebrate system has the potential to reveal targetable genes and pathways that could improve our ability to heal and repair damaged tissue. We have developed a system for clonal labeling of discrete cell lineages and independently inducing gene expression under control of the heat shock promoter in the zebrafish caudal fin. Consequently we are able to test the affects of overexpressing a single gene in the context of regeneration within each of the nine different cell lineage classes that comprise the caudal fin. This can test which lineage is necessary or sufficient to provide gene function. As a first example to demonstrate this approach, we explored which lineages were competent to functionally express the kit ligand a protein as assessed by the local complementation of the mutation in the sparse-like (kitlga(tc244b)) background. We show that dermal fibroblast expression of kit ligand a robustly supports the rescue of melanocytes in the regenerating caudal fin. kit ligand a expression from skin and osteoblasts results in more modest and variable rescue of melanocytes, while lateral line expression was unable to complement the mutation.	[Tryon, Robert C.; Johnson, Stephen L.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL)	Tryon, RC (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.	rtryon@genetics.wustl.edu			NIH [GM056988]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056988, R56GM056988] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH grant GM056988. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimenko MA, 2003, DEV DYNAM, V226, P190, DOI 10.1002/dvdy.10248; Azevedo AS, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-24; Dooley CM, 2013, DEVELOPMENT, V140, P1003, DOI 10.1242/dev.087007; Duszynski RJ, 2011, ZEBRAFISH, V8, P211, DOI 10.1089/zeb.2011.0693; Frohnhofer HG, 2013, DEVELOPMENT, V140, P2997, DOI 10.1242/dev.096719; Grichnik JM, 1998, J INVEST DERMATOL, V111, P233, DOI 10.1046/j.1523-1747.1998.00272.x; Grotek B, 2013, DEVELOPMENT, V140, P1412, DOI 10.1242/dev.087452; Halloran MC, 2000, DEVELOPMENT, V127, P1953; Hultman KA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030017; Hultman KA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000544; Iovine MK, 2007, NAT CHEM BIOL, V3, P613, DOI 10.1038/nchembio.2007.36; Johnson SL, 1999, METHOD CELL BIOL, V59, P301; Knopf F, 2011, DEV CELL, V20, P713, DOI 10.1016/j.devcel.2011.04.014; Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101; Lee Y, 2009, DEV BIOL, V331, P270, DOI 10.1016/j.ydbio.2009.05.545; Mari-Beffa M, 2010, DEV DYNAM, V239, P2779, DOI 10.1002/dvdy.22444; Mathew LK, 2009, BIOCHEM PHARMACOL, V77, P498, DOI 10.1016/j.bcp.2008.09.025; Munch J, 2013, DEVELOPMENT, V140, P1402, DOI 10.1242/dev.087346; Nechiporuk A, 2003, DEV BIOL, V258, P291, DOI 10.1016/S0012-1606(03)00129-5; O'Reilly-Pol T, 2013, DEVELOPMENT, V140, P996, DOI 10.1242/dev.088112; Parichy DM, 1999, DEVELOPMENT, V126, P3425; Parichy DM, 2003, DEVELOPMENT, V130, P817, DOI 10.1242/dev.00307; Patterson LB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003561; Poss KD, 2003, DEV DYNAM, V226, P202, DOI 10.1002/dvdy.10220; Rawls JF, 2000, DEVELOPMENT, V127, P3715; Rawls JF, 2001, DEVELOPMENT, V128, P1943; Stewart S, 2012, DEV BIOL, V365, P339, DOI 10.1016/j.ydbio.2012.02.031; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Thummel R, 2006, DEV DYNAM, V235, P336, DOI 10.1002/dvdy.20630; Tryon RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021010; Tu SM, 2010, CANCER TREAT RES, V154, P137, DOI 10.1007/978-1-4419-5968-3_13; Tu S, 2011, DEV CELL, V20, P725, DOI 10.1016/j.devcel.2011.04.013; WEHRLEHALLER B, 1995, DEVELOPMENT, V121, P731; Yamanaka H, 2014, P NATL ACAD SCI USA, V111, P1867, DOI 10.1073/pnas.1315416111	34	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102317	10.1371/journal.pone.0102317	http://dx.doi.org/10.1371/journal.pone.0102317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25009992	Green Submitted, gold, Green Published			2022-12-27	WOS:000338763800091
J	Esposito, U; Giugliano, M; van Rossum, M; Vasilaki, E				Esposito, Umberto; Giugliano, Michele; van Rossum, Mark; Vasilaki, Eleni			Measuring Symmetry, Asymmetry and Randomness in Neural Network Connectivity	PLOS ONE			English	Article							CIRCUIT RECONSTRUCTION; MODEL	Cognitive functions are stored in the connectome, the wiring diagram of the brain, which exhibits non-random features, so-called motifs. In this work, we focus on bidirectional, symmetric motifs, i.e. two neurons that project to each other via connections of equal strength, and unidirectional, non-symmetric motifs, i.e. within a pair of neurons only one neuron projects to the other. We hypothesise that such motifs have been shaped via activity dependent synaptic plasticity processes. As a consequence, learning moves the distribution of the synaptic connections away from randomness. Our aim is to provide a global, macroscopic, single parameter characterisation of the statistical occurrence of bidirectional and unidirectional motifs. To this end we define a symmetry measure that does not require any a priori thresholding of the weights or knowledge of their maximal value. We calculate its mean and variance for random uniform or Gaussian distributions, which allows us to introduce a confidence measure of how significantly symmetric or asymmetric a specific configuration is, i.e. how likely it is that the configuration is the result of chance. We demonstrate the discriminatory power of our symmetry measure by inspecting the eigenvalues of different types of connectivity matrices. We show that a Gaussian weight distribution biases the connectivity motifs to more symmetric configurations than a uniform distribution and that introducing a random synaptic pruning, mimicking developmental regulation in synaptogenesis, biases the connectivity motifs to more asymmetric configurations, regardless of the distribution. We expect that our work will benefit the computational modelling community, by providing a systematic way to characterise symmetry and asymmetry in network structures. Further, our symmetry measure will be of use to electrophysiologists that investigate symmetry of network connectivity.	[Esposito, Umberto; Giugliano, Michele; Vasilaki, Eleni] Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England; [Giugliano, Michele; Vasilaki, Eleni] Univ Antwerp, Dept Biomed Sci, Theoret Neurobiol & Neuroengn Lab, Antwerp, Belgium; [Giugliano, Michele] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Neural Microcircuitry, Lausanne, Switzerland; [van Rossum, Mark] Univ Edinburgh, Sch Informat, Edinburgh, Midlothian, Scotland	University of Sheffield; University of Antwerp; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Edinburgh	Vasilaki, E (corresponding author), Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England.	e.vasilaki@sheffield.ac.uk	van Rossum, Mark/AAF-6620-2019; Giugliano, Michele/A-5666-2012	van Rossum, Mark/0000-0001-6525-6814; Giugliano, Michele/0000-0003-2626-594X; Vasilaki, Eleni/0000-0003-3705-7070	European Commission (FP7 Marie Curie Initial Training Network "NAMASEN") [264872]; Royal Society [JP091330-2009/R4]; Interuniversity Attraction Poles Program (IUAP); Future Emerging Technology programme project "BRAINLEAP" [306502]; Engineering and Physical Sciences Research Council (EPSRC) [EP/J019534/1]; EPSRC e-futures award [EFXD12003/EFXD12004]; EPSRC [EP/J019534/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/J019534/1] Funding Source: researchfish	European Commission (FP7 Marie Curie Initial Training Network "NAMASEN")(European Commission); Royal Society(Royal Society of London); Interuniversity Attraction Poles Program (IUAP)(Belgian Federal Science Policy Office); Future Emerging Technology programme project "BRAINLEAP"; Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC e-futures award(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was partly supported by the European Commission (FP7 Marie Curie Initial Training Network "NAMASEN", grant n. 264872 (EV, MG), the Royal Society travel grant JP091330-2009/R4 (EV, MG), the Interuniversity Attraction Poles Program (IUAP), initiated by the Belgian Science Policy Office (MG), the Future Emerging Technology programme project "BRAINLEAP" grant n. 306502 (MG), the Engineering and Physical Sciences Research Council (EPSRC), grant n. EP/J019534/1 (EV) and the EPSRC e-futures award EFXD12003/EFXD12004 (EV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babadi B, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002906; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Bourjaily MA, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00037; Bourjaily MA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001091; Briggman KL, 2006, CURR OPIN NEUROBIOL, V16, P562, DOI 10.1016/j.conb.2006.08.010; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; Clopath C, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000248; Dayan P, 2001, COMPUTATIONAL NEUROS; Hines ML, 2004, J COMPUT NEUROSCI, V17, P7, DOI 10.1023/B:JCNS.0000023869.22017.2e; Insel TR, 2003, PLOS BIOL, V1, P9, DOI 10.1371/journal.pbio.0000017; Kistler Gerstner, 2002, SPIKING NEURON MODEL; Koslow S, 2005, DATABASING BRAIN DAT; Kotter R, 2001, PHILOS T ROY SOC B, V356, P1111, DOI 10.1098/rstb.2001.0902; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Lichtman JW, 2008, CURR OPIN NEUROBIOL, V18, P346, DOI 10.1016/j.conb.2008.08.010; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108; Pfister JP, 2006, J NEUROSCI, V26, P9673, DOI 10.1523/JNEUROSCI.1425-06.2006; Pignatelli, 2009, THESIS ECOLE POLYTEC; Richmond P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018539; Seung HS, 2009, NEURON, V62, P17, DOI 10.1016/j.neuron.2009.03.020; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Smith SJ, 2007, CURR OPIN NEUROBIOL, V17, P601, DOI 10.1016/j.conb.2007.11.004; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Vasilaki E, 2012, ICANN 2012 22 INT C; Vasilaki E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084626; Vasilaki E, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000586; Vasilaki E, 2009, BIOL CYBERN, V100, P147, DOI 10.1007/s00422-008-0288-z; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	34	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e100805	10.1371/journal.pone.0100805	http://dx.doi.org/10.1371/journal.pone.0100805			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006663	Green Published, Green Accepted, gold			2022-12-27	WOS:000339040600019
J	Lyu, YH; Zheng, W; Zheng, TL; Tian, Y				Lyu, Yihua; Zheng, Wei; Zheng, Tianling; Tian, Yun			Biodegradation of Polycyclic Aromatic Hydrocarbons by Novosphingobium pentaromativorans US6-1	PLOS ONE			English	Article							SP NOV.; PHENANTHRENE DEGRADATION; GENOME SEQUENCE; MANGROVE; BIOAVAILABILITY; CONTAMINATION; SEDIMENTS; PAHS; PCR	Novosphingobium pentaromativorans US6-1, a marine bacterium isolated from muddy sediments of Ulsan Bay, Republic of Korea, was previously shown to be capable of degrading multiple polycyclic aromatic hydrocarbons (PAHs). In order to gain insight into the characteristics of PAHs degradation, a proteome analysis of N. pentaromativorans US6-1 exposed to phenanthrene, pyrene, and benzo[a]pyrene was conducted. Several enzymes associated with PAHs degradation were identified, including 4-hydroxybenzoate 3-monooxygenase, salicylaldehyde dehydrogenase, and PAH ring-hydroxylating dioxygenase alpha subunit. Reverse transcription and real-time quantitative PCR was used to compare RHD alpha and 4-hydroxybenzoate 3-monooxygenase gene expression, and showed that the genes involved in the production of these two enzymes were upregulated to varying degrees after exposing the bacterium to PAHs. These results suggested that N. pentaromativorans US6-1 degraded PAHs via the metabolic route initiated by ring-hydroxylating dioxygenase, and further degradation occurred via the o-phthalate pathway or salicylate pathway. Both pathways subsequently entered the tricarboxylic acid (TCA) cycle, and were mineralized to CO2.	[Lyu, Yihua; Zheng, Wei; Zheng, Tianling; Tian, Yun] Xiamen Univ, Key Lab, Minist Educ Coastal & Wetland Ecosyst, Xiamen, Peoples R China; [Lyu, Yihua; Zheng, Wei; Zheng, Tianling; Tian, Yun] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China	Xiamen University; Xiamen University	Tian, Y (corresponding author), Xiamen Univ, Key Lab, Minist Educ Coastal & Wetland Ecosyst, Xiamen, Peoples R China.	tianyun@xmu.edu.cn			National Natural Science Foundation of China [40976069, 41176093]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (40976069, 41176093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baboshin MA, 2012, MICROBIOLOGY+, V81, P639, DOI 10.1134/S0026261712060021; Baboshin M, 2008, BIODEGRADATION, V19, P567, DOI 10.1007/s10532-007-9162-2; Bendall ML, 2013, J BACTERIOL, V195, P4966, DOI 10.1128/JB.00935-13; Colquhoun DR, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/408690; Daugulis AJ, 2003, BIOTECHNOL LETT, V25, P1441, DOI 10.1023/A:1025007729355; Felske A, 1998, APPL ENVIRON MICROB, V64, P4581; Herbst FA, 2013, PROTEOMICS, V13, P2910, DOI 10.1002/pmic.201200569; Iwagami SG, 2000, APPL ENVIRON MICROB, V66, P1499, DOI 10.1128/AEM.66.4.1499-1508.2000; Johnsen AR, 2007, APPL MICROBIOL BIOT, V76, P533, DOI 10.1007/s00253-007-1045-2; Johnson DR, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-250; Kanaly RA, 2010, MICROB BIOTECHNOL, V3, P136, DOI 10.1111/j.1751-7915.2009.00130.x; Kim SJ, 2007, J BACTERIOL, V189, P464, DOI 10.1128/JB.01310-06; Kim SJ, 2009, CURR OPIN MICROBIOL, V12, P301, DOI 10.1016/j.mib.2009.03.006; Kurokawa J, 2010, J BIOSCI BIOENG, V109, P218, DOI 10.1016/j.jbiosc.2009.09.040; Kweon O, 2011, J BACTERIOL, V193, P4326, DOI 10.1128/JB.00215-11; Liu HJ, 2010, MAR POLLUT BULL, V60, P2056, DOI 10.1016/j.marpolbul.2010.07.013; Liu HJ, 2008, J EXP MAR BIOL ECOL, V367, P111, DOI 10.1016/j.jembe.2008.09.008; Luo YR, 2009, MAR POLLUT BULL, V58, P1159, DOI 10.1016/j.marpolbul.2009.03.024; Luo YR, 2012, J BACTERIOL, V194, P907, DOI 10.1128/JB.06476-11; Madhumita R, 2012, MICROBIOL, V156, P685; Mann M, 2013, MOL CELL, V49, P583, DOI 10.1016/j.molcel.2013.01.029; Marin M, 2012, J BACTERIOL, V194, P3851, DOI 10.1128/JB.00430-12; Miller TR, 2010, J BACTERIOL, V192, P6101, DOI 10.1128/JB.01030-10; Nayak AS, 2009, BIODEGRADATION, V20, P837, DOI 10.1007/s10532-009-9271-1; Niharika N, 2013, INT J SYST EVOL MICR, V63, P667, DOI 10.1099/ijs.0.039826-0; Pinyakong O, 2003, BIOCHEM BIOPH RES CO, V301, P350, DOI 10.1016/S0006-291X(02)03036-X; Ramdine G, 2012, ECOTOX ENVIRON SAFE, V79, P80, DOI 10.1016/j.ecoenv.2011.12.005; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schuler L, 2009, APPL MICROBIOL BIOT, V83, P465, DOI 10.1007/s00253-009-1858-2; Sim HW, 2013, J KOREAN SOC APPL BI, V56, P401, DOI 10.1007/s13765-013-3080-2; Sohn JH, 2004, INT J SYST EVOL MICR, V54, P1483, DOI 10.1099/ijs.0.02945-0; Somnath M, 2011, CRIT REV MICROBIOL, V37, P64; Suparna K, 2012, ENVIRON ENG SCI, V7, P189; Tatyana YI, 2013, RES MICROBIOL, V164, P244; Tian L, 2002, PROCESS BIOCHEM, V37, P1431, DOI 10.1016/S0032-9592(02)00032-8; Tian Y, 2008, MAR POLLUT BULL, V56, P1184, DOI 10.1016/j.marpolbul.2008.02.014; Vaysse PJ, 2009, RES MICROBIOL, V160, P829, DOI 10.1016/j.resmic.2009.09.010; Verma N, 2012, PROTEOMICS, V12, P1731, DOI 10.1002/pmic.201100466; Woo JH, 2009, APPL MICROBIOL BIOT, V82, P873, DOI 10.1007/s00253-008-1791-9; Yuan J, 2009, INT J SYST EVOL MICR, V59, P2084, DOI 10.1099/ijs.0.002873-0; Yun SH, 2014, PLOS ONE, V3, P1, DOI DOI 10.1038/0NC.2013.472; Zaccai NR, 2008, PROTEINS, V70, P562, DOI 10.1002/prot.21624	42	69	72	2	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101438	10.1371/journal.pone.0101438	http://dx.doi.org/10.1371/journal.pone.0101438			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007154	Green Submitted, gold, Green Published			2022-12-27	WOS:000339040600036
J	Passamani, LM; Abdala, AP; Moraes, DJD; Sampaio, KN; Mill, JG; Paton, JFR				Passamani, Luciana Mesquita; Abdala, Ana Paula; de Almeida Moraes, Davi Jose; Sampaio, Karla Nivea; Mill, Jose Geraldo; Richmond Paton, Julian Francis			Temporal Profile and Mechanisms of the Prompt Sympathoexcitation following Coronary Ligation in Wistar Rats	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; SYMPATHETIC-NERVE ACTIVITY; NUCLEUS-TRACTUS-SOLITARII; HEART-RATE-VARIABILITY; ANGIOTENSIN-II; BAROREFLEX CONTROL; CAROTID-BODY; TIME-COURSE; CARDIAC DYSFUNCTION; THERAPEUTIC TARGET	Our aim was to assess the timing and mechanisms of the sympathoexcitation that occurs immediately after coronary ligation. We recorded thoracic sympathetic (tSNA) and phrenic activities, heart rate (HR) and perfusion pressure in Wistar rats subjected to either ligation of the left anterior descending coronary artery (LAD) or Sham operated in the working heart-brainstem preparation. Thirty minutes after LAD ligation, tSNA had increased (basal: 2.5 +/- 0.2 mu V, 30 min: 3.5 +/- 0.3 mu V), being even higher at 60 min (5.2 +/- 0.5 mu V, P<0.01); while no change was observed in Sham animals. HR increased significantly 45 min after LAD (P<0.01). Sixty minutes after LAD ligation, there was: (i) an augmented peripheral chemoreflex - greater sympathoexcitatory response (50, 45 and 27% of increase to 25, 50 and 75 mu L injections of NaCN 0.03%, respectively, when compared to Sham, P<0.01); (ii) an elevated pressor response (32 +/- 1 versus 23 +/- 1 mmHg in Sham, P<0.01) and a reduced baroreflex sympathetic gain (1.3 +/- 0.1 versus Sham 2.0 +/- 0.1%. mmHg(-1), P<0.01) to phenylephrine injection; (iii) an elevated cardiac sympathetic tone (Delta HR after atenolol: -108 +/- 8 versus -82 +/- 7 bpm in Sham, P<0.05). In contrast, no changes were observed in cardiac vagal tone and bradycardic response to both baroreflex and chemoreflex between LAD and Sham groups. The immediate sympathoexcitatory response in LAD rats was dependent on an excitatory spinal sympathetic cardiocardiac reflex, whereas at 3 h an angiotensin II type 1 receptor mechanism was essential since Losartan curbed the response by 34% relative to LAD rats administered saline (P<0.05). A spinal reflex appears key to the immediate sympathoexcitatory response after coronary ligation. Therefore, the sympathoexcitatory response seems to be maintained by an angiotensinergic mechanism and concomitant augmentation of sympathoexcitatory reflexes.	[Passamani, Luciana Mesquita; Abdala, Ana Paula; Richmond Paton, Julian Francis] Univ Bristol, Bristol Heart Inst, Sch Physiol & Pharmacol, Bristol, Avon, England; [Passamani, Luciana Mesquita; Mill, Jose Geraldo] Univ Fed Espirito Santo, Hlth Sci Ctr, Dept Physiol Sci, Vitoria, Espirito Santo, Brazil; [de Almeida Moraes, Davi Jose] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Physiol, BR-14049 Ribeirao Preto, SP, Brazil; [Sampaio, Karla Nivea] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Pharmaceut Sci, BR-14049 Ribeirao Preto, SP, Brazil	University of Bristol; Universidade Federal do Espirito Santo; Universidade de Sao Paulo; Universidade de Sao Paulo	Paton, JFR (corresponding author), Univ Bristol, Bristol Heart Inst, Sch Physiol & Pharmacol, Med Sci Bldg, Bristol, Avon, England.	Julian.F.R.Paton@Bristol.ac.uk	Moraes, Davi/AAG-6248-2019; Paton, Julian/AAM-2121-2020; Sampaio, Karla/AAI-1195-2021; Sheikh, Ana Paula Abdala/G-9104-2014	Sampaio, Karla/0000-0003-0293-0482; Sheikh, Ana Paula Abdala/0000-0001-6566-9205; Paton, Julian/0000-0001-7410-2913; Mesquita Passamani, Luciana/0000-0002-5700-0111	British Heart Foundation; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES; British Heart Foundation [PG/10/23/28277, RG/12/6/29670] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); British Heart Foundation(British Heart Foundation)	This work was supported by The British Heart Foundation and "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIGGER JT, 1991, J AM COLL CARDIOL, V18, P1643, DOI 10.1016/0735-1097(91)90497-W; Boscan P, 2001, NEUROSCIENCE, V103, P153, DOI 10.1016/S0306-4522(00)00559-5; Bristow M, 2003, CIRCULATION, V107, P1100, DOI 10.1161/01.CIR.0000054530.87613.36; BROWN AM, 1967, J PHYSIOL-LONDON, V190, P35, DOI 10.1113/jphysiol.1967.sp008191; BROWN AM, 1971, J PHYSIOL-LONDON, V212, P685, DOI 10.1113/jphysiol.1971.sp009350; BUNNEMANN B, 1992, J CHEM NEUROANAT, V5, P245, DOI 10.1016/0891-0618(92)90049-V; Cao JM, 2000, CIRC RES, V86, P816, DOI 10.1161/01.RES.86.7.816; CERATI D, 1991, CIRC RES, V69, P1389, DOI 10.1161/01.RES.69.5.1389; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; DIBONA GF, 1995, AM J PHYSIOL-REG I, V269, pR1189, DOI 10.1152/ajpregu.1995.269.5.R1189; FELDER RB, 1979, CIRC RES, V45, P728, DOI 10.1161/01.RES.45.6.728; FELDER RB, 1981, CIRC RES, V48, P685, DOI 10.1161/01.RES.48.5.685; Floras JS, 2009, J AM COLL CARDIOL, V54, P375, DOI 10.1016/j.jacc.2009.03.061; Fu Liang-Wu, 2009, Handb Exp Pharmacol, P185, DOI 10.1007/978-3-540-79090-7_6; Gao L, 2008, HYPERTENSION, V52, P708, DOI 10.1161/HYPERTENSIONAHA.108.116228; GOLDSTEIN RE, 1975, CIRC RES, V36, P571, DOI 10.1161/01.RES.36.5.571; Graham LN, 2002, CIRCULATION, V106, P793, DOI 10.1161/01.CIR.0000025610.14665.21; GRIFFITHS J, 1971, AM HEART J, V82, P171, DOI 10.1016/0002-8703(71)90262-6; Huang Bing S, 2009, Curr Heart Fail Rep, V6, P81; Huang BS, 2009, AM J PHYSIOL-HEART C, V297, pH968, DOI 10.1152/ajpheart.00317.2009; Huang CH, 1999, AM J PHYSIOL-HEART C, V276, pH368, DOI 10.1152/ajpheart.1999.276.2.H368; Huang CH, 2011, ANN THORAC SURG, V92, P1727, DOI 10.1016/j.athoracsur.2011.06.094; Jardine DL, 2007, AM J PHYSIOL-HEART C, V293, pH433, DOI 10.1152/ajpheart.01262.2006; Jardine DL, 2005, J PHYSIOL-LONDON, V565, P325, DOI 10.1113/jphysiol.2004.082198; KARLSBERG RP, 1981, AM HEART J, V102, P24, DOI 10.1016/0002-8703(81)90408-7; Kasparov S, 1999, J PHYSIOL-LONDON, V521, P227, DOI 10.1111/j.1469-7793.1999.00227.x; KAYE DM, 1995, J AM COLL CARDIOL, V26, P1257, DOI 10.1016/0735-1097(95)00332-0; La Rocca HPB, 2001, EUR HEART J, V22, P1136, DOI 10.1053/euhj.2000.2407; La Rovere MT, 1998, LANCET, V351, P478; Liu DM, 2008, CIRC RES, V103, P186, DOI 10.1161/CIRCRESAHA.108.179408; Liu DM, 2006, CIRC RES, V99, P1004, DOI 10.1161/01.RES.0000247066.19878.93; Liu JL, 1999, CIRC RES, V84, P417, DOI 10.1161/01.RES.84.4.417; LOMBARDI F, 1987, AM J CARDIOL, V60, P1239, DOI 10.1016/0002-9149(87)90601-1; LOMBARDI F, 1984, CARDIOVASC RES, V18, P14, DOI 10.1093/cvr/18.1.14; Lombardi F, 1996, AM J CARDIOL, V77, P1037; MacDougall J D, 1995, Can J Appl Physiol, V20, P480; Malliani A, 2002, HYPERTENSION, V39, P63, DOI 10.1161/hy0102.099200; MALLIANI A, 1969, AM J PHYSIOL, V217, P703, DOI 10.1152/ajplegacy.1969.217.3.703; McAlpine H M, 1988, Am J Med, V84, P61, DOI 10.1016/0002-9343(88)90206-9; McBryde FD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3395; MCCANCE AJ, 1989, BRIT HEART J, V61, P238; MELLER ST, 1992, NEUROSCIENCE, V48, P501, DOI 10.1016/0306-4522(92)90398-L; Murakami H, 1997, HYPERTENSION, V29, P564, DOI 10.1161/01.HYP.29.2.564; NINOMIYA I, 1986, AM J PHYSIOL, V251, pH528, DOI 10.1152/ajpheart.1986.251.3.H528; PANTRIDGE JF, 1981, PROG CARDIOVASC DIS, V23, P265, DOI 10.1016/0033-0620(81)90016-5; Paton JFR, 1999, J PHYSIOL-LONDON, V521, P213, DOI 10.1111/j.1469-7793.1999.00213.x; Paton JFR, 1996, J NEUROSCI METH, V65, P63, DOI 10.1016/0165-0270(95)00147-6; Paton JFR, 2013, HYPERTENSION, V61, P5, DOI 10.1161/HYPERTENSIONAHA.111.00064; Petersson M, 2005, EUR HEART J, V26, P906, DOI 10.1093/eurheartj/ehi184; Polson JW, 2007, AM J PHYSIOL-REG I, V293, pR1954, DOI 10.1152/ajpregu.00041.2007; REID IA, 1992, AM J PHYSIOL, V262, pE763, DOI 10.1152/ajpendo.1992.262.6.E763; ROSENSHTRAUKH L, 1994, CIRC RES, V75, P722, DOI 10.1161/01.RES.75.4.722; Schultz HD, 2007, RESP PHYSIOL NEUROBI, V157, P171, DOI 10.1016/j.resp.2007.02.011; SIGGERS DC, 1971, BRIT HEART J, V33, P878; St-John WM, 2000, RESP PHYSIOL, V123, P201, DOI 10.1016/S0034-5687(00)00177-8; Sun SY, 1999, J APPL PHYSIOL, V86, P1264, DOI 10.1152/jappl.1999.86.4.1264; THAMES MD, 1993, J AM COLL CARDIOL, V22, pA56, DOI 10.1016/0735-1097(93)90464-C; VANOLI E, 1991, CIRC RES, V68, P1471, DOI 10.1161/01.RES.68.5.1471; VIDEBAEK J, 1972, CIRCULATION, V46, P846, DOI 10.1161/01.CIR.46.5.846; Wang W, 2000, Heart Fail Rev, V5, P57; WEBB SW, 1972, BMJ-BRIT MED J, V3, P89, DOI 10.1136/bmj.3.5818.89; Yoshimura R, 2000, J CARD FAIL, V6, P66, DOI 10.1016/S1071-9164(00)00013-0; Zoccal DB, 2008, J PHYSIOL-LONDON, V586, P3253, DOI 10.1113/jphysiol.2008.154187; Zucker IH, 2009, AM J PHYSIOL-HEART C, V297, pH1557, DOI 10.1152/ajpheart.00073.2009	65	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101886	10.1371/journal.pone.0101886	http://dx.doi.org/10.1371/journal.pone.0101886			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006809	Green Submitted, Green Published, gold			2022-12-27	WOS:000339040600077
J	Suzuki, Y; Iida, M; Miura, I; Inubushi, T; Morikawa, S				Suzuki, Yoshikazu; Iida, Mitsuru; Miura, Iwao; Inubushi, Toshiro; Morikawa, Shigehiro			A Polymer-Based Magnetic Resonance Tracer for Visualization of Solid Tumors by C-13 Spectroscopic Imaging	PLOS ONE			English	Article							DIFFERENT MOLECULAR-WEIGHTS; TO-NOISE RATIO; POLY(ETHYLENE GLYCOL); ACCUMULATION	Morphological imaging precedes lesion-specific visualization in magnetic resonance imaging (MRI) because of the superior ability of this technique to depict tissue morphology with excellent spatial and temporal resolutions. To achieve lesion-specific visualization of tumors by MRI, we investigated the availability of a novel polymer-based tracer. Although the C-13 nucleus is a candidate for a detection nucleus because of its low background signal in the body, the low magnetic resonance sensitivity of the nucleus needs to be resolved before developing a C-13-based tracer. In order to overcome this problem, we enriched polyethylene glycol (PEG), a biocompatible polymer, with C-13 atoms. C-13-PEG40,000 (C-13-PEG with an average molecular weight of 40 kDa) emitted a single C-13 signal with a high signal-to-noise ratio due to its ability to maintain signal sharpness, as was confirmed by in vivo investigation, and displayed a chemical shift sufficiently distinct from that of endogenous fat. C-13-PEG40,000 intravenously injected into mice showed long retention in circulation, leading to its effective accumulation in tumors reflecting the well-known phenomenon that macromolecules accumulate in tumors because of leaky tumor capillaries. These properties of C-13-PEG40,000 allowed visualization of tumors in mice by C-13 spectroscopic imaging. These findings suggest that a technique based on C-13-PEG is a promising strategy for tumor detection.	[Suzuki, Yoshikazu; Iida, Mitsuru] Otsuka Pharmaceut Co Ltd, Div Diagnost, Tokushima 77101, Japan; [Miura, Iwao] Otsuka Pharmaceut Co Ltd, Div Pharmaceut, Tokushima 77101, Japan; [Inubushi, Toshiro; Morikawa, Shigehiro] Shiga Univ Med Sci, Biomed MR Sci Res Ctr, Otsu, Shiga 52021, Japan	Otsuka Pharmaceutical; Otsuka Pharmaceutical; Shiga University of Medical Science	Suzuki, Y (corresponding author), Otsuka Pharmaceut Co Ltd, Div Diagnost, Tokushima 77101, Japan.	suzukiyo@otsuka.jp			Grants-in-Aid for Scientific Research [24650278, 26670554, 26282145] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; Bhattacharya P, 2007, J MAGN RESON, V186, P150, DOI 10.1016/j.jmr.2007.01.017; Chaumeil MM, 2014, CANCER RES, V74, P4247, DOI 10.1158/0008-5472.CAN-14-0680; Dafni H, 2010, CANCER RES, V70, P7400, DOI 10.1158/0008-5472.CAN-10-0883; Day SE, 2007, NAT MED, V13, P1382, DOI 10.1038/nm1650; Duncan R, 2006, NAT REV CANCER, V6, P688, DOI 10.1038/nrc1958; Gallagher FA, 2008, NATURE, V453, P940, DOI 10.1038/nature07017; Golman K, 2003, P NATL ACAD SCI USA, V100, P10435, DOI 10.1073/pnas.1733836100; Golman K, 2001, MAGNET RESON MED, V46, P1, DOI 10.1002/mrm.1152; Golman K, 2006, CANCER RES, V66, P10855, DOI 10.1158/0008-5472.CAN-06-2564; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Mignion L, 2014, CANCER RES, V74, P686, DOI 10.1158/0008-5472.CAN-13-1914; Murakami Y, 1997, DRUG DELIV, V4, P23, DOI 10.3109/10717549709033184; Pasut G, 2009, ADV DRUG DELIVER REV, V61, P1177, DOI 10.1016/j.addr.2009.02.010; Posey JA, 2005, CLIN CANCER RES, V11, P7866, DOI 10.1158/1078-0432.CCR-05-0783; Rodrigues TB, 2014, NAT MED, V20, P93, DOI 10.1038/nm.3416; Sack M, 2014, NMR BIOMED, V27, P709, DOI 10.1002/nbm.3110; Schmidt R, 2014, J MAGN RESON, V240, P8, DOI 10.1016/j.jmr.2013.12.013; Vandegriff KD, 1997, BIOPHYS CHEM, V69, P23, DOI 10.1016/S0301-4622(97)00079-3; Vasos PR, 2009, P NATL ACAD SCI USA, V106, P18469, DOI 10.1073/pnas.0908123106; Wang M, 2010, PHARMACOL RES, V62, P90, DOI 10.1016/j.phrs.2010.03.005; YAMAOKA T, 1994, J PHARM SCI, V83, P601, DOI 10.1002/jps.2600830432	23	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102132	10.1371/journal.pone.0102132	http://dx.doi.org/10.1371/journal.pone.0102132			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007334	Green Submitted, Green Published, gold			2022-12-27	WOS:000339040600097
J	Wang, T; Liu, HJ; Ning, YY; Xu, Q				Wang, Tong; Liu, Huijuan; Ning, Yanyang; Xu, Qiong			The Histone Acetyltransferase p300 Regulates the Expression of Pluripotency Factors and Odontogenic Differentiation of Human Dental Pulp Cells	PLOS ONE			English	Article							STEM-CELLS; GENE-EXPRESSION; ACETYLATION; NANOG; PROTEINS; SOX2	p300 is a well-known histone acetyltransferase (HAT) and coactivator that plays vital roles in many physiological processes. Despite extensive research on the involvement of p300 in the regulation of transcription in numerous cell lines, the roles of this protein in regulating pluripotency genes and odontogenic differentiation in human dental pulp cells (HDPCs) are poorly understood. To address this issue, we investigated the expression of OCT4, NANOG and SOX2 and the proliferation and odontogenic differentiation capacity of HDPCs following p300 overexpression. We found that p300 overexpression did not overtly affect the ability of HDPCs to proliferate. The overexpression of p300 upregulated the promoter activity and the mRNA and protein expression of NANOG and SOX2. The HAT activity of p300 appeared to partially mediate the regulation of these factors; indeed, when a mutant form of p300 lacking the HAT domain was overexpressed, the promoter activity and expression of NANOG and SOX2 decreased relative to p300 overexpression but was greater than in the control. Furthermore, we demonstrated that the mRNA levels of the odontogenic marker genes dentine matrix protein-1 (DMP-1), dentin sialophosphoprotein (DSPP), dentin sialoprotein (DSP), osteopontin (OPN) and osteocalcin (OCN) were significantly decreased in HDPCs overexpressing p300 cultured under normal culture conditions and increased in HDPCs inducted to undergo odontogenic differentiation. This finding was further confirmed by measuring levels of alkaline phosphatase (ALP) activity and assessing the formation of mineralized nodules. The HAT activity of p300 had no significant effect on odontogenic differentiation. p300 was recruited to the promoter regions of OCN and DSPP and might be acting as a coactivator to increase the acetylation of lysine 9 of histone H3 of OCN and DSPP. Collectively, our results show that p300 plays an important role in regulating the expression of key pluripotency genes in HDPCs and modifying odontogenic differentiation.	[Wang, Tong; Liu, Huijuan; Ning, Yanyang; Xu, Qiong] Sun Yat Sen Univ, Guanghua Sch Stomatol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Tong; Liu, Huijuan; Ning, Yanyang; Xu, Qiong] Sun Yat Sen Univ, Guangdong Prov Key Lab Stomatol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Tong] Hefei Stomatol Hosp, Hefei, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Xu, Q (corresponding author), Sun Yat Sen Univ, Guanghua Sch Stomatol, Guangzhou 510275, Guangdong, Peoples R China.	xqiong@mail.sysu.edu.cn			National Natural Science Foundation of China [81170953]; Natural Science Foundation of Guangdong Province [S2011010004931]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by grants of National Natural Science Foundation of China (No. 81170953) and Natural Science Foundation of Guangdong Province (No. S2011010004931). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Alvares K, 2006, DEV DYNAM, V235, P2980, DOI 10.1002/dvdy.20935; Baltus GA, 2009, STEM CELLS, V27, P2175, DOI 10.1002/stem.168; Chan HM, 2001, J CELL SCI, V114, P2363; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chen Z, 2012, IN VITRO CELL DEV-AN, V48, P61, DOI 10.1007/s11626-011-9472-x; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Darr H, 2006, DEVELOPMENT, V133, P1193, DOI 10.1242/dev.02286; Dissanayaka WL, 2011, J ENDODONT, V37, P1074, DOI 10.1016/j.joen.2011.04.004; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Go MJ, 2008, EXP CELL RES, V314, P1147, DOI 10.1016/j.yexcr.2007.11.021; Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Hening AK, 2013, PLOS ONE, V8; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Jin H, 2013, TISSUE ENG PT A, V19, P613, DOI [10.1089/ten.tea.2012.0163, 10.1089/ten.TEA.2012.0163]; Kawashima N, 2012, ARCH ORAL BIOL, V57, P1439, DOI 10.1016/j.archoralbio.2012.08.010; Kuijk EW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010987; Le May Melanie, 2013, Methods Mol Biol, V977, P315, DOI 10.1007/978-1-62703-284-1_25; Li T, 2009, J GENET GENOMICS, V36, P335, DOI 10.1016/S1673-8527(08)60122-8; Li XZ, 2012, CELL STEM CELL, V11, P163, DOI 10.1016/j.stem.2012.04.023; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Liu L, 2011, J ENDODONT, V37, P466, DOI 10.1016/j.joen.2010.12.012; Liu TM, 2009, STEM CELLS DEV, V18, P1013, DOI 10.1089/scd.2008.0335; Nozaki T, 2011, J PHARMACOL SCI, V115, P354, DOI 10.1254/jphs.10163FP; Paino F, 2014, STEM CELLS, V32, P279, DOI 10.1002/stem.1544; Qin CL, 2003, J BIOL CHEM, V278, P34700, DOI 10.1074/jbc.M305315200; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; Suh JS, 2012, J DENT RES, V91, P90, DOI 10.1177/0022034511424746; Sun HC, 2010, LIFE SCI, V87, P707, DOI 10.1016/j.lfs.2010.10.009; Suzuki K, 2005, BIOORGAN MED CHEM, V13, P4014, DOI 10.1016/j.bmc.2005.03.053; Takeda T, 2008, J DENT RES, V87, P676, DOI 10.1177/154405910808700716; Tamaoki N, 2010, J DENT RES, V89, P773, DOI 10.1177/0022034510366846; Zhong XM, 2009, J BIOL CHEM, V284, P9168, DOI 10.1074/jbc.M805562200	35	21	26	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102117	10.1371/journal.pone.0102117	http://dx.doi.org/10.1371/journal.pone.0102117			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007265	Green Submitted, Green Published, gold			2022-12-27	WOS:000339040600096
J	Yap, DYH; Yung, SS; Zhang, Q; Tang, CL; Chan, TM				Yap, Desmond Y. H.; Yung, Susan; Zhang, Qing; Tang, Colin; Chan, Tak Mao			Mesangial Cell-Binding Activity of Serum Immunoglobulin G in Patients with Lupus Nephritis	PLOS ONE			English	Article							ANTI-DNA ANTIBODIES; LABORATORY TESTS; ERYTHEMATOSUS; GLOMERULONEPHRITIS; CLASSIFICATION; INFLAMMATION; COMPLEMENT; GLOMERULI	In vitro data showed that immunoglobulin G (IgG) from patients with lupus nephritis (LN) could bind to cultured human mesangial cells (HMC). The clinical relevance of such binding was unknown. Binding of IgG and subclasses was measured in 189 serial serum samples from 23 patients with Class III/IV +/- V LN (48 during renal flares, 141 during low level disease activity (LLDA)). 64 patients with non-lupus glomerular diseases (NLGD) and 23 healthy individuals were used as controls. HMC-binding was measured with cellular ELISA and expressed as OD index. HMC-binding index of total IgG was 0.12 +/- 0.09, 0.36 +/- 0.25, 0.59 +/- 0.37 and 0.74 +/- 0.42 in healthy subjects, NLGD, LN patients during LLDA, and LN flares respectively (P = 0.046, LN flare vs. LLDA; P, 0.001, for healthy controls or NLGD vs. LN during flare or LLDA). Binding of serum IgG1 to HMC was 0.05 +/- 0.05, 0.15 +/- 0.11, 0.41 +/- 0.38 and 0.55 +/- 0.40 for the corresponding groups respectively (P = 0.007, LN flare vs. remission; P, 0.001, for healthy controls or NLGD vs. LN during flare or remission). IgG(2), IgG(3) and IgG(4) from patients and controls did not show significant binding to HMC. Total IgG and IgG1 HMC-binding index correlated with anti-dsDNA level (r = 0.26 and 0.39 respectively, P, 0.001 for both), and inversely with C3 (r = 20.17 and 20.45, P, 0.05 for both). Sensitivity/specificity of total IgG or IgG1 binding to HMC in predicting renal flares were 81.3%/39.7% (ROC AUC 0.61, P = 0.03) and 83.8%/41.8% (AUC 0.63, P = 0.009) respectively. HMC-binding by IgG1, but not total IgG, correlated with mesangial immune deposition in LN renal biopsies under electron microscopy. Our results showed that binding of serum total IgG and IgG1 in LN patients correlates with disease activity. The correlation between IgG1 HMC-binding and mesangial immune deposition suggests a potential pathogenic significance.	[Yap, Desmond Y. H.; Yung, Susan; Zhang, Qing; Tang, Colin; Chan, Tak Mao] Univ Hong Kong, Queen Mary Hosp, Dept Med, Div Nephrol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Chan, TM (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Med, Div Nephrol, Hong Kong, Hong Kong, Peoples R China.	dtmchan@hku.hk	/E-7196-2012; /C-4468-2009	/0000-0001-8179-8293; /0000-0003-3124-1328; Chan, Tak Mao/0000-0002-3495-4051	Hong Kong Society of Nephrology Research Grant; endowment fund of the Yu Chiu Kwong Professorship in Medicine at University of Hong Kong; Wai Hung Charitable Foundation	Hong Kong Society of Nephrology Research Grant; endowment fund of the Yu Chiu Kwong Professorship in Medicine at University of Hong Kong; Wai Hung Charitable Foundation	This project was supported by the Hong Kong Society of Nephrology Research Grant 2009 awarded to Desmond Y. H. YAP and the endowment fund of the Yu Chiu Kwong Professorship in Medicine at University of Hong Kong awarded to T. M. Chan. S. Yung is supported by the Wai Hung Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bomback AS, 2010, J AM SOC NEPHROL, V21, P2028, DOI 10.1681/ASN.2010050472; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Budhai L, 1996, J CLIN INVEST, V98, P1585, DOI 10.1172/JCI118952; Chan TM, 2002, J AM SOC NEPHROL, V13, P1219, DOI 10.1097/01.ASN.0000014223.71109.13; Chan TM, 1997, J AUTOIMMUN, V10, P433, DOI 10.1006/jaut.1997.9998; COREMANS IEM, 1995, AM J KIDNEY DIS, V26, P595, DOI 10.1016/0272-6386(95)90595-2; Esdaile JM, 1996, J RHEUMATOL, V23, P1891; Esdaile JM, 1996, ARTHRITIS RHEUM, V39, P370, DOI 10.1002/art.1780390304; GOLBUS J, 1994, RHEUM DIS CLIN N AM, V20, P213; Ho A, 2001, ARTHRITIS RHEUM-US, V44, P2350, DOI 10.1002/1529-0131(200110)44:10<2350::AID-ART398>3.0.CO;2-A; Ho A, 2001, ARTHRITIS RHEUM, V44, P2342, DOI 10.1002/1529-0131(200110)44:10<2342::AID-ART397>3.0.CO;2-8; Imai H, 1997, KIDNEY INT, V51, P270, DOI 10.1038/ki.1997.32; KALUNIAN KC, 1989, ARTHRITIS RHEUM, V32, P513, DOI 10.1002/anr.1780320502; Mery J P, 1975, Proc Eur Dial Transplant Assoc, V11, P506; Moroni G, 2009, ANN RHEUM DIS, V68, P234, DOI 10.1136/ard.2008.094508; ROTHFIELD NF, 1967, J CLIN INVEST, V46, P1785, DOI 10.1172/JCI105669; Rovin BH, 2007, BULL HOSP JT DIS, V65, P187; Rovin BH, 2009, CLIN J AM SOC NEPHRO, V4, P1858, DOI 10.2215/CJN.03530509; Saxena R, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3378; Schlondorff D, 2009, J AM SOC NEPHROL, V20, P1179, DOI 10.1681/ASN.2008050549; TAN EM, 1966, J CLIN INVEST, V45, P1732, DOI 10.1172/JCI105479; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; TERMAAT RM, 1993, LAB INVEST, V68, P164; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; WINFIELD JB, 1977, J CLIN INVEST, V59, P90, DOI 10.1172/JCI108626; Yung S, 2005, J AM SOC NEPHROL, V16, P3281, DOI 10.1681/ASN.2004110917; Yung S, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/317682; Yung S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/139365; Yung S, 2010, J AM SOC NEPHROL, V21, P1912, DOI 10.1681/ASN.2009080805	29	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101987	10.1371/journal.pone.0101987	http://dx.doi.org/10.1371/journal.pone.0101987			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007094	Green Published, gold, Green Submitted			2022-12-27	WOS:000339040600086
J	Ding, YT; Qu, YB; Feng, J; Wang, MZ; Han, Q; So, KF; Wu, WT; Zhou, LB				Ding, Yuetong; Qu, Yibo; Feng, Jia; Wang, Meizhi; Han, Qi; So, Kwok-Fai; Wu, Wutian; Zhou, Libing			Functional Motor Recovery from Motoneuron Axotomy Is Compromised in Mice with Defective Corticospinal Projections	PLOS ONE			English	Article							BRACHIAL-PLEXUS INJURY; VENTRAL ROOT AVULSION; CERVICAL-SPINAL CORD; NITRIC-OXIDE SYNTHASE; NEUROTROPHIC FACTOR; ADULT-RAT; ELECTRICAL-STIMULATION; MULTITRAUMA POPULATION; AXONAL REGENERATION; MUSCLE AFFERENTS	Brachial plexus injury (BPI) and experimental spinal root avulsion result in loss of motor function in the affected segments. After root avulsion, significant motoneuron function is restored by re-implantation of the avulsed root. How much this functional recovery depends on corticospinal inputs is not known. Here, we studied that question using Celsr3 vertical bar Emx1 mice, in which the corticospinal tract (CST) is genetically absent. In adult mice, we tore off right C5-C7 motor and sensory roots and re-implanted the right C6 roots. Behavioral studies showed impaired recovery of elbow flexion in Celsr3 vertical bar Emx1 mice compared to controls. Five months after surgery, a reduced number of small axons, and higher G-ratio of inner to outer diameter of myelin sheaths were observed in mutant versus control mice. At early stages post-surgery, mutant mice displayed lower expression of GAP-43 in spinal cord and of myelin basic protein (MBP) in peripheral nerves than control animals. After five months, mutant animals had atrophy of the right biceps brachii, with less newly formed neuromuscular junctions (NMJs) and reduced peak-to-peak amplitudes in electromyogram (EMG), than controls. However, quite unexpectedly, a higher motoneuron survival rate was found in mutant than in control mice. Thus, following root avulsion/re-implantation, the absence of the CST is probably an important reason to hamper axonal regeneration and remyelination, as well as target re-innervation and formation of new NMJ, resulting in lower functional recovery, while fostering motoneuron survival. These results indicate that manipulation of corticospinal transmission may help improve functional recovery following BPI.	[Ding, Yuetong; Qu, Yibo; Feng, Jia; Wang, Meizhi; Han, Qi; So, Kwok-Fai; Wu, Wutian; Zhou, Libing] Jinan Univ, Guangdong Hongkong Macau Inst CNS Regenerat, Guangzhou, Guangdong, Peoples R China; [Ding, Yuetong; Qu, Yibo; Feng, Jia; Wang, Meizhi; Han, Qi; So, Kwok-Fai; Wu, Wutian; Zhou, Libing] Jinan Univ, Med Key Lab Brain Funct & Dis, Guangzhou, Guangdong, Peoples R China; [So, Kwok-Fai; Wu, Wutian] Univ Hong Kong, Dept Anat, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China; [Zhou, Libing] Jinan Univ, Sch Med, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China; [Zhou, Libing] Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong, Jiangsu, Peoples R China	Jinan University; Jinan University; University of Hong Kong; Jinan University; Nantong University	Wu, WT (corresponding author), Jinan Univ, Guangdong Hongkong Macau Inst CNS Regenerat, Guangzhou, Guangdong, Peoples R China.	wtwu@hku.hk; tlibingzh@jnu.edu.cn		So, Kwok-Fai/0000-0003-4039-4246; Han, Qi/0000-0003-3742-159X; Zhou, Libing/0000-0002-8975-5228	National Natural Science Foundation of China [81171152]; National Basic Research Program of China (973 Program) [2011CB504402]; Foundation for High-level Talents in Higher Education of Guangdong [50524005]; Project of Internation; Hong Kong, Macao & Taiwan Science and Technology Cooperation Innovation Platform in Universities in Guangdong Province [2013gjhz0002]; Programme of Introducing Talents of Discipline to Universities [B14036]; Fundamental Research Funds for the Central Universities [21614603]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Foundation for High-level Talents in Higher Education of Guangdong; Project of Internation; Hong Kong, Macao & Taiwan Science and Technology Cooperation Innovation Platform in Universities in Guangdong Province; Programme of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The National Natural Science Foundation of China (81171152, L. Zhou), National Basic Research Program of China (973 Program, 2011CB504402), Foundation for High-level Talents in Higher Education of Guangdong (50524005), Project of Internation as well as Hong Kong, Macao & Taiwan Science and Technology Cooperation Innovation Platform in Universities in Guangdong Province (2013gjhz0002), the Programme of Introducing Talents of Discipline to Universities (B14036) and Fundamental Research Funds for the Central Universities (21614603). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTELLI JA, 1993, J NEUROSCI METH, V46, P203, DOI 10.1016/0165-0270(93)90068-3; Blits B, 2004, EXP NEUROL, V189, P303, DOI 10.1016/j.expneurol.2004.05.014; Brus-Ramer M, 2007, J NEUROSCI, V27, P13793, DOI 10.1523/JNEUROSCI.3489-07.2007; Bunday KL, 2012, CURR BIOL, V22, P2355, DOI 10.1016/j.cub.2012.10.046; Carlstedt T, 2000, J NEUROSURG, V93, P237, DOI 10.3171/spi.2000.93.2.0237; CARLSTEDT T, 1995, LANCET, V346, P1323, DOI 10.1016/S0140-6736(95)92342-X; Carlstedt T, 2009, NEUROSURG CLIN N AM, V20, P39, DOI 10.1016/j.nec.2008.07.020; Carmel JB, 2013, EUR J NEUROSCI, V37, P1090, DOI 10.1111/ejn.12119; Carmel JB, 2010, J NEUROSCI, V30, P10918, DOI 10.1523/JNEUROSCI.1435-10.2010; Chai H, 2000, NEUROREPORT, V11, P1249, DOI 10.1097/00001756-200004270-00021; Chakrabarty S, 2009, J NEUROSCI, V29, P8816, DOI 10.1523/JNEUROSCI.0735-09.2009; Chomiak T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007754; Chu Tak-Ho, 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P40; Clowry GJ, 2004, EUR J NEUROSCI, V20, P2555, DOI 10.1111/j.1460-9568.2004.03713.x; Clowry GJ, 1997, DEV BRAIN RES, V102, P197, DOI 10.1016/S0165-3806(97)00098-9; CULLHEIM S, 1989, NEUROSCIENCE, V29, P725, DOI 10.1016/0306-4522(89)90144-9; Dekkers J, 2002, DEV NEUROSCI-BASEL, V24, P283, DOI 10.1159/000066742; Dorsi MJ, 2010, J NEUROSURG-PEDIATR, V5, P573, DOI 10.3171/2010.3.PEDS09538; Eyre JA, 2007, NEUROSCI BIOBEHAV R, V31, P1136, DOI 10.1016/j.neubiorev.2007.05.011; Faglioni W, 2014, ACTA NEUROCHIR, V156, P1025, DOI 10.1007/s00701-013-1948-x; Forghani R, 2001, J NEUROSCI, V21, P3780, DOI 10.1523/JNEUROSCI.21-11-03780.2001; Fournier HD, 2005, HAND CLIN, V21, P109, DOI 10.1016/j.hcl.2004.09.001; Gibson CL, 1999, NEUROREPORT, V10, P231, DOI 10.1097/00001756-199902050-00006; Gibson CL, 2000, EXP NEUROL, V166, P422, DOI 10.1006/exnr.2000.7511; Gomes-Leal W, 2012, BRAIN BEHAV, V2, P345, DOI 10.1002/brb3.51; Gu HY, 2005, EXP NEUROL, V192, P89, DOI 10.1016/j.expneurol.2004.10.019; Gu HY, 2004, EUR J NEUROSCI, V19, P2123, DOI 10.1111/j.0953-816X.2004.03295.x; Hammarberg H, 2000, J COMP NEUROL, V426, P587, DOI 10.1002/1096-9861(20001030)426:4<587::AID-CNE7>3.0.CO;2-R; Han Q, 2013, NEUROSCIENCE, V253, P235, DOI 10.1016/j.neuroscience.2013.08.057; Harding DI, 1999, EUR J NEUROSCI, V11, P2237, DOI 10.1046/j.1460-9568.1999.00640.x; Hoang TX, 2006, EXP BRAIN RES, V169, P208, DOI 10.1007/s00221-005-0137-4; Hoffmann CFE, 1996, J NEUROSURG, V84, P234, DOI 10.3171/jns.1996.84.2.0234; Huze C, 2009, AM J HUM GENET, V85, P155, DOI 10.1016/j.ajhg.2009.06.015; JOOSTEN EAJ, 1992, J COMP NEUROL, V326, P133, DOI 10.1002/cne.903260112; KOLIATSOS VE, 1994, J COMP NEUROL, V342, P35, DOI 10.1002/cne.903420105; KUDO N, 1987, J PHYSIOL-LONDON, V389, P441, DOI 10.1113/jphysiol.1987.sp016665; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; LI LX, 1994, J NEUROBIOL, V25, P759, DOI 10.1002/neu.480250702; Midha R, 1997, NEUROSURGERY, V40, P1182, DOI 10.1097/00006123-199706000-00014; Midha R, 1997, NEUROSURGERY, V40, P1188; Midha Rajiv, 2004, Neurosurg Focus, V16, pE5; Navarro X, 2007, PROG NEUROBIOL, V82, P163, DOI 10.1016/j.pneurobio.2007.06.005; Novikov L, 1997, NEUROSCIENCE, V79, P765, DOI 10.1016/S0306-4522(96)00665-3; OUDEGA M, 1994, J COMP NEUROL, V347, P115, DOI 10.1002/cne.903470109; Raivich G, 2004, NEURON, V43, P57, DOI 10.1016/j.neuron.2004.06.005; Risling Marten, 2011, Front Neurol, V1, P159, DOI 10.3389/fneur.2010.00159; ten Donkelaar HJ, 2004, J NEUROL, V251, P1429, DOI 10.1007/s00415-004-0653-3; TERASHIMA T, 1995, NEUROSCI RES, V22, P139, DOI 10.1016/0168-0102(95)00895-9; WU WT, 1994, EXP NEUROL, V129, P335, DOI 10.1006/exnr.1994.1176; WU WT, 1994, NEUROSCI LETT, V179, P157, DOI 10.1016/0304-3940(94)90958-X; Zhou LH, 2006, J NEUROTRAUM, V23, P920, DOI 10.1089/neu.2006.23.920; Zhou LB, 2008, SCIENCE, V320, P946, DOI 10.1126/science.1155244	52	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101918	10.1371/journal.pone.0101918	http://dx.doi.org/10.1371/journal.pone.0101918			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003601	Green Published, Green Submitted, gold			2022-12-27	WOS:000339242700088
J	Foottit, RG; Maw, E; Hebert, PDN				Foottit, Robert G.; Maw, Eric; Hebert, P. D. N.			DNA Barcodes for Nearctic Auchenorrhyncha (Insecta: Hemiptera)	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; GENETIC-STRUCTURE; MITOCHONDRIAL; POPULATIONS; PHYLOGEOGRAPHY; LEAFHOPPER; CALIFORNIA; DIVERSITY; HOMOPTERA; REVEAL	Background: Many studies have shown the suitability of sequence variation in the 59 region of the mitochondrial cytochrome c oxidase I (COI) gene as a DNA barcode for the identification of species in a wide range of animal groups. We examined 471 species in 147 genera of Hemiptera: Auchenorrhyncha drawn from specimens in the Canadian National Collection of Insects to assess the effectiveness of DNA barcoding in this group. Methodology/Principal Findings: Analysis of the COI gene revealed less than 2% intra-specific divergence in 93% of the taxa examined, while minimum interspecific distances exceeded 2% in 70% of congeneric species pairs. Although most species are characterized by a distinct sequence cluster, sequences for members of many groups of closely related species either shared sequences or showed close similarity, with 25% of species separated from their nearest neighbor by less than 1%. Conclusions/Significance: This study, although preliminary, provides DNA barcodes for about 8% of the species of this hemipteran suborder found in North America north of Mexico. Barcodes can enable the identification of many species of Auchenorrhyncha, but members of some species groups cannot be discriminated. Future use of DNA barcodes in regulatory, pest management, and environmental applications will be possible as the barcode library for Auchenorrhyncha expands to include more species and broader geographic coverage.	[Foottit, Robert G.; Maw, Eric] Agr & Agri Food Canada, Invertebrate Biodivers Natl Environm Hlth Program, Ottawa, ON, Canada; [Foottit, Robert G.; Maw, Eric] Canadian Natl Collect Insects Arachnids & Nematod, Ottawa, ON, Canada; [Hebert, P. D. N.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada	Agriculture & Agri Food Canada; University of Guelph	Foottit, RG (corresponding author), Agr & Agri Food Canada, Invertebrate Biodivers Natl Environm Hlth Program, Ottawa, ON, Canada.	Robert.Foottit@agr.gc.ca	Hebert, Paul DN/C-4161-2013	Hebert, Paul DN/0000-0002-3081-6700	NSERC, Genome Canada (through the Ontario Genomics Institute); Agriculture and Agri-Food Canada	NSERC, Genome Canada (through the Ontario Genomics Institute)(Natural Sciences and Engineering Research Council of Canada (NSERC)Genome Canada); Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada)	This research was supported by funding to the Canadian Barcode of Life Network from NSERC, Genome Canada (through the Ontario Genomics Institute), and by Agriculture and Agri-Food Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballman ES, 2011, J ECON ENTOMOL, V104, P279, DOI 10.1603/EC10112; Bennett GM, 2012, MOL PHYLOGENET EVOL, V65, P705, DOI 10.1016/j.ympev.2012.07.024; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Collins RA, 2012, METHODS ECOL EVOL, V3, P457, DOI 10.1111/j.2041-210X.2011.00176.x; Consortium for the Barcode of Life, 2005, DAT STAND BARCODE RE; Cryan JR, 2010, SYST ENTOMOL, V35, P393, DOI 10.1111/j.1365-3113.2009.00520.x; de Leon JH, 2006, ENTOMOL EXP APPL, V119, P109, DOI 10.1111/j.1570-7458.2006.00399.x; Deitz LL, 2012, ZOOTAXA, P1; Doering K. C., 1930, Journal of the Kansas Entomological Society, V3, P53; Floyd Robin M., 2009, P417, DOI 10.1002/9781444308211.ch17; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foottit RG, 2008, MOL ECOL RESOUR, V8, P1189, DOI 10.1111/j.1755-0998.2008.02297.x; Foottit RG, 2009, MOL ECOL RESOUR, V9, P188, DOI 10.1111/j.1755-0998.2009.02644.x; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hamilton KGA, 2012, ZOOTAXA, P41; Hamilton K. G. Andrew, 2011, American Entomologist, V57, P102; Hamilton K.G. Andrew, 2010, P169, DOI 10.3752/9780968932148.ch8; Hamilton KGA, 2005, BIOSCIENCE, V55, P49, DOI 10.1641/0006-3568(2005)055[0049:BRAELN]2.0.CO;2; HAMILTON KGA, 1982, J KANSAS ENTOMOL SOC, V55, P547; Hamilton KGA, 1985, AGR CANADA PUBLICATI; Hamilton KGA, 1982, AGR CANADA PUBLICATI; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hudson A, 2010, SOUTHWEST ENTOMOL, V35, P241, DOI 10.3958/059.035.0303; Jung S, 2011, MOL ECOL RESOUR, V11, P266, DOI 10.1111/j.1755-0998.2010.02945.x; Kamitani Satoshi, 2011, Esakia, P81; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Le Roux JJ, 2009, ANN APPL BIOL, V154, P429, DOI 10.1111/j.1744-7348.2008.00315.x; Lee W, 2011, MOL ECOL RESOUR, V11, P32, DOI 10.1111/j.1755-0998.2010.02877.x; Lee YJ, 2010, SYST ENTOMOL, V35, P277, DOI 10.1111/j.1365-3113.2009.00509.x; Lin CP, 2007, MOL PHYLOGENET EVOL, V45, P750, DOI 10.1016/j.ympev.2007.06.005; Lin CP, 2004, SYST BIOL, V53, P400, DOI 10.1080/10635150490445869; Lin CP, 2002, ANN ENTOMOL SOC AM, V95, P162, DOI 10.1603/0013-8746(2002)095[0162:MPOTNA]2.0.CO;2; Marshall DC, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-177; Marshall DC, 2011, SYST BIOL, V60, P482, DOI 10.1093/sysbio/syr017; Maryanska-Nadachowska A, 2010, SYST ENTOMOL, V35, P318, DOI 10.1111/j.1365-3113.2009.00510.x; Metcalf ZP, 1946, GEN CATALOGUE HOMOPT, V8; Metcalf ZP, 1960, GEN CATALOGUE HOMOPT; Metcalf ZP, 1947, GEN CATALOGUE HOMOPT; Nickel H, 2003, AGR ECOSYST ENVIRON, V98, P183, DOI 10.1016/S0167-8809(03)00080-X; Nielson MW, 1968, USDA ARS TECH B, V1382; OMAN PAUL WILSON, 1949, MEM ENT SOC WASHINGTON, V3, P1; Palomera V, 2012, FLA ENTOMOL, V95, P150, DOI 10.1653/024.095.0123; Park DS, 2011, B ENTOMOL RES, V101, P429, DOI 10.1017/S0007485310000714; Park DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018749; Park DS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-423; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Sanborn AF, 2012, THOMAS SAY PUBLICATI, V32; Seabra SG, 2010, MOL PHYLOGENET EVOL, V56, P462, DOI 10.1016/j.ympev.2010.03.023; Shabani M, 2013, J PEST SCI, V86, P173, DOI 10.1007/s10340-012-0463-9; Smith PT, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.41; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Virant-Doberlet M, 2011, MOL ECOL, V20, P2204, DOI 10.1111/j.1365-294X.2011.05038.x; Wallace Mathew S., 2011, Zootaxa, V3047, P1; Zahiri R, 2014, PLOS ONE IN PRESS	56	23	27	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101385	10.1371/journal.pone.0101385	http://dx.doi.org/10.1371/journal.pone.0101385			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004106	gold, Green Submitted, Green Published			2022-12-27	WOS:000339242700028
J	Agneskog, E; Nowak, P; Steffensson, CM; Casadella, M; Noguera-Julian, M; Paredes, R; Kallander, CFR; Sonnerborg, A				Agneskog, Eva; Nowak, Piotr; Steffensson, Catharina Maijgren; Casadella, Maria; Noguera-Julian, Marc; Paredes, Roger; Kallander, Clas F. R.; Sonnerborg, Anders			Decreased Phenotypic Susceptibility to Etravirine in Patients with Predicted Genotypic Sensitivity	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HIV-1 DRUG-RESISTANCE; TRANSCRIPTASE INHIBITOR RESISTANCE; REAL-TIME PCR; REVERSE-TRANSCRIPTASE; HUMAN PLASMA; ANTIRETROVIRAL THERAPY; MINORITY POPULATIONS; CLINICAL-SAMPLES; MUTATIONS	Background: A sensitive, phenotypic reverse transcriptase (RT)-based drug susceptibility assay for the detection of etravirine (ETR) resistance in patient isolates was developed and compared with the results from direct sequencing and ultra-deep pyrosequencing (UDPS). Methods: Samples were obtained from 15 patients with antiretroviral therapy (ART) failure and from five non-nucleoside reverse transcriptase inhibitor (NNRTI)-naive patients of whom four were infected by an NNRTI-resistant strain (transmitted drug resistance, TDR). In five patients, two consecutive samples (a and b) were taken for follow up of the virological response. HIV-1 RT was purified and drug susceptibility (IC50) to ETR was estimated. Direct sequencing was performed in all samples and UDPS in samples from nine patients. Results: Increased IC50 to ETR was found in samples from 13 patients where direct sequencing predicted resistance in only four. UDPS identified additional (N = 11) NNRTI resistance associated mutations (RAMs) in six of nine tested patients. During early failure, IC50 increases were observed in three of six patients without any ETR-RAMs detected by direct sequencing. In further two patients, who stopped NNRTI before sampling, increased IC50 values were found shortly after, despite absence of ETR-RAMs. In two patients who had stopped NNRTI for >1 year, a concordance between phenotype and genotypes was found. Two patients with TDR had increased IC50 despite no ETR-RAMs were detected by direct sequencing. UDPS revealed additional ETR-RAMs in four patients with a discrepancy between phenotype and direct sequencing. Conclusions: The RT-based phenotypic assay showed decreased ETR susceptibility in patients where direct sequencing predicted ETR-sensitive virus. This increased phenotypic sensitivity was to a large extent supported by UDPS and treatment history. Our method could be valuable for further studies on the phenotypic kinetics of NNRTI resistance. The clinical relevance remains to be studied in larger patient-populations.	[Agneskog, Eva; Sonnerborg, Anders] Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden; [Nowak, Piotr; Steffensson, Catharina Maijgren; Sonnerborg, Anders] Karolinska Inst, Dept Med Huddinge, Infect Dis Unit, Stockholm, Sweden; [Kallander, Clas F. R.] Cavidi AB, Uppsala, Sweden; [Casadella, Maria; Noguera-Julian, Marc; Paredes, Roger] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Inst Recerca SIDA irsiCaixa, Catalonia, Spain	Karolinska Institutet; Karolinska Institutet; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa	Agneskog, E (corresponding author), Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden.	eva.agneskog@karolinska.se	Casadellà, Maria/L-8295-2016; Noguera-Julian, Marc/F-8651-2016; Sönnerborg, Anders/W-2011-2019	Casadellà, Maria/0000-0002-4115-2305; Noguera-Julian, Marc/0000-0002-6194-1395; Sönnerborg, Anders/0000-0001-8928-3374; Nowak, Piotr/0000-0003-2747-0734	Swedish Research Council; EU-funded FP7 CHAIN; Swedish International Developing Agency; Swedish Civil Contingencies Agency; Swedish Society for Medical Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); EU-funded FP7 CHAIN; Swedish International Developing Agency; Swedish Civil Contingencies Agency; Swedish Society for Medical Research	This work was supported by the Swedish Research Council, EU-funded FP7 CHAIN, Swedish International Developing Agency, the Swedish Civil Contingencies Agency and Swedish Society for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agneskog E, 2013, J MED VIROL, V85, P703, DOI 10.1002/jmv.23507; Andries K, 2004, ANTIMICROB AGENTS CH, V48, P4680, DOI 10.1128/AAC.48.12.4680-4686.2004; Basson AE, 2008, JAIDS-J ACQ IMM DEF, V49, P538, DOI 10.1097/QAI.0b013e31818d5dcf; Bertagnolio S, 2012, ANTIVIR THER, V17, P941, DOI 10.3851/IMP2320; Bontell I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059337; Charpentier C, 2004, J VIROL, V78, P4234, DOI 10.1128/JVI.78.8.4234-4247.2004; Chetchotisakd Ploenchan, 2006, J Int Assoc Physicians AIDS Care (Chic), V5, P152, DOI 10.1177/1545109706294288; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Church JD, 2008, AIDS RES HUM RETROV, V24, P595, DOI 10.1089/aid.2007.0224; De Corte BL, 2005, J MED CHEM, V48, P1689, DOI 10.1021/jm040127p; De Luca A, 2013, J INFECT DIS; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Dudley DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036494; Gunthard HF, 1998, AIDS RES HUM RETROV, V14, P869, DOI 10.1089/aid.1998.14.869; Halvas EK, 2006, J CLIN MICROBIOL, V44, P2612, DOI 10.1128/JCM.00449-06; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Hauser A, 2009, ANTIMICROB AGENTS CH, V53, P2965, DOI 10.1128/AAC.01672-08; Hoffmann C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm435; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Karlsson AC, 1998, AIDS, V12, P839, DOI 10.1097/00002030-199808000-00005; Lecossier D, 2005, JAIDS-J ACQ IMM DEF, V38, P37, DOI 10.1097/00126334-200501010-00007; Liang BH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026745; Malmsten A, 2005, J MED VIROL, V76, P291, DOI 10.1002/jmv.20360; Malmsten A, 2003, J MED VIROL, V71, P347, DOI 10.1002/jmv.10492; Marozsan AJ, 2004, J VIROL, V78, P11130, DOI 10.1128/JVI.78.20.11130-11141.2004; Neogi U, 2011, AIDS, V25, P1123, DOI 10.1097/QAD.0b013e328346269f; Paredes R, 2007, J VIROL METHODS, V146, P136, DOI 10.1016/j.jviromet.2007.06.012; Picchio G, 2011, AIDS RES HUM RETROV, V27, P1272, DOI 10.1089/aid.2011.0049; Shao XW, 2003, AIDS, V17, P1463, DOI 10.1097/00002030-200307040-00007; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Sungkanuparph S, 2007, CLIN INFECT DIS, V44, P447, DOI 10.1086/510745; Tambuyzer L, 2011, JAIDS-J ACQ IMM DEF, V58, P18, DOI 10.1097/QAI.0b013e3182237f74; Tambuyzer L, 2010, AIDS RES HUM RETROV, V26, P1197, DOI 10.1089/aid.2009.0302; Varghese V, 2009, JAIDS-J ACQ IMM DEF, V52, P309, DOI 10.1097/QAI.0b013e3181bca669; Vingerhoets J, 2005, J VIROL, V79, P12773, DOI 10.1128/JVI.79.20.12773-12782.2005; Vingerhoets J, 2010, AIDS, V24, P503, DOI 10.1097/QAD.0b013e32833677ac; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307	38	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101508	10.1371/journal.pone.0101508	http://dx.doi.org/10.1371/journal.pone.0101508			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000302	Green Published, gold, Green Submitted			2022-12-27	WOS:000338637300053
J	Boelen, L; Teutsch, S; Wilson, DP; Dolan, K; Dore, GJ; Lloyd, AR; Luciani, F				Boelen, Lies; Teutsch, Suzy; Wilson, David P.; Dolan, Kate; Dore, Greg J.; Lloyd, Andrew R.; Luciani, Fabio		HITS Investigators	Per-Event Probability of Hepatitis C Infection during Sharing of Injecting Equipment	PLOS ONE			English	Article							HEALTH-CARE WORKERS; VIRUS TRANSMISSION; RISK-FACTORS; DRUG-USERS; SEROCONVERSION; METAANALYSIS; PREVALENCE; SURVIVAL; EXPOSURE; SYRINGES	Background: Shared injecting apparatus during drug use is the premier risk factor for hepatitis C virus (HCV) transmission. Aims: To estimate the per-event probability of HCV infection during a sharing event, and the transmission probability of HCV from contaminated injecting apparatus. Methods: Estimates were obtained using a maximum likelihood method with estimated IDU and sharing events obtained from behavioural data. Settings: Cohort study in multiple correction centres in New South Wales, Australia Participants: Subjects (N = 500) with a lifetime history of injecting drug use (IDU) who were followed up between 2005 and 2012. During follow-up, interviews for risk behaviours were taken and blood sampling (HCV-antibody and RNA testing) was performed. Measurements: Self-reported frequencies of injecting drugs and sharing events, as well as other risk behaviours and details on the nature of injecting events. Findings: The best estimate of the per-event probability of infection was 0.57% (CI: 0.32-1.05%). A sensitivity analysis on the likely effect of under-reporting of sharing of the injecting apparatus indicated that the per event infection probability may be as low as 0.17% (95% CI: 0.11%-0.25%). The transmission probability was similarly shown to range up to 6%, dependent on the presumed prevalence of the virus in injecting equipment. Conclusions: The transmission probability of HCV during a sharing event is small. Hence, strategies to reduce the frequency and sharing of injecting equipment are required, as well as interventions focused on decreasing the per event risk.	[Boelen, Lies; Teutsch, Suzy; Lloyd, Andrew R.; Luciani, Fabio] Univ New S Wales, Sch Med Sci, Inflammat & Infect Res Ctr, Sydney, NSW, Australia; [Wilson, David P.; Dore, Greg J.] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Boelen, Lies] Univ London Imperial Coll Sci Technol & Med, Sch Med, Immunol Sect, London, England; [Dolan, Kate] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; Kirby Institute; Imperial College London; University of New South Wales Sydney	Luciani, F (corresponding author), Univ New S Wales, Sch Med Sci, Inflammat & Infect Res Ctr, Sydney, NSW, Australia.	luciani@unsw.edu.au	Dore, Gregory John/ABD-5665-2021; dolan, kate a/G-7859-2017; Lloyd, Andrew/AFJ-8960-2022; Lloyd, Andrew/AAF-6071-2022; Lloyd, Andrew/E-7334-2017; Teutsch, Suzy/AAN-9071-2021	Dore, Gregory John/0000-0002-4741-2622; dolan, kate a/0000-0002-9848-807X; Lloyd, Andrew/0000-0001-6277-8887; Lloyd, Andrew/0000-0001-6277-8887; Teutsch, Suzy/0000-0003-1902-2173; Luciani, Fabio/0000-0003-0666-6324; Maher, Lisa/0000-0001-6020-6519	National Health and Medical Research Council of Australia (NHMRC) [510488]; Australian Centre for HIV and Hepatitis Research (ACH2); NHMRC [1016351, 510428, 510246]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Centre for HIV and Hepatitis Research (ACH2); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia (NHMRC) Program grant (No. 510488), and by a grant from the Australian Centre for HIV and Hepatitis Research (ACH2). The HITS-p cohort was supported by an NHMRC Partnership Grant (No. 1016351). FL was supported by a NHMRC Early Career Fellowship (No. 510428) and AL by a NHMRC Practitioner Fellowship (No. 510246). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baggaley RF, 2006, AIDS, V20, P805, DOI 10.1097/01.aids.0000218543.46963.6d; Butler T., 2017, NATL PRISON ENTRANTS; Butler T, 2007, AUST NZ J PUBL HEAL, V31, P44, DOI 10.1111/j.1753-6405.2007.00009.x; Corson S, 2013, DRUG ALCOHOL DEPEN, V133, P172, DOI 10.1016/j.drugalcdep.2013.05.014; Doerrbecker J, 2011, J INFECT DIS, V204, P1830, DOI 10.1093/infdis/jir535; Dolan KA, 1998, DRUG ALCOHOL REV, V17, P153, DOI 10.1080/09595239800186951; Hagan H, 2008, AM J EPIDEMIOL, V168, P1099, DOI 10.1093/aje/kwn237; Hunt DR, 2009, AM J GASTROENTEROL, V104, P1024, DOI 10.1038/ajg.2008.143; Hutin Y, 2004, J CLIN PHARMACOL, V44, P20, DOI 10.1177/0091270003258669; Indig D., 2010, 2009 NSW INMATE HLTH; Jin FY, 2010, AIDS, V24, P907, DOI 10.1097/QAD.0b013e3283372d90; Macalino GE, 2004, AM J PUBLIC HEALTH, V94, P1218, DOI 10.2105/AJPH.94.7.1218; Page-Shafer K, 2008, J CLIN MICROBIOL, V46, P499, DOI 10.1128/JCM.01229-07; Paintsil E, 2010, J INFECT DIS, V202, P984, DOI 10.1086/656212; Pouget ER, 2012, ADDICTION, V107, P1057, DOI 10.1111/j.1360-0443.2011.03765.x; Rolls DA, 2012, J THEOR BIOL, V297, P73, DOI 10.1016/j.jtbi.2011.12.008; Skipper C, 2003, GUT, V52, P1500, DOI 10.1136/gut.52.10.1500; Team RDC, 2012, LANG ENV STAT COMP; Teutsch S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-633; Tohme RA, 2010, HEPATOLOGY, V52, P1497, DOI 10.1002/hep.23808; Tomkins SE, 2012, J VIRAL HEPATITIS, V19, P199, DOI 10.1111/j.1365-2893.2011.01543.x; Yazdanpanah Y, 2005, CLIN INFECT DIS, V41, P1423, DOI 10.1086/497131	22	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e100749	10.1371/journal.pone.0100749	http://dx.doi.org/10.1371/journal.pone.0100749			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7WB	25000496	Green Submitted, Green Published, gold			2022-12-27	WOS:000338637300014
J	Lo, HC; Yang, RB; Lee, CH				Lo, Hui-Chen; Yang, Ruey-Bing; Lee, Chien-Hsing			Guanylyl Cyclase-G Modulates Jejunal Apoptosis and Inflammation in Mice with Intestinal Ischemia and Reperfusion	PLOS ONE			English	Article							EPITHELIAL-CELL APOPTOSIS; RAT SMALL-INTESTINE; SYSTEMIC INFLAMMATION; BARRIER FUNCTION; ORPHAN RECEPTOR; PROTEIN-KINASE; MOUSE TESTIS; NITRIC-OXIDE; CYCLIC-GMP; INJURY	Background: Membrane bound guanylyl cyclase-G (mGC-G), a novel form of GC mediates ischemia and reperfusion (IR)-induced renal injury. We investigated the roles of mGC-G in intestinal IR-induced jejunal damage, inflammation, and apoptosis. Materials and methods: Male C57BL/6 wild-type (WT) and mGC-G gene knockout (KO) mice were treated with a sham operation or 45 min of superior mesenteric arterial obstruction followed by 3, 6, 12, or 24 h of reperfusion. Results: Sham-operated KO mice had significantly lower plasma nitrate and nitrite (NOx) levels and jejunal villus height, crypt depth, and protein expression of phosphorylated-nuclear factor-kappa-B (NF-kappa B), phosphorylated-c-Jun N-terminal kinases (JNK) 2/3, phosphorylated-p38, and B-cell lymphoma-2 (Bcl-2). They had significantly greater jejunal interleukin-6 mRNA, cytochrome c protein, and apoptotic index compared with sham-operated WT mice. Intestinal IR significantly decreased plasma NOx in WT mice and increased plasma NOx in KO mice. The jejunal apoptotic index and caspase 3 activities were significantly increased, and nuclear phosphorylated-NF-kappa B and phosphorylated-p38 protein were significantly decreased in WT, but not KO mice with intestinal IR. After reperfusion, KO mice had an earlier decrease in jejunal cyclic GMP, and WT mice had an earlier increase in jejunal proliferation and a later increase in cytosol inhibitor of kappa-B-alpha. Intestinal IR induced greater increases in plasma and jejunal interleukin-6 protein in WT mice and a greater increase in jejunal interleukin-6 mRNA in KO mice. Conclusions: mGC-G is involved in the maintenance of jejunal integrity and intestinal IR-induced inflammation and apoptosis. These results suggest that targeting cGMP pathway might be a potential strategy to alleviate IR-induced jejunal damages.	[Lo, Hui-Chen] Fu Jen Catholic Univ, Dept Nutr Sci, New Taipei City, Taiwan; [Yang, Ruey-Bing] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Lee, Chien-Hsing] Changhua Christian Hosp, Div Pediat Surg, Changhau, Taiwan; [Lee, Chien-Hsing] Chang Jung Christian Univ, Grad Inst Med Sci, Tainan, Taiwan	Fu Jen Catholic University; Academia Sinica - Taiwan; Changhua Christian Hospital; Chang Jung Christian University	Yang, RB (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	rbyang@ibms.sinica.edu.tw; 27566@cch.org.tw	Lo, Hui-Chen/AAN-5906-2021; Yang, Ruey-Bing/O-1494-2018	Yang, Ruey-Bing/0000-0003-3017-3714	National Science Council of the Republic of China [NSC 96-2320-B-309-003-MY2]; Changhua Christian Hospital [102-CCH-IRP-025]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan); Changhua Christian Hospital	This work is supported by the National Science Council of the Republic of China under the grant number NSC 96-2320-B-309-003-MY2 and by Changhua Christian Hospital under the grant number 102-CCH-IRP-025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amara M, 2012, TRANSPLANTATION, V93, P880, DOI 10.1097/TP.0b013e31824cd59d; An SC, 2005, HISTOCHEM CELL BIOL, V123, P249, DOI 10.1007/s00418-005-0765-6; Anand-Srivastava MB, 2005, PEPTIDES, V26, P1044, DOI 10.1016/j.peptides.2004.09.023; Cerqueira Nereide Freire, 2005, Acta Cir. Bras., V20, P336, DOI 10.1590/S0102-86502005000400013; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; Chen W, 2005, WORLD J GASTROENTERO, V11, P3419, DOI 10.3748/wjg.v11.i22.3419; Das A, 2006, J BIOL CHEM, V281, P38644, DOI 10.1074/jbc.M606142200; Edelblum KL, 2006, INFLAMM BOWEL DIS, V12, P413, DOI 10.1097/01.MIB.0000217334.30689.3e; Egemnazarov B, 2009, AM J PHYSIOL-LUNG C, V296, pL462, DOI 10.1152/ajplung.90377.2008; Fukatsu K, 2004, JPEN-PARENTER ENTER, V28, P224, DOI 10.1177/0148607104028004224; Huang YH, 2006, ENDOCRINOLOGY, V147, P4792, DOI 10.1210/en.2005-1476; Ikeda H, 1998, GUT, V42, P530, DOI 10.1136/gut.42.4.530; Inserte J, 2011, J MOL CELL CARDIOL, V50, P903, DOI 10.1016/j.yjmcc.2011.02.013; Kuhn M, 2004, BIOCHEM J, V379, P385, DOI 10.1042/BJ20031624; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; Lee CH, 2012, J SURG RES, V175, P67, DOI 10.1016/j.jss.2011.02.003; Li J, 2009, J GASTROINTEST SURG, V13, P478, DOI 10.1007/s11605-008-0728-z; Li XL, 2008, TRANSPL P, V40, P3342, DOI 10.1016/j.transproceed.2008.03.167; Lin H, 2008, J AM SOC NEPHROL, V19, P339, DOI 10.1681/ASN.2007050550; Lo HC, 2001, JPEN-PARENTER ENTER, V25, P73, DOI 10.1177/014860710102500273; Murayama T, 2006, TRANSPLANTATION, V81, P1325, DOI 10.1097/01.tp.0000209167.48030.6b; Naito Y, 2002, REDOX REP, V7, P294, DOI 10.1179/135100002125000983; Noda T, 1998, AM J PHYSIOL-GASTR L, V274, pG270, DOI 10.1152/ajpgi.1998.274.2.G270; Pilz RB, 2003, CIRC RES, V93, P1034, DOI 10.1161/01.RES.0000103311.52853.48; Schleiffer R, 1996, GUT, V39, P194, DOI 10.1136/gut.39.2.194; Schulz S, 1998, J BIOL CHEM, V273, P1032, DOI 10.1074/jbc.273.2.1032; Siednienko J, 2011, CYTOKINE, V54, P282, DOI 10.1016/j.cyto.2011.02.015; Stallion A, 2005, J PEDIATR SURG, V40, P470, DOI 10.1016/j.jpedsurg.2004.11.045; Steinbrecher KA, 2011, J IMMUNOL, V186, P7205, DOI 10.4049/jimmunol.1002469; Stollenwerk MM, 2012, J SURG RES, V178, P692, DOI 10.1016/j.jss.2012.07.056; Vollmar B, 2011, LANGENBECK ARCH SURG, V396, P13, DOI 10.1007/s00423-010-0727-x; Wu B, 2004, AM J PHYSIOL-GASTR L, V286, pG580, DOI 10.1152/ajpgi.00335.2003; Yang Q, 2013, WORLD J GASTROENTERO, V19, P4925, DOI 10.3748/wjg.v19.i30.4925; Zheng SY, 2005, WORLD J GASTROENTERO, V11, P656, DOI 10.3748/wjg.v11.i5.656; Zhou YN, 2005, PEDIATR RES, V58, P1192, DOI 10.1203/01.pdr.0000185133.65966.4e	35	5	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101314	10.1371/journal.pone.0101314	http://dx.doi.org/10.1371/journal.pone.0101314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992336	Green Published, gold, Green Submitted			2022-12-27	WOS:000341253400061
J	Rochfort, KD; Collins, LE; Murphy, RP; Cummins, PM				Rochfort, Keith D.; Collins, Laura E.; Murphy, Ronan P.; Cummins, Philip M.			Downregulation of Blood-Brain Barrier Phenotype by Proinflammatory Cytokines Involves NADPH Oxidase-Dependent ROS Generation: Consequences for Interendothelial Adherens and Tight Junctions	PLOS ONE			English	Article							NF-KAPPA-B; VASCULAR ENDOTHELIAL-CELLS; NECROSIS-FACTOR-ALPHA; TNF-ALPHA; OXIDATIVE STRESS; MOUSE-BRAIN; NAD(P)H OXIDASE; PROTEIN-KINASE; IFN-GAMMA; IN-VITRO	Background and Objectives: Blood-brain barrier (BBB) dysfunction is an integral feature of neurological disorders and involves the action of multiple proinflammatory cytokines on the microvascular endothelial cells lining cerebral capillaries. There is still however, considerable ambiguity throughout the scientific literature regarding the mechanistic role(s) of cytokines in this context, thereby warranting a comprehensive in vitro investigation into how different cytokines may cause dysregulation of adherens and tight junctions leading to BBB permeabilization. Methods: The present study employs human brain microvascular endothelial cells (HBMvECs) to compare/contrast the effects of TNF-alpha and IL-6 on BBB characteristics ranging from the expression of interendothelial junction proteins (VE-cadherin, occludin and claudin-5) to endothelial monolayer permeability. The contribution of cytokine-induced NADPH oxidase activation to altered barrier phenotype was also investigated. Results: In response to treatment with either TNF-alpha or IL-6 (0-100 ng/ml, 0-24 hrs), our studies consistently demonstrated significant dose-and time-dependent decreases in the expression of all interendothelial junction proteins examined, in parallel with dose-and time-dependent increases in ROS generation and HBMvEC permeability. Increased expression and co-association of gp91 and p47, pivotal NADPH oxidase subunits, was also observed in response to either cytokine. Finally, cytokine-dependent effects on junctional protein expression, ROS generation and endothelial permeability could all be attenuated to a comparable extent using a range of antioxidant strategies, which included ROS depleting agents (superoxide dismutase, catalase, N-acetylcysteine, apocynin) and targeted NADPH oxidase blockade (gp91 and p47 siRNA, NSC23766). Conclusion: A timely and wide-ranging investigation comparing the permeabilizing actions of TNF-alpha and IL-6 in HBMvECs is presented, in which we demonstrate how either cytokine can similarly downregulate the expression of interendothelial adherens and tight junction proteins leading to elevation of paracellular permeability. The cytokine-dependent activation of NADPH oxidase leading to ROS generation was also confirmed to be responsible in-part for these events.	[Rochfort, Keith D.; Collins, Laura E.; Cummins, Philip M.] Dublin City Univ, Sch Biotechnol, Dublin 9, Ireland; [Murphy, Ronan P.] Dublin City Univ, Sch Hlth & Human Performance, Dublin 9, Ireland; [Murphy, Ronan P.; Cummins, Philip M.] Dublin City Univ, Ctr Prevent Med, Dublin 9, Ireland	Dublin City University; Dublin City University; Dublin City University	Cummins, PM (corresponding author), Dublin City Univ, Sch Biotechnol, Dublin 9, Ireland.	phil.cummins@dcu.ie	Rochfort, Keith/R-7009-2019; Murphy, Ronan P./V-6697-2019	Rochfort, Keith/0000-0003-1198-5952; Murphy, Ronan P./0000-0002-4579-8007	National Development Plan/Higher Education Authority of Ireland Programme for Research in Third Level Institutes - HEA/PRTLI Cycle 4: Targeted Therapeutics & Theranostics (PMC)	National Development Plan/Higher Education Authority of Ireland Programme for Research in Third Level Institutes - HEA/PRTLI Cycle 4: Targeted Therapeutics & Theranostics (PMC)	This work was funded by the National Development Plan/Higher Education Authority of Ireland Programme for Research in Third Level Institutes - HEA/PRTLI Cycle 4: Targeted Therapeutics & Theranostics (PMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Lopez-Ramirez MA, 2012, J IMMUNOL, V189, P3130, DOI 10.4049/jimmunol.1103460; Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Aslam M, 2012, CYTOKINE, V57, P269, DOI 10.1016/j.cyto.2011.10.016; Aveleira CA, 2010, DIABETES, V59, P2872, DOI 10.2337/db09-1606; Baek KH, 2006, CURR PROTEIN PEPT SC, V7, P171, DOI 10.2174/138920306776359740; Bamforth SD, 1996, ACTA NEUROPATHOL, V91, P624, DOI 10.1007/s004010050476; Basuroy S, 2006, AM J PHYSIOL-CELL PH, V291, pC897, DOI 10.1152/ajpcell.00032.2006; Basuroy S, 2009, AM J PHYSIOL-CELL PH, V296, pC422, DOI 10.1152/ajpcell.00381.2008; Benardais K, 2013, NEUROSCI LETT, V555, P165, DOI 10.1016/j.neulet.2013.09.038; Bennett J, 2010, J NEUROIMMUNOL, V229, P180, DOI 10.1016/j.jneuroim.2010.08.011; Blais V, 2004, J IMMUNOL, V172, P7043, DOI 10.4049/jimmunol.172.11.7043; Bluyssen HAR, 2010, AM J PHYSIOL-CELL PH, V299, pC354, DOI 10.1152/ajpcell.00513.2009; Borlongan CV, 2012, CURR PHARM DESIGN, V18, P3615; Cohen SS, 2013, NEUROIMMUNOMODULAT, V20, P264, DOI 10.1159/000350470; Cummins PM, 2012, MOL CELL BIOL, V32, P242, DOI 10.1128/MCB.06029-11; Figiel I, 2008, ACTA NEUROBIOL EXP, V68, P526; Fitzpatrick PA, 2009, INT J BIOCHEM CELL B, V41, P2287, DOI 10.1016/j.biocel.2009.05.011; Forster C, 2008, J PHYSIOL-LONDON, V586, P1937, DOI 10.1113/jphysiol.2007.146852; Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI [10.1089/ars.2008.2220, 10.1089/ARS.2008.2220]; Frey RS, 2002, CIRC RES, V90, P1012, DOI 10.1161/01.RES.0000017631.28815.8E; Gertzberg N, 2004, AM J PHYSIOL-LUNG C, V286, pL37, DOI 10.1152/ajplung.00116.2003; Gloor SM, 1997, BIOCHEM BIOPH RES CO, V239, P804, DOI 10.1006/bbrc.1997.7557; Griendling KK, 2000, ARTERIOSCL THROM VAS, V20, P2175, DOI 10.1161/01.ATV.20.10.2175; Griffin WS, 2010, US Neurol, V6, P19, Patent No. 61927; Guinan AF, 2013, CARDIOVASC RES, V99, P545, DOI 10.1093/cvr/cvt127; Hou TY, 2008, CURR CARDIOL REV, V4, P179, DOI 10.2174/157340308785160570; Kerkar S, 2006, J SURG RES, V132, P40, DOI 10.1016/j.jss.2005.06.033; Lee YW, 2010, CYTOKINE, V49, P73, DOI 10.1016/j.cyto.2009.08.009; Lv S, 2010, LIVER INT, V30, P1198, DOI 10.1111/j.1478-3231.2010.02211.x; Manea A, 2010, ARTERIOSCL THROM VAS, V30, P105, DOI 10.1161/ATVBAHA.109.193896; Mark KS, 1999, LIFE SCI, V64, P1941, DOI 10.1016/S0024-3205(99)00139-3; MARUO N, 1992, ENDOCRINOLOGY, V131, P710, DOI 10.1210/en.131.2.710; Mckenzie JAG, 2007, J CELL PHYSIOL, V213, P221, DOI 10.1002/jcp.21114; Muzaffar S, 2006, EUR J PHARMACOL, V538, P108, DOI 10.1016/j.ejphar.2006.03.047; Nishioku T, 2010, J PHARMACOL SCI, V112, P251, DOI 10.1254/jphs.09292SC; Saura M, 2006, J BIOL CHEM, V281, P30057, DOI 10.1074/jbc.M606279200; Schieffer B, 2000, CIRC RES, V87, P1195, DOI 10.1161/01.RES.87.12.1195; SHARIEF MK, 1992, J NEUROIMMUNOL, V38, P27, DOI 10.1016/0165-5728(92)90087-2; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Strazza M, 2011, BRAIN RES, V1399, P96, DOI 10.1016/j.brainres.2011.05.015; Sury MD, 2006, FREE RADICAL BIO MED, V41, P1372, DOI 10.1016/j.freeradbiomed.2006.07.016; Szeto A, 2008, AM J PHYSIOL-ENDOC M, V295, pE1495, DOI 10.1152/ajpendo.90718.2008; Szocs K, 2004, GEN PHYSIOL BIOPHYS, V23, P265; Tang C, 2011, PHYTOTHER RES, V25, P376, DOI 10.1002/ptr.3278; TOBOREK M, 1995, ATHEROSCLEROSIS, V117, P179, DOI 10.1016/0021-9150(95)05568-H; Tuttolomondo A, 2008, CURR PHARM DESIGN, V14, P3574, DOI 10.2174/138161208786848739; Voigt A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00042; Walsh TG, 2011, J CELL PHYSIOL, V226, P3053, DOI 10.1002/jcp.22655; Wassmann S, 2004, CIRC RES, V94, P534, DOI 10.1161/01.RES.0000115557.25127.8D; Wilson CM, 2009, INT J RADIAT ONCOL, V74, P934, DOI 10.1016/j.ijrobp.2009.02.035; Yu LX, 1998, P NATL ACAD SCI USA, V95, P7993, DOI 10.1073/pnas.95.14.7993; Zhang S, 2013, MOL MED REP, V7, P93, DOI 10.3892/mmr.2012.1159; Zou JY, 2005, BRAIN RES, V1034, P11, DOI 10.1016/j.brainres.2004.11.014	53	139	141	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101815	10.1371/journal.pone.0101815	http://dx.doi.org/10.1371/journal.pone.0101815			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992685	gold, Green Submitted, Green Published			2022-12-27	WOS:000341253400120
J	Hua, XF; Wang, YW; Tang, YX; Yu, SQ; Jin, SH; Meng, XM; Li, HF; Liu, FJ; Sun, Q; Wang, HY; Li, JY				Hua, Xiu-feng; Wang, Yan-wei; Tang, Yu-xiao; Yu, Sheng-qiang; Jin, Shao-hua; Meng, Xiao-mei; Li, Hua-feng; Liu, Fu-jun; Sun, Qiang; Wang, Hai-yan; Li, Jian-yuan			Pancreatic Insulin-Producing Cells Differentiated from Human Embryonic Stem Cells Correct Hyperglycemia in SCID/NOD Mice, an Animal Model of Diabetes	PLOS ONE			English	Article							TRANSPLANTATION; THERAPY; GROWTH	Background: Human pancreatic islet transplantation is a prospective curative treatment for diabetes. However, the lack of donor pancreases greatly limits this approach. One approach to overcome the limited supply of donor pancreases is to generate functional islets from human embryonic stem cells (hESCs), a cell line with unlimited proliferative capacity, through rapid directed differentiation. This study investigated whether pancreatic insulin-producing cells (IPCs) differentiated from hESCs could correct hyperglycemia in severe combined immunodeficient (SCID)/non-obese diabetic (NOD) mice, an animal model of diabetes. Methods: We generated pancreatic IPCs from two hESC lines, YT1 and YT2, using an optimized four-stage differentiation protocol in a chemically defined culture system. Then, about 5-7x10(6) differentiated cells were transplanted into the epididymal fat pad of SCID/NOD mice (n = 20). The control group were transplanted with undifferentiated hESCs (n = 6). Graft survival and function were assessed using immunohistochemistry, and measuring serum human C-peptide and blood glucose levels. Results: The pancreatic IPCs were generated by the four-stage differentiation protocol using hESCs. About 17.1% of differentiated cells expressed insulin, as determined by flow cytometry. These cells secreted insulin/C-peptide following glucose stimulation, similarly to adult human islets. Most of these IPCs co-expressed mature beta cell-specific markers, including human C-peptide, GLUT2, PDX1, insulin, and glucagon. After implantation into the epididymal fat pad of SCID/NOD mice, the hESC-derived pancreatic IPCs corrected hyperglycemia for >= 8 weeks. None of the animals transplanted with pancreatic IPCs developed tumors during the time. The mean survival of recipients was increased by implanted IPCs as compared to implanted undifferentiated hESCs (P<0.0001). Conclusions: The results of this study confirmed that human terminally differentiated pancreatic IPCs derived from hESCs can correct hyperglycemia in SCID/NOD mice for >8 weeks.	[Hua, Xiu-feng; Tang, Yu-xiao; Meng, Xiao-mei; Li, Hua-feng] Yuhuangding Hosp, Dept Endocrinol, Yantai, Shandong, Peoples R China; [Wang, Yan-wei; Liu, Fu-jun; Wang, Hai-yan; Li, Jian-yuan] Yuhuangding Hosp, Cent Lab, Res Ctr Stem Cell Engn Shandong, Yantai, Shandong, Peoples R China; [Yu, Sheng-qiang] Yuhuangding Hosp, Dept Urol, Yantai, Shandong, Peoples R China; [Jin, Shao-hua] Yuhuangding Hosp, Dept Clin Lab, Yantai, Shandong, Peoples R China; [Sun, Qiang] Chinese Peoples Liberat Army Navy 407 Hosp, Dept Orthoped, Yantai, Shandong, Peoples R China		Li, JY (corresponding author), Yuhuangding Hosp, Cent Lab, Res Ctr Stem Cell Engn Shandong, Yantai, Shandong, Peoples R China.	sdscli@yeah.net	yu, shengqiang/AAT-4994-2020		Science and Technology Plan Project of Yantai City, China [2008142-9, 2011204]	Science and Technology Plan Project of Yantai City, China	This work was supported by the Science and Technology Plan Project of Yantai City, China (2008142-9 and 2011204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brand SJ, 2002, PHARMACOL TOXICOL, V91, P414, DOI 10.1034/j.1600-0773.2002.910621.x; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Donath MY, 2004, DIABETOLOGIA, V47, P581, DOI 10.1007/s00125-004-1336-4; Fiorina P, 2011, ENDOCR REV, V32, P725, DOI 10.1210/er.2011-0008; Francese R, 2010, CLIN IMMUNOL, V136, P309, DOI 10.1016/j.clim.2010.04.010; Guo TX, 2009, ENDOCR REV, V30, P214, DOI 10.1210/er.2009-0004; Hoffman LM, 2005, NAT BIOTECHNOL, V23, P699, DOI 10.1038/nbt1102; Hua XF, 2006, ZHONGGUO YISHI ZA ZH, V8, P1297; Hua XF, 2012, NEURAL REGEN RES, V7, P506, DOI 10.3969/j.issn.1673-5374.2012.07.005; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; Jurewicz M, 2010, DIABETES, V59, P3139, DOI 10.2337/db10-0542; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Korbutt GS, 1996, J CLIN INVEST, V97, P2119, DOI 10.1172/JCI118649; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Liew CG, 2005, ANN MED, V37, P521, DOI 10.1080/07853890500379463; Liu FJ, 2012, ONCOL REP, V27, P1932, DOI 10.3892/or.2012.1714; Murtaugh LC, 2007, DEVELOPMENT, V134, P427, DOI 10.1242/dev.02770; Phillips BW, 2007, STEM CELLS DEV, V16, P561, DOI 10.1089/scd.2007.0029; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Wang YW, 2012, HUM CELL, V25, P16, DOI 10.1007/s13577-011-0039-7; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28	21	24	25	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102198	10.1371/journal.pone.0102198	http://dx.doi.org/10.1371/journal.pone.0102198			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25009980	Green Submitted, Green Published, gold			2022-12-27	WOS:000338763800080
J	Ulyshen, MD				Ulyshen, Michael D.			Interacting Effects of Insects and Flooding on Wood Decomposition	PLOS ONE			English	Article							TERRESTRIAL ECOSYSTEMS; SUBTERRANEAN TERMITES; DEAD WOOD; FOREST; DEBRIS; RHINOTERMITIDAE; RETICULITERMES; DIVERSITY; LITTER; MODEL	Saproxylic arthropods are thought to play an important role in wood decomposition but very few efforts have been made to quantify their contributions to the process and the factors controlling their activities are not well understood. In the current study, mesh exclusion bags were used to quantify how arthropods affect loblolly pine (Pinus taeda L.) decomposition rates in both seasonally flooded and unflooded forests over a 31-month period in the southeastern United States. Wood specific gravity (based on initial wood volume) was significantly lower in bolts placed in unflooded forests and for those unprotected from insects. Approximately 20.5% and 13.7% of specific gravity loss after 31 months was attributable to insect activity in flooded and unflooded forests, respectively. Importantly, minimal between-treatment differences in water content and the results from a novel test carried out separately suggest the mesh bags had no significant impact on wood mass loss beyond the exclusion of insects. Subterranean termites (Isoptera: Rhinotermitidae: Reticulitermes spp.) were 5-6 times more active below-ground in unflooded forests compared to flooded forests based on wooden monitoring stakes. They were also slightly more active above-ground in unflooded forests but these differences were not statistically significant. Similarly, seasonal flooding had no detectable effect on above-ground beetle (Coleoptera) richness or abundance. Although seasonal flooding strongly reduced Reticulitermes activity below-ground, it can be concluded from an insignificant interaction between forest type and exclusion treatment that reduced above-ground decomposition rates in seasonally flooded forests were due largely to suppressed microbial activity at those locations. The findings from this study indicate that southeastern U. S. arthropod communities accelerate above-ground wood decomposition significantly and to a similar extent in both flooded and unflooded forests. Seasonal flooding has the potential to substantially reduce the contributions of these organisms to wood decomposition below-ground, however.	US Forest Serv, Southern Res Stn, USDA, Asheville, NC 28804 USA	United States Department of Agriculture (USDA); United States Forest Service	Ulyshen, MD (corresponding author), US Forest Serv, Southern Res Stn, USDA, Asheville, NC 28804 USA.	mulyshen@fs.fed.us			United States Department of Agriculture forest service southern research station	United States Department of Agriculture forest service southern research station(United States Department of Agriculture (USDA)United States Forest Service)	This research was funded by United States Department of Agriculture forest service southern research station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE T, 1980, REV ECOL BIOL SOL, V17, P23; Abe T., 1978, Malayan Nature Journal, V30, P391; Ballinger A, 2010, RIVER RES APPL, V26, P207, DOI 10.1002/rra.1254; Braccia A, 2008, CAN J FOREST RES, V38, P2697, DOI 10.1139/X08-113; Braccia A, 2001, WETLANDS, V21, P18, DOI 10.1672/0277-5212(2001)021[0018:IAWWDI]2.0.CO;2; Chang TT, 2003, PLANT DIS, V87, P1201, DOI 10.1094/PDIS.2003.87.10.1201; COE R, 2000, EFFECT SIZE CALCULAT; Collins N. M., 1983, Tropical rain forest: ecology and management. Special Publication Number 2 of the British Ecological Society, P311; Cornwell WK, 2009, GLOBAL CHANGE BIOL, V15, P2431, DOI 10.1111/j.1365-2486.2009.01916.x; Delaney M, 1998, BIOTROPICA, V30, P2, DOI 10.1111/j.1744-7429.1998.tb00364.x; EDMONDS RL, 1989, CAN J FOREST RES, V19, P853, DOI 10.1139/x89-130; Forschler BT, 1995, ENVIRON ENTOMOL, V24, P1592, DOI 10.1093/ee/24.6.1592; GENTRY JB, 1982, OECOLOGIA, V54, P63, DOI 10.1007/BF00541109; Gonzalez G, 2008, AMBIO, V37, P588, DOI 10.1579/0044-7447-37.7.588; Guyette RP, 2002, CAN J FISH AQUAT SCI, V59, P578, DOI 10.1139/F02-026; Hedges LV, 2014, STAT METHODS META AN; HOPKINS B, 1966, J ECOL, V54, P687, DOI 10.2307/2257811; HOWARD RW, 1982, ENVIRON ENTOMOL, V11, P1290, DOI 10.1093/ee/11.6.1290; Kampichler C, 2009, BIOL REV, V84, P375, DOI 10.1111/j.1469-185X.2009.00078.x; LAVELLE P, 1993, BIOTROPICA, V25, P130, DOI 10.2307/2389178; Leach JG, 1937, J AGRIC RES, V55, P0129; Lim Su Yee, 2012, Insects, V3, P62, DOI 10.3390/insects3010062; Lloyd AH, 1997, ECOLOGY, V78, P1199, DOI 10.1890/0012-9658(1997)078[1199:HDOTFI]2.0.CO;2; MARTIUS C, 1994, PEDOBIOLOGIA, V38, P407; MARTIUS C, 1989, UNTERSUCHUNGEN OKOLO; MEENTEMEYER V, 1978, ECOLOGY, V59, P465, DOI 10.2307/1936576; Mouzinho JRC, 2010, J NAT HIST, V44, P589, DOI 10.1080/00222930903384758; Muller MM, 2002, FOREST ECOL MANAG, V166, P165, DOI 10.1016/S0378-1127(01)00671-5; MULLER RN, 1991, CAN J FOREST RES, V21, P1567, DOI 10.1139/x91-218; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Progar RA, 2000, OECOLOGIA, V124, P426, DOI 10.1007/PL00008868; RASTETTER EB, 1991, TREE PHYSIOL, V9, P101, DOI 10.1093/treephys/9.1-2.101; Rayner ADM, 1988, FUNGAL DECOMPOSITION; *SAS I, 1999, SAS SYST WIND VERS 8; Schuurman G, 2005, ECOLOGY, V86, P1236, DOI 10.1890/03-0570; Stokland J.N., 2012, BIODIVERSITY DEAD WO; SU NY, 1993, ENVIRON ENTOMOL, V22, P1113, DOI 10.1093/ee/22.5.1113; SWIFT MJ, 1977, SCI PROG, V64, P175; Thorne B.L., 1998, NATL PEST CONTROL AS, P1; Torres JA, 2005, BIOTROPICA, V37, P452, DOI 10.1111/j.1744-7429.2005.00059.x; TURNER DP, 1995, ECOL APPL, V5, P421, DOI 10.2307/1942033; Ulyshen MD, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00365.1; Ulyshen MD, 2013, INSECT CONSERV DIVER, V6, P393, DOI 10.1111/j.1752-4598.2012.00220.x; Ulyshen MD, 2013, METHODS ECOL EVOL, V4, P345, DOI 10.1111/2041-210x.12012; Ulyshen MD, 2009, FOREST ECOL MANAG, V257, P653, DOI 10.1016/j.foreco.2008.09.047; Unger IM, 2009, APPL SOIL ECOL, V42, P1, DOI 10.1016/j.apsoil.2009.01.007; Warren RJ, 2012, INSECT SOC, V59, P215, DOI 10.1007/s00040-011-0208-4; WHITFORD WG, 1981, ECOLOGY, V62, P275, DOI 10.2307/1936687; WHITFORD WG, 1982, OECOLOGIA, V55, P298, DOI 10.1007/BF00376915	49	26	26	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101867	10.1371/journal.pone.0101867	http://dx.doi.org/10.1371/journal.pone.0101867			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25009985	Green Submitted, Green Published, gold			2022-12-27	WOS:000338763800047
J	Kendra, PE; Montgomery, WS; Niogret, J; Pruett, GE; Mayfield, AE; MacKenzie, M; Deyrup, MA; Bauchan, GR; Ploetz, RC; Epsky, ND				Kendra, Paul E.; Montgomery, Wayne S.; Niogret, Jerome; Pruett, Grechen E.; Mayfield, Albert E., III; MacKenzie, Martin; Deyrup, Mark A.; Bauchan, Gary R.; Ploetz, Randy C.; Epsky, Nancy D.			North American Lauraceae: Terpenoid Emissions, Relative Attraction and Boring Preferences of Redbay Ambrosia Beetle, Xyleborus glabratus (Coleoptera: Curculionidae: Scolytinae)	PLOS ONE			English	Article							ANASTREPHA-SUSPENSA DIPTERA; LAUREL WILT; ELECTROANTENNOGRAM RESPONSES; RAFFAELEA-LAURICOLA; MANUKA OIL; PHOEBE OIL; SUSCEPTIBILITY; SYMBIONT; PATHOGEN; AVOCADO	The invasive redbay ambrosia beetle, Xyleborus glabratus, is the primary vector of Raffaelea lauricola, a symbiotic fungus and the etiologic agent of laurel wilt. This lethal disease has caused severe mortality of redbay (Persea borbonia) and swampbay (P. palustris) trees in the southeastern USA, threatens avocado (P. americana) production in Florida, and has potential to impact additional New World species. To date, all North American hosts of X. glabratus and suscepts of laurel wilt are members of the family Lauraceae. This comparative study combined field tests and laboratory bioassays to evaluate attraction and boring preferences of female X. glabratus using freshly-cut bolts from nine species of Lauraceae: avocado (one cultivar of each botanical race), redbay, swampbay, silkbay (Persea humilis), California bay laurel (Umbellularia californica), sassafras (Sassafras albidum), northern spicebush (Lindera benzoin), camphor tree (Cinnamomum camphora), and lancewood (Nectandra coriacea). In addition, volatile collections and gas chromatography-mass spectroscopy (GC-MS) were conducted to quantify terpenoid emissions from test bolts, and electroantennography (EAG) was performed to measure olfactory responses of X. glabratus to terpenoids identified by GC-MS. Significant differences were observed among treatments in both field and laboratory tests. Silkbay and camphor tree attracted the highest numbers of the beetle in the field, and lancewood and spicebush the lowest, whereas boring activity was greatest on silkbay, bay laurel, swampbay, and redbay, and lowest on lancewood, spicebush, and camphor tree. The Guatemalan cultivar of avocado was more attractive than those of the other races, but boring response among the three was equivalent. The results suggest that camphor tree may contain a chemical deterrent to boring, and that different cues are associated with host location and host acceptance. Emissions of alpha-cubebene, alpha-copaene, alpha-humulene, and calamenene were positively correlated with attraction, and EAG analyses confirmed chemoreception of terpenoids by antennal receptors of X. glabratus.	[Kendra, Paul E.; Montgomery, Wayne S.; Niogret, Jerome; Epsky, Nancy D.] USDA ARS, Subtrop Hort Res Stn, Miami, FL 33158 USA; [Pruett, Grechen E.; MacKenzie, Martin] Archbold Biol Stn, Lake Placid, FL USA; [Mayfield, Albert E., III] USDA, Forest Serv, So Res Stn, Asheville, NC USA; [MacKenzie, Martin] USDA, Forest Serv, Forest Hlth Protect, Stanislaus Natl Forest, Sonora, CA USA; [Bauchan, Gary R.] USDA ARS, Beltsville Agr Res Ctr, Elect & Confocal Microscopy Unit, Beltsville, MD 20705 USA; [Ploetz, Randy C.] Univ Florida, Trop Res & Educ Ctr, Homestead, FL USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); State University System of Florida; University of Florida	Kendra, PE (corresponding author), USDA ARS, Subtrop Hort Res Stn, 13601 Old Cutler Rd, Miami, FL 33158 USA.	paul.kendra@ars.usda.gov	Bauchan, Gary/ABH-3800-2020	Bauchan, Gary/0000-0003-3060-7666	USDA-ARS National Plant Disease Recovery System; Florida Avocado Administrative Committee	USDA-ARS National Plant Disease Recovery System; Florida Avocado Administrative Committee	Funding was provided by the USDA-ARS National Plant Disease Recovery System and the Florida Avocado Administrative Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson MN, 2012, CHEM SENSES, V37, P403, DOI 10.1093/chemse/bjs009; Beaver RA, 2010, ZOOTAXA, P1; Box G. E. P., 1978, STAT EXPT INTRO DESI; Brar GS, 2013, FLA ENTOMOL, V96, P1158, DOI 10.1653/024.096.0357; Brar GS, 2012, FLA ENTOMOL, V95, P1003, DOI 10.1653/024.095.0428; Carrillo D, 2014, PLANT PATHOL, V63, P54, DOI 10.1111/ppa.12073; Carrillo D, 2012, FLA ENTOMOL, V95, P573, DOI 10.1653/024.095.0306; Chen H, 2010, CAN ENTOMOL, V142, P378, DOI 10.4039/n10-018; eFloras, 2008, FLORA N AM, V3; Florida Department of Agriculture and Consumer Services Division of Plant Industry, 2010, FIR MOV RUL 5B 65; Fraedrich SW, 2008, PLANT DIS, V92, P1469, DOI 10.1094/PDIS-92-10-1469A; Fraedrich SW, 2008, PLANT DIS, V92, P215, DOI 10.1094/PDIS-92-2-0215; Fraedrich SW, 2011, PLANT DIS, V95, P1056, DOI 10.1094/PDIS-11-10-0841; Hanula JL, 2008, J ECON ENTOMOL, V101, P1276, DOI 10.1603/0022-0493(2008)101[1276:BAHAOR]2.0.CO;2; Hanula JL, 2013, ENVIRON ENTOMOL, V42, P333, DOI 10.1603/EN12337; Hanula JL, 2008, ENVIRON ENTOMOL, V37, P1403, DOI 10.1603/0046-225X-37.6.1403; Harrington TC, 2008, MYCOTAXON, V104, P399; Harrington TC, 2010, MYCOTAXON, V111, P337, DOI 10.5248/111.337; HEATH RR, 1992, J CHEM ECOL, V18, P1209, DOI 10.1007/BF00980075; Hosni K, 2008, IND CROP PROD, V27, P308, DOI 10.1016/j.indcrop.2007.11.004; Hulcr J, 2007, ECOL ENTOMOL, V32, P762, DOI 10.1111/j.1365-2311.2007.00939.x; Hulcr J, 2013, FLA ENTOMOL, V96, P1595, DOI 10.1653/024.096.0444; Hulcr J, 2011, J CHEM ECOL, V37, P1374, DOI 10.1007/s10886-011-0046-x; Ibrahim MA, 2010, FLAVOUR FRAG J, V25, P83, DOI 10.1002/ffj.1971; Inch SA, 2011, PHYTOPATHOLOGY, V101, pS78; KAJIMURA H, 1994, ENTOMOL EXP APPL, V71, P121, DOI 10.1007/BF02382380; Karlsson MF, 2009, J AGR FOOD CHEM, V57, P5903, DOI 10.1021/jf803730h; Kendra P. E., 2013, American Journal of Plant Sciences, V4, P727; Kendra PE, 2014, J PEST SCI, V87, P681, DOI 10.1007/s10340-014-0561-y; Kendra PE, 2013, FLA ENTOMOL, V96, P1442, DOI 10.1653/024.096.0424; Kendra PE, 2012, ENVIRON ENTOMOL, V41, P1597, DOI 10.1603/EN12164; Kendra PE, 2012, FLA ENTOMOL, V95, P513, DOI 10.1653/024.095.0244; Kendra PE, 2012, J ECON ENTOMOL, V105, P659, DOI 10.1603/EC11398; Kendra PE, 2011, J CHEM ECOL, V37, P932, DOI 10.1007/s10886-011-9998-0; Kendra PE, 2005, ENVIRON ENTOMOL, V34, P584, DOI 10.1603/0046-225X-34.3.584; Koch FH, 2008, ENVIRON ENTOMOL, V37, P442, DOI 10.1603/0046-225X(2008)37[442:SAOXGC]2.0.CO;2; Kuhns EH, 2014, J CHEM ECOL, V40, P355, DOI 10.1007/s10886-014-0427-z; Kuhns EH, 2014, AGR FOREST ENTOMOL, V16, P87, DOI 10.1111/afe.12037; Leege JM, 2009, LAUR WILT C SAV GA; Mayfield AE, 2008, FLA ENTOMOL, V91, P485, DOI 10.1653/0015-4040(2008)91[485:AOTRAB]2.0.CO;2; Mayfield AE, 2012, J ECON ENTOMOL, V105, P461, DOI 10.1603/EC11348; Mayfield AE, 2013, ENVIRON ENTOMOL, V42, P743, DOI 10.1603/EN12341; Mayfield AE, 2013, AGR FOREST ENTOMOL, V15, P227, DOI 10.1111/afe.12009; Miller DR, 2009, J CHEM ECOL, V35, P435, DOI 10.1007/s10886-009-9613-9; Mizuno T, 2002, J APPL ENTOMOL, V126, P455, DOI 10.1046/j.1439-0418.2002.00691.x; Niogret J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073601; Niogret J, 2011, FLA ENTOMOL, V94, P1010, DOI 10.1653/024.094.0439; Niogret J, 2011, J CHEM ECOL, V37, P483, DOI 10.1007/s10886-011-9953-0; Pelissier Y., 1995, Journal of Essential Oil Research, V7, P313; Pena JE, 2012, FLA ENTOMOL, V95, P783, DOI 10.1653/024.095.0334; Ploetz RC, 2013, PLANT DIS, V97, P1248, DOI 10.1094/PDIS-01-13-0027-PDN; Ploetz RC, 2012, PLANT PATHOL, V61, P801, DOI 10.1111/j.1365-3059.2011.02564.x; Ploetz RC, 2013, PLANT DIS, V97, P856, DOI 10.1094/PDIS-01-13-0056-FE; Porter NG, 1999, PHYTOCHEMISTRY, V50, P407, DOI 10.1016/S0031-9422(98)00548-2; Rabaglia RJ, 2006, ANN ENTOMOL SOC AM, V99, P1034, DOI 10.1603/0013-8746(2006)99[1034:ROAXCC]2.0.CO;2; Rizzo DM, 2005, ANNU REV PHYTOPATHOL, V43, P309, DOI 10.1146/annurev.phyto.42.040803.140418; SAS Institute, 2001, SAS STAT GUID PERS C; Singh G, 2007, INT J FOOD ENG, V3, DOI 10.2202/1556-3758.1154; Systat Software, 2010, SIGMAPLOT 11 2 US GU; United States Department of Agriculture Economic Research Service, 2013, FRUIT TREE NUT YB 20; United States Department of Agriculture Forest Service, 2014, LAUR WILT DISTR MAP; Vega FE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085860	64	51	51	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102086	10.1371/journal.pone.0102086	http://dx.doi.org/10.1371/journal.pone.0102086			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007073	Green Published, gold			2022-12-27	WOS:000339040600094
J	Lane, M; McPherson, NO; Fullston, T; Spillane, M; Sandeman, L; Kang, WX; Zander-Fox, DL				Lane, Michelle; McPherson, Nicole O.; Fullston, Tod; Spillane, Marni; Sandeman, Lauren; Kang, Wan Xian; Zander-Fox, Deirdre L.			Oxidative Stress in Mouse Sperm Impairs Embryo Development, Fetal Growth and Alters Adiposity and Glucose Regulation in Female Offspring	PLOS ONE			English	Article							OXYGEN SPECIES GENERATION; DIET-INDUCED OBESITY; BODY-MASS INDEX; TRANSCRIPTIONAL PROFILE; BLASTOCYST DEVELOPMENT; PHYSIOLOGICAL CONTROL; HUMAN SPERMATOZOA; PATERNAL OBESITY; FERTILIZATION; RESTRICTION	Paternal health cues are able to program the health of the next generation however the mechanism for this transmission is unknown. Reactive oxygen species (ROS) are increased in many paternal pathologies, some of which program offspring health, and are known to induce DNA damage and alter the methylation pattern of chromatin. We therefore investigated whether a chemically induced increase of ROS in sperm impairs embryo, pregnancy and offspring health. Mouse sperm was exposed to 1500 mu M of hydrogen peroxide (H2O2), which induced oxidative damage, however did not affect sperm motility or the ability to bind and fertilize an oocyte. Sperm treated with H2O2 delayed on-time development of subsequent embryos, decreased the ratio of inner cell mass cells (ICM) in the resulting blastocyst and reduced implantation rates. Crown-rump length at day 18 of gestation was also reduced in offspring produced by H2O2 treated sperm. Female offspring from H2O2 treated sperm were smaller, became glucose intolerant and accumulated increased levels of adipose tissue compared to control female offspring. Interestingly male offspring phenotype was less severe with increases in fat depots only seen at 4 weeks of age, which was restored to that of control offspring later in life, demonstrating sex-specific impacts on offspring. This study implicates elevated sperm ROS concentrations, which are common to many paternal health pathologies, as a mediator of programming offspring for metabolic syndrome and obesity.	[Lane, Michelle; McPherson, Nicole O.; Fullston, Tod; Spillane, Marni; Sandeman, Lauren; Kang, Wan Xian; Zander-Fox, Deirdre L.] Univ Adelaide, Sch Paediat & Reprod Hlth, Discipline Obstet & Gynaecol, Adelaide, SA 5005, Australia; [Lane, Michelle; McPherson, Nicole O.; Fullston, Tod; Spillane, Marni; Sandeman, Lauren; Kang, Wan Xian; Zander-Fox, Deirdre L.] Univ Adelaide, Robinson Inst, Adelaide, SA 5005, Australia; [Lane, Michelle; Zander-Fox, Deirdre L.] Repromed, Dulwich, SA, Australia	University of Adelaide; Robinson Research Institute; University of Adelaide	Lane, M (corresponding author), Univ Adelaide, Sch Paediat & Reprod Hlth, Discipline Obstet & Gynaecol, Adelaide, SA 5005, Australia.	michelle.lane@adelaide.edu.au		McPherson, Nicole/0000-0002-3492-9403	NHMRC; Australian Post Graduate Award; Prospective Lodge Freemasons Scholarship; Freemasons Lodge St Albans Research Scholarship	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Post Graduate Award(Australian Government); Prospective Lodge Freemasons Scholarship; Freemasons Lodge St Albans Research Scholarship	This research was funded by NHMRC project grant awarded to ML. ML was supported by NHMRC Senior Research Fellowship, NOM by an Australian Post Graduate Award and a Prospective Lodge Freemasons Scholarship, TF by NHMRC Peter Doherty Fellowship, and MS by 2012 Freemasons Lodge St Albans Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN J, 1994, BIOESSAYS, V16, P259, DOI 10.1002/bies.950160409; Aitken RJ, 2013, INT J DEV BIOL, V57, P265, DOI 10.1387/ijdb.130146ja; Aitken RJ, 2006, MOL CELL ENDOCRINOL, V250, P66, DOI 10.1016/j.mce.2005.12.026; Aitken RJ, 2002, INT J ANDROL, V25, P191, DOI 10.1046/j.1365-2605.2002.03521.x; Aitken RJ, 2011, ANTIOXID REDOX SIGN, V14, P367, DOI 10.1089/ars.2010.3186; ALVAREZ JG, 1995, MOL REPROD DEV, V42, P334, DOI 10.1002/mrd.1080420311; Aziz N, 2004, FERTIL STERIL, V81, P349, DOI 10.1016/j.fertnstert.2003.06.026; Bakos HW, 2011, INT J ANDROL, V34, P402, DOI 10.1111/j.1365-2605.2010.01092.x; Bakos HW, 2011, FERTIL STERIL, V95, P1700, DOI 10.1016/j.fertnstert.2010.11.044; BALHORN R, 1977, BIOCHEMISTRY-US, V16, P4074, DOI 10.1021/bi00637a021; Barker DJP, 2004, ACTA PAEDIATR, V93, P26, DOI 10.1080/08035320410022730; Binder NK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052304; Binder NK, 2012, REPROD FERT DEVELOP, V24, P804, DOI 10.1071/RD11256; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Chang Jeffrey S., 2009, V472, P103, DOI 10.1007/978-1-60327-492-0_5; Chen SJ, 2013, ARCH GYNECOL OBSTET, V288, P191, DOI 10.1007/s00404-013-2801-4; Danielzik S, 2002, EUR J NUTR, V41, P132, DOI 10.1007/s00394-002-0367-1; De Blasio MJ, 2012, ENDOCRINOLOGY, V153, P2142, DOI 10.1210/en.2011-1955; DELAMIRANDE E, 1995, HUM REPROD, V10, P15, DOI 10.1093/humrep/10.suppl_1.15; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Dunn GA, 2009, ENDOCRINOLOGY, V150, P4999, DOI 10.1210/en.2009-0500; El-Helaly M, 2011, INT J OCCUP MED ENV, V24, P218, DOI 10.2478/s13382-011-0019-x; Fullston T, 2012, HUM REPROD, V27, P1391, DOI 10.1093/humrep/des030; Fullston T, 2013, FASEB J, V27, P4226, DOI 10.1096/fj.12-224048; Fullston T, 2011, REPROD FERT DEVELOP, V23, P691, DOI 10.1071/RD10292; Gardner DK, 2000, MOL REPROD DEV, V57, P256, DOI 10.1002/1098-2795(200011)57:3&lt;256::AID-MRD7&gt;3.0.CO;2-P; Gatford KL, 2010, PLACENTA, V31, pS60, DOI 10.1016/j.placenta.2009.12.015; Gawecka JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056385; Hammoud SS, 2011, HUM REPROD, V26, P2558, DOI 10.1093/humrep/der192; Han MD, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.007; Hultman CM, 2011, MOL PSYCHIATR, V16, P1203, DOI 10.1038/mp.2010.121; Johnson RC, 2011, AM J PUBLIC HEALTH, V101, P2317, DOI 10.2105/AJPH.2011.300252; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Koppers AJ, 2010, FREE RADICAL BIO MED, V48, P112, DOI 10.1016/j.freeradbiomed.2009.10.033; Kusinski LC, 2012, AM J PHYSIOL-REG I, V303, pR86, DOI 10.1152/ajpregu.00600.2011; Kwong WY, 2000, DEVELOPMENT, V127, P4195; Lane M, 1997, J REPROD FERTIL, V109, P153, DOI 10.1530/jrf.0.1090153; Lea RG, 1996, DIABETES, V45, P1463, DOI 10.2337/diabetes.45.11.1463; Lee KM, 2009, LEUKEMIA RES, V33, P250, DOI 10.1016/j.leukres.2008.06.031; Lin CC, 2008, INT J OCCUP ENV HEAL, V14, P112, DOI 10.1179/oeh.2008.14.2.112; McPherson NO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071459; McPherson NO, 2014, FERTIL STERIL; Mitchell M, 2011, FERTIL STERIL, V95, P1349, DOI 10.1016/j.fertnstert.2010.09.038; Myatt L, 2006, J PHYSIOL-LONDON, V572, P25, DOI 10.1113/jphysiol.2006.104968; Naule L, 2014, J ENDOCRINOL, V220, P375, DOI 10.1530/JOE-13-0607; Ng SF, 2014, FASEB J; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Noblanc A, 2013, FREE RADICAL BIO MED, V65, P719, DOI 10.1016/j.freeradbiomed.2013.07.044; Rathod R, 2014, BRAIN DEV; Robbins WA, 2008, J ANDROL, V29, P115, DOI 10.2164/jandrol.107.003541; Sathishkumar K, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-110; Sellayah D, 2014, EUR J NUTR; Shaman JA, 2007, J CELL BIOCHEM, V102, P680, DOI 10.1002/jcb.21321; Silva PFN, 2007, THERIOGENOLOGY, V67, P609, DOI 10.1016/j.theriogenology.2006.09.032; Sung TI, 2009, BIRTH DEFECTS RES A, V85, P119, DOI 10.1002/bdra.20496; Tesarik J, 2004, HUM REPROD, V19, P611, DOI 10.1093/humrep/deh127; THOMPSON JG, 1995, BIOL REPROD, V53, P1385, DOI 10.1095/biolreprod53.6.1385; Tunc O, 2011, ANDROLOGIA, V43, P121, DOI 10.1111/j.1439-0272.2009.01032.x; Tunc O, 2009, J ASSIST REPROD GEN, V26, P537, DOI 10.1007/s10815-009-9346-2; Ward WS, 2010, MOL HUM REPROD, V16, P30, DOI 10.1093/molehr/gap080; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Xiao JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038742; Zorn B, 2003, INT J ANDROL, V26, P279, DOI 10.1046/j.1365-2605.2003.00424.x	64	85	88	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e100832	10.1371/journal.pone.0100832	http://dx.doi.org/10.1371/journal.pone.0100832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006800	Green Published, Green Submitted, gold			2022-12-27	WOS:000339040600020
J	Levitan, CA; Ren, JN; Woods, AT; Boesveldt, S; Chan, JS; McKenzie, KJ; Dodson, M; Levin, JA; Leong, CXR; van den Bosch, JJF				Levitan, Carmel A.; Ren, Jiana; Woods, Andy T.; Boesveldt, Sanne; Chan, Jason S.; McKenzie, Kirsten J.; Dodson, Michael; Levin, Jai A.; Leong, Christine X. R.; van den Bosch, Jasper J. F.			Cross-Cultural Color-Odor Associations	PLOS ONE			English	Article							MODAL ASSOCIATIONS; PERCEPTION; OLFACTION; RESPONSES; LANGUAGE; SCENTS; SMELL	Colors and odors are associated; for instance, people typically match the smell of strawberries to the color pink or red. These associations are forms of crossmodal correspondences. Recently, there has been discussion about the extent to which these correspondences arise for structural reasons (i.e., an inherent mapping between color and odor), statistical reasons (i.e., covariance in experience), and/or semantically-mediated reasons (i.e., stemming from language). The present study probed this question by testing color-odor correspondences in 6 different cultural groups (Dutch, Netherlands-residing-Chinese, German, Malay, Malaysian-Chinese, and US residents), using the same set of 14 odors and asking participants to make congruent and incongruent color choices for each odor. We found consistent patterns in color choices for each odor within each culture, showing that participants were making non-random color-odor matches. We used representational dissimilarity analysis to probe for variations in the patterns of color-odor associations across cultures; we found that US and German participants had the most similar patterns of associations, followed by German and Malay participants. The largest group differences were between Malay and Netherlands-resident Chinese participants and between Dutch and Malaysian-Chinese participants. We conclude that culture plays a role in color-odor crossmodal associations, which likely arise, at least in part, through experience.	[Levitan, Carmel A.; Dodson, Michael; Levin, Jai A.] Occidental Coll, Dept Cognit Sci, Los Angeles, CA 90041 USA; [Ren, Jiana; Boesveldt, Sanne] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands; [Woods, Andy T.] Xperiment, Lausanne, Switzerland; [Chan, Jason S.; van den Bosch, Jasper J. F.] Goethe Univ Frankfurt, Inst Med Psychol, D-60054 Frankfurt, Germany; [McKenzie, Kirsten J.; Leong, Christine X. R.] Univ Nottingham, Sch Psychol, Semenyih, Selangor Darul, Malaysia; [van den Bosch, Jasper J. F.] Univ Washington, Inst Learning & Brain Sci, Seattle, WA 98195 USA	Occidental College; Wageningen University & Research; Goethe University Frankfurt; University of Nottingham Malaysia; University of Washington; University of Washington Seattle	Levitan, CA (corresponding author), Occidental Coll, Dept Cognit Sci, Los Angeles, CA 90041 USA.	levitan@oxy.edu	van den Bosch, Jasper J.F./H-8824-2019; Chan, Jason/F-4656-2010	van den Bosch, Jasper J.F./0000-0001-9326-2090; Levitan, Carmel/0000-0001-5403-444X; Chan, Jason/0000-0002-4663-5779; Woods, Andy/0000-0003-3797-3845; McKenzie, Kirsten/0000-0002-9525-0218; Leong, Christine, Xiang Ru/0000-0003-1110-545X	Occidental College Richter-ASP Grant; Wageningen University; Ready Mind Project (I-LABS); Hessian initiative for the development of scientific and economic excellence (LOEWE Neuronal Coordination Research Focus Frankfurt)	Occidental College Richter-ASP Grant; Wageningen University(European Commission); Ready Mind Project (I-LABS); Hessian initiative for the development of scientific and economic excellence (LOEWE Neuronal Coordination Research Focus Frankfurt)	Financial support was provided by an Occidental College Richter-ASP Grant, by Wageningen University, by the Ready Mind Project (I-LABS), and by the Hessian initiative for the development of scientific and economic excellence (LOEWE Neuronal Coordination Research Focus Frankfurt). Special thanks to Unilever for providing the olfactory stimuli. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayabe-Kanamura S, 1998, ANN NY ACAD SCI, V855, P694, DOI 10.1111/j.1749-6632.1998.tb10647.x; Chrea C, 2004, FOOD QUAL PREFER, V15, P669, DOI 10.1016/j.foodqual.2003.10.005; Dematte ML, 2006, CHEM SENSES, V31, P531, DOI 10.1093/chemse/bjj057; Deroy O, 2013, PSYCHON B REV, V20, P643, DOI 10.3758/s13423-013-0387-2; Djordjevic J, 2008, J NEUROPHYSIOL, V99, P386, DOI 10.1152/jn.00896.2007; Ferdenzi C, 2013, CHEM SENSES, V38, P175, DOI 10.1093/chemse/bjs083; Gilbert AN, 1996, AM J PSYCHOL, V109, P335, DOI 10.2307/1423010; Herz RS, 2005, CHEM SENSES, V30, pI250, DOI 10.1093/chemse/bjh209; Herz RS, 2004, MOTIV EMOTION, V28, P363, DOI 10.1007/s11031-004-2389-x; Herz RS, 2001, PERCEPTION, V30, P381, DOI 10.1068/p3179; Kriegeskorte N, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.004.2008; Kriegeskorte N, 2008, NEURON, V60, P1126, DOI 10.1016/j.neuron.2008.10.043; LAWLESS H, 1977, J EXP PSYCHOL-HUM L, V3, P52, DOI 10.1037/0278-7393.3.1.52; Majid A, 2014, COGNITION, V130, P266, DOI 10.1016/j.cognition.2013.11.004; Maric Y, 2013, FOOD QUAL PREFER, V27, P191, DOI 10.1016/j.foodqual.2012.05.001; Morrot G, 2001, BRAIN LANG, V79, P309, DOI 10.1006/brln.2001.2493; Mur M, 2009, SOC COGN AFFECT NEUR, V4, P101, DOI 10.1093/scan/nsn044; Osterbauer RA, 2005, J NEUROPHYSIOL, V93, P3434, DOI 10.1152/jn.00555.2004; Palmer SE, 2013, P NATL ACAD SCI USA, V110, P8836, DOI 10.1073/pnas.1212562110; Palmer SE, 2010, P NATL ACAD SCI USA, V107, P8877, DOI 10.1073/pnas.0906172107; Pangborn R. M., 1988, Food Quality and Preference, V1, P11, DOI 10.1016/0950-3293(88)90003-1; Regier T, 2009, TRENDS COGN SCI, V13, P439, DOI 10.1016/j.tics.2009.07.001; Schifferstein HNJ, 2004, PERCEPTION, V33, P1249, DOI 10.1068/p5132; Shankar MU, 2010, CONSCIOUS COGN, V19, P380, DOI 10.1016/j.concog.2009.08.008; Spector F, 2012, SEEING PERCEIVING, V25, P655, DOI 10.1163/187847612X648800; Spence C, 2013, CONSCIOUS COGN, V22, P245, DOI 10.1016/j.concog.2012.12.006; Spence C, 2011, ATTEN PERCEPT PSYCHO, V73, P971, DOI 10.3758/s13414-010-0073-7; Stevenson RJ, 2012, PERCEPTION, V41, P606, DOI 10.1068/p7223; Stevenson RJ, 1998, LEARN MOTIV, V29, P113, DOI 10.1006/lmot.1998.0996; Stevenson RJ, 2001, LEARN MOTIV, V32, P154, DOI 10.1006/lmot.2000.1070; Wan X., FLAVOUR, V3, DOI [10.1186/2044-7248-3-3, DOI 10.1186/2044-7248-3-3]; Winawer J, 2007, P NATL ACAD SCI USA, V104, P7780, DOI 10.1073/pnas.0701644104; Yeshurun Y, 2010, ANNU REV PSYCHOL, V61, P219, DOI 10.1146/annurev.psych.60.110707.163639; ZELLNER DA, 1991, AM J PSYCHOL, V104, P547, DOI 10.2307/1422940; Zellner D, 2013, CHEMOSENS PERCEPT, V6, P155, DOI 10.1007/s12078-013-9154-z	35	39	39	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101651	10.1371/journal.pone.0101651	http://dx.doi.org/10.1371/journal.pone.0101651			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL3PK	25007343	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000339040600052
J	Drusano, GL; Neely, M; Van Guilder, M; Schumitzky, A; Brown, D; Fikes, S; Peloquin, C; Louie, A				Drusano, George L.; Neely, Michael; Van Guilder, Michael; Schumitzky, Alan; Brown, David; Fikes, Steven; Peloquin, Charles; Louie, Arnold			Analysis of Combination Drug Therapy to Develop Regimens with Shortened Duration of Treatment for Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; BACTERICIDAL ACTIVITY; RESISTANCE; PHARMACOKINETICS; SIMULATION; EMERGENCE; MODEL; PHARMACODYNAMICS; MOXIFLOXACIN; RIFAMPIN	Rationale: Tuberculosis remains a worldwide problem, particularly with the advent of multi-drug resistance. Shortening therapy duration for Mycobacterium tuberculosis is a major goal, requiring generation of optimal kill rate and resistance-suppression. Combination therapy is required to attain the goal of shorter therapy. Objectives: Our objective was to identify a method for identifying optimal combination chemotherapy. We developed a mathematical model for attaining this end. This is accomplished by identifying drug effect interaction (synergy, additivity, antagonism) for susceptible organisms and subpopulations resistant to each drug in the combination. Methods: We studied the combination of linezolid plus rifampin in our hollow fiber infection model. We generated a fully parametric drug effect interaction mathematical model. The results were subjected to Monte Carlo simulation to extend the findings to a population of patients by accounting for between-patient variability in drug pharmacokinetics. Results: All monotherapy allowed emergence of resistance over the first two weeks of the experiment. In combination, the interaction was additive for each population (susceptible and resistant). For a 600 mg/600 mg daily regimen of linezolid plus rifampin, we demonstrated that >50% of simulated subjects had eradicated the susceptible population by day 27 with the remaining organisms resistant to one or the other drug. Only 4% of patients had complete organism eradication by experiment end. Discussion: These data strongly suggest that in order to achieve the goal of shortening therapy, the original regimen may need to be changed at one month to a regimen of two completely new agents with resistance mechanisms independent of the initial regimen. This hypothesis which arose from the analysis is immediately testable in a clinical trial.	[Drusano, George L.; Brown, David; Fikes, Steven; Louie, Arnold] Univ Florida, Inst Therapeut Innovat, Coll Med, Lake Nona, FL 32827 USA; [Neely, Michael; Van Guilder, Michael; Schumitzky, Alan] Univ So Calif, Sch Med, Lab Appl Pharmacokinet, Los Angeles, CA USA; [Peloquin, Charles] Univ Florida, Coll Pharm, Infect Dis PK Lab, Gainesville, FL USA	State University System of Florida; University of Florida; University of Southern California; State University System of Florida; University of Florida	Drusano, GL (corresponding author), Univ Florida, Inst Therapeut Innovat, Coll Med, Lake Nona, FL 32827 USA.	gdrusano@ufl.edu			National Institute of Allergy and Infectious Diseases [R01 AI079578]; Bill and Melinda Gates Foundation TB Accelerator Program; Pfizer, Inc; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068968] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation TB Accelerator Program; Pfizer, Inc(Pfizer); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institute of Allergy and Infectious Diseases (R01 AI079578); Bill and Melinda Gates Foundation TB Accelerator Program; Pfizer, Inc for the Hollow Fiber System evaluation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2013, ANTIMICROB AGENTS CH, V57, P2522, DOI 10.1128/AAC.02020-12; Almeida D, 2009, ANTIMICROB AGENTS CH, V53, P4178, DOI 10.1128/AAC.00830-09; Balasubramanian V, 2012, ANTIMICROB AGENTS CH, V56, P3054, DOI 10.1128/AAC.06383-11; BLASER J, 1985, J ANTIMICROB CHEMOTH, V15, P125, DOI 10.1093/jac/15.suppl_A.125; Boeree M, 2013, 20 C RETR OPP INF MA; Boselli E, 2005, CRIT CARE MED, V33, P1529, DOI 10.1097/01.CCM.0000168206.59873.80; D'Argenio D, 2009, ADAPT 5 USERS GUIDE; Drusano GL, 2011, MBIO, V2, DOI 10.1128/mBio.00108-11; Drusano GL, 2010, MBIO, V1, DOI 10.1128/mBio.00139-10; Drusano GL, 2009, ANTIMICROB AGENTS CH, V53, P2266, DOI 10.1128/AAC.01680-08; Goutelle S, 2009, ANTIMICROB AGENTS CH, V53, P2974, DOI 10.1128/AAC.01520-08; GRECO WR, 1995, PHARMACOL REV, V47, P331; Grosset JH, 2013, AM J RESP CRIT CARE, V188, P608, DOI 10.1164/rccm.201304-0753OC; Gumbo T, 2005, ANTIMICROB AGENTS CH, V49, P3178, DOI 10.1128/AAC.49.8.3178-3181.2005; Gumbo T, 2004, J INFECT DIS, V190, P1642, DOI 10.1086/424849; Gumbo T, 2007, ANTIMICROB AGENTS CH, V51, P3781, DOI 10.1128/AAC.01533-06; Gumbo T, 2007, ANTIMICROB AGENTS CH, V51, P2329, DOI 10.1128/AAC.00185-07; Gumbo T, 2007, J INFECT DIS, V195, P194, DOI 10.1086/510247; Honeybourne D, 2003, J ANTIMICROB CHEMOTH, V51, P1431, DOI 10.1093/jac/dkg262; Jumbe N, 2003, J CLIN INVEST, V112, P275, DOI 10.1172/JCI200316814; Leary RH, 2001, COMPUTER, V1, P389; Lee M, 2012, NEW ENGL J MED, V367, P1508, DOI 10.1056/NEJMoa1201964; Lienhardt C, 2012, J INFECT DIS, V205, pS241, DOI 10.1093/infdis/jis034; McGee B, 2009, ANTIMICROB AGENTS CH, V53, P3981, DOI 10.1128/AAC.01378-08; Neely MN, 2012, THER DRUG MONIT, V34, P467, DOI 10.1097/FTD.0b013e31825c4ba6; Peloquin C, 2003, INT J TUBERC LUNG D, V7, P3; SELKON JB, 1964, B WORLD HEALTH ORGAN, V31, P273; van Klingeren B, 2007, J CLIN MICROBIOL, V45, P2662, DOI 10.1128/JCM.00244-07; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2009, TREATM TUB GUID; Zhang M, 2012, ANTIMICROB AGENTS CH, V56, P5782, DOI 10.1128/AAC.01125-12	31	47	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101311	10.1371/journal.pone.0101311	http://dx.doi.org/10.1371/journal.pone.0101311			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003557	Green Published, Green Submitted, gold			2022-12-27	WOS:000339242700024
J	Malaquias, JB; Ramalho, FS; Lira, ACS; Oliveira, FQ; Fernandes, FS; Godoy, WAC; Zanuncio, JC				Malaquias, Jose B.; Ramalho, Francisco S.; Lira, Aline C. S.; Oliveira, Flavia Q.; Fernandes, Francisco S.; Godoy, Wesley A. C.; Zanuncio, Jose C.			The Biology and Thermal Requirements of the Fennel Aphid Hyadaphis foeniculi (Passerini) (Hemiptera: Aphididae)	PLOS ONE			English	Article							TEMPERATURE REQUIREMENTS; PLANT-DISTRIBUTION; COTTON CULTIVARS; COLORED FIBERS; VULGARE; REPRODUCTION; LEPIDOPTERA; TORTRICIDAE; SURVIVAL; EXTRACT	The relationship between the insect development rate and temperature was established very early and represents an important ecological variable for modeling the population dynamics of insects. The accurate determination of thermal constant values and the lower and upper developmental thresholds of Hyadaphis foeniculi (Passerini) (Hemiptera: Aphididae) on fennel (Foeniculum vulgare Miller (Apiales: Apiaceae)) crops would obviously benefit the effective application of control measures. This paper is a study of the biology and thermal requirements of H. foeniculi. Winged insects were collected from fennel crops at the Embrapa Algodao in Campina Grande, Paraiba. Nymphs (age <= 24 h) produced by winged insects were subjected to constant temperatures of 15, 20, 25, 28, 30 or 33 degrees C, a photophase of 12 h and a relative humidity of 70 +/- 10%. The results of the study showed that at temperatures between 15 and 30 degrees C, H. foeniculi nymphs were able to develop normally. The four instars were found at all temperatures tested. However, temperatures of 3 and 33 degrees C were lethal to the nymphs. The nymph stage development time varied from 5 (30 degrees C) to 19 (15 degrees C) days. The influence of temperature on the development time is dependent on the instar. The base temperature (Tb) and the thermal constant (K) for the nymph stage were estimated at 11.2 degrees C and 107.5 degree-days, respectively. The shortest nymph development stage was observed at 30 degrees C, and the highest nymph viability (85.0%) was observed at 28 degrees C. This information can be used for developing phenological models based on the temperature and development rate relationships so that outbreaks of H. foeniculi in the fennel crop can be predicted, therefore improving the application of control programs targeting this fennel pest.	[Malaquias, Jose B.; Ramalho, Francisco S.; Lira, Aline C. S.; Fernandes, Francisco S.] Embrapa Algodao, Unidade Controle Biol, Campina Grande, PB, Brazil; [Oliveira, Flavia Q.] Univ Estadual Paulista UNESP, Jaboticabal, SP, Brazil; [Godoy, Wesley A. C.] Escola Super Agr Luiz de Queiroz USP, Piracicaba, SP, Brazil; [Zanuncio, Jose C.] Univ Fed Vicosa, Vicosa, MG, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Estadual Paulista; Universidade Federal de Vicosa	Ramalho, FS (corresponding author), Embrapa Algodao, Unidade Controle Biol, Av Osvaldo Cruz, Campina Grande, PB, Brazil.	ramalhohvv@globo.com	Godoy, Wesley AC/B-9787-2012; Malaquias, José Bruno B/I-1945-2015; FS, Ramalho/AAC-8058-2019; Lira, Aline/C-2354-2017; Fernandes, Francisco/E-4608-2016	Malaquias, José Bruno B/0000-0003-3937-9575; Lira, Aline/0000-0002-8592-2068; Fernandes, Francisco/0000-0002-0592-2536	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq; Financiadora de Estudos e Projetos - FINEP	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos - FINEP(Financiadora de Inovacao e Pesquisa (Finep))	This research was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq and Financiadora de Estudos e Projetos - FINEP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson Charles Ira, 2007, Cienc. Rural, V37, P1524, DOI 10.1590/S0103-84782007000600003; Abramson CI, 2006, AM J ENV SCI, V3, P9; Barbosa Leonardo Rodrigues, 2006, Acta Scientiarum Agronomy, V28, P221; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Briere JF, 1998, ENVIRON ENTOMOL, V27, P94, DOI 10.1093/ee/27.1.94; CAMPBELL A, 1974, J APPL ECOL, V11, P431, DOI 10.2307/2402197; Cividanes Francisco J., 2003, Neotrop. entomol., V32, P413, DOI 10.1590/S1519-566X2003000300005; Cividanes Francisco J., 2003, Bragantia, V62, P61, DOI 10.1590/S0006-87052003000100008; Cocu N, 2005, AGR FOREST ENTOMOL, V7, P31, DOI 10.1111/j.1461-9555.2005.00245.x; Dixon A.F.G., 1987, World Crop Pests, V2A, P269; Dixon AFG, 1997, APHID ECOLOGY OPTIMI; Dunbar HE, 2007, PLOS BIOL, V5, P1006, DOI 10.1371/journal.pbio.0050096; EL-AWADI M. E., 2011, NAT SCI, V9, P97; Fernandes FS, 2013, FLA ENTOMOL, V96, P92, DOI 10.1653/024.096.0112; Fernandes FS, 2012, AN ACAD BRAS CIENC, V84, P707, DOI 10.1590/S0001-37652012005000040; Ferreira RG, 2004, PESQUI AGROPECU BRAS, V39, P1265, DOI 10.1590/S0100-204X2004001200015; Funichello M., 2012, Arq. Inst. Biol., V79, P84; HADDAD L. L., 1999, METODOS ESTIMAR LIMI; HAGSTRUM DW, 1970, ANN ENTOMOL SOC AM, V63, P1385, DOI 10.1093/aesa/63.5.1385; He WP, 2011, J MED PLANTS RES, V5, P3595; Hendawy S., 2010, OZEAN J APPL SCI, V3, P113; HIGLEY LG, 1986, ENVIRON ENTOMOL, V15, P999, DOI 10.1093/ee/15.5.999; HUTCHISON WD, 1984, ENVIRON ENTOMOL, V13, P1173, DOI 10.1093/ee/13.5.1173; Jarosik V, 2002, AM NAT, V160, P497, DOI 10.1086/342077; JONES D, 1979, ENVIRON ENTOMOL, V8, P1118, DOI 10.1093/ee/8.6.1118; LACTIN DJ, 1995, ENVIRON ENTOMOL, V24, P68, DOI 10.1093/ee/24.1.68; Lazzari SMN, 2005, REV BRAS ZOOL, V22, P891, DOI 10.1590/S0101-81752005000400013; Leite MV, 2008, CIENC AGROTEC, V32, P1394, DOI 10.1590/S1413-70542008000500006; LOGAN JA, 1976, ENVIRON ENTOMOL, V5, P1133, DOI 10.1093/ee/5.6.1133; LYSYK TJ, 1988, J ECON ENTOMOL, V81, P1045, DOI 10.1093/jee/81.4.1045; Malaquias JB, 2010, TURK J AGRIC FOR, V34, P235, DOI 10.3906/tar-0811-18; Nimbalkar RK, 2010, J ECOBIOTECH, V2, P29; Ozder N, 2008, J CENT EUR AGRIC, V9, P155; Ramalho FS, 2012, J ECON ENTOMOL, V105, P113, DOI 10.1603/EC11219; Ramalho FS, 2012, ANN ENTOMOL SOC AM, V105, P20, DOI 10.1603/AN11122; Regniere J, 2012, J INSECT PHYSIOL, V58, P634, DOI 10.1016/j.jinsphys.2012.01.010; SAS Institute, 2006, SAS STAT US GUID; Singh G, 2006, FOOD CONTROL, V17, P745, DOI 10.1016/j.foodcont.2005.03.010; STINNER RE, 1974, CAN ENTOMOL, V106, P519, DOI 10.4039/Ent106519-5; Tanira MOM, 1996, PHYTOTHER RES, V10, P33, DOI 10.1002/(SICI)1099-1573(199602)10:1&lt;33::AID-PTR769&gt;3.0.CO;2-L; Terblanche JS, 2007, P ROY SOC B-BIOL SCI, V274, P2935, DOI 10.1098/rspb.2007.0985; WAGNER TL, 1984, ANN ENTOMOL SOC AM, V77, P208, DOI 10.1093/aesa/77.2.208; WOODSON WD, 1988, ANN ENTOMOL SOC AM, V81, P252, DOI 10.1093/aesa/81.2.252	43	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e100983	10.1371/journal.pone.0100983	http://dx.doi.org/10.1371/journal.pone.0100983			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003593	Green Submitted, Green Published, gold			2022-12-27	WOS:000339242700015
J	Xiao, WF; Ge, XG; Zeng, LX; Huang, ZL; Lei, JP; Zhou, BZ; Li, MH				Xiao, Wenfa; Ge, Xiaogai; Zeng, Lixiong; Huang, Zhilin; Lei, Jingpin; Zhou, Benzhi; Li, Maihe			Rates of Litter Decomposition and Soil Respiration in Relation to Soil Temperature and Water in Different-Aged Pinus massoniana Forests in the Three Gorges Reservoir Area, China	PLOS ONE			English	Article							CO2 EFFLUX; HETEROTROPHIC RESPIRATION; OAK FOREST; CARBON; MOISTURE; PLANTATION; DIVERSITY; CHEMISTRY; RESPONSES; DYNAMICS	To better understand the soil carbon dynamics and cycling in terrestrial ecosystems in response to environmental changes, we studied soil respiration, litter decomposition, and their relations to soil temperature and soil water content for 18-months (Aug. 2010-Jan. 2012) in three different-aged Pinus massoniana forests in the Three Gorges Reservoir Area, China. Across the experimental period, the mean total soil respiration and litter respiration were 1.94 and 0.81, 2.00 and 0.60, 2.19 and 0.71 mu mol CO2 m(-2) s(-1), and the litter dry mass remaining was 57.6%, 56.2% and 61.3% in the 20-, 30-, and 46-year-old forests, respectively. We found that the temporal variations of soil respiration and litter decomposition rates can be well explained by soil temperature at 5 cm depth. Both the total soil respiration and litter respiration were significantly positively correlated with the litter decomposition rates. The mean contribution of the litter respiration to the total soil respiration was 31.0%-45.9% for the three different-aged forests. The present study found that the total soil respiration was not significantly affected by forest age when P. masonniana stands exceed a certain age (e.g. >20 years old), but it increased significantly with increased soil temperature. Hence, forest management strategies need to protect the understory vegetation to limit soil warming, in order to reduce the CO2 emission under the currently rapid global warming. The contribution of litter decomposition to the total soil respiration varies across spatial and temporal scales. This indicates the need for separate consideration of soil and litter respiration when assessing the climate impacts on forest carbon cycling.	[Xiao, Wenfa; Ge, Xiaogai; Zeng, Lixiong; Huang, Zhilin] Chinese Acad Forestry, State Forestry Adm, Key Lab Forest Ecol & Environm, Res Inst Forest Ecol Environm & Protect, Beijing, Peoples R China; [Ge, Xiaogai; Zhou, Benzhi] Chinese Acad Forestry, Res Inst Subtrop Forestry, Fuyang, Zhejiang, Peoples R China; [Lei, Jingpin] Chinese Acad Forestry, Res Inst Forestry, Key Lab Forest Silviculture, State Forestry Adm, Beijing, Peoples R China; [Li, Maihe] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland; [Li, Maihe] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China	Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF; Chinese Academy of Forestry; Research Institute of Subtropical Forestry, CAF; Chinese Academy of Forestry; Research Institute of Forestry, CAF; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS	Xiao, WF (corresponding author), Chinese Acad Forestry, State Forestry Adm, Key Lab Forest Ecol & Environm, Res Inst Forest Ecol Environm & Protect, Beijing, Peoples R China.	xiaowenf@caf.ac.cn; gexiaogai2006@163.com	Li, Mai-He/L-6390-2013	Li, Mai-He/0000-0002-7029-2841	Special Research Programme In Forestry Industry, State Forestry Administration of China [201104008]; National 'Twelfth Five-Year'' Plan for Science & Technology Project of China [2011BAD38B04]; Zigui National Forest Ecological Research Station; CFERN&GENE Award Funds on Ecological Paper	Special Research Programme In Forestry Industry, State Forestry Administration of China; National 'Twelfth Five-Year'' Plan for Science & Technology Project of China; Zigui National Forest Ecological Research Station; CFERN&GENE Award Funds on Ecological Paper	This work was supported by the Special Research Programme In Forestry Industry, State Forestry Administration of China (Project No. 201104008), National 'Twelfth Five-Year'' Plan for Science & Technology Project of China (2011BAD38B04), Zigui National Forest Ecological Research Station and CFERN&GENE Award Funds on Ecological Paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2006, J ECOL, V94, P713, DOI 10.1111/j.1365-2745.2006.01142.x; Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Aerts R, 1997, OIKOS, V80, P353, DOI 10.2307/3546603; Badot PM, 1998, ANN FOREST SCI, V56, P221; Barlow J, 2007, FOREST ECOL MANAG, V247, P91, DOI 10.1016/j.foreco.2007.04.017; Berbeco MR, 2012, PLANT SOIL, V344, P10; Berger TW, 2010, SOIL BIOL BIOCHEM, V42, P986, DOI 10.1016/j.soilbio.2010.02.020; Berryman EM, 2014, CAN J FOREST RES, V44, P432, DOI 10.1139/cjfr-2013-0334; Bini D, 2013, EUR J SOIL BIOL, V55, P117, DOI 10.1016/j.ejsobi.2012.12.010; Bolstad PV, 2004, TREE PHYSIOL, V24, P493, DOI 10.1093/treephys/24.5.493; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Borken W, 2003, SOIL SCI SOC AM J, V67, P1888, DOI 10.2136/sssaj2003.1888; BOWDEN RD, 1993, CAN J FOREST RES, V23, P1402, DOI 10.1139/x93-177; Buchmann N, 2000, SOIL BIOL BIOCHEM, V32, P1625, DOI 10.1016/S0038-0717(00)00077-8; Butenschoen O, 2011, SOIL BIOL BIOCHEM, V43, P1902, DOI 10.1016/j.soilbio.2011.05.011; Cisneros-Dozal LM, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000197; Cortez J, 1998, SOIL BIOL BIOCHEM, V30, P783, DOI 10.1016/S0038-0717(97)00163-6; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; DESANTO AV, 1993, SOIL BIOL BIOCHEM, V25, P1423, DOI 10.1016/0038-0717(93)90057-I; EWEL KC, 1987, CAN J FOREST RES, V17, P325, DOI 10.1139/x87-054; Fang C, 2001, SOIL BIOL BIOCHEM, V33, P155, DOI 10.1016/S0038-0717(00)00125-5; Fanin N, 2011, SOIL BIOL BIOCHEM, V43, P1014, DOI 10.1016/j.soilbio.2011.01.018; Fierer N, 2005, ECOLOGY, V86, P320, DOI 10.1890/04-1254; Fioretto A, 1998, SOIL BIOL BIOCHEM, V30, P721, DOI 10.1016/S0038-0717(97)00182-X; Gong Z.T., 2003, CHINESE SOIL TAXONOM; HANSON PJ, 1993, TREE PHYSIOL, V13, P1, DOI 10.1093/treephys/13.1.1; Hattenschwiler S, 2005, P NATL ACAD SCI USA, V102, P1519, DOI 10.1073/pnas.0404977102; Kammer A, 2012, BIOGEOCHEMISTRY, V108, P395, DOI 10.1007/s10533-011-9607-x; Kirschbaum MUF, 2004, GLOBAL CHANGE BIOL, V10, P1870, DOI 10.1111/j.1365-2486.2004.00852.x; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Lee H, 2014, SOIL BIOL BIOCHEM, V72, P123, DOI 10.1016/j.soilbio.2014.01.027; Lellei-Kovacs E, 2011, EUR J SOIL BIOL, V47, P247, DOI 10.1016/j.ejsobi.2011.05.004; Li FL, 2013, APPL SOIL ECOL, V64, P1, DOI 10.1016/j.apsoil.2012.10.006; Liu LL, 2009, GLOBAL CHANGE BIOL, V15, P441, DOI 10.1111/j.1365-2486.2008.01747.x; Luan JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064167; Luan JW, 2011, SOIL BIOL BIOCHEM, V43, P503, DOI 10.1016/j.soilbio.2010.11.010; Meier CL, 2008, P NATL ACAD SCI USA, V105, P19780, DOI 10.1073/pnas.0805600105; Moyano FE, 2012, BIOGEOSCIENCES, V9, P1173, DOI 10.5194/bg-9-1173-2012; Moyano FE, 2013, SOIL BIOL BIOCHEM, V59, P72, DOI 10.1016/j.soilbio.2013.01.002; Nguyen Tu TT, 2011, SOIL BIOL BIOCHEM, V43, P2222, DOI 10.1016/j.soilbio.2011.07.009; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Pandey RR, 2007, FOREST ECOL MANAG, V240, P96, DOI 10.1016/j.foreco.2006.12.013; Peng SS, 2009, SOIL BIOL BIOCHEM, V41, P1008, DOI 10.1016/j.soilbio.2008.10.023; Prevost-Boure NC, 2010, APPL SOIL ECOL, V46, P26, DOI 10.1016/j.apsoil.2010.06.004; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Raich JW, 2002, GLOBAL CHANGE BIOL, V8, P800, DOI 10.1046/j.1365-2486.2002.00511.x; Raich JW, 1998, FOREST ECOL MANAG, V107, P309, DOI 10.1016/S0378-1127(97)00347-2; Rey A, 2002, GLOBAL CHANGE BIOL, V8, P851, DOI 10.1046/j.1365-2486.2002.00521.x; Reynolds BC, 2001, SOIL BIOL BIOCHEM, V33, P1641, DOI 10.1016/S0038-0717(01)00085-2; Rubino M, 2010, SOIL BIOL BIOCHEM, V42, P1009, DOI 10.1016/j.soilbio.2010.02.018; Saiz G, 2006, GLOBAL CHANGE BIOL, V12, P1007, DOI 10.1111/j.1365-2486.2006.01145.x; Sayer EJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001299; Schaefer DA, 2009, SOIL BIOL BIOCHEM, V41, P1000, DOI 10.1016/j.soilbio.2008.11.015; Shi WY, 2012, SOIL BIOL BIOCHEM, V52, P99, DOI 10.1016/j.soilbio.2012.04.020; Smolander A, 2008, FOREST ECOL MANAG, V256, P1080, DOI 10.1016/j.foreco.2008.06.008; Subke JA, 2004, OECOLOGIA, V139, P551, DOI 10.1007/s00442-004-1540-4; Tang JW, 2009, GLOBAL CHANGE BIOL, V15, P145, DOI 10.1111/j.1365-2486.2008.01741.x; Tang JW, 2005, BIOGEOCHEMISTRY, V73, P183, DOI 10.1007/s10533-004-5889-6; Vasconcelos HL, 2005, OECOLOGIA, V144, P456, DOI 10.1007/s00442-005-0117-1; Wang CK, 2006, GLOBAL CHANGE BIOL, V12, P2103, DOI 10.1111/j.1365-2486.2006.01234.x; Wiseman PE, 2004, FOREST ECOL MANAG, V192, P297, DOI 10.1016/j.foreco.2004.01.017; Xiao W.F., 2000, TERRESTRIAL ANIMAL P, P320; Xuluc-Tolosa FJ, 2003, FOREST ECOL MANAG, V174, P401, DOI 10.1016/S0378-1127(02)00059-2; Yan LM, 2010, GLOBAL CHANGE BIOL, V16, P2345, DOI 10.1111/j.1365-2486.2009.02091.x; Yuste JC, 2003, TREE PHYSIOL, V23, P1263, DOI 10.1093/treephys/23.18.1263; Zimmermann M, 2009, SOIL BIOL BIOCHEM, V41, P1	66	53	56	1	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101890	10.1371/journal.pone.0101890	http://dx.doi.org/10.1371/journal.pone.0101890			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004164	Green Published, gold			2022-12-27	WOS:000339242700083
J	Alfsnes, K; Raynaud, X; Tonjum, T; Ambur, OH				Alfsnes, Kristian; Raynaud, Xavier; Tonjum, Tone; Ambur, Ole Herman			Mathematical and Live Meningococcal Models for Simple Sequence Repeat Dynamics - Coherent Predictions and Observations	PLOS ONE			English	Article							PHASE-VARIABLE GENES; HIGH MUTATION-RATES; NEISSERIA-MENINGITIDIS; MISMATCH REPAIR; HAEMOPHILUS-INFLUENZAE; CONTINGENCY LOCI; RELATIVE CONTRIBUTIONS; ADAPTIVE EVOLUTION; DNA; RECOMBINATION	Evolvability by means of simple sequence repeat (SSR) instability is a feature under the constant influence of opposing selective pressures to expand and compress the repeat tract and is mechanistically influenced by factors that affect genetic instability. In addition to direct selection for protein expression and structural integrity, other factors that influence tract length evolution were studied. The genetic instability of SSRs that switch the expression of antibiotic resistance ON and OFF was modelled mathematically and monitored in a panel of live meningococcal strains. The mathematical model showed that the SSR length of a theoretical locus in an evolving population may be shaped by direct selection of expression status (ON or OFF), tract length dependent (alpha) and tract length independent factors (beta). According to the model an increase in alpha drives the evolution towards shorter tracts. An increase in b drives the evolution towards a normal distribution of tract lengths given that an upper and a lower limit are set. Insertion and deletion biases were shown to skew allelic distributions in both directions. The meningococcal SSR model was tested in vivo by monitoring the frequency of spectinomycin resistance OFF -> ON switching in a designed locus. The instability of a comprehensive panel of the homopolymeric SSRs, constituted of a range of 5-13 guanine nucleotides, was monitored in wildtype and mismatch repair deficient backgrounds. Both the repeat length itself and mismatch repair deficiency were shown to influence the genetic instability of the homopolymeric tracts. A possible insertion bias was observed in tracts <= G(10). Finally, an inverse correlation between the number of tract-encoded amino acids and growth in the presence of ON-selection illustrated a limitation to SSR expansion in an essential gene associated with the designed model locus and the protein function mediating antibiotic resistance.	[Alfsnes, Kristian; Tonjum, Tone; Ambur, Ole Herman] Univ Oslo, Dept Microbiol, Oslo, Norway; [Alfsnes, Kristian; Tonjum, Tone; Ambur, Ole Herman] Oslo Univ Hosp, Rigshosp, Dept Microbiol, Oslo, Norway; [Raynaud, Xavier] Univ Oslo, Dept Math, Oslo, Norway; [Ambur, Ole Herman] Akershus Univ, Dept Microbiol & Infect Control, Lorenskog, Norway	University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; Oslo Metropolitan University (OsloMet)	Ambur, OH (corresponding author), Univ Oslo, Dept Microbiol, Oslo, Norway.	ole.herman.ambur@ahus.no	Tønjum, Tone/J-4581-2014; Ambur, Ole Herman/O-5342-2019; Ambur, Ole/G-6641-2016	Ambur, Ole Herman/0000-0001-9870-6375; Ambur, Ole/0000-0001-9870-6375; Tonjum, Tone/0000-0002-1709-6921	Research Council of Norway; Centre of Excellence grant (Centre for Molecular Biology and Neuroscience, CMBN)	Research Council of Norway(Research Council of Norway); Centre of Excellence grant (Centre for Molecular Biology and Neuroscience, CMBN)	The study was supported by the Research Council of Norway by a Centre of Excellence grant (Centre for Molecular Biology and Neuroscience, CMBN) to TT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas FE, 2007, MOL MICROBIOL, V65, P607, DOI 10.1111/j.1365-2958.2007.05806.x; Ackermann M, 2006, PLOS GENET, V2, P224, DOI 10.1371/journal.pgen.0020022; Alamro M, 2014, INFECT IMMUN, V82, P2472, DOI 10.1128/IAI.01521-14; Alexander HL, 2004, INFECT IMMUN, V72, P6743, DOI 10.1128/IAI.72.11.6743-6747.2004; Alexander HL, 2004, MOL MICROBIOL, V52, P771, DOI 10.1111/j.1365-2958.2004.04013.x; Ambur OH, 2007, J BACTERIOL, V189, P2077, DOI 10.1128/JB.01408-06; Ambur OH, 2009, FEMS MICROBIOL REV, V33, P453, DOI 10.1111/j.1574-6976.2009.00173.x; Bayliss CD, 2004, J BACTERIOL, V186, P2928, DOI 10.1128/JB.186.10.2928-2935.2004; Bayliss CD, 2004, FEMS IMMUNOL MED MIC, V40, P11, DOI 10.1016/S0928-8244(03)00325-0; Bayliss CD, 2001, J CLIN INVEST, V107, P657, DOI 10.1172/JCI12557; Bayliss CD, 2008, INFECT IMMUN, V76, P5038, DOI 10.1128/IAI.00395-08; Bayliss CD, 2012, ANN NY ACAD SCI, V1267, P39, DOI 10.1111/j.1749-6632.2012.06584.x; Bayliss CD, 2012, NUCLEIC ACIDS RES, V40, P5876, DOI 10.1093/nar/gks246; Bayliss CD, 2009, FEMS MICROBIOL REV, V33, P504, DOI 10.1111/j.1574-6976.2009.00162.x; Belland RJ, 1997, MOL MICROBIOL, V23, P123, DOI 10.1046/j.1365-2958.1997.1971556.x; Bentley SD, 2007, PLOS GENET, V3, P230, DOI 10.1371/journal.pgen.0030023; Bucci C, 1999, MOL CELL, V3, P435, DOI 10.1016/S1097-2765(00)80471-2; Carroll PA, 1997, MOL MICROBIOL, V25, P1099, DOI 10.1046/j.1365-2958.1997.5371901.x; Chen Y, 2013, STRUCTURAL BIOCH STU; Davidsen T, 2006, NAT REV MICROBIOL, V4, P11, DOI 10.1038/nrmicro1324; De Bolle X, 2000, MOL MICROBIOL, V35, P211, DOI 10.1046/j.1365-2958.2000.01701.x; DYBVIG K, 1993, MOL MICROBIOL, V10, P465, DOI 10.1111/j.1365-2958.1993.tb00919.x; Fazekas AJ, 2010, BIOTECHNIQUES, V48, P277, DOI 10.2144/000113369; Feil EJ, 1999, MOL BIOL EVOL, V16, P1496, DOI 10.1093/oxfordjournals.molbev.a026061; Feil EJ, 2000, RES MICROBIOL, V151, P465, DOI 10.1016/S0923-2508(00)00168-6; Galimand M, 2000, ANTIMICROB AGENTS CH, V44, P1365, DOI 10.1128/AAC.44.5.1365-1366.2000; Giraud A, 2001, SCIENCE, V291, P2606, DOI 10.1126/science.1056421; Gu TT, 2010, GENETICS, V186, P1077, DOI 10.1534/genetics.110.121137; Hall LMC, 2006, MICROBIOL-SGM, V152, P2505, DOI 10.1099/mic.0.29079-0; Hallet B, 2001, CURR OPIN MICROBIOL, V4, P570, DOI 10.1016/S1369-5274(00)00253-8; Hammerschmidt S, 1996, MOL MICROBIOL, V20, P1211, DOI 10.1111/j.1365-2958.1996.tb02641.x; Harrison OB, 2013, MICROBIOL-SGM, V159, P1920, DOI 10.1099/mic.0.068874-0; Henderson IR, 1999, MOL MICROBIOL, V33, P919, DOI 10.1046/j.1365-2958.1999.01555.x; Jolley KA, 2005, MOL BIOL EVOL, V22, P562, DOI 10.1093/molbev/msi041; Kandler JL, 2014, ANTIMICROB AGENTS CH, V58, P4230, DOI 10.1128/AAC.03108-14; Kline KA, 2003, MOL MICROBIOL, V50, P3, DOI 10.1046/j.1365-2958.2003.03679.x; Lawrence JG, 1999, CURR OPIN MICROBIOL, V2, P519, DOI 10.1016/S1369-5274(99)00010-7; LEVINSON G, 1987, NUCLEIC ACIDS RES, V15, P5323, DOI 10.1093/nar/15.13.5323; Lin WH, 2012, NUCLEIC ACIDS RES, V40, P2399, DOI 10.1093/nar/gkr1078; LORENZ MG, 1994, MICROBIOL REV, V58, P563, DOI 10.1128/MMBR.58.3.563-602.1994; Martin P, 2004, MICROBIOL-SGM, V150, P3001, DOI 10.1099/mic.0.27182-0; Martin P, 2003, MOL MICROBIOL, V50, P245, DOI 10.1046/j.1365-2958.2003.03678.x; Metzgar D, 2002, GENOME RES, V12, P408, DOI 10.1101/gr.198602; Morel P, 1998, P NATL ACAD SCI USA, V95, P10003, DOI 10.1073/pnas.95.17.10003; MOXON ER, 1994, CURR BIOL, V4, P24, DOI 10.1016/S0960-9822(00)00005-1; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Omer H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017145; Orsi RH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-102; Palmer ME, 2013, MBIO, V4, DOI 10.1128/mBio.00430-12; Richardson AR, 2002, P NATL ACAD SCI USA, V99, P6103, DOI 10.1073/pnas.092568699; Richardson AR, 2001, MOL MICROBIOL, V40, P645, DOI 10.1046/j.1365-2958.2001.02408.x; Saunders NJ, 2000, MOL MICROBIOL, V37, P207, DOI 10.1046/j.1365-2958.2000.02000.x; Saunders NJ, 2003, MICROBIOL-SGM, V149, P485, DOI 10.1099/mic.0.25807-0; Schofield MJ, 2003, ANNU REV MICROBIOL, V57, P579, DOI 10.1146/annurev.micro.57.030502.090847; Sia E, 1997, MOL CELL BIOL, V17; Siddique A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001277; Snyder LAS, 2001, MICROBIOL-SGM, V147, P2321, DOI 10.1099/00221287-147-8-2321; SPRATT BG, 1988, NATURE, V332, P173, DOI 10.1038/332173a0; STRAND M, 1995, P NATL ACAD SCI USA, V92, P10418, DOI 10.1073/pnas.92.22.10418; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; Tauseef I, 2011, MICROBIOL-SGM, V157, P1446, DOI 10.1099/mic.0.046946-0; Tibballs KL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-7; Tran HT, 1997, MOL CELL BIOL, V17, P2859, DOI 10.1128/MCB.17.5.2859; van Belkum A, 1998, MICROBIOL MOL BIOL R, V62, P275, DOI 10.1128/MMBR.62.2.275-293.1998; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	67	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101637	10.1371/journal.pone.0101637	http://dx.doi.org/10.1371/journal.pone.0101637			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999629	gold, Green Published, Green Submitted			2022-12-27	WOS:000338637300064
J	Hua, S; Lecuroux, C; Saez-Cirion, A; Pancino, G; Girault, I; Versmisse, P; Boufassa, F; Taulera, O; Sinet, M; Lambotte, O; Venet, A				Hua, Stephane; Lecuroux, Camille; Saez-Cirion, Asier; Pancino, Gianfranco; Girault, Isabelle; Versmisse, Pierre; Boufassa, Faroudy; Taulera, Olivier; Sinet, Martine; Lambotte, Olivier; Venet, Alain			Potential Role for HIV-Specific CD38(-)/HLA-DR+ CD8(+) T Cells in Viral Suppression and Cytotoxicity in HIV Controllers	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; HIV-1-INFECTED PATIENTS; IMMUNE ACTIVATION; LYMPHOCYTE-ACTIVATION; ELITE CONTROLLERS; RNA LEVELS; IFN-ALPHA; EX-VIVO; CLASS-I; INFECTION	Background: HIV controllers (HIC) are rare HIV-1-infected patients who exhibit spontaneous viral control. HIC have high frequency of CD38(-)/HLA-DR+ HIV-specific CD8(+) T cells. Here we examined the role of this subset in HIC status. Materials and Methods: We compared CD38(-)/HLA-DR+ CD8(+) T cells with the classical CD38(+)/HLA-DR+ activated phenotype in terms of 1) their activation status, reflected by CD69, CD25, CD71, CD40 and Ki67 expression, 2) functional parameters: Bcl-2 expression, proliferative capacity, and IFN-gamma and IL-2 production, and 3) cytotoxic activity. We also investigated how this particular profile is generated. Results: Compared to CD38(-)/HLA-DR+ CD8(+) cells, CD38(-)/HLA-DR+ cells exhibited lower expression of several activation markers, better survival capacity (Bcl-2 MFI, 367 [134-462] vs 638 [307-747], P = 0.001), higher frequency of polyfunctional cells (15% [7%-33%] vs 21% [16%-43%], P = 0.0003), greater proliferative capacity (0-fold [0-2] vs 3-fold [2-11], P = 0.007), and higher cytotoxicity in vitro (7% [3%-11%] vs 13% [6%-22%], P = 0.02). The CD38(-)/HLA-DR+ profile was preferentially generated in response to low viral antigen concentrations. Conclusions: These data highlight the role of CD38(-)/HLA-DR+ HIV-specific CD8(+) T cell cytotoxicity in HIC status and provide insights into the mechanism by which they are generated. Induction of this protective CD8(+) subset may be important for vaccine strategies.	[Hua, Stephane; Lecuroux, Camille; Girault, Isabelle; Sinet, Martine; Lambotte, Olivier; Venet, Alain] INSERM, U1012, F-94275 Le Kremlin Bicetre, France; [Hua, Stephane; Lecuroux, Camille; Girault, Isabelle; Boufassa, Faroudy; Sinet, Martine; Lambotte, Olivier; Venet, Alain] Univ Paris 11, Le Kremlin Bicetre, France; [Saez-Cirion, Asier; Pancino, Gianfranco; Versmisse, Pierre] Inst Pasteur, Unite Regulat Infect Retrovirales, Paris, France; [Boufassa, Faroudy] INSERM, U1018, F-94275 Le Kremlin Bicetre, France; [Boufassa, Faroudy] Hop Bicetre, AP HP, Dept Epidemiol, Le Kremlin Bicetre, France; [Taulera, Olivier] Hop St Louis, AP HP, Paris, France; [Lambotte, Olivier] Hop Bicetre, AP HP, Serv Med Interne, Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Venet, A (corresponding author), INSERM, U1012, F-94275 Le Kremlin Bicetre, France.	alain.venet@u-psud.fr	HUA, Stéphane/I-6690-2019; Saez-Cirion, Asier/A-8640-2008; Lambotte, Olivier/GRT-0160-2022	HUA, Stéphane/0000-0002-2244-5663; Saez-Cirion, Asier/0000-0003-2406-7536; Girault, Isabelle/0000-0002-9587-5197	Institut National de la Sante et de la Recherche Medicale, Agence Nationale de Recherche sur le SIDA and Sidaction; Ministere de l'Enseignement Superieur et de la Recherche and Sidaction	Institut National de la Sante et de la Recherche Medicale, Agence Nationale de Recherche sur le SIDA and Sidaction; Ministere de l'Enseignement Superieur et de la Recherche and Sidaction	This work was supported in part by institutional grants from Institut National de la Sante et de la Recherche Medicale, Agence Nationale de Recherche sur le SIDA and Sidaction. SH received institutional grants from Ministere de l'Enseignement Superieur et de la Recherche and Sidaction. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Almeida JR, 2009, BLOOD, V113, P6351, DOI 10.1182/blood-2009-02-206557; Barblu L, 2012, J INFECT DIS, V206, P790, DOI 10.1093/infdis/jis384; Berger CT, 2011, J VIROL, V85, P9334, DOI 10.1128/JVI.00460-11; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2004, J IMMUNOL, V172, P6407, DOI 10.4049/jimmunol.172.10.6407; Boufassa F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018726; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Buckheit RW, 2012, J VIROL, V86, P13679, DOI 10.1128/JVI.02439-12; Campillo-Gimenez L, 2010, J VIROL, V84, P1838, DOI 10.1128/JVI.01496-09; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Carrington M, 2012, ANNU REV MED, V63, P131, DOI 10.1146/annurev-med-062909-130018; Caruso A, 1997, CYTOMETRY, V27, P71, DOI 10.1002/(SICI)1097-0320(19970101)27:1<71::AID-CYTO9>3.0.CO;2-O; Chen H, 2009, J VIROL, V83, P3138, DOI 10.1128/JVI.02073-08; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Doisne JM, 2004, J IMMUNOL, V173, P2410, DOI 10.4049/jimmunol.173.4.2410; GIORGI JV, 1994, J INFECT DIS, V170, P775, DOI 10.1093/infdis/170.4.775; Giorgi JV, 2002, J ACQ IMMUN DEF SYND, V29, P346, DOI 10.1097/00126334-200204010-00004; Goulder PJR, 2012, IMMUNITY, V37, P426, DOI 10.1016/j.immuni.2012.09.005; Herbeuval JP, 2007, CLIN IMMUNOL, V123, P121, DOI 10.1016/j.clim.2006.09.016; Herbeuval JP, 2006, P NATL ACAD SCI USA, V103, P7000, DOI 10.1073/pnas.0600363103; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Hervas-Stubbs S, 2010, EUR J IMMUNOL, V40, P3389, DOI 10.1002/eji.201040664; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Imamichi H, 2012, EUR J IMMUNOL, V42, P2608, DOI 10.1002/eji.201142046; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; Lecuroux C, 2014, J VIROL, V88, P176, DOI 10.1128/JVI.02098-13; Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07; Manion M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030306; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Ndhlovu ZM, 2012, J VIROL, V86, P6959, DOI 10.1128/JVI.00531-12; Okulicz JF, 2009, J INFECT DIS, V200, P1714, DOI 10.1086/646609; Pereyra F, 2009, J INFECT DIS, V200, P984, DOI 10.1086/605446; Sachdeva M, 2010, JAIDS-J ACQ IMM DEF, V54, P447, DOI 10.1097/QAI.0b013e3181e0c7d0; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Saez-Cirion A, 2013, IMMUNOL REV, V254, P281, DOI 10.1111/imr.12076; Saez-Cirion A, 2010, NAT PROTOC, V5, P1033, DOI 10.1038/nprot.2010.73; Saez-Cirion A, 2009, J IMMUNOL, V182, P7828, DOI 10.4049/jimmunol.0803928; Sandoval-Montes C, 2005, J LEUKOCYTE BIOL, V77, P513, DOI 10.1189/jlb.0404262; Speiser DE, 2001, EUR J IMMUNOL, V31, P459, DOI 10.1002/1521-4141(200102)31:2<459::AID-IMMU459>3.0.CO;2-Y; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Varela-Rohena A, 2008, NAT MED, V14, P1390, DOI 10.1038/nm.1779; West EE, 2011, IMMUNITY, V35, P285, DOI 10.1016/j.immuni.2011.05.017; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006	48	45	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101920	10.1371/journal.pone.0101920	http://dx.doi.org/10.1371/journal.pone.0101920			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000587	Green Published, Green Submitted, gold			2022-12-27	WOS:000338637300103
J	Luz, Y; Shamir, M				Luz, Yotam; Shamir, Maoz			The Effect of STDP Temporal Kernel Structure on the Learning Dynamics of Single Excitatory and Inhibitory Synapses	PLOS ONE			English	Article							TIMING-DEPENDENT PLASTICITY; ASYMMETRIC HEBBIAN PLASTICITY; SYNAPTIC PLASTICITY; DENDRITIC LOCATION; SPIKING NEURONS; INPUT; COACTIVATION; DETERMINES; NETWORKS; CORTEX	Spike-Timing Dependent Plasticity (STDP) is characterized by a wide range of temporal kernels. However, much of the theoretical work has focused on a specific kernel - the "temporally asymmetric Hebbian'' learning rules. Previous studies linked excitatory STDP to positive feedback that can account for the emergence of response selectivity. Inhibitory plasticity was associated with negative feedback that can balance the excitatory and inhibitory inputs. Here we study the possible computational role of the temporal structure of the STDP. We represent the STDP as a superposition of two processes: potentiation and depression. This allows us to model a wide range of experimentally observed STDP kernels, from Hebbian to anti-Hebbian, by varying a single parameter. We investigate STDP dynamics of a single excitatory or inhibitory synapse in purely feed-forward architecture. We derive a mean-field-Fokker-Planck dynamics for the synaptic weight and analyze the effect of STDP structure on the fixed points of the mean field dynamics. We find a phase transition along the Hebbian to anti-Hebbian parameter from a phase that is characterized by a unimodal distribution of the synaptic weight, in which the STDP dynamics is governed by negative feedback, to a phase with positive feedback characterized by a bimodal distribution. The critical point of this transition depends on general properties of the STDP dynamics and not on the fine details. Namely, the dynamics is affected by the pre-post correlations only via a single number that quantifies its overlap with the STDP kernel. We find that by manipulating the STDP temporal kernel, negative feedback can be induced in excitatory synapses and positive feedback in inhibitory. Moreover, there is an exact symmetry between inhibitory and excitatory plasticity, i.e., for every STDP rule of inhibitory synapse there exists an STDP rule for excitatory synapse, such that their dynamics is identical.	[Luz, Yotam; Shamir, Maoz] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol & Cell Biol, Beer Sheva, Israel; [Shamir, Maoz] Ben Gurion Univ Negev, Dept Phys, Fac Nat Sci, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Luz, Y (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol & Cell Biol, Beer Sheva, Israel.	yotam.luz@gmail.com	SHAMIR, MAOZ/F-1641-2012	SHAMIR, MAOZ/0000-0002-1489-6704	Israel Science Foundation ISF [722/10]	Israel Science Foundation ISF(Israel Science Foundation)	This work was supported by the Israel Science Foundation ISF grant No 722/10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; Bi GQ, 2002, PHYSIOL BEHAV, V77, P551, DOI 10.1016/S0031-9384(02)00933-2; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; Cateau H, 2003, NEURAL COMPUT, V15, P597, DOI 10.1162/089976603321192095; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Froemke RC, 2005, NATURE, V434, P221, DOI 10.1038/nature03366; Froemke RC, 2006, J NEUROPHYSIOL, V95, P1620, DOI 10.1152/jn.00910.2005; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Gerstner W, 2000, NEURAL COMPUT, V12, P43, DOI 10.1162/089976600300015899; Gilson M, 2009, BIOL CYBERN, V101, P81, DOI [10.1007/S00422-009-0319-4, 10.1007/s00422-009-0319-4]; Graupner M, 2012, P NATL ACAD SCI USA, V109, P3991, DOI 10.1073/pnas.1109359109; Gutig R, 2003, J NEUROSCI, V23, P3697; Haas JS, 2006, J NEUROPHYSIOL, V96, P3305, DOI 10.1152/jn.00551.2006; Hulme SR, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0148; Kempter R, 1999, PHYS REV E, V59, P4498, DOI 10.1103/PhysRevE.59.4498; Luz Y, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002334; Morrison A, 2008, BIOL CYBERN, V98, P459, DOI 10.1007/s00422-008-0233-1; Morrison A, 2007, NEURAL COMPUT, V19, P1437, DOI 10.1162/neco.2007.19.6.1437; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Plesser HE, 2000, NEURAL COMPUT, V12, P367, DOI 10.1162/089976600300015835; Rubin J, 2001, PHYS REV LETT, V86, P364, DOI 10.1103/PhysRevLett.86.364; Sjostrom PJ, 2006, NEURON, V51, P227, DOI 10.1016/j.neuron.2006.06.017; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Standage D, 2007, BIOL CYBERN, V96, P615, DOI 10.1007/s00422-007-0152-6; Tzounopoulos T, 2004, NAT NEUROSCI, V7, P719, DOI 10.1038/nn1272; Tzounopoulos T, 2007, NEURON, V54, P291, DOI 10.1016/j.neuron.2007.03.026; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; Vogels TP, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00119; Vogels TP, 2011, SCIENCE, V334, P1569, DOI 10.1126/science.1211095; Wang HX, 2005, NAT NEUROSCI, V8, P187, DOI 10.1038/nn1387; Woodin MA, 2003, NEURON, V39, P807, DOI 10.1016/S0896-6273(03)00507-5	34	10	10	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101109	10.1371/journal.pone.0101109	http://dx.doi.org/10.1371/journal.pone.0101109			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999634	Green Submitted, Green Published, gold			2022-12-27	WOS:000338637300024
J	Zhou, FQ; Zhuang, Y; Gong, HH; Wang, B; Wang, X; Chen, Q; Wu, L; Wan, H				Zhou, Fuqing; Zhuang, Ying; Gong, Honghan; Wang, Bo; Wang, Xing; Chen, Qi; Wu, Lin; Wan, Hui			Altered Inter-Subregion Connectivity of the Default Mode Network in Relapsing Remitting Multiple Sclerosis: A Functional and Structural Connectivity Study	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; BRAIN; TRACTOGRAPHY; PATHOLOGY; DEMYELINATION; DYSFUNCTION; DISABILITY; MATTERS; DEEP	Background and Purpose: Little is known about the interactions between the default mode network (DMN) subregions in relapsing-remitting multiple sclerosis (RRMS). This study used diffusion tensor imaging (DTI) and resting-state functional MRI (rs-fMRI) to examine alterations of long white matter tracts in paired DMN subregions and their functional connectivity in RRMS patients. Methods: Twenty-four RRMS patients and 24 healthy subjects participated in this study. The fiber connections derived from DTI tractography and the temporal correlation coefficient derived from rs-fMRI were combined to examine the inter-subregion structural-functional connectivity (SC-FC) within the DMN and its correlations with clinical markers. Results: Compared with healthy subjects, the RRMS patients showed the following: 1) significantly decreased SC and increased FC in the pair-wise subregions; 2) two significant correlations in SC-FC coupling patterns, including the positive correlation between slightly increased FC value and long white matter tract damage in the PCC/PCUN-MPFC connection, and the negative correlations between significantly increased FC values and long white matter tract damage in the PCC/PCUN-bilateral mTL connections; 3) SC alterations [log(N track) of the PCC/PCUN-left IPL, RD value of the MPFC-left IPL, FA value of the PCC/PCUN-left mTL connections] correlated with EDSS, increases in the RD value of MPFC-left IPL connection was positively correlated to the MFIS; and decreases in the FA value of PCC/PCUN-right IPL connection was negatively correlated with the PASAT; 4) decreased SC (FA value of the MPFC-left IPL, track volume of the PCC/PCUN-MPFC, and log(N track) of PCC/PCUN-left mTL connections) was positively correlated with brain atrophy. Conclusions: In the connections of paired DMN subregions, we observed decreased SC and increased FC in RRMS patients. The relationship between MS-related structural abnormalities and clinical markers suggests that the disruption of this longdistance "inter-subregion'' connectivity (white matter) may significantly impact the integrity of the network's function.	[Zhou, Fuqing; Gong, Honghan; Wang, Bo; Wang, Xing; Chen, Qi; Wu, Lin] Nanchang Univ, Affiliated Hosp 1, Dept Radiol, Nanchang, Jiangxi, Peoples R China; [Zhou, Fuqing; Gong, Honghan] Jiangxi Prov Med Imaging Res Inst, Nanchang, Jiangxi, Peoples R China; [Zhuang, Ying] Second Hosp Nanchang, Dept Oncol, Nanchang, Jiangxi, Peoples R China; [Wan, Hui] Nanchang Univ, Affiliated Hosp 1, Dept Neurol, Nanchang, Jiangxi, Peoples R China	Nanchang University; Nanchang University; Nanchang University	Zhou, FQ (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Radiol, Nanchang, Jiangxi, Peoples R China.	fq.chou@yahoo.com; honghan_gong@sina.com			National Science Foundation of China [81101041, 81060116, 81260217]; JiangXi Province science and technology support program [20111BBG70028-1]; Hong Kong Scholars Program [XJ2012026]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); JiangXi Province science and technology support program; Hong Kong Scholars Program	This work was supported by the National Science Foundation of China (Grant No. 81101041 for FZ, Grant No. 81060116 for HG, and Grant No. 81260217 for HG), JiangXi Province science and technology support program (Grant No. 20111BBG70028-1 for FZ), Hong Kong Scholars Program (Grant No. XJ2012026 for FZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Andrews-Hanna JR, 2010, J NEUROPHYSIOL, V104, P322, DOI 10.1152/jn.00830.2009; Audoin B, 2006, J NEUROL SCI, V245, P87, DOI 10.1016/j.jns.2005.08.026; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Bodini B, 2011, J NEUROL NEUROSUR PS, V82, P72, DOI 10.1136/jnnp.2009.201574; Bonavita S, 2011, MULT SCLER J, V17, P411, DOI 10.1177/1352458510394609; Bruck W, 2005, J NEUROL, V252, pV3, DOI 10.1007/s00415-005-5002-7; Ciccarelli O, 2007, BRAIN, V130, P2220, DOI 10.1093/brain/awm152; Ciccarelli O, 2001, NEUROLOGY, V56, P926, DOI 10.1212/WNL.56.7.926; Cruz-Gomez AJ, 2013, MULT SCLER; Dogonowski AM, 2013, ACTA NEUROL SCAND, V128, P328, DOI 10.1111/ane.12121; Dziedzic T, 2010, BRAIN PATHOL, V20, P976, DOI 10.1111/j.1750-3639.2010.00401.x; Enzinger C, 2012, NEUROLOGY, V79, P1416, DOI 10.1212/WNL.0b013e31826d600d; Faivre A, 2012, MULT SCLER J, V18, P1251, DOI 10.1177/1352458511435930; Filippi M, 2013, J NEUROL, V260, P1709, DOI 10.1007/s00415-012-6695-z; Filippi M, 2012, RADIOLOGY, V262, P932, DOI 10.1148/radiol.11111299; Geurts JJG, 2008, LANCET NEUROL, V7, P841, DOI 10.1016/S1474-4422(08)70191-1; Gorgoraptis N, 2010, MULT SCLER J, V16, P555, DOI 10.1177/1352458510362440; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hawellek DJ, 2011, P NATL ACAD SCI USA, V108, P19066, DOI 10.1073/pnas.1110024108; Honey CJ, 2010, NEUROIMAGE, V52, P766, DOI 10.1016/j.neuroimage.2010.01.071; Horn Andreas, 2014, NEUROIMAGE; Hu B, 2011, EUR J RADIOL, V79, P101, DOI 10.1016/j.ejrad.2009.11.021; Hurwitz BJ, 2009, ANN INDIAN ACAD NEUR, V12, P226, DOI 10.4103/0972-2327.58276; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Joel SE, 2011, MAGN RESON MED, V66, P644, DOI 10.1002/mrm.22818; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Kern KC, 2011, NEUROIMAGE, V55, P1169, DOI 10.1016/j.neuroimage.2010.10.077; Khalsa S, 2013, NEUROIMAGE; Koch MA, 2002, NEUROIMAGE, V16, P241, DOI 10.1006/nimg.2001.1052; Kurtzke JF, 2008, NEUROEPIDEMIOLOGY, V31, P1, DOI 10.1159/000136645; Liao W, 2011, HUM BRAIN MAPP, V32, P883, DOI 10.1002/hbm.21076; Loitfelder M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042862; Lowe MJ, 2008, HUM BRAIN MAPP, V29, P818, DOI 10.1002/hbm.20576; Morris DM, 2008, NEUROIMAGE, V42, P1329, DOI 10.1016/j.neuroimage.2008.06.012; Pelletier D, 2004, J NEUROIMAGING, V14, p11S, DOI 10.1111/j.1552-6569.2004.tb00274.x; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Qi RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041376; Ramli N, 2010, J CLIN NEUROSCI, V17, P422, DOI 10.1016/j.jocn.2009.09.014; Rocca MA, 2010, NEUROLOGY, V74, P1252, DOI 10.1212/WNL.0b013e3181d9ed91; Roosendaal SD, 2009, NEUROIMAGE, V44, P1397, DOI 10.1016/j.neuroimage.2008.10.026; Roosendaal SD, 2010, BRAIN, V133, P1612, DOI 10.1093/brain/awq058; Sbardella E, 2013, MULT SCLER INT, V2013, DOI 10.1155/2013/671730; Schoonheim MM, 2012, NEUROLOGY, V79, P1418, DOI 10.1212/WNL.0b013e31826d602e; Schoonheim MM, 2010, NEUROLOGY, V74, P1246, DOI 10.1212/WNL.0b013e3181db9957; Shu N, 2011, CEREB CORTEX, V21, P2565, DOI 10.1093/cercor/bhr039; Taylor PA, 2013, BRAIN CONNECT, V3, P523, DOI 10.1089/brain.2013.0154; van den Heuvel MP, 2012, P NATL ACAD SCI USA, V109, P11372, DOI 10.1073/pnas.1203593109; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; van Oort ESB, 2014, NEUROIMAGE, V90, P381, DOI 10.1016/j.neuroimage.2013.12.051; Vercellino M, 2009, J NEUROPATH EXP NEUR, V68, P489, DOI 10.1097/NEN.0b013e3181a19a5a; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhou FQ, 2010, J COMPUT ASSIST TOMO, V34, P431, DOI 10.1097/RCT.0b013e3181cbf73c; Zhou FQ, 2010, J MAGN RESON IMAGING, V31, P789, DOI 10.1002/jmri.22103	56	37	41	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101198	10.1371/journal.pone.0101198	http://dx.doi.org/10.1371/journal.pone.0101198			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999807	Green Submitted, Green Published, gold			2022-12-27	WOS:000338637300025
J	Khng, KH; Lee, K				Kiat Hui Khng; Lee, Kerry			The Relationship between Stroop and Stop-Signal Measures of Inhibition in Adolescents: Influences from Variations in Context and Measure Estimation	PLOS ONE			English	Article							WORKING-MEMORY CAPACITY; RESPONSE-INHIBITION; EXECUTIVE FUNCTIONS; COGNITIVE CONTROL; DEVELOPMENTAL-CHANGES; NEURAL BASIS; INTERFERENCE; MODEL; METAANALYSIS; IMPULSIVITY	The Stroop and stop-signal tasks are commonly used to index prepotent response inhibition in studies of cognitive development and individual differences. Inhibitory measures from the two tasks have been derived using a variety of methods. Findings of low inter-correlations amongst these measures have been interpreted as evidence for different kinds of inhibitory functions. Our previous study found Stroop and stop-signal accuracy measures to be uncorrelated and they loaded on different inhibitory components in a principal component analysis. The present study examined whether this finding is replicated across different task contexts, derived measures, and methods of derivation. Adolescents (N = 247) were administered a number-quantity Stroop and word and number stop-signal tasks. For each stop-signal task, inhibitory efficiency was estimated using a stop-signal reaction time measure estimated with the central versus the integration methods. For the Stroop interference task, inhibitory efficiency was indexed by reaction time measures (including inverse efficiency scores) generated from difference scores and regression residuals, and delta-plot slopes. The reaction time measures from the two tasks were generally not correlated. The only exception was that Stroop inhibitory ability, indexed by Stroop errors, was related to stop-signal inhibitory efficiency, indexed by stop-signal reaction time. These findings are consistent with previous findings suggesting that measures from the Stroop and stop-signal tasks are influenced by different underlying processes. The impact of variations in dependent measure derivation on the resulting reliabilities of Stroop and stop-signal measures and on observed correlations between them were examined. Variables that may have contributed to the null findings are discussed.	[Kiat Hui Khng] Nanyang Technol Univ, Ctr Res Pedag & Practice, Natl Inst Educ, Singapore 639798, Singapore; [Lee, Kerry] Nanyang Technol Univ, Ctr Res Pedag & Practice, Natl Inst Educ, Psychol Studies Acad Grp,Off Educ Res, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Institute of Education (NIE) Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Institute of Education (NIE) Singapore	Khng, KH (corresponding author), Nanyang Technol Univ, Ctr Res Pedag & Practice, Natl Inst Educ, Singapore 639798, Singapore.	kiathui.khng@nie.edu.sg	Lee, Kerry/A-9427-2011; Khng, Kiat Hui/AAD-6942-2020	Lee, Kerry/0000-0002-8296-8028; Khng, Kiat Hui/0000-0001-7656-9146	 [CRPP 22/03KL];  [9/05KL]	; 	This study was supported in part by the grants CRPP 22/03KL and 9/05KL (http://www.nie.edu.sg/), awarded to the second author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichert DS, 2012, J CLIN EXP NEUROPSYC, V34, P1016, DOI 10.1080/13803395.2012.706261; Amieva HA, 2002, J CLIN EXP NEUROPSYC, V24, P503, DOI 10.1076/jcen.24.4.503.1034; Aron AR, 2007, J NEUROSCI, V27, P11860, DOI 10.1523/JNEUROSCI.3644-07.2007; Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Aron AR, 2011, BIOL PSYCHIAT, V69, pE55, DOI 10.1016/j.biopsych.2010.07.024; Band GPH, 1999, ACTA PSYCHOL, V101, P179, DOI 10.1016/S0001-6918(99)00005-0; Band GPH, 2003, ACTA PSYCHOL, V112, P105, DOI 10.1016/S0001-6918(02)00079-3; Bedard AC, 2002, DEV NEUROPSYCHOL, V21, P93, DOI 10.1207/S15326942DN2101_5; Belanger S, 2010, NEUROPSYCHOLOGIA, V48, P581, DOI 10.1016/j.neuropsychologia.2009.10.021; Boehler CN, 2012, BEHAV BRAIN RES, V229, P123, DOI 10.1016/j.bbr.2012.01.003; Braver T. S., 2007, VARIATION WORKING ME, P76, DOI DOI 10.1093/ACPROF:OSO/9780195168648.003.0004; Braver TS, 2012, TRENDS COGN SCI, V16, P106, DOI 10.1016/j.tics.2011.12.010; Bruyer R, 2011, PSYCHOL BELG, V51, P5, DOI 10.5334/pb-51-1-5; Bryant FB., 2007, OXFORD HDB METHODS P, P61; Chan WWL, 2011, J EXP CHILD PSYCHOL, V109, P263, DOI 10.1016/j.jecp.2011.01.010; Cohen J.E., 1988, STAT POWER ANAL BEHA; Congdon E, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00037; Cronbach L. J., 1941, EDUC PSYCHOL MEAS, V1, P269, DOI [DOI 10.1177/001316444100100121, 10.1177/001316444100100121]; CRONBACH LJ, 1970, PSYCHOL BULL, V74, P68, DOI 10.1037/h0029382; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; DEJONG R, 1994, J EXP PSYCHOL HUMAN, V20, P731, DOI 10.1037/0096-1523.20.4.731; Dempster F. N., 1993, EMERGING THEMES COGN, V1, P3, DOI DOI 10.1007/978-1-4613-9220-0_1; DEMPSTER FN, 1992, DEV REV, V12, P45, DOI 10.1016/0273-2297(92)90003-K; Durston S, 2002, DEVELOPMENTAL SCI, V5, pF9, DOI 10.1111/1467-7687.00235; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Federico P, 2014, EXP BRAIN RES, V232, P1293, DOI 10.1007/s00221-014-3846-8; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Hanes DP, 1998, J NEUROPHYSIOL, V79, P817, DOI 10.1152/jn.1998.79.2.817; Hogeveen J, 2013, EXP BRAIN RES, V224, P613, DOI 10.1007/s00221-012-3339-6; Hooper D., 2008, EJBRM, V6, P53, DOI DOI 10.21427/D7CF7R; Huizinga M, 2006, NEUROPSYCHOLOGIA, V44, P2017, DOI 10.1016/j.neuropsychologia.2006.01.010; Kalanthroff E, 2013, J EXP PSYCHOL HUMAN, V39, P579, DOI 10.1037/a0027429; Kane MJ, 2003, J EXP PSYCHOL GEN, V132, P47, DOI 10.1037/0096-3445.132.1.47; Khng KH, 2009, LEARN INDIVID DIFFER, V19, P262, DOI 10.1016/j.lindif.2009.01.004; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; Lampe K, 2007, PSYCHOL MED, V37, P1717, DOI 10.1017/S0033291707000517; Lee K, 2013, CHILD DEV, V84, P1933, DOI 10.1111/cdev.12096; Leon-Carrion J, 2004, INT J NEUROSCI, V114, P1291, DOI 10.1080/00207450490476066; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Ley P., 1972, QUANTITATIVE ASPECTS; Livesey D, 2006, HUM MOVEMENT SCI, V25, P50, DOI 10.1016/j.humov.2005.10.008; LLABRE MM, 1991, PSYCHOPHYSIOLOGY, V28, P701, DOI 10.1111/j.1469-8986.1991.tb01017.x; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Logan GD, 2000, PSYCHON B REV, V7, P107, DOI 10.3758/BF03210728; Lustig C., 2007, INHIBITION COGNITION, P145, DOI [DOI 10.1037/11587-008, 10.1037/11587-008]; MacLeod CM, 2003, PSYCHOL LEARN MOTIV, V43, P163, DOI 10.1016/S0079-7421(03)01014-4; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; McVay JC, 2012, J EXP PSYCHOL LEARN, V38, P525, DOI 10.1037/a0025896; Mirabella G, 2011, J NEUROPHYSIOL, V106, P1454, DOI 10.1152/jn.00995.2010; Mirabella G, 2008, COGN NEUROPSYCHOL, V25, P996, DOI 10.1080/02643290802003216; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Moore A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00018; Nee DE, 2007, COGN AFFECT BEHAV NE, V7, P1, DOI 10.3758/CABN.7.1.1; Nigg JT, 2000, PSYCHOL BULL, V126, P220, DOI 10.1037/0033-2909.126.2.220; Oosterlaan J, 1998, J CHILD PSYCHOL PSYC, V39, P411, DOI 10.1111/1469-7610.00336; Potter AS, 2004, PSYCHOPHARMACOLOGY, V176, P182, DOI 10.1007/s00213-004-1874-y; Pratte MS, 2010, ATTEN PERCEPT PSYCHO, V72, P2013, DOI 10.3758/APP.72.7.2013; Ridderinkhof KR, 2005, J ABNORM PSYCHOL, V114, P197, DOI 10.1037/0021-843X.114.2.197; Shilling VM, 2002, NEUROPSYCHOLOGIA, V40, P605, DOI 10.1016/S0028-3932(01)00157-9; Society SP, 1999, COD PROF ETH; St Clair-Thompson HL, 2006, Q J EXP PSYCHOL, V59, P745, DOI 10.1080/17470210500162854; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.2096; Van der Schoot M, 2005, SCAND J PSYCHOL, V46, P331, DOI 10.1111/j.1467-9450.2005.00463.x; Verbruggen F, 2004, ACTA PSYCHOL, V116, P21, DOI 10.1016/j.actpsy.2003.12.011; Verbruggen F, 2013, PSYCHOL SCI, V24, P352, DOI 10.1177/0956797612457390; Verbruggen F, 2009, J EXP PSYCHOL HUMAN, V35, P835, DOI 10.1037/a0012726; Wager TD, 2005, NEUROIMAGE, V27, P323, DOI 10.1016/j.neuroimage.2005.01.054; Whelan R, 2012, NAT NEUROSCI, V15, P920, DOI 10.1038/nn.3092; Wignall ND, 2011, EXP CLIN PSYCHOPHARM, V19, P183, DOI 10.1037/a0023292; Williams BR, 1999, DEV PSYCHOL, V35, P205, DOI 10.1037/0012-1649.35.1.205; Zandbelt BB, 2013, HUM BRAIN MAPP, V34, P2015, DOI 10.1002/hbm.22047	72	49	50	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101356	10.1371/journal.pone.0101356	http://dx.doi.org/10.1371/journal.pone.0101356			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3RT	24992683	gold, Green Submitted, Green Published			2022-12-27	WOS:000341253400064
J	Perez, L; Padilla, C; Parmentier, FBR; Andres, P				Perez, Laura; Padilla, Concepcion; Parmentier, Fabrice B. R.; Andres, Pilar			The Effects of Chronic Exercise on Attentional Networks	PLOS ONE			English	Article							COGNITIVE FUNCTION; PHYSICAL-ACTIVITY; OLDER-ADULTS; CORTICAL PLASTICITY; EXECUTIVE FUNCTIONS; INHIBITORY CONTROL; BRAIN; FITNESS; CONFLICT; AGE	The aim of this study was to test the hypothesis that chronic physical exercise improves attentional control in young healthy participants. To do this, we compared the performance of physically active and passive participants in the Attentional Network Task, which allows for the assessment of the executive, orienting and alerting networks. The results showed a selective positive effect of exercise on the executive network. These results extend the evidence gathered in children, older adults and certain clinical populations suggesting that exercise can also improve attentional control in healthy young adults.	[Perez, Laura; Padilla, Concepcion; Parmentier, Fabrice B. R.; Andres, Pilar] Univ Balearic Isl, Res Inst Hlth Sci, Neuropsychol & Cognit Grp, Palma De Mallorca, Spain; [Perez, Laura; Padilla, Concepcion; Parmentier, Fabrice B. R.; Andres, Pilar] Univ Balearic Isl, Dept Psychol, Palma De Mallorca, Spain; [Perez, Laura; Padilla, Concepcion; Parmentier, Fabrice B. R.; Andres, Pilar] Inst Invest Sanitaria Palma, Neuropsychol & Cognit Grp, Palma De Mallorca, Spain	Universitat de les Illes Balears; Universitat de les Illes Balears; Institut Investigacio Sanitaria Illes Balears (IdISBa)	Andres, P (corresponding author), Univ Balearic Isl, Res Inst Hlth Sci, Neuropsychol & Cognit Grp, Palma De Mallorca, Spain.	pilar.andres@uib.es	Benito, Pilar Andres/G-3411-2011; Parmentier, Fabrice B. R./B-4485-2011; Meijer, Anna/K-5118-2016	Parmentier, Fabrice B. R./0000-0001-7439-0097; Padilla, Concepcion/0000-0003-4102-6787; Andres, Pilar/0000-0003-2220-8198	Spanish Ministry of Science and Innovation [PSI2010-21609-C02-02]; Spanish Ministry of Economy and Competitivity [BES-2011-043565]; Ramon y Cajal Fellowship from the Ministry of Economy and Competitiveness [RYC-2007-00701]; Plan E from the Spanish Ministry of Science and Innovation; Campus of International Excellence Program from the Ministry of Education, Culture and Sports	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Economy and Competitivity(Spanish Government); Ramon y Cajal Fellowship from the Ministry of Economy and Competitiveness; Plan E from the Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)); Campus of International Excellence Program from the Ministry of Education, Culture and Sports	This work was supported by a grant from the Spanish Ministry of Science and Innovation (PSI2010-21609-C02-02). Concepcion Padilla was granted with a FPI predoctoral studentship from the Spanish Ministry of Economy and Competitivity (BES-2011-043565). Fabrice Parmentier is an External Research Associate and an Adjunct Senior Lecturer at the School of Psychology, University of Western Australia, and was supported by a Ramon y Cajal Fellowship (RYC-2007-00701) from the Ministry of Economy and Competitiveness and Plan E from the Spanish Ministry of Science and Innovation, and the Campus of International Excellence Program from the Ministry of Education, Culture and Sports. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres P, 2008, DEV NEUROPSYCHOL, V33, P101, DOI 10.1080/87565640701884212; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Bandura A., 1991, SELF EFFICACY MECH P, P229, DOI DOI 10.4135/9781412952576.N182; Bialystok E, 2012, TRENDS COGN SCI, V16, P240, DOI 10.1016/j.tics.2012.03.001; Boucard GK, 2012, J SPORT EXERCISE PSY, V34, P808, DOI 10.1123/jsep.34.6.808; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Burgess P. W., 1997, METHODOLOGY FRONTAL, P79; Callejas A, 2004, BRAIN COGNITION, V54, P225, DOI 10.1016/j.bandc.2004.02.012; Chao LL, 1997, CEREB CORTEX, V7, P63, DOI 10.1093/cercor/7.1.63; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Colcombe SJ, 2003, J GERONTOL A-BIOL, V58, P176; Dishman RK, 2006, OBESITY, V14, P345, DOI 10.1038/oby.2006.46; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Guiney H, 2013, PSYCHON B REV, V20, P73, DOI 10.3758/s13423-012-0345-4; Hall CD, 2001, EUR J COGN PSYCHOL, V13, P279, DOI 10.1080/09541440042000313; Hillman CH, 2006, INT J PSYCHOPHYSIOL, V59, P30, DOI 10.1016/j.ijpsycho.2005.04.009; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Huertas F, 2011, J SPORT EXERCISE PSY, V33, P649, DOI 10.1123/jsep.33.5.649; Johnson KA, 2008, J CHILD PSYCHOL PSYC, V49, P1339, DOI 10.1111/j.1469-7610.2008.01936.x; Kempermann G, 2008, TRENDS NEUROSCI, V31, P163, DOI 10.1016/j.tins.2008.01.002; KLINE GM, 1987, MED SCI SPORT EXER, V19, P253; Kramer AF, 2007, TRENDS COGN SCI, V11, P342, DOI 10.1016/j.tics.2007.06.009; Kuczmarski RJ, 2000, ADV DATA, V314, P1; LaBerge D., 1995, ATTENTIONAL PROCESSI; MacLeod JW, 2010, NEUROPSYCHOLOGY, V24, P637, DOI 10.1037/a0019803; McAuley Edward, 2011, Ment Health Phys Act, V4, P5, DOI 10.1016/j.mhpa.2011.01.001; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Nassauer KW, 2003, J INT NEUROPSYCH SOC, V9, P25, DOI 10.1017/S1355617703910034; Netz Y, 2005, PSYCHOL AGING, V20, P272, DOI 10.1037/0882-7974.20.2.272; Padilla C, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00049; Padilla C, 2013, APPL COGNITIVE PSYCH, V27, P505, DOI 10.1002/acp.2929; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Posner MI, 2002, P NATL ACAD SCI USA, V99, P16366, DOI 10.1073/pnas.252644699; Prakash RS, 2011, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00229; Rabbitt P., 1997, METHODOLOGY FRONTAL, P1; Reason J. T., 1984, VARIETIES ATTENTION; Rueda MR, 2004, NEUROPSYCHOLOGIA, V42, P1029, DOI 10.1016/j.neuropsychologia.2003.12.012; Schneider W., 2002, E PRIME USERS GUIDE; Sibley BA, 2007, J SPORT EXERCISE PSY, V29, P783, DOI 10.1123/jsep.29.6.783; Sibley BA, 2006, J SPORT EXERCISE PSY, V28, P285, DOI 10.1123/jsep.28.3.285; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Verbruggen F, 2008, BEHAV RES METHODS, V40, P479, DOI 10.3758/BRM.40.2.479; Voelcker-Rehage C, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00026; Voss MW, 2013, HUM BRAIN MAPP, V34, P2972, DOI 10.1002/hbm.22119; Voss MW, 2013, BRAIN BEHAV IMMUN, V28, P90, DOI 10.1016/j.bbi.2012.10.021; Wechsler D, 1999, WECHSLER ADULT INTEL; Weiglein L, 2011, MIL MED, V176, P669, DOI 10.7205/MILMED-D-10-00444; Weinstein AM, 2012, BRAIN BEHAV IMMUN, V26, P811, DOI 10.1016/j.bbi.2011.11.008; Yucel M, 2012, NEUROPSYCHOLOGY, V26, P347, DOI 10.1037/a0027693; Zoeller RF, 2010, AM J LIFESTYLE MED, V4, P397, DOI 10.1177/1559827610374413	54	25	27	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101478	10.1371/journal.pone.0101478	http://dx.doi.org/10.1371/journal.pone.0101478			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK9RG	25010057	Green Published, gold, Green Submitted			2022-12-27	WOS:000338763800026
J	Cruickshank-Quinn, CI; Mahaffey, S; Justice, MJ; Hughes, G; Armstrong, M; Bowler, RP; Reisdorph, R; Petrache, I; Reisdorph, N				Cruickshank-Quinn, Charmion I.; Mahaffey, Spencer; Justice, Matthew J.; Hughes, Grant; Armstrong, Michael; Bowler, Russell P.; Reisdorph, Richard; Petrache, Irina; Reisdorph, Nichole			Transient and Persistent Metabolomic Changes in Plasma following Chronic Cigarette Smoke Exposure in a Mouse Model	PLOS ONE			English	Article							MASS-SPECTROMETRY; ADENOSINE-TRIPHOSPHATE; FATTY-ACIDS; HUMAN URINE; BIOMARKERS; NICOTINE; DISEASE; TOBACCO; PATHWAY; PENTAPHOSPHATE	Cigarette smoke exposure is linked to the development of a variety of chronic lung and systemic diseases in susceptible individuals. Metabolomics approaches may aid in defining disease phenotypes, may help predict responses to treatment, and could identify biomarkers of risk for developing disease. Using a mouse model of chronic cigarette smoke exposure sufficient to cause mild emphysema, we investigated whether cigarette smoke induces distinct metabolic profiles and determined their persistence following smoking cessation. Metabolites were extracted from plasma and fractionated based on chemical class using liquid-liquid and solid-phase extraction prior to performing liquid chromatography mass spectrometry-based metabolomics. Metabolites were evaluated for statistically significant differences among group means (p-value <= 0.05) and fold change >= 1.5). Cigarette smoke exposure was associated with significant differences in amino acid, purine, lipid, fatty acid, and steroid metabolite levels compared to air exposed animals. Whereas 60% of the metabolite changes were reversible, 40% of metabolites remained persistently altered even following 2 months of smoking cessation, including nicotine metabolites. Validation of metabolite species and translation of these findings to human plasma metabolite signatures induced by cigarette smoking may lead to the discovery of biomarkers or pathogenic pathways of smoking-induced disease.	[Cruickshank-Quinn, Charmion I.; Mahaffey, Spencer; Armstrong, Michael; Reisdorph, Richard; Reisdorph, Nichole] Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO USA; [Cruickshank-Quinn, Charmion I.; Mahaffey, Spencer; Armstrong, Michael; Reisdorph, Richard; Reisdorph, Nichole] Univ Colorado, Sch Med, Denver, CO USA; [Mahaffey, Spencer] Univ Colorado Denver, Sch Med, Dept Pharmacol, Aurora, CO USA; [Justice, Matthew J.; Petrache, Irina] Indiana Univ, Dept Med, Indianapolis, IN 46202 USA; [Justice, Matthew J.; Petrache, Irina] Indiana Univ, Dept Biochem & Mol Biol, Indianapolis, IN USA; [Hughes, Grant] Univ Colorado Denver, Dept Biostat & Informat, Aurora, CO USA; [Bowler, Russell P.] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Reisdorph, Richard] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [Petrache, Irina] Richard L Roudebush VA Med Ctr, Indianapolis, IN USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health; National Jewish Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Petrache, I (corresponding author), Indiana Univ, Dept Med, Indianapolis, IN 46202 USA.	ipetrach@iu.edu; ReisdorphN@NJHealth.org	Mahaffey, Spencer/AAC-8712-2021; Petrache, Irina/AAZ-9648-2020; Reisdorph, Nichole/AAX-8774-2020	Reisdorph, Nichole/0000-0002-0425-8012; Cruickshank-Quinn, Charmion/0000-0002-5553-8663	National Heart, Lung and Blood Institute (NHLBI) [RO1HL 09543, P20 HL-113445-01, U01 HL089856, U01 HL089897]; NCRR/HIH [UL1 RR025780]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077328, R01HL095432, R01HL089856, P20HL113445, U01HL089897, R01HL105772, U01HL089856] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR/HIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Heart, Lung and Blood Institute (NHLBI RO1HL 095432, P20 HL-113445-01, U01 HL089856, U01 HL089897); and UL1 RR025780 from NCRR/HIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon M, 2013, TALANTA, V115, P896, DOI 10.1016/j.talanta.2013.07.010; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Barr J, 2010, J PROTEOME RES, V9, P4501, DOI 10.1021/pr1002593; Bartalesi B, 2005, EUR RESPIR J, V25, P15, DOI 10.1183/09031936.04.00067204; Bolte G, 2006, CLIN EXP ALLERGY, V36, P293, DOI 10.1111/j.1365-2222.2006.02441.x; Diab KJ, 2010, AM J RESP CRIT CARE, V181, P344, DOI 10.1164/rccm.200906-0826OC; Dong J, 2010, METABOLOMICS, V6, P478, DOI 10.1007/s11306-010-0215-x; DRIVER AG, 1993, AM REV RESPIR DIS, V148, P91, DOI 10.1164/ajrccm/148.1.91; Duskova M, 2013, J STEROID BIOCH MOL; Esther CR, 2011, CHEST, V140, P954, DOI 10.1378/chest.10-2471; FIELD AE, 1994, J CLIN ENDOCR METAB, V79, P1310, DOI 10.1210/jc.79.5.1310; Gibellini F, 2010, IUBMB LIFE, V62, P414, DOI 10.1002/iub.337; Golfman LS, 1999, J LIPID RES, V40, P1818; Hecht SS, 1999, CHEM RES TOXICOL, V12, P172, DOI 10.1021/tx980214i; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hu CW, 2014, ARCH TOXICOL, V88, P291, DOI 10.1007/s00204-013-1137-y; HUANG TW, 1977, AM J PATHOL, V87, P647; Hughes G, 2014, BIOINFORMATICS, V30, P133, DOI 10.1093/bioinformatics/btt589; Jacob P, 1999, AM J PUBLIC HEALTH, V89, P731, DOI 10.2105/AJPH.89.5.731; Jacob P, 2011, J CHROMATOGR B, V879, P267, DOI 10.1016/j.jchromb.2010.12.012; Kang SM, 2011, CLIN BIOCHEM, V44, P293, DOI 10.1016/j.clinbiochem.2010.11.010; Kapoor D, 2005, EUR J ENDOCRINOL, V152, P491, DOI 10.1530/eje.1.01867; Lazar Z, 2008, INFLAMM RES, V57, P367, DOI 10.1007/s00011-008-8009-6; Lommatzsch M, 2010, AM J RESP CRIT CARE, V181, P928, DOI 10.1164/rccm.200910-1506OC; Luo JK, 2004, HYPERTENSION, V43, P1055, DOI 10.1161/01.hyp.0000126110.46402.dd; M'Koma AE, 2007, BIOCHEM BIOPH RES CO, V353, P829, DOI 10.1016/j.bbrc.2006.12.111; Matsuyama W, 2005, CHEST, V128, P3817, DOI 10.1378/chest.128.6.3817; Murphy SE, 2013, J EXPO SCI ENV EPID, V23, P513, DOI 10.1038/jes.2013.7; OOSTERHOFF Y, 1993, AM REV RESPIR DIS, V147, P553, DOI 10.1164/ajrccm/147.3.553; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Petrusca DN, 2010, J BIOL CHEM, V285, P40322, DOI 10.1074/jbc.M110.137604; Saha S, 2013, ANAL BIOANAL CHEM, V405, P9265, DOI 10.1007/s00216-013-7351-x; Schweitzer KS, 2011, AM J RESP CRIT CARE, V183, P215, DOI 10.1164/rccm.201001-0126OC; Shoji T, 2010, PLANT CELL, V22, P3390, DOI 10.1105/tpc.110.078543; Steiber Alison, 2004, Molecular Aspects of Medicine, V25, P455, DOI 10.1016/j.mam.2004.06.006; Sumner L. W., 2007, PROPOSED MINIMUM REP; Tolle M, 2006, J HYPERTENS, V24, P1991; Togna AR, 2008, PLATELETS, V19, P537, DOI 10.1080/09537100802272626; Ubhi BK, 2012, MOL BIOSYST, V8, P3125, DOI 10.1039/c2mb25194a; Vasan RS, 2006, CIRCULATION, V113, P2335, DOI 10.1161/CIRCULATIONAHA.104.482570; Versluis M, 2009, VIRCHOWS ARCH, V454, P273, DOI 10.1007/s00428-009-0727-9; Virmani Ashraf, 2004, Molecular Aspects of Medicine, V25, P533, DOI 10.1016/j.mam.2004.06.003; WAGNER R, 1986, PHYSIOL PLANTARUM, V68, P667, DOI 10.1111/j.1399-3054.1986.tb03415.x; Weems JM, 2009, TOXICOL SCI, V112, P59, DOI 10.1093/toxsci/kfp201; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Xie FW, 2013, TALANTA, V115, P435, DOI 10.1016/j.talanta.2013.05.048; Xu T, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-60; Yang YH, 2013, J CHROMATOGR A, V1300, P217, DOI 10.1016/j.chroma.2013.04.030	50	30	30	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101855	10.1371/journal.pone.0101855	http://dx.doi.org/10.1371/journal.pone.0101855			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007263	Green Published, Green Submitted, gold			2022-12-27	WOS:000339040600074
J	Dovega, R; Tsutakawa, S; Quistgaard, EM; Anandapadamanaban, M; Low, C; Nordlund, P				Dovega, Rebecca; Tsutakawa, Susan; Quistgaard, Esben M.; Anandapadamanaban, Madhanagopal; Low, Christian; Nordlund, Par			Structural and Biochemical Characterization of Human PR70 in Isolation and in Complex with the Scaffolding Subunit of Protein Phosphatase 2A	PLOS ONE			English	Article							CALCIUM-BINDING PROTEIN; SERINE/THREONINE PHOSPHATASES; REGULATORY SUBUNIT; B''/PR72 SUBUNIT; PP2A; IDENTIFICATION; CONFORMATIONS; COMPUTATION; HOLOENZYME; INTERACTS	Protein Phosphatase 2A (PP2A) is a major Ser/Thr phosphatase involved in the regulation of various cellular processes. PP2A assembles into diverse trimeric holoenzymes, which consist of a scaffolding (A) subunit, a catalytic (C) subunit and various regulatory (B) subunits. Here we report a 2.0 angstrom crystal structure of the free B ''/PR70 subunit and a SAXS model of an A/PR70 complex. The crystal structure of B ''/PR70 reveals a two domain elongated structure with two Ca2+ binding EF-hands. Furthermore, we have characterized the interaction of both binding partner and their calcium dependency using biophysical techniques. Ca2+ biophysical studies with Circular Dichroism showed that the two EF-hands display different affinities to Ca2+. In the absence of the catalytic C-subunit, the scaffolding A-subunit remains highly mobile and flexible even in the presence of the B ''/PR70 subunit as judged by SAXS. Isothermal Titration Calorimetry studies and SAXS data support that PR70 and the A-subunit have high affinity to each other. This study provides additional knowledge about the structural basis for the function of B '' containing holoenzymes.	[Dovega, Rebecca; Quistgaard, Esben M.; Anandapadamanaban, Madhanagopal; Low, Christian; Nordlund, Par] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Tsutakawa, Susan] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Anandapadamanaban, Madhanagopal] Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden; [Nordlund, Par] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	Karolinska Institutet; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Linkoping University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Nordlund, P (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	par.nordlund@ki.se	Anandapadamanaban, Madhanagopal/F-3702-2014	Quistgaard, Esben/0000-0002-1381-3364; Loew, Christian/0000-0003-0764-7483; Tsutakawa, Susan/0000-0002-4918-4571; Anandapadamanaban, Madhanagopal/0000-0002-4237-0048	Danish Council for Independent Research (Medical Sciences) [271-09-0187]; European Molecular Biology Organization (EMBO); Swedish Research council; European Community under BioStruct-X [783]; Swedish Cancer Society	Danish Council for Independent Research (Medical Sciences)(Det Frie Forskningsrad (DFF)); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Swedish Research council(Swedish Research CouncilEuropean Commission); European Community under BioStruct-X; Swedish Cancer Society(Swedish Cancer Society)	The authors thank their group members for suggestions and comments on the manuscript. E.M.Q. was supported by The Danish Council for Independent Research (Medical Sciences; grant 271-09-0187). C.L. was supported by a European Molecular Biology Organization (EMBO) postdoctoral fellowship. This research was further supported by grants from the Swedish Research council and Swedish Cancer Society. The authors thank Diamond Light Source for access to beamline 104 (MX5873 and MX6603) that contributed to the results presented here. The authors acknowledge the Protein Science Facility at the Karolinska Institutet for providing crystallization infrastructure. The research leading to these results has furthermore received funding from the European Community's Seventh Framework Program (FP7/2007-2013) under BioStruct-X (grant agreement No783). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahn JH, 2007, P NATL ACAD SCI USA, V104, P9876, DOI 10.1073/pnas.0703589104; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho US, 2007, PLOS BIOL, V5, P1810, DOI 10.1371/journal.pbio.0050202; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Classen S, 2013, J APPL CRYSTALLOGR, V46, P1, DOI 10.1107/S0021889812048698; Classen S, 2010, J SYNCHROTRON RADIAT, V17, P774, DOI 10.1107/S0909049510028566; COOK WJ, 1993, J MOL BIOL, V229, P461, DOI 10.1006/jmbi.1993.1046; Creyghton MP, 2006, P NATL ACAD SCI USA, V103, P5397, DOI 10.1073/pnas.0507237103; Creyghton MP, 2005, GENE DEV, V19, P376, DOI 10.1101/gad.328905; Davis AJ, 2008, J BIOL CHEM, V283, P16104, DOI 10.1074/jbc.M710313200; DeLano W, 2003, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gallego M, 2005, CURR OPIN CELL BIOL, V17, P197, DOI 10.1016/j.ceb.2005.01.002; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Graslund S, 2008, PROTEIN EXPRES PURIF, V58, P210, DOI 10.1016/j.pep.2007.11.008; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Grinthal A, 2010, P NATL ACAD SCI USA, V107, P2467, DOI 10.1073/pnas.0914073107; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Hura GL, 2013, NAT METHODS, V10, P453, DOI 10.1038/nmeth.2453; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Janssens V, 2003, J BIOL CHEM, V278, P10697, DOI 10.1074/jbc.M211717200; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lambrecht C, 2013, METHODS MOL BIOL, V1053, P283, DOI 10.1007/978-1-62703-562-0_17; Lechward K, 2001, ACTA BIOCHIM POL, V48, P921; Low C, 2013, BBA-GEN SUBJECTS, V1830, P3497, DOI 10.1016/j.bbagen.2013.02.001; Low C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038244; Magenta A, 2008, MOL CELL BIOL, V28, P873, DOI 10.1128/MCB.00480-07; Magnusdottir A, 2009, PROTEINS, V74, P212, DOI 10.1002/prot.22150; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Poornam GP, 2009, PROTEINS, V76, P201, DOI 10.1002/prot.22339; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Sablina AA, 2010, CANCER RES, V70, P10474, DOI 10.1158/0008-5472.CAN-10-2855; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Sents W, 2013, FEBS J, V280, P644, DOI 10.1111/j.1742-4658.2012.08579.x; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Shi YG, 2009, SCI CHINA SER C, V52, P135, DOI 10.1007/s11427-009-0018-3; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Tsutakawa SE, 2011, P NATL ACAD SCI USA, V108, P17672, DOI 10.1073/pnas.1110480108; VIJAYKUMAR S, 1992, J MOL BIOL, V224, P413, DOI 10.1016/0022-2836(92)91004-9; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wlodarchak N, 2013, CELL RES, V23, P931, DOI 10.1038/cr.2013.77; Wurzenberger C, 2011, NAT REV MOL CELL BIO, V12, P469, DOI 10.1038/nrm3149; Xing Y, 2006, CELL, V127, P341, DOI 10.1016/j.cell.2006.09.025; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Xu Z, 2009, MOL CELL, V35, P426, DOI 10.1016/j.molcel.2009.06.031; Yan Z, 2000, MOL CELL BIOL, V20, P1021, DOI 10.1128/MCB.20.3.1021-1029.2000; Zhou J, 2003, BIOCHEM J, V369, P387, DOI 10.1042/BJ20021244	59	9	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101846	10.1371/journal.pone.0101846	http://dx.doi.org/10.1371/journal.pone.0101846			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007185	Green Published, Green Submitted, gold			2022-12-27	WOS:000339040600073
J	Kared, H; Saeed, S; Klein, MB; Shoukry, NH				Kared, Hassen; Saeed, Sahar; Klein, Marina B.; Shoukry, Naglaa H.			CD127 Expression, Exhaustion Status and Antigen Specific Proliferation Predict Sustained Virologic Response to IFN in HCV/HIV Co-Infected Individuals	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; HUMAN-IMMUNODEFICIENCY-VIRUS; CD8 T-CELLS; INTERLEUKIN-7 RECEPTOR-ALPHA; LIVER-DISEASE; PLUS RIBAVIRIN; HIV-INFECTION; LYMPHOCYTE ACTIVATION; IMMUNE ACTIVATION; GENE-EXPRESSION	Hepatitis C virus (HCV) infection is a major cause of morbidity and mortality in the HIV co-infected population. Interferon-alpha (IFN-alpha) remains a major component of anti-HCV therapy despite its deleterious effects on the immune system. Furthermore, IFN-alpha was recently shown to diminish the size of the latent HIV reservoir. The objectives of this study were to monitor the impact of IFN-alpha on T cell phenotype and proliferation of HIV and HCV-specific T cells during IFN therapy, and to identify immune markers that can predict the response to IFN in HICV/HIV co-infected patients. We performed longitudinal analyses of T cell numbers, phenotype and function in co-infected patients undergoing IFN-alpha therapy with different outcomes including IFN-alpha non-responders (NR) (n = 9) and patients who achieved sustained virologic response (SVR) (n = 19). We examined the expression of activation (CD38, HLA-DR), functional (CD127) and exhaustion markers (PD1, Tim-3, CD160 and CD244) on total CD4 and CD8 T cells before, during and after therapy. In addition, we examined the HIV- and HCV-specific proliferative responses against HIV-p24 and HCV-NS3 proteins. Frequencies of CD127(+) CD4 T cells were higher in SVR than in NR patients at baseline. An increase in CD127 expression on CD8 T cells was observed after IFN-alpha therapy in all patients. In addition, CD8 T cells from NR patients expressed a higher exhaustion status at baseline. Finally, SVR patients exhibited higher proliferative response against both HIV and HCV antigens at baseline. Altogether, SVR correlated with higher expression of CD127, lower T cell exhaustion status and better HIV and HCV proliferative responses at baseline. Such factors might be used as non-invasive methods to predict the success of IFN-based therapies in co-infected individuals.	[Kared, Hassen; Shoukry, Naglaa H.] CRCHUM, Montreal, PQ, Canada; [Saeed, Sahar; Klein, Marina B.] McGill Univ, Hlth Ctr, Royal Victoria Hosp, Dept Med,Div Infect Dis,Chron Viral Illness Serv, Montreal, PQ, Canada; [Shoukry, Naglaa H.] Univ Montreal, Fac Med, Dept Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; McGill University; Royal Victoria Hospital; Universite de Montreal	Shoukry, NH (corresponding author), CRCHUM, Montreal, PQ, Canada.	naglaa.shoukry@umontreal.ca	Kared, Hassen/AAD-7247-2020	Klein, Marina/0000-0002-3063-8430; Saeed, Sahar/0000-0002-0224-379X	Canadian Foundation of AIDS Research (CANFAR); Canadian Institutes for Health Research (CIHR); Fonds de recherche du Quebec - Sante (FRQS); FRQS; FRQS AIDS and Infectious Disease Network (Reseau FRQS SIDA-MI); Canadian Institutes of Health Research [CIHR MOP-79529]; CIHR Canadian HIV Trials Network [CTN222]	Canadian Foundation of AIDS Research (CANFAR); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec - Sante (FRQS)(Fonds de la Recherche en Sante du Quebec); FRQS; FRQS AIDS and Infectious Disease Network (Reseau FRQS SIDA-MI); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); CIHR Canadian HIV Trials Network(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Foundation of AIDS Research (CANFAR). HK received a postdoctoral fellowship from the Canadian Institutes for Health Research (CIHR). NHS is supported by a Chercheur boursier - Senior career award from the Fonds de recherche du Quebec - Sante (FRQS). MBK is supported by a Chercheur nationaux career award from the FRQS. This Canadian Co-infection cohort is funded by the FRQS AIDS and Infectious Disease Network (Reseau FRQS SIDA-MI), the Canadian Institutes of Health Research (CIHR MOP-79529) and the CIHR Canadian HIV Trials Network (CTN222). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Mohsen M, 2014, J VIROL, V88, P763, DOI 10.1128/JVI.02687-13; Al-Mohri H, 2005, HIV MED, V6, P375, DOI 10.1111/j.1468-1293.2005.00330.x; Apolinario A, 2002, AM J GASTROENTEROL, V97, P2861, DOI 10.1111/j.1572-0241.2002.07054.x; Azzoni L, 2013, J INFECT DIS, V207, P213, DOI 10.1093/infdis/jis663; Badr G, 2008, J VIROL, V82, P10017, DOI 10.1128/JVI.01083-08; Bengsch B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000947; Beq S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034326; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Byrnes AA, 2001, EUR J IMMUNOL, V31, P2026, DOI 10.1002/1521-4141(200107)31:7<2026::AID-IMMU2026>3.3.CO;2-L; Carrat F, 2004, JAMA-J AM MED ASSOC, V292, P2839, DOI 10.1001/jama.292.23.2839; Chandele A, 2008, J IMMUNOL, V180, P5309, DOI 10.4049/jimmunol.180.8.5309; Chattopadhyay PK, 2010, CYTOM PART A, V77A, P614, DOI 10.1002/cyto.a.20905; Chen JY, 2014, NAT REV GASTRO HEPAT, V11, DOI 10.1038/nrgastro.2014.17; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Chevalier MF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003453; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chung RT, 2004, NEW ENGL J MED, V351, P451, DOI 10.1056/NEJMoa032653; Douek DC, 2003, ANNU REV IMMUNOL, V21, P265, DOI 10.1146/annurev.immunol.21.120601.141053; EYSTER ME, 1994, BLOOD, V84, P1020; Favre D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000295; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Goedert JJ, 2002, BLOOD, V100, P1584; Golden-Mason L, 2006, HEPATOLOGY, V44, P1098, DOI 10.1002/hep.21365; Gonzalez VD, 2009, J VIROL, V83, P11407, DOI 10.1128/JVI.01211-09; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; Grenningloh R, 2011, J IMMUNOL, V186, P969, DOI 10.4049/jimmunol.1002099; Haas A, 2011, J VIROL, V85, P12102, DOI 10.1128/JVI.05607-11; He XS, 1999, P NATL ACAD SCI USA, V96, P5692, DOI 10.1073/pnas.96.10.5692; Henriques CM, 2010, BLOOD, V115, P3269, DOI 10.1182/blood-2009-10-246876; Heydtmann M, 2005, J IMMUNOL, V174, P1055, DOI 10.4049/jimmunol.174.2.1055; Joshi D, 2011, LANCET, V377, P1198, DOI 10.1016/S0140-6736(10)62001-6; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kared H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003422; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kim AY, 2006, PLOS MED, V3, P2324, DOI 10.1371/journal.pmed.0030492; Kim AY, 2005, BLOOD, V105, P1170, DOI 10.1182/blood-2004-06-2336; Klein MB, 2010, INT J EPIDEMIOL, V39, P1162, DOI 10.1093/ije/dyp297; Kong XN, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00069; Kovacs A, 2008, J INFECT DIS, V197, P1402, DOI 10.1086/587696; Kovacs A, 2010, J INFECT DIS, V201, P823, DOI 10.1086/650997; Labarga P, 2010, JAIDS-J ACQ IMM DEF, V53, P364, DOI 10.1097/QAI.0b013e3181bd5ce1; Larrubia JR, 2007, J HEPATOL, V47, P632, DOI 10.1016/j.jhep.2007.04.009; Luetkemeyer A, 2006, JAIDS-J ACQ IMM DEF, V41, P31, DOI 10.1097/01.qai.0000191281.77954.27; Luo HY, 2011, J BIOL CHEM, V286, P44976, DOI 10.1074/jbc.M111.316414; Manion M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030306; Marchetti G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032028; McNamara LA, 2013, J INFECT DIS, V207, P201, DOI 10.1093/infdis/jis667; Moir S, 2011, ANNU REV PATHOL-MECH, V6, P223, DOI 10.1146/annurev-pathol-011110-130254; Naggie S, 2012, GASTROENTEROLOGY, V142, P1324, DOI 10.1053/j.gastro.2012.02.012; Netski DM, 2007, J INFECT DIS, V195, P857, DOI 10.1086/511826; Oo YH, 2010, DIGEST DIS, V28, P31, DOI 10.1159/000282062; Parker R, 2010, BLOOD, V116, P5589, DOI 10.1182/blood-2010-03-276261; PLEIMAN CM, 1991, MOL CELL BIOL, V11, P3052, DOI 10.1128/MCB.11.6.3052; RAMZAOUI S, 1995, CLIN IMMUNOL IMMUNOP, V77, P33, DOI 10.1016/0090-1229(95)90134-5; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Shields PL, 1999, J IMMUNOL, V163, P6236; Sodora DL, 2008, AIDS, V22, P439, DOI 10.1097/QAD.0b013e3282f2dbe7; Soriano V, 2007, AIDS, V21, P1073, DOI 10.1097/QAD.0b013e3281084e4d; Sulkowski MS, 2007, J VIRAL HEPATITIS, V14, P371, DOI 10.1111/j.1365-2893.2006.00816.x; Sulkowski MS, 2013, LIVER INT, V33, P63, DOI 10.1111/liv.12082; Taylor LE, 2012, CLIN INFECT DIS, V55, pS33, DOI 10.1093/cid/cis367; Thomas DL, 1996, J INFECT DIS, V174, P690, DOI 10.1093/infdis/174.4.690; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; Torriani FJ, 2004, NEW ENGL J MED, V351, P438, DOI 10.1056/NEJMoa040842; Vali B, 2010, EUR J IMMUNOL, V40, P2493, DOI 10.1002/eji.201040340; Vali B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003454; Xue HH, 2004, NAT IMMUNOL, V5, P1036, DOI 10.1038/ni1117; Younes SA, 2003, J EXP MED, V198, P1909, DOI 10.1084/jem.20031598	70	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101441	10.1371/journal.pone.0101441	http://dx.doi.org/10.1371/journal.pone.0101441			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007250	Green Published, gold, Green Submitted			2022-12-27	WOS:000339040600037
J	Zheng, HZ; Gaff, H; Smith, G; DeLisle, S				Zheng, Hongzhang; Gaff, Holly; Smith, Gary; DeLisle, Sylvain			Epidemic Surveillance Using an Electronic Medical Record: An Empiric Approach to Performance Improvement	PLOS ONE			English	Article							MEDIATED ISOTHERMAL AMPLIFICATION; ECHINOCOCCUS-GRANULOSUS; CYSTIC ECHINOCOCCOSIS; RAPID DETECTION; CANINE ECHINOCOCCOSIS; HYDATID-DISEASE; MULTILOCULARIS; LAMP; INFECTION; DIAGNOSIS	Backgrounds: Electronic medical records (EMR) form a rich repository of information that could benefit public health. We asked how structured and free-text narrative EMR data should be combined to improve epidemic surveillance for acute respiratory infections (ARI). Methods: Eight previously characterized ARI case detection algorithms (CDA) were applied to historical EMR entries to create authentic time series of daily ARI case counts (background). An epidemic model simulated influenza cases (injection). From the time of the injection, duster-detection statistics were applied daily on paired background+injection (combined) and background-only time series. This cycle was then repeated with the injection shifted to each week of the evaluation year. We computed: a) the time from injection to the first statistical alarm uniquely found in the combined dataset (Detection Delay); b) how often alarms originated in the background-only dataset (false-alarm rate, or FAR); and c) the number of cases found within these false alarms (Caseload). For each CDA, we plotted the Detection Delay as a function of FAR or Caseload, over a broad range of alarm thresholds. Results: CDAs that combined text analyses seeking ARI symptoms in clinical notes with provider-assigned diagnostic codes in order to maximize the precision rather than the sensitivity of case-detection lowered Detection Delay at any given FAR or Caseload. Conclusion: An empiric approach can guide the integration of EMR data into case-detection methods that improve both the timeliness and efficiency of epidemic detection.	[Zheng, Hongzhang; DeLisle, Sylvain] Vet Affairs Maryland Hlth Care Syst, Baltimore, MD 21201 USA; [Zheng, Hongzhang; DeLisle, Sylvain] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Gaff, Holly] Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA; [Smith, Gary] Univ Penn, Sch Vet Med, Kennett Sq, PA USA	University System of Maryland; University of Maryland Baltimore; Old Dominion University; University of Pennsylvania	DeLisle, S (corresponding author), Vet Affairs Maryland Hlth Care Syst, Baltimore, MD 21201 USA.	sdelisle@umaryland.edu		Gaff, Holly/0000-0002-4034-2684	Office of Research and Development, Health Services Research and Development Service, Department of Veterans Affairs [IIR 06-119-1]; Centers for Disease Control and Prevention [R01 CI000098, 5U38HK000013-02]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [R01CI000098] Funding Source: NIH RePORTER	Office of Research and Development, Health Services Research and Development Service, Department of Veterans Affairs(US Department of Veterans Affairs); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This material is the result of work supported with resources and the use of facilities at the VA Maryland Health Care System. This work was also supported in part by grant IIR 06-119-1 from the Office of Research and Development, Health Services Research and Development Service, Department of Veterans Affairs. Development and validation of the ARI case-detection algorithm was supported by grants R01 CI000098 and 5U38HK000013-02 from the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrasi I, 2003, AM J TROP MED HYG, V69, P324, DOI 10.4269/ajtmh.2003.69.324; Aminzhanov M, 1975, Veterinariia, P70; Atkinson JAM, 2013, GLOBAL CHANGE BIOL, V19, P677, DOI 10.1111/gcb.12088; Bart JM, 2006, PARASITOLOGY, V133, P571, DOI 10.1017/S0031182006000734; Benner C, 2010, B WORLD HEALTH ORGAN, V88, P49, DOI 10.2471/BLT.09.066795; Boda K, 2002, STUD HEALTH TECHNOL, V90, P437; Boufana B, 2013, ACTA TROP, V127, P21, DOI 10.1016/j.actatropica.2013.02.019; Budke CM, 2006, EMERG INFECT DIS, V12, P296; Chai Jun-Jie, 1995, Biomedical and Environmental Sciences, V8, P122; Craig PS, 2007, LANCET INFECT DIS, V7, P385, DOI 10.1016/S1473-3099(07)70134-2; CRAIG PS, 1995, VET PARASITOL, V56, P293, DOI 10.1016/0304-4017(94)00680-B; Deplazes P., 1996, Applied Parasitology, V37, P245; Dinkel A, 1998, J CLIN MICROBIOL, V36, P1871, DOI 10.1128/JCM.36.7.1871-1876.1998; Eckert J, 2004, CLIN MICROBIOL REV, V17, P107, DOI 10.1128/CMR.17.1.107-135.2004; GEMMELL MA, 1986, PARASITOLOGY, V92, P599, DOI 10.1017/S0031182000065483; Heath D, 2006, PARASITOL INT, V55, pS247, DOI 10.1016/j.parint.2005.11.052; Hegglin D, 2013, INT J PARASITOL, V43, P327, DOI 10.1016/j.ijpara.2012.11.013; Huang Y, 2014, J HELMINTHOL, V88, P189, DOI 10.1017/S0022149X12000922; Ibrahim MM, 2010, ACTA TROP, V113, P26, DOI 10.1016/j.actatropica.2009.08.029; Jia WZ, 2011, CHINESE MED J-PEKING, V124, P2849, DOI 10.3760/cma.j.issn.0366-6999.2011.18.010; Kaneko H, 2007, J BIOCHEM BIOPH METH, V70, P499, DOI 10.1016/j.jbbm.2006.08.008; Le TH, 2002, PARASITOLOGY, V124, P97, DOI 10.1017/S0031182001008976; Lin ZB, 2012, VET PARASITOL, V185, P296, DOI 10.1016/j.vetpar.2011.10.016; Ma JY, 2012, PARASITOL RES, V111, P179, DOI 10.1007/s00436-012-2815-z; Ma ML, 2011, J CLIN MICROBIOL, V49, P2143, DOI 10.1128/JCM.02536-10; Mathis A, 1996, J HELMINTHOL, V70, P219, DOI 10.1017/S0022149X00015443; McManus DP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3866; McManus DP, 2003, PARASITOLOGY, V127, pS37, DOI 10.1017/S0031182003003524; McManus DP, 2003, LANCET, V362, P1295, DOI 10.1016/S0140-6736(03)14573-4; Morel N, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001967; Nakao R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-296; Nkouawa A, 2009, J CLIN MICROBIOL, V47, P168, DOI 10.1128/JCM.01573-08; Otero-Abad B, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002249; Parida M, 2004, J CLIN MICROBIOL, V42, P257, DOI 10.1128/JCM.42.1.257-263.2004; Salant H, 2012, AM J TROP MED HYG, V87, P883, DOI 10.4269/ajtmh.2012.12-0184; Sanchez E, 2010, MEM I OSWALDO CRUZ, V105, P806, DOI 10.1590/S0074-02762010000600013; Stefanic S, 2004, PARASITOL RES, V92, P347, DOI 10.1007/s00436-003-1043-y; Torgerson PR, 2009, TRENDS PARASITOL, V25, P164, DOI 10.1016/j.pt.2008.12.008; Varcasia A, 2011, VET PARASITOL, V181, P335, DOI 10.1016/j.vetpar.2011.05.006; Vuitton DA, 2003, PARASITOLOGY, V127, pS87, DOI 10.1017/S0031182003004153; Wang L, 2012, T ROY SOC TROP MED H, V106, P743, DOI 10.1016/j.trstmh.2012.09.003; Wang ZH, 2008, ECOHEALTH, V5, P115, DOI 10.1007/s10393-008-0174-0; Wassermann M, 2014, VET PARASITOL, V200, P97, DOI 10.1016/j.vetpar.2013.12.012; Xiao N, 2006, AM J TROP MED HYG, V75, P292, DOI 10.4269/ajtmh.2006.75.292; Yang YR, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000426; Zhang WB, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000534; Zhang YL, 2006, VET PARASITOL, V139, P244, DOI 10.1016/j.vetpar.2006.03.003; Zhang YL, 2005, CHINESE J PARASITOLO, V18, P333	48	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e100845	10.1371/journal.pone.0100845	http://dx.doi.org/10.1371/journal.pone.0100845			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006878	Green Submitted, Green Published, gold			2022-12-27	WOS:000339040600021
J	Jojart, B; Posa, M; Fiser, B; Szori, M; Farkas, Z; Viskolcz, B				Jojart, Balazs; Posa, Mihalj; Fiser, Bela; Szori, Milan; Farkas, Zita; Viskolcz, Bela			Mixed Micelles of Sodium Cholate and Sodium Dodecylsulphate 1:1 Binary Mixture at Different Temperatures - Experimental and Theoretical Investigations	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATION; COUNTERION CONDENSATION THEORY; BILE-ACID SALTS; INITIAL CONFIGURATIONS; AQUEOUS-SOLUTIONS; SOLUBILIZATION; MICELLIZATION; ASSOCIATION; COMPLEXES; MORPHINE	Micellisation process for sodium dodecyl sulphate and sodium cholate in 1:1 molar ratio was investigated in a combined approach, including several experimental methods and coarse grained molecular dynamics simulation. The critical micelle concentration (cmc) of mixed micelle was determined by spectrofluorimetric and surface tension measurements in the temperature range of 0-50 degrees C and the values obtained agreed with each other within the statistical error of the measurements. In range of 0-25 degrees C the cmc values obtained are temperature independent while cmc values were increased at higher temperature, which can be explained by the intensive motion of the monomers due to increased temperature. The evidence of existing synergistic effect among different constituent units of the micelle is indicated clearly by the interaction parameter (beta(1,2)) calculated from cmc values according to Rubingh. As the results of the conductivity measurements showed the negative surface charges of the SDS-NaCA micelle are not neutralized by counterions. Applying a 10 mu s long coarse-grained molecular dynamics simulation for system including 30-30 SDS and CA (with appropriate number of Na+ cations and water molecules) we obtained semi-quantitative agreement with the experimental results. Spontaneous aggregation of the surfactant molecules was obtained and the key steps of the micelle formation are identified: First a stable SDS core was formed and thereafter due to the entering CA molecules the size of the micelle increased and the SDS content decreased. In addition the size distribution and composition as well as the shape and structure of micelles are also discussed.	[Jojart, Balazs; Fiser, Bela; Szori, Milan; Viskolcz, Bela] Univ Szeged, Fac Educ, Dept Chem Informat, Szeged, Hungary; [Posa, Mihalj; Farkas, Zita] Univ Novi Sad, Fac Med, Dept Pharm, Novi Sad 21000, Serbia	Szeged University; University of Novi Sad	Jojart, B (corresponding author), Univ Szeged, Fac Educ, Dept Chem Informat, Szeged, Hungary.	jojartb@jgypk.u-szeged.hu	Viskolcz, Béla/Q-6225-2019; Szőri, Milán/B-7152-2011; Viskolcz, Bela/R-3927-2017	Viskolcz, Béla/0000-0002-0777-9569; Szőri, Milán/0000-0003-4895-0999; Viskolcz, Bela/0000-0002-0777-9569; Fiser, Bela/0000-0003-0603-4626; Posa, Mihalj/0000-0002-8044-2655	Hungary-Serbia IPA Cross-border Co-operation programme Bile Acid Nanosystems as Molecule Carriers in Pharmaceutical Applications (BANAMOCA) [HUSRB/1002/214/193]; New Functional Materials and Their Biological and Environmental Answers' [TAMOP-4.2.2.A-11/1/KONV-2012-0047]; European Union and Hungary - European Social Fund in the framework of TAMOP [4.2.4.A/2-11-1-2012-0001]; National Excellence Program [A2-MZPD-12-0139]; European Union; European Social Fund through project Supercomputer, the national virtual lab [TAMOP-4.2.2.C-11/1/KONV-2012-0010]	Hungary-Serbia IPA Cross-border Co-operation programme Bile Acid Nanosystems as Molecule Carriers in Pharmaceutical Applications (BANAMOCA); New Functional Materials and Their Biological and Environmental Answers'; European Union and Hungary - European Social Fund in the framework of TAMOP; National Excellence Program; European Union(European Commission); European Social Fund through project Supercomputer, the national virtual lab	This work was supported by the Hungary-Serbia IPA Cross-border Co-operation programme Bile Acid Nanosystems as Molecule Carriers in Pharmaceutical Applications (BANAMOCA) (project ID: HUSRB/1002/214/193). Infrastructural support was provided by "New Functional Materials and Their Biological and Environmental Answers'' (project ID: the TAMOP-4.2.2.A-11/1/KONV-2012-0047,). M.Sz. is a Magyary Zoltan fellow supported by the European Union and Hungary, co-financed by the European Social Fund in the framework of TAMOP (project ID: 4.2.4.A/2-11-1-2012-0001 'National Excellence Program' (A2-MZPD-12-0139)). This work was partially supported by the European Union and the European Social Fund through project Supercomputer, the national virtual lab (grant no.: TAMOP-4.2.2.C-11/1/KONV-2012-0010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balazs J, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4869832; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Calabresi M, 2007, MOLECULES, V12, P1731, DOI 10.3390/12081731; Camile W., 2003, PRACTICE MED CHEM; CLINT JH, 1975, J CHEM SOC FARAD T 1, V71, P1327, DOI 10.1039/f19757101327; HOFMANN AF, 1984, J LIPID RES, V25, P1477; Jalili S, 2009, COLLOID SURFACE A, V352, P99, DOI 10.1016/j.colsurfa.2009.10.007; KAWAMURA H, 1989, J PHYS CHEM-US, V93, P3321, DOI 10.1021/j100345a087; Kim JH, 1999, J PHYS CHEM B, V103, P10582, DOI 10.1021/jp991720z; Kuhajda I, 2009, EUR J DRUG METAB PH, V34, P73; MACKERELL AD, 1995, J PHYS CHEM-US, V99, P1846, DOI 10.1021/j100007a011; Manning GS, 2007, J PHYS CHEM B, V111, P8554, DOI 10.1021/jp0670844; Manning GS, 2010, J PHYS CHEM B, V114, P5435, DOI 10.1021/jp912234x; Manning GS, 2002, BIOPHYS CHEM, V101, P461, DOI 10.1016/S0301-4622(02)00162-X; Manning GS, 1996, PHYSICA A, V231, P236, DOI 10.1016/0378-4371(95)00452-1; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2004, FALK SYMP, V139, P98; Martinez JM, 2003, J COMPUT CHEM, V24, P819, DOI 10.1002/jcc.10216; Martinez L, 2009, J COMPUT CHEM, V30, P2157, DOI 10.1002/jcc.21224; Mikov M., 2007, BILE ACIDS; Mittal K.L., 1979, SOLUTION CHEM SURFAC; Partay LB, 2007, J PHYS CHEM B, V111, P9886, DOI 10.1021/jp072974k; PAULA S, 1995, J PHYS CHEM-US, V99, P11742, DOI 10.1021/j100030a019; Posa M, 2008, EUR J PHARM SCI, V34, P281, DOI 10.1016/j.ejps.2008.04.011; Posa M, 2012, COLLOID SURFACE B, V94, P317, DOI 10.1016/j.colsurfb.2012.02.014; Posa M, 2011, STEROIDS, V76, P85, DOI 10.1016/j.steroids.2010.09.003; Posa M, 2010, COLLECT CZECH CHEM C, V75, P767, DOI 10.1135/cccc2009559; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; RODA A, 1983, J BIOL CHEM, V258, P6362; Small D.M., 1971, BILE ACIDS CHEM PHYS, V1; Subuddhi U, 2007, COLLOID SURFACE B, V57, P102, DOI 10.1016/j.colsurfb.2007.01.009; Yu HR, 2000, J COLLOID INTERF SCI, V229, P375, DOI 10.1006/jcis.2000.7032	32	23	23	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e102114	10.1371/journal.pone.0102114	http://dx.doi.org/10.1371/journal.pone.0102114			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004142	Green Submitted, Green Published, gold			2022-12-27	WOS:000339242700110
J	Kim, HW; Kim, YH; Han, K; Nam, GE; Kim, GS; Han, BD; Lee, A; Ahn, JY; Ko, BJ				Kim, Hye Won; Kim, Yang-Hyun; Han, Kyungdo; Nam, Ga Eun; Kim, Gwang Seon; Han, Byoung-Duck; Lee, Anna; Ahn, Ji Yong; Ko, Byung Joon			Atrophic Gastritis: A Related Factor for Osteoporosis in Elderly Women	PLOS ONE			English	Article							BONE-MINERAL DENSITY; INTESTINAL METAPLASIA; HIP FRACTURE; RISK; CALCIUM; CLASSIFICATION; METAANALYSIS; PREVALENCE; DIAGNOSIS	Purpose: Osteoporosis poses a great threat to the aging society. Hypochlorhydric or achlorhydric conditions are risk factors for osteoporosis. Atrophic gastritis also decreases gastric acid production; however, the role of atrophic gastritis as a related factor for osteoporosis is unclear. We investigated the relationship between atrophic gastritis and osteoporosis in postmenopausal women over 60 years of age. Subjects and Methods: A total of 401 postmenopausal women were included in this cross-sectional study, which was conducted during their medical check-ups. Bone mineral densitometry was measured using a dual energy X-ray absorptiometry. Atrophic gastritis was defined endoscopically if gastric mucosa in the antrum and the body were found to be atrophied and thinned and submucosal vessels could be well visualized. Results: The proportion of people with atrophic gastritis was higher in the osteoporotic group than in the group without osteoporosis. A linear relationship was observed in the proportion of atrophic gastritis according to the categories of normal, osteopenia, and osteoporosis at the lumbar spine (p for trend = 0.039) and femur (p for trend = 0.001). A multiple logistic regression analysis revealed that the presence of atrophic gastritis was associated with an increased odds of osteoporosis after adjusting for age, body mass index, triglyceride, high-density lipoprotein cholesterol, alcohol consumption, and smoking status (odds ratio 1.89, 95% confidence interval 1.15-3.11). Conclusions: Atrophic gastritis is associated with an increased likelihood of osteoporosis in Korean elderly women.	[Kim, Hye Won; Kim, Yang-Hyun; Nam, Ga Eun; Kim, Gwang Seon; Han, Byoung-Duck; Ko, Byung Joon] Korea Univ, Coll Med, Dept Family Med, Seoul 136705, South Korea; [Han, Kyungdo] Catholic Univ, Coll Med, Dept Biostat, Seoul, South Korea; [Lee, Anna] Univ Hawaii Manoa, Coll Language Linguist & Literature, Dept East Asian Languages, Honolulu, HI 96822 USA; [Ahn, Ji Yong] Univ Ulsan, Coll Med, Dept Internal Med, Asan Med Ctr, Seoul, South Korea; [Ko, Byung Joon] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA	Korea University; Korea University Medicine (KU Medicine); Catholic University of Korea; University of Hawaii System; University of Hawaii Manoa; University of Ulsan; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Ahn, JY (corresponding author), Univ Ulsan, Coll Med, Dept Internal Med, Asan Med Ctr, Seoul, South Korea.	ji110@hanmail.net; basslove1@hanmail.net	Song, Young Goo/AGV-5104-2022; Nam, Ga Eun/AAA-1577-2021; Nam, Ga Eun/AAU-6055-2020; Ahn, Ji Yong/AGO-1695-2022	Song, Young Goo/0000-0002-0733-4156; Nam, Ga Eun/0000-0002-6739-9904; Kim, Yang-Hyun/0000-0003-3548-8758; han, byoungduck/0000-0003-2830-1174				Ahn SY, 2011, DIGEST DIS SCI, V56, P1119, DOI 10.1007/s10620-010-1531-8; AXELSON J, 1991, GUT, V32, P1298, DOI 10.1136/gut.32.11.1298; Berg KM, 2008, AM J MED, V121, P406, DOI 10.1016/j.amjmed.2007.12.012; CORREA P, 1988, AM J GASTROENTEROL, V83, P504; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; EASTELL R, 1992, CLIN SCI, V82, P681, DOI 10.1042/cs0820681; Eshmuratov A, 2010, DIGEST DIS SCI, V55, P1364, DOI 10.1007/s10620-009-0891-4; Finkelstein JS, 2008, J CLIN ENDOCR METAB, V93, P861, DOI 10.1210/jc.2007-1876; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kakehasi Adriana M., 2007, Arq. Gastroenterol., V44, P266, DOI 10.1590/S0004-28032007000300016; Kakehasi AM, 2009, DIGEST DIS SCI, V54, P819, DOI 10.1007/s10620-008-0417-5; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Kim N, 2008, HELICOBACTER, V13, P245, DOI 10.1111/j.1523-5378.2008.00604.x; Law MR, 1997, BMJ-BRIT MED J, V315, P841, DOI 10.1136/bmj.315.7112.841; Leung WK, 2004, GUT, V53, P1244, DOI 10.1136/gut.2003.034629; Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; MELTON LJ, 1992, J BONE MINER RES, V7, P1005, DOI 10.1002/jbmr.5650070902; Nguyen TV, 2000, J BONE MINER RES, V15, P322, DOI 10.1359/jbmr.2000.15.2.322; PAAKKONEN M, 1984, ACTA CHIR SCAND, V150, P485; RECKER RR, 1985, NEW ENGL J MED, V313, P70, DOI 10.1056/NEJM198507113130202; Rembiasz K, 2005, DIGEST DIS SCI, V50, P474, DOI 10.1007/s10620-005-2461-8; RICO H, 1992, CALCIFIED TISSUE INT, V51, P251, DOI 10.1007/BF00334483; Scibora LM, 2012, OBES SURG, V22, P654, DOI 10.1007/s11695-012-0596-1; Vilarrasa N, 2011, OBES SURG, V21, P465, DOI 10.1007/s11695-010-0338-1; Yang YX, 2006, JAMA-J AM MED ASSOC, V296, P2947, DOI 10.1001/jama.296.24.2947; Yoo KY, 2008, JPN J CLIN ONCOL, V38, P327, DOI 10.1093/jjco/hyn026; Yu EW, 2011, AM J MED, V124, P519, DOI 10.1016/j.amjmed.2011.01.007	28	26	28	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101852	10.1371/journal.pone.0101852	http://dx.doi.org/10.1371/journal.pone.0101852			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003598	gold, Green Published, Green Submitted			2022-12-27	WOS:000339242700078
J	Stoneburner, R; Korenromp, E; Lazenby, M; Tassie, JM; Letebele, J; Motlapele, D; Granich, R; Boerma, T; Low-Beer, D				Stoneburner, Rand; Korenromp, Eline; Lazenby, Mark; Tassie, Jean-Michel; Letebele, Judith; Motlapele, Diemo; Granich, Reuben; Boerma, Ties; Low-Beer, Daniel			Using Health Surveillance Systems Data to Assess the Impact of AIDS and Antiretroviral Treatment on Adult Morbidity and Mortality in Botswana	PLOS ONE			English	Article							HIV; THERAPY; PREVALENCE; COMMUNITY; SPECTRUM; DEATHS; TRENDS; BRAZIL; RISK	Introduction: Botswana's AIDS response included free antiretroviral treatment (ART) since 2002, achieving 80% coverage of persons with CD4<350 cells/mu l by 2009-10. We explored impact on mortality and HIV prevalence, analyzing surveillance and civil registration data. Methods: Hospital natural cause admissions and deaths from the Health Statistics Unit (HSU) over 1990-2009, all-cause deaths from Midnight Bed Census (MNC) over 1990-2011, institutional and non-institutional deaths recorded in the Registry of Birth and Deaths (RBD) over 2003-2010, and antenatal sentinel surveillance (ANC) over 1992-2011 were compared to numbers of persons receiving ART. Mortality was adjusted for differential coverage and completeness of institutional and non-institutional deaths, and compared to WHO and UNAIDS Spectrum projections. Results: HSU deaths per 1000 admissions declined 49% in adults 15-64 years over 2003-2009. RBD mortality declined 44% (807 to 452/100,000 population in adults 15-64 years) over 2003-2010, similarly in males and females. Generally, death rates were higher in males; declines were greater and earlier in younger adults, and in females. In contrast, death rates in adults 65+, particularly females increased over 2003-2006. MNC all-age post-neonatal mortality declined 46% and 63% in primary and secondary level hospitals, over 2003-2011. We estimated RBD captured 80% of adult deaths over 2006-2011. Comparing empirical, completeness-adjusted deaths to Spectrum estimates, declines over 2003-2009 were similar overall (47% vs. 54%); however, Spectrum projected larger and earlier declines particularly in women. Following stabilization and modest decreases over 1998-2002, HIV prevalence in pregnant women 15-24 and 25-29-years declined by >50% and >30% through 2011, while continuing to increase in older women. Conclusions: Adult mortality in Botswana fell markedly as ART coverage increased. HIV prevalence declines may reflect ART-associated reductions in sexual transmission. Triangulation of surveillance system data offers a reasonable approach to evaluate impact of HIV/AIDS interventions, complementing cohort approaches that monitor individual-level health outcomes.	[Stoneburner, Rand; Granich, Reuben] UNAIDS, Geneva, Switzerland; [Korenromp, Eline] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Korenromp, Eline] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Lazenby, Mark] Yale Univ, Sch Nursing, New Haven, CT 06536 USA; [Tassie, Jean-Michel] World Hlth Org, Geneva, Switzerland; [Letebele, Judith; Motlapele, Diemo] Republ Botswana Minist Hlth, Gaborone, Botswana; [Low-Beer, Daniel] Grad Inst Int & Dev Studies, Global Hlth Program, Geneva, Switzerland	UNAIDS; Erasmus University Rotterdam; Erasmus MC; Yale University; World Health Organization	Stoneburner, R (corresponding author), UNAIDS, Geneva, Switzerland.	rlstoneburner@gmail.com			Health Metrics Network, WHO	Health Metrics Network, WHO	The study was carried out as a collaborative investigation between UNAIDS (R. S. and R.G.), WHO (J.T. and T.B.), the Global Fund (E.K. and D.L.), the Yale University School of Nursing (M.L.) and the Botswana Ministry of Health (J.L. and D.M). The lead author (R. S.) was supported as an employee of UNAIDS from September 2009-2011 and afterwards, along with M.L under a contract from the Health Metrics Network, WHO. The conclusions and views are those of the authors, and do not necessarily represent the decisions, policy or views of UNAIDS, the Global Fund to Fight AIDS, Tuberculosis and Malaria, the World Health Organization, the Yale University School of Nursing, or the Botswana Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouZahr C, 2007, LANCET, V370, P1791, DOI 10.1016/S0140-6736(07)61310-5; Birnbaum JK, 2011, B WORLD HEALTH ORGAN, V89, P278, DOI 10.2471/BLT.11.086280; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; *BOTSW CENTR STAT, 2005, BOTSW AIDS IMP SURV; Botswana Central Statistics Office, 2011, BOTSW POP HOUS CENS; Botswana Central Statistics Office Botswana National AIDS Coordinating Agency, 2009, 2008 BOTSW AIDS IMP; Botswana National AIDS Control Programme (NACA), 2012, 4 BOTSW HIV AIDS IMP; Bradshaw D, 2012, RAPID MORTALITY SURV; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Chiasson MA, 1999, J ACQ IMMUN DEF SYND, V21, P59, DOI 10.1097/00126334-199905010-00008; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; Dako-Gyeke P, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-62; Dorrington R. E., 2006, DEMOGRAPHIC IMPACT H; Fazito E, 2012, SEX TRANSM INFECT, V88, pI86, DOI 10.1136/sextrans-2012-050632; Floyd S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013499; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Herbst AJ, 2009, B WORLD HEALTH ORGAN, V87, P754, DOI 10.2471/BLT.08.058982; Jahn A, 2008, LANCET, V371, P1603, DOI 10.1016/S0140-6736(08)60693-5; Johnson LF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001418; Joubert J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064592; Krishnan S, 2012, JAIDS-J ACQ IMM DEF, V61, P381, DOI 10.1097/QAI.0b013e3182690e3c; Lazenby M, 2010, PALLIAT SUPPORT CARE, V8, P177, DOI 10.1017/S1478951509990939; Letamo G, 2011, J BIOSOC SCI, V43, P75, DOI 10.1017/S0021932010000519; Majelantle A, 2006, COMMUNICATION; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; Ministry of Health of the Republic of Botswana, 2011, 2011 BOTSW 2 GEN HIV; Mwagomba B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010452; Negin J, 2010, JAIDS-J ACQ IMM DEF, V55, P239, DOI 10.1097/QAI.0b013e3181e9b3f2; Obermeyer Z, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000260; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Reniers G, 2009, AIDS, V23, P511, DOI 10.1097/QAD.0b013e32832403d0; STONEBURNER RL, 1988, SCIENCE, V242, P916, DOI 10.1126/science.3187532; Stoneburner RL, 1996, AM J EPIDEMIOL, V144, P682, DOI 10.1093/oxfordjournals.aje.a008981; Stover J, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010157; Taffa N, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-24; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; THOMAS PA, 1993, AM J EPIDEMIOL, V137, P121, DOI 10.1093/oxfordjournals.aje.a116652; Todd J, 2012, TROP MED INT HEALTH, V17, pe1, DOI 10.1111/j.1365-3156.2011.02947.x; Torres TS, 2013, BRAZ J INFECT DIS, V17, P324, DOI 10.1016/j.bjid.2012.10.024; UNAIDS, 2010, UNAIDS REP GLOB AIDS; *UNAIDS, 2009, AIDS EP UPD; UNAIDS, 2011, SPECTR EPP HIV POL M; United Nations Dept. of Economic and Social Affairs - population division peaps, 2012, WORLD POP PROSP 2012; United Nations Development Indicators Unit Statistics Division, 2008, MILL DEV GOALS IND; van Schalkwyk C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069437; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; World Health Organization, GLOB HLTH OBS DAT RE; Zaba B, 2007, AIDS, V21, pS87, DOI 10.1097/01.aids.0000299415.67646.26	48	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e100431	10.1371/journal.pone.0100431	http://dx.doi.org/10.1371/journal.pone.0100431			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003870	Green Published, gold, Green Submitted			2022-12-27	WOS:000339242700008
J	Fok, MLY; Stewart, R; Hayes, RD; Moran, P				Fok, Marcella Lei-Yee; Stewart, Robert; Hayes, Richard D.; Moran, Paul			Predictors of Natural and Unnatural Mortality among Patients with Personality Disorder: Evidence from a Large UK Case Register	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; SUBSTANCE USE DISORDERS; SERIOUS MENTAL-ILLNESS; OUTCOME SCALES HONOS; RISK-FACTORS; MEDICAL ILLNESSES; SUICIDAL-BEHAVIOR; SELF-HARM; PEOPLE; HEALTH	Background: People with personality disorder have reduced life expectancy, yet, within this population, little is known about the clinical predictors of natural and unnatural deaths. We set out to investigate this, using a large cohort of secondary mental health patients with personality disorder. Methods: We identified patients with an ICD-10 diagnosis of personality disorder, aged >= 15 years in a large secondary mental healthcare case register. The case register was linked to national mortality tracing. Using Cox regression, we modelled the effect of a number of pre-specified clinical variables on all-cause, natural cause and unnatural cause mortality. Findings: 2,440 patients were identified. Eighty-five deaths (3.5% of cohort) occurred over a 5-year observation period, of which over 50% were from natural causes. All-cause mortality was associated with alcohol or drug use (adjusted Hazard Ratio [aHR] 2.3; 95% CI 1.3-4.1), physical illness (aHR 1.9; 95% CI 1.0-3.6), and functional impairment (aHR 1.9; 95% CI 1.0-3.6). Natural cause mortality was associated with mild problems of alcohol or drug use (aHR 3.4; 95% CI 1.5-7.4), and physical illness (aHR 2.4; 95% CI 1.0-5.6). Unnatural cause mortality was associated only with severe alcohol or drug use (aHR 3.1; 95% CI 1.3-7.3). Interpretation: Alcohol and drug use, physical illness, and functional impairment are predictors of mortality in individuals with personality disorder. Clinicians should be aware of the existence of problems in these domains, even at mild levels, when assessing the needs of patients with personality disorder.	[Fok, Marcella Lei-Yee; Moran, Paul] Kings Coll London, Kings Hlth Partners, Dept Hlth Serv & Populat Res, Inst Psychiat, London, England; [Stewart, Robert; Hayes, Richard D.] Kings Coll London, Kings Hlth Partners, Dept Psychol Med, Inst Psychiat, London, England	University of London; King's College London; University of London; King's College London	Fok, MLY (corresponding author), Kings Coll London, Kings Hlth Partners, Dept Hlth Serv & Populat Res, Inst Psychiat, London, England.	marcella.fok@kcl.ac.uk	Stewart, Robert/B-1667-2010; Moran, Paul A/B-1740-2010; Hayes, Richard/D-2382-2010	Stewart, Robert/0000-0002-4435-6397; Moran, Paul A/0000-0002-9257-8699; Hayes, Richard/0000-0003-4453-244X	Clinical Records Interactive Search (CRIS) system - National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust; King's College London and a joint infrastructure grant from Guy's and St Thomas' Charity and the Maudsley Charity; Medical Research Council (MRC) Population Health Scientist Fellowship; MRC [MR/J01219X/1] Funding Source: UKRI; Medical Research Council [MR/J01219X/1] Funding Source: researchfish	Clinical Records Interactive Search (CRIS) system - National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust; King's College London and a joint infrastructure grant from Guy's and St Thomas' Charity and the Maudsley Charity; Medical Research Council (MRC) Population Health Scientist Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the Clinical Records Interactive Search (CRIS) system funded and developed by the National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London and a joint infrastructure grant from Guy's and St Thomas' Charity and the Maudsley Charity. The authors appreciated the technical support from informatics personnel in the Biomedical Research Centre. RH is funded by a Medical Research Council (MRC) Population Health Scientist Fellowship. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auquier P, 2006, PHARMACOEPIDEM DR S, V15, P873, DOI 10.1002/pds.1325; Bergen H, 2012, LANCET, V380, P1568, DOI 10.1016/S0140-6736(12)61141-6; Black DW, 2004, J PERS DISORD, V18, P226, DOI 10.1521/pedi.18.3.226.35445; Boyle SH, 2004, PSYCHOSOM MED, V66, P629, DOI 10.1097/01.psy.0000138122.93942.4a; Chang CK, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-77; Fagiolini A, 2009, J CLIN PSYCHIAT, V70, P22, DOI 10.4088/JCP.7075su1c.04; Felker B, 1996, PSYCHIAT SERV, V47, P1356; Fernandes AC, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-71; Fok M, 2013, J PERSONAL DISORD; Fok MLY, 2012, J PSYCHOSOM RES, V73, P104, DOI 10.1016/j.jpsychores.2012.05.001; Fok ML-Y, 2014, SOC PSYCH PSYCH EPID, P1; Gunderson JG, 2011, ARCH GEN PSYCHIAT, V68, P827, DOI 10.1001/archgenpsychiatry.2011.37; Haw C, 2007, SUICIDE LIFE-THREAT, V37, P379, DOI 10.1521/suli.2007.37.4.379; Hayes RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044613; Hayes RD, 2012, J PSYCHOSOM RES, V72, P114, DOI 10.1016/j.jpsychores.2011.09.012; Hinshelwood RD, 1999, BRIT J PSYCHIAT, V174, P187, DOI 10.1192/bjp.174.3.187; Hiroeh U, 2001, LANCET, V358, P2110, DOI 10.1016/S0140-6736(01)07216-6; Hiroeh U, 2008, J PSYCHOSOM RES, V64, P275, DOI 10.1016/j.jpsychores.2007.09.008; Hunter R, 2009, PSYCHIAT SERV, V60, P240, DOI 10.1176/appi.ps.60.2.240; Jones S, 2008, ACTA PSYCHIAT SCAND, V118, P169, DOI 10.1111/j.1600-0447.2008.01211.x; Kolla NJ, 2008, ARCH SUICIDE RES, V12, P1, DOI 10.1080/13811110701542010; Large M, 2011, AUST NZ J PSYCHIAT, V45, P619, DOI 10.3109/00048674.2011.590465; Laursen TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067133; LEWIS G, 1988, BRIT J PSYCHIAT, V153, P44, DOI 10.1192/bjp.153.1.44; Moran P, 2006, BRIT J PSYCHIAT, V188, P374, DOI 10.1192/bjp.188.4.374; Moran P, 2007, J CLIN PSYCHIAT, V68, P69, DOI 10.4088/JCP.v68n0109; Mykletun A, 2009, BRIT J PSYCHIAT, V195, P118, DOI 10.1192/bjp.bp.108.054866; Noble M, 2008, ENGLISH INDICES DEPR; Nordentoft M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055176; Pirkis Jane E, 2005, Health Qual Life Outcomes, V3, P76, DOI 10.1186/1477-7525-3-76; Roshanaei-Moghaddam B, 2009, PSYCHIAT SERV, V60, P147, DOI 10.1176/appi.ps.60.2.147; Samuels J, 2011, INT REV PSYCHIATR, V23, P223, DOI 10.3109/09540261.2011.588200; Siris SG, 2001, J PSYCHOPHARMACOL, V15, P127, DOI 10.1177/026988110101500209; Stewart R, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-51; Tidemalm Dag, 2008, Clin Pract Epidemiol Ment Health, V4, P23, DOI 10.1186/1745-0179-4-23; Tulloch AD, 2008, SOC PSYCH PSYCH EPID, V43, P569, DOI 10.1007/s00127-008-0332-2; Viron MJ, 2010, PSYCHOSOMATICS, V51, P458, DOI 10.1176/appi.psy.51.6.458; Wahlbeck K, 2011, BRIT J PSYCHIAT; Wilson RS, 2005, AM J GERIAT PSYCHIAT, V13, P984, DOI 10.1176/appi.ajgp.13.11.984; Wing J, 1999, BRIT J PSYCHIAT, V174, P432, DOI 10.1192/bjp.174.5.432; Wing JK, 1998, BRIT J PSYCHIAT, V172, P11, DOI 10.1192/bjp.172.1.11; World Health Organization, 2000, MAN INT STAT CLASS D; Wu C., 2011, P IEEE GLOB TEL C, P1, DOI [10.1109/GLOCOM.2011.6133715, DOI 10.1109/GLOCOM.2011.6133715]	43	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e100979	10.1371/journal.pone.0100979	http://dx.doi.org/10.1371/journal.pone.0100979			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7WB	25000503	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000338637300022
J	Jiang, X; Kanda, T; Wu, S; Nakamoto, S; Saito, K; Shirasawa, H; Kiyohara, T; Ishii, K; Wakita, T; Okamoto, H; Yokosuka, O				Jiang, Xia; Kanda, Tatsuo; Wu, Shuang; Nakamoto, Shingo; Saito, Kengo; Shirasawa, Hiroshi; Kiyohara, Tomoko; Ishii, Koji; Wakita, Takaji; Okamoto, Hiroaki; Yokosuka, Osamu			Suppression of La Antigen Exerts Potential Antiviral Effects against Hepatitis A Virus	PLOS ONE			English	Article							TRACT-BINDING-PROTEIN; IRES-DEPENDENT TRANSLATION; SITE-MEDIATED TRANSLATION; SMALL INTERFERING RNAS; HOST-TARGETING AGENTS; HAV 3C PROTEINASE; ENTRY SITE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; 5'-UNTRANSLATED REGION; BETA-LACTONES	Background: Despite the development and availability of hepatitis A virus (HAV) vaccine, HAV infection is still a major cause of acute hepatitis that occasionally leads to fatal liver disease. HAV internal ribosomal entry-site (IRES) is one of the attractive targets of antiviral agents against HAV. The aim of the present study is to evaluate the impact of La, one of the cellular proteins, on HAV IRES-mediated translation and HAV replication. Methods and Findings: We investigated the therapeutic feasibility of siRNAs specific for cellular cofactors for HAV IRES-mediated translation in cell culture. It was revealed that siRNA against La could inhibit HAV IRES activities as well as HAV subgenomic replication. We also found that the Janus kinase (JAK) inhibitors SD-1029 and AG490, which reduce La expression, could inhibit HAV IRES activities as well as HAV replication. Conclusions: Inhibition of La by siRNAs and chemical agents could lead to the efficient inhibition of HAV IRES-mediated translation and HAV replication in cell culture models. La might play important roles in HAV replication and is being exploited as one of the therapeutic targets of host-targeting antivirals.	[Jiang, Xia; Kanda, Tatsuo; Wu, Shuang; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan; [Nakamoto, Shingo; Saito, Kengo; Shirasawa, Hiroshi] Chiba Univ, Grad Sch Med, Dept Mol Virol, Chiba, Japan; [Kiyohara, Tomoko; Ishii, Koji; Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Musashimurayama, Japan; [Okamoto, Hiroaki] Jichi Med Univ, Sch Med, Dept Infect & Immun, Div Virol, Shimotsuke, Japan	Chiba University; Chiba University; National Institute of Infectious Diseases (NIID); Jichi Medical University	Kanda, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan.	kandat@aol.com	Jiang, Xia/P-4220-2014; Okamoto, Hiroaki/H-4371-2011	Jiang, Xia/0000-0003-4572-0039; Okamoto, Hiroaki/0000-0003-0827-0964; Kanda, Tatsuo/0000-0002-1654-5385	Ministry of Health, Labour and Welfare of Japan [H24-Hepatitis-General-002]; Grants-in-Aid for Scientific Research [25460580] Funding Source: KAKEN	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Health, Labour and Welfare of Japan (H24-Hepatitis-General-002)(OY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner S, 2000, EMBO J, V19, P6230, DOI 10.1093/emboj/19.22.6230; Ali IK, 2001, J VIROL, V75, P7854, DOI 10.1128/JVI.75.17.7854-7863.2001; Basu A, 2001, VIROLOGY, V288, P379, DOI 10.1006/viro.2001.1100; Baugh JM, 2013, ANTIVIR RES, V100, P555, DOI 10.1016/j.antiviral.2013.09.020; Borman AM, 1997, VIROLOGY, V237, P129, DOI 10.1006/viro.1997.8761; Casas N, 2007, INT J FOOD MICROBIOL, V120, P179, DOI 10.1016/j.ijfoodmicro.2007.01.017; Ching KZ, 2002, J GEN VIROL, V83, P53, DOI 10.1099/0022-1317-83-1-53; Cordes S, 2008, BIOCHEM BIOPH RES CO, V368, P1014, DOI 10.1016/j.bbrc.2008.01.163; CRANCE JM, 1990, J MED VIROL, V31, P155, DOI 10.1002/jmv.1890310214; Cutolo M, 2013, J INFLAMM RES, V6, P129, DOI 10.2147/JIR.S35901; Das S, 1998, J VIROL, V72, P5638, DOI 10.1128/JVI.72.7.5638-5647.1998; Debing Y, 2014, MED RES REV, V34, P895, DOI 10.1002/med.21292; Debing Y, 2013, ANTIVIR RES, V98, P325, DOI 10.1016/j.antiviral.2013.03.016; Duan ZF, 2006, CLIN CANCER RES, V12, P6844, DOI 10.1158/1078-0432.CCR-06-1330; Gauss-Muller V, 2002, J GEN VIROL, V83, P2183, DOI 10.1099/0022-1317-83-9-2183; Gonzales AJ, 2014, J VET PHARMACOL THER, V37, P317, DOI 10.1111/jvp.12101; Goswami BB, 2004, ANTIVIR RES, V63, P153, DOI 10.1016/j.antiviral.2004.02.004; Graff J, 1998, J VIROL, V72, P9668, DOI 10.1128/JVI.72.12.9668-9675.1998; Hsu S, 2005, J PHARMACOL EXP THER, V315, P805, DOI 10.1124/jpet.105.090399; Huang YT, 1999, BIOORGAN MED CHEM, V7, P607, DOI 10.1016/S0968-0896(99)00006-1; Jacobsen KH, 2010, VACCINE, V28, P6653, DOI 10.1016/j.vaccine.2010.08.037; Kanda T, 2005, BIOCHEM BIOPH RES CO, V331, P621, DOI 10.1016/j.bbrc.2005.03.212; Kanda T, 2005, BIOCHEM BIOPH RES CO, V330, P1217, DOI 10.1016/j.bbrc.2005.03.105; Kanda T, 2004, BIOCHEM BIOPH RES CO, V318, P341, DOI 10.1016/j.bbrc.2004.03.194; Kanda T, 2010, J VIRAL HEPATITIS, V17, P618, DOI 10.1111/j.1365-2893.2009.01221.x; Kanda T, 2012, VIRAL IMMUNOL, V25, P379, DOI 10.1089/vim.2012.0021; Kanda T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015139; Kanda T, 2010, HEPATOL INT, V4, P548, DOI 10.1007/s12072-010-9193-3; Kim YK, 2001, NUCLEIC ACIDS RES, V29, P5009, DOI 10.1093/nar/29.24.5009; Kiyohara T, 2009, ARCH VIROL, V154, P1263, DOI 10.1007/s00705-009-0433-6; Kusov Y, 2006, J VIROL, V80, P5599, DOI 10.1128/JVI.01773-05; Lall MS, 2002, J ORG CHEM, V67, P1536, DOI 10.1021/jo0109016; Lall MS, 1999, ORG LETT, V1, P803, DOI 10.1021/ol990148r; Lavanchy D, 2012, J CLIN VIROL, V55, P296, DOI 10.1016/j.jcv.2012.08.022; MADORE SJ, 1984, J BIOL CHEM, V259, P1929; MALCOLM BA, 1995, BIOCHEMISTRY-US, V34, P8172, DOI 10.1021/bi00025a024; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Morris TS, 1997, BIOORGAN MED CHEM, V5, P797, DOI 10.1016/S0968-0896(97)88649-X; Nakatake M, 2012, ONCOGENE, V31, P1323, DOI 10.1038/onc.2011.313; Okitsu Kohichiroh, 2010, Genes Cancer, V1, P859, DOI 10.1177/1947601910383417; Redondo N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052065; ROBERTSON BH, 1992, J GEN VIROL, V73, P1365, DOI 10.1099/0022-1317-73-6-1365; Rosenthal A, 2014, EXPERT OPIN PHARMACO, V15, P1265, DOI 10.1517/14656566.2014.913024; Schultz DE, 1996, J BIOL CHEM, V271, P14134, DOI 10.1074/jbc.271.24.14134; Sjogren M, 2003, HEPATOLOGY, V38, P554, DOI 10.1053/jhep.2003.50401; Tang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036363; Taylor RM, 2006, HEPATOLOGY, V44, P1589, DOI 10.1002/hep.21439; VALLBRACHT A, 1984, J GEN VIROL, V65, P609, DOI 10.1099/0022-1317-65-3-609; Venkatramana M, 2003, VIRUS RES, V98, P141, DOI 10.1016/j.virusres.2003.09.004; Wang Q, 2012, VIRUS RES, V167, P302, DOI 10.1016/j.virusres.2012.05.014; WIDELL A, 1986, ANTIVIR RES, V6, P103, DOI 10.1016/0166-3542(86)90030-6; Wolin SL, 2002, ANNU REV BIOCHEM, V71, P375, DOI 10.1146/annurev.biochem.71.090501.150003; Wu S, 2014, INT J MED SCI, V11, P60, DOI 10.7150/ijms.7728; Yang LL, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-212; Yi MY, 2000, J VIROL, V74, P6459, DOI 10.1128/JVI.74.14.6459-6468.2000; Yin J, 2006, J MOL BIOL, V361, P673, DOI 10.1016/j.jmb.2006.06.047; YOSHIBA M, 1994, LANCET, V343, P288, DOI 10.1016/S0140-6736(94)91132-0; Zeisel MB, 2013, J HEPATOL, V58, P375, DOI 10.1016/j.jhep.2012.09.022; Zhang B, 2007, NUCLEIC ACIDS RES, V35, P5975, DOI 10.1093/nar/gkm645	59	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101993	10.1371/journal.pone.0101993	http://dx.doi.org/10.1371/journal.pone.0101993			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999657	Green Submitted, gold, Green Published			2022-12-27	WOS:000338637300112
J	Wang, GJ; Tomasi, D; Convit, A; Logan, J; Wong, CT; Shumay, E; Fowler, JS; Volkow, ND				Wang, Gene-Jack; Tomasi, Dardo; Convit, Antonio; Logan, Jean; Wong, Christopher T.; Shumay, Elena; Fowler, Joanna S.; Volkow, Nora D.			BMI Modulates Calorie-Dependent Dopamine Changes in Accumbens from Glucose Intake	PLOS ONE			English	Article							D2 RECEPTORS; REWARD VALUE; TASTE; FOOD; RACLOPRIDE; BEHAVIORS; STRIATUM; COCAINE; TIME; PET	Objective: Dopamine mediates the rewarding effects of food that can lead to overeating and obesity, which then trigger metabolic neuroadaptations that further perpetuate excessive food consumption. We tested the hypothesis that the dopamine response to calorie intake (independent of palatability) in striatal brain regions is attenuated with increases in weight. Method: We used positron emission tomography with [C-11]raclopride to measure dopamine changes triggered by calorie intake by contrasting the effects of an artificial sweetener (sucralose) devoid of calories to that of glucose to assess their association with body mass index (BMI) in nineteen healthy participants (BMI range 21-35). Results: Neither the measured blood glucose concentrations prior to the sucralose and the glucose challenge days, nor the glucose concentrations following the glucose challenge vary as a function of BMI. In contrast the dopamine changes in ventral striatum (assessed as changes in non-displaceable binding potential of [C-11] raclopride) triggered by calorie intake (contrast glucose - sucralose) were significantly correlated with BMI (r = 0.68) indicating opposite responses in lean than in obese individuals. Specifically whereas in normal weight individuals (BMI <25) consumption of calories was associated with increases in dopamine in the ventral striatum in obese individuals it was associated with decreases in dopamine. Conclusion: These findings show reduced dopamine release in ventral striatum with calorie consumption in obese subjects, which might contribute to their excessive food intake to compensate for the deficit between the expected and the actual response to food consumption.	[Wang, Gene-Jack; Tomasi, Dardo; Wong, Christopher T.; Shumay, Elena; Volkow, Nora D.] NIAAA, Lab Neuroimaging, Bethesda, MD 20892 USA; [Convit, Antonio; Logan, Jean] NYU, Dept Psychiat, New York, NY 10016 USA; [Convit, Antonio] Nathan S Kline Inst Psychiat Res, Orangeburg, NY USA; [Fowler, Joanna S.] Brookhaven Natl Lab, Dept Biosci, Upton, NY 11973 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); New York University; Nathan Kline Institute for Psychiatric Research; United States Department of Energy (DOE); Brookhaven National Laboratory	Wang, GJ (corresponding author), NIAAA, Lab Neuroimaging, Bethesda, MD 20892 USA.	gene-jack.wang@nih.gov	Tomasi, Dardo/J-2127-2015	Convit, Antonio/0000-0003-2201-2689; Logan, Jean/0000-0002-6993-9994	Royalty Funds; National Institute of Health [Z01AA000550, R01DK064087-09, K01DA025280]; U. S. Department of Energy OBER [DE-ACO2-76CH00016]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000550, ZIAAA000550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA025280] Funding Source: NIH RePORTER	Royalty Funds; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U. S. Department of Energy OBER(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	U. S. Department of Energy OBER: DE-ACO2-76CH00016 for infrastructure support of Brookhaven National Laboratory and Royalty Funds to GJW. National Institute of Health: Z01AA000550 to NDV, R01DK064087-09 to AC, K01DA025280 to ES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beeler JA, 2012, EUR J NEUROSCI, V36, P2533, DOI 10.1111/j.1460-9568.2012.08167.x; Bonacchi KB, 2008, PHYSIOL BEHAV, V95, P235, DOI 10.1016/j.physbeh.2008.06.006; de Araujo IE, 2008, NEURON, V57, P930, DOI 10.1016/j.neuron.2008.01.032; EHRIN E, 1985, INT J APPL RADIAT IS, V36, P269, DOI 10.1016/0020-708X(85)90083-3; Frank GKW, 2008, NEUROIMAGE, V39, P1559, DOI 10.1016/j.neuroimage.2007.10.061; GORMALLY J, 1982, ADDICT BEHAV, V7, P47, DOI 10.1016/0306-4603(82)90024-7; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Kegeles LS, 2010, ARCH GEN PSYCHIAT, V67, P231, DOI 10.1001/archgenpsychiatry.2010.10; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Maayan L, 2011, OBESITY, V19, P1382, DOI 10.1038/oby.2011.15; Martinez D, 2007, AM J PSYCHIAT, V164, P622, DOI 10.1176/appi.ajp.164.4.622; Richardson NR, 2008, EUR J NEUROSCI, V27, P2714, DOI 10.1111/j.1460-9568.2008.06236.x; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schultz W, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-24; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; VIGORITO M, 1994, PHARMACOL BIOCHEM BE, V47, P515, DOI 10.1016/0091-3057(94)90153-8; VOLKOW ND, 1994, SYNAPSE, V16, P255, DOI 10.1002/syn.890160402; Volkow ND, 2003, INT J EAT DISORDER, V33, P136, DOI 10.1002/eat.10118; Volkow ND, 2002, SYNAPSE, V44, P175, DOI 10.1002/syn.10075; Volkow ND, 1997, NATURE, V386, P830, DOI 10.1038/386830a0; Volkow ND, MOL PSYCHIA IN PRESS; Volkow ND, 2008, NEUROIMAGE, V42, P1537, DOI 10.1016/j.neuroimage.2008.06.002; Volkow ND, 2013, BIOL PSYCHIAT, V73, P811, DOI 10.1016/j.biopsych.2012.12.020; Wang GJ, 2012, MOL PSYCHIATR, V17, P918, DOI 10.1038/mp.2011.86; Wang GJ, 2008, OBESITY, V16, pS88, DOI 10.1038/oby.2008.469; Wise RA, 2013, BIOL PSYCHIAT, V73, P819, DOI 10.1016/j.biopsych.2012.09.001	26	41	41	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101585	10.1371/journal.pone.0101585	http://dx.doi.org/10.1371/journal.pone.0101585			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000285	Green Published, Green Submitted, gold			2022-12-27	WOS:000338637300060
J	Wlodarska-Kowalczuk, M; Jankowska, E; Kotwicki, L; Balazy, P				Wlodarska-Kowalczuk, Maria; Jankowska, Emilia; Kotwicki, Lech; Balazy, Piotr			Evidence of Season-Dependency in Vegetation Effects on Macrofauna in Temperate Seagrass Meadows (Baltic Sea)	PLOS ONE			English	Article							EELGRASS ZOSTERA-MARINA; COMMUNITY COMPOSITION; RELATIVE IMPORTANCE; POSIDONIA-OCEANICA; SHOOT-DENSITY; SEDIMENT CHARACTERISTICS; TROPHIC INTERACTIONS; HABITAT COMPLEXITY; SPATIAL VARIATION; MYTILUS-EDULIS	Seagrasses and associated macrophytes are important components of coastal systems as ecosystem engineers, habitat formers, and providers of food and shelter for other organisms. The positive impacts of seagrass vegetation on zoobenthic abundance and diversity (as compared to bare sands) are well documented, but only in surveys performed in summer, which is the season of maximum canopy development. Here we present the results of the first study of the relationship between the seasonal variability of seagrass vegetation and persistence and magnitude of contrasts in faunal communities between vegetated and bare sediments. The composition, abundance, biomass, and diversity of macrozoobenthos in both habitats were compared five times throughout the year in temperate eelgrass meadows in the southern Baltic Sea. Significant positive effects of macrophyte cover on invertebrate density and biomass were recorded only in June, July, and October when the seagrass canopy was relatively well developed. The effects of vegetation cover on faunal species richness, diversity, and composition persisted throughout the year, but the magnitude of these effects varied seasonally and followed changes in macrophyte biomass. The strongest effects were observed in July and coincided with maximums in seagrass biomass and the diversity and biomass of other macrophytes. These observations indicate that in temperate, clearly seasonal systems the assessment of macrophyte impact cannot be based solely on observations performed in just one season, especially when that season is the one in which macrophyte growth is at its maximum. The widely held belief that macrophyte cover strongly influences benthic fauna in marine coastal habitats, which is based on summer surveys, should be revisited and complemented with information obtained in other seasons.	[Wlodarska-Kowalczuk, Maria; Jankowska, Emilia; Kotwicki, Lech; Balazy, Piotr] Polish Acad Sci, Inst Oceanol, Dept Marine Ecol, Sopot, Poland	Polish Academy of Sciences; Institute of Oceanology of the Polish Academy of Sciences	Wlodarska-Kowalczuk, M (corresponding author), Polish Acad Sci, Inst Oceanol, Dept Marine Ecol, Sopot, Poland.	maria@iopan.gda.pl	Kotwicki, Lech/S-9275-2017; Kotwicki, Lech/CAH-0296-2022; Balazy, Piotr/D-2949-2018	Kotwicki, Lech/0000-0001-5876-5696; Kotwicki, Lech/0000-0001-5876-5696; Balazy, Piotr/0000-0002-1126-3151	European Regional Development Fund [POIS.05.01.00-00-205/09-00]; European Community [266445]; Institute ofOceanology Polish Academy of Sciences	European Regional Development Fund(European Commission); European Community(European Commission); Institute ofOceanology Polish Academy of Sciences	The research leading to these results has received funding from the European Regional Development Fund ("ZOSTERA. Restitution of key elements of the inner Puck Bay ecosystem.", no. POIS.05.01.00-00-205/09-00) and European Community's Seventh Framework Programme (FP7/2007-2013) within the Ocean of Tomorrow call under Grant Agreement No. 266445 for the project Vectors of Change in Oceans and Seas Marine Life, Impact on Economic Sectors (VECTORS). MWK and LK were supported by the Institute ofOceanology Polish Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Arroyo MDC, 2006, MAR ECOL-EVOL PERSP, V27, P417, DOI 10.1111/j.1439-0485.2006.00117.x; Attrill MJ, 2000, ECOGRAPHY, V23, P114, DOI 10.1034/j.1600-0587.2000.230112.x; Baden S, 2010, LIMNOL OCEANOGR, V55, P1435, DOI 10.4319/lo.2010.55.3.1435; Berkenbusch K, 2000, MAR ECOL PROG SER, V192, P249, DOI 10.3354/meps192249; Bologna PAX, 1999, J EXP MAR BIOL ECOL, V242, P21, DOI 10.1016/S0022-0981(99)00092-1; Bostrom C, 2000, MAR ECOL PROG SER, V205, P123, DOI 10.3354/meps205123; Bostrom C, 1999, OECOLOGIA, V120, P162, DOI 10.1007/s004420050845; Bostrom C, 1997, J SEA RES, V37, P153, DOI 10.1016/S1385-1101(96)00007-X; Bostrom C, 2010, J EXP MAR BIOL ECOL, V390, P106, DOI 10.1016/j.jembe.2010.05.008; Bouma TJ, 2009, HELGOLAND MAR RES, V63, P3, DOI 10.1007/s10152-008-0133-8; Bowden DA, 2001, J EXP MAR BIOL ECOL, V259, P133, DOI 10.1016/S0022-0981(01)00236-2; Brearley A., 2000, BIOL MAR MEDIT, V7, P199; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Dalsgaard T, 2000, PROTOCOL HDB NICE NI; Duarte CM, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P271; DUARTE CM, 1989, MAR ECOL PROG SER, V51, P269, DOI 10.3354/meps051269; Folk R. L., 1957, J SEDIMENT PETROL, V27, P3, DOI [10.1306/74d70646-2b21-11d7-8648000102c1865, 10.1306/74D70646-2B21-11D7-8648000102C1865D, DOI 10.1306/74D70646-2B21-11D7-8648000102C1865D]; Fortino K, 2006, HYDROBIOLOGIA, V559, P463, DOI 10.1007/s10750-005-5325-5; Fourqurean JW, 2001, MAR BIOL, V138, P341, DOI 10.1007/s002270000448; Fredriksen S, 2010, MAR BIOL RES, V6, P189, DOI 10.1080/17451000903042461; Gacia E, 1999, AQUAT BOT, V65, P255, DOI 10.1016/S0304-3770(99)00044-3; Gambi MC, 1998, SCI MAR, V62, P1; Gartner A, 2013, J EXP MAR BIOL ECOL, V439, P143, DOI 10.1016/j.jembe.2012.11.009; Gic-Grusza G., 2009, ATLAS POLISH MARINE; GORE RH, 1981, ESTUAR COAST SHELF S, V12, P485, DOI 10.1016/S0302-3524(81)80007-2; Guidetti P, 2002, MAR ECOL-P S Z N I, V23, P51, DOI 10.1046/j.1439-0485.2002.02722.x; Harley CDG, 2011, OECOLOGIA, V166, P531, DOI 10.1007/s00442-010-1864-1; Hasegawa N, 2008, HYDROBIOLOGIA, V596, P387, DOI 10.1007/s10750-007-9111-4; Heck KL, 2006, J EXP MAR BIOL ECOL, V330, P420, DOI 10.1016/j.jembe.2005.12.044; Hemminga M.A., 2000, SEAGRASS ECOLOGY, DOI [10.1017/CBO9780511525551, DOI 10.1017/CBO9780511525551]; Herkul K, 2009, MAR ECOL-EVOL PERSP, V30, P74, DOI 10.1111/j.1439-0485.2009.00307.x; Jankowska E, 2014, ESTUAR COAST SHELF S, V139, P159, DOI 10.1016/j.ecss.2014.01.003; Jephson T, 2008, MAR ECOL PROG SER, V369, P63, DOI 10.3354/meps07646; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; KITTING CL, 1984, OECOLOGIA, V62, P145, DOI 10.1007/BF00379006; Kruk-Dowgiallo L., 1998, OCEANOLOGICAL STUDIE, V27, P105; Leidenberger S, 2012, J CRUSTACEAN BIOL, V32, P359, DOI 10.1163/193724012X626485; Nowacki J., 1993, PUCK BAY, P71; Pranovi F, 2000, SCI MAR, V64, P303, DOI 10.3989/scimar.2000.64n3303; REUSCH TBH, 1995, J EXP MAR BIOL ECOL, V192, P257, DOI 10.1016/0022-0981(95)00074-2; REUSCH TBH, 1994, MAR ECOL PROG SER, V108, P265, DOI 10.3354/meps108265; Rueda JL, 2003, ESTUAR COAST SHELF S, V57, P909, DOI 10.1016/S0272-7714(02)00421-3; Rueda JL, 2008, ESTUAR COAST SHELF S, V79, P157, DOI 10.1016/j.ecss.2008.03.018; Sirota L, 2006, MAR ECOL PROG SER, V326, P115, DOI 10.3354/meps326115; STONER AW, 1985, J EXP MAR BIOL ECOL, V94, P19, DOI 10.1016/0022-0981(85)90048-6; Tomczak MT, 2009, PROG OCEANOGR, V81, P111, DOI 10.1016/j.pocean.2009.04.017; Urra J, 2013, ESTUAR COAST SHELF S, V117, P136, DOI 10.1016/j.ecss.2012.11.005; van Katwijk MM, 2010, BIOL CONSERV, V143, P248, DOI 10.1016/j.biocon.2009.08.014; VANLENT F, 1994, AQUAT BOT, V48, P31, DOI 10.1016/0304-3770(94)90072-8; Vonk JA, 2010, MAR BIOL RES, V6, P282, DOI 10.1080/17451000903233789; Webster PJ, 1998, ESTUAR COAST SHELF S, V47, P351, DOI 10.1006/ecss.1998.0358	53	25	25	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e100788	10.1371/journal.pone.0100788	http://dx.doi.org/10.1371/journal.pone.0100788			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000560	gold, Green Submitted, Green Published			2022-12-27	WOS:000338637300015
J	Yeh, ML; Huang, CF; Huang, CI; Liu, SF; Yang, HL; Hsieh, MY; Huang, JF; Dai, CY; Chuang, WL; Yu, ML				Yeh, Ming-Lun; Huang, Chung-Feng; Huang, Ching-I; Liu, Shu-Fen; Yang, Hua-Ling; Hsieh, Ming-Yen; Huang, Jee-Fu; Dai, Chia-Yen; Chuang, Wan-Long; Yu, Ming-Lung			Abbott RealTime HBV Assay Is More Sensitive in Detection of Low Viral Load and Little Impacted by Drug Resistant Mutation in Chronic Hepatitis B Patients under Nucleot(s)ide Analogues Therapy	PLOS ONE			English	Article							VIRUS-INFECTION; NATURAL-HISTORY; PCR ASSAY; DNA; LAMIVUDINE; QUANTIFICATION; MANAGEMENT; UPDATE; CORE	Background: Selection of drug-resistant strains may lead to failure of HBV antiviral therapy. There is little information whether there is detection difference in drug resistant mutations between different viral load assays of HBV. Objectives: This study is aimed to investigate whether there is drug-resistant strains related detection difference between Abbott RealTime HBV (RealTime) and CobasAmpliPrep/CobasTaqMan HBV assays 2.0 (TaqMan). Study Design: One hundred and thirty-four CHB patients who received HBV anti-viral therapy were enrolled. HBV virological markers were tested 3 months apart regularly. Serum HBV DNA levels were determined using the TaqMan and RealTime. YMDD (rt180M and rt204V) mutation was checked in patients who experienced virologic breakthrough (VBT). Results: The correlation of HBV DNA observed between the RealTime and TaqMan was good for all 571 samples (R-2 = 0.797; P<0.001). However, the correlation in the 434 samples with HBV DNA level <3 log(10) IU/ml was not as good as in all samples (R-2 = 0.457). Overall, 21.5% of samples had a detection difference of >= 1 log(10) IU/ml with 91.9% of these having HBV DNA level < 3 log(10) IU/ml. Twenty-four patients experiencedVBT. Three of these patients had acquired the YMDD mutation and exhibited discordant viral load results between the two methods tested. In each case, persistent HBV DNA was detected by RealTime and undetectable with TaqMan. Of the patients who experienced a VBT and had acquired YMDD mutation, 4.7% had undetectable HBV DNA by TaqMan while all were detectable with RealTime. Conclusions: RealTime assay is more sensitive and is little impacted by the development of drug resistant mutation.	[Yeh, Ming-Lun; Huang, Chung-Feng; Liu, Shu-Fen; Yang, Hua-Ling; Huang, Jee-Fu; Dai, Chia-Yen; Chuang, Wan-Long; Yu, Ming-Lung] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Hepatobiliary, Kaohsiung, Taiwan; [Yeh, Ming-Lun; Dai, Chia-Yen] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Huang, Chung-Feng; Huang, Jee-Fu; Dai, Chia-Yen; Chuang, Wan-Long; Yu, Ming-Lung] Kaohsiung Med Univ, Coll Med, Fac Internal Med, Kaohsiung, Taiwan; [Huang, Chung-Feng] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Occupat Med, Kaohsiung, Taiwan; [Huang, Jee-Fu] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Huang, Ching-I; Hsieh, Ming-Yen] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Yeh, Ming-Lun; Yang, Hua-Ling; Dai, Chia-Yen; Chuang, Wan-Long; Yu, Ming-Lung] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Hepatitis Ctr, Kaohsiung, Taiwan; [Huang, Chung-Feng; Yu, Ming-Lung] Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Yu, ML (corresponding author), Kaohsiung Med Univ Hosp, Dept Internal Med, Div Hepatobiliary, Kaohsiung, Taiwan.	fish6069@gmail.com	Yu, Ming-Lung/AAZ-4306-2020; Chuang, Wan-Long/ABF-7427-2021; Huang, Jee-Fu/AAX-4622-2020	Yu, Ming-Lung/0000-0001-8145-1900; Chuang, Wan-Long/0000-0002-2376-421X; Huang, Jee-Fu/0000-0002-2752-7051				Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Dai CY, 2013, J ANTIMICROB CHEMOTH, V68, P2332, DOI 10.1093/jac/dkt193; Dienstag JL, 1999, NEW ENGL J MED, V341, P1256, DOI 10.1056/NEJM199910213411702; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; European Association For The Study Of The Liver, 2012, J HEPATOL, V57, P167; Fares MA, 2002, J MOL EVOL, V54, P807, DOI 10.1007/s00239-001-0084-z; Fattovich G, 2008, J HEPATOL, V48, P335, DOI 10.1016/j.jhep.2007.11.011; Garbuglia AR, 2007, J VIROL METHODS, V146, P274, DOI 10.1016/j.jviromet.2007.07.005; Gish R, 2012, LANCET INFECT DIS, V12, P341, DOI 10.1016/S1473-3099(11)70314-0; Gray AH, 1997, J VIRAL HEPATITIS, V4, P371, DOI 10.1046/j.1365-2893.1997.00075.x; Lampertico P, 2005, HEPATOLOGY, V42, P1414, DOI 10.1002/hep.20939; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Lindh M, 2006, J CLIN MICROBIOL, V44, P2587, DOI 10.1128/JCM.00265-06; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Morris CJ, 2013, J VIROL METHODS, V193, P391, DOI 10.1016/j.jviromet.2013.06.036; Ntziora F, 2009, J CLIN MICROBIOL, V47, P2544, DOI 10.1128/JCM.00045-09; Osiowy C, 2006, J VIROL, V80, P10307, DOI 10.1128/JVI.00996-06; Paraskevis D, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-57; Tassopoulos NC, 1999, HEPATOLOGY, V29, P889, DOI 10.1002/hep.510290321; Thibault V, 2007, J CLIN MICROBIOL, V45, P3948, DOI 10.1128/JCM.01180-07; van de Klundert MAA, 2012, J VIRAL HEPATITIS, V19, pE34, DOI 10.1111/j.1365-2893.2011.01506.x; Wang HY, 2010, J VIROL, V84, P3454, DOI 10.1128/JVI.02164-09; Yeh ML, 2014, J CLIN VIROL; Yim HJ, 2006, HEPATOLOGY, V43, pS173, DOI 10.1002/hep.20956	24	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101790	10.1371/journal.pone.0101790	http://dx.doi.org/10.1371/journal.pone.0101790			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000502	Green Published, Green Submitted, gold			2022-12-27	WOS:000338637300086
J	Zhang, SL; Zeng, J; Zhang, CB; Li, YL; Zhao, HJ; Cheng, F; Yu, SL; Wang, M; Chen, WX				Zhang, Shunli; Zeng, Jie; Zhang, Chuanbao; Li, Yilong; Zhao, Haijian; Cheng, Fei; Yu, Songlin; Wang, Mo; Chen, Wenxiang			Commutability of Possible External Quality Assessment Materials for Cardiac Troponin Measurement	PLOS ONE			English	Article							CANDIDATE REFERENCE MATERIALS; I MEASUREMENTS; STANDARDIZATION; HARMONIZATION; ASSAYS; IMMUNOASSAY; MATTERS	Background: The measurement of cardiac troponin is crucial in the diagnosis of myocardial infarction. The performance of troponin measurement is most conveniently monitored by external quality assessment (EQA) programs. The commutability of EQA samples is often unknown and the effectiveness of EQA programs is limited. Methods: Commutability of possible EQA materials was evaluated. Commercial control materials used in an EQA program, human serum pools prepared from patient samples, purified analyte preparations, swine sera from model animals and a set of patient samples were measured for cTnI with 4 assays including Abbott Architect, Beckman Access, Ortho Vitros and Siemens Centaur. The measurement results were logarithm-transformed, and the transformed data for patient samples were pairwise analyzed with Deming regression and 95% prediction intervals were calculated for each pair of assays. The commutability of the materials was evaluated by comparing the logarithmic results of the materials with the limits of the intervals. Matrix-related biases were estimated for noncommutable materials. The impact of matrix-related bias on EQA was analyzed and a possible correction for the bias was proposed. Results: Human serum pools were commutable for all assays; purified analyte preparations were commutable for 2 of the 6 assay pairs; commercial control materials and swine sera were all noncommutable; swine sera showed no reactivity to Vitros assay. The matrix-related biases for noncommutable materials ranged from -83% to 944%. Matrix-related biases of the EQA materials caused major abnormal between-assay variations in the EQA program and correction of the biases normalized the variations. Conclusion: Commutability of materials has major impact on the effectiveness of EQA programs for cTnI measurement. Human serum pools prepared from patient samples are commutable and other materials are mostly noncommutable. EQA programs should include at least one human serum pool to allow proper interpretation of EQA results.	[Zhang, Shunli; Zeng, Jie; Zhang, Chuanbao; Zhao, Haijian; Cheng, Fei; Wang, Mo; Chen, Wenxiang] Beijing Hosp, Beijing, Peoples R China; [Zhang, Shunli; Zeng, Jie; Zhang, Chuanbao; Zhao, Haijian; Cheng, Fei; Wang, Mo; Chen, Wenxiang] Minist Hlth, Natl Ctr Clin Labs, Beijing, Peoples R China; [Zhang, Shunli; Cheng, Fei; Wang, Mo] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Zhang, Shunli; Cheng, Fei; Wang, Mo] Peking Union Med Coll, Beijing 100021, Peoples R China; [Li, Yilong] Minist Hlth, Beijing Hosp, Dept Lab Med, Beijing, Peoples R China; [Yu, Songlin] Beijing Union Med Coll Hosp, Dept Lab Med, Beijing, Peoples R China	Beijing Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Beijing Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Chen, WX (corresponding author), Beijing Hosp, Beijing, Peoples R China.	wchen@bjhmoh.cn			National High Technology Research and Development Program of China (863 Program) [2011AA02A102, 2011AA02A116]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This study was supported by research grants from the National High Technology Research and Development Program of China (863 Program) (No. 2011AA02A102 and No. 2011AA02A116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apple FS, 2012, CLIN CHEM, V58, P54, DOI 10.1373/clinchem.2011.165795; Apple FS, 2008, CLIN CHEM, V54, P1982, DOI 10.1373/clinchem.2007.097568; Bunk DM, 2006, CLIN CHEM, V52, P212, DOI 10.1373/clinchem.2005.051359; Candas-Estebanez B, 2012, CLIN CHEM LAB MED, V50, P2237, DOI 10.1515/cclm-2011-0738; Christenson RH, 2001, CLIN CHEM, V47, P431; Christenson RH, 2006, CLIN CHEM, V52, P1685, DOI 10.1373/clinchem.2006.068437; CLSI, 1999, G37A CLSI; CLSI, 2010, G53A CLSI; He HJ, 2011, CLIN CHIM ACTA, V412, P107, DOI 10.1016/j.cca.2010.09.017; HyTest Ltd, 2014, MARK CARD DIS MET SY; Miller WG, 2013, CLIN CHEM, V59, P1291, DOI 10.1373/clinchem.2013.208785; Miller WG, 2011, CLIN CHEM, V57, P1670, DOI 10.1373/clinchem.2011.168641; Miller WG, 2011, CLIN CHEM, V57, P1108, DOI 10.1373/clinchem.2011.164012; Miller WG, 2006, CLIN CHEM, V52, P553, DOI 10.1373/clinchem.2005.063511; Noble JE, 2010, CLIN CHEM LAB MED, V48, P1603, DOI 10.1515/CCLM.2010.316; O'Brien PJ, 1997, CLIN CHEM, V43, P2333; Panteghini M, 2008, CLIN CHEM LAB MED, V46, P1501, DOI 10.1515/CCLM.2008.291; Tate JR, 2014, CLIN CHIM ACTA, V432, P4, DOI 10.1016/j.cca.2013.08.021; Tate JR, 2010, PATHOLOGY, V42, P402, DOI 10.3109/00313025.2010.495246; Tate JR, 2002, CLIN CHIM ACTA, V324, P13, DOI 10.1016/S0009-8981(02)00214-0; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058	21	14	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e102046	10.1371/journal.pone.0102046	http://dx.doi.org/10.1371/journal.pone.0102046			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000586	gold, Green Published, Green Submitted			2022-12-27	WOS:000338637300119
J	Zhao, W; Wang, RJ; Zhang, WZ; Liu, AQ; Cao, JP; Shen, YJ; Yang, FK; Zhang, LX				Zhao, Wei; Wang, Rongjun; Zhang, Weizhe; Liu, Aiqin; Cao, Jianping; Shen, Yujuan; Yang, Fengkun; Zhang, Longxian			MLST Subtypes and Population Genetic Structure of Cryptosporidium andersoni from Dairy Cattle and Beef Cattle in Northeastern China's Heilongjiang Province	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; PREVALENCE; IDENTIFICATION; EPIDEMIOLOGY; GENOTYPES; CHILDREN; GIARDIA; HUMANS; PARVUM; WATER	Cattle are the main reservoir host of C. andersoni, which shows a predominance in yearlings and adults of cattle. To understand the subtypes of C. andersoni and the population genetic structure in Heilongjiang Province, fecal specimens were collected from 420 dairy cattle and 405 beef cattle at the age of 12-14 months in eight cattle farms in five areas within this province and were screened for the presence of Cryptosporidium oocysts by microscopy after Sheather's sugar flotation technique. The average prevalence of Cryptosporidium spp. was 19.15% (158/825) and all the Cryptosporidium isolates were identified as C. andersoni by the SSU rRNA gene nested PCR-RFLP using SspI, VspI and MboII restriction enzymes. A total of 50 C. andersoni isolates were randomly selected and sequenced to confirm the RFLP results before they were subtyped by multilocus sequence typing (MLST) at the four microsatellite/minisatellite loci (MS1, MS2, MS3 and MS16). Four, one, two and one haplotypes were obtained at the four loci, respectively. The MLST subtype A4, A4, A4, A1 showed an absolute predominance and a wide distribution among the six MLST subtypes obtained in the investigated areas. Linkage disequilibrium analysis showed the presence of a clonal population genetic structure of C. andersoni in cattle, suggesting the absence of recombination among lineages. The finding of a clonal population genetic structure indicated that the prevalence of C. andersoni in cattle in Heilongjiang Province is not attributed to the introduction of cattle. Thus, prevention and control strategies should be focused on making stricter measures to avoid the occurrence of cross-transmission and reinfection between cattle individuals. These molecular data will also be helpful to explore the source attribution of infection/contamination of C. andersoni and to elucidate its transmission dynamics in Heilongjiang Province, even in China.	[Zhao, Wei; Zhang, Weizhe; Liu, Aiqin; Yang, Fengkun] Harbin Med Univ, Dept Parasitol, Harbin, Heilongjiang, Peoples R China; [Wang, Rongjun; Zhang, Longxian] Henan Agr Univ Zhengzhou, Coll Anim Sci & Vet Med, Zhengzhou, Henan, Peoples R China; [Cao, Jianping; Shen, Yujuan] WHO Collaborating Ctr Malaria Schistosomiasis & F, Chinese Ctr Dis Control & Prevent, Key Lab Parasite & Vector Biol, Natl Inst Parasit Dis,Minist Hlth, Shanghai, Peoples R China	Harbin Medical University; Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; World Health Organization	Liu, AQ (corresponding author), Harbin Med Univ, Dept Parasitol, Harbin, Heilongjiang, Peoples R China.	liuaiqin1128@126.com; zhanglx8999@gmail.com	Zhang, Longxian/HGE-1918-2022; Zhang, Longxian/R-7799-2019; Zhang, Longxian/I-9223-2019; Cao, Jianping/AFL-5468-2022	Zhang, Longxian/0000-0002-5706-131X; Cao, Jianping/0000-0002-1974-0047	National Natural Science Foundation of China [31110103901]; National S & T Major Program for Infectious Disease of China [2012ZX10004-201, 2009ZX10004-201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National S & T Major Program for Infectious Disease of China	The study was supported partially by the National Natural Science Foundation of China (No. 31110103901) (Longxian Zhang) and the National S & T Major Program for Infectious Disease of China Nos. 2012ZX10004-201 and 2009ZX10004-201 (Jianping Cao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agholi M, 2013, AIDS RES HUM RETROV, V29, P35, DOI [10.1089/aid.2012.0119, 10.1089/AID.2012.0119]; Elwin K, 2012, INT J PARASITOL, V42, P675, DOI 10.1016/j.ijpara.2012.04.016; Fayer R, 2006, VET PARASITOL, V135, P105, DOI 10.1016/j.vetpar.2005.08.003; Fayer R, 2010, EXP PARASITOL, V124, P90, DOI 10.1016/j.exppara.2009.03.005; Feng YY, 2007, VET PARASITOL, V144, P1, DOI 10.1016/j.vetpar.2006.10.001; Feng YY, 2011, J CLIN MICROBIOL, V49, P34, DOI 10.1128/JCM.01329-10; Gatei W, 2007, INFECT GENET EVOL, V7, P197, DOI 10.1016/j.meegid.2006.08.006; Goldstein ST, 1996, ANN INTERN MED, V124, P459, DOI 10.7326/0003-4819-124-5-199603010-00001; Helmy YA, 2013, VET PARASITOL, V193, P15, DOI 10.1016/j.vetpar.2012.12.015; Hijjawi N, 2010, EXP PARASITOL, V125, P161, DOI 10.1016/j.exppara.2010.01.011; Langkjaer RB, 2007, PARASITOLOGY, V134, P339, DOI 10.1017/S0031182006001533; Leoni F, 2006, J MED MICROBIOL, V55, P703, DOI 10.1099/jmm.0.46251-0; Liu AQ, 2011, PARASITOL RES, V109, P913, DOI 10.1007/s00436-011-2333-4; Liu AQ, 2009, PARASITOL RES, V105, P797, DOI 10.1007/s00436-009-1457-2; Liu H, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-25; Lv CC, 2009, APPL ENVIRON MICROB, V75, P7692, DOI 10.1128/AEM.01386-09; Mor SM, 2009, CLIN INFECT DIS, V48, P698, DOI 10.1086/597033; Morse TD, 2007, EPIDEMIOL INFECT, V135, P1307, DOI 10.1017/S0950268806007758; Nahrevanian H, 2008, J MICROBIOL IMMUNOL, V41, P74; Plutzer J, 2009, VET PARASITOL, V165, P187, DOI 10.1016/j.vetpar.2009.07.003; Quilez J, 2011, APPL ENVIRON MICROB, V77, P7779, DOI 10.1128/AEM.00751-11; Robinson G, 2012, EXP PARASITOL, V132, P200, DOI 10.1016/j.exppara.2012.06.016; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Santin M, 2004, VET PARASITOL, V122, P103, DOI 10.1016/j.vetpar.2004.03.020; Sodqi M, 2012, PRESSE MED, V41, P386; Waldron LS, 2011, APPL ENVIRON MICROB, V77, P7757, DOI 10.1128/AEM.00615-11; Wang RJ, 2008, PARASITOL RES, V102, P915, DOI 10.1007/s00436-007-0851-x; Wang RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043782; Wang RJ, 2011, PARASITOL INT, V60, P1, DOI 10.1016/j.parint.2010.09.002; Xiao LH, 2001, J INFECT DIS, V183, P492, DOI 10.1086/318090; Xiao LH, 2001, APPL ENVIRON MICROB, V67, P1097, DOI 10.1128/AEM.67.3.1097-1101.2001; Xiao LH, 2008, FEMS IMMUNOL MED MIC, V52, P309, DOI 10.1111/j.1574-695X.2008.00377.x; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018; Yang RC, 2014, VET PARASITOL, V200, P50, DOI 10.1016/j.vetpar.2013.11.014; Zhang WZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054857; Zhao GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060112	36	25	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e102006	10.1371/journal.pone.0102006	http://dx.doi.org/10.1371/journal.pone.0102006			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999982	gold, Green Submitted, Green Published			2022-12-27	WOS:000338637300114
J	Chami, B; Yeung, AWS; van Vreden, C; King, NJC; Bao, SS				Chami, Belal; Yeung, Amanda W. S.; van Vreden, Caryn; King, Nicholas J. C.; Bao, Shisan			The Role of CXCR3 in DSS-Induced Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; DEXTRAN SULFATE SODIUM; CHEMOKINE RECEPTOR EXPRESSION; COLONY-STIMULATING FACTOR; IFN-GAMMA; TH17 CELLS; NKT CELLS; T-CELLS; PATHOGENESIS; BLOCKADE	Inflammatory bowel disease (IBD) is a group of disorders that are characterized by chronic, uncontrolled inflammation in the intestinal mucosa. Although the aetiopathogenesis is poorly understood, it is widely believed that IBD stems from a dysregulated immune response towards otherwise harmless commensal bacteria. Chemokines induce and enhance inflammation through their involvement in cellular trafficking. Reducing or limiting the influx of these proinflammatory cells has previously been demonstrated to attenuate inflammation. CXCR3, a chemokine receptor in the CXC family that binds to CXCL9, CXCL10 and CXCL11, is strongly overexpressed in the intestinal mucosa of IBD patients. We hypothesised that CXCR3 KO mice would have impaired cellular trafficking, thereby reducing the inflammatory insult by proinflammatory cell and attenuating the course of colitis. To investigate the role of CXCR3 in the progression of colitis, the development of dextran sulfate sodium (DSS)-induced colitis was investigated in CXCR3(-/-) mice over 9 days. This study demonstrated attenuated DSS-induced colitis in CXCR3(-/-) mice at both the macroscopic and microscopic level. Reduced colitis correlated with lower recruitment of neutrophils (p=0.0018), as well as decreased production of IL-6 (p<0.0001), TNF (p=0.0038), and IFN-gamma (p=0.0478). Overall, our results suggest that CXCR3 plays an important role in recruiting proinflammatory cells to the colon during colitis and that CXCR3 may be a therapeutic target to reduce the influx of proinflammatory cells in the inflamed colon.	[Chami, Belal; van Vreden, Caryn; King, Nicholas J. C.; Bao, Shisan] Univ Sydney, Sydney Med Sch, Bosch Inst, Discipline Pathol, Sydney, NSW 2006, Australia; [Chami, Belal; van Vreden, Caryn; King, Nicholas J. C.; Bao, Shisan] Univ Sydney, Sydney Med Sch, Sch Med Sci, Sydney, NSW 2006, Australia; [Yeung, Amanda W. S.] Univ New S Wales, Lowy Canc Res Ctr, Ctr Vasc Res, Sydney, NSW, Australia; [King, Nicholas J. C.] Univ Sydney, Sydney Med Sch, Sydney Inst Emerging Infect Dis & Biosecur SEIB, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of New South Wales Sydney; University of Sydney	Bao, SS (corresponding author), Univ Sydney, Sydney Med Sch, Bosch Inst, Discipline Pathol, Sydney, NSW 2006, Australia.	bob.bao@sydney.edu.au	Bao, Shisan/AAF-6464-2020; Bao, Shisan/C-6072-2014; King, Nicholas Jonathan Cole/C-4138-2011	Bao, Shisan/0000-0002-6687-3846; King, Nicholas Jonathan Cole/0000-0002-3877-9772; van Vreden, Caryn/0000-0003-4151-3470	Ramaciotti Foundation; Australian Postgraduate Award; University of Sydney International Scholarship; National Research Foundation Free-Standing Doctoral Scholarship	Ramaciotti Foundation; Australian Postgraduate Award(Australian Government); University of Sydney International Scholarship(University of Sydney); National Research Foundation Free-Standing Doctoral Scholarship	This work was supported by the Ramaciotti Foundation. A.W.S.Y. was the recipient of an Australian Postgraduate Award. C.V. is the recipient of the University of Sydney International Scholarship and a National Research Foundation Free-Standing Doctoral Scholarship for Study Abroad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki Y, 2006, ONCOL REP, V16, P1357; Bao SS, 2011, IMMUNOL CELL BIOL, V89, P853, DOI 10.1038/icb.2011.4; Barbi J, 2007, BLOOD, V110, P2215, DOI 10.1182/blood-2007-03-081307; Boxer Laurence A, 2008, J Pediatr Gastroenterol Nutr, V46 Suppl 1, pE17, DOI 10.1097/01.mpg.0000313830.01466.21; Chen SC, 2010, ARCH DERMATOL RES, V302, P113, DOI 10.1007/s00403-009-0966-2; Choi J, 2012, BLOOD, V120, P4093, DOI 10.1182/blood-2012-01-403196; Cohen SB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003706; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Danese S, 2006, Eur Rev Med Pharmacol Sci, V10, P3; Fang Y, 2010, BRIT J DERMATOL, V162, P478, DOI 10.1111/j.1365-2133.2009.09528.x; Friswell M, 2010, GUT LIVER, V4, P295, DOI 10.5009/gnl.2010.4.3.295; Goldberg SH, 2001, NEUROPATH APPL NEURO, V27, P127, DOI 10.1046/j.1365-2990.2001.00312.x; Groom JR, 2012, IMMUNITY, V37, P1091, DOI 10.1016/j.immuni.2012.08.016; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Gunnarsson C, 2012, DIGEST DIS SCI, V57, P3080, DOI 10.1007/s10620-012-2289-y; Hart D, 2008, J IMMUNOL, V181, P8053, DOI 10.4049/jimmunol.181.11.8053; Heaton PC, 2012, J PEDIATR GASTR NUTR, V54, P477, DOI 10.1097/MPG.0b013e318239bc79; Hundorfean G, 2012, INFLAMM BOWEL DIS, V18, P180, DOI 10.1002/ibd.21677; Ichikawa A, 2013, AM J RESP CRIT CARE, V187, P65, DOI 10.1164/rccm.201203-0508OC; Johansson MEV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012238; Kim CH, 2001, J CLIN INVEST, V108, P1331, DOI 10.1172/JCI13543; Kim HS, 2013, MUCOSAL IMMUNOL, V6, P347, DOI 10.1038/mi.2012.77; Lacotte S, 2009, ANN NY ACAD SCI, V1173, P310, DOI 10.1111/j.1749-6632.2009.04813.x; Lalor SJ, 2013, EUR J IMMUNOL, V43, P2866, DOI 10.1002/eji.201343499; Lazebnik L B, 2011, Eksp Klin Gastroenterol, P3; Lee IA, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-7; Lee PY, 2013, J LEUKOCYTE BIOL, V94, P585, DOI 10.1189/jlb.0113014; Martinez Gomez JM, 2014, PLOS ONE, V9; Mohan K, 2007, J IMMUNOL, V179, P8463, DOI 10.4049/jimmunol.179.12.8463; Murphy PM, 2000, PHARMACOL REV, V52, P145; Nanki T, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2823; Nishimura M, 2009, ANN NY ACAD SCI, V1173, P350, DOI 10.1111/j.1749-6632.2009.04738.x; Papadakis KA, 2004, CURR ALLERGY ASTHM R, V4, P83, DOI 10.1007/s11882-004-0048-7; PARK CM, 1987, J MICROSC-OXFORD, V145, P115, DOI 10.1111/j.1365-2818.1987.tb01321.x; Park KT, 2011, INFLAMM BOWEL DIS, V17, P1603, DOI 10.1002/ibd.21488; Pedersen J, 2014, WORLD J GASTROENTERO, V20, P64, DOI 10.3748/wjg.v20.i1.64; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Raza A, 2012, EXPERT REV CLIN IMMU, V8, P161, DOI [10.1586/ECI.11.96, 10.1586/eci.11.96]; Rose WA, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-41; Schroepf S, 2010, INFLAMM BOWEL DIS, V16, P1882, DOI 10.1002/ibd.21312; Singh Udai P., 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P111, DOI 10.2174/187153007780832109; STEINBECK MJ, 1986, CELL IMMUNOL, V98, P137, DOI 10.1016/0008-8749(86)90274-1; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Thomas SY, 2003, J IMMUNOL, V171, P2571, DOI 10.4049/jimmunol.171.5.2571; Tokuyama H, 2005, INT IMMUNOL, V17, P1023, DOI 10.1093/intimm/dxh284; Xie JH, 2003, J LEUKOCYTE BIOL, V73, P771, DOI 10.1189/jlb.1102573; Xu YH, 2008, J NEUROIMMUNOL, V200, P53, DOI 10.1016/j.jneuroim.2008.06.008; Xu YH, 2008, CELL RES, V18, P1220, DOI 10.1038/cr.2008.310; Yadav PK, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/348530; Yan F, 2012, AM J PHYSIOL-GASTR L, V302, pG504, DOI 10.1152/ajpgi.00312.2011; Yellin M, 2012, ARTHRITIS RHEUM-US, V64, P1730, DOI 10.1002/art.34330; Yoon KC, 2010, INVEST OPHTH VIS SCI, V51, P643, DOI 10.1167/iovs.09-3425; Yuan YH, 2001, INFLAMM BOWEL DIS, V7, P281, DOI 10.1097/00054725-200111000-00001	53	46	47	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101622	10.1371/journal.pone.0101622	http://dx.doi.org/10.1371/journal.pone.0101622			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992040	Green Published, Green Submitted, gold			2022-12-27	WOS:000341253400099
J	Maloney, SR; Almarines, D; Goolkasian, P				Maloney, Sean R.; Almarines, David; Goolkasian, Paula			Vitamin D Levels and Monospot Tests in Military Personnel with Acute Pharyngitis: A Retrospective Chart Review	PLOS ONE			English	Review							SEASONAL-VARIATION; 25-HYDROXYVITAMIN-D	Some recent studies have proposed an important role for vitamin D in reducing the risk of infection by assisting in the suppression of viruses and by controlling the inflammatory response. A low vitamin D state may have a detrimental effect on the immune system's ability to produce activated CD8+ T cells, and it may increase the inflammatory reaction to Epstein Barr virus. The aim of this chart review was to see if serum 25 OH vitamin D-3 levels in service members with acute pharyngitis were lower in those who had positive rather than negative monospot tests. A retrospective chart review was conducted on the medical records of service members who presented to sick call at Camp Lejeune, NC with acute pharyngitis from October 8, 2010 until June 30, 2011. Serum 25 OH vitamin D-3 levels were compared between those with positive and negative monospot test results. Of the 25 records that were reviewed, there were 9 (36%) service members with positive results, and they were found to have lower vitamin D levels (Median = 20.80 ng/ml, Interquartile range = 10.15) than those with negative test results (Median = 30.35 ng/ml, Interquartile range = 17.05), Mann-Whitney U = 41, p = .039. Only 1 of the 9 with positive test results had a normal serum 25 OH vitamin D-3 level (30 ng/ml or greater) compared with 9 of the 16 with negative test results. Optimal vitamin D stores may play a significant role in reducing the risk of developing acute mononucleosis but larger, prospective studies will be needed to verify these findings.	[Maloney, Sean R.; Almarines, David] Navy Mobilizat Proc Site, Deployment Proc Command East, Camp Lejeune, NC USA; [Maloney, Sean R.] WG Bill Hefner VA Med Ctr, Salisbury, NC USA; [Goolkasian, Paula] Univ N Carolina, Dept Psychol, Charlotte, NC 28223 USA	University of North Carolina; University of North Carolina Charlotte	Goolkasian, P (corresponding author), Univ N Carolina, Dept Psychol, Charlotte, NC 28223 USA.	pagoolka@uncc.edu	Goolkasian, Paula/AAP-7727-2020	Goolkasian, Paula/0000-0002-0463-6992; Maloney, Sean/0000-0002-4574-9344	U.S. Navy; Office of Research and Training at Naval Hospital Camp Lejeune	U.S. Navy(United States Department of Defense); Office of Research and Training at Naval Hospital Camp Lejeune	This paper is based on research supported by the U.S. Navy and the Office of Research and Training at Naval Hospital Camp Lejeune during the mobilization of CAPT Sean R. Maloney MC USN as a medical officer to the Navy Mobilization Processing Site, Deployment Processing Command - East, Camp Lejeune, N.C. including part time assignment to the Sports Medicine Clinic, Naval Hospital Camp Lejeune between August 2010 and May 2012.	Adams J, 2008, J MARIT ARCHAEOL, V3, P1, DOI 10.1007/s11457-008-9028-8; Amon W, 2005, REV MED VIROL, V15, P149, DOI 10.1002/rmv.456; Beard JA, 2011, J CLIN VIROL, V50, P194, DOI 10.1016/j.jcv.2010.12.006; Bikle DD, 2010, TRENDS ENDOCRIN MET, V21, P375, DOI 10.1016/j.tem.2010.01.003; Bolland MJ, 2007, AM J CLIN NUTR, V86, P959, DOI 10.1093/ajcn/86.4.959; Candy B, 2002, BRIT J GEN PRACT, V52, P844; Cunha BA, 2013, INFECT MONONUCLEOSIS; D'Alessandro DM, WHAT CAUSES FALSE PO; Ebell MH, 2004, AM FAM PHYSICIAN, V70, P1279; Gordon Y, 2004, INVEST OPHTHALMOL VI, V45; Hewison M, 2010, MOL CELL ENDOCRINOL, V321, P103, DOI 10.1016/j.mce.2010.02.013; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Maloney CDRSR, 2013, MED HYPOTHESES, V80, P220, DOI 10.1016/j.mehy.2012.11.024; Moran-Auth Y, 2013, J STEROID BIOCHEM, V136, P83, DOI 10.1016/j.jsbmb.2013.02.005; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Pender MP, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/189096; Salzer J, 2013, MULT SCLER J, V19, P1587, DOI 10.1177/1352458513483888; Shoben AB, 2011, AM J EPIDEMIOL, V174, P1363, DOI 10.1093/aje/kwr258; VANCAUWENBERGE PB, 1991, PEDIATR INFECT DIS J, V10, pS39, DOI 10.1097/00006454-199110001-00009; Zwart SR, 2011, J NUTR, V141, P692, DOI 10.3945/jn.110.134742	21	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101180	10.1371/journal.pone.0101180	http://dx.doi.org/10.1371/journal.pone.0101180			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25009977	gold, Green Published, Green Submitted			2022-12-27	WOS:000338763800014
J	Knikou, M				Knikou, Maria			Transpinal and Transcortical Stimulation Alter Corticospinal Excitability and Increase Spinal Output	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MOTOR CORTEX EXCITABILITY; ELECTRICAL-STIMULATION; TIBIALIS ANTERIOR; REFLEX RESPONSES; CORD STIMULATION; BASIC PRINCIPLES; H-REFLEX; POTENTIALS; ACTIVATION	The objective of this study was to assess changes in corticospinal excitability and spinal output following noninvasive transpinal and transcortical stimulation in humans. The size of the motor evoked potentials (MEPs), induced by transcranial magnetic stimulation (TMS) and recorded from the right plantar flexor and extensor muscles, was assessed following transcutaneous electric stimulation of the spine (tsESS) over the thoracolumbar region at conditioning-test (C-T) intervals that ranged from negative 50 to positive 50 ms. The size of the transpinal evoked potentials (TEPs), induced by tsESS and recorded from the right and left plantar flexor and extensor muscles, was assessed following TMS over the left primary motor cortex at 0.7 and at 1.1 x MEP resting threshold at C-T intervals that ranged from negative 50 to positive 50 ms. The recruitment curves of MEPs and TEPs had a similar shape, and statistically significant differences between the sigmoid function parameters of MEPs and TEPs were not found. Anodal tsESS resulted in early MEP depression followed by long-latency MEP facilitation of both ankle plantar flexors and extensors. TEPs of ankle plantar flexors and extensors were increased regardless TMS intensity level. Subthreshold and suprathreshold TMS induced short-latency TEP facilitation that was larger in the TEPs ipsilateral to TMS. Noninvasive transpinal stimulation affected ipsilateral and contralateral actions of corticospinal neurons, while corticocortical and corticospinal descending volleys increased TEPs in both limbs. Transpinal and transcortical stimulation is a noninvasive neuromodulation method that alters corticospinal excitability and increases motor output of multiple spinal segments in humans.	[Knikou, Maria] CUNY, Grad Ctr, New York, NY 10021 USA; [Knikou, Maria] CUNY, Coll Staten Isl, Dept Phys Therapy, Staten Isl, NY USA; [Knikou, Maria] CUNY, Coll Staten Isl, Dept Neurosci, Staten Isl, NY USA; [Knikou, Maria] Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA; [Knikou, Maria] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA	City University of New York (CUNY) System; City University of New York (CUNY) System; College of Staten Island (CUNY); City University of New York (CUNY) System; College of Staten Island (CUNY); Shirley Ryan AbilityLab; Northwestern University; Feinberg School of Medicine	Knikou, M (corresponding author), CUNY, Grad Ctr, New York, NY 10021 USA.	Maria.Knikou@csi.cuny.edu	Knikou, Maria/E-5568-2015	Knikou, Maria/0000-0002-6277-236X				Aguilar J, 2011, J PHYSIOL-LONDON, V589, P4981, DOI 10.1113/jphysiol.2011.214189; BARKER AT, 1991, J CLIN NEUROPHYSIOL, V8, P26, DOI 10.1097/00004691-199101000-00005; BERARDELLI A, 1990, NEUROSCI LETT, V112, P54, DOI 10.1016/0304-3940(90)90321-Y; Brinkworth RSA, 2003, J NEUROSCI METH, V122, P179, DOI 10.1016/S0165-0270(02)00321-7; BURKE D, 1993, J PHYSIOL-LONDON, V470, P383, DOI 10.1113/jphysiol.1993.sp019864; Capaday C, 1997, J NEUROSCI METH, V74, P201, DOI 10.1016/S0165-0270(97)02250-4; Carroll TJ, 2001, J NEUROSCI METH, V112, P193, DOI 10.1016/S0165-0270(01)00468-X; Courtine GG, 2007, J PHYSIOL-LONDON, V582, P1125, DOI 10.1113/jphysiol.2007.128447; CRAYTON JW, 1981, J NEUROL NEUROSUR PS, V44, P239, DOI 10.1136/jnnp.44.3.239; DAVEY NJ, 1994, J PHYSIOL-LONDON, V477, P223, DOI 10.1113/jphysiol.1994.sp020186; DAY BL, 1989, J PHYSIOL-LONDON, V412, P449, DOI 10.1113/jphysiol.1989.sp017626; Dechent P, 2003, HUM BRAIN MAPP, V18, P272, DOI 10.1002/hbm.10084; Deng ZD, 2014, CLIN NEUROPHYSIOL, V125, P1202, DOI 10.1016/j.clinph.2013.11.038; DENOORDHOUT AM, 1988, J NEUROL NEUROSUR PS, V51, P174, DOI 10.1136/jnnp.51.2.174; Devanne H, 1997, EXP BRAIN RES, V114, P329, DOI 10.1007/PL00005641; Devanne H, 2009, EUR J NEUROSCI, V30, P439, DOI 10.1111/j.1460-9568.2009.06815.x; Di Lazzaro V, 2012, BRAIN STIMUL, V5, P512, DOI 10.1016/j.brs.2011.07.008; Di Lazzaro V, 1998, ELECTROMYOGR MOTOR C, V109, P397, DOI 10.1016/S0924-980X(98)00038-1; Di Lazzaro V, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00018; Duclay J, 2011, J PHYSIOL-LONDON, V589, P2901, DOI 10.1113/jphysiol.2011.207472; Einhorn J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076940; ELLAWAY PH, 1978, ELECTROEN CLIN NEURO, V45, P302, DOI 10.1016/0013-4694(78)90017-2; Geertsen SS, 2010, J PHYSIOL-LONDON, V588, P2391, DOI 10.1113/jphysiol.2010.190678; Gerasimenko YP, 2006, J NEUROSCI METH, V157, P253, DOI 10.1016/j.jneumeth.2006.05.004; HENNEMAN E, 1957, SCIENCE, V126, P1345, DOI 10.1126/science.126.3287.1345; Hofstoetter US, 2008, ARTIF ORGANS, V32, P644, DOI 10.1111/j.1525-1594.2008.00616.x; HUNTER JP, 1994, J PHYSIOL-LONDON, V474, P407, DOI 10.1113/jphysiol.1994.sp020032; INGHILLERI M, 1989, J NEUROL NEUROSUR PS, V52, P970, DOI 10.1136/jnnp.52.8.970; Jackson A, 2006, J PHYSIOL-LONDON, V573, P107, DOI 10.1113/jphysiol.2005.100537; Kaneko K, 1996, MUSCLE NERVE, V19, P659, DOI 10.1002/(SICI)1097-4598(199605)19:5<659::AID-MUS17>3.3.CO;2-B; Kaneko K, 1997, J NEUROL SCI, V151, P217, DOI 10.1016/S0022-510X(97)00135-4; KATZ R, 1977, J NEUROL NEUROSUR PS, V40, P575, DOI 10.1136/jnnp.40.6.575; Khaslavskaia S, 2002, EXP BRAIN RES, V145, P309, DOI 10.1007/s00221-002-1094-9; Kleinschmidt A, 1997, EUR J NEUROSCI, V9, P2178, DOI 10.1111/j.1460-9568.1997.tb01384.x; Klimstra M, 2008, EXP BRAIN RES, V186, P93, DOI 10.1007/s00221-007-1207-6; Knikou M, 2008, J NEUROSCI METH, V171, P1, DOI 10.1016/j.jneumeth.2008.02.012; Knikou M, 2013, CLIN NEUROPHYSIOL, V124, P2431, DOI 10.1016/j.clinph.2013.06.004; Knikou M, 2013, BIOELECTROMAGNETICS, V34, P630, DOI 10.1002/bem.21808; Knikou M, 2013, BIOELECTROMAGNETICS, V34, P200, DOI 10.1002/bem.21768; Knikou M, 2010, CLIN NEUROPHYSIOL, V121, P1655, DOI 10.1016/j.clinph.2010.01.039; KONRAD PE, 1994, SPINE, V19, P2812, DOI 10.1097/00007632-199412150-00014; Ladenbauer J, 2010, IEEE T NEUR SYS REH, V18, P637, DOI 10.1109/TNSRE.2010.2054112; Lamy JC, 2005, EXP BRAIN RES, V166, P248, DOI 10.1007/s00221-005-2360-4; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Lontis ER, 2006, J CLIN NEUROPHYSIOL, V23, P462; MILLS KR, 1986, ELECTROEN CLIN NEURO, V63, P582, DOI 10.1016/0013-4694(86)90145-8; Minassian K, 2007, MUSCLE NERVE, V35, P327, DOI 10.1002/mus.20700; Miranda PC, 2003, IEEE T BIO-MED ENG, V50, P1074, DOI 10.1109/TBME.2003.816079; Mrachacz-Kersting N, 2007, J NEUROPHYSIOL, V97, P1951, DOI 10.1152/jn.01176.2006; Nielsen J, 1999, EEG CL N SU, P93; NIELSEN J, 1994, J PHYSIOL-LONDON, V477, P47, DOI 10.1113/jphysiol.1994.sp020170; PATTON HD, 1954, J NEUROPHYSIOL, V17, P345, DOI 10.1152/jn.1954.17.4.345; Petersen N, 1998, J PHYSIOL-LONDON, V512, P267, DOI 10.1111/j.1469-7793.1998.267bf.x; Petersen NT, 2001, J PHYSIOL-LONDON, V537, P651, DOI 10.1111/j.1469-7793.2001.00651.x; Pierrot-Deseilligny E., 2012, SPINAL CORTICOSPINAL; Poon DE, 2008, EXP BRAIN RES, V188, P13, DOI 10.1007/s00221-008-1334-8; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rothwell J C, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P97; Roy FD, 2008, J PHYSIOL-LONDON, V586, P4091, DOI 10.1113/jphysiol.2008.153726; Roy FD, 2014, EXP BRAIN RES, V232, P1717, DOI 10.1007/s00221-014-3864-6; Roy FD, 2012, EXP BRAIN RES, V223, P281, DOI 10.1007/s00221-012-3258-6; Schneider C, 2004, J APPL PHYSIOL, V97, P2220, DOI 10.1152/japplphysiol.00542.2004; Sharpe AN, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/1/016005; Toschi N, 2008, J PSYCHIATR RES, V43, P255, DOI 10.1016/j.jpsychires.2008.04.008; Wagner TA, 2004, IEEE T BIO-MED ENG, V51, P1586, DOI 10.1109/TBME.2004.827925; Wagner T, 2009, CORTEX, V45, P1025, DOI 10.1016/j.cortex.2008.10.002	66	38	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102313	10.1371/journal.pone.0102313	http://dx.doi.org/10.1371/journal.pone.0102313			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007330	gold, Green Published			2022-12-27	WOS:000339040600111
J	van Ackeren, MJ; Rueschemeyer, SA				van Ackeren, Markus J.; Rueschemeyer, Shirley-Ann			Cross-Modal Integration of Lexical-Semantic Features during Word Processing: Evidence from Oscillatory Dynamics during EEG	PLOS ONE			English	Article							GAMMA-BAND ACTIVITY; THETA-POWER INCREASES; WORKING-MEMORY; BRAIN; MOTOR; BINDING; REPRESENTATION; FLEXIBILITY; PERCEPTION; ACTIVATION	In recent years, numerous studies have provided converging evidence that word meaning is partially stored in modality-specific cortical networks. However, little is known about the mechanisms supporting the integration of this distributed semantic content into coherent conceptual representations. In the current study we aimed to address this issue by using EEG to look at the spatial and temporal dynamics of feature integration during word comprehension. Specifically, participants were presented with two modality-specific features (i.e., visual or auditory features such as silver and loud) and asked to verify whether these two features were compatible with a subsequently presented target word (e.g., WHISTLE). Each pair of features described properties from either the same modality (e.g., silver, tiny = visual features) or different modalities (e.g., silver, loud = visual, auditory). Behavioral and EEG data were collected. The results show that verifying features that are putatively represented in the same modality-specific network is faster than verifying features across modalities. At the neural level, integrating features across modalities induces sustained oscillatory activity around the theta range (4-6 Hz) in left anterior temporal lobe (ATL), a putative hub for integrating distributed semantic content. In addition, enhanced long-range network interactions in the theta range were seen between left ATL and a widespread cortical network. These results suggest that oscillatory dynamics in the theta range could be involved in integrating multimodal semantic content by creating transient functional networks linking distributed modality-specific networks and multimodal semantic hubs such as left ATL.	[van Ackeren, Markus J.; Rueschemeyer, Shirley-Ann] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England	University of York - UK	van Ackeren, MJ (corresponding author), Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England.	mjva500@york.ac.uk			Department of Psychology at the University of York	Department of Psychology at the University of York	This work was funded by the Department of Psychology at the University of York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsalou L. W., 2003, CATEGORIZATION INSID, DOI [10.1037/11156-014, DOI 10.1037/11156-014]; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Bastiaansen MCM, 2008, BRAIN LANG, V106, P15, DOI 10.1016/j.bandl.2007.10.006; Bastiaansen MCM, 2005, J COGNITIVE NEUROSCI, V17, P530, DOI 10.1162/0898929053279469; Bastiaansen MCM, 2002, NEUROSCI LETT, V323, P13, DOI 10.1016/S0304-3940(01)02535-6; Binder JR, 2011, TRENDS COGN SCI, V15, P527, DOI 10.1016/j.tics.2011.10.001; Boulenger V, 2009, CEREB CORTEX, V19, P1905, DOI 10.1093/cercor/bhn217; Chatterjee A, 2010, LANG COGN, V2, P79, DOI 10.1515/LANGCOG.2010.004; Damasio AR, 1989, NEURAL COMPUT, V1, P123, DOI 10.1162/neco.1989.1.1.123; Donner TH, 2011, TRENDS COGN SCI, V15, P191, DOI 10.1016/j.tics.2011.03.007; Gonzalez J, 2006, NEUROIMAGE, V32, P906, DOI 10.1016/j.neuroimage.2006.03.037; Hagoort P, 2004, SCIENCE, V304, P438, DOI 10.1126/science.1095455; Hald LA, 2006, BRAIN LANG, V96, P90, DOI 10.1016/j.bandl.2005.06.007; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Hauk O, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00050; Hoenig K, 2008, J COGNITIVE NEUROSCI, V20, P1799, DOI 10.1162/jocn.2008.20123; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Kiefer M, 2008, J NEUROSCI, V28, P12224, DOI 10.1523/JNEUROSCI.3579-08.2008; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2010, NEUROSCI BIOBEHAV R, V34, P1002, DOI 10.1016/j.neubiorev.2009.10.004; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Landauer TK, 1998, DISCOURSE PROCESS, V25, P259, DOI 10.1080/01638539809545028; Lynott D, 2009, BEHAV RES METHODS, V41, P558, DOI 10.3758/BRM.41.2.558; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Martin A, 2001, CURR OPIN NEUROBIOL, V11, P194, DOI 10.1016/S0959-4388(00)00196-3; McNorgan C, 2011, COGNITION, V118, P211, DOI 10.1016/j.cognition.2010.10.017; MILNER PM, 1974, PSYCHOL REV, V81, P521, DOI 10.1037/h0037149; Neuper C, 2006, PROG BRAIN RES, V159, P211, DOI 10.1016/S0079-6123(06)59014-4; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Oostenveld R, 2003, CLIN NEUROPHYSIOL, V114, P1194, DOI 10.1016/S1388-2457(03)00059-2; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Pecher D, 2003, PSYCHOL SCI, V14, P119, DOI 10.1111/1467-9280.t01-1-01429; Plaut DC, 2002, COGN NEUROPSYCHOL, V19, P603, DOI 10.1080/02643290244000112; Pulvermuller F, 2010, NAT REV NEUROSCI, V11, P351, DOI 10.1038/nrn2811; Raghavachari S, 2006, J NEUROPHYSIOL, V95, P1630, DOI 10.1152/jn.00409.2005; Raposo A, 2009, NEUROPSYCHOLOGIA, V47, P388, DOI 10.1016/j.neuropsychologia.2008.09.017; Rosenblum LD, 2008, CURR DIR PSYCHOL SCI, V17, P405, DOI 10.1111/j.1467-8721.2008.00615.x; Schneider TR, 2008, NEUROIMAGE, V42, P1244, DOI 10.1016/j.neuroimage.2008.05.033; Schneider TR, 2008, EXP PSYCHOL, V55, P121, DOI 10.1027/1618-3169.55.2.121; Schneider TR, 2011, J NEUROSCI, V31, P2502, DOI 10.1523/JNEUROSCI.6447-09.2011; Senkowski D, 2008, TRENDS NEUROSCI, V31, P401, DOI 10.1016/j.tins.2008.05.002; Simmons WK, 2007, NEUROPSYCHOLOGIA, V45, P2802, DOI 10.1016/j.neuropsychologia.2007.05.002; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Sober SJ, 2003, J NEUROSCI, V23, P6982, DOI 10.1523/JNEUROSCI.23-18-06982.2003; Summerfield C, 2005, NEUROIMAGE, V24, P692, DOI 10.1016/j.neuroimage.2004.09.012; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Van Ackeren M J, 2012, J COGN NEUROSCI, V24; van Dam WO, 2012, HUM BRAIN MAPP, V33, P2322, DOI 10.1002/hbm.21365; van Dantzig S, 2011, BEHAV RES METHODS, V43, P145, DOI 10.3758/s13428-010-0038-8; Van der Werf J, 2008, J NEUROSCI, V28, P8397, DOI 10.1523/JNEUROSCI.0630-08.2008; Vigliocco G, 2009, LANG COGN, V1, P219, DOI 10.1515/LANGCOG.2009.011; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; VONDERMALSBURG C, 1986, BIOL CYBERN, V54, P29, DOI 10.1007/BF00337113; Wang L, 2012, HUM BRAIN MAPP, V33, P2898, DOI 10.1002/hbm.21410; WARRINGTON EK, 1975, Q J EXP PSYCHOL, V27, P635, DOI 10.1080/14640747508400525; Wu X, 2007, NEUROIMAGE, V35, P1654, DOI 10.1016/j.neuroimage.2007.02.011	57	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101042	10.1371/journal.pone.0101042	http://dx.doi.org/10.1371/journal.pone.0101042			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007074	Green Published, gold, Green Submitted			2022-12-27	WOS:000339040600028
J	Xie, GQ; Laskowitz, DT; Turner, EL; Egger, JR; Shi, P; Ren, FX; Gao, W; Wu, YF				Xie, Gaoqiang; Laskowitz, Daniel T.; Turner, Elizabeth L.; Egger, Joseph R.; Shi, Ping; Ren, Fuxiu; Gao, Wei; Wu, Yangfeng			Baseline Health-Related Quality of Life and 10-Year All-Cause Mortality among 1739 Chinese Adults	PLOS ONE			English	Article							PREDICTS MORTALITY; DISEASE	Background and Purpose: Health-related quality of life (HRQOL) may be associated with the longevity of patients; yet it is not clear whether this association holds in a general population, especially in low- and middle-income countries. The objective of this study was to determine whether baseline HRQOL was associated with 10-year all-cause mortality in a Chinese general population. Methods: A prospective cohort study was conducted from 2002 to 2012 on 1739 participants in 11 villages of Beijing. Baseline data on six domains of HRQOL, chronic diseases and cardiovascular risk factors were collected in either 2002 (n = 1290) or 2005 (n = 449). Subjects were followed through the end of the study period, or until they were censored due to death or loss to follow-up, whichever came first. Results: A multivariable Cox model estimated that Total HRQOL score (bottom 50% versus top 50%) was associated with a 44% increase in all-cause mortality (Hazard Ratio [HR] = 1.44; 95% confidence interval [CI]: 1.00-2.06), after adjusting for sex, age, education levels, occupation, marital status, smoking status, fruit intake, vegetable intake, physical exercise, hypertension, history of a stroke, myocardial infarction, chronic respiratory disease, and kidney disease. Among the six HRQOL domains, the Independence domain had the largest fully adjusted HR (HR = 1.66; 95% CI: 1.13-2.42), followed by Psychological (HR = 1.47; 95% CI: 1.03-2.09), Environmental (HR = 1.43, 95% CI: 1.003-2.03), Physical (HR = 1.38; 95% CI: 0.97-1.95), General (HR = 1.37; 95% CI: 0.97-1.94), and the Social domain (HR = 1.15; 95% CI: 0.81-1.65). Conclusion: Lower HRQOL, especially the inability to live independently, was associated with a significantly increased risk of 10-year all-cause mortality. The inclusion of HRQOL measures in clinical assessment may improve diagnostic accuracy to improve clinical outcomes and better target public health promotions.	[Xie, Gaoqiang; Wu, Yangfeng] Peking Univ, Clin Res Inst, Beijing 100871, Peoples R China; [Laskowitz, Daniel T.] Duke Univ, Med Ctr, Dept Neurol, Durham, NC USA; [Turner, Elizabeth L.] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA; [Turner, Elizabeth L.; Egger, Joseph R.] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Shi, Ping; Ren, Fuxiu] Shijingshan Ctr Dis Control & Prevent, Beijing, Peoples R China; [Gao, Wei] Peking Univ, Hosp 3, Dept Cardiol, Beijing 100871, Peoples R China; [Gao, Wei] Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing, Peoples R China; [Wu, Yangfeng] Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China; [Wu, Yangfeng] Peking Univ, Hlth Sci Ctr, George Inst Global Hlth, Beijing 100871, Peoples R China	Peking University; Duke University; Duke University; Duke University; Peking University; Peking University; Peking University	Xie, GQ (corresponding author), Peking Univ, Clin Res Inst, Beijing 100871, Peoples R China.	gqxie72@163.com; ywu@georgeinstitute.org.cn			People's Republic of China National 10th Five-Year Plan Science and Technology Key Projects [2001BA703B01]; National Natural Science Foundation of China [30471494, 30872168]; Duke University, Medical Center, and Health System [P-1-00242]; National Institutes of Health, USA [1D43-TW008308-01]; FOGARTY INTERNATIONAL CENTER [D43TW008308] Funding Source: NIH RePORTER	People's Republic of China National 10th Five-Year Plan Science and Technology Key Projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Duke University, Medical Center, and Health System; National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by grants from the People's Republic of China National 10th Five-Year Plan Science and Technology Key Projects (grant no: 2001BA703B01), the National Natural Science Foundation of China (grant no: 30471494 and 30872168), Duke University, Medical Center, and Health System (Exchange Visitor Program Number: P-1-00242) and the National Institutes of Health, USA (grant no.: 1D43-TW008308-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelha FJ, 2010, REV BRAS ANESTESIOL, V60, P268, DOI 10.1016/S0034-7094(10)70035-0; Antonelli-Incalzi R, 2009, RESPIROLOGY, V14, P98, DOI 10.1111/j.1440-1843.2008.01441.x; Bezjak A, 2006, J CLIN ONCOL, V24, P3831, DOI 10.1200/JCO.2006.05.8073; Brown DS, 2013, PREV SCI; Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; Zuluaga MC, 2010, EUR J HEART FAIL, V12, P1372, DOI 10.1093/eurjhf/hfq163; Delcourt C, 2011, STROKE, V42, P433, DOI 10.1161/STROKEAHA.110.596627; Domingo-Salvany A, 2002, AM J RESP CRIT CARE, V166, P680, DOI 10.1164/rccm.2112043; Drayer RA, 2006, GEN HOSP PSYCHIAT, V28, P306, DOI 10.1016/j.genhosppsych.2006.03.008; Fan VS, 2002, CHEST, V122, P429, DOI 10.1378/chest.122.2.429; Giaquinto S, 2010, CLIN EXP HYPERTENS, V32, P426, DOI 10.3109/10641961003667963; Haring R, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-103; Kaplan MS, 2007, QUAL LIFE RES, V16, P1539, DOI 10.1007/s11136-007-9256-7; Kleefstra N, 2008, DIABETES CARE, V31, P932, DOI 10.2337/dc07-2072; Lord F.M., 1980, APPL ITEM RESPONSE T; Lu Yi-hua, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P87; Mathews WC, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-5; Murray C, 2011, QUAL LIFE RES, V20, P81, DOI 10.1007/s11136-010-9718-1; Myint PK, 2007, PSYCHOSOM MED, V69, P410, DOI 10.1097/psy.0b013e318068fcd4; Naess H, 2012, J STROKE CEREBROVASC; Naess H, 2013, J STROKE CEREBROVASC, V22, pE79, DOI 10.1016/j.jstrokecerebrovasdis.2012.06.010; Nishida M, 2007, CLIN CHIM ACTA, V384, P99, DOI 10.1016/j.cca.2007.06.009; Osthus TBH, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-46; Peng XZ, 2011, SCIENCE, V333, P581, DOI 10.1126/science.1209396; Power M, 1998, SOC SCI MED, V46, P1569, DOI 10.1016/s0277-9536(98)00009-4; Raczek AE, 1998, J CLIN EPIDEMIOL, V51, P1203, DOI 10.1016/S0895-4356(98)00112-7; Sadetsky N, 2009, QUAL LIFE RES, V18, P1019, DOI 10.1007/s11136-009-9526-7; Testa MA, 1996, NEW ENGL J MED, V334, P835, DOI 10.1056/NEJM199603283341306; Tsai YC, 2010, NEPHROL DIAL TRANSPL, V25, P1621, DOI 10.1093/ndt/gfp671; Vollmer WM, 2002, ANN EPIDEMIOL, V12, P295, DOI 10.1016/S1047-2797(01)00288-5; Wu Y, 2010, HDB DIS BURDENS QUAL; Wu Yang-feng, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P751; Xie GQ, 2005, CHEST, V128, P2448, DOI 10.1378/chest.128.4.2448; Zhu Wu, 2008, CHINESE J BEHAV MED, V17, DOI [10.3760/cma.j.issn.1674-6554.2008.3707.3011, DOI 10.3760/CMA.J.ISSN.1674-6554.2008.3707.3011]	35	20	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101527	10.1371/journal.pone.0101527	http://dx.doi.org/10.1371/journal.pone.0101527			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL3PK	25007092	Green Published, gold, Green Submitted			2022-12-27	WOS:000339040600042
J	Zhang, LC; Liang, J; Luo, WZ; Liu, X; Yan, H; Zhao, KB; Shi, HB; Zhang, YB; Wang, LG; Wang, LX				Zhang, Longchao; Liang, Jing; Luo, Weizhen; Liu, Xin; Yan, Hua; Zhao, Kebin; Shi, Huibi; Zhang, Yuebo; Wang, Ligang; Wang, Lixian			Genome-Wide Scan Reveals LEMD3 and WIF1 on SSC5 as the Candidates for Porcine Ear Size	PLOS ONE			English	Article							ASSOCIATION ANALYSIS; MUSCLE MASS; TGF-BETA; WNT; TRAITS; GENE; QTL; GROWTH; LOCUS; CELLS	The quantitative trait loci (QTL) for porcine ear size was previously reported to mainly focus on SSC5 and SSC7. Recently, a missense mutation, G32E, in PPARD in the QTL interval on SSC7 was identified as the causative mutation for ear size. However, on account of the large interval of QTL, the responsible gene on SSC5 has not been identified. In this study, an intercross population was constructed from the large-eared Minzhu, an indigenous Chinese pig breed, and the Western commercial Large White pig to examine the genetic basis of ear size diversity. A GWAS was performed to detect SNPs significantly associated with ear size. Thirty-five significant SNPs defined a 10.78-Mb (30.14-40.92 Mb) region on SSC5. Further, combining linkage disequilibrium and haplotype sharing analysis, a reduced region of 3.07-Mb was obtained. Finally, by using a selective sweep analysis, a critical region of about 450-kb interval containing two annotated genes LEMD3 and WIF1 was refined in this work. Functional analysis indicated that both represent biological candidates for porcine ear size, with potential application in breeding programs. The two genes could also be used as novel references for further study of the mechanism underlying human microtia.	[Zhang, Longchao; Liang, Jing; Liu, Xin; Yan, Hua; Zhao, Kebin; Shi, Huibi; Zhang, Yuebo; Wang, Ligang; Wang, Lixian] Chinese Acad Agr Sci, Inst Anim Sci, Minist Agr, Key Lab Farm Anim Genet Resources & Germplasm Inn, Beijing 100193, Peoples R China; [Luo, Weizhen] Beijing Sanyuan Breeding Technol Co Ltd, Anim Husb Res Inst, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Ministry of Agriculture & Rural Affairs	Wang, LG (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Minist Agr, Key Lab Farm Anim Genet Resources & Germplasm Inn, Beijing 100193, Peoples R China.	ligwang@126.com; iaswlx@263.net	Liang, Jing/GOK-1970-2022		Agricultural Science and Technology Innovation Program [ASTIP-IAS02]; earmarked fund for Modern Agro-industry Technology Research System; National Key Technology R&D Program of China [2011BAD28B01]; National Natural Science Foundation of China [31201781]; National Technology Program of China [2011ZX08006-003]; Chinese Academy of Agricultural Sciences Foundation [2011cj-5, 2012ZL069]	Agricultural Science and Technology Innovation Program; earmarked fund for Modern Agro-industry Technology Research System; National Key Technology R&D Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Technology Program of China; Chinese Academy of Agricultural Sciences Foundation(Chinese Academy of Sciences)	This research was supported by Agricultural Science and Technology Innovation Program (ASTIP-IAS02), earmarked fund for Modern Agro-industry Technology Research System, the National Key Technology R&D Program of China (No. 2011BAD28B01), National Natural Science Foundation of China (31201781), National Technology Program of China (No. 2011ZX08006-003), and Chinese Academy of Agricultural Sciences Foundation (No. 2011cj-5 and No. 2012ZL069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bolormaa S, 2011, J ANIM SCI, V89, P2297, DOI 10.2527/jas.2010-3138; Bourgeois B, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003411; Bouwman AC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-43; Boyko AR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000451; Chen DM, 2012, DEVELOPMENT, V139, P1522, DOI 10.1242/dev.076463; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Fan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014726; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hsieh JC, 1999, NATURE, V398, P431, DOI 10.1038/18899; Jacques BE, 2012, DEVELOPMENT, V139, P4395, DOI 10.1242/dev.080358; Jayasena CS, 2008, DEVELOPMENT, V135, P2251, DOI 10.1242/dev.017905; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Li PH, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-6; Liu WB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028600; Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200; Luo WZ, 2012, INT J BIOL SCI, V8, P580, DOI 10.7150/ijbs.3614; Luquetti DV, 2012, AM J MED GENET A, V158A, P124, DOI 10.1002/ajmg.a.34352; Ma J, 2009, ANIM GENET, V40, P463, DOI 10.1111/j.1365-2052.2009.01867.x; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Macsai CE, 2008, J CELL PHYSIOL, V215, P578, DOI 10.1002/jcp.21342; Madsen P., 2006, WORLD C GENETICS APP; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nezer C, 1999, NAT GENET, V21, P155, DOI 10.1038/5935; Nezer C, 2003, GENETICS, V165, P277; Polychronakos C, 2011, NAT REV GENET, V12, P781, DOI 10.1038/nrg3069; Ren J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002043; Rooryck C, 2009, EUR J MED GENET, V52, P446, DOI 10.1016/j.ejmg.2009.08.005; ROTHSCHILD MF, 1998, GENETICS PIG; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; Vaysse A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002316; Wang LF, 2010, P NATL ACAD SCI USA, V107, P7317, DOI 10.1073/pnas.1000031107; Wei WH, 2007, ANIM GENET, V38, P222, DOI 10.1111/j.1365-2052.2007.01591.x; XIANG X, 1990, SCIENCE, V247, P967, DOI 10.1126/science.2305264; Yang Q, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S134; ZHANG Z, 1986, PIG BREEDS CHINA; Zhou SH, 2004, J BONE MINER RES, V19, P463, DOI 10.1359/JBMR.0301239	40	16	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102085	10.1371/journal.pone.0102085	http://dx.doi.org/10.1371/journal.pone.0102085			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006967	Green Published, Green Submitted, gold			2022-12-27	WOS:000339040600093
J	Gonzalez-Perez, A; Saez, ME; Johansson, S; Nagy, P; Rodriguez, LAG				Gonzalez-Perez, Antonio; Saez, Maria E.; Johansson, Saga; Nagy, Peter; Garcia Rodriguez, Luis A.			Risk Factors Associated with Uncomplicated Peptic Ulcer and Changes in Medication Use after Diagnosis	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PROTON-PUMP INHIBITORS; HELICOBACTER-PYLORI; GASTROINTESTINAL COMPLICATIONS; ASPIRIN; POPULATION; DISEASE; BLEEDING/PERFORATION; THERAPY; REDUCE	Background: Few epidemiologic studies have investigated predictors of uncomplicated peptic ulcer disease (PUD) separately from predictors of complicated PUD. Objective: To analyze risk factors associated with uncomplicated PUD and medication use after diagnosis. Methods: Patients diagnosed with uncomplicated PUD (n = 3,914) were identified from The Health Improvement Network database among individuals aged 40-84 years during 1997-2005, with no previous history of PUD. Prescription records for the year after the date of diagnosis were reviewed and a nested case-control analysis was performed to calculate the odds ratios for the association of potential risk factors with PUD. Results: Medications associated with developing uncomplicated PUD included current use of acetylsalicylic acid (ASA), nonsteroidal anti-inflammatory drugs (NSAIDs), paracetamol, selective serotonin reuptake inhibitors, antidepressants, antihypertensives or acid suppressants. Uncomplicated PUD was significantly associated with being a current or former smoker and having had a score of at least 3 on the Townsend deprivation index. Approximately 50% of patients who were users of ASA (19% of patients) or chronic users of NSAIDs (7% of patients) at diagnosis did not receive another prescription of the medication in the 60 days after diagnosis, and 30% were not represcribed therapy within a year. Among patients who were current users of ASA or chronic NSAIDs at the time of the PUD diagnosis and received a subsequent prescription for their ASA or NSAID during the following year, the vast majority (80-90%) also received a proton pump inhibitor coprescription. Conclusions: Our results indicate that several risk factors for upper gastrointestinal bleeding are also predictors of uncomplicated PUD, and that some patients do not restart therapy with ASA or NSAIDs after a diagnosis of uncomplicated PUD. Further investigation is needed regarding the consequences for these patients in terms of increased cardiovascular burden due to discontinuation of antiplatelet therapy.	[Gonzalez-Perez, Antonio; Saez, Maria E.; Garcia Rodriguez, Luis A.] Spanish Ctr Pharmacoepidemiol Res CEIFE, Madrid, Spain; [Gonzalez-Perez, Antonio; Saez, Maria E.] Andalusian Bioinformat Res Ctr CAEBi, Seville, Spain; [Johansson, Saga; Nagy, Peter] AstraZeneca R&D, Molndal, Sweden	AstraZeneca	Rodriguez, LAG (corresponding author), Spanish Ctr Pharmacoepidemiol Res CEIFE, Madrid, Spain.	lagarcia@ceife.es	Gonzalez-Perez, Antonio/A-5247-2010; rodriguez, luis a garcia/B-1980-2010; González-Pérez, Antonio/AAY-4179-2021; Saez, Maria E/C-8093-2012	Gonzalez-Perez, Antonio/0000-0001-9771-5982; González-Pérez, Antonio/0000-0001-9771-5982; Nagy, Peter/0000-0001-8836-2310; Saez, Maria/0000-0001-9299-2534	AstraZeneca R&D, Molndal, Sweden	AstraZeneca R&D, Molndal, Sweden(AstraZeneca)	The study was funded by AstraZeneca R&D, Molndal, Sweden. Two of the manuscript authors, Saga Johansson and Peter Nagy, are employees of AstraZeneca. Saga Johansson and Peter Nagy provided input on the design of the study, were involved in analysis and interpretation of the data and contributed fully to the development and finalization of the manuscript, and approved it for submission. Other employees of AstraZeneca were given the opportunity to comment on manuscript drafts and the authors gave consideration to any relevant comments received.	Barkun A, 2010, AM J MED, V123, P358, DOI 10.1016/j.amjmed.2009.09.031; Bhatt DL, 2008, CIRCULATION, V118, P1894, DOI 10.1161/CIRCULATIONAHA.108.191087; Bourke Alison, 2004, Inform Prim Care, V12, P171; Cai S, 2009, ALIMENT PHARM THER, V30, P1039, DOI 10.1111/j.1365-2036.2009.04131.x; Dall M, 2012, ALIMENT PHARM THER, V35, P948, DOI 10.1111/j.1365-2036.2012.05006.x; de Abajo FJ, 1999, BRIT MED J, V319, P1106, DOI 10.1136/bmj.319.7217.1106; GABRIEL SE, 1991, ANN INTERN MED, V115, P787, DOI 10.7326/0003-4819-115-10-787; Rodriguez LAG, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4094; Rodriguez LAG, 2011, CIRCULATION, V123, P1108, DOI 10.1161/CIRCULATIONAHA.110.973008; Hernandez-Diaz S, 2000, ARCH INTERN MED, V160, P2093, DOI 10.1001/archinte.160.14.2093; Hernandez-Diaz S, 2002, J CLIN EPIDEMIOL, V55, P157, DOI 10.1016/S0895-4356(01)00461-9; Hernandez-Diaz S, 2013, DIGEST DIS SCI, V58, P1653, DOI 10.1007/s10620-013-2561-9; Lanas A, 2012, AM J GASTROENTEROL, V107, P707, DOI 10.1038/ajg.2012.13; Lassen A, 2006, AM J GASTROENTEROL, V101, P945, DOI 10.1111/j.1572-0241.2006.00518.x; Lau JY, 2011, DIGESTION, V84, P102, DOI 10.1159/000323958; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; Lin KJ, 2011, GASTROENTEROLOGY, V141, P71, DOI 10.1053/j.gastro.2011.03.049; LUBIN JH, 1984, BIOMETRICS, V40, P63, DOI 10.2307/2530744; Margulis AV, 2009, PHARMACOEPIDEM DR S, V18, P900, DOI 10.1002/pds.1787; Martin-Merino E, 2012, PRAGMAT OBS RES, V3, P1, DOI 10.2147/POR.S29557; Miyake K, 2013, DIGEST ENDOSC, V25, P25, DOI 10.1111/j.1443-1661.2012.01334.x; NOMURA A, 1994, ANN INTERN MED, V120, P977, DOI 10.7326/0003-4819-120-12-199406150-00001; ONEIL M, 1995, METHOD INFORM MED, V34, P187; PETERSON WL, 1991, NEW ENGL J MED, V324, P1043, DOI 10.1056/NEJM199104113241507; Pilotto A, 2004, ALIMENT PHARM THER, V20, P1091, DOI 10.1111/j.1365-2036.2004.02246.x; Rodriguez LAG, 2004, AM J EPIDEMIOL, V159, P23, DOI 10.1093/aje/kwh005; Rodriguez LAG, 1998, ARCH INTERN MED, V158, P33, DOI 10.1001/archinte.158.1.33; Rodriguez LAG, 2001, BRIT J CLIN PHARMACO, V52, P563, DOI 10.1046/j.0306-5251.2001.01476.x; Stack WA, 2002, ALIMENT PHARM THER, V16, P497, DOI 10.1046/j.1365-2036.2002.01197.x; Townsend PP., 1988, HLTH DEPRIVATION INE; Udd M, 2007, SCAND J GASTROENTERO, V42, P1395, DOI 10.1080/00365520701478758; Yeomans ND, 2011, J GASTROEN HEPATOL, V26, P426, DOI 10.1111/j.1440-1746.2010.06569.x	32	9	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101768	10.1371/journal.pone.0101768	http://dx.doi.org/10.1371/journal.pone.0101768			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003908	gold, Green Published, Green Submitted			2022-12-27	WOS:000339242700063
J	Iwamoto, K; Hamada, H; Eguchi, Y; Okamoto, M				Iwamoto, Kazunari; Hamada, Hiroyuki; Eguchi, Yukihiro; Okamoto, Masahiro			Stochasticity of Intranuclear Biochemical Reaction Processes Controls the Final Decision of Cell Fate Associated with DNA Damage	PLOS ONE			English	Article							GROWTH ARREST; P53 PULSES; APOPTOSIS; MECHANISM; DEATH; MODEL; GENE; DOWNSTREAM; ACTIVATION; INDUCTION	A massive integrative mathematical model of DNA double-strand break (DSB) generation, DSB repair system, p53 signaling network, and apoptosis induction pathway was constructed to explore the dominant factors of unknown criteria of cell fate decision. In the proposed model, intranuclear reactions were modeled as stochastic processes and cytoplasmic reactions as deterministic processes, and both reaction sets were simulated simultaneously. The simulated results at the single-cell level showed that the model generated several sustained oscillations ( pulses) of p53, Mdm2, ATM, and Wip1, and cell-to-cell variability in the number of p53 pulses depended on IR intensity. In cell populations, the model generated damped p53 oscillations, and IR intensity affected the amplitude of the first p53 oscillation. Cells were then subjected to the same IR dose exhibiting apoptosis induction variability. These simulated results are in quantitative agreement with major biological findings observed in human breast cancer epithelial MCF7, NIH3T3, and fibrosarcoma cells, demonstrating that the proposed model was concededly biologically appropriate. Statistical analysis of the simulated results shows that the generation of multiple p53 pulses is a prerequisite for apoptosis induction. Furthermore, cells exhibited considerable individual variability in p53 dynamics, which correlated with intrinsic apoptosis induction. The simulated results based on the proposed model demonstrated that the stochasticity of intranuclear biochemical reaction processes controls the final decision of cell fate associated with DNA damage. Applying stochastic simulation to an exploration of intranuclear biochemical reaction processes is indispensable in enhancing the understanding of the dynamic characteristics of biological multi-layered systems of higher organisms.	[Iwamoto, Kazunari] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 812, Japan; [Iwamoto, Kazunari] Japan Soc Promot Sci, Tokyo, Japan; [Hamada, Hiroyuki; Okamoto, Masahiro] Kyushu Univ, Dept Syst Life Sci, Fukuoka 812, Japan; [Hamada, Hiroyuki; Okamoto, Masahiro] Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Fukuoka 812, Japan; [Hamada, Hiroyuki; Okamoto, Masahiro] Kyushu Univ, Synthet Syst Biol Res Ctr, Fukuoka 812, Japan; [Eguchi, Yukihiro] Kyushu Univ, Bioarchitecture Ctr, Fukuoka 812, Japan	Kyushu University; Japan Society for the Promotion of Science; Kyushu University; Kyushu University; Kyushu University; Kyushu University	Hamada, H (corresponding author), Kyushu Univ, Dept Syst Life Sci, Fukuoka 812, Japan.	hamada@brs.kyushu-u.ac.jp		Iwamoto, Kazunari/0000-0001-9794-9420	Research Fellowship of the Japan Society for the Promotion of Science; JSPS KAKENHI [23119001]; Research Grant for Young Investigators of Faculty of Agriculture, Kyushyu University	Research Fellowship of the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Research Grant for Young Investigators of Faculty of Agriculture, Kyushyu University	The research of KI was supported by the Research Fellowship of the Japan Society for the Promotion of Science (http://www.jsps.go.jp/j-pd/index.html). The work of HH MO was supported by JSPS KAKENHI Grant (23119001; http://www.syn-biol.com/). The work of HH was supported by the Research Grant for Young Investigators of Faculty of Agriculture, Kyushyu University (http://www.agr.kyushu-u.ac.jp/investigation/faculty_subsidy/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeck JG, 2008, PLOS BIOL, V6, P2831, DOI 10.1371/journal.pbio.0060299; Audibert A, 2002, MOL CELL BIOL, V22, P6706, DOI 10.1128/MCB.22.19.6706-6718.2002; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Cance E., 2005, ESAIM P, V14, P1, DOI DOI 10.1051/PROC:2005001; Ciliberto A, 2005, CELL CYCLE, V4, P488, DOI 10.4161/cc.4.3.1548; Datta R, 2000, J BIOL CHEM, V275, P31733, DOI 10.1074/jbc.M910231199; Erster S, 2004, MOL CELL BIOL, V24, P6728, DOI 10.1128/MCB.24.15.6728-6741.2004; Fei PW, 2003, ONCOGENE, V22, P5774, DOI 10.1038/sj.onc.1206677; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Guerrero M, 2002, PHYS MED BIOL, V47, P3197, DOI 10.1088/0031-9155/47/17/310; Hamada H, 2013, BIOSYSTEMS, V111, P208, DOI 10.1016/j.biosystems.2013.02.007; Hamada H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004795; Hamstra DA, 2006, CANCER RES, V66, P7482, DOI 10.1158/0008-5472.CAN-06-1405; Hua F, 2005, J IMMUNOL, V175, P985, DOI 10.4049/jimmunol.175.2.985; Kim KH, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4822103; Kracikova M, 2013, CELL DEATH DIFFER, V20, P576, DOI 10.1038/cdd.2012.155; Kren BT, 1996, EMBO J, V10, P819; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Li G, 1998, BRIT J DERMATOL, V139, P3; Loewer A, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-114; Ma L, 2005, P NATL ACAD SCI USA, V102, P14266, DOI 10.1073/pnas.0501352102; Norbury CJ, 2004, ONCOGENE, V23, P2797, DOI 10.1038/sj.onc.1207532; Okamura S, 2001, MOL CELL, V8, P85, DOI 10.1016/S1097-2765(01)00284-2; Pastorino JG, 1998, J BIOL CHEM, V273, P7770, DOI 10.1074/jbc.273.13.7770; Pellegata NS, 1996, P NATL ACAD SCI USA, V93, P15209, DOI 10.1073/pnas.93.26.15209; Riches LC, 2008, MUTAGENESIS, V23, P331, DOI 10.1093/mutage/gen039; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Shreeram S, 2006, MOL CELL, V23, P757, DOI 10.1016/j.molcel.2006.07.010; Smeenk L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017574; Srinivasula SM, 2000, J BIOL CHEM, V275, P36152, DOI 10.1074/jbc.C000533200; Stewart RD, 2001, RADIAT RES, V156, P365, DOI 10.1667/0033-7587(2001)156[0365:TLKMOD]2.0.CO;2; Suzuki A, 1998, ONCOGENE, V17, P931, DOI 10.1038/sj.onc.1202021; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Upton JP, 2008, MOL CELL BIOL, V28, P3943, DOI 10.1128/MCB.00013-08; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Yoshida K, 2006, J BIOL CHEM, V281, P5734, DOI 10.1074/jbc.M512074200; Zhang TL, 2007, CELL CYCLE, V6, P85, DOI 10.4161/cc.6.1.3705; Zhang XP, 2011, P NATL ACAD SCI USA, V108, P8990, DOI 10.1073/pnas.1100600108; Zhang XP, 2009, P NATL ACAD SCI USA, V106, P12245, DOI 10.1073/pnas.0813088106; Zhang YK, 1999, ONCOGENE, V18, P1131, DOI 10.1038/sj.onc.1202426	44	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101333	10.1371/journal.pone.0101333	http://dx.doi.org/10.1371/journal.pone.0101333			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003668	Green Published, Green Submitted, gold			2022-12-27	WOS:000339242700025
J	Toyoda, S; Yoshimura, T; Mizuta, J; Miyazaki, J				Toyoda, Shuichi; Yoshimura, Takuji; Mizuta, Junya; Miyazaki, Jun-ichi			Auto-Regulation of the Sohlh1 Gene by the SOHLH2/SOHLH1/SP1 Complex: Implications for Early Spermatogenesis and Oogenesis	PLOS ONE			English	Article							DNA-BINDING; C-MYC; DEVELOPMENTAL EXPRESSION; SIGNALING PATHWAY; KIT EXPRESSION; TRANSCRIPTION; SP1; MAX; SPERMATOGONIA; ACTIVATION	Tissue-specific basic helix-loop-helix (bHLH) transcription factor proteins often play essential roles in cellular differentiation. The bHLH proteins SOHLH2 and SOHLH1 are expressed specifically in spermatogonia and oocytes and are required for early spermatogonial and oocyte differentiation. We previously reported that knocking out Sohlh2 causes defects in spermatogenesis and oogenesis similar to those in Sohlh1-null mice, and that Sohlh1 is downregulated in the gonads of Sohlh2-null mice. We also demonstrated that SOHLH2 and SOHLH1 can form a heterodimer. These observations led us to hypothesize that the SOHLH2/SOHLH1 heterodimer regulates the Sohlh1 promoter. Here, we show that SOHLH2 and SOHLH1 synergistically upregulate the Sohlh1 gene through E-boxes upstream of the Sohlh1 promoter. Interestingly, we identified an SP1-binding sequence, called a GC-box, adjacent to these E-boxes, and found that SOHLH1 could bind to SP1. Furthermore, chromatin-immunoprecipitation analysis using testes from mice on postnatal day 8 showed that SOHLH1 and SP1 bind to the Sohlh1 promoter region in vivo. Our findings suggest that an SOHLH2/SOHLH1/SP1 ternary complex autonomously and cooperatively regulates Sohlh1 gene transcription through juxtaposed E-and GC-boxes during early spermatogenesis and oogenesis.	[Toyoda, Shuichi; Yoshimura, Takuji; Mizuta, Junya; Miyazaki, Jun-ichi] Osaka Univ, Div Stem Cell Regulat Res, Grad Sch Med, Osaka, Japan; [Yoshimura, Takuji] Osaka Univ, Sch Med, Inst Expt Anim Sci, Lab Reprod Engn, Osaka, Japan	Osaka University; Osaka University	Miyazaki, J (corresponding author), Osaka Univ, Div Stem Cell Regulat Res, Grad Sch Med, Osaka, Japan.	jimiyaza@nutri.med.osaka-u.ac.jp	Miyazaki, Jun-ichi/N-1976-2015	Miyazaki, Jun-ichi/0000-0003-2475-589X; Yoshimura, Takuji/0000-0002-7856-0679	Japanese Society for the Promotion of Science [22590190]; Grants-in-Aid for Scientific Research [25460364] Funding Source: KAKEN	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid (No. 22590190) from the Japanese Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMATI B, 1992, NATURE, V359, P423, DOI 10.1038/359423a0; Ballow D, 2006, DEV BIOL, V294, P161, DOI 10.1016/j.ydbio.2006.02.027; Ballow DJ, 2006, GENE EXPR PATTERNS, V6, P1014, DOI 10.1016/j.modgep.2006.04.007; Barrios F, 2012, J CELL SCI, V125, P1455, DOI 10.1242/jcs.092593; Biesiada E, 1999, MOL CELL BIOL, V19, P2577; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; Choi Y, 2008, BIOL REPROD, V79, P1176, DOI 10.1095/biolreprod.108.071217; Ding XY, 2013, MOL REPROD DEV, V80, P70, DOI 10.1002/mrd.22138; Edson MA, 2009, ENDOCR REV, V30, P624, DOI 10.1210/er.2009-0012; FISHER F, 1993, EMBO J, V12, P5075, DOI 10.1002/j.1460-2075.1993.tb06201.x; Hao J, 2008, STEM CELLS, V26, P1587, DOI 10.1634/stemcells.2007-0502; KRETZNER L, 1992, NATURE, V359, P426, DOI 10.1038/359426a0; Kumar P, 2010, J BIOL CHEM, V285, P37521, DOI 10.1074/jbc.M110.132795; Kyo S, 2000, NUCLEIC ACIDS RES, V28, P669, DOI 10.1093/nar/28.3.669; Lecuyer E, 2002, BLOOD, V100, P2430, DOI 10.1182/blood-2002-02-0568; Lee TL, 2006, GENOMICS, V88, P18, DOI 10.1016/j.ygeno.2006.03.008; Li H, 2009, BIOL REPROD, V81, P996, DOI 10.1095/biolreprod.109.078808; Ma WL, 2008, BIOL REPROD, V79, P289, DOI 10.1095/biolreprod.107.067082; Mithraprabhu S, 2009, REPRODUCTION, V138, P743, DOI 10.1530/REP-08-0537; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; Pangas SA, 2006, P NATL ACAD SCI USA, V103, P8090, DOI 10.1073/pnas.0601083103; Park GH, 1998, BLOOD, V92, P4138, DOI 10.1182/blood.V92.11.4138.423k44_4138_4149; Pellegrini M, 2003, J CELL SCI, V116, P3363, DOI 10.1242/jcs.00650; PRENDERGAST GC, 1991, CELL, V65, P395, DOI 10.1016/0092-8674(91)90457-A; Ray SK, 2007, MOL CELL BIOL, V27, P7839, DOI 10.1128/MCB.00438-07; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; Suzuki H, 2012, DEV BIOL, V361, P301, DOI 10.1016/j.ydbio.2011.10.027; Swanson HI, 1999, NUCLEIC ACIDS RES, V27, P3205, DOI 10.1093/nar/27.15.3205; Toyoda S, 2009, DEV BIOL, V325, P238, DOI 10.1016/j.ydbio.2008.10.019; VANPELT AMM, 1995, BIOL REPROD, V53, P570, DOI 10.1095/biolreprod53.3.570; Worrad DM, 1997, MOL REPROD DEV, V46, P268, DOI 10.1002/(SICI)1098-2795(199703)46:3&lt;268::AID-MRD5&gt;3.0.CO;2-N; Yoshimura T, 2007, GENE EXPR PATTERNS, V8, P27, DOI 10.1016/j.modgep.2007.08.003	33	23	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101681	10.1371/journal.pone.0101681	http://dx.doi.org/10.1371/journal.pone.0101681			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003626	gold, Green Published, Green Submitted			2022-12-27	WOS:000339242700052
J	Vazacova, K; Munzbergova, Z				Vazacova, Kristyna; Muenzbergova, Zuzana			The Importance of Species Traits for Species Distribution on Oceanic Islands	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; SEED DISPERSAL; GENETIC-STRUCTURE; EUROPEAN FORESTS; PLANT DISPERSAL; RANGE; GRASSLAND; POPULATION; LANDSCAPE; SCALE	Understanding species' ability to colonize new habitats is a key knowledge allowing us to predict species' survival in the changing landscapes. However, most studies exploring this topic observe distribution of species in landscapes which are under strong human influence being fragmented only recently and ignore the fact that the species distribution in these landscapes is far from equilibrium. Oceanic islands seem more appropriate systems for studying the relationship between species traits and its distribution as they are fragmented without human contribution and as they remained unchanged for a long evolutionary time. In our study we compared the values of dispersal as well as persistence traits among 18 species pairs from the Canary Islands differing in their distribution within the archipelago. The data were analyzed both with and without phylogenetic correction. The results demonstrate that no dispersal trait alone can explain the distribution of the species in the system. They, however, also suggest that species with better dispersal compared to their close relatives are better colonizers. Similarly, abundance of species in the archipelago seems to be an important predictor of species colonization ability only when comparing closely related species. This implies that analyses including phylogenetic correction may provide different insights than analyses without such a correction and both types of analyses should be combined to understand the importance of various plant traits for species colonization ability.	[Vazacova, Kristyna; Muenzbergova, Zuzana] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic; [Vazacova, Kristyna; Muenzbergova, Zuzana] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences	Vazacova, K (corresponding author), Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic.	vazacova@seznam.cz	Münzbergová, Zuzana/F-6321-2013	Münzbergová, Zuzana/0000-0002-4026-6220	GACR [P505/10/0593]; GAUK [48807]; Mobility Fund of the Charles University in Prague; MSMT; RVO [67985939]	GACR(Grant Agency of the Czech Republic); GAUK; Mobility Fund of the Charles University in Prague; MSMT(Ministry of Education, Youth & Sports - Czech Republic); RVO	This project was supported by GACR P505/10/0593, GAUK 48807, Mobility Fund of the Charles University in Prague and partly by MSMT and RVO 67985939. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIZEN MA, 1990, J BIOGEOGR, V17, P327, DOI 10.2307/2845128; Allan GJ, 2004, MOL PHYLOGENET EVOL, V32, P123, DOI 10.1016/j.ympev.2003.11.018; [Anonymous], S PLUS 2000 PROF ED; Arechavaleta M., 2010, LISTA ESPECIES SILVE; Boedeltje G, 2003, J ECOL, V91, P855, DOI 10.1046/j.1365-2745.2003.00820.x; Bonet A, 2004, PLANT ECOL, V174, P257, DOI 10.1023/B:VEGE.0000049106.96330.9c; BRAMWELL D, 1979, PLANTS ISLANDS; Bramwell D, 2001, WILD FLOWERS CANARY, V2nd; Bramwell D, 1985, BOTANICA MACARONESIC, V14, P3, DOI DOI 10.1002/aps3.1032; CARLQUIST S, 1967, B TORREY BOT CLUB, V94, P129, DOI 10.2307/2484044; Carlquist S, 1965, ISLAND LIFE NATURAL; Castroviejo S., 1986, FLORA IBRICA PLANTAS; Caujape-Castells J., 2011, The biology of island floras, P284; Caujape-Castells J, 2010, PERSPECT PLANT ECOL, V12, P107, DOI 10.1016/j.ppees.2009.10.001; Chylova T, 2008, PRESLIA, V80, P183; COTTRELL HJ, 1947, NATURE, V159, P748, DOI 10.1038/159748a0; Couvreur M, 2004, SEED SCI RES, V14, P147, DOI 10.1079/SSR2004164; Darling E, 2008, NEW PHYTOL, V178, P424, DOI 10.1111/j.1469-8137.2007.02349.x; Aguilar MJA, 2010, BIODIVERS CONSERV, V19, P3089, DOI 10.1007/s10531-010-9881-2; Duarte MC, 2008, BIODIVERS CONSERV, V17, P453, DOI 10.1007/s10531-007-9226-y; EVENARI M, 1977, FLORA, V166, P223; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fernandez-Palacios JM, 2000, ACTA PHYTOGEOGRAPHIC, V85, P41; Gabrielova J, 2013, FOLIA GEOBOT, V48, P449, DOI 10.1007/s12224-012-9145-x; Gallagher RV, 2013, ECOGRAPHY, V36, P531, DOI 10.1111/j.1600-0587.2012.07514.x; GESSAMAN JA, 1988, CONDOR, V90, P662, DOI 10.2307/1368356; Goodwin NB, 2005, OIKOS, V110, P209, DOI 10.1111/j.0030-1299.2005.13859.x; GRIME JP, 1987, NEW PHYTOL, V106, P283; Hansen DM, 2012, J BIOGEOGR, V39, P1935, DOI 10.1111/jbi.12014; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Heinken T, 2002, FORSTWISS CENTRALBL, V121, P179, DOI 10.1046/j.1439-0337.2002.02029.x; Herben T, 2006, J ECOL, V94, P131, DOI 10.1111/j.1365-2745.2005.01063.x; Hewitt N, 2002, J BIOGEOGR, V29, P351, DOI 10.1046/j.1365-2699.2002.00679.x; Hill G, 2003, WIND PROSPECTING CAN; Hylander K, 2013, TRENDS ECOL EVOL, V28, P341, DOI 10.1016/j.tree.2013.01.010; Kelly CK, 1996, PHILOS T R SOC B, V351, P1261, DOI 10.1098/rstb.1996.0109; Kelly CK, 1996, J VEG SCI, V7, P417, DOI 10.2307/3236285; Klotz S, 2002, BIOLFLOR DATENBANK B; Knappova J, 2012, LANDSCAPE ECOL, V27, P97, DOI 10.1007/s10980-011-9680-5; Knevel I.C., 2005, LEDA TRAITBASE COLLE; Koch MA, 2006, MOL ECOL, V15, P825, DOI 10.1111/j.1365-294X.2005.02848.x; Lanta V, 2011, PERSPECT PLANT ECOL, V13, P189, DOI 10.1016/j.ppees.2011.05.003; Lester SE, 2007, ECOL LETT, V10, P745, DOI 10.1111/j.1461-0248.2007.01070.x; Lindborg R, 2007, J ECOL, V95, P555, DOI 10.1111/j.1365-2745.2007.01232.x; Lindborg R, 2012, ECOGRAPHY, V35, P356, DOI 10.1111/j.1600-0587.2011.07286.x; Malo JE, 2000, J RANGE MANAGE, V53, P322, DOI 10.2307/4003440; Marini L, 2012, DIVERS DISTRIB, V18, P898, DOI 10.1111/j.1472-4642.2012.00893.x; Maurer K, 2003, BASIC APPL ECOL, V4, P307, DOI 10.1078/1439-1791-00162; Medail F, 1999, PLANT ECOL, V140, P221, DOI 10.1023/A:1009775327616; Melendo M, 2003, FLORA, V198, P260, DOI 10.1078/0367-2530-00099; Munzbergova Z, 2013, PLANT BIOLOGY, V15, P195, DOI 10.1111/j.1438-8677.2012.00601.x; Munzbergova Z, 2004, J ECOL, V92, P854, DOI 10.1111/j.0022-0477.2004.00919.x; Murray BR, 2002, AUSTRAL ECOL, V27, P291, DOI 10.1046/j.1442-9993.2002.01181.x; Nogales M, 2001, J BIOGEOGR, V28, P1137, DOI 10.1046/j.1365-2699.2001.00622.x; Nogales M, 1999, ECOSCIENCE, V6, P56, DOI 10.1080/11956860.1999.11952193; Olesen J., 2004, ECOLOGIA INSULAR ISL, P229; Ortiz JE, 2006, J QUATERNARY SCI, V21, P287, DOI 10.1002/jqs.962; Parisod C, 2008, HEREDITY, V101, P536, DOI 10.1038/hdy.2008.95; Parisod C, 2008, NEW PHYTOL, V178, P436, DOI 10.1111/j.1469-8137.2007.02361.x; Percy DM, 2002, AM J BOT, V89, P854, DOI 10.3732/ajb.89.5.854; Piqueray J, 2011, LANDSCAPE ECOL, V26, P823, DOI 10.1007/s10980-011-9611-5; Pocock MJO, 2006, J ECOL, V94, P581, DOI 10.1111/j.1365-2745.2006.01123.x; Purschke O, 2012, OECOLOGIA, V168, P773, DOI 10.1007/s00442-011-2142-6; Riba M, 2009, NEW PHYTOL, V183, P667, DOI 10.1111/j.1469-8137.2009.02948.x; Romermann C, 2005, THE LEDA TRAITBASE C, P124; Saar L, 2012, DIVERS DISTRIB, V18, P808, DOI 10.1111/j.1472-4642.2012.00885.x; Sadeh A, 2009, EVOL ECOL, V23, P373, DOI 10.1007/s10682-007-9232-2; Sanmartin I, 2008, J BIOGEOGR, V35, P428, DOI 10.1111/j.1365-2699.2008.01885.x; Santamaria L, 2002, ARCH HYDROBIOL, V156, P11, DOI 10.1127/0003-9136/2002/0156-0011; Schonfelder I., 2002, KOSMOS ATLAS MITTELM; Schonfelder P, 2002, KVETENA KANARSKYCH O; Schwartz MW, 2006, ECOLOGY, V87, P1611, DOI 10.1890/0012-9658(2006)87[1611:PEAARO]2.0.CO;2; Statsoft I, 2013, STAT 12 0; Stevens VM, 2013, EVOL APPL, V6, P630, DOI 10.1111/eva.12049; STRATTON DA, 1989, BIOTROPICA, V21, P308, DOI 10.2307/2388281; Tackenberg O, 2003, ECOL MONOGR, V73, P191, DOI 10.1890/0012-9615(2003)073[0191:AOWDPI]2.0.CO;2; Talavera M, 2011, MOL PHYLOGENET EVOL, V61, P659, DOI 10.1016/j.ympev.2011.08.005; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Thompson K, 2005, LEDA TRAITBASE COLLE, P122; Tremlova K, 2007, ECOLOGY, V88, P965, DOI 10.1890/06-0924; Tutin T.G., 1968, FLORA EUROPAEA, V2, P368; Van der Pijl L, 1982, PRINCIPLES DISPERSAL; Van der Veken S, 2007, J BIOGEOGR, V34, P1723, DOI 10.1111/j.1365-2699.2007.01738.x; Vargas P, 2014, BOT J LINN SOC, V174, P349, DOI 10.1111/boj.12142; Vazacova K, 2013, FOLIA GEOBOT, P1; Wald EJ, 2005, AM MIDL NAT, V154, P342, DOI 10.1674/0003-0031(2005)154[0342:DOLSEE]2.0.CO;2; Weiher E, 1999, J VEG SCI, V10, P609, DOI 10.2307/3237076; WESTOBY M, 1992, TRENDS ECOL EVOL, V7, P368, DOI 10.1016/0169-5347(92)90006-W; WESTOBY M, 1995, J ECOL, V83, P727, DOI 10.2307/2261640; WESTOBY M, 1995, J ECOL, V83, P892; Zhou M, 2000, J GEOPHYS RES-OCEANS, V105, P21893, DOI 10.1029/2000JC900096	91	9	9	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101046	10.1371/journal.pone.0101046	http://dx.doi.org/10.1371/journal.pone.0101046			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003737	Green Published, Green Submitted, gold			2022-12-27	WOS:000339242700016
J	Bird, MJ; Needham, K; Frazier, AE; van Rooijen, J; Leung, J; Hough, S; Denham, M; Thornton, ME; Parish, CL; Nayagam, BA; Pera, M; Thorburn, DR; Thompson, LH; Dottori, M				Bird, Matthew J.; Needham, Karina; Frazier, Ann E.; van Rooijen, Jorien; Leung, Jessie; Hough, Shelley; Denham, Mark; Thornton, Matthew E.; Parish, Clare L.; Nayagam, Bryony A.; Pera, Martin; Thorburn, David R.; Thompson, Lachlan H.; Dottori, Mirella			Functional Characterization of Friedreich Ataxia iPS-Derived Neuronal Progenitors and Their Integration in the Adult Brain	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; COMPLEX I; IRON; DEFICIENCY; FRATAXIN; GENE; DIFFERENTIATION; FIBROBLASTS; DISEASE	Friedreich ataxia (FRDA) is an autosomal recessive disease characterised by neurodegeneration and cardiomyopathy that is caused by an insufficiency of the mitochondrial protein, frataxin. Our previous studies described the generation of FRDA induced pluripotent stem cell lines (FA3 and FA4 iPS) that retained genetic characteristics of this disease. Here we extend these studies, showing that neural derivatives of FA iPS cells are able to differentiate into functional neurons, which don't show altered susceptibility to cell death, and have normal mitochondrial function. Furthermore, FA iPS-derived neural progenitors are able to differentiate into functional neurons and integrate in the nervous system when transplanted into the cerebellar regions of host adult rodent brain. These are the first studies to describe both in vitro and in vivo characterization of FA iPS-derived neurons and demonstrate their capacity to survive long term. These findings are highly significant for developing FRDA therapies using patient-derived stem cells.	[Bird, Matthew J.; Frazier, Ann E.; Thorburn, David R.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Bird, Matthew J.; Frazier, Ann E.; Thorburn, David R.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Bird, Matthew J.; Dottori, Mirella] Univ Melbourne, Dept Elect & Elect Engn, Ctr Neural Engn, Melbourne, Vic, Australia; [Needham, Karina] Univ Melbourne, Dept Otolaryngol, Melbourne, Vic, Australia; [van Rooijen, Jorien; Leung, Jessie; Hough, Shelley; Denham, Mark; Pera, Martin; Dottori, Mirella] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic, Australia; [Thornton, Matthew E.] Childrens Hosp Los Angeles, Saban Res Inst, Div Maternal Fetal Med, Los Angeles, CA 90027 USA; [Parish, Clare L.; Pera, Martin; Thompson, Lachlan H.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Nayagam, Bryony A.] Univ Melbourne, Dept Audiol & Speech Pathol, Melbourne, Vic, Australia; [Pera, Martin] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; [Thorburn, David R.] Royal Childrens Hosp, Victorian Clin Genet Serv, Melbourne, Vic, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Children's Hospital Los Angeles; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; Walter & Eliza Hall Institute; Royal Children's Hospital Melbourne	Dottori, M (corresponding author), Univ Melbourne, Dept Elect & Elect Engn, Ctr Neural Engn, Melbourne, Vic, Australia.	mdottori@unimelb.edu.au	PERA, MARTIN/A-9812-2012; Thornton, Matt/HGF-1319-2022; Denham, Mark/N-9268-2016; Thorburn, David R/G-6266-2013; Thompson, Lachlan/B-4545-2013	PERA, MARTIN/0000-0001-6239-0428; Thornton, Matt/0000-0002-1083-2703; Denham, Mark/0000-0001-5279-5915; Bird, Matthew/0000-0003-3185-0780; Nayagam, Bryony/0000-0003-1069-6059; thorburn, david/0000-0002-7725-9470; Frazier, Ann/0000-0002-6491-3437; Thompson, Lachlan/0000-0003-2632-0304; Parish, Clare/0000-0001-8212-9884; Needham, Karina/0000-0002-3869-5448; Dottori, Mirella/0000-0003-0598-4195	Friedreich's Ataxia Research Association USA; Friedreich's Ataxia Research Association Australasia; Australian Mitochondrial Disease Foundation; Australian National Health and Medical Research Council; Victorian Government's Operational Infrastructure Support Program; Viertel charitable foundation; Brain Foundation Award	Friedreich's Ataxia Research Association USA; Friedreich's Ataxia Research Association Australasia; Australian Mitochondrial Disease Foundation; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; Viertel charitable foundation; Brain Foundation Award	These studies were supported by the Friedreich's Ataxia Research Association USA (www.curefa.org) and Australasia (www.fara.org.au/) (MD), the Australian Mitochondrial Disease Foundation (www.amdf.org.au/) (MJB), an Australian Postgraduate Award (http://services.unimelb.edu.au/scholarships/research/local/available/apa) (MJB), a Principal Research Fellowship (DRT), Career Development Awards (AEF, LHT) and a Medical Research Council Peter Doherty Fellowship (BAN) all from the Australian National Health and Medical Research Council (www.nhmrc.gov.au/), a Victorian Government's Operational Infrastructure Support Program (http://www.business.vic.gov.au/industries/science-technology-and-innovation/programs/medical-research-operational-infrastructureprogram), a senior medical research fellowship (CLP) provided by the Viertel charitable foundation (www.anz.com.au/personal/private-bank./scholarshipsfellowships/), and a Brain Foundation Award (brainfoundation.org.au). The authors would also like to thank Brian Mendenhall from the USC High Performance Computing Cluster for installing and testing high content analysis software. The authors declare no conflict of interest relating to this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00; Bradley JL, 2000, HUM MOL GENET, V9, P275, DOI 10.1093/hmg/9.2.275; Calabrese V, 2005, J NEUROL SCI, V233, P145, DOI 10.1016/j.jns.2005.03.012; Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cossee M, 2000, HUM MOL GENET, V9, P1219, DOI 10.1093/hmg/9.8.1219; Coyne L, 2011, NEUROCHEM INT, V59, P404, DOI 10.1016/j.neuint.2011.01.022; Delatycki MB, 2012, J CHILD NEUROL, V27, P1133, DOI 10.1177/0883073812448230; Denham M, 2012, STEM CELLS, V30, P2400, DOI 10.1002/stem.1204; Denham M, 2011, METHODS MOL BIOL, V793, P99, DOI 10.1007/978-1-61779-328-8_7; Deutsch EC, 2010, MOL GENET METAB, V101, P238, DOI 10.1016/j.ymgme.2010.07.001; Eigentler A, 2013, STEM CELLS DEV, V22, P3271, DOI 10.1089/scd.2013.0126; Frazier AE, 2012, METHODS MOL BIOL, V837, P49, DOI 10.1007/978-1-61779-504-6_4; Greene E, 2007, NUCLEIC ACIDS RES, V35, P3383, DOI 10.1093/nar/gkm271; Heidari MM, 2009, CAN J NEUROL SCI, V36, P26, DOI 10.1017/S0317167100006260; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Hick A, 2013, DIS MODEL MECH, V6, P608, DOI 10.1242/dmm.010900; Kakhlon O, 2008, BLOOD, V112, P5219, DOI 10.1182/blood-2008-06-161919; Ku S, 2010, CELL STEM CELL, V7, P631, DOI 10.1016/j.stem.2010.09.014; Liu J, 2011, STEM CELL REV REP, V7, P703, DOI 10.1007/s12015-010-9210-x; Lodi R, 1999, P NATL ACAD SCI USA, V96, P11492, DOI 10.1073/pnas.96.20.11492; Meijering EHW, 2001, MED IMAGE ANAL, V5, P111, DOI 10.1016/S1361-8415(00)00040-2; Needham K, 2014, STEM CELL RES, V12, P241, DOI 10.1016/j.scr.2013.10.011; Nikkhah G, 2000, NEUROMETH, V36, P207, DOI 10.1007/978-1-59259-690-4_12; Pandolfo M, 2008, ARCH NEUROL-CHICAGO, V65, P1296, DOI 10.1001/archneur.65.10.1296; Pandolfo M, 2009, J NEUROL, V256, P3, DOI 10.1007/s00415-009-1002-3; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; Seguin A, 2009, MITOCHONDRION, V9, P130, DOI 10.1016/j.mito.2009.01.007; Selak MA, 2011, MITOCHONDRION, V11, P342, DOI 10.1016/j.mito.2010.12.003; Sommer C, 2011, BIOM IM NAN MACR IEE; Sturm B, 2005, J BIOL CHEM, V280, P6701, DOI 10.1074/jbc.M408717200; Thompson L, 2005, J NEUROSCI, V25, P6467, DOI 10.1523/JNEUROSCI.1676-05.2005; Vonesch C, 2008, IEEE T IMAGE PROCESS, V17, P539, DOI 10.1109/TIP.2008.917103; WANDERS RJA, 1993, BIOCHIM BIOPHYS ACTA, V1181, P219, DOI 10.1016/0925-4439(93)90024-U	38	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101718	10.1371/journal.pone.0101718	http://dx.doi.org/10.1371/journal.pone.0101718			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000412	Green Published, gold			2022-12-27	WOS:000338637300078
J	Goehring, KC; Kennedy, AD; Prieto, PA; Buck, RH				Goehring, Karen C.; Kennedy, Adam D.; Prieto, Pedro A.; Buck, Rachael H.			Direct Evidence for the Presence of Human Milk Oligosaccharides in the Circulation of Breastfed Infants	PLOS ONE			English	Article							NEUTRAL OLIGOSACCHARIDES; MASS-SPECTROMETRY; BOVINE-MILK; IN-VITRO; URINARY-EXCRETION; QUANTIFICATION; CHROMATOGRAPHY; CONSUMPTION; LACTATION; LACTOSE	Background: It has been hypothesized that human milk oligosaccharides (HMOs) confer systemic health benefits to breastfed infants; however, plausible mechanisms for some effects, such as systemic immunomodulation, require HMOs to access the bloodstream of the developing infant. While small concentrations of HMOs have been detected in the urine of breastfed infants there are no published studies of these oligosaccharides accessing the plasma compartment of breastfed infants. Here we determined the relative fractions of several ingested HMOs in infant urine and plasma. Plasma from formula-fed infants was used as a control. Methods: Using gas chromatography/mass spectrometry (GC/MS), liquid chromatography/mass spectrometry/tandem mass spectrometry (LC/MS/MS), and high performance liquid chromatography (HPLC), we analyzed the urine and plasma from 17 healthy formula-fed infants and 16 healthy breast-fed infants (and the milk from their mothers). Results: Multiple HMOs were detected in the urine and plasma of breastfed infants, but not in formula-fed infants. Levels of 2'-fucosyllactose (2'FL), 3FL and lacto-N-neotetraose (LNnT) in both plasma (r = 0.98, p<0.001; r = 0.75, p = 0.002; r = 0.71, p = 0.004) and urine (r = 0.81, p<0.001; r = 0.56, p = 0.026; NS) correlated significantly with concentrations in the corresponding breast milk. The relative fractions of HMOs were low, 0.1% of milk levels for plasma and 4% of milk levels for urine. Within the breastfed cohort, there were significant differences between secretor and nonsecretor groups in levels of several fucosylated HMOs. Conclusion: At least some ingested HMOs are absorbed intact into the circulation and excreted in the urine and their concentrations in these fluids correlate with levels of the corresponding mother's milk. While relative fractions of absorbed HMOs were low, these levels have been shown to have biological effects in vitro, and could explain some of the postulated benefits of human milk.	[Goehring, Karen C.; Prieto, Pedro A.; Buck, Rachael H.] Abbott Nutr, Dept Global Discovery Res, Columbus, OH 43229 USA; [Kennedy, Adam D.] Metabolon Inc, Durham, NC USA	Metabolon	Buck, RH (corresponding author), Abbott Nutr, Dept Global Discovery Res, Columbus, OH 43229 USA.	rachael.buck@abbott.com		Prieto, Pedro/0000-0001-9549-3730	Abbott Nutrition; Metabolon, Inc.	Abbott Nutrition(Abbott Laboratories); Metabolon, Inc.	This research was funded by Abbott Nutrition http://abbottnutrition.com/. The funder Abbott Nutrition provided support in the form of salaries for authors KCG, PAP, and RHB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Metabolon, Inc., provided support in the form of a salary for author ADK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Asakuma S, 2008, EUR J CLIN NUTR, V62, P488, DOI 10.1038/sj.ejcn.1602738; Asakuma S, 2011, J BIOL CHEM, V286, P34583, DOI 10.1074/jbc.M111.248138; Bode L, 2004, THROMB HAEMOSTASIS, V92, P1402, DOI 10.1160/TH04-01-0055; Bode L, 2004, J LEUKOCYTE BIOL, V76, P820, DOI 10.1189/jlb.0304198; Bode L, 2012, GLYCOBIOLOGY, V22, P1147, DOI 10.1093/glycob/cws074; Chaturvedi P, 2001, GLYCOBIOLOGY, V11, P365, DOI 10.1093/glycob/11.5.365; de Kivit S, 2011, EUR J PHARMACOL, V668, pS124, DOI 10.1016/j.ejphar.2011.05.086; De Leoz MLA, 2012, J PROTEOME RES, V11, P4662, DOI 10.1021/pr3004979; De Leoz ML, 2013, ANAL BIOANAL CHEM; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Dotz V, 2014, GLYCOBIOLOGY, V24, P185, DOI 10.1093/glycob/cwt099; Duijts L, 2010, PEDIATRICS, V126, pE18, DOI 10.1542/peds.2008-3256; Eiwegger T, 2004, PEDIATR RES, V56, P536, DOI 10.1203/01.PDR.0000139411.35619.B4; Eiwegger T, 2010, PEDIAT ALLERG IMM-UK, V21, P1179, DOI 10.1111/j.1399-3038.2010.01062.x; Erney RM, 2000, J PEDIATR GASTR NUTR, V30, P181, DOI 10.1097/00005176-200002000-00016; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fanaro S, 2005, ACTA PAEDIATR, V94, P22, DOI 10.1080/08035320510043538; Fong B, 2011, J AGR FOOD CHEM, V59, P9788, DOI 10.1021/jf202035m; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Gnoth MJ, 2001, J BIOL CHEM, V276, P34363, DOI 10.1074/jbc.M104805200; IP S, 2007, EVID REP TECHNOL ASS, V153, P1; Jantscher-Krenn E, 2012, MINERVA PEDIATR, V64, P83; Kramer MS, 2003, AM J CLIN NUTR, V78, P291, DOI 10.1093/ajcn/78.2.291; Kuntz S, 2008, BRIT J NUTR, V99, P462, DOI 10.1017/S0007114507824068; Kunz C, 2000, ANNU REV NUTR, V20, P699, DOI 10.1146/annurev.nutr.20.1.699; Labbok MH, 2004, NAT REV IMMUNOL, V4, P565, DOI 10.1038/nri1393; Locascio RG, 2007, J AGR FOOD CHEM, V55, P8914, DOI 10.1021/jf0710480; Marcobal A, 2010, J AGR FOOD CHEM, V58, P5334, DOI 10.1021/jf9044205; Espinosa RM, 2007, BRIT J NUTR, V98, pS74, DOI 10.1017/S0007114507838062; Martin-Sosa S, 2003, J DAIRY SCI, V86, P52, DOI 10.3168/jds.S0022-0302(03)73583-8; Matrosovich M, 2003, REV MED VIROL, V13, P85, DOI 10.1002/rmv.372; Naaraing MA, 2003, J CLIN INVEST, V115, P3256; Ninonuevo MR, 2009, NUTR REV, V67, pS216, DOI 10.1111/j.1753-4887.2009.00243.x; Penttila IA, 2010, J PEDIATR-US, V156, pS21, DOI 10.1016/j.jpeds.2009.11.016; Prieto PA, 2005, FOODS FOODS INGREDIE, V219, P1018; Prieto PA, 2012, ADV NUTR, V3, p456S, DOI 10.3945/an.111.001529; Quigley MA, 2007, PEDIATRICS, V119, pE837, DOI 10.1542/peds.2006-2256; Rabinovich GA, 2012, ANN NY ACAD SCI, V1253, P1, DOI 10.1111/j.1749-6632.2012.06492.x; Radzanowski G, 2013, FASEB J, V27; Rudloff S, 2006, GLYCOBIOLOGY, V16, P477, DOI 10.1093/glycob/cwj092; Rudloff S, 1996, ACTA PAEDIATR, V85, P598, DOI 10.1111/j.1651-2227.1996.tb14095.x; Rudloff S, 2012, BRIT J NUTR, V107, P957, DOI 10.1017/S0007114511004016; Sotgiu S, 2006, Int J Biomed Sci, V2, P114; Stepans MBF, 2006, BREASTFEED MED, V1, P207, DOI 10.1089/bfm.2006.1.207; Takei M, 2010, TOXICOL SCI, V118, P643, DOI 10.1093/toxsci/kfq211; THURL S, 1993, Z ERNAHRUNGSWISS, V32, P262, DOI 10.1007/BF01611164; Thurl S, 1996, ANAL BIOCHEM, V235, P202, DOI 10.1006/abio.1996.0113; Thurl S, 2010, BRIT J NUTR, V104, P1261, DOI 10.1017/S0007114510002072; Totten SM, 2012, J PROTEOME RES, V11, P6124, DOI 10.1021/pr300769g; Vohr B.R, 2002, J PERINATOL, V22, P354; Yamamoto K, 2012, BIOSCI BIOTECH BIOCH, V76, P1815, DOI 10.1271/bbb.120401; Yang B, 2012, OPEN GLYCOSCIENCE, V5, P19, DOI DOI 10.2174/1875398101205010019; Yu ZT, 2013, GLYCOBIOLOGY, V23, P169, DOI 10.1093/glycob/cws138; Zivkovic AM, 2011, ADV NUTR, V2, P284, DOI 10.3945/an.111.000455	54	146	152	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101692	10.1371/journal.pone.0101692	http://dx.doi.org/10.1371/journal.pone.0101692			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999728	Green Published, Green Submitted, gold			2022-12-27	WOS:000338637300073
J	Pascopella, L; Franks, J; Marks, SM; Salcedo, K; Schmitz, K; Colson, PW; Hirsch-Moverman, Y; Flood, J; Sayles, J				Pascopella, Lisa; Franks, Julie; Marks, Suzanne M.; Salcedo, Katya; Schmitz, Kjersti; Colson, Paul W.; Hirsch-Moverman, Yael; Flood, Jennifer; Sayles, Jennifer			Opportunities for Tuberculosis Diagnosis and Prevention among Persons Living with HIV: A Cross-Sectional Study of Policies and Practices at Four Large Ryan White Program-Funded HIV Clinics	PLOS ONE			English	Article							INFECTION; GUIDELINES; CARE	Objective: We describe the frequency and attributes of tuberculosis testing and treatment at four publicly-funded HIV clinics. Methods: We abstracted medical records from a random sample of 600 HIV-infected patients having at least one clinic visit in 2009 at four clinics in New York and Los Angeles Metropolitan Statistical areas. We described testing and treatment for tuberculosis infection (TBI), 2008-2010, and estimated adjusted odds ratios (aORs). We interviewed key informants and described clinic policies and practices. Results: Of 600 patients, 500 were eligible for testing, and 393 (79%) were tested 2008-2010; 107 (21%) did not receive at least one tuberculin skin test or interferon gamma release assay. Results were positive in 20 (5%) patients, negative in 357 (91%), and unknown in 16 (4%). Fourteen (70%) of 20 patients with TBI initiated treatment at the clinics; only three were documented to have completed treatment. Three hundred twenty three (54%) patients had chest radiography, 346 (58%) had tuberculosis symptom screening, and three had tuberculosis disease (117 per 100,000 person-years, 95% confidence interval (CI) = 101-165). Adjusting for site, non-Hispanic ethnicity (aOR = 4.9, 95% CI = 2.6-9.5), and employment (aOR = 1.9, 95% CI = 1.0-3.4) were associated with TBI testing; female gender (aOR = 2.0, 95% CI = 1.4-3.3), non-black race (aOR = 1.7, 95% CI = 1.3-2.5), and unemployment (aOR = 1.5, 95% CI = 1.1-2.1) were associated with chest radiography. Clinics evaluated TBI testing performance annually and identified challenges to TB prevention. Conclusions: Study clinics routinely tested patients for TBI, but did not always document treatment. In a population with a high TB rate, ensuring treatment of TBI may enhance TB prevention.	[Pascopella, Lisa; Salcedo, Katya; Flood, Jennifer] Calif Dept Publ Hlth, TB Control Branch, Div Communicable Dis Control, Ctr Infect Dis, Richmond, CA 94804 USA; [Franks, Julie; Schmitz, Kjersti; Colson, Paul W.; Hirsch-Moverman, Yael] Columbia Univ, Mailman Sch Publ Hlth, Int Ctr AIDS Care & Treatment Programs ICAP, New York, NY USA; [Marks, Suzanne M.] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; [Sayles, Jennifer] Los Angeles Cty Dept Publ Hlth, Off AIDS Programs & Policy, Los Angeles, CA USA	California Department of Public Health; Columbia University; Centers for Disease Control & Prevention - USA; Los Angeles County Department of Public Health	Pascopella, L (corresponding author), Calif Dept Publ Hlth, TB Control Branch, Div Communicable Dis Control, Ctr Infect Dis, Richmond, CA 94804 USA.	lisa.pascopella@cdph.ca.gov			Tuberculosis Epidemiologic Studies Consortium, Centers for Disease Control and Prevention	Tuberculosis Epidemiologic Studies Consortium, Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research was funded through the Tuberculosis Epidemiologic Studies Consortium, Centers for Disease Control and Prevention. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention or funding agencies.	American Thoracic Society, 2000, AM J RESP CRIT CARE, V49, P1, DOI DOI 10.1164/AJRCCM.161.SUPPLEMENT_3.ATS600; Backus LI, 2010, ARCH INTERN MED, V170, P1239, DOI 10.1001/archinternmed.2010.234; Centers for Disease Control and Prevention, LAT TUB INF GUID PRI; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P333; Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Heath Resources and Services Administration HAB, 2010, GOING DIST RYAN WHIT; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Landon BE, 2004, ANN INTERN MED, V140, P887, DOI 10.7326/0003-4819-140-11-200406010-00010; Lee LM, 2006, INT J TUBERC LUNG D, V10, P209; Mannino D M, 1998, MMWR CDC Surveill Summ, V47, P1; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Metcalfe JZ, 2013, EMERG INFECT DIS, V19, P400, DOI 10.3201/eid1903.121521; Sterling T, RIFAPENTINE ISONIAZI; Sterling TR, 2011, J INFECT DIS, V204, P893, DOI 10.1093/infdis/jir421; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; US Department of Health Services Health and Human Resources (HHS) Health Resources and Service Administration, GUIDE HIV AIDS CLIN	18	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101313	10.1371/journal.pone.0101313	http://dx.doi.org/10.1371/journal.pone.0101313			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000260	Green Published, gold, Green Submitted			2022-12-27	WOS:000338637300035
J	Syed, BM; Green, AR; Nolan, CC; Morgan, DAL; Ellis, IO; Cheung, KL				Syed, Binafsha M.; Green, Andrew R.; Nolan, Christopher C.; Morgan, David A. L.; Ellis, Ian O.; Cheung, Kwok-Leung			Biological Characteristics and Clinical Outcome of Triple Negative Primary Breast Cancer in Older Women - Comparison with Their Younger Counterparts	PLOS ONE			English	Article							TISSUE MICROARRAY TECHNOLOGY; PROGNOSTIC INDEX; LARGE SERIES; BASAL; EXPRESSION; RECEPTORS; TAMOXIFEN; SURVIVAL; MARKERS; PROTEIN	Triple negative (ER, PgR and HER2 negative) breast cancers (TNBCs) are often considered as a poor prognostic phenotype. There is dearth of evidence showing the prevalence and biological behaviour of TNBCs in older women. This study aimed to analyse their biological characteristics in comparison with a well characterised younger series from a single centre with long term clinical follow-up. Over 37 years (1973-2010), 1,758 older (>= 70 years) women with early operable (< 5 cm) primary breast cancer were managed in a dedicated clinic and have complete clinical information available. Of these 813 patients underwent primary surgery and 575 had good quality tumour samples available for tissue microarray analysis using indirect immunohistochemistry. A total of 127 patients (22.1%) had TNBCs and full biological analysis of 15 biomarkers was performed. The results were compared with those of their younger (< 70 years) counterparts 342 (18.9%) from a previously characterised, consecutive series of primary breast cancer treated in the same unit (1986-1998). The 127 older patients with TNBCs showed lower rates of Ki67 and CK 7/8 positivity and high rates of bcl2 and CK18 positivity when compared with their younger counterparts (p < 0.05). There was no significant difference in the long term clinical outcome between the two age groups, despite the fact that 47% of the younger patients had adjuvant chemotherapy, while none in the older cohort received such treatment. EGFR, axillary stage and pathological size showed prognostic significance in older women with TNBCs on univariate analysis. Despite not having received adjuvant chemotherapy, the older series had clinical outcome similar to the younger patients almost half of whom had chemotherapy. This appears to be related to other biomarkers (in addition to ER/PgR/HER2) eg Ki67, bcl2 and cytokeratins which have different expression patterns influencing prognosis.	[Syed, Binafsha M.; Green, Andrew R.; Nolan, Christopher C.; Ellis, Ian O.; Cheung, Kwok-Leung] Univ Nottingham, Sch Med, Nottingham, England; [Morgan, David A. L.] Univ Nottingham Hosp, Dept Oncol, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham	Cheung, KL (corresponding author), Univ Nottingham, Sch Med, Nottingham, England.	kl.cheung@nottingham.ac.uk	Syed, Binafsha/AAC-6670-2020; Green, Andrew/AAF-1991-2020	Green, Andrew/0000-0002-0488-5913; Morgan, David/0000-0002-2291-1740; Cheung, Kwok-Leung/0000-0003-2973-0755; Ellis, Ian/0000-0001-5292-8474	Liaquat University of Medical & Health Sciences, Jamshoro/Higher Education Commission of Pakistan	Liaquat University of Medical & Health Sciences, Jamshoro/Higher Education Commission of Pakistan	The study is part of BM Syed's PhD project funded by her home institution Liaquat University of Medical & Health Sciences, Jamshoro/Higher Education Commission of Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aapro M, 2012, ANN ONCOL, V23, P52, DOI 10.1093/annonc/mds189; Abd El-Rehim DM, 2005, INT J CANCER, V116, P340, DOI 10.1002/ijc.21004; Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Al-Kuraya K, 2004, CANCER RES, V64, P8534, DOI 10.1158/0008-5472.CAN-04-1945; Aleskandarany MA, 2011, BREAST CANCER RES TR, V127, P591, DOI 10.1007/s10549-010-1028-3; Balducci L, 2000, Oncologist, V5, P224, DOI 10.1634/theoncologist.5-3-224; Billar JAY, 2010, ANN SURG ONCOL, V17, pS384, DOI 10.1245/s10434-010-1260-4; Camp RL, 2000, LAB INVEST, V80, P1943, DOI 10.1038/labinvest.3780204; Carol D, 2010, BREAST CANC FACTS FI; Cheung KL, 2008, CRIT REV ONCOL HEMAT, V67, P263, DOI 10.1016/j.critrevonc.2008.04.002; Choi YL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-507; Diab SG, 2000, J NATL CANCER I, V92, P550, DOI 10.1093/jnci/92.7.550; El-Rehim DMA, 2004, J PATHOL, V203, P661, DOI 10.1002/path.1559; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Fleming ST, 1999, MED CARE, V37, P601, DOI 10.1097/00005650-199906000-00009; Gusterson BA, 2005, BREAST CANCER RES, V7, P143, DOI 10.1186/bcr1041; HAYBITTLE JL, 1982, BRIT J CANCER, V45, P361, DOI 10.1038/bjc.1982.62; Hind D, 2007, BRIT J CANCER, V96, P1025, DOI 10.1038/sj.bjc.6603600; HOWELL A, 1984, LANCET, V1, P588; Huang HJ, 2005, ANN ONCOL, V16, P1755, DOI 10.1093/annonc/mdi364; Kim JM, 2009, J BREAST CANCER, V12, P4, DOI 10.4048/jbc.2009.12.1.4; Knoop AS, 2001, J CLIN ONCOL, V19, P3376, DOI 10.1200/JCO.2001.19.14.3376; Nogi H, 2009, ONCOL REP, V21, P413, DOI 10.3892/or_00000238; Rakha EA, 2008, HUM PATHOL, V39, P857, DOI 10.1016/j.humpath.2007.10.011; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Rakha EA, 2009, CLIN CANCER RES, V15, P2302, DOI 10.1158/1078-0432.CCR-08-2132; Syed B, 2011, ANN ONCOL; Syed BM, 2011, BRIT J CANCER, V104, P1393, DOI 10.1038/bjc.2011.105; Tan DSP, 2008, BREAST CANCER RES TR, V111, P27, DOI 10.1007/s10549-007-9756-8; Tsutsui S, 2002, J SURG ONCOL, V79, P216, DOI 10.1002/jso.10079; Zhou X, 2010, CHINESE J CANCER RES, V22, P17, DOI 10.1007/s11670-010-0017-8	31	21	23	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e100573	10.1371/journal.pone.0100573	http://dx.doi.org/10.1371/journal.pone.0100573			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999743	Green Published, Green Submitted, gold			2022-12-27	WOS:000338637300009
J	Umesh, V; Rape, AD; Ulrich, TA; Kumar, S				Umesh, Vaibhavi; Rape, Andrew D.; Ulrich, Theresa A.; Kumar, Sanjay			Microenvironmental Stiffness Enhances Glioma Cell Proliferation by Stimulating Epidermal Growth Factor Receptor Signaling	PLOS ONE			English	Article							FOCAL ADHESION KINASE; GLIOBLASTOMA-MULTIFORME; EXTRACELLULAR-MATRIX; EGF RECEPTOR; MYOSIN-II; PHASE-II; INHIBITOR; INVASION; ACID; MECHANOTRANSDUCTION	The aggressive and rapidly lethal brain tumor glioblastoma (GBM) is associated with profound tissue stiffening and genomic lesions in key members of the epidermal growth factor receptor (EGFR) pathway. Previous studies from our laboratory have shown that increasing microenvironmental stiffness in culture can strongly enhance glioma cell behaviors relevant to tumor progression, including proliferation, yet it has remained unclear whether stiffness and EGFR regulate proliferation through common or independent signaling mechanisms. Here we test the hypothesis that microenvironmental stiffness regulates cell cycle progression and proliferation in GBM tumor cells by altering EGFR-dependent signaling. We began by performing an unbiased reverse phase protein array screen, which revealed that stiffness modulates expression and phosphorylation of a broad range of signals relevant to proliferation, including members of the EGFR pathway. We subsequently found that culturing human GBM tumor cells on progressively stiffer culture substrates both dramatically increases proliferation and facilitates passage through the G1/S checkpoint of the cell cycle, consistent with an EGFR-dependent process. Western Blots showed that increasing microenvironmental stiffness enhances the expression and phosphorylation of EGFR and its downstream effector Akt. Pharmacological loss-of-function studies revealed that the stiffness-sensitivity of proliferation is strongly blunted by inhibition of EGFR, Akt, or PI3 kinase. Finally, we observed that stiffness strongly regulates EGFR clustering, with phosphorylated EGFR condensing into vinculin-positive focal adhesions on stiff substrates and dispersing as microenvironmental stiffness falls to physiological levels. Our findings collectively support a model in which tissue stiffening promotes GBM proliferation by spatially and biochemically amplifying EGFR signaling.	[Umesh, Vaibhavi; Rape, Andrew D.; Ulrich, Theresa A.; Kumar, Sanjay] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Kumar, S (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	skumar@berkeley.edu			National Institutes of Health NRSA postdoctoral fellowship [1F32CA174361]; National Institutes of Health [1DP2OD004213, 1U54CA143836]; National Science Foundation [CMMI PESO 1105539]; National Cancer Institute [2P30CA016672]; NATIONAL CANCER INSTITUTE [F32CA174361, U54CA143836, P30CA016672] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004213] Funding Source: NIH RePORTER; Directorate For Engineering [1105539] Funding Source: National Science Foundation	National Institutes of Health NRSA postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	A.R. gratefully acknowledges the support of a National Institutes of Health NRSA postdoctoral fellowship (1F32CA174361). S.K. gratefully acknowledges support from the National Institutes of Health (1DP2OD004213 and 1U54CA143836) and National Science Foundation (CMMI PESO 1105539). The MD Anderson RPPA Core facility is funded by a grant through the National Cancer Institute (2P30CA016672). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri S, 2013, ARCH IMMUNOL THER EX, V61, P25, DOI 10.1007/s00005-012-0203-0; Ananthanarayanan B, 2011, BIOMATERIALS, V32, P7913, DOI 10.1016/j.biomaterials.2011.07.005; Beadle C, 2008, MOL BIOL CELL, V19, P3357, DOI 10.1091/mbc.E08-03-0319; Belot N, 2001, GLIA, V36, P375, DOI 10.1002/glia.1124; Benlimame N, 2005, J CELL BIOL, V171, P505, DOI 10.1083/jcb.200504124; Berens ME, 1999, BIOL ONCOLOGY INVASI, V1, P208; Brennan DJ, 2010, NAT REV CANCER, V10, P605, DOI 10.1038/nrc2902; Cabodi S, 2004, BIOCHEM SOC T, V32, P438, DOI 10.1042/BST0320438; Collins NL, 2005, MOL CELL BIOL, V25, P5282, DOI 10.1128/MCB.25.12.5282-5291.2005; de l'Hortet AC, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/476910; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fan QW, 2006, CANCER CELL, V9, P341, DOI 10.1016/j.ccr.2006.03.029; Friedlander DR, 1996, CANCER RES, V56, P1939; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gan HK, 2009, J CLIN NEUROSCI, V16, P748, DOI 10.1016/j.jocn.2008.12.005; GINGRAS MC, 1995, J NEUROIMMUNOL, V57, P143, DOI 10.1016/0165-5728(94)00178-Q; Golubovskaya VM, 2013, MOL CANCER THER, V12, P162, DOI 10.1158/1535-7163.MCT-12-0701; GRUNT TW, 1991, J CELL SCI, V100, P657; Halatsch ME, 2004, J NEUROSURG, V100, P523, DOI 10.3171/jns.2004.100.3.0523; Hirata E, 2012, J CELL SCI, V125, P858, DOI 10.1242/jcs.089995; Hwang Y, 2011, MOL CANCER RES, V9, P1199, DOI 10.1158/1541-7786.MCR-11-0229; Ivkovic S, 2012, MOL BIOL CELL, V23, P533, DOI 10.1091/mbc.E11-01-0039; Jones TS, 2011, TOXICOL PATHOL, V39, P158, DOI 10.1177/0192623310387617; Joy AM, 2003, J CELL SCI, V116, P4409, DOI 10.1242/jcs.00712; KANESKI CR, 1991, PROSTATE, V18, P47, DOI 10.1002/pros.2990180105; Klein EA, 2009, CURR BIOL, V19, P1511, DOI 10.1016/j.cub.2009.07.069; Kook SH, 2011, J APPL PHYSIOL, V111, P1575, DOI 10.1152/japplphysiol.00348.2011; Lathia JD, 2012, ANN NEUROL, V72, P766, DOI 10.1002/ana.23674; Lathia JD, 2010, CELL STEM CELL, V6, P421, DOI 10.1016/j.stem.2010.02.018; Lefranc F, 2005, J CLIN ONCOL, V23, P2411, DOI 10.1200/JCO.2005.03.089; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lopez JI, 2011, INTEGR BIOL-UK, V3, P910, DOI 10.1039/c1ib00043h; Lu ZM, 2001, MOL CELL BIOL, V21, P4016, DOI 10.1128/MCB.21.12.4016-4031.2001; Lui VWY, 2002, ANTICANCER RES, V22, P1; Mih JD, 2012, J CELL SCI, V125, P5974, DOI 10.1242/jcs.108886; Mishima K, 2001, CANCER RES, V61, P5349; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Natarajan M, 2003, CANCER J, V9, P126, DOI 10.1097/00130404-200303000-00008; Owa T, 2001, CURR MED CHEM, V8, P1487, DOI 10.2174/0929867013371996; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; PAULUS W, 1993, AM J PATHOL, V143, P154; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Raizer JJ, 2010, NEURO-ONCOLOGY, V12, P95, DOI 10.1093/neuonc/nop015; Raynaud FI, 2009, MOL CANCER THER, V8, P1725, DOI 10.1158/1535-7163.MCT-08-1200; Reardon DA, 2008, J CLIN ONCOL, V26, P5610, DOI 10.1200/JCO.2008.16.7510; Sahin O, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-1; Shih YRV, 2011, J BONE MINER RES, V26, P730, DOI 10.1002/jbmr.278; Shinojima N, 2003, CANCER RES, V63, P6962; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Srikanth M, 2013, NEURO-ONCOLOGY, V15, P319, DOI 10.1093/neuonc/nos316; Stabley D, 2013, INTEGR BIOL-UK, V5, P659, DOI 10.1039/c3ib20239a; Stepanenko AA, 2014, GENE, V540, P263, DOI 10.1016/j.gene.2014.02.053; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2013, J CLIN ONCOL, V31; Taylor TE, 2012, CURR CANCER DRUG TAR, V12, P197; Torsvik A, 2010, CANCER RES, V70, P6393, DOI 10.1158/0008-5472.CAN-10-1305; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Unsgaard G, 2006, ACTA NEUROCHIR, V148, P235, DOI 10.1007/s00701-005-0688-y; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Wymann MP, 1996, MOL CELL BIOL, V16, P1722; YAISH P, 1988, SCIENCE, V242, P933, DOI 10.1126/science.3263702; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343	66	78	79	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101771	10.1371/journal.pone.0101771	http://dx.doi.org/10.1371/journal.pone.0101771			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000176	Green Published, gold, Green Submitted			2022-12-27	WOS:000338637300083
J	Verma, HK; Shukla, P; Alfatah, M; Khare, AK; Upadhyay, U; Ganesan, K; Singh, J				Verma, Hemant Kumar; Shukla, Poonam; Alfatah, Md.; Khare, Asheesh Kumar; Upadhyay, Udita; Ganesan, Kaliannan; Singh, Jagmohan			High Level Constitutive Expression of Luciferase Reporter by lsd90 Promoter in Fission Yeast	PLOS ONE			English	Article							SCHIZOSACCHAROMYCES-POMBE; PICHIA-PASTORIS; HETEROLOGOUS PROTEINS; INDUCIBLE EXPRESSION; SYSTEM; GENE; THIAMINE	Because of a large number of molecular similarities with higher eukaryotes, the fission yeast Schizosaccharomyces pombe has been considered a potentially ideal host for expressing human proteins having therapeutic and pharmaceutical applications. However, efforts in this direction are hampered by lack of a strong promoter. Here, we report the isolation and characterization of a strong, constitutive promoter from S. pombe. A new expression vector was constructed by cloning the putative promoter region of the lsd90 gene (earlier reported to be strongly induced by heat stress) into a previously reported high copy number vector pJH5, which contained an ARS element corresponding to the mat2P flanking region and a truncated URA3m selectable marker. The resulting vector was used to study and compare the level of expression of the luciferase reporter with that achieved with the known vectors containing regulatable promoter nmt1 and the strong constitutive promoter adh1 in S. pombe and the methanol-inducible AOX1 promoter in Pichia pastoris. Following growth in standard media the new vector containing the putative lsd90 promoter provided constitutive expression of luciferase, at a level, which was 19-, 39- and 10-fold higher than that achieved with nmt1, adh1 and AOX1 promoters, respectively. These results indicate a great potential of the new lsd90 promoter-based vector for commercial scale expression of therapeutic proteins in S. pombe.	[Verma, Hemant Kumar; Shukla, Poonam; Alfatah, Md.; Khare, Asheesh Kumar; Upadhyay, Udita; Ganesan, Kaliannan; Singh, Jagmohan] Inst Microbial Technol, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Singh, J (corresponding author), Inst Microbial Technol, Chandigarh, India.	jag@imtech.res.in	Singh, Jagmohan/CAF-5276-2022; Upadhyay, Udita/R-4111-2019	MISHRA, POONAM/0000-0002-5410-5217	Council of Scientific and Industrial Research (CSIR), New Delhi, India; Council of Scientific and Industrial Research	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	The Council of Scientific and Industrial Research (CSIR), New Delhi, India is acknowledged for fellowship to Hemant Kumar Verma. This work was supported by intra-mural support from the Council of Scientific and Industrial Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Bellemare DR, 2001, GENE, V273, P191, DOI 10.1016/S0378-1119(01)00591-1; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Cregg JM, 2000, MOL BIOTECHNOL, V16, P23, DOI 10.1385/MB:16:1:23; David SM, 2005, EUKARYOT CELL, V4, P1539; Erler A, 2006, YEAST, V23, P813, DOI 10.1002/yea.1396; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Fujita Y, 2006, FEMS YEAST RES, V6, P883, DOI 10.1111/j.1567-1364.2006.00093.x; Giga-Hama Y, 1999, BIOTECHNOL APPL BIOC, V30, P235; Higgins DR, 1998, METH MOL B, V103, P1; Hollis RP, 2000, APPL ENVIRON MICROB, V66, P1676, DOI 10.1128/AEM.66.4.1676-1679.2000; Iacovoni JS, 1999, GENE, V232, P53, DOI 10.1016/S0378-1119(99)00116-X; Idiris A, 2010, APPL MICROBIOL BIOT, V85, P667, DOI 10.1007/s00253-009-2151-0; Johnson B.F, 1989, MOL BIOL FISSION YEA, P243; Kumar R, 2004, YEAST, V21, P1343, DOI 10.1002/yea.1184; Leskinen P, 2003, YEAST, V20, P1109, DOI 10.1002/yea.1024; Li PZ, 2007, APPL BIOCHEM BIOTECH, V142, P105, DOI 10.1007/s12010-007-0003-x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macauley-Patrick S, 2005, YEAST, V22, P249, DOI 10.1002/yea.1208; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; MCLEOD M, 1987, EMBO J, V6, P729, DOI 10.1002/j.1460-2075.1987.tb04814.x; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mukaiyama H, 2009, APPL MICROBIOL BIOT, V85, P155, DOI 10.1007/s00253-009-2130-5; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Shaw RJ, 2002, J BIOL CHEM, V277, P24420, DOI 10.1074/jbc.M202059200; Siam R, 2004, METHODS, V33, P189, DOI 10.1016/j.ymeth.2003.11.013; SMERDON GR, 1995, GENE, V165, P313, DOI 10.1016/0378-1119(95)00495-R; Takegawa K, 2009, BIOTECHNOL APPL BIOC, V53, P227, DOI 10.1042/BA20090048; Verma HK, 2012, PLASMID, V68, P186, DOI 10.1016/j.plasmid.2012.07.001; Watt S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001428; Yoeyong L, 2005, BIOTECHNOL LETT, V27, P1529	32	8	9	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101201	10.1371/journal.pone.0101201	http://dx.doi.org/10.1371/journal.pone.0101201			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999979	gold, Green Published, Green Submitted			2022-12-27	WOS:000338637300026
J	Wang, PP; An, FM; Zhuang, XJ; Liu, J; Zhao, LY; Zhang, B; Liu, L; Lin, PP; Li, MC				Wang, Peipei; An, Fengmei; Zhuang, Xingjun; Liu, Jiao; Zhao, Liyan; Zhang, Bin; Liu, Liang; Lin, Pingping; Li, Mingchun			Chronopharmacology and Mechanism of Antitumor Effect of Erlotinib in Lewis Tumor-Bearing Mice	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CIRCADIAN-RHYTHMS; DNA-SYNTHESIS; EXPRESSION; TARGET; LUNG; EFFICACY; KINASE	The epidermal growth factor receptor (EGFR), a ubiquitously expressed receptor tyrosine kinase, is recognized as a key mediator of tumorigenesis in many human epithelial tumors. Erlotinib is tyrosine kinase inhibitor approved by FDA for use in oncology. It inhibits the intracellular phosphorylation of tyrosine kinase associated with the EGFR to restrain the development of the tumor. To investigate the antitumor effect of erlotinib at different dosing times and the underlying molecular mechanism via the PI3K/AKT pathway, we established a mouse model of Lewis lung cancer xenografts. The tumor-bearing mice were housed four or five per cage under standardized light-dark cycle conditions (light on at 7:00 AM, 500 Lux, off at 7:00 PM, 0 Lux) with food and water provided ad libitum. The mice were observed for quality of life, their body weight and tumor volume measured, and the tumor growth curves drawn. After being bled, the mice were sacrificed by cervical dislocation. The tumor masses were removed at different time points and weighed. The mRNA expression of EGFR, AKT, Cyclin D1 and CDK-4 were assayed by quantitative real-time PCR (qRT-PCR). Protein expression levels of AKT, P-AKT and Cyclin D1 were determined by Western blot analysis. The results suggest that erlotinib has a significant antitumor effect on xenografts of non-small cell lung cancer in mice, and its efficacy and toxicity is dependent on the time of day of administration. Its molecular mechanism of action might be related to the EGFR-AKT-Cyclin D1-CDK-4 pathway which plays a crucial role in the development of pathology. Therefore, our findings suggest that the time of day of administration of Erlotinib may be a clinically important variable.	[Wang, Peipei; Liu, Jiao; Zhang, Bin; Liu, Liang; Lin, Pingping] Qingdao Univ, Coll Med, Dept Pharmacol, Qingdao 266071, Peoples R China; [An, Fengmei] 401 Hosp Chinese Peoples Liberat Army, Hand Surg Ctr Whole Army, Qingdao, Peoples R China; [Zhuang, Xingjun] 401 Hosp Chinese Peoples Liberat Army, Dept Oncol, Qingdao, Peoples R China; [Zhao, Liyan; Li, Mingchun] 401 Hosp Chinese Peoples Liberat Army, Dept Pharm, Qingdao, Peoples R China	Qingdao University	Li, MC (corresponding author), 401 Hosp Chinese Peoples Liberat Army, Dept Pharm, Qingdao, Peoples R China.	lmc401y@163.com						Abolmaali K, 2009, SURGERY, V146, P269, DOI 10.1016/j.surg.2009.05.005; Albanell J, 2002, J CLIN ONCOL, V20, P110, DOI 10.1200/JCO.20.1.110; ASCHOFF J, 1963, ANNU REV PHYSIOL, V25, P581, DOI 10.1146/annurev.ph.25.030163.003053; Bjarnason GA, 2002, CHRONOBIOL INT, V19, P129, DOI 10.1081/CBI-120002595; Darzacq X, 2002, EMBO J, V21, P2746, DOI 10.1093/emboj/21.11.2746; Eriguchi M, 2003, BIOMED PHARMACOTHER, V57, p92S, DOI 10.1016/j.biopha.2003.08.012; Filipski E, 1999, J PHARMACOL EXP THER, V289, P231; Grunwald Viktor, 2002, Current Problems in Cancer, V26, P109; Harbour VL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076391; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Herberman RB, 2002, SEMIN ONCOL, V29, P27, DOI 10.1053/sonc.2002.33079; Herbst RS, 2005, J CLIN ONCOL, V23, P5892, DOI 10.1200/JCO.2005.02.840; HRUSHESKY WJM, 1985, SCIENCE, V228, P73, DOI 10.1126/science.3883493; Kersemaekers AMF, 1999, CLIN CANCER RES, V5, P577; Lemmer B, 2007, ADV DRUG DELIVER REV, V59, P825, DOI 10.1016/j.addr.2007.08.001; Liu W, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/651207; Mendelsohn J, 2001, ENDOCR-RELAT CANCER, V8, P3, DOI 10.1677/erc.0.0080003; Modi Shanu, 2002, Curr Oncol Rep, V4, P47, DOI 10.1007/s11912-002-0047-6; Morshed K, 2007, ACTA OTO-LARYNGOL, V127, P760, DOI 10.1080/00016480601001957; Ohdo S, 1997, JPN J PHARMACOL, V75, P283, DOI 10.1254/jjp.75.283; Ohdo S, 2007, J PHARMACOL SCI, V103, P155, DOI 10.1254/jphs.FMJ06003X6; Oster H, 2003, GENE DEV, V17, P1366, DOI 10.1101/gad.256103; Patel DM, 2011, INT J PHARM INVESTIG, V1, P172, DOI 10.4103/2230-973X.85969; Paz-Ares L, 2006, J CLIN ONCOL, V24, p369S; Perez-Soler R, 2006, CLIN LUNG CANCER, V8, pS7, DOI 10.3816/CLC.2006.s.008; Ritter CA, 2003, SEMIN ONCOL, V30, P3, DOI 10.1053/sonc.2003.50027; Smaaland R, 2002, CHRONOBIOL INT, V19, P101, DOI 10.1081/CBI-120002594; Wang XHS, 1996, J BIOL CHEM, V271, P31607; Wei QC, 2008, ANN SURG ONCOL, V15, P1193, DOI 10.1245/s10434-007-9771-3; Xian LJ, 2002, CHRONOBIOL INT, V19, P69, DOI 10.1081/CBI-120002590; Xu Fei, 2011, Chin J Cancer, V30, P701, DOI 10.5732/cjc.011.10107	31	7	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101720	10.1371/journal.pone.0101720	http://dx.doi.org/10.1371/journal.pone.0101720			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000529	Green Published, Green Submitted, gold			2022-12-27	WOS:000338637300079
J	Wang, Y; Sun, CK; Li, TW; Xu, H; Zhou, Y; Dan, HX; Jiang, L; Zeng, X; Li, LJ; Li, J; Liao, G; Chen, QM				Wang, Yun; Sun, Chongkui; Li, Taiwen; Xu, Hao; Zhou, Yu; Dan, Hongxia; Jiang, Lu; Zeng, Xin; Li, Longjiang; Li, Jing; Liao, Ga; Chen, Qianming			Integrative Approach Detected Association between Genetic Variants of microRNA Binding Sites of TLRs Pathway Genes and OSCC Susceptibility in Chinese Han Population	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; MESSENGER-RNA; CANCER; TOLL; EXPRESSION; TRAF6; INFLAMMATION; PROGRESSION; RECEPTORS; DISEASE	Oral squamous cell carcinoma (OSCC) is a leading malignancy worldwide; the overall 5-year survival rate is approximately 50%. A variety of proteins in Toll-like receptors (TLRs) pathway have been related with the risk of OSCC. However, the influence of genetic variations in TLRs pathway genes on OSCC susceptibility is unclear. Previous studies mainly focused on the coding region of genes, while the UTR region remains unstudied. In the current study, a bioinformatics approach was performed to select candidate single nucleotide polymorphisms (SNPs) on microRNA binding sites of TLRs pathway genes related with OSCC. After screening 90 OSCC related TLRs pathway genes, 16 SNPs were selected for genotyping. We found that rs5030486, the polymorphisms on 3' UTR of TRAF6, was significantly associated with OSCC risk. AG genotype of TRAF6 was strongly associated with a decreased risk of OSCC (OR = 0.252; 95% CI = 0.106, 0.598; p = 0.001). In addition, AG genotype was also related with a reduced risk of OSCC progression both in univariable analysis (HR = 0.303, 95% CI = 0.092, 0.995) and multivariable analysis (HR = 0.272, 95% CI = 0.082, 0.903). Furthermore, after detecting the mRNA expression level of TRAF6 in 24 OSCC patients, we found that TRAF6 expression level was significantly different between patients carrying different genotypes at locus rs5030486 (p = 0.013), indicating that rs5030486 of TRAF6 might contribute to OSCC risk by altering TRAF6 expression level. In general, these data indicated that SNP rs5030486 could be a potential bio-marker for OSCC risk and our results might provide new insights into the association of polymorphisms within the non-coding area of genes with cancers.	[Wang, Yun; Sun, Chongkui; Li, Taiwen; Xu, Hao; Zhou, Yu; Dan, Hongxia; Jiang, Lu; Zeng, Xin; Li, Longjiang; Li, Jing; Liao, Ga; Chen, Qianming] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610064, Peoples R China; [Xu, Hao] Sichuan Univ, West China Sch Publ Hlth, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University	Li, J; Liao, G (corresponding author), Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610064, Peoples R China.	lijing1984@scu.edu.cn; liaoga@Gmail.com	Li, Taiwen/GQP-1715-2022; xu, Hao/AAJ-2460-2020; Sun, Chongkui/Q-1534-2019	Sun, Chongkui/0000-0003-0362-4129; Dan, Hongxia/0000-0002-9765-0012; Li, Long-jiang/0000-0003-1446-0692; XU, Hao/0000-0002-5665-0139; Li, Taiwen/0000-0001-7940-8196	National Natural Science Foundation of China [81321002, 81072218, 81270040, 81102060, 81200791, 81001208, 81302371]; Doctoral Program of the Ministry of Education of China [20110181110055, 20100181120057]; International Science and Technology Cooperation Program of China [2012DFA31370]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Program of the Ministry of Education of China(Ministry of Education, China); International Science and Technology Cooperation Program of China	This work was supported by grants from the National Natural Science Foundation of China (No. 81321002, 81072218, 81270040, 81102060, 81200791, 81001208, 81302371, 81321002), Doctoral Program of the Ministry of Education of China (No. 20110181110055, 20100181120057) and the International Science and Technology Cooperation Program of China (No. 2012DFA31370). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Campayo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022509; Chen R, 2008, ONCOGENE, V27, P225, DOI 10.1038/sj.onc.1210907; Choi S, 2008, J DENT RES, V87, P14, DOI 10.1177/154405910808700104; Engle LJ, 2006, ONCOGENE, V25, P1594, DOI 10.1038/sj.onc.1209368; Freudlsperger C, 2013, ONCOGENE, V32, P1549, DOI 10.1038/onc.2012.171; Johnson N W, 2011, Adv Dent Res, V23, P237, DOI 10.1177/0022034511402082; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kauppila JH, 2013, BRIT J CANCER, V108, P638, DOI 10.1038/bjc.2012.589; Kawai T, 2005, ARTHRITIS RES THER, V7, P12, DOI 10.1186/ar1469; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Kim S, 2011, ANN NY ACAD SCI, V1217, P191, DOI 10.1111/j.1749-6632.2010.05882.x; Kim VN, 2005, MOL CELLS, V19, P1; King CG, 2006, NAT MED, V12, P1088, DOI 10.1038/nm1449; Kotrashetti VS, 2013, BIOTECH HISTOCHEM, V88, P311, DOI 10.3109/10520295.2013.785592; Lamothe B, 2007, BIOCHEM BIOPH RES CO, V359, P1044, DOI 10.1016/j.bbrc.2007.06.017; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Mishra A, 2010, INT J CANCER, V126, P819, DOI 10.1002/ijc.24807; Moss SF, 2005, NAT CLIN PRACT ONCOL, V2, P90, DOI 10.1038/ncponc0081; Paik JH, 2011, CLIN CANCER RES, V17, P4761, DOI 10.1158/1078-0432.CCR-11-0494; Paleja B, 2013, HUM IMMUNOL, V74, P927, DOI 10.1016/j.humimm.2013.04.018; Pinto A, 2011, CANCER IMMUNOL IMMUN, V60, P1211, DOI 10.1007/s00262-011-1057-8; Pisani P, 1996, Cancer Treat Res, V86, P113; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Santarpia M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-163; Sethi G, 2012, BIOSCIENCE REP, V32, P1, DOI 10.1042/BSR20100136; Stadler ME, 2008, HEMATOL ONCOL CLIN N, V22, P1099, DOI 10.1016/j.hoc.2008.08.007; Sun ZJ, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-33; Wu YY, 2013, INT J ORAL SCI, V5, P212, DOI 10.1038/ijos.2013.65; Wynendaele J, 2010, CANCER RES, V70, P9641, DOI 10.1158/0008-5472.CAN-10-0527; Yang MC, 2005, CYTOKINE GROWTH F R, V16, P387, DOI 10.1016/j.cytogfr.2005.02.008; Yao F, 2013, TUMOR BIOL, V34, P3201, DOI 10.1007/s13277-013-0890-0; Zhang LN, 2011, P NATL ACAD SCI USA, V108, P13653, DOI 10.1073/pnas.1103360108; Zhong L, 2013, TUMOR BIOL, V34, P231, DOI 10.1007/s13277-012-0543-8	37	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101695	10.1371/journal.pone.0101695	http://dx.doi.org/10.1371/journal.pone.0101695			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999832	Green Submitted, Green Published, gold			2022-12-27	WOS:000338637300074
J	Waltrick, D; Jones, SM; Simpfendorfer, CA; Awruch, CA				Waltrick, Daniela; Jones, Susan M.; Simpfendorfer, Colin A.; Awruch, Cynthia A.			Endocrine Control of Embryonic Diapause in the Australian Sharpnose Shark Rhizoprionodon taylori	PLOS ONE			English	Article							SKATE RAJA-ERINACEA; STEROID-HORMONES; REPRODUCTIVE-BIOLOGY; SERUM CONCENTRATIONS; PROGESTERONE PRODUCTION; SEASONAL REPRODUCTION; FEMALE ELASMOBRANCHS; VIVIPAROUS DOGFISH; CORPUS-LUTEUM; CYCLE	The reproductive cycle of the Australian sharpnose shark, Rhizoprionodon taylori, includes a temporary suspension of development at the commencement of embryogenesis termed embryonic diapause. This study investigated levels of 17 beta-estradiol (E-2), testosterone (T) and progesterone (P-4) in plasma samples of mature wild female R. taylori captured throughout the reproductive cycle and correlated them with internal morphological changes. Levels of T were elevated through most of the embryonic diapause period, suggesting a role of this hormone in the maintenance of this condition. Increasing plasma T concentrations from late diapause to early active development were associated with a possible role of androgens in the termination of embryonic diapause. As in other elasmobranchs, a concomitant increase of E-2 with ovarian follicle size indicated a direct role of this hormone in regulating vitellogenesis, while a peak in P-4 suggested this hormone is associated with preovulation and ovulation. Additionally, significant correlations between photoperiod or water temperature and maximum follicular diameter and hepatosomatic index suggest that these abiotic factors may also play a role triggering and regulating the synchrony and timing of reproductive events.	[Waltrick, Daniela; Simpfendorfer, Colin A.; Awruch, Cynthia A.] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia; [Waltrick, Daniela; Simpfendorfer, Colin A.; Awruch, Cynthia A.] James Cook Univ, Sch Earth & Environm Sci, Townsville, Qld 4811, Australia; [Jones, Susan M.; Awruch, Cynthia A.] Univ Tasmania, Sch Zool, Hobart, Tas, Australia; [Awruch, Cynthia A.] Consejo Nacl Invest Cient & Tecn, CENPAT, Patagonian Natl Ctr, Puerto Madryn, Chubut, Argentina	James Cook University; James Cook University; University of Tasmania; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Waltrick, D (corresponding author), James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia.	daniela.waltrick@my.jcu.edu.au	Simpfendorfer, Colin A/G-9681-2011	Simpfendorfer, Colin A/0000-0002-0295-2238; Waltrick, Daniela/0000-0002-5436-4577	Winifred Violet Scott foundation [Sco-2.181/51]; Australian National Network of Marine Science (ANNIMS); School of Earth and Environmental Sciences, James Cook University	Winifred Violet Scott foundation; Australian National Network of Marine Science (ANNIMS); School of Earth and Environmental Sciences, James Cook University	The major funding for this research was provided by the Winifred Violet Scott foundation (Sco-2.181/51). Additionally, this research received funds from the Australian National Network of Marine Science (ANNIMS) through the postgraduate mobility award and the School of Earth and Environmental Sciences, James Cook University, through the postgraduate research scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIMS, 2012, DAT OBT 23 FEBR 2012; ANGELINI F, 1984, Bollettino di Zoologia, V51, P121; Atkins N, 2007, BIOL J LINN SOC, V90, P735, DOI 10.1111/j.1095-8312.2007.00770.x; Awruch CA, 2008, J EXP ZOOL PART A, V309A, P184, DOI 10.1002/jez.445; Awruch CA, 2008, MAR ECOL PROG SER, V355, P277, DOI 10.3354/meps07227; Callard Ian P., 2005, P283; CALLARD IP, 1989, J EXP ZOOL, P12; CALLARD IP, 1993, ENVIRON BIOL FISH, V38, P175, DOI 10.1007/BF00842914; CALLARD IP, 1992, AM ZOOL, V32, P264; CALLARD IP, 1991, J STEROID BIOCHEM, V40, P571, DOI 10.1016/0960-0760(91)90278-D; Carrier JC, 2004, CRC MAR BIOL SER, P269; CASTRO JI, 1993, ENVIRON BIOL FISH, V36, P219, DOI 10.1007/BF00001717; CHIEFFI G., 1962, GEN AND COMP ENDOCRINOL SUPPL, V1, P275, DOI 10.1016/0016-6480(62)90098-9; CLIFF G, 1988, S AFR J MARINE SCI, V7, P255, DOI 10.2989/025776188784379035; CRAIK JCA, 1978, J MAR BIOL ASSOC UK, V58, P719, DOI 10.1017/S0025315400041369; CRAIK JCA, 1978, GEN COMP ENDOCR, V35, P455, DOI 10.1016/0016-6480(78)90141-7; CURLEWIS JD, 1992, REPROD FERT DEVELOP, V4, P1, DOI 10.1071/RD9920001; Desmarais JA, 2004, BIOL REPROD, V70, P662, DOI 10.1095/biolreprod.103.023572; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Ewert MA, 2004, EGG INCUBATION ITS E, P173; FORESMAN KR, 1978, BIOL REPROD, V18, P490, DOI 10.1095/biolreprod18.3.490; Gelsleichter J, 2004, CRC MAR BIOL SER, P287; Girling JE, 2003, GEN COMP ENDOCR, V133, P100, DOI 10.1016/S0016-6480(03)00147-3; Guarino FM, 1998, GEN COMP ENDOCR, V111, P261, DOI 10.1006/gcen.1998.7098; Hastings M, 2006, ANN NY ACAD SCI, V453, P182; Heupel MR, 1999, J EXP ZOOL, V284, P586, DOI 10.1002/(SICI)1097-010X(19991001)284:5<586::AID-JEZ14>3.0.CO;2-B; Jacobs JD, 2000, CONDOR, V102, P35, DOI 10.1650/0010-5422(2000)102[0035:ECOLCS]2.0.CO;2; Koob TJ, 1999, J EXP ZOOL, V284, P557; KOOB TJ, 1986, BIOL REPROD, V35, P267, DOI 10.1095/biolreprod35.2.267; LANCE V, 1969, GEN COMP ENDOCR, V13, P255, DOI 10.1016/0016-6480(69)90247-0; Last P. R., 2009, SHARKS RAYS AUSTR, V2; Lopes FL, 2004, REPRODUCTION, V128, P669, DOI 10.1530/rep.1.00444; Lucifora LO, 2002, ICES J MAR SCI, V59, P553, DOI 10.1006/jmsc.2002.1183; Lutton BV, 2005, ELASMOBRANCH OVARY R, P562; MANIRE CA, 1995, GEN COMP ENDOCR, V97, P366, DOI 10.1006/gcen.1995.1036; Marshall LJ, 2007, MAR FRESHWATER RES, V58, P104, DOI 10.1071/MF05165; MEAD RA, 1993, J EXP ZOOL, V266, P629, DOI 10.1002/jez.1402660611; Mull CG, 2010, GEN COMP ENDOCR, V166, P379, DOI 10.1016/j.ygcen.2009.12.009; Mull CG, 2008, COMP BIOCHEM PHYS A, V151, P717, DOI 10.1016/j.cbpa.2008.08.029; MURPHY BD, 1983, BIOL REPROD, V28, P497, DOI 10.1095/biolreprod28.2.497; Musick John A., 2005, P45; Nicol S, 2005, GEN COMP ENDOCR, V144, P204, DOI 10.1016/j.ygcen.2005.05.013; Norris DO, 2007, ENDOCRINOLOGY MAMMAL, P322; PEREZ L, 1993, J EXP ZOOL, V266, P31, DOI 10.1002/jez.1402660105; Ptak GE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033027; R Development Core Team, 2012, R LANG ENV STAT COMP; RASMUSSEN L E L, 1990, NOAA Technical Report NMFS, P143; RASMUSSEN LEL, 1992, AUST J MAR FRESH RES, V43, P273; RASMUSSEN LEL, 1993, ENVIRON BIOL FISH, V38, P167, DOI 10.1007/BF00842913; Renfree MB, 2000, ANNU REV PHYSIOL, V62, P353, DOI 10.1146/annurev.physiol.62.1.353; Savicky P, 2009, PSPEARMAN SPEARMANS; Shanbhag BA, 2001, GEN COMP ENDOCR, V123, P73, DOI 10.1006/gcen.2001.7647; SIMPFENDORFER CA, 1992, AUST J MAR FRESH RES, V43, P67, DOI 10.1071/MF9920067; Simpfendorfer CA, 1993, BIOL FAMILY CARCHARH; Snelson FF, 1997, GEN COMP ENDOCR, V108, P67, DOI 10.1006/gcen.1997.6949; SORBERA LA, 1995, AM J PHYSIOL-REG I, V269, pR389, DOI 10.1152/ajpregu.1995.269.2.R389; Sulikowski JA, 2005, ENVIRON BIOL FISH, V72, P429, DOI 10.1007/s10641-004-2866-9; SUMPTER JP, 1979, J FISH BIOL, V15, P687, DOI 10.1111/j.1095-8649.1979.tb03678.x; TEWINKEL LE, 1972, J MORPHOL, V136, P433, DOI 10.1002/jmor.1051360404; Tricas TC, 2000, GEN COMP ENDOCR, V118, P209, DOI 10.1006/gcen.2000.7466; TSANG P, 1987, J EXP ZOOL, V241, P377, DOI 10.1002/jez.1402410313; TSANG PCW, 1987, GEN COMP ENDOCR, V66, P182, DOI 10.1016/0016-6480(87)90266-8; USNO, 2011, ASTR APPL DEP DAT OB; Waltrick D, 2012, REV FISH BIOL FISHER, V22, P849, DOI 10.1007/s11160-012-9267-5; Yamaguchi A., 2006, ARIAKE BAY KYUSHU JA	65	16	16	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101234	10.1371/journal.pone.0101234	http://dx.doi.org/10.1371/journal.pone.0101234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992673	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000341253400056
J	Hennigs, JK; Muller, J; Adam, M; Spin, JM; Riedel, E; Graefen, M; Bokemeyer, C; Sauter, G; Huland, H; Schlomm, T; Minner, S				Hennigs, Jan K.; Mueller, Julia; Adam, Matti; Spin, Joshua M.; Riedel, Emilia; Graefen, Markus; Bokemeyer, Carsten; Sauter, Guido; Huland, Hartwig; Schlomm, Thorsten; Minner, Sarah			Loss of Somatostatin Receptor Subtype 2 in Prostate Cancer Is Linked to an Aggressive Cancer Phenotype, High Tumor Cell Proliferation and Predicts Early Metastatic and Biochemical Relapse	PLOS ONE			English	Article							TARGETED CYTOTOXIC ANALOGS; ISUP CONSENSUS CONFERENCE; GENE-EXPRESSION; IMMUNOHISTOCHEMICAL EXPRESSION; INTERNATIONAL-SOCIETY; PANCREATIC-CARCINOMA; LUNG-CARCINOMA; GROWTH; INHIBITION; THERAPY	Somatostatin receptor subtype 2 (SSTR2) is the most frequently expressed SSTR subtype in normal human tissues. SSTR2 expression is differentially regulated in various tumor types and therapeutic somatostatin analogs binding to SSTR2 are in clinical use. In prostate cancers highly contradictory results in terms of SSTR2 expression and its consequences have been published over the past years. The aim of this study was to clarify prevalence and clinical significance of SSTR2 expression in prostate cancer. Therefore, quantitative immunohistochemistry (IHC) using a tissue microarray containing samples from 3,261 prostate cancer patients with extensive clinical and molecular cancer characteristics and oncological follow-up data was performed. IHC data was compared to publicly available Gene Expression Omnibus datasets of human prostate cancer gene expression arrays. While membranous SSTR2 staining was always seen in normal prostate epithelium, SSTR2 staining was absent in more than half (56.1%) of 2,195 interpretable prostate cancer samples. About 13% of all analyzed prostate cancers showed moderate to strong cytoplasmic and membranous SSTR2 staining. Staining intensities were inversely correlated with high Gleason grade, advanced pT category, high tumor cell proliferation (p<0.0001 each), high preoperative PSA levels, (p = 0.0011) and positive surgical margins (p = 0.006). In silico analysis confirmed lower SSTR2 gene expression in prostate cancers vs. normal adjacent tissue (p = 0.0424), prostate cancer metastases vs. primary cancers (p = 0.0011) and recurrent vs. non-recurrent prostate cancers (p = 0.0438). PSA-free survival gradually declined with SSTR2 staining intensity (p<0.0001). SSTR2-negative cancers were more likely to develop metastases over time (p<0.05). In conclusion, most prostate cancers are indeed SSTR2-negative and loss of SSTR2 strongly predicts an unfavorable tumor phenotype and poor prognosis. Therefore, SSTR2 expression seems an important factor in the pathogenesis of prostate cancer and re-introduction of the receptor in SSTR2-negative prostate cancers may feature a promising target for novel gene therapy approaches.	[Hennigs, Jan K.; Mueller, Julia; Sauter, Guido; Minner, Sarah] Univ Med Ctr Hamburg Eppendorf, Dept Pathol, Hamburg, Germany; [Hennigs, Jan K.; Bokemeyer, Carsten] Univ Med Ctr Hamburg Eppendorf, Dept Internal Med Oncol 2, BMT Sect Pneumol, Hubertus Wald Tumorzentrum,UCCH, Hamburg, Germany; [Adam, Matti; Spin, Joshua M.] Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Adam, Matti; Spin, Joshua M.] Stanford Univ, Sch Med, Cardiovasc Inst, Stanford, CA 94305 USA; [Graefen, Markus; Huland, Hartwig; Schlomm, Thorsten] Univ Med Ctr Hamburg Eppendorf, Prostate Canc Ctr, Martini Clin, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Stanford University; Stanford University; University of Hamburg; University Medical Center Hamburg-Eppendorf	Hennigs, JK (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Pathol, Hamburg, Germany.	j.hennigs@uke.de		Adam, Matti/0000-0002-6990-8135; Spin, Joshua/0000-0002-4256-9161; Schlomm, Thorsten/0000-0001-9557-4653; Hennigs, Jan K./0000-0002-7784-8267	University Medical Center Hamburg-Eppendorf; Hubertus Wald Tumorzentrum / University Cancer Center Hamburg	University Medical Center Hamburg-Eppendorf; Hubertus Wald Tumorzentrum / University Cancer Center Hamburg	This work was funded by the University Medical Center Hamburg-Eppendorf. JKH received a research fellowship from the "Hubertus Wald Tumorzentrum / University Cancer Center Hamburg" during this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appetecchia M, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-19; Barbieri F, 2008, ENDOCRINOLOGY, V149, P4736, DOI 10.1210/en.2007-1762; Barbieri F, 2009, AM J PHYSIOL-ENDOC M, V297, pE1078, DOI 10.1152/ajpendo.00292.2009; Benali N, 2000, P NATL ACAD SCI USA, V97, P9180, DOI 10.1073/pnas.130196697; BRAZEAU P, 1973, SCIENCE, V179, P77, DOI 10.1126/science.179.4068.77; Buchholz S, 2006, P NATL ACAD SCI USA, V103, P10403, DOI 10.1073/pnas.0602971103; Buscail L, 1996, CANCER RES, V56, P1823; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Engel JB, 2005, CANCER-AM CANCER SOC, V104, P1312, DOI 10.1002/cncr.21327; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Cariaga-Martinez AE, 2009, ADV UROL, V2009, DOI 10.1155/2009/723831; Evangelou I, 2012, EUR J CLIN INVEST, V42, P777, DOI 10.1111/j.1365-2362.2012.02648.x; Feng Yanping, 2006, J Huazhong Univ Sci Technolog Med Sci, V26, P68; Grozinsky-Glasberg S, 2008, ENDOCR-RELAT CANCER, V15, P701, DOI 10.1677/ERC-07-0288; Halmos G, 2000, J CLIN ENDOCR METAB, V85, P2564, DOI 10.1210/jc.85.7.2564; Hansson J, 2002, PROSTATE, V53, P50, DOI 10.1002/pros.10121; He Y, 2009, ACTA PHARMACOL SIN, V30, P1053, DOI 10.1038/aps.2009.59; Keller G, 2005, INT J CANCER, V114, P831, DOI 10.1002/ijc.20806; Keller G, 2006, INT J ONCOL, V28, P1507; Kiaris H, 2001, EUR J CANCER, V37, P620, DOI 10.1016/S0959-8049(00)00437-8; Kwekkeboom D, 2000, J NUCL MED, V41, P1704; Kwekkeboom DJ, 2010, ENDOCR-RELAT CANCER, V17, pR53, DOI 10.1677/ERC-09-0078; Lahlou H, 2005, MOL CELL BIOL, V25, P4034, DOI 10.1128/MCB.25.10.4034-4045.2005; Lopez F, 1997, J BIOL CHEM, V272, P24448, DOI 10.1074/jbc.272.39.24448; Mazzucchelli R, 2011, CELL ONCOL, V34, P235, DOI 10.1007/s13402-011-0031-y; Minner S, 2011, CLIN CANCER RES, V17, P5878, DOI 10.1158/1078-0432.CCR-11-1251; Minner S, 2010, CLIN CANCER RES, V16, P1553, DOI 10.1158/1078-0432.CCR-09-2546; Morichetti D, 2010, BJU INT, V106, P1072, DOI 10.1111/j.1464-410X.2010.09238.x; Patel YC, 1999, FRONT NEUROENDOCRIN, V20, P157, DOI 10.1006/frne.1999.0183; PATEL YC, 1994, ENDOCRINOLOGY, V135, P2814, DOI 10.1210/en.135.6.2814; Plonowski A, 1999, CANCER RES, V59, P1947; Port M, 2011, UROL ONCOL-SEMIN ORI, V29, P764, DOI 10.1016/j.urolonc.2009.08.008; Qiu CZ, 2006, WORLD J GASTROENTERO, V12, P2011, DOI 10.3748/wjg.v12.i13.2011; REUBI JC, 1995, J CLIN ENDOCR METAB, V80, P2806, DOI 10.1210/jc.80.9.2806; Rochaix P, 1999, HUM GENE THER, V10, P995, DOI 10.1089/10430349950018391; Schlomm T, 2008, MODERN PATHOL, V21, P1371, DOI 10.1038/modpathol.2008.104; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sun YJ, 2009, PROSTATE, V69, P1119, DOI 10.1002/pros.20961; Szepeshazi K, 2003, CANCER, V98, P1401, DOI 10.1002/cncr.11649; Szepeshazi K, 2002, CANCER RES, V62, P781; Szereday Z, 2003, INT J ONCOL, V22, P1141; Tan PH, 2011, MODERN PATHOL, V24, P48, DOI 10.1038/modpathol.2010.155; Tang XY, 2010, INT J ONCOL, V37, P1077, DOI 10.3892/ijo_00000759; TAYLOR JE, 1994, PEPTIDES, V15, P1229, DOI 10.1016/0196-9781(94)90146-5; Tennstedt P, 2013, INT J CANCER, V132, P2118, DOI 10.1002/ijc.27907; Torrisani J, 2008, ENDOCRINOLOGY, V149, P3137, DOI 10.1210/en.2007-1525; Trock BJ, 2014, CURR OPIN UROL, V24, P293, DOI 10.1097/MOU.0000000000000050; Vernejoul F, 2002, CANCER RES, V62, P6124; Vockel M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019740; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zhou TH, 2009, ACTA ONCOL, V48, P401, DOI 10.1080/02841860802314746; Ziegler CG, 2009, P NATL ACAD SCI USA, V106, P15879, DOI 10.1073/pnas.0907843106; Zou Y, 2009, ONCOL REP, V21, P379, DOI 10.3892/or_00000233	53	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e100469	10.1371/journal.pone.0100469	http://dx.doi.org/10.1371/journal.pone.0100469			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010045	Green Submitted, Green Published, gold			2022-12-27	WOS:000338763800004
J	Askarian-Amiri, ME; Seyfoddin, V; Smart, CE; Wang, JL; Kim, JE; Hansji, H; Baguley, BC; Finlay, GJ; Leung, EY				Askarian-Amiri, Marjan E.; Seyfoddin, Vahid; Smart, Chanel E.; Wang, Jingli; Kim, Ji Eun; Hansji, Herah; Baguley, Bruce C.; Finlay, Graeme J.; Leung, Euphemia Y.			Emerging Role of Long Non-Coding RNA SOX2OT in SOX2 Regulation in Breast Cancer	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; SELF-RENEWAL; TAMOXIFEN RESISTANCE; HUMAN FIBROBLASTS; EXPRESSION; CARCINOMA; IDENTIFICATION; TRANSCRIPTION; TUMOR; GENERATION	The transcription factor SOX2 is essential for maintaining pluripotency in a variety of stem cells. It has important functions during embryonic development, is involved in cancer stem cell maintenance, and is often deregulated in cancer. The mechanism of SOX2 regulation has yet to be clarified, but the SOX2 gene lies in an intron of a long multi-exon non-coding RNA called SOX2 overlapping transcript (SOX2OT). Here, we show that the expression of SOX2 and SOX2OT is concordant in breast cancer, differentially expressed in estrogen receptor positive and negative breast cancer samples and that both are up-regulated in suspension culture conditions that favor growth of stem cell phenotypes. Importantly, ectopic expression of SOX2OT led to an almost 20-fold increase in SOX2 expression, together with a reduced proliferation and increased breast cancer cell anchorage-independent growth. We propose that SOX2OT plays a key role in the induction and/or maintenance of SOX2 expression in breast cancer.	[Askarian-Amiri, Marjan E.; Seyfoddin, Vahid; Wang, Jingli; Kim, Ji Eun; Hansji, Herah; Baguley, Bruce C.; Finlay, Graeme J.; Leung, Euphemia Y.] Univ Auckland, Auckland Canc Soc Res Ctr, Auckland 1, New Zealand; [Smart, Chanel E.] Univ Queensland, Clin Res Ctr, Herston, Qld, Australia	University of Auckland; University of Queensland	Finlay, GJ (corresponding author), Univ Auckland, Auckland Canc Soc Res Ctr, Auckland 1, New Zealand.	g.finlay@auckland.ac.nz; e.leung@auckland.ac.nz	Leung, Euphemia/D-2642-2009; Askarian-Amiri, Marjan E./F-7910-2010; Smart, Chanel E/C-9583-2011	Leung, Euphemia/0000-0002-6932-3188; Askarian-Amiri, Marjan E./0000-0003-3524-9626; 	New Zealand Breast Cancer Foundation; Maurice and Phyllis Paykel trust; Auckland Medical Research Foundation; Robert McClelland Trust; Auckland Cancer Society Research Centre	New Zealand Breast Cancer Foundation; Maurice and Phyllis Paykel trust; Auckland Medical Research Foundation; Robert McClelland Trust; Auckland Cancer Society Research Centre	Funding for this work was obtained from the New Zealand Breast Cancer Foundation, the Maurice and Phyllis Paykel trust, Auckland Medical Research Foundation, and the Robert McClelland Trust. This work is also supported by Auckland Cancer Society Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026740; Amaral PP, 2009, RNA, V15, P2013, DOI 10.1261/rna.1705309; Askarian-Amiri ME, 2011, RNA, V17, P878, DOI 10.1261/rna.2528811; Baguley B.C., 2011, BREAST CANC CARCINOG, P245; Basu-Roy U, 2012, ONCOGENE, V31, P2270, DOI 10.1038/onc.2011.405; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Boer B, 2007, NUCLEIC ACIDS RES, V35, P1773, DOI 10.1093/nar/gkm059; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Cariati M, 2008, INT J CANCER, V122, P298, DOI 10.1002/ijc.23103; Carninci P, 2007, J EXP BIOL, V210, P1497, DOI 10.1242/jeb.000406; Chen L, 2012, BIOMATERIALS, V33, P1437, DOI 10.1016/j.biomaterials.2011.10.056; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; Comtesse N, 2005, P NATL ACAD SCI USA, V102, P9601, DOI 10.1073/pnas.0500404102; Corominas-Faja B, 2013, CELL CYCLE, V12, P3109, DOI 10.4161/cc.26173; Cox JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044087; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Girouard SD, 2012, LAB INVEST, V92, P362, DOI 10.1038/labinvest.2011.188; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Gure AO, 2000, P NATL ACAD SCI USA, V97, P4198, DOI 10.1073/pnas.97.8.4198; Jenkins DE, 2005, BREAST CANCER RES, V7, pR444, DOI 10.1186/bcr1026; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kondo T, 2004, GENE DEV, V18, P2963, DOI 10.1101/gad.309404; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Leis O, 2011, ONCOGENE; Lengerke C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-42; Leung E, 2014, BREAST CERV IN PRESS; Leung E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/836769; Leung E, 2012, INVEST NEW DRUG, V30, P2103, DOI 10.1007/s10637-011-9768-4; Leung E, 2011, CANCER BIOL THER, V11, P938, DOI 10.4161/cbt.11.11.15527; Leung E, 2010, CANCER BIOL THER, V9, P717, DOI 10.4161/cbt.9.9.11432; Li XL, 2004, INT J ONCOL, V24, P257; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Miyagi S, 2004, MOL CELL BIOL, V24, P4207, DOI 10.1128/MCB.24.10.4207-4220.2004; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nielsen MM, 2014, RNA, V20, P236, DOI 10.1261/rna.038927.113; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Piva M, 2014, EMBO MOL MED, V6, P66, DOI 10.1002/emmm.201303411; Rodriguez-Pinilla SM, 2007, MODERN PATHOL, V20, P474, DOI 10.1038/modpathol.3800760; Sanada Y, 2006, PANCREAS, V32, P164, DOI 10.1097/01.mpa.0000202947.80117.a0; Sattler HP, 2000, PROSTATE, V45, P207, DOI 10.1002/1097-0045(20001101)45:3<207::AID-PROS2>3.0.CO;2-H; Seo E, 2011, MOL CELL BIOL, V31, P4593, DOI 10.1128/MCB.05798-11; Shahryari A, 2014, STEM CELLS, V32, P126, DOI 10.1002/stem.1542; Simoes BM, 2011, BREAST CANCER RES TR, V129, P23, DOI 10.1007/s10549-010-1169-4; Smart CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064388; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wilson M, 2002, CURR OPIN GENET DEV, V12, P441, DOI 10.1016/S0959-437X(02)00323-4; Wu F, 2012, CELL SIGNAL, V24, P1989, DOI 10.1016/j.cellsig.2012.07.008; Zhou JX, 2009, P NATL ACAD SCI USA, V106, P7840, DOI 10.1073/pnas.0901854106	57	96	102	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102140	10.1371/journal.pone.0102140	http://dx.doi.org/10.1371/journal.pone.0102140			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006803	gold, Green Submitted, Green Published			2022-12-27	WOS:000339040600099
J	Leze, E; Maciel-Osorio, CFE; Mandarim-de-Lacerda, CA				Leze, Eduardo; Maciel-Osorio, Clarice F. E.; Mandarim-de-Lacerda, Carlos A.			Advantages of Evaluating Mean Nuclear Volume as an Adjunct Parameter in Prostate Cancer	PLOS ONE			English	Article							INTEROBSERVER REPRODUCIBILITY; GLEASON SCORE; RADICAL PROSTATECTOMY; TUMOR BIOLOGY; BIOPSY; CARCINOMA; GRADE; PATHOLOGISTS; ANTIGEN; DETERMINANTS	Background: Efforts to improve the diagnosis, prognosis and surveillance of prostate cancer (PCa) are relevant. Gleason score (GSc) overestimation may subject individuals to unnecessary aggressive treatment. We aimed to use stereology in PCa evaluations and investigate whether mean nuclear volume (MNV) correlates with the Gleason primary pattern (Gpp) and to improve the subjective GSc to obtain an objective and reliable method without inter-observer dissension. Methods: We identified 74 radical prostatectomy specimens that were divided into six groups based on Gpp, from 3 to 5. Controls (C) were designed in paired non-tumor regions of the same specimens. MNV was estimated using the "point-sampled intercepts'' method. Differences in MNV among the C groups and the Gpp groups were tested with the Kruskall-Wallis test and Dunn post-hoc test. Differences between each Gpp group and its control counterpart were tested with the Wilcoxon test. Correlations were evaluated with the Spearman rank correlation (R-[Spearman]). Results: The correlations between prostate-specific antigen (PSA) and GSc (R-[Spearman] of 0.76) and between PSA and MNV (R-[Spearman] of 0.78) were moderately strong and highly significant, and the correlation between MNV and Gpp (R-[Spearman] of 0.53) was moderate and highly significant. MNV was significantly greater in cancerous regions than in paired-control regions. Limitations included sample size. Conclusions: Proper planning of a study, as well as the availability of equipment and software for morphological quantification, can provide incentive to quickly and accurately estimate MNV as an adjunct parameter in the assessment of PCa. Current data are in favor of the use of MNV associated with GSc and PSA in the assessment of PCa.	[Leze, Eduardo; Maciel-Osorio, Clarice F. E.; Mandarim-de-Lacerda, Carlos A.] Univ Estado Rio De Janeiro, Biomed Ctr, Lab Morphometry Metab & Cardiovasc Dis, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro	Mandarim-de-Lacerda, CA (corresponding author), Univ Estado Rio De Janeiro, Biomed Ctr, Lab Morphometry Metab & Cardiovasc Dis, Rio De Janeiro, Brazil.	mandarim@uerj.br	Mandarim-de-Lacerda, Carlos A/F-7125-2012; Mandarim-de-Lacerda, Carlos Alberto/P-2360-2019	Mandarim-de-Lacerda, Carlos Alberto/0000-0003-4134-7978				Allsbrook WC, 2001, HUM PATHOL, V32, P74, DOI 10.1053/hupa.2001.21134; Allsbrook WC, 2001, HUM PATHOL, V32, P81, DOI 10.1053/hupa.2001.21135; Arai Y, 2001, BJU INT, V88, P909, DOI 10.1046/j.1464-4096.2001.01558.x; Arai Y, 2001, PROSTATE, V46, P134, DOI 10.1002/1097-0045(20010201)46:2<134::AID-PROS1017>3.0.CO;2-9; Arima K, 1997, BRIT J CANCER, V76, P234, DOI 10.1038/bjc.1997.367; Billis A, 2008, J UROLOGY, V180, P548, DOI 10.1016/j.juro.2008.04.018; Buhmeida AB, 2000, ANAL QUANT CYTOL, V22, P291; Burchardt M, 2008, J CANCER RES CLIN, V134, P1071, DOI 10.1007/s00432-008-0388-0; Chen X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045178; Cirak Y, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0526-7; Corcoran NM, 2012, BJU INT, V110, P36, DOI 10.1111/j.1464-410X.2011.10681.x; Dahl KN, 2008, CIRC RES, V102, P1307, DOI 10.1161/CIRCRESAHA.108.173989; Egevad L, 2013, HISTOPATHOLOGY, V62, P247, DOI 10.1111/his.12008; Epstein JI, 2012, EUR UROL, V61, P1019, DOI 10.1016/j.eururo.2012.01.050; Fanning DM, 2010, BJU INT, V105, P631, DOI 10.1111/j.1464-410X.2009.08810.x; Fujikawa K, 2000, J UROLOGY, V164, P1587, DOI 10.1016/S0022-5347(05)67034-6; Fujikawa K, 2000, ANAL QUANT CYTOL, V22, P55; Goodman M, 2012, PROSTATE, V72, P1389, DOI 10.1002/pros.22484; GUNDERSEN HJG, 1985, J MICROSC-OXFORD, V138, P127, DOI 10.1111/j.1365-2818.1985.tb02607.x; Haas GP, 2008, CAN J UROL, V15, P3866; Helpap B, 2008, ANAL QUANT CYTOL, V30, P133; Katz B, 2012, UROL ONCOL-SEMIN ORI, V30, P794, DOI 10.1016/j.urolonc.2010.10.010; Matsui Y, 2004, J UROLOGY, V171, P687, DOI 10.1097/01.ju.0000106864.91375.80; Oh JJ, 2012, BJU INT, V110, pE494, DOI 10.1111/j.1464-410X.2012.11182.x; Oyama T, 2005, ARCH PATHOL LAB MED, V129, P1004; Pierorazio PM, 2013, BJU INT, V111, P753, DOI 10.1111/j.1464-410X.2012.11611.x; Rapiti E, 2013, BMC UROL, V13, DOI 10.1186/1471-2490-13-19; Shapiro RH, 2012, UROLOGY, V80, P661, DOI 10.1016/j.urology.2012.06.022; Veltri RW, 2008, CANCER EPIDEM BIOMAR, V17, P102, DOI 10.1158/1055-9965.EPI-07-0175	29	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102156	10.1371/journal.pone.0102156	http://dx.doi.org/10.1371/journal.pone.0102156			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007252	gold, Green Submitted, Green Published			2022-12-27	WOS:000339040600103
J	Reeves, ME; Firek, M; Chen, ST; Amaar, YG				Reeves, Mark E.; Firek, Matthew; Chen, Shin-Tai; Amaar, Yousef G.			Evidence that RASSF1C Stimulation of Lung Cancer Cell Proliferation Depends on IGFBP-5 and PIWIL1 Expression Levels	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; EPIGENETIC INACTIVATION; GROWTH; PROTEIN; BREAST; IDENTIFICATION; PROMOTES; 3P21.3; AMPK	RASSF1C is a major isoform of the RASSF1 gene, and is emerging as an oncogene. This is in contradistinction to the RASSF1A isoform, which is an established tumor suppressor. We have previously shown that RASSF1C promotes lung cancer cell proliferation and have identified RASSF1C target genes with growth promoting functions. Here, we further report that RASSF1C promotes lung cancer cell migration and enhances lung cancer cell tumor sphere formation. We also show that RASSF1C over-expression reduces the inhibitory effects of the anti-cancer agent, betulinic acid ( BA), on lung cancer cell proliferation. In previous work, we demonstrated that RASSF1C up-regulates piwil1 gene expression, which is a stem cell self-renewal gene that is over-expressed in several human cancers, including lung cancer. Here, we report on the effects of BA on piwil1 gene expression. Cells treated with BA show decreased piwil1 expression. Also, interaction of IGFBP-5 with RASSF1C appears to prevent RASSF1C from up-regulating PIWIL1 protein levels. These findings suggest that IGFBP-5 may be a negative modulator of RASSF1C/PIWIL1 growth-promoting activities. In addition, we found that inhibition of the ATM-AMPK pathway up-regulates RASSF1C gene expression.	[Reeves, Mark E.; Firek, Matthew; Amaar, Yousef G.] Loma Linda VA Med Ctr, Surg Oncol Lab, Loma Linda, CA 92354 USA; [Chen, Shin-Tai] Loma Linda VA Med Ctr, Musculoskeletal Dis Ctr, Loma Linda, CA USA; [Reeves, Mark E.; Amaar, Yousef G.] Loma Linda Univ, Sch Med, Dept Surg, Loma Linda, CA USA	Loma Linda University; Loma Linda University; Loma Linda University	Amaar, YG (corresponding author), Loma Linda VA Med Ctr, Surg Oncol Lab, Loma Linda, CA 92354 USA.	yousef.amaar@va.gov			Loma Linda University Cancer Center	Loma Linda University Cancer Center	We thank Dr. Donna Strong for the critical reading of the manuscript. This work was carried out at the Loma Linda VA Medical Center, Loma Linda, CA; and the work was supported by a grant from Loma Linda University Cancer Center.	Agathanggelou A, 2003, CANCER RES, V63, P5344; Agathanggelou A, 2001, ONCOGENE, V20, P1509, DOI 10.1038/sj.onc.1204175; Amaar YG, 2005, J BONE MINER RES, V20, P1430, DOI 10.1359/JBMR.050311; Amaar YG, 2006, AM J PHYSIOL-LUNG C, V291, pL1185, DOI 10.1152/ajplung.00072.2006; Burbee DG, 2001, JNCI-J NATL CANCER I, V93, P691, DOI 10.1093/jnci/93.9.691; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; Dammann R, 2001, ONCOGENE, V20, P3563, DOI 10.1038/sj.onc.1204469; Dreijerink K, 2001, P NATL ACAD SCI USA, V98, P7504, DOI 10.1073/pnas.131216298; Estrabaud E, 2007, CANCER RES, V67, P1054, DOI 10.1158/0008-5472.CAN-06-2530; Gheorgheosu D, 2014, ANTICANCER AGENTS ME; Gullu G, 2012, CHIN J CANCER, V31, P266, DOI 10.5732/cjc.011.10405; Hamilton G, 2009, CURR BIOL, V19, P2020, DOI 10.1016/j.cub.2009.10.040; Hsu YF, 2012, BBA-GEN SUBJECTS, V1820, P104, DOI 10.1016/j.bbagen.2011.11.011; Li JF, 2004, ONCOGENE, V23, P5941, DOI 10.1038/sj.onc.1207789; Liang D, 2013, ASIAN PAC J CANCER P, V14, P1067, DOI 10.7314/APJCP.2013.14.2.1067; Liu LM, 2002, ONCOGENE, V21, P6835, DOI 10.1038/sj.onc.1205814; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Meng XJ, 2009, CANCER SCI, V100, P1040, DOI 10.1111/j.1349-7006.2009.01144.x; Pelosi G, 2010, ANTICANCER RES, V30, P4269; Reeves M. E., 2013, MOL BIOL INT, V2013, P145096; Reeves Mark E, 2012, BMC Res Notes, V5, P239, DOI 10.1186/1756-0500-5-239; Reeves ME, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-562; Rzeski W, 2009, BASIC CLIN PHARMACOL, V105, P425, DOI 10.1111/j.1742-7843.2009.00471.x; Sanli T, 2010, INT J RADIAT ONCOL, V78, P221, DOI 10.1016/j.ijrobp.2010.03.005; Siddiqi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033711; Siddiqi S, 2012, J CELL BIOCHEM, V113, P373, DOI 10.1002/jcb.23363; Storozhuk Y, 2013, BRIT J CANCER, V108, P2021, DOI 10.1038/bjc.2013.187; Tirino V, 2009, EUR J CARDIO-THORAC, V36, P446, DOI 10.1016/j.ejcts.2009.03.063; Tommasi S, 2005, CANCER RES, V65, P92; Vos MD, 2000, J BIOL CHEM, V275, P35669, DOI 10.1074/jbc.C000463200; Yang LJ, 2010, ACTA PHARMACOL SIN, V31, P66, DOI 10.1038/aps.2009.177	32	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101679	10.1371/journal.pone.0101679	http://dx.doi.org/10.1371/journal.pone.0101679			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007054	Green Published, gold, Green Submitted			2022-12-27	WOS:000339040600057
J	Yin, J; Wang, LM; Zheng, L; Wang, X; Shi, YJ; Shao, AZ; Ding, GW; Liu, C; Chen, SC; Tang, WF; Gu, HY				Yin, Jun; Wang, Liming; Zheng, Liang; Wang, Xu; Shi, Yijun; Shao, Aizhong; Ding, Guowen; Liu, Chao; Chen, Suocheng; Tang, Weifeng; Gu, Haiyong			TERT-CLPTM1L Rs401681 C > T Polymorphism Was Associated with a Decreased Risk of Esophageal Cancer in a Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; CARCINOMA; GENE; TERT	Background: Esophageal cancer was the fifth most commonly diagnosed cancer and the fourth leading cause of cancer-related death in China in 2009. Esophageal squamous cell carcinoma (ESCC) accounts for more than 90 percent of esophageal cancers. Genetic factors probably play an important role in the ESCC carcinogenesis. Methods: We conducted a hospital based case-control study to evaluate functional hTERT rs2736098 G>A and TERT-CLPTM1L rs401681 C>T single nucleotide polymorphisms (SNPs) on the risk of ESCC. Six hundred and twenty-nine ESCC cases and 686 controls were recruited. Their genotypes were determined using the ligation detection reaction (LDR) method. Results: When the TERT-CLPTM1L rs401681 CC homozygote genotype was used as the reference group, the CT genotype was associated with a significantly decreased risk of ESCC (adjusted OR = 0.74, 95% CI = 0.58-0.94, p = 0.012); the CT/TT variants were associated with a 26% decreased risk of ESCC (adjusted OR = 0.74, 95% CI = 0.59-0.93, P = 0.009). The significantly decreased risk of ESCC associated with the TERT-CLPTM1L rs401681 C>T polymorphism was associated with male sex, young age (<63 years in our study) and alcohol consumption. No association between the hTERT rs2736098 G>A polymorphism and ESCC risk was observed. Conclusion: TERT-CLPTM1L rs401681 CT and CT/TT genotypes were associated with decreased risk of ESCC, particularly among men, young patients and those reported to be drinkers. However, our results are preliminary conclusions. Larger studies with more rigorous study designs are required to confirm the current findings.	[Yin, Jun; Wang, Xu; Shi, Yijun; Shao, Aizhong; Ding, Guowen; Liu, Chao; Chen, Suocheng; Tang, Weifeng; Gu, Haiyong] Jiangsu Univ, Affiliated Peoples Hosp, Dept Cardiothorac Surg, Zhenjiang, Jiangsu, Peoples R China; [Wang, Liming] Jiangsu Univ, Peoples Hosp, Inst Canc, Dept Chemotherapy, Zhenjiang, Jiangsu, Peoples R China; [Zheng, Liang] Suzhou Univ, Peoples Hosp Changzhou 1, Dept Cardiothorac Surg, Changzhou, Jiangsu, Peoples R China; [Zheng, Liang] Suzhou Univ, Affiliated Hosp 3, Changzhou, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University	Tang, WF (corresponding author), Jiangsu Univ, Affiliated Peoples Hosp, Dept Cardiothorac Surg, Zhenjiang, Jiangsu, Peoples R China.	twf001001@126.com; haiyong_gu@hotmail.com			National Natural Science Foundation of China [81101889, 81000028]; Jiangsu Province Natural Science Foundation [BK2010333, BK2011481]; Social Development Foundation of Zhenjiang [SH2010017]; Changzhou Young Talents and Science-Technology Foundation of Health Bureau [QN201102]; "333" Elitist Training Program of Jiangsu [BRA2013135]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Social Development Foundation of Zhenjiang; Changzhou Young Talents and Science-Technology Foundation of Health Bureau; "333" Elitist Training Program of Jiangsu	This study was supported in part by National Natural Science Foundation of China (81101889, 81000028), Jiangsu Province Natural Science Foundation (BK2010333, BK2011481), Social Development Foundation of Zhenjiang (SH2010017), Changzhou Young Talents and Science-Technology Foundation of Health Bureau (QN201102), and The "333" Elitist Training Program of Jiangsu (BRA2013135). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird DM, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S146239941000147X; Chen WQ, 2013, J THORAC DIS, V5, P19, DOI 10.3978/j.issn.2072-1439.2013.01.04; Chen ZJ, 2011, NAT GENET, V43, P55, DOI 10.1038/ng.732; Colombo J, 2009, ONCOL REP, V21, P649, DOI 10.3892/or_00000268; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Gu HY, 2012, MOL BIOL REP, V39, P9105, DOI 10.1007/s11033-012-1782-x; James MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036116; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jiang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084277; Law MH, 2012, J INVEST DERMATOL, V132, P485, DOI 10.1038/jid.2011.322; Liu ZS, 2010, CARCINOGENESIS, V31, P1977, DOI 10.1093/carcin/bgq179; MACFARLANE GJ, 1994, J ROY SOC MED, V87, P334; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; MORITA M, 1994, INT J CANCER, V58, P207, DOI 10.1002/ijc.2910580211; Myneni AA, 2013, LUNG CANCER, V80, P131, DOI 10.1016/j.lungcan.2013.01.021; Nan HM, 2011, HUM GENET, V129, P247, DOI 10.1007/s00439-010-0921-5; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Pooley KA, 2010, CANCER EPIDEM BIOMAR, V19, P1862, DOI 10.1158/1055-9965.EPI-10-0281; Prescott J, 2012, MUTAT RES-FUND MOL M, V730, P75, DOI 10.1016/j.mrfmmm.2011.06.009; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Rodier F, 2005, INT J BIOCHEM CELL B, V37, P977, DOI 10.1016/j.biocel.2004.10.012; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Wyatt HDM, 2010, NUCLEIC ACIDS RES, V38, P5609, DOI 10.1093/nar/gkq370; Yamamoto K, 2001, BIOCHEM BIOPH RES CO, V280, P1148, DOI 10.1006/bbrc.2001.4250; Young NS, 2010, HEMATOL-AM SOC HEMAT, P30, DOI 10.1182/asheducation-2010.1.30; Zienolddiny S, 2009, CARCINOGENESIS, V30, P1368, DOI 10.1093/carcin/bgp131	26	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e100667	10.1371/journal.pone.0100667	http://dx.doi.org/10.1371/journal.pone.0100667			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007268	Green Published, gold, Green Submitted			2022-12-27	WOS:000339040600017
J	Samanta, K; Douglas, S; Parekh, AB				Samanta, Krishna; Douglas, Sophie; Parekh, Anant B.			Mitochondrial Calcium Uniporter MCU Supports Cytoplasmic Ca2+ Oscillations, Store-Operated Ca2+ Entry and Ca2+-Dependent Gene Expression in Response to Receptor Stimulation	PLOS ONE			English	Article							INOSITOL TRISPHOSPHATE; ESSENTIAL COMPONENT; ENDOPLASMIC-RETICULUM; ACTIVATION; RELEASE; INACTIVATION; PROTEINS; DETERMINANTS; MICRODOMAINS; CHANNELS	Ca2+ flux into mitochondria is an important regulator of cytoplasmic Ca2+ signals, energy production and cell death pathways. Ca2+ uptake can occur through the recently discovered mitochondrial uniporter channel (MCU) but whether the MCU is involved in shaping Ca2+ signals and downstream responses to physiological levels of receptor stimulation is unknown. Here, we show that modest stimulation of leukotriene receptors with the pro-inflammatory signal LTC4 evokes a series of cytoplasmic Ca2+ oscillations that are rapidly and faithfully propagated into mitochondrial matrix. Knockdown of MCU or mitochondrial depolarisation, to reduce the driving force for Ca2+ entry into the matrix, prevents the mitochondrial Ca2+ rise and accelerates run down of the oscillations. The loss of cytoplasmic Ca2+ oscillations appeared to be a consequence of enhanced Ca2+ -dependent inactivation of InsP(3) receptors, which arose from the loss of mitochondrial Ca2+ buffering. Ca2+ dependent gene expression in response to leukotriene receptor activation was suppressed following knockdown of the MCU. In addition to buffering Ca2+ release, mitochondria also sequestrated Ca2+ entry through storeoperated Ca2+ channels and this too was prevented following loss of MCU. MCU is therefore an important regulator of physiological pulses of cytoplasmic Ca2+.	[Samanta, Krishna; Douglas, Sophie; Parekh, Anant B.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England	University of Oxford	Parekh, AB (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.	anant.parekh@dpag.ox.ac.uk			Medical Research Council; American Asthma Foundation	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); American Asthma Foundation	This work received funding from the Medical Research Council and the American Asthma Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MR, 2012, J BIOL CHEM, V287, P34445, DOI 10.1074/jbc.M112.392084; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Bird GS, 2005, J PHYSIOL-LONDON, V562, P697, DOI 10.1113/jphysiol.2004.077289; Chang WC, 2004, J BIOL CHEM, V279, P29994, DOI 10.1074/jbc.M403969200; Chaudhuri D, 2013, ELIFE, V2, DOI 10.7554/eLife.00704; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Di Capite J, 2009, CURR BIOL, V19, P853, DOI 10.1016/j.cub.2009.03.063; Drago I, 2012, P NATL ACAD SCI USA, V109, P12986, DOI 10.1073/pnas.1210718109; Duchen MR, 1999, J PHYSIOL-LONDON, V516, P1, DOI 10.1111/j.1469-7793.1999.001aa.x; Fierro L, 1999, J MEMBRANE BIOL, V168, P9, DOI 10.1007/s002329900493; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Gilabert JA, 2000, EMBO J, V19, P6401, DOI 10.1093/emboj/19.23.6401; Gilabert JA, 2001, EMBO J, V20, P2672, DOI 10.1093/emboj/20.11.2672; Glitsch MD, 2002, EMBO J, V21, P6744, DOI 10.1093/emboj/cdf675; Hoth M, 2000, P NATL ACAD SCI USA, V97, P10607, DOI 10.1073/pnas.180143997; Huang G, 2014, NATURW COMMUNICATION, V4, P2865; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Kar P, 2012, P NATL ACAD SCI USA, V109, P6969, DOI 10.1073/pnas.1201204109; Kar P, 2012, CURR BIOL, V22, P242, DOI 10.1016/j.cub.2011.12.025; Kar P, 2011, J BIOL CHEM, V286, P14795, DOI 10.1074/jbc.M111.220582; Kim MS, 2009, J NEUROSCI, V29, P12101, DOI 10.1523/JNEUROSCI.3384-09.2009; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Logan CV, 2014, NAT GENET, V46, P188, DOI 10.1038/ng.2851; Mak DOD, 1997, J GEN PHYSIOL, V109, P571, DOI 10.1085/jgp.109.5.571; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; Moreau B, 2006, CURR BIOL, V16, P1672, DOI 10.1016/j.cub.2006.06.059; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Ng SW, 2012, NATURE, V482, P111, DOI 10.1038/nature10731; Ng SW, 2009, J BIOL CHEM, V284, P24767, DOI 10.1074/jbc.M109.011692; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Pan X, 2013, NAT CELL BIOL, V15, P1464, DOI 10.1038/ncb2868; Parekh AB, 1998, J BIOL CHEM, V273, P14925, DOI 10.1074/jbc.273.24.14925; Parekh AB, 2011, TRENDS BIOCHEM SCI, V36, P78, DOI 10.1016/j.tibs.2010.07.013; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Plovanich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055785; Prudent J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3330; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Robert V, 2001, EMBO J, V20, P4998, DOI 10.1093/emboj/20.17.4998; Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993; Tarasov AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039722; Wedel B, 2007, J PHYSIOL-LONDON, V579, P679, DOI 10.1113/jphysiol.2006.125641	49	61	63	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101188	10.1371/journal.pone.0101188	http://dx.doi.org/10.1371/journal.pone.0101188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004162	Green Published, gold, Green Submitted			2022-12-27	WOS:000339242700020
J	Xu, Y; Wang, N; Yu, Y; Li, Y; Li, YB; Yu, YB; Zhou, XQ; Sun, ZW				Xu, Ying; Wang, Na; Yu, Yang; Li, Yang; Li, Yan-Bo; Yu, Yong-Bo; Zhou, Xian-Qing; Sun, Zhi-Wei			Exposure to Silica Nanoparticles Causes Reversible Damage of the Spermatogenic Process in Mice	PLOS ONE			English	Article							MALE-INFERTILITY; OXIDATIVE STRESS; CARBON NANOTUBES; MALE RATS; IN-VITRO; TOXICITY; KERATINOCYTES; FERTILITY; SYSTEM; SIO2	Environmental exposure to nanomaterials is inevitable, as nanomaterials have become part of our daily life now. In this study, we firstly investigated the effects of silica nanoparticles on the spermatogenic process according to their time course in male mice. 48 male mice were randomly divided into control group and silica nanoparticle group with 24 mice per group, with three evaluation time points (15, 35 and 60 days after the first dose) per group. Mice were exposed to the vehicle control and silica nanoparticles at a dosage of 20 mg/kg every 3 days, five times over a 13-day period, and were sacrificed at 15, 35 and 60 days after the first dose. The results showed that silica nanoparticles caused damage to the mitochondrial cristae and decreased the levels of ATP, resulting in oxidative stress in the testis by days 15 and 35; however, the damage was repaired by day 60. DNA damage and the decreases in the quantity and quality of epididymal sperm were found by days 15 and 35; but these changes were recovered by day 60. In contrast, the acrosome integrity and fertility in epididymal sperm, the numbers of spermatogonia and sperm in the testes, and the levels of three major sex hormones were not significantly affected throughout the 60-day period. The results suggest that nanoparticles can cause reversible damage to the sperms in the epididymis without affecting fertility, they are more sensitive than both spermatogonia and spermatocytes to silica nanoparticle toxicity. Considering the spermatogenesis time course, silica nanoparticles primarily influence the maturation process of sperm in the epididymis by causing oxidative stress and damage to the mitochondrial structure, resulting in energy metabolism dysfunction.	[Xu, Ying; Wang, Na; Yu, Yang; Li, Yang; Li, Yan-Bo; Yu, Yong-Bo; Zhou, Xian-Qing; Sun, Zhi-Wei] Capital Med Univ, Dept Hlth Toxicol & Hlth Chem, Sch Publ Hlth, Beijing, Peoples R China; [Xu, Ying; Yu, Yang; Li, Yang; Li, Yan-Bo; Yu, Yong-Bo; Zhou, Xian-Qing; Sun, Zhi-Wei] Capital Med Univ, Beijing Key Lab Environm Toxicol, Beijing, Peoples R China; [Wang, Na] Capital Med Univ, Dept Lab Anim Sci, Sch Basic Med Sci, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Zhou, XQ (corresponding author), Capital Med Univ, Dept Hlth Toxicol & Hlth Chem, Sch Publ Hlth, Beijing, Peoples R China.	xqzhou@ccmu.edu.cn; zwsun@ccmu.edu.cn	Yu, Yongbo/AAE-9353-2019		National Natural Science Foundation of China [81172704]; Human Resources Development of the Beijing Education Committee [PHR201006110]; Innovative Team Project of the Beijing Education Committee [PHR201107116]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Human Resources Development of the Beijing Education Committee; Innovative Team Project of the Beijing Education Committee	The study was supported by the National Natural Science Foundation of China (No. 81172704), the Human Resources Development of the Beijing Education Committee (No. PHR201006110) and from the Innovative Team Project of the Beijing Education Committee (No. PHR201107116). Their websites are: http://www.nsfc.gov.cn, http://www.bjedu.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ JG, 1987, J ANDROL, V8, P338; Bai YH, 2010, NAT NANOTECHNOL, V5, P683, DOI [10.1038/NNANO.2010.153, 10.1038/nnano.2010.153]; [陈秋菊 Chen Qiuju], 2005, [中国病理生理杂志, Chinese Journal of Pathophysiology], V21, P811; Duan C, 2003, CYTOGENET GENOME RES, V103, P352, DOI 10.1159/000076824; Fan Yi-Ou, 2006, Wei Sheng Yan Jiu, V35, P549; Hayes AW, 1994, PRINCIPLES METHODS T, P937; Hong WenXu, 2011, Journal of Environment and Health, V28, P1048; HOWARDS SS, 1995, NEW ENGL J MED, V332, P312, DOI 10.1056/NEJM199502023320507; Jiang QG, 1994, MALE MAN REPROD TOXI, P215; Kong Lu, 2011, Asian Journal of Ecotoxicology, V6, P655; Li C, 2009, TOXICOL LETT, V185, P1, DOI 10.1016/j.toxlet.2008.11.012; Li X, 2007, J BIOMED MATER RES B, V83B, P431, DOI 10.1002/jbm.b.30813; Lin BC, 2008, J PREVENTIVE MED CHI, V26, P172; Lin Ben-cheng, 2007, Asian Journal of Ecotoxicology, V2, P195; Liu TL, 2011, BIOMATERIALS, V32, P1657, DOI 10.1016/j.biomaterials.2010.10.035; Nagy A, 2003, MANIPULATING MOUSE E, P415; Ozaki T., 2002, Archives of Gynecology and Obstetrics, V266, P114, DOI 10.1007/s004040000112; [曲秋莲 Qu Qiulian], 2010, [军事医学科学院院刊, Bulletin of the Academy of Military Medical Sciences], V34, P306; Radin S, 2005, BIOMATERIALS, V26, P1043, DOI 10.1016/j.biomaterials.2004.04.004; Ramalho-Santos J, 2007, MODERN RES ED TOPICS, V1, P394; Ramdhan DH, 2009, TOXICOL LETT, V191, P103, DOI 10.1016/j.toxlet.2009.08.013; Rao AV, 1997, FREE RADIC BIOL MED, V29, P1015; Roy I, 2003, J AM CHEM SOC, V125, P7860, DOI 10.1021/ja0343095; Saleh RA, 2002, J ANDROL, V23, P737; Sergerie M, 2005, HUM REPROD, V20, P3446, DOI 10.1093/humrep/dei231; Shi C, 2008, EXP GERONTOL, V43, P589, DOI 10.1016/j.exger.2008.02.004; Sun L, 2011, TOXICOL IN VITRO, V25, P1619, DOI 10.1016/j.tiv.2011.06.012; Tremellen K, 2008, HUM REPROD UPDATE, V14, P243, DOI 10.1093/humupd/dmn004; Wang B, 2012, J NANOSCI NANOTECHNO, V12, P293, DOI 10.1166/jnn.2012.5127; Wang SG, 2011, ENVIRON MOL MUTAGEN, V52, P614, DOI 10.1002/em.20660; WATANABE T, 1991, MUTAT RES, V262, P93, DOI 10.1016/0165-7992(91)90113-I; Xu C, 2005, REPROD BIOL THEORY P, P19; Yang ST, 2008, TOXICOL LETT, V181, P182, DOI 10.1016/j.toxlet.2008.07.020; Yoshida S, 2009, INT J ANDROL, V32, P337, DOI 10.1111/j.1365-2605.2007.00865.x; Yu KO, 2009, J NANOPART RES, V11, P15, DOI 10.1007/s11051-008-9417-9; Yu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061346; Zhang Y, 2011, J FUJIAN MED U, V45, P122	37	53	57	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101572	10.1371/journal.pone.0101572	http://dx.doi.org/10.1371/journal.pone.0101572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003337	Green Published, gold, Green Submitted			2022-12-27	WOS:000339242700040
J	Lai, NS; Tsai, TY; Koo, M; Huang, KY; Tung, CH; Lu, MC				Lai, Ning-Sheng; Tsai, Tzung-Yi; Koo, Malcolm; Huang, Kuang-Yung; Tung, Chien-Hsueh; Lu, Ming-Chi			Patterns of Ambulatory Medical Care Utilization and Rheumatologist Consultation Predating the Diagnosis of Systemic Lupus Erythematosus: A National Population-Based Study	PLOS ONE			English	Article							COLLEGE-OF-RHEUMATOLOGY; CLINICS CLASSIFICATION CRITERIA; AUTOANTIBODIES; MANIFESTATIONS; PREVALENCE; ONSET; FEATURES; DISEASE; REGION	Objective: To investigate the records of ambulatory medical care from patients predating the diagnosis of systemic lupus erythematosus (SLE) using nationwide, population-based claims data. Methods: The frequencies and costs of ambulatory medical care utilization in 337 newly-diagnosed SLE cases between 2004 and 2010, identified from Taiwan's National Health Insurance Research Database, were compared with 1,348 controls who were frequency matched for sex, age, and the catastrophic illness certificate application year of the cases. Results: Patients with SLE had a median frequency of ambulatory medical care utilization compared with controls one year prior to the index date (22 vs. 2, P<0.001). The differences were significant throughout all eight annual periods. Similarly, the inflation-adjusted costs of ambulatory medical care utilization in patients with SLE increased annually over the study period, from a median of US$18 eight years prior to the index date to US$680 one year prior to the index date. Diseases of the respiratory system (International Classification of Diseases, Ninth Revision, Clinical Modification [ICD-9-CM] codes 460-519), digestive system (ICD-9-CM codes 520-579), musculoskeletal system and connective tissue (ICD-9-CM codes 710-739, excluding 710.0), and skin and subcutaneous tissue (ICD-9-CM codes 680-709) were the top four common causes of visits in the 0.5 to 2 year period preceding the index date and percentages of SLE patients suffered from these disorders increased progressively over the study period. Only 56.4% of the patients with SLE had consulted a rheumatologist and most of the serology tests were done within one year predating the index date. Conclusions: Increased frequencies and costs of ambulatory care utilization among Taiwanese patients with SLE occurred several years predating their definitive SLE diagnosis. When multisystemic disorders are presented in young female patients, the possibility of SLE should be considered and screened with tools such as the antinuclear antibody test.	[Lai, Ning-Sheng; Huang, Kuang-Yung; Tung, Chien-Hsueh; Lu, Ming-Chi] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Div Allergy Immunol & Rheumatol, Chiayi, Taiwan; [Lai, Ning-Sheng; Huang, Kuang-Yung; Lu, Ming-Chi] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Tsai, Tzung-Yi; Koo, Malcolm] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Med Res, Chiayi, Taiwan; [Tsai, Tzung-Yi] Tzu Chi Coll Technol, Dept Nursing, Hualien, Taiwan; [Tsai, Tzung-Yi] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Koo, Malcolm] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University of Science & Technology; National Cheng Kung University; University of Toronto	Lu, MC (corresponding author), Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Div Allergy Immunol & Rheumatol, Chiayi, Taiwan.	e360187@yahoo.com.tw	Koo, Malcolm/AAE-5822-2020	Koo, Malcolm/0000-0002-9242-9167	Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taiwan [DTCRD101-E-08]	Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taiwan	This work was supported by a grant from the Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation (DTCRD101-E-08), Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbuckle MR, 2001, SCAND J IMMUNOL, V54, P211, DOI 10.1046/j.1365-3083.2001.00959.x; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Bernatsky S, 2013, J AUTOIMMUN, V42, P130, DOI 10.1016/j.jaut.2012.12.009; Bertsias GK, 2013, NAT REV RHEUMATOL, V9, P687, DOI 10.1038/nrrheum.2013.103; Bruner BF, 2012, ARTHRITIS RHEUM-US, V64, P3677, DOI 10.1002/art.34651; Cerovec M, 2012, CROAT MED J, V53, P149, DOI 10.3325/cmj.2012.53.149; Chen TJ, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-54; Cheng SH, 1997, JAMA-J AM MED ASSOC, V278, P89, DOI 10.1001/jama.278.2.89; D'Cruz DP, 2007, LANCET, V369, P587, DOI 10.1016/S0140-6736(07)60279-7; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Ebert EC, 2011, J CLIN GASTROENTEROL, V45, P436, DOI 10.1097/MCG.0b013e31820f81b8; Eriksson C, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3258; Heinlen LD, 2007, ARTHRITIS RHEUM, V56, P2344, DOI 10.1002/art.22665; Heinlen LD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009599; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Jakes RW, 2012, ARTHRIT CARE RES, V64, P159, DOI 10.1002/acr.20683; Jolly M, 2006, ARTHRIT RHEUM-ARTHR, V55, P821, DOI 10.1002/art.22233; Kastanioudakis I, 2002, J LARYNGOL OTOL, V116, P103; Kumar K, 2012, RHEUMATOL INT, V32, P73, DOI 10.1007/s00296-010-1556-5; Lai NS, 2014, ARTHRIT CARE RES, V66, P371, DOI 10.1002/acr.22146; Lin YJ, 2008, CLIN IMMUNOL, V129, P36, DOI 10.1016/j.clim.2008.05.011; Lin YC, 2012, RHEUMATOL INT, V32, P1669, DOI 10.1007/s00296-011-1847-5; Lionaki S, 2013, LUPUS, V22, P95, DOI 10.1177/0961203312467668; LU R, 2012, AUTOIMMUNE DIS, V2012; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Pego-Reigosa JM, 2009, BEST PRACT RES CL RH, V23, P469, DOI 10.1016/j.berh.2009.01.002; McClain MT, 2004, ARTHRITIS RHEUM-US, V50, P1226, DOI 10.1002/art.20120; Organisation for Economic Co-operation and Development, 2011, HLTH GLANC 2011 OECD; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Pons-Estel GJ, 2014, LUPUS, V23, P3, DOI 10.1177/0961203313512883; Pyne D, 2002, ANN RHEUM DIS, V61, P70, DOI 10.1136/ard.61.1.70; Sivaraj RR, 2007, RHEUMATOLOGY, V46, P1757, DOI 10.1093/rheumatology/kem173; Spinillo A, 2012, ANN RHEUM DIS, V71, P918, DOI 10.1136/annrheumdis-2011-154146; Sultan SM, 1999, RHEUMATOLOGY, V38, P917, DOI 10.1093/rheumatology/38.10.917; Torre Olga, 2011, Presse Med, V40, pe19, DOI 10.1016/j.lpm.2010.11.004; VLACHOYIANNOPOULOS PG, 1993, LUPUS, V2, P303, DOI 10.1177/096120339300200505; Wichainun R, 2013, ASIAN PAC J ALLERGY, V31, P292, DOI 10.12932/AP0272.31.4.2013	37	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101485	10.1371/journal.pone.0101485	http://dx.doi.org/10.1371/journal.pone.0101485			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999630	Green Published, Green Submitted, gold			2022-12-27	WOS:000338637300048
J	Miettinen, ME; Kinnunen, L; Leiviska, J; Keinanen-Kiukaanniemi, S; Korpi-Hyovalti, E; Niskanen, L; Oksa, H; Saaristo, T; Tuomilehto, J; Vanhala, M; Uusitupa, M; Peltonen, M				Miettinen, Maija E.; Kinnunen, Leena; Leiviska, Jaana; Keinanen-Kiukaanniemi, Sirkka; Korpi-Hyovalti, Eeva; Niskanen, Leo; Oksa, Heikki; Saaristo, Timo; Tuomilehto, Jaakko; Vanhala, Mauno; Uusitupa, Matti; Peltonen, Markku			Association of Serum 25-Hydroxyvitamin D with Lifestyle Factors and Metabolic and Cardiovascular Disease Markers: Population-Based Cross-Sectional Study (FIN-D2D)	PLOS ONE			English	Article							VITAMIN-D STATUS; APOLIPOPROTEIN-A-I; DIABETES PREVENTION PROGRAM; INTIMA-MEDIA THICKNESS; INSULIN-RESISTANCE; HYPOVITAMINOSIS-D; RISK; MORTALITY; SUPPLEMENTATION; HEALTH	Objectives: Low serum 25-hydroxyvitamin D (25OHD) level has been associated with an increased risk of several chronic diseases. Our aim was to determine lifestyle and clinical factors that are associated with 25OHD level and to investigate connection of 25OHD level with metabolic and cardiovascular disease markers. Design: In total, 2868 Finnish men and women aged 45-74 years participated in FIN-D2D population-based health survey in 2007. Participants that had a serum sample available (98.4%; n = 2822) were included in this study. 25OHD was measured with chemiluminescent microparticle immunoassay method. Results: The mean 25OHD level was 58.2 nmol/l in men (n = 1348) and 57.1 nmol/l in women (n = 1474). Mean 25OHD level was lower in the younger age groups than in the older ones (p<0.0001 both in men and women). This study confirmed that low physical activity (p<0.0001 both in men and women), smoking (p = 0.0002 in men and p = 0.03 in women) and high BMI (p<0.0001 in women) are factors that independently associate with low 25OHD level. Of the metabolic and cardiovascular disease markers high triglyceride concentration (p = 0.02 in men and p = 0.001 in women) and high apolipoprotein B/apolipoprotein A1 ratio (p = 0.04 in men and p = 0.03 in women) were independently associated with low 25OHD level. Conclusions: Higher age did not predict lower 25OHD level in this study population of aged 45-74 years which may derive from a healthy life-style of "active pensioners''. Low physical activity and smoking came up as independent lifestyle factors associated with low 25OHD level. Defining the molecular mechanisms behind the associations of 25OHD with low physical activity and smoking are important objective in future studies. The association of 25OHD with BMI, high triglyceride concentration and apolipoprotein B/apolipoprotein A1 ratio may be related to the role of vitamin D in inflammation, but more detailed studies are needed.	[Miettinen, Maija E.; Kinnunen, Leena; Tuomilehto, Jaakko] Natl Inst Hlth & Welf, Diabet Prevent Unit, Helsinki, Finland; [Leiviska, Jaana] Natl Inst Hlth & Welf, Dis Risk Unit, Helsinki, Finland; [Keinanen-Kiukaanniemi, Sirkka] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Keinanen-Kiukaanniemi, Sirkka] Oulu Univ Hosp, Unit Primary Hlth Care, Oulu, Finland; [Korpi-Hyovalti, Eeva; Tuomilehto, Jaakko] South Ostrobothnia Cent Hosp, Dept Internal Med, Seinajoki, Finland; [Niskanen, Leo] Finnish Med Agcy, Helsinki, Finland; [Niskanen, Leo] Univ Eastern Finland, Fac Hlth Sci, Kuopio, Finland; [Oksa, Heikki] Tampere Univ Hosp, Tampere, Finland; [Saaristo, Timo] Pirkanmaa Hosp Dist, Tampere, Finland; [Saaristo, Timo] Finnish Diabet Assoc, Tampere, Finland; [Tuomilehto, Jaakko] Danube Univ Krems, Ctr Vasc Prevent, Krems, Austria; [Tuomilehto, Jaakko] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia; [Vanhala, Mauno] Cent Finland Cent Hosp, Primary Hlth Care Unit, Jyvaskyla, Finland; [Uusitupa, Matti] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Uusitupa, Matti] Kuopio Univ Hosp, Res Unit, SF-70210 Kuopio, Finland; [Peltonen, Markku] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland	Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; University of Eastern Finland; Tampere University; Tampere University Hospital; Pirkanmaa Hospital District; Danube University Krems; King Abdulaziz University; Central Finland Central Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Finland National Institute for Health & Welfare	Miettinen, ME (corresponding author), Natl Inst Hlth & Welf, Diabet Prevent Unit, Helsinki, Finland.	maija.miettinen@thl.fi	Uusitupa, Matti Ilmari Julius/AAX-4929-2020; Peltonen, Markku/F-3037-2015; Kinnunen, Leena/B-7059-2012	Peltonen, Markku/0000-0002-3767-4223; Kinnunen, Leena/0000-0001-8739-4812; Miettinen, Maija E/0000-0002-5587-7227	Finnish Foundation for Cardiovascular Research	Finnish Foundation for Cardiovascular Research	The study was funded by Finnish Foundation for Cardiovascular Research (www.sydantutkimussaatio.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud M, 2013, ENDOCRINOLOGY, V154, P3022, DOI 10.1210/en.2012-2245; Abboud M, 2014, J STEROID BIOCHEM, V144, P232, DOI 10.1016/j.jsbmb.2013.10.020; Afzal S, 2013, CLIN CHEM, V59, P771, DOI 10.1373/clinchem.2012.201939; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; AUSTIN MA, 1990, CIRCULATION, V82, P495, DOI 10.1161/01.CIR.82.2.495; Baeke F, 2010, CURR OPIN PHARMACOL, V10, P482, DOI 10.1016/j.coph.2010.04.001; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Brock K, 2007, J STEROID BIOCHEM, V103, P786, DOI 10.1016/j.jsbmb.2006.12.048; Brody JS, 2012, INT J CANCER, V131, P2754, DOI 10.1002/ijc.27829; Brot C, 1999, EUR J CLIN NUTR, V53, P920, DOI 10.1038/sj.ejcn.1600870; Chiu KC, 2004, AM J CLIN NUTR, V79, P820; Delvin EE, 2010, J NUTR, V140, P987, DOI 10.3945/jn.109.112250; Foo LH, 2009, OSTEOPOROSIS INT, V20, P417, DOI 10.1007/s00198-008-0667-2; Forouhi NG, 2012, DIABETOLOGIA, V55, P2173, DOI 10.1007/s00125-012-2544-y; Guillot X, 2010, JOINT BONE SPINE, V77, P552, DOI 10.1016/j.jbspin.2010.09.018; Harald K, 2007, J EPIDEMIOL COMMUN H, V61, P449, DOI 10.1136/jech.2006.049908; Hathcock JN, 2007, AM J CLIN NUTR, V85, P6, DOI 10.1093/ajcn/85.1.6; HealthyPeople.gov, 2020, NUTR PHYS ACT; Heaney RP, 2009, J AM COLL NUTR, V28, P252, DOI 10.1080/07315724.2009.10719779; Heikkinen AM, 1997, EUR J ENDOCRINOL, V137, P495, DOI 10.1530/eje.0.1370495; Hiraki, 2013, PLOS MED, V10, P1549; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hurskainen AR, 2012, DIABETES-METAB RES, V28, P418, DOI 10.1002/dmrr.2286; Hypponen E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010801; Hypponen E, 2008, DIABETES, V57, P298, DOI 10.2337/db07-1122; Inderjeeth Charles A, 2007, N Z Med J, V120, pU2730; Jaaskelainen T, 2013, EUR J NUTR, V52, P513, DOI 10.1007/s00394-012-0354-0; John WG, 2005, AM J CLIN NUTR, V82, P517, DOI 10.1093/ajcn/82.3.517; Jones G, 2008, AM J CLIN NUTR, V88, p582S, DOI 10.1093/ajcn/88.2.582S; Jorde R, 2010, J INTERN MED, V267, P462, DOI 10.1111/j.1365-2796.2009.02181.x; Jorde R, 2011, PROG LIPID RES, V50, P303, DOI 10.1016/j.plipres.2011.05.001; Jorde R, 2010, EUR J NUTR, V49, P401, DOI 10.1007/s00394-010-0098-7; Juonala M, 2008, J AM COLL CARDIOL, V52, P293, DOI 10.1016/j.jacc.2008.03.054; Kayaniyil S, 2014, CLIN ENDOCRINOL, V80, P502, DOI 10.1111/cen.12190; Laaksi I, 2007, AM J CLIN NUTR, V86, P714, DOI 10.1093/ajcn/86.3.714; LIEL Y, 1988, CALCIFIED TISSUE INT, V43, P199, DOI 10.1007/BF02555135; Luxwolda MF, 2012, BRIT J NUTR, V108, P1557, DOI 10.1017/S0007114511007161; MACLAUGHLIN J, 1985, J CLIN INVEST, V76, P1536, DOI 10.1172/JCI112134; Mastaglia SR, 2011, J NUTR HEALTH AGING, V15, P349, DOI 10.1007/s12603-010-0287-3; McGill AT, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-4; McQueen MJ, 2008, LANCET, V372, P224, DOI 10.1016/S0140-6736(08)61076-4; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Murad MH, 2011, J CLIN ENDOCR METAB, V96, P2997, DOI 10.1210/jc.2011-1193; O'Shaughnessy PJ, 2011, J CLIN ENDOCR METAB, V96, P2851, DOI 10.1210/jc.2011-1437; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; Pittas AG, 2010, DIABETES CARE, V33, P2021, DOI 10.2337/dc10-0790; Prassl R, 2009, EUR BIOPHYS J BIOPHY, V38, P145, DOI 10.1007/s00249-008-0368-y; Querfeld U, 2013, PEDIATR NEPHROL, V28, P605, DOI 10.1007/s00467-012-2377-4; Raitakari OT, 2013, ATHEROSCLEROSIS, V226, P245, DOI 10.1016/j.atherosclerosis.2012.10.049; Rizzo M, 2009, CLIN ENDOCRINOL, V70, P870, DOI 10.1111/j.1365-2265.2008.03407.x; Romero-Corral A, 2010, EUR HEART J, V31, P737, DOI 10.1093/eurheartj/ehp487; Saaristo T, 2007, INT J CIRCUMPOL HEAL, V66, P101, DOI 10.3402/ijch.v66i2.18239; Saaristo T, 2010, DIABETES CARE, V33, P2146, DOI 10.2337/dc10-0410; Sathe MN, 2010, NUTR CLIN PRACT, V25, P340, DOI 10.1177/0884533610374198; Scanu AM, 2008, FASEB J, V22, P4044, DOI 10.1096/fj.08-117150; Scragg R, 1992, Ann Epidemiol, V2, P697; Sempos CT, 2013, J CLIN ENDOCR METAB, V98, P3001, DOI 10.1210/jc.2013-1333; The National Findiet 2007 Survey, NAT FIND 2007 SURV; UK Department of Health, 1998, NUTR BON HLTH PART R; W.H. Organization, 1999, DEFINITION DIAGNOSIS; Wallenfeldt K, 2004, STROKE, V35, P2248, DOI 10.1161/01.STR.0000140629.65145.3c; Wicherts IS, 2007, J CLIN ENDOCR METAB, V92, P2058, DOI 10.1210/jc.2006-1525; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Zittermann A, 2014, EUR J NUTR, V53, P367, DOI 10.1007/s00394-013-0634-3	65	26	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e100235	10.1371/journal.pone.0100235	http://dx.doi.org/10.1371/journal.pone.0100235			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000408	Green Published, gold, Green Submitted			2022-12-27	WOS:000338637300007
J	Wynne, C; Lazzari, E; Smith, S; McCarthy, EM; Gabhann, JN; Kallal, LE; Higgs, R; Cryan, SA; Biron, CA; Jefferies, CA				Wynne, Claire; Lazzari, Elisa; Smith, Siobhan; McCarthy, Eoghan M.; Gabhann, Joan Ni; Kallal, Lara E.; Higgs, Rowan; Cryan, Sally Ann; Biron, Christine A.; Jefferies, Caroline A.			TRIM68 Negatively Regulates IFN-beta Production by Degrading TRK Fused Gene, a Novel Driver of IFN-beta Downstream of Anti-Viral Detection Systems	PLOS ONE			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTOR; PROSTATE-CANCER; FAMILY PROTEINS; IKK-EPSILON; CROSS-TALK; KINASE; IDENTIFICATION; DEGRADATION; EXPRESSION	In recent years members of the tripartite motif-containing (TRIM) family of E3 ubiquitin ligases have been shown to both positively and negatively regulate viral defence and as such are emerging as compelling targets for modulating the anti-viral immune response. In this study we identify TRIM68, a close homologue of TRIM21, as a novel regulator of Toll-like receptor (TLR)-and RIG-I-like receptor (RLR)-driven type I IFN production. Proteomic analysis of TRIM68-containing complexes identified TRK-fused gene (TFG) as a potential TRIM68 target. Overexpression of TRIM68 and TFG confirmed their ability to associate, with TLR3 stimulation appearing to enhance the interaction. TFG is a known activator of NF-kB via its ability to interact with inhibitor of NF-kB kinase subunit gamma (IKK-gamma) and TRAF family member-associated NF-kB activator (TANK). Our data identifies a novel role for TFG as a positive regulator of type I IFN production and suggests that TRIM68 targets TFG for lysosomal degradation, thus turning off TFG-mediated IFN-beta production. Knockdown of TRIM68 in primary human monocytes resulted in enhanced levels of type I IFN and TFG following poly(I: C) treatment. Thus TRIM68 targets TFG, a novel regulator of IFN production, and in doing so turns off and limits type I IFN production in response to anti-viral detection systems.	[Wynne, Claire; Lazzari, Elisa; Smith, Siobhan; McCarthy, Eoghan M.; Gabhann, Joan Ni; Higgs, Rowan; Jefferies, Caroline A.] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Wynne, Claire] Dublin Inst Technol, Sch Biol Sci, Dublin, Ireland; [Kallal, Lara E.; Biron, Christine A.] Brown Univ, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA; [Cryan, Sally Ann] Royal Coll Surgeons Ireland, Sch Pharm, Dublin 2, Ireland; [Cryan, Sally Ann] Univ Dublin Trinity Coll, Trinity Ctr Bioengn, Dublin 2, Ireland	Royal College of Surgeons - Ireland; Technological University Dublin; Brown University; Royal College of Surgeons - Ireland; Trinity College Dublin	Jefferies, CA (corresponding author), Royal Coll Surgeons Ireland, Dublin 2, Ireland.	cjefferies@rcsi.ie	Lazzari, Elisa/K-7804-2016; Lazzari, Elisa/AAE-6437-2019; Jefferies, Caroline/AAI-1543-2021	Lazzari, Elisa/0000-0001-5299-7525; Jefferies, Caroline/0000-0002-8879-6722; Ni Gabhann-Dromgoole, Joan/0000-0002-4247-3952; Wynne, Claire/0000-0002-0481-8366; Cryan, Sally-Ann/0000-0002-3941-496X	Health Research Board in Ireland [PHD/2007/11]; Science Foundation Ireland [08/IN.1/B2091]; National Institutes of Health [AI055677]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI055677, R01AI055677] Funding Source: NIH RePORTER	Health Research Board in Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Health Research Board in Ireland (grant PHD/2007/11), Science Foundation Ireland (grant 08/IN.1/B2091) and National Institutes of Health (grant AI055677). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSPAUGH MA, 1975, J CLIN INVEST, V55, P1067, DOI 10.1172/JCI108007; BENCHETRIT E, 1988, J EXP MED, V167, P1560, DOI 10.1084/jem.167.5.1560; Billaut-Mulot O, 2001, J CLIN INVEST, V108, P861, DOI 10.1172/JCI13469; Chariot A, 2002, J BIOL CHEM, V277, P37029, DOI 10.1074/jbc.M205069200; CLARK G, 1969, J IMMUNOL, V102, P117; Clark K, 2011, P NATL ACAD SCI USA, V108, P17093, DOI 10.1073/pnas.1114194108; Clark K, 2011, BIOCHEM J, V434, P93, DOI 10.1042/BJ20101701; D'Cruz AA, 2013, PROTEIN SCI, V22, P1, DOI 10.1002/pro.2185; Dutton-Regester K, 2012, GENE CHROMOSOME CANC, V51, P452, DOI 10.1002/gcc.21932; Endoh K, 2012, PROSTATE, V72, P626, DOI 10.1002/pros.21466; Espinosa A, 2009, J EXP MED, V206, P1661, DOI 10.1084/jem.20090585; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Garlanda C, 2004, P NATL ACAD SCI USA, V101, P3522, DOI 10.1073/pnas.0308680101; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Higgs R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011776; Jefferies C, 2011, NAT REV IMMUNOL, V11, P617, DOI 10.1038/nri3043; Kawai T, 2011, EMBO MOL MED, V3, P513, DOI 10.1002/emmm.201100160; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kondo T, 2012, BIOCHEM BIOPH RES CO, V422, P501, DOI 10.1016/j.bbrc.2012.05.028; Kong HJ, 2007, J IMMUNOL, V179, P26, DOI 10.4049/jimmunol.179.1.26; Lee NR, 2013, BIOCHEM BIOPH RES CO, V437, P168, DOI 10.1016/j.bbrc.2013.06.061; Li Q, 2011, P NATL ACAD SCI USA, V108, P19341, DOI 10.1073/pnas.1110946108; Li YW, 2012, EPIGENETICS-US, V7, P940, DOI 10.4161/epi.21236; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MATTIOLI M, 1974, ARTHRITIS RHEUM-US, V17, P421, DOI 10.1002/art.1780170413; McEwan WA, 2013, NAT IMMUNOL, V14, P327, DOI 10.1038/ni.2548; Mcnab FW, 2011, CURR OPIN IMMUNOL, V23, P46, DOI 10.1016/j.coi.2010.10.021; Miranda C, 2006, J CELL PHYSIOL, V208, P154, DOI 10.1002/jcp.20644; Miyajima N, 2008, CANCER RES, V68, P3486, DOI 10.1158/0008-5472.CAN-07-6059; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Noguchi K, 2011, CARCINOGENESIS, V32, P995, DOI 10.1093/carcin/bgr068; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Perez-Caballero D, 2005, J VIROL, V79, P8969, DOI 10.1128/JVI.79.14.8969-8978.2005; Qiu H, 2013, VIROLOGICA SINICA, P1; Rajsbaum R, 2008, EUR J IMMUNOL, V38, P619, DOI 10.1002/eji.200737916; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Shibata M, 2012, BIOCHEM BIOPH RES CO, V423, P104, DOI 10.1016/j.bbrc.2012.05.090; Sjostrand M, 2012, ANN RHEUM DIS, V71, pA81, DOI 10.1136/annrheumdis-2011-201238.21; Sorensen RB, 2009, J INVEST DERMATOL, V129, P1992, DOI 10.1038/jid.2009.10; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Tiseo M, 2011, EXPERT REV ANTICANC, V11, P1677, DOI [10.1586/ERA.11.157, 10.1586/era.11.157]; Tojima Y, 2000, NATURE, V404, P778, DOI 10.1038/35008109; Versteeg GA, 2013, IMMUNITY, V38, P384, DOI 10.1016/j.immuni.2012.11.013; Xiao H, 2010, GASTROENTEROLOGY, V139, P574, DOI 10.1053/j.gastro.2010.04.043; Xue QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046825; Yang B, 2013, J IMMUNOL, V190, P3613, DOI 10.4049/jimmunol.1202507; Yang K, 2009, J IMMUNOL, V182, P3782, DOI 10.4049/jimmunol.0803126; Yu SS, 2011, BIOCHEM BIOPH RES CO, V410, P247, DOI 10.1016/j.bbrc.2011.05.124; Zhang L, 2013, J LIPID RES, V54, P1410, DOI 10.1194/jlr.M035774; Zhang ZQ, 2013, NAT IMMUNOL, V14, P172, DOI 10.1038/ni.2492; Zhao W, 2012, J IMMUNOL, V188, P5311, DOI 10.4049/jimmunol.1103506; Zhao W, 2012, J IMMUNOL, V188, P2567, DOI 10.4049/jimmunol.1103255	55	20	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101503	10.1371/journal.pone.0101503	http://dx.doi.org/10.1371/journal.pone.0101503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999993	Green Submitted, Green Published, gold			2022-12-27	WOS:000338637300051
J	Yi, CH; Zhang, Y; Yu, ZL; Xiao, Y; Wang, JS; Qiu, HJ; Yu, WD; Tang, RR; Yuan, YH; Guo, W; Deng, WG				Yi, Canhui; Zhang, Yong; Yu, Zhenlong; Xiao, Yao; Wang, Jingshu; Qiu, Huijuan; Yu, Wendan; Tang, Ranran; Yuan, Yuhui; Guo, Wei; Deng, Wuguo			Melatonin Enhances the Anti-Tumor Effect of Fisetin by Inhibiting COX-2/iNOS and NF-kappa B/p300 Signaling Pathways	PLOS ONE			English	Article							CYCLOOXYGENASE-2 PROMOTER ACTIVATION; NITRIC-OXIDE SYNTHASE; LIVER-CANCER CELLS; POOR SURVIVAL; UP-REGULATION; SKIN-CANCER; IN-VITRO; MELANOMA; EXPRESSION; FLAVONOIDS	Melatonin is a hormone identified in plants and pineal glands of mammals and possesses diverse physiological functions. Fisetin is a bio-flavonoid widely found in plants and exerts antitumor activity in several types of human cancers. However, the combinational effect of melatonin and fisetin on antitumor activity, especially in melanoma treatment, remains unclear. Here, we tested the hypothesis that melatonin could enhance the antitumor activity of fisetin in melanoma cells and identified the underlying molecular mechanisms. The combinational treatment of melanoma cells with fisetin and melatonin significantly enhanced the inhibitions of cell viability, cell migration and clone formation, and the induction of apoptosis when compared with the treatment of fisetin alone. Moreover, such enhancement of antitumor effect by melatonin was found to be mediated through the modulation of the multiply signaling pathways in melanoma cells. The combinational treatment of fisetin with melatonin increased the cleavage of PARP proteins, triggered more release of cytochrome-c from the mitochondrial inter-membrane, enhanced the inhibition of COX-2 and iNOS expression, repressed the nuclear localization of p300 and NF-kappa B proteins, and abrogated the binding of NF-kappa B on COX-2 promoter. Thus, these results demonstrated that melatonin potentiated the anti-tumor effect of fisetin in melanoma cells by activating cytochrome-c-dependent apoptotic pathway and inhibiting COX-2/iNOS and NF-kappa B/p300 signaling pathways, and our study suggests the potential of such a combinational treatment of natural products in melanoma therapy.	[Yi, Canhui; Yu, Zhenlong; Xiao, Yao; Yu, Wendan; Tang, Ranran; Yuan, Yuhui; Guo, Wei; Deng, Wuguo] Dalian Med Univ, Ctr Canc, Inst Canc Stem Cell, Dalian, Peoples R China; [Wang, Jingshu; Qiu, Huijuan; Deng, Wuguo] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Yong] Guangdong Prov Peoples Hosp 2, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China; [Yi, Canhui; Yu, Zhenlong; Tang, Ranran; Yuan, Yuhui; Guo, Wei; Deng, Wuguo] Dalian Med Univ, Ctr Canc, Affiliated Hosp 1, Dalian, Peoples R China	Dalian Medical University; State Key Lab Oncology South China; Sun Yat Sen University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Dalian Medical University	Guo, W (corresponding author), Dalian Med Univ, Ctr Canc, Inst Canc Stem Cell, Dalian, Peoples R China.	wei1015@msn.com; dengwg@sysucc.org.cn		Yuan, Yuhui/0000-0002-7109-6703	National Natural Science Foundation of China [81301721, 81071687, 81272195]; Education Department of Liaoning Province, China (the "Program for Pan-Deng scholars''; the "Program for Liaoning Excellent Talents in University'')	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Department of Liaoning Province, China (the "Program for Pan-Deng scholars''; the "Program for Liaoning Excellent Talents in University'')	This work was supported by the funds from the National Natural Science Foundation of China (81301721, 81071687, 81272195); the Education Department of Liaoning Province, China (the "Program for Pan-Deng scholars''; the "Program for Liaoning Excellent Talents in University''). Authors who received the funding: Wuguo Deng. URLs of funder's website: http://www.nsfc.gov.cn/; or http://www.lnen.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchini F, 2007, PROSTAG OTH LIPID M, V83, P320, DOI 10.1016/j.prostaglandins.2007.03.003; Carbajo-Pescador S, 2013, BRIT J CANCER, V109, P83, DOI 10.1038/bjc.2013.285; Chou RH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071983; Chwirot BW, 2007, MELANOMA RES, V17, P139, DOI 10.1097/CMR.0b013e3280dec6ac; Deng WG, 2004, BLOOD, V103, P2135, DOI 10.1182/blood-2003-09-3131; Deng WG, 2003, J BIOL CHEM, V278, P4770, DOI 10.1074/jbc.M209286200; Deng WG, 2007, ARTERIOSCL THROM VAS, V27, P1752, DOI 10.1161/ATVBAHA.107.144352; DuBois RN, 1996, GASTROENTEROLOGY, V110, P1259, DOI 10.1053/gast.1996.v110.pm8613017; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Ekmekcioglu S, 2000, CLIN CANCER RES, V6, P4768; Ekmekcioglu S, 2006, INT J CANCER, V119, P861, DOI 10.1002/ijc.21767; Galano A, 2013, J PINEAL RES, V54, P245, DOI 10.1111/jpi.12010; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; Geraets L, 2009, BIOCHEM BIOPH RES CO, V382, P598, DOI 10.1016/j.bbrc.2009.03.071; Goldberg MS, 2007, J AM ACAD DERMATOL, V57, P60, DOI 10.1016/j.jaad.2007.02.010; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Jerant AF, 2000, AM FAM PHYSICIAN, V62, P357; Johansson CC, 2009, CANCER IMMUNOL IMMUN, V58, P1085, DOI 10.1007/s00262-008-0631-1; Jung JH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/879746; Kang SY, 2012, J MICROBIOL, V50, P293, DOI 10.1007/s12275-012-2068-7; Khan N, 2008, CARCINOGENESIS, V29, P1049, DOI 10.1093/carcin/bgn078; Khan N, 2008, ANTIOXID REDOX SIGN, V10, P475, DOI 10.1089/ars.2007.1740; Kundu JK, 2005, MUTAT RES-FUND MOL M, V591, P123, DOI 10.1016/j.mrfmmm.2005.04.019; Lin YJ, 2012, J VIROL METHODS, V182, P93, DOI 10.1016/j.jviromet.2012.03.020; Looi CY, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-166; Massi D, 2001, J PATHOL, V194, P194, DOI 10.1002/1096-9896(200106)194:2<194::AID-PATH851>3.0.CO;2-S; Matsumoto T, 2013, BIOORG MED CHEM LETT, V23, P5178, DOI 10.1016/j.bmcl.2013.07.010; Mercader AG, 2013, ANTI-CANCER AGENT ME, V13, P1217, DOI 10.2174/18715206113139990300; Murakami A, 2013, BIOFACTORS, V39, P221, DOI 10.1002/biof.1054; Ordonez R, 2014, J PINEAL RES, V56, P20, DOI 10.1111/jpi.12092; Pal HC, 2013, EXP DERMATOL, V22, P470, DOI 10.1111/exd.12181; Parisotto EB, 2012, J SUPERCRIT FLUID, V61, P101, DOI 10.1016/j.supflu.2011.08.016; Park HH, 2008, ARCH PHARM RES, V31, P1303, DOI 10.1007/s12272-001-2110-5; Park JH, 2013, NUTR CANCER, V65, P1192, DOI 10.1080/01635581.2013.828090; Qu JG, 2013, ONCOL LETT, V6, P347, DOI 10.3892/ol.2013.1413; Rondanelli M, 2013, AGING CLIN EXP RES, V25, P499, DOI 10.1007/s40520-013-0118-6; Sarkar FH, 2007, ACTA PHARMACOL SIN, V28, P1305, DOI 10.1111/j.1745-7254.2007.00689.x; Shi DB, 2012, J PINEAL RES, V53, P154, DOI 10.1111/j.1600-079X.2012.00982.x; Stratigos A, 2007, J EUR ACAD DERMATOL, V21, P56, DOI 10.1111/j.1468-3083.2006.01865.x; Takeda S, 2008, DRUG METAB DISPOS, V36, P1917, DOI 10.1124/dmd.108.020909; Tarver T, 2012, J CONS HLTH INTERNET, V16, P366, DOI 10.1080/15398285.2012.701177; Wang D, 2006, GUT, V55, P115, DOI 10.1136/gut.2004.047100; Wu KK, 2003, THROMB RES, V110, P273, DOI 10.1016/S0049-3848(03)00412-2; Xiao XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022934; Ying TH, 2012, ARCH TOXICOL, V86, P263, DOI 10.1007/s00204-011-0754-6; Yu SH, 2011, CANCER LETT, V300, P96, DOI 10.1016/j.canlet.2010.09.015; Zandi K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-560	47	60	63	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e99943	10.1371/journal.pone.0099943	http://dx.doi.org/10.1371/journal.pone.0099943			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000190	Green Published, gold			2022-12-27	WOS:000338637300005
J	Chen, ZZ; Gong, X; Lu, Y; Du, SY; Yang, ZH; Bai, J; Li, PY; Wu, HC				Chen, Zhenzhen; Gong, Xin; Lu, Yang; Du, Shouying; Yang, Zhihui; Bai, Jie; Li, Pengyue; Wu, Huichao			Enhancing Effect of Borneol and Muscone on Geniposide Transport across the Human Nasal Epithelial Cell Monolayer	PLOS ONE			English	Article							IN-VITRO; INTRANASAL DELIVERY; MEMBRANE-FLUIDITY; ABSORPTION; CULTURE; ENHANCEMENT; BRAIN; RABBIT; MODEL; MICE	Geniposide is widely used in the treatment of cerebral ischemic stroke and cerebrovascular diseases for its anti-thrombotic and anti-inflammatory effects. Recent studies demonstrated that geniposide could be absorbed promptly and thoroughly by intranasal administration in mice and basically transported into the brain. Here, we explored its transport mechanism and the effect of borneol and muscone on its transport by human nasal epithelial cell (HNEC) monolayer. The cytotoxicity of geniposide, borneol, muscone and their combinations on HNECs was evaluated by the MTT assay. Transcellular transport of geniposide and the influence of borneol and muscone were studied using the HNEC monolayer. Immunostaining and transepithelial electrical resistance were measured to assess the integrity of the monolayer. The membrane fluidity of HNEC was evaluated by fluorescence recovery after photobleaching. Geniposide showed relatively poor absorption in the HNEC monolayer and it was not a P-gp substrate. Geniposide transport in both directions significantly increased when co-administrated with increasing concentrations of borneol and muscone. The enhancing effect of borneol and muscone on geniposide transport across the HNEC may be attributed to the significant enhancement on cell membrane fluidity, disassembly effect on tight junction integrity and the process was reversible. These results indicated that intranasal administration has good potential to treat cerebrovascular diseases.	[Chen, Zhenzhen; Lu, Yang; Du, Shouying; Bai, Jie; Li, Pengyue; Wu, Huichao] Beijing Univ Chinese Med, Sch Chinese Mat Med, Beijing, Peoples R China; [Gong, Xin] Beijing Univ Chinese Med, Dongfang Hosp, Ctr Reprod Endocrinol, Beijing, Peoples R China; [Yang, Zhihui] Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA	Beijing University of Chinese Medicine; Beijing University of Chinese Medicine; State University System of Florida; University of Florida	Du, SY (corresponding author), Beijing Univ Chinese Med, Sch Chinese Mat Med, Beijing, Peoples R China.	dsying607@126.com	Lu, Yang/ABB-8660-2021		National Basic Research Program of China (973 Program) [2012CB724000]; Natural Science Foundation of China [81073057]; Innovation Team Development Program of Beijing University of Chinese Medicine [2011-CXTD-13]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Team Development Program of Beijing University of Chinese Medicine	This work was supported by the National Basic Research Program of China (973 Program, No. 2012CB724000). This research was also supported by the Natural Science Foundation of China (No. 81073057) and Innovation Team Development Program of Beijing University of Chinese Medicine (No. 2011-CXTD-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agu RU, 2002, INT J PHARM, V237, P179, DOI 10.1016/S0378-5173(02)00039-X; Alvarez-Berrios MP, 2013, INT J NANOMED, V8, P1003, DOI 10.2147/IJN.S38842; Cai Z, 2008, J DRUG TARGET, V16, P178, DOI 10.1080/10611860701794395 ; Chen Wen-Kai, 2004, Zhong Xi Yi Jie He Xue Bao, V2, P288; Chen Yan-ming, 2004, Zhongguo Zhong Xi Yi Jie He Za Zhi, V24, P632; Chen ZZ, 2013, INT J PHARMACEUT, V456, P73, DOI 10.1016/j.ijpharm.2013.08.017; Cui Y, 2011, ARCH PHARM RES, V34, P1477, DOI 10.1007/s12272-011-0909-2; Davis SS, 2003, CLIN PHARMACOKINET, V42, P1107, DOI 10.2165/00003088-200342130-00003; Dimova S, 2005, TOXICOL IN VITRO, V19, P107, DOI 10.1016/j.tiv.2004.07.003; Forbes B, 2005, EUR J PHARM BIOPHARM, V60, P193, DOI 10.1016/j.ejpb.2005.02.010; Gabbanini S, 2009, J PHARMACEUT BIOMED, V50, P370, DOI 10.1016/j.jpba.2009.05.018; Ghaffarian R, 2013, JOVE-J VIS EXP, DOI 10.3791/50638; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hanson LR, 2013, JOVE-J VIS EXP, DOI 10.3791/4440; Haratake M, 2013, COLLOID SURFACE B, V107, P90, DOI 10.1016/j.colsurfb.2013.01.070; Illum L, 1996, J DRUG TARGET, V3, P427, DOI 10.3109/10611869609015963; Johnson NJ, 2010, MOL PHARMACEUT, V7, P884, DOI 10.1021/mp100029t; Kadan S, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/549345; Lehrner J, 2005, PHYSIOL BEHAV, V86, P92, DOI 10.1016/j.physbeh.2005.06.031; Li ZJ, 2010, CURR EYE RES, V35, P565, DOI 10.3109/02713681003718091; Lin HX, 2007, J PHARM SCI-US, V96, P341, DOI 10.1002/jps.20803; Lu Y, 2012, INT J MOL SCI, V13, P14127, DOI 10.3390/ijms131114127; Lu Y, 2011, J ZHEJIANG UNIV-SC B, V12, P143, DOI 10.1631/jzus.B1000121; MCMARTIN C, 1987, J PHARM SCI-US, V76, P535, DOI 10.1002/jps.2600760709; Merkle HP, 1998, ADV DRUG DELIV REV, V29, P51; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Pardeshi CV, 2013, EXPERT OPIN DRUG DEL; Paris L, 2008, BBA-BIOMEMBRANES, V1778, P646, DOI 10.1016/j.bbamem.2007.08.004; Portnoy E, 2012, MOL PHARM; Qi HP, 2013, EUR J PHARMACOL, V705, P20, DOI 10.1016/j.ejphar.2013.02.031; Reitz M, 2012, STEM CELL TRANSL MED, V1, P866, DOI 10.5966/sctm.2012-0045; Renner DB, 2012, J PHARM PHARMACOL, V64, P1709, DOI 10.1111/j.2042-7158.2012.01555.x; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ugwoke MI, 2000, INT J PHARM, V205, P43, DOI 10.1016/S0378-5173(00)00484-1; Ugwoke MI, 2001, J PHARM PHARMACOL, V53, P3, DOI 10.1211/0022357011775145; Vadlapudi AD, 2012, INT J PHARMACEUT, V434, P315, DOI 10.1016/j.ijpharm.2012.05.033; van Woensel Matthias, 2013, Cancers (Basel), V5, P1020, DOI 10.3390/cancers5031020; Vilas-Boasa V, 2013, TOXICOL LETT, V220, P259, DOI 10.1016/j.toxlet.2013.05.005; Wang Ning, 2012, Zhong Yao Cai, V35, P1291; WERNER U, 1995, PHARMACEUT RES, V12, P565, DOI 10.1023/A:1016210231121; Wu SY, 2009, ACTA PHARMACOL SIN, V30, P202, DOI 10.1038/aps.2008.17; Yang JP, 2009, NEUROSCI LETT, V449, P108, DOI 10.1016/j.neulet.2008.10.090; Yoo JW, 2003, PHARMACEUT RES, V20, P1690, DOI 10.1023/A:1026112107100; Zhou YQ, 2010, ENVIRON TOXICOL PHAR, V29, P229, DOI 10.1016/j.etap.2010.01.004	44	28	35	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101414	10.1371/journal.pone.0101414	http://dx.doi.org/10.1371/journal.pone.0101414			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992195	gold, Green Published, Green Submitted			2022-12-27	WOS:000341253400068
J	Hogan, DJ; Vincent, TM; Fish, S; Marcusson, EG; Bhat, B; Chau, BN; Zisoulis, DG				Hogan, Daniel J.; Vincent, Thomas M.; Fish, Sarah; Marcusson, Eric G.; Bhat, Balkrishen; Chau, B. Nelson; Zisoulis, Dimitrios G.			Anti-miRs Competitively Inhibit microRNAs in Argonaute Complexes	PLOS ONE			English	Article							IN-VIVO; MESSENGER-RNAS; BIOGENESIS; ROLES; LET-7; SPECIFICITY; MIR-122	MicroRNAs (miRNAs), small RNA molecules that post-transcriptionally regulate mRNA expression, are crucial in diverse developmental and physiological programs and their misregulation can lead to disease. Chemically modified oligonucleotides have been developed to modulate miRNA activity for therapeutic intervention in disease settings, but their mechanism of action has not been fully elucidated. Here we show that the miRNA inhibitors (anti-miRs) physically associate with Argonaute proteins in the context of the cognate target miRNA in vitro and in vivo. The association is mediated by the seed region of the miRNA and is sensitive to the placement of chemical modifications. Furthermore, the targeted miRNAs are stable and continue to be associated with Argonaute. Our results suggest that anti-miRs specifically associate with Argonaute-bound miRNAs, preventing association with target mRNAs, which leads to subsequent stabilization and thus increased expression of the targeted mRNAs.	[Hogan, Daniel J.; Vincent, Thomas M.; Fish, Sarah; Marcusson, Eric G.; Bhat, Balkrishen; Chau, B. Nelson; Zisoulis, Dimitrios G.] Regulus Therapeut, San Diego, CA 92121 USA	Isis Pharmaceuticals Inc	Zisoulis, DG (corresponding author), Regulus Therapeut, San Diego, CA 92121 USA.	nchau@regulusrx.com; dzisoulis@regulusrx.com		Marcusson, Eric/0000-0002-0504-8674	Regulus Therapeutics Inc	Regulus Therapeutics Inc	Funding for these studies was provided by Regulus Therapeutics Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Burnett WV, 1997, BIOTECHNIQUES, V22, P668, DOI 10.2144/97224st01; Chau BN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003205; Crooke ST, 2008, ANTISENSE DRUG TECHN, Vxvii; Davis S, 2006, NUCLEIC ACIDS RES, V34, P2294, DOI 10.1093/nar/gkl183; Davis S, 2009, NUCLEIC ACIDS RES, V37, P70, DOI 10.1093/nar/gkn904; De N, 2013, MOL CELL, V50, P344, DOI 10.1016/j.molcel.2013.04.001; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Esau CC, 2008, METHODS, V44, P55, DOI 10.1016/j.ymeth.2007.11.001; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009; Gebert LFR, 2014, NUCLEIC ACIDS RES, V42, P609, DOI 10.1093/nar/gkt852; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Gurtan AM, 2013, GENE DEV, V27, P941, DOI 10.1101/gad.215376.113; Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Ikeda K, 2006, J IMMUNOL METHODS, V317, P38, DOI 10.1016/j.jim.2006.09.010; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Krutzfeldt J, 2007, NUCLEIC ACIDS RES, V35, P2885, DOI 10.1093/nar/gkm024; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lu TX, 2011, J IMMUNOL, V187, P3362, DOI 10.4049/jimmunol.1101235; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; McKay RA, 1996, NUCLEIC ACIDS RES, V24, P411, DOI 10.1093/nar/24.3.411; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Obad S, 2011, NAT GENET, V43, P371, DOI 10.1038/ng.786; Robertson Barbara, 2010, Silence, V1, P10, DOI 10.1186/1758-907X-1-10; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Smibert P, 2013, NAT STRUCT MOL BIOL, V20, P789, DOI 10.1038/nsmb.2606; Soifer HS, 2007, MOL THER, V15, P2070, DOI 10.1038/sj.mt.6300311; Stenvang Jan, 2012, Silence, V3, P1, DOI 10.1186/1758-907X-3-1; Winter J, 2011, RNA BIOL, V8, P1149, DOI 10.4161/rna.8.6.17665; Yan LX, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2803; Zisoulis DG, 2012, NATURE, V486, P541, DOI 10.1038/nature11134; Zisoulis DG, 2010, NAT STRUCT MOL BIOL, V17, P173, DOI 10.1038/nsmb.1745	43	33	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100951	10.1371/journal.pone.0100951	http://dx.doi.org/10.1371/journal.pone.0100951			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992387	Green Published, Green Submitted, gold			2022-12-27	WOS:000341253400037
J	Liaw, N; Fox, JMD; Siddiqui, AH; Meng, H; Kolega, J				Liaw, Nicholas; Fox, Jennifer M. Dolan; Siddiqui, Adnan H.; Meng, Hui; Kolega, John			Endothelial Nitric Oxide Synthase and Superoxide Mediate Hemodynamic Initiation of Intracranial Aneurysms	PLOS ONE			English	Article							INDUCED ARTERIAL ENLARGEMENT; INTERNAL CAROTID-ARTERY; BASILAR TERMINUS; MATRIX METALLOPROTEINASES; RESISTANCE ARTERIES; CEREBRAL ANEURYSMS; CELL PROLIFERATION; RABBIT MODEL; HIGH-FLOW; IN-VIVO	Background: Hemodynamic insults at arterial bifurcations are believed to play a critical role in initiating intracranial aneurysms. Recent studies in a rabbit model indicate that aneurysmal damage initiates under specific wall shear stress conditions when smooth muscle cells (SMCs) become pro-inflammatory and produce matrix metalloproteinases (MMPs). The mechanisms leading to SMC activation and MMP production during hemodynamic aneurysm initiation are unknown. The goal is to determine if nitric oxide and/or superoxide induce SMC changes, MMP production and aneurysmal remodeling following hemodynamic insult. Methods: Bilateral common carotid artery ligation was performed on rabbits (n = 19, plus 5 sham operations) to induce aneurysmal damage at the basilar terminus. Ligated animals were treated with the nitric oxide synthase (NOS) inhibitor LNAME (n = 7) or the superoxide scavenger TEMPOL (n = 5) and compared to untreated animals (n = 7). Aneurysm development was assessed histologically 5 days after ligation. Changes in NOS isoforms, peroxynitrite, reactive oxygen species (ROS), MMP-2, MMP-9, and smooth muscle a-actin were analyzed by immunohistochemistry. Results: LNAME attenuated ligation-induced IEL loss, media thinning and bulge formation. In untreated animals, immunofluorescence showed increased endothelial NOS (eNOS) after ligation, but no change in inducible or neuronal NOS. Furthermore, during aneurysm initiation ROS increased in the media, but not the intima, and there was no change in peroxynitrite. In LNAME-treated animals, ROS production did not change. Together, this suggests that eNOS is important for aneurysm initiation but not by producing superoxide. TEMPOL treatment reduced aneurysm development, indicating that the increased medial superoxide is also necessary for aneurysm initiation. LNAME and TEMPOL treatment in ligated animals restored a-actin and decreased MMPs, suggesting that eNOS and superoxide both lead to SMC de-differentiation and MMP production. Conclusion: Aneurysm-inducing hemodynamics lead to increased eNOS and superoxide, which both affect SMC phenotype, increasing MMP production and aneurysmal damage.	[Liaw, Nicholas; Fox, Jennifer M. Dolan; Siddiqui, Adnan H.; Meng, Hui] SUNY Buffalo, Toshiba Stroke & Vasc Res Ctr, Buffalo, NY 14260 USA; [Liaw, Nicholas] SUNY Buffalo, Dept Mech & Aerosp Engn, Buffalo, NY 14260 USA; [Fox, Jennifer M. Dolan; Siddiqui, Adnan H.] SUNY Buffalo, Dept Neurosurg, Buffalo, NY 14260 USA; [Siddiqui, Adnan H.] SUNY Buffalo, Dept Radiol, Buffalo, NY 14260 USA; [Kolega, John] SUNY Buffalo, Dept Mech & Aerosp Engn, Dept Neurosurg, Buffalo, NY 14260 USA; [Meng, Hui] SUNY Buffalo, Dept Biomed Engn, Buffalo, NY 14260 USA; [Kolega, John] SUNY Buffalo, Dept Pathol & Anat Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Kolega, J (corresponding author), SUNY Buffalo, Toshiba Stroke & Vasc Res Ctr, Buffalo, NY 14260 USA.	kolega@buffalo.edu	Kolega, John/J-8386-2016; Meng, Hui/F-7929-2010; Siddiqui, Adnan H./AAG-9781-2019	Kolega, John/0000-0001-6933-8681; 	National Institute of Neurological Disorders and Stroke [R01NS064592]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064592] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Neurological Disorders and Stroke Grant R01NS064592 (H. Meng), http://www.ninds.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki T, 2007, STROKE, V38, P162, DOI 10.1161/01.STR.0000252129.18605.c8; Aoki T, 2011, LAB INVEST, V91, P619, DOI 10.1038/labinvest.2010.204; Aoki T, 2009, LAB INVEST, V89, P730, DOI 10.1038/labinvest.2009.36; Aoki T, 2009, STROKE, V40, P942, DOI 10.1161/STROKEAHA.108.532556; Briganti F, 2002, NEURORADIOLOGY, V44, P604, DOI 10.1007/s00234-001-0732-4; Buus CL, 2001, CIRC RES, V89, P180, DOI 10.1161/hh1401.093575; Castier Y, 2005, CIRC RES, V97, P533, DOI 10.1161/01.RES.0000181759.63239.21; Dolan JM, 2013, ANN BIOMED ENG, V41, P1411, DOI 10.1007/s10439-012-0695-0; Dumont O, 2007, ARTERIOSCL THROM VAS, V27, P317, DOI 10.1161/01.ATV.0000254684.80662.44; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; FUJIWARA S, 1993, ACTA NEUROCHIR, V120, P20, DOI 10.1007/BF02001464; Fukai T, 2002, CARDIOVASC RES, V55, P239, DOI 10.1016/S0008-6363(02)00328-0; Fukuda S, 2000, CIRCULATION, V101, P2532, DOI 10.1161/01.CIR.101.21.2532; Gao L, 2008, STROKE, V39, P2085, DOI 10.1161/STROKEAHA.107.509422; Gomez D, 2012, CARDIOVASC RES, V95, P156, DOI 10.1093/cvr/cvs115; Gurjar MV, 2001, J APPL PHYSIOL, V91, P1380, DOI 10.1152/jappl.2001.91.3.1380; Guzman RJ, 1997, SURGERY, V122, P273, DOI 10.1016/S0039-6060(97)90018-0; Hashimoto T, 2006, NEUROL RES, V28, P372, DOI 10.1179/016164106X14973; Hoi YM, 2008, J NEUROSURG, V109, P1141, DOI 10.3171/JNS.2008.109.12.1141; JONES GT, 1994, INT J EXP PATHOL, V75, P225; Kolega J, 2011, J VASC RES, V48, P429, DOI 10.1159/000324840; Lee MY, 2008, ANTIOXID REDOX SIGN, V10, P1045, DOI 10.1089/ars.2007.1986; Mandelbaum M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074357; McAdam E, 2012, CARCINOGENESIS, V33, P2035, DOI 10.1093/carcin/bgs241; Melikian N, 2009, TRENDS CARDIOVAS MED, V19, P256, DOI 10.1016/j.tcm.2010.02.007; Meng H., 2012, INT REV THROMB, V7, P40; Meng H, 2011, J NEUROSURG, V114, P1095, DOI 10.3171/2010.9.JNS10368; Metaxa E, 2008, AM J PHYSIOL-HEART C, V295, pH736, DOI 10.1152/ajpheart.01156.2007; Metaxa E, 2010, STROKE, V41, P1774, DOI 10.1161/STROKEAHA.110.585992; Montezano AC, 2012, CAN J CARDIOL, V28, P288, DOI 10.1016/j.cjca.2012.01.017; Nelson KK, 2004, FREE RADICAL BIO MED, V37, P768, DOI 10.1016/j.freeradbiomed.2004.06.008; Nuki Y, 2009, J CEREBR BLOOD F MET, V29, P495, DOI 10.1038/jcbfm.2008.136; Orr AW, 2010, J VASC RES, V47, P168, DOI 10.1159/000250095; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; SCHIFFRIN EL, 1992, HYPERTENSION, V19, P1; Sho E, 2003, EXP MOL PATHOL, V75, P1, DOI 10.1016/S0014-4800(03)00032-7; STEHBENS WE, 1989, J NEUROSURG, V70, P823, DOI 10.3171/jns.1989.70.6.0823; Sung HJ, 2005, ANN BIOMED ENG, V33, P1546, DOI 10.1007/s10439-005-7545-2; Suzuki MTM, 2011, NEUROCIRUGIA, V22, P251; TIMPERMAN PE, 1995, AM J NEURORADIOL, V16, P329; Tronc F, 2000, ARTERIOSCL THROM VAS, V20, pE120, DOI 10.1161/01.ATV.20.12.e120; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Wang SW, 1999, ANN CLIN LAB SCI, V29, P192; West NEJ, 2001, ARTERIOSCL THROM VAS, V21, P189, DOI 10.1161/01.ATV.21.2.189; Wolf RL, 2002, NEURORADIOLOGY, V44, P443, DOI 10.1007/s00234-001-0723-5	45	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101721	10.1371/journal.pone.0101721	http://dx.doi.org/10.1371/journal.pone.0101721			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992254	Green Published, gold, Green Submitted			2022-12-27	WOS:000341253400108
J	Licona-Vera, Y; Ornelas, JF				Licona-Vera, Yuyini; Francisco Ornelas, Juan			Genetic, Ecological and Morphological Divergence between Populations of the Endangered Mexican Sheartail Hummingbird (Doricha eliza)	PLOS ONE			English	Article							HAPLOTYPE RECONSTRUCTION; PHYLOGENETIC ANALYSIS; MAXIMUM-LIKELIHOOD; STATISTICAL-METHOD; SPECIES TREES; DIVERSIFICATION; PHYLOGEOGRAPHY; SIMULATIONS; INFERENCE; RATES	The Mexican Sheartail (Doricha eliza), an endangered hummingbird, is endemic to Mexico where two populations have a disjunct distribution. One population is distributed along the northern tip of the Yucatan Peninsula whereas the other is mostly restricted to central Veracruz. Despite their disjunct distribution, previous work has failed to detect morphological or behavioral differences between these populations. Here we use variation in morphology, mtDNA and nuDNA sequences to determine the degree of morphological and molecular divergence between populations, their divergence time, and historical demography. We use species distribution modeling and niche divergence tests to infer the relative roles of vicariance and dispersal in driving divergence in the genus. Our Bayesian and maximum likelihood phylogenetic analyses revealed that Doricha eliza populations form a monophyletic clade and support their sister relationship with D. enicura. We found marked genetic differentiation, with reciprocal monophyly of haplotypes and highly restricted gene flow, supporting a history of isolation over the last 120,000 years. Genetic divergence between populations is consistent with the lack of overlap in environmental space and slight morphological differences between males. Our findings indicate that the divergence of the Veracruz and Yucatan populations is best explained by a combination of a short period of isolation exacerbated by subsequent divergence in climate conditions, and that rather than vicariance, the two isolated ranges of D. eliza are the product of recent colonization and divergence in isolation.	[Licona-Vera, Yuyini; Francisco Ornelas, Juan] Inst Ecol, AC, Dept Biol, Xalapa, Veracruz, Mexico	Instituto de Ecologia - Mexico	Ornelas, JF (corresponding author), Inst Ecol, AC, Dept Biol, Xalapa, Veracruz, Mexico.	francisco.ornelas@inecol.mx	Ornelas, Juan Francisco/A-2250-2014	Ornelas, Juan Francisco/0000-0002-1124-1163; Licona-Vera, Yuyini/0000-0001-6616-361X	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [61710, 155686]; INECOL [20030/10563]; Master of Science scholarship [262561]	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); INECOL; Master of Science scholarship	This project was funded by competitive grants (grant numbers 61710 and 155686) from Consejo Nacional de Ciencia y Tecnologia (CONACyT, http://www.conacyt.mx) and research funds from INECOL (20030/10563) awarded to Juan Francisco Ornelas. Yuyini Licona-Vera was supported by a Master of Science scholarship (no. 262561). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro ME, 2006, SYST BIOL, V55, P89, DOI 10.1080/10635150500433565; Arbelaez-Cortes E, 2013, ZOOTAXA, V3716, P81; Backstroem N, 2008, MOL ECOL, V17, P964, DOI 10.1111/j.1365-294X.2007.03551.x; Berns CM, 2013, EVOL BIOL, V40, P246, DOI 10.1007/s11692-012-9206-3; Bleiweiss R, 1998, BIOL J LINN SOC, V65, P77, DOI 10.1111/j.1095-8312.1998.tb00352.x; Braconnot P, 2007, CLIM PAST, V3, P279, DOI 10.5194/cp-3-279-2007; Calder William A., 1992, Birds of North America, V16, P1; Chaves JA, 2007, MOL PHYLOGENET EVOL, V43, P795, DOI 10.1016/j.ympev.2006.11.006; Clark CJ, 2013, CONDOR, V115, P558, DOI 10.1525/cond.2013.120047; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; des Granges J.-L., 1979, Living Bird, V17, P199; Diaz-Valenzuela R, 2011, CONDOR, V113, P177, DOI 10.1525/cond.2011.090225; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eberhard JR, 2004, AUK, V121, P318, DOI 10.1642/0004-8038(2004)121[0318:PABOTA]2.0.CO;2; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ornelas JF, 2014, J BIOGEOGR, V41, P168, DOI 10.1111/jbi.12184; Fu YX, 1997, GENETICS, V147, P915; Gonzalez C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-38; Hammer O, 2022, SOFTWARE NATURAL HIS; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hasumi H, 2004, 1 CLIM SYST RES; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Ho SYW, 2011, MOL ECOL RESOUR, V11, P423, DOI 10.1111/j.1755-0998.2011.02988.x; Hosner PA, 2013, J BIOGEOGR, V40, P1094, DOI 10.1111/jbi.12074; Howell S. N. G., 1995, GUIDE BIRDS MEXICO N; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; IUCN, 2013, IUCN RED LIST THREAT; Lande R., 2003, OXFORD SERIES ECOLOG; Lees AC, 2014, GLOBAL ECOL BIOGEOGR, V23, P405, DOI 10.1111/geb.12129; Lemmon AR, 2009, SYST BIOL, V58, P130, DOI 10.1093/sysbio/syp017; Lerner HRL, 2011, CURR BIOL, V21, P1838, DOI 10.1016/j.cub.2011.09.039; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Malpica A, 2014, MOL ECOL, V23, P435, DOI 10.1111/mec.12614; Marino IAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028567; McCormack JE, 2010, EVOLUTION, V64, P1231, DOI 10.1111/j.1558-5646.2009.00900.x; McGuire JA, 2007, SYST BIOL, V56, P837, DOI 10.1080/10635150701656360; McGuire JA, 2014, CURR BIOL, V24, P910, DOI 10.1016/j.cub.2014.03.016; McGuire JA, 2009, J ORNITHOL, V150, P155, DOI 10.1007/s10336-008-0330-x; Mertz CE, 1978, SEMIN NUCL MED, V8, P283, DOI [10.1016/0S0001-2998(78)80014-2, DOI 10.1016/0S0001-2998(78)80014-2.]; Miller M.A., 2010, P GAT COMP ENV WORKS; Miller MJ, 2011, CONDOR, V113, P806, DOI 10.1525/cond.2011.100226; Navarro AG, 2003, B BRIT ORNITHOLO A S, V123A; Nei M., 1987, MOL EVOLUTIONARY GEN; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Ornelas J. F., 1995, MISCELLANEOUS PUBLIC, V727, P98; Ornelas JF, 2014, LIBRO ROJO FAUNA EST, P148; Ortiz-Pulido R, 2002, WILSON BULL, V114, P153, DOI 10.1676/0043-5643(2002)114[0153:TMSDEM]2.0.CO;2; Ortiz-Pulido Raul, 1998, Ornitologia Neotropical, V9, P223; Otto-Bliesner BL, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029475; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Pacheco MA, 2011, MOL BIOL EVOL, V28, P1927, DOI 10.1093/molbev/msr014; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ridgway R, 1911, B US NAT MUS, V50, P650; Rodriguez-Gomez F, 2014, J ZOOL SYST EVOL RES, V52, P142, DOI 10.1111/jzs.12047; Rodriguez-Gomez F, 2013, J BIOGEOGR, V40, P1360, DOI 10.1111/jbi.12093; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruiz-Gutierrez V, 2012, AUK, V129, P500, DOI 10.1525/auk.2012.11171; Santamaría-Rivero Waldemar, 2013, Huitzil, V14, P139; Schneider S, 1999, GENETICS, V152, P1079; Schuchmann K.-L., 1999, HDB BIRDS WORLD, P468; Scott PE, 1994, BIRDS N AM; SLATKIN M, 1991, GENETICS, V129, P555; Smith BT, 2010, ECOGRAPHY, V33, P333, DOI 10.1111/j.1600-0587.2009.06335.x; Sorenson MD, 1999, MOL PHYLOGENET EVOL, V12, P105, DOI 10.1006/mpev.1998.0602; Spellman GM, 2006, P ROY SOC B-BIOL SCI, V273, P3057, DOI 10.1098/rspb.2006.3682; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Storchova R, 2010, EVOLUTION, V64, P456, DOI 10.1111/j.1558-5646.2009.00841.x; TAJIMA F, 1989, GENETICS, V123, P585; Voelker G, 2013, MOL ECOL, V22, P3333, DOI 10.1111/mec.12305; Wiens JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042925; Wiens JJ, 2011, SYST BIOL, V60, P719, DOI 10.1093/sysbio/syr025; Woerner AE, 2007, BIOINFORMATICS, V23, P1851, DOI 10.1093/bioinformatics/btm253	88	14	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101870	10.1371/journal.pone.0101870	http://dx.doi.org/10.1371/journal.pone.0101870			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992589	gold, Green Published, Green Submitted			2022-12-27	WOS:000341253400127
J	Swanson, D; Zhang, YF; King, M				Swanson, David; Zhang, Yufeng; King, Marisa			Mechanistic Drivers of Flexibility in Summit Metabolic Rates of Small Birds	PLOS ONE			English	Article							SEASONAL PHENOTYPIC FLEXIBILITY; AEROBIC PERFORMANCE VARIATION; CATABOLIC ENZYME-ACTIVITIES; FLIGHT-MUSCLE SIZE; IN-HOUSE FINCHES; BODY-COMPOSITION; THERMOGENIC CAPACITY; OXYGEN-CONSUMPTION; ORGAN MASSES; INDIVIDUAL VARIATION	Flexible metabolic phenotypes allow animals to adjust physiology to better fit ecological or environmental demands, thereby influencing fitness. Summit metabolic rate (M-sum = maximal thermogenic capacity) is one such flexible trait. Skeletal muscle and heart masses and myocyte metabolic intensity are potential drivers of M-sum flexibility in birds. We examined correlations of skeletal muscle and heart masses and pectoralis muscle citrate synthase (CS) activity (an indicator of cellular metabolic intensity) with M-sum in house sparrows (Passer domesticus) and dark-eyed juncos (Junco hyemalis) to determine whether these traits are associated with M-sum variation. Pectoralis mass was positively correlated with M-sum for both species, but no significant correlation remained for either species after accounting for body mass (M-b) variation. Combined flight and leg muscle masses were also not significantly correlated with M-sum for either species. In contrast, heart mass was significantly positively correlated with M-sum for juncos and nearly so (P = 0.054) for sparrows. Mass-specific and total pectoralis CS activities were significantly positively correlated with M-sum for sparrows, but not for juncos. Thus, myocyte metabolic intensity influences M-sum variation in house sparrows, although the stronger correlation of total (r = 0.495) than mass-specific (r = 0.378) CS activity with M-sum suggests that both pectoralis mass and metabolic intensity impact M-sum. In contrast, neither skeletal muscle masses nor pectoralis metabolic intensity varied with M-sum in juncos. However, heart mass was associated with M-sum variation in both species. These data suggest that drivers of metabolic flexibility are not uniform among bird species.	[Swanson, David; Zhang, Yufeng; King, Marisa] Univ S Dakota, Dept Biol, Vermillion, SD 57069 USA	University of South Dakota	Swanson, D (corresponding author), Univ S Dakota, Dept Biol, Vermillion, SD 57069 USA.	david.swanson@usd.edu	Zhang, Yufeng/GZL-1973-2022		U.S. National Science Foundation [IOS-1021218]	U.S. National Science Foundation(National Science Foundation (NSF))	U.S. National Science Foundation (http://www.nsf.gov/dir/index.jsp?org = BIO), grant number IOS-1021218, to DS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arens JR, 2005, PHYSIOL BIOCHEM ZOOL, V78, P579, DOI 10.1086/430235; BARTHOLOMEW GA, 1981, J EXP BIOL, V90, P17; Battley PF, 2001, PHYSIOL BIOCHEM ZOOL, V74, P435, DOI 10.1086/320432; Box J, 2010, AVIAN BIOL RES, V3, P107, DOI 10.3184/175815510X12823045556835; Burness GP, 1998, PHYSIOL ZOOL, V71, P247, DOI 10.1086/515917; Buttemer William A., 2010, Australian Zoologist, V35, P378; Carey C., 1989, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, V173, P95; CAREY C, 1978, J COMP PHYSIOL, V125, P101, DOI 10.1007/BF00686746; Chappell MA, 1999, J EXP BIOL, V202, P2269; Christians JK, 1999, PHYSIOL BIOCHEM ZOOL, V72, P250, DOI 10.1086/316661; Clavijo-Baquet S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037069; COOPER SJ, 1994, CONDOR, V96, P638, DOI 10.2307/1369467; Cooper SJ, 2002, PHYSIOL BIOCHEM ZOOL, V75, P386, DOI 10.1086/342256; DAWSON WR, 1976, J COMP PHYSIOL, V112, P317, DOI 10.1007/BF00692302; DRIEDZIC WR, 1993, CAN J ZOOL, V71, P1602, DOI 10.1139/z93-226; Guglielmo CG, 2003, PHYSIOL BIOCHEM ZOOL, V76, P84, DOI 10.1086/367942; Hammond KA, 2000, J EXP BIOL, V203, P2053; Hayes JP, 1999, EVOLUTION, V53, P1280, DOI 10.1111/j.1558-5646.1999.tb04540.x; Holloway JC, 2001, PHYSIOL BIOCHEM ZOOL, V74, P219, DOI 10.1086/319666; King MO, 2012, INTEGR COMP BIOL, V52, pE276; Landys-Ciannelli MM, 2003, FUNCT ECOL, V17, P151, DOI 10.1046/j.1365-2435.2003.00715.x; Liknes ET, 2011, J THERM BIOL, V36, P430, DOI 10.1016/j.jtherbio.2011.07.011; Liknes ET, 2011, J THERM BIOL, V36, P363, DOI 10.1016/j.jtherbio.2011.06.010; Liknes ET, 2002, CONDOR, V104, P548, DOI 10.1650/0010-5422(2002)104[0548:SAITAG]2.0.CO;2; Lill A, 2006, AUST J ZOOL, V54, P23, DOI 10.1071/ZO05029; Liu Jin-Song, 2006, Acta Zoologica Sinica, V52, P469; Maillet D, 2007, J EXP BIOL, V210, P413, DOI 10.1242/jeb.02660; Marsh R L., 1989, ADV COMP ENV PHYSL, V4, P206; MARSH RL, 1981, J COMP PHYSIOL, V141, P417, DOI 10.1007/BF01101461; McFarlan JT, 2009, J EXP BIOL, V212, P2934, DOI 10.1242/jeb.031682; McKechnie AE, 2008, J COMP PHYSIOL B, V178, P235, DOI 10.1007/s00360-007-0218-8; Mckechnie AE, 2010, CURR ZOOL, V56, P741, DOI 10.1093/czoolo/56.6.741; OCONNOR TP, 1995, J COMP PHYSIOL B, V165, P298, DOI 10.1007/BF00367313; OCONNOR TP, 1995, PHYSIOL ZOOL, V68, P985, DOI 10.1086/physzool.68.6.30163790; Oring, 2010, GUIDELINES USE WILD; Pena-Villalobos I, 2014, CURR ZOOL IN PRESS, V60; Petit M, 2014, PHYSL BIOCH IN PRESS, V87; Petit M, 2014, J EXP BIOL, V217, P824, DOI 10.1242/jeb.095703; Petit M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068292; Piersma T, 1999, PHYSIOL BIOCHEM ZOOL, V72, P405, DOI 10.1086/316680; Piersma T, 1998, J AVIAN BIOL, V29, P511, DOI 10.2307/3677170; Piersma T, 2003, TRENDS ECOL EVOL, V18, P228, DOI 10.1016/S0169-5347(03)00036-3; Piersma T., 2011, FLEXIBLE PHENOTYPE B; ROSENMANN M, 1974, AM J PHYSIOL, V226, P490, DOI 10.1152/ajplegacy.1974.226.3.490; Sears MW, 2006, FUNCT ECOL, V20, P97, DOI 10.1111/j.1365-2435.2006.01067.x; Sgueo C, 2012, J EXP BIOL, V215, P2418, DOI 10.1242/jeb.061168; Swanson D, 2014, J EXP BIOL, V217, P866, DOI 10.1242/jeb.096677; Swanson DL, 2014, J COMP PHYSIOL B, V184, P249, DOI 10.1007/s00360-013-0798-4; Swanson DL, 2013, PHYSIOL BIOCHEM ZOOL, V86, P421, DOI 10.1086/671447; Swanson DL, 2013, J ORNITHOL, V154, P119, DOI 10.1007/s10336-012-0877-4; Swanson DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034271; Swanson DL, 2011, PHYSIOL BIOCHEM ZOOL, V84, P185, DOI 10.1086/658291; Swanson DL, 2010, CURR ORNITHOL, V17, P75, DOI 10.1007/978-1-4419-6421-2_3; Swanson DL, 2009, EVOLUTION, V63, P184, DOI 10.1111/j.1558-5646.2008.00522.x; SWANSON DL, 1990, AUK, V107, P561; Swanson DL, 2006, J EXP BIOL, V209, P466, DOI 10.1242/jeb.02024; Swanson DL, 1999, J AVIAN BIOL, V30, P245, DOI 10.2307/3677350; Swanson DL, 1995, AUK, V112, P870, DOI 10.2307/4089019; SWANSON DL, 1991, PHYSIOL ZOOL, V64, P1578, DOI 10.1086/physzool.64.6.30158232; Swanson DL, 1996, J THERM BIOL, V21, P221, DOI 10.1016/0306-4565(96)00005-8; Swanson DL, 2001, J COMP PHYSIOL B, V171, P475, DOI 10.1007/s003600100197; van de Ven TMFN, 2013, PHYSIOL BIOCHEM ZOOL, V86, P19, DOI 10.1086/667989; Vezina F, 2003, PHYSIOL BIOCHEM ZOOL, V76, P716, DOI 10.1086/376425; Vezina F, 2007, AM J PHYSIOL-REG I, V292, pR1287, DOI 10.1152/ajpregu.00683.2006; Vezina F, 2006, J EXP BIOL, V209, P3141, DOI 10.1242/jeb.02338; Weber TP, 1996, J AVIAN BIOL, V27, P215, DOI 10.2307/3677225; Wells ME, 2012, J AVIAN BIOL, V43, P481, DOI 10.1111/j.1600-048X.2012.05709.x; Wiersma P, 2007, P NATL ACAD SCI USA, V104, P20866, DOI 10.1073/pnas.0707683104; Zheng WH, 2014, PHYSIOL BIOCHEM ZOOL, V87, P432, DOI 10.1086/675439; Zheng WH, 2008, COMP BIOCHEM PHYS A, V151, P519, DOI 10.1016/j.cbpa.2008.07.009	70	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101577	10.1371/journal.pone.0101577	http://dx.doi.org/10.1371/journal.pone.0101577			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992186	gold, Green Published, Green Submitted			2022-12-27	WOS:000341253400092
J	Rossi, E; Radi, O; De Lorenzi, L; Vetro, A; Groppetti, D; Bigliardi, E; Luvoni, GC; Rota, A; Camerino, G; Zuffardi, O; Parma, P				Rossi, Elena; Radi, Orietta; De Lorenzi, Lisa; Vetro, Annalisa; Groppetti, Debora; Bigliardi, Enrico; Luvoni, Gaia Cecilia; Rota, Ada; Camerino, Giovanna; Zuffardi, Orsetta; Parma, Pietro			Sox9 Duplications Are a Relevant Cause of Sry-Negative XX Sex Reversal Dogs	PLOS ONE			English	Article							TESTIS DEVELOPMENT; REGION UPSTREAM; GENE; DIFFERENTIATION; GENOME; EXPRESSION; MUTATIONS; ENHANCER; MAMMALS; PROTEIN	Sexual development in mammals is based on a complicated and delicate network of genes and hormones that have to collaborate in a precise manner. The dark side of this pathway is represented by pathological conditions, wherein sexual development does not occur properly either in the XX and the XY background. Among them a conundrum is represented by the XX individuals with at least a partial testis differentiation even in absence of SRY. This particular condition is present in various mammals including the dog. Seven dogs characterized by XX karyotype, absence of SRY gene, and testicular tissue development were analysed by Array-CGH. In two cases the array-CGH analysis detected an interstitial heterozygous duplication of chromosome 9. The duplication contained the SOX9 coding region. In this work we provide for the first time a causative mutation for the XXSR condition in the dog. Moreover this report supports the idea that the dog represents a good animal model for the study of XXSR condition caused by abnormalities in the SOX9 locus.	[Rossi, Elena; Radi, Orietta; Camerino, Giovanna; Zuffardi, Orsetta] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy; [De Lorenzi, Lisa; Parma, Pietro] Univ Milan, Dept Agr & Environm Sci, Milan, Italy; [Vetro, Annalisa] Fdn IRCCS Policlin San Matteo, Biotechnol Res Labs, Pavia, Italy; [Groppetti, Debora] Univ Milan, Dept Vet Sci & Publ Hlth, Milan, Italy; [Bigliardi, Enrico] Univ Parma, Dept Vet Sci, I-43100 Parma, Italy; [Luvoni, Gaia Cecilia] Univ Milan, Dept Hlth Anim Sci & Food Safety, Milan, Italy; [Rota, Ada] Univ Turin, Dept Vet Sci, Turin, Italy	University of Pavia; University of Milan; IRCCS Fondazione San Matteo; University of Milan; University of Parma; University of Milan; University of Turin	Parma, P (corresponding author), Univ Milan, Dept Agr & Environm Sci, Milan, Italy.	pietro.parma@unimi.it	Groppetti, Debora/U-3648-2019; Vetro, Annalisa/J-8203-2018; Groppetti, Debora/K-5939-2017; Luvoni, Gaia Cecilia/M-4339-2019; Rossi, Elena/O-1664-2016	Vetro, Annalisa/0000-0003-2437-7526; Groppetti, Debora/0000-0003-0566-1580; Luvoni, Gaia Cecilia/0000-0002-9598-9098; Rossi, Elena/0000-0001-9152-435X; bigliardi, enrico/0000-0001-7969-1518; zuffardi, orsetta/0000-0002-1466-4559; Rota, Ada/0000-0002-4765-9764; Parma, Pietro/0000-0003-1544-6673				Bannasch D, 2007, VET J, V173, P437, DOI 10.1016/j.tvjl.2005.11.008; Benko S, 2011, J MED GENET, V48, P825, DOI 10.1136/jmedgenet-2011-100255; Berglund J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r73; Bigliardi E, REPROD BIOL ENDOCRIN, V9, P12; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; Chassot AA, 2008, SEX DEV, V2, P219, DOI 10.1159/000152038; Chen WK, 2009, GENOME RES, V19, P500, DOI 10.1101/gr.083741.108; Chen YS, 2013, P NATL ACAD SCI USA, V110, pE3567, DOI 10.1073/pnas.1300828110; Cox JJ, 2011, NEW ENGL J MED, V364, P91, DOI 10.1056/NEJMc1010311; daSilva SM, 1996, NAT GENET, V14, P62, DOI 10.1038/ng0996-62; De Lorenzi L, 2008, SEX DEV, V2, P84, DOI 10.1159/000129693; De Lorenzi L, 2010, CYTOGENET GENOME RES, V129, P298, DOI 10.1159/000315891; DEGROUCHY J, 1964, ANN GENET-PARIS, V7, pG45; Fonseca ACS, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-50; Georg I, 2010, SEX DEV, V4, P321, DOI 10.1159/000320142; Groppetti D, 2012, SEX DEV, V6, P135, DOI 10.1159/000331274; Huang B, 1999, AM J MED GENET, V87, P349, DOI 10.1002/(SICI)1096-8628(19991203)87:4<349::AID-AJMG13>3.0.CO;2-N; Jobling MA, 1998, CURR BIOL, V8, P1391, DOI 10.1016/S0960-9822(98)00020-7; Kashimada K, 2010, DEVELOPMENT, V137, P3921, DOI 10.1242/dev.048983; Kuroki S, 2013, SCIENCE, V341, P1106, DOI 10.1126/science.1239864; Meyers-Wallen VN, 2009, REPROD DOMEST ANIM, V44, P40, DOI 10.1111/j.1439-0531.2009.01433.x; Montazer-Torbati F, 2010, DEV DYNAM, V239, P3324, DOI 10.1002/dvdy.22452; Nicholas TJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-414; Nicholas TJ, 2009, GENOME RES, V19, P491, DOI 10.1101/gr.084715.108; PAILHOUX E, 1994, ANIM GENET, V25, P299, DOI 10.1111/j.1365-2052.1994.tb00362.x; Pailhoux E, 2001, DEV DYNAM, V222, P328, DOI 10.1002/dvdy.1194; Pailhoux E, 2001, NAT GENET, V29, P453, DOI 10.1038/ng769; PAILHOUX E, 1994, J REPROD FERTIL, V100, P491, DOI 10.1530/jrf.0.1000491; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Pujar S, 2007, J HERED, V98, P438, DOI 10.1093/jhered/esm028; Quilez J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-339; Quinn A, 2012, SEMIN REPROD MED, V30, P351, DOI 10.1055/s-0032-1324718; Rota A, 2010, REPROD DOMEST ANIM, V45, P743, DOI 10.1111/j.1439-0531.2008.01335.x; Sekido R, 2013, SEX DEV, V7, P21, DOI 10.1159/000342221; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; SELDEN JR, 1984, HUM GENET, V67, P62, DOI 10.1007/BF00270560; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Sutton E, 2011, J CLIN INVEST, V121, P328, DOI 10.1172/JCI42580; Vetro A, 2011, J MED GENET, V48, P710, DOI 10.1136/jmedgenet-2011-100036; Vidal VPI, 2001, NAT GENET, V28, P216, DOI 10.1038/90046; Wachtel SS, 1994, MOL GENETICS SEX DET, P267; WILKER CE, 1994, J AM VET MED ASSOC, V204, P112; Xiao B, 2013, EUR J MED GENET, V56, P695, DOI 10.1016/j.ejmg.2013.10.001	43	41	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101244	10.1371/journal.pone.0101244	http://dx.doi.org/10.1371/journal.pone.0101244			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010117	Green Submitted, gold, Green Published			2022-12-27	WOS:000338763800016
J	Gonzalez, OJA; van Aerde, KI; Mansvelder, HD; van Pelt, J; van Ooyen, A				Gonzalez, Oscar J. Avella; van Aerde, Karlijn I.; Mansvelder, Huibert D.; van Pelt, Jaap; van Ooyen, Arjen			Inter-Network Interactions: Impact of Connections between Oscillatory Neuronal Networks on Oscillation Frequency and Pattern	PLOS ONE			English	Article							LONG-RANGE SYNCHRONIZATION; GAMMA OSCILLATIONS; BETA RHYTHMS; TEMPORAL CORRELATIONS; BRAIN OSCILLATIONS; THETA-OSCILLATIONS; REALISTIC NETWORK; WORKING-MEMORY; HIPPOCAMPUS; INHIBITION	Oscillations in electrical activity are a characteristic feature of many brain networks and display a wide variety of temporal patterns. A network may express a single oscillation frequency, alternate between two or more distinct frequencies, or continually express multiple frequencies. In addition, oscillation amplitude may fluctuate over time. The origin of this complex repertoire of activity remains unclear. Different cortical layers often produce distinct oscillation frequencies. To investigate whether interactions between different networks could contribute to the variety of oscillation patterns, we created two model networks, one generating on its own a relatively slow frequency (20 Hz; slow network) and one generating a fast frequency (32 Hz; fast network). Taking either the slow or the fast network as source network projecting connections to the other, or target, network, we systematically investigated how type and strength of inter-network connections affected target network activity. For high inter-network connection strengths, we found that the slow network was more effective at completely imposing its rhythm on the fast network than the other way around. The strongest entrainment occurred when excitatory cells of the slow network projected to excitatory or inhibitory cells of the fast network The fast network most strongly imposed its rhythm on the slow network when its excitatory cells projected to excitatory cells of the slow network. Interestingly, for lower inter-network connection strengths, multiple frequencies coexisted in the target network. Just as observed in rat prefrontal cortex, the target network could express multiple frequencies at the same time, alternate between two distinct oscillation frequencies, or express a single frequency with alternating episodes of high and low amplitude. Together, our results suggest that input from other oscillating networks may markedly alter a network's frequency spectrum and may partly be responsible for the rich repertoire of temporal oscillation patterns observed in the brain.	[Gonzalez, Oscar J. Avella; van Aerde, Karlijn I.; Mansvelder, Huibert D.; van Pelt, Jaap; van Ooyen, Arjen] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Integrat Neurophysiol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	van Ooyen, A (corresponding author), Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Integrat Neurophysiol, Amsterdam, Netherlands.	arjen.van.ooyen@falw.vu.nl	Mansvelder, Huibert/N-6138-2018	Mansvelder, Huibert/0000-0003-1365-5340	EC Marie Curie Research and Training Network (RTN), NEURoVERS-it [019247]	EC Marie Curie Research and Training Network (RTN), NEURoVERS-it	OJAG was supported by a grant from the EC Marie Curie Research and Training Network (RTN), NEURoVERS-it 019247. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth M, 2011, J NEUROSCI, V31, P17040, DOI 10.1523/JNEUROSCI.2209-11.2011; Axmacher N, 2006, BRAIN RES REV, V52, P170, DOI 10.1016/j.brainresrev.2006.01.007; Bazhenov M, 2008, J NEUROPHYSIOL, V100, P1562, DOI 10.1152/jn.90613.2008; BIANCHI R, 1994, J NEUROPHYSIOL, V72, P131, DOI 10.1152/jn.1994.72.1.131; Bibbig A, 2002, J NEUROPHYSIOL, V88, P1634, DOI 10.1152/jn.2002.88.4.1634; Bibbig A, 2007, J NEUROPHYSIOL, V97, P2812, DOI 10.1152/jn.01105.2006; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Borgers C, 2005, P NATL ACAD SCI USA, V102, P7002, DOI 10.1073/pnas.0502366102; Borgers C, 2005, NEURAL COMPUT, V17, P557, DOI 10.1162/0899766053019908; BORISYUK GN, 1995, B MATH BIOL, V57, P809, DOI 10.1016/S0092-8240(95)80002-6; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; Buia C, 2006, J COMPUT NEUROSCI, V20, P247, DOI 10.1007/s10827-006-6358-0; Bush P, 1996, J COMPUT NEUROSCI, V3, P91, DOI 10.1007/BF00160806; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Caplan JB, 2001, J NEUROPHYSIOL, V86, P368, DOI 10.1152/jn.2001.86.1.368; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Deco G, 2009, P NATL ACAD SCI USA, V106, P10302, DOI 10.1073/pnas.0901831106; Dehaene S, 2005, PLOS BIOL, V3, P910, DOI 10.1371/journal.pbio.0030141; Draguhn A, 2009, J PHYSIOL-LONDON, V587, P5297, DOI 10.1113/jphysiol.2009.182105; Engel AK, 1999, CONSCIOUS COGN, V8, P128, DOI 10.1006/ccog.1999.0389; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; ERMENTROUT GB, 1991, J MATH BIOL, V29, P195, DOI 10.1007/BF00160535; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Freyer F, 2011, J NEUROSCI, V31, P6353, DOI 10.1523/JNEUROSCI.6693-10.2011; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Gireesh ED, 2008, P NATL ACAD SCI USA, V105, P7576, DOI 10.1073/pnas.0800537105; Gonzalez OJA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002666; Gray CM, 1996, SCIENCE, V274, P109, DOI 10.1126/science.274.5284.109; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Haenschel C, 2009, J NEUROSCI, V29, P9481, DOI 10.1523/JNEUROSCI.1428-09.2009; Heistek TS, 2013, J PHYSIOL-LONDON, V591, P845, DOI 10.1113/jphysiol.2012.243725; Heistek TS, 2010, FRONTIERS CELLULAR N, V4, P1; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Howard MW, 2003, CEREB CORTEX, V13, P1369, DOI 10.1093/cercor/bhg084; Jensen O, 2005, NEUROIMAGE, V26, P347, DOI 10.1016/j.neuroimage.2005.02.008; JOHANSSON S, 1992, J PHYSIOL-LONDON, V445, P129, DOI 10.1113/jphysiol.1992.sp018915; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Kopell N., 2002, HDB DYN SYST, V2, P3, DOI [10.1016/S1874-575X(02)80022-4, DOI 10.1016/S1874-575X(02)80022-4]; Lim DH, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00011; Linkenkaer-Hansen K, 2001, J NEUROSCI, V21, P1370; Middleton S, 2008, P NATL ACAD SCI USA, V105, P18572, DOI 10.1073/pnas.0809302105; Miltner WHR, 1999, NATURE, V397, P434, DOI 10.1038/17126; Montez T, 2009, P NATL ACAD SCI USA, V106, P1614, DOI 10.1073/pnas.0811699106; Pauluis Q, 1999, J COMPUT NEUROSCI, V6, P27, DOI 10.1023/A:1008804916112; Penttonen Markku, 2003, Thalamus & Related Systems, V2, P145, DOI 10.1016/S1472-9288(03)00007-4; Pfurtscheller G, 2000, NEUROSCI LETT, V286, P66, DOI 10.1016/S0304-3940(00)01055-7; Poil SS, 2011, EUR J NEUROSCI, V34, P394, DOI 10.1111/j.1460-9568.2011.07748.x; Raffone A, 2001, J COGNITIVE NEUROSCI, V13, P766, DOI 10.1162/08989290152541430; Roopun AK, 2008, FRONT CELL NEUROSCI, V2, DOI 10.3389/neuro.03.001.2008; Thomson AM, 2002, J NEUROCYTOL, V31, P239, DOI 10.1023/A:1024117908539; Tiesinga PHE, 2001, HIPPOCAMPUS, V11, P251, DOI 10.1002/hipo.1041; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; van Aerde KI, 2009, J PHYSIOL-LONDON, V587, P5177, DOI 10.1113/jphysiol.2009.178384; van Aerde KI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002725; VANOOYEN A, 1992, BIOL CYBERN, V67, P269, DOI 10.1007/BF00204400; Whittington MA, 2000, INT J PSYCHOPHYSIOL, V38, P315, DOI 10.1016/S0167-8760(00)00173-2; Widmer H, 2006, HIPPOCAMPUS, V16, P617, DOI 10.1002/hipo.20191; Womelsdorf T, 2007, CURR OPIN NEUROBIOL, V17, P154, DOI 10.1016/j.conb.2007.02.002	60	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e100899	10.1371/journal.pone.0100899	http://dx.doi.org/10.1371/journal.pone.0100899			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007325	Green Published, gold, Green Submitted			2022-12-27	WOS:000339040600024
J	Stapleton, S; LaRue, M; Lecomte, N; Atkinson, S; Garshelis, D; Porter, C; Atwood, T				Stapleton, Seth; LaRue, Michelle; Lecomte, Nicolas; Atkinson, Stephen; Garshelis, David; Porter, Claire; Atwood, Todd			Polar Bears from Space: Assessing Satellite Imagery as a Tool to Track Arctic Wildlife	PLOS ONE			English	Article							SURVIVAL	Development of efficient techniques for monitoring wildlife is a priority in the Arctic, where the impacts of climate change are acute and remoteness and logistical constraints hinder access. We evaluated high resolution satellite imagery as a tool to track the distribution and abundance of polar bears. We examined satellite images of a small island in Foxe Basin, Canada, occupied by a high density of bears during the summer ice-free season. Bears were distinguished from other light-colored spots by comparing images collected on different dates. A sample of ground-truthed points demonstrated that we accurately classified bears. Independent observers reviewed images and a population estimate was obtained using mark-recapture models. This estimate (N : 94; 95% Confidence Interval: 92-105) was remarkably similar to an abundance estimate derived from a line transect aerial survey conducted a few days earlier (N: 102; 95% CI: 69-152). Our findings suggest that satellite imagery is a promising tool for monitoring polar bears on land, with implications for use with other Arctic wildlife. Large scale applications may require development of automated detection processes to expedite review and analysis. Future research should assess the utility of multi-spectral imagery and examine sites with different environmental characteristics.	[Stapleton, Seth; Atwood, Todd] US Geol Survey, Alaska Sci Ctr, Anchorage, AK USA; [Garshelis, David] Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA; [LaRue, Michelle; Porter, Claire] Univ Minnesota, Dept Earth Sci, St Paul, MN 55108 USA; [Lecomte, Nicolas; Atkinson, Stephen] Govt Nunavut, Dept Environm, Igloolik, NU, Canada; [Garshelis, David] Minnesota Dept Nat Resources, Grand Rapids, MN USA	United States Department of the Interior; United States Geological Survey; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Stapleton, S (corresponding author), Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA.	stapl078@umn.edu		Lecomte, Nicolas/0000-0002-8473-5375				Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; Boltunov A, 2012, SPACE TECHNOLOGY MAR; Buckland S.T., 2001, pi; Burkanov V, 2008, IUCN 2012 IUCN RED L; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Comiso JC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031972; Eberhardt L. L., 1979, WILDLIFE MONOGR, V63, P3; Fretwell PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033751; HUGGINS RM, 1991, BIOMETRICS, V47, P725, DOI 10.2307/2532158; HUGGINS RM, 1989, BIOMETRIKA, V76, P133, DOI 10.1093/biomet/76.1.133; Laake JL, 2004, ADVANCED DISTANCE SAMPLING: ESTIMATING ABUNDANCE OF BIOLOGICAL POPULATIONS, P108; Laidre KL, 2008, ECOL APPL, V18, pS97, DOI 10.1890/06-0546.1; LaRue MA, 2011, POLAR BIOL, V34, P1727, DOI 10.1007/s00300-011-1023-0; Lowry L, 2008, IUCN 2012 IUCN RED L; Marques TA, 2006, WILDLIFE SOC B, V34, P759, DOI 10.2193/0091-7648(2006)34[759:TUOGPS]2.0.CO;2; Maslowski W, 2012, ANNU REV EARTH PL SC, V40, P625, DOI 10.1146/annurev-earth-042711-105345; McDonald LL, 1999, MARINE MAMMAL SURVEY AND ASSESSMENT METHODS, P37; Obbard M.E., 2010, P 15 WORK M IUCN SSC; OTIS DL, 1978, WILDLIFE MONOGR, P1; Overland JE, 2013, GEOPHYS RES LETT, V40, P2097, DOI 10.1002/grl.50316; Platonov NG, 2013, BIOL BULL+, V40, P197, DOI 10.1134/S1062359013020106; Regehr EV, 2007, J WILDLIFE MANAGE, V71, P2673, DOI 10.2193/2006-180; Schliebe S, 2008, POLAR BIOL, V31, P999, DOI 10.1007/s00300-008-0439-7; Schliebe S, 2008, IUCN 2013 IUCN RED L; Stapleton S, 2012, FOXE BASIN POLAR BEA; Stroeve J, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029703; Stroeve JC, 2012, CLIMATIC CHANGE, V110, P1005, DOI 10.1007/s10584-011-0101-1; Taylor BL, 2007, MAR MAMMAL SCI, V23, P157, DOI 10.1111/j.1748-7692.2006.00092.x; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Updike T., 2010, RADIOMETRIC USE WORL; Vongraven Dag, 2012, Ursus Monograph Series, V5, P1; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239	32	32	34	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101513	10.1371/journal.pone.0101513	http://dx.doi.org/10.1371/journal.pone.0101513			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006979	Green Published, Green Submitted, gold			2022-12-27	WOS:000339040600041
J	Boschker, HTS; Vasquez-Cardenas, D; Bolhuis, H; Moerdijk-Poortvliet, TWC; Moodley, L				Boschker, Henricus T. S.; Vasquez-Cardenas, Diana; Bolhuis, Henk; Moerdijk-Poortvliet, Tanja W. C.; Moodley, Leon			Chemoautotrophic Carbon Fixation Rates and Active Bacterial Communities in Intertidal Marine Sediments	PLOS ONE			English	Article							FATTY-ACIDS; SULFATE REDUCTION; RUBISCO GENOTYPES; HYDROGEN-SULFIDE; SULFUR OXIDATION; MEMBRANE-LIPIDS; SP-NOV; GROWTH; THIOBACILLUS; BEGGIATOA	Chemoautotrophy has been little studied in typical coastal marine sediments, but may be an important component of carbon recycling as intense anaerobic mineralization processes in these sediments lead to accumulation of high amounts of reduced compounds, such as sulfides and ammonium. We studied chemoautotrophy by measuring dark-fixation of C-13-bicarbonate into phospholipid derived fatty acid (PLFA) biomarkers at two coastal sediment sites with contrasting sulfur chemistry in the Eastern Scheldt estuary, the Netherlands. At one site where free sulfide accumulated in the pore water right to the top of the sediment, PLFA labeling was restricted to compounds typically found in sulfur and ammonium oxidizing bacteria. At the other site, with no detectable free sulfide in the pore water, a very different PLFA labeling pattern was found with high amounts of label in branched i- and a-PLFA besides the typical compounds for sulfur and ammonium oxidizing bacteria. This suggests that other types of chemoautotrophic bacteria were also active, most likely Deltaproteobacteria related to sulfate reducers. Maximum rates of chemoautotrophy were detected in first 1 to 2 centimeters of both sediments and chemosynthetic biomass production was high ranging from 3 to 36 mmol C m(-2) d(-1). Average dark carbon fixation to sediment oxygen uptake ratios were 0.22 +/- 0.07 mol C (mol O-2)(-1), which is in the range of the maximum growth yields reported for sulfur oxidizing bacteria indicating highly efficient growth. Chemoautotrophic biomass production was similar to carbon mineralization rates in the top of the free sulfide site, suggesting that chemoautotrophic bacteria could play a crucial role in the microbial food web and labeling in eukaryotic poly-unsaturated PLFA was indeed detectable. Our study shows that dark carbon fixation by chemoautotrophic bacteria is a major process in the carbon cycle of coastal sediments, and should therefore receive more attention in future studies on sediment biogeochemistry and microbial ecology.	[Boschker, Henricus T. S.; Vasquez-Cardenas, Diana; Bolhuis, Henk; Moerdijk-Poortvliet, Tanja W. C.] Royal Netherlands Inst Sea Res NIOZ, Dept Marine Microbiol, Yerseke, Netherlands; [Moodley, Leon] Int Res Inst Stavanger IRIS, Marine Environm Grp, Randaberg, Norway	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Boschker, HTS (corresponding author), Royal Netherlands Inst Sea Res NIOZ, Dept Marine Microbiol, Yerseke, Netherlands.	eric.boschker@nioz.nl	Bolhuis, Henk/S-2986-2019; moodley, leon/AAH-1674-2019; Bolhuis, Henk/H-8535-2014; Bolhuis, Henk/M-6677-2019	Bolhuis, Henk/0000-0002-4772-1898; Bolhuis, Henk/0000-0002-4772-1898; Moodley, Leon/0000-0002-0617-3514; Vasquez-Cardenas, Diana/0000-0002-8366-2020	Netherlands Organization for Scientific Research (NWO) VIDI [864.04.009]; Darwin Center for Biogeosciences [142.16.3061]; ESF [855.01.130]	Netherlands Organization for Scientific Research (NWO) VIDI(Netherlands Organization for Scientific Research (NWO)); Darwin Center for Biogeosciences; ESF(European Commission)	This work was supported by the following grants: Netherlands Organization for Scientific Research (NWO) VIDI grant number 864.04.009 to HTSB, Darwin Center for Biogeosciences grant number 142.16.3061 to HTSB, and ESF grant number 855.01.130. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida M, 2008, MICROBES ENVIRON, V23, P81, DOI 10.1264/jsme2.23.81; ALLER RC, 1985, J MAR RES, V43, P615, DOI 10.1357/002224085788440349; BAK F, 1987, ARCH MICROBIOL, V147, P184, DOI 10.1007/BF00415282; Billerbeck M, 2006, MAR ECOL PROG SER, V326, P61, DOI 10.3354/meps326061; BLUMER M, 1969, J BACTERIOL, V99, P366, DOI 10.1128/JB.99.2.366-370.1969; BOSCHKER H. T. S., 2004, MOL MICROBIAL ECOLOG, P1673; Boschker HTS, 1998, NATURE, V392, P801, DOI 10.1038/33900; Boudreau BP, 2006, GEOLOGY, V34, P693, DOI 10.1130/G22771.1; BRINCHIVERSEN J, 1990, FEMS MICROBIOL ECOL, V74, P345; CAVANAUGH CM, 1983, NATURE, V302, P58, DOI 10.1038/302058a0; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; Damste JSS, 2005, FEBS J, V272, P4270, DOI 10.1111/j.1742-4658.2005.04842.x; de Bie MJM, 2002, FEMS MICROBIOL ECOL, V42, P99, DOI 10.1111/j.1574-6941.2002.tb00999.x; del Giorgio PA, 1998, ANNU REV ECOL SYST, V29, P503, DOI 10.1146/annurev.ecolsys.29.1.503; Dijkhuizen L., 1985, COMPREHENSIVE BIOTEC, P409; Dijkman NA, 2006, MAR ECOL PROG SER, V324, P113, DOI 10.3354/meps324113; EDLUND A, 1985, J LIPID RES, V26, P982; Elferink SJWHO, 1998, GEOMICROBIOL J, V15, P3; Elsaied HE, 2007, EXTREMOPHILES, V11, P191, DOI 10.1007/s00792-006-0025-2; ENOKSSON V, 1987, MAR ECOL PROG SER, V36, P181, DOI 10.3354/meps036181; Feisthauer S, 2008, ENVIRON MICROBIOL, V10, P1641, DOI 10.1111/j.1462-2920.2008.01573.x; Finster K, 1998, APPL ENVIRON MICROB, V64, P119; Giri BJ, 2004, APPL ENVIRON MICROB, V70, P3443, DOI 10.1128/AEM.70.6.3443-3448.2004; Glaubitz S, 2009, ENVIRON MICROBIOL, V11, P326, DOI 10.1111/j.1462-2920.2008.01770.x; Glud RN, 2008, MAR BIOL RES, V4, P243, DOI 10.1080/17451000801888726; GOTTSCHAL JC, 1979, ARCH MICROBIOL, V121, P241, DOI 10.1007/BF00425062; Hagen KD, 1996, APPL ENVIRON MICROB, V62, P947, DOI 10.1128/AEM.62.3.947-953.1996; HEMPFLING WP, 1967, J BACTERIOL, V93, P874, DOI 10.1128/JB.93.3.874-878.1967; Hoehler TM, 1998, GEOCHIM COSMOCHIM AC, V62, P1745, DOI 10.1016/S0016-7037(98)00106-9; JANNASCH HW, 1979, BIOSCIENCE, V29, P592, DOI 10.2307/1307765; Jansen S, 2009, OCEAN DYNAM, V59, P317, DOI 10.1007/s10236-009-0179-4; Jorgensen B.B., 2004, GEOL S AM, V379, P63, DOI DOI 10.1130/0-8137-2379-5.63; JORGENSEN BB, 1978, GEOMICROBIOL J, V1, P11; JORGENSEN BB, 1991, APPL ENVIRON MICROB, V57, P847; Kelly DP, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P441, DOI 10.1007/0-387-30742-7_15; Kelly DP, 1999, ARCH MICROBIOL, V171, P219, DOI 10.1007/s002030050703; KERGER BD, 1986, FEMS MICROBIOL ECOL, V38, P67, DOI 10.1016/0378-1097(86)90144-8; KESTER DR, 1967, LIMNOL OCEANOGR, V12, P176, DOI 10.4319/lo.1967.12.1.0176; Knief C, 2003, ENVIRON MICROBIOL, V5, P1155, DOI 10.1046/j.1462-2920.2003.00510.x; Kristensen E, 1999, CONT SHELF RES, V19, P1331, DOI 10.1016/S0278-4343(99)00024-2; Lenk S, 2011, ENVIRON MICROBIOL, V13, P758, DOI 10.1111/j.1462-2920.2010.02380.x; Lipski A, 2001, SYST APPL MICROBIOL, V24, P377, DOI 10.1078/0723-2020-00049; Meysman FJR, 2006, TRENDS ECOL EVOL, V21, P688, DOI 10.1016/j.tree.2006.08.002; Middelburg JJ, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049725; Middelburg JJ, 2000, LIMNOL OCEANOGR, V45, P1224, DOI 10.4319/lo.2000.45.6.1224; Moodley L, 2005, J MAR RES, V63, P457, DOI 10.1357/0022240053693662; Mussmann M, 2007, PLOS BIOL, V5, P1923, DOI 10.1371/journal.pbio.0050230; NELSON DC, 1986, APPL ENVIRON MICROB, V52, P225, DOI 10.1128/AEM.52.2.225-233.1986; NELSON DC, 1983, ARCH MICROBIOL, V136, P262, DOI 10.1007/BF00425214; Nigro LM, 2007, FEMS MICROBIOL ECOL, V60, P113, DOI 10.1111/j.1574-6941.2007.00272.x; ODINTSOVA EV, 1993, ARCH MICROBIOL, V160, P152, DOI 10.1007/BF00288718; PROSSER JI, 1989, ADV MICROB PHYSIOL, V30, P125; Rabus R, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P659, DOI 10.1007/0-387-30742-7_22; REDFIELD AC, 1958, AM SCI, V46, P205; Risgaard-Petersen N, 2003, LIMNOL OCEANOGR-METH, V1, P63, DOI 10.4319/lom.2011.1.63; Robertson LA, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P985, DOI 10.1007/0-387-30742-7_31; Romanenko V. I., 1964, MIKROBIOLOGIYA, V33, P610; Sakata S, 2008, ORG GEOCHEM, V39, P1725, DOI 10.1016/j.orggeochem.2008.08.005; Santoro AL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065813, 10.1371/journal.pone.0066932]; Schouten S, 2000, P NATL ACAD SCI USA, V97, P14421, DOI 10.1073/pnas.97.26.14421; SKYRING GW, 1987, GEOMICROBIOL J, V5, P295, DOI 10.1080/01490458709385974; Smaal AC, 2009, HELGOLAND MAR RES, V63, P75, DOI 10.1007/s10152-008-0138-3; Soetaert K, 1996, GEOCHIM COSMOCHIM AC, V60, P1019, DOI 10.1016/0016-7037(96)00013-0; SOROKIN YI, 1972, J CONSEIL, V34, P423; Tabita FR, 1999, PHOTOSYNTH RES, V60, P1, DOI 10.1023/A:1006211417981; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TAYLOR J, 1983, J GEN MICROBIOL, V129, P3303; Thomsen U, 1997, AQUAT MICROB ECOL, V12, P165, DOI 10.3354/ame012165; TIMMERTENHOOR A, 1981, A VAN LEEUW J MICROB, V47, P231; Trimmer M, 2003, APPL ENVIRON MICROB, V69, P6447, DOI 10.1128/AEM.69.11.6447-6454.2003; TUTTLE JH, 1979, LIMNOL OCEANOGR, V24, P746, DOI 10.4319/lo.1979.24.4.0746; Van Frausum J, 2010, ECOL MODEL, V221, P2054, DOI 10.1016/j.ecolmodel.2010.06.001; Van Gaever S, 2009, MAR BIOL, V156, P1289, DOI 10.1007/s00227-009-1170-9; Wuchter C, 2003, FEMS MICROBIOL LETT, V219, P203, DOI 10.1016/S0378-1097(03)00060-0; Zhang CL, 2005, APPL ENVIRON MICROB, V71, P2106, DOI 10.1128/AEM.71.4.2106-2112.2005	75	43	44	4	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101443	10.1371/journal.pone.0101443	http://dx.doi.org/10.1371/journal.pone.0101443			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003508	Green Published, gold, Green Submitted			2022-12-27	WOS:000339242700032
J	Kodahl, AR; Zeuthen, P; Binder, H; Knoop, AS; Ditzel, HJ				Kodahl, Annette R.; Zeuthen, Pernille; Binder, Harald; Knoop, Ann S.; Ditzel, Henrik J.			Alterations in Circulating miRNA Levels following Early-Stage Estrogen Receptor-Positive Breast Cancer Resection in Post-Menopausal Women	PLOS ONE			English	Article							BLOOD-BASED MARKERS; MICRORNAS; SERUM; EXPRESSION; BIOMARKERS; PLASMA; RNAS	Introduction: Circulating microRNAs (miRNAs) exhibit remarkable stability and may serve as biomarkers in several clinical cancer settings. The aim of this study was to investigate changes in the levels of specific circulating miRNA following breast cancer surgery and evaluate whether these alterations were also observed in an independent data set. Methods: Global miRNA analysis was performed on prospectively collected serum samples from 24 post-menopausal women with estrogen receptor-positive early-stage breast cancer before surgery and 3 weeks after tumor resection using global LNA-based quantitative real-time PCR (qPCR). Results: Numbers of specific miRNAs detected in the samples ranged from 142 to 161, with 107 miRNAs detectable in all samples. After correction for multiple comparisons, 3 circulating miRNAs (miR-338-3p, miR-223 and miR-148a) exhibited significantly lower, and 1 miRNA (miR-107) higher levels in post-operative vs. pre-operative samples (p<0.05). No miRNAs were consistently undetectable in the post-operative samples compared to the pre-operative samples. Subsequently, our findings were compared to a dataset from a comparable patient population analyzed using similar study design and the same qPCR profiling platform, resulting in limited agreement. Conclusions: A panel of 4 circulating miRNAs exhibited significantly altered levels following radical resection of primary ER+ breast cancers in post-menopausal women. These specific miRNAs may be involved in tumorigenesis and could potentially be used to monitor whether all cancer cells have been removed at surgery and/or, subsequently, whether the patients develop recurrence.	[Kodahl, Annette R.; Ditzel, Henrik J.] Odense Univ Hosp, Dept Oncol, DK-5000 Odense, Denmark; [Kodahl, Annette R.; Ditzel, Henrik J.] Univ Southern Denmark, Odense, Denmark; [Zeuthen, Pernille] Odense Univ Hosp, Dept Surg Z, DK-5000 Odense, Denmark; [Binder, Harald] Johannes Gutenberg Univ Mainz, IMBEI, D-55122 Mainz, Germany; [Knoop, Ann S.] Copenhagen Univ Hosp, Rigshosp, Dept Oncol, Copenhagen, Denmark; [Ditzel, Henrik J.] Univ Southern Denmark, Dept Canc & Inflammat, Inst Mol Med, Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; Johannes Gutenberg University of Mainz; Rigshospitalet; University of Copenhagen; University of Southern Denmark	Kodahl, AR (corresponding author), Odense Univ Hosp, Dept Oncol, DK-5000 Odense, Denmark.	annette.kodahl@rsyd.dk	Knoop, Ann Soeegaard/GLR-2775-2022; Binder, Harald/C-7413-2009	Knoop, Ann Soeegaard/0000-0003-2898-1093; Binder, Harald/0000-0002-5666-8662; Kodahl, Annette/0000-0003-0515-9144; Ditzel, Henrik J./0000-0003-3927-5135	Odense University Hospital; Region of Southern Denmark and University of Southern Denmark; A. P. Moller and wife Chastine Mc-Kinney Mollers Foundation; Beckett Foundation; Danish Cancer Society; Danish Research Council; Danish Center for Translational Breast Cancer Research (DCTB); A Race Against Breast Cancer; The Danish Cancer Society [R99-A6362] Funding Source: researchfish	Odense University Hospital; Region of Southern Denmark and University of Southern Denmark; A. P. Moller and wife Chastine Mc-Kinney Mollers Foundation; Beckett Foundation; Danish Cancer Society(Danish Cancer Society); Danish Research Council(Det Frie Forskningsrad (DFF)); Danish Center for Translational Breast Cancer Research (DCTB); A Race Against Breast Cancer; The Danish Cancer Society(Danish Cancer Society)	This study was supported by Odense University Hospital. The support for this research was provided by The Region of Southern Denmark (http://www.regionsyddanmark.dk/wm157175) and University of Southern Denmark (http://www.sdu.dk/en/). Further support was obtained from A. P. Moller and wife Chastine Mc-Kinney Mollers Foundation (http://www.apmollerfonde.dk/), Beckett Foundation (http://www.beckett-fonden.dk/), Danish Cancer Society (http://www.cancer.dk/), Danish Research Council (http://ufm.dk/en), Danish Center for Translational Breast Cancer Research (DCTB) and A Race Against Breast Cancer (http://www.araceagainstbreastcancer.dk/dctb/Service/En). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Andreasen D, 2010, METHODS, V50, pS6, DOI 10.1016/j.ymeth.2010.01.006; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Asaga S, 2011, CLIN CHEM, V57, P84, DOI 10.1373/clinchem.2010.151845; Blondal T, 2013, METHODS, V59, pS1, DOI 10.1016/j.ymeth.2012.09.015; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Chan M., 2013, CLIN CANC RES; Chen PS, 2011, J CLIN INVEST, V121, P3442, DOI 10.1172/JCI45390; Cookson VJ, 2012, CELL ONCOL, V35, P301, DOI 10.1007/s13402-012-0089-1; Cuk K, 2013, INT J CANCER, V132, P1602, DOI 10.1002/ijc.27799; Di Leva G, 2010, TRENDS MOL MED, V16, P257, DOI 10.1016/j.molmed.2010.04.001; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gong B, 2013, BIOMED PHARMACOTHER, V67, P629, DOI 10.1016/j.biopha.2013.06.006; Heneghan HM, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2798; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Khatcheressian JL, 2013, J CLIN ONCOL, V31, P961, DOI 10.1200/JCO.2012.45.9859; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Kodahl AR, 2014, MOL ONCOL, V8, P874, DOI 10.1016/j.molonc.2014.03.002; Leidner RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057841; Li M, 2009, WORLD J SURG, V33, P667, DOI 10.1007/s00268-008-9836-x; McDermott AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087032; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mirza NQ, 2002, ANN SURG ONCOL, V9, P256, DOI 10.1245/aso.2002.9.3.256; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ng EKO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053141; Pinatel EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084859; Roth C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2766; Schrauder MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029770; Siegel R., 2014, CA CANC J CLIN; van Schooneveld E, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3127; Weiland M, 2012, RNA BIOL, V9, P850, DOI 10.4161/rna.20378; Wijnhoven BPL, 2007, BRIT J SURG, V94, P23, DOI 10.1002/bjs.5673; Wu Q, 2012, CLIN CHIM ACTA, V413, P1058, DOI 10.1016/j.cca.2012.02.016; Wu Q, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/597145; Yu J, 2011, J BIOMED RES, V25, P170, DOI 10.1016/S1674-8301(11)60022-5; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	38	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101950	10.1371/journal.pone.0101950	http://dx.doi.org/10.1371/journal.pone.0101950			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004125	Green Published, Green Submitted, gold			2022-12-27	WOS:000339242700092
J	Ozgen, H; Schrimpf, W; Hendrix, J; de Jonge, JC; Lamb, DC; Hoekstra, D; Kahya, N; Baron, W				Ozgen, Hande; Schrimpf, Waldemar; Hendrix, Jelle; de Jonge, Jenny C.; Lamb, Don C.; Hoekstra, Dick; Kahya, Nicoletta; Baron, Wia			The Lateral Membrane Organization and Dynamics of Myelin Proteins PLP and MBP Are Dictated by Distinct Galactolipids and the Extracellular Matrix	PLOS ONE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; CENTRAL-NERVOUS-SYSTEM; PULSED INTERLEAVED EXCITATION; GROWTH-FACTOR INTERACTIONS; LASER-SCANNING MICROSCOPE; BASIC-PROTEIN; PLASMA-MEMBRANE; SIGNAL-TRANSDUCTION; PARANODAL JUNCTION; MULTIPLE-SCLEROSIS	In the central nervous system, lipid-protein interactions are pivotal for myelin maintenance, as these interactions regulate protein transport to the myelin membrane as well as the molecular organization within the sheath. To improve our understanding of the fundamental properties of myelin, we focused here on the lateral membrane organization and dynamics of peripheral membrane protein 18.5-kDa myelin basic protein (MBP) and transmembrane protein proteolipid protein (PLP) as a function of the typical myelin lipids galactosylceramide (GalC), and sulfatide, and exogenous factors such as the extracellular matrix proteins laminin-2 and fibronectin, employing an oligodendrocyte cell line, selectively expressing the desired galactolipids. The dynamics of MBP were monitored by z-scan point fluorescence correlation spectroscopy (FCS) and raster image correlation spectroscopy (RICS), while PLP dynamics in living cells were investigated by circular scanning FCS. The data revealed that on an inert substrate the diffusion rate of 18.5-kDa MBP increased in GalC-expressing cells, while the diffusion coefficient of PLP was decreased in sulfatide-containing cells. Similarly, when cells were grown on myelination-promoting laminin-2, the lateral diffusion coefficient of PLP was decreased in sulfatide-containing cells. In contrast, PLP's diffusion rate increased substantially when these cells were grown on myelination-inhibiting fibronectin. Additional biochemical analyses revealed that the observed differences in lateral diffusion coefficients of both proteins can be explained by differences in their biophysical, i.e., galactolipid environment, specifically with regard to their association with lipid rafts. Given the persistence of pathological fibronectin aggregates in multiple sclerosis lesions, this fundamental insight into the nature and dynamics of lipid-protein interactions will be instrumental in developing myelin regenerative strategies.	[Ozgen, Hande; de Jonge, Jenny C.; Hoekstra, Dick; Kahya, Nicoletta; Baron, Wia] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Groningen, Netherlands; [Schrimpf, Waldemar; Hendrix, Jelle; Lamb, Don C.] Univ Munich, Dept Chem, Munich Ctr Integrated Prot Sci CiPSM, Munich, Germany; [Schrimpf, Waldemar; Hendrix, Jelle; Lamb, Don C.] Univ Munich, Ctr Nanosci CeNS, Munich, Germany	University of Groningen; University of Munich; University of Munich	Kahya, N (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Groningen, Netherlands.	nicoletta.kahya@gmail.com; w.baron@umcg.nl	Lamb, Don C/G-9501-2014; HENDRIX, Jelle/H-1721-2018	Lamb, Don C/0000-0002-0232-1903; HENDRIX, Jelle/0000-0001-5731-1297; Baron, Wia/0000-0002-6673-4766	Netherlands Organization of Scientific Research (NWO) [016.096.329]; Dutch MS Research Foundation ('Stichting MS Research'); Research Foundation Flanders; Deutsche Forschungsgemeinschaft (DFG, DCL) [SFB1032]; Excellence Initiative Nanosystems Initiative Munich (NIM); Ludwig-Maximilians-Universitat Munich via the LMU Innovative BioImaging Network; Center for NanoScience; EMBO Short Term Fellowship [ASTF 463-2012/EMBO]; NWO [175-010-2009-023]	Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch MS Research Foundation ('Stichting MS Research'); Research Foundation Flanders(FWO); Deutsche Forschungsgemeinschaft (DFG, DCL); Excellence Initiative Nanosystems Initiative Munich (NIM); Ludwig-Maximilians-Universitat Munich via the LMU Innovative BioImaging Network; Center for NanoScience; EMBO Short Term Fellowship(European Molecular Biology Organization (EMBO)); NWO(Netherlands Organization for Scientific Research (NWO))	This work was supported by grants from the Netherlands Organization of Scientific Research (NWO, www.nwo.nl, WB, 016.096.329), the Dutch MS Research Foundation ('Stichting MS Research', www.msresearch.nl, WB, DH), the Research Foundation Flanders (www.fwo.be, JH), and the Deutsche Forschungsgemeinschaft (DFG, DCL) through the collaborative research grant SFB1032 and the Excellence Initiative Nanosystems Initiative Munich (NIM) and Ludwig-Maximilians-Universitat Munich via the LMU Innovative BioImaging Network and the Center for NanoScience. The research visit to Dr. Don C. Lamb's laboratory was supported by an EMBO Short Term Fellowship (www.EMBO.org, ASTF 463-2012/EMBO, HO). Part of the work has been performed at the UMCG Microscopy and Imaging Center (UMIC), which is sponsored by NWO grant 175-010-2009-023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2011, TRENDS CELL BIOL, V21, P585, DOI 10.1016/j.tcb.2011.06.004; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Baron W, 2003, CURR BIOL, V13, P151, DOI 10.1016/S0960-9822(02)01437-9; Baron W, 2014, GLIA, V62, P927, DOI 10.1002/glia.22650; Baron W, 2010, FEBS LETT, V584, P1760, DOI 10.1016/j.febslet.2009.10.085; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Boggs JM, 2006, CELL MOL LIFE SCI, V63, P1945, DOI 10.1007/s00018-006-6094-7; Boggs JM, 2004, J NEUROSCI RES, V76, P342, DOI 10.1002/jnr.20080; Boggs JA, 2008, BBA-GEN SUBJECTS, V1780, P445, DOI 10.1016/j.bbagen.2007.10.015; Boggs JM, 2008, J NEUROSCI RES, V86, P1448, DOI 10.1002/jnr.21603; Boggs JM, 2010, FEBS LETT, V584, P1771, DOI 10.1016/j.febslet.2009.11.074; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bosio A, 1998, J NEUROCHEM, V70, P308; BROWN MC, 1993, J NEUROSCI RES, V35, P402, DOI 10.1002/jnr.490350407; Buttery PC, 1999, MOL CELL NEUROSCI, V14, P199, DOI 10.1006/mcne.1999.0781; Chun SJ, 2003, J CELL BIOL, V163, P397, DOI 10.1083/jcb.200304154; Colognato H, 2005, TRENDS NEUROSCI, V28, P480, DOI 10.1016/j.tins.2005.07.004; Colognato H, 2002, NAT CELL BIOL, V4, P833, DOI 10.1038/ncb865; Colognato H, 2011, DEV NEUROBIOL, V71, P924, DOI 10.1002/dneu.20966; DeBruin LS, 2005, J NEUROSCI RES, V80, P211, DOI 10.1002/jnr.20452; Decker L, 2004, BIOCHEM SOC T, V32, P426, DOI 10.1042/BST0320426; Digman MA, 2005, BIOPHYS J, V88, pL33, DOI 10.1529/biophysj.105.061788; Digman MA, 2005, BIOPHYS J, V89, P1317, DOI 10.1529/biophysj.105.062836; Dupree JL, 2010, PROSTAG OTH LIPID M, V91, P118, DOI 10.1016/j.prostaglandins.2009.04.005; DYER CA, 1989, J NEUROSCI RES, V24, P212, DOI 10.1002/jnr.490240212; DYER CA, 1994, J NEUROSCI RES, V39, P97, DOI 10.1002/jnr.490390112; DYER CA, 1991, J NEUROSCI RES, V30, P699, DOI 10.1002/jnr.490300414; Fewou SN, 2010, J NEUROCHEM, V112, P599, DOI 10.1111/j.1471-4159.2009.06464.x; Fitzner D, 2006, EMBO J, V25, P5037, DOI 10.1038/sj.emboj.7601376; Heinemann F, 2012, LANGMUIR, V28, P13395, DOI 10.1021/la302596h; Hendrix J, 2014, METHODS MOL BIOL, V1076, P653, DOI 10.1007/978-1-62703-649-8_30; Hendrix J, 2013, BIOPHYS J, V105, P848, DOI 10.1016/j.bpj.2013.05.059; Hendrix J, 2011, NUCLEIC ACIDS RES, V39, P1310, DOI 10.1093/nar/gkq933; Honke K, 2002, P NATL ACAD SCI USA, V99, P4227, DOI 10.1073/pnas.032068299; Jackman N, 2009, PHYSIOLOGY, V24, P290, DOI 10.1152/physiol.00016.2009; Kahya N, 2006, MOL MEMBR BIOL, V23, P29, DOI 10.1080/09687860500489099; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; Klunder B, 2008, J NEUROSCI RES, V86, P1007, DOI 10.1002/jnr.21556; Maier O, 2006, EXP CELL RES, V312, P500, DOI 10.1016/j.yexcr.2005.11.014; Maier O, 2005, MOL CELL NEUROSCI, V28, P390, DOI 10.1016/j.mcn.2004.09.012; Maier O, 2008, J MOL NEUROSCI, V35, P35, DOI 10.1007/s12031-007-9024-8; Maier O, 2007, GLIA, V55, P885, DOI 10.1002/glia.20510; Ozgen H, 2014, BBA-MOL CELL RES, V1843, P517, DOI 10.1016/j.bbamcr.2013.11.026; PETERSEN NO, 1986, BIOPHYS J, V49, P809, DOI 10.1016/S0006-3495(86)83709-2; Petrasek Z, 2011, OPT EXPRESS, V19, P25006, DOI 10.1364/OE.19.025006; Philip F, 2007, J BIOL CHEM, V282, P19203, DOI 10.1074/jbc.M701558200; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; Relvas JB, 2001, CURR BIOL, V11, P1039, DOI 10.1016/S0960-9822(01)00292-5; RichterLandsberg C, 1996, J NEUROSCI RES, V45, P161, DOI 10.1002/(SICI)1097-4547(19960715)45:2<161::AID-JNR8>3.0.CO;2-8; ROBERTS DD, 1985, P NATL ACAD SCI USA, V82, P1306, DOI 10.1073/pnas.82.5.1306; Ruan QQ, 2004, BIOPHYS J, V87, P1260, DOI 10.1529/biophysj.103.036483; Sezgin E, 2012, NAT PROTOC, V7, P1042, DOI 10.1038/nprot.2012.059; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons M, 2000, J CELL BIOL, V151, P143, DOI 10.1083/jcb.151.1.143; Siskova Z, 2006, MOL CELL NEUROSCI, V33, P150, DOI 10.1016/j.mcn.2006.07.001; Smith GST, 2011, J NEUROSCI RES, V89, P467, DOI 10.1002/jnr.22570; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; Stoffels JMJ, 2013, CELL MOL LIFE SCI, V70, P4243, DOI 10.1007/s00018-013-1350-0; Stoffels JMJ, 2013, BRAIN, V136, P116, DOI 10.1093/brain/aws313; Horssen J, 2007, J NEUROCHEM, V103, P1293, DOI 10.1111/j.1471-4159.2007.04897.x	61	26	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101834	10.1371/journal.pone.0101834	http://dx.doi.org/10.1371/journal.pone.0101834			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003183	Green Published, gold, Green Submitted			2022-12-27	WOS:000339242700075
J	Sau, S; Sutradhar, S; Paul, R; Sinha, P				Sau, Soumitra; Sutradhar, Sabyasachi; Paul, Raja; Sinha, Pratima			Budding Yeast Kinetochore Proteins, Chl4 and Ctf19, Are Required to Maintain SPB-Centromere Proximity during G1 and Late Anaphase	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; CHROMOSOME SEGREGATION; MICROTUBULE DYNAMICS; MOLECULAR-MECHANISMS; BIPOLAR ATTACHMENT; OUTER KINETOCHORE; NUCLEAR-ENVELOPE; FORCE-GENERATION; FISSION YEAST	In the budding yeast, centromeres stay clustered near the spindle pole bodies (SPBs) through most of the cell cycle. This SPB-centromere proximity requires microtubules and functional kinetochores, which are protein complexes formed on the centromeres and capable of binding microtubules. The clustering is suggested by earlier studies to depend also on protein-protein interactions between SPB and kinetochore components. Previously it has been shown that the absence of nonessential kinetochore proteins of the Ctf19 complex weakens kinetochore-microtubule interaction, but whether this compromised interaction affects centromere/kinetochore positioning inside the nucleus is unknown. We found that in G1 and in late anaphase, SPB-centromere proximity was disturbed in mutant cells lacking Ctf19 complex members, Chl4p and/or Ctf19p, whose centromeres lay further away from their SPBs than those of the wild-type cells. We unequivocally show that the SPB-centromere proximity and distances are not dependent on physical interactions between SPB and kinetochore components, but involve microtubule-dependent forces only. Further insight on the positional difference between wild-type and mutant kinetochores was gained by generating computational models governed by (1) independently regulated, but constant kinetochore microtubule (kMT) dynamics, (2) poleward tension on kinetochore and the antagonistic polar ejection force and (3) length and force dependent kMT dynamics. Numerical data obtained from the third model concurs with experimental results and suggests that the absence of Chl4p and/or Ctf19p increases the penetration depth of a growing kMT inside the kinetochore and increases the rescue frequency of a depolymerizing kMT. Both the processes result in increased distance between SPB and centromere.	[Sau, Soumitra; Sinha, Pratima] Bose Inst, Dept Biochem, Kolkata, India; [Sutradhar, Sabyasachi; Paul, Raja] Indian Assoc Cultivat Sci, Dept Solid State Phys, Kolkata, India	Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Indian Association for the Cultivation of Science (IACS) - Jadavpur	Paul, R (corresponding author), Indian Assoc Cultivat Sci, Dept Solid State Phys, Kolkata, India.	ssprp@iacs.res.in; pratima@jcbose.ac.in		Sutradhar, Sabyasachi/0000-0002-5826-5891	Council of Scientific and Industrial Research (CSIR) [37(1094)/02-EMR-II]; Department of Science and Technology (DST), Government of India [SR/S2/CMP-0107/2010]; CSIR [9/15(314)/2006-EMR-I, 09/080(0707)/2010-EMR-I]	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a Council of Scientific and Industrial Research (CSIR) grant [37(1094)/02-EMR-II] along with Institutional support (partial) by the Department of Science and Technology (DST), Government of India, to P.S and DST India grant [SR/S2/CMP-0107/2010] to R.P.S. Sau and S. Sutradhar were supported by CSIR grants (Sanction Numbers: 9/15(314)/2006-EMR-I and 09/080(0707)/2010-EMR-I). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M, 2009, MOL BIOL CELL, V20, P4131, DOI 10.1091/mbc.E09-05-0359; Appelgren H, 2003, J CELL SCI, V116, P4035, DOI 10.1242/jcs.00707; Breeden LL, 1997, METHOD ENZYMOL, V283, P332; Bystricky K, 2004, P NATL ACAD SCI USA, V101, P16495, DOI 10.1073/pnas.0402766101; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Cho US, 2010, COLD SH Q B, V75, P395, DOI 10.1101/sqb.2010.75.040; Civelekoglu-Scholey G, 2006, BIOPHYS J, V90, P3966, DOI 10.1529/biophysj.105.078691; Cui H, 2009, J CELL BIOL, V185, P251, DOI 10.1083/jcb.200810130; Das SP, 2005, BIOCHEM BIOPH RES CO, V337, P167, DOI 10.1016/j.bbrc.2005.09.034; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; Ding R, 1997, MOL BIOL CELL, V8, P1461, DOI 10.1091/mbc.8.8.1461; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; DOHENY KF, 1993, CELL, V73, P761, DOI 10.1016/0092-8674(93)90255-O; Dorn JF, 2005, BIOPHYS J, V89, P2835, DOI 10.1529/biophysj.104.058461; Efremov A, 2007, P NATL ACAD SCI USA, V104, P19017, DOI 10.1073/pnas.0709524104; Foethke D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.76; Franck AD, 2007, NAT CELL BIOL, V9, P832, DOI 10.1038/ncb1609; FUNABIKI H, 1993, J CELL BIOL, V121, P961, DOI 10.1083/jcb.121.5.961; Gandhi SR, 2011, DEV CELL, V21, P920, DOI 10.1016/j.devcel.2011.09.006; Gardner MK, 2005, MOL BIOL CELL, V16, P3764, DOI 10.1091/mbc.E05-04-0275; Ghosh SK, 2004, CURR GENET, V46, P82, DOI 10.1007/s00294-004-0516-6; Ghosh SK, 2001, MOL GENET GENOMICS, V265, P249, DOI 10.1007/s004380000408; Gonen S, 2012, NAT STRUCT MOL BIOL, V19, P925, DOI 10.1038/nsmb.2358; Grishchuk EL, 2005, NATURE, V438, P384, DOI 10.1038/nature04132; Guacci V, 1997, MOL BIOL CELL, V8, P957, DOI 10.1091/mbc.8.6.957; Hou HT, 2012, J CELL BIOL, V199, P735, DOI 10.1083/jcb.201208001; Hyland KM, 1999, J CELL BIOL, V145, P15, DOI 10.1083/jcb.145.1.15; INOUE S, 1995, MOL BIOL CELL, V6, P1619, DOI 10.1091/mbc.6.12.1619; JACOBS CW, 1988, J CELL BIOL, V107, P1409, DOI 10.1083/jcb.107.4.1409; James P, 1996, GENETICS, V144, P1425; Janke C, 2001, EMBO J, V20, P777, DOI 10.1093/emboj/20.4.777; Janson ME, 2003, J CELL BIOL, V161, P1029, DOI 10.1083/jcb.200301147; Jin QW, 2000, J CELL SCI, V113, P1903; Jin QW, 1998, J CELL BIOL, V141, P21, DOI 10.1083/jcb.141.1.21; Joglekar AP, 2010, CURR OPIN CELL BIOL, V22, P57, DOI 10.1016/j.ceb.2009.12.010; Joglekar AP, 2009, CURR BIOL, V19, P694, DOI 10.1016/j.cub.2009.02.056; KILMARTIN JV, 1984, J CELL BIOL, V98, P922, DOI 10.1083/jcb.98.3.922; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Kitamura E, 2007, GENE DEV, V21, P3319, DOI 10.1101/gad.449407; KOUPRINA N, 1993, GENETICS, V135, P327; Laan L, 2008, P NATL ACAD SCI USA, V105, P8920, DOI 10.1073/pnas.0710311105; Laha S, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-83; Lahiri S, 2013, FEMS YEAST RES, V13, P375, DOI 10.1111/1567-1364.12041; Le Masson I, 2002, MOL MICROBIOL, V43, P1431; Levesque AA, 2001, J CELL BIOL, V154, P1135, DOI 10.1083/jcb.200106093; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; McIntosh JR, 2008, CELL, V135, P322, DOI 10.1016/j.cell.2008.08.038; Measday V, 2002, GENE DEV, V16, P101, DOI 10.1101/gad.949302; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Poddar A, 1999, MOL MICROBIOL, V31, P349, DOI 10.1046/j.1365-2958.1999.01179.x; Pot I, 2003, MOL BIOL CELL, V14, P460, DOI 10.1091/mbc.E02-08-0517; Richmond D, 2013, MOL BIOL CELL, V24, P566, DOI 10.1091/mbc.E12-07-0552; RIEDER CL, 1986, J CELL BIOL, V103, P581, DOI 10.1083/jcb.103.2.581; Roy N, 1997, CURR GENET, V32, P182, DOI 10.1007/s002940050264; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Sanyal K, 1998, MOL GEN GENET, V260, P242, DOI 10.1007/s004380050892; Sarkar S, 2010, FEMS YEAST RES, V10, P660, DOI 10.1111/j.1567-1364.2010.00655.x; Shang C, 2003, MOL BIOL CELL, V14, P3342, DOI 10.1091/mbc.E02-11-0765; Sprague BL, 2003, BIOPHYS J, V84, P3529, DOI 10.1016/S0006-3495(03)75087-5; Tanaka K, 2005, NATURE, V434, P987, DOI 10.1038/nature03483; Tanaka K, 2007, J CELL BIOL, V178, P269, DOI 10.1083/jcb.200702141; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Tischer C, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.5; Varga V, 2009, CELL, V138, P1174, DOI 10.1016/j.cell.2009.07.032; Westermann S, 2007, ANNU REV BIOCHEM, V76, P563, DOI 10.1146/annurev.biochem.76.052705.160607; Wolyniak MJ, 2006, MOL BIOL CELL, V17, P2789, DOI 10.1091/mbc.E05-09-0892	68	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101294	10.1371/journal.pone.0101294	http://dx.doi.org/10.1371/journal.pone.0101294			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003500	Green Published, Green Submitted, gold			2022-12-27	WOS:000339242700023
J	Shukla, A; Sharma, P; Prakash, O; Singh, M; Kalani, K; Khan, F; Bawankule, DU; Luqman, S; Srivastava, SK				Shukla, Aparna; Sharma, Pooja; Prakash, Om; Singh, Monika; Kalani, Komal; Khan, Feroz; Bawankule, Dnyaneshwar Umrao; Luqman, Suaib; Srivastava, Santosh Kumar			QSAR and Docking Studies on Capsazepine Derivatives for Immunomodulatory and Anti-Inflammatory Activity	PLOS ONE			English	Article							NF-KAPPA-B; NITRIC-OXIDE SYNTHASE; VANILLOID RECEPTOR; CAPSAICIN; INHIBITORS; BIOACTIVITIES; DISCOVERY; ANTAGONIST; INDUCTION; TARGET	Capsazepine, an antagonist of capsaicin, is discovered by the structure and activity relationship. In previous studies it has been found that capsazepine has potency for immunomodulation and anti-inflammatory activity and emerging as a favourable target in quest for efficacious and safe anti-inflammatory drug. Thus, a 2D quantitative structural activity relationship (QSAR) model against target tumor necrosis factor-alpha (TNF-alpha) was developed using multiple linear regression method (MLR) with good internal prediction (r(2) = 0.8779) and external prediction (r(pred)(2) = 0.5865) using Discovery Studio v3.5 (Accelrys, USA). The predicted activity was further validated by in vitro experiment. Capsazepine was tested in lipopolysaccharide (LPS) induced inflammation in peritoneal mouse macrophages. Anti-inflammatory profile of capsazepine was assessed by its potency to inhibit the production of inflammatory mediator TNF-alpha. The in vitro experiment indicated that capsazepine is an efficient anti-inflammatory agent. Since, the developed QSAR model showed significant correlations between chemical structure and anti-inflammatory activity, it was successfully applied in the screening of forty-four virtual derivatives of capsazepine, which finally afforded six potent derivatives, CPZ-29, CPZ-30, CPZ-33, CPZ-34, CPZ-35 and CPZ36. To gain more insights into the molecular mechanism of action of capsazepine and its derivatives, molecular docking and in silico absorption, distribution, metabolism, excretion and toxicity (ADMET) studies were performed. The results of QSAR, molecular docking, in silico ADMET screening and in vitro experimental studies provide guideline and mechanistic scope for the identification of more potent anti-inflammatory & immunomodulatory drug.	[Shukla, Aparna; Sharma, Pooja; Prakash, Om; Khan, Feroz] CSIR Cent Inst Med & Aromat Plants, Metab & Struct Biol Dept, Lucknow, Uttar Pradesh, India; [Singh, Monika; Bawankule, Dnyaneshwar Umrao; Luqman, Suaib] CSIR Cent Inst Med & Aromat Plants, Mol Bioprospect Dept, Lucknow, Uttar Pradesh, India; [Kalani, Komal; Srivastava, Santosh Kumar] CSIR Cent Inst Med & Aromat Plants, Div Analyt Chem, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP)	Khan, F (corresponding author), CSIR Cent Inst Med & Aromat Plants, Metab & Struct Biol Dept, PO CIMAP,Kukrail Picn Spot Rd, Lucknow, Uttar Pradesh, India.	f.khan@cimap.res.in	Khan, Feroz/AHC-3474-2022; Bawankule, Dnyaneshwar/AAD-8093-2022; Luqman, Suaib/M-5541-2015	Khan, Feroz/0000-0002-2704-5925; Bawankule, Dnyaneshwar/0000-0003-0677-0981; PRAKASH, OM/0000-0001-7893-8873	'Science and Engineering Research Board (SERB), Department of Science & Technology (DST)', New Delhi, India; CSIR - Central Institute of Medicinal and Aromatic Plants, Lucknow, India [SR/FT/LS-25/2010]	'Science and Engineering Research Board (SERB), Department of Science & Technology (DST)', New Delhi, India; CSIR - Central Institute of Medicinal and Aromatic Plants, Lucknow, India	This study was supported by the 'Science and Engineering Research Board (SERB), Department of Science & Technology (DST)', New Delhi, India for the financial support at CSIR - Central Institute of Medicinal and Aromatic Plants, Lucknow, India (SR/FT/LS-25/2010 dated May 2, 2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009; Alam S, 2014, DRUG DES DEV THER, V8, P183, DOI 10.2147/DDDT.S51577; Appendino G, 2003, EXPERT OPIN THER PAT, V13, P1825, DOI 10.1517/eotp.13.12.1825.22908; Bawankule D. U., 2008, Inflammopharmacology, V16, P272, DOI 10.1007/s10787-008-8012-0; Brown E, 2008, METAL IONS BIOL MED, V10, P583; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Chao Q, 1999, J MED CHEM, V42, P3860, DOI 10.1021/jm9805900; Chen CW, 2003, BRIT J PHARMACOL, V140, P1077, DOI 10.1038/sj.bjp.0705533; Chen F, 2001, AM J PATHOL, V159, P387, DOI 10.1016/S0002-9440(10)61708-7; Cheng JF, 2004, BIOORG MED CHEM LETT, V14, P2411, DOI 10.1016/j.bmcl.2004.03.022; Cheng JF, 2003, BIOORG MED CHEM LETT, V13, P3647, DOI 10.1016/j.bmcl.2003.08.025; Cichewicz RH, 1996, J ETHNOPHARMACOL, V52, P61, DOI 10.1016/0378-8741(96)01384-0; FRANCOCERECEDA A, 1988, N-S ARCH PHARMACOL, V337, P649; Fujita M, 2002, BIOORG MED CHEM LETT, V12, P1897, DOI 10.1016/S0960-894X(02)00332-3; Fujita M, 2002, BIOORG MED CHEM LETT, V12, P1607, DOI 10.1016/S0960-894X(02)00228-7; Fujita M, 2002, BIOORGAN MED CHEM, V10, P3113, DOI 10.1016/S0968-0896(02)00224-9; JANCSO G, 1977, NATURE, V270, P741, DOI 10.1038/270741a0; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Luqman S, 2011, J MED FOOD, V14, P1344, DOI 10.1089/jmf.2010.0236; Luqman S, 2010, PHYTOTHER RES, V24, P949, DOI 10.1002/ptr.3171; Macho A, 1999, CELL DEATH DIFFER, V6, P155, DOI 10.1038/sj.cdd.4400465; Meena A, 2011, CHEM BIOL DRUG DES, V78, P567, DOI 10.1111/j.1747-0285.2011.01173.x; Melisi D, 2007, EXPERT OPIN THER TAR, V11, P133, DOI 10.1517/14728222.11.2.133; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Oh GS, 2001, INT IMMUNOPHARMACOL, V1, P777, DOI 10.1016/S1567-5769(01)00012-1; SRINIVASAN MR, 1989, INDIAN J EXP BIOL, V27, P910; Szallasi A, 1999, PHARMACOL REV, V51, P159; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; UCHIDA M, 1991, JPN J PHARMACOL, V55, P279, DOI 10.1254/jjp.55.279; WALPOLE CSJ, 1994, J MED CHEM, V37, P1942, DOI 10.1021/jm00039a006; Yadav DK, 2010, DRUG DES DEV THER, V4, P173	31	28	29	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e100797	10.1371/journal.pone.0100797	http://dx.doi.org/10.1371/journal.pone.0100797			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003344	Green Published, gold, Green Submitted			2022-12-27	WOS:000339242700013
J	Aghili, F; Gamper, HA; Eikenberg, J; Khoshgoftarmanesh, AH; Afyuni, M; Schulin, R; Jansa, J; Frossard, E				Aghili, Forough; Gamper, Hannes A.; Eikenberg, Jost; Khoshgoftarmanesh, Amir H.; Afyuni, Majid; Schulin, Rainer; Jansa, Jan; Frossard, Emmanuel			Green Manure Addition to Soil Increases Grain Zinc Concentration in Bread Wheat	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZA; NUTRITION; GENOTYPES; DEFICIENCY; CROPS; YIELD; COLONIZATION; EXUDATION; BENEFITS; RELEASE	Zinc (Zn) deficiency is a major problem for many people living on wheat-based diets. Here, we explored whether addition of green manure of red clover and sunflower to a calcareous soil or inoculating a non-indigenous arbuscular mycorrhizal fungal (AMF) strain may increase grain Zn concentration in bread wheat. For this purpose we performed a multifactorial pot experiment, in which the effects of two green manures (red clover, sunflower), ZnSO4 application, soil gamma-irradiation (elimination of naturally occurring AMF), and AMF inoculation were tested. Both green manures were labeled with Zn-65 radiotracer to record the Zn recoveries in the aboveground plant biomass. Application of ZnSO4 fertilizer increased grain Zn concentration from 20 to 39 mg Zn kg(-1) and sole addition of green manure of sunflower to soil raised grain Zn concentration to 31 mg Zn kg(-1). Adding the two together to soil increased grain Zn concentration even further to 54 mg Zn kg(-1). Mixing green manure of sunflower to soil mobilized additional 48 mu g Zn (kg soil)(-1) for transfer to the aboveground plant biomass, compared to the total of 132 mu g Zn (kg soil)(-1) taken up from plain soil when neither green manure nor ZnSO4 were applied. Green manure amendments to soil also raised the DTPA-extractable Zn in soil. Inoculating a non-indigenous AMF did not increase plant Zn uptake. The study thus showed that organic matter amendments to soil can contribute to a better utilization of naturally stocked soil micronutrients, and thereby reduce any need for major external inputs.	[Aghili, Forough; Gamper, Hannes A.; Frossard, Emmanuel] ETH, Swiss Fed Inst Technol, Dept Environm Syst Sci, Inst Agr Sci, Zurich, Switzerland; [Eikenberg, Jost] Paul Scherrer Inst, Radioanalyt Lab, Villigen, Switzerland; [Khoshgoftarmanesh, Amir H.; Afyuni, Majid] Isfahan Univ Technol, Dept Soil Sci, Coll Agr, Esfahan, Iran; [Schulin, Rainer] ETH, Swiss Fed Inst Technol, Dept Environm Syst Sci, Inst Terr Ecosyst, Zurich, Switzerland; [Jansa, Jan] Acad Sci Czech Republ, Inst Microbiol, Prague, Czech Republic	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Isfahan University of Technology; Swiss Federal Institutes of Technology Domain; ETH Zurich; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Aghili, F (corresponding author), ETH, Swiss Fed Inst Technol, Dept Environm Syst Sci, Inst Agr Sci, Zurich, Switzerland.	forough.aghili@usys.ethz.ch	Gamper, Hannes A./N-4937-2017; Aghili, Forough/AAN-7003-2021; Jansa, Jan/H-3161-2014	Gamper, Hannes A./0000-0002-8185-3472; Jansa, Jan/0000-0002-0331-1774	Swiss National Science Foundation (SNF) [123920]; Swiss Agency for Development and Cooperation (SDC); J.E. Purkyne Fellowship; long-term development program [RVO61388971]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Swiss Agency for Development and Cooperation (SDC); J.E. Purkyne Fellowship; long-term development program	This study was supported by the grant 123920 of the Swiss National Science Foundation (SNF) and the Swiss Agency for Development and Cooperation (SDC) in the framework of Research Partnerships with Developing Countries. The funding body and host institutions had no role in study-design, data collection, analysis, and manuscript preparation. JJ was further supported by the J.E. Purkyne Fellowship and the long-term development program RVO61388971.	Alloway BJ, 2009, ENVIRON GEOCHEM HLTH, V31, P537, DOI 10.1007/s10653-009-9255-4; [Anonymous], 2010, KEYS SOIL TAXONOMY; Barker SJ, 1998, PLANT J, V15, P791, DOI 10.1046/j.1365-313X.1998.00252.x; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bonfante P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1046; Burt R, 2004, 42 USDA NAT RES CONS; Cakmak I, 2010, J AGR FOOD CHEM, V58, P9092, DOI 10.1021/jf101197h; Cakmak I, 2008, PLANT SOIL, V302, P1, DOI 10.1007/s11104-007-9466-3; Cavagnaro TR, 2008, PLANT SOIL, V304, P315, DOI 10.1007/s11104-008-9559-7; Cavagnaro TR, 2004, NEW PHYTOL, V161, P485, DOI 10.1111/j.1469-8137.2004.00967.x; Curtis, 2002, BREAD WHEAT IMPROVEM; Dakora FD, 2002, PLANT SOIL, V245, P35, DOI 10.1023/A:1020809400075; Daneshbakhsh B, 2013, J PLANT PHYSIOL, V170, P41, DOI 10.1016/j.jplph.2012.08.016; Diesing WE, 2008, EUR J SOIL SCI, V59, P716, DOI 10.1111/j.1365-2389.2008.01032.x; FITTER AH, 1991, EXPERIENTIA, V47, P350, DOI 10.1007/BF01972076; Gao XP, 2009, J ENVIRON QUAL, V38, P2315, DOI 10.2134/jeq2009.0043; Gee G.W., 1986, METHODS SOIL ANAL PA, P383; GERDEMANN J. W., 1963, TRANS BRIT MYCOL SOC, V46, P235; Gramlich A, 2013, J AGR FOOD CHEM, V61, P10409, DOI 10.1021/jf401117d; Hoffland E, 2006, PLANT SOIL, V283, P155, DOI 10.1007/s11104-005-3937-1; Hogland DR, 1938, WATER CULTURE METHOD; Jansa J, 2002, MYCORRHIZA, V12, P225, DOI [10.1007/s005572-002-0163-z, 10.1007/s00572-002-0163-z]; JONER EJ, 1995, SOIL BIOL BIOCHEM, V27, P1153, DOI 10.1016/0038-0717(95)00047-I; Kalayci M, 1999, FIELD CROP RES, V63, P87, DOI 10.1016/S0378-4290(99)00028-3; Karami M, 2009, J AGR FOOD CHEM, V57, P10876, DOI 10.1021/jf902074f; Kariman K, 2014, NEW PHYTOL, V201, P1413, DOI 10.1111/nph.12600; Khoshgoftar AH, 2006, J PLANT NUTR, V29, P1543, DOI 10.1080/01904160600848771; Lehmann A, 2014, SOIL BIOL BIOCHEM, V69, P123, DOI 10.1016/j.soilbio.2013.11.001; LINDSAY WL, 1978, SOIL SCI SOC AM J, V42, P421, DOI 10.2136/sssaj1978.03615995004200030009x; MAAS E V, 1986, Applied Agricultural Research, V1, P12; Marschner B, 2002, SOIL BIOL BIOCHEM, V34, P459, DOI 10.1016/S0038-0717(01)00203-6; McNamara NP, 2003, APPL SOIL ECOL, V24, P117, DOI 10.1016/S0929-1393(03)00073-8; Mostafazadeh-Fard B, 2009, J IRRIG DRAIN ENG, V135, P32, DOI 10.1061/(ASCE)0733-9437(2009)135:1(32); Nazeri NK, 2013, PLANT SOIL, V373, P699, DOI 10.1007/s11104-013-1838-2; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Oliveira RS, 2005, MYCORRHIZA, V16, P23, DOI 10.1007/s00572-005-0010-0; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Rengel Z, 1999, PLANT SCI, V143, P221, DOI 10.1016/S0168-9452(99)00029-1; Rhoades J. D., 1996, Methods of soil analysis. Part 3 - chemical methods., P417; Ryan MH, 2004, J SCI FOOD AGR, V84, P207, DOI 10.1002/jsfa.1634; Ryan MH, 2003, PLANT SOIL, V250, P225, DOI 10.1023/A:1022839930134; Sadeghzadeh B, 2013, J SOIL SCI PLANT NUT, V13, P905, DOI 10.4067/S0718-95162013005000072; SCHENCK NC, 1982, MYCOLOGIA, V74, P77, DOI 10.2307/3792631; Soltani S, 2014, BIOL FERT SOILS, V50, P239, DOI 10.1007/s00374-013-0851-1; THOMPSON JP, 1990, SOIL BIOL BIOCHEM, V22, P229, DOI 10.1016/0038-0717(90)90092-E; Ueno D, 2007, NEW PHYTOL, V174, P304, DOI 10.1111/j.1469-8137.2007.02056.x; van de Voorde TFJ, 2012, SOIL BIOL BIOCHEM, V55, P1, DOI 10.1016/j.soilbio.2012.05.020; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Welch RM, 2004, J EXP BOT, V55, P353, DOI 10.1093/jxb/erh064; White PJ, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00080	50	37	38	3	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101487	10.1371/journal.pone.0101487	http://dx.doi.org/10.1371/journal.pone.0101487			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999738	Green Published, Green Submitted, gold			2022-12-27	WOS:000338637300049
J	Koning, H; van Oosterhout, AJM; Brouwer, U; den Boef, LE; Gras, R; Reinders-Luinge, M; Brandsma, CA; van der Toorn, M; Hylkema, MN; Willemse, BWM; Sayers, I; Koppelman, GH; Nawijn, MC				Koning, Henk; van Oosterhout, Antoon J. M.; Brouwer, Uilke; den Boef, Lisette E.; Gras, Renee; Reinders-Luinge, Marjan; Brandsma, Corry-Anke; van der Toorn, Marco; Hylkema, Machteld N.; Willemse, Brigitte W. M.; Sayers, Ian; Koppelman, Gerard H.; Nawijn, Martijn C.			Mouse Protocadherin-1 Gene Expression Is Regulated by Cigarette Smoke Exposure In Vivo	PLOS ONE			English	Article							EPITHELIAL BARRIER FUNCTION; AIRWAY; ASTHMA; FAMILY; CELLS	Protocadherin-1 (PCDH1) is a novel susceptibility gene for airway hyperresponsiveness, first identified in families exposed to cigarette smoke and is expressed in bronchial epithelial cells. Here, we asked how mouse Pcdh1 expression is regulated in lung structural cells in vivo under physiological conditions, and in both short-term cigarette smoke exposure models characterized by airway inflammation and hyperresponsiveness and chronic cigarette smoke exposure models. Pcdh1 gene-structure was investigated by Rapid Amplification of cDNA Ends. Pcdh1 mRNA and protein expression was investigated by qRT-PCR, western blotting using isoform-specific antibodies. We observed 87% conservation of the Pcdh1 nucleotide sequence, and 96% conservation of the Pcdh1 protein sequence between men and mice. We identified a novel Pcdh1 isoform encoding only the intracellular signalling motifs. Cigarette smoke exposure for 4 consecutive days markedly reduced Pcdh1 mRNA expression in lung tissue (3 to 4-fold), while neutrophilia and airway hyperresponsiveness was induced. Moreover, Pcdh1 mRNA expression in lung tissue was reduced already 6 hours after an acute cigarette-smoke exposure in mice. Chronic exposure to cigarette smoke induced loss of Pcdh1 protein in lung tissue after 2 months, while Pcdh1 protein levels were no longer reduced after 9 months of cigarette smoke exposure. We conclude that Pcdh1 is highly homologous to human PCDH1, encodes two transmembrane proteins and one intracellular protein, and is regulated by cigarette smoke exposure in vivo.	[Koning, Henk; Willemse, Brigitte W. M.; Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Groningen, Netherlands; [Koning, Henk; van Oosterhout, Antoon J. M.; Brouwer, Uilke; den Boef, Lisette E.; Gras, Renee; van der Toorn, Marco; Nawijn, Martijn C.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Lab Allergol & Pulm Dis, Groningen, Netherlands; [Reinders-Luinge, Marjan; Brandsma, Corry-Anke; Hylkema, Machteld N.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Koning, Henk; van Oosterhout, Antoon J. M.; Brouwer, Uilke; den Boef, Lisette E.; Gras, Renee; Reinders-Luinge, Marjan; Brandsma, Corry-Anke; van der Toorn, Marco; Hylkema, Machteld N.; Willemse, Brigitte W. M.; Sayers, Ian; Koppelman, Gerard H.; Nawijn, Martijn C.] Univ Groningen, Univ Med Ctr Groningen, GRIAC Res Inst, Groningen, Netherlands; Univ Nottingham, Queens Med Ctr, Div Therapeut & Mol Med, Nottingham Resp Biomed Res Unit, Nottingham NG7 2RD, England	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Nottingham	Koppelman, GH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Groningen, Netherlands.	g.h.koppelman@umcg.nl	Koppelman, Gerard/AAG-9187-2020	Sayers, Ian/0000-0001-5601-5410; Koppelman, Gerard/0000-0001-8567-3252; Nawijn, Martijn/0000-0003-3372-6521; van der Toorn, Marco/0000-0002-8540-3874	Netherlands' Lung Foundation [NAF 3.2.09.055]; Stichting Astmabestrijding [SAB 2010/043]; EU-funded FP6 project Gabriel; University Medical Center Groningen	Netherlands' Lung Foundation; Stichting Astmabestrijding; EU-funded FP6 project Gabriel; University Medical Center Groningen	This study was supported by research grants from the Netherlands' Lung Foundation (project NAF 3.2.09.055), the Stichting Astmabestrijding (SAB 2010/043) and the EU-funded FP6 project Gabriel (a multidisciplinary study to identify the genetic and environmental causes of asthma). GHK has received grant support from the University Medical Center Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Botelho FM, 2010, AM J RESP CELL MOL, V42, P394, DOI 10.1165/rcmb.2008-0301OC; Davies Donna E, 2009, Proc Am Thorac Soc, V6, P678, DOI 10.1513/pats.200907-067DP; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Haas IG, 2005, J BIOL CHEM, V280, P9313, DOI 10.1074/jbc.M412909200; Hackett TL, 2011, AM J RESP CELL MOL, V45, P1090, DOI 10.1165/rcmb.2011-0031OC; Heijink IH, 2012, EUR RESPIR J, V39, P419, DOI 10.1183/09031936.00193810; Heijink IH, 2010, EUR RESPIR J, V35, P894, DOI 10.1183/09031936.00065809; Ierodiakonou D, 2011, EUR RESPIR J, V38, P1044, DOI 10.1183/09031936.00194710; Kicic A, 2010, AM J RESP CRIT CARE, V181, P889, DOI 10.1164/rccm.200907-1071OC; Koning H, 2012, FASEB J, V26, P439, DOI 10.1096/fj.11-185207; Koppelman GH, 2006, CURR ALLERGY ASTHM R, V6, P103, DOI 10.1007/s11882-006-0047-y; Koppelman GH, 2009, AM J RESP CRIT CARE, V180, P929, DOI 10.1164/rccm.200810-1621OC; LOCK P, 1991, MOL CELL BIOL, V11, P4363, DOI 10.1128/MCB.11.9.4363; Matsumoto K, 1998, EUR RESPIR J, V12, P387, DOI 10.1183/09031936.98.12020387; Nawijn MC, 2011, TRENDS IMMUNOL, V32, P248, DOI 10.1016/j.it.2011.03.004; Ober C, 2011, IMMUNOL REV, V242, P10, DOI 10.1111/j.1600-065X.2011.01029.x; Petecchia L, 2009, CHEST, V135, P1502, DOI 10.1378/chest.08-1780; Pichavant M, 2005, J ALLERGY CLIN IMMUN, V115, P771, DOI 10.1016/j.jaci.2004.11.043; Post S, 2012, THORAX, V67, P488, DOI 10.1136/thoraxjnl-2011-200606; Prefontaine D, 2010, J ALLERGY CLIN IMMUN, V125, P752, DOI 10.1016/j.jaci.2009.12.935; Redies C, 2008, DEV DYNAM, V237, P2496, DOI 10.1002/dvdy.21650; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; SANO K, 1993, EMBO J, V12, P2249, DOI 10.1002/j.1460-2075.1993.tb05878.x; Seymour Brian W P, 2003, Clin Dev Immunol, V10, P35, DOI 10.1080/10446670310001598483; Shaykhiev R, 2011, CELL MOL LIFE SCI, V68, P877, DOI 10.1007/s00018-010-0500-x; Uller L, 2010, THORAX, V65, P626, DOI 10.1136/thx.2009.125930; van der Strate BWA, 2006, AM J RESP CRIT CARE, V173, P751, DOI 10.1164/rccm.200504-594OC; Vanhalst K, 2005, CELL MOL LIFE SCI, V62, P1247, DOI 10.1007/s00018-005-5021-7; Vlahos R, 2006, AM J PHYSIOL-LUNG C, V290, pL931, DOI 10.1152/ajplung.00201.2005; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038; Yoshida K, 1999, FEBS LETT, V460, P93, DOI 10.1016/S0014-5793(99)01309-5	32	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e98197	10.1371/journal.pone.0098197	http://dx.doi.org/10.1371/journal.pone.0098197			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992194	Green Published, gold, Green Submitted			2022-12-27	WOS:000341253400004
J	Rani, DS; Dhandapany, PS; Nallari, P; Narasimhan, C; Thangaraj, K				Rani, Deepa Selvi; Dhandapany, Perundurai S.; Nallari, Pratibha; Narasimhan, Calambur; Thangaraj, Kumarasamy			A Novel Arginine to Tryptophan (R144W) Mutation in Troponin T (cTnT) Gene in an Indian Multigenerational Family with Dilated Cardiomyopathy (FDCM)	PLOS ONE			English	Article							HYPERTROPHIC CARDIOMYOPATHY; SOUTH-ASIA; TNNT2 MUTATIONS; TAIL DOMAIN; PROTEIN; FEATURES; MYBPC3; TNNI3	Cardiomyopathy is a major cause of heart failure and sudden cardiac death; several mutations in sarcomeric protein genes have been associated with this disease. Our aim in the present study is to investigate the genetic variations in Troponin T (cTnT) gene and its association with dilated cardiomyopathy (DCM) in south-Indian patients. Analyses of all the exons and exon-intron boundaries of cTnT in 147 DCM and in 207 healthy controls had revealed a total of 15 SNPs and a 5 bp INDEL; of which, polymorphic SNPs were compared with the HapMap population data. Interestingly, a novel R144W mutation, that substitutes polar-neutral tryptophan for a highly conserved basic arginine in cTnT, altering the charge drastically, was identified in a DCM, with a family history of sudden-cardiac death (SCD). This mutation was found within the tropomyosin (TPM1) binding domain, and was evolutionarily conserved across species, therefore it is expected to have a significant impact on the structure and function of the protein. Family studies had revealed that the R144W is co-segregating with disease in the family as an autosomal dominant trait, but it was completely absent in 207 healthy controls and in 162 previously studied HCM patients. Further screening of the proband and three of his family members (positive for R144W mutant) with eight other genes beta-MYH7, MYBPC3, TPM1, TNNI3, TTN, ACTC, MYL2 and MYL3, did not reveal any disease causing mutation, proposing the absence of compound heterozygosity. Therefore, we strongly suggest that the novel R144W unique/private mutant identified in this study is associated with FDCM. This is furthermore signifying the unique genetic architecture of Indian population.	[Rani, Deepa Selvi; Thangaraj, Kumarasamy] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Telangana, India; [Dhandapany, Perundurai S.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Nallari, Pratibha] Osmania Univ, Dept Genet, Hyderabad 500007, Telangana, India; [Narasimhan, Calambur] CARE Hosp, Dept Cardiol, Hyderabad, Telangana, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Icahn School of Medicine at Mount Sinai; Osmania University	Thangaraj, K (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad, Telangana, India.	thangs@ccmb.res.in		Thangaraj, Kumarasamy/0000-0002-0075-0106; Perundurai, Dhandapany/0000-0001-7831-9570	Council of Scientific and Industrial Research (CSIR), Centre for Cellular and Molecular Biology (CCMB), Hyderabad, Telangana, India; Network project grant, Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi, India [CardioMed-BSC0122]	Council of Scientific and Industrial Research (CSIR), Centre for Cellular and Molecular Biology (CCMB), Hyderabad, Telangana, India; Network project grant, Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi, India	DSR and KT, supported by the Council of Scientific and Industrial Research (CSIR), Centre for Cellular and Molecular Biology (CCMB), Hyderabad, Telangana, India. KT supported by Network project grant (CardioMed-BSC0122), Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi, India. DSR and PN acknowledge OU-DST-PURSE, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman MJ, 2011, EUROPACE, V13, P1077, DOI 10.1093/europace/eur245; Burkett EL, 2005, J AM COLL CARDIOL, V45, P969, DOI 10.1016/j.jacc.2004.11.066; Chaubey G, 2007, BIOESSAYS, V29, P91, DOI 10.1002/bies.20525; CODD MB, 1989, CIRCULATION, V80, P564, DOI 10.1161/01.CIR.80.3.564; Dhandapany PS, 2009, NAT GENET, V41, P187, DOI 10.1038/ng.309; Du CK, 2007, CIRC RES, V101, P185, DOI 10.1161/CIRCRESAHA.106.146670; Girolami F, 2010, J AM COLL CARDIOL, V55, P1444, DOI 10.1016/j.jacc.2009.11.062; Grunig E, 1998, J AM COLL CARDIOL, V31, P186, DOI 10.1016/S0735-1097(97)00434-8; Hershberger RE, 2010, GENET MED, V12, P655, DOI 10.1097/GIM.0b013e3181f2481f; Hershberger RE, 2010, CIRC-CARDIOVASC GENE, V3, P155, DOI 10.1161/CIRCGENETICS.109.912345; Hershberger RE, 2009, CIRC-CARDIOVASC GENE, V2, P306, DOI 10.1161/CIRCGENETICS.108.846733; Hershberger RE, 2009, CIRC-HEART FAIL, V2, P253, DOI 10.1161/CIRCHEARTFAILURE.108.817346; Hershberger RE, 2009, J CARD FAIL, V15, P83, DOI 10.1016/j.cardfail.2009.01.006; Hinkle A, 1999, J BIOL CHEM, V274, P7157, DOI 10.1074/jbc.274.11.7157; Hinkle A, 2003, J BIOL CHEM, V278, P506, DOI 10.1074/jbc.M209194200; Ingles J, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.033886; Jefferies JL, 2010, LANCET, V375, P752, DOI 10.1016/S0140-6736(09)62023-7; Judge DP, 2009, JAMA-J AM MED ASSOC, V302, P2471, DOI 10.1001/jama.2009.1787; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/s0092-8674(02)01226-6; Li DX, 2001, CIRCULATION, V104, P2188, DOI 10.1161/hc4301.098285; Li YY, 1997, J MOL CELL CARDIOL, V29, P2699, DOI 10.1006/jmcc.1997.0501; Luedde M, 2010, CARDIOVASC RES, V86, P452, DOI 10.1093/cvr/cvq009; Metspalu M, 2011, AM J HUM GENET, V89, P731, DOI 10.1016/j.ajhg.2011.11.010; Mirza M, 2005, J BIOL CHEM, V280, P28498, DOI 10.1074/jbc.M412281200; Mogensen J, 2004, J AM COLL CARDIOL, V44, P2033, DOI 10.1016/j.jacc.2004.08.027; Pinto JR, 2008, J BIOL CHEM, V283, P2156, DOI 10.1074/jbc.M707066200; Ramachandran G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070704; Rangaraju A, 2012, EXP CLIN CARDIOL, V17, P26; Rani DS, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-69; Rani DS, 2012, DNA CELL BIOL, V31, P616, DOI 10.1089/dna.2011.1366; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Santorelli FM, 1996, AM J HUM GENET, V58, P933; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Serio A, 2012, HERZ, V37, P822, DOI 10.1007/s00059-012-3707-9; SUGRUE DD, 1992, ANN INTERN MED, V117, P117, DOI 10.7326/0003-4819-117-2-117; WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603; WILES HB, 1991, AM J CARDIOL, V68, P1372, DOI 10.1016/0002-9149(91)90248-J	38	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101451	10.1371/journal.pone.0101451	http://dx.doi.org/10.1371/journal.pone.0101451			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992688	Green Published, gold, Green Submitted			2022-12-27	WOS:000341253400072
J	Sansone, C; Braca, A; Ercolesi, E; Romano, G; Palumbo, A; Casotti, R; Francone, M; Ianora, A				Sansone, Clementina; Braca, Alessandra; Ercolesi, Elena; Romano, Giovanna; Palumbo, Anna; Casotti, Raffaella; Francone, Maria; Ianora, Adrianna			Diatom-Derived Polyunsaturated Aldehydes Activate Cell Death in Human Cancer Cell Lines but Not Normal Cells	PLOS ONE			English	Article							ADENOCARCINOMA A549 CELLS; GROWTH-INHIBITION; MARINE DIATOMS; APOPTOSIS; COPEPOD; REPRODUCTION; SEA; CALANOIDA; DEFENSE; SUCCESS	Diatoms are an important class of unicellular algae that produce bioactive polyunsaturated aldehydes (PUAs) that induce abortions or malformations in the offspring of invertebrates exposed to them during gestation. Here we compare the effects of the PUAs 2-trans,4-trans-decadienal (DD), 2-trans,4- trans-octadienal (OD) and 2-trans,4-trans-heptadienal (HD) on the adenocarcinoma cell lines lung A549 and colon COLO 205, and the normal lung/brunch epithelial BEAS-2B cell line. Using the viability MTT/Trypan blue assays, we show that PUAs have a toxic effect on both A549 and COLO 205 tumor cells but not BEAS-2B normal cells. DD was the strongest of the three PUAs tested, at all time-intervals considered, but HD was as strong as DD after 48 h. OD was the least active of the three PUAs. The effect of the three PUAs was somewhat stronger for A549 cells. We therefore studied the death signaling pathway activated in A549 showing that cells treated with DD activated Tumor Necrosis Factor Receptor 1 (TNFR1) and Fas Associated Death Domain (FADD) leading to necroptosis via caspase-3 without activating the survival pathway Receptor-Interacting Protein (RIP). The TNFR1/FADD/caspase pathway was also observed with OD, but only after 48 h. This was the only PUA that activated RIP, consistent with the finding that OD causes less damage to the cell compared to DD and HD. In contrast, cells treated with HD activated the Fas/FADD/caspase pathway. This is the first report that PUAs activate an extrinsic apoptotic machinery in contrast to other anticancer drugs that promote an intrinsic death pathway, without affecting the viability of normal cells from the same tissue type. These findings have interesting implications also from the ecological viewpoint considering that HD is one of the most common PUAs produced by diatoms.	[Sansone, Clementina; Braca, Alessandra; Ercolesi, Elena; Romano, Giovanna; Palumbo, Anna; Casotti, Raffaella; Francone, Maria; Ianora, Adrianna] Staz Zoolog Anton Dohrn, Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli	Ianora, A (corresponding author), Staz Zoolog Anton Dohrn, Naples, Italy.	adrianna.ianora@szn.it	Casotti, Raffaella/I-9833-2019; Romano, Giovanna/F-4561-2015; Sansone, Clementina/P-3936-2014; Casotti, Raffaella/H-1697-2016; Ianora, Adrianna/O-3408-2019; Braca, Alessandra/A-5910-2015	Casotti, Raffaella/0000-0002-9876-4601; Romano, Giovanna/0000-0002-4898-7153; Sansone, Clementina/0000-0002-3007-8154; Casotti, Raffaella/0000-0002-9876-4601; Braca, Alessandra/0000-0003-3669-0536; Palumbo, Anna/0000-0002-5972-5589	Stazione Zoologica Anton Dohrn; Italian National Operative Project [PON01_02093]	Stazione Zoologica Anton Dohrn; Italian National Operative Project	This work was funded by the Stazione Zoologica Anton Dohrn and by the Italian National Operative Project PON01_02093 Study of new technologies and technological platforms for the improvement of production processes of active pharmaceutical ingredients of industrial interest and search for new bioactive molecules from natural sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolph S, 2003, TETRAHEDRON, V59, P3003, DOI 10.1016/S0040-4020(03)00382-X; Andreou A, 2009, PROG LIPID RES, V48, P148, DOI 10.1016/j.plipres.2009.02.002; Ask J, 2006, J PLANKTON RES, V28, P683, DOI 10.1093/plankt/fbl005; Balestra C, 2011, AQUAT MICROB ECOL, V63, P123, DOI 10.3354/ame01486; Buttino I, 2008, J EXP BIOL, V211, P1426, DOI 10.1242/jeb.015859; Caldwell GS, 2009, MAR DRUGS, V7, P367, DOI 10.3390/md7030367; Carotenuto Y, 2011, J EXP MAR BIOL ECOL, V396, P99, DOI 10.1016/j.jembe.2010.10.012; Casotti R, 2005, J PHYCOL, V41, P7, DOI 10.1111/j.1529-8817.2005.04052.x; Ceballos S, 2003, J EXP MAR BIOL ECOL, V294, P189, DOI 10.1016/S0022-0981(03)00263-6; Cheah SC, 2013, MOLECULES, V18, P8764, DOI 10.3390/molecules18088764; Chen QY, 2010, ONCOL REP, V23, P397, DOI 10.3892/or_00000648; Ciniglia C, 2010, ALLELOPATHY J, V26, P301; d'Ippolito G, 2002, TETRAHEDRON LETT, V43, P6133, DOI 10.1016/S0040-4039(02)01285-6; d'Ippolito G, 2002, TETRAHEDRON LETT, V43, P6137, DOI 10.1016/S0040-4039(02)01283-2; Fontana A, 2007, CHEMBIOCHEM, V8, P1810, DOI 10.1002/cbic.200700269; Halsband-Lenk C, 2005, PROG OCEANOGR, V67, P332, DOI 10.1016/j.pocean.2005.09.003; Hung JY, 2008, CLIN EXP PHARMACOL P, V35, P141, DOI 10.1111/j.1440-1681.2007.04795.x; Ianora A, 2004, NATURE, V429, P403, DOI 10.1038/nature02526; Ianora A, 2011, HYDROBIOLOGIA, V666, P265, DOI 10.1007/s10750-010-0420-7; Ianora A, 2010, ECOTOXICOLOGY, V19, P493, DOI 10.1007/s10646-009-0434-y; Leflaive J, 2009, NEW PHYTOL, V184, P794, DOI 10.1111/j.1469-8137.2009.03033.x; Miralto A, 1999, NATURE, V402, P173, DOI 10.1038/46023; Mou HB, 2011, TOXICOL IN VITRO, V25, P1027, DOI 10.1016/j.tiv.2011.03.023; Park SH, 2012, TOXICOL LETT, V212, P252, DOI 10.1016/j.toxlet.2012.06.007; Phetteplace KL, 2010, TRYPAN BLUE ASSAY ST; Pohnert G, 2005, CHEMBIOCHEM, V6, P946, DOI 10.1002/cbic.200400348; Poulet SA, 2007, J EXP MAR BIOL ECOL, V352, P187, DOI 10.1016/j.jembe.2007.07.019; Poulet SA, 2003, MAR BIOL, V143, P889, DOI 10.1007/s00227-003-1142-4; Ribalet F, 2008, AQUAT TOXICOL, V86, P249, DOI 10.1016/j.aquatox.2007.11.005; Ribalet F, 2007, AQUAT TOXICOL, V85, P219, DOI 10.1016/j.aquatox.2007.09.006; Romano G, 2003, J EXP BIOL, V206, P3487, DOI 10.1242/jeb.00580; Romano G, 2010, MAR DRUGS, V8, P950, DOI 10.3390/md8040950; Sughra K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012683; Vardi A, 2006, PLOS BIOL, V4, P411, DOI 10.1371/journal.pbio.0040060; Vidoudez C, 2008, J PLANKTON RES, V30, P1305, DOI 10.1093/plankt/fbn085; Vidoudez C, 2011, MAR DRUGS, V9, P500, DOI 10.3390/md9040500; Vidoudez C, 2011, MAR DRUGS, V9, P345, DOI 10.3390/md9030345; Wajant H, 2002, SCIENCE, V296, P1635, DOI 10.1126/science.1071553; Weinberger F, 2007, BIOL BULL-US, V213, P290, DOI 10.2307/25066646; Wichard T, 2005, J CHEM ECOL, V31, P949, DOI 10.1007/s10886-005-3615-z; Zhang YL, 2013, AM J CHINESE MED, V41, P1137, DOI 10.1142/S0192415X13500778	41	33	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101220	10.1371/journal.pone.0101220	http://dx.doi.org/10.1371/journal.pone.0101220			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992192	Green Published, gold, Green Submitted			2022-12-27	WOS:000341253400052
J	Hung, SF; Huang, CY; Lin, CL; Chung, SD; Chung, CJ; Kao, CH; Chang, CH				Hung, Shun-Fa; Huang, Chao-Yuan; Lin, Cheng-Li; Chung, Shiu-Dong; Chung, Chi-Jung; Kao, Chia-Hung; Chang, Chao-Hsiang			Increased Risk of Acute Coronary Syndrome among Patients with Urinary Stone Disease: A Nationwide Population-Based Cohort Study	PLOS ONE			English	Article							METABOLIC SYNDROME; KIDNEY-STONES; FOLLOW-UP; NEPHROLITHIASIS; ASSOCIATION; HYPERTENSION; MORTALITY; DEFINITION; PREVALENCE; SEVERITY	Background/Objectives: Urinary stones (US) are associated with systemic metabolic and endocrine disorders that share risk factors typically associated with acute coronary syndrome (ACS). Methods: For this investigation, 30 142 patients with US were set as the research group, and 121 768 randomly selected patients were set as the comparison group through frequency matching by age, sex, and index year. Each patient was individually tracked to identify those who developed ACS during the follow-up period. Cox proportional hazards regression and the Kaplan-Meier method were adopted to calculate the hazard ratios of ACS risk and plot the survival curve. Results: Overall, 275 (13.4 per 10 000 person-y) and 736 events (9.1 per 10 000 person-y) were observed among patients in the research and comparison cohorts, respectively. The patients with US had a substantially lower ACS-free survival rate compared with that of the patients in the comparison cohort (P<.001). After adjusting for potential risk factors, the patients with US were observed to have a 1.22-fold higher risk of ACS compared with patients in the comparison cohort (95% confidence interval = 1.05-1.40, P<.001), particularly among younger patients. Conclusions: The results indicate that US is associated with increased risk of developing ACS, particularly among young (<= 49 years) and male adults. Future studies should examine the possible mechanisms of US-related ACS morbidity by conducting multicenter recruitment and measurements of laboratory data.	[Hung, Shun-Fa] Far Eastern Mem Hosp, Dept Surg, Div Urol, Taipei, Taiwan; [Hung, Shun-Fa] Fu Jen Catholic Univ, Grad Inst Clin Med, Coll Med, New Taipei, Taiwan; [Huang, Chao-Yuan] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Cheng-Li; Chang, Chao-Hsiang] China Med Univ, Coll Med, Taichung, Taiwan; [Chung, Shiu-Dong] Far Eastern Mem Hosp, Dept Surg, Div Urol, New Taipei, Taiwan; [Chung, Shiu-Dong] Fu Jen Catholic Univ, Coll Med, Sch Med, Taipei, Taiwan; [Chung, Shiu-Dong] Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan; [Chung, Shiu-Dong] Tzu Chi Univ, Hualien, Taiwan; [Chung, Chi-Jung] China Med Univ, Coll Publ Hlth, Dept Hlth Risk Management, Taichung, Taiwan; [Chung, Chi-Jung] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan; [Chang, Chao-Hsiang] China Med Univ & Hosp, Dept Urol, Taichung, Taiwan	Far Eastern Memorial Hospital; Fu Jen Catholic University; National Taiwan University; National Taiwan University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Far Eastern Memorial Hospital; Fu Jen Catholic University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Kao, CH (corresponding author), China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan.	d10040@mail.cmuh.org.tw; urology8395@yahoo.com.tw	Chung, Chi-Jung/G-4755-2013	HUANG, CHAO-YUAN/0000-0002-9322-6062	China Medical University Hospital [DMR-103-012, DMR-103-018]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW103-TDU-B-212-113002]; Health and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence (Taiwan) [MOHW103-TD-B-111-03]; International Research-Intensive Centers of Excellence, Taiwan [NSC101-2911-I-002-303]	China Medical University Hospital; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; Health and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence (Taiwan); International Research-Intensive Centers of Excellence, Taiwan	This study was supported by grants from China Medical University Hospital (DMR-103-012 and DMR-103-018); Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW103-TDU-B-212-113002); Health and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence (MOHW103-TD-B-111-03, Taiwan); and the International Research-Intensive Centers of Excellence, Taiwan (NSC101-2911-I-002-303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate N, 2004, KIDNEY INT, V65, P386, DOI 10.1111/j.1523-1755.2004.00386.x; American College of Cardiology, 2006, J Am Coll Cardiol, V48, pe1, DOI 10.1016/j.jacc.2006.05.021; Aydin H, 2011, UROL RES, V39, P451, DOI 10.1007/s00240-011-0383-9; Borghi L, 1999, KIDNEY INT, V55, P2397, DOI 10.1046/j.1523-1755.1999.00483.x; Cameron MA, 2006, J AM SOC NEPHROL, V17, P1422, DOI 10.1681/ASN.2005121246; CAPPUCCIO FP, 1990, BRIT MED J, V300, P1234, DOI 10.1136/bmj.300.6734.1234; Chung SD, 2011, J UROLOGY, V186, P1888, DOI 10.1016/j.juro.2011.07.011; Daudon M, 2006, J AM SOC NEPHROL, V17, P2026, DOI 10.1681/ASN.2006030262; Domingos F, 2011, NEPHROL DIAL TRANSPL, V26, P864, DOI 10.1093/ndt/gfq501; Eisner BH, 2010, J UROLOGY, V183, P2244, DOI 10.1016/j.juro.2010.02.007; Ferraro PM, 2013, JAMA-J AM MED ASSOC, V310, P408, DOI 10.1001/jama.2013.8780; Findlay IN, 2005, HEART, V91, P857, DOI 10.1136/hrt.2004.052795; Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444; Gillen DL, 2005, AM J KIDNEY DIS, V46, P263, DOI 10.1053/j.ajkd.2005.04.030; Gorbachinsky Ilya, 2010, Rev Urol, V12, pe157; Gumina RJ, 2007, MED CLIN N AM, V91, P729, DOI 10.1016/j.mcna.2007.04.003; Huang PL, 2009, DIS MODEL MECH, V2, P231, DOI 10.1242/dmm.001180; Jeong IG, 2011, AM J KIDNEY DIS, V58, P383, DOI 10.1053/j.ajkd.2011.03.021; Kohjimoto Y, 2013, AM J KIDNEY DIS, V61, P923, DOI 10.1053/j.ajkd.2012.12.028; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; Maalouf NM, 2007, CLIN J AM SOC NEPHRO, V2, P883, DOI 10.2215/CJN.00670207; Meigs JB, 2003, ACTA DIABETOL, V40, pS358, DOI 10.1007/s00592-003-0120-0; Pak CYC, 2003, UROLOGY, V61, P523, DOI 10.1016/S0090-4295(02)02421-4; Reiner AP, 2011, J UROLOGY, V185, P920, DOI 10.1016/j.juro.2010.10.086; Rendina D, 2009, NEPHROL DIAL TRANSPL, V24, P900, DOI 10.1093/ndt/gfn548; Rule AD, 2010, J AM SOC NEPHROL, V21, P1641, DOI 10.1681/ASN.2010030253; Sakhaee K, 2002, KIDNEY INT, V62, P971, DOI 10.1046/j.1523-1755.2002.00508.x; Sakhaee K, 2008, CURR OPIN NEPHROL HY, V17, P304, DOI 10.1097/MNH.0b013e3282f8b34d; Sakhaee K, 2012, NEPHROL DIAL TRANSPL, V27, P3201, DOI 10.1093/ndt/gfr703; Scales CD, 2012, EUR UROL, V62, P160, DOI 10.1016/j.eururo.2012.03.052; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Stoller ML, 2004, J UROLOGY, V171, P1920, DOI 10.1097/01.ju.0000120291.90839.49; Tang J, 2013, AM J NEPHROL, V37, P501, DOI 10.1159/000350691; Taylor EN, 2005, KIDNEY INT, V68, P1230, DOI 10.1111/j.1523-1755.2005.00516.x; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; VERSCHUREN WMM, 1995, JAMA-J AM MED ASSOC, V274, P131, DOI 10.1001/jama.274.2.131; Weinberg AE, 2014, EUR UROL, V65, P242, DOI 10.1016/j.eururo.2013.03.026; West B, 2008, AM J KIDNEY DIS, V51, P741, DOI 10.1053/j.ajkd.2007.12.030; Worcester EM, 2007, AM J PHYSIOL-RENAL, V292, pF66, DOI 10.1152/ajprenal.00115.2006	39	1	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102349	10.1371/journal.pone.0102349	http://dx.doi.org/10.1371/journal.pone.0102349			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010058	Green Published, gold, Green Submitted			2022-12-27	WOS:000338763800092
J	[Anonymous]				[Anonymous]			Expression of Concern: Bacillus pumilus Reveals a Remarkably High Resistance to Hydrogen Peroxide Provoked Oxidative Stress	PLOS ONE			English	Editorial Material																		Handtke S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085625	1	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e100716	10.1371/journal.pone.0100716	http://dx.doi.org/10.1371/journal.pone.0100716			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010116	Green Published, gold, Green Submitted			2022-12-27	WOS:000338763800005
J	Dhimal, M; Aryal, KK; Dhimal, ML; Gautam, I; Singh, SP; Bhusal, CL; Kuch, U				Dhimal, Meghnath; Aryal, Krishna Kumar; Dhimal, Mandira Lamichhane; Gautam, Ishan; Singh, Shanker Pratap; Bhusal, Chop Lal; Kuch, Ulrich			Knowledge, Attitude and Practice Regarding Dengue Fever among the Healthy Population of Highland and Lowland Communities in Central Nepal	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; VIRUS; TRANSMISSION; ALBOPICTUS; CULICIDAE; RESPONSES; DISEASE; BURDEN; FRANCE; URBAN	Background: Dengue fever (DF) is the most rapidly spreading mosquito-borne viral disease in the world. In this decade it has expanded to new countries and from urban to rural areas. Nepal was regarded DF free until 2004. Since then dengue virus (DENV) has rapidly expanded its range even in mountain regions of Nepal, and major outbreaks occurred in 2006 and 2010. However, no data on the local knowledge, attitude and practice (KAP) of DF in Nepal exist although such information is required for prevention and control measures. Methods: We conducted a community based cross-sectional survey in five districts of central Nepal between September 2011 and February 2012. We collected information on the socio-demographic characteristics of the participants and their knowledge, attitude and practice regarding DF using a structured questionnaire. We then statistically compared highland and lowland communities to identify possible causes of observed differences. Principal Findings: Out of 589 individuals interviewed, 77% had heard of DF. Only 12% of the sample had good knowledge of DF. Those living in the lowlands were five times more likely to possess good knowledge than highlanders (P<0.001). Despite low knowledge levels, 83% of the people had good attitude and 37% reported good practice. We found a significantly positive correlation among knowledge, attitude and practice (P<0.001). Among the socio-demographic variables, the education level of the participants was an independent predictor of practice level (P<0.05), and education level and interaction between the sex and age group of the participants were independent predictors of attitude level (P<0.05). Conclusion: Despite the rapid expansion of DENV in Nepal, the knowledge of people about DF was very low. Therefore, massive awareness programmes are urgently required to protect the health of people from DF and to limit its further spread in this country.	[Dhimal, Meghnath; Aryal, Krishna Kumar; Singh, Shanker Pratap; Bhusal, Chop Lal] NHRC, Kathmandu, Nepal; [Dhimal, Meghnath; Dhimal, Mandira Lamichhane; Kuch, Ulrich] Senckenberg Gesell Naturforsch BiK F, Frankfurt, Germany; [Dhimal, Meghnath] Goethe Univ Frankfurt, Inst Atmosphere & Environm, D-60054 Frankfurt, Germany; [Dhimal, Mandira Lamichhane] Goethe Univ Frankfurt, Fac Social Sci, D-60054 Frankfurt, Germany; [Gautam, Ishan] Tribhuvan Univ, Nat Hist Museum, Kathmandu, Nepal	Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt; Goethe University Frankfurt; Tribhuvan University	Dhimal, M (corresponding author), NHRC, Kathmandu, Nepal.	meghdhimal@gmail.com	Dhimal, Meghnath/AAD-7261-2021	Dhimal, Meghnath/0000-0001-7176-7821; Lamichhane Dhimal, Mandira/0000-0003-0258-5148	Government of Nepal; DAAD PhD scholarship; research funding programme "LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz'' of the Ministry of Higher Education, Research; Arts of the State of Hesse, Germany	Government of Nepal; DAAD PhD scholarship; research funding programme "LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz'' of the Ministry of Higher Education, Research; Arts of the State of Hesse, Germany	This research was performed as a part of the collaborative research project "A longitudinal study on Aedes mosquitoes and climate change along an altitudinal transect in central Nepal'' by the Nepal Health Research Council (NHRC) and the Biodiversity and Climate Research Centre (BiK-F). It was financially supported by a research grant from the Government of Nepal, a DAAD PhD scholarship to MD and the research funding programme "LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz'' of the Ministry of Higher Education, Research and the Arts of the State of Hesse, Germany. The funding bodies had no role in the study design, data collection, data analysis, interpretation of results, decision to publish or preparation of manuscript.	Acharya Anita, 2005, Journal of Vector Borne Diseases, V42, P122; Adams SA, 2005, AM J EPIDEMIOL, V161, P389, DOI 10.1093/aje/kwi054; Ali M, 2003, AM J TROP MED HYG, V69, P634, DOI 10.4269/ajtmh.2003.69.634; Arunachalam N, 2010, B WORLD HEALTH ORGAN, V88, P173, DOI 10.2471/BLT.09.067892; Arya SC, 2009, TRANSFUS APHER SCI, V41, P231, DOI 10.1016/j.transci.2009.09.009; BARKERHUDSON P, 1988, J MED ENTOMOL, V25, P178, DOI 10.1093/jmedent/25.3.178; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; CHAN YC, 1971, B WORLD HEALTH ORGAN, V44, P651; Chongsuvivatwong V, 2012, EPICALC EPIDEMIOLOGI; Crawley M.J., 2007, R BOOK; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; DARSIE R F JR, 1990, Mosquito Systematics, V22, P69; Dhimal M, 2009, J NEPAL HLTH RES COU, V7, P140; DOHS, 2012, 206768 DOHS GOV NEP; Dumre SP, 2013, AM J TROP MED HYG, V88, P677, DOI 10.4269/ajtmh.12-0436; Gautam I., 2009, J NATURAL HIST MUSEU, V24, P156, DOI [10.3126/jnhm.v24i1.2298, DOI 10.3126/JNHM.V24I1.2298, DOI 10.3126/jnhm.v24i1.2298]; Gautam I, 2012, J NAT HIST MUS, V26, P181, DOI DOI 10.3126/jnhm.v26i0.14142; Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Griffiths K, 2013, J TROP MED, V2013, P8; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Gupta Pushpa, 1998, Journal of Communicable Diseases, V30, P107; Hairi Farizah, 2003, Asia Pac J Public Health, V15, P37, DOI 10.1177/101053950301500107; Halstead SB, 2012, LANCET, V380, P1535, DOI 10.1016/S0140-6736(12)61510-4; Iacobucci D, 2003, J CONSUM PSYCHOL, V13, P478, DOI 10.1207/S15327663JCP1304_14; Itrat A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002620; Koenraadt CJM, 2006, AM J TROP MED HYG, V74, P692, DOI 10.4269/ajtmh.2006.74.692; La Ruche G, 2010, EUROSURVEILLANCE, V15, P2; LUMSDEN W. H. R., 1957, BULL ENT RES, V48, P769, DOI 10.1017/S0007485300002881; Luskin RC, 2011, J POLIT, V73, P547, DOI 10.1017/S0022381611000132; Mayxay M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-434; NELSON MJ, 1978, J MED ENTOMOL, V14, P504, DOI 10.1093/jmedent/14.5.504; Nepal Health Research Council (NHRC), 2011, NAT ETH GUID HLTH RE; Pandey Basu D, 2013, Trop Med Health, V41, P103, DOI 10.2149/tmh.2012-17; Pandey BD, 2008, EMERG INFECT DIS, V14, P514, DOI 10.3201/eid1403.070473; Pandey Basu Dev, 2004, Nepal Med Coll J, V6, P157; Peters W., 1956, Indian Journal of Malariology, V10, P37; Petersen LR, 2012, TRANSFUSION, V52, P1647, DOI 10.1111/j.1537-2995.2011.03529.x; Pun SB, 2011, J NEPAL MED ASSOC, V51, P203; R Development Core Team, 2012, R LANG ENV STAT COMP; Radhakrishna RB., 2007, J EXT, V45, P1; Sedhain A, 2011, INT J INFECT DIS, V15, pS113, DOI 10.1016/S1201-9712(11)60396-2; Sharma B, 2012, INT J PHARM BIOL ARC, V3, P1383; Shepard DS, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002055, 10.1371/journal.pntd.0002056]; Shuaib F, 2010, W INDIAN MED J, V59, P139; Takasaki T, 2008, J TRAVEL MED, V15, P46, DOI 10.1111/j.1708-8305.2007.00165.x; Tambyah PA, 2008, NEW ENGL J MED, V359, P1526, DOI 10.1056/NEJMc0708673; Uma Deavi Ayyamani, 1986, Med J Malaysia, V41, P108; van Benthem BHB, 2002, TROP MED INT HEALTH, V7, P993, DOI 10.1046/j.1365-3156.2002.00950.x; Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716; Wang H, 1997, J ENVIRON ECON MANAG, V32, P219, DOI 10.1006/jeem.1996.0965; WHO/SEARO, 2011, COMPR GUID PREV CONT; WHO/TDR, 2009, DENG GUID DIAGN TREA; Wilder-Smith A, 2009, EMERG INFECT DIS, V15, P8, DOI 10.3201/eid1501.071097; YASUNO M, 1970, B WORLD HEALTH ORGAN, V43, P319; Yboa BC, 2013, AM J PUBLIC HLTH RES, V1, P47, DOI [10.12691/ajphr-1-2-2, DOI 10.12691/AJPHR-1-2-2]	58	93	97	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102028	10.1371/journal.pone.0102028	http://dx.doi.org/10.1371/journal.pone.0102028			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL3PK	25007284	gold, Green Submitted, Green Published			2022-12-27	WOS:000339040600088
J	Oshima, N; Yamada, Y; Nagayama, S; Kawada, K; Hasegawa, S; Okabe, H; Sakai, Y; Aoi, T				Oshima, Nobu; Yamada, Yasuhiro; Nagayama, Satoshi; Kawada, Kenji; Hasegawa, Suguru; Okabe, Hiroshi; Sakai, Yoshiharu; Aoi, Takashi			Induction of Cancer Stem Cell Properties in Colon Cancer Cells by Defined Factors	PLOS ONE			English	Article							HUMAN COLORECTAL-CANCER; SIDE-POPULATION; HUMAN FIBROBLASTS; MARKER; EXPRESSION; PHENOTYPE; CARCINOMA; NANOG; CDX2; ADENOCARCINOMAS	Cancer stem cells (CSCs) are considered to be responsible for the dismal prognosis of cancer patients. However, little is known about the molecular mechanisms underlying the acquisition and maintenance of CSC properties in cancer cells because of their rarity in clinical samples. We herein induced CSC properties in cancer cells using defined factors. We retrovirally introduced a set of defined factors (OCT3/4, SOX2 and KLF4) into human colon cancer cells, followed by culture with conventional serum-containing medium, not human embryonic stem cell medium. We then evaluated the CSC properties in the cells. The colon cancer cells transduced with the three factors showed significantly enhanced CSC properties in terms of the marker gene expression, sphere formation, chemoresistance and tumorigenicity. We designated the cells with CSC properties induced by the factors, a subset of the transduced cells, as induced CSCs (iCSCs). Moreover, we established a novel technology to isolate and collect the iCSCs based on the differences in the degree of the dye-effluxing activity enhancement. The xenografts derived from our iCSCs were not teratomas. Notably, in contrast to the tumors from the parental cancer cells, the iCSC-based tumors mimicked actual human colon cancer tissues in terms of their immunohistological findings, which showed colonic lineage differentiation. In addition, we confirmed that the phenotypes of our iCSCs were reproducible in serial transplantation experiments. By introducing defined factors, we generated iCSCs with lineage specificity directly from cancer cells, not via an induced pluripotent stem cell state. The novel method enables us to obtain abundant materials of CSCs that not only have enhanced tumorigenicity, but also the ability to differentiate to recapitulate a specific type of cancer tissues. Our method can be of great value to fully understand CSCs and develop new therapies targeting CSCs.	[Oshima, Nobu; Yamada, Yasuhiro] Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Reprogramming Sci, Kyoto, Japan; [Oshima, Nobu; Aoi, Takashi] Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Fundamental Cell Technol, Kyoto, Japan; [Oshima, Nobu; Nagayama, Satoshi; Kawada, Kenji; Hasegawa, Suguru; Okabe, Hiroshi; Sakai, Yoshiharu] Kyoto Univ, Dept Surg, Grad Sch Med, Kyoto, Japan; [Nagayama, Satoshi] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Ctr, Tokyo, Japan; [Aoi, Takashi] Kobe Univ, Grad Sch Med, Dept iPS Cell Applicat, Kobe, Hyogo 657, Japan	Kyoto University; Kyoto University; Kyoto University; Japanese Foundation for Cancer Research; Kobe University	Aoi, T (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Fundamental Cell Technol, Kyoto, Japan.	takaaoi@med.kobe-u.ac.jp			Shinryokukai General Incorporated Association; Japan Society for the Promotion of Science (JSPS) [10J06242]	Shinryokukai General Incorporated Association; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study had been made possible thanks to the Balzan Prize to Shinya Yamanaka (http://www.balzan.org/en/about-us/balzan-prize-milan), and supported by Research Assistance Funds from Shinryokukai General Incorporated Association (https://www.shinryokukai.com/) (to TA) which is a not for profit alumni association of Kobe university school of medicine, and Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (JSPS; http://www.jsps.go.jp/english/index.html): 10J06242 (to NO), and NO was JSPS research fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, and this does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Bayrak R, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-9; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; Chan CWM, 2009, P NATL ACAD SCI USA, V106, P1936, DOI 10.1073/pnas.0812904106; Chen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033544; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dennis JL, 2005, CLIN CANCER RES, V11, P3766, DOI 10.1158/1078-0432.CCR-04-2236; Ding XW, 2010, LIFE SCI, V86, P631, DOI 10.1016/j.lfs.2010.02.012; Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034; EE HC, 1995, AM J PATHOL, V147, P586; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Haraguchi N, 2006, STEM CELLS, V24, P506, DOI 10.1634/stemcells.2005-0282; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Inoda S, 2011, AM J PATHOL, V178, P1805, DOI 10.1016/j.ajpath.2011.01.004; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Matsui T, 2012, STEM CELLS, V30, P1109, DOI 10.1002/stem.1091; Matsuoka J, 2012, J SURG RES, V174, P130, DOI 10.1016/j.jss.2010.11.903; MOLL R, 1992, AM J PATHOL, V140, P427; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Neumann J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-518; Nishi M., 2013, ONCOGENE; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Saigusa S, 2009, ANN SURG ONCOL, V16, P3488, DOI 10.1245/s10434-009-0617-z; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Schoenhals M, 2009, BIOCHEM BIOPH RES CO, V383, P157, DOI 10.1016/j.bbrc.2009.02.156; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Todaro M, 2010, GASTROENTEROLOGY, V138, P2151, DOI 10.1053/j.gastro.2009.12.063; Tot T, 2002, EUR J CANCER, V38, P758, DOI 10.1016/S0959-8049(02)00008-4; Vaiopoulos AG, 2012, STEM CELLS, V30, P363, DOI 10.1002/stem.1031; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Werling RW, 2003, AM J SURG PATHOL, V27, P303, DOI 10.1097/00000478-200303000-00003; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591; Zhang J, 2013, ONCOGENE, V32, P4397, DOI 10.1038/onc.2012.461; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	43	68	74	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101735	10.1371/journal.pone.0101735	http://dx.doi.org/10.1371/journal.pone.0101735			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006808	Green Published, Green Submitted, gold			2022-12-27	WOS:000339040600063
J	Chen, C; Zhang, BY; Yu, SL; Sun, F; Ruan, QL; Zhang, WH; Shao, LY; Chen, S				Chen, Chen; Zhang, Bingyan; Yu, Shenglei; Sun, Feng; Ruan, Qiaoling; Zhang, Wenhong; Shao, Lingyun; Chen, Shu			The Incidence and Risk Factors of Meningitis after Major Craniotomy in China: A Retrospective Cohort Study	PLOS ONE			English	Article							SURGICAL SITE INFECTIONS; BACTERIAL-MENINGITIS; NEUROSURGICAL PROCEDURES; ANTIBIOTIC-PROPHYLAXIS; WOUND-INFECTION; POSTOPERATIVE MENINGITIS; SURGERY	Background: Meningitis after neurosurgery can result in severe morbidity and high mortality. Incidence varies among regions and limited data are focused on meningitis after major craniotomy. Aim: This retrospective cohort study aimed to determine the incidence, risk factors and microbiological spectrum of postcraniotomy meningitis in a large clinical center of Neurosurgery in China. Methods: Patients who underwent neurosurgeries at the Department of Neurosurgery in Huashan Hospital, the largest neurosurgery center in Asia and the Pacific, between 1st January and 31st December, 2008 were selected. Individuals with only shunts, burr holes, stereotactic surgery, transsphenoidal or spinal surgery were excluded. The complete medical records of each case were reviewed, and data on risk factors were extracted and evaluated for meningitis. Results: A total of 65 meningitides were identified among 755 cases in the study, with an incidence of 8.60%. The risk of meningitis was increased by the presence of diabetes mellitus (odds ratio [OR], 6.27; P = 0.009), the use of external ventricular drainage (OR, 4.30; P = 0.003) and the use of lumbar drainage (OR, 17.23; P<0.001). The isolated microorganisms included Acinetobacter baumannii, Enterococcus sp, Streptococcus intermedius and Klebsiella pneumonia. Conclusions: Meningitis remains an important source of morbidity and mortality after major craniotomy. Diabetic patients or those with cerebral spinal fluid shunts carry significant high risk of infection. Thus, identification of the risk factors as soon as possible will help physicians to improve patient care.	[Chen, Chen; Zhang, Bingyan; Yu, Shenglei; Sun, Feng; Ruan, Qiaoling; Zhang, Wenhong; Shao, Lingyun; Chen, Shu] Fudan Univ, Dept Infect Dis, Huashan Hosp, Shanghai 200433, Peoples R China	Fudan University	Shao, LY (corresponding author), Fudan Univ, Dept Infect Dis, Huashan Hosp, Shanghai 200433, Peoples R China.	lingyun26@fudan.edu.cn; shuchen@fudan.edu.cn			Scientific Project of Science and Technology Commission of Shanghai Municipality [114119b1900]	Scientific Project of Science and Technology Commission of Shanghai Municipality	The study was funded by the research grant of Scientific Project of Science and Technology Commission of Shanghai Municipality (Fund No. 114119b1900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2003, NURS J INDIA, V94, P212; Agarwal Mesna, 2003, Nurs J India, V94, P197; BALCH RE, 1967, J NEUROSURG, V26, P41, DOI 10.3171/jns.1967.26.1part1.0041; Barker FG, 2002, NEUROSURGERY, V51, P391, DOI 10.1097/00006123-200208000-00017; BLOMSTEDT GC, 1985, ACTA NEUROCHIR, V78, P81, DOI 10.1007/BF01808684; Briggs S, 2004, SCAND J INFECT DIS, V36, P165, DOI 10.1080/00365540410027193; BUCKWOLD FJ, 1977, J NEUROSURG, V46, P494, DOI 10.3171/jns.1977.46.4.0494; Buffet-Bataillon S, 2013, AM J INFECT CONTROL, V41, P1290, DOI 10.1016/j.ajic.2013.02.006; Coplin WM, 1999, J NEUROL NEUROSUR PS, V67, P468, DOI 10.1136/jnnp.67.4.468; Dashti SR, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/6/E10; Erdem I, 2008, NEUROL INDIA, V56, P433, DOI 10.4103/0028-3886.44629; Erman T, 2005, SURG NEUROL, V63, P107, DOI 10.1016/j.surneu.2004.04.024; Federico G, 2001, SCAND J INFECT DIS, V33, P533, DOI 10.1080/00365540110026557; HORAN TC, 1992, INFECT CONT HOSP EP, V13, P606; Huang CR, 2001, INFECTION, V29, P75, DOI 10.1007/s15010-001-0087-0; Khan FY, 2012, J HOSP INFECT, V80, P176, DOI 10.1016/j.jhin.2011.08.021; Korinek AM, 2005, BRIT J NEUROSURG, V19, P155, DOI 10.1080/02688690500145639; Kourbeti IS, 2007, NEUROSURGERY, V60, P317, DOI 10.1227/01.NEU.0000249266.26322.25; Lietard C, 2008, J NEUROSURG, V109, P729, DOI 10.3171/JNS/2008/109/10/0729; Mao Y, 2011, WORLD NEUROSURG, V75, P369, DOI 10.1016/j.wneu.2011.02.002; McClelland S, 2007, CLIN INFECT DIS, V45, P55, DOI 10.1086/518580; MOLLMAN HD, 1986, J NEUROSURG, V64, P902, DOI 10.3171/jns.1986.64.6.0902; PATIR R, 1992, ACTA NEUROCHIR, V119, P80, DOI 10.1007/BF01541786; QUADERY LA, 1977, ACTA NEUROCHIR, V39, P133, DOI 10.1007/BF01406722; Reichert MCF, 2002, AM J INFECT CONTROL, V30, P158, DOI 10.1067/mic.2002.119925; Scheithauer S, 2010, INFECTION, V38, P205, DOI 10.1007/s15010-010-0006-3; Sneh-Arbib O, 2013, EUR J CLIN MICROBIOL, V32, P1511, DOI 10.1007/s10096-013-1904-y; Srinivas D, 2011, NEUROL INDIA, V59, P195, DOI 10.4103/0028-3886.79136; TENNEY JH, 1985, J NEUROSURG, V62, P243, DOI 10.3171/jns.1985.62.2.0243; van de Beek D, 2010, NEW ENGL J MED, V362, P146, DOI 10.1056/NEJMra0804573; Wang C, 2008, NEUROSURGERY, V62, P947, DOI 10.1227/01.neu.0000318181.80040.99; WRIGHT RL, 1966, J NEUROSURG, V25, P125	32	58	62	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101961	10.1371/journal.pone.0101961	http://dx.doi.org/10.1371/journal.pone.0101961			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003204	Green Published, gold, Green Submitted			2022-12-27	WOS:000339242700093
J	Edzuka, T; Yamada, L; Kanamaru, K; Sawada, H; Goshima, G				Edzuka, Tomoya; Yamada, Lixy; Kanamaru, Kyoko; Sawada, Hitoshi; Goshima, Gohta			Identification of the Augmin Complex in the Filamentous Fungus Aspergillus nidulans	PLOS ONE			English	Article							GAMMA-TUBULIN COMPLEXES; SPINDLE-POLE-BODY; MICROTUBULE NUCLEATION; MITOTIC SPINDLE; GENERATION; COMPONENT; REVEALS; GENES; YEAST	Augmin is a protein complex that binds to spindle microtubules (MTs), recruits the potent MT nucleator, gamma-tubulin, and thereby promotes the centrosome-independent MT generation within mitotic and meiotic spindles. Augmin is essential for acentrosomal spindle assembly, which is commonly observed during mitosis in plants and meiosis in female animals. In many animal somatic cells that possess centrosomes, the centrosome- and augmin-dependent mechanisms work cooperatively for efficient spindle assembly and cytokinesis. Yeasts have lost the augmin genes during evolution. It is hypothesized that their robust MT nucleation from the spindle pole body (SPB), the centrosome-equivalent structure in fungi, compensates for the lack of augmin. Intriguingly, however, a gene homologous to an augmin subunit (Aug6/AUGF) has been found in the genome of filamentous fungi, which has the SPB as a robust MT nucleation centre. Here, we aimed to clarify if the augmin complex is present in filamentous fungi and to identify its role in mitosis. By analysing the Aug6-like gene in the filamentous fungus Aspergillus nidulans, we found that it forms a large complex with several other proteins that share weak but significant homology to known augmin subunits. In A. nidulans, augmin was enriched at the SPB and also associated with spindle MTs during mitosis. However, the augmin gene disruptants did not exhibit growth defects under normal, checkpoint-deficient, or MT-destabilised conditions. Moreover, we obtained no evidence that A. nidulans augmin plays a role in gamma-tubulin recruitment or in mitotic cell division. Our study uncovered the conservation of the augmin complex in the fungal species, and further suggests that augmin has several functions, besides mitotic spindle MT nucleation, that are yet to be identified.	[Edzuka, Tomoya; Goshima, Gohta] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Yamada, Lixy; Sawada, Hitoshi] Nagoya Univ, Sugashima Marine Biol Lab, Grad Sch Sci, Toba, Mie, Japan; [Kanamaru, Kyoko] Nagoya Univ, Grad Sch Bioagr Sci, Dept Biol Mech & Funct, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University; Nagoya University	Goshima, G (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	goshima@bio.nagoya-u.ac.jp		Kanamaru, Kyoko/0000-0003-3964-7891	Japan Society for Promotion of Science	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Next Generation grant (Japan Society for Promotion of Science) to GG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki Y, 2012, EUKARYOT CELL, V11, P638, DOI 10.1128/EC.00028-12; BALLANCE DJ, 1985, GENE, V36, P321, DOI 10.1016/0378-1119(85)90187-8; Duncan T, 2011, CHROMOSOME RES, V19, P321, DOI 10.1007/s10577-011-9205-8; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Fujita A, 2002, MOL BIOL CELL, V13, P2360, DOI 10.1091/mbc.02-01-0603; Gibeaux R, 2012, J CELL SCI, V125, P5830, DOI 10.1242/jcs.111005; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Horio T, 2005, MOL BIOL CELL, V16, P918, DOI 10.1091/mbc.E04-09-0798; Hotta T, 2012, PLANT CELL, V24, P1494, DOI 10.1105/tpc.112.096610; Johmura Y, 2011, P NATL ACAD SCI USA, V108, P11446, DOI 10.1073/pnas.1106223108; Lawo S, 2009, CURR BIOL, V19, P816, DOI 10.1016/j.cub.2009.04.033; Meireles M, 2009, J CELL BIOL, V184, P777, DOI 10.1083/jcb.200811102; Moritz M, 2001, CURR OPIN STRUC BIOL, V11, P174, DOI 10.1016/S0959-440X(00)00187-1; Motoyama T, 1996, MOL GEN GENET, V251, P442, DOI 10.1007/BF02172373; Murata T, 2005, NAT CELL BIOL, V7, P961, DOI 10.1038/ncb1306; Nakaoka Y, 2012, PLANT CELL, V24, P1478, DOI 10.1105/tpc.112.098509; Nayak T, 2010, J CELL BIOL, V190, P317, DOI 10.1083/jcb.201002105; OAKLEY BR, 1990, CELL, V61, P1289, DOI 10.1016/0092-8674(90)90693-9; Oegema K, 1999, J CELL BIOL, V144, P721, DOI 10.1083/jcb.144.4.721; Osmani SA, 2004, FUNGAL GENET BIOL, V41, P401, DOI 10.1016/j.fgb.2003.11.009; Petry S, 2011, P NATL ACAD SCI USA, V108, P14473, DOI 10.1073/pnas.1110412108; Uehara R, 2009, P NATL ACAD SCI USA, V106, P6998, DOI 10.1073/pnas.0901587106; Veith D, 2005, J CELL SCI, V118, P3705, DOI 10.1242/jcs.02501; Wainman A, 2009, GENE DEV, V23, P1876, DOI 10.1101/gad.532209; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601; Xiong Y, 2009, J CELL SCI, V122, P4218, DOI 10.1242/jcs.059196; Yamada L, 2009, J BIOL CHEM, V284, P9402, DOI 10.1074/jbc.M809672200	29	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101471	10.1371/journal.pone.0101471	http://dx.doi.org/10.1371/journal.pone.0101471			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003582	Green Published, gold, Green Submitted			2022-12-27	WOS:000339242700033
J	Fukushima, T; Iizuka, H; Yokota, A; Suzuki, T; Ohno, C; Kono, Y; Nishikiori, M; Seki, A; Ichiba, H; Watanabe, Y; Hongo, S; Utsunomiya, M; Nakatani, M; Sadamoto, K; Yoshio, T				Fukushima, Takeshi; Iizuka, Hideaki; Yokota, Ayaka; Suzuki, Takehiro; Ohno, Chihiro; Kono, Yumiko; Nishikiori, Minami; Seki, Ayaka; Ichiba, Hideaki; Watanabe, Yoshinori; Hongo, Seiji; Utsunomiya, Mamoru; Nakatani, Masaki; Sadamoto, Kiyomi; Yoshio, Takashi			Quantitative Analyses of Schizophrenia-Associated Metabolites in Serum: Serum D-Lactate Levels Are Negatively Correlated with Gamma-Glutamylcysteine in Medicated Schizophrenia Patients	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; COLUMN-SWITCHING HPLC; ANTIOXIDANT ENZYME-ACTIVITIES; ACID-BINDING PROTEIN; D-SERINE; CEREBROSPINAL-FLUID; OXIDATIVE STRESS; KYNURENIC ACID; FATTY-ACIDS; PLASMA	The serum levels of several metabolites are significantly altered in schizophrenia patients. In this study, we performed a targeted analysis of 34 candidate metabolites in schizophrenia patients (n = 25) and compared them with those in age- and gender-matched healthy subjects (n = 27). Orthogonal partial least square-discriminant analysis revealed that complete separation between controls and patients was achieved based on these metabolites. We found that the levels of gamma-glutamylcysteine (gamma-GluCys), linoleic acid, arachidonic acid, D-serine, 3-hydroxybutyrate, glutathione (GSH), 5-hydroxytryptamine, threonine, and tyrosine were significantly lower, while D-lactate, tryptophan, kynurenine, and glutamate levels were significantly higher in schizophrenia patients compared to controls. Using receiver operating characteristics (ROC) curve analysis, the sensitivity, specificity, and the area under curve of gamma-GluCys, a precursor of GSH, and D-lactate, a terminal metabolite of methylglyoxal, were 88.00%, 81.48%, and 0.8874, and 88.00%, 77.78%, and 0.8415, respectively. In addition, serum levels of D-lactate were negatively correlated with gamma-GluCys levels in patients, but not in controls. The present results suggest that oxidative stress-induced damage may be involved in the pathogenesis of schizophrenia.	[Fukushima, Takeshi; Iizuka, Hideaki; Yokota, Ayaka; Suzuki, Takehiro; Ohno, Chihiro; Kono, Yumiko; Nishikiori, Minami; Seki, Ayaka; Ichiba, Hideaki] Toho Univ, Fac Pharmaceut Sci, Dept Analyt Chem, Funabashi, Chiba 274, Japan; [Watanabe, Yoshinori; Hongo, Seiji] Med Corp JISENKAI, Nanko Clin Psychiat, Himorogi Grp, Shirakawa, Fukushima, Japan; [Utsunomiya, Mamoru; Nakatani, Masaki] Sumiyoshi kaiseikai Sumiyoshi Hosp, Publ Interest Inc Fdn, Koufu, Yamanashi, Japan; [Sadamoto, Kiyomi] Yokohama Coll Pharm, Dept Clin Pharm, Yokohama, Kanagawa, Japan; [Yoshio, Takashi] Toho Univ, Fac Pharmaceut Sci, Dept Clin Pharm, Funabashi, Chiba 274, Japan	Toho University; Toho University	Fukushima, T (corresponding author), Toho Univ, Fac Pharmaceut Sci, Dept Analyt Chem, 2-2-1 Miyama, Funabashi, Chiba 274, Japan.	t-fukushima@phar.toho-u.ac.jp			Japan Society for the Promotion of Science; Faculty of Pharmaceutical sciences, Toho University;  [23617027];  [25460224]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Faculty of Pharmaceutical sciences, Toho University; ; 	This research was financially supported by the Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (C) Grant Numbers 23617027 and 25460224, and the Faculty of Pharmaceutical sciences, Toho University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama C, 2004, BIOMED CHROMATOGR, V18, P630, DOI 10.1002/bmc.365; Arai M, 2010, ARCH GEN PSYCHIAT, V67, P589, DOI 10.1001/archgenpsychiatry.2010.62; Batabyal D, 2007, J AM CHEM SOC, V129, P15690, DOI 10.1021/ja076186k; Bitanihirwe BKY, 2011, NEUROSCI BIOBEHAV R, V35, P878, DOI 10.1016/j.neubiorev.2010.10.008; Cai HL, 2012, J PROTEOME RES, V11, P4338, DOI 10.1021/pr300459d; Calcia MA, 2012, SCHIZOPHR RES, V142, P83, DOI 10.1016/j.schres.2012.09.014; Chumakov I, 2002, P NATL ACAD SCI USA, V99, P13675, DOI 10.1073/pnas.182412499; Erhardt S, 2001, NEUROSCI LETT, V313, P96, DOI 10.1016/S0304-3940(01)02242-X; Freedman R, 2003, NEW ENGL J MED, V349, P1738, DOI 10.1056/NEJMra035458; Fukushima T, 2004, BIOMED CHROMATOGR, V18, P813, DOI 10.1002/bmc.394; Fukushima T, 2007, CLIN CHIM ACTA, V377, P174, DOI 10.1016/j.cca.2006.09.019; Gawryluk JW, 2011, INT J NEUROPSYCHOPH, V14, P123, DOI 10.1017/S1461145710000805; Gysin R, 2007, P NATL ACAD SCI USA, V104, P16621, DOI 10.1073/pnas.0706778104; Hasegawa H, 2003, ANAL BIOANAL CHEM, V377, P886, DOI 10.1007/s00216-003-2108-6; Hashimoto K, 2003, ARCH GEN PSYCHIAT, V60, P572, DOI 10.1001/archpsyc.60.6.572; Hashimoto K, 2005, CURR PSYCHIATRY REV, V1, P151, DOI 10.2174/1573400054065569; Hsu WY, 2011, J CHROMATOGR B, V879, P3331, DOI 10.1016/j.jchromb.2011.07.038; Hubbard KE, 2010, BIOMED CHROMATOGR, V24, P626, DOI 10.1002/bmc.1338; Isokawa M, 2013, ANALYST, V138, P3802, DOI 10.1039/c3an00527e; Iwayama Y, 2010, AM J MED GENET B, V153B, P484, DOI 10.1002/ajmg.b.31004; Kalapos MP, 1999, TOXICOL LETT, V110, P145, DOI 10.1016/S0378-4274(99)00160-5; Madeira C, 2008, SCHIZOPHR RES, V101, P76, DOI 10.1016/j.schres.2008.02.002; Maekawa M, 2011, CURR PHARM DESIGN, V17, P168, DOI 10.2174/138161211795049615; Miljevic C, 2013, HUM PSYCHOPHARM CLIN, V28, P1, DOI 10.1002/hup.2272; Mitsuhashi S, 2006, ANAL CHIM ACTA, V562, P36, DOI 10.1016/j.aca.2006.01.031; Moroni F, 1999, EUR J PHARMACOL, V375, P87, DOI 10.1016/S0014-2999(99)00196-X; Myint AM, 2012, FEBS J, V279, P1375, DOI 10.1111/j.1742-4658.2012.08551.x; Nichenarnetla SN, 2008, FREE RADICAL BIO MED, V45, P645, DOI 10.1016/j.freeradbiomed.2008.05.012; Ohashi H, 2013, INT J TRYPTOPHAN RES, P9, DOI 10.4137/IJTR.S11459; Prados P, 1997, ANAL CHIM ACTA, V344, P227, DOI 10.1016/S0003-2670(97)00020-2; Raffa M, 2009, PROG NEURO-PSYCHOPH, V33, P1178, DOI 10.1016/j.pnpbp.2009.06.018; Ramos-Loyo J, 2013, PROG NEURO-PSYCHOPH, V44, P154, DOI 10.1016/j.pnpbp.2013.02.007; Reiter RJ, 2008, NEUROENDOCRINOL LETT, V29, P391; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Schell MJ, 1997, J NEUROSCI, V17, P1604; Schwarcz R, 2001, BIOL PSYCHIAT, V50, P521, DOI 10.1016/S0006-3223(01)01078-2; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; THORNALLEY PJ, 1994, AMINO ACIDS, V6, P15, DOI 10.1007/BF00808119; Tomiya M, 2007, CLIN CHIM ACTA, V380, P186, DOI 10.1016/j.cca.2007.02.011; Tomiya M, 2006, BIOMED CHROMATOGR, V20, P628, DOI 10.1002/bmc.677; Tortorella A, 2001, NEUROPSYCHOBIOLOGY, V44, P167, DOI 10.1159/000054937; Tsai YC, 2003, ANAL BIOCHEM, V319, P34, DOI 10.1016/S0003-2697(03)00283-5; Xuan JK, 2011, J PROTEOME RES, V10, P5433, DOI 10.1021/pr2006796; Yang J, 2013, MOL PSYCHIATR, V18, P67, DOI 10.1038/mp.2011.131; Yao JK, 2010, MOL PSYCHIATR, V15, P938, DOI 10.1038/mp.2009.33; Yao JK, 2011, ANTIOXID REDOX SIGN, V15, P2011, DOI 10.1089/ars.2010.3603	46	65	69	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101652	10.1371/journal.pone.0101652	http://dx.doi.org/10.1371/journal.pone.0101652			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004141	Green Submitted, Green Published, gold			2022-12-27	WOS:000339242700047
J	La Clair, JJ; Loveridge, ST; Tenney, K; O'Neil-Johnson, M; Chapman, E; Crews, P				La Clair, James J.; Loveridge, Steven T.; Tenney, Karen; O'Neil-Johnson, Mark; Chapman, Eli; Crews, Phillip			In Situ Natural Product Discovery via an Artificial Marine Sponge	PLOS ONE			English	Article							BIOLOGICAL-PROPERTIES; ACTIN; AGENTS; DEPSIPEPTIDES; BIOSYNTHESIS; MYXOBACTERIA; DIVERSITY; APPARATUS; DRUGS	There is continuing international interest in exploring and developing the therapeutic potential of marine-derived small molecules. Balancing the strategies for ocean based sampling of source organisms versus the potential to endanger fragile ecosystems poses a substantial challenge. In order to mitigate such environmental impacts, we have developed a deployable artificial sponge. This report provides details on its design followed by evidence that it faithfully recapitulates traditional natural product collection protocols. Retrieving this artificial sponge from a tropical ecosystem after deployment for 320 hours afforded three actin-targeting jasplakinolide depsipeptides that had been discovered two decades earlier using traditional sponge specimen collection and isolation procedures. The successful outcome achieved here could reinvigorate marine natural products research, by producing new environmentally innocuous sources of natural products and providing a means to probe the true biosynthetic origins of complex marine-derived scaffolds.	[La Clair, James J.] Xenobe Res Inst, San Diego, CA 92116 USA; [Loveridge, Steven T.; Tenney, Karen; Crews, Phillip] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [O'Neil-Johnson, Mark] Sequoia Sci Inc, Lead Discovery & Rapid Struct Elucidat Grp, St Louis, MO USA; [Chapman, Eli] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA	University of California System; University of California Santa Cruz; University of Arizona	La Clair, JJ (corresponding author), Xenobe Res Inst, San Diego, CA 92116 USA.	i@xenobe.org; chapman@pharmacy.arizona.edu; pcrews@ucsc.edu			NIH [R01CA047135]; Xenobe Research Institute; University of Arizona; NATIONAL CANCER INSTITUTE [R01CA047135] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Xenobe Research Institute; University of Arizona; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funding from the NIH, R01CA047135 (P. C.), program funds from the Xenobe Research Institute (J. J. L.), as well as startup funds from the University of Arizona (E. C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allingham JS, 2006, CELL MOL LIFE SCI, V63, P2119, DOI 10.1007/s00018-006-6157-9; Ayers J, 2007, PHILOS T R SOC A, V365, P273, DOI 10.1098/rsta.2006.1910; Blunt J., 2012, HDB MARINE NATURAL P, P3, DOI [10.1007/978-90-481-3834-0_1, DOI 10.1007/978-90-481-3834-0_1]; Butler MS, 2008, NAT PROD REP, V25, P475, DOI 10.1039/b514294f; COLL JC, 1982, J EXP MAR BIOL ECOL, V60, P293, DOI 10.1016/0022-0981(82)90166-6; CREWS P, 1986, TETRAHEDRON LETT, V27, P2797, DOI 10.1016/S0040-4039(00)84645-6; DeLong EF, 1997, TRENDS BIOTECHNOL, V15, P203, DOI 10.1016/S0167-7799(97)01044-5; Doolittle LK, 2013, METHODS MOL BIOL, V1046, P273, DOI 10.1007/978-1-62703-538-5_16; Fisch KM, 2009, NAT CHEM BIOL, V5, P494, DOI 10.1038/nchembio.176; Hentschel U, 2012, NAT REV MICROBIOL, V10, P641, DOI 10.1038/nrmicro2839; Hill R., 2005, U.S. Patent, Patent No. [20050244938A1, 20050244938, 20,050,244,938 A1]; Iizuka T, 2006, J ANTIBIOT, V59, P385, DOI 10.1038/ja.2006.55; Johnson TA, 2012, BIOORGAN MED CHEM, V20, P4348, DOI 10.1016/j.bmc.2012.05.043; KUNZE B, 1995, J ANTIBIOT, V48, P1262, DOI 10.7164/antibiotics.48.1262; La Clair JJ, 2010, NAT PROD REP, V27, P969, DOI 10.1039/b909989c; Lee J, 2012, NAT PROD REP, V29, P404, DOI 10.1039/c2np00065b; Leys SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027787; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Nagle A, 2006, CURR DRUG TARGETS, V7, P305, DOI 10.2174/138945006776054933; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Newman DJ, 2009, FUTURE MED CHEM, V1, P1415, DOI 10.4155/FMC.09.113; Noro JC, 2012, CHEM BIODIVERS, V9, P2077, DOI 10.1002/cbdv.201100292; Park EY, 2004, ADV BIOCHEM ENG BIOT, V90, P1; Peraud O, 2006, THESIS U MARYLAND; Radjasa OK, 2011, BIOORGAN MED CHEM, V19, P6658, DOI 10.1016/j.bmc.2011.07.017; Robinson SJ, 2010, J MED CHEM, V53, P1651, DOI 10.1021/jm9013554; Rodriguez AD, 2008, J AM CHEM SOC, V130, P7256, DOI 10.1021/ja7114019; Schmidt EW, 2005, P NATL ACAD SCI USA, V102, P7315, DOI 10.1073/pnas.0501424102; SCHULTE BA, 1991, J CHEM ECOL, V17, P1327, DOI 10.1007/BF00983765; Sharma R, 2005, CURR SCI INDIA, V89, P72; Tannert R, 2010, J AM CHEM SOC, V132, P3063, DOI 10.1021/ja9095126; Terracciano S, 2008, BIOORGAN MED CHEM, V16, P6580, DOI 10.1016/j.bmc.2008.05.019; THOMPSON JE, 1983, ACTA ZOOL-STOCKHOLM, V64, P199, DOI 10.1111/j.1463-6395.1983.tb00801.x; Tsukimoto M, 2011, J NAT PROD, V74, P2329, DOI 10.1021/np200543z; Watts KR, 2011, J NAT PROD, V74, P341, DOI 10.1021/np100721g; Xu Y, 2012, J AM CHEM SOC, V134, P8625, DOI 10.1021/ja301735a; Zabriskie MT, 1987, J AM CHEM SOC, V108, P3123; Zampella A, 1999, J NAT PROD, V62, P332, DOI 10.1021/np9803225	38	6	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e100474	10.1371/journal.pone.0100474	http://dx.doi.org/10.1371/journal.pone.0100474			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004127	gold, Green Submitted, Green Published			2022-12-27	WOS:000339242700010
J	Pineda-Pena, AC; Schrooten, Y; Vinken, L; Ferreira, F; Li, GD; Trovao, NS; Khouri, R; Derdelinckx, I; De Munter, P; Kucherer, C; Kostrikis, LG; Nielsen, C; Littsola, K; Wensing, A; Stanojevic, M; Paredes, R; Balotta, C; Albert, J; Boucher, C; Gomez-Lopez, A; Van Wijngaerden, E; Van Ranst, M; Vercauteren, J; Vandamme, AM; Van Laethem, K				Pineda-Pena, Andrea-Clemencia; Schrooten, Yoeri; Vinken, Lore; Ferreira, Fossie; Li, Guangdi; Trovao, Nidia Sequeira; Khouri, Ricardo; Derdelinckx, Inge; De Munter, Paul; Kuecherer, Claudia; Kostrikis, Leondios G.; Nielsen, Claus; Littsola, Kirsi; Wensing, Annemarie; Stanojevic, Maja; Paredes, Roger; Balotta, Claudia; Albert, Jan; Boucher, Charles; Gomez-Lopez, Arley; Van Wijngaerden, Eric; Van Ranst, Marc; Vercauteren, Jurgen; Vandamme, Anne-Mieke; Van Laethem, Kristel			Trends and Predictors of Transmitted Drug Resistance (TDR) and Clusters with TDR in a Local Belgian HIV-1 Epidemic	PLOS ONE			English	Article							TRANSMISSION NETWORK; GENOTYPING SYSTEM; SUBTYPE B; SEQUENCES; PREVALENCE; MUTATIONS; EUROPE	We aimed to study epidemic trends and predictors for transmitted drug resistance (TDR) in our region, its clinical impact and its association with transmission clusters. We included 778 patients from the AIDS Reference Center in Leuven (Belgium) diagnosed from 1998 to 2012. Resistance testing was performed using population-based sequencing and TDR was estimated using the WHO-2009 surveillance list. Phylogenetic analysis was performed using maximum likelihood and Bayesian techniques. The cohort was predominantly Belgian (58.4%), men who have sex with men (MSM) (42.8%), and chronically infected (86.5%). The overall TDR prevalence was 9.6% (95% confidence interval (Cl): 7.7-11.9), 6.5% (CI: 5.0-8.5) for nucleoside reverse transcriptase inhibitors (NRTI), 2.2% (CI: 1.4-3.5) for non-NRTI (NNRTI), and 2.2% (CI: 1.4-3.5) for protease inhibitors. A significant parabolic trend of NNRTI-TDR was found (p = 0.019). Factors significantly associated with TDR in univariate analysis were male gender, Belgian origin, MSM, recent infection, transmission clusters and subtype B, while multivariate and Bayesian network analysis singled out subtype B as the most predictive factor of TDR. Subtype B was related with transmission clusters with TDR that included 42.6% of the TDR patients. Thanks to resistance testing, 83% of the patients with TDR who started therapy had undetectable viral load whereas half of the patients would likely have received a suboptimal therapy without this test. In conclusion, TDR remained stable and a NNRTI up-and-down trend was observed. While the presence of clusters with TDR is worrying, we could not identify an independent, non-sequence based predictor for TDR or transmission clusters with TDR that could help with guidelines or public health measures.	[Pineda-Pena, Andrea-Clemencia; Schrooten, Yoeri; Vinken, Lore; Ferreira, Fossie; Li, Guangdi; Trovao, Nidia Sequeira; Khouri, Ricardo; Van Ranst, Marc; Vercauteren, Jurgen; Vandamme, Anne-Mieke; Van Laethem, Kristel] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Leuven, Belgium; [Pineda-Pena, Andrea-Clemencia; Gomez-Lopez, Arley] Univ Rosario, Clin & Mol Infect Dis Grp, Fac Sci & Math, Bogota, Colombia; [Schrooten, Yoeri; Van Ranst, Marc; Van Laethem, Kristel] Univ Hosp Leuven, AIDS Reference Lab, Leuven, Belgium; [Derdelinckx, Inge; De Munter, Paul; Van Wijngaerden, Eric] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Derdelinckx, Inge; De Munter, Paul; Van Wijngaerden, Eric] Univ Hosp Leuven, Leuven, Belgium; [Kuecherer, Claudia] Robert Koch Inst, Berlin, Germany; [Kostrikis, Leondios G.] Univ Cyprus, Nicosia, Cyprus; [Nielsen, Claus] Statens Serum Inst, DK-2300 Copenhagen, Denmark; [Littsola, Kirsi] Natl Inst Hlth & Welf, Helsinki, Finland; [Wensing, Annemarie] Univ Med Ctr Utrecht, Dept Virol, Utrecht, Netherlands; [Stanojevic, Maja] Univ Belgrade, Fac Med, Belgrade, Serbia; [Paredes, Roger] IrsiCaixa Fdn, Badalona, Spain; [Balotta, Claudia] Luigi Sacco Univ Hosp, Milan, Italy; [Albert, Jan] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Albert, Jan] Karolinska Univ Hosp, Dept Clin Microbiol, Stockholm, Sweden; [Boucher, Charles] Univ Med Ctr, Erasmus MC, Rotterdam, Netherlands; [Vandamme, Anne-Mieke] Univ Nova Lisboa, Ctr Malaria & Outras Doencas Tropicais, P-1200 Lisbon, Portugal; [Vandamme, Anne-Mieke] Univ Nova Lisboa, Unidade Microbiol, Inst Higiene & Med Trop, P-1200 Lisbon, Portugal	KU Leuven; Universidad del Rosario; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; University Hospital Leuven; Robert Koch Institute; University of Cyprus; Statens Serum Institut; Finland National Institute for Health & Welfare; Utrecht University; Utrecht University Medical Center; University of Belgrade; Institut de Recerca de la Sida - IrsiCaixa; University of Milan; Luigi Sacco Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Erasmus University Rotterdam; Erasmus MC; Universidade Nova de Lisboa; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL	Van Laethem, K (corresponding author), Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Leuven, Belgium.	kristel.vanlaethem@uzleuven.be	Van Ranst, Marc/P-7522-2017; Van Wijngaerden, Eric/AAB-9187-2021; De Munter, Paul/AAB-5725-2021; Pineda-Peña, Andrea-Clemencia/N-9809-2015; KOSTRIKIS, LEONDIOS G/A-5330-2016; Vandamme, Anne-Mieke/I-4127-2012; Li, Guangdi/AAU-6951-2020; Trovão, Nídia/GPX-3458-2022; Van Laethem, Kristel/R-6282-2016; Vercauteren, Jurgen/P-7676-2019; Khouri, Ricardo/M-3184-2018; Balotta, Claudia/L-7295-2017	Van Ranst, Marc/0000-0002-1674-4157; Van Wijngaerden, Eric/0000-0001-8926-099X; De Munter, Paul/0000-0002-5944-3530; Pineda-Peña, Andrea-Clemencia/0000-0003-1937-0506; KOSTRIKIS, LEONDIOS G/0000-0002-5340-7109; Vandamme, Anne-Mieke/0000-0002-6594-2766; Van Laethem, Kristel/0000-0001-6036-2271; Vercauteren, Jurgen/0000-0003-0698-4736; Khouri, Ricardo/0000-0001-5664-4436; Stanojevic, Maja/0000-0002-4643-4272; Balotta, Claudia/0000-0002-1107-9119; Sequeira Trovao, Nidia/0000-0002-2106-1166	AIDS Reference Laboratory of Leuven from the Belgian Ministry of Social Affairs through a fund within the Health Insurance System; Fonds voor Wetenschappelijk Onderzoek - Flanders (FWO) [G069214N]; European Community under the project "Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)'' [223131]; University of Leuven [PF/10/018]; Departamento Administrativo de Ciencia, Tecnologia e Innovacion, COLCIENCIAS, Republic of Colombia; ERACOL	AIDS Reference Laboratory of Leuven from the Belgian Ministry of Social Affairs through a fund within the Health Insurance System; Fonds voor Wetenschappelijk Onderzoek - Flanders (FWO)(FWO); European Community under the project "Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)''; University of Leuven(KU Leuven); Departamento Administrativo de Ciencia, Tecnologia e Innovacion, COLCIENCIAS, Republic of Colombia(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); ERACOL	This work was supported in part by the AIDS Reference Laboratory of Leuven that receives support from the Belgian Ministry of Social Affairs through a fund within the Health Insurance System; by the Fonds voor Wetenschappelijk Onderzoek - Flanders (FWO) grant G069214N; and by the European Community's Seventh Framework Programme (FP7/2007-2013) under the project "Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)'' grant agreement No 223131; by the University of Leuven (Program Financing no. PF/10/018); by the Doctoral Research Training Program "Francisco Jose de Caldas'' by the Departamento Administrativo de Ciencia, Tecnologia e Innovacion, COLCIENCIAS, Republic of Colombia and by ERACOL, a scholarship for academic exchange in medicine and the health sciences between Europe and Latin America to A.C.P.P. The computational resources and services used in this work were provided by the Hercules Foundation and the Flemish Government - department EWI-FWO Krediet aan Navorsers (Theys, KAN2012 1.5.249.12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis AB, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-7; [Anonymous], 2011, US ASS REC INF EST H; [Anonymous], INFECT GENET EVOL; [Anonymous], MMWR; [Anonymous], EPIDEMIOLOGY HIV 1 T; [Anonymous], HIV AIDS SURV EUR 20; [Anonymous], J ANTIMICRO IN PRESS; [Anonymous], DIR OP SANT PUBL SUR; [Anonymous], 8 EUR HIV DRUG RES W; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Brown AJL, 2011, J INFECT DIS, V204, P1463, DOI 10.1093/infdis/jir550; Callegaro A, 2011, INFECT GENET EVOL, V11, P624, DOI 10.1016/j.meegid.2011.01.019; Carr JK, 2005, JAIDS-J ACQ IMM DEF, V39, P570; Castro E, 2010, AIDS RES HUM RETROV, V26, P1233, DOI 10.1089/aid.2010.0083; Chalmet K, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-262; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Deforche K, 2006, BIOINFORMATICS, V22, P2975, DOI 10.1093/bioinformatics/btl508; Derdelinckx I, 2004, JAIDS-J ACQ IMM DEF, V37, P1664, DOI 10.1097/00126334-200412150-00022; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Frentz D, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-36; Frentz D, 2011, JAIDS-J ACQ IMM DEF, V58, pE135, DOI 10.1097/QAI.0b013e3182364c80; Hue S, 2004, AIDS, V18, P719, DOI [10.1097/00002030-200403260-00002, 10.1097/01.aids.0000111455.61782.c3]; Karlsson A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033484; Kaye M, 2008, JAIDS-J ACQ IMM DEF, V49, P9, DOI 10.1097/QAI.0b013e318180c8af; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Maes B, 2004, J VIROL METHODS, V119, P45, DOI 10.1016/j.jviromet.2004.02.005; Paraskevis D, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-49; Ragonnet-Cronin M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-317; Readhead AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040533; Rhee SY, 2006, AIDS, V20, P643, DOI 10.1097/01.aids.0000216363.36786.2b; Ruelle J, 2013, AIDS RES HUM RETROV, V29, P1306, DOI [10.1089/aid.2013.0108, 10.1089/AID.2013.0108]; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Skoura L, 2011, J ANTIMICROB CHEMOTH, V66, P2831, DOI 10.1093/jac/dkr386; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Van Vaerenbergh K, 2001, ANTIVIR THER, V6, P63; Vercauteren J, 2008, AIDS RES HUM RETROV, V24, P355, DOI 10.1089/aid.2007.0212; Vercauteren J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061436; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Wensing AMJ, 2008, AIDS, V22, P625, DOI 10.1097/QAD.0b013e3282f5e062; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9; Yebra G, 2013, INFECT GENET EVOL, V14, P232, DOI 10.1016/j.meegid.2012.12.006; Yebra G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026757; Yerly S, 2007, AIDS, V21, P2223, DOI 10.1097/QAD.0b013e3282f0b685	47	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101738	10.1371/journal.pone.0101738	http://dx.doi.org/10.1371/journal.pone.0101738			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003369	Green Published, gold, Green Submitted			2022-12-27	WOS:000339242700059
J	Konno, T; Hayashi, K; Fujino, N; Nagata, Y; Hodatsu, A; Masuta, E; Sakata, K; Nakamura, H; Kawashiri, MA; Yamagishi, M				Konno, Tetsuo; Hayashi, Kenshi; Fujino, Noboru; Nagata, Yoji; Hodatsu, Akihiko; Masuta, Eiichi; Sakata, Kenji; Nakamura, Hiroyuki; Kawashiri, Masa-aki; Yamagishi, Masakazu			High Sensitivity of Late Gadolinium Enhancement for Predicting Microscopic Myocardial Scarring in Biopsied Specimens in Hypertrophic Cardiomyopathy	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; COLLEGE-OF-CARDIOLOGY; ENDOMYOCARDIAL BIOPSY; HYPERTENSIVE HEARTS; FIBROSIS; ASSOCIATION; QUANTIFICATION; DIAGNOSIS; IMPACT	Background: Myocardial scarring can be assessed by cardiac magnetic resonance imaging with late gadolinium enhancement and by endomyocardial biopsy. However, accuracy of late gadolinium enhancement for predicting microscopic myocardial scarring in biopsied specimens remains unknown in hypertrophic cardiomyopathy. We investigated whether late gadolinium enhancement in the whole heart reflects microscopic myocardial scarring in the small biopsied specimens in hypertrophic cardiomyopathy. Methods and Results: Twenty-one consecutive patients with hypertrophic cardiomyopathy who were examined both by cardiac magnetic resonance imaging and by endomyocardial biopsy were retrospectively studied. The right interventricular septum was the target site for endomyocardial biopsy in all patients. Late gadolinium enhancement in the ventricular septum had an excellent sensitivity (100%) with a low specificity (40%) for predicting microscopic myocardial scarring in biopsied specimens. The sensitivity of late gadolinium enhancement in the whole heart remained 100% with a specificity of 27% for predicting microscopic myocardial scarring in biopsied specimens. Quantitative assessments of fibrosis revealed that the extent of late gadolinium enhancement in the whole heart was the only independent variable related to the microscopic collagen fraction in biopsied specimens (beta = 0.59, 95% confident interval: 0.15 - 1.0, p = 0.012). Conclusions: Although there was a compromise in the specificity, the sensitivity of late gadolinium enhancement was excellent for prediction of microscopic myocardial scarring in hypertrophic cardiomyopathy. Moreover, the severity of late gadolinium enhancement was independently associated with the quantitative collagen fraction in biopsied specimens in hypertrophic cardiomyopathy. These findings indicate that late gadolinium enhancement can reflect both the presence and the extent of microscopic myocardial scarring in the small biopsied specimens in hypertrophic cardiomyopathy.	[Konno, Tetsuo; Hayashi, Kenshi; Fujino, Noboru; Nagata, Yoji; Hodatsu, Akihiko; Masuta, Eiichi; Sakata, Kenji; Kawashiri, Masa-aki; Yamagishi, Masakazu] Kanazawa Univ, Grad Sch Med, Div Cardiovasc Med, Kanazawa, Ishikawa, Japan; [Konno, Tetsuo; Nakamura, Hiroyuki; Yamagishi, Masakazu] Kanazawa Univ, Res & Educ Ctr Innovat & Prevent Med, Kanazawa, Ishikawa, Japan; [Nakamura, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Publ Hlth, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University; Kanazawa University	Konno, T (corresponding author), Kanazawa Univ, Grad Sch Med, Div Cardiovasc Med, Kanazawa, Ishikawa, Japan.	konnokontetsu@staff.kanazawa-u.ac.jp	KAWASHIRI, Masaaki/ABA-7159-2020	KAWASHIRI, Masaaki/0000-0002-5759-1353	Ministry of Education, Science and Culture of Japan [24790748]	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Ministry of Education, Science and Culture of Japan to TK; Research Project Number: 24790748 (URL: http://kaken.nii.ac.jp/d/p/24790748.en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adabag AS, 2008, J AM COLL CARDIOL, V51, P1369, DOI 10.1016/j.jacc.2007.11.071; Basso C, 2009, EUR HEART J, V30, P1627, DOI 10.1093/eurheartj/ehp121; Cooper LT, 2007, J AM COLL CARDIOL, V50, P1914, DOI 10.1016/j.jacc.2007.09.008; Delcre SDL, 2013, INT J CARDIOL, V167, P1038, DOI 10.1016/j.ijcard.2012.03.074; Flett AS, 2011, JACC-CARDIOVASC IMAG, V4, P150, DOI 10.1016/j.jcmg.2010.11.015; Gersh BJ, 2011, J AM COLL CARDIOL, V58, pE212, DOI 10.1016/j.jacc.2011.06.011; Grimes DA, 2002, LANCET, V359, P881, DOI 10.1016/S0140-6736(02)07948-5; Harris KM, 2006, CIRCULATION, V114, P216, DOI 10.1161/CIRCULATIONAHA.105.583500; HOSHINO T, 1983, CIRCULATION, V67, P1109, DOI 10.1161/01.CIR.67.5.1109; John BT, 2004, HEART RHYTHM, V1, P141, DOI 10.1016/j.hrthm.2004.02.021; Karamitsos TD, 2011, EUR J HEART FAIL, V13, P927, DOI 10.1093/eurjhf/hfr084; Konno T, 2010, P NATL ACAD SCI USA, V107, P18097, DOI 10.1073/pnas.1012826107; Kuusisto J, 2012, HEART, V98, P1007, DOI 10.1136/heartjnl-2011-300960; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; Mewton N, 2011, J AM COLL CARDIOL, V57, P891, DOI 10.1016/j.jacc.2010.11.013; Moon JCC, 2004, J AM COLL CARDIOL, V43, P2260, DOI 10.1016/j.jacc.2004.03.035; Moravsky G, 2013, JACC-CARDIOVASC IMAG, V6, P587, DOI 10.1016/j.jcmg.2012.09.018; Mori M, 2011, J CARDIOL, V57, P89, DOI 10.1016/j.jjcc.2010.08.006; O'Hanlon R, 2010, J AM COLL CARDIOL, V56, P867, DOI 10.1016/j.jacc.2010.05.010; Rubinshtein R, 2010, CIRC-HEART FAIL, V3, P51, DOI 10.1161/CIRCHEARTFAILURE.109.854026; SAKAKIBARA S, 1962, JPN HEART J, V3, P537; Schalla S, 2010, EUR J HEART FAIL, V12, P227, DOI 10.1093/eurjhf/hfq004; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Simonetti OP, 2001, RADIOLOGY, V218, P215, DOI 10.1148/radiology.218.1.r01ja50215; TANAKA M, 1986, BRIT HEART J, V55, P575; Teekakirikul P, 2010, J CLIN INVEST, V120, P3520, DOI 10.1172/JCI42028; Weidemann F, 2009, CIRCULATION, V120, P577, DOI 10.1161/CIRCULATIONAHA.108.847772; Yamada T, 2013, J CARD FAIL, V19, P557, DOI 10.1016/j.cardfail.2013.05.018; Yilmaz A, 2010, CIRCULATION, V122, P900, DOI 10.1161/CIRCULATIONAHA.109.924167; Yoshida A, 2013, EUR J HEART FAIL, V15, P166, DOI 10.1093/eurjhf/hfs206; Zimmermann O, 2006, EUR J HEART FAIL, V8, P162, DOI 10.1016/j.ejheart.2005.06.001	32	9	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101465	10.1371/journal.pone.0101465	http://dx.doi.org/10.1371/journal.pone.0101465			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000555	Green Published, gold, Green Submitted			2022-12-27	WOS:000338637300047
J	Li, SH; Chen, JZ; Xu, HY; Long, J; Xie, XB; Zhang, YJ				Li, Shuhua; Chen, Juanzhi; Xu, Huiyong; Long, Jie; Xie, Xiaobin; Zhang, Yajie			The Targeted Transduction of MMP-Overexpressing Tumor Cells by ACPP-HPMA Copolymer-Coated Adenovirus Conjugates	PLOS ONE			English	Article							TYPE-1 MATRIX-METALLOPROTEINASE; HUMAN IMMUNODEFICIENCY VIRUS; OVARIAN-CARCINOMA CELLS; GROWTH-FACTOR RECEPTOR; IN-VIVO; GENE DELIVERY; TAT PEPTIDE; NEUTRALIZING ANTIBODIES; INTRACELLULAR DELIVERY; PENETRATING PEPTIDES	We have designed and tested a new way to selectively deliver HPMA polymer-coated adenovirus type 5 (Ad5) particles into matrix metalloproteinase (MMP)-overexpressing tumor cells. An activatable cell penetrating peptide (ACPP) was designed and attached to the reactive 4-nitrophenoxy groups of HPMA polymers by the C-terminal amino acid (asparagine, N). ACPPs are activatable cell penetrating peptides (CPPs) with a linker between polycationic and polyanionic domains, and MMP-mediated cleavage releases the CPP portion and its attached cargo to enable cell entry. Our data indicate that the transport of these HPMA polymer conjugates by a single ACPP molecule to the cytoplasm occurs via a nonendocytotic and concentration-independent process. The uptake was observed to finish within 20 minutes by inverted fluorescence microscopy. In contrast, HPMA polymer-coated Ad5 without ACPPs was internalized solely by endocytosis. The optimal formulation was not affected by the presence of Ad5 neutralizing antibodies during transduction, and ACPP/polymercoated Ad5 also retained high targeting capability to several MMP-overexpressing tumor cell types. For the first time, ACPP-mediated cytoplasmic delivery of polymer-bound Ad5 to MMP-overexpressing tumor cells was demonstrated. These findings are significant, as they demonstrate the use of a polymer-based system for the targeted delivery into MMP-overexpressing solid tumors and highlight how to overcome major cellular obstacles to achieve intracellular macromolecular delivery.	[Li, Shuhua; Chen, Juanzhi; Xu, Huiyong; Zhang, Yajie] Southern Med Univ, Sch Basic Med Sci, Dept Pathol & Stomatol, Guangzhou, Guangdong, Peoples R China; [Li, Shuhua; Long, Jie; Xie, Xiaobin; Zhang, Yajie] Guangzhou Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Chen, Juanzhi; Xu, Huiyong] Southern Med Univ, Nanfang Hosp, Dept Pathol & Stomatol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Guangzhou Medical University; Southern Medical University - China	Zhang, YJ (corresponding author), Southern Med Univ, Sch Basic Med Sci, Dept Pathol & Stomatol, Guangzhou, Guangdong, Peoples R China.	yajie.zhang@163.com			National Nature Science Foundation of China [30971146, 81201960]; International Cooperation and Exchanges Projects of Guangdong Province, China [2010B050700023]; Medical Scientific Research Foundation of Guangdong Province, China [A2013244]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation and Exchanges Projects of Guangdong Province, China; Medical Scientific Research Foundation of Guangdong Province, China	This work was funded by the National Nature Science Foundation of China (grant Nos. 30971146 and 81201960). This work was also supported by International Cooperation and Exchanges Projects of Guangdong Province, China (No. 2010B050700023) and Medical Scientific Research Foundation of Guangdong Province, China (No. A2013244). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachtarzi H, 2011, J DRUG TARGET, V19, P690, DOI 10.3109/1061186X.2010.547585; Benihoud K, 1999, CURR OPIN BIOTECH, V10, P440, DOI 10.1016/S0958-1669(99)00007-5; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bremer C, 2001, NAT MED, V7, P743, DOI 10.1038/89126; Bremer C, 2001, RADIOLOGY, V221, P523, DOI 10.1148/radiol.2212010368; Campos SK, 2007, CURR GENE THER, V7, P189, DOI 10.2174/156652307780859062; Caron NJ, 2001, MOL THER, V3, P310, DOI 10.1006/mthe.2001.0279; Chillon M, 1998, GENE THER, V5, P995, DOI 10.1038/sj.gt.3300665; Croyle MA, 2000, HUM GENE THER, V11, P1713, DOI 10.1089/10430340050111368; Dodds E, 1999, J NEUROCHEM, V72, P2105, DOI 10.1046/j.1471-4159.1999.0722105.x; Elliott G, 1997, CELL, V88, P223, DOI 10.1016/S0092-8674(00)81843-7; Fasbender A, 1997, J BIOL CHEM, V272, P6479, DOI 10.1074/jbc.272.10.6479; Fisher KD, 2001, GENE THER, V8, P341, DOI 10.1038/sj.gt.3301389; Fisher KD, 2007, J DRUG TARGET, V15, P546, DOI 10.1080/10611860701501014; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Green NK, 2008, J GENE MED, V10, P280, DOI 10.1002/jgm.1121; Green NK, 2004, GENE THER, V11, P1256, DOI 10.1038/sj.gt.3302295; Han J, 2010, NANOTECHNOLOGY, V21, P105; Hitt MM, 2006, CELL BIOL LAB HDB, V1, P435; Jiang T, 2004, P NATL ACAD SCI USA, V101, P17867, DOI 10.1073/pnas.0408191101; JOLIOT A, 1991, P NATL ACAD SCI USA, V88, P1864, DOI 10.1073/pnas.88.5.1864; Josephson L, 1999, BIOCONJUGATE CHEM, V10, P186, DOI 10.1021/bc980125h; Kasman LM, 2009, MOL PHARMACEUT, V6, P1612, DOI 10.1021/mp9000958; Kim PH, 2010, BIOMATERIALS, V31, P1865, DOI 10.1016/j.biomaterials.2009.11.043; La Rocca G, 2004, BRIT J CANCER, V90, P1414, DOI 10.1038/sj.bjc.6601725; Lewin M, 2000, NAT BIOTECHNOL, V18, P410, DOI 10.1038/74464; Mattila T, 2003, BRIT J CANCER, V89, P1270; Mi ZB, 2000, MOL THER, V2, P339, DOI 10.1006/mthe.2000.0137; Mie M, 2003, BIOCHEM BIOPH RES CO, V310, P730, DOI 10.1016/j.bbrc.2003.09.071; Morrison J, 2008, MOL THER, V16, P244, DOI 10.1038/sj.mt.6300363; Morrison J, 2009, HUM GENE THER, V20, P239, DOI 10.1089/hum.2008.167; Moy P, 1996, MOL BIOTECHNOL, V6, P105, DOI 10.1007/BF02740767; Nguyen QT, 2010, P NATL ACAD SCI USA, V107, P4317, DOI 10.1073/pnas.0910261107; Nori A, 2003, J CONTROL RELEASE, V91, P53, DOI 10.1016/S0168-3659(03)00213-X; Nori A, 2003, BIOCONJUGATE CHEM, V14, P44, DOI 10.1021/bc0255900; O'Riordan CR, 1999, HUM GENE THER, V10, P1349, DOI 10.1089/10430349950018021; Oess S, 2000, GENE THER, V7, P750, DOI 10.1038/sj.gt.3301154; Ogawara KI, 2004, HUM GENE THER, V15, P433, DOI 10.1089/10430340460745766; Olson ES, 2010, P NATL ACAD SCI USA, V107, P4311, DOI 10.1073/pnas.0910283107; Park JW, 2010, J CONTROL RELEASE, V142, P238, DOI 10.1016/j.jconrel.2009.11.001; Peng ZH, 2008, IDRUGS, V11, P346; Ratnikov BI, 2002, LAB INVEST, V82, P1583, DOI 10.1097/01.LAB.0000038555.67772.DB; REJMANOVA P, 1977, MAKROMOL CHEM, V178, P2159, DOI 10.1002/macp.1977.021780803; RIHOVA B, 1989, BIOMATERIALS, V10, P335, DOI 10.1016/0142-9612(89)90075-6; Rittner K, 2002, MOL THER, V5, P104, DOI 10.1006/mthe.2002.0523; Romanczuk H, 1999, HUM GENE THER, V10, P2615, DOI 10.1089/10430349950016654; Searle PF, 1998, GENE THER, V5, P725, DOI 10.1038/sj.gt.3300686; Singh R, 2008, FASEB J, V22, P3389, DOI 10.1096/fj.08-103275; Snyder EL, 2001, CURR OPIN MOL THER, V3, P147; Sounni NE, 2003, MATRIX BIOL, V22, P55, DOI 10.1016/S0945-053X(03)00003-9; Subr V, 2009, J CONTROL RELEASE, V135, P152, DOI 10.1016/j.jconrel.2008.12.009; Talvensaari-Mattila A, 2003, BRIT J CANCER, V89, P1270, DOI 10.1038/sj.bjc.6601238; Torchilin VP, 2001, P NATL ACAD SCI USA, V98, P8786, DOI 10.1073/pnas.151247498; Torchilin VP, 2003, CURR PROTEIN PEPT SC, V4, P133, DOI 10.2174/1389203033487298; Toyoda K, 2001, J CEREBR BLOOD F MET, V21, P1125, DOI 10.1097/00004647-200109000-00010; Wang CHK, 2011, BIOMATERIALS, V32, P9536, DOI 10.1016/j.biomaterials.2011.08.069; Willemsen RA, 2010, PHARM RES-DORDR, V27, P2274, DOI 10.1007/s11095-010-0088-8; Xiang QY, 2012, EUR J PHARM BIOPHARM, V80, P379, DOI 10.1016/j.ejpb.2011.10.020; Yang Y, 2012, BIOMATERIALS, V33, P2260, DOI 10.1016/j.biomaterials.2011.12.007; YANG YP, 1995, J VIROL, V69, P2004, DOI 10.1128/JVI.69.4.2004-2015.1995; Zhao M, 2002, BIOCONJUGATE CHEM, V13, P840, DOI 10.1021/bc0255236	62	6	7	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e100670	10.1371/journal.pone.0100670	http://dx.doi.org/10.1371/journal.pone.0100670			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000246	Green Published, Green Submitted, gold			2022-12-27	WOS:000338637300012
J	Anderson, W; Guikema, S; Zaitchik, B; Pan, W				Anderson, Weston; Guikema, Seth; Zaitchik, Ben; Pan, William			Methods for Estimating Population Density in Data-Limited Areas: Evaluating Regression and Tree-Based Models in Peru	PLOS ONE			English	Article								Obtaining accurate small area estimates of population is essential for policy and health planning but is often difficult in countries with limited data. In lieu of available population data, small area estimate models draw information from previous time periods or from similar areas. This study focuses on model-based methods for estimating population when no direct samples are available in the area of interest. To explore the efficacy of tree-based models for estimating population density, we compare six different model structures including Random Forest and Bayesian Additive Regression Trees. Results demonstrate that without information from prior time periods, non-parametric tree-based models produced more accurate predictions than did conventional regression methods. Improving estimates of population density in non-sampled areas is important for regions with incomplete census data and has implications for economic, health and development policies.	[Anderson, Weston; Guikema, Seth] Johns Hopkins Univ, Dept Geog & Environm Engn, Baltimore, MD 21218 USA; [Zaitchik, Ben] Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA; [Anderson, Weston] Int Food Policy Res Inst, Washington, DC 20036 USA; [Pan, William] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Pan, William] Duke Univ, Duke Global Hlth Inst, Durham, NC USA	Johns Hopkins University; Johns Hopkins University; CGIAR; International Food Policy Research Institute (IFPRI); Duke University; Duke University	Anderson, W (corresponding author), Johns Hopkins Univ, Dept Geog & Environm Engn, Baltimore, MD 21218 USA.	Weston.B.Anderson@gmail.com	Zaitchik, Benjamin/AAB-3298-2020; Anderson, Weston/V-2616-2019	Zaitchik, Benjamin/0000-0002-0698-0658; Anderson, Weston/0000-0003-3755-9943	NASA Applied Sciences award [NNX11AH53G]	NASA Applied Sciences award	This research was supported in part by NASA Applied Sciences award NNX11AH53G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding was received for this study.	Asner GP, 2009, CONSERV BIOL, V23, P1386, DOI 10.1111/j.1523-1739.2009.01333.x; Ballas D, 2005, POPUL SPACE PLACE, V11, P13, DOI 10.1002/psp.351; BATTESE GE, 1988, J AM STAT ASSOC, V83, P28, DOI 10.2307/2288915; BOUDOT Y, 1993, EARSEL ADV REMOTE SE, V3; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Chambers R, 2006, BIOMETRIKA, V93, P255, DOI 10.1093/biomet/93.2.255; Chipman HA, 2010, ANN APPL STAT, V4, P266, DOI 10.1214/09-AOAS285; *CIESIN COL U, 2005, POV MAPP PROJ SMALL; CLAYTON D, 1987, BIOMETRICS, V43, P671, DOI 10.2307/2532003; DEICHMANN U, 2001, WORKING PAPER; Dobson J.E., 2000, PHOTOGRAMMETRIC ENG, V66; Eicher C. L., 2001, CARTOGR GEOGR INF SC, V28, P125, DOI [10.1559/152304001782173727, DOI 10.1559/152304001782173727]; ESCOBAL J, 2011, 78 PROGR DIN TERR RU, P1; FAY RE, 1979, J AM STAT ASSOC, V74, P269, DOI 10.1080/01621459.1979.10482505; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Fritz S, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/044005; GHOSH M, 1994, STAT SCI, V9, P55, DOI 10.1214/ss/1177010647; Hansen MC, 2010, P NATL ACAD SCI USA, V107, P8650, DOI 10.1073/pnas.0912668107; Harvey JT, 2002, PHOTOGRAMM ENG REM S, V68, P1181; Hastie T., 2009, ELEMENTS STAT LEARNI; Herold M, 2008, REMOTE SENS ENVIRON, V112, P2538, DOI 10.1016/j.rse.2007.11.013; HIJMANS R, 2012, GADM GLOBAL ADM AREA; Langford M, 2001, IEEE/ISPRS JOINT WORKSHOP ON REMOTE SENSING AND DATA FUSION OVER URBAN AREAS, P260, DOI 10.1109/DFUA.2001.985892; Langford M., 1991, HANDLING GEOGRAPHICA, P55; LIU X, 2002, P 3 S REM SENS URB A; LO CP, 2003, REMOTELY SENSED CITI, P157; Meinshausen N, 2006, J MACH LEARN RES, V7, P983; Monmonier MS, 1984, INT YB CARTOGRAPHY, V24, P115; O'Neill B, 2001, DEMOGR RES, V4, P203, DOI [10.4054/DemRes.2001.4.8, DOI 10.4054/DEMRES.2001.4.8]; Opsomer JD, 2008, J R STAT SOC B, V70, P265, DOI 10.1111/j.1467-9868.2007.00635.x; Pfeffermann D, 2002, INT STAT REV, V70, P125, DOI 10.1111/j.1751-5823.2002.tb00352.x; Pfeffermann D, 2013, STAT SCI, V28, P40, DOI 10.1214/12-STS395; PUISSANT A, 2010, ESTIMATING POPULATIO; Rao J. N. K., 1999, SURV METHODOL, V25, P175; Tobler W, 1997, Int J Popul Geogr, V3, P203; Tzavidis N, 2015, STAT METHODS MED RES, V24, P373, DOI 10.1177/0962280214520731; Wakefield J, 2007, BIOSTATISTICS, V8, P158, DOI 10.1093/biostatistics/kxl008; Wu S., 2005, GISCI REMOTE SENS, V42, P80, DOI [10.2747/1548-1603.42.1.80, DOI 10.2747/1548-1603.42.1.80]	40	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100037	10.1371/journal.pone.0100037	http://dx.doi.org/10.1371/journal.pone.0100037			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992657	Green Submitted, Green Published, gold			2022-12-27	WOS:000341253400015
J	Jenum, S; Grewal, HMS; Hokey, DA; Kenneth, J; Vaz, M; Doherty, TM; Jahnsen, FL				Jenum, Synne; Grewal, Harleen M. S.; Hokey, David A.; Kenneth, John; Vaz, Mario; Doherty, Timothy Mark; Jahnsen, Frode Lars		TB Trials Study Grp	The Frequencies of IFN gamma+IL2+TNF alpha plus PPD-Specific CD4+CD45RO+T-Cells Correlate with the Magnitude of the QuantiFERON (R) Gold In-Tube Response in a Prospective Study of Healthy Indian Adolescents	PLOS ONE			English	Article							T-CELL RESPONSES; TUBERCULOSIS-SPECIFIC CD4(+); INTERFERON-GAMMA RESPONSES; BCG VACCINATION; LATENT TUBERCULOSIS; PREDICTIVE-VALUE; RELEASE ASSAYS; MYCOBACTERIUM; PROTECTION; INFECTION	Background: QuantiFERON-TB Gold In-Tube (QFT) is an IFN gamma-release assay used in the diagnosis of Mycobacterium tuberculosis (MTB) infection. The risk of TB progression increases with the magnitude of the MTB-specific IFN gamma-response. QFT reversion, also associated with low Tuberculin Skin Test responses, may therefore represent a transient immune response with control of M. tuberculosis infection. However, studies at the single cell level have suggested that the quality (polyfunctionality) of the T-cell response is more important than the quantity of cytokines produced. Objective: To explore the quality and/or magnitude of mycobacteria-specific T-cell responses associated with QFT reversion and persistent QFT-positivity. Methods: Multi-color flowcytometry on prospectively collected peripheral blood mononuclear cells was applied to assess mycobacteria-specific T-cell responses in 42 QFT positive Indian adolescents of whom 21 became QFT negative (reverters) within one year. Ten QFT consistent negatives were also included as controls. Results: There was no difference in the qualitative PPD-specific CD4+ T-cell response between QFT consistent positives and reverters. However, compared with QFT consistent positives, reverters displayed lower absolute frequencies of polyfunctional (IFN gamma+IL2+TNF alpha+) CD4+ T-cells at baseline, which were further reduced to the point where they were not different to QFT negative controls one year later. Moreover, absolute frequencies of these cells correlated well with the magnitude of the QFT-response. Conclusion: Whereas specific polyfunctional CD4+ T-cells have been suggested to protect against TB progression, our data do not support that higher relative or absolute frequencies of PPD-specific polyfunctional CD4+ T-cells in peripheral blood can explain the reduced risk of TB progression observed in QFT reverters. On the contrary, absolute frequencies of these cells correlated with the QFT-response, suggesting that this readout reflects antigenic load.	[Jenum, Synne; Jahnsen, Frode Lars] Univ Oslo, Rikshosp, Oslo Univ Hosp, Ctr Immune Regulat, N-0027 Oslo, Norway; [Jenum, Synne; Jahnsen, Frode Lars] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Pathol, N-0027 Oslo, Norway; [Jenum, Synne; Jahnsen, Frode Lars] Univ Oslo, N-0027 Oslo, Norway; [Grewal, Harleen M. S.] Univ Bergen, Fac Med & Dent, Dept Clin Sci, N-5020 Bergen, Norway; [Grewal, Harleen M. S.] Haukeland Hosp, Dept Microbiol, N-5021 Bergen, Norway; [Hokey, David A.] Aeras, Rockville, MD USA; [Kenneth, John] St Johns Res Inst, Div Infect Dis, Bangalore, Karnataka, India; [Vaz, Mario] St Johns Med Coll, Bangalore, Karnataka, India; [Vaz, Mario] St Johns Res Inst, Bangalore, Karnataka, India; [Doherty, Timothy Mark] GlaxoSmithKline Pharma, Vaccines, Copenhagen, Denmark	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Bergen; University of Bergen; Haukeland University Hospital; St. John's National Academy of Health Sciences; St. John's Research Institute; St. John's National Academy of Health Sciences; St. John's Medical College; St. John's National Academy of Health Sciences; St. John's Research Institute; GlaxoSmithKline	Jenum, S (corresponding author), Univ Oslo, Rikshosp, Oslo Univ Hosp, Ctr Immune Regulat, N-0027 Oslo, Norway.	Synne.Jenum@rr-research.no	Grewal, Harleen/ABC-5831-2020; Lindtjorn, Bernt/K-9465-2018	Lindtjorn, Bernt/0000-0002-6267-6984; Jenum, Synne/0000-0001-8187-775X	Research Council of Norway [179342, 192534, 179573]; University of Bergen, Norway, Aeras, USA; St. John's Research Institute, India; Foundation for Innovative New Diagnostics	Research Council of Norway(Research Council of Norway); University of Bergen, Norway, Aeras, USA; St. John's Research Institute, India; Foundation for Innovative New Diagnostics	This study was supported by the Research Council of Norway (http://www.forskningsradet.no/en/), grants 179342 and 192534, the University of Bergen, Norway (http://www.uib.no/en), Aeras, USA (http://www.aeras.org/) and St. John's Research Institute, India (http://www.sjri.res.in/). Synne Jenum received a doctoral stipend covered by grant 179342 (Research council of Norway), administered and coordinated by University of Bergen, Norway. The work was also partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 179573. QFT kits were supported in part by Foundation for Innovative New Diagnostics (http://www.finddiagnostics.org/). Larry Geiter, formerly at Aeras contributed to the initial protocol development of the Adolescent Cohort Study. Ravi Anantha and Lew Barker, also at Aeras, reviewed the manuscript prior to submission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel B, 2010, AM J RESP CRIT CARE; Andersen P, 2007, TRENDS MOL MED, V13, P175, DOI 10.1016/j.molmed.2007.03.004; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Cruz A, 2010, J EXP MED, V207, P1609, DOI 10.1084/jem.20100265; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; Doherty M, 2009, CURR OPIN PULM MED, V15, P181, DOI 10.1097/MCP.0b013e328326f42c; Doherty TM, 2002, J CLIN MICROBIOL, V40, P704, DOI 10.1128/JCM.40.2.704-706.2002; Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Franken WPJ, 2008, INT J TUBERC LUNG D, V12, P1286; Gopi PG, 2003, INT J TUBERC LUNG D, V7, P1154; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Hill PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001379; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; Hinks TSC, 2009, INFECT IMMUN, V77, P5486, DOI 10.1128/IAI.01436-08; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Kaufmann SHE, 2008, CELL HOST MICROBE, V4, P219, DOI 10.1016/j.chom.2008.08.002; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kim YJ, 2012, AIDS RES HUM RETROV, V28, P838, DOI [10.1089/aid.2011.0360, 10.1089/AID.2011.0360]; Lienhardt C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010508; Lin PL, 2009, INFECT IMMUN, V77, P4631, DOI 10.1128/IAI.00592-09; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104; Mueller H, 2008, CYTOKINE, V43, P143, DOI 10.1016/j.cyto.2008.05.002; Pai M, 2009, INT J TUBERC LUNG D, V13, P84; Pai M, 2007, PLOS MED, V4, P980, DOI 10.1371/journal.pmed.0040208; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Pai M, 2014, CLIN MICROBIOL REV, V27, P3, DOI 10.1128/CMR.00034-13; Pantaleo G, 2006, NAT REV IMMUNOL, V6, P417, DOI 10.1038/nri1840; Ringshausen FC, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-220; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784; Saunders BM, 2002, CELL IMMUNOL, V216, P65, DOI 10.1016/S0008-8749(02)00510-5; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Streitz M, 2012, CYTOM PART B-CLIN CY, V82B, P360, DOI [10.1002/cyto.b.21027, 10.1002/cyto.b.21041, 10.1002/cyto.b.21040, 10.1002/cyto.b.21051, 10.1002/cyto.b.21038]; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Turner J, 2000, INFECT IMMUN, V68, P1706, DOI 10.1128/IAI.68.3.1706-1709.2000; van Zyl-Smit RN, 2009, AM J RESP CRIT CARE, V180, P49, DOI 10.1164/rccm.200811-1704OC; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Watkins RE, 2000, INT J TUBERC LUNG D, V4, P895; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Young JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011237	45	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101224	10.1371/journal.pone.0101224	http://dx.doi.org/10.1371/journal.pone.0101224			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992314	Green Published, gold			2022-12-27	WOS:000341253400053
J	Khan, S; Musekiwa, A; Chikte, UME; Omar, R				Khan, Saadika; Musekiwa, Alfred; Chikte, Usuf M. E.; Omar, Ridwaan			Differences in Functional Outcomes for Adult Patients with Prosthodontically-Treated and -Untreated Shortened Dental Arches: A Systematic Review	PLOS ONE			English	Article							REMOVABLE PARTIAL DENTURES; QUALITY-OF-LIFE; ORAL FUNCTION; FOLLOW-UP; TEMPOROMANDIBULAR DISORDERS; OCCLUSAL STABILITY; CANTILEVER BRIDGES; RESTORATION; SYMPTOMS; SURVIVAL	This review examined differences in functional outcomes and patient satisfaction when shortened dental arches are left untreated compared to their restoration to complete arch lengths with different prosthodontic interventions. Methods: A protocol was developed according to the criteria for a systematic review. All relevant databases were searched to identify appropriate clinical trials regardless of language or publication status. Predetermined eligibility criteria were applied, trial quality assessed and data extracted for each study. Relevant outcomes assessed were: functioning ability, patient satisfaction and harmful effects on oral structures. Results: Searches yielded 101 articles: 81 from electronic databases and 20 from reference lists of retrieved articles (PEARLing searches). Sixty-nine citations were assessed for eligibility after removing 32 duplicate records. After reading titles and abstracts, a total of 41 records were excluded and the full-texts of the remaining 28 records were read. Only 21 records were included for the SR because 7 records were excluded after reading the full-text reports. These 21 records report the outcomes of four randomized controlled trials (RCTs) and one non-randomized clinical trial (CT) which were pre-specified and used for this review. No on-going studies were found and no eligible studies were excluded for failure to report the reviewer's pre-specified outcomes. Outcomes were reported in the retrieved 21 articles. A narrative explanation of the pre-specified outcomes is reported for the 3 comparison groups (which were based on the different interventions used for the individual clinical trials). The shortened dental arch as a treatment option is encouraging in terms of functioning, patient satisfaction and cost-effectiveness. By using only high quality studies it was expected that the results would be more reliable when making conclusions and recommendations, but some of the included studies had to be downgraded due to methodological errors.	[Khan, Saadika] Univ Western Cape, Dept Restorat Dent, Cape Town, South Africa; [Musekiwa, Alfred] Univ Stellenbosch, Fac Med & Hlth Sci, Ctr Evidence Based Hlth Care, Cape Town, South Africa; [Chikte, Usuf M. E.] Univ Stellenbosch, Dept Interdisciplinary Hlth Sci, Cape Town, South Africa; [Omar, Ridwaan] Kuwait Univ, Fac Dent, Safat, Kuwait	University of the Western Cape; Stellenbosch University; Stellenbosch University; Kuwait University	Khan, S (corresponding author), Univ Western Cape, Dept Restorat Dent, Cape Town, South Africa.	skhan@uwc.ac.za	Chikte, Usuf/AAJ-4127-2020; Omar, Ridwaan/AAO-4724-2020	Musekiwa, Alfred/0000-0001-5880-3680	University of the Western Cape	University of the Western Cape	University of the Western Cape funded the services of a statistician for this review. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abt E, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003814.pub2; Abu-Saleh Tareq, 2008, J Contemp Dent Pract, V9, P114; Allen PF, 1996, J ORAL REHABIL, V23, P481, DOI 10.1111/j.1365-2842.1996.tb00883.x; [Anonymous], 1992, WHO TECHN REP SER, V826, P16; Armellini D, 2004, J PROSTHET DENT, V92, P531, DOI 10.1016/j.prosdent.2004.08.013; Baba K, 2008, J ORAL REHABIL, V35, P621, DOI 10.1111/j.1365-2842.2007.01803.x; Balevi Ben, 2008, Evid Based Dent, V9, P105, DOI 10.1038/sj.ebd.6400610; BUDTZJORGENSEN E, 1987, J ORAL REHABIL, V14, P239, DOI 10.1111/j.1365-2842.1987.tb00715.x; BUDTZORGENSEN E, 1990, J PROSTHET DENT, V64, P42, DOI 10.1016/0022-3913(90)90151-2; Carlsson GE, 2010, J ORAL REHABIL, V37, P143, DOI 10.1111/j.1365-2842.2009.02039.x; Carlsson GE, 2010, ACTA ODONTOL SCAND, V68, P313, DOI 10.3109/00016357.2010.517412; Creugers NHJ, 2010, INT J DENT, V2010, DOI 10.1155/2010/807850; CREUGERS NHJ, 1992, J DENT RES, V71, P1822, DOI 10.1177/00220345920710111101; Creugers NHJ, 1997, J DENT, V25, P239, DOI 10.1016/S0300-5712(96)00033-4; De Kanter RJAM, 1998, J DENT RES, V77, P609, DOI 10.1177/00220345980770041401; de Sa e Frias Vladimir, 2004, J Prosthodont, V13, P104, DOI 10.1111/j.1532-849X.2004.04016.x; Elias AC, 1998, J ORAL REHABIL, V25, P649, DOI 10.1046/j.1365-2842.1998.00313.x; Faggion CM, 2011, J ORAL REHABIL, V38, P940, DOI 10.1111/j.1365-2842.2011.02230.x; Frank RP, 2000, J PROSTHET DENT, V83, P521, DOI 10.1016/S0022-3913(00)70008-4; Fueki K, 2011, JPN DENT SCI REV, V47, P167, DOI 10.1016/j.jdsr.2011.03.003; Gerritsen AE, 2013, CLIN ORAL INVEST, V17, P859, DOI 10.1007/s00784-012-0765-6; Gotfredsen K, 2007, CLIN ORAL IMPLAN RES, V18, P34, DOI 10.1111/j.1600-0501.2007.01436.x; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Higgins J., 2009, COCHRANE HDB SYSTEMA; ISIDOR F, 1990, J PERIODONTOL, V61, P21, DOI 10.1902/jop.1990.61.1.21; Ivanhoe JR, 2002, J PROSTHET DENT, V88, P631, DOI 10.1067/mpr.2002.130147; Jepson N, 2003, INT J PROSTHODONT, V16, P409; Jepson NJA, 2001, BRIT DENT J, V191, P140, DOI 10.1038/sj.bdj.4801122a; Kayser A F, 1989, Int J Periodontics Restorative Dent, V9, P426; KAYSER AF, 1981, J ORAL REHABIL, V8, P457, DOI 10.1111/j.1365-2842.1981.tb00519.x; Khan S, 2013, J DENT ED IN PRESS; Khan S B, 2012, SADJ, V67, P62; Luthardt RG, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-15; McKenna G, 2012, GERODONT, V28, P1; McKenna G, 2012, GERODONTOLOGY, V29, pE883, DOI 10.1111/j.1741-2358.2011.00579.x; Moynihan PJ, 2000, J DENT, V28, P557, DOI 10.1016/S0300-5712(00)00044-0; Muller T, 2007, CLIN ORAL IMPLAN RES, V18, P2, DOI 10.1111/j.1600-0501.2007.01459.x; Omar R, 2004, SADJ, V59, P198; Sarita PT, 2007, EUR J ORAL SCI, V115, P265; Sarita PTN, 2003, COMMUNITY DENT ORAL, V31, P111, DOI 10.1034/j.1600-0528.2003.00018.x; Sarita PTN, 2003, COMMUNITY DENT ORAL, V31, P328, DOI 10.1034/j.1600-0528.2003.t01-1-00011.x; Sarita PTN, 2003, INT J PROSTHODONT, V16, P375; Sarita PTN, 2003, INT J PROSTHODONT, V16, P265; Thomason JM, 2007, J DENT RES, V86, P646, DOI 10.1177/154405910708600712; Ueno M, 2008, J ORAL REHABIL, V35, P337, DOI 10.1111/j.1365-2842.2008.01847.x; Walter MH, 2010, J DENT RES, V89, P818, DOI 10.1177/0022034510366817; Walter MH, 2012, DTSCH ZAHNARZT Z, V67, P360; Walter MH, 2012, CLIN ORAL INVEST, P1, DOI [10.1007/s00784-01-0761-x, DOI 10.1007/S00784-01-0761-X]; Witter DJ, 2007, J DENT, V35, P521, DOI 10.1016/j.jdent.2007.02.003; WITTER DJ, 1988, J ORAL REHABIL, V15, P413, DOI 10.1111/j.1365-2842.1988.tb00177.x; WITTER DJ, 1994, J ORAL REHABIL, V21, P353, DOI 10.1111/j.1365-2842.1994.tb01150.x; WITTER DJ, 1994, J ORAL REHABIL, V21, P113, DOI 10.1111/j.1365-2842.1994.tb01131.x; WITTER DJ, 1989, J ORAL REHABIL, V16, P27, DOI 10.1111/j.1365-2842.1989.tb01314.x; Witter DJ, 2001, J DENT RES, V80, P432, DOI 10.1177/00220345010800020601; Wolfart S, 2005, J ORAL REHABIL, V32, P815, DOI 10.1111/j.1365-2842.2005.01522.x; Wolfart S, 2014, CLIN ORAL INVEST, V18, P525, DOI 10.1007/s00784-013-0991-6; Wolfart S, 2012, J DENT RES, V91, pS65, DOI 10.1177/0022034512447950; Zarb GA, 1997, BOUCHERS PROSTHODONT; Zeng X, 2008, J ORAL REHABIL, V35, P37, DOI 10.1111/j.1365-2842.2007.01811.x; Zhang Q, 2012, CLIN ORAL INVEST, P1	60	19	19	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101143	10.1371/journal.pone.0101143	http://dx.doi.org/10.1371/journal.pone.0101143			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992473	Green Submitted, Green Published, gold			2022-12-27	WOS:000341253400046
J	Shatil, E; Mikulecka, J; Bellotti, F; Bures, V				Shatil, Evelyn; Mikulecka, Jaroslava; Bellotti, Francesco; Bures, Vladimir			Novel Television-Based Cognitive Training Improves Working Memory and Executive Function	PLOS ONE			English	Article							OLDER-ADULTS; SENIORS; TRIAL	The main study objective was to investigate the effect of interactive television-based cognitive training on cognitive performance of 119 healthy older adults, aged 60-87 years. Participants were randomly allocated to a cognitive training group or to an active control group in a single-blind controlled two-group design. Before and after training interactive television cognitive performance was assessed on well validated tests of fluid, higher-order ability, and system usability was evaluated. The participants in the cognitive training group completed a television-based cognitive training programme, while the participants in the active control group completed a TV-based programme of personally benefiting activities. Significant improvements were observed in well validated working memory and executive function tasks in the cognitive training but not in the control group. None of the groups showed statistically significant improvement in life satisfaction score. Participants' reports of "adequate'' to "high'' system usability testify to the successful development and implementation of the interactive television-based system and compliant cognitive training contents. The study demonstrates that cognitive training delivered by means of an interactive television system can generate genuine cognitive benefits in users and these are measurable using well-validated cognitive tests. Thus, older adults who cannot use or afford a computer can easily use digital interactive television to benefit from advanced software applications designed to train cognition.	[Shatil, Evelyn] CogniFit Inc, New York, NY USA; [Shatil, Evelyn] Max Stern Acad Coll Emek Yezreel, Dept Psychol, Yezreel Valley, Israel; [Shatil, Evelyn] Max Stern Acad Coll Emek Yezreel, Ctr Psychobiol Res, Yezreel Valley, Israel; [Shatil, Evelyn; Mikulecka, Jaroslava; Bures, Vladimir] Univ Hradec Kralove, Fac Informat & Management, Hradec Kralove, Czech Republic; [Bellotti, Francesco] Univ Genoa, Dept Elect Elect Telecommun Engn & Naval Architec, Genoa, Italy	University of Hradec Kralove; University of Genoa	Bures, V (corresponding author), Univ Hradec Kralove, Fac Informat & Management, Hradec Kralove, Czech Republic.	vladimir.bures@uhk.cz	Mikulecka, Jaroslava/M-3419-2014; Bureš, Vladimír/A-4353-2013	Mikulecka, Jaroslava/0000-0002-1009-4309; Bureš, Vladimír/0000-0001-7788-7445	Vital Mind project - 7th EU Framework Programme [215387]; University of Hradec Kralove	Vital Mind project - 7th EU Framework Programme; University of Hradec Kralove	This study was created with the support of the Vital Mind project - 7th EU Framework Programme project num. 215387. This manuscript creation has been partially supported by the internal Excellence Project 'Agent-based models and Social Simulation' funded by the University of Hradec Kralove. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anguera JA, 2013, NATURE, V501, P97, DOI 10.1038/nature12486; Bonsignore M, 2001, EUR ARCH PSY CLIN N, V251, P27; Brown L., 1997, TEST NONVERBAL INTEL; Buiza C, 2009, LECT NOTES COMPUT SC, V5614, P324, DOI 10.1007/978-3-642-02707-9_37; Bures V, 2012, ELEKTRON ELEKTROTECH, V122, P87, DOI 10.5755/j01.eee.122.6.1827; Cangoz B, 2009, J NEUROL SCI, V283, P73, DOI 10.1016/j.jns.2009.02.313; Charness N, 2009, CURR DIR PSYCHOL SCI, V18, P253, DOI 10.1111/j.1467-8721.2009.01647.x; Cohen J, 2002, APPL MULTIPLE REGRES; Craik FIM, 2006, TRENDS COGN SCI, V10, P131, DOI 10.1016/j.tics.2006.01.007; Eurostat, 2012, MED US EUR UN STAND, V78; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gawlinski M., 2003, INTERACTIVE TELEVISI; Gigler Kathryn L, 2013, Gerontechnology, V12, P26, DOI 10.4017/gt.2013.12.1.009.00; Haimov I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061390; Haimov I, 2008, BEHAV SLEEP MED, V6, P32, DOI 10.1080/15402000701796080; Horowitz-Kraus T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007141; Jones HE, 1933, GENET PSYCHOL MONOGR, V13, P223; Kleplova V, 2007, FORM STRENGTHEN YOUR; Krejcar O, 2009, IFMBE PROC, V25, P141, DOI 10.1007/978-3-642-03904-1_40; Krivohlavy J, 2009, PSYCHOL HLTH; Lee B, 2011, COMPUT HUM BEHAV, V27, P1231, DOI 10.1016/j.chb.2011.01.003; McMurtrey ME, 2011, J COMPUT INFORM SYST, V51, P22; Mikulecky P, 2012, LECT NOTES ARTIF INT, V7197, P401, DOI 10.1007/978-3-642-28490-8_42; Nap HH, 2013, INT J COGN PERFORM S, V1, P27, DOI DOI 10.1504/IJCPS.2013.053553; Neves BB, 2013, SOCIOL RES ONLINE, V18, DOI 10.5153/sro.2998; O'Boyle C., 1993, SCHEDULE EVALUATION; Papp KV, 2009, ALZHEIMERS DEMENT, V5, P50, DOI 10.1016/j.jalz.2008.10.008; Peretz C, 2011, NEUROEPIDEMIOLOGY, V36, P91, DOI 10.1159/000323950; Preiss M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00108; Reitan R.M., 1992, TRAIL MAKING TEST MA; Seybert H, 2011, INTERNET USE HOUSEHO; Shatil E, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00008; Shatil E, 2010, NEUROREHABILITATION, V26, P143, DOI 10.3233/NRE-2010-0546; Strauss E, 2006, COMPENDIUM NEUROPSYC; Tabachnick B. G., 2013, USING MULTIVARIATE S; Thompson HJ, 2011, TELEMED E-HEALTH, V17, P794, DOI 10.1089/tmj.2011.0059; Valenzuela MJ, 2006, NEUROLOGY, V67, P729, DOI 10.1212/01.wnl.0000239615.49557.63; Verghese J, 2010, J GERONTOL A-BIOL, V65, P1338, DOI 10.1093/gerona/glq127	38	42	44	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101472	10.1371/journal.pone.0101472	http://dx.doi.org/10.1371/journal.pone.0101472			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3RT	24992187	gold, Green Published, Green Submitted			2022-12-27	WOS:000341253400076
J	Ishikawa, T; Takahashi, S; Morita, K; Okinaga, H; Teramoto, T				Ishikawa, Toshio; Takahashi, Satoshi; Morita, Koji; Okinaga, Hiroko; Teramoto, Tamio			Induction of AhR-Mediated Gene Transcription by Coffee	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; POLYCYCLIC AROMATIC-HYDROCARBONS; CULTURE-MEDIUM; CELLS; EXPRESSION; ACTIVATION; SERUM; IDENTIFICATION; ASSOCIATION; CONSUMPTION	Background: Aryl hydrocarbon receptor (AhR) is classically known to be activated by xenobiotics such as dioxins and polycyclic aromatic hydrocarbons (PAHs). Although it has been reported that PAHs are contained in roasted coffee beans, in general coffee beverages are not considered to be AhR activators. We tested whether exposure to coffee would activate AhR in cultured cells. Methods: HepG2 cells stably expressing an AhR-responsive reporter gene were treated with coffee samples. Also, expression of CYP1A1, an endogenous AhR-responsive gene, was quantitated by RT-PCR and Western blotting in HepG2, Caco-2, and MCF-7 cells, after treatment with coffee. In order to obtain sensitive and reproducible results, all the experiments were performed with the cells placed in either phosphate-buffered saline (PBS) or pure serum, instead of routinely-used culture medium, whose intrinsic AhR-stimulating activity turned out to be so strong as to interfere with the analyses. Results: All the coffee samples tested robustly stimulated AhR-mediated transcription in the reporter gene assays. Of note, to what extent coffee and other AhR agonists activated AhR was different, depending on whether the experiments were done in PBS or serum. CYP1A1 mRNA was induced by coffee, in HepG2, Caco-2, and MCF-7 cells placed in either PBS or serum. CYP1A1 protein expression, which was not detected in these cells incubated in PBS, was also increased by coffee in cells placed in serum. Conclusions: By using culture medium-free experimental settings, we have shown that coffee is a strong AhR activator. Our observation may help elucidate as-yet-unrecognized effects of coffee on human health.	[Ishikawa, Toshio; Takahashi, Satoshi; Morita, Koji; Okinaga, Hiroko] Teikyo Univ, Sch Med, Dept Internal Med, Tokyo 173, Japan; [Teramoto, Tamio] Teikyo Univ, Teikyo Acad Res Ctr, Tokyo 173, Japan	Teikyo University; Teikyo University	Ishikawa, T (corresponding author), Teikyo Univ, Sch Med, Dept Internal Med, Tokyo 173, Japan.	tishi-tky@umin.ac.jp						Bosetti C, 2007, ANN ONCOL, V18, P431, DOI 10.1093/annonc/mdl172; Chen C, 1998, SOMAT CELL MOLEC GEN, V24, P249, DOI 10.1023/B:SCAM.0000007127.80657.10; Chobtang J, 2011, SENSORS-BASEL, V11, P11692, DOI 10.3390/s111211692; Freedman ND, 2012, NEW ENGL J MED, V366, P1891, DOI 10.1056/NEJMoa1112010; Grover IS, 2013, ENVIRON MONIT ASSESS, V185, P6459, DOI 10.1007/s10661-012-3037-7; Hestermann EV, 2002, BIOCHEM PHARMACOL, V63, P1405, DOI 10.1016/S0006-2952(02)00892-4; Hestermann EV, 2000, TOXICOL SCI, V53, P316, DOI 10.1093/toxsci/53.2.316; Hu WY, 2007, MOL PHARMACOL, V71, P1475, DOI 10.1124/mol.106.032748; Ilchmann A, 2012, MOL IMMUNOL, V51, P42, DOI 10.1016/j.molimm.2012.02.005; Ishikawa T, 2004, MOL CELL BIOL, V24, P8323, DOI 10.1128/MCB.24.19.8323-8331.2004; Ishikawa T, 2012, THYROID, V22, P769, DOI 10.1089/thy.2012.0057; Kalthoff S, 2010, GASTROENTEROLOGY, V139, P1699, DOI 10.1053/j.gastro.2010.06.048; Kim SH, 2006, MOL PHARMACOL, V69, P1871, DOI 10.1124/mol.105.021832; Korashy HM, 2005, TOXICOL SCI, V88, P39, DOI 10.1093/toxsci/kfi282; Liu JX, 2013, MAYO CLIN PROC, V88, P1066, DOI 10.1016/j.mayocp.2013.06.020; Miller CA, 1997, J BIOL CHEM, V272, P32824, DOI 10.1074/jbc.272.52.32824; Oberg M, 2005, TOXICOL SCI, V85, P935, DOI 10.1093/toxsci/kfi154; Okamura S, 2005, BIOL PHARM BULL, V28, P271, DOI 10.1248/bpb.28.271; Okey Allan B, 2005, Toxicol Appl Pharmacol, V207, P43, DOI 10.1016/j.taap.2004.12.028; Pieterse B, 2013, ENVIRON SCI TECHNOL, V47, P11651, DOI 10.1021/es403810w; Sinal CJ, 1997, MOL PHARMACOL, V52, P590, DOI 10.1124/mol.52.4.590; Tilg H, 2012, NEW ENGL J MED, V366, P181, DOI 10.1056/NEJMcibr1113158; Zhao B, 2010, TOXICOL SCI, V117, P393, DOI 10.1093/toxsci/kfq217; Zhou YP, 2012, PREV MED, V55, P14, DOI 10.1016/j.ypmed.2012.04.020	24	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102152	10.1371/journal.pone.0102152	http://dx.doi.org/10.1371/journal.pone.0102152			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007155	Green Published, Green Submitted, gold			2022-12-27	WOS:000339040600102
J	Sumigray, K; Zhou, K; Lechler, T				Sumigray, Kaelyn; Zhou, Kang; Lechler, Terry			Cell-Cell Adhesions and Cell Contractility Are Upregulated upon Desmosome Disruption	PLOS ONE			English	Article							TIGHT JUNCTIONS; ADHERENS JUNCTIONS; PEMPHIGUS-VULGARIS; E-CADHERIN; EPIDERMAL BARRIER; ALPHA-CATENIN; COMPLEX; AUTOANTIBODIES; KERATINOCYTES; PATHOGENICITY	Desmosomes are perturbed in a number of disease states - including genetic disorders, autoimmune and bacterial diseases. Here, we report unexpected changes in other cell-cell adhesion structures upon loss of desmosome function. We found that perturbation of desmosomes by either loss of the core desmosomal protein desmoplakin or treatment with pathogenic anti-desmoglein 3 (Dsg3) antibodies resulted in changes in adherens junctions consistent with increased tension. The total amount of myosin IIA was increased in desmoplakin-null epidermis, and myosin IIA became highly localized to cell contacts in both desmoplakin-null and anti-Dsg3-treated mouse keratinocytes. Inhibition of myosin II activity reversed the changes to adherens junctions seen upon desmosome disruption. The increased cortical myosin IIA promoted epithelial sheet fragility, as myosin IIA-null cells were less susceptible to disruption by anti-Dsg3 antibodies. In addition to the changes in adherens junctions, we found a significant increase in the expression of a number of claudin genes, which encode for transmembrane components of the tight junction that provide barrier function. These data demonstrate that desmosome disruption results in extensive transcriptional and posttranslational changes that alter the activity of other cell adhesion structures.	[Lechler, Terry] Duke Univ, Med Ctr, Dept Dermatol, Durham, NC 27705 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University; Duke University	Lechler, T (corresponding author), Duke Univ, Med Ctr, Dept Dermatol, Durham, NC 27705 USA.	terry.lechler@duke.edu		Sumigray, Kaelyn/0000-0002-1267-7559	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R01AR055926]; NATIONAL CANCER INSTITUTE [P30CA014236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055926] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (R01AR055926) to TL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amagai M, 2000, NAT MED, V6, P1275, DOI 10.1038/81385; Amagai M, 2012, J INVEST DERMATOL, V132, P776, DOI 10.1038/jid.2011.390; Amagai M, 2010, P JPN ACAD B-PHYS, V86, P524, DOI 10.2183/pjab.86.524; Ando-Akatsuka Y, 1999, J CELL PHYSIOL, V179, P115, DOI 10.1002/(SICI)1097-4652(199905)179:2<115::AID-JCP1>3.0.CO;2-T; Bektas M, 2013, J BIOL CHEM, V288, P9447, DOI 10.1074/jbc.M112.438010; Elkouby-Naor L, 2010, INT REV CEL MOL BIO, V279, P1, DOI 10.1016/S1937-6448(10)79001-8; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; GUMBINER B, 1988, J CELL BIOL, V107, P1575, DOI 10.1083/jcb.107.4.1575; Huen AC, 2002, J CELL BIOL, V159, P1005, DOI 10.1083/jcb.200206098; Ishii K, 2005, J INVEST DERMATOL, V124, P939, DOI 10.1111/j.0022-202X.2005.23714.x; Ishiyama N, 2013, J BIOL CHEM, V288, P15913, DOI 10.1074/jbc.M113.453928; Jolly PS, 2010, J BIOL CHEM, V285, P8936, DOI 10.1074/jbc.M109.087999; Lai-Cheong JE, 2007, J INVEST DERMATOL, V127, P2713, DOI 10.1038/sj.jid.5700727; Lanza A, 2008, J BIOL CHEM, V283, P8736, DOI 10.1074/jbc.M702186200; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Lechler T, 2007, J CELL BIOL, V176, P147, DOI 10.1083/jcb.200609109; LEWIS JE, 1994, J INVEST DERMATOL, V102, P870, DOI 10.1111/1523-1747.ep12382690; Mao X, 2013, J INVEST DERMATOL; Michels C, 2009, J INVEST DERMATOL, V129, P2072, DOI 10.1038/jid.2009.17; Miyake Y, 2006, EXP CELL RES, V312, P1637, DOI 10.1016/j.yexcr.2006.01.031; Pretel M, 2009, EXP DERMATOL, V18, P771, DOI 10.1111/j.1600-0625.2009.00893.x; Raiko L, 2012, EXP DERMATOL, V21, P586, DOI 10.1111/j.1600-0625.2012.01520.x; Rajasekaran AK, 1996, J CELL BIOL, V132, P451, DOI 10.1083/jcb.132.3.451; Saito M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050696; Smutny M, 2010, NAT CELL BIOL, V12, P696, DOI 10.1038/ncb2072; Spindler V, 2010, J IMMUNOL, V185, P6831, DOI 10.4049/jimmunol.1002675; Sumigray KD, 2012, J CELL BIOL, V199, P513, DOI 10.1083/jcb.201206143; Taguchi K, 2011, J CELL BIOL, V194, P643, DOI 10.1083/jcb.201104124; Tsunoda K, 2003, J IMMUNOL, V170, P2170, DOI 10.4049/jimmunol.170.4.2170; Tunggal JA, 2005, EMBO J, V24, P1146, DOI 10.1038/sj.emboj.7600605; Turksen K, 2002, DEVELOPMENT, V129, P1775; Vasioukhin V, 2001, NAT CELL BIOL, V3, P1076, DOI 10.1038/ncb1201-1076; Yamamoto Y, 2007, J BIOL CHEM, V282, P17866, DOI 10.1074/jbc.M607963200; YONEMURA S, 1995, J CELL SCI, V108, P127; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	35	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101824	10.1371/journal.pone.0101824	http://dx.doi.org/10.1371/journal.pone.0101824			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006807	Green Published, gold, Green Submitted			2022-12-27	WOS:000339040600070
J	Wu, LL; Cai, HJ; Gu, RL; Luo, YLL; Zhang, JX; Yang, J; Shi, YY; Ding, L				Wu, Lili; Cai, Huajian; Gu, Ruolei; Luo, Yu L. L.; Zhang, Jianxin; Yang, Jing; Shi, Yuanyuan; Ding, Lei			Neural Manifestations of Implicit Self-Esteem: An ERP Study	PLOS ONE			English	Article							SOCIAL COMPARISONS; AMYGDALA ACTIVITY; ASSOCIATION TEST; BRAIN; RACE; ATTITUDES; EXPLICIT; COMPONENTS; METAANALYSIS; CATEGORY	Behavioral research has established that humans implicitly tend to hold a positive themselves. In this study, we employed the event-related potential (ERP) technique to explore neural manifestations of positive implicit self-esteem using the Go/Nogo association task (GNAT). Participants generated a response (Go) or withheld a response (Nogo) to self or others words and good or bad attributes. Behavioral data showed that participants responded faster to the self paired with good he self paired with bad, whereas the opposite proved true for others, reflecting the positive nature of implicit self-esteem. ERP results showed an augmented N200 over the frontal areas in Nogo responses relative to Go responses. Moreover, the positive implicit self-positivity bias delayed the onset time of the N200 wave difference between Nogo and Gotrails, suggesting that positive implicit self-esteem is manifested on neural activity about 270 ms after the presentation of self-relevant stimuli. These findings provide neural evidence for the positivity and automaticity of implicit self-esteem.	[Wu, Lili; Zhang, Jianxin] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Cai, Huajian; Gu, Ruolei; Luo, Yu L. L.; Yang, Jing; Shi, Yuanyuan] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Ding, Lei] Univ Oklahoma, Sch Elect & Comp Engn, Norman, OK 73019 USA	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; Institute of Psychology, CAS; University of Oklahoma System; University of Oklahoma - Norman	Cai, HJ (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	caihj@psych.ac.cn	Gu, Ruolei/H-6946-2019	Gu, Ruolei/0000-0001-8722-2172; Shi, Yuanyuan/0000-0003-0005-7106	National Natural Science Foundation of China [31200789, 31070919]; Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences [Y0CX363501]; Hundred Talents Program [Y0C2024002]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-J-8]; Directorate For Engineering [0955260] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences(Chinese Academy of Sciences); Hundred Talents Program(Chinese Academy of Sciences); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by the National Natural Science Foundation of China [Grant Nos. 31200789, 31070919], the Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences [Grant No. Y0CX363501], the Hundred Talents Program [Grant No. Y0C2024002] and the Knowledge Innovation Program of the Chinese Academy of Sciences [Grant No. KSCX2-EW-J-8]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON NH, 1968, J PERS SOC PSYCHOL, V9, P272, DOI 10.1037/h0025907; Banfield JF, 2006, NEUROIMAGE, V31, P1841, DOI 10.1016/j.neuroimage.2006.02.017; Baron AS, 2006, PSYCHOL SCI, V17, P53, DOI 10.1111/j.1467-9280.2005.01664.x; Beer JS, 2007, TRENDS COGN SCI, V11, P187, DOI 10.1016/j.tics.2007.02.004; Beer JS, 2010, J COGNITIVE NEUROSCI, V22, P2108, DOI 10.1162/jocn.2009.21359; Borsboom D, 2004, PSYCHOL REV, V111, P1061, DOI 10.1037/0033-295x.111.4.1061; Bosson JK, 2000, J PERS SOC PSYCHOL, V79, P631, DOI 10.1037//0022-3514.79.4.631; Boucher HC, 2009, J CROSS CULT PSYCHOL, V40, P24, DOI 10.1177/0022022108326195; Buhrmester MD, 2011, J PERS SOC PSYCHOL, V100, P365, DOI 10.1037/a0021341; Cai HJ, 2009, ASIAN J SOC PSYCHOL, V12, P104, DOI 10.1111/j.1467-839X.2009.01278.x; Chavez RS, 2015, SOC COGN AFFECT NEUR, V10, P364, DOI 10.1093/scan/nsu063; De Houwer J., 2007, IMPLICIT MEASURES AT, P179; De Houwer J, 2009, PSYCHOL BULL, V135, P347, DOI 10.1037/a0014211; Denny BT, 2012, J COGNITIVE NEUROSCI, V24, P1742, DOI 10.1162/jocn_a_00233; Dickter CL, 2010, PSYCHOPHYSIOLOGY, V47, P596, DOI 10.1111/j.1469-8986.2010.00963.x; Eisenberger NI, 2011, J COGNITIVE NEUROSCI, V23, P3448, DOI 10.1162/jocn_a_00027; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; GEMBA DH, 1989, NEUROSCI LETT, V101, P263, DOI 10.1016/0304-3940(89)90543-0; Gozzi M, 2010, HUM BRAIN MAPP, V31, P1763, DOI 10.1002/hbm.20976; Greenwald AG, 2002, PSYCHOL REV, V109, P3, DOI 10.1037/0033-295X.109.1.3; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Greenwald AG, 2000, J PERS SOC PSYCHOL, V79, P1022, DOI 10.1037//0022-3514.79.6.1022; Gregg AP, 2010, SELF IDENTITY, V9, P142, DOI 10.1080/15298860902815451; He Y, 2009, SOC NEUROSCI-UK, V4, P426, DOI 10.1080/17470910902949184; Hetts JJ, 1999, J EXP SOC PSYCHOL, V35, P512, DOI 10.1006/jesp.1999.1391; Ito TA, 2003, J PERS SOC PSYCHOL, V85, P616, DOI 10.1037/0022-3514.85.4.616; Ito TA, 2010, SOC COGNITION, V28, P686, DOI 10.1521/soco.2010.28.6.686; Karpinski A, 2004, PERS SOC PSYCHOL B, V30, P22, DOI 10.1177/0146167203258835; Knutson KM, 2006, SOC NEUROSCI-UK, V1, P25, DOI 10.1080/17470910600670603; KOK A, 1986, BIOL PSYCHOL, V23, P21, DOI 10.1016/0301-0511(86)90087-6; Koole SL, 2001, J PERS SOC PSYCHOL, V80, P669, DOI 10.1037//0022-3514.80.4.669; Li HJ, 2013, NEUROSCI LETT, V548, P286, DOI 10.1016/j.neulet.2013.05.071; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; Lieberman MD, 2005, NAT NEUROSCI, V8, P720, DOI 10.1038/nn1465; Liotti M, 2000, NEUROPSYCHOLOGIA, V38, P701, DOI 10.1016/S0028-3932(99)00106-2; Miller J, 1998, PSYCHOPHYSIOLOGY, V35, P99, DOI 10.1111/1469-8986.3510099; Moran JM, 2006, J COGNITIVE NEUROSCI, V18, P1586, DOI 10.1162/jocn.2006.18.9.1586; Moran JM, 2009, SOC NEUROSCI-UK, V4, P197, DOI 10.1080/17470910802250519; Nieuwenhuis S, 2004, PSYCHOPHYSIOLOGY, V41, P157, DOI 10.1046/j.1469-8986.2003.00128.x; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Nosek BA, 2001, SOC COGNITION, V19, P625, DOI 10.1521/soco.19.6.625.20886; Phelps EA, 2000, J COGNITIVE NEUROSCI, V12, P729, DOI 10.1162/089892900562552; Pinter B, 2005, EXP PSYCHOL, V52, P74, DOI 10.1027/1618-3169.52.1.74; Rameson LT, 2010, NEUROIMAGE, V50, P701, DOI 10.1016/j.neuroimage.2009.12.098; Ronquillo J, 2007, SOC COGN AFFECT NEUR, V2, P39, DOI 10.1093/scan/nsl043; SASAKI K, 1993, NEUROSCI RES, V18, P249, DOI 10.1016/0168-0102(93)90062-U; Schiller NO, 2006, BRAIN RES, V1082, P153, DOI 10.1016/j.brainres.2006.01.087; Schmitt BM, 2001, J COGNITIVE NEUROSCI, V13, P510, DOI 10.1162/08989290152001925; Sedikides C, 2003, J PERS SOC PSYCHOL, V84, P60, DOI 10.1037/0022-3514.84.1.60; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Sharot T, 2012, CURR BIOL, V22, P1477, DOI 10.1016/j.cub.2012.05.053; Sharot T, 2011, NAT NEUROSCI, V14, P1475, DOI 10.1038/nn.2949; Sharot T, 2009, CURR BIOL, V19, P2077, DOI 10.1016/j.cub.2009.10.025; Somerville LH, 2010, CEREB CORTEX, V20, P3005, DOI 10.1093/cercor/bhq049; Stapel DA, 2004, J PERS SOC PSYCHOL, V87, P468, DOI 10.1037/0022-3514.87.4.468; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Ulrich R, 2001, PSYCHOPHYSIOLOGY, V38, P816, DOI 10.1111/1469-8986.3850816; van der Lugt AH, 2012, BRAIN RES, V1429, P98, DOI 10.1016/j.brainres.2011.10.032; Watson LA, 2007, BRAIN RES, V1152, P106, DOI 10.1016/j.brainres.2007.03.049; Wheeler ME, 2005, PSYCHOL SCI, V16, P56, DOI 10.1111/j.0956-7976.2005.00780.x; WOOD JV, 1989, PSYCHOL BULL, V106, P231, DOI 10.1037/0033-2909.106.2.231; Yamaguchi S, 2007, PSYCHOL SCI, V18, P498, DOI 10.1111/j.1467-9280.2007.01928.x; Yang J, 2014, BIOL PSYCHOL, V97, P22, DOI 10.1016/j.biopsycho.2014.01.004; Yang J, 2013, NEUROCASE, V19, P470, DOI 10.1080/13554794.2012.701636; Yang J, 2012, BRAIN RES, V1471, P75, DOI 10.1016/j.brainres.2012.06.033; Zhang HD, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065277, 10.1371/journal.pone.0054510, 10.1371/journal.pone.0068634, 10.1371/journal.pone.0079454]	67	97	101	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101837	10.1371/journal.pone.0101837	http://dx.doi.org/10.1371/journal.pone.0101837			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006966	Green Submitted, Green Published, gold			2022-12-27	WOS:000339040600071
J	Zhao, KL; Li, Y; Yue, BS; Wu, M				Zhao, Kelei; Li, Yi; Yue, Bisong; Wu, Min			Genes as Early Responders Regulate Quorum-Sensing and Control Bacterial Cooperation in Pseudomonas aeruginosa	PLOS ONE			English	Article							SMALL RNAS; SECONDARY METABOLISM; HOMOSERINE LACTONE; BIOFILM FORMATION; SYSTEM; GACA; INHIBITORS; VIRULENCE; QUANTIFICATION; IDENTIFICATION	Quorum-sensing (QS) allows bacterial communication to coordinate the production of extracellular products essential for population fitness at higher cell densities. It has been generally accepted that a significant time duration is required to reach appropriate cell density to activate the relevant quiescent genes encoding these costly but beneficial public goods. Which regulatory genes are involved and how these genes control bacterial communication at the early phases are largely unexplored. By determining time-dependent expression of QS-related genes of the opportunistic pathogen Pseudomonas aerugionsa, we show that the induction of social cooperation could be critically influenced by environmental factors to optimize the density of population. In particular, small regulatory RNAs (RsmY and RsmZ) serving as early responders, can promote the expression of dependent genes (e. g. lasR) to boost the synthesis of intracellular enzymes and coordinate instant cooperative behavior in bacterial cells. These early responders, acting as a rheostat to finely modulate bacterial cooperation, which may be quickly activated under environment threats, but peter off when critical QS dependent genes are fully functional for cooperation. Our findings suggest that RsmY and RsmZ critically control the timing and levels of public goods production, which may have implications in sociomicrobiology and infection control.	[Zhao, Kelei; Li, Yi; Wu, Min] Univ N Dakota, Sch Med & Hlth Sci, Dept Basic Sci, Grand Forks, ND 58201 USA; [Zhao, Kelei; Yue, Bisong] Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu 610064, Sichuan, Peoples R China	University of North Dakota Grand Forks; Sichuan University	Yue, BS (corresponding author), Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu 610064, Sichuan, Peoples R China.	bsyue@scu.edu.cn; min.wu@med.und.edu		Wu, Min/0000-0003-1205-982X	National Basic Research Program of China [2012CB722207]; Flight Attendant Medical Research Institute (FAMRI) [103007]; National Institutes of Health [AI101973-01, AI097532-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI097532, R15AI101973] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); Flight Attendant Medical Research Institute (FAMRI); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by: National Basic Research Program of China (973 Project: 2012CB722207)(www.973.gov.cn); Flight Attendant Medical Research Institute (FAMRI, Grant #103007)(www.famri.org); National Institutes of Health (AI101973-01, and AI097532-01A1)(www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRENCIC A, 2009, MOL MICROBIOL, V73, P434, DOI DOI 10.1111/j.1365-2958.2009.06782.x; Dandekar AA, 2012, SCIENCE, V338, P264, DOI 10.1126/science.1227289; Darch SE, 2012, P NATL ACAD SCI USA, V109, P8259, DOI 10.1073/pnas.1118131109; Deng X, 2013, CELL HOST MICROBE, V13, P358, DOI 10.1016/j.chom.2013.02.004; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Frangipani E, 2014, ENVIRON MICROBIOL, V16, P676, DOI 10.1111/1462-2920.12164; Garg N, 2014, ANTON LEEUW INT J G, V105, P289, DOI 10.1007/s10482-013-0082-3; Geske GD, 2005, J AM CHEM SOC, V127, P12762, DOI 10.1021/ja0530321; Hense BA, 2007, NAT REV MICROBIOL, V5, P230, DOI 10.1038/nrmicro1600; Heurlier K, 2005, J BACTERIOL, V187, P4875, DOI 10.1128/JB.187.14.4875-4883.2005; Heurlier K, 2004, J BACTERIOL, V186, P2936, DOI 10.1128/JB.186.10.2936-2945.2004; Intile PJ, 2014, J BACTERIOL, V196, P357, DOI 10.1128/JB.01199-13; Kannan S, 2006, CELL DEATH DIFFER, V13, P311, DOI 10.1038/sj.cdd.4401736; Kay E, 2005, P NATL ACAD SCI USA, V102, P17136, DOI 10.1073/pnas.0505673102; Kay E, 2006, J BACTERIOL, V188, P6026, DOI 10.1128/JB.00409-06; Kim C, 2008, APPL MICROBIOL BIOT, V80, P37, DOI 10.1007/s00253-008-1474-6; LaSarre B, 2013, MICROBIOL MOL BIOL R, V77, P73, DOI 10.1128/MMBR.00046-12; Latifi A, 1996, MOL MICROBIOL, V21, P1137, DOI 10.1046/j.1365-2958.1996.00063.x; Maeda T, 2012, ISME J, V6, P493, DOI 10.1038/ismej.2011.122; Muh U, 2006, ANTIMICROB AGENTS CH, V50, P3674, DOI 10.1128/AAC.00665-06; Parkins MD, 2001, MOL MICROBIOL, V40, P1215, DOI 10.1046/j.1365-2958.2001.02469.x; Pesci EC, 1997, J BACTERIOL, V179, P3127, DOI 10.1128/jb.179.10.3127-3132.1997; Pessi G, 2001, J BACTERIOL, V183, P6676, DOI 10.1128/JB.183.22.6676-6683.2001; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Popat R, 2012, P ROY SOC B-BIOL SCI, V279, P4765, DOI 10.1098/rspb.2012.1976; Reimmann C, 1997, MOL MICROBIOL, V24, P309, DOI 10.1046/j.1365-2958.1997.3291701.x; Ryan WJ, 2013, APPL ENVIRON MICROB, V79, P1795, DOI 10.1128/AEM.02962-12; Sandoz KM, 2007, P NATL ACAD SCI USA, V104, P15876, DOI 10.1073/pnas.0705653104; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Schuster M, 2013, ANNU REV MICROBIOL, V67, P43, DOI 10.1146/annurev-micro-092412-155635; Smith DR, 2010, MBIO, V1, DOI 10.1128/mBio.00131-10; Smith KM, 2003, CHEM BIOL, V10, P81, DOI 10.1016/s1074-5521(03)00002-4; Wei X, 2013, J BACTERIOL, V195, P3387, DOI 10.1128/JB.00214-13; Weilbacher T, 2003, MOL MICROBIOL, V48, P657, DOI 10.1046/j.1365-2958.2003.03459.x; West SA, 2012, TRENDS MICROBIOL, V20, P586, DOI 10.1016/j.tim.2012.09.004; Wilder CN, 2011, ISME J, V5, P1332, DOI 10.1038/ismej.2011.13; WITZANY G, 2008, OPEN EVOL J, V2, P44; Wu H, 2004, J ANTIMICROB CHEMOTH, V53, P1054, DOI 10.1093/jac/dkh223; Yang L, 2009, ANTIMICROB AGENTS CH, V53, P2432, DOI 10.1128/AAC.01283-08; Yuan KF, 2011, J BIOL CHEM, V286, P21814, DOI 10.1074/jbc.M111.237628; Zhao KL, 2013, INFECT IMMUN, V81, P4509, DOI 10.1128/IAI.01008-13; Zhou XK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4619	42	11	12	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101887	10.1371/journal.pone.0101887	http://dx.doi.org/10.1371/journal.pone.0101887			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006971	Green Published, gold, Green Submitted			2022-12-27	WOS:000339040600078
J	Chen, X; Quan, YR; Wang, HB; Luo, H				Chen, Xi; Quan, Yaru; Wang, Hongbin; Luo, Hong			Trehalase Regulates Neuroepithelial Stem Cell Maintenance and Differentiation in the Drosophila Optic Lobe	PLOS ONE			English	Article							GENE-EXPRESSION; LARVAL BRAIN; MELANOGASTER; JAK/STAT; NOTCH; PROLIFERATION; METABOLISM; PATHWAYS; DIVISION; PATTERN	As one of the major hydrolases in Drosophila, trehalase (Treh) catalyzes the hydrolysis of trehalose into glucose providing energy for flight muscle activity. Treh is highly conserved from bacteria to humans, but little is known about its function during animal development. Here, we analyze the function of Treh in Drosophila optic lobe development. In the optic lobe, neuroepithelial cells (NEs) first divide symmetrically to expand the stem cell pool and then differentiate into neuroblasts, which divide asymmetrically to generate medulla neurons. We find that the knockdown of Treh leads to a loss of the lamina and a smaller medulla. Analyses of Treh RNAi-expressing clones and loss-of-function mutants indicate that the lamina and medulla phenotypes result from neuroepithelial disintegration and premature differentiation into medulla neuroblasts. Although the principal role of Treh is to generate glucose, the Treh loss-of-function phenotype cannot be rescued by exogenous glucose. Thus, our results indicate that in addition to being a hydrolase, Treh plays a role in neuroepithelial stem cell maintenance and differentiation during Drosophila optic lobe development.	[Chen, Xi; Quan, Yaru; Wang, Hongbin; Luo, Hong] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Quan, Yaru] Natl Inst Food & Drug Control, Inst Biol Prod Control, Beijing, Peoples R China	Tsinghua University; National Institute of Food & Drug Control - China	Chen, X (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.	chenxi5566a@163.com; luohong@mail.tsinghua.edu.cn			National Science Foundation of China [30671035]; National Basic Sciences Research Program of Ministry of Science and Technology of China [2007CB947203]; National Basic Research Program of Ministry of Science and Technology of China [2013CB835100]; Tsinghua University Initiative Scientific Research Program [20111080956]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Sciences Research Program of Ministry of Science and Technology of China; National Basic Research Program of Ministry of Science and Technology of China; Tsinghua University Initiative Scientific Research Program	This work was supported by grants from National Science Foundation of China (grant number: 30671035, http://www.nsfc.gov.cn/), National Basic Sciences Research Program of Ministry of Science and Technology of China (grant number: 2007CB947203, http://www.most.gov.cn) to H. Luo, and National Basic Research Program of Ministry of Science and Technology of China (grant number: 2013CB835100, http://www.most.gov.cn), the Tsinghua University Initiative Scientific Research Program (grant number: 20111080956, http://www.moe.gov.cn) to Y. Zhong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonini BM, 2004, MYCOTA, V3, P291; BRAND AH, 1993, DEVELOPMENT, V118, P401; BURTON RS, 1986, BIOCHEM GENET, V24, P715, DOI 10.1007/BF00499004; Chell JM, 2010, CELL, V143, P1161, DOI 10.1016/j.cell.2010.12.007; CLEGG JS, 1961, SCIENCE, V134, P54, DOI 10.1126/science.134.3471.54; Egger B, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-1; Egger B, 2010, DEVELOPMENT, V137, P2981, DOI 10.1242/dev.051250; Elbein A D, 1974, Adv Carbohydr Chem Biochem, V30, P227, DOI 10.1016/S0065-2318(08)60266-8; GREEN P, 1993, CELL TISSUE RES, V273, P583, DOI 10.1007/BF00333712; Hayden MA, 2007, DEV BIOL, V305, P358, DOI 10.1016/j.ydbio.2007.02.018; HOFBAUER A, 1990, ROUX ARCH DEV BIOL, V198, P264, DOI 10.1007/BF00377393; Hrdlicka L, 2002, GENESIS, V34, P51, DOI 10.1002/gene.10125; Huang Z, 1996, CELL, V86, P411, DOI 10.1016/S0092-8674(00)80114-2; Huang Z, 1998, CELL, V95, P693, DOI 10.1016/S0092-8674(00)81639-6; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.0.CO;2-L; Meinertzhagen Ian A., 1993, P1363; Nassif C, 2003, J COMP NEUROL, V455, P417, DOI 10.1002/cne.10482; Ngo KT, 2010, DEV BIOL, V346, P284, DOI 10.1016/j.ydbio.2010.07.036; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; OLIVER MJ, 1978, BIOCHEM GENET, V16, P927, DOI 10.1007/BF00483744; Orihara-Ono M, 2011, DEV BIOL, V351, P163, DOI 10.1016/j.ydbio.2010.12.044; Ouyang YH, 2009, BIOCHEM BIOPH RES CO, V379, P621, DOI 10.1016/j.bbrc.2008.12.134; Reddy BVVG, 2010, DEVELOPMENT, V137, P2397, DOI 10.1242/dev.050013; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; SACKTOR B, 1968, P NATL ACAD SCI USA, V60, P1007, DOI 10.1073/pnas.60.3.1007; Takahashi T, 1999, J NEUROSCI, V19, P10357; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Toriya M, 2006, DEV NEUROSCI-BASEL, V28, P142, DOI 10.1159/000090760; Wang HB, 2013, GENETICS, V195, P1291, DOI 10.1534/genetics.113.155945; Wang W, 2011, BIOCHEM BIOPH RES CO, V410, P714, DOI 10.1016/j.bbrc.2011.05.119; Wang W, 2011, DEV BIOL, V350, P414, DOI 10.1016/j.ydbio.2010.12.002; Weng M, 2012, DEV NEUROBIOL, V72, P1376, DOI 10.1002/dneu.20995; Wyatt G.R., 1967, ADV INSECT PHYSIOL, V4, P287, DOI DOI 10.1016/S0065-2806(08)60210-6; Yasugi T, 2008, DEVELOPMENT, V135, P1471, DOI 10.1242/dev.019117; Yasugi T, 2010, DEVELOPMENT, V137, P3193, DOI 10.1242/dev.048058	35	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101433	10.1371/journal.pone.0101433	http://dx.doi.org/10.1371/journal.pone.0101433			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003205	Green Submitted, Green Published, gold			2022-12-27	WOS:000339242700030
J	Dorfman, D; Aranda, ML; Fleitas, MFG; Chianelli, MS; Fernandez, DC; Sande, PH; Rosenstein, RE				Dorfman, Damian; Aranda, Marcos L.; Gonzalez Fleitas, Maria Florencia; Chianelli, Monica S.; Fernandez, Diego C.; Sande, Pablo H.; Rosenstein, Ruth E.			Environmental Enrichment Protects the Retina from Early Diabetic Damage in Adult Rats	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INDUCED RETINOPATHY; CEREBRAL-ISCHEMIA; OXIDATIVE DAMAGE; NEURAL APOPTOSIS; BDNF; EXPRESSION; EXERCISE; MICE; SYNAPTOPHYSIN	Diabetic retinopathy is a leading cause of reduced visual acuity and acquired blindness. Available treatments are not completely effective. We analyzed the effect of environmental enrichment on retinal damage induced by experimental diabetes in adult Wistar rats. Diabetes was induced by an intraperitoneal injection of streptozotocin. Three days after vehicle or streptozotocin injection, animals were housed in enriched environment or remained in a standard environment. Retinal function (electroretinogram, and oscillatory potentials), retinal morphology, blood-retinal barrier integrity, synaptophysin, astrocyte and Muller cell glial fibrillary acidic protein, vascular endothelial growth factor, tumor necrosis factor-alpha, and brain-derived neurotrophic factor levels, as well as lipid peroxidation were assessed in retina from diabetic animals housed in standard or enriched environment. Environmental enrichment preserved scotopic electroretinogram a-wave, b-wave and oscillatory potential amplitude, avoided albumin-Evan's blue leakage, prevented the decrease in retinal synaptophysin and astrocyte glial fibrillary acidic protein levels, the increase in Muller cell glial fibrillary acidic protein, vascular endothelial growth factor and tumor necrosis factor-alpha levels, as well as oxidative stress induced by diabetes. In addition, enriched environment prevented the decrease in retinal brain-derived neurotrophic factor levels induced by experimental diabetes. When environmental enrichment started 7 weeks after diabetes onset, retinal function was significantly preserved. These results indicate that enriched environment could attenuate the early diabetic damage in the retina from adult rats.	[Dorfman, Damian; Aranda, Marcos L.; Gonzalez Fleitas, Maria Florencia; Chianelli, Monica S.; Fernandez, Diego C.; Sande, Pablo H.; Rosenstein, Ruth E.] Univ Buenos Aires, Lab Retinal Neurochem & Expt Ophthalmol, Dept Human Biochem, Sch Med,CEFyBO,CONICET, Buenos Aires, DF, Argentina; [Fernandez, Diego C.] Univ Moron, Histol Lab, Sch Med, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Rosenstein, RE (corresponding author), Univ Buenos Aires, Lab Retinal Neurochem & Expt Ophthalmol, Dept Human Biochem, Sch Med,CEFyBO,CONICET, Buenos Aires, DF, Argentina.	ruthr@fmed.uba.ar		Aranda, Marcos/0000-0003-1891-3476; Fernandez, Diego Carlos/0000-0002-4363-1318; Gonzalez Fleitas, Maria Florencia/0000-0001-5795-8365	Agencia Nacional de Promocion Cientifica y Tecnica [PICT 0610]; Consejo Nacional de Investigacion Cientifica y Tecnica [PIP 0446]; Universidad de Buenos Aires [UBACyT 20020100100678]; Fundacion Florencio Fiorini	Agencia Nacional de Promocion Cientifica y Tecnica(ANPCyT); Consejo Nacional de Investigacion Cientifica y Tecnica; Universidad de Buenos Aires(University of Buenos Aires); Fundacion Florencio Fiorini	Agencia Nacional de Promocion Cientifica y Tecnica (PICT 0610), Consejo Nacional de Investigacion Cientifica y Tecnica (PIP 0446) and Universidad de Buenos Aires (UBACyT 20020100100678) and Fundacion Florencio Fiorini. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2004, NEUROSCIENCE, V124, P985, DOI 10.1016/j.neuroscience.2003.12.039; Arevalo JF, 2007, OPHTHALMOLOGY, V114, P743, DOI 10.1016/j.ophtha.2006.12.028; Bai YJ, 2010, INVEST OPHTH VIS SCI, V51, P4722, DOI 10.1167/iovs.09-5032; Barber AJ, 2000, INVEST OPHTH VIS SCI, V41, P3561; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Barber AJ, 2011, INVEST OPHTH VIS SCI, V52, P1156, DOI 10.1167/iovs.10-6293; Barone I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050726; Beauquis J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013993; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Briones TL, 2006, EXP NEUROL, V198, P530, DOI 10.1016/j.expneurol.2005.12.032; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Dorfman D, 2013, EXP NEUROL, V240, P146, DOI 10.1016/j.expneurol.2012.11.017; Fernandez DC, 2011, AM J PATHOL, V178, P2264, DOI 10.1016/j.ajpath.2011.01.040; Jurgens HA, 2012, BRAIN BEHAV IMMUN, V26, P1006, DOI 10.1016/j.bbi.2012.05.015; Kanwar M, 2007, INVEST OPHTH VIS SCI, V48, P3805, DOI 10.1167/iovs.06-1280; Kern TS, 2008, CONTEMP DIABETES, P137, DOI 10.1007/978-1-59745-563-3_5; Kiss P, 2013, INT J MOL SCI, V14, P16111, DOI 10.3390/ijms140816111; Kohzaki K, 2008, INVEST OPHTH VIS SCI, V49, P3595, DOI 10.1167/iovs.08-1679; Kurihara T, 2008, DIABETES, V57, P2191, DOI 10.2337/db07-1281; Landi S, 2007, FASEB J, V21, P130, DOI 10.1096/fj.06-6083com; Landi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000346; LAVAIL MM, 1992, P NATL ACAD SCI USA, V89, P11249, DOI 10.1073/pnas.89.23.11249; Lenzser G, 2007, J CEREBR BLOOD F MET, V27, P1318, DOI 10.1038/sj.jcbfm.9600437; Liu Y, 2013, MOL MED REP, V7, P1773, DOI 10.3892/mmr.2013.1433; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma NL, 1996, AM J PATHOL, V149, P1745; MASLIAH E, 1990, J HISTOCHEM CYTOCHEM, V38, P837, DOI 10.1177/38.6.2110586; Okoye G, 2003, J NEUROSCI, V23, P4164; Ola MS, 2013, CELL MOL NEUROBIOL, V33, P359, DOI 10.1007/s10571-012-9901-8; Palenski TL, 2013, MICROVASC RES, V89, P57, DOI 10.1016/j.mvr.2013.06.007; Penn JS, 2008, PROG RETIN EYE RES, V27, P331, DOI 10.1016/j.preteyeres.2008.05.001; Piazza FV, 2011, BEHAV BRAIN RES, V217, P16, DOI 10.1016/j.bbr.2010.09.017; Pinaud R, 2002, MOL BRAIN RES, V98, P93, DOI 10.1016/S0169-328X(01)00328-X; Prusky GT, 2000, BEHAV BRAIN RES, V114, P11, DOI 10.1016/S0166-4328(00)00186-8; Robinson R, 2012, DIS MODEL MECH, V5, P444, DOI 10.1242/dmm.009597; Salido EM, 2012, EXP NEUROL, V236, P151, DOI 10.1016/j.expneurol.2012.04.010; Seki M, 2003, INVEST OPHTH VIS SCI, V44, P3211, DOI 10.1167/iovs.02-1089; Shinoda K, 2007, CLIN EXP OPHTHALMOL, V35, P847, DOI 10.1111/j.1442-9071.2007.01607.x; Tarr JM, 2013, ADV EXP MED BIOL, V771, P88; Tolentino MJ, 2002, AM J OPHTHALMOL, V133, P373, DOI 10.1016/S0002-9394(01)01381-2; Tremolada G, 2012, EXP DIABETES RES, DOI 10.1155/2012/728325; VanGuilder HD, 2008, EUR J NEUROSCI, V28, P1, DOI 10.1111/j.1460-9568.2008.06322.x; WALAAS SI, 1988, SYNAPSE, V2, P516, DOI 10.1002/syn.890020507; Wang FH, 2009, OPHTHALMOLOGY, V116, P461, DOI 10.1016/j.ophtha.2008.10.003; Wei Michael, 2003, Heart Lung Circ, V12, P44, DOI 10.1046/j.1444-2892.2003.00160.x; Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001; Xu XH, 2009, EXP BIOL MED, V234, P296, DOI 10.3181/0804-RM-128; Yoshida Y, 2009, DIABETES-METAB RES, V25, P678, DOI 10.1002/dmrr.1007; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449; Yu KW, 2013, BRAIN RES, V1538, P93, DOI 10.1016/j.brainres.2013.09.036; Zhang SX, 2005, AM J PATHOL, V166, P313, DOI 10.1016/S0002-9440(10)62255-9; Zhang XZ, 2010, JAMA-J AM MED ASSOC, V304, P649, DOI 10.1001/jama.2010.1111	53	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101829	10.1371/journal.pone.0101829	http://dx.doi.org/10.1371/journal.pone.0101829			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004165	gold, Green Submitted, Green Published			2022-12-27	WOS:000339242700074
J	Tejero, R; Navarro, A; Campayo, M; Vinolas, N; Marrades, RM; Cordeiro, A; Ruiz-Martinez, M; Santasusagna, S; Molins, L; Ramirez, J; Monzo, M				Tejero, Rut; Navarro, Alfons; Campayo, Marc; Vinolas, Nuria; Marrades, Ramon M.; Cordeiro, Anna; Ruiz-Martinez, Marc; Santasusagna, Sandra; Molins, Laureano; Ramirez, Josep; Monzo, Mariano			miR-141 and miR-200c as Markers of Overall Survival in Early Stage Non-Small Cell Lung Cancer Adenocarcinoma	PLOS ONE			English	Article							PROGNOSTIC MARKER; FAMILY; TRANSITION; EXPRESSION; MICRORNAS; INVASION; CLUSTER; ZEB1	Background: Several treatments in non-small cell lung cancer (NSCLC) are histology-dependent, and the need for histology-related markers is increasing. MicroRNAs (miRNAs) are promising molecular markers in multiple cancers and show differences in expression depending on histological subtype. The miRNA family miR-200 has been associated with the regulation of epithelial-mesenchymal (EMT)/mesenchymal-epithelial transition (MET). EMT involves profound phenotypic changes that include the loss of cell-cell adhesion, the loss of cell polarity, and the acquisition of migratory and invasive properties that facilitates metastasis. A dual role for the miR-200 family in the prognosis of several tumors has been related to tumor cell origin. However, the prognostic role and function of miR-200 family in early-stage NSCLC adenocarcinoma and squamous cell carcinoma (SCC) have not been well established. Methods: miRNA expression was determined using TaqMan assays in 155 tumors from resected NSCLC patients. Functional studies were conducted in three NSCLC cell lines: H23, A-549 and HCC-44. Results: High miR-200c expression was associated with shorter overall survival (OS) in the entire cohort (p = 0.024). High miR-200c (p = 0.0004) and miR-141 (p = 0.009) expression correlated with shorter OS in adenocarcinoma - but not in SCC. In the multivariate analysis, a risk score based on miR-141 and miR-200c expression emerged as an independent prognostic factor for OS in the entire cohort (OR, 2.787; p = 0.033) and in adenocarcinoma patients (OR, 10.649; p = 0.002). Functional analyses showed that miR-200c, was related to mesenchymal-epithelial transition (MET) and affected cell migration and E-cadherin levels, while overexpression of miR-141 reduced KLF6 protein levels and produced an increase of secretion of VEGFA in vitro (H23, p = 0.04; A-549, p = 0.03; HCC-44, p = 0.02) and was associated with higher blood microvessel density in patient tumor samples (p<0.001). Conclusion: High miR-141 and miR-200c expression are associated with shorter OS in NSCLC patients with adenocarcinoma through MET and angiogenesis.	[Tejero, Rut; Navarro, Alfons; Cordeiro, Anna; Ruiz-Martinez, Marc; Santasusagna, Sandra; Monzo, Mariano] Univ Barcelona, Mol Oncol & Embryol Lab, Human Anat Unit, Sch Med,IDIBAPS, Barcelona, Spain; [Campayo, Marc; Vinolas, Nuria] Univ Barcelona, Dept Med Oncol, ICMHO, Hosp Clin Barcelona, Barcelona, Spain; [Marrades, Ramon M.] Univ Barcelona, Dept Pneumol, ICT, Hosp Clin Barcelona,IDIBAPS,CIBER Enfermedades Re, Barcelona, Spain; [Ramirez, Josep] Univ Barcelona, Dept Pathol, CDB, Hosp Clin Barcelona,IDIBAPS,CIBERES, Barcelona, Spain; [Molins, Laureano] Univ Barcelona, Hosp Clin Barcelona, Dept Thorac Surg, ICT, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona	Navarro, A (corresponding author), Univ Barcelona, Mol Oncol & Embryol Lab, Human Anat Unit, Sch Med,IDIBAPS, Barcelona, Spain.	anavarroponz@ub.edu; mmonzo@ub.edu	Navarro, Alfons/C-2453-2015; MArrades, Ramón M/AFU-6757-2022	Navarro, Alfons/0000-0001-6071-0926; Ruiz Martinez, Marc/0000-0002-9106-6536; Campayo, Marc/0000-0002-9874-4707; Tejero-Villalba, Rut/0000-0001-5134-4813; Santasusagna Canal, Sandra/0000-0002-4919-4577; Cordeiro, Anna/0000-0001-6012-1259; MONZO, MARIANO/0000-0003-2322-4851	Instituto de Salud Carlos III [FIS-PI0900547]; SDCSD of University of Barcelona; AECC-Catalunya	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); SDCSD of University of Barcelona; AECC-Catalunya	This work was supported by grants from Instituto de Salud Carlos III (FIS-PI0900547), SDCSD of University of Barcelona and AECC-Catalunya 2013. Rut Tejero, Anna Cordeiro, Marc Ruiz-Martinez are APIF fellows of University of Barcelona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artells R, 2011, ANAT REC, V294, P462, DOI 10.1002/ar.21333; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brabletz T, 2012, NAT REV CANCER, V12, P425, DOI 10.1038/nrc3265; Bremnes RM, 2006, LUNG CANCER, V51, P143, DOI 10.1016/j.lungcan.2005.09.005; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Campayo M, 2012, EUR RESP J; Ceppi P, 2010, MOL CANCER RES, V8, P1207, DOI 10.1158/1541-7786.MCR-10-0052; Chen J, 2011, METALLOGENIC SETTING, P1; Cheng HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017745; Diaz T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018856; Difeo A, 2006, CLIN CANCER RES, V12, P3730, DOI 10.1158/1078-0432.CCR-06-0054; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; Gallardo E, 2009, CARCINOGENESIS, V30, P1903, DOI 10.1093/carcin/bgp219; Goldstraw P, 2011, LANCET, V378, P1727, DOI 10.1016/S0140-6736(10)62101-0; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hu XX, 2009, GYNECOL ONCOL, V114, P457, DOI 10.1016/j.ygyno.2009.05.022; KAWAI T, 1988, AM J CLIN PATHOL, V89, P455, DOI 10.1093/ajcp/89.4.455; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu XG, 2012, MED ONCOL, V29, P618, DOI 10.1007/s12032-011-9923-y; Mateescu B, 2011, NAT MED, V17, P1627, DOI 10.1038/nm.2512; Navarro A, 2010, YONSEI MED J, V51, P622, DOI 10.3349/ymj.2010.51.5.622; Pacurari M, 2013, INT J ONCOL, V43, P548, DOI 10.3892/ijo.2013.1963; Patel JD, 2007, J CLIN ONCOL, V25; Pecot CV, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3427; Raponi M, 2009, CANCER RES, V69, P5776, DOI 10.1158/0008-5472.CAN-09-0587; Roybal JD, 2011, MOL CANCER RES, V9, P25, DOI 10.1158/1541-7786.MCR-10-0497; Saito M, 2011, CLIN CANCER RES, V17, P1875, DOI 10.1158/1078-0432.CCR-10-2961; Scagliotti G, 2009, ONCOLOGIST, V14, P253, DOI 10.1634/theoncologist.2008-0232; Siegel R, 2012, CANCER STAT 2012; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Travis WD., 2004, TRAVIS WB WHO CLASSI; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; UPTON MP, 1986, AM J SURG PATHOL, V10, P560, DOI 10.1097/00000478-198608000-00006; Valladares-Ayerbes M, 2012, J TRANSL MED, V10, P1; Valladares-Ayerbes M, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-186; Wang GY, 2013, P NATL ACAD SCI USA, V110, P2858, DOI 10.1073/pnas.1212769110	37	112	119	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101899	10.1371/journal.pone.0101899	http://dx.doi.org/10.1371/journal.pone.0101899			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003366	gold, Green Published, Green Submitted			2022-12-27	WOS:000339242700086
J	Zhu, J; Luz-Madrigal, A; Haynes, T; Zavada, J; Burke, AK; Del Rio-Tsonis, K				Zhu, Jie; Luz-Madrigal, Agustin; Haynes, Tracy; Zavada, Julia; Burke, Amy K.; Del Rio-Tsonis, Katia			beta-Catenin Inactivation Is a Pre-Requisite for Chick Retina Regeneration	PLOS ONE			English	Article							TADPOLE TAIL REGENERATION; CILIARY MARGINAL ZONE; OPTIC CUP; PIGMENT EPITHELIUM; ZEBRAFISH RETINA; MUSCLE REGENERATION; CELL PROLIFERATION; SIGNALING PATHWAYS; VERTEBRATE RETINA; WNT/BETA-CATENIN	In the present study we explored the role of beta-catenin in mediating chick retina regeneration. The chick can regenerate its retina by activating stem/progenitor cells present in the ciliary margin (CM) of the eye or via transdifferentiation of the retinal pigmented epithelium (RPE). Both modes require fibroblast growth factor 2 (FGF2). We observed, by immunohistochemistry, dynamic changes of nuclear beta-catenin in the CM and RPE after injury (retinectomy). beta-catenin nuclear accumulation was transiently lost in cells of the CM in response to injury alone, while the loss of nuclear beta-catenin was maintained as long as FGF2 was present. However, nuclear beta-catenin positive cells remained in the RPE in response to injury and were BrdU-/p27+, suggesting that nuclear beta-catenin prevents those cells from entering the cell cycle. If FGF2 is present, the RPE undergoes dedifferentiation and proliferation concomitant with loss of nuclear beta-catenin. Moreover, retinectomy followed by disruption of active beta-catenin by using a signaling inhibitor (XAV939) or over-expressing a dominant negative form of Lef-1 induces regeneration from both the CM and RPE in the absence of FGF2. Our results imply that beta-catenin protects cells of the CM and RPE from entering the cell cycle in the developing eye, and specifically for the RPE during injury. Thus inactivation of beta-catenin is a pre-requisite for chick retina regeneration.	[Zhu, Jie; Luz-Madrigal, Agustin; Haynes, Tracy; Zavada, Julia; Burke, Amy K.; Del Rio-Tsonis, Katia] Miami Univ, Dept Biol, Oxford, OH 45056 USA	University System of Ohio; Miami University	Del Rio-Tsonis, K (corresponding author), Miami Univ, Dept Biol, Oxford, OH 45056 USA.	delriok@miamioh.edu		LUZ MADRIGAL, AGUSTIN/0000-0002-7504-2753	NIA [AG024937]; NEI [EY017319]; Sigma Xi grant; CONACYT [162930, 142523]; DUOS scholarship from Miami University; USS; NATIONAL EYE INSTITUTE [R01EY017319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG024937] Funding Source: NIH RePORTER	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Sigma Xi grant; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DUOS scholarship from Miami University; USS; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIA grant AG024937 and NEI grant EY017319 to KDRT; Sigma Xi grant to JZ; CONACYT 162930 and 142523 to ALM; and USS and DUOS scholarship from Miami University to Julia Z and Amy KB, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa-Sabanero K, 2012, BIOCHEM J, V447, P321, DOI 10.1042/BJ20120813; Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Belecky-Adams Teri L, 2012, Methods Mol Biol, V884, P71, DOI 10.1007/978-1-61779-848-1_5; BeleckyAdams T, 1997, INVEST OPHTH VIS SCI, V38, P1293; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Canto-Soler MV, 2006, DEV BIOL, V294, P119, DOI 10.1016/j.ydbio.2006.02.033; Chiba C, 2014, EXP EYE RES, V123, P107, DOI 10.1016/j.exer.2013.07.009; Cho SH, 2006, DEVELOPMENT, V133, P3167, DOI 10.1242/dev.02474; Choi YS, 2013, CELL STEM CELL, V13, P720, DOI 10.1016/j.stem.2013.10.003; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; da Silva MRD, 2007, DEV BIOL, V304, P272, DOI 10.1016/j.ydbio.2006.12.033; Fischer AJ, 2000, DEV BIOL, V220, P197, DOI 10.1006/dbio.2000.9640; Fujimura N, 2009, DEV BIOL, V334, P31, DOI 10.1016/j.ydbio.2009.07.002; Gallina D, 2014, EXP EYE RES, V123, P121, DOI 10.1016/j.exer.2013.06.019; Gorsuch RA, 2014, EXP EYE RES, V123, P131, DOI 10.1016/j.exer.2013.07.012; Halfter W, 2005, INVEST OPHTH VIS SCI, V46, P2202, DOI 10.1167/iovs.04-1419; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Haynes T, 2004, CURR NEUROVASC RES, V1, P231, DOI 10.2174/1567202043362216; Haynes T, 2007, P NATL ACAD SCI USA, V104, P20380, DOI 10.1073/pnas.0708202104; Haynes T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3312; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jasoni C, 1999, DEV DYNAM, V215, P215, DOI 10.1002/(SICI)1097-0177(199907)215:3<215::AID-AJA4>3.0.CO;2-W; Kengaku M, 1998, SCIENCE, V280, P1274, DOI 10.1126/science.280.5367.1274; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Kitamoto J, 2010, MOL VIS, V16, P2701; Kubo F, 2005, DEVELOPMENT, V132, P2759, DOI 10.1242/dev.01856; Kubo F, 2003, DEVELOPMENT, V130, P587, DOI 10.1242/dev.00244; Kubo F, 2009, DEVELOPMENT, V136, P1823, DOI 10.1242/dev.029272; Kubota R, 2004, DEV DYNAM, V229, P529, DOI 10.1002/dvdy.20000; La Torre Anna, 2012, Methods Mol Biol, V884, P229, DOI 10.1007/978-1-61779-848-1_16; Lin G, 2008, DEV BIOL, V316, P323, DOI 10.1016/j.ydbio.2008.01.032; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu H, 2003, DEV DYNAM, V227, P323, DOI 10.1002/dvdy.10315; Liu H, 2007, DEV BIOL, V308, P54, DOI 10.1016/j.ydbio.2007.04.052; Liu H, 2006, INVEST OPHTH VIS SCI, V47, P5088, DOI 10.1167/iovs.06-0403; Liu SY, 2013, NATURE, V500, P81, DOI 10.1038/nature12414; Loftus SK, 2001, DNA RES, V8, P221, DOI 10.1093/dnares/8.5.221; Love NR, 2013, NAT CELL BIOL, V15, P222, DOI 10.1038/ncb2659; Meyers JR, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-30; Osakada F, 2007, J NEUROSCI, V27, P4210, DOI 10.1523/JNEUROSCI.4193-06.2007; Otto A, 2008, J CELL SCI, V121, P2939, DOI 10.1242/jcs.026534; PARK CM, 1989, DEV BIOL, V134, P201, DOI 10.1016/0012-1606(89)90089-4; PARK CM, 1991, DEV BIOL, V148, P322, DOI 10.1016/0012-1606(91)90341-Y; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Poss KD, 2000, DEV DYNAM, V219, P282, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1045>3.3.CO;2-3; Ramachandran R, 2011, P NATL ACAD SCI USA, V108, P15858, DOI 10.1073/pnas.1107220108; Rezza A, 2010, J CELL SCI, V123, P3256, DOI 10.1242/jcs.065284; Rhee J, 2007, NAT CELL BIOL, V9, P883, DOI 10.1038/ncb1614; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Sikes JM, 2013, NATURE, V500, P77, DOI 10.1038/nature12403; Sodhi D, 2005, J HEPATOL, V43, P132, DOI 10.1016/j.jhep.2005.02.019; Spence JR, 2007, DEV DYNAM, V236, P1161, DOI 10.1002/dvdy.21115; Spence JR, 2007, MOL VIS, V13, P57; Spence JR, 2004, DEVELOPMENT, V131, P4607, DOI 10.1242/dev.01298; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Takeo M, 2013, NATURE, V499, P228, DOI 10.1038/nature12214; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Trimarchi JM, 2009, DEV DYNAM, V238, P2327, DOI 10.1002/dvdy.21973; Tutter AV, 2001, GENE DEV, V15, P3342, DOI 10.1101/gad.946501; Umesono Y, 2013, NATURE, V500, P73, DOI 10.1038/nature12359; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Van Raay TJ, 2005, NEURON, V46, P23, DOI 10.1016/j.neuron.2005.02.023; Venters SJ, 2011, MOL VIS, V17, P3347; Wang QC, 2012, ADV GENET ENG BIOTEC, V1, P1, DOI [DOI 10.4172/AGEB.1000E101, 10.4172/2324-9021.1000e101, DOI 10.4172/2324-9021.1000E101]; Westenskow P, 2009, DEVELOPMENT, V136, P2505, DOI 10.1242/dev.032136; Westenskow PD, 2010, INVEST OPHTH VIS SCI, V51, P5328, DOI 10.1167/iovs.09-5015; Yang HJ, 2009, DEV DYNAM, V238, P2823, DOI 10.1002/dvdy.22116; Yoshikawa T, 2012, PIGM CELL MELANOMA R, V25, P66, DOI 10.1111/j.1755-148X.2011.00935.x; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zhong N, 2006, BONE, V39, P5, DOI 10.1016/j.bone.2005.12.008; Zhu J. G., 2012, ENG OPTIM, P1, DOI DOI 10.1109/ESARS.2012.6387393	77	18	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101748	10.1371/journal.pone.0101748	http://dx.doi.org/10.1371/journal.pone.0101748			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003522	Green Submitted, gold, Green Published			2022-12-27	WOS:000339242700060
J	Gan, HC; McKenzie, R; Hao, Q; Idell, S; Tang, H				Gan, Huachen; McKenzie, Raymond; Hao, Qin; Idell, Steven; Tang, Hua			Protein Kinase D Is Increased and Activated in Lung Epithelial Cells and Macrophages in Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; PROSTATE-CANCER; RECEPTOR; EXPRESSION; GROWTH; HYPERRESPONSIVENESS; FIBROBLASTS; THERAPIES; SECRETION; PATHWAY	Idiopathic pulmonary fibrosis (IPF) is a relentlessly progressive and usually fatal lung disease of unknown etiology for which no effective treatments currently exist. Hence, there is a profound need for the identification of novel drugable targets to develop more specific and efficacious therapeutic intervention in IPF. In this study, we performed immunohistochemical analyses to assess the cell type-specific expression and activation of protein kinase D (PKD) family kinases in normal and IPF lung tissue sections. We also analyzed PKD activation and function in human lung epithelial cells. We found that PKD family kinases (PKD1, PKD2 and PKD3) were increased and activated in the hyperplastic and regenerative alveolar epithelial cells lining remodeled fibrotic alveolar septa and/or fibroblast foci in IPF lungs compared with normal controls. We also found that PKD family kinases were increased and activated in alveolar macrophages, bronchiolar epithelium, and honeycomb cysts in IPF lungs. Interestingly, PKD1 was highly expressed and activated in the cilia of IPF bronchiolar epithelial cells, while PKD2 and PKD3 were expressed in the cell cytoplasm and nuclei. In contrast, PKD family kinases were not apparently increased and activated in IPF fibroblasts or myofibroblasts. We lastly found that PKD was predominantly activated by poly-L-arginine, lysophosphatidic acid and thrombin in human lung epithelial cells and that PKD promoted epithelial barrier dysfunction. These findings suggest that PKD may participate in the pathogenesis of IPF and may be a novel target for therapeutic intervention in this disease.	[Gan, Huachen; McKenzie, Raymond; Hao, Qin; Idell, Steven; Tang, Hua] Univ Texas Tyler, Hlth Sci Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX 75799 USA; [Idell, Steven] Univ Texas Tyler, Hlth Sci Ctr Tyler, Texas Lung Injury Inst, Tyler, TX 75799 USA	University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Tang, H (corresponding author), Univ Texas Tyler, Hlth Sci Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX 75799 USA.	hua.tang@uthct.edu	Gan, Huachen/AAE-5925-2021		National Institutes of Health (NIH) [R03-HL095438, R21-HL097216]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL097216, R03HL095438] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part or in whole by the National Institutes of Health (NIH) Grants R03-HL095438 and R21-HL097216 (HT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamali HI, 2012, DRUG DES DEV THER, V6, P261, DOI 10.2147/DDDT.S29928; Ask Kjetil, 2006, Proc Am Thorac Soc, V3, P389, DOI 10.1513/pats.200602-021TK; Auer A, 2005, MOL BIOL CELL, V16, P4375, DOI 10.1091/mbc.E05-03-0251; Azoitei N, 2010, GUT, V59, P1316, DOI 10.1136/gut.2009.206813; Camelo A, 2014, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00173; Chen J, 2008, CANCER RES, V68, P3844, DOI 10.1158/0008-5472.CAN-07-5156; Chilosi M, 2002, LAB INVEST, V82, P1335, DOI 10.1097/01.LAB.0000032380.82232.67; Chiu TT, 2007, AM J PHYSIOL-CELL PH, V292, pC767, DOI 10.1152/ajpcell.00308.2006; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Fu Y, 2011, EMBO REP, V12, P785, DOI 10.1038/embor.2011.139; FULMER JD, 1977, J CLIN INVEST, V60, P595, DOI 10.1172/JCI108811; Gan HC, 2013, J BIOL CHEM, V288, P37343, DOI 10.1074/jbc.M113.511527; Hao Q, 2013, ANTICANCER RES, V33, P393; Hao Q, 2009, AM J PHYSIOL-CELL PH, V296, pC821, DOI 10.1152/ajpcell.00504.2008; Hao Q, 2009, J BIOL CHEM, V284, P799, DOI 10.1074/jbc.M807546200; Hinata Nae, 2003, Journal of Medical and Dental Sciences, V50, P213; Homma T, 2005, AM J PHYSIOL-LUNG C, V289, pL413, DOI 10.1152/ajplung.00059.2005; Howell DC, 2002, BIOCHEM SOC T, V30, P211, DOI 10.1042/BST0300211; Jakubzick C, 2004, AM J PATHOL, V164, P1989, DOI 10.1016/S0002-9440(10)63759-5; Katzenstein ALA, 1998, AM J RESP CRIT CARE, V157, P1301, DOI 10.1164/ajrccm.157.4.9707039; KAWANAMI O, 1982, LAB INVEST, V46, P39; Kim YI, 2010, J IMMUNOL, V184, P3145, DOI 10.4049/jimmunol.0903718; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Lappi-Blanco E, 2013, HUM PATHOL, V44, P895, DOI 10.1016/j.humpath.2012.08.016; LaValle CR, 2012, MOL CANCER THER, V11, P1389, DOI 10.1158/1535-7163.MCT-11-0887; Loomis-King H, 2013, CURR OPIN PHARMACOL, V13, P377, DOI 10.1016/j.coph.2013.03.015; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Murray LA, 2008, INT J BIOCHEM CELL B, V40, P2174, DOI 10.1016/j.biocel.2008.02.016; Murray LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009683; Ohta H, 2012, AM J PHYSIOL-LUNG C, V302, pL193, DOI 10.1152/ajplung.00349.2010; Olayioye MA, 2013, CELL SIGNAL, V25, P1739, DOI 10.1016/j.cellsig.2013.04.010; Papazyan R, 2006, BIOCHEM BIOPH RES CO, V342, P685, DOI 10.1016/j.bbrc.2006.02.013; Park JE, 2009, J IMMUNOL, V182, P6316, DOI 10.4049/jimmunol.0804239; Rafii R, 2013, J THORAC DIS, V5, P48, DOI 10.3978/j.issn.2072-1439.2012.12.07; Rey O, 2003, J BIOL CHEM, V278, P23773, DOI 10.1074/jbc.M300226200; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Seibold MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058658; Selman Moises, 2006, Proc Am Thorac Soc, V3, P364, DOI 10.1513/pats.200601-003TK; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Tang H, 2000, J BIOL CHEM, V275, P8389, DOI 10.1074/jbc.275.12.8389	40	6	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101983	10.1371/journal.pone.0101983	http://dx.doi.org/10.1371/journal.pone.0101983			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000413	gold, Green Published, Green Submitted			2022-12-27	WOS:000338637300110
J	Mizuno, T; Souma, W; Watanabe, T				Mizuno, Takayuki; Souma, Wataru; Watanabe, Tsutomu			The Structure and Evolution of Buyer-Supplier Networks	PLOS ONE			English	Article								In this paper, we investigate the structure and evolution of customer-supplier networks in Japan using a unique dataset that contains information on customer and supplier linkages for more than 500,000 incorporated non-financial firms for the five years from 2008 to 2012. We find, first, that the number of customer links is unequal across firms; the customer link distribution has a power-law tail with an exponent of unity (i.e., it follows Zipf's law). We interpret this as implying that competition among firms to acquire new customers yields winners with a large number of customers, as well as losers with fewer customers. We also show that the shortest path length for any pair of firms is, on average, 4.3 links. Second, we find that link switching is relatively rare. Our estimates indicate that the survival rate per year for customer links is 92 percent and for supplier links 93 percent. Third and finally, we find that firm growth rates tend to be more highly correlated the closer two firms are to each other in a customer-supplier network (i.e., the smaller is the shortest path length for the two firms). This suggests that a non-negligible portion of fluctuations in firm growth stems from the propagation of microeconomic shocks - shocks affecting only a particular firm - through customer-supplier chains.	[Mizuno, Takayuki] Natl Inst Informat, Tokyo, Japan; [Mizuno, Takayuki] Grad Univ Adv Studies, Dept Informat, Tokyo, Japan; [Mizuno, Takayuki] Japan Sci & Technol Agcy, PRESTO, Tokyo, Japan; [Mizuno, Takayuki; Souma, Wataru] Nihon Univ, Coll Sci & Technol, Chiba, Japan; [Mizuno, Takayuki; Watanabe, Tsutomu] Univ Tokyo, Grad Sch Econ, Tokyo, Japan; [Mizuno, Takayuki; Watanabe, Tsutomu] Canon Inst Global Studies, Tokyo, Japan	Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan; Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST); Nihon University; University of Tokyo	Mizuno, T (corresponding author), Natl Inst Informat, Tokyo, Japan.	mizuno@nii.ac.jp	Souma, Wataru/L-3652-2018	Souma, Wataru/0000-0002-1051-4350	Ministry of Education, Culture, Sports, Science, and Technology; Grants-in-Aid for Scientific Research [24710156] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research forms part of a project on "Designing Interfirm Networks to Achieve Sustainable Economic Growth'' carried out at Hitotsubashi University with financial support from the Ministry of Education, Culture, Sports, Science, and Technology. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acemoglu D., 2013, NETWORK ORIGINS LARG; Acemoglu D, 2012, ECONOMETRICA, V80, P1977, DOI 10.3982/ECTA9623; [Anonymous], [No title captured]; [Anonymous], 2010, SOCIAL EC NETWORKS; Atalay E, 2011, P NATL ACAD SCI USA, V108, P5199, DOI 10.1073/pnas.1015564108; Axtell RL, 2001, SCIENCE, V293, P1818, DOI 10.1126/science.1062081; Battiston S, 2007, J ECON DYN CONTROL, V31, P2061, DOI 10.1016/j.jedc.2007.01.004; Bonanno G, 2004, EUR PHYS J B, V38, P363, DOI 10.1140/epjb/e2004-00129-6; Carvalho V.M, 2010, WORKING PAPERS; Carvalho VM, 2012, SURVEY PAPER RECENT; Chaney T, 2008, AM ECON REV, V98, P1707, DOI 10.1257/aer.98.4.1707; di Giovanni J, 2010, AM ECON J-MACROECON, V2, P95, DOI 10.1257/mac.2.2.95; Foerster AT, 2011, J POLIT ECON, V119, P1, DOI 10.1086/659311; Fujiwara Y, 2010, EUR PHYS J B, V77, P565, DOI 10.1140/epjb/e2010-00275-2; Garlaschelli D, 2005, PHYSICA A, V355, P138, DOI 10.1016/j.physa.2005.02.075; Garlaschelli D, 2005, PHYSICA A, V350, P491, DOI 10.1016/j.physa.2004.11.040; Gourio F, 2011, 17191 NAT BUR EC; Goyal S, 2012, CONNECTIONS INTRO EC; Ibuki T, 2013, CLUSTER ANAL GAUSSIA, P239; Kelly B, 2013, 1256 CHIC BOOTH; Leontief WW, 1936, REV ECON STATISTICS, V18, P105, DOI 10.2307/1927837; Luttmer EGJ, 2006, 645 FED RES BANK MIN; Ohnishi T, 2009, PROG THEOR PHYS SUPP, P157, DOI 10.1143/PTPS.179.157; Plerou V, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066126; Riccaboni M, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/2/023003; Saito YU, 2007, PHYSICA A, V383, P158, DOI 10.1016/j.physa.2007.04.097; Souma W, 2003, PHYSICA A, V324, P396, DOI 10.1016/S0378-4371(02)01859-7; Stella A, 2013, FIRM DYNAMICS ORIGIN; Watanabe H, 2013, PHYSICA A, V392, P741, DOI 10.1016/j.physa.2012.10.020; Watanabe H, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/4/043034; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	32	18	19	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e100712	10.1371/journal.pone.0100712	http://dx.doi.org/10.1371/journal.pone.0100712			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7WB	25000368	Green Submitted, Green Published, gold			2022-12-27	WOS:000338637300013
J	Zielke, DE; Werner, D; Schaffner, F; Kampen, H; Fonseca, DM				Zielke, Dorothee E.; Werner, Doreen; Schaffner, Francis; Kampen, Helge; Fonseca, Dina M.			Unexpected Patterns of Admixture in German Populations of Aedes japonicus japonicus (Diptera: Culicidae) Underscore the Importance of Human Intervention	PLOS ONE			English	Article							RIFT-VALLEY FEVER; INVASIVE MOSQUITOS; GENETIC-VARIATION; 1ST RECORD; THEOBALD; ALBOPICTUS; ESTABLISHMENT; SPREAD; INFORMATION; SOFTWARE	The mosquito Aedes japonicus japonicus, originally restricted to temperate East Asia, is now widespread in North America and more recently has become established in Europe. To ascertain the putative number of separate introductions to Europe and examine patterns of expansion we analyzed the genetic makeup of Ae. j. japonicus populations from five cemeteries in North Rhine-Westphalia and Rhineland-Palatinate, two western German federal states, as well as of specimens from populations in Belgium, Switzerland, and Austria/Slovenia. To do so, we genotyped individual specimens at seven preexisting polymorphic microsatellite loci and sequenced part of the nad4 mitochondrial locus. We found evidence of two different genotypic signatures associated with different nad4 mitochondrial haplotypes, indicating at least two genetically differentiated populations of Ae. j. japonicus in Europe (i.e. two distinct genotypes). Belgian, Swiss, and Austrian/Slovenian populations all share the same genotypic signature although they have become differentiated since isolation. Contrary to expectations, the German Ae. j. japonicus are not closely related to those in Belgium which are geographically nearest but are also highly inbred. German populations have a unique genotype but also evidence of mixing between the two genotypes. Also unexpectedly, the populations closest to the center of the German infestation had the highest levels of admixture indicating that separate introductions did not expand and merge but instead their expansion was driven by punctuated human-mediated transport. Critically, the resulting admixed populations have higher genetic diversity and appear invasive as indicated by their increased abundance and recent spread across western Germany.	[Zielke, Dorothee E.; Werner, Doreen] Leibniz Ctr Agr Landscape Res, Muncheberg, Germany; [Schaffner, Francis] Univ Zurich, Inst Parasitol, Natl Ctr Vector Entomol, CH-8057 Zurich, Switzerland; [Schaffner, Francis] Avia GIS, Zoersel, Belgium; [Kampen, Helge] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Greifswald, Germany; [Fonseca, Dina M.] Rutgers State Univ, Ctr Vector Biol, New Brunswick, NJ 08903 USA; [Fonseca, Dina M.] Rutgers State Univ, Dept Entomol, New Brunswick, NJ 08903 USA	Leibniz Zentrum fur Agrarlandschaftsforschung (ZALF); University of Zurich; Friedrich Loeffler Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Zielke, DE (corresponding author), Leibniz Ctr Agr Landscape Res, Muncheberg, Germany.	zielke@zalf.de	Fonseca, Dina/HHS-1320-2022; Fonseca, Dina Madeira/B-9951-2011	Fonseca, Dina Madeira/0000-0003-4726-7100; Schaffner, Francis/0000-0001-9166-7617	German Federal Ministry of Food, Agriculture and Consumer Protection (BMELV) through the Federal Office for Agriculture and Food [2810HS022]; Robert Koch Institute [1362/1-982]; USDA Hatch [NJ08194]; Multistate funds [NE-1043]	German Federal Ministry of Food, Agriculture and Consumer Protection (BMELV) through the Federal Office for Agriculture and Food; Robert Koch Institute; USDA Hatch(United States Department of Agriculture (USDA)); Multistate funds	This work was supported by the German Federal Ministry of Food, Agriculture and Consumer Protection (BMELV: www.bmelv.de/DE/Startseite/startseite_node.html) through the Federal Office for Agriculture and Food (BLE: www.ble.de/DE/00_Home/homepage_node.html), grant number 2810HS022, by the Robert Koch Institute, grant number 1362/1-982, by a USDA Hatch Grant #NJ08194: www.usda.gov/wps/portal/usda/usdahome, and NE-1043 Multistate funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, J MED ENTOMOL, V42, P511; Becker N, 2013, PARASITOL RES, V112, P1787, DOI 10.1007/s00436-012-3230-1; Becker Norbert, 2011, European Mosquito Bulletin, V29, P88; Cameron EC, 2010, J MED ENTOMOL, V47, P527, DOI 10.1603/ME09259; Chikhi N., 2004, 5000 CNRS UMR U MONT; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crowl TA, 2008, FRONT ECOL ENVIRON, V6, P238, DOI 10.1890/070151; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Egizi A, 2014, BIOL INVASI IN PRESS; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fonseca DM, 2010, MOL ECOL, V19, P1559, DOI 10.1111/j.1365-294X.2010.04576.x; Fonseca DM, 2001, J MED ENTOMOL, V38, P135, DOI 10.1603/0022-2585-38.2.135; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1; Ibanez-Justicia Adolfo, 2014, Journal of the European Mosquito Control Association, V32, P9; Kampen H, 2014, J EUR MOSQ CONTROL A, V31, P36; Kampen H, 2013, PARASITOL RES, V112, P905, DOI 10.1007/s00436-012-3128-y; Kampen H, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-284; Kaufman MG, 2014, ANNU REV ENTOMOL, V59, P31, DOI 10.1146/annurev-ento-011613-162012; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; LAIRD M, 1994, J AM MOSQUITO CONTR, V10, P14; Larish LB, 2005, J AM MOSQUITO CONTR, V21, P318, DOI 10.2987/8756-971X(2005)21[318:IAEOAF]2.0.CO;2; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814; Molaei G, 2009, J AM MOSQUITO CONTR, V25, P210, DOI 10.2987/09-0012.1; Myers JH, 1998, ANNU REV ENTOMOL, V43, P471, DOI 10.1146/annurev.ento.43.1.471; Neitzel DF, 2009, J AM MOSQUITO CONTR, V25, P367, DOI 10.2987/09-0015.1; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peyton EL, 1999, J AM MOSQUITO CONTR, V15, P238; Pritchard JK, 2000, GENETICS, V155, P945; Reinert JF, 2009, ZOOL J LINN SOC-LOND, V157, P700, DOI 10.1111/j.1096-3642.2009.00570.x; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; ROSS KG, 1993, GENETICS, V135, P843; Schaffner F, 2013, CLIN MICROBIOL INFEC, V19, P685, DOI 10.1111/1469-0691.12189; Schaffner F, 2009, MED VET ENTOMOL, V23, P448, DOI 10.1111/j.1365-2915.2009.00825.x; Schaffner F, 2003, J AM MOSQUITO CONTR, V19, P1; Schaffner F., 2001, MOSQUITOES EUROPE ID; Schaffner F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-209; Schaffner Francis, 2003, European Mosquito Bulletin, V16, P7; Schneider Katharina, 2011, European Mosquito Bulletin, V29, P129; Seidel Bernhard, 2012, Entomologische Zeitschrift, V122, P223; Sherwin WB, 2006, MOL ECOL, V15, P2857, DOI 10.1111/j.1365-294X.2006.02992.x; Sherwin WB, 2010, ENTROPY-SWITZ, V12, P1765, DOI 10.3390/e12071765; TANAKA K, 1979, Contributions of the American Entomological Institute, V16, P1; Thielman A, 2006, J MED ENTOMOL, V43, P138, DOI 10.1603/0022-2585(2006)043[0138:EOOJDC]2.0.CO;2; Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Tsutsui ND, 2001, MOL ECOL, V10, P2151, DOI 10.1046/j.0962-1083.2001.01363.x; Turell MJ, 2013, J AM MOSQUITO CONTR, V29, P133, DOI 10.2987/12-6316r.1; Versteirt V, 2009, J MED ENTOMOL, V46, P1464, DOI 10.1603/033.046.0632; Vezzani D, 2007, TROP MED INT HEALTH, V12, P299, DOI [10.1111/j.1365-3165.2006.01781.x, 10.1111/j.1365-3156.2006.01781.x]; Waser PM, 1998, TRENDS ECOL EVOL, V13, P43, DOI 10.1016/S0169-5347(97)01255-X; Werner D, 2013, PARASITOL RES, V112, P3665, DOI 10.1007/s00436-013-3564-3; Widdel AK, 2005, AM J TROP MED HYG, V73, P744, DOI 10.4269/ajtmh.2005.73.744; Woods CW, 2002, EMERG INFECT DIS, V8, P138, DOI 10.3201/eid0802.010023	58	34	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e99093	10.1371/journal.pone.0099093	http://dx.doi.org/10.1371/journal.pone.0099093			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992470	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000341253400006
J	Abdullah, AS; Driezen, P; Ruthbah, UH; Nargis, N; Quah, ACK; Fong, GT				Abdullah, Abu S.; Driezen, Pete; Ruthbah, Ummul H.; Nargis, Nigar; Quah, Anne C. K.; Fong, Geoffrey T.			Patterns and Predictors of Smokeless Tobacco Use among Adults in Bangladesh: Findings from the International Tobacco Control (ITC) Bangladesh Survey	PLOS ONE			English	Article							MORTALITY; SMOKING; INDIA; WOMEN	Background: Although smokeless tobacco (SLT) use is prevalent in South Asian countries including Bangladesh, information about the pattern and correlates of SLT use is scarce. This study described the pattern and predictors of SLT use among Bangladeshi adults. Methods: The data for this study were derived from the International Tobacco Control Policy Evaluation Bangladesh (ITC BD) Survey, a prospective cohort survey of a nationally representative sample of smokers and non-smokers, conducted during November 2011 and May 2012. The study included 5522 adults aged 15 or above. We used multiple logistic regression models to identify predictors of SLT use. Results: Of the respondents (N = 5522), 20% were SLT users. In general, SLT use was significantly higher among women, the illiterate and residents of the Dhaka slums or non-tribal/non-border areas outside Dhaka; SLT use increased with age. Several attitudinal factors were also associated with SLT use. Multivariable logistic regression analyses revealed several predictors of SLT use: being female (OR = 1.96, 95% confidence interval, CI: 1.18-3.24), an increasing age, being a resident of a Dhaka slum (OR = 5.86; 95% CI: 3.73-9.21) or non-tribal/non-border areas outside Dhaka (OR = 3.42; 95% CI: 1.94-6.03), being illiterate (OR = 3.37; 95% CI: 1.99-5.71), holding positive opinion towards societal approval of SLT use (OR = 5.84; 95% CI: 3.38-10.09), holding positive opinion towards SLT use by women (OR = 2.63; 95% CI: 1.53-4.54), believing that SLT is addictive (OR = 2.96; 95% CI: 1.51-5.81), and believing SLT is less harmful than bidi (OR = 2.22; 95% CI: 1.36-3.62). Conclusion: The findings suggest that coordinated efforts of governmental and non-governmental organizations, targeting both smoked tobacco and SLT use reduction and cessation, could be modified to reach each level of population including those who are marginalized, female, less educated and elderly. As most tobacco control programs in Bangladesh target mainly cigarette or bidi smoking, coordinated programs are needed that will also include SLT use within the tobacco control policy and prevention strategies.	[Abdullah, Abu S.] Boston Univ, Sch Med, Boston Med Ctr, Boston, MA 02118 USA; [Abdullah, Abu S.] Guangxi Med Univ, Sch Publ Hlth, Nanning, Peoples R China; [Driezen, Pete] Univ Waterloo, Propel Ctr Populat Hlth Impact, Waterloo, ON N2L 3G1, Canada; [Ruthbah, Ummul H.] Univ Dhaka, Dept Econ, Dhaka 1000, Bangladesh; [Nargis, Nigar] WHO, CH-1211 Geneva, Switzerland; [Quah, Anne C. K.; Fong, Geoffrey T.] Univ Waterloo, Dept Psychol, Waterloo, ON N2L 3G1, Canada; [Fong, Geoffrey T.] Ontario Inst Canc Res, Toronto, ON, Canada	Boston Medical Center; Boston University; Guangxi Medical University; University of Waterloo; University of Dhaka; World Health Organization; University of Waterloo; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Abdullah, AS (corresponding author), Boston Univ, Sch Med, Boston Med Ctr, Boston, MA 02118 USA.	asm.abdullah@graduate.hku.hk	Fong, Geoffrey T/H-2810-2014; Nargis, Nigar/ABV-7173-2022; Driezen, Pete/AAX-2804-2020	Fong, Geoffrey T/0000-0001-9098-6472; Nargis, Nigar/0000-0003-4501-1398; Driezen, Pete/0000-0003-2320-0999; Ruthbah, Ummul/0000-0002-5720-371X	International Development Research Centre (IDRC) [104831-002]; Canadian Institutes for Health Research [79551, 115016]; US National Cancer Institute [P01 CA138389]; Ontario Institute for Cancer Research; Canadian Cancer Research Institute; Flight Attendant Medical Research Institute, USA; NATIONAL CANCER INSTITUTE [P01CA138389] Funding Source: NIH RePORTER	International Development Research Centre (IDRC); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ontario Institute for Cancer Research; Canadian Cancer Research Institute; Flight Attendant Medical Research Institute, USA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The ITC Bangladesh Project was supported by the International Development Research Centre (IDRC Grant 104831-002), Canadian Institutes for Health Research (Operating Grants 79551 and 115016), the US National Cancer Institute (P01 CA138389). Geoffrey T. Fong was supported by a Senior Investigator Award from Ontario Institute for Cancer Research and by a Prevention Scientist Award from the Canadian Cancer Research Institute. Abu S. Abdullah was supported by a Clinical Innovator Award from the Flight Attendant Medical Research Institute, USA through a grant to the American Academy of Pediatrics (AAP) Julius B. Richmond Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah A, 2011, INT J ENV RES PUB HE, V8, P842, DOI 10.3390/ijerph8030842; Agaku IT, 2013, NICOTINE TOB RES, V15, P1956, DOI 10.1093/ntr/ntt083; Alam DS, 2013, B WORLD HEALTH ORGAN, V91, P757, DOI 10.2471/BLT.13.120196; [Anonymous], ASIA PAC J PUBLIC HL; BBS, 2014, BANGL POP HOUS CENS; BOLINDER G, 1994, AM J PUBLIC HEALTH, V84, P399, DOI 10.2105/AJPH.84.3.399; BOYD GM, 1989, J SCHOOL HEALTH, V59, P189, DOI 10.1111/j.1746-1561.1989.tb04700.x; Choudhury K, 2007, J HEALTH POPUL NUTR, V25, P456; DHHS, 1986, DHHS PUBL; England LJ, 2010, ACTA OBSTET GYN SCAN, V89, P454, DOI 10.3109/00016341003605719; Fong GT, 2006, TOB CONTROL, V15, P3, DOI 10.1136/tc.2005.015438; Gupta PC, 2003, RESPIROLOGY, V8, P419, DOI 10.1046/j.1440-1843.2003.00507.x; Hergens MP, 2008, J INTERN MED, V264, P187, DOI 10.1111/j.1365-2796.2008.01939.x; Hussain AKMG, 2012, 15 WORKD C TOB HLTH; International Agency for Research on Cancer, 2007, IARC MONOGRAPHS EVAL, V89; International Agency for Research on Cancer (IARC), 1985, TOB HAB OTH SMOK BET; John RM, 2009, TOB CONTROL, V18, P138, DOI 10.1136/tc.2008.027466; Nargis N, 2014, TOB CONTROL, V23, P39, DOI 10.1136/tobaccocontrol-2012-050835; Office on Smoking and Health (OSH), 1988, DHHS PUBL; Pau AKH, 2003, NICOTINE TOB RES, V5, P419, DOI 10.1080/1462220031000094204; Persson PG, 2000, J INTERN MED, V248, P103, DOI 10.1046/j.1365-2796.2000.00708.x; Psoter WJ, 2001, PREV MED, V32, P1, DOI 10.1006/pmed.2000.0780; Quandt SA, 2005, J CROSS-CULT GERONTO, V20, P109, DOI 10.1007/s10823-005-9086-4; Rani M, 2003, Tob Control, V12, pe4, DOI 10.1136/tc.12.4.e4; Rooban T, 2010, Indian J Cancer, V47 Suppl 1, P91, DOI 10.4103/0019-509X.63865; STOLERMAN IP, 1995, PSYCHOPHARMACOLOGY, V117, P2, DOI 10.1007/BF02245088; SUSSMAN S, 1989, Health Education Research, V4, P213, DOI 10.1093/her/4.2.213; Tomar SL, 1988, AM J PUBLIC HEALTH, V88, P20; World Health Organization, 2019, WHO REPORT GLOBAL TO; World Health Organization (WHO), 2007, IMP TOB REL ILLN BAN; World Health Organization (WHO), 2009, BANGL GLOB AD TOB SU; Zaman M. M., 2007, IMPACT TOBACCO RELAT	32	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101934	10.1371/journal.pone.0101934	http://dx.doi.org/10.1371/journal.pone.0101934			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007266	gold, Green Submitted, Green Published			2022-12-27	WOS:000339040600081
J	Weber, AR; Schuermann, D; Schar, P				Weber, Alain R.; Schuermann, David; Schaer, Primo			Versatile Recombinant SUMOylation System for the Production of SUMO-Modified Protein	PLOS ONE			English	Article							THYMINE-DNA GLYCOSYLASE; ESCHERICHIA-COLI; STRUCTURAL BASIS; IN-VITRO; UBIQUITIN; UBC9; COMPLEX; REPAIR; PURIFICATION; CONJUGATION	Posttranslational modification by small ubiquitin-like modifiers (SUMO) is being associated with a growing number of regulatory functions in diverse cellular processes. The biochemical investigation into the underlying molecular mechanisms, however, has been lagging behind due to the difficulty to generate sufficient amounts of recombinant SUMOylated proteins. Here, we present two newly designed two-component vector systems for the expression and purification of SUMO-modified target proteins in Escherichia coli. One system consists of a vector for SUMO conjugation, expressing human SUMO-activating (SAE1/SAE2) and conjugating (Ubc9) enzymes together with His(6)-tagged SUMO1, 2 or 3, that can be combined with commonly used expression constructs for any gene of interest. To facilitate SUMOylation of targets normally requiring a SUMO-E3 ligase for efficient modification, a second system is designed to express the target protein as a fusion with the human SUMO-conjugating enzyme Ubc9, thus compensating the absence of a potential SUMO ligase. We demonstrate the proficiency of these systems by SUMOylation of two DNA repair proteins, the thymine DNA glycosylase (TDG) and XRCC1, and describe purification schemes for SUMOylated proteins in native and active form. This SUMO toolbox facilitates "in-cell'' and "in-extract'' production and purification of recombinant SUMO-modified target proteins for functional and structural analysis.	[Weber, Alain R.; Schuermann, David; Schaer, Primo] Univ Basel, Dept Biomed, Basel, Switzerland	University of Basel	Schuermann, D (corresponding author), Univ Basel, Dept Biomed, Basel, Switzerland.	david.schuermann@unibas.ch; primo.schaer@unibas.ch	Schuermann, David/AAC-4075-2019; Schär, Primo/G-5967-2012	Schuermann, David/0000-0003-2904-1378; Schär, Primo/0000-0003-1843-6147	Swiss National Science Foundation [SNF 3100A0-122574/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by a grant from the Swiss National Science Foundation to PS (SNF 3100A0-122574/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Bologna Serena, 2013, Frontiers in Genetics, V4, P106, DOI 10.3389/fgene.2013.00106; Bruderer R, 2011, EMBO REP, V12, P142, DOI 10.1038/embor.2010.206; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; Chong SR, 1997, GENE, V192, P271, DOI 10.1016/S0378-1119(97)00105-4; Cubenas-Potts C, 2013, DEV CELL, V24, P1, DOI 10.1016/j.devcel.2012.11.020; Cuneo MJ, 2011, NUCLEIC ACIDS RES, V39, P7816, DOI 10.1093/nar/gkr419; Desterro JMP, 1997, FEBS LETT, V417, P297, DOI 10.1016/S0014-5793(97)01305-7; Dohmen RJ, 2004, BBA-MOL CELL RES, V1695, P113, DOI 10.1016/j.bbamcr.2004.09.021; Duda DM, 2007, J MOL BIOL, V369, P619, DOI 10.1016/j.jmb.2007.04.007; Fitzgerald ME, 2008, J BIOL CHEM, V283, P32680, DOI 10.1074/jbc.M805504200; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Flotho A, 2012, METHODS MOL BIOL, V832, P93, DOI 10.1007/978-1-61779-474-2_5; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gocke CB, 2005, J BIOL CHEM, V280, P5004, DOI 10.1074/jbc.M411718200; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; Hay RT, 2013, BIOCHEM SOC T, V41, P463, DOI 10.1042/BST20130015; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Jacobs AL, 2012, CHROMOSOMA, V121, P1, DOI 10.1007/s00412-011-0347-4; Jakobs A, 2007, NAT METHODS, V4, P245, DOI 10.1038/NMETH1006; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kim ET, 2009, BIOCHEM BIOPH RES CO, V388, P41, DOI 10.1016/j.bbrc.2009.07.103; Klug H, 2013, MOL CELL, V50, P625, DOI 10.1016/j.molcel.2013.03.027; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Lens Z, 2011, PROTEIN EXPRES PURIF, V80, P211, DOI 10.1016/j.pep.2011.06.009; Mencia M, 2004, PROTEIN EXPRES PURIF, V37, P409, DOI 10.1016/j.pep.2004.07.001; Mikolajczyk J, 2007, J BIOL CHEM, V282, P26217, DOI 10.1074/jbc.M702444200; Mohan RD, 2007, MOL CELL BIOL, V27, P229, DOI 10.1128/MCB.00323-06; Niedenthal Rainer, 2009, V497, P63, DOI 10.1007/978-1-59745-566-4_5; O'Brien SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038671; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; Takahashi H, 2005, J BIOL CHEM, V280, P5611, DOI 10.1074/jbc.M408130200; Uchimura Y, 2004, ANAL BIOCHEM, V331, P204, DOI 10.1016/j.ab.2004.04.034; Uchimura Y, 2004, FEBS LETT, V564, P85, DOI 10.1016/S0014-5793(04)00321-7; Ulrich HD, 2012, J CELL SCI, V125, P249, DOI 10.1242/jcs.091801; Werner Andreas, 2009, V497, P187, DOI 10.1007/978-1-59745-566-4_12; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4	39	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102157	10.1371/journal.pone.0102157	http://dx.doi.org/10.1371/journal.pone.0102157			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007328	Green Published, gold, Green Submitted			2022-12-27	WOS:000339040600104
J	Christner, M; Trusch, M; Rohde, H; Kwiatkowski, M; Schluter, H; Wolters, M; Aepfelbacher, M; Hentschke, M				Christner, Martin; Trusch, Maria; Rohde, Holger; Kwiatkowski, Marcel; Schlueter, Hartmut; Wolters, Manuel; Aepfelbacher, Martin; Hentschke, Moritz			Rapid MALDI-TOF Mass Spectrometry Strain Typing during a Large Outbreak of Shiga-Toxigenic Escherichia coli	PLOS ONE			English	Article							ASSISTED LASER-DESORPTION; HEMOLYTIC-UREMIC SYNDROME; IONIZATION-TIME; IDENTIFICATION; DESORPTION/IONIZATION; BACTERIA; PACKAGE; GERMANY	Background: In 2011 northern Germany experienced a large outbreak of Shiga-Toxigenic Escherichia coli O104:H4. The large amount of samples sent to microbiology laboratories for epidemiological assessment highlighted the importance of fast and inexpensive typing procedures. We have therefore evaluated the applicability of a MALDI-TOF mass spectrometry based strategy for outbreak strain identification. Methods: Specific peaks in the outbreak strain's spectrum were identified by comparative analysis of archived pre-outbreak spectra that had been acquired for routine species-level identification. Proteins underlying these discriminatory peaks were identified by liquid chromatography tandem mass spectrometry and validated against publicly available databases. The resulting typing scheme was evaluated against PCR genotyping with 294 E. coli isolates from clinical samples collected during the outbreak. Results: Comparative spectrum analysis revealed two characteristic peaks at m/z 6711 and m/z 10883. The underlying proteins were found to be of low prevalence among genome sequenced E. coli strains. Marker peak detection correctly classified 292 of 293 study isolates, including all 104 outbreak isolates. Conclusions: MALDI-TOF mass spectrometry allowed for reliable outbreak strain identification during a large outbreak of Shiga-Toxigenic E. coli. The applied typing strategy could probably be adapted to other typing tasks and might facilitate epidemiological surveys as part of the routine pathogen identification workflow.	[Christner, Martin; Rohde, Holger; Wolters, Manuel; Aepfelbacher, Martin; Hentschke, Moritz] Univ Med Ctr Hamburg Eppendorf, Dept Med Microbiol Virol & Hyg, Hamburg, Germany; [Trusch, Maria] Univ Hamburg, Inst Organ Chem, Mass Spectrometry Facil, Hamburg, Germany; [Kwiatkowski, Marcel; Schlueter, Hartmut] Univ Med Ctr Hamburg Eppendorf, Dept Clin Chem, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Christner, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med Microbiol Virol & Hyg, Hamburg, Germany.	m.christner@uke.de	Schluter, Hartmut/D-1371-2015; Kwiatkowski, Marcel/M-3384-2016; Riedner, Maria/W-5546-2019	Schluter, Hartmut/0000-0002-9358-7036; Kwiatkowski, Marcel/0000-0002-5804-6031; Rohde, Holger/0000-0001-8587-4433	Bundesministerium fur Bildung und Forschung [0315341B]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by the Bundesministerium fur Bildung und Forschung (http://www.bmbf.de/), grant number 0315341B to Hartmut Schluter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbuddhe SB, 2008, APPL ENVIRON MICROB, V74, P5402, DOI 10.1128/AEM.02689-07; Bielaszewska M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001024; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Boggs SR, 2012, J MED MICROBIOL, V61, P640, DOI 10.1099/jmm.0.037978-0; Dieckmann R, 2011, APPL ENVIRON MICROB, V77, P4136, DOI 10.1128/AEM.02418-10; Fagerquist CK, 2010, ANAL CHEM, V82, P2717, DOI 10.1021/ac902455d; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Franke S, 2003, J BACTERIOL, V185, P3804, DOI 10.1128/JB.185.13.3804-3812.2003; Freiwald A, 2009, NAT PROTOC, V4, P732, DOI 10.1038/nprot.2009.37; Friedrichs C, 2007, J CLIN MICROBIOL, V45, P2392, DOI 10.1128/JCM.00556-07; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gibb S, 2012, BIOINFORMATICS, V28, P2270, DOI 10.1093/bioinformatics/bts447; Griffin PM, 2012, J CLIN MICROBIOL, V50, P2918, DOI 10.1128/JCM.01000-12; Grosse-Herrenthey A, 2008, ANAEROBE, V14, P242, DOI 10.1016/j.anaerobe.2008.06.002; Holland RD, 1996, RAPID COMMUN MASS SP, V10, P1227, DOI 10.1002/(SICI)1097-0231(19960731)10:10<1227::AID-RCM659>3.0.CO;2-6; Karger A, 2011, APPL ENVIRON MICROB, V77, P896, DOI 10.1128/AEM.01686-10; Kuhns M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040004; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Mulet M, 2012, SYST APPL MICROBIOL, V35, P145, DOI 10.1016/j.syapm.2011.12.003; Munoz R, 2011, SYST APPL MICROBIOL, V34, P69, DOI 10.1016/j.syapm.2010.11.012; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pritchard L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034498; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Qin JJ, 2011, J CLIN MICROBIOL, V49, P3439, DOI 10.1128/JCM.01312-11; R Core Team, 2018, R LANG ENV STAT COMP; Reil M, 2011, EUR J CLIN MICROBIOL, V30, P1431, DOI 10.1007/s10096-011-1238-6; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Ryzhov V, 2001, ANAL CHEM, V73, P746, DOI 10.1021/ac0008791; Sato H, 2011, SYST APPL MICROBIOL, V34, P76, DOI 10.1016/j.syapm.2010.07.003; Sauer S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002843; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Stephan R, 2011, J MICROBIOL METH, V87, P150, DOI 10.1016/j.mimet.2011.08.016; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wolters M, 2011, INT J MED MICROBIOL, V301, P64, DOI 10.1016/j.ijmm.2010.06.002; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	37	66	66	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101924	10.1371/journal.pone.0101924	http://dx.doi.org/10.1371/journal.pone.0101924			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003758	Green Published, gold, Green Submitted			2022-12-27	WOS:000339242700089
J	Coca, R; Soler, F; Cortes-Castell, E; Gil-Guillen, V; Fernandez-Belda, F				Coca, Ramon; Soler, Fernando; Cortes-Castell, Ernesto; Gil-Guillen, Vicente; Fernandez-Belda, Francisco			Inhibition Mechanism of the Intracellular Transporter Ca2+-Pump from Sarco-Endoplasmic Reticulum by the Antitumor Agent Dimethyl-Celecoxib	PLOS ONE			English	Article							CYCLOOXYGENASE-2 GENE-EXPRESSION; SARCOPLASMIC-RETICULUM; IN-VITRO; CALCIUM; ATPASE; CA2+; CA2+-ATPASE; CANCER; VISUALIZATION; THAPSIGARGIN	Dimethyl-celecoxib is a celecoxib analog that lacks the capacity as cyclo-oxygenase-2 inhibitor and therefore the life-threatening effects but retains the antineoplastic properties. The action mechanism at the molecular level is unclear. Our in vitro assays using a sarcoplasmic reticulum preparation from rabbit skeletal muscle demonstrate that dimethyl-celecoxib inhibits Ca (2+)-ATPase activity and ATP-dependent Ca2+ transport in a concentration-dependent manner. Celecoxib was a more potent inhibitor of Ca2+-ATPase activity than dimethyl-celecoxib, as deduced from the half-maximum effect but dimethyl-celecoxib exhibited higher inhibition potency when Ca2+ transport was evaluated. Since Ca2+ transport was more sensitive to inhibition than Ca2+-ATPase activity the drugs under study caused Ca2+/Pi uncoupling. Dimethyl-celecoxib provoked greater uncoupling and the effect was dependent on drug concentration but independent of Ca2+-pump functioning. Dimethyl-celecoxib prevented Ca2+ binding by stabilizing the inactive Ca2+-free conformation of the pump. The effect on the kinetics of phosphoenzyme accumulation and the dependence of the phosphoenzyme level on dimethyl-celecoxib concentration were independent of whether or not the Ca2+-pump was exposed to the drug in the presence of Ca2+ before phosphorylation. This provided evidence of non-preferential interaction with the Ca2+-free conformation. Likewise, the decreased phosphoenzyme level in the presence of dimethyl-celecoxib that was partially relieved by increasing Ca2+ was consistent with the mentioned effect on Ca2+ binding. The kinetics of phosphoenzyme decomposition under turnover conditions was not altered by dimethyl-celecoxib. The dual effect of the drug involves Ca2+-pump inhibition and membrane permeabilization activity. The reported data can explain the cytotoxic and anti-proliferative effects that have been attributed to the celecoxib analog. Ligand docking simulation predicts interaction of celecoxib and dimethyl-celecoxib with the intracellular Ca2+ transporter at the inhibition site of hydroquinones.	[Coca, Ramon; Gil-Guillen, Vicente] Univ Miguel Hernandez, Dept Med Clin, Alicante, Spain; [Soler, Fernando; Fernandez-Belda, Francisco] Univ Murcia, Dept Bioquim & Biol Mol A, Murcia, Spain; [Cortes-Castell, Ernesto] Univ Miguel Hernandez, Dept Farmacol Pediat & Quim Organ, Alicante, Spain	Universidad Miguel Hernandez de Elche; University of Murcia; Universidad Miguel Hernandez de Elche	Fernandez-Belda, F (corresponding author), Univ Murcia, Dept Bioquim & Biol Mol A, Campus Espinardo, Murcia, Spain.	fbelda@um.es	Cortés-Castell, Ernesto/H-8528-2019; Guillén, Vicente Francisco Gil/AAE-8201-2019; Soler, Fernando/S-1441-2019	Gil-Guillen, Vicente F/0000-0003-3793-9786; Coca Zuniga, Ramon/0000-0001-5014-5644; CORTES CASTELL, ERNESTO/0000-0002-8079-1695	University of Murcia; University Miguel Hernandez	University of Murcia; University Miguel Hernandez	This study was supported by research funds from the University of Murcia and University Miguel Hernandez. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber N, 2006, NEW ENGL J MED, V355, P885, DOI 10.1056/NEJMoa061652; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bertagnolli MM, 2009, CANCER PREV RES, V2, P310, DOI 10.1158/1940-6207.CAPR-08-0206; BLINKS JR, 1982, PROG BIOPHYS MOL BIO, V40, P1, DOI 10.1016/0079-6107(82)90011-6; Cannon CP, 2012, SCIENCE, V336, P1386, DOI 10.1126/science.1224398; CHAMPEIL P, 1986, BIOCHEMISTRY-US, V25, P7623, DOI 10.1021/bi00371a053; Chuang HC, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-38; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; Deye J, 2009, BIOORGAN MED CHEM, V17, P1353, DOI 10.1016/j.bmc.2008.12.010; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Elam C, 2011, EUR J MED CHEM, V46, P1512, DOI 10.1016/j.ejmech.2011.01.069; ELETR S, 1972, BIOCHIM BIOPHYS ACTA, V282, P174, DOI 10.1016/0005-2736(72)90321-5; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; Fortea MI, 2001, J BIOL CHEM, V276, P37266, DOI 10.1074/jbc.M103949200; Fortea MI, 2000, J BIOL CHEM, V275, P12521, DOI 10.1074/jbc.275.17.12521; Gupta S, 2000, PROSTATE, V42, P73, DOI 10.1002/(SICI)1097-0045(20000101)42:1<73::AID-PROS9>3.0.CO;2-G; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Harris RE, 2000, CANCER RES, V60, P2101; INESI G, 1988, METHOD ENZYMOL, V157, P154; INESI G, 1980, J BIOL CHEM, V255, P3025; Johnson AJ, 2002, BIOCHEM J, V366, P831, DOI 10.1042/BJ20020279; Kardosh A, 2005, CANCER BIOL THER, V4, P571, DOI 10.4161/cbt.4.5.1699; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lax A, 2002, AM J PHYSIOL-CELL PH, V283, pC85, DOI 10.1152/ajpcell.00580.2001; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARTONOSI A, 1964, J BIOL CHEM, V239, P648; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; Parrett ML, 1997, INT J ONCOL, V10, P503; Penning TD, 1997, J MED CHEM, V40, P1347, DOI 10.1021/jm960803q; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pyrko P, 2007, MOL CANCER THER, V6, P1262, DOI 10.1158/1535-7163.MCT-06-0629; Reddy BS, 1996, CANCER RES, V56, P4566; Ristimaki A, 1997, CANCER RES, V57, P1276; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Schonthal AH, 2007, BRIT J CANCER, V97, P1465, DOI 10.1038/sj.bjc.6604049; SCHWARZENBACH G, 1957, HELV CHIM ACTA, V40, P1886, DOI 10.1002/hlca.19570400640; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Soler F, 2012, J BIOENERG BIOMEMBR, V44, P597, DOI 10.1007/s10863-012-9462-z; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Song XQ, 2002, J NATL CANCER I, V94, P585; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; Tanaka K, 2005, J BIOL CHEM, V280, P31059, DOI 10.1074/jbc.M502956200; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Williams CS, 2000, CANCER RES, V60, P6045; WU KD, 1995, AM J PHYSIOL-CELL PH, V269, pC775, DOI 10.1152/ajpcell.1995.269.3.C775; YU X, 1995, J BIOL CHEM, V270, P4361, DOI 10.1074/jbc.270.9.4361; Zhu JX, 2002, JNCI-J NATL CANCER I, V94, P1745	50	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e102083	10.1371/journal.pone.0102083	http://dx.doi.org/10.1371/journal.pone.0102083			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003576	Green Published, Green Submitted, gold			2022-12-27	WOS:000339242700105
J	Sun, YP; Zheng, YH; Liu, WJ; Zheng, YL; Zhang, ZG				Sun, Yang-peng; Zheng, You-hua; Liu, Wen-jing; Zheng, Yu-liang; Zhang, Zhi-guang			Synovium Fragment-Derived Cells Exhibit Characteristics Similar to Those of Dissociated Multipotent Cells in Synovial Fluid of the Temporomandibular Joint	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HUMAN BONE-MARROW; HUMAN ADIPOSE-TISSUE; ADULT HUMAN BONE; CARTILAGE DEFECTS; STROMAL CELLS; IN-VITRO; INTRAARTICULAR INJECTION; KNEE OSTEOARTHRITIS; RHEUMATIC-DISEASES	Multipotent mesenchymal stem cells (MSCs) found in the synovial fluid (SFMSCs) of the tempromandibular joint (TMJ) remain poorly understood. During TMJ arthrocentesis, we discovered that synovial fluid collected from some patients with TMJ disorders contained not only SFMSCs but also synovium fragments (SFs). In this study, we attempted to characterize both the SFMSCs and SF-derived cells (SFCs) in order to further understand the role of MSCs in the synovial fluid of the TMJ. The SFs were membranous and translucent and consisted of several cell layers, indicating that their origin was only from the intima. SFCs were obtained by digestion of the SFs and subsequently expanded in vitro. SFMSCs were enriched by centrifugation of the synovial fluid and expanded in vitro. SFCs and SFMSCs displayed a similar fibroblast-like, spindle-shaped morphology, and we observed that some SFMSCs grew out of small tissue masses in culture. Flow cytometric analysis showed that both groups of cells expressed similar surface markers, including CD90, CD44, CD105, and CD73. However, both were negative for Stro-1, CD146, CD45, CD34, CD11b, CD19, and HLA-DR. Immunofluorescent staining showed that both SFs and SFMSCs expressed vascular cell adhesion molecule 1. Both SFCs and SFMSCs could be induced to differentiate down osteogenic, chondrogenic, adipogenic, and neurogenic lineages in vitro. Together, our results indicate that the intima is the most likely tissue origin of SFMSCs in the TMJ. Moreover, the SFs are composed of only intima and thus offer an improved source of synovium-derived MSCs compared to synovium specimens obtained by surgery, which contain both intima and subintima.	[Sun, Yang-peng; Zheng, You-hua; Liu, Wen-jing; Zheng, Yu-liang; Zhang, Zhi-guang] Sun Yat Sen Univ, Dept Oral & Maxillofacial Surg, Guanghua Sch Stomatol, Hosp Stomatol,Guangdong Prov Key Lab Stomatol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zhang, ZG (corresponding author), Sun Yat Sen Univ, Dept Oral & Maxillofacial Surg, Guanghua Sch Stomatol, Hosp Stomatol,Guangdong Prov Key Lab Stomatol, Guangzhou 510275, Guangdong, Peoples R China.	kouqiangzzg@hotmail.com			Science Foundation of the Key Hospital Clinical Program of the Ministry of China [(2010)439]; National Science Foundation of China [81271115]	Science Foundation of the Key Hospital Clinical Program of the Ministry of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the Science Foundation of the Key Hospital Clinical Program of the Ministry of China[(2010)439] and the National Science Foundation of China (81271115), http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Faqeh H, 2012, EXP GERONTOL, V47, P458, DOI 10.1016/j.exger.2012.03.018; Chen K, 2013, INT J ORAL MAX SURG, V42, P240, DOI 10.1016/j.ijom.2012.05.030; De Bari C, 2003, J CELL BIOL, V160, P909, DOI 10.1083/jcb.200212064; De Bari C, 2001, ARTHRITIS RHEUM-US, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Edwards JCW, 2000, ARTHRITIS RES, V2, P344, DOI 10.1186/ar110; Emadedin M, 2012, ARCH IRAN MED, V15, P422, DOI 012157/AIM.0010; Fickert S, 2003, OSTEOARTHR CARTILAGE, V11, P790, DOI 10.1016/S1063-4584(03)00167-5; Fukiage K, 2008, BIOCHEM BIOPH RES CO, V365, P406, DOI 10.1016/j.bbrc.2007.10.149; Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138; Haleem AM, 2010, CARTILAGE, V1, P253, DOI 10.1177/1947603510366027; Harvanova D, 2011, FOLIA BIOL-PRAGUE, V57, P119; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Hung SC, 2002, STEM CELLS, V20, P249, DOI 10.1634/stemcells.20-3-249; Johnson K, 2012, SCIENCE, V336, P717, DOI 10.1126/science.1215157; Jones EA, 2004, ARTHRITIS RHEUM-US, V50, P817, DOI 10.1002/art.20203; Jones EA, 2008, ARTHRITIS RHEUM-US, V58, P1731, DOI 10.1002/art.23485; Koyama N, 2011, LIFE SCI, V89, P741, DOI 10.1016/j.lfs.2011.09.005; Lee DH, 2012, OSTEOARTHR CARTILAGE, V20, P106, DOI 10.1016/j.joca.2011.11.010; Liang J, 2012, CLIN RHEUMATOL, V31, P157, DOI 10.1007/s10067-011-1816-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long XX, 2005, STEM CELLS DEV, V14, P65, DOI 10.1089/scd.2005.14.65; Luyten FR, 2006, BEST PRACT RES CL RH, V20, P829, DOI 10.1016/j.berh.2006.06.009; MORALESDUCRET J, 1992, J IMMUNOL, V149, P1424; Morito T, 2008, RHEUMATOLOGY, V47, P1137, DOI 10.1093/rheumatology/ken114; Neidhart M, 2003, ARTHRITIS RHEUM, V48, P1873, DOI 10.1002/art.11166; Olivier EN, 2006, STEM CELLS, V24, P1914, DOI 10.1634/stemcells.2005-0648; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qi YY, 2012, MOL BIOL REP, V39, P5683, DOI 10.1007/s11033-011-1376-z; Ringe J, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2572; Russell KC, 2013, TISSUE ENG PT A, V19, P2253, DOI [10.1089/ten.tea.2012.0649, 10.1089/ten.TEA.2012.0649]; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; Sekiya I, 2012, J ORTHOP RES, V30, P943, DOI 10.1002/jor.22029; SIMMONS PJ, 1991, BLOOD, V78, P55; Stewart K, 1999, J BONE MINER RES, V14, P1345, DOI 10.1359/jbmr.1999.14.8.1345; Wakitani S, 2002, OSTEOARTHR CARTILAGE, V10, P199, DOI 10.1053/joca.2001.0504; Wakitani S, 2004, CELL TRANSPLANT, V13, P595, DOI 10.3727/000000004783983747; Xu Y, 2012, J ORAL REHABIL, V39, P719, DOI 10.1111/j.1365-2842.2012.02307.x; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022622; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	40	20	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101896	10.1371/journal.pone.0101896	http://dx.doi.org/10.1371/journal.pone.0101896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003199	Green Submitted, Green Published, gold			2022-12-27	WOS:000339242700084
J	Wen, L; Zhu, MD; Madigan, MC; You, JJ; King, NJC; Billson, FA; McClellan, K; Sutton, G; Petsoglou, C				Wen, Li; Zhu, Meidong; Madigan, Michele C.; You, Jingjing; King, Nicholas J. C.; Billson, Francis A.; McClellan, Kathryn; Sutton, Gerard; Petsoglou, Con			Immunomodulatory Effects of Bone Marrow-Derived Mesenchymal Stem Cells on Pro-Inflammatory Cytokine-Stimulated Human Corneal Epithelial Cells	PLOS ONE			English	Article							REGULATORY T-CELLS; INDOLEAMINE 2,3-DIOXYGENASE; KAPPA-B; ENDOTHELIAL-CELLS; GLIAL ACTIVATION; IMMUNE-RESPONSES; INTERFERON-GAMMA; IFN-GAMMA; WEST-NILE; IN-VIVO	Purpose: To investigate the modulatory effect of rat bone marrow mesenchymal stem cells (MSC) on human corneal epithelial cells (HCE-T) stimulated with pro-inflammatory cytokines interferon gamma (IFN-gamma) and tumor necrosis factor alpha (TNF-alpha) in an in vitro co-cultured model. Methods: HCE-T alone and co-cultured with MSC were stimulated with IFN-gamma/TNF for 24 and 48 hours or left untreated. The expression of intracellular adhesion molecule (ICAM)-1, human leukocyte antigen ABC, DR and G (HLA-ABC, HLA-DR, HLA-G) were investigated by flow cytometry. Subcellular localization of nuclear factor-kappa B (NF-kappa B) and expression of indoleamine 2,3-dioxygenase (IDO) were assessed by immunofluorescence staining and western blot. The concentration of transforming growth factor beta 1 (TGF-beta 1) in the conditioned media from different cultures was evaluated by enzyme-linked immunosorbent assay. NF-kappa B and TGF-beta 1 signaling pathway blocking experiments were performed to analyze associations between the expression of cell surface molecules and the NF-kappa B transcription pathway, and the expression of IDO and TGF-beta 1 signaling pathway. Results: IFN-gamma/TNF treatment significantly up-regulated expression of ICAM-1, HLA-ABC, and induced de novo expression of HLA-DR and IDO on HCE-T cultured alone, while HLA-G expression remained unaffected. Up-regulation was significantly inhibited by co-culture with MSC. Increased TGF-beta 1 secretion was detected in 48 h IFN-gamma/TNF-stimulated MSC monocultures and HCE-T/MSC co-cultures. MSC attenuated the activation of cytokine-induced NF-kappa B and IDO induction. Blockade of NF-kappa B transcription pathway by BMS-345541 significantly reduced the up-regulation of ICAM-1, HLA-ABC, HLA-DR and IDO expression, while blockade of TGF-beta 1 signaling pathways reversed the modulatory effect of MSC on IDO expression. Conclusions: MSC reduced the expression of adhesion and immunoregulatory molecules on pro-inflammatory cytokine-stimulated HCE-T via the NF-kappa B transcription pathway. MSC attenuated expression of IDO through both NF-kappa B transcription and TGF-beta 1 signaling pathways. Co-culture of HCEC with MSC therefore provides a useful in vitro model to study the anti-inflammatory properties of MSC on corneal epithelium.	[Wen, Li; Zhu, Meidong; Madigan, Michele C.; You, Jingjing; Billson, Francis A.; McClellan, Kathryn; Sutton, Gerard; Petsoglou, Con] Univ Sydney, Save Sight Inst, Sydney, NSW 2006, Australia; [Wen, Li; Zhu, Meidong; Madigan, Michele C.; You, Jingjing; Billson, Francis A.; McClellan, Kathryn; Sutton, Gerard; Petsoglou, Con] Univ Sydney, Discipline Clin Ophthalmol, Sydney, NSW 2006, Australia; [Zhu, Meidong; McClellan, Kathryn; Sutton, Gerard; Petsoglou, Con] Lions New South Wales Eye Bank, NSW Organ & Tissue Donat Serv, Sydney, NSW, Australia; [Zhu, Meidong; Billson, Francis A.; McClellan, Kathryn; Sutton, Gerard; Petsoglou, Con] Sydney Eye Hosp, Sydney, NSW, Australia; [Madigan, Michele C.] Univ New S Wales, Sch Optometry & Vis Sci, Kensington, NSW 2033, Australia; [King, Nicholas J. C.] Univ Sydney, Discipline Pathol, Sch Med Sci, Camperdown, NSW, Australia; [King, Nicholas J. C.] Univ Sydney, Bosch Inst, Sydney Med Sch, Camperdown, NSW, Australia; [Billson, Francis A.] Sight Life Fdn, Sydney, NSW, Australia; [Sutton, Gerard] Vis Eye Inst, Chatswood, NSW, Australia; [Sutton, Gerard] Univ Auckland, Auckland 1, New Zealand	University of Sydney; University of Sydney; University of New South Wales Sydney; University of Sydney; University of Sydney; University of Auckland	Zhu, MD (corresponding author), Univ Sydney, Save Sight Inst, Sydney, NSW 2006, Australia.	meidong.zhu@sydney.edu.au	King, Nicholas Jonathan Cole/C-4138-2011; You, Jingjing/AAO-2671-2020; Petsoglou, Constantinos/GLN-8047-2022	King, Nicholas Jonathan Cole/0000-0002-3877-9772; Sutton, Gerard/0000-0002-0645-018X; , Jingjing You/0000-0002-2461-0140	Lions NSW Eye Bank; Sydney Foundation for Medical Research; Save Sight Institute Special Stem Cell Research Grant; Sydney Eye Hospital Foundation	Lions NSW Eye Bank; Sydney Foundation for Medical Research; Save Sight Institute Special Stem Cell Research Grant; Sydney Eye Hospital Foundation	The study was supported by Sydney Eye Hospital Foundation, Lions NSW Eye Bank, Sydney Foundation for Medical Research, Save Sight Institute Special Stem Cell Research Grant. These funding bodies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnalich-Montiel F, 2008, STEM CELLS, V26, P570, DOI 10.1634/stemcells.2007-0653; Bahri R, 2006, J IMMUNOL, V176, P1331, DOI 10.4049/jimmunol.176.3.1331; Bell LV, 2011, PARASITE IMMUNOL, V33, P244, DOI 10.1111/j.1365-3024.2010.01272.x; Bellner L, 2011, INVEST OPHTH VIS SCI, V52, P3246, DOI 10.1167/iovs.10-6219; Chang JH, 2012, SURV OPHTHALMOL, V57, P415, DOI 10.1016/j.survophthal.2012.01.007; Cho M, 2001, AM J PHYSIOL-HEART C, V280, pH2357, DOI 10.1152/ajpheart.2001.280.5.H2357; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; DOUGLAS MW, 1994, IMMUNOLOGY, V82, P561; Du YY, 2008, CYTOTHERAPY, V10, P469, DOI 10.1080/14653240802129893; Flores B, 2012, J ALZHEIMERS DIS, V32, P417, DOI 10.3233/JAD-2012-120721; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; Frumento Guido, 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P223, DOI 10.2174/187153006778250019; Ge W, 2010, TRANSPLANTATION, V90, P1312, DOI 10.1097/TP.0b013e3181fed001; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gu SF, 2009, MOL VIS, V15, P99; Han X, 2012, NEUROSCI LETT, V511, P28, DOI 10.1016/j.neulet.2012.01.030; He JC, 2006, ARCH OPHTHALMOL-CHIC, V124, P70, DOI 10.1001/archopht.124.1.70; Jiang TS, 2010, MOL VIS, V16, P1304; Kao WWY, 1996, CORNEA, V15, P397, DOI 10.1097/00003226-199607000-00010; Kesson AM, 2002, VIRAL IMMUNOL, V15, P273, DOI 10.1089/08828240260066224; Kim JY, 2010, INT IMMUNOPHARMACOL, V10, P1185, DOI 10.1016/j.intimp.2010.06.025; Kota DJ, 2013, DIABETES, V62, P2048, DOI 10.2337/db12-0931; Lan YN, 2012, INVEST OPHTH VIS SCI, V53, P3638, DOI 10.1167/iovs.11-9311; Lee YJ, 2010, AM J CHINESE MED, V38, P585, DOI 10.1142/S0192415X1000807X; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Li Z, 2007, AM J PATHOL, V171, P838, DOI 10.2353/ajpath.2007.070008; Li ZJ, 2006, AM J PATHOL, V169, P1590, DOI 10.2353/ajpath.2006.060415; Liu J, 2004, TRANSPL P, V36, P3272, DOI 10.1016/j.transproceed.2004.11.090; Luu NT, 2013, STEM CELLS, V13; Ma YL, 2006, STEM CELLS, V24, P315, DOI 10.1634/stemcells.2005-0046; Macchiarulo A, 2009, AMINO ACIDS, V37, P219, DOI 10.1007/s00726-008-0137-3; MacKenzie CR, 1999, ADV EXP MED BIOL, V467, P533; MacMaster JF, 2003, INFLAMM RES, V52, P508, DOI 10.1007/s00011-003-1206-4; Mailankot M, 2008, INVEST OPHTH VIS SCI, V49, P5466, DOI 10.1167/iovs.08-2374; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Mika J, 2013, EUR J PHARMACOL, V716, P106, DOI 10.1016/j.ejphar.2013.01.072; Oh JY, 2008, STEM CELLS, V26, P1047, DOI 10.1634/stemcells.2007-0737; Oh JY, 2012, EMBO MOL MED, V4, P435, DOI 10.1002/emmm.201200221; Oh JY, 2009, CURR EYE RES, V34, P85, DOI 10.1080/02713680802607740; Oh JY, 2009, CYTOKINE, V46, P100, DOI 10.1016/j.cyto.2008.12.011; Pati S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025171; Pennino D, 2013, J ALLERGY CLIN IMMUN, V131, P562, DOI 10.1016/j.jaci.2012.09.036; Reinshagen H, 2011, ACTA OPHTHALMOL, V89, P741, DOI 10.1111/j.1755-3768.2009.01812.x; Robinson CM, 2003, J INTERF CYTOK RES, V23, P413, DOI 10.1089/107999003322277829; Roddy GW, 2011, STEM CELLS, V29, P1572, DOI 10.1002/stem.708; Ryan JM, 2007, CLIN EXP IMMUNOL, V149, P353, DOI 10.1111/j.1365-2249.2007.03422.x; Sadrai Z, 2011, INVEST OPHTH VIS SCI, V52, P2525, DOI 10.1167/iovs.10-5658; Selmani Z, 2008, STEM CELLS, V26, P212, DOI 10.1634/stemcells.2007-0554; Serbecic N, 2006, EXP EYE RES, V82, P416, DOI 10.1016/j.exer.2005.07.016; Tchedre K, 2013, EYE CONTACT LENS, V39, P394, DOI 10.1097/ICL.0b013e3182a2f8d9; Uwaydat S, 2011, CURR EYE RES, V36, P787, DOI 10.3109/02713683.2010.544441; Vitkovic L, 2001, NEUROIMMUNOMODULAT, V9, P295, DOI 10.1159/000059387; Wen L, 2014, CHIN J CELL STEM CEL, V4, P5; Yao L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030842; Ye J, 2006, EYE, V20, P482, DOI 10.1038/sj.eye.6701913; Yomogida S, 2008, INT J MOL MED, V22, P205, DOI 10.3892/ijmm_00000010; You JJ, 2012, EXP EYE RES, V99, P55, DOI 10.1016/j.exer.2012.03.012; Yuan WH, 1998, J CELL PHYSIOL, V177, P174, DOI 10.1002/(SICI)1097-4652(199810)177:1<174::AID-JCP18>3.0.CO;2-D; Zaher SS, 2011, INVEST OPHTH VIS SCI, V52, P2640, DOI 10.1167/iovs.10-5793; Zhang R, 2013, J NEUROINFLAMM, V10, P1742	60	24	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101841	10.1371/journal.pone.0101841	http://dx.doi.org/10.1371/journal.pone.0101841			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003339	Green Published, gold, Green Submitted			2022-12-27	WOS:000339242700076
J	Bormann, T; Wolfer, SA; Hachmann, W; Lagreze, WA; Konieczny, L				Bormann, Tobias; Wolfer, Sascha A.; Hachmann, Wibke; Lagreze, Wolf A.; Konieczny, Lars			An Eye Movement Study on the Role of the Visual Field Defect in Pure Alexia	PLOS ONE			English	Article							HEMIANOPIC DYSLEXIA; WORD; IMPAIRMENT; AGRAPHIA; ANATOMY	Pure alexia is a severe impairment of word reading which is usually accompanied by a right-sided visual field defect. Patients with pure alexia exhibit better preserved writing and a considerable word length effect, claimed to result from a serial letter processing strategy. Two experiments compared the eye movements of four patients with pure alexia to controls with simulated visual field defects (sVFD) when reading single words. Besides differences in response times and differential effects of word length on word reading in both groups, fixation durations and the occurrence of a serial, letter-by-letter fixation strategy were investigated. The analyses revealed quantitative and qualitative differences between pure alexic patients and unimpaired individuals reading with sVFD. The patients with pure alexia read words slower and exhibited more fixations. The serial, letter-by-letter fixation strategy was observed only in the patients but not in the controls with sVFD. It is argued that the VFD does not cause pure alexic reading.	[Bormann, Tobias] Neurol Univ Klin Freiburg, Freiburg, Germany; [Wolfer, Sascha A.; Konieczny, Lars] Univ Freiburg, D-79106 Freiburg, Germany; [Wolfer, Sascha A.] Inst Deutsch Sprache, Mannheim, Germany; [Hachmann, Wibke] Univ Trento, Trento, Trento, Italy; [Lagreze, Wolf A.] Univ Augenklin Freiburg, Freiburg, Germany	University of Freiburg; University of Freiburg; Institut fur Deutsche Sprache (IDS); University of Trento; University of Freiburg	Bormann, T (corresponding author), Neurol Univ Klin Freiburg, Freiburg, Germany.	tobias.bormann@uniklinik-freiburg.de	Wolfer, Sascha/AHD-5519-2022	Bormann, Tobias/0000-0001-5502-6505	Albert Ludwigs University Freiburg	Albert Ludwigs University Freiburg	The article processing charge was funded by the open access publication fund of the Albert Ludwigs University Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby J., 2011, PSYCHOL READING; Baayen R Harald, 1993, CELEX LEXICAL DATA B; Balota DA, 2004, J EXP PSYCHOL GEN, V133, P283, DOI 10.1037/0096-3445.133.2.283; BALOTA DA, 1993, J MEM LANG, V32, P573, DOI 10.1006/jmla.1993.1029; BEHRMANN M, 1990, BRAIN LANG, V39, P405, DOI 10.1016/0093-934X(90)90148-A; Behrmann M, 1998, NEUROPSYCHOLOGIA, V36, P1115, DOI 10.1016/S0028-3932(98)00005-0; Behrmann M, 2001, NEUROPSYCHOLOGIA, V39, P983, DOI 10.1016/S0028-3932(01)00021-5; BEHRMANN M, 1995, COGN NEUROPSYCHOL, V12, P409, DOI 10.1080/02643299508252004; BINDER JR, 1992, BRAIN, V115, P1807, DOI 10.1093/brain/115.6.1807; Bormann T, NEUROCASE IN PRESS; Caplan LR, 1988, HDB CLIN NEUROLOGY, V53, P409; Chialant D, 1998, COGN NEUROPSYCHOL, V15, P167, DOI 10.1080/026432998381258; Cohen L, 2004, NEUROIMAGE, V22, P466, DOI 10.1016/j.neuroimage.2003.12.049; DAMASIO AR, 1983, NEUROLOGY, V33, P1573, DOI 10.1212/WNL.33.12.1573; De Bleser R., 2004, LEMO LEXIKON MODELLO; DERENZI E, 1987, BRAIN, V110, P1099, DOI 10.1093/brain/110.5.1099; Farah M., 2004, VISUAL AGNOSIA, V2nd; FARAH MJ, 1991, COGN NEUROPSYCHOL, V8, P313, DOI 10.1080/02643299108253376; GREENBLATT SH, 1976, BRAIN LANG, V3, P229, DOI 10.1016/0093-934X(76)90019-5; GREENBLATT SH, 1973, BRAIN, V96, P307, DOI 10.1093/brain/96.2.307; GROCHOWICKI M, 1991, BRIT J OPHTHALMOL, V75, P624, DOI 10.1136/bjo.75.10.624; Heister J, 2011, PSYCHOL RUNDSCH, V62, P10, DOI 10.1026/0033-3042/a000029; JUST MA, 1982, J EXP PSYCHOL GEN, V111, P228, DOI 10.1037/0096-3445.111.2.228; Leff AP, 2006, J NEUROL NEUROSUR PS, V77, P1004, DOI 10.1136/jnnp.2005.086983; Leff AP, 2001, BRAIN, V124, P510, DOI 10.1093/brain/124.3.510; Miozzo M, 1998, COGN NEUROPSYCHOL, V15, P203, DOI 10.1080/026432998381267; Mycroft RH, 2009, NEUROPSYCHOLOGIA, V47, P1733, DOI 10.1016/j.neuropsychologia.2009.02.014; PATTERSON K, 1982, Q J EXP PSYCHOL-A, V34, P411, DOI 10.1080/14640748208400852; Pflugshaupt T, 2009, BRAIN, V132, P1907, DOI 10.1093/brain/awp141; Rayner K, 2005, PSYCHOL SCI, V16, P530, DOI 10.1111/j.0956-7976.2005.01570.x; Rayner K., 1989, PSYCHOL READING; Riddoch MJ., 1993, BORB BIRMINGHAM OBJE; Roberts DJ, 2013, CEREB CORTEX, V23, P2568, DOI 10.1093/cercor/bhs224; Rosazza C, 2007, COGN NEUROPSYCHOL, V24, P393, DOI 10.1080/02643290701377877; Schiefer U, 2007, CLIN NEURO OPHTH, P19; Schofield TM, 2009, CURR OPIN NEUROL, V22, P36, DOI 10.1097/WCO.0b013e32831f1b2c; Schuett S, 2008, NEUROPSYCHOLOGIA, V46, P2445, DOI 10.1016/j.neuropsychologia.2008.04.016; Sheldon CA, 2012, NEUROPSYCHOLOGIA, V50, P841, DOI 10.1016/j.neuropsychologia.2012.01.020; Starrfelt R, 2013, BEHAV NEUROL, V26, P167, DOI [10.1155/2013/271815, 10.3233/BEN-2012-129002]; Starrfelt R., 2014, ALEXIA DIAGNOSIS TRE; Starrfelt R, 2009, CEREB CORTEX, V19, P2880, DOI 10.1093/cercor/bhp059; WARRINGTON EK, 1980, BRAIN, V103, P99, DOI 10.1093/brain/103.1.99; Warrington EK., 1991, VISUAL OBJECT SPACE; Weekes BS, 1997, Q J EXP PSYCHOL-A, V50, P439, DOI 10.1080/027249897392170; ZIHL J, 1995, BRAIN, V118, P891, DOI 10.1093/brain/118.4.891; ZIHL J, 1996, NEUROLOGICAL DISORDE, P201; Zihl J, 1999, REHABILITATION VISUA	47	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e100898	10.1371/journal.pone.0100898	http://dx.doi.org/10.1371/journal.pone.0100898			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7WB	24999811	Green Submitted, Green Published, gold			2022-12-27	WOS:000338637300017
J	Chu, WM; Song, XM; Yang, XM; Ma, L; Zhu, J; He, MY; Wang, ZL; Wu, YN				Chu, Weiming; Song, Xiaomeng; Yang, Xueming; Ma, Lu; Zhu, Jiang; He, Mengying; Wang, Zilu; Wu, Yunong			Neuropilin-1 Promotes Epithelial-to-Mesenchymal Transition by Stimulating Nuclear Factor-Kappa B and Is Associated with Poor Prognosis in Human Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CANCER STEM-CELLS; TUMOR PROGRESSION; SEMAPHORIN-III; RECEPTOR; METASTASIS; EXPRESSION; DISEASE; INITIATION; MIGRATION	Background: The epithelial-to-mesenchymal transition (EMT) is a key process in carcinogenesis, invasion, and metastasis of oral squamous cell carcinoma (OSCC). In our previous studies, we found that neuropilin-1 (NRP1) is overexpressed in tongue squamous cell carcinoma and that this overexpression is associated with cell migration and invasion. Nuclear factor-kappa B (NF-kB) plays an essential role both in the induction and the maintenance of EMT and tumor metastasis. Therefore, we hypothesized that NRP1 induces EMT, and that NRP1-induced migration and invasion may be an important mechanism for promoting invasion and metastasis of OSCC through NF-kB activation. Methods/Results: The variations in gene and protein expression and the changes in the biological behavior of OSCC cell lines transfected with a vector encoding NRP1, or the corresponding vector control, were evaluated. NRP1 overexpression promoted EMT and was associated with enhanced invasive and metastatic properties. Furthermore, the induction of EMT promoted the acquisition of some cancer stem cell (CSC)-like characteristics in OSCC cells. We addressed whether selective inhibition of NF-kB suppresses the NRP1-mediated EMT by treating cells with pyrrolidinedithiocarbamate ammonium (PDTC), an inhibitor of NF-kB. Immunohistochemical analysis of NRP1 in OSCC tissue samples further supported a key mediator role for NRP1 in tumor progression, lymph node metastasis, and indicated that NRP1 is a predictor for poor prognosis in OSCC patients. Conclusion: Our results indicate that NRP1 may regulate the EMT process in OSCC cell lines through NF-kB activation, and that higher NRP1 expression levels are associated with lymph node metastasis and poor prognosis in OSCC patients. Further investigation of the role of NRP1 in tumorigenesis may help identify novel targets for the prevention and therapy of oral cancers.	[Chu, Weiming; Song, Xiaomeng; Ma, Lu; Zhu, Jiang; He, Mengying; Wang, Zilu; Wu, Yunong] Nanjing Med Univ, Inst Stomatol, Nanjing, Jiangsu, Peoples R China; [Chu, Weiming; Song, Xiaomeng; Yang, Xueming; Ma, Lu; Zhu, Jiang; Wu, Yunong] Stomatol Hosp Jiangsu Prov, Dept Oral & Maxillofacial Surg, Nanjing, Jiangsu, Peoples R China; [He, Mengying] Nanjing Med Univ, Coll Stomatol, Dept Basic Sci Stomatol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Wang, ZL (corresponding author), Nanjing Med Univ, Inst Stomatol, Nanjing, Jiangsu, Peoples R China.	wzl710@163.com; wynoms@gmail.com			Natural Science Foundation of Jiangsu Province [BK2010531]; University Science Research Project of Jiangsu Province [10KJB320003]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) [2014-37]	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); University Science Research Project of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by the Natural Science Foundation of Jiangsu Province (BK2010531), the University Science Research Project of Jiangsu Province (10KJB320003), and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD; ID: 2014-37). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alattar M, 2013, EUR J CARDIOTHORAC S; Bagri A, 2009, CLIN CANCER RES, V15, P1860, DOI 10.1158/1078-0432.CCR-08-0563; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Bielenberg DR, 2006, EXP CELL RES, V312, P584, DOI 10.1016/j.yexcr.2005.11.024; Broholm H, 2004, APMIS, V112, P257, DOI 10.1111/j.1600-0463.2004.apm11204-0505.x; Bruder D, 2004, EUR J IMMUNOL, V34, P623, DOI 10.1002/eji.200324799; Cao Y, 2008, CANCER RES, V68, P8667, DOI 10.1158/0008-5472.CAN-08-2614; Carvalho AL, 2005, INT J CANCER, V114, P806, DOI 10.1002/ijc.20740; Cieslik M, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-28; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Ellis LM, 2006, MOL CANCER THER, V5, P1099, DOI 10.1158/1535-7163.MCT-05-0538; Glinka Y, 2012, BIOCHEM BIOPH RES CO, V425, P775, DOI 10.1016/j.bbrc.2012.07.151; Guttmann-Raviv N, 2006, CANCER LETT, V231, P1, DOI 10.1016/j.canlet.2004.12.047; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Huber MA, 2004, CELL CYCLE, V3, P1477, DOI 10.4161/cc.3.12.1280; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kawakami T, 2002, CANCER, V95, P2196, DOI 10.1002/cncr.10936; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Latil A, 2000, INT J CANCER, V89, P167, DOI 10.1002/(SICI)1097-0215(20000320)89:2<167::AID-IJC11>3.0.CO;2-9; Lin Kimberly, 2010, Genes Cancer, V1, P409; Nakamura M, 2011, J DERMATOL SCI, V61, P7, DOI 10.1016/j.jdermsci.2010.11.015; O'Brien CA, 2009, SEMIN RADIAT ONCOL, V19, P71, DOI 10.1016/j.semradonc.2008.11.001; Ochiumi T, 2006, INT J ONCOL, V29, P105; Parikh AA, 2003, CANCER, V98, P720, DOI 10.1002/cncr.11560; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; Peng Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094422; Prud'homme GJ, 2012, ONCOTARGET, V3, P921, DOI 10.18632/oncotarget.626; Prud'homme GJ, 2012, CURR PHARM DESIGN, V18, P2838; Romeo PH, 2002, ADV EXP MED BIOL, V515, P49; Rossignol M, 2000, GENOMICS, V70, P211, DOI 10.1006/geno.2000.6381; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Song X, 2012, MED ORAL PATOL ORAL, V17, pE962, DOI 10.4317/medoral.18168; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Uniewicz KA, 2008, FRONT BIOSCI-LANDMRK, V13, P4339, DOI 10.2741/3008; Wang L, 2003, J BIOL CHEM, V278, P48848, DOI 10.1074/jbc.M310047200; Wang L, 2006, FASEB J, V20, P1513, DOI 10.1096/fj.05-5504fje; Wang ZL, 2012, HEAD NECK ONCOL, V4, P54; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zhu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087904	44	57	60	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101931	10.1371/journal.pone.0101931	http://dx.doi.org/10.1371/journal.pone.0101931			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999732	Green Published, gold, Green Submitted			2022-12-27	WOS:000338637300105
J	Espinosa-Gongora, C; Moodley, A; Lipinska, U; Broens, EM; Hermans, K; Butaye, P; Devriese, LA; Haesebrouck, F; Guardabassi, L				Espinosa-Gongora, Carmen; Moodley, Arshnee; Lipinska, Urszula; Broens, Els M.; Hermans, Katleen; Butaye, Patrick; Devriese, Luc A.; Haesebrouck, Freddy; Guardabassi, Luca			Phenotypes and Genotypes of Old and Contemporary Porcine Strains Indicate a Temporal Change in the S-aureus Population Structure in Pigs	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; CRYSTAL VIOLET REACTIONS; METHICILLIN-RESISTANT; MOLECULAR CHARACTERIZATION; ANTIMICROBIAL RESISTANCE; SLAUGHTER PIGS; ST398; MRSA; PREVALENCE; ANIMALS	Introduction: Staphylococcus aureus sequence type ST398 has recently gained attention due to the spread of methicillin-resistant strains among people exposed to livestock. The aim of this study was to explore temporal changes in the population structure of S. aureus in pigs over the last 40 years with particular reference to the occurrence of ST398. Methods: We analysed a unique collection of 91 porcine strains isolated in six countries between 1973 and 2009 using a biotyping scheme described in the 1970's in combination with spa typing and multi-locus sequence typing (MLST). The collection comprised 32 historical isolates from 1973-1974 (n = 19) and from 1991-2003 (n = 13), and 59 contemporary isolates from 2004-2009. The latter isolates represented the most common MLST types (ST1, ST9, ST97 and ST433) and spa types isolated from pigs in Europe. Results and Discussion: S. aureus sequence type ST398 was not found among old isolates from the 1970's or from 19912003, suggesting that this lineage was absent or present at low frequencies in pigs in the past. This hypothesis is supported by the observed association of ST398 with the ovine ecovar, which was not described in pigs by studies carried out in the 1970's. In addition, various phenotypic and genotypic differences were observed between old and contemporary isolates. Some biotypes commonly reported in pigs in the 1970's were either absent (human ecovar) or rare (biotype A) among contemporary isolates. Nine clonal lineages found among old porcine isolates are occasionally reported in pigs today (ST8, ST30, ST97, ST387, ST1092, ST2468) or have never been described in this animal host (ST12, ST133, ST1343). These results indicate that the population structure of porcine S. aureus has changed over the last 40 years and confirm the current theory that S. aureus ST398 does not originate from pigs.	[Espinosa-Gongora, Carmen; Moodley, Arshnee; Guardabassi, Luca] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg C, Denmark; [Lipinska, Urszula; Hermans, Katleen; Butaye, Patrick; Devriese, Luc A.; Haesebrouck, Freddy] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium; [Broens, Els M.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Vet Microbiol Diagnost Ctr, Utrecht, Netherlands; [Butaye, Patrick] Ctr Etud & Rech Vet & Agrochim, Ctr Onderzoek Diergeneeskunde & Agrochem, Unit Gen Bacteriol, Brussels, Belgium	University of Copenhagen; Ghent University; Utrecht University	Guardabassi, L (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg C, Denmark.	lg@sund.ku.dk	Haesebrouck, Freddy/M-3857-2014; Butaye, Patrick/AAJ-8240-2020	Haesebrouck, Freddy/0000-0002-1709-933X; Moodley, Arshnee/0000-0002-6469-3948; Butaye, Patrick/0000-0003-0780-6384; Espinosa-Gongora, Carmen/0000-0002-9536-0548; Guardabassi, Luca/0000-0002-2389-5084				Aamot HV, 2012, J CLIN MICROBIOL, V50, P3111, DOI 10.1128/JCM.01352-12; Agerso Y, 2012, VET MICROBIOL, V157, P246, DOI 10.1016/j.vetmic.2011.12.023; AKATOV AK, 1983, ZH MIKROB EPID IMMUN, P29; [Anonymous], 2009, EFSA J, V7; Argudin MA, 2010, APPL ENVIRON MICROB, V76, P652, DOI 10.1128/AEM.01721-09; Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Aspiroz C, 2012, ENFERM INFEC MICR CL, V30, P18, DOI 10.1016/j.eimc.2011.07.013; Bae T, 2006, MOL MICROBIOL, V62, P1035, DOI 10.1111/j.1365-2958.2006.05441.x; Bagcigil FA, 2007, VET MICROBIOL, V121, P307, DOI 10.1016/j.vetmic.2006.12.007; Battisti A, 2010, VET MICROBIOL, V142, P361, DOI 10.1016/j.vetmic.2009.10.008; COLEMAN DC, 1989, J GEN MICROBIOL, V135, P1679; Crombe F, 2012, MICROB DRUG RESIST, V18, P125, DOI 10.1089/mdr.2011.0138; de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027; DEVRIESE LA, 1984, J APPL BACTERIOL, V56, P215, DOI 10.1111/j.1365-2672.1984.tb01341.x; DEVRIESE LA, 1976, RES VET SCI, V21, P284, DOI 10.1016/S0034-5288(18)33337-X; DIMITRACOPOULOS G, 1977, APPL ENVIRON MICROB, V34, P461, DOI 10.1128/AEM.34.5.461-464.1977; Dressler AE, 2012, VET REC, V170, P495, DOI 10.1136/vr.100570; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; FREEMAN R, 1990, EPIDEMIOL INFECT, V105, P493, DOI 10.1017/S0950268800048111; FREEMAN R, 1994, J CLIN PATHOL, V47, P283, DOI 10.1136/jcp.47.3.283; Goerke C, 2006, MOL MICROBIOL, V61, P1673, DOI 10.1111/j.1365-2958.2006.05354.x; Gomez-Sanz E, 2011, COMP IMMUNOL MICROB, V34, P447, DOI [10.1016/j.cimid.2011.08.002, 10.1016/j.cimid.2010.06.006]; Graveland H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010990; Grisold AJ, 2010, DIAGN MICR INFEC DIS, V66, P217, DOI 10.1016/j.diagmicrobio.2009.09.006; Guardabassi L, 2007, VET MICROBIOL, V122, P384, DOI 10.1016/j.vetmic.2007.03.021; Guardabassi L, 2009, EMERG INFECT DIS, V15, P1998, DOI 10.3201/eid1512.090378; HAJEK V, 1971, ZENTRALBL BAKT P INF, V217, P176; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Hartmeyer GN, 2010, SCAND J INFECT DIS, V42, P318, DOI 10.3109/00365540903510708; Hasman H, 2010, VET MICROBIOL, V141, P326, DOI 10.1016/j.vetmic.2009.09.025; Hudson LO, 2012, J CLIN MICROBIOL, V50, P573, DOI 10.1128/JCM.05336-11; Huijsdens Xander W, 2006, Ann Clin Microbiol Antimicrob, V5, P26, DOI 10.1186/1476-0711-5-26; Lozano C, 2011, EMERG INFECT DIS, V17, P138, DOI 10.3201/eid1701.100307; MEYER W, 1966, ZENTBL BAKTERIOLOG P, V201, P465; Moodley A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049344; Nemati M, 2008, ANTIMICROB AGENTS CH, V52, P3817, DOI 10.1128/AAC.00613-08; OEDING P, 1972, ACTA PATHOLOG MICROB, VB 80, P525; Poulsen AB, 2003, J ANTIMICROB CHEMOTH, V51, P419, DOI 10.1093/jac/dkg084; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Schijffelen MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-376; Stegger M, 2011, J CLIN MICROBIOL, V49, P732, DOI 10.1128/JCM.01970-10; van Belkum A, 2008, EMERG INFECT DIS, V14, P479, DOI 10.3201/eid1403.070760; van der Wolf PJ, 2012, VET MICROBIOL, V158, P136, DOI 10.1016/j.vetmic.2012.01.025; van Duijkeren E, 2010, VET MICROBIOL, V141, P96, DOI 10.1016/j.vetmic.2009.08.009; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Vandendriessche S, 2011, GENOTYPE DIVERSITY S; Vandendriessche S, 2014, J ANTIMICROB CHEMOTH, V69, P355, DOI 10.1093/jac/dkt366; Verhegghe M., 2012, ZOONOSES PUBLIC HLTH; Werner G, 2012, VET MICROBIOL, V160, P162, DOI [10.1016/j.vetmic.2012.05.019, 10.1016/j.vetmic.2012.05.005]; WITTE W, 1978, J HYG EPID MICROB IM, V22, P177	50	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101988	10.1371/journal.pone.0101988	http://dx.doi.org/10.1371/journal.pone.0101988			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000530	Green Submitted, Green Published, gold			2022-12-27	WOS:000338637300111
J	Hou, DP; Wang, QS; Jiang, CH; Tian, C; Li, HQ; Ji, B				Hou, Dapeng; Wang, Qiushi; Jiang, Cuihua; Tian, Cui; Li, Huaqing; Ji, Bo			Evaluation of the Short-Term Effects of Antimicrobial Stewardship in the Intensive Care Unit at a Tertiary Hospital in China	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; ANTIBIOTIC-RESISTANCE; RESTRICTION POLICY; IMPACT; SURVEILLANCE; STATES; SUSCEPTIBILITY; PATTERNS; PROGRAM; SYSTEMS	Antibiotic abuse can lead to antibiotic resistance, which is a severe problem in China. The purpose of this study is to evaluate the short-term effects of antimicrobial stewardship strategies, including formulary restriction, preauthorization, perioperative quinolone restriction, and control of total antibiotic consumption in the ICU at a tertiary hospital in China. After implementation of antimicrobial stewardship, the total antibiotic consumption in the ICU significantly decreased. The defined daily doses (DDDs) per 100 patient-days decreased from 197.65 to 143.41; however, the consumption of cephalosporins increased from 53.65 to 63.17 DDDs. Significant improvements in resistance to amikacin, gentamicin, ciprofloxacin, ofloxacin, ceftriaxone, ceftazidime, and piperacillin in Enterobacteriaceae and resistance to ceftazidime, imipenem, and meropenem in non-fermenting Gram-negative rods were observed. In addition, the initial use of no antibiotics or of a single antibiotic significantly increased (P<0.001) and the use of two antibiotics in combination significantly decreased (P<0.001). Our results demonstrate that implementation of antimicrobial stewardship in a short period in the ICU dramatically reduced antibiotic consumption and significantly improved antibiotic resistance, which leads to more reasonable antibiotic selections by ICU physicians.	[Hou, Dapeng; Wang, Qiushi; Jiang, Cuihua; Tian, Cui; Li, Huaqing] Taishan Med Coll, Affiliated Hosp, Dept Intens Care Unit, Tai An, Shandong, Peoples R China; [Ji, Bo] Taishan Med Coll, Affiliated Hosp, Dept Thorac Surg, Tai An, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences	Hou, DP (corresponding author), Taishan Med Coll, Affiliated Hosp, Dept Intens Care Unit, Tai An, Shandong, Peoples R China.	hdptyfy@163.com; jibotyty@163.com						Armstrong GL, 1999, JAMA-J AM MED ASSOC, V281, P61, DOI 10.1001/jama.281.1.61; Bassetti M, 2000, INT J ANTIMICROB AG, V16, P295, DOI 10.1016/S0924-8579(00)00249-1; Belongia EA, 2005, EMERG INFECT DIS, V11, P912; Bliziotis IA, 2005, CLIN INFECT DIS, V41, P149, DOI 10.1086/430912; Brown EM, 2005, J ANTIMICROB CHEMOTH, V55, P6, DOI 10.1093/jac/dkh482; Clinical and Laboratory Standards Institute, 2005, PERF STAND ANT SUS S; Cook PP, 2008, INFECT CONT HOSP EP, V29, P716, DOI 10.1086/589813; Fridkin SK, 1999, CLIN INFECT DIS, V29, P245, DOI 10.1086/520193; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Kaki R, 2011, J ANTIMICROB CHEMOTH, V66, P1223, DOI 10.1093/jac/dkr137; Kohler T, 1999, ANTIMICROB AGENTS CH, V43, P424, DOI 10.1128/AAC.43.2.424; Livermore DM, 2002, CLIN INFECT DIS, V34, P634, DOI 10.1086/338782; MacDougall C, 2005, CLIN MICROBIOL REV, V18, P638, DOI 10.1128/CMR.18.4.638-656.2005; Meyer E, 2006, INFECTION, V34, P303, DOI 10.1007/s15010-006-6619-x; Mohr JF, 2004, INT J ANTIMICROB AG, V24, P346, DOI 10.1016/j.ijantimicag.2004.06.002; Ntagiopoulos PG, 2007, INT J ANTIMICROB AG, V30, P360, DOI 10.1016/j.ijantimicag.2007.05.012; Ochs MM, 1999, ANTIMICROB AGENTS CH, V43, P1085, DOI 10.1128/AAC.43.5.1085; Reynolds L, 2009, HEALTH POLICY, V90, P32, DOI 10.1016/j.healthpol.2008.09.002; Wang H, 2005, DIAGN MICR INFEC DIS, V51, P201, DOI 10.1016/j.diagmicrobio.2004.09.001; Zhang RF, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-6	20	28	29	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101447	10.1371/journal.pone.0101447	http://dx.doi.org/10.1371/journal.pone.0101447			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000225	Green Published, gold, Green Submitted			2022-12-27	WOS:000338637300044
J	Hu, F; Xu, L; Liu, ZH; Ge, MM; Ruan, DY; Wang, HL				Hu, Fan; Xu, Li; Liu, Zhi-Hua; Ge, Meng-Meng; Ruan, Di-Yun; Wang, Hui-Li			Developmental Lead Exposure Alters Synaptogenesis through Inhibiting Canonical Wnt Pathway In Vivo and In Vitro	PLOS ONE			English	Article							LONG-TERM POTENTIATION; SIGNALING PATHWAY; SYNAPTIC-TRANSMISSION; DENDRITIC SPINES; NERVOUS-SYSTEM; DICKKOPF-1; PLASTICITY; RECEPTORS; HIPPOCAMPUS; ACTIVATION	Lead (Pb) exposure has been implicated in the impairment of synaptic plasticity in the developing hippocampus, but the mechanism remains unclear. Here, we investigated whether developmental lead exposure affects the dendritic spine formation through Wnt signaling pathway in vivo and in vitro. Sprague-Dawley rats were exposed to lead throughout the lactation period and Golgi-Cox staining method was used to examine the spine density of pyramidal neurons in the hippocampal CA1 area of rats. We found that lead exposure significantly decreased the spine density in both 14 and 21 days-old pups, accompanied by a significant age-dependent decline of the Wnt7a expression and stability of its downstream protein (beta-catenin). Furthermore, in cultured hippocampal neurons, lead (0.1 and 1 mu M lead acetate) significantly decreased the spine density in a dose-dependent manner. Exogenous Wnt7a application attenuated the decrease of spine density and increased the stability of the downstream molecules in Wnt signaling pathway. Together, our results suggest that lead has a negative impact on spine outgrowth in the developing hippocampus through altering the canonical Wnt pathway.	[Hu, Fan; Xu, Li; Liu, Zhi-Hua; Ge, Meng-Meng; Ruan, Di-Yun; Wang, Hui-Li] Hefei Univ Technol, Sch Biotechnol & Food Engn, Hefei, Anhui, Peoples R China; [Ruan, Di-Yun] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China	Hefei University of Technology; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wang, HL (corresponding author), Hefei Univ Technol, Sch Biotechnol & Food Engn, Hefei, Anhui, Peoples R China.	wanghl@hfut.edu.cn		Hu, Fan/0000-0001-9951-6557	National Key Basic Research Program of China (973 Program) [2012CB525003]; National Science Foundation of China [31200851, 21307024]; Program for New Century Excellent Talents in University [NCET-12-0835]; Specialized Research Fund for the Doctoral Program of Higher Education [20130111110024]; China Postdoctoral Science Foundation [2013M531500]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Key Basic Research Program of China (973 Program, No. 2012CB525003, www.973.gov.cn), the National Science Foundation of China (No. 31200851 and 21307024, www.nsfc.gov.cn), the Program for New Century Excellent Talents in University (NCET-12-0835, www.dost.moe.edu.cn), the Specialized Research Fund for the Doctoral Program of Higher Education (No. 20130111110024, www.cutech.edu.cn/cn), and the China Postdoctoral Science Foundation (2013M531500, www.chinapostdoctor.org.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; ALFANO DP, 1982, EXP NEUROL, V75, P275, DOI 10.1016/0014-4886(82)90160-1; Bihaqi SW, 2013, NEUROTOXICOLOGY, V39, P95, DOI 10.1016/j.neuro.2013.07.010; Byun Y. H., 2013, PLOS ONE, V8; Cerpa W, 2008, J BIOL CHEM, V283, P5918, DOI 10.1074/jbc.M705943200; Chen SP, 1999, TOXICOLOGY, V132, P67, DOI 10.1016/S0300-483X(98)00139-5; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Ciani L, 2011, P NATL ACAD SCI USA, V108, P10732, DOI 10.1073/pnas.1018132108; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Cuitino L, 2010, J NEUROSCI, V30, P8411, DOI 10.1523/JNEUROSCI.5736-09.2010; Davis EK, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-32; Eubig PA, 2010, ENVIRON HEALTH PERSP, V118, P1654, DOI 10.1289/ehp.0901852; FLETCHER TL, 1994, J NEUROSCI, V14, P6695; Gibb R, 1998, J NEUROSCI METH, V79, P1, DOI 10.1016/S0165-0270(97)00163-5; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Hall AC, 2002, MOL CELL NEUROSCI, V20, P257, DOI 10.1006/mcne.2002.1117; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Hattori T, 2010, MOL PSYCHIATR, V15, P798, DOI 10.1038/mp.2010.60; Hu F, 2008, BRAIN RES BULL, V77, P77, DOI 10.1016/j.brainresbull.2008.06.007; Inestrosa NC, 2012, J NEUROIMMUNE PHARM, V7, P788, DOI 10.1007/s11481-012-9417-5; Jang MH, 2013, CELL STEM CELL, V12, P215, DOI 10.1016/j.stem.2012.11.021; Jusko TA, 2008, ENVIRON HEALTH PERSP, V116, P243, DOI 10.1289/ehp.10424; Koyama Y, 2013, NEUROCHEM INT, V63, P35, DOI 10.1016/j.neuint.2013.04.009; Li CC, 2008, TOXICOL APPL PHARM, V229, P351, DOI 10.1016/j.taap.2008.01.039; Liu M., 2012, PLOS ONE, V7; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Loikkanen J, 2003, TOXICOL LETT, V144, P235, DOI 10.1016/S0378-4274(03)00220-0; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Meng XM, 2005, NEUROLOGY, V64, P1644, DOI 10.1212/01.WNL.0000160391.58004.D4; Mike A, 2000, BRAIN RES, V873, P112, DOI 10.1016/S0006-8993(00)02533-6; Miller TE, 1998, TOXICOL SCI, V42, P129, DOI 10.1093/toxsci/42.2.129; Neal AP, 2011, NEUROTOXICOLOGY, V32, P281, DOI 10.1016/j.neuro.2010.12.013; Neal AP, 2010, TOXICOL SCI, V116, P249, DOI 10.1093/toxsci/kfq111; Nihei MK, 2000, NEUROSCIENCE, V99, P233, DOI 10.1016/S0306-4522(00)00192-5; OTUAMA LA, 1976, TOXICOL APPL PHARM, V36, P1, DOI 10.1016/0041-008X(76)90021-1; PETIT TL, 1983, NEUROTOXICOLOGY, V4, P79; Purro SA, 2012, J NEUROSCI, V32, P3492, DOI 10.1523/JNEUROSCI.4562-11.2012; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Richards DA, 2005, P NATL ACAD SCI USA, V102, P6166, DOI 10.1073/pnas.0501881102; Rochefort NL, 2012, EMBO REP, V13, P699, DOI 10.1038/embor.2012.102; Rosi MC, 2010, J NEUROCHEM, V112, P1539, DOI 10.1111/j.1471-4159.2009.06566.x; Ruan DY, 1998, BRAIN RES, V806, P196, DOI 10.1016/S0006-8993(98)00739-2; Saneyoshi T, 2008, NEURON, V57, P94, DOI 10.1016/j.neuron.2007.11.016; Segal M, 2005, NAT REV NEUROSCI, V6, P277, DOI 10.1038/nrn1649; Seib DRM, 2013, CELL STEM CELL, V12, P204, DOI 10.1016/j.stem.2012.11.010; Toscano CD, 2005, BRAIN RES REV, V49, P529, DOI 10.1016/j.brainresrev.2005.02.004; Varela-Nallar L, 2010, P NATL ACAD SCI USA, V107, P21164, DOI 10.1073/pnas.1010011107; Vargas JY, 2014, J NEUROSCI, V34, P2191, DOI 10.1523/JNEUROSCI.0862-13.2014; Wang HL, 2006, EUR J NEUROSCI, V23, P1111, DOI 10.1111/j.1460-9568.2006.04645.x; Wang HL, 2008, ENVIRON HEALTH PERSP, V116, P1401, DOI 10.1289/ehp.11400; Wang HL, 2011, J NEUROSCI, V31, P17764, DOI 10.1523/JNEUROSCI.3964-11.2011; Wang L, 2007, NEUROTOXICOLOGY, V28, P499, DOI 10.1016/j.neuro.2006.11.003; Yu SS, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-51; Yu XZ, 2011, CURR OPIN NEUROBIOL, V21, P169, DOI 10.1016/j.conb.2010.07.010; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zito K, 2004, NEURON, V44, P321, DOI 10.1016/j.neuron.2004.09.022	56	33	34	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101894	10.1371/journal.pone.0101894	http://dx.doi.org/10.1371/journal.pone.0101894			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999626	gold, Green Submitted, Green Published			2022-12-27	WOS:000338637300096
J	Lowerre-Barbieri, S; Villegas-Rios, D; Walters, S; Bickford, J; Cooper, W; Muller, R; Trotter, A				Lowerre-Barbieri, Susan; Villegas-Rios, David; Walters, Sarah; Bickford, Joel; Cooper, Wade; Muller, Robert; Trotter, Alexis			Spawning Site Selection and Contingent Behavior in Common Snook, Centropomus undecimalis	PLOS ONE			English	Article							POPULATION-STRUCTURE; SPATIAL-DISTRIBUTION; RELATIVE ABUNDANCE; DIEL BEHAVIOR; LIFE-HISTORY; RED TIDE; FISH; FISHERIES; STOCK; AGGREGATIONS	Reproductive behavior affects spatial population structure and our ability to manage for sustainability in marine and diadromous fishes. In this study, we used fishery independent capture-based sampling to evaluate where Common Snook occurred in Tampa Bay and if it changed with spawning season, and passive acoustic telemetry to assess fine scale behavior at an inlet spawning site (2007-2009). Snook concentrated in three areas during the spawning season only one of which fell within the expected spawning habitat. Although in lower numbers, they remained in these areas throughout the winter months. Acoustically-tagged snook (n = 31) showed two seasonal patterns at the spawning site: Most fish occurred during the spawning season but several fish displayed more extended residency, supporting the capture-based findings that Common Snook exhibit facultative catadromy. Spawning site selection for iteroparous, multiple-batch spawning fishes occurs at the lifetime, annual, or intra-annual temporal scales. In this study we show colonization of a new spawning site, indicating that lifetime spawning site fidelity of Common Snook is not fixed at this fine spatial scale. However, individuals did exhibit annual and intra-seasonal spawning site fidelity to this new site over the three years studied. The number of fish at the spawning site increased in June and July (peak spawning months) and on new and full lunar phases indicating within population variability in spawning and movement patterns. Intra-seasonal patterns of detection also differed significantly with sex. Common Snook exhibited divergent migration tactics and habitat use at the annual and estuarine scales, with contingents using different overwintering habitat. Migration tactics also varied at the spawning site at the intra-seasonal scale and with sex. These results have important implications for understanding how reproductive behavior affects spatio-temporal patterns of fish abundance and their resilience to disturbance events and fishing pressure.	[Lowerre-Barbieri, Susan; Walters, Sarah; Bickford, Joel; Cooper, Wade; Muller, Robert; Trotter, Alexis] Florida Fish & Wildlife Conservat Commiss, Florida Fish & Wildlife Res Inst, St Petersburg, FL 33701 USA; [Villegas-Rios, David] Inst Marine Res IIM CSIC, Dept Ecol & Marine Resources, Vigo, Pontevedra, Spain	Florida Fish & Wildlife Conservation Commission; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM)	Lowerre-Barbieri, S (corresponding author), Florida Fish & Wildlife Conservat Commiss, Florida Fish & Wildlife Res Inst, St Petersburg, FL 33701 USA.	Susan.Barbieri@myfwc.com	Villegas Ríos, David/G-3091-2016	Villegas Ríos, David/0000-0001-5660-5322	US Fish and Wildlife Service Sport Fish Restoration program [F-59]	US Fish and Wildlife Service Sport Fish Restoration program(US Fish & Wildlife Service)	This project was supported by Grant F-59 from the US Fish and Wildlife Service Sport Fish Restoration program. http://wsfrprograms.fws.gov/Subpages/GrantPrograms/SFR/SFR.htm. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A, 2009, MAR ECOL PROG SER, V389, P213, DOI 10.3354/meps08198; Adams Aaron J., 2012, Gulf and Caribbean Research, V24, P13; Adams AJ, 2011, ENVIRON BIOL FISH, P1; Ager L.A., 1976, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V30, P158; Alos J, 2012, MAR ECOL PROG SER, V460, P207, DOI 10.3354/meps09755; Barbour AB, 2012, MARINE ECOLOGY PROGR; Berkeley SA, 2004, FISHERIES, V29, P23, DOI 10.1577/1548-8446(2004)29[23:FSVPOA]2.0.CO;2; Bijoux JP, 2013, MAR ECOL PROG SER, V475, P233, DOI 10.3354/meps10113; Blewett David A., 2009, Florida Scientist, V72, P310; Blewett David A., 2006, Gulf and Caribbean Research, V18, P1; Botsford LW, 2009, REV FISH BIOL FISHER, V19, P69, DOI 10.1007/s11160-008-9092-z; Brown-Peterson NJ, 2011, MAR COAST FISH, V3, P52, DOI 10.1080/19425120.2011.555724; Cadrin SX, 2009, FISH FISH SER, V31, P405, DOI 10.1007/978-1-4020-9210-7_22; Cardinale M, 2011, FISH FISH, V12, P289, DOI 10.1111/j.1467-2979.2010.00393.x; Chapman P, 1982, FINAL REPORT SPORTFI; CLARK J, 1968, T AM FISH SOC, V97, P320, DOI 10.1577/1548-8659(1968)97[320:SMOSBC]2.0.CO;2; Claydon J, 2004, OCEANOGR MAR BIOL, V42, P265; Colin PL, 1996, COPEIA, P189, DOI 10.2307/1446955; Danylchuk AJ, 2011, MAR BIOL, V158, P1981, DOI 10.1007/s00227-011-1707-6; Daverat F, 2006, MAR ECOL PROG SER, V308, P231, DOI 10.3354/meps308231; Daverat F, 2012, MAR ECOL PROG SER, V465, P267, DOI 10.3354/meps09910; Flaherty KE, 2011, ESTUAR COAST, V34, P417, DOI 10.1007/s12237-010-9350-x; Frank KT, 2001, J SEA RES, V45, P173, DOI 10.1016/S1385-1101(01)00056-9; Goethel DR, 2011, REV FISH SCI, V19, P119, DOI 10.1080/10641262.2011.557451; GROSS MR, 1988, SCIENCE, V239, P1291, DOI 10.1126/science.239.4845.1291; Hedger RD, 2008, ICES J MAR SCI, V65, P1248, DOI 10.1093/icesjms/fsn109; Hjort J., 1914, P RAPPORTS PROCRS VE; Hunter J.R., 1985, NOAA Technical Report NMFS, V36, P79; Hutchinson WF, 2003, P ROY SOC B-BIOL SCI, V270, P2125, DOI 10.1098/rspb.2003.2493; Kerr LA, 2010, ECOL APPL, V20, P497, DOI 10.1890/08-1382.1; Kraus RT, 2004, MAR ECOL PROG SER, V279, P247, DOI 10.3354/meps279247; Kucera CJ, 2002, J FISH BIOL, V61, P726, DOI 10.1006/jfbi.2002.2097; Leis JM, 2011, INTEGR COMP BIOL, V51, P826, DOI 10.1093/icb/icr004; LEVINS RICHARD, 1968; Ley JA, 2013, FISH RES, V144, P60, DOI 10.1016/j.fishres.2012.10.008; Lowerre-Barbieri SK, 1998, CAN J FISH AQUAT SCI, V55, P2244, DOI 10.1139/cjfas-55-10-2244; Lowerre-Barbieri SK, 2003, T AM FISH SOC, V132, P940, DOI 10.1577/T02-001; Lowerre-Barbieri SK, 2013, MAR ECOL PROG SER, V481, P181, DOI 10.3354/meps10224; Lowerre-Barbieri SK, 2009, MAR ECOL PROG SER, V394, P231, DOI 10.3354/meps08262; Lozano C, 2012, J FISH BIOL, V81, P1665, DOI 10.1111/j.1095-8649.2012.03426.x; March D, 2010, MAR ECOL PROG SER, V400, P195, DOI 10.3354/meps08410; Maunder MN, 2013, FISH RES, V146, P96, DOI 10.1016/j.fishres.2013.03.021; McDowall RM, 1997, REV FISH BIOL FISHER, V7, P443, DOI 10.1023/A:1018404331601; Meyer CG, 2007, AQUAT LIVING RESOUR, V20, P291, DOI 10.1051/alr:2008002; Miles NG, 2014, MAR FRESHWATER RES, V65, P12, DOI 10.1071/MF12340; Muller RG, 2014, 2013 STOCK ASSESSMEN; Palmer M, 2011, MAR ECOL PROG SER, V430, P87, DOI 10.3354/meps09109; Paris CB, 2013, ENVIRON MODELL SOFTW, V42, P47, DOI 10.1016/j.envsoft.2012.12.006; Payne NL, 2010, MAR ECOL PROG SER, V419, P295, DOI 10.3354/meps08864; Peters KM, 1998, B MAR SCI, V62, P509; Petitgas P, 2010, ICES J MARINE SCI; QUINTEROHUNTER I, 1991, BIOTECH HISTOCHEM, V66, P169, DOI 10.3109/10520299109109964; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Secor DH, 1999, FISH RES, V43, P13, DOI 10.1016/S0165-7836(99)00064-8; Semmens JM, 2010, MAR ECOL PROG SER, V403, P193, DOI 10.3354/meps08469; Simpfendorfer CA, 2002, CAN J FISH AQUAT SCI, V59, P23, DOI 10.1139/F01-191; Smedbol RK, 2002, FISH RES, V55, P161; Smedbol RK, 2001, J FISH BIOL, V59, P109, DOI 10.1006/jfbi.2001.1765; Svedang H, 2007, MAR ECOL PROG SER, V345, P1, DOI 10.3354/meps07140; Syedang H, 2010, ENVIRON BIOL FISH, V89, P383, DOI 10.1007/s10641-010-9669-y; Taylor RG, 1998, J FISH BIOL, V53, P502, DOI 10.1006/jfbi.1998.0721; Taylor RG, 2000, FISH B-NOAA, V98, P612; Thibault I, 2007, MAR ECOL PROG SER, V344, P219, DOI 10.3354/meps06944; Trotter AA, 2012, T AM FISH SOC, V141, P1016, DOI 10.1080/00028487.2012.675903; TUCKER JW, 1987, PROG FISH CULT, V49, P49, DOI 10.1577/1548-8640(1987)49&lt;49:SATSCA&gt;2.0.CO;2; Villegas-Rios D, 2013, J SEA RES, V80, P61, DOI 10.1016/j.seares.2013.02.009; Volpe AV, 1959, TECHNICAL SERIES FLO, P38; Walsh CT, 2012, ECOL FRESHW FISH, V21, P145, DOI 10.1111/j.1600-0633.2011.00534.x; Walters S, 2013, MAR ECOL PROG SER, V479, P191, DOI 10.3354/meps10219; Winner BL, 2010, T AM FISH SOC, V139, P62, DOI 10.1577/T08-215.1; Wood S, 2013, GEN ADDITIVE MIXED M; Yanes-Roca C, 2009, AQUACULTURE, V287, P335, DOI 10.1016/j.aquaculture.2008.10.043; Ying YP, 2011, CAN J FISH AQUAT SCI, V68, P2101, DOI 10.1139/F2011-116; Young JM, 2014, MAR ECOL PROG SER, V505, P227, DOI 10.3354/meps10774; Zuur Alain F., 2009, P1	75	37	37	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101809	10.1371/journal.pone.0101809	http://dx.doi.org/10.1371/journal.pone.0101809			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999986	Green Submitted, Green Published, gold			2022-12-27	WOS:000338637300090
J	Mannarini, S; Boffo, M				Mannarini, Stefania; Boffo, Marilisa			An Implicit Measure of Associations with Mental Illness versus Physical Illness: Response Latency Decomposition and Stimuli Differential Functioning in Relation to IAT Order of Associative Conditions and Accuracy	PLOS ONE			English	Article							BIOGENETIC EXPLANATIONS; SOCIAL REJECTION; PERCEIVED STIGMA; EXPLICIT STIGMA; ATTITUDE-CHANGE; CAUSAL BELIEFS; SCHIZOPHRENIA; DIMENSION; MODEL; ATTRIBUTION	The present study aimed at the definition of a latent measurement dimension underlying an implicit measure of automatic associations between the concept of mental illness and the psychosocial and biogenetic causal explanatory attributes. To this end, an Implicit Association Test (IAT) assessing the association between the Mental Illness and Physical Illness target categories to the Psychological and Biologic attribute categories, representative of the causal explanation domains, was developed. The IAT presented 22 stimuli (words and pictures) to be categorized into the four categories. After 360 university students completed the IAT, a Many-Facet Rasch Measurement (MFRM) modelling approach was applied. The model specified a person latency parameter and a stimulus latency parameter. Two additional parameters were introduced to denote the order of presentation of the task associative conditions and the general response accuracy. Beyond the overall definition of the latent measurement dimension, the MFRM was also applied to disentangle the effect of the task block order and the general response accuracy on the stimuli response latency. Further, the MFRM allowed detecting any differential functioning of each stimulus in relation to both block ordering and accuracy. The results evidenced: a) the existence of a latency measurement dimension underlying the Mental Illness versus Physical Illness - Implicit Association Test; b) significant effects of block order and accuracy on the overall latency; c) a differential functioning of specific stimuli. The results of the present study can contribute to a better understanding of the functioning of an implicit measure of semantic associations with mental illness and give a first blueprint for the examination of relevant issues in the development of an IAT.	[Mannarini, Stefania; Boffo, Marilisa] Univ Padua, Dept Philosophy Sociol Educ & Appl Psychol, Padua, Italy	University of Padua	Mannarini, S (corresponding author), Univ Padua, Dept Philosophy Sociol Educ & Appl Psychol, Padua, Italy.	stefania.mannarini@unipd.it		MANNARINI, STEFANIA/0000-0002-8446-785X; Boffo, Marilisa/0000-0003-4730-7838	University of Padova	University of Padova	University of Padova is the source of funding of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angermeyer MC, 2011, BRIT J PSYCHIAT, V199, P367, DOI 10.1192/bjp.bp.110.085563; Angermeyer MC, 2005, BRIT J PSYCHIAT, V186, P331, DOI 10.1192/bjp.186.4.331; [Anonymous], 2005, SIGMA MENTAL ILLNESS; Blanton H, 2006, AM PSYCHOL, V61, P62, DOI 10.1037/0003-066X.61.1.62; Bluemke M, 2006, J EXP SOC PSYCHOL, V42, P163, DOI 10.1016/j.jesp.2005.03.004; Bond TG., 2020, APPL RASCH MODEL FUN; Bos W, 2011, EDUC RES EVAL, V17, P413, DOI 10.1080/13803611.2011.634580; Brohan E, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-80; Bushnell J, 2005, FAM PRACT, V22, P631, DOI 10.1093/fampra/cmi080; Corrigan P, 2003, J HEALTH SOC BEHAV, V44, P162, DOI 10.2307/1519806; Corrigan PW, 2000, CLIN PSYCHOL-SCI PR, V7, P48, DOI 10.1093/clipsy/7.1.48; COYNE JC, 1991, ANNU REV PSYCHOL, V42, P401, DOI 10.1146/annurev.ps.42.020191.002153; Dovidio JF, 1997, J EXP SOC PSYCHOL, V33, P510, DOI 10.1006/jesp.1997.1331; Embretson SE, 2006, AM PSYCHOL, V61, P50, DOI 10.1037/0003-066X.61.1.50; Feldman DB, 2007, J SOC CLIN PSYCHOL, V26, P137, DOI 10.1521/jscp.2007.26.2.137; Gawronski B., HDB RES METHODS SOCI; Gawronski B, 2006, PSYCHOL BULL, V132, P692, DOI 10.1037/0033-2909.132.5.692; Greenwald A. G., 2009, ATTITUDES INSIGHTS N, P65; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Harre N., 2001, J MENT HEALTH, V10, P223, DOI DOI 10.1080/09638230123129; Higgins E.T., 1996, SOCIAL PSYCHOL HDB B, P133; Hinshaw S. P., 2007, MARK SHAME STIGMA ME; Jones E. E., 1984, SOCIAL STIGMA PSYCHO; Karabatsos G, 2001, J Appl Meas, V2, P389; Karpinski A, 2006, J PERS SOC PSYCHOL, V91, P16, DOI 10.1037/0022-3514.91.1.16; Kendler K.S., 2006, GENES ENV PSYCHOPATH, V1st ed.; King M, 2007, BRIT J PSYCHIAT, V190, P248, DOI 10.1192/bjp.bp.106.024638; Klauer KC, 2005, PERS SOC PSYCHOL B, V31, P208, DOI 10.1177/0146167204271416; Kvaale EP, 2013, SOC SCI MED, V96, P95, DOI 10.1016/j.socscimed.2013.07.017; Kvaale EP, 2013, CLIN PSYCHOL REV, V33, P782, DOI 10.1016/j.cpr.2013.06.002; Kyngdon A, 2011, BRIT J MATH STAT PSY, V64, P478, DOI 10.1348/2044-8317.002004; Lee AA, 2014, SOC PSYCH PSYCH EPID, V49, P781, DOI 10.1007/s00127-013-0764-1; Linacre JM, 2006, FACETS COMPUTER PROG; Linacre JM, 2010, FACET RASCH MODEL CO; LINACRE JM, 1989, MULTIFACET RASCH MEA; Linacre John M, 2002, J Appl Meas, V3, P486; Lincoln TM, 2008, SCHIZOPHRENIA BULL, V34, P984, DOI 10.1093/schbul/sbm131; Link BG, 2004, SCHIZOPHRENIA BULL, V30, P511, DOI 10.1093/oxfordjournals.schbul.a007098; LINK BG, 1987, AM J SOCIOL, V92, P1461, DOI 10.1086/228672; LUCE RD, 1964, J MATH PSYCHOL, V1, P1, DOI 10.1016/0022-2496(64)90015-X; Luty J, 2006, PSYCHIATR BULL, V30, P257, DOI 10.1192/pb.30.7.257; Mannarini S, 2013, TPM-TEST PSYCHOM MET, V20, P277, DOI 10.4473/TPM20.3.6; Mannarini S, 2014, SCAND J PSYCHOL, V55, P53, DOI 10.1111/sjop.12091; Mannarini S, 2013, COMMUNITY MENT HLT J, V49, P686, DOI 10.1007/s10597-012-9581-3; Mannarini S, 2013, J CLIN NURS, V22, P2404, DOI 10.1111/jocn.12264; Mannarini S, 2009, BEHAV RES METHODS, V41, P1029, DOI 10.3758/BRM.41.4.1029; Mehta S, 1997, J SOC CLIN PSYCHOL, V16, P405, DOI 10.1521/jscp.1997.16.4.405; Messner C, 2010, J MARKETING RES, V47, P374, DOI 10.1509/jmkr.47.2.374; Monteith LL, 2011, J SOC CLIN PSYCHOL, V30, P484, DOI 10.1521/jscp.2011.30.5.484; Myford Carol M, 2003, J Appl Meas, V4, P386; National Alliance for Mental Illness, 2008, UND SCHIZ REC WHAT Y; NATIONAL ALLIANCE ON MENTAL ILLNESS, 2009, MAJ DEPR FACT SHEET; Nosek BA, 2005, PERS SOC PSYCHOL B, V31, P166, DOI 10.1177/0146167204271418; Olsen LR, 2004, ACTA PSYCHIAT SCAND, V110, P225, DOI 10.1111/j.1600-0447.2004.00399.x; Penke L, 2006, EXP PSYCHOL, V53, P283, DOI 10.1027/1618-3169.53.4.283; Peris TS, 2008, J NERV MENT DIS, V196, P752, DOI 10.1097/NMD.0b013e3181879dfd; Prieto L, 2003, ACTA PSYCHIAT SCAND, V107, P24, DOI 10.1034/j.1600-0447.107.s416.6.x; Pryor JB, 2004, J PERS SOC PSYCHOL, V87, P436, DOI 10.1037/0022-3514.87.4.436; Ranger J, 2011, EDUC PSYCHOL MEAS, V71, P389, DOI 10.1177/0013164410382895; Rasch G., 1980, PROBABILISTIC MODELS; Read J, 2006, ACTA PSYCHIAT SCAND, V114, P303, DOI 10.1111/j.1600-0447.2006.00824.x; Reeder Glenn D, 2008, Mens Sana Monogr, V6, P175, DOI 10.4103/0973-1229.36546; Rothermund K, 2009, Q J EXP PSYCHOL, V62, P84, DOI 10.1080/17470210701822975; Rusch N, 2011, PSYCHIAT RES, V186, P34, DOI 10.1016/j.psychres.2010.08.024; Ruesch N, 2010, EUR ARCH PSY CLIN N, V260, P617, DOI 10.1007/s00406-010-0111-4; Rusch N, 2010, PSYCHIAT RES, V179, P328, DOI 10.1016/j.psychres.2009.09.010; Schomerus G, 2012, ACTA PSYCHIAT SCAND, V125, P440, DOI 10.1111/j.1600-0447.2012.01826.x; Sirey JA, 2001, AM J PSYCHIAT, V158, P479, DOI 10.1176/appi.ajp.158.3.479; Stier A, 2007, AUST PSYCHOL, V42, P106, DOI 10.1080/00050060701280599; Strack F, 2004, PERS SOC PSYCHOL REV, V8, P220, DOI 10.1207/s15327957pspr0803_1; Teachman BA, 2006, J SOC CLIN PSYCHOL, V25, P75, DOI 10.1521/jscp.2006.25.1.75; Teige-Mocigemba S., 2010, HDB IMPLICIT SOCIAL, P117; Weiner B., 1995, JUDGMENTS RESPONSIBI	74	21	21	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101911	10.1371/journal.pone.0101911	http://dx.doi.org/10.1371/journal.pone.0101911			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7WB	25000406	Green Submitted, Green Published, gold			2022-12-27	WOS:000338637300101
J	Du, WX; Gao, J; Wang, TT; Wang, JK				Du, Wenxin; Gao, Jing; Wang, Tingting; Wang, Jinke			Single-Nucleotide Mutation Matrix: A New Model for Predicting the NF-kappa B DNA Binding Sites	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; SPECIFICITIES; FABRICATION; MICROARRAYS; ALGORITHM; SEQUENCES; PROTEINS; PATTERNS; MOTIFS; P50	In this study, we established a single nucleotide mutation matrix (SNMM) model based on the relative binding affinities of NF-kappa B p50 homodimer to a wild-type binding site (GGGACTTTCC) and its all single-nucleotide mutants detected with the double-stranded DNA microarray. We evaluated this model by scoring different groups of 10-bp DNA sequences with this model and analyzing the correlations between the scores and the relative binding affinities detected with three wet experiments, including the electrophoresis mobility shift assay (EMSA), the protein-binding microarray (PBM) and the systematic evolution of ligands by exponential enrichment-sequencing (SELEX-Seq). The results revealed that the SNMM scores were strongly correlated with the detected binding affinities. We also scored the DNA sequences with other three models, including the principal coordinate (PC) model, the position weight matrix scoring algorithm (PWMSA) model and the Match model, and analyzed the correlations between the scores and the detected binding affinities. In comparison with these models, the SNMM model achieved reliable results. We finally determined 0.747 as the optimal threshold for predicting the NF-kappa B DNA-binding sites with the SNMM model. The SNMM model thus provides a new alternative model for scoring the relative binding affinities of NF-kappa B to the 10-bp DNA sequences and predicting the NF-kappa B DNA-binding sites.	[Du, Wenxin; Gao, Jing; Wang, Tingting; Wang, Jinke] Southeast Univ, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China	Southeast University - China	Wang, JK (corresponding author), Southeast Univ, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China.	wangjinke@seu.edu.cn	wang, tingting/AAK-2640-2020; Wang, Jinke/AAT-7832-2021		National Natural Science Foundation of China [61171030]; Technology Support Program of Jiangsu [BE2012741]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Technology Support Program of Jiangsu	This work was supported by the grants from the National Natural Science Foundation of China ( 61171030) and the Technology Support Program of Jiangsu (BE2012741). The authors declare no conflict of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltimore D, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000026; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chekmenev DS, 2005, NUCLEIC ACIDS RES, V33, pW432, DOI 10.1093/nar/gki441; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gu GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076109; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; Linnell J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh042; Marinescu VD, 2005, NUCLEIC ACIDS RES, V33, pD91, DOI 10.1093/nar/gki103; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; Nijnik A, 2003, NUCLEIC ACIDS RES, V31, P1497, DOI 10.1093/nar/gkg231; Pearson K, 1920, BIOMETRIKA, V13, P25, DOI 10.1093/biomet/13.1.25; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Sen R, 2006, IMMUNITY, V25, P871, DOI 10.1016/j.immuni.2006.12.003; Siggers T, 2012, NAT IMMUNOL, V13, P95, DOI 10.1038/ni.2151; Slattery M, 2011, CELL, V147, P1270, DOI 10.1016/j.cell.2011.10.053; STORMO GD, 1982, NUCLEIC ACIDS RES, V10, P2997, DOI 10.1093/nar/10.9.2997; Udalova IA, 2002, P NATL ACAD SCI USA, V99, P8167, DOI 10.1073/pnas.102674699; Veprintsev DB, 2008, NUCLEIC ACIDS RES, V36, P1589, DOI 10.1093/nar/gkm1040; Wang J, 2003, J BIOCHEM BIOPH METH, V55, P215, DOI 10.1016/S0165-022X(03)00048-4; Wang JK, 2003, MOLECULES, V8, P153, DOI 10.3390/80100153; Wang JK, 2003, ANAL BIOCHEM, V316, P192, DOI 10.1016/S0003-2697(03)00049-6; Weirauch MT, 2013, NAT BIOTECHNOL, V31, P126, DOI 10.1038/nbt.2486; Wong D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r70; Zhou F, 2014, ANAL BIOCHEM, V448, P105, DOI 10.1016/j.ab.2013.12.003; Zykovich A, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp802	32	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101490	10.1371/journal.pone.0101490	http://dx.doi.org/10.1371/journal.pone.0101490			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992458	Green Published, Green Submitted, gold			2022-12-27	WOS:000341253400078
J	Wang, C; Niu, LN; Wang, YJ; Jiao, K; Liu, Y; Zhou, W; Shen, LJ; Fang, M; Li, M; Zhang, X; Tay, FR; Chen, JH				Wang, Chen; Niu, Li-na; Wang, Ying-jie; Jiao, Kai; Liu, Yan; Zhou, Wei; Shen, Li-juan; Fang, Ming; Li, Meng; Zhang, Xiang; Tay, Franklin R.; Chen, Ji-hua			Bonding of Resin Cement to Zirconia with High Pressure Primer Coating	PLOS ONE			English	Article							FIXED DENTAL PROSTHESES; LUTING CEMENTS; SURFACE MODIFICATION; OXIDE CERAMICS; HEMA-FREE; STRENGTH; SOLVENT; MONOMER; SILANE; TEMPERATURE	Objectives: To investigate the effect of air-drying pressure during ceramic primer coating on zirconia/resin bonding and the surface characteristics of the primed zirconia. Methods: Two ceramic primers (Clearfil Ceramic Primer, CCP, Kuraray Medical Inc. and Z-Prime Plus, ZPP, Bisco Inc.) were applied on the surface of air-abraded zirconia (Katana zirconia, Noritake) and dried at 4 different air pressures (0.1-0.4 MPa). The primed zirconia ceramic specimens were bonded with a resin-based luting agent (SA Luting Cement, Kuraray). Micro-shear bond strengths of the bonded specimens were tested after 3 days of water storage or 5,000x thermocycling (n = 12). Failure modes of the fractured specimens were examined with scanning electron miscopy. The effects of air pressure on the thickness of the primer layers and the surface roughness (S-a) of primed zirconia were evaluated using spectroscopic ellipsometry (n = 6), optical profilometry and environmental scanning electron microscopy (ESEM) (n = 6), respectively. Results: Clearfil Ceramic Primer air-dried at 0.3 and 0.4 MPa, yielding significantly higher mu SBS than gentle air-drying subgroups (p < 0.05). Compared to vigorous drying conditions, Z-Prime Plus air-dried at 0.2 MPa exhibited significantly higher mSBS (p < 0.05). Increasing air-drying pressure reduced the film thickness for both primers. Profilometry measurements and ESEM showed rougher surfaces in the high pressure subgroups of CCP and intermediate pressure subgroup of ZPP. Conclusion: Air-drying pressure influences resin/zirconia bond strength and durability significantly. Higher air-drying pressure (0.3-0.4 MPa) for CCP and intermediate pressure (0.2 MPa) for ZPP are recommended to produce strong, durable bonds between resin cement and zirconia ceramics.	[Wang, Chen; Niu, Li-na; Liu, Yan; Zhou, Wei; Shen, Li-juan; Fang, Ming; Li, Meng; Zhang, Xiang; Chen, Ji-hua] Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, State Key Lab Mil Stomatol, Xian 710032, Peoples R China; [Wang, Ying-jie] Fourth Mil Med Univ, Sch Stomatol, Dept Gen & Emergency, State Key Lab Mil Stomatol, Xian 710032, Peoples R China; [Jiao, Kai] Fourth Mil Med Univ, Sch Stomatol, Dept Oral Anat & Physiol, State Key Lab Mil Stomatol, Xian 710032, Peoples R China; [Tay, Franklin R.] Georgia Regents Univ, Coll Dent Med, Dept Endodont, Augusta, GA 30912 USA	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; University System of Georgia; Augusta University	Tay, FR (corresponding author), Georgia Regents Univ, Coll Dent Med, Dept Endodont, Augusta, GA 30912 USA.	tayfranklin7@gmail.com; jhchen@fmmu.edu.cn	meng, li/GVT-2063-2022; niu, lina/GWR-3585-2022	Chen, Ji-hua/0000-0002-1151-0693; jiao, kai/0000-0002-1901-8329; Tay, Franklin/0000-0003-3769-0626	Program for Changjiang Scholars and Innovative Research Team in University [IRT13051]; Major Program of National Natural Science Foundation of China [81130078]; early stage of State Key Development Program of Basic Research Program of China [2012CB526704]; young investigator supporting grant of China [13QNP138]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Major Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); early stage of State Key Development Program of Basic Research Program of China; young investigator supporting grant of China	This study was financially supported by Supported by Program for Changjiang Scholars and Innovative Research Team in University (No. IRT13051), the Major Program of National Natural Science Foundation of China (No. 81130078), the early stage of State Key Development Program of Basic Research Program of China (No. 2012CB526704) and young investigator supporting grant of China (No. 13QNP138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Tara M, 2011, J DENT, V39, P208, DOI 10.1016/j.jdent.2010.12.005; Aboushelib MN, 2011, J ADHES DENT, V13, P255, DOI 10.3290/j.jad.a19241; Aboushellib MN, 2007, J PROSTHET DENT, V98, P379, DOI 10.1016/S0022-3913(07)60123-1; Atsu SS, 2006, J PROSTHET DENT, V95, P430, DOI 10.1016/j.prosdent.2006.03.016; Attia A, 2011, J PROSTHET DENT, V106, P319, DOI 10.1016/S0022-3913(11)60137-6; Bail M, 2012, J MATER SCI-MATER M, V23, P629, DOI 10.1007/s10856-011-4541-y; Carriere D, 2004, LANGMUIR, V20, P3449, DOI 10.1021/la036249m; Queiroz JRC, 2012, DENT MATER, V28, P189, DOI 10.1016/j.dental.2011.10.009; Chen CF, 2012, DENT MATER, V28, pE127, DOI 10.1016/j.dental.2012.04.020; Chen L, 2013, J PROSTHET DENT, V110, P402, DOI 10.1016/j.prosdent.2013.04.005; Chen L, 2012, AM J DENT, V25, P103; Felizardo Klíssia Romero, 2011, Braz. Dent. J., V22, P468, DOI 10.1590/S0103-64402011000600005; Hiraishi N, 2007, DENT MATER, V23, P498, DOI 10.1016/j.dental.2006.03.007; Ikeda T, 2008, DENT MATER, V24, P1316, DOI 10.1016/j.dental.2008.02.009; Inokoshi M, 2013, J DENT, V41, P170, DOI 10.1016/j.jdent.2012.10.017; Kern M, 1998, DENT MATER, V14, P64, DOI 10.1016/S0109-5641(98)00011-6; Kern M, 2009, J DENT RES, V88, P817, DOI 10.1177/0022034509340881; Kern M, 2009, J ADHES SCI TECHNOL, V23, P1097, DOI 10.1163/156856109X432721; Kim MJ, 2011, J DENT, V39, P795, DOI 10.1016/j.jdent.2011.08.012; Kitayama S, 2010, DENT MATER, V26, P426, DOI 10.1016/j.dental.2009.11.159; Kumbuloglu O, 2006, OPER DENT, V31, P248, DOI 10.2341/05-22; Gomes AL, 2013, J DENT, V41, P31, DOI 10.1016/j.jdent.2012.09.013; Luthy H, 2006, DENT MATER, V22, P195, DOI 10.1016/j.dental.2005.04.016; Magne P, 2010, DENT MATER, V26, P345, DOI 10.1016/j.dental.2009.12.005; Monticelli F, 2006, DENT MATER, V22, P1024, DOI 10.1016/j.dental.2005.11.024; Ozcan M, 2004, DENT MATER, V20, P586, DOI 10.1016/j.dental.2003.10.003; Papacchini F, 2007, J ADHES DENT, V9, P391; Papia E, 2014, J BIOMED MATER RES B, V102, P395, DOI 10.1002/jbm.b.33013; Perdigao J, 2013, OPER DENT, V38, P168, DOI 10.2341/11-489-L; Piascik JR, 2009, DENT MATER, V25, P1116, DOI 10.1016/j.dental.2009.03.008; Piascik JR, 2012, DENT MATER, V28, P604, DOI 10.1016/j.dental.2012.01.008; Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6; Sasse M, 2013, INT J COMPUT DENT, V16, P109; Spohr AM, 2008, PHOTOMED LASER SURG, V26, P203, DOI 10.1089/pho.2007.2130; Tanaka R, 2008, J DENT RES, V87, P666, DOI 10.1177/154405910808700705; Thompson JY, 2011, DENT MATER, V27, P71, DOI 10.1016/j.dental.2010.10.022; Van Landuyt KL, 2005, J DENT RES, V84, P183, DOI 10.1177/154405910508400214; Wolfart M, 2007, DENT MATER, V23, P45, DOI 10.1016/j.dental.2005.11.040; Yang B, 2010, DENT MATER, V26, P44, DOI 10.1016/j.dental.2009.08.008; Yiu CKY, 2005, BIOMATERIALS, V26, P6863, DOI 10.1016/j.biomaterials.2005.05.011; Yoshida K, 2006, J BIOMED MATER RES B, V77B, P28, DOI 10.1002/jbm.b.30424; Zandparsa R, 2014, J PROSTHODONT, V23, P117, DOI 10.1111/jopr.12075	42	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101174	10.1371/journal.pone.0101174	http://dx.doi.org/10.1371/journal.pone.0101174			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992678	Green Published, Green Submitted, gold			2022-12-27	WOS:000341253400048
J	Fens, MH; Larkin, SK; Oronsky, B; Scicinski, J; Morris, CR; Kuypers, FA				Fens, Marcel H.; Larkin, Sandra K.; Oronsky, Bryan; Scicinski, Jan; Morris, Claudia R.; Kuypers, Frans A.			The Capacity of Red Blood Cells to Reduce Nitrite Determines Nitric Oxide Generation under Hypoxic Conditions	PLOS ONE			English	Article							PULMONARY-HYPERTENSION; S-NITROSOHEMOGLOBIN; FLOW REGULATION; RELAXING FACTOR; HEMOGLOBIN; DISEASE; SYNTHASE; NO; MECHANISMS; RELEASE	Nitric oxide (NO) is a key regulator of vascular tone. Endothelial nitric oxide synthase (eNOS) is responsible for NO generation under normoxic conditions. Under hypoxia however, eNOS is inactive and red blood cells (RBC) provide an alternative NO generation pathway from nitrite to regulate hypoxic vasodilation. While nitrite reductase activity of hemoglobin is well acknowledged, little is known about generation of NO by intact RBC with physiological hemoglobin concentrations. We aimed to develop and apply a new approach to provide insights in the ability of RBC to convert nitrite into NO under hypoxic conditions. We established a novel experimental setup to evaluate nitrite uptake and the release of NO from RBC into the gas-phase under different conditions. NO measurements were similar to well-established clinical measurements of exhaled NO. Nitrite uptake was rapid, and after an initial lag phase NO release from RBC was constant in time under hypoxic conditions. The presence of oxygen greatly reduced NO release, whereas inhibition of eNOS and xanthine oxidoreductase (XOR) did not affect NO release. A decreased pH increased NO release under hypoxic conditions. Hypothermia lowered NO release, while hyperthermia increased NO release. Whereas fetal hemoglobin did not alter NO release compared to adult hemoglobin, sickle RBC showed an increased ability to release NO. Under all conditions nitrite uptake by RBC was similar. This study shows that nitrite uptake into RBC is rapid and release of NO into the gas-phase continues for prolonged periods of time under hypoxic conditions. Changes in the RBC environment such as pH, temperature or hemoglobin type, affect NO release.	[Fens, Marcel H.; Larkin, Sandra K.; Kuypers, Frans A.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Oronsky, Bryan; Scicinski, Jan] RadioRx Inc, Mountain View, CA USA; [Morris, Claudia R.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Emory University	Kuypers, FA (corresponding author), Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA.	fkuypers@chori.org		Scicinski, Jan/0000-0002-1063-7705	Netherlands Organisation for Scientific Research, The Hague, The Netherlands	Netherlands Organisation for Scientific Research, The Hague, The Netherlands(Netherlands Organization for Scientific Research (NWO)Netherlands Government)	MHF is supported by the Netherlands Organisation for Scientific Research, The Hague, The Netherlands. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelo M, 2006, P NATL ACAD SCI USA, V103, P8366, DOI 10.1073/pnas.0600942103; ARMSTRONG DH, 1963, BLOOD, V22, P554, DOI 10.1182/blood.V22.5.554.554; Cabrales P, 2011, AM J PHYSIOL-HEART C, V300, pH49, DOI 10.1152/ajpheart.00665.2010; Cantu-Medellin N, 2011, NITRIC OXIDE-BIOL CH, V25, P59, DOI 10.1016/j.niox.2011.01.006; Cooke JP, 1997, ANNU REV MED, V48, P489, DOI 10.1146/annurev.med.48.1.489; Cortese-Krott MM, 2012, BLOOD, V120, P4229, DOI 10.1182/blood-2012-07-442277; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Crawford JH, 2006, BLOOD, V107, P566, DOI 10.1182/blood-2005-07-2668; Deem S, 2007, AM J PHYSIOL-HEART C, V292, pH963, DOI 10.1152/ajpheart.00812.2006; Dejam A, 2007, CIRCULATION, V116, P1821, DOI 10.1161/CIRCULATIONAHA.107.712133; DeNicola LR, 2000, PEDIATR EMERG CARE, V16, P290, DOI 10.1097/00006565-200008000-00021; Fish JE, 2010, J BIOL CHEM, V285, P810, DOI 10.1074/jbc.M109.067868; Girgis RE, 2003, AM J HEMATOL, V72, P177, DOI 10.1002/ajh.10284; Gladwin MT, 2008, BLOOD, V112, P2636, DOI 10.1182/blood-2008-01-115261; Gladwin MT, 2006, AM J PHYSIOL-HEART C, V291, pH2026, DOI 10.1152/ajpheart.00407.2006; Gladwin MT, 2009, ACCOUNTS CHEM RES, V42, P157, DOI 10.1021/ar800089j; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Grubina R, 2008, J BIOL CHEM, V283, P3628, DOI 10.1074/jbc.M705222200; Grubina R, 2007, J BIOL CHEM, V282, P12916, DOI 10.1074/jbc.M700546200; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; Jensen FB, 2005, ACTA PHYSIOL SCAND, V184, P243, DOI 10.1111/j.1365-201X.2005.01448.x; Jensen FB, 2010, AM J PHYSIOL-REG I, V298, pR972, DOI 10.1152/ajpregu.00813.2009; Kleinbongard P, 2006, BLOOD, V107, P2943, DOI 10.1182/blood-2005-10-3992; LEVINE RL, 1993, FASEB J, V7, P1242, DOI 10.1096/fasebj.7.13.8405809; Li HT, 2008, J BIOL CHEM, V283, P17855, DOI 10.1074/jbc.M801785200; Lundberg JO, 2004, FREE RADICAL BIO MED, V37, P395, DOI 10.1016/j.freeradbiomed.2004.04.027; Machado RF, 2007, BRIT J HAEMATOL, V136, P319, DOI 10.1111/j.1365-2141.2006.06417.x; Mack AK, 2008, BRIT J HAEMATOL, V142, P971, DOI 10.1111/j.1365-2141.2008.07259.x; McMahon TJ, 2002, NAT MED, V8, P711, DOI 10.1038/nm718; MCQUILLAN LP, 1994, AM J PHYSIOL-HEART C, V267, pH1921; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; Morris CR, 2005, JAMA-J AM MED ASSOC, V294, P81, DOI 10.1001/jama.294.1.81; Morris CR, 2004, AM J RESP CRIT CARE, V170, P148, DOI 10.1164/rccm.200309-1304OC; Morris CR, 2003, J PEDIAT HEMATOL ONC, V25, P629, DOI 10.1097/00043426-200308000-00008; Noritomi DT, 2009, CRIT CARE MED, V37, P2733, DOI 10.1097/CCM.0b013e3181a59165; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Park JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055699; Radhakrishnan DK, 2012, J PEDIATR-US, V160, P93, DOI 10.1016/j.jpeds.2011.06.048; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Ritkind JM, 2007, NITRIC OXIDE-BIOL CH, V16, P448, DOI 10.1016/j.niox.2007.04.002; Roche CJ, 2011, J BIOL CHEM, V286, P23452, DOI 10.1074/jbc.M110.183186; Shiva S, 2006, NAT CHEM BIOL, V2, P486, DOI 10.1038/nchembio813; Silkoff PE, 1999, CHEST, V116, P754, DOI 10.1378/chest.116.3.754; Singel DJ, 2005, ANNU REV PHYSIOL, V67, P99, DOI 10.1146/annurev.physiol.67.060603.090918; Stamler JS, 1997, SCIENCE, V276, P2034, DOI 10.1126/science.276.5321.2034; Sullivan KJ, 2010, J PEDIAT HEMATOL ONC, V32, pE249, DOI 10.1097/MPH.0b013e3181ec0ae5; Thomas DD, 2002, METHOD ENZYMOL, V359, P84; Velmurugan S, 2013, FREE RADICAL BIO MED, V65, P1521, DOI 10.1016/j.freeradbiomed.2013.06.031; Vitturi DA, 2009, AM J PHYSIOL-HEART C, V296, pH1398, DOI 10.1152/ajpheart.01303.2008; Webb A, 2004, P NATL ACAD SCI USA, V101, P13683, DOI 10.1073/pnas.0402927101; Webb AJ, 2008, CIRC RES, V103, P957, DOI 10.1161/CIRCRESAHA.108.175810; Zhurova M., 2012, J BLOOD TRANSFUSION, V2012, P1, DOI [10.1155/2012/102809, DOI 10.1155/2012/102809]	53	21	23	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101626	10.1371/journal.pone.0101626	http://dx.doi.org/10.1371/journal.pone.0101626			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007272	Green Published, Green Submitted, gold			2022-12-27	WOS:000339040600051
J	Kao, LT; Xirasagar, S; Chung, KH; Lin, HC; Liu, SP; Chung, SD				Kao, Li-Ting; Xirasagar, Sudha; Chung, Kuo-Hsuan; Lin, Herng-Ching; Liu, Shih-Ping; Chung, Shiu-Dong			Weekly and Holiday-Related Patterns of Panic Attacks in Panic Disorder: A Population-Based Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; NATIONAL COMORBIDITY SURVEY; OCCUPATIONAL-THERAPY; ANXIETY SENSITIVITY; MYOCARDIAL-INFARCTION; SEASONAL-VARIATION; PHYSICAL-ACTIVITY; LEISURE-TIME; DEPRESSION; STRESS	Background: While chronobiological studies have reported seasonal variation in panic attacks (PA) episodes, information on the timing of PA by week-days may enable better understanding of the triggers of PA episodes and thereby provide pointers for suitable interventional approaches to minimize PA attacks. This study investigated weekly variation in potential PA admissions including associations with holidays using a population-based longitudinal, administrative claims-based dataset in an Asian population. Methods:This study used ambulatory care data from the "Longitudinal Health Insurance Database 2000. We identified 993 patients with panic disorder (PD), and they had 4228 emergency room (ER) admissions for potential PA in a 3-year period between 1 January 2009 and 31 December 2011. One-way analysis of variance (ANOVA) was used to examine associations between the potential PA admissions and holidays/weekend days/work-days of the week Results: The daily mean number of potential PA admissions was 3.96 (standard deviation 2.05). One-way ANOVA showed significant differences in potential PA admissions by holiday and day of the week (p<0.001). Daily frequencies showed a trough on Wednesday-Thursday, followed by a sharp increase on Saturday and a peak on Sunday. Potential PA admissions were higher than the daily mean for the sample patients by 29.4% and 22.1%, respectively on Sundays and holidays. Furthermore, the weekly variations were similar for females and males, although females always had higher potential PA admissions on both weekdays and holidays than the males. Conclusions: We found that potential PA admissions among persons with PD varied systematically by day of the week, with a significant peak on weekends and holidays.	[Kao, Li-Ting] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Kao, Li-Ting; Lin, Herng-Ching; Chung, Shiu-Dong] Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan; [Xirasagar, Sudha] Univ S Carolina, Dept Hlth Serv Policy & Management, Arnold Sch Publ Hlth, Columbia, SC 29208 USA; [Chung, Kuo-Hsuan] Taipei Med Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Chung, Kuo-Hsuan] Taipei Med Univ, Sch Med, Dept Psychiat, Taipei, Taiwan; [Lin, Herng-Ching] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan; [Liu, Shih-Ping] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan; [Liu, Shih-Ping] Coll Med, Taipei, Taiwan; [Chung, Shiu-Dong] Far Eastern Mem Hosp, Dept Surg, Div Urol, Taipei, Taiwan; [Chung, Shiu-Dong] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan	National Defense Medical Center; Taipei Medical University; Taipei Medical University Hospital; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; National Taiwan University; National Taiwan University Hospital; Far Eastern Memorial Hospital; Fu Jen Catholic University	Chung, SD (corresponding author), Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan.	chungshiudong@gmail.com	Xirasagar, Sudha/AAA-2350-2022; Kao, Li-Ting/W-9287-2018	Kao, Li-Ting/0000-0003-0692-7408; Chung, Kuo-Hsuan/0000-0002-5570-3972; LIU, SHIH-PING/0000-0002-8015-0695				APA, 2000, DIAGN STAT MAN MENT; Arntz HR, 2000, EUR HEART J, V21, P315, DOI 10.1053/euhj.1999.1739; Breslau N, 1999, ARCH GEN PSYCHIAT, V56, P1141, DOI 10.1001/archpsyc.56.12.1141; Bulbena A, 2005, INT J BIOMETEOROL, V49, P238, DOI 10.1007/s00484-004-0236-0; Coley KC, 2009, J EMERG MED, V36, P3, DOI 10.1016/j.jemermed.2007.06.002; Cook S, 2009, CLIN REHABIL, V23, P40, DOI 10.1177/0269215508098898; COWLEY DS, 1992, AM J MED, V92, pS41, DOI 10.1016/0002-9343(92)90136-Y; Craske MG, 2010, DEPRESS ANXIETY, V27, P93, DOI 10.1002/da.20654; de Lima C, 2013, EPILEPSY BEHAV, V28, P47, DOI 10.1016/j.yebeh.2013.03.016; Deacon B, 2008, J ANXIETY DISORD, V22, P344, DOI 10.1016/j.janxdis.2007.03.004; Foruzandeh N, 2013, JPN J NURS SCI, V10, P136, DOI 10.1111/j.1742-7924.2012.00211.x; Herlitz J, 2002, RESUSCITATION, V54, P133, DOI 10.1016/S0300-9572(02)00097-7; Kaiya H, 2005, PSYCHIAT CLIN NEUROS, V59, P177, DOI 10.1111/j.1440-1819.2005.01354.x; Kessler RC, 2006, ARCH GEN PSYCHIAT, V63, P415, DOI 10.1001/archpsyc.63.4.415; Kohn M, 2012, AUST OCCUP THER J, V59, P437, DOI 10.1111/1440-1630.12005; Kremer P, 2014, J SCI MED SPORT, V17, P183, DOI 10.1016/j.jsams.2013.03.012; Kushner MG, 2000, CLIN PSYCHOL REV, V20, P149, DOI 10.1016/S0272-7358(99)00027-6; Manfredini R, 2001, AM J MED, V111, P401, DOI 10.1016/S0002-9343(01)00836-1; Manfredini R, 2009, AM J EMERG MED, V27, P1097, DOI 10.1016/j.ajem.2008.08.009; MARRIOTT PF, 1994, J AFFECT DISORDERS, V31, P75, DOI 10.1016/0165-0327(94)90110-4; McNally RJ, 2002, BIOL PSYCHIAT, V52, P938, DOI 10.1016/S0006-3223(02)01475-0; Melchior M, 2007, PSYCHOL MED, V37, P1119, DOI 10.1017/S0033291707000414; Ohtani T, 2006, PSYCHIAT CLIN NEUROS, V60, P379, DOI 10.1111/j.1440-1819.2006.01517.x; Roy-Byrne PP, 2006, LANCET, V368, P1023, DOI 10.1016/S0140-6736(06)69418-X; Schmidt NB, 1997, J ABNORM PSYCHOL, V106, P355, DOI 10.1037/0021-843X.106.3.355; Schmidt NB, 2006, J PSYCHIATR RES, V40, P691, DOI 10.1016/j.jpsychires.2006.07.009; Schmidt NB, 2010, ANNU REV CLIN PSYCHO, V6, P241, DOI 10.1146/annurev.clinpsy.121208.131317; Sheikh JI, 2002, AM J PSYCHIAT, V159, P55, DOI 10.1176/appi.ajp.159.1.55; Sieri S, 2002, PUBLIC HEALTH NUTR, V5, P1287, DOI 10.1079/PHN2002405; Tuomisto MT, 2006, PHYSIOL BEHAV, V87, P650, DOI 10.1016/j.physbeh.2005.12.012; Wang HB, 2002, INT J BIOMETEOROL, V47, P13, DOI 10.1007/s00484-002-0147-x; WILLICH SN, 1994, CIRCULATION, V90, P87, DOI 10.1161/01.CIR.90.1.87; Zuccato E, 2008, ENVIRON HEALTH PERSP, V116, P1027, DOI 10.1289/ehp.11022	33	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e100913	10.1371/journal.pone.0100913	http://dx.doi.org/10.1371/journal.pone.0100913			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL3PK	25006664	Green Published, gold, Green Submitted			2022-12-27	WOS:000339040600025
J	Ekram, MB; Kim, J				Ekram, Muhammad B.; Kim, Joomyeong			High-Throughput Targeted Repeat Element Bisulfite Sequencing (HT-TREBS): Genome-Wide DNA Methylation Analysis of IAP LTR Retrotransposon	PLOS ONE			English	Article							L1 RETROTRANSPOSITION; CYTOSINE METHYLATION; CELLS; MOUSE; MAPS; METHYLTRANSFERASE; TRANSCRIPTION; PLURIPOTENT; MAINTENANCE; DIVERSITY	In vertebrates, DNA methylation-mediated repression of retrotransposons is essential for the maintenance of genomic integrity. In the current study, we developed a technique termed HT-TREBS (High-Throughput Targeted Repeat Element Bisulfite Sequencing). This technique is designed to measure the DNA methylation levels of individual loci of any repeat families with next-generation sequencing approaches. To test the feasibility of HT-TREBS, we analyzed the DNA methylation levels of the IAP LTR family using a set of 12 different genomic DNA isolated from the brain, liver and kidney of 4 one-week-old littermates of the mouse strain C57BL/6N. This technique has successfully generated the CpG methylation data of 5,233 loci common in all the samples, representing more than 80% of the individual loci of the five targeted subtypes of the IAP LTR family. According to the results, approximately 5% of the IAP LTR loci have less than 80% CpG methylation levels with no genomic position preference. Further analyses of the IAP LTR loci also revealed the presence of extensive DNA methylation variations between different tissues and individuals. Overall, these data demonstrate the efficiency and robustness of the new technique, HT-TREBS, and also provide new insights regarding the genome-wide DNA methylation patterns of the IAP LTR repeat elements.	[Ekram, Muhammad B.; Kim, Joomyeong] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Kim, J (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jkim@lsu.edu			National Institute of Health [R01-GM066225, R15-ES019118]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R15ES019118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066225] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of Health [R01-GM066225, R15-ES019118]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba Y, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-125; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dolinoy DC, 2007, REPROD TOXICOL, V23, P297, DOI 10.1016/j.reprotox.2006.08.012; Druker R, 2004, NUCLEIC ACIDS RES, V32, P5800, DOI 10.1093/nar/gkh914; Ekram MB, 2012, EPIGENETICS-US, V7, P370, DOI 10.4161/epi.19462; Gaudet F, 2004, MOL CELL BIOL, V24, P1640, DOI 10.1128/MCB.24.4.1640-1648.2004; Hedges DJ, 2007, MUTAT RES-FUND MOL M, V616, P46, DOI 10.1016/j.mrfmmm.2006.11.021; Howard G, 2008, ONCOGENE, V27, P404, DOI 10.1038/sj.onc.1210631; Huang JM, 2009, GENE, V442, P18, DOI 10.1016/j.gene.2009.04.016; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Jurka J, 2007, ANNU REV GENOM HUM G, V8, P241, DOI 10.1146/annurev.genom.8.080706.092416; Kazazian HH, 1998, NAT GENET, V19, P19, DOI 10.1038/ng0598-19; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lees-Murdock DJ, 2008, EPIGENETICS-US, V3, P5, DOI 10.4161/epi.3.1.5553; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lutsik P, 2011, NUCLEIC ACIDS RES, V39, pW551, DOI 10.1093/nar/gkr312; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Rakyan VK, 2002, TRENDS GENET, V18, P348, DOI 10.1016/S0168-9525(02)02709-9; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; SCHMID CW, 1975, CELL, V6, P345, DOI 10.1016/0092-8674(75)90184-1; Ting DT, 2011, SCIENCE, V331, P593, DOI 10.1126/science.1200801; Vilkaitis G, 2005, J BIOL CHEM, V280, P64, DOI 10.1074/jbc.M411126200; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Whitelaw NC, 2006, HUM MOL GENET, V15, pR131, DOI 10.1093/hmg/ddl200; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Zhang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000007	37	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101683	10.1371/journal.pone.0101683	http://dx.doi.org/10.1371/journal.pone.0101683			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003790	gold, Green Published, Green Submitted			2022-12-27	WOS:000339242700053
J	Odagiri, F; Inoue, H; Sugihara, M; Suzuki, T; Murayama, T; Shioya, T; Konishi, M; Nakazato, Y; Daida, H; Sakurai, T; Morimoto, S; Kurebayashi, N				Odagiri, Fuminori; Inoue, Hana; Sugihara, Masami; Suzuki, Takeshi; Murayama, Takashi; Shioya, Takao; Konishi, Masato; Nakazato, Yuji; Daida, Hiroyuki; Sakurai, Takashi; Morimoto, Sachio; Kurebayashi, Nagomi			Effects of Candesartan on Electrical Remodeling in the Hearts of Inherited Dilated Cardiomyopathy Model Mice	PLOS ONE			English	Article							RECEPTOR BLOCKER; K+ CURRENTS; ANGIOTENSIN; FAILURE; EXPRESSION; INFARCTION; LOSARTAN; SYSTEM	Inherited dilated cardiomyopathy (DCM) is characterized by dilatation and dysfunction of the ventricles, and often results in sudden death or heart failure (HF). Although angiotensin receptor blockers (ARBs) have been used for the treatment of HF, little is known about the effects on postulated electrical remodeling that occurs in inherited DCM. The aim of this study was to examine the effects of candesartan, one of the ARBs, on cardiac function and electrical remodeling in the hearts of inherited DCM model mice (TNNT2 Delta K210). DCM mice were treated with candesartan in drinking water for 2 months from 1 month of age. Control, non-treated DCM mice showed an enlargement of the heart with prolongation of QRS and QT intervals, and died at t(1/2) of 70 days. Candesartan dramatically extended the lifespan of DCM mice, suppressed cardiac dilatation, and improved the functional parameters of the myocardium. It also greatly suppressed prolongation of QRS and QT intervals and action potential duration (APD) in the left ventricular myocardium and occurrence of ventricular arrhythmia. Expression analysis revealed that down-regulation of Kv4.2 (I-to channel protein), KChIP2 (auxiliary subunit of Kv4.2), and Kv1.5 (I-Kur channel protein) in DCM was partially reversed by candesartan administration. Interestingly, non-treated DCM heart had both normal-sized myocytes with moderately decreased I-to and I-Kur and enlarged cells with greatly reduced K+ currents (I-to, I-Kur I-K1 and I-ss). Treatment with candesartan completely abrogated the emergence of the enlarged cells but did not reverse the Ito, and IKur in normal-sized cells in DCM hearts. Our results indicate that candesartan treatment suppresses structural remodeling to prevent severe electrical remodeling in inherited DCM.	[Odagiri, Fuminori; Sugihara, Masami; Suzuki, Takeshi; Murayama, Takashi; Sakurai, Takashi; Kurebayashi, Nagomi] Juntendo Univ, Grad Sch Med, Dept Cellular & Mol Pharmacol, Tokyo, Japan; [Odagiri, Fuminori; Sugihara, Masami; Suzuki, Takeshi; Nakazato, Yuji; Daida, Hiroyuki] Juntendo Univ, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; [Inoue, Hana; Konishi, Masato] Tokyo Med Univ, Dept Physiol, Tokyo 1608402, Japan; [Shioya, Takao] Saga Univ, Fac Med, Dept Physiol, Saga 840, Japan; [Morimoto, Sachio] Kyushu Univ, Grad Sch Med Sci, Dept Clin Pharmacol, Fukuoka 812, Japan	Juntendo University; Juntendo University; Tokyo Medical University; Saga University; Kyushu University	Kurebayashi, N (corresponding author), Juntendo Univ, Grad Sch Med, Dept Cellular & Mol Pharmacol, Tokyo, Japan.	nagomik@juntendo.ac.jp	Inoue, Hana/AFN-8856-2022	Inoue, Hana/0000-0002-2278-5617; Morimoto, Sachio/0000-0001-9171-3636	Ministry of Education, Culture, Sports, Science and Technology (MEXT) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Vehicle Racing Commemorative Foundation; Institute of Seizon and Life Sciences;  [23136514];  [S1311011]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) from the Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Vehicle Racing Commemorative Foundation; Institute of Seizon and Life Sciences; ; 	This study was supported by a Grant-in Aid (23136514, S1311011) and the Ministry of Education, Culture, Sports, Science and Technology (MEXT)-supported Program for the Strategic Research Foundation at Private Universities (2011-2015) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors also thank the Vehicle Racing Commemorative Foundation (http://www.vecof.or.jp/index.html) and the Institute of Seizon and Life Sciences (http://seizon.umin.jp/) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arozal W, 2010, FREE RADICAL RES, V44, P1369, DOI 10.3109/10715762.2010.509399; Brouillette J, 2004, J PHYSIOL-LONDON, V559, P777, DOI 10.1113/jphysiol.2004.063446; Bru-Mercier G, 2003, J MOL CELL CARDIOL, V35, P153, DOI 10.1016/S0022-2828(02)00290-0; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; DEC GW, 1994, NEW ENGL J MED, V331, P1564, DOI 10.1056/NEJM199412083312307; Du CK, 2007, CIRC RES, V101, P185, DOI 10.1161/CIRCRESAHA.106.146670; GOLDBERG MR, 1995, HYPERTENSION, V25, P37, DOI 10.1161/01.HYP.25.1.37; Hongo K, 2009, J PHYSIOL SCI, V59, P24; Inada Y, 1997, CLIN EXP HYPERTENS, V19, P1079, DOI 10.3109/10641969709083206; Janse MJ, 2004, CARDIOVASC RES, V61, P208, DOI 10.1016/j.cardiores.2003.11.018; KASPER EK, 1994, J AM COLL CARDIOL, V23, P586, DOI 10.1016/0735-1097(94)90740-4; Mitchell GF, 1998, AM J PHYSIOL-HEART C, V274, pH747, DOI 10.1152/ajpheart.1998.274.3.H747; Morimoto S, 2009, CIRC RES, V105, P313, DOI 10.1161/CIRCRESAHA.109.204180; Nattel S, 2007, PHYSIOL REV, V87, P425, DOI 10.1152/physrev.00014.2006; Nieminen T, 2010, ANN NONINVAS ELECTRO, V15, P276, DOI 10.1111/j.1542-474X.2010.00376.x; Nishizawa H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007069; Otten E, 2010, NETH HEART J, V18, P478, DOI 10.1007/BF03091819; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; Pourdjabbar A, 2005, AM J PHYSIOL-HEART C, V288, pH1997, DOI 10.1152/ajpheart.00671.2004; Qin M, 2012, J MOL CELL CARDIOL, V53, P880, DOI 10.1016/j.yjmcc.2012.10.003; Rivard K, 2008, CARDIOVASC RES, V78, P53, DOI 10.1093/cvr/cvn020; Rosati B, 2004, CIRC RES, V94, P874, DOI 10.1161/01.RES.0000124921.81025.1F; Shimoni Y, 2003, AM J PHYSIOL-HEART C, V284, pH1168, DOI 10.1152/ajpheart.00748.2002; Shioya T, 2007, J PHYSIOL SCI, V57, P327, DOI 10.2170/physiolsci.RP010107; Sugihara M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055514, 10.1371/journal.pone.0061483]; Suzuki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035353; TAKIMOTO K, 1994, CIRC RES, V75, P1006, DOI 10.1161/01.RES.75.6.1006; Thuringer D, 1996, CARDIOVASC RES, V31, P747, DOI 10.1016/0008-6363(96)00018-1; Wang YY, 2010, CARDIOVASC RES, V87, P636, DOI 10.1093/cvr/cvq133; Yu HG, 1999, CIRCULATION, V99, P1898, DOI 10.1161/01.CIR.99.14.1898; Yue LX, 2011, CARDIOVASC RES, V89, P744, DOI 10.1093/cvr/cvq329	31	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101838	10.1371/journal.pone.0101838	http://dx.doi.org/10.1371/journal.pone.0101838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000405	gold, Green Published, Green Submitted			2022-12-27	WOS:000338637300093
J	Dassa, B; Borovok, I; Ruimy-Israeli, V; Lamed, R; Flint, HJ; Duncan, SH; Henrissat, B; Coutinho, P; Morrison, M; Mosoni, P; Yeoman, CJ; White, BA; Bayer, EA				Dassa, Bareket; Borovok, Ilya; Ruimy-Israeli, Vered; Lamed, Raphael; Flint, Harry J.; Duncan, Sylvia H.; Henrissat, Bernard; Coutinho, Pedro; Morrison, Mark; Mosoni, Pascale; Yeoman, Carl J.; White, Bryan A.; Bayer, Edward A.			Rumen Cellulosomics: Divergent Fiber-Degrading Strategies Revealed by Comparative Genome-Wide Analysis of Six Ruminococcal Strains	PLOS ONE			English	Article							CARBOHYDRATE-BINDING MODULES; ADHESION-DEFECTIVE MUTANT; CLOSTRIDIUM-THERMOCELLUM; CELL-SURFACE; ENDOGLUCANASE CELD; DUPLICATED SEGMENT; BACTERIAL ADHESION; GENE-CLUSTER; ALBUS SY3; FLAVEFACIENS	Background: A complex community of microorganisms is responsible for efficient plant cell wall digestion by many herbivores, notably the ruminants. Understanding the different fibrolytic mechanisms utilized by these bacteria has been of great interest in agricultural and technological fields, reinforced more recently by current efforts to convert cellulosic biomass to biofuels. Methodology/Principal Findings: Here, we have used a bioinformatics-based approach to explore the cellulosome-related components of six genomes from two of the primary fiber-degrading bacteria in the rumen: Ruminococcus flavefaciens (strains FD-1, 007c and 17) and Ruminococcus albus (strains 7, 8 and SY3). The genomes of two of these strains are reported for the first time herein. The data reveal that the three R. flavefaciens strains encode for an elaborate reservoir of cohesin-and dockerin-containing proteins, whereas the three R. albus strains are cohesin-deficient and encode mainly dockerins and a unique family of cell-anchoring carbohydrate-binding modules (family 37). Conclusions/Significance: Our comparative genome-wide analysis pinpoints rare and novel strain-specific protein architectures and provides an exhaustive profile of their numerous lignocellulose-degrading enzymes. This work provides blueprints of the divergent cellulolytic systems in these two prominent fibrolytic rumen bacterial species, each of which reflects a distinct mechanistic model for efficient degradation of cellulosic biomass.	[Dassa, Bareket; Ruimy-Israeli, Vered; Bayer, Edward A.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Borovok, Ilya; Lamed, Raphael] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, Ramat Aviv, Israel; [Flint, Harry J.; Duncan, Sylvia H.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Microbial Ecol Grp, Aberdeen, Scotland; [Henrissat, Bernard; Coutinho, Pedro] Aix Marseille Univ, Marseille, France; [Henrissat, Bernard; Coutinho, Pedro] CNRS, Marseille, France; [Morrison, Mark] Univ Queensland, Diamantina Inst, Woolloongabba, Qld, Australia; [Morrison, Mark] Ohio State Univ, Dept Anim Sci, Columbus, OH 43210 USA; [Mosoni, Pascale] French Natl Inst Agr Res INRA, UR454, Unite Microbiol, St Genes Champanelle, France; [Yeoman, Carl J.] Montana State Univ, Dept Anim & Range Sci, Bozeman, MT 59717 USA; [White, Bryan A.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [White, Bryan A.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA	Weizmann Institute of Science; Tel Aviv University; University of Aberdeen; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); University of Queensland; University System of Ohio; Ohio State University; INRAE; Montana State University System; Montana State University Bozeman; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Bayer, EA (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	ed.bayer@weizmann.ac.il	Yeoman, Carl/ABA-1906-2021; BOROVOK, ILYA/ABB-7370-2022; , Pascale/HGB-1451-2022; Henrissat, Bernard/J-2475-2012; Morrison, Mark/C-9707-2013	Yeoman, Carl/0000-0002-8775-7879; Henrissat, Bernard/0000-0002-3434-8588; Morrison, Mark/0000-0001-9257-9133; BOROVOK, ILYA/0000-0003-1602-4499; Mosoni, Pascale/0000-0002-2752-4555; Duncan, Sylvia/0000-0002-4903-0978	Sidney E. Frank Foundation through the Israel Science Foundation (ISF) [24/11]; ISF [1349/13]; Israeli Center of Research Excellence (I-CORE) [152/11]; United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel; Weizmann Institute of Science Alternative Energy Research Initiative (AERI); Helmsley Foundation; ERA-NET Scheme of the 7th EU Framework Programme European Union; Israel Ministry of Science; Initiative for Future Agriculture and Food Systems; USDA Cooperative State Research, Education, and Extension Service's National Research Initiative Competitive Grants Program [2000-52100-9618, 2001-52100-11330]	Sidney E. Frank Foundation through the Israel Science Foundation (ISF); ISF(Israel Science Foundation); Israeli Center of Research Excellence (I-CORE); United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel(US-Israel Binational Science Foundation); Weizmann Institute of Science Alternative Energy Research Initiative (AERI); Helmsley Foundation; ERA-NET Scheme of the 7th EU Framework Programme European Union; Israel Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel); Initiative for Future Agriculture and Food Systems; USDA Cooperative State Research, Education, and Extension Service's National Research Initiative Competitive Grants Program(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	The research described in this communication was supported by a grant (No. 24/11) issued to RL by The Sidney E. Frank Foundation through the Israel Science Foundation (ISF) and by a grant (No. 1349/13) to EAB also from the ISF (http://www.isf.org.il/english/). This research was also supported by the establishment of an Israeli Center of Research Excellence (I-CORE Center No. 152/11, EAB) managed by the ISF, grants from the United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel (http://www.bsf.org.il/BSFPublic/Default.aspx), by the Weizmann Institute of Science Alternative Energy Research Initiative (AERI) and the Helmsley Foundation (http://helmsleytrust.org/), a project (FiberFuel) funded through the ERA-NET Scheme of the 7th EU Framework Programme European Union Contract (within the framework of the Third ERA-IB Call). A grant to EAB and RL from the Israel Ministry of Science (http://most.gov.il/english/Pages/default.aspx) is gratefully acknowledged. The North American Consortium for Genomics of Rumen Bacteria Consortium was supported by the Initiative for Future Agriculture and Food Systems, Grant no. 2000-52100-9618 and Grant No 2001-52100-11330, from the USDA Cooperative State Research, Education, and Extension Service's National Research Initiative Competitive Grants Program (http://www.csrees.usda.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aurilia V, 2000, MICROBIOL-SGM, V146, P1391, DOI 10.1099/00221287-146-6-1391; BAYER EA, 1994, TRENDS BIOTECHNOL, V12, P379, DOI 10.1016/0167-7799(94)90039-6; BAYER EA, 1983, J BACTERIOL, V156, P818, DOI 10.1128/JB.156.2.818-827.1983; Bayer EA, 1998, J STRUCT BIOL, V124, P221, DOI 10.1006/jsbi.1998.4065; Bayer EA, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P578, DOI 10.1007/0-387-30742-7_19; Belanche A, 2012, J NUTR, V142, P1684, DOI 10.3945/jn.112.159574; Berg M, 2010, VEHICLE SYST DYN, V48, P1, DOI 10.1080/00423114.2010.528963; Bevillard E, 2004, J BACTERIOL, V186, P136, DOI 10.1128/JB.186.1.136-145.2004; Brulc JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025329; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Brumm P, 2011, APPL BIOCHEM BIOTECH, V163, P649, DOI 10.1007/s12010-010-9070-5; BRYANT MP, 1958, J BACTERIOL, V76, P529, DOI 10.1128/JB.76.5.529-537.1958; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Dassa B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-210; Ding SY, 2001, J BACTERIOL, V183, P1945, DOI 10.1128/JB.183.6.1945-1953.2001; Dougal K, 2012, FEMS MICROBIOL ECOL, V82, P642, DOI 10.1111/j.1574-6941.2012.01441.x; Ezer A, 2008, J BACTERIOL, V190, P8220, DOI 10.1128/JB.00609-08; Ferrer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038134; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; FLINT HJ, 1989, APPL ENVIRON MICROB, V55, P1230, DOI 10.1128/AEM.55.5.1230-1233.1989; Flint HJ, 1997, TRENDS MICROBIOL, V5, P483, DOI 10.1016/S0966-842X(97)01159-1; FLINT HJ, 1993, J BACTERIOL, V175, P2943, DOI 10.1128/JB.175.10.2943-2951.1993; FONTY G, 1983, REPROD NUTR DEV, V23, P857, DOI 10.1051/rnd:19830606; GERNGROSS UT, 1993, MOL MICROBIOL, V8, P325, DOI 10.1111/j.1365-2958.1993.tb01576.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HALLIWELL G, 1963, J GEN MICROBIOL, V32, P441, DOI 10.1099/00221287-32-3-441; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; HUNGATE RE, 1982, APPL ENVIRON MICROB, V44, P79, DOI 10.1128/AEM.44.1.79-83.1982; HUNGATE RE, 1966, RUMEN ITS MICROBES; JAYNEWILLIAMS DJ, 1979, J APPL BACTERIOL, V47, P271, DOI 10.1111/j.1365-2672.1979.tb01754.x; Jindou S, 2008, FEMS MICROBIOL LETT, V285, P188, DOI 10.1111/j.1574-6968.2008.01234.x; Jindou S, 2006, J BACTERIOL, V188, P7971, DOI 10.1128/JB.00973-06; Kelly WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011942; LAMED R, 1983, BIOTECHNOL BIOENG, P163; LAMED R, 1988, ADV APPL MICROBIOL, V33, P1, DOI 10.1016/S0065-2164(08)70203-X; LAMED R, 1983, J BACTERIOL, V156, P828, DOI 10.1128/JB.156.2.828-836.1983; Lemaire M, 1998, MICROBIOL-UK, V144, P211, DOI 10.1099/00221287-144-1-211; Li LL, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-10; Miller MEB, 2012, ENVIRON MICROBIOL, V14, P207, DOI 10.1111/j.1462-2920.2011.02593.x; Miron J, 2001, J APPL MICROBIOL, V91, P677, DOI 10.1046/j.1365-2672.2001.01434.x; Miron J, 1998, J APPL MICROBIOL, V84, P249; Mizrahi I., 2013, PROKARYOTES PROKARYO, P533, DOI DOI 10.1007/978-3-642-30194-0_1; Mizrahi Itzhak, 2012, Mob Genet Elements, V2, P152; MORAG E, 1995, APPL ENVIRON MICROB, V61, P1980, DOI 10.1128/AEM.61.5.1980-1986.1995; Morrison M, 2000, FEMS MICROBIOL LETT, V185, P109; Morrison M, 2010, MICROB ECOL, V59, P212, DOI 10.1007/s00248-009-9562-4; Mosoni P, 2001, ARCH MICROBIOL, V176, P52, DOI 10.1007/s002030100292; Ohara H, 2000, BIOSCI BIOTECH BIOCH, V64, P254, DOI 10.1271/bbb.64.254; Ohara H, 2000, BIOSCI BIOTECH BIOCH, V64, P80, DOI 10.1271/bbb.64.80; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Peer A, 2009, FEMS MICROBIOL LETT, V291, P1, DOI 10.1111/j.1574-6968.2008.01420.x; Pegden RS, 1998, J BACTERIOL, V180, P5921, DOI 10.1128/JB.180.22.5921-5927.1998; POOLE DM, 1992, FEMS MICROBIOL LETT, V99, P181, DOI 10.1111/j.1574-6968.1992.tb05563.x; Purushe J, 2010, MICROB ECOL, V60, P721, DOI 10.1007/s00248-010-9692-8; Rakotoarivonina H, 2002, MICROBIOL-SGM, V148, P1871, DOI 10.1099/00221287-148-6-1871; Rakotoarivonina H, 2005, MICROBIOL-SGM, V151, P1291, DOI 10.1099/mic.0.27735-0; Rakotoarivonina H, 2009, ARCH MICROBIOL, V191, P379, DOI 10.1007/s00203-009-0463-1; Raman B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005271; Rincon MT, 2007, J BACTERIOL, V189, P4774, DOI 10.1128/JB.00143-07; Rincon MT, 2005, J BACTERIOL, V187, P7569, DOI 10.1128/JB.187.22.7569-7578.2005; Rincon MT, 2004, J BACTERIOL, V186, P2576, DOI 10.1128/JB.186.9.2576-2585.2004; Rincon MT, 2003, J BACTERIOL, V185, P703, DOI 10.1128/JB.185.3.703-713.2003; SALAMITOU S, 1994, J BACTERIOL, V176, P2822, DOI 10.1128/JB.176.10.2822-2827.1994; SALAMITOU S, 1992, FEBS LETT, V304, P89, DOI 10.1016/0014-5793(92)80595-8; Schwarz WH, 2004, ADV APPL MICROBIOL, V56, P215, DOI 10.1016/S0065-2164(04)56007-0; Selinger LB, 1996, ANAEROBE, V2, P263, DOI 10.1006/anae.1996.0036; Shi Y, 1996, APPL ENVIRON MICROB, V62, P1084, DOI 10.1128/AEM.62.3.1084-1088.1996; Shoham Y, 1999, TRENDS MICROBIOL, V7, P275, DOI 10.1016/S0966-842X(99)01533-4; SHOSEYOV O, 1992, P NATL ACAD SCI USA, V89, P3483, DOI 10.1073/pnas.89.8.3483; STEWART CS, 1981, APPL ENVIRON MICROB, V41, P504, DOI 10.1128/AEM.41.2.504-510.1981; STEWART CS, 1990, FEMS MICROBIOL LETT, V72, P47, DOI 10.1016/0378-1097(90)90342-N; Suen G, 2011, J BACTERIOL, V193, P5574, DOI 10.1128/JB.05621-11; Tajima K, 2001, APPL ENVIRON MICROB, V67, P2766, DOI 10.1128/AEM.67.6.2766-2774.2001; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOKATLIDIS K, 1991, FEBS LETT, V291, P185, DOI 10.1016/0014-5793(91)81279-H; TOKATLIDIS K, 1993, PROTEIN ENG, V6, P947, DOI 10.1093/protein/6.8.947; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; VAREL VH, 1989, APPL ENVIRON MICROB, V55, P3080, DOI 10.1128/AEM.55.12.3080-3084.1989; Vodovnik M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065333; Weimer PJ, 2006, APPL ENVIRON MICROB, V72, P7559, DOI 10.1128/AEM.01632-06; WOLIN MJ, 1983, FED PROC, V42, P109; WOOD TM, 1982, BIOCHEM J, V205, P129, DOI 10.1042/bj2050129; Xu Q, 2004, FEBS LETT, V566, P11, DOI 10.1016/j.febslet.2004.04.005; ZHANG JX, 1992, MOL MICROBIOL, V6, P1013, DOI 10.1111/j.1365-2958.1992.tb02167.x	85	52	57	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e99221	10.1371/journal.pone.0099221	http://dx.doi.org/10.1371/journal.pone.0099221			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992679	Green Published, gold, Green Submitted			2022-12-27	WOS:000341253400008
J	Lee, S; Manjunatha, DH; Jeon, W; Ban, C				Lee, Seonghwan; Manjunatha, D. H.; Jeon, Weejeong; Ban, Changill			Cationic Surfactant-Based Colorimetric Detection of Plasmodium Lactate Dehydrogenase, a Biomarker for Malaria, Using the Specific DNA Aptamer	PLOS ONE			English	Article							GOLD NANOPARTICLE; APTASENSOR; AGGREGATION; ASSAY; NANOSTRUCTURES; BIOSENSOR; DIAGNOSIS	A simple, sensitive, and selective colorimetric biosensor for the detection of the malarial biomarkers Plasmodium vivax lactate dehydrogenase (PvLDH) and Plasmodium falciparum LDH (PfLDH) was demonstrated using the pL1 aptamer as the recognition element and gold nanoparticles (AuNPs) as probes. The proposed method is based on the aggregation of AuNPs using hexadecyltrimethylammonium bromide (CTAB). The AuNPs exhibited a sensitive color change from red to blue, which could be seen directly with the naked eye and was monitored using UV-visible absorption spectroscopy and transmission electron microscopy (TEM). The reaction conditions were optimized to obtain the maximum color intensity. PvLDH and PfLDH were discernible with a detection limit of 1.25 pM and 2.94 pM, respectively. The applicability of the proposed biosensor was also examined in commercially available human serum.	[Lee, Seonghwan; Manjunatha, D. H.; Jeon, Weejeong; Ban, Changill] Pohang Univ Sci & Technol, Dept Chem, Pohang, Gyeongbuk, South Korea	Pohang University of Science & Technology (POSTECH)	Ban, C (corresponding author), Pohang Univ Sci & Technol, Dept Chem, Pohang, Gyeongbuk, South Korea.	ciban@postech.ac.kr	Hadagali, Manjunatha Devagondanahalli/A-2625-2013; Ban, Changill/F-5426-2013	Hadagali, Manjunatha Devagondanahalli/0000-0002-0634-6198; 	Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A122001-1211-0000200]; National Research Foundation of Korea [NRF-2013R1A2A1A09008202]	Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea; National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by a grant of the Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A122001-1211-0000200), and the National Research Foundation of Korea (NRF-2013R1A2A1A09008202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Centi S, 2007, ANAL CHEM, V79, P1466, DOI 10.1021/ac061879p; Cheng XH, 2009, ANAL CHIM ACTA, V633, P97, DOI 10.1016/j.aca.2008.11.031; Cho M, 2008, CHEM COMMUN, P4573, DOI 10.1039/b811346g; Elghanian R, 1997, SCIENCE, V277, P1078, DOI 10.1126/science.277.5329.1078; Fenger R, 2012, PHYS CHEM CHEM PHYS, V14, P9343, DOI 10.1039/c2cp40792b; GRABAR KC, 1995, ANAL CHEM, V67, P735, DOI 10.1021/ac00100a008; Hayat A, 2013, TALANTA, V103, P14, DOI 10.1016/j.talanta.2012.09.048; Jayasena SD, 1999, CLIN CHEM, V45, P1628; Jeon W, 2013, ANAL BIOCHEM, V439, P11, DOI 10.1016/j.ab.2013.03.032; Jiang Y, 2010, ANGEW CHEM INT EDIT, V49, P4800, DOI 10.1002/anie.201001057; Kim YS, 2010, BIOSENS BIOELECTRON, V26, P1644, DOI 10.1016/j.bios.2010.08.046; Lee S, 2012, BIOSENS BIOELECTRON, V35, P291, DOI 10.1016/j.bios.2012.03.003; Li HL, 2010, CHEM COMMUN, V46, P3750, DOI 10.1039/b916797h; Lin CY, 2010, ANAL CHEM, V82, P6830, DOI 10.1021/ac1007909; Lin JH, 2010, ANAL CHEM, V82, P8775, DOI 10.1021/ac102020n; Liu XY, 2010, J PHYS CHEM B, V114, P15554, DOI 10.1021/jp107936b; Maehashi K, 2007, ANAL CHEM, V79, P782, DOI 10.1021/ac060830g; Maltha J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043094; Medley CD, 2008, ANAL CHEM, V80, P1067, DOI 10.1021/ac702037y; Min K, 2011, BIOMATERIALS, V32, P2124, DOI 10.1016/j.biomaterials.2010.11.035; Min K, 2010, CHEM COMMUN, V46, P5566, DOI 10.1039/c002524k; Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f; Santhiya D, 2009, LANGMUIR, V25, P13770, DOI 10.1021/la901546t; Sato K, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni007; Sato K, 2003, J AM CHEM SOC, V125, P8102, DOI 10.1021/ja034876s; Schulz-Dobrick M, 2005, J AM CHEM SOC, V127, P12816, DOI 10.1021/ja054734t; Song KM, 2012, SENSORS-BASEL, V12, P612, DOI 10.3390/s120100612; Song KM, 2011, ANAL BIOCHEM, V415, P175, DOI 10.1016/j.ab.2011.04.007; Stewart ME, 2008, CHEM REV, V108, P494, DOI 10.1021/cr068126n; Wang JL, 2009, TALANTA, V79, P72, DOI 10.1016/j.talanta.2009.03.003; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Wu YG, 2012, ANALYST, V137, P4171, DOI 10.1039/c2an35711a; Zhang LP, 2012, ANAL CHIM ACTA, V717, P127, DOI 10.1016/j.aca.2011.12.037; Zhao W, 2008, CHEMBIOCHEM, V9, P2363, DOI 10.1002/cbic.200800282; Zhou SQ, 2004, BIOMACROMOLECULES, V5, P1256, DOI 10.1021/bm034524d	35	13	15	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100847	10.1371/journal.pone.0100847	http://dx.doi.org/10.1371/journal.pone.0100847			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992632	Green Submitted, gold, Green Published			2022-12-27	WOS:000341253400031
J	Sun, QQ; Wang, XJ; Yang, WG				Sun, Qian-Quan; Wang, Xinjun; Yang, Weiguo			Laserspritzer: A Simple Method for Optogenetic Investigation with Subcellular Resolutions	PLOS ONE			English	Article							CHANNELRHODOPSIN VARIANTS; EXCITATORY CONNECTIONS; PYRAMIDAL NEURONS; NEURAL CIRCUITS; MOTOR CORTEX; LAYER 5; NEOCORTEX; INPUT; ORGANIZATION; STIMULATION	To build a detailed circuit diagram in the brain, one needs to measure functional synaptic connections between specific types of neurons. A high-resolution circuit diagram should provide detailed information at subcellular levels such as soma, distal and basal dendrites. However, a limitation lies in the difficulty of studying long-range connections between brain areas separated by millimeters. Brain slice preparations have been widely used to help understand circuit wiring within specific brain regions. The challenge exists because long-range connections are likely to be cut in a brain slice. The optogenetic approach overcomes these limitations, as channelrhodopsin 2 (ChR2) is efficiently transported to axon terminals that can be stimulated in brain slices. Here, we developed a novel fiber optic based simple method of optogenetic stimulation: the laserspritzer approach. This method facilitates the study of both long-range and local circuits within brain slice preparations. This is a convenient and low cost approach that can be easily integrated with a slice electrophysiology setup, and repeatedly used upon initial validation. Our data with direct ChR2 mediated-current recordings demonstrates that the spatial resolution of the laserspritzer is correlated with the size of the laserspritzer, and the resolution lies within the 30 mm range for the 5 micrometer laserspritzer. Using olfactory cortical slices, we demonstrated that the laserspritzer approach can be applied to selectively activate monosynaptic perisomatic GABAergic basket synapses, or long-range intracortical glutamatergic inputs formed on different subcellular domains within the same cell (e.g. distal and proximal dendrites). We discuss significant advantages of the laserspritzer	[Sun, Qian-Quan; Wang, Xinjun; Yang, Weiguo] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Wang, Xinjun; Yang, Weiguo] Univ Wyoming, Grad Neurosci Program, Laramie, WY 82071 USA	University of Wyoming; University of Wyoming	Sun, QQ (corresponding author), Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA.	neuron@uwyo.edu	Yang, Wei/GWV-4107-2022; Yang, Wei/HIA-0360-2022	Sun, Qian-Quan/0000-0002-5807-9327	National Institutes of Health [1R21NS082958-01A1, 1R21 NS084182-01, 1R15NS081628-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS081628, R21NS082958, R21NS084182] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by the National Institutes of Health Grants 1R21NS082958-01A1, 1R21 NS084182-01 and 1R15NS081628-01A1 to QQS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyden Edward S, 2011, F1000 Biol Rep, V3, P11, DOI 10.3410/B3-11; Cardin JA, 2012, J PHYSIOL-PARIS, V106, P104, DOI 10.1016/j.jphysparis.2011.09.005; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Cruikshank SJ, 2010, NEURON, V65, P230, DOI 10.1016/j.neuron.2009.12.025; DEUCHARS J, 1994, J PHYSIOL-LONDON, V478, P423, DOI 10.1113/jphysiol.1994.sp020262; Feldmeyer D, 2000, J PHYSIOL-LONDON, V525, P31, DOI 10.1111/j.1469-7793.2000.00031.x; Franks KM, 2006, NEURON, V49, P357, DOI 10.1016/j.neuron.2005.12.026; Han X, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00018; Hooks BM, 2013, J NEUROSCI, V33, P748, DOI 10.1523/JNEUROSCI.4338-12.2013; Ledergerber D, 2010, J NEUROSCI, V30, P13031, DOI 10.1523/JNEUROSCI.2254-10.2010; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; Lin John Y, 2013, Methods Mol Biol, V998, P401, DOI 10.1007/978-1-62703-351-0_31; Lin JY, 2012, PROG BRAIN RES, V196, P29, DOI 10.1016/B978-0-444-59426-6.00002-1; Lin JY, 2011, EXP PHYSIOL, V96, P19, DOI 10.1113/expphysiol.2009.051961; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Mao TY, 2011, NEURON, V72, P111, DOI 10.1016/j.neuron.2011.07.029; Markram H, 1997, CEREB CORTEX, V7, P523, DOI 10.1093/cercor/7.6.523; Packer AM, 2012, NAT METHODS, V9, P1202, DOI [10.1038/NMETH.2249, 10.1038/nmeth.2249]; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Prakash R, 2012, NAT METHODS, V9, P1171, DOI 10.1038/NMETH.2215; Rickgauer JP, 2009, P NATL ACAD SCI USA, V106, P15025, DOI 10.1073/pnas.0907084106; Rocco MM, 2007, J NEUROSCI METH, V162, P139, DOI 10.1016/j.jneumeth.2007.01.002; Stepanyants A, 2009, P NATL ACAD SCI USA, V106, P3555, DOI 10.1073/pnas.0810390106; Suter BA, 2010, FRONT NEURAL CIRCUIT, V4, P100, DOI DOI 10.3389/FNCIR.2010.00100; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; Thomson AM, 2002, J NEUROCYTOL, V31, P239, DOI 10.1023/A:1024117908539; Xiong WH, 2012, J NEUROSCI METH, V210, P119, DOI 10.1016/j.jneumeth.2012.07.019; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Zhang JY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/055007; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668	32	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101600	10.1371/journal.pone.0101600	http://dx.doi.org/10.1371/journal.pone.0101600			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992677	Green Published, gold, Green Submitted			2022-12-27	WOS:000341253400096
J	van Rijen, MML; Bosch, T; Verkade, EJM; Schouls, L; Kluytmans, JAJW				van Rijen, Miranda M. L.; Bosch, Thijs; Verkade, Erwin J. M.; Schouls, Leo; Kluytmans, Jan A. J. W.		CAM Study Grp	Livestock-Associated MRSA Carriage in Patients without Direct Contact with Livestock	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; METHICILLIN-RESISTANT; NASAL COLONIZATION; ST398; PREVALENCE; EMERGENCE; HUMANS; ORIGIN	Background: Livestock-associated MRSA (MC398) has emerged and is related to an extensive reservoir in pigs and veal calves. Individuals with direct contact with these animals and their family members are known to have high MC398 carriage rates. Until now it was assumed that MC398 does not spread to individuals in the community without pig or veal calf exposure. To test this, we identified the proportion of MC398 in MRSA positive individuals without contact with pigs/veal calves or other known risk factors (MRSA of unknown origin; MUO). Methods: In 17 participating hospitals, we determined during two years the occurrence of MC398 in individuals without direct contact with livestock and no other known risk factor (n = 271) and tested in a post analysis the hypothesis whether hospitals in pig-dense areas have higher proportions of MC398 of all MUO. Results: Fifty-six individuals (20.7%) without animal contact carried MC398. In hospitals with high pig-densities in the adherence area, the proportion of MC398 of all MUO was higher than this proportion in hospitals without pigs in the surroundings. Conclusions: One fifth of the individuals carrying MUO carried MC398. So, MC398 is found in individuals without contact to pigs or veal calves. The way of transmission from the animal reservoir to these individuals is unclear, probably by human-to-human transmission or by exposure to the surroundings of the stables. Further research is needed to investigate the way of transmission.	[van Rijen, Miranda M. L.; Verkade, Erwin J. M.; Kluytmans, Jan A. J. W.] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands; [Bosch, Thijs; Schouls, Leo] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control Netherlands, NL-3720 BA Bilthoven, Netherlands; [Verkade, Erwin J. M.] St Elizabeth Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands; [Kluytmans, Jan A. J. W.] VUmc Med Univ, Dept Med Microbiol & Infect ControlJK, Amsterdam, Netherlands	Amphia Hospital; Netherlands National Institute for Public Health & the Environment; Elisabeth-TweeSteden Ziekenhuis (ETZ); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	van Rijen, MML (corresponding author), Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands.	mvrijen@amphia.nl; jankluytmans@gmail.com	Kluytmans - van den Bergh, Marjolein/A-7267-2016; Verweij, Paul/H-8108-2014	Kluytmans - van den Bergh, Marjolein/0000-0002-6576-6408; Verweij, Paul/0000-0002-8600-9860	Netherlands Organisation for Health Research and Development [125020007]	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	This work was supported by The Netherlands Organisation for Health Research and Development [grant number 125020007]. ZonMw is a non-profit organisation working for the Ministry of Health, Welfare and Sport (VWS) and the Dutch Organisation for Scientific Research (NOW). ZonMw had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.zonmw.nl/nl/	Bootsma MCJ, 2011, J R SOC INTERFACE, V8, P578, DOI 10.1098/rsif.2010.0349; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; de Boer E, 2009, INT J FOOD MICROBIOL, V134, P52, DOI 10.1016/j.ijfoodmicro.2008.12.007; Declercq P, 2008, INFECTION, V36, P590, DOI 10.1007/s15010-007-7029-4; Dutch Workingparty on Infection Prevention, 2007, MRSA HOSP; Ekkelenkamp M B, 2006, Ned Tijdschr Geneeskd, V150, P2442; Fanoy E, 2009, EUROSURVEILLANCE, V14; Feingold BJ, 2012, EMERG INFECT DIS, V18, P1841, DOI 10.3201/eid1811.111850; Grisold AJ, 2010, DIAGN MICR INFEC DIS, V66, P217, DOI 10.1016/j.diagmicrobio.2009.09.006; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Huijsdens Xander W, 2006, Ann Clin Microbiol Antimicrob, V5, P26, DOI 10.1186/1476-0711-5-26; Infectieziekten Bulletin, 2012, INFECTIEZIEKTEN B; Kock R, 2012, APPL ENVIRON MICROB, V78, P4046, DOI 10.1128/AEM.00212-12; Krziwanek K, 2009, EMERG INFECT DIS, V15, P766, DOI 10.3201/eid1505.080326; Lekkerkerk WSN, 2012, CLIN MICROBIOL INFEC, V18, P656, DOI 10.1111/j.1469-0691.2011.03662.x; Mulders MN, 2010, EPIDEMIOL INFECT, V138, P743, DOI 10.1017/S0950268810000075; Pan A, 2009, EMERG INFECT DIS, V15, P845, DOI 10.3201/eid1505.081417; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Schouls LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005082; Schulz J, 2012, APPL ENVIRON MICROB, V78, P5666, DOI 10.1128/AEM.00550-12; Slingerland BCGC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048896; Smith TC, 2011, VECTOR-BORNE ZOONOT, V11, P327, DOI 10.1089/vbz.2010.0072; Tristan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051172; Valentin-Domelier AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028369; van Belkum A, 2008, EMERG INFECT DIS, V14, P479, DOI 10.3201/eid1403.070760; van Cleef BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009385; van Cleef BAGL, 2011, EMERG INFECT DIS, V17, P502, DOI 10.3201/eid1703.101036; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; van Rijen MML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065594; van Rijen MML, 2008, CLIN INFECT DIS, V46, P261, DOI 10.1086/524672; Verkade E, 2013, CLIN INFECT DIS, V57, pE11, DOI 10.1093/cid/cit228; Verkade E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041855; Wassenberg MWM, 2011, CLIN MICROBIOL INFEC, V17, P316, DOI 10.1111/j.1469-0691.2010.03260.x; Witte W, 2007, EMERG INFECT DIS, V13, P255, DOI 10.3201/eid1302.060924	35	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100294	10.1371/journal.pone.0100294	http://dx.doi.org/10.1371/journal.pone.0100294			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	25000521	Green Submitted, gold, Green Published			2022-12-27	WOS:000338512200024
J	Kefayati, S; Milner, JS; Holdsworth, DW; Poepping, TL				Kefayati, Sarah; Milner, Jaques S.; Holdsworth, David W.; Poepping, Tamie L.			In Vitro Shear Stress Measurements Using Particle Image Velocimetry in a Family of Carotid Artery Models: Effect of Stenosis Severity, Plaque Eccentricity, and Ulceration	PLOS ONE			English	Article							INDUCED PLATELET ACTIVATION; BLOOD-MIMICKING FLUID; WALL SHEAR; TRANSITIONAL FLOW; BIFURCATION; RUPTURE; AGGREGATION; SIMULATION; THROMBOSIS; MORPHOLOGY	Atherosclerotic disease, and the subsequent complications of thrombosis and plaque rupture, has been associated with local shear stress. In the diseased carotid artery, local variations in shear stress are induced by various geometrical features of the stenotic plaque. Greater stenosis severity, plaque eccentricity (symmetry) and plaque ulceration have been associated with increased risk of cerebrovascular events based on clinical trial studies. Using particle image velocimetry, the levels and patterns of shear stress (derived from both laminar and turbulent phases) were studied for a family of eight matched-geometry models incorporating independently varied plaque features - i.e. stenosis severity up to 70%, one of two forms of plaque eccentricity, and the presence of plaque ulceration). The level of laminar (ensemble-averaged) shear stress increased with increasing stenosis severity resulting in 2-16 Pa for free shear stress (FSS) and approximately double (4-36 Pa) for wall shear stress (WSS). Independent of stenosis severity, marked differences were found in the distribution and extent of shear stress between the concentric and eccentric plaque formations. The maximum WSS, found at the apex of the stenosis, decayed significantly steeper along the outer wall of an eccentric model compared to the concentric counterpart, with a 70% eccentric stenosis having 249% steeper decay coinciding with the large outer-wall recirculation zone. The presence of ulceration (in a 50% eccentric plaque) resulted in both elevated FSS and WSS levels that were sustained longer (similar to 20 ms) through the systolic phase compared to the non-ulcerated counterpart model, among other notable differences. Reynolds (turbulent) shear stress, elevated around the point of distal jet detachment, became prominent during the systolic deceleration phase and was widely distributed over the large recirculation zone in the eccentric stenoses.	[Kefayati, Sarah; Poepping, Tamie L.] Univ Western Ontario, Dept Phys & Astron, London, ON, Canada; [Milner, Jaques S.; Holdsworth, David W.; Poepping, Tamie L.] Robarts Res Inst, Imaging Res Labs, London, ON N6A 5C1, Canada; [Holdsworth, David W.] Univ Western Ontario, Dept Surg, London, ON N6A 3K7, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Poepping, TL (corresponding author), Univ Western Ontario, Dept Phys & Astron, London, ON, Canada.	poepping@uwo.ca	Poepping, Tamie L/E-3015-2015; Holdsworth, David W/F-6315-2012	Poepping, Tamie L/0000-0002-4953-5204; Holdsworth, David W/0000-0002-0603-5322	Canada Foundation for Innovation (PIV system); Ontario Ministry of Research and Innovation (PIV system, Early Researcher Award), Heart and Stroke Foundation of Ontario [T-6427]; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research Training Fellowship in Vascular Research	Canada Foundation for Innovation (PIV system); Ontario Ministry of Research and Innovation (PIV system, Early Researcher Award), Heart and Stroke Foundation of Ontario; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research Training Fellowship in Vascular Research(Canadian Institutes of Health Research (CIHR))	Financial support is acknowledged from the Canada Foundation for Innovation (PIV system) and Ontario Ministry of Research and Innovation (PIV system, Early Researcher Award), Heart and Stroke Foundation of Ontario (operating grant #T-6427), Natural Sciences and Engineering Research Council of Canada (Discovery Grant), S. K. was partially supported by a Canadian Institutes of Health Research Training Fellowship in Vascular Research. D. W. H. is the Dr. Sandy Kirkley Chair of Musculoskeletal Research in the Schulich School of Medicine and Dentistry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu Y, 2007, ARTIF ORGANS, V31, P677, DOI 10.1111/j.1525-1594.2007.00446.x; [Anonymous], 1991, STROKE, V22, P816; Antiga L, 2009, BIORHEOLOGY, V46, P77, DOI 10.3233/BIR-2009-0538; Bark DL, 2010, J BIOMECH, V43, P2970, DOI 10.1016/j.jbiomech.2010.07.011; Bascom PAJ, 1997, ULTRASOUND MED BIOL, V23, P25, DOI 10.1016/S0301-5629(96)00171-8; Birchall D, 2006, EUR RADIOL, V16, P1074, DOI 10.1007/s00330-005-0048-6; Bluestein D, 2000, J BIOMECH ENG-T ASME, V122, P125, DOI 10.1115/1.429634; Bluestein D, 1999, ANN BIOMED ENG, V27, P763, DOI 10.1114/1.230; Buchmann NA, 2011, EXP FLUIDS, V50, P1131, DOI 10.1007/s00348-011-1042-1; Clemens MS, 2007, NEUROSURGERY, V61, P842, DOI [10.1227/01.NEU.0000280081.68618.22, 10.1227/01.NEU.0000280054.23770.3E]; COLANTUONI G, 1977, T AM SOC ART INT ORG, V23, P626; Dolan JM, 2013, ANN BIOMED ENG, V41, P1411, DOI 10.1007/s10439-012-0695-0; Fisher M, 2005, STROKE, V36, P253, DOI 10.1161/01.STR.0000152336.71224.21; Ford MD, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2900724; Gijsen FJH, 2008, AM J PHYSIOL-HEART C, V295, pH1608, DOI 10.1152/ajpheart.01081.2007; Goldstein LB, 2003, STROKE, V34, P2767, DOI 10.1161/01.STR.0000097803.90702.31; Grinberg L, 2009, ANN BIOMED ENG, V37, P2200, DOI 10.1007/s10439-009-9769-z; Groen HC, 2007, STROKE, V38, P2379, DOI 10.1161/STROKEAHA.107.484766; Harloff A, 2013, EUR RADIOL; Heffernan KS, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.22; HELLUMS JD, 1994, ANN BIOMED ENG, V22, P445, DOI 10.1007/BF02367081; Holdsworth DW, 1999, PHYSIOL MEAS, V20, P219, DOI 10.1088/0967-3334/20/3/301; HOLDSWORTH DW, 1991, MED BIOL ENG COMPUT, V29, P565, DOI 10.1007/BF02446086; HOLDSWORTH RJ, 1995, EUR J VASC ENDOVASC, V9, P80, DOI 10.1016/S1078-5884(05)80229-1; Holme PA, 1997, ARTERIOSCL THROM VAS, V17, P646, DOI 10.1161/01.ATV.17.4.646; HUNG TC, 1976, T AM SOC ART INT ORG, V22, P285; Jackson SP, 2009, J THROMB HAEMOST, V7, P17, DOI 10.1111/j.1538-7836.2009.03401.x; Kaazempur-Mofrad MR, 2005, INT J HEAT MASS TRAN, V48, P4510, DOI 10.1016/j.ijheatmasstransfer.2005.05.004; Kahler CJ, 2012, EXP FLUIDS, V52, P1641, DOI 10.1007/s00348-012-1307-3; Kefayati S, 2014, J BIOMECH, V47, P253, DOI 10.1016/j.jbiomech.2013.09.007; Kefayati S, 2013, MED ENG PHYS, V35, P898, DOI 10.1016/j.medengphy.2012.08.020; KLANCHAR M, 1990, CIRC RES, V66, P1624, DOI 10.1161/01.RES.66.6.1624; Leach JR, 2010, ANN BIOMED ENG, V38, P2748, DOI 10.1007/s10439-010-0004-8; Lee SE, 2008, J BIOMECH, V41, P2551, DOI 10.1016/j.jbiomech.2008.03.038; Li FY, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-37; Lu PC, 2001, J BIOMECH, V34, P1361, DOI 10.1016/S0021-9290(01)00084-7; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Massai D, 2012, EUR J MECH B-FLUID, V35, P92, DOI 10.1016/j.euromechflu.2012.03.011; Nesbitt WS, 2009, NAT MED, V15, P665, DOI 10.1038/nm.1955; Niu LL, 2012, CLIN PHYSIOL FUNCT I, V32, P323, DOI 10.1111/j.1475-097X.2012.01130.x; Ohara T, 2008, AM J NEURORADIOL, V29, P1200, DOI 10.3174/ajnr.A0997; Pedley TJ., 1980, FLUID MECH LARGE BLO; PERKTOLD K, 1995, J BIOMECH, V28, P845, DOI 10.1016/0021-9290(95)95273-8; Poelma C, 2012, EUR J MECH B-FLUID, V35, P70, DOI 10.1016/j.euromechflu.2012.03.003; Poepping TL, 2010, ULTRASOUND MED BIOL, V36, P1125, DOI 10.1016/j.ultrasmedbio.2010.02.005; Raffel M, 2007, EXP FLUID MECH, P1, DOI 10.1007/978-3-540-72308-0; Ramnarine KV, 1998, ULTRASOUND MED BIOL, V24, P451, DOI 10.1016/S0301-5629(97)00277-9; RAMSTACK JM, 1979, J BIOMECH, V12, P113, DOI 10.1016/0021-9290(79)90150-7; Raschi M, 2012, INT J NUMER METH BIO, V28, P214, DOI 10.1002/cnm.1459; Raz S, 2007, ANN BIOMED ENG, V35, P493, DOI 10.1007/s10439-007-9257-2; REYNOLDS WC, 1972, J FLUID MECH, V54, P263, DOI 10.1017/S0022112072000679; Rothwell PM, 2000, STROKE, V31, P615, DOI 10.1161/01.STR.31.3.615; Rouleau L, 2010, J BIOMECH ENG, V132; Sadat U, 2010, EUR J VASC ENDOVASC, V40, P485, DOI 10.1016/j.ejvs.2010.07.015; SALLAM AM, 1984, BIORHEOLOGY, V21, P783; Schirmer CM, 2008, NEUROSURGERY, V63, P326, DOI 10.1227/01.NEU.0000313119.73941.9E; Schirmer CM, 2012, BRAIN BEHAV, V2, P42, DOI 10.1002/brb3.25; Shadden S, 2012, BIOMECH MODEL MECHAN, DOI [10.1007/s10237-012-0417-4:1-8, DOI 10.1007/S10237-012-0417-4:1-8]; Sheriff J, 2010, ANN BIOMED ENG, V38, P1442, DOI 10.1007/s10439-010-9936-2; Slager CJ, 2005, NAT CLIN PRACT CARD, V2, P456, DOI 10.1038/ncpcardio0298; Smith RF, 1999, JMRI-J MAGN RESON IM, V10, P533, DOI 10.1002/(SICI)1522-2586(199910)10:4<533::AID-JMRI6>3.0.CO;2-Z; Spagnoli LG, 2004, JAMA-J AM MED ASSOC, V292, P1845, DOI 10.1001/jama.292.15.1845; Spencer A.J.M., 2004, CONTINUUM MECH, Vfirst; Steinman DA, 2000, ANN BIOMED ENG, V28, P415, DOI 10.1114/1.279; Stroud JS, 2002, J BIOMECH ENG-T ASME, V124, P9, DOI 10.1115/1.1427042; Tambasco M, 2003, ANN BIOMED ENG, V31, P1054, DOI 10.1114/1.1603257; Teng ZZ, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001028; Vengrenyuk Y, 2006, P NATL ACAD SCI USA, V103, P14678, DOI 10.1073/pnas.0606310103; Vetel J, 2009, EXP FLUIDS, V46, P1067, DOI 10.1007/s00348-009-0615-8; Wentzel JJ, 2012, CARDIOVASC RES, V96, P234, DOI 10.1093/cvr/cvs217; WURZINGER LJ, 1985, THROMB HAEMOSTASIS, V54, P381; Xue YJ, 2008, ACTA RADIOL, V49, P558, DOI 10.1080/02841850801918548; Yousif MY, 2011, EXP FLUIDS, V50, P769, DOI 10.1007/s00348-010-0958-1; Zheng HR, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2216875	74	25	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e98209	10.1371/journal.pone.0098209	http://dx.doi.org/10.1371/journal.pone.0098209			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007248	Green Submitted, Green Published, gold			2022-12-27	WOS:000339040600002
J	Kim, Y; Escalante, AA; Schneider, KA				Kim, Yuseob; Escalante, Ananias A.; Schneider, Kristan A.			A Population Genetic Model for the Initial Spread of Partially Resistant Malaria Parasites under Anti-Malarial Combination Therapy and Weak Intrahost Competition	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; DRUG-RESISTANCE; ARTEMISININ RESISTANCE; EVOLUTION; CHEMOTHERAPY; EMERGENCE; TRANSMISSION; ELIMINATION; MUTATIONS; SELECTION	To develop public-health policies that extend the lifespan of affordable anti-malarial drugs as effective treatment options, it is necessary to understand the evolutionary processes leading to the origin and spread of mutations conferring drug resistance in malarial parasites. We built a population-genetic model for the emergence of resistance under combination drug therapy. Reproductive cycles of parasites are specified by their absolute fitness determined by clinical parameters, thus coupling the evolutionary-genetic with population-dynamic processes. Initial mutations confer only partial drug-resistance. Therefore, mutant parasites rarely survive combination therapy and within-host competition is very weak among parasites. The model focuses on the early phase of such unsuccessful recurrent mutations. This ends in the rare event of mutants enriching in an infected individual from which the successful spread of resistance over the entire population is initiated. By computer simulations, the waiting time until the establishment of resistant parasites is analysed. Resistance spreads quickly following the first appearance of a host infected predominantly by mutant parasites. This occurs either through a rare transmission of a resistant parasite to an uninfected host or through a rare failure of drugs in removing "transient'' mutant alleles. The emergence of resistance is delayed with lower mutation rate, earlier treatment, higher metabolic cost of resistance, longer duration of high drug dose, and higher drug efficacy causing a stronger reduction in the sensitive and resistant parasites' fitnesses. Overall, contrary to other studies' proposition, the current model based on absolute fitness suggests that aggressive drug treatment delays the emergence of drug resistance.	[Kim, Yuseob] Ewha Womans Univ, Dept Life Sci, Seoul, South Korea; [Kim, Yuseob] Ewha Womans Univ, Div EcoSci, Seoul, South Korea; [Escalante, Ananias A.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Escalante, Ananias A.] Arizona State Univ, Ctr Evolutionary Med & Informat, Biodesign Inst, Tempe, AZ USA; [Schneider, Kristan A.] Univ Appl Sci, Dept Math, Mittweida, Germany	Ewha Womans University; Ewha Womans University; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Kim, Y (corresponding author), Ewha Womans Univ, Dept Life Sci, Seoul, South Korea.	yuseob@ewha.ac.kr		Escalante, Ananias/0000-0002-1532-3430; Schneider, Kristan/0000-0003-4138-1180	National Research Foundation of Korea grants - Korean government (MEST) [20110001575]; Ewha Global Top5 of Ewha Womans University; WTZ [KR 05/2011]; U.S. National Institutes of Health [R01GM084320, 1U19AI089702]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084320] Funding Source: NIH RePORTER	National Research Foundation of Korea grants - Korean government (MEST); Ewha Global Top5 of Ewha Womans University; WTZ; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Research Foundation of Korea grants funded by the Korean government (MEST) (Grant number: 20110001575) and by the Ewha Global Top5 Grant 2013 of Ewha Womans University to YK, the WTZ project KR 05/2011 to KS, and by the grants R01GM084320 and 1U19AI089702 from the U.S. National Institutes of Health to AE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antao T, 2011, P ROY SOC B-BIOL SCI, V278, P1705, DOI 10.1098/rspb.2010.1907; Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10; Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; Churcher TS, 2013, ELIFE, V2, DOI 10.7554/eLife.00626; Consortium REX, 2013, TRENDS ECOL EVOL, V28, P111; CURTIS CF, 1986, T ROY SOC TROP MED H, V80, P889, DOI 10.1016/0035-9203(86)90248-8; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; DYE C, 1991, PARASITOL TODAY, V7, P236, DOI 10.1016/0169-4758(91)90236-H; Dye C, 1997, P ROY SOC B-BIOL SCI, V264, P61, DOI 10.1098/rspb.1997.0009; Ellegren H, 2009, EVOLUTION, V63, P301, DOI 10.1111/j.1558-5646.2008.00560.x; Escalante AA, 2009, TRENDS PARASITOL, V25, P557, DOI 10.1016/j.pt.2009.09.008; Gatton ML, 2002, AM J TROP MED HYG, V66, P467, DOI 10.4269/ajtmh.2002.66.467; Hastings I, 2011, TRENDS PARASITOL, V27, P67, DOI 10.1016/j.pt.2010.09.005; Hastings IM, 1997, PARASITOLOGY, V115, P133, DOI 10.1017/S0031182097001261; Hastings IM, 2000, PARASITOL TODAY, V16, P340, DOI 10.1016/S0169-4758(00)01707-5; Hastings IM, 2004, TRENDS PARASITOL, V20, P512, DOI 10.1016/j.pt.2004.08.006; Hastings IM, 2002, PHILOS T ROY SOC B, V357, P505, DOI 10.1098/rstb.2001.1036; Hastings IM, 1998, PARASITOLOGY, V117, P411, DOI 10.1017/S0031182098003291; Hayton K, 2008, CURR GENET, V54, P223, DOI 10.1007/s00294-008-0214-x; Hedrick P.W., 2011, GENETICS POPULATIONS, V4th ed.; Huijben S, 2010, EVOLUTION, V64, P2952, DOI 10.1111/j.1558-5646.2010.01068.x; Klein EY, 2013, INT J ANTIMICROB AG, V41, P311, DOI 10.1016/j.ijantimicag.2012.12.007; Klein EY, 2014, J THEOR BIOL, V340, P177, DOI 10.1016/j.jtbi.2013.09.022; Koella JC, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-3; Mackinnon MJ, 1998, T ROY SOC TROP MED H, V92, P188, DOI 10.1016/S0035-9203(98)90745-3; Mackinnon MJ, 2005, ACTA TROP, V94, P207, DOI 10.1016/j.actatropica.2005.04.006; McCollum AM, 2007, ANTIMICROB AGENTS CH, V51, P2085, DOI 10.1128/AAC.01228-06; McCollum AM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-77; Miotto O, 2013, NATURE GENETICS; Na-Bangchang K, 2013, EXPERT REV CLIN PHAR, V6, P307, DOI [10.1586/ecp.13.17, 10.1586/ECP.13.17]; Nair S, 2003, MOL BIOL EVOL, V20, P1526, DOI 10.1093/molbev/msg162; PAYNE D, 1987, PARASITOL TODAY, V3, P241, DOI 10.1016/0169-4758(87)90147-5; PETERS W, 1990, PHARMACOL THERAPEUT, V47, P499, DOI 10.1016/0163-7258(90)90067-C; Pongtavornpinyo W, 2009, EVOL APPL, V2, P52, DOI 10.1111/j.1752-4571.2008.00067.x; Read AF, 2011, P NATL ACAD SCI USA, V108, P10871, DOI 10.1073/pnas.1100299108; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Schneider KA, 2010, THEOR POPUL BIOL, V78, P93, DOI 10.1016/j.tpb.2010.06.005; Takala-Harrison S, 2013, P NATL ACAD SCI USA, V110, P240, DOI 10.1073/pnas.1211205110; Wargo AR, 2007, P NATL ACAD SCI USA, V104, P19914, DOI 10.1073/pnas.0707766104; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]; White NJ, 2003, P ROY SOC B-BIOL SCI, V270, P545, DOI 10.1098/rspb.2002.2241; White NJ, 1998, DRUG RESIST UPDATE, V1, P3, DOI 10.1016/S1368-7646(98)80208-2; WHO, 2010, GUID TREATM MAL, V2nd	44	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101601	10.1371/journal.pone.0101601	http://dx.doi.org/10.1371/journal.pone.0101601			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007207	Green Published, gold, Green Submitted			2022-12-27	WOS:000339040600050
J	Rodriguez-Carballo, E; Gamez, B; Sedo-Cabezon, L; Sanchez-Feutrie, M; Zorzano, A; Manzanares-Cespedes, C; Rosa, JL; Ventura, F				Rodriguez-Carballo, Edgardo; Gamez, Beatriz; Sedo-Cabezon, Lara; Sanchez-Feutrie, Manuela; Zorzano, Antonio; Manzanares-Cespedes, Cristina; Rosa, Jose Luis; Ventura, Francesc			The p38 alpha MAPK Function in Osteoprecursors Is Required for Bone Formation and Bone Homeostasis in Adult Mice	PLOS ONE			English	Article							TRANSCRIPTION FACTOR OSTERIX; ACTIVATED PROTEIN-KINASE; MALE C57BL/6J MICE; OSTEOBLAST DIFFERENTIATION; GENE-EXPRESSION; TRABECULAR BONE; MOUSE SKELETON; BODY-WEIGHT; P38; PHOSPHORYLATION	Background: p38 MAPK activity plays an important role in several steps of the osteoblast lineage progression through activation of osteoblast-specific transcription factors and it is also essential for the acquisition of the osteoblast phenotype in early development. Although reports indicate p38 signalling plays a role in early skeletal development, its specific contributions to adult bone remodelling are still to be clarified. Methodology/Principal Findings: We evaluated osteoblast-specific deletion of p38 alpha to determine its significance in early skeletogenesis, as well as for bone homeostasis in adult skeleton. Early p38 alpha deletion resulted in defective intramembranous and endochondral ossification in both calvaria and long bones. Mutant mice showed reduction of trabecular bone volume in distal femurs, associated with low trabecular thickness. In addition, knockout mice also displayed decreased femoral cortical bone volume and thickness. Deletion of p38 alpha did not affect osteoclast function. Yet it impaired osteoblastogenesis and osteoblast maturation and activity through decreased expression of osteoblast-specific transcription factors and their targets. Furthermore, the inducible Cre system allowed us to control the onset of p38 alpha disruption after birth by removal of doxycycline. Deletion of p38 alpha at three or eight weeks postnatally led to significantly lower trabecular and cortical bone volume after 6 or 12 months. Conclusions: Our data demonstrates that, in addition to early skeletogenesis, p38 alpha is essential for osteoblasts to maintain their function in mineralized adult bone, as bone anabolism should be sustained throughout life. Moreover, our data also emphasizes that clinical development of p38 inhibitors should take into account their potential bone effects.	[Rodriguez-Carballo, Edgardo; Gamez, Beatriz; Sedo-Cabezon, Lara; Rosa, Jose Luis; Ventura, Francesc] Univ Barcelona, IDIBELL, Hosp Llobregat, Dept Ciencies Fisiol 2, E-08007 Barcelona, Spain; [Manzanares-Cespedes, Cristina] Univ Barcelona, IDIBELL, Hosp Llobregat, Dept Patol & Terapeut Expt, E-08007 Barcelona, Spain; [Sanchez-Feutrie, Manuela; Zorzano, Antonio] Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Sanchez-Feutrie, Manuela; Zorzano, Antonio] Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, Barcelona, Spain; [Sanchez-Feutrie, Manuela; Manzanares-Cespedes, Cristina] CIBER Diabet Enfermedades Metab Asociadas CIBERDE, Inst Salud Carlos III, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III	Ventura, F (corresponding author), Univ Barcelona, IDIBELL, Hosp Llobregat, Dept Ciencies Fisiol 2, E-08007 Barcelona, Spain.	fventura@ub.edu	Ventura, Francesc/K-9700-2014; Rosa, Jose Luis/K-6685-2014; Céspedes, Maria Cristina Manzanares/H-5489-2015; Ventura, Francesc/ABG-2285-2020; Zorzano, Antonio/R-5479-2018; Sedo-Cabezon, Lara/H-5359-2015	Ventura, Francesc/0000-0001-9673-9405; Rosa, Jose Luis/0000-0002-6161-5688; Céspedes, Maria Cristina Manzanares/0000-0002-4585-4953; Ventura, Francesc/0000-0001-9673-9405; Sedo-Cabezon, Lara/0000-0003-0563-8903; Rodriguez-Carballo, Eddie/0000-0003-4321-508X	MEC (Ministry of Education of Spain) [BFU2011-24254]; La Marato de TV3	MEC (Ministry of Education of Spain); La Marato de TV3	This research was supported by grants from the MEC (Ministry of Education of Spain) (BFU2011-24254) and La Marato de TV3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand P, 2011, EUR J PAIN, V15, P1040, DOI 10.1016/j.ejpain.2011.04.005; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; Bidder M, 1998, J BONE MINER RES, V13, P609, DOI 10.1359/jbmr.1998.13.4.609; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Caverzasio J, 2008, J BONE MINER RES, V23, P1389, DOI 10.1359/JBMR.080410; Celil AB, 2005, J CELL BIOCHEM, V95, P518, DOI 10.1002/jcb.20429; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Dacic S, 2001, J BONE MINER RES, V16, P1228, DOI 10.1359/jbmr.2001.16.7.1228; Davey RA, 2012, TRANSGENIC RES, V21, P885, DOI 10.1007/s11248-011-9581-z; Ferguson VL, 2003, BONE, V33, P387, DOI 10.1016/S8756-3282(03)00199-6; Fritton JC, 2008, J BONE MINER RES, V23, P663, DOI [10.1359/jbmr.080104, 10.1359/JBMR.080104]; Frost HM, 1999, J BONE MINER RES, V14, P1816, DOI 10.1359/jbmr.1999.14.11.1816; Gamell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016477; Gamez B, 2013, J BIOL CHEM, V288, P14264, DOI 10.1074/jbc.M112.432104; Ge CX, 2012, J BONE MINER RES, V27, P538, DOI 10.1002/jbmr.561; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Greenblatt M. B., 2013, ANN REV CELL DEV BIO; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060; Hamrick MW, 2008, OSTEOPOROSIS INT, V19, P905, DOI 10.1007/s00198-007-0487-9; Hamrick MW, 2008, J BONE MINER RES, V23, P870, DOI [10.1359/jbmr.080213, 10.1359/JBMR.080213]; HANSON DA, 1992, J BONE MINER RES, V7, P1251; Heinrichsdorff J, 2008, EMBO REP, V9, P1048, DOI 10.1038/embor.2008.149; Hofbauer LC, 2000, J BONE MINER RES, V15, P2, DOI 10.1359/jbmr.2000.15.1.2; Joos H, 2010, BRIT J PHARMACOL, V160, P1252, DOI 10.1111/j.1476-5381.2010.00760.x; Ortuno MJ, 2013, BONE, V52, P548, DOI 10.1016/j.bone.2012.11.007; Ortuno MJ, 2010, J BIOL CHEM, V285, P31985, DOI 10.1074/jbc.M110.123612; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Kawano T, 2013, BONE, V52, P70, DOI 10.1016/j.bone.2012.09.024; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Maatta JA, 2013, FASEB J, V27, P478, DOI 10.1096/fj.12-213587; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Miller LM, 2007, J BONE MINER RES, V22, P1037, DOI 10.1359/JBMR.070402; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Payne KA, 2010, TISSUE ENG PT A, V16, P3647, DOI 10.1089/ten.TEA.2009.0738; Price C, 2005, J BONE MINER RES, V20, P1983, DOI 10.1359/JBMR.050707; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Salazar VS, 2013, J CELL SCI, V126, P4974, DOI 10.1242/jcs.131953; Seeman E, 2001, Rev Endocr Metab Disord, V2, P45; Seibel Markus J, 2005, Clin Biochem Rev, V26, P97; Sinha KM, 2010, EMBO J, V29, P68, DOI 10.1038/emboj.2009.332; Thouverey C, 2012, CELL MOL LIFE SCI, V69, P3115, DOI 10.1007/s00018-012-0983-8; Ulsamer A, 2008, J BIOL CHEM, V283, P3816, DOI 10.1074/jbc.M704724200; Vinals F, 2002, FEBS LETT, V510, P99, DOI 10.1016/S0014-5793(01)03236-7; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang XY, 2007, ENDOCRINOLOGY, V148, P1629, DOI 10.1210/en.2006-1000; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zhang C, 2008, P NATL ACAD SCI USA, V105, P6936, DOI 10.1073/pnas.0710831105; Zhou FH, 2006, J BONE MINER RES, V21, P1075, DOI 10.1359/JBMR.060410; Zhou X, 2010, P NATL ACAD SCI USA, V107, P12919, DOI 10.1073/pnas.0912855107	54	22	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102032	10.1371/journal.pone.0102032	http://dx.doi.org/10.1371/journal.pone.0102032			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007355	Green Published, Green Submitted, gold			2022-12-27	WOS:000339040600089
J	Lynfield, R; Davey, R; Dwyer, DE; Losso, MH; Wentworth, D; Cozzi-Lepri, A; Herman-Lamin, K; Cholewinska, G; David, D; Kuetter, S; Ternesgen, Z; Uyeki, TM; Lane, HC; Lundgren, J; Neaton, JD				Lynfield, Ruth; Davey, Richard; Dwyer, Dominic E.; Losso, Marcelo H.; Wentworth, Deborah; Cozzi-Lepri, Alessandro; Herman-Lamin, Kathy; Cholewinska, Grazyna; David, Daniel; Kuetter, Stefan; Ternesgen, Zelalem; Uyeki, Timothy M.; Lane, H. Clifford; Lundgren, Jens; Neaton, James D.		INSIGHT Influenza Study Grp	Outcomes of Influenza A(H1N1)pdm09 Virus Infection: Results from Two International Cohort Studies	PLOS ONE			English	Article							2009 H1N1 INFLUENZA; A H1N1; UNITED-STATES; HOSPITALIZED-PATIENTS; BACTERIAL; ILLNESS; ADULTS; RISK; SURVEILLANCE; COINFECTION	Background: Data from prospectively planned cohort studies on risk of major clinical outcomes and prognostic factors for patients with influenza A(H1N1)pdm09 virus are limited. In 2009, in order to assess outcomes and evaluate risk factors for progression of illness, two cohort studies were initiated: FLU 002 in outpatients and FLU 003 in hospitalized patients. Methods and Findings: Between October 2009 and December 2012, adults with influenza-like illness (ILI) were enrolled; outpatients were followed for 14 days and inpatients for 60 days. Disease progression was defined as hospitalization and/or death for outpatients, and hospitalization for >28 days, transfer to intensive care unit (ICU) if enrolled from general ward, and/or death for inpatients. Infection was confirmed by RT-PCR. 590 FLU 002 and 392 FLU 003 patients with influenza A(H1N1)pdm09 were enrolled from 81 sites in 17 countries at 2 days (IQR 1-3) and 6 days (IQR 4-10) following ILI onset, respectively. Disease progression was experienced by 29 (1 death) outpatients (5.1%; 95% CI: 3.4-7.2%) and 80 inpatients [death (32), hospitalization >28 days (43) or ICU transfer (20)] (21.6%; 95% CI: 17.5-26.2%). Disease progression (death) for hospitalized patients was 53.1% (26.6%) and 12.8% (3.8%), respectively, for those enrolled in the ICU and general ward. In pooled analyses for both studies, predictors of disease progression were age, longer duration of symptoms at enrollment and immunosuppression. Patients hospitalized during the pandemic period had a poorer prognosis than in subsequent seasons. Conclusions: Patients with influenza A(H1N1)pdm09, particularly when requiring hospital admission, are at high risk for disease progression, especially if they are older, immunodeficient, or admitted late in infection. These data reinforce the need for international trials of novel treatment strategies for influenza infection and serve as a reminder of the need to monitor the severity of seasonal and pandemic influenza epidemics globally.	[Lynfield, Ruth] Minnesota Dept Hlth, Div Infect Dis, St Paul, MN 55124 USA; [Davey, Richard; Lane, H. Clifford] NIAID, NIH, Bethesda, MD 20892 USA; [Dwyer, Dominic E.] Univ Sydney, Westmead Hosp, Ctr Infect Dis & Microbiol, Dept Virol, Westmead, NSW 2145, Australia; [Dwyer, Dominic E.] Univ Sydney, Westmead, NSW 2145, Australia; [Losso, Marcelo H.] Hosp Jose Maria Ramos Mejia, Dept Med, HIV Unit, Buenos Aires, DF, Argentina; [Wentworth, Deborah; Herman-Lamin, Kathy; Lundgren, Jens] Univ Minnesota, Div Biostat, Minneapolis, MN USA; [Cozzi-Lepri, Alessandro] UCL, Res Dept Infect & Populat Hlth, London, England; [Cholewinska, Grazyna] Hosp Infect Dis, Warsaw, Poland; [David, Daniel] Hosp Rawson, Cordoba, Argentina; [Kuetter, Stefan] Marlow Med Grp, Marlow, Bucks, England; [Ternesgen, Zelalem] Mayo Clin, Rochester, MN USA; [Uyeki, Timothy M.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Lundgren, Jens] Univ Copenhagen Hosp, Dept Infect Dis, Rigshosp, DK-2100 Copenhagen, Denmark; [Lundgren, Jens] Univ Copenhagen, Copenhagen, Denmark	Minnesota Department of Health (MHD); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Sydney; University of Sydney; Hospital Ramos Mejia; University of Minnesota System; University of Minnesota Twin Cities; University of London; University College London; Mayo Clinic; Centers for Disease Control & Prevention - USA; Rigshospitalet; University of Copenhagen; University of Copenhagen	Lynfield, R (corresponding author), Minnesota Dept Hlth, Div Infect Dis, St Paul, MN 55124 USA.	Ruth.Lynfield@state.mn.us	Montejano, Rocio/H-5344-2017; Emery, Sean/J-3825-2017; Lundgren, Jens/AAE-6876-2019; Ostergaard, Lars/AAA-3020-2020; Montejano, Rocio/P-6141-2019; Emery, Sean/O-9122-2019; Soriano, Vicente/O-5730-2018	Montejano, Rocio/0000-0002-3446-0545; Emery, Sean/0000-0001-6072-8309; Ostergaard, Lars/0000-0003-2459-0511; Montejano, Rocio/0000-0002-3446-0545; Emery, Sean/0000-0001-6072-8309; Soriano, Vicente/0000-0002-4624-5199; Estrada, Vicente/0000-0002-7795-5986; Polenakovik, Hari/0000-0001-5793-5729; Carbone, Javier/0000-0003-2056-0534; Lundgren, Jens/0000-0001-8901-7850	Leidos Prime [HHSN261200800001E]; NCI/NIAID; Medical Research Council [MC_UU_12023/16, MC_U122886352] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000936, ZIAAI000984] Funding Source: NIH RePORTER; MRC [MC_UU_12023/16, MC_U122886352] Funding Source: UKRI	Leidos Prime; NCI/NIAID; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Leidos Prime Contract HHSN261200800001E, NCI/NIAID. The funders had no role in study design, data collection and analysis, decision to Funding: publish, or preparation of the manuscript.	Almond MH, 2013, THORAX, V68, P684, DOI 10.1136/thoraxjnl-2012-203009; [Anonymous], INFL SURV MON; Beadling C, 2004, CURR OPIN INFECT DIS, V17, P185, DOI 10.1097/00001432-200406000-00003; Belongia EA, 2010, JAMA-J AM MED ASSOC, V304, P1091, DOI 10.1001/jama.2010.1277; Brun-Buisson C, 2011, AM J RESP CRIT CARE, V183, P1200, DOI 10.1164/rccm.201101-0135OC; Campbell A, 2010, CAN MED ASSOC J, V182, P349, DOI 10.1503/cmaj.091823; Centers for Disease Control and Prevention, SEAS INFL FLU; Cheng VCC, 2012, CLIN MICROBIOL REV, V25, P223, DOI 10.1128/CMR.05012-11; Cordero E, 2012, EUR J CLIN MICROBIOL, V31, P547, DOI 10.1007/s10096-011-1346-3; Cox CM, 2012, J INFECT DIS, V206, P1350, DOI 10.1093/infdis/jis517; Davey RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057121; Dwyer DE, 2011, VACCINE, V29, pB56, DOI 10.1016/j.vaccine.2011.04.105; Fleming DM, 2003, VACCINE, V21, P1749, DOI 10.1016/S0264-410X(03)00066-5; Food and Drug Administration, 2011, CLIN ANT INFL DEV DR; Fowlkes AL, 2011, CLIN INFECT DIS, V52, pS60, DOI 10.1093/cid/ciq022; Hanshaoworakul W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006051; Helferty M, 2010, CAN MED ASSOC J, V182, P1981, DOI 10.1503/cmaj.100746; Hewagama S, 2010, CLIN INFECT DIS, V50, P686, DOI 10.1086/650460; Ison MG, 2010, J INFECT DIS, V201, P1654, DOI 10.1086/652498; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Joseph C, 2013, INFLUENZA OTHER RESP, V7, P105, DOI 10.1111/irv.12089; Karlsson EA, 2012, INFLUENZA OTHER RESP, V6, P449, DOI 10.1111/j.1750-2659.2012.00342.x; Khandaker G, 2011, INFLUENZA OTHER RESP, V5, P148, DOI 10.1111/j.1750-2659.2011.00199.x; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Martin-Loeches I, 2011, CRIT CARE, V15, DOI 10.1186/cc10573; Mertz D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5061; Mosby LG, 2011, AM J OBSTET GYNECOL, V205, P10, DOI 10.1016/j.ajog.2010.12.033; Muthuri SG, 2013, J INFECT DIS, V207, P553, DOI 10.1093/infdis/jis726; Myles PR, 2012, THORAX, V67, P709, DOI 10.1136/thoraxjnl-2011-200266; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Ortiz JR, 2013, CRIT CARE MED, V41, P1345, DOI 10.1097/CCM.0b013e3182771386; Palacios G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008540; Rice TW, 2012, CRIT CARE MED, V40, P1487, DOI 10.1097/CCM.0b013e3182416f23; Sedyaningsih ER, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3039; Sheth Anandi N, 2011, Curr HIV/AIDS Rep, V8, P181, DOI 10.1007/s11904-011-0086-4; Shrestha SS, 2011, CLIN INFECT DIS, V52, pS75, DOI 10.1093/cid/ciq012; Skarbinski J, 2011, CLIN INFECT DIS, V52, pS50, DOI 10.1093/cid/ciq021; Szewczuk E, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-113; van Hoek AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017030; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Venkata C, 2010, MAYO CLIN PROC, V85, P798, DOI 10.4065/mcp.2010.0166; Viasus D, 2011, CLIN MICROBIOL INFEC, V17, P738, DOI 10.1111/j.1469-0691.2010.03362.x; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; Yang P, 2010, J INFECTION, V61, P277, DOI 10.1016/j.jinf.2010.07.010	45	26	27	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101785	10.1371/journal.pone.0101785	http://dx.doi.org/10.1371/journal.pone.0101785			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004134	gold, Green Published, Green Submitted			2022-12-27	WOS:000339242700065
J	Naganuma, T; Kihara, A				Naganuma, Tatsuro; Kihara, Akio			Two Modes of Regulation of the Fatty Acid Elongase ELOVL6 by the 3-Ketoacyl-CoA Reductase KAR in the Fatty Acid Elongation Cycle	PLOS ONE			English	Article							STARGARDT-3 MACULAR DYSTROPHY; SACCHAROMYCES-CEREVISIAE; PERMEABILITY BARRIER; MENTAL-RETARDATION; GENE; MUTATION; PROTEIN; CELLS; MICE; IDENTIFICATION	Fatty acids (FAs) are diverse molecules, and such diversity is important for lipids to exert their functions under several environmental conditions. FA elongation occurs at the endoplasmic reticulum and produces a variety of FA species; the FA elongation cycle consists of four distinct enzyme reactions. For this cycle to be driven efficiently, there must exist coordinated regulation of protein components of the FA elongation machinery. However, such regulation is poorly understood. In the present study, we performed biochemical analyses using the FA elongase ELOVL6 and the 3-ketoacyl-CoA reductase KAR, which catalyze the first and second steps of the FA elongation cycle, respectively. In vitro FA elongation assays using membrane fractions demonstrated that ELOVL6 activity was enhanced similar to 10-fold in the presence of NADPH, although ELOVL6 itself did not require NADPH for its catalysis. On the other hand, KAR does use NADPH as a reductant in its enzyme reaction. Activity of purified ELOVL6 was enhanced by similar to 3-fold in the presence of KAR. This effect was KAR enzyme activity-independent, since it was observed in the absence of NADPH and in the KAR mutant. However, ELOVL6 enzyme activity was further enhanced in a KAR enzyme activity-dependent manner. Therefore, KAR regulates ELOVL6 via two modes. In the first mode, KAR may induce conformational changes in ELOVL6 to become structure that can undergo catalysis. In the second mode, conversion of 3-ketoacyl-CoA to 3-hydroxyacyl-CoA by KAR may facilitate release of the product from the presumed ELOVL6-KAR complex.	[Naganuma, Tatsuro; Kihara, Akio] Hokkaido Univ, Fac Pharmaceut Sci, Biochem Lab, Sapporo, Hokkaido 060, Japan	Hokkaido University	Kihara, A (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Biochem Lab, Kita 12, Sapporo, Hokkaido 060, Japan.	kihara@pharm.hokudai.ac.jp	KIHARA, AKIO/A-3802-2012	KIHARA, AKIO/0000-0001-5889-0788; Naganuma, Tatsuro/0000-0002-8653-5553	Japan Society for the Promotion of Science (JSPS) [26251010]; JSPS Fellows [25-744]; Grants-in-Aid for Scientific Research [26251010] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS Fellows(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (A) (26251010) to AK from the Japan Society for the Promotion of Science (JSPS) and by a Grant-in-Aid for JSPS Fellows (25-744) to TN from JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2013, J BIOL CHEM, V288, P36741, DOI 10.1074/jbc.M113.493221; Agbaga MP, 2008, P NATL ACAD SCI USA, V105, P12843, DOI 10.1073/pnas.0802607105; Agbaga MP, 2010, J LIPID RES, V51, P1624, DOI 10.1194/jlr.R005025; Aldahmesh MA, 2011, AM J HUM GENET, V89, P745, DOI 10.1016/j.ajhg.2011.10.011; Caliskan M, 2011, HUM MOL GENET, V20, P1285, DOI 10.1093/hmg/ddq569; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Han GS, 2002, J BIOL CHEM, V277, P35440, DOI 10.1074/jbc.M205620200; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Ikeda M, 2008, FEBS LETT, V582, P2435, DOI 10.1016/j.febslet.2008.06.007; Kihara A, 2003, J BIOL CHEM, V278, P14578, DOI 10.1074/jbc.M211416200; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; Konishi H, 2010, J BIOCHEM, V148, P617, DOI 10.1093/jb/mvq092; Li WM, 2007, INT J BIOL SCI, V3, P120; Matsuzaka T, 2002, J LIPID RES, V43, P911; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; McMahon A, 2007, FEBS LETT, V581, P5459, DOI 10.1016/j.febslet.2007.10.050; Moeller G, 2009, MOL CELL ENDOCRINOL, V301, P7, DOI 10.1016/j.mce.2008.10.040; Moon YA, 2003, J BIOL CHEM, V278, P7335, DOI 10.1074/jbc.M211684200; Moon YA, 2001, J BIOL CHEM, V276, P45358, DOI 10.1074/jbc.M108413200; Moon YA, 2009, J LIPID RES, V50, P412, DOI 10.1194/jlr.M800383-JLR200; Muhammad E, 2013, HUM MOL GENET, V22, P5229, DOI 10.1093/hmg/ddt380; Naganuma T, 2011, FEBS LETT, V585, P3337, DOI 10.1016/j.febslet.2011.09.024; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; NUGTEREN DH, 1965, BIOCHIM BIOPHYS ACTA, V106, P280, DOI 10.1016/0005-2760(65)90036-6; Obara K, 2013, J LIPID RES, V54, P831, DOI 10.1194/jlr.M034678; Obara K, 2012, J BIOL CHEM, V287, P38473, DOI 10.1074/jbc.M112.394205; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P18439, DOI 10.1073/pnas.1005572107; Okuda A, 2010, MOL VIS, V16, P2438; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Park H, 2010, J LIPID RES, V51, P480, DOI 10.1194/jlr.M000984; SanGiovanni JP, 2005, PROG RETIN EYE RES, V24, P87, DOI 10.1016/j.preteyeres.2004.06.002; Sassa T, 2014, BIOMOL THER, V22, P83, DOI 10.4062/biomolther.2014.017; Sassa T, 2013, MOL CELL BIOL, V33, P2787, DOI 10.1128/MCB.00192-13; Schweizer E, 2004, MICROBIOL MOL BIOL R, V68, P501, DOI 10.1128/MMBR.68.3.501-517.2004; SMITH S, 1994, FASEB J, V8, P1248, DOI 10.1096/fasebj.8.15.8001737; Sunaga H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3563; Uchida Y, 2008, J DERMATOL SCI, V51, P77, DOI 10.1016/j.jdermsci.2008.01.002; Vasireddy V, 2007, HUM MOL GENET, V16, P471, DOI 10.1093/hmg/ddl480; Wainwright PE, 2002, P NUTR SOC, V61, P61, DOI 10.1079/PNS2001130; Westerberg R, 2004, J BIOL CHEM, V279, P5621, DOI 10.1074/jbc.M310529200; Zadravec D, 2011, J LIPID RES, V52, P245, DOI 10.1194/jlr.M011346; Zhang K, 2001, NAT GENET, V27, P89, DOI 10.1038/83817	42	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101823	10.1371/journal.pone.0101823	http://dx.doi.org/10.1371/journal.pone.0101823			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003994	Green Published, Green Submitted, gold			2022-12-27	WOS:000339242700072
J	Sun, L; Meng, YX; Xie, YC; Zhang, H; Zhang, Z; Wang, XX; Jiang, B; Li, W; Li, Y; Yang, Z				Sun, Liang; Meng, Yunxiao; Xie, Yanchen; Zhang, Hua; Zhang, Zheng; Wang, Xiaoxia; Jiang, Bin; Li, Wei; Li, Yao; Yang, Ze			CTLA4 Variants and Haplotype Contribute Genetic Susceptibility to Myasthenia Gravis in Northern Chinese Population	PLOS ONE			English	Article							AUTOIMMUNE THYROID-DISEASE; ACETYLCHOLINE-RECEPTOR; JAPANESE PATIENTS; POLYMORPHISM; ASSOCIATION; PROMOTER; REGION; ONSET; HLA; EXPRESSION	Background: Cytotoxic T lymphocyte-associated antigen-4 (CTLA4), a critical negative regulator of the T-cell response, has been considered a candidate for many autoimmune diseases. Evidence from Caucasians supported a genetic predisposition of CTLA4 to myasthenia gravis (MG), but the contribution in East Asians has not been established. Objectives: To investigate the role of CTLA4 variants in the susceptibility to MG and the contribution to subtypes of MG. Methods: Six autoimmune disease-related risk alleles of CTLA4 (rs1863800, rs733618, rs4553808, rs5742909, rs231775, and rs3087243) were investigated for MG in northern Chinese. 168 patients with MG (mean age 37.1 +/- 20.5 years, 64 men and 104 women) and 233 healthy controls (mean age 53.3 +/- 8.7 years, 96 men and 137 women) were screened, and the contribution of CTLA4 to the general risk of MG and each subgroup was explored. Results: rs1863800*C, rs733618*C, and rs231775*G were significantly associated with the whole cohort of patients with MG after permutation correction for multiple-testing adjustment (P = 0.027, 0.001, and 0.032, respectively). A risk haplotype (CCACG) [odds ratio (OR) = 1.535, range = 1.150-2.059, P = 0.004)] was also identified. The stratified subtype analysis indicated that the positive contribution was possibly derived from early onset MG (EOMG), seropositive MG (SPMG), female patients, and MG without thymoma. No association was observed in juvenile MG/LOMG, and MG coupled with thymoma. Conclusion: A predisposing effect of rs1863800*C, rs733618*C, and rs231775*G of CTLA4 gene to general risk of MG in Chinese was demonstrated for the first time, which was likely derived from EOMG, SPMG, MG without thymoma and the female patients.	[Sun, Liang; Wang, Xiaoxia; Yang, Ze] Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China; [Sun, Liang; Wang, Xiaoxia; Yang, Ze] Minist Hlth, Beijing Inst Geriatr, Beijing, Peoples R China; [Meng, Yunxiao] Tsinghua Univ, Dept Pathol, Peking Union Med Coll Hosp, Chinese Acad Med Sci, Beijing 100084, Peoples R China; [Xie, Yanchen; Jiang, Bin; Li, Yao] Capital Med Univ, Dept Neurol, Beijing Friendship Hosp, Beijing, Peoples R China; [Zhang, Hua; Li, Wei] Minist Hlth, Dept Neurol, Beijing Hosp, Beijing, Peoples R China; [Zhang, Zheng] Ningxia Med Univ, Dept Publ Hlth, Yinchuan, Peoples R China	Beijing Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Tsinghua University; Capital Medical University; Beijing Hospital; Ningxia Medical University	Xie, YC (corresponding author), Capital Med Univ, Dept Neurol, Beijing Friendship Hosp, Beijing, Peoples R China.	drycxie@gmail.com; yang.ze@live.cn	Xie, Yanchen/GXM-9448-2022	Xie, Yanchen/0000-0002-7879-0554	Beijing Nova program [Z121107002512058]; Natural Science Foundation of China [81061120527, 30700242]	Beijing Nova program(Beijing Municipal Science & Technology Commission); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partially supported by Beijing Nova program (Z121107002512058), Natural Science Foundation of China (81061120527, 30700242). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarli JA, 1999, ARCH NEUROL-CHICAGO, V56, P25, DOI 10.1001/archneur.56.1.25; Anjos S, 2002, J BIOL CHEM, V277, P46478, DOI 10.1074/jbc.M206894200; Awata T, 1998, DIABETES, V47, P128, DOI 10.2337/diab.47.1.128; Carreno BM, 2000, J IMMUNOL, V165, P1352, DOI 10.4049/jimmunol.165.3.1352; Chang MC, 2007, CLIN CHEM, V53, P1700, DOI 10.1373/clinchem.2007.085951; CHEN WH, 1993, J NEUROL NEUROSUR PS, V56, P382, DOI 10.1136/jnnp.56.4.382; CHIU HC, 1987, NEUROLOGY, V37, P1854, DOI 10.1212/WNL.37.12.1854; Chuang WY, 2005, ANN NEUROL, V58, P644, DOI 10.1002/ana.20577; Chuang WY, 2013, J AUTOIMMUN; Donner H, 1998, DIABETES, V47, P1158, DOI 10.2337/diabetes.47.7.1158; DRACHMAN DB, 1994, NEW ENGL J MED, V330, P1797, DOI 10.1056/NEJM199406233302507; Gonzalez-Escribano MF, 1999, TISSUE ANTIGENS, V53, P296, DOI 10.1034/j.1399-0039.1999.530311.x; Grob D, 2008, MUSCLE NERVE, V37, P141, DOI 10.1002/mus.20950; Gu LQ, 2010, CLIN ENDOCRINOL, V72, P248, DOI 10.1111/j.1365-2265.2009.03617.x; Huang D, 1998, J NEUROIMMUNOL, V88, P192, DOI 10.1016/S0165-5728(98)00119-2; Kawaguchi N, 2004, J NEUROL SCI, V224, P43, DOI 10.1016/j.jns.2003.09.016; Kemp EH, 1998, CLIN ENDOCRINOL, V49, P609; Kotsa K, 1997, CLIN ENDOCRINOL, V46, P551, DOI 10.1046/j.1365-2265.1997.1710996.x; Kristiansen OP, 2000, GENES IMMUN, V1, P170, DOI 10.1038/sj.gene.6363655; Lee YH, 2005, HUM GENET, V116, P361, DOI 10.1007/s00439-004-1244-1; Ligers A, 1999, J NEUROIMMUNOL, V97, P182, DOI 10.1016/S0165-5728(99)00072-7; Ligers A, 2001, GENES IMMUN, V2, P145, DOI 10.1038/sj.gene.6363752; Lindstrom JM, 1998, NEUROLOGY, V51, P933; Maniaol AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036603; MATSUKI K, 1990, J CLIN INVEST, V86, P392, DOI 10.1172/JCI114724; Maurer M, 2002, IMMUNOGENETICS, V54, P1, DOI 10.1007/s00251-002-0429-9; Meriggioli MN, 2009, LANCET NEUROL, V8, P475, DOI 10.1016/S1474-4422(09)70063-8; Nagvekar N, 1998, J CLIN INVEST, V101, P2268, DOI 10.1172/JCI2068; Ngo ST, 2014, FRONT NEUROENDOCRINO; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; Nithiyananthan R, 2002, THYROID, V12, P3, DOI 10.1089/105072502753451896; OOSTERHUIS HJGH, 1981, CLIN NEUROL NEUROSUR, V83, P105, DOI 10.1016/0303-8467(81)90014-7; Poulas K, 2001, LANCET, V357, P234, DOI 10.1016/S0140-6736(05)71337-4; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Quintero-Ronderos P, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/593720; Reinhardt C, 2000, ANN NEUROL, V48, P603; Rioux JD, 2009, P NATL ACAD SCI USA, V106, P18680, DOI 10.1073/pnas.0909307106; Sallakci N, 2005, CLIN EXP DERMATOL, V30, P546, DOI 10.1111/j.1365-2230.2005.01846.x; Scuderi F, 2002, LAB INVEST, V82, P1139, DOI 10.1097/01.LAB.0000028144.48023.9B; Shinomiya N, 2004, CLIN IMMUNOL, V110, P154, DOI 10.1016/j.clim.2003.10.004; Simmonds MJ, 2004, CLIN EXP IMMUNOL, V136, P1, DOI 10.1111/j.1365-2249.2004.02424.x; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Sun L, 2006, DIABETIC MED, V23, P1085, DOI 10.1111/j.1464-5491.2006.01949.x; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; Teft WA, 2006, ANNU REV IMMUNOL, V24, P65, DOI 10.1146/annurev.immunol.24.021605.090535; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Wang XB, 2008, J INTERN MED, V263, P61, DOI 10.1111/j.1365-2796.2007.01879.x; Wang XB, 2002, GENES IMMUN, V3, P46, DOI 10.1038/sj.gene.6363816; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Waterman EA, 1998, CLIN ENDOCRINOL, V49, P251, DOI 10.1046/j.1365-2265.1998.00537.x; YANAGAWA T, 1995, J CLIN ENDOCR METAB, V80, P41, DOI 10.1210/jc.80.1.41; Zhang P, 2012, J EUR ACAD DERMATOL, V26, P399, DOI 10.1111/j.1468-3083.2011.04261.x; Zhang XF, 2007, J NEUROL NEUROSUR PS, V78, P386, DOI 10.1136/jnnp.2006.100545	53	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101986	10.1371/journal.pone.0101986	http://dx.doi.org/10.1371/journal.pone.0101986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003519	Green Published, gold, Green Submitted			2022-12-27	WOS:000339242700096
J	Tang, K; Luo, C; Li, Y; Lu, CS; Zhou, WQ; Huang, HH; Chen, XG				Tang, Ke; Luo, Can; Li, Yan; Lu, Chenshu; Zhou, Wanqi; Huang, Haihong; Chen, Xiaoguang			The Study of a Novel Sorafenib Derivative HLC-080 as an Antitumor Agent	PLOS ONE			English	Article							REFRACTORY SOLID TUMORS; FACTOR RECEPTOR INHIBITOR; RAF KINASE; MULTIKINASE INHIBITOR; COLORECTAL-CANCER; COLON-CANCER; HEPATOCELLULAR-CARCINOMA; RAF/MEK/ERK PATHWAY; SIGNALING PATHWAY; IN-VIVO	In this study, our objective is to evaluate the potential of a novel Sorafenib derivative, named HLC-080, as a new anticancer agent for colon cancer. We firstly carried out MTT assay, colony formation assay, flow cytometry analysis and transwell invasion assay to determine effect of our compound HLC-080 on cell viability, anti-proliferation activity, cell cycle arrest and the intervention on cell invasion, respectively. On the other hand, in vivo antitumor activity of HLC-080 was also tested using H22 xenograft model and the angiogenesis effect of HLC-080 was measured by EA.hy926 tube formation assay. The expression levels of various proteins in HLC-080 treated with HT-29 cell lines were examined using Western blot and ELISA experiments. The results showed that HLC-080 could dramatically inhibit the growth and colony formation of various tumor cells, therefore exhibited remarkable antitumor activity. HLC-080 can induce cell cycle arrest at G1 phase in HT-29 cells and subsequently inhibit the invasive potential of colon cancer cells. HLC-080 also exhibits anti-angiogenesis effect in EA.hy926 model. Additionally, the in vivo study showed that HLC-080 was able to reduced the tumor weight with the rate of 35.81%. And at the concentration of 0.352 +/- 0.034 mu M, HLC-080 is able to reduce half of the regular protein level of p-c-Raf (Ser259), consequently block Raf/MEK/ERK signaling in HT-29 cell lines. In conclusion, our study suggests that Sorafenib derivative HLC-080 has the potential to inhibit cell proliferation and angiogenesis, Since, HLC-080 is particularly active against human colon cancer cells, our study highlights that HLC-080 and its related analogues may serve as a new anti-cancer drug, particularly against colon cancer.	[Tang, Ke; Luo, Can; Li, Yan; Lu, Chenshu; Zhou, Wanqi; Huang, Haihong; Chen, Xiaoguang] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China; [Tang, Ke; Luo, Can; Li, Yan; Lu, Chenshu; Zhou, Wanqi; Huang, Haihong; Chen, Xiaoguang] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Huang, HH (corresponding author), Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China.	joyce@imm.ac.cn; chxg@imm.ac.cn			National Science AMP; Technology Major Project [2009ZX09301-003-9-1]	National Science AMP; Technology Major Project	This subject was financially supported by the National Science & Technology Major Project (2009ZX09301-003-9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia A, 2013, CURR PHARM IN PRESS; Al-Marrawi MY, 2013, CANCER BIOL THER, V14, P703, DOI 10.4161/cbt.25191; Chaparro M, 2008, ALIMENT PHARM THER, V28, P1269, DOI 10.1111/j.1365-2036.2008.03857.x; Clark JW, 2005, CLIN CANCER RES, V11, P5472, DOI 10.1158/1078-0432.CCR-04-2658; Dahut WL, 2008, CLIN CANCER RES, V14, P209, DOI 10.1158/1078-0432.CCR-07-1355; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Dent P, 2013, CANCER BIOL THER, V14, P877, DOI 10.4161/cbt.26176; Gollob JA, 2006, SEMIN ONCOL, V33, P392, DOI 10.1053/j.seminoncol.2006.04.002; Guruvayoorappan C, 2008, IMMUNOPHARM IMMUNOT, V30, P711, DOI 10.1080/08923970802278276 ; Huang D, 2006, CANCER LETT, V233, P289, DOI 10.1016/j.canlet.2005.03.019; Joudeh J, 2013, ADV EXP MED BIOL, V779, P1, DOI 10.1007/978-1-4614-6176-0_1; Komorowski J, 2006, LIFE SCI, V78, P2558, DOI 10.1016/j.lfs.2005.10.016; Li M, 2005, WORLD J GASTROENTERO, V11, P4685, DOI 10.3748/wjg.v11.i30.4685; Li QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033379; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Luo C, 2013, SCI CHINA CHEM, V56, P1564, DOI 10.1007/s11426-013-4903-z; Luo WJ, 2013, J CELL MOL MED, V17, P1316, DOI 10.1111/jcmm.12108; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Min LH, 2011, SEMIN CANCER BIOL, V21, P10, DOI 10.1016/j.semcancer.2010.10.011; Mo SY, 2004, J NAT PROD, V67, P823, DOI 10.1021/np030505d; Moore M, 2005, ANN ONCOL, V16, P1688, DOI 10.1093/annonc/mdi310; Nelson VM, 2013, J GASTROINTEST ONCOL, V4, P245, DOI 10.3978/j.issn.2078-6891.2013.035; Olsen Sonja K, 2010, Therap Adv Gastroenterol, V3, P55, DOI 10.1177/1756283X09346669; Pignochino Y, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-118; Ratain MJ, 2006, J CLIN ONCOL, V24, P2505, DOI 10.1200/JCO.2005.03.6723; Reimann Manja, 2013, Exp Transl Stroke Med, V5, P7, DOI 10.1186/2040-7378-5-7; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Strumberg D, 2005, J CLIN ONCOL, V23, P965, DOI 10.1200/JCO.2005.06.124; [唐克 Tang Ke], 2011, [中国新药杂志, Chinese Journal New Drugs], V20, P2434; Wang XQ, 2011, INT J PHARMACEUT, V419, P339, DOI 10.1016/j.ijpharm.2011.08.003; Wilhelm S, 2002, CURR PHARM DESIGN, V8, P2255, DOI 10.2174/1381612023393026; Wilhelm S, 2006, NAT REV DRUG DISCOV, V5, P835, DOI 10.1038/nrd2130; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Wu DD, 2010, PEPTIDES, V31, P850, DOI 10.1016/j.peptides.2010.01.007; Xu RH, 2010, CHINA PHARM, V14, P1254; Xu YF, 2007, EUR J PHARMACOL, V564, P1, DOI 10.1016/j.ejphar.2007.01.086; Yao Z, 2006, PEPTIDES, V27, P1167, DOI 10.1016/j.peptides.2005.02.026; Yoon JH, 2002, CANCER RES, V62, P6500; Yu CR, 2005, ONCOGENE, V24, P6861, DOI 10.1038/sj.onc.1208841; Yu M, 2012, THER ADV GASTROENTER, V5, P319, DOI 10.1177/1756283X12448456; Yuan F, 2008, EUR J PHARM BIOPHARM, V70, P770, DOI 10.1016/j.ejpb.2008.06.028; Zhou AP, 2006, ONCOLOGY PROGR, V6, P529	43	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101889	10.1371/journal.pone.0101889	http://dx.doi.org/10.1371/journal.pone.0101889			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004130	Green Published, Green Submitted, gold			2022-12-27	WOS:000339242700082
J	Childs, LM; England, WE; Young, MJ; Weitz, JS; Whitaker, RJ				Childs, Lauren M.; England, Whitney E.; Young, Mark J.; Weitz, Joshua S.; Whitaker, Rachel J.			CRISPR-Induced Distributed Immunity in Microbial Populations	PLOS ONE			English	Article							SHORT PALINDROMIC REPEATS; ADAPTIVE IMMUNITY; STREPTOCOCCUS-THERMOPHILUS; ANTAGONISTIC COEVOLUTION; BACTERIAL-POPULATIONS; ACQUIRED-RESISTANCE; ANTIVIRAL DEFENSE; ESCHERICHIA-COLI; PHAGE; BACTERIOPHAGE	In bacteria and archaea, viruses are the primary infectious agents, acting as virulent, often deadly pathogens. A form of adaptive immune defense known as CRISPR-Cas enables microbial cells to acquire immunity to viral pathogens by recognizing specific sequences encoded in viral genomes. The unique biology of this system results in evolutionary dynamics of host and viral diversity that cannot be fully explained by the traditional models used to describe microbe-virus coevolutionary dynamics. Here, we show how the CRISPR-mediated adaptive immune response of hosts to invading viruses facilitates the emergence of an evolutionary mode we call distributed immunity - the coexistence of multiple, equally-fit immune alleles among individuals in a microbial population. We use an eco-evolutionary modeling framework to quantify distributed immunity and demonstrate how it emerges and fluctuates in multi-strain communities of hosts and viruses as a consequence of CRISPR-induced coevolution under conditions of low viral mutation and high relative numbers of viral protospacers. We demonstrate that distributed immunity promotes sustained diversity and stability in host communities and decreased viral population density that can lead to viral extinction. We analyze sequence diversity of experimentally coevolving populations of Streptococcus thermophilus and their viruses where CRISPR-Cas is active, and find the rapid emergence of distributed immunity in the host population, demonstrating the importance of this emergent phenomenon in evolving microbial communities.	[Childs, Lauren M.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Ctr Communicable Dis Dynam, Boston, MA 02115 USA; [England, Whitney E.; Whitaker, Rachel J.] Univ Illinois, Dept Microbiol, Urbana, IL USA; [Young, Mark J.] Montana State Univ, Thermal Biol Inst, Bozeman, MT USA; [Young, Mark J.] Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT USA; [Weitz, Joshua S.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Weitz, Joshua S.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; [Whitaker, Rachel J.] Univ Illinois, Inst Genom Biol, Urbana, IL USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Illinois System; University of Illinois Urbana-Champaign; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University of Illinois System; University of Illinois Urbana-Champaign	Weitz, JS (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	jsweitz@gatech.edu; rwhitaker@life.illinois.edu	England, Whitney/AAA-5016-2019	England, Whitney/0000-0001-6712-0101; Childs, Lauren/0000-0003-3904-3895	NSF [DEB-0816885]; Institute for Advanced Computing Applications and Technologies at the University of Illinois; National Institutes of Health [5T32AI078876]; James S. McDonnell Foundation; Burroughs Wellcome Fund; Division Of Environmental Biology [0816885] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI078876] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Institute for Advanced Computing Applications and Technologies at the University of Illinois; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	RJW acknowledges support from NSF DEB-0816885 and a fellowship from the Institute for Advanced Computing Applications and Technologies at the University of Illinois. WEE acknowledges support from National Institutes of Health training grant 5T32AI078876. JSW acknowledges the support of a grant from the James S. McDonnell Foundation and support from a Career Award at the Scientific Interface from the Burroughs Wellcome Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Attar S, 2011, BIOL CHEM, V392, P277, DOI 10.1515/BC.2011.042; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Ayala F.J., 1974, Annual Rev Ecol Syst, V5, P115, DOI 10.1146/annurev.es.05.110174.000555; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2012, ANNU REV FOOD SCI T, V3, P143, DOI 10.1146/annurev-food-022811-101134; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Bikard D, 2012, CURR OPIN IMMUNOL, V24, P15, DOI 10.1016/j.coi.2011.10.005; Bohannan BJM, 1997, ECOLOGY, V78, P2303; Breitbart M, 2005, TRENDS MICROBIOL, V13, P278, DOI 10.1016/j.tim.2005.04.003; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Buckling A, 2006, P ROY SOC B-BIOL SCI, V273, P45, DOI 10.1098/rspb.2005.3279; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; Childs LM, 2012, EVOLUTION, V66, P2015, DOI 10.1111/j.1558-5646.2012.01595.x; Chopin MC, 2005, CURR OPIN MICROBIOL, V8, P473, DOI 10.1016/j.mib.2005.06.006; Cui YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002652; Desai MM, 2007, CURR BIOL, V17, P385, DOI 10.1016/j.cub.2007.01.072; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Drake JW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000520; Fisher RA, 1930, GENETICAL THEORY NAT; Forde SE, 2008, EVOLUTION, V62, P1830, DOI 10.1111/j.1558-5646.2008.00411.x; Gandon S, 2014, J EVOLUTION BIOL, V27, P303, DOI 10.1111/jeb.12291; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Haerter JO, 2012, MBIO, V3, DOI 10.1128/mBio.00126-12; He JK, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.128102; Held N. L., 2013, CRISPR CAS SYSTEMS, P221, DOI DOI 10.1007/978-3-642-34657-6; Held NL, 2013, ENVIRON MICROBIOL, V15, P3065, DOI 10.1111/1462-2920.12146; Held NL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012988; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hyman P, 2010, ADV APPL MICROBIOL, V70, P217, DOI 10.1016/S0065-2164(10)70007-1; Iranzo J, 2013, J BACTERIOL, V195, P3834, DOI 10.1128/JB.00412-13; Jiang WY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003844; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; LENSKI RE, 1985, AM NAT, V125, P585, DOI 10.1086/284364; LENSKI RE, 1988, EVOLUTION, V42, P425, DOI 10.1111/j.1558-5646.1988.tb04149.x; LEVIN BR, 1988, PHILOS T R SOC B, V319, P459, DOI 10.1098/rstb.1988.0059; Levin BR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003312; Levin BR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001171; Lopez-Pascua LDC, 2008, J EVOLUTION BIOL, V21, P853, DOI 10.1111/j.1420-9101.2008.01501.x; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; MOLINEUX IJ, 1991, NEW BIOL, V3, P230; Paez-Espino D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2440; Rainey PB, 2000, TRENDS ECOL EVOL, V15, P243, DOI 10.1016/S0169-5347(00)01871-1; Rho M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002441; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Sun CL, 2013, ENVIRON MICROBIOL, V15, P463, DOI 10.1111/j.1462-2920.2012.02879.x; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Tock MR, 2005, CURR OPIN MICROBIOL, V8, P466, DOI 10.1016/j.mib.2005.06.003; Touchon M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011126; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Weinberger AD, 2012, MBIO, V3, DOI 10.1128/mBio.00456-12; Weinberger AD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002475; Weitz JS, 2005, P NATL ACAD SCI USA, V102, P9535, DOI 10.1073/pnas.0504062102; Westra ER, 2012, ANNU REV GENET, V46, P311, DOI 10.1146/annurev-genet-110711-155447; WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/annurev.ge.25.120191.003101; Winter C, 2010, MICROBIOL MOL BIOL R, V74, P42, DOI 10.1128/MMBR.00034-09	64	47	47	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101710	10.1371/journal.pone.0101710	http://dx.doi.org/10.1371/journal.pone.0101710			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000306	Green Submitted, Green Published, gold			2022-12-27	WOS:000338637300077
J	Kang, N; Cauraugh, JH				Kang, Nyeonju; Cauraugh, James H.			Bimanual Force Variability and Chronic Stroke: Asymmetrical Hand Control	PLOS ONE			English	Article							MOTOR CORTEX EXCITABILITY; FINGER EXTENSION; INCREASES; COORDINATION; SURVIVORS; MOVEMENT; DEFICITS	The purpose of this study was to investigate force variability generated by both the paretic and non-paretic hands during bimanual force control. Nine chronic stroke individuals and nine age-matched individuals with no stroke history performed a force control task with both hands simultaneously. The task involved extending the wrist and fingers at 5%, 25%, and 50% of maximum voluntary contraction. Bimanual and unimanual force variability during bimanual force control was determined by calculating the coefficient of variation. Analyses revealed two main findings: (a) greater bimanual force variability in the stroke group than the control group and (b) increased force variability by the paretic hands during bimanual force control in comparison to the non-paretic hands at the 5% and 25% force production conditions. A primary conclusion is that post stroke bimanual force variability is asymmetrical between hands.	[Kang, Nyeonju; Cauraugh, James H.] Univ Florida, Motor Behav Lab, Appl Physiol & Kinesiol Dept, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Cauraugh, JH (corresponding author), Univ Florida, Motor Behav Lab, Appl Physiol & Kinesiol Dept, Gainesville, FL 32611 USA.	cauraugh@ufl.edu	Kang, Nyeonju/AAX-1879-2021		American Heart Association [00093013]	American Heart Association(American Heart Association)	Funding from the American Heart Association is gratefully acknowledged in supporting this research with a grant to JHC (#00093013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aramaki Y, 2006, NEUROSCIENCE, V141, P2147, DOI 10.1016/j.neuroscience.2006.05.030; Baweja HS, 2009, EXP BRAIN RES, V197, P35, DOI 10.1007/s00221-009-1883-5; Bellew JW, 2002, AGING CLIN EXP RES, V14, P35; Blennerhassett JM, 2006, ARCH PHYS MED REHAB, V87, P418, DOI 10.1016/j.apmr.2005.11.018; Cauraugh JH, 2010, HUM MOVEMENT SCI, V29, P853, DOI 10.1016/j.humov.2009.09.004; Cauraugh JH, 2005, PROG NEUROBIOL, V75, P309, DOI 10.1016/j.pneurobio.2005.04.001; Chang SH, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.10; Davids K, 2006, HUMAN SYSTEM VARIABI; Duncan PW, 2003, NEUROLOGY, V60, P291, DOI 10.1212/01.WNL.0000041493.65665.D6; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Inui N, 2002, HUM MOVEMENT SCI, V21, P131, DOI 10.1016/S0167-9457(02)00094-5; Kennedy DM, 2011, EXP BRAIN RES, V213, P351, DOI 10.1007/s00221-011-2777-x; Lang CE, 2009, J NEUROPHYSIOL, V102, P451, DOI 10.1152/jn.91310.2008; Lindberg PG, 2012, BRAIN RES, V1452, P96, DOI 10.1016/j.brainres.2012.03.007; Lodha N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083468; Lodha N, 2012, NEUROPSYCHOLOGIA, V50, P2536, DOI 10.1016/j.neuropsychologia.2012.06.025; Lodha N, 2012, CLIN NEUROPHYSIOL, V123, P787, DOI 10.1016/j.clinph.2011.08.014; Lodha N, 2010, CLIN NEUROPHYSIOL, V121, P1952, DOI 10.1016/j.clinph.2010.04.005; Maki Y, 2008, NEUROIMAGE, V42, P1295, DOI 10.1016/j.neuroimage.2008.06.045; Massie CL, 2013, NEUROREHABILITATION, V33, P185, DOI 10.3233/NRE-130944; Massie CL, 2013, CLIN NEUROPHYSIOL, V124, P371, DOI 10.1016/j.clinph.2012.07.026; Montgomery D. C., 2021, INTRO LINEAR REGRESS, P12; Naik SK, 2011, EXP BRAIN RES, V211, P1, DOI 10.1007/s00221-011-2637-8; Prodoehl J, 2010, EXP BRAIN RES, V200, P67, DOI 10.1007/s00221-009-1966-3; Quaney BM, 2005, NEUROREHAB NEURAL RE, V19, P338, DOI 10.1177/1545968305282269; Schaefer SY, 2009, NEUROPSYCHOLOGIA, V47, P2953, DOI 10.1016/j.neuropsychologia.2009.06.025; Sleimen-Malkoun R, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-11; Sosnov JJ, 2006, EXP BRAIN RES, V174, P86, DOI 10.1007/s00221-006-0422-x; Stinear JW, 2004, J CLIN NEUROPHYSIOL, V21, P124, DOI 10.1097/00004691-200403000-00008; Trlep M, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-43; Vaillancourt DE, 2006, EXP BRAIN RES, V173, P742, DOI 10.1007/s00221-006-0454-2; Wetter S, 2005, ARCH PHYS MED REHAB, V86, P776, DOI 10.1016/j.apmr.2004.08.009	33	16	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101817	10.1371/journal.pone.0101817	http://dx.doi.org/10.1371/journal.pone.0101817			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000185	gold, Green Published, Green Submitted			2022-12-27	WOS:000338637300091
J	Kauffman, J; Kittas, A; Bennett, L; Tsoka, S				Kauffman, Julie; Kittas, Aristotelis; Bennett, Laura; Tsoka, Sophia			DyCoNet: A Gephi Plugin for Community Detection in Dynamic Complex Networks	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; FUNCTIONAL MODULES; TIME-COURSE	Community structure detection has proven to be important in revealing the underlying organisation of complex networks. While most current analyses focus on static networks, the detection of communities in dynamic data is both challenging and timely. An analysis and visualisation procedure for dynamic networks is presented here, which identifies communities and sub-communities that persist across multiple network snapshots. An existing method for community detection in dynamic networks is adapted, extended, and implemented. We demonstrate the applicability of this method to detect communities in networks where individuals tend not to change their community affiliation very frequently. When stability of communities cannot be assumed, we show that the sub-community model may be a better alternative. This is illustrated through test cases of social and biological networks. A plugin for Gephi, an open-source software program used for graph visualisation and manipulation, named "DyCoNet'', was created to execute the algorithm and is freely available from https://github.com/juliemkauffman/DyCoNet.	[Kauffman, Julie; Kittas, Aristotelis; Tsoka, Sophia] Kings Coll London, Dept Informat, London, England; [Bennett, Laura] UCL, Dept Chem Engn, Ctr Proc Syst Engn, London, England	University of London; King's College London; University of London; University College London	Tsoka, S (corresponding author), Kings Coll London, Dept Informat, London, England.	sophia.tsoka@kcl.ac.uk		Tsoka, Sophia/0000-0001-8403-1282	United Kingdom Leverhulme Trust [RPG-2012-6860]	United Kingdom Leverhulme Trust	This work was funded by the United Kingdom Leverhulme Trust (RPG-2012-6860). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; Berger-Wolf T, 2010, LINK MINING: MODELS, ALGORITHMS, AND APPLICATIONS, P307, DOI 10.1007/978-1-4419-6515-8_12; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Chen B, 2013, BRIEF BIOINFORM; Chen JC, 2006, BIOINFORMATICS, V22, P2283, DOI 10.1093/bioinformatics/btl370; Davis A., 2009, DEEP S SOCIAL ANTHR; Fernandez A, 2007, PLOS COMPUT BIOL, V3, P2247, DOI 10.1371/journal.pcbi.0030226; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Freeman LC, 2003, DYNAMIC SOCIAL NETWORK MODELING AND ANALYSIS, P39; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001; Lewis ACF, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-100; Newman MEJ, 2012, NAT PHYS, V8, P25, DOI 10.1038/nphys2162; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Tang XW, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-339; Tantipathananandh C, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P717; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wang JX, 2013, PROTEOMICS, V13, P301, DOI 10.1002/pmic.201200277	21	34	34	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101357	10.1371/journal.pone.0101357	http://dx.doi.org/10.1371/journal.pone.0101357			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000497	Green Published, gold, Green Submitted			2022-12-27	WOS:000338637300037
J	Zhalnina, KV; Dias, R; Leonard, MT; de Quadros, PD; Camargo, FAO; Drew, JC; Farmerie, WG; Daroub, SH; Triplett, EW				Zhalnina, Kateryna V.; Dias, Raquel; Leonard, Michael T.; de Quadros, Patricia Dorr; Camargo, Flavio A. O.; Drew, Jennifer C.; Farmerie, William G.; Daroub, Samira H.; Triplett, Eric W.			Genome Sequence of Candidatus Nitrososphaera evergladensis from Group I.1b Enriched from Everglades Soil Reveals Novel Genomic Features of the Ammonia-Oxidizing Archaea	PLOS ONE			English	Article							CENTRAL CARBOHYDRATE-METABOLISM; STRESS-RESPONSE; NITROSOMONAS-EUROPAEA; COPPER RESISTANCE; NITROUS-OXIDE; SYSTEM; DIVERSITY; OXIDATION; BACTERIA; NITRIFICATION	The activity of ammonia-oxidizing archaea (AOA) leads to the loss of nitrogen from soil, pollution of water sources and elevated emissions of greenhouse gas. To date, eight AOA genomes are available in the public databases, seven are from the group I.1a of the Thaumarchaeota and only one is from the group I.1b, isolated from hot springs. Many soils are dominated by AOA from the group I.1b, but the genomes of soil representatives of this group have not been sequenced and functionally characterized. The lack of knowledge of metabolic pathways of soil AOA presents a critical gap in understanding their role in biogeochemical cycles. Here, we describe the first complete genome of soil archaeon Candidatus Nitrososphaera evergladensis, which has been reconstructed from metagenomic sequencing of a highly enriched culture obtained from an agricultural soil. The AOA enrichment was sequenced with the high throughput next generation sequencing platforms from Pacific Biosciences and Ion Torrent. The de novo assembly of sequences resulted in one 2.95 Mb contig. Annotation of the reconstructed genome revealed many similarities of the basic metabolism with the rest of sequenced AOA. Ca. N. evergladensis belongs to the group I.1b and shares only 40% of whole-genome homology with the closest sequenced relative Ca. N. gargensis. Detailed analysis of the genome revealed coding sequences that were completely absent from the group I.1a. These unique sequences code for proteins involved in control of DNA integrity, transporters, two-component systems and versatile CRISPR defense system. Notably, genomes from the group I.1b have more gene duplications compared to the genomes from the group I.1a. We suggest that the presence of these unique genes and gene duplications may be associated with the environmental versatility of this group.	[Zhalnina, Kateryna V.; Dias, Raquel; Leonard, Michael T.; Drew, Jennifer C.; Triplett, Eric W.] Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [de Quadros, Patricia Dorr; Camargo, Flavio A. O.] Univ Fed Rio Grande do Sul, Dept Soil Sci, Porto Alegre, RS, Brazil; [Farmerie, William G.] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Genome Sequencing Serv Lab, Gainesville, FL USA; [Daroub, Samira H.] Univ Florida, Everglades Res & Educ Ctr, Belle Glade, FL 33430 USA	State University System of Florida; University of Florida; Universidade Federal do Rio Grande do Sul; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Triplett, EW (corresponding author), Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA.	ewt@ufl.edu	Dörr de Quadros, Patricia/H-5668-2016; de Quadros, Patricia Dorr/X-4347-2019; Camargo, Flavio A O/J-6914-2013	Dörr de Quadros, Patricia/0000-0002-7742-5723; de Quadros, Patricia Dorr/0000-0002-7742-5723; Drew, Jennifer/0000-0002-4037-108X; camargo, flavio/0000-0003-1080-0549; Zhalnina, Kateryna/0000-0002-1893-1888; Daroub, Samira/0000-0003-0814-4618	National Science Foundation [MCB-0454030]; United States Department of Agriculture [2005-35319-16300, 00067345]	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture(United States Department of Agriculture (USDA))	This work was supported by the National Science Foundation (grant number MCB-0454030); and the United States Department of Agriculture (grant numbers 2005-35319-16300, 00067345). University of Florida, Interdisciplinary Center for Biotechnology Research, Electron Microscopy and Bio-Imaging lab for assistance with SEM and TEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Saez L, 2012, P NATL ACAD SCI USA, V109, P17989, DOI 10.1073/pnas.1201914109; Arp DJ, 2002, ARCH MICROBIOL, V178, P250, DOI 10.1007/s00203-002-0452-0; Auguet JC, 2010, ISME J, V4, P182, DOI 10.1038/ismej.2009.109; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Beaumont HJE, 2004, J BACTERIOL, V186, P4417, DOI 10.1128/JB.186.13.4417-4421.2004; Beaumont HJE, 2002, J BACTERIOL, V184, P2557, DOI 10.1128/JB.184.9.2557-2560.2002; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Berg IA, 2010, NAT REV MICROBIOL, V8, P447, DOI 10.1038/nrmicro2365; Berube PM, 2012, J BACTERIOL, V194, P3448, DOI 10.1128/JB.00133-12; Blainey PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016626; Brochier-Armanet C, 2011, CURR OPIN MICROBIOL, V14, P274, DOI 10.1016/j.mib.2011.04.015; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHEESEMAN P, 1972, J BACTERIOL, V112, P527, DOI 10.1128/JB.112.1.527-531.1972; Chevreux B., 1999, COMPUTER SCI BIOL P, P45; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Criscuolo A, 2011, MOL PHYLOGENET EVOL, V61, P944, DOI 10.1016/j.ympev.2011.08.029; Damste JSS, 2012, APPL ENVIRON MICROB, V78, P6866, DOI 10.1128/AEM.01681-12; Damste JSS, 2002, J LIPID RES, V43, P1641, DOI 10.1194/jlr.M200148-JLR200; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; de Koning B, 2010, ARCHAEA, V2010, DOI 10.1155/2010/960298; de Koning B, 2009, BIOCHEM SOC T, V37, P52, DOI 10.1042/BST0370052; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; Delcher Arthur L, 2003, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1003s00; Doring B, 2012, CURR TOP MEMBR, V70, P105, DOI 10.1016/B978-0-12-394316-3.00004-1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ettema TJG, 2006, MICROBIOL-SGM, V152, P1969, DOI 10.1099/mic.0.28724-0; Filee J, 2007, MICROBIOL MOL BIOL R, V71, P121, DOI 10.1128/MMBR.00031-06; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Fried L, 2013, J BACTERIOL, V195, P807, DOI 10.1128/JB.02051-12; Furumoto T, 2011, NATURE, V476, P472, DOI 10.1038/nature10250; Giner-Lamia J, 2012, PLANT PHYSIOL, V159, P1806, DOI 10.1104/pp.112.200659; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Haft DH, 2013, NUCLEIC ACIDS RES, V41, pD387, DOI 10.1093/nar/gks1234; Hallam SJ, 2006, PLOS BIOL, V4, P520, DOI 10.1371/journal.pbio.0040095; Hatzenpichler R, 2008, P NATL ACAD SCI USA, V105, P2134, DOI 10.1073/pnas.0708857105; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Jung MY, 2011, APPL ENVIRON MICROB, V77, P8635, DOI 10.1128/AEM.05787-11; Kim JG, 2012, ENVIRON MICROBIOL, V14, P1528, DOI 10.1111/j.1462-2920.2012.02740.x; Kirchman DL, 2012, P NATL ACAD SCI USA, V109, P17732, DOI 10.1073/pnas.1215654109; Klotz MG, 2008, FEMS MICROBIOL LETT, V278, P146, DOI 10.1111/j.1574-6968.2007.00970.x; Kobayashi K, 2010, P NATL ACAD SCI USA, V107, P17575, DOI 10.1073/pnas.1009598107; Konneke M, 2014, P NATL ACAD SCI USA, V111, P8239, DOI 10.1073/pnas.1402028111; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Korkhin Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000102; Kowalchuk GA, 2001, ANNU REV MICROBIOL, V55, P485, DOI 10.1146/annurev.micro.55.1.485; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lebedeva EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080835; Leblanc SKD, 2011, J BACTERIOL, V193, P3367, DOI 10.1128/JB.01534-10; Lehtovirta-Morley LE, 2011, P NATL ACAD SCI USA, V108, P15892, DOI 10.1073/pnas.1107196108; Li XF, 2009, PLANT SOIL, V324, P209, DOI 10.1007/s11104-009-9947-7; Loscher CR, 2012, BIOGEOSCIENCES, V9, P2419, DOI 10.5194/bg-9-2419-2012; Maezato Yukari, 2012, Life-Basel, V2, P229, DOI 10.3390/life2030229; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; Mosier AC, 2012, J BACTERIOL, V194, P2121, DOI 10.1128/JB.00013-12; Mosier AC, 2012, J BACTERIOL, V194, P2119, DOI 10.1128/JB.00007-12; Muller V, 2005, CURR OPIN MICROBIOL, V8, P729, DOI 10.1016/j.mib.2005.10.011; Murphy DJ, 2012, PROTOPLASMA, V249, P541, DOI 10.1007/s00709-011-0329-7; Norton JM, 2002, ARCH MICROBIOL, V177, P139, DOI 10.1007/s00203-001-0369-z; Ochsenreiter T, 2003, ENVIRON MICROBIOL, V5, P787, DOI 10.1046/j.1462-2920.2003.00476.x; Orell A, 2013, ARCHAEA, V2013, DOI 10.1155/2013/289236; Park BJ, 2010, APPL ENVIRON MICROB, V76, P7575, DOI 10.1128/AEM.01478-10; Park SJ, 2012, J BACTERIOL, V194, P6948, DOI 10.1128/JB.01869-12; Park SJ, 2012, J BACTERIOL, V194, P6940, DOI 10.1128/JB.01857-12; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Pester M, 2012, ENVIRON MICROBIOL, V14, P525, DOI 10.1111/j.1462-2920.2011.02666.x; Petitjean C, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-226; Pikuta EV, 2007, CRIT REV MICROBIOL, V33, P183, DOI 10.1080/10408410701451948; Pitcher A, 2010, ISME J, V4, P542, DOI 10.1038/ismej.2009.138; Quillaguaman J, 2010, APPL MICROBIOL BIOT, V85, P1687, DOI 10.1007/s00253-009-2397-6; Radax R, 2012, ENVIRON MICROBIOL, V14, P909, DOI 10.1111/j.1462-2920.2011.02661.x; Ragan MA, 1996, FEMS MICROBIOL LETT, V144, P151, DOI 10.1111/j.1574-6968.1996.tb08522.x; Raun WR, 1999, AGRON J, V91, P357, DOI 10.2134/agronj1999.00021962009100030001x; Rees A, 1999, MAR ECOL PROG SER, V187, P295, DOI 10.3354/meps187295; Remonsellez F, 2006, MICROBIOL-SGM, V152, P59, DOI 10.1099/mic.0.28241-0; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Roessler M, 2001, ENVIRON MICROBIOL, V3, P743, DOI 10.1046/j.1462-2920.2001.00252.x; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Rowland JL, 2013, J BACTERIOL, V195, P3724, DOI 10.1128/JB.00546-13; Santoro AE, 2011, SCIENCE, V333, P1282, DOI 10.1126/science.1208239; Schleper C, 2010, ADV MICROB PHYSIOL, V57, P1, DOI 10.1016/B978-0-12-381045-8.00001-1; Shan Yue, 2012, Subcell Biochem, V64, P159, DOI 10.1007/978-94-007-5055-5_8; Siebers B, 2005, CURR OPIN MICROBIOL, V8, P695, DOI 10.1016/j.mib.2005.10.014; Siebers B, 2004, J BACTERIOL, V186, P2179, DOI 10.1128/JB.186.7.2179-2194.2004; Smit A, 2000, GENOME RES, V10, P1468, DOI 10.1101/gr.145600; Snyder JC, 2010, APPL ENVIRON MICROB, V76, P7251, DOI 10.1128/AEM.01109-10; Sola-Landa A, 2003, P NATL ACAD SCI USA, V100, P6133, DOI 10.1073/pnas.0931429100; Spang A, 2012, ENVIRON MICROBIOL, V14, P3122, DOI 10.1111/j.1462-2920.2012.02893.x; Spang A, 2010, TRENDS MICROBIOL, V18, P331, DOI 10.1016/j.tim.2010.06.003; Stahl DA, 2012, ANNU REV MICROBIOL, V66, P83, DOI 10.1146/annurev-micro-092611-150128; Stieglmeier M, 2014, ISME J, V8, P1135, DOI 10.1038/ismej.2013.220; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tang KH, 2010, J BIOL CHEM, V285, P35848, DOI 10.1074/jbc.M110.157834; Tanghe A, 2006, TRENDS MICROBIOL, V14, P78, DOI 10.1016/j.tim.2005.12.001; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Taylor M, 2013, TRENDS BIOTECHNOL, V31, P63, DOI 10.1016/j.tibtech.2012.09.003; Tortosa P, 2001, J BACTERIOL, V183, P451, DOI 10.1128/JB.183.2.451-460.2001; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Vajrala N, 2013, P NATL ACAD SCI USA, V110, P1006, DOI 10.1073/pnas.1214272110; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; Wende A, 2009, J BACTERIOL, V191, P3852, DOI 10.1128/JB.01642-08; White MF, 2003, BIOCHEM SOC T, V31, P690, DOI 10.1042/BST0310690.; Whittaker M, 2000, BBA-BIOENERGETICS, V1459, P346, DOI 10.1016/S0005-2728(00)00171-7; Yin YB, 2010, P NATL ACAD SCI USA, V107, P6310, DOI 10.1073/pnas.0911237107; Zaparty M, 2008, J BACTERIOL, V190, P2231, DOI 10.1128/JB.01524-07; Zart D, 2000, ANTON LEEUW INT J G, V77, P49, DOI 10.1023/A:1002077726100; Zhalnina K, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00104; Zhalnina K, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00210; Zhang LM, 2010, P NATL ACAD SCI USA, V107, P17240, DOI 10.1073/pnas.1004947107	113	55	59	5	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101648	10.1371/journal.pone.0101648	http://dx.doi.org/10.1371/journal.pone.0101648			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999826	Green Submitted, gold, Green Published			2022-12-27	WOS:000338637300066
J	Bonanno, A; Giannoulaki, M; Barra, M; Basilone, G; Machias, A; Genovese, S; Goncharov, S; Popov, S; Rumolo, P; Di Bitetto, M; Aronica, S; Patti, B; Fontana, I; Giacalone, G; Ferreri, R; Buscaino, G; Somarakis, S; Pyrounaki, MM; Tsoukali, S; Mazzola, S				Bonanno, Angelo; Giannoulaki, Marianna; Barra, Marco; Basilone, Gualtiero; Machias, Athanassios; Genovese, Simona; Goncharov, Sergey; Popov, Sergey; Rumolo, Paola; Di Bitetto, Massimiliano; Aronica, Salvatore; Patti, Bernardo; Fontana, Ignazio; Giacalone, Giovanni; Ferreri, Rosalia; Buscaino, Giuseppa; Somarakis, Stylianos; Pyrounaki, Maria-Myrto; Tsoukali, Stavroula; Mazzola, Salvatore			Habitat Selection Response of Small Pelagic Fish in Different Environments. Two Examples from the Oligotrophic Mediterranean Sea	PLOS ONE			English	Article							ANCHOVY ENGRAULIS-ENCRASICOLUS; SARDINE SARDINOPS-SAGAX; HUMBOLDT CURRENT SYSTEM; EARLY-LIFE HISTORY; SPAWNING HABITAT; EUROPEAN ANCHOVY; AEGEAN SEA; CALIFORNIA CURRENT; POTENTIAL HABITAT; SICILIAN CHANNEL	A number of scientific papers in the last few years singled out the influence of environmental conditions on the spatial distribution of fish species, highlighting the need for the fisheries scientific community to investigate, besides biomass estimates, also the habitat selection of commercially important fish species. The Mediterranean Sea, although generally oligotrophic, is characterized by high habitat variability and represents an ideal study area to investigate the adaptive behavior of small pelagics under different environmental conditions. In this study the habitat selection of European anchovy Engraulis encrasicolus and European sardine Sardina pilchardus is analyzed in two areas of the Mediterranean Sea that largely differentiate in terms of environmental regimes: the Strait of Sicily and the North Aegean Sea. A number of environmental parameters were used to investigate factors influencing anchovy and sardine habitat selection. Acoustic surveys data, collected during the summer period 2002-2010, were used for this purpose. The quotient analysis was used to identify the association between high density values and environmental variables; it was applied to the entire dataset in each area in order to identify similarities or differences in the "mean'' spatial behavioral pattern for each species. Principal component analysis was applied to selected environmental variables in order to identify those environmental regimes which drive each of the two ecosystems. The analysis revealed the effect of food availability along with bottom depth selection on the spatial distribution of both species. Furthermore PCA results highlighted that observed selectivity for shallower waters is mainly associated to specific environmental processes that locally increase productivity. The common trends in habitat selection of the two species, as observed in the two regions although they present marked differences in hydrodynamics, seem to be driven by the oligotrophic character of the study areas, highlighting the role of areas where the local environmental regimes meet 'the ocean triad hypothesis'.	[Bonanno, Angelo; Barra, Marco; Basilone, Gualtiero; Genovese, Simona; Rumolo, Paola; Patti, Bernardo; Fontana, Ignazio; Giacalone, Giovanni; Ferreri, Rosalia; Buscaino, Giuseppa; Mazzola, Salvatore] CNR, Inst Coastal & Marine Environm IAMC, Detached Units Capo Granitola TP, Mazara Dell Vallo, TP, Italy; [Bonanno, Angelo; Barra, Marco; Basilone, Gualtiero; Genovese, Simona; Rumolo, Paola; Aronica, Salvatore; Patti, Bernardo; Fontana, Ignazio; Giacalone, Giovanni; Ferreri, Rosalia; Buscaino, Giuseppa; Mazzola, Salvatore] CNR, Inst Coastal & Marine Environm IAMC, Detached Units Capo Granitola TP, Naples, Italy; [Giannoulaki, Marianna; Machias, Athanassios; Somarakis, Stylianos; Pyrounaki, Maria-Myrto; Tsoukali, Stavroula] Inst Marine Biol Resources, Hellenic Ctr Marine Res, Iraklion, Greece; [Goncharov, Sergey; Popov, Sergey] Russian Fed Res Inst Fisheries & Oceanog VNIRO, Moscow, Russia; [Di Bitetto, Massimiliano] CNR, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); Hellenic Centre for Marine Research; Research lnstitute of Fisheries & Oceanography; Consiglio Nazionale delle Ricerche (CNR)	Bonanno, A (corresponding author), CNR, Inst Coastal & Marine Environm IAMC, Detached Units Capo Granitola TP, Mazara Dell Vallo, TP, Italy.	angelo.bonanno@cnr.it	Ferreri, Rosalia/AAQ-8033-2020; Barra, Marco/AAY-1562-2020; Genovese, Simona/ABH-1171-2020; Rumolo, Paola/AAY-1671-2020; Basilone, Gualtiero/D-2896-2017; Bonanno, Angelo/H-9025-2013; Patti, Bernardo/ABG-7214-2020; Rumolo, Paola/L-8109-2014; buscaino, giuseppa/O-8705-2015	Ferreri, Rosalia/0000-0001-7339-4942; Barra, Marco/0000-0002-8621-504X; Rumolo, Paola/0000-0002-1726-1077; Basilone, Gualtiero/0000-0002-5732-5055; Bonanno, Angelo/0000-0002-3868-751X; Rumolo, Paola/0000-0002-1726-1077; Patti, Bernardo/0000-0003-0193-5628; Giacalone, Giovanni/0000-0001-8172-4710; buscaino, giuseppa/0000-0002-4848-4185; aronica, salvatore/0000-0003-3489-1473; Fontana, Ignazio/0000-0002-0527-9827; Mazzola, Salvatore/0000-0002-4622-8129	Commission of the European Union through the MEDIAS Project; Italian Data Collection Program; Greece Data Collection Program	Commission of the European Union through the MEDIAS Project; Italian Data Collection Program; Greece Data Collection Program	This study was supported by the Commission of the European Union through the MEDIAS Project, Italian Data Collection Program, and Greece Data Collection Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini VN, 2002, FISH OCEANOGR, V11, P129, DOI 10.1046/j.1365-2419.2002.00201.x; Asch RG, 2013, DEEP-SEA RES PT I, V71, P79, DOI 10.1016/j.dsr.2012.08.006; Bakun A., 1996, OCEAN PROCESSES MARI; Basilone G, 2006, FISH OCEANOGR, V15, P271, DOI 10.1111/j.1365-2419.2005.00391.x; Basilone G, 2004, FISH RES, V68, P9, DOI 10.1016/j.fishres.2004.02.012; Basilone G, 2013, FISH OCEANOGR, V22, P309, DOI 10.1111/fog.12024; Bellier E, 2007, FISH OCEANOGR, V16, P1, DOI 10.1111/j.1365-2419.2006.00410.x; Bernal M, 2007, PROG OCEANOGR, V74, P210, DOI 10.1016/j.pocean.2007.04.018; Bertrand A, 2008, PROG OCEANOGR, V79, P264, DOI 10.1016/j.pocean.2008.10.018; Bonanno A, 2013, HYDROBIOLOGIA, V701, P273, DOI 10.1007/s10750-012-1285-8; Brankart J.M.., 1994, TECHNICAL REPORT; Brochier T, 2008, PROG OCEANOGR, V79, P313, DOI 10.1016/j.pocean.2008.10.004; Bustos CA, 2008, REV BIOL MAR OCEANOG, V43, P381; Cardinale M, 2009, REPORT SGMED 09 02 1; Checkley DM, 2009, CLIMATE CHANGE AND SMALL PELAGIC FISH, P12; Claramunt G, 2012, REV BIOL MAR OCEANOG, V47, P227, DOI 10.4067/S0718-19572012000200006; Cuttitta A, 2003, HYDROBIOLOGIA, V503, P117, DOI 10.1023/B:HYDR.0000008473.96144.d3; Cuttitta A, 2004, HYDROBIOLOGIA, V527, P177, DOI 10.1023/B:HYDR.0000043299.65829.2f; Dimmlich WF, 2009, J FISH BIOL, V75, P1560, DOI 10.1111/j.1095-8649.2009.02361.x; Dimmlich WF, 2004, FISH OCEANOGR, V13, P310, DOI 10.1111/j.1365-2419.2004.00296.x; Dopolo MT, 2008, AFR J MAR SCI, V30, P133, DOI 10.2989/AJMS.2008.30.1.13.463; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Ganias K, 2007, MAR BIOL, V151, P1559, DOI 10.1007/s00227-006-0601-0; Garcia A, 1996, SCI MAR, V60, P155; Giannoulaki M, 2013, FISH OCEANOGR, V22, P69, DOI 10.1111/fog.12005; Giannoulaki M, 2008, HYDROBIOLOGIA, V612, P225, DOI 10.1007/s10750-008-9498-6; Giannoulaki M, 2011, FISH OCEANOGR, V20, P367, DOI 10.1111/j.1365-2419.2011.00590.x; GRASS Development Team, 2012, GRASS 6 4 US MAN; Isari S, 2006, J PLANKTON RES, V28, P241, DOI 10.1093/plankt/fbi058; Lafuente JG, 2002, FISH OCEANOGR, V11, P31, DOI 10.1046/j.1365-2419.2002.00186.x; LAPRISE R, 1995, MAR ECOL PROG SER, V122, P73, DOI 10.3354/meps122073; Lermusiaux PFJ, 2001, DEEP-SEA RES PT I, V48, P1953, DOI 10.1016/S0967-0637(00)00114-X; Lleonart J, 2003, SCI MAR, V67, P37, DOI 10.3989/scimar.2003.67s137; MOREL A, 1978, DEEP-SEA RES, V25, P673, DOI 10.1016/0146-6291(78)90623-9; Motos L, 1996, SCI MAR, V60, P117; Palomera I, 2007, PROG OCEANOGR, V74, P377, DOI 10.1016/j.pocean.2007.04.012; PALOMERA I, 1992, MAR ECOL PROG SER, V79, P215; Paramo J, 2003, AQUAT LIVING RESOUR, V16, P239, DOI 10.1016/S0990-7440(03)00043-3; Patti B., 2004, Chemistry and Ecology, V20, P365; Patti B, 2010, SCI MAR, V74, P577, DOI 10.3989/scimar.2010.74n3577; PERRY RI, 1994, CAN J FISH AQUAT SCI, V51, P589, DOI 10.1139/f94-061; Pierre P, 2006, SCI MAR, V70, P161, DOI 10.3989/scimar.2006.70s1161; Tugores MP, 2011, MAR ECOL PROG SER, V443, P181, DOI 10.3354/meps09366; Placenti F, 2013, J MARINE SYST, V121, P36, DOI 10.1016/j.jmarsys.2013.03.012; Planque B, 2007, FISH OCEANOGR, V16, P16, DOI 10.1111/j.1365-2419.2006.00411.x; Reiss CS, 2008, FISH OCEANOGR, V17, P126, DOI 10.1111/j.1365-2419.2008.00469.x; Robinson AR, 1999, J MARINE SYST, V20, P129, DOI 10.1016/S0924-7963(98)00079-7; Sammari C, 1999, DEEP-SEA RES PT I, V46, P1671, DOI 10.1016/S0967-0637(99)00026-6; Schwartzlose RA, 1999, S AFR J MARINE SCI, V21, P289; Simmonds J., 2005, FISHERIES ACOUSTICS, V2nd edn; Somarakis S, 2004, ICES J MAR SCI, V61, P944, DOI 10.1016/j.icesjms.2004.07.018; Somarakis S, 2007, MAR BIOL, V152, P1143, DOI 10.1007/s00227-007-0761-6; Swartzman G, 2008, PROG OCEANOGR, V79, P228, DOI 10.1016/j.pocean.2008.10.021; Tsagarakis K, 2008, HYDROBIOLOGIA, V612, P215, DOI 10.1007/s10750-008-9500-3; Twatwa NM, 2005, AFR J MAR SCI, V27, P487, DOI 10.2989/18142320509504107; van der Lingen CD, 2003, BIG FISH BANG, P303; van der Lingen CD, 2004, 21 GLOBEC, V21; Weber ED, 2010, MAR ECOL PROG SER, V406, P251, DOI 10.3354/meps08544; ZERVAKIS V, 2002, MEDITERR MAR SCI, V3, P5, DOI DOI 10.12681/MMS.254; Zwolinski JP, 2011, ICES J MAR SCI, V68, P867, DOI 10.1093/icesjms/fsr038; Zwolinski JP, 2010, ICES J MAR SCI, V67, P1553, DOI 10.1093/icesjms/fsq068	61	48	49	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101498	10.1371/journal.pone.0101498	http://dx.doi.org/10.1371/journal.pone.0101498			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992576	Green Published, Green Submitted, gold			2022-12-27	WOS:000341253400079
J	Li, CY; Chen, J; Lu, BM; Shi, Z; Wang, HL; Zhang, B; Zhao, KL; Qi, W; Bao, JK; Wang, Y				Li, Chunyang; Chen, Jie; Lu, Bangmin; Shi, Zheng; Wang, Hailian; Zhang, Bin; Zhao, Kailiang; Qi, Wei; Bao, Jinku; Wang, Yi			Molecular Switch Role of Akt in Polygonatum odoratum Lectin-Induced Apoptosis and Autophagy in Human Non-Small Cell Lung Cancer A549 Cells	PLOS ONE			English	Article							MELANOMA A375 CELLS; CONCANAVALIN-A; PATHWAY; THERAPY; DEATH; BIOLOGY; P53	Polygonatum odoratum lectin (POL), isolated from traditional Chinese medicine herb (Mill.) Druce, has drawn rising attention due to its wide biological activities. In the present study, anti-tumor effects, including apoptosis- and autophagy-inducing properties of POL, were determined by a series of cell biology methods such as MTT, cellular morphology observation, flow cytometry, immunoblotting. Herein, we found that POL could simultaneously induce apoptosis and autophagy in human non-small cell lung cancer A549 cells. POL initiated apoptosis through inhibiting Akt-NF-kappa B pathway, while POL triggered autophagy via suppressing Akt-mTOR pathway, suggesting the molecular switch role of Akt in regulating between POL-induced apoptosis and autophagy. Moreover, ROS was involved in POL-induced inhibition of Akt expression, and might therefore mediate both apoptosis and autophagy in A549 cells. In addition, POL displayed no significant cytotoxicity toward normal human embryonic lung fibroblast HELF cells. Due to the anti-tumor activities, POL might become a potent anticancer drug in future therapy, which might pave the way for exploring GNA-related lectins into effective drugs in cancer treatment.	[Li, Chunyang; Lu, Bangmin; Shi, Zheng; Wang, Hailian; Zhang, Bin; Zhao, Kailiang; Qi, Wei; Bao, Jinku] Sichuan Univ, Sch Life Sci, Chengdu 610064, Peoples R China; [Li, Chunyang; Lu, Bangmin; Shi, Zheng; Wang, Hailian; Zhang, Bin; Zhao, Kailiang; Qi, Wei; Bao, Jinku] Sichuan Univ, Key Lab Bioresources & Ecoenvironm, Minist Educ, Chengdu 610064, Peoples R China; [Chen, Jie] Sichuan Acad Med Sci, Cent Lab Clin Med, Chengdu, Peoples R China; [Chen, Jie; Wang, Hailian; Wang, Yi] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China; [Wang, Hailian] Sichuan Acad Med Sci, Inst Organ Transplantat, Chengdu, Peoples R China; [Wang, Yi] Sichuan Acad Med Sci, Dept Pharm, Chengdu, Peoples R China; [Wang, Yi] Nationwide Childrens Hosp, Ctr Perinatal Res, Columbus, OH USA	Sichuan University; Sichuan University; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Bao, JK (corresponding author), Sichuan Univ, Sch Life Sci, Chengdu 610064, Peoples R China.	jinkubao@yahoo.com; Yi.Wang@nationwidechildrens.org	Wang, Yi/GLU-8903-2022; Zhao, Kailiang/AAE-2828-2021; Wang, Yi/GSD-4852-2022	Zhao, Kailiang/0000-0001-8149-1494; Wang, Yi/0000-0001-9921-0304	National Natural Science Foundation of China [81373311, 31300674, 30970643, 81173093, J1103518]; Special Program for Youth Science and the Technology Innovative Research Group of Sichuan Province, China [2011JTD0026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Program for Youth Science and the Technology Innovative Research Group of Sichuan Province, China	This work was supported in part by the National Natural Science Foundation of China (No. 81373311, No. 31300674, No. 30970643, No. 81173093 and No. J1103518), the Special Program for Youth Science and the Technology Innovative Research Group of Sichuan Province, China (No. 2011JTD0026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang CP, 2007, HEPATOLOGY, V45, P286, DOI 10.1002/hep.21509; Cheng Y, 2008, BIOCHEM BIOPH RES CO, V376, P483, DOI 10.1016/j.bbrc.2008.09.018; Cheng Y, 2013, PHARMACOL REV, V65, P1162, DOI 10.1124/pr.112.007120; Choi KS, 2012, EXP MOL MED, V44, P109, DOI 10.3858/emm.2012.44.2.033; Ciuffreda L, 2010, CURR CANCER DRUG TAR, V10, P484, DOI 10.2174/156800910791517172; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Fu LL, 2011, INT J BIOCHEM CELL B, V43, P1442, DOI 10.1016/j.biocel.2011.07.004; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Kessel D, 2007, CANCER LETT, V249, P294, DOI 10.1016/j.canlet.2006.09.009; Lee YC, 2010, EUR J PHARMACOL, V632, P23, DOI 10.1016/j.ejphar.2010.01.009; Lei HY, 2007, AUTOPHAGY, V3, P402, DOI 10.4161/auto.4280; Li CY, 2013, CELL PROLIFERAT, V46, P272, DOI 10.1111/cpr.12034; Li CY, 2011, INT J BIOCHEM CELL B, V43, P701, DOI 10.1016/j.biocel.2011.01.020; Li CY, 2011, PROCESS BIOCHEM, V46, P533, DOI 10.1016/j.procbio.2010.10.005; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Liu B, 2009, CANCER LETT, V275, P54, DOI 10.1016/j.canlet.2008.09.042; Liu B, 2010, BIOCHIMIE, V92, P1934, DOI 10.1016/j.biochi.2010.08.009; Liu B, 2009, BBA-GEN SUBJECTS, V1790, P840, DOI 10.1016/j.bbagen.2009.04.020; Liu B, 2009, ARCH BIOCHEM BIOPHYS, V482, P1, DOI 10.1016/j.abb.2008.12.003; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Meng L, 2009, CURR CHEM BIOL, V3, P324, DOI [10.2174/2212796810903030324, DOI 10.2174/2212796810903030324, DOI 10.2174/187231309789054913]; SHARON N, 1989, SCIENCE, V246, P227, DOI 10.1126/science.2552581; Shi Z, 2013, COMPUT BIOL CHEM, V47, P56, DOI 10.1016/j.compbiolchem.2013.07.001; Shi Z, 2013, CANCER LETT, V337, P149, DOI 10.1016/j.canlet.2013.06.004; Sun ZJ, 2010, APOPTOSIS, V15, P850, DOI 10.1007/s10495-010-0497-5; Thorburn A, 2008, APOPTOSIS, V13, P1, DOI 10.1007/s10495-007-0154-9; Damme EJM, 2011, ADV EXP MED BIOL, V705, P757, DOI 10.1007/978-1-4419-7877-6_39; Wang Y, 2012, HORM METAB RES, V44, P33, DOI 10.1055/s-0031-1295416; Wang Y, 2012, EXP BIOL MED, V237, P287, DOI 10.1258/ebm.2011.011251; Xu HL, 2012, J MOL MODEL, V18, P27, DOI 10.1007/s00894-011-1022-7; Yang Y, 2011, PHYTOMEDICINE, V18, P748, DOI 10.1016/j.phymed.2010.11.001	31	32	33	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101526	10.1371/journal.pone.0101526	http://dx.doi.org/10.1371/journal.pone.0101526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992302	gold, Green Published, Green Submitted			2022-12-27	WOS:000341253400084
J	Wang, SC; Lin, XL; Li, J; Zhang, TT; Wang, HY; Shi, JW; Yang, S; Zhao, WT; Xie, RY; Wei, F; Qin, YJ; Chen, L; Yang, J; Yao, KT; Xiao, D				Wang, Sheng-Chun; Lin, Xiao-Lin; Li, Jing; Zhang, Ting-Ting; Wang, Hui-Yan; Shi, Jun-Wen; Yang, Sheng; Zhao, Wen-Tao; Xie, Rao-Ying; Wei, Fang; Qin, Yu-Juan; Chen, Lin; Yang, Jie; Yao, Kai-Tai; Xiao, Dong			MicroRNA-122 Triggers Mesenchymal-Epithelial Transition and Suppresses Hepatocellular Carcinoma Cell Motility and Invasion by Targeting RhoA	PLOS ONE			English	Article							NUCLEAR FACTOR 4-ALPHA; TUMOR-SUPPRESSOR; LIPID-METABOLISM; MIR-122 EXPRESSION; DOWN-REGULATION; CANCER-CELLS; CYCLE ARREST; IN-VIVO; LIVER; METASTASIS	The loss of microRNA-122 (miR-122) expression is strongly associated with increased invasion and metastasis, and poor prognosis of hepatocellular carcinoma (HCC), however, the underlying mechanisms remain poorly understood. In the present study, we observed that miR-122 over-expression in HCC cell lines Sk-hep-1 and Bel-7402 triggered the mesenchymal-epithelial transition (MET), as demonstrated by epithelial-like morphological changes, up-regulated epithelial proteins (E-cadherin, ZO-1, alpha-catenin, occludin, BVES, and MST4), and down-regulated mesenchymal proteins (vimentin and fibronectin). The over-expression of miRNA-122 also caused cytoskeleton disruption, RhoA/Rock pathway inactivation, enhanced cell adhesion, and suppression of migration and invasion of Sk-hep-1 and Bel-7402 cells, whereas, these effects could be reversed through miR-122 inhibition. Additional studies demonstrated that the inhibition of wild-type RhoA function induced MET and inhibited cell migration and invasion, while RhoA over-expression reversed miR-122-induced MET and inhibition of migration and invasion of HCC cells, suggesting that miR-122 induced MET and suppressed the migration and invasion of HCC cells by targeting RhoA. Moreover, our results demonstrated that HNF4 alpha up-regulated its target gene miR-122 that subsequently induced MET and inhibited cell migration and invasion, whereas miR-122 inhibition reversed these HNF4 alpha-induced phenotypes. These results revealed functional and mechanistic links among the tumor suppressors HNF4 alpha, miR-122, and RhoA in EMT and invasive and metastatic phenotypes of HCC. Taken together, our study provides the first evidence that the HNF4 alpha/miR-122/RhoA axis negatively regulates EMT and the migration and invasion of HCC cells.	[Wang, Sheng-Chun; Lin, Xiao-Lin; Li, Jing; Zhang, Ting-Ting; Wang, Hui-Yan; Shi, Jun-Wen; Yang, Sheng; Zhao, Wen-Tao; Xie, Rao-Ying; Wei, Fang; Qin, Yu-Juan; Chen, Lin; Yang, Jie; Yao, Kai-Tai; Xiao, Dong] Southern Med Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China; [Xiao, Dong] Southern Med Univ, Inst Comparat Med, Guangzhou, Guangdong, Peoples R China; [Xiao, Dong] Southern Med Univ, Lab Anim Ctr, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Yao, KT (corresponding author), Southern Med Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China.	Ktyao@fimmu.com; Xiao_d@hotmail.com	wang, shengchun/AAL-7101-2020	Wang, Shengchun/0000-0003-2296-1577; Chen, Lin/0000-0002-7552-8673	National Natural Science Foundation of China [81172587, 81372896, 81100573]; Natural Science Foundation of Guangdong Province of China [9151063101000015, S2012010009212]; Science and Technology Planning Project of Guangdong Province of China [2009B060300008]; Fundamental Research Funds for the Central Universities of China [10ykpy21]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province of China(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province of China; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (Grant No. 81172587 and 81372896, to D. Xiao; Grant No. 81100573, to T. Du), the Natural Science Foundation of Guangdong Province of China (Grant No. 9151063101000015, to J.-S. Jia; Grant No. S2012010009212, to K Xu), the Science and Technology Planning Project of Guangdong Province of China (Grant No. 2009B060300008, to D. Xiao), and Fundamental Research Funds for the Central Universities of China (Grant No. 10ykpy21, to K Xu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai SM, 2009, J BIOL CHEM, V284, P32015, DOI 10.1074/jbc.M109.016774; Cheng IK, 2012, J PATHOL; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; Deng XG, 2014, LIVER INT, V34, P281, DOI 10.1111/liv.12239; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Filipowicz W, 2011, PROG DRUG RES, V67, P221, DOI 10.1007/978-3-7643-8989-5_11; Fornari F, 2009, CANCER RES, V69, P5761, DOI 10.1158/0008-5472.CAN-08-4797; Fukuhara T, 2013, J GASTROENTEROL, V48, P169, DOI 10.1007/s00535-012-0661-5; Fukui K, 2006, J CANCER RES CLIN, V132, P627, DOI 10.1007/s00432-006-0107-7; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Gou LT, 2011, J MOL MED, V89, P817, DOI 10.1007/s00109-011-0753-3; Grise F, 2009, BBA-REV CANCER, V1795, P137, DOI 10.1016/j.bbcan.2008.12.003; Hsu SH, 2013, AM J PATHOL, V183, P1719, DOI 10.1016/j.ajpath.2013.08.004; Hsu SH, 2012, J CLIN INVEST, V122, P2871, DOI 10.1172/JCI63539; Hu J, 2012, PROTEIN CELL, V3, P364, DOI 10.1007/s13238-012-2036-3; Hu TH, 2013, ONCOL REP, V30, P1707, DOI 10.3892/or.2013.2608; Jopling CL, 2012, RNA BIOL, V9, DOI 10.4161/rna.18827; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kojima K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1345; Kutay H, 2006, J CELL BIOCHEM, V99, P671, DOI 10.1002/jcb.20982; Lazarevich N, 2004, HEPATOLOGY, V39, P1038, DOI 10.1002/hep.20155; Lewis AP, 2010, BIOCHEM SOC T, V38, P1553, DOI 10.1042/BST0381553; Li CF, 2013, J VIROL, V87, P2193, DOI 10.1128/JVI.02831-12; Li J, 2013, J HEPATOL, V58, P522, DOI 10.1016/j.jhep.2012.11.011; Li XR, 2006, EJSO-EUR J SURG ONC, V32, P1130, DOI 10.1016/j.ejso.2006.05.012; Li XR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-205; Li ZY, 2011, J HEPATOL, V55, P602, DOI 10.1016/j.jhep.2010.12.023; Liang L, 2013, GASTROENTEROLOGY, V144, P624, DOI 10.1053/j.gastro.2012.11.033; Ma LN, 2010, CANCER BIOL THER, V9, P554, DOI 10.4161/cbt.9.7.11267; Nassirpour R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079655; Ning BF, 2010, CANCER RES, V70, P7640, DOI 10.1158/0008-5472.CAN-10-0824; Santangelo L, 2011, HEPATOLOGY, V53, P2063, DOI 10.1002/hep.24280; Shi JW, 2013, CELL CYCLE, V12, P1119, DOI 10.4161/cc.24164; Spath GF, 1998, J CELL BIOL, V140, P935, DOI 10.1083/jcb.140.4.935; Struckhoff AP, 2011, FRONT BIOSCI-LANDMRK, V16, P1915, DOI 10.2741/3830; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Trebicka J, 2013, J HEPATOL, V58, P234, DOI 10.1016/j.jhep.2012.10.015; Tsai WC, 2012, J CLIN INVEST, V122, P2884, DOI 10.1172/JCI63455; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Tzur G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003726; Waidmann O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045652; Wang DS, 2007, J GASTROEN HEPATOL, V22, P1916, DOI 10.1111/j.1440-1746.2006.04534.x; Wen J, 2012, J CLIN INVEST, V122, P2773, DOI 10.1172/JCI63966; Xu YM, 2011, CANCER LETT, V310, P160, DOI 10.1016/j.canlet.2011.06.027; Yang F, 2011, NEOPLASIA, V13, P590, DOI 10.1593/neo.11422; Yang YM, 2012, HEPATOLOGY, V56, P2209, DOI 10.1002/hep.25912; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yoshikawa T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00637; Zeisel MB, 2013, J HEPATOL, V58, P821, DOI 10.1016/j.jhep.2012.10.010; Zheng F, 2012, GUT, V61, P278, DOI 10.1136/gut.2011.239145	51	90	97	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101330	10.1371/journal.pone.0101330	http://dx.doi.org/10.1371/journal.pone.0101330			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992599	Green Published, gold, Green Submitted			2022-12-27	WOS:000341253400063
J	Grsboll, K; Nielsen, SS; Toft, N; Christiansen, LE				Grsboll, Kaare; Nielsen, Soren Saxmose; Toft, Nils; Christiansen, Lasse Engbo			How Fitness Reduced, Antimicrobial Resistant Bacteria Survive and Spread: A Multiple Pig - Multiple Bacterial Strain Model	PLOS ONE			English	Article							ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; MATHEMATICAL-MODEL; IN-VITRO; POPULATIONS; IMPACT; EMERGENCE; REGIMENS	More than 30% of E. coli strains sampled from pig farms in Denmark over the last five years were resistant to the commonly used antimicrobial tetracycline. This raises a number of questions: How is this high level sustained if resistant bacteria have reduced growth rates? Given that there are multiple susceptible and resistant bacterial strains in the pig intestines, how can we describe their coexistence? To what extent does the composition of these multiple strains in individual pigs influence the total bacterial population of the pig pen? What happens to a complex population when antimicrobials are used? To investigate these questions, we created a model where multiple strains of bacteria coexist in the intestines of pigs sharing a pen, and explored the parameter limits of a stable system; both with and without an antimicrobial treatment. The approach taken is a deterministic bacterial population model with stochastic elements of bacterial distributions and transmission. The rates that govern the model are process-oriented to represent growth, excretion, and uptake from environment, independent of herd and meta-population structures. Furthermore, an entry barrier and elimination process for the individual strains in each pig were implemented. We demonstrate how competitive growth between multiple bacterial strains in individual pigs, and the transmission between pigs in a pen allow for strains of antimicrobial resistant bacteria to persist in a pig population to different extents, and how quickly they can become dominant if antimicrobial treatment is initiated. The level of spread depends in a non-linear way of the parameters that govern excretion and uptake. Furthermore, the sampling of initial distributions of strains and stochastic transmission events give rise to large variation in how homogenous and how resistant the bacterial population becomes. Most important: resistant bacteria are demonstrated to survive with a disadvantage in growth rate of well over 10%.	[Grsboll, Kaare; Christiansen, Lasse Engbo] Tech Univ Denmark, Dept Appl Math & Comp Sci, DK-2800 Lyngby, Denmark; [Nielsen, Soren Saxmose; Toft, Nils] Univ Copenhagen, Dept Large Anim Sci, Frederiksberg, Denmark; [Toft, Nils] Tech Univ Denmark, Natl Vet Inst, Frederiksberg, Denmark	Technical University of Denmark; University of Copenhagen; Technical University of Denmark	Grsboll, K (corresponding author), Tech Univ Denmark, Dept Appl Math & Comp Sci, DK-2800 Lyngby, Denmark.	kagr@dtu.dk		Graesboll, Kaare/0000-0002-6258-8212; Toft, Nils/0000-0002-0265-3764; Christiansen, Lasse Engbo/0000-0001-5019-1931; Nielsen, Soren/0000-0003-2417-0787	Danish Strategic Research Council [10-0934909]	Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF))	This study was supported by the Danish Strategic Research Council (http://fivu.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-strategic-research/the-danish-council-for-strategic-research), grant number 10-0934909, through the MINIRESIST project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abatih EN, 2009, J THEOR BIOL, V256, P561, DOI 10.1016/j.jtbi.2008.10.017; D'Agata EMC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004036; DANMAP, 2012, TECHNICAL REPORT; FRETER R, 1983, INFECT IMMUN, V39, P686, DOI 10.1128/IAI.39.2.686-703.1983; GARBER AM, 1987, THEOR POPUL BIOL, V32, P326, DOI 10.1016/0040-5809(87)90053-0; Hellweger FL, 2013, FEMS MICROBIOL ECOL, V83, P622, DOI 10.1111/1574-6941.12019; Jumbe N, 2003, J CLIN INVEST, V112, P275, DOI 10.1172/JCI200316814; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; LI RC, 1994, J PHARM SCI-US, V83, P970, DOI 10.1002/jps.2600830711; Li YJ, 2008, INT J ANTIMICROB AG, V31, P369, DOI 10.1016/j.ijantimicag.2007.11.015; Mouton JW, 2005, J ANTIMICROB CHEMOTH, V55, P601, DOI 10.1093/jac/dki079; Ng KM, 2013, NATURE, V502, P96, DOI 10.1038/nature12503; Opatowski L, 2011, CURR OPIN INFECT DIS, V24, P279, DOI 10.1097/QCO.0b013e3283462362; Pepin J, 2005, CLIN INFECT DIS, V41, P1254, DOI 10.1086/496986; Philipsen KR, 2010, J THEOR BIOL, V263, P134, DOI 10.1016/j.jtbi.2009.11.011; R Core Team, 2018, R LANG ENV STAT COMP; Reeve R, 2013, J BIOPHARM STAT, V23, P648, DOI 10.1080/10543406.2012.756496; Regoes RR, 2004, ANTIMICROB AGENTS CH, V48, P3670, DOI 10.1128/AAC.48.10.3670-3676.2004; Schierack P, 2007, MICROBIOL-SGM, V153, P3830, DOI 10.1099/mic.0.2007/010173-0; Schrag SJ, 1997, P ROY SOC B-BIOL SCI, V264, P1287, DOI 10.1098/rspb.1997.0178; Silbergeld EK, 2008, ANNU REV PUBL HEALTH, V29, P151, DOI 10.1146/annurev.publhealth.29.020907.090904; Spicknall IH, 2013, AM J EPIDEMIOLOGY; Teale CJ, 2012, REV SCI TECH OIE, V31, P343; Temime L, 2008, EPIDEMIOL INFECT, V136, P289, DOI 10.1017/S0950268807009442; Treyaprasert W, 2007, INT J ANTIMICROB AG, V29, P263, DOI 10.1016/j.ijantimicag.2006.08.049; Volkova VV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036738; Winfield MD, 2003, APPL ENVIRON MICROB, V69, P3687, DOI 10.1128/AEM.69.7.3687-3694.2003	27	22	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e100458	10.1371/journal.pone.0100458	http://dx.doi.org/10.1371/journal.pone.0100458			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006965	Green Published, gold, Green Submitted			2022-12-27	WOS:000339040600014
J	Raman, H; Raman, R; Kilian, A; Detering, F; Carling, J; Coombes, N; Diffey, S; Kadkol, G; Edwards, D; McCully, M; Ruperao, P; Parkin, IAP; Batley, J; Luckett, DJ; Wratten, N				Raman, Harsh; Raman, Rosy; Kilian, Andrzej; Detering, Frank; Carling, Jason; Coombes, Neil; Diffey, Simon; Kadkol, Gururaj; Edwards, David; McCully, Margaret; Ruperao, Pradeep; Parkin, Isobel A. P.; Batley, Jacqueline; Luckett, David J.; Wratten, Neil			Genome-Wide Delineation of Natural Variation for Pod Shatter Resistance in Brassica napus	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; SILIQUA STRENGTH; CELL-SEPARATION; SEED DISPERSAL; SNP DISCOVERY; OILSEED RAPE; LINKAGE MAP; ARABIDOPSIS; GENE; QTL	Resistance to pod shattering (shatter resistance) is a target trait for global rapeseed (canola, Brassica napus L.), improvement programs to minimise grain loss in the mature standing crop, and during windrowing and mechanical harvest. We describe the genetic basis of natural variation for shatter resistance in B. napus and show that several quantitative trait loci (QTL) control this trait. To identify loci underlying shatter resistance, we used a novel genotyping-by-sequencing approach DArT-Seq. QTL analysis detected a total of 12 significant QTL on chromosomes A03, A07, A09, C03, C04, C06, and C08; which jointly account for approximately 57% of the genotypic variation in shatter resistance. Through Genome-Wide Association Studies, we show that a large number of loci, including those that are involved in shattering in Arabidopsis, account for variation in shatter resistance in diverse B. napus germplasm. Our results indicate that genetic diversity for shatter resistance genes in B. napus is limited; many of the genes that might control this trait were not included during the natural creation of this species, or were not retained during the domestication and selection process. We speculate that valuable diversity for this trait was lost during the natural creation of B. napus. To improve shatter resistance, breeders will need to target the introduction of useful alleles especially from genotypes of other related species of Brassica, such as those that we have identified.	[Raman, Harsh; Raman, Rosy; Coombes, Neil; Luckett, David J.; Wratten, Neil] Wagga Wagga Agr Inst, Graham Ctr Agr Innovat, Wagga Wagga, NSW, Australia; [Kilian, Andrzej; Detering, Frank; Carling, Jason] Univ Canberra, Div Arrays Technol Pty Ltd, Bruce, ACT, Australia; [Diffey, Simon] Univ Wollongong, Wollongong, NSW, Australia; [Kadkol, Gururaj] Tamworth Agr Inst, 4NSW Dept Primary Ind, Tamworth, NSW, Australia; [Edwards, David; Ruperao, Pradeep] Univ Queensland, Sch Agr & Food Sci, Australian Ctr Plant Funct Gen, St Lucia, Qld, Australia; [Edwards, David; Batley, Jacqueline] Univ Western Australia, Sch Plant Biol, Perth, WA 6009, Australia; [McCully, Margaret] CSIRO Div Plant Ind, Canberra, ACT, Australia; [Ruperao, Pradeep] Int Crops Res Inst Semi Arid Trop, Hyderabad, Andhra Pradesh, India; [Parkin, Isobel A. P.] Agr & Agri Food Canada, Saskatoon, SK, Canada; [Batley, Jacqueline] Univ Queensland, Sch Agr & Food Sci, St Lucia, Qld, Australia	University of Canberra; University of Wollongong; NSW Department of Primary Industries; University of Queensland; University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); Agriculture & Agri Food Canada; University of Queensland	Raman, H (corresponding author), Wagga Wagga Agr Inst, Graham Ctr Agr Innovat, Wagga Wagga, NSW, Australia.	harsh.raman@dpi.nsw.gov.au	Parkin, Isobel/AAD-6625-2020; Batley, Jacqueline/A-5723-2008; RAMAN, HARSH/N-8891-2016; Edwards, David/H-3710-2015	Batley, Jacqueline/0000-0002-5391-5824; RAMAN, HARSH/0000-0001-9761-1518; Edwards, David/0000-0001-7599-6760; Parkin, Isobel/0000-0002-5807-9466; Diffey, Simon/0000-0001-5583-0480; Kilian, Andrzej/0000-0002-2730-7462; Luckett, David John/0000-0002-1687-5413	Australian Grains Research and Development Corporation [DAN00117]	Australian Grains Research and Development Corporation(Grains R&D Corp)	This work was funded by the Australian Grains Research and Development Corporation (research project DAN00117). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Balasubramanian S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004318; Bedo J, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-35; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Butler D.G., 2009, TECHNICAL REPORT; Cheung F, 2009, PLANT CELL, V21, P1912, DOI 10.1105/tpc.108.060376; Coombes N.E, 2002, THESIS LIVERPOOL J M; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Ferrandiz C, 2000, SCIENCE, V289, P436, DOI 10.1126/science.289.5478.436; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Girin T, 2010, PLANT J, V63, P329, DOI 10.1111/j.1365-313X.2010.04244.x; Gomez-Campo C, 1999, DEV PL GEN, V4, P33; Hossain S, 2011, PLANT BREEDING, P313; Hou JN, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-238; Hu ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034253; Inaba R, 2002, THEOR APPL GENET, V105, P1159, DOI 10.1007/s00122-002-0968-3; Jenkins ES, 1999, PLANT CELL ENVIRON, V22, P159, DOI 10.1046/j.1365-3040.1999.00372.x; KADKOL GP, 1986, CAN J GENET CYTOL, V28, P365, DOI 10.1139/g86-054; KADKOL GP, 1985, EUPHYTICA, V34, P915, DOI 10.1007/BF00035431; KADKOL GP, 1986, AUST J BOT, V34, P595, DOI 10.1071/BT9860595; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kilian Andrzej, 2012, Methods Mol Biol, V888, P67, DOI 10.1007/978-1-61779-870-2_5; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Larkan NJ, 2013, NEW PHYTOL, V197, P595, DOI 10.1111/nph.12043; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Liljegren SJ, 2009, DEVELOPMENT, V136, P1909, DOI 10.1242/dev.033605; Liljegren SJ, 2004, CELL, V116, P843, DOI 10.1016/S0092-8674(04)00217-X; Liljegren SJ, 2000, NATURE, V404, P766, DOI 10.1038/35008089; LIN S, 1973, OPER RES, V21, P498, DOI 10.1287/opre.21.2.498; Lin ZW, 2012, NAT GENET, V44, P720, DOI 10.1038/ng.2281; LIU XY, 1994, J TEXTURE STUD, V25, P179, DOI 10.1111/j.1745-4603.1994.tb01325.x; Lysak MA, 2005, GENOME RES, V15, P516, DOI 10.1101/gr.3531105; MacLeod J., 1981, HARVESTING OILSEED R, P107; Matsuzawa Y, 1986, CRUCIFERAE NEWSLETTE, V11, P17; MCNAUGHT.IH, 1973, EUPHYTICA, V22, P301, DOI 10.1007/BF00022638; Meuwissen T, 2010, GENETICS, V185, P623, DOI 10.1534/genetics.110.116590; Mitsuda N, 2007, PLANT CELL, V19, P270, DOI 10.1105/tpc.106.047043; Mongkolporn O, 2003, PLANT BREEDING, V122, P479, DOI 10.1046/j.0179-9541.2003.00910.x; Morgan CL, 2000, J AGR SCI, V135, P347, DOI 10.1017/S0021859699008424; Muhlhausen A, 2013, PLANT J, V73, P824, DOI 10.1111/tpj.12079; Ogawa M, 2009, PLANT CELL, V21, P216, DOI 10.1105/tpc.108.063768; Osborn TC, 2003, GENETICS, V165, P1569; Ostergaard L, 2006, PLANT BIOTECHNOL J, V4, P45, DOI 10.1111/j.1467-7652.2005.00156.x; Peng P, 2011, P 13 INT RAP C 05 09, P185; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Qiu D, 2006, THEOR APPL GENET, V114, P67, DOI 10.1007/s00122-006-0411-2; Rajani S, 2001, CURR BIOL, V11, P1914, DOI 10.1016/S0960-9822(01)00593-0; Raman H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-277; Raman H, 2013, THEOR APPL GENET, V126, P119, DOI 10.1007/s00122-012-1966-8; Raman H, 2012, DNA RES, V19, P51, DOI 10.1093/dnares/dsr041; Raman H, 2010, GENOME, V53, P957, DOI 10.1139/G10-058; Raman R, 2012, THEOR APPL GENET, V125, P405, DOI 10.1007/s00122-012-1842-6; Ron M, 2007, ANIM GENET, V38, P429, DOI 10.1111/j.1365-2052.2007.01640.x; Shi JQ, 2009, GENETICS, V182, P851, DOI 10.1534/genetics.109.101642; SONG K, 1990, THEOR APPL GENET, V79, P497, DOI 10.1007/BF00226159; Sorefan K, 2009, NATURE, V459, P583, DOI 10.1038/nature07875; Town CD, 2006, PLANT CELL, V18, P1348, DOI 10.1105/tpc.106.041665; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; U. N., 1935, Japanese Journal of Botany, V7, P389; Verbyla AP, 2007, THEOR APPL GENET, V116, P95, DOI 10.1007/s00122-007-0650-x; Wang R, 2007, PLANT BREEDING, V126, P588, DOI 10.1111/j.1439-0523.2007.01382.x; Wen YC, 2012, CROP PASTURE SCI, V63, P1082, DOI 10.1071/CP12318; Yang TJ, 2006, PLANT CELL, V18, P1339, DOI 10.1105/tpc.105.040535; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhou Y, 2012, PLANT CELL, V24, P1034, DOI 10.1105/tpc.111.094383; Zou XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045751	69	132	142	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101673	10.1371/journal.pone.0101673	http://dx.doi.org/10.1371/journal.pone.0101673			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006804	Green Published, Green Submitted, gold			2022-12-27	WOS:000339040600055
J	Tian, SB; Yu, JC; Kang, WM; Ma, ZQ; Ye, X; Cao, ZJ				Tian, Shu-bo; Yu, Jian-chun; Kang, Wei-ming; Ma, Zhi-qiang; Ye, Xin; Cao, Zhan-jiang			Association between Dairy Intake and Gastric Cancer: A Meta-Analysis of Observational Studies	PLOS ONE			English	Article							STOMACH-CANCER; DIETARY FACTORS; PTERIDIUM-AQUILINUM; MILK CONSUMPTION; PROSTATE-CANCER; OVARIAN-CANCER; BRACKEN FERN; RISK-FACTORS; POPULATION; COHORT	Purpose: Observational studies have given inconsistent findings on the relationship between intake of dairy products and gastric cancer. We therefore conducted a systematic review with a meta-analysis of observational studies to summarize available evidence on this point. Methods: We searched the electronic literature databases of PubMed (Medline), EMBASE and the Chinese Biomedical Literature Database up until August 30, 2013. All studies were limited to the English language. Random-effects models were used to pool study results between dairy products consumption and the risk of gastric cancer. We also performed subgroup, publication bias and sensitivity analysis. Results: Eight prospective studies and 18 case-control studies were included in our analysis, with a total number of 7272 gastric cancer cases and 223,355 controls. Pooled relative risks of all studies showed no significant association between dairy intake and gastric cancer (odds ratio [OR]: 1.09, 95% confidence interval [CI]: 0.96-1.25). When study design was separately analyzed, population-based case-control studies showed a positive association between dairy intake and gastric cancer risk (OR: 1.36; 95% CI: 1.07-1.74), whereas no associations were shown by hospital-based case-control studies (OR: 0.86, 95% CI: 0.72-1.02) or cohort studies (OR = 1.01, 95% CI = 0.91-1.13). Conclusions: The meta-analysis shows that no clear association apparently exists between consumption of dairy products and gastric cancer risk. Further well-designed cohort and intervention studies should be conducted to verify this lack of association.	[Tian, Shu-bo; Yu, Jian-chun; Kang, Wei-ming; Ma, Zhi-qiang; Ye, Xin; Cao, Zhan-jiang] Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Gen Surg, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital	Yu, JC (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Gen Surg, Beijing 100730, Peoples R China.	yujch_pumch@126.com		Kang, Weiming/0000-0002-6736-4728	Beijing Municipal Natural Science Foundation of China [7132209]	Beijing Municipal Natural Science Foundation of China	This work was financially supported by Beijing Municipal Natural Science Foundation of China (No. 7132209) http://www.bjnsf.org/nsf_xmsq/nsf_zzxm/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Amelot ME, 2002, CURR MED CHEM, V9, P675, DOI 10.2174/0929867023370743; Aune D, 2012, ANN ONCOL, V23, P37, DOI 10.1093/annonc/mdr269; BOEING H, 1991, INT J CANCER, V47, P858, DOI 10.1002/ijc.2910470612; BOEING H, 1991, CANCER CAUSE CONTROL, V2, P227, DOI 10.1007/BF00052138; Chen HL, 2002, AM J CLIN NUTR, V75, P137, DOI 10.1093/ajcn/75.1.137; Chen Y, 2013, CANCER EPIDEM BIOMAR, V22, P1395, DOI 10.1158/1055-9965.EPI-13-0042; CORNEE J, 1995, EUR J EPIDEMIOL, V11, P55, DOI 10.1007/BF01719946; De Stefani Eduardo, 2004, Gastric Cancer, V7, P211, DOI 10.1007/s10120-004-0295-2; DIOMEDE L, 1993, INT J CANCER, V53, P124, DOI 10.1002/ijc.2910530123; Dong JY, 2011, BREAST CANCER RES TR, V127, P23, DOI 10.1007/s10549-011-1467-5; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El-Adawi H, 2013, IRISH J MED SCI, V182, P439, DOI 10.1007/s11845-013-0909-y; Fairfield KM, 2004, INT J CANCER, V110, P271, DOI 10.1002/ijc.20086; Fei Su Juan, 2006, Chin J Dig Dis, V7, P83, DOI 10.1111/j.1443-9573.2006.00252.x; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Franciosi CM, 2003, HEPATO-GASTROENTEROL, V50, P297; Fung KYC, 2012, BRIT J NUTR, V108, P820, DOI 10.1017/S0007114512001948; Galanis DJ, 1998, INT J EPIDEMIOL, V27, P173, DOI 10.1093/ije/27.2.173; Gao X, 2005, JNCI-J NATL CANCER I, V97, P1768, DOI 10.1093/jnci/dji402; Gao Y, 2011, CANCER EPIDEMIOL, V35, pE91, DOI 10.1016/j.canep.2011.06.006; Gomes J, 2012, TOXICOL SCI, V126, P60, DOI 10.1093/toxsci/kfr329; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; HANSSON LE, 1993, INT J CANCER, V55, P181, DOI 10.1002/ijc.2910550203; Harrison LE, 1997, CANCER-AM CANCER SOC, V80, P1021; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huang Yue-xiang, 2009, Zhonghua Yufang Yixue Zazhi, V43, P193, DOI 10.3760/cma.j.issn.0253-9624.2009.03.004; Ito LS, 2003, ANN EPIDEMIOL, V13, P24, DOI 10.1016/S1047-2797(02)00269-7; Karagianni V, 2010, ANN GASTROENTEROL, V23, P237; Khan M M H, 2004, Asian Pac J Cancer Prev, V5, P58; Kim HJ, 2002, INT J CANCER, V97, P531, DOI 10.1002/ijc.10111; KNELLER RW, 1991, CANCER, V68, P672, DOI 10.1002/1097-0142(19910801)68:3<672::AID-CNCR2820680339>3.0.CO;2-T; Ko KP, 2013, J EPIDEMIOL, V23, P337, DOI 10.2188/jea.JE20120232; Larsson SC, 2004, AM J CLIN NUTR, V80, P1353, DOI 10.1093/ajcn/80.5.1353; Lazarevic K, 2010, J BUON, V15, P89; Lissowska J, 2004, NUTR CANCER, V48, P149, DOI 10.1207/s15327914nc4802_4; Ljungh Asa, 2006, Current Issues in Intestinal Microbiology, V7, P73; Munoz N, 2001, INT J CANCER, V93, P417, DOI 10.1002/ijc.1333; Ngoan LT, 2002, BRIT J CANCER, V87, P37, DOI 10.1038/sj.bjc.6600415; NOMURA A, 1990, CANCER RES, V50, P627; Pakseresht M, 2011, CANCER CAUSE CONTROL, V22, P725, DOI 10.1007/s10552-011-9744-5; PAMUKCU AM, 1978, CANCER RES, V38, P1556; Parodi PW, 1997, J NUTR, V127, P1055, DOI 10.1093/jn/127.6.1055; Pourfarzi F, 2009, INT J CANCER, V125, P1953, DOI 10.1002/ijc.24499; Qin LQ, 2007, ASIA PAC J CLIN NUTR, V16, P467; Shahin M, 1999, MUTAT RES-GEN TOX EN, V443, P69, DOI 10.1016/S1383-5742(99)00011-3; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Silvera SAN, 2008, INT J CANCER, V123, P852, DOI 10.1002/ijc.23544; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Tokui N, 2005, J EPIDEMIOL, V15, pS98, DOI 10.2188/jea.15.S98; van der Pols JC, 2007, AM J CLIN NUTR, V86, P1722; Ward MH, 1999, AM J EPIDEMIOL, V149, P925, DOI 10.1093/oxfordjournals.aje.a009736; Werner H, 1996, ADV CANCER RES, V68, P183, DOI 10.1016/S0065-230X(08)60354-1; Yu XF, 2012, WORLD J GASTROENTERO, V18, P7362, DOI 10.3748/wjg.v18.i48.7362; Zhang JJ, 2005, NUTR CANCER, V53, P65, DOI 10.1207/s15327914nc5301_8	54	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101728	10.1371/journal.pone.0101728	http://dx.doi.org/10.1371/journal.pone.0101728			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006674	Green Published, gold, Green Submitted			2022-12-27	WOS:000339040600062
J	Azam, S; Rathore, A; Shah, TM; Telluri, M; Amindala, B; Ruperao, P; Katta, MAVSK; Varshney, RK				Azam, Sarwar; Rathore, Abhishek; Shah, Trushar M.; Telluri, Mohan; Amindala, BhanuPrakash; Ruperao, Pradeep; Katta, Mohan A. V. S. K.; Varshney, Rajeev K.			An Integrated SNP Mining and Utilization (ISMU) Pipeline for Next Generation Sequencing Data	PLOS ONE			English	Article							CHICKPEA CICER-ARIETINUM; NUCLEOTIDE POLYMORPHISM DISCOVERY; READ ALIGNMENT; TRANSCRIPTOME; CROP; DIVERSITY; ANNOTATION; SOFTWARE; GENOTYPE; FORMAT	Open source single nucleotide polymorphism (SNP) discovery pipelines for next generation sequencing data commonly requires working knowledge of command line interface, massive computational resources and expertise which is a daunting task for biologists. Further, the SNP information generated may not be readily used for downstream processes such as genotyping. Hence, a comprehensive pipeline has been developed by integrating several open source next generation sequencing (NGS) tools along with a graphical user interface called Integrated SNP Mining and Utilization (ISMU) for SNP discovery and their utilization by developing genotyping assays. The pipeline features functionalities such as pre-processing of raw data, integration of open source alignment tools (Bowtie2, BWA, Maq, NovoAlign and SOAP2), SNP prediction (SAMtools/SOAPsnp/CNS2snp and CbCC) methods and interfaces for developing genotyping assays. The pipeline outputs a list of high quality SNPs between all pairwise combinations of genotypes analyzed, in addition to the reference genome/sequence. Visualization tools (Tablet and Flapjack) integrated into the pipeline enable inspection of the alignment and errors, if any. The pipeline also provides a confidence score or polymorphism information content value with flanking sequences for identified SNPs in standard format required for developing marker genotyping (KASP and Golden Gate) assays. The pipeline enables users to process a range of NGS datasets such as whole genome re-sequencing, restriction site associated DNA sequencing and transcriptome sequencing data at a fast speed. The pipeline is very useful for plant genetics and breeding community with no computational expertise in order to discover SNPs and utilize in genomics, genetics and breeding studies. The pipeline has been parallelized to process huge datasets of next generation sequencing.	[Azam, Sarwar; Rathore, Abhishek; Shah, Trushar M.; Telluri, Mohan; Amindala, BhanuPrakash; Ruperao, Pradeep; Katta, Mohan A. V. S. K.; Varshney, Rajeev K.] Int Crops Res Inst Semi Arid Trop, Ctr Excellence Genom, Patancheru, Andhra Pradesh, India; [Ruperao, Pradeep] Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld, Australia	CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); University of Queensland	Varshney, RK (corresponding author), Int Crops Res Inst Semi Arid Trop, Ctr Excellence Genom, Patancheru, Andhra Pradesh, India.	r.k.varshney@cgiar.org	Varshney, Rajeev K/C-5295-2014	Varshney, Rajeev K/0000-0002-4562-9131; Shah, Trushar/0000-0002-0091-7981; Amindala, BhanuPrakash/0000-0001-8825-1370	CGIAR Generation Challenge Program (GCP), Mexico	CGIAR Generation Challenge Program (GCP), Mexico(CGIAR)	CGIAR Generation Challenge Program (GCP), Mexico funded this project. This work has been undertaken as a part of CGIAR Research Programme on Dryland Cereals and CGIAR Research Programme on Grain Legumes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov E, 2009, THEOR APPL GENET, V119, P507, DOI 10.1007/s00122-009-1059-5; Azam S, 2012, AM J BOT, V99, P186, DOI 10.3732/ajb.1100419; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Blanca JM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-285; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Deng XT, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-267; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Deschamps S, 2010, PLANT GENOME-US, V3, P53, DOI 10.3835/plantgenome2009.09.0026; Dubey A, 2011, DNA RES, V18, P153, DOI 10.1093/dnares/dsr007; Duran C, 2009, PLANT BIOTECHNOL J, V7, P326, DOI 10.1111/j.1467-7652.2009.00407.x; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fischer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041948; Flicek P, 2009, NAT METHODS, V6, pS6, DOI [10.1038/NMETH.1376, 10.1038/nmeth.1376]; Ganal MW, 2012, J BIOSCIENCES, V37, P821, DOI 10.1007/s12038-012-9225-3; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Gaur R, 2012, DNA RES, V19, P357, DOI 10.1093/dnares/dss018; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Gupta PK, 2008, HEREDITY, V101, P5, DOI 10.1038/hdy.2008.35; Hiremath PJ, 2012, PLANT BIOTECHNOL J, V10, P716, DOI 10.1111/j.1467-7652.2012.00710.x; Hiremath PJ, 2011, PLANT BIOTECHNOL J, V9, P922, DOI 10.1111/j.1467-7652.2011.00625.x; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Hyten DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-38; Imelfort M, 2009, BRIEF BIOINFORM, V10, P609, DOI 10.1093/bib/bbp039; Kilian B, 2012, BRIEF FUNCT GENOMICS, V11, P38, DOI 10.1093/bfgp/elr046; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; Marshall DJ, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-19; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Michael TP, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2013.03.0001in; Milne I, 2010, BIOINFORMATICS, V26, P3133, DOI 10.1093/bioinformatics/btq580; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Qi J, 2010, BIOINFORMATICS, V26, P127, DOI 10.1093/bioinformatics/btp615; Rachit KS, 2012, DNA RES, V19, P449, DOI 10.1093/dnares/dss025; Sana ME, 2011, BIOINFORMATICS, V27, P9, DOI 10.1093/bioinformatics/btq603; van Orsouw NJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001172; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Wu XL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-469; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; You FM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-59; Yu HH, 2014, PLANT BIOTECHNOL J, V12, P28, DOI 10.1111/pbi.12113	54	10	11	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101754	10.1371/journal.pone.0101754	http://dx.doi.org/10.1371/journal.pone.0101754			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003610	Green Published, gold			2022-12-27	WOS:000339242700061
J	Trier, T; Bello, N; Bush, TR; Bix, L				Trier, Tony; Bello, Nora; Bush, Tamara Reid; Bix, Laura			The Role of Packaging Size on Contamination Rates during Simulated Presentation to a Sterile Field	PLOS ONE			English	Article							BACTERIAL-CONTAMINATION; INSERTION; GLOVES	Objective: The objective of this study was to assess the impact of package size on the contact between medical devices and non-sterile surfaces (i.e. the hands of the practitioner and the outside of the package) during aseptic presentation to a simulated sterile field. Rationale for this objective stems from the decades-long problem of hospital-acquired infections. This work approaches the problem from a unique perspective, namely packaging size. Design: Randomized complete block design with subsampling. Setting: Research study conducted at professional conferences for surgical technologists and nursing professionals. Participants: Ninety-seven healthcare providers, primarily surgical technologists and nurses. Methods: Participants were gloved and asked to present the contents of six pouches of three different sizes to a simulated sterile field. The exterior of pouches and gloves of participants were coated with a simulated contaminant prior to each opening trial. After presentation to the simulated sterile field, the presence of the contaminant on package contents was recorded as indicative of contact with non-sterile surfaces and analyzed in a binary fashion using a generalized linear mixed model. Results: Recruited subjects were 26-64 years of age (81 females, 16 males), with 2.5-44 years of professional experience. Results indicated a significant main effect of pouch size on contact rate of package contents (P = 0.0108), whereby larger pouches induced greater rates of contact than smaller pouches (estimates +/- SEM: 14.7 +/- 2.9% vs. 6.0 +/- 1.7%, respectively). Discussion and Conclusion: This study utilized novel methodologies which simulate contamination in aseptic presentation. Results of this work indicate that increased contamination rates are associated with larger pouches when compared to smaller pouches. The results add to a growing body of research which investigate packaging's role in serving as a pathway for product contamination during aseptic presentation. Future work should investigate other packaging design factors (e. g. material, rigidity, and closure systems) and their role in contamination.	[Trier, Tony; Bix, Laura] Michigan State Univ, Sch Packaging, E Lansing, MI 48824 USA; [Bello, Nora] Kansas State Univ, Dept Stat, Manhattan, KS 66506 USA; [Bush, Tamara Reid] Michigan State Univ, Dept Mech Engn, E Lansing, MI 48824 USA	Michigan State University; Kansas State University; Michigan State University	Bix, L (corresponding author), Michigan State Univ, Sch Packaging, E Lansing, MI 48824 USA.	bixlaura@msu.edu	Bix, Laura/T-5117-2019	Bix, Laura/0000-0002-5779-7474	Michigan State University	Michigan State University	Funding for this study was internal from the Michigan State University. Several in-kind donations were made in support of this work through various companies, specifically: Oliver-Tolas Healthcare Packaging, Kimberly Clark, Cardinal Health, and DePuy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Crick B, 2008, ANZ J SURG, V78, P266, DOI 10.1111/j.1445-2197.2008.04433.x; Dalstrom DJ, 2008, J BONE JOINT SURG AM, V90A, P1022, DOI 10.2106/JBJS.G.00689; Dietze B, 2001, J HOSP INFECT, V49, P255, DOI 10.1053/jhin.2001.1094; Fenik Y, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-60; Jones C, 2010, ANZ J SURG, V80, P174, DOI 10.1111/j.1445-2197.2010.05211.x; Kassarjian O, 2011, THESIS MICHIGAN STAT; KLAPES NA, 1987, J HOSP INFECT, V10, P299, DOI 10.1016/0195-6701(87)90013-2; Klevens RM, 2007, ESTIMATING HLTH CARE; KONG KC, 1994, J HOSP INFECT, V26, P293, DOI 10.1016/0195-6701(94)90020-5; Malpiedi PJ, 2011, NATL STATE HEALTHCAR; MINCKLEY B, 1969, NURS RES, V18, P267; Scott RD, 2009, DIRECT MED COSTS HEA; Siegel JD, 2007, 2007 GUIDELINE ISOLA; Smith G, 2009, INJURY, V40, P163, DOI 10.1016/j.injury.2008.06.024; Sorensen P, 2008, BRIT J NEUROSURG, V22, P675, DOI 10.1080/02688690802295645; Stone PW, 2002, AM J INFECT CONTROL, V30, P145, DOI 10.1067/mic.2002.121099; Yambrach F, 2010, WILEY ENCY PACKAGING, P851	17	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e100414	10.1371/journal.pone.0100414	http://dx.doi.org/10.1371/journal.pone.0100414			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003738	gold, Green Published, Green Submitted			2022-12-27	WOS:000339242700007
J	Xia, F; Dong, FL; Yang, Y; Huang, AF; Chen, S; Sun, D; Xiong, SD; Zhang, JP				Xia, Fei; Dong, Fulu; Yang, Yi; Huang, Anfei; Chen, Si; Sun, Di; Xiong, Sidong; Zhang, Jinping			Dynamic Transcription of Long Non-Coding RNA Genes during CD4+T Cell Development and Activation	PLOS ONE			English	Article							GENOME; CHROMATIN; IDENTIFICATION; ANNOTATION; REVEALS	Background: Recent evidence shows that long non-coding RNA (LncRNA) play important regulatory roles in many biology process, including cell development, activation and oncogenesis. However, the roles of these LncRNAs in the development and activation of CD4+ T cells, which is an important component of immune response, remain unknown. Results: To predict the function of LncRNA in the development and activation of CD4+ T cells, first, we examined the expression profiles of LncRNAs and mRNAs in CD4(-) CD8(-) (DN), CD4(+)CD8(+)(DP), CD4(+)CD8(-), and activated CD4(+)CD8(-) T cells in a microarray analysis and verified these results by real time PCRs (qPCR). We found that the expression of hundreds of LncRNAs significantly changed in each process of developmental transition, including DN into DP, DP into CD4(+)CD8(-), and CD4(+)CD8(-) into activated CD4(+) T cells. A Kendall distance analysis suggested that the expression of LncRNAs in DN, DP, CD4(+)CD8(-) T cells and activated CD4(+) T cells were correlated with the expression of mRNAs in these T cells. The Blat algorithm and GO analysis suggested that LncRNAs may exert important roles in the development and activation of CD4+ T cells. These roles included proliferation, homeostasis, maturation, activation, migration, apoptosis and calcium ion transportation. Conclusion: The present study found that the expression profiles of LncRNAs in different stages of CD4(+) T cells are distinguishable. LncRNAs are involved in the key biological process in CD4(+) T cell development and activation.	[Zhang, Jinping] Soochow Univ, Inst Biol, Suzhou, Jiangsu, Peoples R China; Soochow Univ, Inst Med Sci, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China	Zhang, JP (corresponding author), Soochow Univ, Inst Biol, Suzhou, Jiangsu, Peoples R China.	j_pzhang@suda.edu.cn	zhang, jin/GXV-9154-2022		Priority Academic Development Program of Jiangsu Higher Education Institutions (PAPD); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) [IRT1075]; Jiangsu Key Laboratory of Infection and Immunity; Institutes of Biology and Medical Sciences of Soochow University; Jiangsu Provincial Innovative Research Team; Soochow University [Q413401810, Q313406711]; National Natural Science Foundation of China [31270939, 31200660]; Fulu Dong [81300553]; Natural Science Foundation of Jiangsu Province [BK2012617]; Natural Science Foundation of Jiangsu High education [13KJA310004]	Priority Academic Development Program of Jiangsu Higher Education Institutions (PAPD); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Jiangsu Key Laboratory of Infection and Immunity; Institutes of Biology and Medical Sciences of Soochow University; Jiangsu Provincial Innovative Research Team; Soochow University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fulu Dong; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Natural Science Foundation of Jiangsu High education	This work is Supported by grants from the Priority Academic Development Program of Jiangsu Higher Education Institutions (PAPD), Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT, IRT1075), Jiangsu Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences of Soochow University, Jiangsu Provincial Innovative Research Team, and intramural research funding to Jinping Zhang (Q413401810, Q313406711) from Soochow University, National Natural Science Foundation of China to Jinping Zhang (No: 31270939), Fei Xia (No: 31200660) and Fulu Dong (81300553), Natural Science Foundation of Jiangsu Province to Jinping Zhang (BK2012617) and Major Natural Science Foundation of Jiangsu High education to Jinping Zhang (13KJA310004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Fink PJ, 2013, ANNU REV IMMUNOL, V31, P31, DOI 10.1146/annurev-immunol-032712-100010; Guil S, 2012, NAT STRUCT MOL BIOL, V19, P1068, DOI 10.1038/nsmb.2428; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Haasch D, 2002, CELL IMMUNOL, V217, P78, DOI 10.1016/S0008-8749(02)00506-3; Hauptman N, 2013, INT J MOL SCI, V14, P4655, DOI 10.3390/ijms14034655; Huang Y, 2011, J PHYSIOL BIOCHEM, V67, P129, DOI 10.1007/s13105-010-0050-6; Jia H, 2010, RNA, V16, P1478, DOI 10.1261/rna.1951310; Liao Q, 2011, NUCLEIC ACIDS RES, V39, P3864, DOI 10.1093/nar/gkq1348; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Louro R, 2008, GENOMICS, V92, P18, DOI 10.1016/j.ygeno.2008.03.013; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; Murad JM, 2005, BLOOD CELL MOL DIS, V34, P1, DOI 10.1016/j.bcmd.2004.08.025; Naito T, 2011, INT IMMUNOL, V23, P661, DOI 10.1093/intimm/dxr078; Pang KC, 2009, J IMMUNOL, V182, P7738, DOI 10.4049/jimmunol.0900603; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Prasanth KV, 2007, GENE DEV, V21, P11, DOI 10.1101/gad.1484207; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Sun L, 2011, NAT CELL BIOL, V13, P958, DOI 10.1038/ncb2286; Toes REM, 1999, J EXP MED, V189, P753, DOI 10.1084/jem.189.5.753; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang RQ, 2011, CRIT REV IMMUNOL, V31, P447, DOI 10.1615/CritRevImmunol.v31.i6.10; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Wierzbicki AT, 2012, CURR OPIN PLANT BIOL, V15, P517, DOI 10.1016/j.pbi.2012.08.008; Zhang H, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-37	31	23	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101588	10.1371/journal.pone.0101588	http://dx.doi.org/10.1371/journal.pone.0101588			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003630	gold, Green Published, Green Submitted			2022-12-27	WOS:000339242700043
J	Xu, Q; Xu, X; Shi, Y; Xu, JC; Huang, BR				Xu, Qian; Xu, Xiao; Shi, Yang; Xu, Jichen; Huang, Bingru			Transgenic Tobacco Plants Overexpressing a Grass PpEXP1 Gene Exhibit Enhanced Tolerance to Heat Stress	PLOS ONE			English	Article							MAIZE PRIMARY ROOT; EXPANSIN GENE; CELL-WALLS; SUPEROXIDE-DISMUTASE; HIGH-TEMPERATURE; ALPHA-EXPANSIN; GROWTH; EXPRESSION; ELONGATION; IDENTIFICATION	Heat stress is a detrimental abiotic stress limiting the growth of many plant species and is associated with various cellular and physiological damages. Expansins are a family of proteins which are known to play roles in regulating cell wall elongation and expansion, as well as other growth and developmental processes. The in vitro roles of expansins regulating plant heat tolerance are not well understood. The objectives of this study were to isolate and clone an expansin gene in a perennial grass species (Poa pratensis) and to determine whether over-expression of expansin may improve plant heat tolerance. Tobacco (Nicotiana tabacum) was used as the model plant for gene transformation and an expansin gene PpEXP1 from Poa pratensis was cloned. Sequence analysis showed PpEXP1 belonged to a-expansins and was closely related to two expansin genes in other perennial grass species (Festuca pratensis and Agrostis stolonifera) as well as Triticum aestivum, Oryza sativa, and Brachypodium distachyon. Transgenic tobacco plants over-expressing PpEXP1 were generated through Agrobacterium-mediated transformation. Under heat stress (42 degrees C) in growth chambers, transgenic tobacco plants over-expressing the PpEXP1 gene exhibited a less structural damage to cells, lower electrolyte leakage, lower levels of membrane lipid peroxidation, and lower content of hydrogen peroxide, as well as higher chlorophyll content, net photosynthetic rate, relative water content, activity of antioxidant enzyme, and seed germination rates, compared to the wild-type plants. These results demonstrated the positive roles of PpEXP1 in enhancing plant tolerance to heat stress and the possibility of using expansins for genetic modification of cool-season perennial grasses in the development of heat-tolerant germplasm and cultivars.	[Xu, Qian; Xu, Xiao; Shi, Yang; Xu, Jichen] Beijing Forestry Univ, Natl Engn Lab Tree Breeding, Beijing, Peoples R China; [Huang, Bingru] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA	Beijing Forestry University; Rutgers State University New Brunswick	Xu, JC (corresponding author), Beijing Forestry Univ, Natl Engn Lab Tree Breeding, Beijing, Peoples R China.	jcxu282@sina.com; huang@aesop.rutgers.edu			National Natural Science Foundation of China [31128016]; Beijing Natural Science Foundation [5112015]; Rutgers Center for Turfgrass Science	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Rutgers Center for Turfgrass Science	National Natural Science Foundation of China (#31128016), Beijing Natural Science Foundation (#5112015), and Rutgers Center for Turfgrass Science for funding support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; BLUM A, 1981, CROP SCI, V21, P43, DOI 10.2135/cropsci1981.0011183X002100010013x; Chiang CM, 2014, J PLANT BIOCHEM BIOT, V23, P266, DOI 10.1007/s13562-013-0210-1; Cho HT, 2000, P NATL ACAD SCI USA, V97, P9783, DOI 10.1073/pnas.160276997; Cho HT, 1997, PLANT PHYSIOL, V113, P1137, DOI 10.1104/pp.113.4.1137; Cho HT, 1997, PLANT CELL, V9, P1661, DOI 10.1105/tpc.9.9.1661; Choi DS, 2003, PLANT CELL, V15, P1386, DOI 10.1105/tpc.011965; Christie JM, 2002, PLANT J, V32, P205, DOI 10.1046/j.1365-313X.2002.01415.x; Cosgrove DJ, 1997, PLANT CELL, V9, P1031, DOI 10.1105/tpc.9.7.1031; Cosgrove DJ, 2000, PLANT PHYSIOL BIOCH, V38, P109, DOI 10.1016/S0981-9428(00)00164-9; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; Gallois P, 1995, Methods Mol Biol, V49, P39; Goh HH, 2012, PLANT PHYSIOL, V159, P1759, DOI 10.1104/pp.112.200881; Han YY, 2012, PLANT PHYSIOL BIOCH, V54, P49, DOI 10.1016/j.plaphy.2012.02.007; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Hu LW, 2007, PHYSIOL PLANTARUM, V130, P560, DOI 10.1111/j.1399-3054.2007.00912.x; Huang J, 2000, PLANTA, V211, P467, DOI 10.1007/s004250000311; Jespersen D, 2013, INT TURFS SOC RES J, V12, P459; Kam MJ, 2005, J PLANT BIOL, V48, P304, DOI 10.1007/BF03030527; Keller E, 1995, PLANT J, V8, P795, DOI 10.1046/j.1365-313X.1995.8060795.x; Lee DK, 2003, PLANT PHYSIOL, V131, P985, DOI 10.1104/pp.009902; Li F, 2013, J BIOTECHNOL, V163, P281, DOI 10.1016/j.jbiotec.2012.11.008; Li F, 2011, J PLANT PHYSIOL, V168, P960, DOI 10.1016/j.jplph.2010.11.023; LI ZC, 1993, PLANTA, V191, P349, DOI 10.1007/BF00195692; Lin C, 2011, MOL CELLS, V31, P393, DOI 10.1007/s10059-011-0046-2; Mathews S, 2000, AM J BOT, V87, P96, DOI 10.2307/2656688; MCQUEENMASON SJ, 1995, PLANT PHYSIOL, V107, P87, DOI 10.1104/pp.107.1.87; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nilsen ET, 1996, FIELD CROP RES, P192; Ookawara R, 2005, ANN BOT-LONDON, V96, P693, DOI 10.1093/aob/mci221; PATTERSON BD, 1984, ANAL BIOCHEM, V139, P487, DOI 10.1016/0003-2697(84)90039-3; Queitsch C, 2000, PLANT CELL, V12, P479, DOI 10.1105/tpc.12.4.479; Rachmilevitch S DM, 2006, PLANT ENV INTERACTIO; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang L, 2006, PLANT CELL REP, V25, P1380, DOI 10.1007/s00299-006-0199-1; Wu YJ, 1996, PLANT PHYSIOL, V111, P765, DOI 10.1104/pp.111.3.765; Wu YJ, 2001, PLANT PHYSIOL, V126, P1471, DOI 10.1104/pp.126.4.1471; Xu JC, 2008, ENVIRON EXP BOT, V63, P240, DOI 10.1016/j.envexpbot.2007.11.011; Xu JC, 2007, J EXP BOT, V58, P3789, DOI 10.1093/jxb/erm229; YANESHITA M, 1993, THEOR APPL GENET, V87, P129, DOI 10.1007/BF00223756; Yang KA, 2006, PLANT SCI, V171, P175, DOI 10.1016/j.plantsci.2006.03.013; Yang XH, 2005, PLANT PHYSIOL, V138, P2299, DOI 10.1104/pp.105.063164; Yokotani N, 2008, PLANTA, V227, P957, DOI 10.1007/s00425-007-0670-4; Yu ZM, 2011, PLANT J, V66, P725, DOI 10.1111/j.1365-313X.2011.04533.x; Zhang JX, 1996, NEW PHYTOL, V132, P361, DOI 10.1111/j.1469-8137.1996.tb01856.x; Zhang M, 2005, PLANT J, V44, P361, DOI 10.1111/j.1365-313X.2005.02536.x; Zhou P, 2011, CROP SCI, V51, P333, DOI 10.2135/cropsci2010.07.0391	51	60	63	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e100792	10.1371/journal.pone.0100792	http://dx.doi.org/10.1371/journal.pone.0100792			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003197	gold, Green Published, Green Submitted			2022-12-27	WOS:000339242700012
J	Andersson, H; Andersson, B; Eklund, D; Ngoh, E; Persson, A; Svensson, K; Lerm, M; Blomgran, R; Stendahl, O				Andersson, Henrik; Andersson, Blanka; Eklund, Daniel; Ngoh, Eyler; Persson, Alexander; Svensson, Kristoffer; Lerm, Maria; Blomgran, Robert; Stendahl, Olle			Apoptotic Neutrophils Augment the Inflammatory Response to Mycobacterium tuberculosis Infection in Human Macrophages	PLOS ONE			English	Article							INTRACELLULAR PATHOGENS; CELL-DEATH; ACTIVATION; RECEPTOR; GROWTH; MECHANISM; AUTOPHAGY; MICE	Macrophages in the lung are the primary cells being infected by Mycobacterium tuberculosis (Mtb) during the initial manifestation of tuberculosis. Since the adaptive immune response to Mtb is delayed, innate immune cells such as macrophages and neutrophils mount the early immune protection against this intracellular pathogen. Neutrophils are short-lived cells and removal of apoptotic cells by resident macrophages is a key event in the resolution of inflammation and tissue repair. Since anti-inflammatory activity is not compatible with effective immunity to intracellular pathogens, we therefore investigated how uptake of apoptotic neutrophils modulates the function of Mtb-activated human macrophages. We show that Mtb infection exerts a potent proinflammatory activation of human macrophages with enhanced gene activation and release of proinflammatory cytokines and that this response was augmented by apoptotic neutrophils. The enhanced macrophage response is linked to apoptotic neutrophil-driven activation of the NLRP3 inflammasome and subsequent IL-1 beta signalling. We also demonstrate that apoptotic neutrophils not only modulate the inflammatory response, but also enhance the capacity of infected macrophages to control intracellular growth of virulent Mtb. Taken together, these results suggest a novel role for apoptotic neutrophils in the modulation of the macrophage-dependent inflammatory response contributing to the early control of Mtb infection.	[Andersson, Henrik; Andersson, Blanka; Eklund, Daniel; Ngoh, Eyler; Persson, Alexander; Svensson, Kristoffer; Lerm, Maria; Blomgran, Robert; Stendahl, Olle] Linkoping Univ, Fac Hlth Sci, Div Microbiol & Mol Med, Dept Clin & Expt Med, Linkoping, Sweden	Linkoping University	Stendahl, O (corresponding author), Linkoping Univ, Fac Hlth Sci, Div Microbiol & Mol Med, Dept Clin & Expt Med, Linkoping, Sweden.	Olle.Stendahl@liu.se	Lerm, Maria/AAM-8705-2020; Lerm, Maria/AAA-1780-2020	Lerm, Maria/0000-0002-5092-9892; Blomgran, Robert/0000-0002-2767-8175; Eklund, Daniel/0000-0002-6045-4800; Persson, Alexander/0000-0002-9631-2169; Andersson, Henrik/0000-0002-6020-5177	Swedish Research Council, Sida; Swedish Heart & Lung Foundation; County Council of Ostergotland; T & R Soderberg Foundations	Swedish Research Council, Sida(Swedish Research Council); Swedish Heart & Lung Foundation(Swedish Heart-Lung Foundation); County Council of Ostergotland; T & R Soderberg Foundations	This work was supported by the Swedish Research Council, Sida, the Swedish Heart & Lung Foundation, the County Council of Ostergotland and the T & R Soderberg Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso L, 2008, J LEUKOCYTE BIOL, V84, P389, DOI 10.1189/jlb.0108018; Bennouna S, 2003, J IMMUNOL, V171, P6052, DOI 10.4049/jimmunol.171.11.6052; Blomgran R, 2011, J IMMUNOL, V186, P7110, DOI 10.4049/jimmunol.1100001; Braian C, 2013, J INNATE IMMUN, V5, P591, DOI 10.1159/000348676; de Luca A, 2014, P NATL ACAD SCI USA, V111, P3526, DOI 10.1073/pnas.1322831111; Dutta RK, 2012, INT J BIOCHEM CELL B, V44, P942, DOI 10.1016/j.biocel.2012.02.021; Eklund D, 2014, J INFECT DIS, V209, P749, DOI 10.1093/infdis/jit572; Eklund D, 2010, CLIN VACCINE IMMUNOL, V17, P513, DOI 10.1128/CVI.00446-09; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Filardy AA, 2010, J IMMUNOL, V185, P2044, DOI 10.4049/jimmunol.1000017; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; HALL SE, 1994, J IMMUNOL, V153, P3218; Hedlund S, 2010, HUM IMMUNOL, V71, P535, DOI 10.1016/j.humimm.2010.02.022; HIRSCH CS, 1994, J INFECT DIS, V170, P1229, DOI 10.1093/infdis/170.5.1229; Jayaraman P, 2013, J IMMUNOL, V190, P4196, DOI 10.4049/jimmunol.1202688; Kisich KO, 2002, INFECT IMMUN, V70, P4591, DOI 10.1128/IAI.70.8.4591-4599.2002; Lowe DM, 2012, TRENDS IMMUNOL, V33, P14, DOI 10.1016/j.it.2011.10.003; Martin CJ, 2012, CELL HOST MICROBE, V12, P289, DOI 10.1016/j.chom.2012.06.010; Martineau AR, 2007, J CLIN INVEST, V117, P1988, DOI 10.1172/JCI31097; Nunes MP, 1998, J IMMUNOL, V160, P1313; O'Leary S, 2011, AM J RESP CELL MOL, V45, P172, DOI 10.1165/rcmb.2010-0319OC; Persson YAZ, 2008, MICROBES INFECT, V10, P233, DOI 10.1016/j.micinf.2007.11.007; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Redpath S, 2001, TRENDS MICROBIOL, V9, P86, DOI 10.1016/S0966-842X(00)01919-3; Rosseels V, 2006, INFECT IMMUN, V74, P3684, DOI 10.1128/IAI.01521-05; Russell DG, 2011, IMMUNOL REV, V240, P252, DOI 10.1111/j.1600-065X.2010.00984.x; Tan BH, 2006, J IMMUNOL, V177, P1864, DOI 10.4049/jimmunol.177.3.1864; Tsao T.C.Y., 1999, Tubercle and Lung Disease, V79, P279, DOI 10.1054/tuld.1999.0215; van Zandbergen G, 2004, J IMMUNOL, V173, P6521, DOI 10.4049/jimmunol.173.11.6521; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Watson RWG, 1996, J IMMUNOL, V156, P3986; Welin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020302; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Zheng LM, 2004, J IMMUNOL, V173, P6319, DOI 10.4049/jimmunol.173.10.6319	35	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101514	10.1371/journal.pone.0101514	http://dx.doi.org/10.1371/journal.pone.0101514			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000410	Green Submitted, gold, Green Published			2022-12-27	WOS:000338637300054
J	Khoo, BL; Warkiani, ME; Tan, DSW; Bhagat, AAS; Irwin, D; Lau, DP; Lim, AST; Lim, KH; Krisna, SS; Lim, WT; Yap, YS; Lee, SC; Soo, RA; Han, J; Lim, CT				Khoo, Bee Luan; Warkiani, Majid Ebrahimi; Tan, Daniel Shao-Weng; Bhagat, Ali Asgar S.; Irwin, Darryl; Lau, Dawn Pingxi; Lim, Alvin S. T.; Lim, Kiat Hon; Krisna, Sai Sakktee; Lim, Wan-Teck; Yap, Yoon Sim; Lee, Soo Chin; Soo, Ross A.; Han, Jongyoon; Lim, Chwee Teck			Clinical Validation of an Ultra High-Throughput Spiral Microfluidics for the Detection and Enrichment of Viable Circulating Tumor Cells	PLOS ONE			English	Article							EML4-ALK FUSION GENE; BREAST-CANCER; FLOW-CYTOMETRY; LUNG-CANCER; DNA; IDENTIFICATION; PROGRESSION; MUTATIONS; BLOOD	Background: Circulating tumor cells (CTCs) are cancer cells that can be isolated via liquid biopsy from blood and can be phenotypically and genetically characterized to provide critical information for guiding cancer treatment. Current analysis of CTCs is hindered by the throughput, selectivity and specificity of devices or assays used in CTC detection and isolation. Methodology/Principal Findings: Here, we enriched and characterized putative CTCs from blood samples of patients with both advanced stage metastatic breast and lung cancers using a novel multiplexed spiral microfluidic chip. This system detected putative CTCs under high sensitivity (100%, n = 56) (Breast cancer samples: 12-1275 CTCs/ml; Lung cancer samples: 10-1535 CTCs/ml) rapidly from clinically relevant blood volumes (7.5 ml under 5 min). Blood samples were completely separated into plasma, CTCs and PBMCs components and each fraction were characterized with immunophenotyping (Pan-cytokeratin/CD45, CD44/CD24, EpCAM), fluorescence in-situ hybridization (FISH) (EML4-ALK) or targeted somatic mutation analysis. We used an ultra-sensitive mass spectrometry based system to highlight the presence of an EGFR-activating mutation in both isolated CTCs and plasma cell-free DNA (cf-DNA), and demonstrate concordance with the original tumor-biopsy samples. Conclusions/Significance: We have clinically validated our multiplexed microfluidic chip for the ultra high-throughput, lowcost and label-free enrichment of CTCs. Retrieved cells were unlabeled and viable, enabling potential propagation and realtime downstream analysis using next generation sequencing (NGS) or proteomic analysis.	[Khoo, Bee Luan; Lim, Chwee Teck] Natl Univ Singapore, Mechanobiol Inst, Singapore 117548, Singapore; [Warkiani, Majid Ebrahimi; Han, Jongyoon; Lim, Chwee Teck] Singapore MIT Alliance Res & Technol SMART Ctr, BioSyst & Micromech BioSyM IRG, Singapore, Singapore; [Lim, Chwee Teck] Natl Univ Singapore, Dept Biomed Engn, Singapore 117548, Singapore; [Tan, Daniel Shao-Weng; Lau, Dawn Pingxi; Krisna, Sai Sakktee; Lim, Wan-Teck; Yap, Yoon Sim] Natl Canc Ctr Singapore, Dept Med Oncol, Singapore, Singapore; [Tan, Daniel Shao-Weng; Lau, Dawn Pingxi; Krisna, Sai Sakktee] Natl Canc Ctr Singapore, Canc Therapeut Res Lab, Singapore, Singapore; [Bhagat, Ali Asgar S.; Lim, Chwee Teck] Clearbridge BioMed Pte Ltd, Singapore, Singapore; [Irwin, Darryl] Sequenom Inc, San Diego, CA USA; [Lim, Alvin S. T.; Lim, Kiat Hon] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore; [Lee, Soo Chin; Soo, Ross A.] Natl Univ Singapore Hosp, Dept Hematol Oncol, Singapore, Singapore; [Han, Jongyoon] MIT, Dept Elect Engn & Comp Sci, Dept Biol Engn, Cambridge, MA 02139 USA	National University of Singapore; Singapore-MIT Alliance for Research & Technology Centre (SMART); National University of Singapore; National Cancer Centre Singapore (NCCS); National Cancer Centre Singapore (NCCS); Sequenom; Singapore General Hospital; National University of Singapore; Massachusetts Institute of Technology (MIT)	Han, J (corresponding author), Singapore MIT Alliance Res & Technol SMART Ctr, BioSyst & Micromech BioSyM IRG, Singapore, Singapore.	jyhan@mit.edu; ctlim@nus.edu.sg	Warkiani, Majid Ebrahimi/AAK-7467-2020; Lee, Soo Chin/S-9111-2016; Lim, Darren Wan-Teck/V-8435-2019; Khoo, Bee Luan/AAW-6696-2021; Lim, Darren Wan Teck/L-2007-2016; Lim, chwee Teck/B-3307-2011; Krisna, Sai Sakktee/N-4891-2015; EBRAHIMI WARKIANI, MAJID/J-8838-2015	Lee, Soo Chin/0000-0002-5835-6419; Lim, Darren Wan-Teck/0000-0002-4655-0206; Khoo, Bee Luan/0000-0003-1100-9994; Lim, Darren Wan Teck/0000-0002-4655-0206; Lim, chwee Teck/0000-0003-4019-9782; Krisna, Sai Sakktee/0000-0001-6733-6869; EBRAHIMI WARKIANI, MAJID/0000-0002-4184-1944; Yap, Yoon-Sim/0000-0002-0347-5066; Bhagat, Ali Asgar/0000-0002-4695-8762	Mechanobiology Institute (MBI); Singapore-MIT Alliance for Research and Technology (SMART) Centre (BioSyM IRG); Clearbridge BioMedics Pte Ltd	Mechanobiology Institute (MBI); Singapore-MIT Alliance for Research and Technology (SMART) Centre (BioSyM IRG); Clearbridge BioMedics Pte Ltd	Financial support by the Mechanobiology Institute (MBI) and Singapore-MIT Alliance for Research and Technology (SMART) Centre (BioSyM IRG). Clearbridge BioMedics Pte Ltd provided support in the form of salary for author AASB but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alix-Panabieres C, 2012, ANNU REV MED, V63, P199, DOI 10.1146/annurev-med-062310-094219; Allan AL, 2005, CYTOM PART A, V65A, P4, DOI 10.1002/cyto.a.20132; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; De Mattos-Arruda L, 2013, NAT REV CLIN ONCOL, V10, P377, DOI 10.1038/nrclinonc.2013.80; Ding CM, 2004, P NATL ACAD SCI USA, V101, P10762, DOI 10.1073/pnas.0403962101; Farace F, 2011, BRIT J CANCER, V105, P847, DOI 10.1038/bjc.2011.294; Gertler R, 2003, RECENT RES CANCER, V162, P149; Guan G, 2013, P 17 INT C MIN SYST, P23; He W, 2007, P NATL ACAD SCI USA, V104, P11760, DOI 10.1073/pnas.0703875104; Hou HW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01259; Jin C, 2013, LAB CHIP; Khoo B, 2014, ULTRA HIGH THROUGHPU, P1; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Majid EW, 2013, CISM COURSES LECT, V546, P107, DOI 10.1007/978-3-7091-1574-9_6; Majid EW, 2013, LAB CHIP; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Paris PL, 2009, CANCER LETT, V277, P164, DOI 10.1016/j.canlet.2008.12.007; Parker WT, 2011, J CLIN ONCOL, V29, P4250, DOI 10.1200/JCO.2011.35.0934; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Tan SJ, 2010, BIOSENS BIOELECTRON, V26, P1701, DOI 10.1016/j.bios.2010.07.054; Thiery JP, 2013, CANCER CELL, V23, P272, DOI 10.1016/j.ccr.2013.03.004; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Warkiani ME, 2013, ACS NANO, V7, P1882, DOI 10.1021/nn305616k; Yip PY, 2013, J THORAC ONCOL, V8, P408, DOI 10.1097/JTO.0b013e318283558e; Zheng SY, 2011, BIOMED MICRODEVICES, V13, P203, DOI 10.1007/s10544-010-9485-3	28	142	144	5	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e99409	10.1371/journal.pone.0099409	http://dx.doi.org/10.1371/journal.pone.0099409			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999991	Green Published, Green Submitted, gold			2022-12-27	WOS:000338637300004
J	Ankarfeldt, MZ; Angquist, L; Stocks, T; Jakobsen, MU; Overvad, K; Halkjaer, J; Saris, WHM; Astrup, A; Sorensen, TIA				Ankarfeldt, Mikkel Z.; Angquist, Lars; Stocks, Tanja; Jakobsen, Marianne U.; Overvad, Kim; Halkjaer, Jytte; Saris, Wim H. M.; Astrup, Arne; Sorensen, Thorkild I. A.			Body Characteristics, Dietary Protein and Body Weight Regulation. Reconciling Conflicting Results from Intervention and Observational Studies?	PLOS ONE			English	Article							ELECTRONIC MEDICAL-RECORD; MIDDLE-AGED MEN; WAIST CIRCUMFERENCE; GLYCEMIC INDEX; DATABASE; SIMULATION; MORTALITY; HEALTH; TRIALS	Background/Objectives: Physiological evidence indicates that high-protein diets reduce caloric intake and increase thermogenic response, which may prevent weight gain and regain after weight loss. Clinical trials have shown such effects, whereas observational cohort studies suggest an association between greater protein intake and weight gain. In both types of studies the results are based on average weight changes, and show considerable diversity in both directions. This study investigates whether the discrepancy in the evidence could be due to recruitment of overweight and obese individuals into clinical trials. Subjects/Methods: Data were available from the European Diet, Obesity and Genes (DiOGenes) post-weight-loss weight-maintenance trial and the Danish Diet, Cancer and Health (DCH) cohort. Participants of the DCH cohort were matched with participants from the DiOGenes trial on gender, diet, and body characteristics. Different subsets of the DCH-participants, comparable with the trial participants, were analyzed for weight maintenance according to the randomization status (high or low protein) of the matched trial participants. Results: Trial participants were generally heavier, had larger waist circumference and larger fat mass than the participants in the entire DCH cohort. A better weight maintenance in the high-protein group compared to the low protein group was observed in the subgroups of the DCH cohort matching body characteristics of the trial participants. Conclusion: This modified observational study, minimized the differences between the RCT and observational data with regard to dietary intake, participant characteristics and statistical analysis. Compared with low protein diet the high protein diet was associated with better weight maintenance when individuals with greater body mass index and waist circumference were analyzed. Selecting subsets of large-scale observational cohort studies with similar characteristics as participants in clinical trials may reconcile the otherwise conflicting results.	[Ankarfeldt, Mikkel Z.; Angquist, Lars; Sorensen, Thorkild I. A.] Bispebjerg & Frederiksberg Hosp, Inst Prevent Med, Copenhagen, Denmark; [Ankarfeldt, Mikkel Z.] Univ Copenhagen, Fac Med & Hlth Sci, Copenhagen, Denmark; [Stocks, Tanja] Lund Univ, Dept Clin Sci Malmo Diabet & Cardiovasc Dis Genet, Lund, Sweden; [Stocks, Tanja] Umea Univ, Dept Surg & Perioperat Sci Urol & Androl, Umea, Sweden; [Jakobsen, Marianne U.; Overvad, Kim] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Halkjaer, Jytte] Danish Canc Soc, Res Ctr, Copenhagen, Denmark; [Saris, Wim H. M.] Univ Maastricht, NUTRIM Sch Nutr Toxicol & Metab, Maastricht, Netherlands; [Astrup, Arne] Univ Copenhagen, Fac Sci, Dept Nutr Exercise & Sports NEXS, Frederiksberg, Denmark; [Sorensen, Thorkild I. A.] Univ Copenhagen, Novo Nordisk Fdn, Fac Med & Hlth Sci, Ctr Basic Metab Res, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Lund University; Umea University; Aarhus University; Danish Cancer Society; Maastricht University; Maastricht University Medical Centre (MUMC); University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen	Ankarfeldt, MZ (corresponding author), Bispebjerg & Frederiksberg Hosp, Inst Prevent Med, Copenhagen, Denmark.	mikkelza@gmail.com	Jakobsen, Marianne Uhre/I-8550-2018; Astrup, Arne/B-1407-2015	Jakobsen, Marianne Uhre/0000-0001-6518-4136; Angquist, Lars/0000-0002-9516-4424; Astrup, Arne/0000-0001-8968-8996; Overvad, Kim/0000-0001-6429-7921	Danish Council for Strategic Research [09-067111]	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This work is carried out as a part of the research program of Gene-diet interactions in obesity (GENDINOB). GENDINOB is supported by the Danish Council for Strategic Research (Grant 09-067111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abete I, 2010, NUTR REV, V68, P214, DOI 10.1111/j.1753-4887.2010.00280.x; Ankarfeldt MZ, 2014, INT J OBES IN PRESS; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Bigaard J, 2005, INT J OBESITY, V29, P778, DOI 10.1038/sj.ijo.0802976; Bigaard J, 2003, OBES RES, V11, P895, DOI 10.1038/oby.2003.123; Britton A, 1998, HEALTH TECHNOL ASSES, V2, pi; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Danaei G, 2012, AM J EPIDEMIOL, V175, P250, DOI 10.1093/aje/kwr301; Deeks J J, 2003, Health Technol Assess, V7, piii; Du HD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017436; Due A, 2004, INT J OBESITY, V28, P1283, DOI 10.1038/sj.ijo.0802767; Everitt B. S, 2011, CLUSTER ANAL, DOI DOI 10.1002/9780470977811; Guo S.Y., 2014, PROPENSITY SCORE ANA; Halkjaer J, 2011, INT J OBESITY, V35, P1104, DOI 10.1038/ijo.2010.254; Halton TL, 2004, J AM COLL NUTR, V23, P373, DOI 10.1080/07315724.2004.10719381; Hernan MA, 2008, EPIDEMIOLOGY, V19, P766, DOI 10.1097/EDE.0b013e3181875e61; Hernan MA, 2012, CLIN TRIALS, V9, P48, DOI 10.1177/1740774511420743; HORWITZ RI, 1990, AM J MED, V89, P630, DOI 10.1016/0002-9343(90)90182-D; Johnson RA., 2007, APPL MULTIVARIATE ST; Lajous M, 2013, AM J EPIDEMIOL, V178, P382, DOI 10.1093/aje/kws478; Larsen TM, 2010, OBES REV, V11, P76, DOI 10.1111/j.1467-789X.2009.00603.x; Larsen TM, 2010, NEW ENGL J MED, V363, P2102, DOI 10.1056/NEJMoa1007137; MacLehose R R, 2000, Health Technol Assess, V4, P1; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Michaelsen KF, 2014, AM J CLIN NUTR, V99, p718S, DOI 10.3945/ajcn.113.072603; Munsters MJ, 2013, APPL PHYSIOL NUTR ME, V38, P1107, DOI 10.1139/apnm-2012-0409; Paddon-Jones D, 2008, AM J CLIN NUTR, V87, p1558S, DOI 10.1093/ajcn/87.5.1558S; Schneeweiss S, 2007, MED CARE, V45, pS131, DOI 10.1097/MLR.0b013e318070c08e; Tannen RL, 2008, PHARMACOEPIDEM DR S, V17, P671, DOI 10.1002/pds.1584; Tannen RL, 2007, J CLIN EPIDEMIOL, V60, P686, DOI 10.1016/j.jclinepi.2006.10.012; Tannen RL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b81; Tannen RL, 2006, J CLIN EPIDEMIOL, V59, P254, DOI 10.1016/j.jclinepi.2005.08.008; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; Vergnaud AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057300; Weiner MG, 2008, PHARMACOEPIDEM DR S, V17, P661, DOI 10.1002/pds.1585	35	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101134	10.1371/journal.pone.0101134	http://dx.doi.org/10.1371/journal.pone.0101134			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992329	Green Published, Green Submitted, gold			2022-12-27	WOS:000341253400045
J	Green, RE; Bower, AS; Lugo-Fernandez, A				Green, Rebecca E.; Bower, Amy S.; Lugo-Fernandez, Alexis			First Autonomous Bio-Optical Profiling Float in the Gulf of Mexico Reveals Dynamic Biogeochemistry in Deep Waters	PLOS ONE			English	Article							INHERENT OPTICAL-PROPERTIES; DISSOLVED ORGANIC-MATTER; TEMPORAL VARIABILITY; CONTINENTAL-MARGIN; NORTH-ATLANTIC; OCEAN; PHYTOPLANKTON; SCATTERING; PARTICLES; BIOMASS	Profiling floats equipped with bio-optical sensors well complement ship-based and satellite ocean color measurements by providing highly-resolved time-series data on the vertical structure of biogeochemical processes in oceanic waters. This is the first study to employ an autonomous profiling (APEX) float in the Gulf of Mexico for measuring spatiotemporal variability in bio-optics and hydrography. During the 17-month deployment (July 2011 to December 2012), the float mission collected profiles of temperature, salinity, chlorophyll fluorescence, particulate backscattering (b(bp)), and colored dissolved organic matter (CDOM) fluorescence from the ocean surface to a depth of 1,500 m. Biogeochemical variability was characterized by distinct depth trends and local "hot spots", including impacts from mesoscale processes associated with each of the water masses sampled, from ambient deep waters over the Florida Plain, into the Loop Current, up the Florida Canyon, and eventually into the Florida Straits. A deep chlorophyll maximum (DCM) occurred between 30 and 120 m, with the DCM depth significantly related to the unique density layer rho = 1023.6 (R-2 = 0.62). Particulate backscattering, b(bp), demonstrated multiple peaks throughout the water column, including from phytoplankton, deep scattering layers, and resuspension. The bio-optical relationship developed between b(bp) and chlorophyll (R-2 = 0.49) was compared to a global relationship and could significantly improve regional ocean-color algorithms. Photooxidation and autochthonous production contributed to CDOM distributions in the upper water column, whereas in deep water, CDOM behaved as a semi-conservative tracer of water masses, demonstrating a tight relationship with density (R-2 = 0.87). In the wake of the Deepwater Horizon oil spill, this research lends support to the use of autonomous drifting profilers as a powerful tool for consideration in the design of an expanded and integrated observing network for the Gulf of Mexico.	[Green, Rebecca E.; Lugo-Fernandez, Alexis] Bur Ocean Energy Management, Environm Studies Sect, New Orleans, LA 70123 USA; [Bower, Amy S.] Woods Hole Oceanog Inst, Dept Phys Oceanog, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Green, RE (corresponding author), Bur Ocean Energy Management, Environm Studies Sect, New Orleans, LA 70123 USA.	rebecca.green@boem.gov		Bower, Amy/0000-0003-0902-4984	Bureau of Ocean Energy Management (BOEM) [M10PC00112]	Bureau of Ocean Energy Management (BOEM)	This project was funded by Bureau of Ocean Energy Management (BOEM) Contract M10PC00112 to Leidos, Inc. with subcontract to ASB (www.boem.gov). BOEM employees, REG and ALF, were involved in the study design, data analysis, decision to publish, and preparation of the manuscript.	Barnard A. H., 2013, OCEAN NEWS TECHNOL, V19, P16; BIGGS DC, 1994, J GEOPHYS RES-OCEANS, V99, P7371, DOI 10.1029/93JC02153; Biggs Douglas C., 2001, Gulf of Mexico Science, V19, P7; BOEHME J, 1993, MAR ECOL PROG SER, V97, P1, DOI 10.3354/meps097001; Boss E, 2008, LIMNOL OCEANOGR, V53, P2112, DOI 10.4319/lo.2008.53.5_part_2.2112; Boss E, 2001, J GEOPHYS RES-OCEANS, V106, P9499, DOI 10.1029/2000JC900008; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; Briggs N, 2011, DEEP-SEA RES PT I, V58, P1031, DOI 10.1016/j.dsr.2011.07.007; Conmy RN, 2004, MAR CHEM, V89, P127, DOI 10.1016/j.marchem.2004.02.010; Cordes EE, 2008, DEEP-SEA RES PT I, V55, P777, DOI 10.1016/j.dsr.2008.03.005; D'Sa EJ, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031192; Davis RE, 2001, J ATMOS OCEAN TECH, V18, P982, DOI 10.1175/1520-0426(2001)018<0982:PAAOAI>2.0.CO;2; DeRada S, 2009, OCEANS 2009 MTS IEEE, P1; El-Sayed S.Z., 1972, CHEM PRIMARY PRODUCT, P8; Estapa ML, 2013, BIOGEOSCIENCES, V10, P5517, DOI 10.5194/bg-10-5517-2013; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; GARDNER WD, 1990, DEEP-SEA RES, V37, P401, DOI 10.1016/0198-0149(90)90016-O; Green RE, 2003, LIMNOL OCEANOGR, V48, P2377, DOI 10.4319/lo.2003.48.6.2377; Green RE, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004594; Gruber N, 2011, PHILOS T R SOC A, V369, P1980, DOI 10.1098/rsta.2011.0003; Hansell DA, 2013, ANNU REV MAR SCI, V5, P421, DOI 10.1146/annurev-marine-120710-100757; Hansell DA, 2009, OCEANOGRAPHY, V22, P202, DOI 10.5670/oceanog.2009.109; HOBSON LA, 1972, DEEP-SEA RES, V19, P297, DOI 10.1016/0011-7471(72)90023-X; Huot Y, 2008, BIOGEOSCIENCES, V5, P495, DOI 10.5194/bg-5-495-2008; Jochens AE, 2013, MAR TECHNOL SOC J, V47, P118, DOI 10.4031/MTSJ.47.1.11; Kaltenberg A. M., 2007, Gulf of Mexico Science, V25, P97; Leben RR, 2005, GEOPH MONOG SERIES, V161, P181; Lohrenz S, 2014, US GULF MEX CARB CYC, P28; Montgomery RB, 1941, J MAR RES, V4, P198; Morel A, 2001, J GEOPHYS RES-OCEANS, V106, P7163, DOI 10.1029/2000JC000319; MULLERKARGER FE, 1991, J GEOPHYS RES-OCEANS, V96, P12645, DOI 10.1029/91JC00787; National Oceanographic and Atmospheric Administration, 2013, GULF MEX DAT ATL BOT; National Oceanographic and Atmospheric Administration, 2011, 25 NOAA NOS OR R; National Research Council, 2013, EC SERV APPR ASS IMP; Nelson N.B., 2002, BIOGEOCHEMISTRY MARI, P547; Nelson NB, 1998, DEEP-SEA RES PT I, V45, P931, DOI 10.1016/S0967-0637(97)00106-4; NOWLIN WD, 1967, J MAR RES, V25, P29; Operational Science Advisory Team, 2010, SUMM REP SUBS SUBS O; Qian YR, 2003, CONT SHELF RES, V23, P1, DOI 10.1016/S0278-4343(02)00173-5; Robbins LL, 2014, US GULF MEX CARB CYC, P17; Rossby T, 1986, J ATMOS OCEAN TECH, V3, P672, DOI 10.1175/1520-0426(1986)003<0672:TRS>2.0.CO;2; Rowe GT, 2008, DEEP-SEA RES PT II, V55, P2699, DOI 10.1016/j.dsr2.2008.07.020; Stramski D, 2001, APPL OPTICS, V40, P2929, DOI 10.1364/AO.40.002929; Swan CM, 2009, DEEP-SEA RES PT I, V56, P2175, DOI 10.1016/j.dsr.2009.09.002; Xing XG, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007632; Xing XG, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006899; Xue Z, 2013, BIOGEOSCIENCES, V10, P7219, DOI 10.5194/bg-10-7219-2013; Zhang XD, 2009, OPT EXPRESS, V17, P5698, DOI 10.1364/OE.17.005698	48	19	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101658	10.1371/journal.pone.0101658	http://dx.doi.org/10.1371/journal.pone.0101658			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992646	Green Published, gold			2022-12-27	WOS:000341253400103
J	Jakola, AS; Berntsen, EM; Christensen, P; Gulati, S; Unsgard, G; Kvistad, KA; Solheim, O				Jakola, Asgeir S.; Berntsen, Erik M.; Christensen, Pal; Gulati, Sasha; Unsgard, Geirmund; Kvistad, Kjell A.; Solheim, Ole			Surgically Acquired Deficits and Diffusion Weighted MRI Changes after Glioma Resection - A Matched Case-Control Study with Blinded Neuroradiological Assessment	PLOS ONE			English	Article							GRADE II GLIOMAS; HEMORRHAGIC TRANSFORMATION; 5-AMINOLEVULINIC ACID; TENSOR TRACTOGRAPHY; MALIGNANT GLIOMA; AWAKE CRANIOTOMY; 3D ULTRASOUND; SURGERY; STROKE; EXTENT	Background: Acquired deficits following glioma resection may not only occur due to accidental resection of normal brain tissue. The possible importance of ischemic injuries in causing neurological deficits after brain tumor surgery is not much studied. We aimed to study the volume and frequency of early postoperative circulatory changes (i.e. infarctions) detected by diffusion weighted resonance imaging (DWI) in patients with surgically acquired neurological deficits compared to controls. Methods: We designed a 1:1 matched case-control study in patients with diffuse gliomas (WHO grade II-IV) operated with 3D ultrasound guided resection. 42 consecutive patients with acquired postoperative dysphasia and/or new motor deficits were compared to 42 matched controls without acquired deficits. Controls were matched with respect to histopathology, preoperative tumor volumes, and eloquence of location. Two independent radiologists blinded for clinical status assessed the postoperative DWI findings. Results: Postoperative peri-tumoral infarctions were more often seen in patients with acquired deficits (63% versus 41%, p = 0.046) and volumes of DWI abnormalities were larger in cases than in controls with median 1.08 cm(3) (IQR 0-2.39) versus median 0 cm(3) (IQR 0-1.67), p = 0.047. Inter-rater agreement was substantial (67/82, k = 0.64, p < 0.001) for diagnosing radiological significant DWI abnormalities. Conclusion: Peri-tumoral infarctions were more common and were larger in patients with acquired deficits after glioma surgery compared to glioma patients without deficits when assessed by early postoperative DWI. Infarctions may be a frequent and underestimated cause of acquired deficits after glioma resection. DWI changes may be an attractive endpoint in brain tumor surgery with both good inter-rater reliability among radiologists and clinical relevance.	[Jakola, Asgeir S.; Gulati, Sasha; Unsgard, Geirmund; Solheim, Ole] St Olavs Univ Hosp, Dept Neurosurg, Trondheim, Norway; [Jakola, Asgeir S.; Solheim, Ole] Norwegian Univ Sci & Technol, MI Lab, N-7034 Trondheim, Norway; [Jakola, Asgeir S.; Unsgard, Geirmund; Solheim, Ole] Natl Ctr Ultrasound & Image Guided Therapy, Trondheim, Norway; [Berntsen, Erik M.; Christensen, Pal; Kvistad, Kjell A.] St Olavs Univ Hosp, Dept Radiol, Trondheim, Norway; [Berntsen, Erik M.; Kvistad, Kjell A.] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway; [Unsgard, Geirmund] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Jakola, AS (corresponding author), St Olavs Univ Hosp, Dept Neurosurg, Trondheim, Norway.	asgeir.s.jakola@ntnu.no	Jakola, Asgeir S/J-1738-2018; Berntsen, Erik Magnus/AAM-7134-2020	Jakola, Asgeir S/0000-0002-2860-9331; Solheim, Ole/0000-0002-5954-4817				Alexandrov AV, 1997, STROKE, V28, P1198, DOI 10.1161/01.STR.28.6.1198; Alvarez-Sabin J, 2013, LANCET NEUROL, V12, P689, DOI 10.1016/S1474-4422(13)70055-3; Barone DG, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009685.pub2; Belhawi SMK, 2011, EUR RADIOL, V21, P1526, DOI 10.1007/s00330-011-2081-y; Berntsen EM, 2010, NEUROSURGERY, V67, P251, DOI 10.1227/01.NEU.0000371731.20246.AC; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Dutzmann S, 2012, J NEUROONCOLOGY, P1; Fiebach JB, 2002, NEURORADIOLOGY, V44, P294, DOI 10.1007/s00234-001-0720-8; Gempt J, 2013, J NEUROSURG, V118, P801, DOI 10.3171/2012.12.JNS12125; Gil-Robles S, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.12.FOCUS09236; Girot M, 2003, CEREBROVASC DIS, V16, P122, DOI 10.1159/000070591; Gulati S, 2009, MINIM INVAS NEUROSUR, V52, P17, DOI 10.1055/s-0028-1104566; Huisman TAGM, 2003, EUR RADIOL, V13, P2283, DOI 10.1007/s00330-003-1843-6; Jakola AS, 2012, JAMA-J AM MED ASSOC, P1; Jakola AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028592; Jakola AS, 2011, J NEUROSURG, V114, P1622, DOI 10.3171/2011.1.JNS101657; Kelly PJ, 2001, NEUROLOGY, V56, P914, DOI 10.1212/WNL.56.7.914; Khan RB, 2006, NEUROSURGERY, V59, P60, DOI 10.1227/01.NEU.0000219218.43128.FC; Kim SS, 2009, NEUROSURGERY, V64, P836, DOI 10.1227/01.NEU.0000342405.80881.81; Kumabe T, 2007, J NEUROSURG, V106, P263, DOI 10.3171/jns.2007.106.2.263; Lovblad KO, 1998, AM J NEURORADIOL, V19, P1061; Marks MP, 1996, RADIOLOGY, V199, P403, DOI 10.1148/radiology.199.2.8668785; McGirt MJ, 2009, NEUROSURGERY, V65, P463, DOI 10.1227/01.NEU.0000349763.42238.E9; Neuloh G, 2007, NEUROPHYSIOL CLIN, V37, P383, DOI 10.1016/j.neucli.2007.09.002; Oppenlander ME, 2014, J NEUROSURG; Sawaya R, 1998, NEUROSURGERY, V42, P1044, DOI 10.1097/00006123-199805000-00054; Schaefer PW, 2002, AM J NEURORADIOL, V23, P1785; Senft C, 2011, LANCET ONCOL, V12, P997, DOI 10.1016/S1470-2045(11)70196-6; Singer MB, 1998, STROKE, V29, P133, DOI 10.1161/01.STR.29.1.133; Smith JS, 2005, J NEUROSURG, V103, P428, DOI 10.3171/jns.2005.103.3.0428; Smith JS, 2008, J CLIN ONCOL, V26, P1338, DOI 10.1200/JCO.2007.13.9337; Solheim O, 2014, J NEUROSURG; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Stummer W, 2008, NEUROSURGERY, V62, P564, DOI [10.1227/01.NEU.0000297118.47076.5F, 10.1227/01.NEU.0000346230.80425.3A, 10.1227/01.neu.0000317304.31579.17]; Stummer W, 2011, J NEUROSURG, V114, P613, DOI 10.3171/2010.3.JNS097; Szelenyi A, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.12.FOCUS09237; Ulmer S, 2006, NEUROLOGY, V67, P1668, DOI 10.1212/01.wnl.0000242894.21705.3c; Unsgaard G, 2006, ACTA NEUROCHIR, V148, P235, DOI 10.1007/s00701-005-0688-y; Unsgard G, 2011, ACTA NEUROCHIR SUPPL, V109, P181, DOI 10.1007/978-3-211-99651-5_28; Wilson SR, 2010, RADIOLOGY, V257, P24, DOI 10.1148/radiol.10091210; Yordanova YN, 2011, J NEUROSURG, V115, P232, DOI 10.3171/2011.3.JNS101333	41	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101805	10.1371/journal.pone.0101805	http://dx.doi.org/10.1371/journal.pone.0101805			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992634	Green Published, Green Submitted, gold			2022-12-27	WOS:000341253400119
J	Salanti, G; Del Giovane, C; Chaimani, A; Caldwell, DM; Higgins, JPT				Salanti, Georgia; Del Giovane, Cinzia; Chaimani, Anna; Caldwell, Deborah M.; Higgins, Julian P. T.			Evaluating the Quality of Evidence from a Network Meta-Analysis	PLOS ONE			English	Article							MULTIPLE-TREATMENTS; INCONSISTENCY; CONSISTENCY	Systematic reviews that collate data about the relative effects of multiple interventions via network meta-analysis are highly informative for decision-making purposes. A network meta-analysis provides two types of findings for a specific outcome: the relative treatment effect for all pairwise comparisons, and a ranking of the treatments. It is important to consider the confidence with which these two types of results can enable clinicians, policy makers and patients to make informed decisions. We propose an approach to determining confidence in the output of a network meta-analysis. Our proposed approach is based on methodology developed by the Grading of Recommendations Assessment, Development and Evaluation (GRADE) Working Group for pairwise meta-analyses. The suggested framework for evaluating a network meta-analysis acknowledges (i) the key role of indirect comparisons (ii) the contributions of each piece of direct evidence to the network meta-analysis estimates of effect size; (iii) the importance of the transitivity assumption to the validity of network meta-analysis; and (iv) the possibility of disagreement between direct evidence and indirect evidence. We apply our proposed strategy to a systematic review comparing topical antibiotics without steroids for chronically discharging ears with underlying eardrum perforations. The proposed framework can be used to determine confidence in the results from a network meta-analysis. Judgements about evidence from a network meta-analysis can be different from those made about evidence from pairwise meta-analyses.	[Salanti, Georgia; Chaimani, Anna] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Del Giovane, Cinzia] Univ Modena & Reggio Emilia, Dept Clin & Diagnost Med & Publ Hlth, Stat Unit, Modena, Italy; [Caldwell, Deborah M.; Higgins, Julian P. T.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Higgins, Julian P. T.] Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England	University of Ioannina; Universita di Modena e Reggio Emilia; University of Bristol; University of York - UK	Higgins, JPT (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	julian.higgins@bristol.ac.uk	Chaimani, Anna/AAA-3048-2020; Higgins, Julian PT/H-4008-2011	Chaimani, Anna/0000-0003-2828-6832; Higgins, Julian PT/0000-0002-8323-2514; Del Giovane, Cinzia/0000-0002-5028-932X; Salanti, Georgia/0000-0002-3830-8508; , Deborah/0000-0001-8014-7480	European Research Council (IMMA) [260559]; Medical Research Council Population Health Scientist fellowship award [G0902118]; Cochrane Collaboration's Methods Innovation Funding programme; MRC [MR/K025643/1, G0902118, MR/K023233/1] Funding Source: UKRI; Medical Research Council [MR/K023233/1, MR/K025643/1, G0902118] Funding Source: researchfish	European Research Council (IMMA)(European Research Council (ERC)); Medical Research Council Population Health Scientist fellowship award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cochrane Collaboration's Methods Innovation Funding programme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	GS and AC received funding from the European Research Council (IMMA, grant no. 260559). DC was supported by a Medical Research Council Population Health Scientist fellowship award (grant no. G0902118). This research was also supported in part by The Cochrane Collaboration's Methods Innovation Funding programme. The views expressed in this article are those of the authors and not necessarily those of The Cochrane Collaboration or its registered entities, committees, or working groups. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Chaimani A, 2012, RES SYNTH METHODS, V3, P161, DOI 10.1002/jrsm.57; Cipriani A, 2013, ANN INTERN MED, V159, P130, DOI 10.7326/0003-4819-159-2-201307160-00008; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Dias S, 2013, MED DECIS MAKING, V33, P607, DOI 10.1177/0272989X12458724; Dumville JC, 2012, DIABETOLOGIA, V55, P1902, DOI 10.1007/s00125-012-2558-5; Guyatt G, 2013, J CLIN EPIDEMIOL, V66, P151, DOI 10.1016/j.jclinepi.2012.01.006; Guyatt GH, 2013, J CLIN EPIDEMIOL, V66, P158, DOI 10.1016/j.jclinepi.2012.01.012; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1303, DOI 10.1016/j.jclinepi.2011.04.014; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P407, DOI 10.1016/j.jclinepi.2010.07.017; Higgins JPT, 2012, RES SYNTH METHODS, V3, P98, DOI 10.1002/jrsm.1044; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; Jansen JP, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-159; Krahn U, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-35; Li TJ, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-79; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lu G, 2006, J AM STAT ASS, V101; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; Macfadyen CA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004618.pub2; Peters JL, 2008, J CLIN EPIDEMIOL, V61, P991, DOI 10.1016/j.jclinepi.2007.11.010; Puhan MA, 2013, GRADE M ROM AV GRAD; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Salanti G, 2012, RES SYNTH METHODS, V3, P80, DOI 10.1002/jrsm.1037; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Salanti G, 2009, J CLIN EPIDEMIOL, V62, P857, DOI 10.1016/j.jclinepi.2008.10.001; Song F, 2008, J CLIN EPIDEMIOL, V61, P455, DOI 10.1016/j.jclinepi.2007.06.006; Song FJ, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-138; Tan SH, 2014, J CLIN EPIDEMIOL, V67, P672, DOI 10.1016/j.jclinepi.2013.11.006; Turner RM, 2012, INT J EPIDEMIOL, V41, P818, DOI 10.1093/ije/dys041	32	615	620	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e99682	10.1371/journal.pone.0099682	http://dx.doi.org/10.1371/journal.pone.0099682			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992266	Green Submitted, Green Published, gold			2022-12-27	WOS:000341253400012
J	Fox, GJ; Sy, DN; Nhung, NV; Yu, B; Ellis, MK; Hung, NV; Cuong, NK; Lien, LT; Marks, GB; Saunders, BM; Britton, WJ				Fox, Gregory J.; Dinh Ngoc Sy; Nguyen Viet Nhung; Yu, Bing; Ellis, Magda K.; Nguyen Van Hung; Nguyen Kim Cuong; Luu Thi Lien; Marks, Guy B.; Saunders, Bernadette M.; Britton, Warwick J.			Polymorphisms of SP110 Are Associated with both Pulmonary and Extra-Pulmonary Tuberculosis among the Vietnamese	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENE POLYMORPHISMS; VENOOCCLUSIVE DISEASE; INNATE IMMUNITY; SUSCEPTIBILITY; EPIDEMIOLOGY; POPULATION; EFFICIENCY; VARIANTS; LOCUS	Background: Tuberculosis (TB) is an infectious disease that remains a major cause of morbidity and mortality worldwide, yet reasons why only 10% of people infected with Mycobacterium tuberculosis go on to develop clinical disease are poorly understood. Genetically determined variation in the host immune response is one factor influencing the response to M. tuberculosis. SP110 is an interferon-responsive nuclear body protein with critical roles in cell cycling, apoptosis and immunity to infection. However association studies of the gene with clinical TB in different populations have produced conflicting results. Methods: To examine the importance of the SP110 gene in immunity to TB in the Vietnamese we conducted a case-control genetic association study of 24 SP110 variants, in 663 patients with microbiologically proven TB and 566 unaffected control subjects from three tertiary hospitals in northern Vietnam. Results: Five SNPs within SP110 were associated with all forms of TB, including four SNPs at the C terminus (rs10208770, rs10498244, rs16826860, rs11678451) under a dominant model and one SNP under a recessive model, rs7601176. Two of these SNPs were associated with pulmonary TB (rs10208770 and rs16826860) and one with extra-pulmonary TB (rs10498244). Conclusion: SP110 variants were associated with increased susceptibility to both pulmonary and extra-pulmonary TB in the Vietnamese. Genetic variants in SP110 may influence macrophage signaling responses and apoptosis during M. tuberculosis infection, however further research is required to establish the mechanism by which SP110 influences immunity to tuberculosis infection.	[Fox, Gregory J.; Marks, Guy B.] Woolcock Inst Med Res, Resp & Environm Epidemiol Res Grp, Sydney, NSW, Australia; [Fox, Gregory J.; Yu, Bing; Marks, Guy B.; Saunders, Bernadette M.; Britton, Warwick J.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Fox, Gregory J.; Ellis, Magda K.; Saunders, Bernadette M.; Britton, Warwick J.] Centenary Inst, TB Res Grp, Sydney, NSW, Australia; [Dinh Ngoc Sy; Nguyen Viet Nhung; Nguyen Van Hung] Natl Lung Hosp, Hanoi, Vietnam; [Nguyen Kim Cuong] Hanoi Med Univ, Hanoi, Vietnam; [Yu, Bing] Royal Prince Alfred Hosp, Dept Med Genom, Sydney, NSW, Australia; [Luu Thi Lien] Hanoi Lung Hosp, Hanoi, Vietnam; [Marks, Guy B.] Liverpool Hosp, Sydney, NSW, Australia	University of Sydney; Woolcock Institute of Medical Research; University of Sydney; University of Sydney; Centenary Institute; Hanoi Medical University; University of Sydney; Liverpool Hospital	Fox, GJ (corresponding author), Woolcock Inst Med Res, Resp & Environm Epidemiol Res Grp, Sydney, NSW, Australia.	greg.fox@sydney.edu.au	Marks, Guy B./F-5058-2013	Marks, Guy B./0000-0002-8976-8053; Britton, Warwick/0000-0001-6721-9646; Yu, Bing/0000-0001-6013-5220; Saunders, Bernadette/0000-0003-0540-4445	Australian National Health and Medical Research Council Postgraduate Scholarship [571220]; Rebecca L. Cooper Foundation	Australian National Health and Medical Research Council Postgraduate Scholarship(National Health and Medical Research Council (NHMRC) of Australia); Rebecca L. Cooper Foundation	This work was supported by Australian National Health and Medical Research Council Postgraduate Scholarship [571220 to GJF] and a grant from the Rebecca L. Cooper Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhimanyu, 2011, HUM IMMUNOL, V72, P576, DOI 10.1016/j.humimm.2011.03.014; Azad AK, 2012, INFECT IMMUN, V80, P3343, DOI 10.1128/IAI.00443-12; Babb C, 2007, HUM GENET, V121, P521, DOI 10.1007/s00439-007-0335-1; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bloch DB, 2000, MOL CELL BIOL, V20, P6138, DOI 10.1128/MCB.20.16.6138-6146.2000; Cai L, 2013, HUM GENET, V132, P265, DOI 10.1007/s00439-012-1244-5; Cliffe ST, 2012, J ALLERGY CLIN IMMUN, V130, P735, DOI 10.1016/j.jaci.2012.02.054; Cordell HJ, 2005, LANCET, V366, P1121, DOI 10.1016/S0140-6736(05)67424-7; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Fox GJ, 2013, ADV EXP MED BIOL, V783, P1, DOI 10.1007/978-1-4614-6111-1_1; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Glaziou P, 2013, SEMIN RESP CRIT CARE, V34, P3, DOI 10.1055/s-0032-1333467; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Harper J, 2012, J INFECT DIS, V205, P595, DOI 10.1093/infdis/jir786; Hijikata M, 2012, HUM GENET, V131, P675, DOI 10.1007/s00439-011-1112-8; Lei X, 2012, INFECT GENET EVOL, V12, P1473, DOI 10.1016/j.meegid.2012.05.011; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; LI WH, 1984, J MOL EVOL, V21, P58, DOI 10.1007/BF02100628; Liang L, 2011, INFECT GENET EVOL, V11, P934, DOI 10.1016/j.meegid.2011.02.017; Lien Luu Thi, 2009, PLoS One, V4, pe6798, DOI 10.1371/journal.pone.0006798; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Mahasirimongkol S, 2012, J HUM GENET, V57, P363, DOI 10.1038/jhg.2012.35; Marks GB, 2000, AM J RESP CRIT CARE, V162, P1851, DOI 10.1164/ajrccm.162.5.2004154; MELLIS C, 1976, J PEDIATR-US, V88, P236, DOI 10.1016/S0022-3476(76)80988-2; Moller M, 2010, TUBERCULOSIS, V90, P71, DOI 10.1016/j.tube.2010.02.002; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Nyholt DR, 2001, HUM GENET, V109, P564, DOI 10.1007/s00439-001-0611-4; Owen HR, 2007, J MOL BIOL, V366, P725, DOI 10.1016/j.jmb.2006.11.099; Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419; Png E, 2012, INFECT GENET EVOL, V12, P1319, DOI 10.1016/j.meegid.2012.04.006; Saito T, 2004, BIOCHEM BIOPH RES CO, V317, P335, DOI 10.1016/j.bbrc.2004.03.056; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Szeszko JS, 2007, HUM GENET, V121, P155, DOI 10.1007/s00439-006-0293-z; Thye T, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.037960; Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639; Tosh K, 2006, P NATL ACAD SCI USA, V103, P10364, DOI 10.1073/pnas.0603340103; van der Eijk EA, 2007, AM J RESP CRIT CARE, V176, P1281, DOI 10.1164/rccm.200703-435OC; Westfall Peter H, 2002, Methods Mol Biol, V184, P143; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; Yan BS, 2007, J IMMUNOL, V179, P6919, DOI 10.4049/jimmunol.179.10.6919; Zembrzuski VM, 2010, TUBERCULOSIS, V90, P44, DOI 10.1016/j.tube.2009.11.002	42	22	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e99496	10.1371/journal.pone.0099496	http://dx.doi.org/10.1371/journal.pone.0099496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006821	Green Published, Green Submitted, gold			2022-12-27	WOS:000339040600006
J	Gill, MJ; Andreychik, MR				Gill, Michael J.; Andreychik, Michael R.			The Social Explanatory Styles Questionnaire: Assessing Moderators of Basic Social-Cognitive Phenomena Including Spontaneous Trait Inference, the Fundamental Attribution Error, and Moral Blame	PLOS ONE			English	Article							LAY THEORIES APPROACH; IMPLICIT THEORIES; CAUSAL ATTRIBUTION; ACHIEVEMENT-MOTIVATION; CULTURAL-DIFFERENCES; CORRESPONDENCE BIAS; CONSEQUENCES; DISPOSITIONS; PERCEPTION; JUDGMENTS	Why is he poor? Why is she failing academically? Why is he so generous? Why is she so conscientious? Answers to such everyday questions-social explanations-have powerful effects on relationships at the interpersonal and societal levels. How do people select an explanation in particular cases? We suggest that, often, explanations are selected based on the individual's pre-existing general theories of social causality. More specifically, we suggest that over time individuals develop general beliefs regarding the causes of social events. We refer to these beliefs as social explanatory styles. Our goal in the present article is to offer and validate a measure of individual differences in social explanatory styles. Accordingly, we offer the Social Explanatory Styles Questionnaire (SESQ), which measures three independent dimensions of social explanatory style: Dispositionism, historicism, and controllability. Studies 1-3 examine basic psychometric properties of the SESQ and provide positive evidence regarding internal consistency, factor structure, and both convergent and divergent validity. Studies 4-6 examine predictive validity for each subscale: Does each explanatory dimension moderate an important phenomenon of social cognition? Results suggest that they do. In Study 4, we show that SESQ dispositionism moderates the tendency to make spontaneous trait inferences. In Study 5, we show that SESQ historicism moderates the tendency to commit the Fundamental Attribution Error. Finally, in Study 6 we show that SESQ controllability predicts polarization of moral blame judgments: Heightened blaming toward controllable stigmas (assimilation), and attenuated blaming toward uncontrollable stigmas (contrast). Decades of research suggest that explanatory style regarding the self is a powerful predictor of self-functioning. We think it is likely that social explanatory styles-perhaps comprising interactive combinations of the basic dimensions tapped by the SESQ-will be similarly potent predictors of social functioning. We hope the SESQ will be a useful tool for exploring that possibility.	[Gill, Michael J.] Lehigh Univ, Dept Psychol, Bethlehem, PA 18015 USA; [Andreychik, Michael R.] Fairfield Univ, Dept Psychol, Fairfield, CT 06430 USA	Lehigh University; Fairfield University	Gill, MJ (corresponding author), Lehigh Univ, Dept Psychol, Bethlehem, PA 18015 USA.	m.gill@lehigh.edu	Andreychik, Michael R./AAM-5637-2021	Andreychik, Michael/0000-0002-8542-5504	Society for the Psychological Study of Social Issues	Society for the Psychological Study of Social Issues	This work was supported by a Grant-in-Aid award to Michael Gill from the Society for the Psychological Study of Social Issues. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alicke MD, 2000, PSYCHOL BULL, V126, P556, DOI 10.1037//0033-2909.126.4.556; Altemeyer B., 1988, ENEMIES FREEDOM UNDE; Andreychik MR, 2009, PERS SOC PSYCHOL B, V39, P73; [Anonymous], 1998, HDB SOCIAL PSYCHOL; Bauman CW, 2006, J CROSS CULT PSYCHOL, V37, P438, DOI 10.1177/0022022106288479; BRADBURY TN, 1990, PSYCHOL BULL, V107, P3, DOI 10.1037/0033-2909.107.1.3; Bruner J.S., 1990, ACTS MEANING 4 LECT; Buchanan G.M., 1995, EXPLANATORY STYLE, V1st; Chiu CY, 1997, J PERS SOC PSYCHOL, V73, P19, DOI 10.1037/0022-3514.73.1.19; Choi I, 1998, PERS SOC PSYCHOL B, V24, P949, DOI 10.1177/0146167298249003; Church AT, 2003, J PERS SOC PSYCHOL, V85, P332, DOI 10.1037/0022-3514.85.2.332; Cohen J., 1983, APPL MULTIPLE REGRES; Dweck C. S, 1999, SELF THEORIES THEIR; FINCHAM FD, 1992, J PERS SOC PSYCHOL, V62, P457, DOI 10.1037/0022-3514.62.3.457; Fincham FD, 2007, BLACKWELL HDB SOCIAL; GILBERT DT, 1995, PSYCHOL BULL, V117, P21, DOI 10.1037/0033-2909.117.1.21; GILBERT DT, 1988, J PERS SOC PSYCHOL, V54, P733, DOI 10.1037/0022-3514.54.5.733; Gill MJ, 2007, GROUP PROCESS INTERG, V10, P87, DOI 10.1177/1368430207071343; Gill MJ, 2013, PERS SOC PSYCHOL B, V39, P73, DOI 10.1177/0146167212460281; Gill MJ, 2009, SOC PERSONAL PSYCHOL, V3, P1038, DOI 10.1111/j.1751-9004.2009.00218.x; Gratz KL, 2004, J PSYCHOPATHOL BEHAV, V26, P41, DOI 10.1023/B:JOBA.0000007455.08539.94; GUIMOND S, 1989, SOC PSYCHOL QUART, V52, P126, DOI 10.2307/2786912; Ham J, 2003, J EXP SOC PSYCHOL, V39, P434, DOI 10.1016/S0022-1031(03)00033-7; Heider F., 1958, PSYCHOL INTERPERSONA, DOI [10.1037/10628-000, DOI 10.1037/10628-000]; HEWSTONE M, 1990, EUR J SOC PSYCHOL, V20, P311; Hong YY, 2001, PERS SOC PSYCHOL REV, V5, P98, DOI 10.1207/S15327957PSPR0502_1; Jayaratne TE, 2006, GROUP PROCESS INTERG, V9, P77, DOI 10.1177/1368430206059863; John O, 1991, BIG 5 INVENTORY VERS; Joiner TE, 1995, CLIN PSYCHOL REV, V15, P777, DOI 10.1016/0272-7358(95)00046-1; JONES EE, 1965, ADV EXP SOC PSYCHOL, V2, P219; JONES EE, 1967, J EXP SOC PSYCHOL, V3, P1, DOI 10.1016/0022-1031(67)90034-0; Judd CM, 2001, PSYCHOL METHODS, V6, P115, DOI 10.1037/1082-989X.6.2.115; KAMEN LP, 1987, CURR PSYCHOL RES REV, V6, P207, DOI 10.1007/BF02686648; KELLEY HH, 1973, AM PSYCHOL, V28, P107, DOI 10.1037/h0034225; Kelly G., 1955, PSYCHOL PERSONAL CON; Kluegel James R, 1993, PREJUDICE POLITICS A; Krieglmeyer R, 2009, J EXP SOC PSYCHOL, V45, P379, DOI 10.1016/j.jesp.2008.10.003; Levy SR, 1998, J PERS SOC PSYCHOL, V74, P1421, DOI 10.1037//0022-3514.74.6.1421; Levy SR, 2006, GROUP PROCESS INTERG, V9, P5, DOI 10.1177/1368430206059855; Levy SR, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P179; Lopez GE, 1998, POLIT PSYCHOL, V19, P305, DOI 10.1111/0162-895X.00106; Malle B.F., 2004, MIND EXPLAINS BEHAV; MCARTHUR LA, 1972, J PERS SOC PSYCHOL, V22, P171, DOI 10.1037/h0032602; McConnell AR, 2001, J EXP SOC PSYCHOL, V37, P215, DOI 10.1006/jesp.2000.1445; MCKOON G, 1986, J EXP PSYCHOL LEARN, V12, P82, DOI 10.1037/0278-7393.12.1.82; Menon T, 1999, J PERS SOC PSYCHOL, V76, P701, DOI 10.1037/0022-3514.76.5.701; MILLER JG, 1984, J PERS SOC PSYCHOL, V46, P961; Molden DC, 2006, AM PSYCHOL, V61, P192, DOI 10.1037/0003-066X.61.3.192; MORRIS MW, 1994, J PERS SOC PSYCHOL, V67, P949, DOI 10.1037/0022-3514.67.6.949; Moskowitz G. B., 2013, OXFORD HDB COGNITIVE; Norenzayan A, 2002, PERS SOC PSYCHOL B, V28, P109, DOI 10.1177/0146167202281010; PETERSON C, 1982, COGNITIVE THER RES, V6, P287, DOI 10.1007/BF01173577; Peterson C, 1995, EXPLANATORY STYLE; Pizarro D, 2003, PSYCHOL SCI, V14, P267, DOI 10.1111/1467-9280.03433; Plaks JE, 2007, J PERS SOC PSYCHOL, V93, P667, DOI 10.1037/0022-3514.93.4.667; Plaks JE, 2009, SOC PERSONAL PSYCHOL, V3, P1069, DOI 10.1111/j.1751-9004.2009.00222.x; Poon CSK, 2006, J EXP SOC PSYCHOL, V42, P177, DOI 10.1016/j.jesp.2005.04.001; QUATTRONE GA, 1982, J PERS SOC PSYCHOL, V42, P593, DOI 10.1037/0022-3514.42.4.593; Rangel U, 2011, J PERS SOC PSYCHOL, V100, P1056, DOI 10.1037/a0022401; Ross L., 1977, ADV EXP SOC PSYCHOL, V10, P173, DOI [10.1016/S0065-2601(08)60357-3, DOI 10.1016/S0065-2601(08)60357-3]; ROSS LD, 1977, J PERS SOC PSYCHOL, V35, P485, DOI 10.1037/0022-3514.35.7.485; Satterfield JM, 1997, BEHAV SCI LAW, V15, P95, DOI 10.1002/(SICI)1099-0798(199724)15:1<95::AID-BSL255>3.0.CO;2-Y; SATTERFIELD JM, 1994, PSYCHOL SCI, V5, P77, DOI 10.1111/j.1467-9280.1994.tb00634.x; Savani K, 2011, PSYCHOL SCI, V22, P795, DOI 10.1177/0956797611407928; SELIGMAN MEP, 1990, PSYCHOL SCI, V1, P143, DOI 10.1111/j.1467-9280.1990.tb00084.x; SELIGMAN MEP, 1986, J PERS SOC PSYCHOL, V50, P832, DOI 10.1037/0022-3514.50.4.832; Sidanius J., 2001, SOCIAL DOMINANCE INT; Skitka LJ, 1999, PERS SOC PSYCHOL B, V25, P793, DOI 10.1177/0146167299025007003; SKITKA LJ, 1993, J PERS SOC PSYCHOL, V65, P1205, DOI 10.1037/0022-3514.65.6.1205; Skitka LJ, 2002, J PERS SOC PSYCHOL, V83, P470, DOI [10.1037/0022-3514.83.2.470, 10.1037//0022-3514.83.2.470]; SWEENEY PD, 1986, J PERS SOC PSYCHOL, V50, P974, DOI 10.1037/0022-3514.50.5.974; TROPE Y, 1986, PSYCHOL REV, V93, P239, DOI 10.1037/0033-295X.93.3.239; Uleman JS, 2008, ANNU REV PSYCHOL, V59, P329, DOI 10.1146/annurev.psych.59.103006.093707; Uleman JS, 1996, ADV EXP SOC PSYCHOL, V28, P211, DOI 10.1016/S0065-2601(08)60239-7; WEBSTER DM, 1994, J PERS SOC PSYCHOL, V67, P1049, DOI 10.1037/0022-3514.67.6.1049; WEINER B, 1985, PSYCHOL REV, V92, P548, DOI 10.1037/0033-295X.92.4.548; WEINER B, 1988, J PERS SOC PSYCHOL, V55, P738, DOI 10.1037/0022-3514.55.5.738; WEINER B, 1970, J PERS SOC PSYCHOL, V15, P1, DOI 10.1037/h0029211; Weiner B., 2006, SOCIAL MOTIVATION JU; Wigboldus DLH, 2003, J PERS SOC PSYCHOL, V84, P470, DOI 10.1037/0022-3514.84.3.470; WINTER L, 1984, J PERS SOC PSYCHOL, V47, P237, DOI 10.1037/0022-3514.47.2.237; Yzerbyt V, 2001, PSYCHOL LEGITIMACY E; ZUCKER GS, 1993, J APPL SOC PSYCHOL, V23, P925, DOI 10.1111/j.1559-1816.1993.tb01014.x	83	11	11	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e100886	10.1371/journal.pone.0100886	http://dx.doi.org/10.1371/journal.pone.0100886			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL3PK	25007152	gold, Green Published			2022-12-27	WOS:000339040600022
J	Koch, FH; Yemshanov, D; Haack, RA; Magarey, RD				Koch, Frank H.; Yemshanov, Denys; Haack, Robert A.; Magarey, Roger D.			Using a Network Model to Assess Risk of Forest Pest Spread via Recreational Travel	PLOS ONE			English	Article							BIOLOGICAL INVASIONS; PROPAGULE PRESSURE; DISPERSAL; FIREWOOD; TRANSPORT; PATHWAYS; SURVEILLANCE; INSECTS; TRADE	Long-distance dispersal pathways, which frequently relate to human activities, facilitate the spread of alien species. One pathway of concern in North America is the possible spread of forest pests in firewood carried by visitors to campgrounds or recreational facilities. We present a network model depicting the movement of campers and, by extension, potentially infested firewood. We constructed the model from US National Recreation Reservation Service data documenting more than seven million visitor reservations (including visitors from Canada) at campgrounds nationwide. This bi-directional model can be used to identify likely origin and destination locations for a camper-transported pest. To support broad-scale decision making, we used the model to generate summary maps for 48 US states and seven Canadian provinces that depict the most likely origins of campers traveling from outside the target state or province. The maps generally showed one of two basic spatial patterns of out-of-state (or out-of-province) origin risk. In the eastern United States, the riskiest out-of-state origin locations were usually found in a localized region restricted to portions of adjacent states. In the western United States, the riskiest out-of-state origin locations were typically associated with major urban areas located far from the state of interest. A few states and the Canadian provinces showed characteristics of both patterns. These model outputs can guide deployment of resources for surveillance, firewood inspections, or other activities. Significantly, the contrasting map patterns indicate that no single response strategy is appropriate for all states and provinces. If most out-of-state campers are traveling from distant areas, it may be effective to deploy resources at key points along major roads (e.g., interstate highways), since these locations could effectively represent bottlenecks of camper movement. If most campers are from nearby areas, they may have many feasible travel routes, so a more widely distributed deployment may be necessary.	[Koch, Frank H.] USDA, Forest Serv, Southern Res Stn, Eastern Forest Environm Threat Assessment Ctr, Res Triangle Pk, NC 27709 USA; [Yemshanov, Denys] Nat Resources Canada, Canadian Forest Serv, Great Lakes Forestry Ctr, Sault Ste Marie, ON, Canada; [Haack, Robert A.] USDA, Forest Serv, No Res Stn, E Lansing, MI USA; [Magarey, Roger D.] N Carolina State Univ, Ctr Integrated Pest Management, Raleigh, NC 27695 USA	United States Department of Agriculture (USDA); United States Forest Service; Natural Resources Canada; Canadian Forest Service; Great Lakes Forestry Centre; United States Department of Agriculture (USDA); United States Forest Service; University of North Carolina; North Carolina State University	Koch, FH (corresponding author), USDA, Forest Serv, Southern Res Stn, Eastern Forest Environm Threat Assessment Ctr, Res Triangle Pk, NC 27709 USA.	fhkoch@fs.fed.us		Koch, Frank/0000-0002-3750-4507; Magarey, Roger/0000-0002-5651-5965	US Department of Agriculture; interdepartmental Natural Resources Canada - Canadian Food Inspection Agency Forest Invasive Alien Species initiative	US Department of Agriculture(United States Department of Agriculture (USDA)); interdepartmental Natural Resources Canada - Canadian Food Inspection Agency Forest Invasive Alien Species initiative(Natural Resources CanadaCanadian Forest Service)	This work was supported by the US Department of Agriculture and an interdepartmental Natural Resources Canada - Canadian Food Inspection Agency Forest Invasive Alien Species initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal H, 2004, TOURISM MANAGE, V25, P387, DOI 10.1016/S0261-5177(03)00135-3; Barlow LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090511; Bodin O, 2010, ECOL MODEL, V221, P2393, DOI 10.1016/j.ecolmodel.2010.06.017; Cappaert David, 2005, American Entomologist, V51, P152; Cook DC, 2010, RISK ANAL, V30, P1303, DOI 10.1111/j.1539-6924.2010.01439.x; Cordell H. K., 2008, Forest History Today, P4; Cordell H.K., 2012, SRS150 USDA FOR SERV, P1, DOI [10.2737/SRS-GTR-150, DOI 10.2737/SRS-GTR-150]; Cordell HK., 2008, INT J WILDERNESS, V14, P7; Eagles P. F. J., 2002, Journal of Sustainable Tourism, V10, P132, DOI 10.1080/09669580208667158; Epanchin-Niell RS, 2012, ECOL LETT, V15, P803, DOI 10.1111/j.1461-0248.2012.01800.x; Filbey M, 2002, HALTING INVASION STA; Guichard S, 2012, J APPL ECOL, V49, P287, DOI 10.1111/j.1365-2664.2011.02072.x; Haack R.A., 1987, P449; Haack R. A., 2011, Bulletin OEPP, V41, P39, DOI 10.1111/j.1365-2338.2010.02432.x; Haack RA, 1997, J FOREST, V95, P11; Haack RA, 2010, J ECON ENTOMOL, V103, P1682, DOI 10.1603/EC10041; Haack RA, 2010, ANNU REV ENTOMOL, V55, P521, DOI 10.1146/annurev-ento-112408-085427; Hastings A, 2005, ECOL LETT, V8, P91, DOI 10.1111/j.1461-0248.2004.00687.x; Hauser CE, 2009, ECOL LETT, V12, P683, DOI 10.1111/j.1461-0248.2009.01323.x; Hengeveld R., 1989, DYNAMICS BIOL INVASI; Hulme PE, 2008, J APPL ECOL, V45, P403, DOI 10.1111/j.1365-2664.2007.01442.x; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Jacobi WR, 2012, J ECON ENTOMOL, V105, P1645, DOI 10.1603/EC12069; Jacobi W. R., 2011, Arboriculture & Urban Forestry, V37, P126; Jeger MJ, 2007, NEW PHYTOL, V174, P279, DOI 10.1111/j.1469-8137.2007.02028.x; Kaluza P, 2010, J R SOC INTERFACE, V7, P1093, DOI 10.1098/rsif.2009.0495; Karlin S., 1975, 1 COURSE STOCHASTIC, V2; Koch FH, 2012, J ECON ENTOMOL, V105, P438, DOI 10.1603/EC11270; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kot M, 1996, ECOLOGY, V77, P2027, DOI 10.2307/2265698; Levine JM, 2003, CONSERV BIOL, V17, P322, DOI 10.1046/j.1523-1739.2003.02038.x; Liebhold AM, 2008, ANNU REV ENTOMOL, V53, P387, DOI 10.1146/annurev.ento.52.110405.091401; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lockwood JL, 2007, INVASION ECOLOGY; Lue C.C., 1996, J TRAVEL RES, V35, P41, DOI DOI 10.1177/004728759603500107; Mehta SV, 2007, ECOL ECON, V61, P237, DOI 10.1016/j.ecolecon.2006.10.024; Moslonka-Lefebvre M, 2011, PHYTOPATHOLOGY, V101, P392, DOI 10.1094/PHYTO-07-10-0192; Neubert MG, 2000, ECOLOGY, V81, P1613, DOI 10.1890/0012-9658(2000)081[1613:DADCAS]2.0.CO;2; Ontario Ministry of Natural Resources, 2011, AR YOU MOV FIR IMP I; Paini DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044589; Peterson K, 2009, RES MANAGEMENT FINDI; Peterson K, 2012, J ENVIRON MANAGE, V112, P104, DOI 10.1016/j.jenvman.2012.06.023; Petrice TR, 2006, J ECON ENTOMOL, V99, P790, DOI 10.1603/0022-0493-99.3.790; Prasad AM, 2010, LANDSCAPE ECOL, V25, P353, DOI 10.1007/s10980-009-9434-9; Reaser JK, 2008, BIOL INVASIONS, V10, P1085, DOI 10.1007/s10530-007-9186-x; Ricciardi A, 2011, BIOSCIENCE, V61, P312, DOI 10.1525/bio.2011.61.4.11; Savage D, 2011, ECOL MODEL, V222, P1673, DOI 10.1016/j.ecolmodel.2011.03.003; Siikamaki J, 2011, P NATL ACAD SCI USA, V108, P14031, DOI 10.1073/pnas.1108688108; SOLOMON JD, 1995, AGR HDB, V706; Tobin PC, 2010, J ECON ENTOMOL, V103, P1569, DOI 10.1603/EC10140; United States Government Accountability Office, 2006, INV FOR PESTS LESS L; USDA Animal and Plant Health Inspection Service, 2011, RISK ASS MOV FIR US; VANDENBOSCH F, 1990, J MATH BIOL, V28, P529, DOI 10.1007/BF00164162; Westphal MI, 2008, BIOL INVASIONS, V10, P391, DOI 10.1007/s10530-007-9138-5; Williamson M, 1996, ECOLOGY, V77, P1661, DOI 10.2307/2265769; Wilson JRU, 2009, TRENDS ECOL EVOL, V24, P136, DOI 10.1016/j.tree.2008.10.007; Yemshanov D, 2013, J ENVIRON MANAGE, V129, P173, DOI 10.1016/j.jenvman.2013.07.013; Yemshanov D, 2012, DIVERS DISTRIB, V18, P33, DOI 10.1111/j.1472-4642.2011.00848.x	58	16	17	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102105	10.1371/journal.pone.0102105	http://dx.doi.org/10.1371/journal.pone.0102105			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL3PK	25007186	Green Submitted, gold, Green Published			2022-12-27	WOS:000339040600095
J	Machida, RJ; Lin, YY				Machida, Ryuji J.; Lin, Ya-Ying			Four Methods of Preparing mRNA 5 ' End Libraries Using the Illumina Sequencing Platform	PLOS ONE			English	Article							GENE-EXPRESSION; BIAS; CAP; REGIONS	Background: The 5' untranslated regions of mRNA play an important role in their translation. Results: Here, we describe the development of four methods of profiling mRNA 5' ends using the Illumina sequencing platform; the first method utilizes SMART (Switching Mechanism At 5' end of RNA Transcript) technology, while the second involves replacing the 5' cap structure with RNA oligomers via ligation. The third and fourth methods are modifications of SMART, and involve enriching mRNA molecules with (nuclear transcripts) and without (mitochondrial transcripts) 5' end cap structures, respectively. Libraries prepared using SMART technology gave more reproducible results, but the ligation method was advantageous in that it only sequenced mRNAs with a cap structure at the 5' end. Conclusions: These methods are suitable for global mapping of mRNA 5' ends, both with and without cap structures, at a single molecule resolution. In addition, comparison of the present results obtained using different methods revealed the presence of abundant messenger RNAs without a cap structure.	[Machida, Ryuji J.; Lin, Ya-Ying] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan	Academia Sinica - Taiwan	Machida, RJ (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan.	ryujimachida@gmail.com; yylinas@gmail.com			Academia Sinica; National Science Council Taiwan [102-2611-M-001-002-MY3]	Academia Sinica(Academia Sinica - Taiwan); National Science Council Taiwan(Ministry of Science and Technology, Taiwan)	This work was funded by Academia Sinica and National Science Council Taiwan (102-2611-M-001-002-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon S, 2011, GENOME RES, V21, P1506, DOI 10.1101/gr.121715.111; Barrett LW, 2012, CELL MOL LIFE SCI, V69, P3613, DOI 10.1007/s00018-012-0990-9; Batut P, 2013, GENOME RES, V23, P169, DOI 10.1101/gr.139618.112; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CARLSON JR, 1985, DEV BIOL, V108, P355, DOI 10.1016/0012-1606(85)90039-9; Illumina Inc., 2013, ILL TECHN NOT SEQUEN; Kapteyn J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-413; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li Y, 2010, WIRES RNA, V1, P253, DOI 10.1002/wrna.15; MARUYAMA K, 1994, GENE, V138, P171; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Otsuka Y, 2009, MOL CELL BIOL, V29, P2155, DOI 10.1128/MCB.01325-08; Resch AM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-162; Rojas-Duran MF, 2012, RNA, V18, P2299, DOI 10.1261/rna.035865.112; Salimullah M, 2011, COLD SPRING HARB PRO, DOI [10.1101/pdb.prot5559, DOI 10.1101/PDB.PR0T5559]; Schoenberg DR, 2009, TRENDS BIOCHEM SCI, V34, P435, DOI 10.1016/j.tibs.2009.05.003; Shiroguchi K, 2012, P NATL ACAD SCI USA, V109, P1347, DOI 10.1073/pnas.1118018109; Smith CD, 2007, SCIENCE, V316, P1586, DOI 10.1126/science.1139815; Takahashi H, 2012, NAT PROTOC, V7, P542, DOI 10.1038/nprot.2012.005; Van Nieuwerburgh F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026969; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02; Zhuang FL, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1263	25	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101812	10.1371/journal.pone.0101812	http://dx.doi.org/10.1371/journal.pone.0101812			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003736	Green Published, gold, Green Submitted			2022-12-27	WOS:000339242700070
J	Modica, MV; Puillandre, N; Castelin, M; Zhang, Y; Holford, M				Modica, Maria Vittoria; Puillandre, Nicolas; Castelin, Magalie; Zhang, Yu; Holford, Mande			A Good Compromise: Rapid and Robust Species Proxies for Inventorying Biodiversity Hotspots Using the Terebridae (Gastropoda: Conoidea)	PLOS ONE			English	Article							INTEGRATIVE TAXONOMY; DELIMITATION METHOD; DNA; SPECIATION; DISCOVERY; EVOLUTION; MODEL; NEED	Devising a reproducible approach for species delimitation of hyperdiverse groups is an ongoing challenge in evolutionary biology. Speciation processes combine modes of passive and adaptive trait divergence requiring an integrative taxonomy approach to accurately generate robust species hypotheses. However, in light of the rapid decline of diversity on Earth, complete integrative approaches may not be practical in certain species-rich environments. As an alternative, we applied a two-step strategy combining ABGD (Automated Barcode Gap Discovery) and Klee diagrams, to balance speed and accuracy in producing primary species hypotheses (PSHs). Specifically, an ABGD/Klee approach was used for species delimitation in the Terebridae, a neurotoxin-producing marine snail family included in the Conoidea. Delimitation of species boundaries is problematic in the Conoidea, as traditional taxonomic approaches are hampered by the high levels of variation, convergence and morphological plasticity of shell characters. We used ABGD to analyze gaps in the distribution of pairwise distances of 454 COI sequences attributed to 87 morphospecies and obtained 98 to 125 Primary Species Hypotheses (PSHs). The PSH partitions were subsequently visualized as a Klee diagram color map, allowing easy detection of the incongruences that were further evaluated individually with two other species delimitation models, General Mixed Yule Coalescent (GMYC) and Poisson Tree Processes (PTP). GMYC and PTP results confirmed the presence of 17 putative cryptic terebrid species in our dataset. The consensus of GMYC, PTP, and ABGD/Klee findings suggest the combination of ABGD and Klee diagrams is an effective approach for rapidly proposing primary species proxies in hyperdiverse groups and a reliable first step for macroscopic biodiversity assessment.	[Modica, Maria Vittoria] Univ Roma La Sapienza, Dept Biol & Biotechnol C Darwin, I-00185 Rome, Italy; [Puillandre, Nicolas; Castelin, Magalie] Museum Natl Hist Nat, Dept Systemat & Evolut Systemat Adaptat & Evolut, UMR 7138, F-75231 Paris, France; [Castelin, Magalie] Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC V9T 6N7, Canada; [Zhang, Yu] Ernst & Young, New York, NY USA; [Modica, Maria Vittoria; Castelin, Magalie; Holford, Mande] CUNY, Hunter Coll, Dept Chem, New York, NY 10021 USA; [Holford, Mande] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA	Sapienza University Rome; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Fisheries & Oceans Canada; City University of New York (CUNY) System; Hunter College (CUNY); American Museum of Natural History (AMNH)	Holford, M (corresponding author), CUNY, Hunter Coll, Dept Chem, New York, NY 10021 USA.	mholford@hunter.cuny.edu	Modica, Maria Vittoria/P-8407-2018	Modica, Maria Vittoria/0000-0003-2532-6763; Holford, Mande/0000-0001-9476-2687	NSF [1247550]; Alfred P. Sloan Foundation [B2010-37]; Consortium National de Recherche en Genomique; Service de Systematique Moleculaire [2005/67]; Division Of Chemistry [1247550] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Consortium National de Recherche en Genomique; Service de Systematique Moleculaire; Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Funding for this work was provided by NSF (Grant 1247550) and The Alfred P. Sloan Foundation (Grant B2010-37) grants to M. H. This work was also supported by the "Consortium National de Recherche en Genomique'' and the "Service de Systematique Moleculaire'' (UMS 2700b CNRS-MNHN) as part of agreement 2005/67 between Genoscope and MNHN for the project "Macrophylogeny of life'' directed by G. Lecointre. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2014, TRACER V1 6; [Anonymous], 2021, SPLITS SPECIES LIMIT; BOUCHET P, 1981, MALACOLOGIA, V21, P363; Bouchet P, 2011, J MOLLUS STUD, V77, P273, DOI 10.1093/mollus/eyr017; Camargo A, 2013, SPECIES PROBLEM ONGO; Cardoso A, 2009, MOL ECOL, V18, P648, DOI 10.1111/j.1365-294X.2008.04048.x; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Castelin M, 2012, MOL ECOL, V21, P4828, DOI 10.1111/j.1365-294X.2012.05743.x; Castelin M, 2012, MOL PHYLOGENET EVOL, V64, P21, DOI 10.1016/j.ympev.2012.03.001; Castroviejo-Fisher S, 2009, ZOOTAXA, P16, DOI 10.11646/zootaxa.1980.1.2; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duda TF, 1999, P NATL ACAD SCI USA, V96, P10272, DOI 10.1073/pnas.96.18.10272; Duda TF, 2008, MOL PHYLOGENET EVOL, V49, P867, DOI 10.1016/j.ympev.2008.08.009; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erwin TL, 2001, ENCY BIODIVERSITY; Esselstyn JA, 2012, P ROY SOC B-BIOL SCI, V279, P3678, DOI 10.1098/rspb.2012.0705; Fonseca G, 2008, BIOL J LINN SOC, V94, P737, DOI 10.1111/j.1095-8312.2008.01015.x; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Gibbs J, 2009, ZOOTAXA, P1; Holford M, 2009, TOXICON, V53, P90, DOI 10.1016/j.toxicon.2008.10.017; Holford M, 2009, MOL BIOL EVOL, V26, P15, DOI 10.1093/molbev/msn211; Huerta-Cepas J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-24; Kantor YI, 2008, ZOOL SCI, V25, P1156, DOI 10.2108/zsj.25.1156; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Miljanich GP, 2004, CURR MED CHEM, V11, P3029, DOI 10.2174/0929867043363884; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Nagy ZT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034506; Oliverio M, 1996, VIE MILIEU, V46, P163; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Padial JM, 2009, ZOOL SCR, V38, P431, DOI 10.1111/j.1463-6409.2008.00381.x; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Puillandre N, 2012, MOL ECOL, V21, P2671, DOI 10.1111/j.1365-294X.2012.05559.x; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Puillandre N, 2010, SYST BIODIVERS, V8, P371, DOI 10.1080/14772001003748709; R Development Core Team, 2010, LANG ENV STAT COMP; Rex M.A., 2010, DEEP SEA BIODIVERSIT, P354; Richer de Forges B, 2005, CENSUS DEEPSEA SPECI, P113; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Shaffer HB, 2007, SYST BIOL, V56, P896, DOI 10.1080/10635150701772563; Sirovich L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009266; Sirovich L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007051; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Stamatakis A, 2014, BIOINFORMATICS; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Tanzler R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028832; TERRYN Y, 2007, COLLECTORS GUIDE REC; Valdecasas AG, 2008, BIOL J LINN SOC, V93, P211; Wiens JJ, 2002, SYST BIOL, V51, P69, DOI 10.1080/106351502753475880; Wiens JJ, 2007, SYST BIOL, V56, P875, DOI 10.1080/10635150701748506; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Williams S, 2011, EVOLUTION, V65, P1752, DOI 10.1111/j.1558-5646.2011.01255.x; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	55	27	27	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e102160	10.1371/journal.pone.0102160	http://dx.doi.org/10.1371/journal.pone.0102160			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003611	Green Submitted, Green Published, gold			2022-12-27	WOS:000339242700115
J	Torres-Leguizamon, M; Mathieu, J; Decaens, T; Dupont, L				Torres-Leguizamon, Magally; Mathieu, Jerome; Decaens, Thibaud; Dupont, Lise			Genetic Structure of Earthworm Populations at a Regional Scale: Inferences from Mitochondrial and Microsatellite Molecular Markers in Aporrectodea icterica (Savigny 1826)	PLOS ONE			English	Article							POSTGLACIAL COLONIZATION ROUTES; LUMBRICUS-TERRESTRIS; DIVERSITY; DNA; SOFTWARE; BEHAVIOR; TESTS; PHYLOGEOGRAPHY; BOTTLENECKS; NEUTRALITY	Despite the fundamental role that soil invertebrates (e. g. earthworms) play in soil ecosystems, the magnitude of their spatial genetic variation is still largely unknown and only a few studies have investigated the population genetic structure of these organisms. Here, we investigated the genetic structure of seven populations of a common endogeic earthworm (Aporrectodea icterica) sampled in northern France to explore how historical species range changes, microevolutionary processes and human activities interact in shaping genetic variation at a regional scale. Because combining markers with distinct modes of inheritance can provide extra, complementary information on gene flow, we compared the patterns of genetic structure revealed using nuclear (7 microsatellite loci) and mitochondrial markers (COI). Both types of markers indicated low genetic polymorphism compared to other earthworm species, a result that can be attributed to ancient bottlenecks, for instance due to species isolation in southern refugia during the ice ages with subsequent expansion toward northern Europe. Historical events can also be responsible for the existence of two divergent, but randomly interbreeding mitochondrial lineages within all study populations. In addition, the comparison of observed heterozygosity among microsatellite loci and heterozygosity expected under mutation-drift equilibrium suggested a recent decrease in effective size in some populations that could be due to contemporary events such as habitat fragmentation. The absence of relationship between geographic and genetic distances estimated from microsatellite allele frequency data also suggested that dispersal is haphazard and that human activities favour passive dispersal among geographically distant populations.	[Torres-Leguizamon, Magally; Dupont, Lise] Univ Paris Est Creteil, Inst Ecol & Environm Sci Paris, Creteil, France; [Torres-Leguizamon, Magally] INRA, Unite Zool Forestiere UR0633, Orleans, France; [Mathieu, Jerome] Univ Paris 06, Inst Ecol & Environm Sci Paris, Paris, France; [Decaens, Thibaud] Univ Rouen, EA ECODIV 1293, Mont St Aignan, France	UDICE-French Research Universities; Sorbonne Universite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite de Rouen Normandie	Dupont, L (corresponding author), Univ Paris Est Creteil, Inst Ecol & Environm Sci Paris, Creteil, France.	lise.dupont@u-pec.fr	mathieu, jerome/B-8478-2008; Dupont, Lise/M-1712-2013; Decaens, Thibaud/AAA-5287-2020	mathieu, jerome/0000-0002-9106-6106; Dupont, Lise/0000-0003-4824-2685; 	French National Research Agency (ANR) [ANR-08-JCJC-0023]	French National Research Agency (ANR)(French National Research Agency (ANR))	This work was funded by the French National Research Agency (ANR) as a part of the project EDISP No ANR-08-JCJC-0023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos W, 1998, PHILOS T ROY SOC B, V353, P177, DOI 10.1098/rstb.1998.0200; ASMUSSEN MA, 1994, GENETICS, V138, P1351; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Basten CJ, 1997, GENETICS, V146, P1165; Bernier N, 1998, BIOL FERT SOILS, V26, P215, DOI 10.1007/s003740050370; Bouche M.B., 1972, LOMBRICIENS FRANCE E; Bouma J., 1991, ADV AGRONOMY, V46, P1; Brown George G., 2004, P13; Capowiez Y, 2006, SOIL BIOL BIOCHEM, V38, P285, DOI 10.1016/j.soilbio.2005.05.014; Capowiez Y, 2005, BIOL FERT SOILS, V41, P135, DOI 10.1007/s00374-004-0829-0; Capowiez Y, 2006, ECOTOX ENVIRON SAFE, V64, P198, DOI 10.1016/j.ecoenv.2005.02.013; Capowiez Y, 2010, ENVIRON POLLUT, V158, P388, DOI 10.1016/j.envpol.2009.09.003; Caro G, 2013, SOIL BIOL BIOCHEM, V58, P181, DOI 10.1016/j.soilbio.2012.11.019; Casellato S., 1987, Collana U.Z.I. Selected Symposia and Monographs, P75; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cornuet JM, 1996, GENETICS, V144, P2001; Costa D, 2013, APPL SOIL ECOL, V68, P61, DOI 10.1016/j.apsoil.2013.03.003; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Dupont L, 2007, DIVERS DISTRIB, V13, P808, DOI 10.1111/j.1472-4642.2007.00405.x; Dupont L, 2011, PEDOBIOLOGIA, V54, P217, DOI 10.1016/j.pedobi.2011.03.004; Edwards Clive A., 2004, P3; Eijsackers H, 2011, APPL SOIL ECOL, V50, P1, DOI 10.1016/j.apsoil.2011.07.008; Eisenhauer N, 2011, J ECOL, V99, P572, DOI 10.1111/j.1365-2745.2010.01783.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fernandez R, 2011, SOIL BIOL BIOCHEM, V43, P2085, DOI 10.1016/j.soilbio.2011.06.007; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fu YX, 1997, GENETICS, V147, P915; Gorres JH, 2001, SOIL BIOL BIOCHEM, V33, P1881, DOI 10.1016/S0038-0717(01)00068-2; Goudet J., 2000, FSTAT PROGRAM ESTIMA; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harper GL, 2006, MOL ECOL NOTES, V6, P325, DOI 10.1111/j.1471-8286.2005.01219.x; HARRISON RG, 1991, ANNU REV ECOL SYST, V22, P281, DOI 10.1146/annurev.ecolsys.22.1.281; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; James SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015629; King RA, 2008, MOL ECOL, V17, P4694; Knott KE, 2010, HEREDITY, V105, P341, DOI 10.1038/hdy.2010.31; Kvie KS, 2013, ECOL EVOL, V3, P126, DOI 10.1002/ece3.434; Laossi KR, 2008, PEDOBIOLOGIA, V51, P397, DOI 10.1016/j.pedobi.2007.11.001; Lavelle P, 2002, ECOL RES, V17, P441, DOI 10.1046/j.1440-1703.2002.00509.x; Lavelle P, 2001, EARTHWORM ECOLOGY; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MANTEL N, 1967, CANCER RES, V27, P209; Mathieu J, 2014, J BIOGEOGR IN PRESS; Mathieu J, 2010, SOIL BIOL BIOCHEM, V42, P203, DOI 10.1016/j.soilbio.2009.10.018; MINAMIYA Y, 2009, EUR J SOIL BIOL, V45, P423, DOI DOI 10.1016/j.ejsobi.2009.06.004; Novak SJ, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P201; Novo M, 2008, MOL ECOL RESOUR, V8, P901, DOI 10.1111/j.1755-0998.2008.02105.x; Novo M, 2010, PEDOBIOLOGIA, V53, P375, DOI 10.1016/j.pedobi.2010.07.002; Novo Marta, 2009, Zoologica Scripta, V38, P537, DOI 10.1111/j.1463-6409.2009.00389.x; Nuria R, 2011, SOIL BIOL BIOCHEM, V43, P2032, DOI 10.1016/j.soilbio.2011.05.019; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Pelosi C, 2013, AGR ECOSYST ENVIRON, V181, P223, DOI 10.1016/j.agee.2013.10.003; Petit RJ, 2002, FOREST ECOL MANAG, V156, P49, DOI 10.1016/S0378-1127(01)00634-X; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Ponge JF, 2013, SOIL BIOL BIOCHEM, V67, P271, DOI 10.1016/j.soilbio.2013.08.026; Postma-Blaauw MB, 2006, PEDOBIOLOGIA, V50, P243, DOI 10.1016/j.pedobi.2006.02.001; Pritchard JK, 2000, GENETICS, V155, P945; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rousset F, 1997, GENETICS, V145, P1219; Scheu S, 2002, OECOLOGIA, V133, P254, DOI 10.1007/s00442-002-1023-4; SCHWERT DP, 1977, CAN J ZOOL, V55, P245, DOI 10.1139/z77-029; Siqueira FD, 2013, PEDOBIOLOGIA, V56, P15, DOI 10.1016/j.pedobi.2012.08.006; Somers CM, 2011, PEDOBIOLOGIA, V54, P111, DOI 10.1016/j.pedobi.2010.11.002; Strunk H, 2012, EUR J SOIL BIOL, V48, P56, DOI 10.1016/j.ejsobi.2011.11.004; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas E, 2012, PLOS ONE, V7; Tomimatsu H, 2009, MOL ECOL, V18, P3918, DOI 10.1111/j.1365-294X.2009.04341.x; Torres-Leguizamon M, 2012, SOIL BIOL BIOCHEM, V51, P16, DOI 10.1016/j.soilbio.2012.03.020; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Velavan TP, 2007, MOL ECOL NOTES, V7, P1060, DOI 10.1111/j.1471-8286.2007.01776.x; Velavan TP, 2009, SOIL BIOL BIOCHEM, V41, P1591, DOI 10.1016/j.soilbio.2009.03.026; Webb WC, 2011, MOL ECOL, V20, P2390, DOI 10.1111/j.1365-294X.2011.05095.x; Wolf DE, 2001, CONSERV BIOL, V15, P1039, DOI 10.1046/j.1523-1739.2001.0150041039.x; YOUNG AG, 1993, HEREDITY, V71, P277, DOI 10.1038/hdy.1993.136	80	27	28	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101597	10.1371/journal.pone.0101597	http://dx.doi.org/10.1371/journal.pone.0101597			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003795	Green Published, Green Submitted, gold			2022-12-27	WOS:000339242700044
J	Yao, X; Jennings, S; Ireland, SK; Pham, T; Temple, B; Davis, M; Chen, RW; Davenport, I; Biliran, H				Yao, Xin; Jennings, Scott; Ireland, Shubha Kale; Tri Pham; Temple, Brandi; Davis, Mya; Chen, Renwei; Davenport, Ian; Biliran, Hector			The Anoikis Effector Bit1 Displays Tumor Suppressive Function in Lung Cancer Cells	PLOS ONE			English	Article							DOWN-REGULATION; INTEGRINS; PROTEIN; CHEMORESISTANCE; DETACHMENT; CARCINOMA; REGULATOR; MATRIX; DEATH; TLE1	The mitochondrial Bit1 (Bcl-2 inhibitor of transcription 1) protein is a part of an apoptotic pathway that is uniquely regulated by integrin-mediated attachment. As an anoikis effector, Bit1 is released into the cytoplasm following loss of cell attachment and induces a caspase-independent form of apoptosis. Considering that anoikis resistance is a critical determinant of transformation, we hypothesized that cancer cells may circumvent the Bit1 apoptotic pathway to attain anchorage-independence and tumorigenic potential. Here, we provide the first evidence of the tumor suppressive effect of Bit1 through a mechanism involving anoikis induction in human lung adenocarcinoma derived A549 cells. Restitution of Bit1 in anoikis resistant A549 cells is sufficient to induce detachment induced-apoptosis despite defect in caspase activation and impairs their anchorage-independent growth. Conversely, stable downregulation of Bit1 in these cells significantly enhances their anoikis resistance and anchorage-independent growth. The Bit1 knockdown cells exhibit significantly enhanced tumorigenecity in vivo. It has been previously shown that the nuclear TLE1 corepressor is a putative oncogene in lung cancer, and we show here that TLE1 blocks Bit1 mediated anoikis in part by sequestering the pro-apoptotic partner of Bit1, the Amino-terminal Enhancer of Split (AES) protein, in the nucleus. Taken together, these findings suggest a tumor suppressive role of the caspase-independent anoikis effector Bit1 in lung cancer. Consistent with its role as a tumor suppressor, we have found that Bit1 is downregulated in human non-small cell lung cancer (NSCLC) tissues.	[Chen, Renwei] Univ Calif Santa Barbara, Sanford Burnham Med Res Inst, Ctr Nanomed, Santa Barbara, CA 93106 USA; [Chen, Renwei] Univ Calif Santa Barbara, Dept Mol Cell & Dev Biol, Santa Barbara, CA 93106 USA; [Yao, Xin; Jennings, Scott; Ireland, Shubha Kale; Tri Pham; Temple, Brandi; Davis, Mya; Davenport, Ian; Biliran, Hector] Xavier Univ Louisiana, Dept Biol, New Orleans, LA 70125 USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Xavier University of Louisiana	Biliran, H (corresponding author), Xavier Univ Louisiana, Dept Biol, New Orleans, LA 70125 USA.	hbiliran@xula.edu		Glover, Brandi/0000-0002-5760-8143	Louisiana Cancer Research Consortium (LCRC) Start up Grant; NIH [RCMI G12RR026250-03, 1R15CA158677-01A1]; NATIONAL CANCER INSTITUTE [R15CA158677] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007595] Funding Source: NIH RePORTER	Louisiana Cancer Research Consortium (LCRC) Start up Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by Louisiana Cancer Research Consortium (LCRC) Start up Grant (HB), NIH RCMI G12RR026250-03 Grant (to Xavier University of Losuiana), and NIH 1R15CA158677-01A1 Grant (HB). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen T, 2006, CANCER RES, V66, P1294, DOI 10.1158/0008-5472.CAN-05-1634; Biliran H, 2008, J BIOL CHEM, V283, P28029, DOI 10.1074/jbc.M803139200; Bondar VM, 2002, PROSTATE, V51, P42, DOI 10.1002/pros.10070; Brunquell C, 2012, MOL CANCER RES, V10, P1482, DOI 10.1158/1541-7786.MCR-12-0144; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Chen RW, 2013, CANCER RES, V73, P1352, DOI 10.1158/0008-5472.CAN-12-1979; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Frisch SM, 1999, CURR BIOL, V9, P1047, DOI 10.1016/S0960-9822(99)80455-2; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Gallego MA, 2008, ONCOGENE, V27, P1981, DOI 10.1038/sj.onc.1210833; Gallego MA, 2004, ONCOGENE, V23, P6282, DOI 10.1038/sj.onc.1207835; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Jan YW, 2004, CELL, V116, P751, DOI 10.1016/S0092-8674(04)00204-1; Kairouz-Wahbe R, 2008, P NATL ACAD SCI USA, V105, P1528, DOI 10.1073/pnas.0711357105; Karmali PP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023840; Li ZG, 2008, P NATL ACAD SCI USA, V105, P162, DOI 10.1073/pnas.0710905105; Rosen K, 2000, J CELL BIOL, V149, P447, DOI 10.1083/jcb.149.2.447; Ruoslahti E, 1999, ADV CANCER RES, V76, P1, DOI 10.1016/S0065-230X(08)60772-1; Rytomaa M, 1999, CURR BIOL, V9, P1043, DOI 10.1016/S0960-9822(99)80454-0; Seo SW, 2011, J ORTHOP RES, V29, P1131, DOI 10.1002/jor.21318; Sonderegger CK, 2003, ONCOGENE, V22, P1749, DOI 10.1038/sj.onc.1206308; Sonoshita M, 2011, CANCER CELL, V19, P125, DOI 10.1016/j.ccr.2010.11.008; Zhang XG, 2008, J NEUROSCI RES, V86, P2423, DOI 10.1002/jnr.21680	24	14	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101564	10.1371/journal.pone.0101564	http://dx.doi.org/10.1371/journal.pone.0101564			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003198	Green Published, gold			2022-12-27	WOS:000339242700039
J	Gothwal, VK; Bagga, DK; Bharani, S; Sumalini, R; Reddy, SP				Gothwal, Vijaya K.; Bagga, Deepak K.; Bharani, Seelam; Sumalini, Rebecca; Reddy, Shailaja P.			The Patient Health Questionnaire-9: Validation among Patients with Glaucoma	PLOS ONE			English	Article							QUALITY-OF-LIFE; VISUAL FUNCTION QUESTIONNAIRE; ITEM RESPONSE THEORY; RASCH ANALYSIS; RATING-SCALES; DEPRESSION; VISION; IMPACT; PHQ-9; PREVALENCE	Background: Depression and anxiety are two common normal responses to a chronic disease such as glaucoma. This study analysed the measurement properties of the depression screening instrument - Patient Health Questionnaire-9 (PHQ-9) using Rasch analysis to determine if it can be used as a measure. Methods: In this hospital-based cross-sectional study, the PHQ-9 was administered to primary glaucoma adults attending a glaucoma clinic of a tertiary eye care centre, South India. All patients underwent a comprehensive clinical evaluation. Patient demographics and sub-type of glaucoma were abstracted from the medical record. Rasch analysis was used to investigate the following properties of the PHQ-9: behaviour of the response categories, measurement precision (assessed using person separation reliability, PSR; minimum recommended value 0.80), unidimensionality (assessed using item fit [0.7-1.3] and principal components analysis of residuals), and targeting. Results: 198 patients (mean age +/- standard deviation = 59.83 +/- 12.34 years; 67% male) were included. The native PHQ-9 did not fit the Rasch model. The response categories showed disordered thresholds which became ordered after category reorganization. Measurement precision was below acceptable limits (0.62) and targeting was sub-optimal (-1.27 logits). Four items misfit that were deleted iteratively following which a set of five items fit the Rasch model. However measurement precision failed to improve and targeting worsened further (-1.62 logits). Conclusions: The PHQ-9, in its present form, provides suboptimal assessment of depression in patients with glaucoma in India. Therefore, there is a need to develop a new depression instrument for our glaucoma population. A superior strategy would be to use the item bank for depression but this will also need to be validated in glaucoma patients before deciding its utility.	[Gothwal, Vijaya K.; Bagga, Deepak K.; Bharani, Seelam; Sumalini, Rebecca] LV Prasad Eye Inst, Vis Rehabil Ctr, Meera & LB Deshpande Ctr Sight Enhancement, Hyderabad, Andhra Pradesh, India; [Reddy, Shailaja P.] LV Prasad Eye Inst, Bausch & Lomb Sch Optometry, Hyderabad, Andhra Pradesh, India	L. V. Prasad Eye Institute; Bausch Health; Bausch + Lomb; L. V. Prasad Eye Institute	Gothwal, VK (corresponding author), LV Prasad Eye Inst, Vis Rehabil Ctr, Meera & LB Deshpande Ctr Sight Enhancement, Hyderabad, Andhra Pradesh, India.	vijayagothwal@gmail.com	Bagga, Deepak/AAD-7763-2021; Gothwal, Vijaya/AAY-4526-2020		Hyderabad Eye Research Foundation, Hyderabad, India	Hyderabad Eye Research Foundation, Hyderabad, India	This study was supported by the Hyderabad Eye Research Foundation, Hyderabad, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; ANDRICH D, 1978, PSYCHOMETRIKA, V43, P561, DOI 10.1007/BF02293814; Bechetoille A, 2008, ACTA OPHTHALMOL, V86, P71, DOI 10.1111/j.1600-0420.2007.00999.x; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; DEMAILLY P, 1989, J FR OPHTALMOL, V12, P595; DeVellis RF, 2016, SCALE DEV THEORY APP; Erb C., 1993, Ophthalmologe, V90, P635; Fliege H, 2005, QUAL LIFE RES, V14, P2277, DOI 10.1007/s11136-005-6651-9; Forkmann T, 2013, J AFFECT DISORDERS, V148, P323, DOI 10.1016/j.jad.2012.12.019; Friedman DS, 2009, OPHTHALMOLOGY, V116, P1097, DOI 10.1016/j.ophtha.2009.01.021; Garamendi E, 2006, VISION RES, V46, P1375, DOI 10.1016/j.visres.2005.07.007; Gothwal VK, 2009, BRIT J OPHTHALMOL, V93, P1652, DOI 10.1136/bjo.2009.159806; Gothwal VK, 2012, INVEST OPHTH VIS SCI, V53, P6081, DOI 10.1167/iovs.12-9885; Gothwal VK, 2012, INVEST OPHTH VIS SCI, V53, P4730, DOI 10.1167/iovs.11-8776; Gothwal VK, 2012, BRIT J OPHTHALMOL, V96, P619, DOI 10.1136/bjophthalmol-2011-300092; Gothwal VK, 2010, INVEST OPHTH VIS SCI, V51, P694, DOI 10.1167/iovs.09-3448; Gothwal VK, 2003, INVEST OPHTH VIS SCI, V44, P4131, DOI 10.1167/iovs.02-1238; Hamelin N, 2002, J FR OPHTALMOL, V25, P795; Hays RD, 2000, MED CARE, V38, P28; Hobart JC, 2007, LANCET NEUROL, V6, P1094, DOI 10.1016/S1474-4422(07)70290-9; Holland PW., 1993, DIFFERENTIAL ITEM FU, DOI DOI 10.4324/9780203357811; Jayawant SS, 2007, J GLAUCOMA, V16, P513, DOI 10.1097/IJG.0b013e31804a5ec6; Jette AM, 2007, PHYS THER, V87, P385, DOI 10.2522/ptj.20060121; Kendel F, 2010, J AFFECT DISORDERS, V122, P241, DOI 10.1016/j.jad.2009.07.004; Khadka J, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-80; Khadka J, 2010, BRIT J OPHTHALMOL, V94, P730, DOI 10.1136/bjo.2009.171181; Kosinski M, 2006, J CLIN EPIDEMIOL, V59, P715, DOI 10.1016/j.jclinepi.2005.07.019; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lamoureux EL, 2009, OPTOMETRY VISION SCI, V86, P139, DOI 10.1097/OPX.0b013e318194eb47; Lin HC, 2010, OPHTHALMOLOGY, V117, P2088, DOI 10.1016/j.ophtha.2010.03.003; Linacre J M, 1998, J Outcome Meas, V2, P266; Linacre J.M., 1998, RASCH MEAS T, V12, P636; Linacre JM, 2008, WINSTEPS RASCH MEASU; Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006; Lowe B, 2004, J AFFECT DISORDERS, V81, P61, DOI 10.1016/S0165-0327(03)00198-8; Mabuchi F, 2008, J GLAUCOMA, V17, P552, DOI 10.1097/IJG.0b013e31816299d4; Mallinson T, 2004, MED CARE, V42, P17, DOI 10.1097/01.mlr.0000103522.78233.c3; Mangione CM, 1998, ARCH OPHTHALMOL-CHIC, V116, P227; Marella M, 2009, OPTOMETRY VISION SCI, V86, P826, DOI 10.1097/OPX.0b013e3181ae1b3f; Massof RW, 2002, OPTOMETRY VISION SCI, V79, P516, DOI 10.1097/00006324-200208000-00015; Norquist JM, 2004, MED CARE, V42, P25, DOI 10.1097/01.mlr.0000103530.13056.88; Owsley C, 2004, OPHTHALMOLOGY, V111, P2259, DOI 10.1016/j.ophtha.2004.06.026; Pesudovs K, 2004, OPTOMETRY VISION SCI, V81, P769, DOI 10.1097/00006324-200410000-00009; Pesudovs K, 2007, OPTOMETRY VISION SCI, V84, P663, DOI 10.1097/OPX.0b013e318141fe75; Pesudovs K, 2006, INVEST OPHTH VIS SCI, V47, P2789, DOI 10.1167/iovs.05-0933; Pickard AS, 2006, VALUE HEALTH, V9, P59, DOI 10.1111/j.1524-4733.2006.00082.x; Prieto Luis, 2003, Health Qual Life Outcomes, V1, P27, DOI 10.1186/1477-7525-1-27; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rasch G., 1960, PROBABILISTIC MODELS; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Revicki DA, 1997, QUAL LIFE RES, V6, P595, DOI 10.1023/A:1018420418455; Skalicky S, 2008, J GLAUCOMA, V17, P546, DOI 10.1097/IJG.0b013e318163bdd1; Smith R M, 2000, J Appl Meas, V1, P199; Smith R. M., 1994, OBJECTIVE MEASUREMEN, P316; Streiner D. L., 2003, HLTH MEASUREMENT SCA; Tastan S, 2010, PSYCHOL REP, V106, P343, DOI 10.2466/PR0.106.2.343-357; Wainer H, 2000, COMPUTERIZED ADAPTIV, DOI DOI 10.4324/9781410605931; Wang SY, 2012, AM J OPHTHALMOL, V154, P436, DOI 10.1016/j.ajo.2012.03.039; Wang SY, 2012, INVEST OPHTH VIS SCI, V53, P725, DOI 10.1167/iovs.11-9038; Ware JE, 2000, MED CARE, V38, P73; Williams RT, 2009, REHABIL PSYCHOL, V54, P198, DOI 10.1037/a0015529; Wilson MR, 2002, OPHTHALMOLOGY, V109, P1018, DOI 10.1016/S0161-6420(02)00993-4; Wright BD, 1982, RATING SCALE ANAL; Wright BD., 1994, RASCH MEASUREMENT T, V8, P370, DOI DOI 10.1177/01461672012710004; Yochim BP, 2012, J GLAUCOMA, V21, P250, DOI 10.1097/IJG.0b013e3182071b7e	66	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101295	10.1371/journal.pone.0101295	http://dx.doi.org/10.1371/journal.pone.0101295			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7WB	24999659	gold, Green Submitted, Green Published			2022-12-27	WOS:000338637300032
J	Joseph, C; Tseng, CY; Zocchi, G; Tlusty, T				Joseph, Collin; Tseng, Chiao-Yu; Zocchi, Giovanni; Tlusty, Tsvi			Asymmetric Effect of Mechanical Stress on the Forward and Reverse Reaction Catalyzed by an Enzyme	PLOS ONE			English	Article							FORCE; CATCH; MODEL; DYNAMICS; FIELD	The concept of modulating enzymatic activity by exerting a mechanical stress on the enzyme has been established in previous work. Mechanical perturbation is also a tool for probing conformational motion accompanying the enzymatic cycle. Here we report measurements of the forward and reverse kinetics of the enzyme Guanylate Kinase from yeast (Saccharomyces cerevisiae). The enzyme is held in a state of stress using the DNA spring method. The observation that mechanical stress has different effects on the forward and reverse reaction kinetics suggests that forward and reverse reactions follow different paths, on average, in the enzyme's conformational space. Comparing the kinetics of the stressed and unstressed enzyme we also show that the maximum speed of the enzyme is comparable to the predictions of the relaxation model of enzyme action, where we use the independently determined dissipation coefficient gamma approximate to 10(-1) g/s for the enzyme's conformational motion. The present experiments provide a mean to explore enzyme kinetics beyond the static energy landscape picture of transition state theory.	[Joseph, Collin; Tseng, Chiao-Yu; Zocchi, Giovanni] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Tlusty, Tsvi] Inst Adv Study, Princeton, NJ 08540 USA	University of California System; University of California Los Angeles; Institute for Advanced Study - USA	Zocchi, G (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA.	zocchi@physics.ucla.edu	Tlusty, Tsvi/A-9880-2008	Tlusty, Tsvi/0000-0002-9662-3725	United States-Israel Binational Science Foundation [201044]	United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation)	This work was supported by the United States-Israel Binational Science Foundation under grant number 201044. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal K C, 1978, Methods Enzymol, V51, P483; Ariyaratne A, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.011010; Barsegov V, 2005, P NATL ACAD SCI USA, V102, P1835, DOI 10.1073/pnas.0406938102; Bartolo D, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051910; Blumenfeld L.A., 2012, BIOPHYSICAL THERMODY; Cantor C. R., 1980, BIOPHYSICAL CHEM 3; Choi B, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.078102; Evans E, 2004, PNAS, V101; FREY CM, 1972, J AM CHEM SOC, V94, P8898, DOI 10.1021/ja00780a042; GUPTA RK, 1983, BIOCHEM BIOPH RES CO, V117, P210, DOI 10.1016/0006-291X(83)91562-0; HOPFIELD JJ, 1973, J MOL BIOL, V77, P207, DOI 10.1016/0022-2836(73)90332-X; Howard J, 2009, ANNU REV BIOPHYS, V38, P217, DOI 10.1146/annurcv.biophys.050708.133732; KOSHLAND DE, 1994, ANGEW CHEM INT EDIT, V33, P2375; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Lankas F, 2006, STRUCTURE, V14, P1527, DOI 10.1016/j.str.2006.08.004; Li Y, 1996, J BIOL CHEM, V271, P28038, DOI 10.1074/jbc.271.45.28038; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; Mayans O, 1998, NATURE, V395, P863, DOI 10.1038/27603; Michaelis L, 1913, BIOCHEM Z, V49, P333; Pereverzev YV, 2011, BIOPHYS J, V101, P2026, DOI 10.1016/j.bpj.2011.09.005; Pereverzev YV, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051913; Pereverzev YV, 2005, BIOPHYS J, V89, P1446, DOI 10.1529/biophysj.105.062158; PERUTZ MF, 1972, NATURE, V237, P495, DOI 10.1038/237495a0; Puchner EM, 2008, P NATL ACAD SCI USA, V105, P13385, DOI 10.1073/pnas.0805034105; Qu H, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.011009; Qu H, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.021008; Qu H, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/18003; RADMACHER M, 1994, LANGMUIR, V10, P3809, DOI 10.1021/la00022a068; Simonson T, 2013, J COMPUT CHEM, V34, P836, DOI 10.1002/jcc.23207; Suzuki Y, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.048101; Thomas W, 2006, BIOPHYS J, V90, P753, DOI 10.1529/biophysj.105.066548; Tseng CY, 2010, EPL-EUROPHYS LETT, V91, DOI 10.1209/0295-5075/91/18005; Tseng CY, 2013, J AM CHEM SOC, V135, P11879, DOI 10.1021/ja4043565; Tseng CY, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.061912; von Castelmur E, 2012, P NATL ACAD SCI USA, V109, P13608, DOI 10.1073/pnas.1200697109; Wang Y, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/18003; Wang Y, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/33/335103; Zocchi G, 2009, ANNU REV BIOPHYS, V38, P75, DOI 10.1146/annurev.biophys.050708.133637	38	9	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101442	10.1371/journal.pone.0101442	http://dx.doi.org/10.1371/journal.pone.0101442			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000118	Green Submitted, Green Published, gold			2022-12-27	WOS:000338637300043
J	Klocker, A; Oddo, CM; Camboni, D; Penta, M; Thonnard, JL				Klocker, Anne; Oddo, Calogero Maria; Camboni, Domenico; Penta, Massimo; Thonnard, Jean-Louis			Physical Factors Influencing Pleasant Touch during Passive Fingertip Stimulation	PLOS ONE			English	Article							PERCEIVED ROUGHNESS; PERCEPTION; DISCRIMINATION; AFFERENTS; FRICTION; RECOGNITION; PATTERNS; FINE	Objective: Tactile explorations with the fingertips provide information regarding the physical properties of surfaces and their relative pleasantness. Previously, we performed an investigation in the active touch domain and linked several surface properties (i.e. frictional force fluctuations and net friction) with their pleasantness levels. The aim of the present study was to investigate physical factors being important for pleasantness perception during passive fingertip stimulation. Specifically we were interested to see whether factors, such as surfaces' topographies or their frictional characteristics could influence pleasantness. Furthermore, we ascertained how the stimulus pleasantness level was impacted by (i) the normal force of stimulus application (F-N) and (ii) the stimulus temperature (T-S). Methods and Results: The right index fingertips of 22 blindfolded participants were stimulated using 27 different stimuli, which varied in average roughness (Ra) and T-S. A 4-axis robot moved the stimuli horizontally under participants' fingertips with three levels of F-N. The robot was equipped with force sensors, which recorded the F-N and friction force (F-T) during stimulation. Participants rated each stimulus according to a three-level pleasantness scale, as very pleasant (scored 0), pleasant (scored 1), or unpleasant (scored 2). These ordinal pleasantness ratings were logarithmically transformed into linear and unidimensional pleasantness measures with the Rasch model. Statistical analyses were conducted to investigate a possible link between the stimulus properties (i.e. Ra, F-N, F-T, and T-S) and their respective pleasantness levels. Only the mean Ra and FT values were negatively correlated with pleasantness. No significant correlation was detected between F-N or T-S and pleasantness. Conclusion: Pleasantness perception, resulting from passive fingertip stimulation, seems to be influenced by the surfaces' average roughness levels and average F-T occurring during fingertip stimulation.	[Klocker, Anne; Penta, Massimo; Thonnard, Jean-Louis] Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium; [Oddo, Calogero Maria; Camboni, Domenico] Scuola Super Sant Anna, BioRobot Inst, Pisa, Italy; [Thonnard, Jean-Louis] Catholic Univ Louvain, Clin Univ St Luc, Phys & Rehabil Med Dept, B-1200 Brussels, Belgium	Universite Catholique Louvain; Scuola Superiore Sant'Anna; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Thonnard, JL (corresponding author), Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium.	jean-louis.thonnard@uclouvain.be	Oddo, Calogero Maria/K-5358-2019	Oddo, Calogero Maria/0000-0002-1489-5701; CAMBONI, Domenico/0000-0002-6853-475X	Commission of the European Union [EU-FP7-NMP4-SL-2009-228844]; NanoBioTouch; HandBot Italian project [PRIN MIUR 20102YF2RY_004]	Commission of the European Union(European Commission); NanoBioTouch; HandBot Italian project	This work was supported by a grant from the Commission of the European Union under Contract No. EU-FP7-NMP4-SL-2009-228844, NanoBioTouch. This work was supported in part by the HandBot Italian project (PRIN MIUR 20102YF2RY_004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Ackerley R, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00034; Adams MJ, 2007, TRIBOL LETT, V26, P239, DOI 10.1007/s11249-007-9206-0; Adams MJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0467; Andre T, 2009, J NEUROSCI METH, V179, P224, DOI 10.1016/j.jneumeth.2009.01.031; Bensmaia S, 2005, PERCEPT PSYCHOPHYS, V67, P842, DOI 10.3758/BF03193537; Chen XJ, 2009, INT J DES, V3, P67; EKMAN G, 1965, J EXP PSYCHOL, V70, P18, DOI 10.1037/h0021985; Essick GK, 2010, NEUROSCI BIOBEHAV R, V34, P192, DOI 10.1016/j.neubiorev.2009.02.003; Gerhardt LC, 2008, J R SOC INTERFACE, V5, P1317, DOI 10.1098/rsif.2008.0034; GIBSON JJ, 1962, PSYCHOL REV, V69, P477, DOI 10.1037/h0046962; Guest S, 2009, ACTA PSYCHOL, V130, P115, DOI 10.1016/j.actpsy.2008.10.007; HELLER MA, 1984, J GEN PSYCHOL, V110, P243, DOI 10.1080/00221309.1984.9709968; Ho HN, 2006, PERCEPT PSYCHOPHYS, V68, P118, DOI 10.3758/BF03193662; Hollins M, 2001, SOMATOSENS MOT RES, V18, P253; Hollins M, 2000, PERCEPTION, V29, P1455, DOI 10.1068/p3044; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; JOHANSSON RS, 1988, EXP BRAIN RES, V72, P204, DOI 10.1007/BF00248518; Johnson KO, 2001, CURR OPIN NEUROBIOL, V11, P455, DOI 10.1016/S0959-4388(00)00234-8; Kitada R, 2012, PERCEPTION, V41, P204, DOI 10.1068/p7168; Klocker A, 2012, FRONT NEUROROBOTICS, V6, P1; Klocker A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079085; LANDRIGAN DT, 1974, J EXP PSYCHOL, V103, P1124, DOI 10.1037/h0037356; LEDERMAN SJ, 1983, CAN J PSYCHOL, V37, P498, DOI 10.1037/h0080750; LEDERMAN SJ, 1981, B PSYCHONOMIC SOC, V18, P253; Major DR, 1895, THOUGHTS DECLINE MAJ, V7, P57, DOI [10.2307/1412037, DOI 10.2307/1412037]; McGlone F, 2007, CAN J EXP PSYCHOL, V61, P173, DOI 10.1037/cjep2007019; McGlone F, 2010, NEUROSCI BIOBEHAV R, V34, P148, DOI 10.1016/j.neubiorev.2009.08.004; Morin C, 1998, PAIN, V74, P67, DOI 10.1016/S0304-3959(97)00152-8; NORDIN M, 1990, J PHYSIOL-LONDON, V426, P229, DOI 10.1113/jphysiol.1990.sp018135; Oddo CM, 2011, IEEE T ROBOT, V27, P522, DOI 10.1109/TRO.2011.2116930; Olausson H, 2002, NAT NEUROSCI, V5, P900, DOI 10.1038/nn896; Rasch G., 1960, PROBABILISTIC MODELS; RICHARDSON BL, 1981, BRIT J PSYCHOL, V72, P353, DOI 10.1111/j.2044-8295.1981.tb02194.x; Rolls ET, 2008, NEUROIMAGE, V41, P1504, DOI 10.1016/j.neuroimage.2008.03.005; Schmelz M, 2011, EUR J DERMATOL, V21, P43, DOI 10.1684/ejd.2011.1265; Smith AM, 2009, J NEUROPHYSIOL, V102, P3519, DOI 10.1152/jn.00043.2009; Smith AM, 1996, J NEUROPHYSIOL, V75, P1957, DOI 10.1152/jn.1996.75.5.1957; SRINIVASAN MA, 1990, J NEUROPHYSIOL, V63, P1323, DOI 10.1152/jn.1990.63.6.1323; Vallbo AB, 1999, J NEUROPHYSIOL, V81, P2753, DOI 10.1152/jn.1999.81.6.2753; Van Kuilenburg J, 2013, P I MECH ENG J-J ENG, V0, P1; VEGABERMUDEZ F, 1991, J NEUROPHYSIOL, V65, P531, DOI 10.1152/jn.1991.65.3.531; Verrillo RT, 1999, SOMATOSENS MOT RES, V16, P352; Wheat HE, 2010, J NEUROPHYSIOL, V103, P950, DOI 10.1152/jn.00502.2009; Wright BD, 1979, BEST TEST DESIGN RAS; Yoshioka T, 2001, J NEUROSCI, V21, P6905, DOI 10.1523/JNEUROSCI.21-17-06905.2001	46	22	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101361	10.1371/journal.pone.0101361	http://dx.doi.org/10.1371/journal.pone.0101361			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000561	gold, Green Published, Green Submitted			2022-12-27	WOS:000338637300038
J	Omerov, P; Steineck, G; Nyberg, T; Runeson, B; Nyberg, U				Omerov, Pernilla; Steineck, Gunnar; Nyberg, Tommy; Runeson, Bo; Nyberg, Ullakarin			Viewing the Body after Bereavement Due to Suicide: A Population-Based Survey in Sweden	PLOS ONE			English	Article							PRIMARY-CARE; DEATH; DEPRESSION; PHQ-9	Background: Research on the assumed, positive and negative, psychological effects of viewing the body after a suicide loss is sparse. We hypothesized that suicide-bereaved parents that viewed their childs body in a formal setting seldom regretted the experience, and that viewing the body was associated with lower levels of psychological morbidity two to five years after the loss. Methods and Findings: We identified 915 suicide-bereaved parents by linkage of nationwide population-based registries and collected data by a questionnaire. The outcome measures included the Patient Health Questionnaire (PHQ-9). In total, 666 (73%) parents participated. Of the 460 parents (69%) that viewed the body, 96% answered that they did not regret the experience. The viewing was associated with a higher risk of reliving the child's death through nightmares (RR 1.61, 95% CI 1.13 to 2.32) and intrusive memories (RR 1.20, 95% CI 1.04 to 1.38), but not with anxiety (RR 1.02, 95% CI 0.74 to 1.40) and depression (RR 1.25, 95% CI 0.85 to 1.83). One limitation of our study is that we lack data on the informants' personality and coping strategies. Conclusions: In this Swedish population-based survey of suicide-bereaved parents, we found that by and large everyone that had viewed their deceased child in a formal setting did not report regretting the viewing when asked two to five years after the loss. Our findings suggest that most bereaved parents are capable of deciding if they want to view the body or not. Officials may assist by giving careful information about the child's appearance and other details concerning the viewing, thus facilitating mental preparation for the bereaved person. This is the first large-scale study on the effects of viewing the body after a suicide and additional studies are needed before clinical recommendations can be made.	[Omerov, Pernilla; Runeson, Bo; Nyberg, Ullakarin] Karolinska Inst, Dept Clin Neurosci, Ctr Psychiat Res & Educ, Stockholm, Sweden; [Omerov, Pernilla; Steineck, Gunnar; Nyberg, Tommy; Nyberg, Ullakarin] Karolinska Inst, Dept Pathol & Oncol, Div Clin Canc Epidemiol, Stockholm, Sweden; [Steineck, Gunnar] Sahlgrens Acad, Inst Clin Sci, Dept Oncol, Div Clin Canc Epidemiol, Gothenburg, Sweden	Karolinska Institutet; Karolinska Institutet; University of Gothenburg	Omerov, P (corresponding author), Karolinska Inst, Dept Clin Neurosci, Ctr Psychiat Res & Educ, Stockholm, Sweden.	Pernilla.Omerov@Ki.se	Steineck, Gunnar/W-1515-2019; Nyberg, Tommy/AGG-2330-2022; Omerov, Pernilla/Y-8340-2019; Omerov, Pernilla/N-5127-2017	Steineck, Gunnar/0000-0002-0787-3969; Nyberg, Tommy/0000-0002-9436-0626; Omerov, Pernilla/0000-0003-1835-1960; Omerov, Pernilla/0000-0003-1835-1960; Runeson, Bo/0000-0003-4122-4636	Swedish Council for Working Life Social Research (FAS) [2006-1099]; ALF Grants, County Council of Stockholm [20110338]; Swedish Lundbeck foundation	Swedish Council for Working Life Social Research (FAS); ALF Grants, County Council of Stockholm; Swedish Lundbeck foundation(Lundbeckfonden)	The study was supported by The Swedish Council for Working Life Social Research (FAS) (2006-1099, http://www.forte.se/), ALF Grants, County Council of Stockholm (20110338, www.forskningsstod.sll.se) and Swedish Lundbeck foundation (2010, http://www.lundbeck.com/se/om-lundbeck/svenskalundbeckstiftelsen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroll B, 2010, ANN FAM MED, V8, P348, DOI 10.1370/afm.1139; Buglass Edith, 2010, Nurs Stand, V24, P44; Callahan J, 2000, SUICIDE LIFE-THREAT, V30, P104; Chapple A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2032; COOKE MW, 1992, BRIT MED J, V304, P1207, DOI 10.1136/bmj.304.6836.1207; Donker T, 2011, PSYCHIAT RES, V188, P58, DOI 10.1016/j.psychres.2011.01.016; DUBIN WR, 1986, ANN EMERG MED, V15, P54, DOI 10.1016/S0196-0644(86)80488-7; Feigelman W, 2008, OMEGA-J DEATH DYING, V58, P251, DOI 10.2190/OM.58.4.a; Hills Marika, 2010, Nurs Times, V106, P22; Hills Marika, 2010, Nurs Times, V106, P19; Kreicbergs U, 2004, NEW ENGL J MED, V351, P1175, DOI 10.1056/NEJMoa040366; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Omerov P, 2013, PSYCHOL MED, P1; Omerov P, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003108; Omerov P, 2013, CRISIS, V34, P200, DOI 10.1027/0227-5910/a000175; Parris RJ, 2012, TRAUMA, V14, P139, DOI 10.1177/1460408611420352; Radestad I, 2009, MIDWIFERY, V25, P422, DOI 10.1016/j.midw.2007.03.005; Steineck G, 2006, ACTA ONCOL, V45, P421, DOI 10.1080/02841860600649293; Vanezis M, 1999, Br J Nurs, V8, P932	21	12	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101799	10.1371/journal.pone.0101799	http://dx.doi.org/10.1371/journal.pone.0101799			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7WB	24999660	Green Published, gold, Green Submitted			2022-12-27	WOS:000338637300088
J	Veit, LE; Maranda, L; Fong, J; Nwosu, BU				Veit, Lauren Elizabeth; Maranda, Louise; Fong, Jay; Nwosu, Benjamin Udoka			The Vitamin D Status in Inflammatory Bowel Disease	PLOS ONE			English	Article							PEDIATRIC CROHNS-DISEASE; BONE-MINERAL DENSITY; D DEFICIENCY; YOUNG-ADULTS; RISK-FACTORS; CHILDREN; ADOLESCENTS; PREVALENCE; OBESITY; COLITIS	Context: There is no consensus on the vitamin D status of children and adolescents with inflammatory bowel disease (IBD). Aim: To determine the vitamin D status of patients with IBD by comparing their serum 25(OH)D concentration to that of healthy controls. Hypothesis: Serum 25(OH)D concentration will be lower in patients with IBD compared to controls. Subjects and Methods: A case-controlled retrospective study of subjects with IBD (n = 58) of 2-20 years (male n = 31, age 16.38 +/- 2.21 years; female n = 27, age 16.56 +/- 2.08 years) and healthy controls (n = 116; male n = 49, age 13.90 +/- 4.59 years; female n = 67, age 15.04 +/- 4.12years). Study subject inclusion criteria: diagnosis of Crohn's disease (CD) or ulcerative colitis (UC). Vitamin D deficiency was defined as 25(OH)D of (< 20 ng/mL) (< 50 nmol/L), overweight as BMI of >= 85th but < 95th percentile, and obesity as BMI >= 95th percentile. Data were expressed as mean +/- SD. Results: Patients with CD, UC, and their controls had mean serum 25(OH)D concentrations of 61.69 +/- 24.43 nmol/L, 53.26 +/- 25.51, and 65.32 +/- 27.97 respectively (ANOVA, p = 0.196). The overweight/obese controls had significantly lower 25(OH)D concentration compared to the normal-weight controls (p = 0.031); whereas 25(OH)D concentration was similar between the normal-weight and overweight/obese IBD patients (p = 0.883). There was no difference in 25(OH)D between patients with UC and CD, or between subjects with active IBD and controls. However, IBD subjects with elevated ESR had significantly lower 25(OH)D than IBD subjects with normal ESR (p = 0.025), as well as controls (65.3 +/- 28.0 nmol/L vs. 49.5 +/- 25.23, p = 0.045). Conclusion: There is no difference in mean serum 25(OH)D concentration between children and adolescents with IBD and controls. However, IBD subjects with elevated ESR have significantly lower 25(OH)D than controls. Therefore, IBD subjects with elevated ESR should be monitored for vitamin D deficiency.	[Veit, Lauren Elizabeth; Fong, Jay; Nwosu, Benjamin Udoka] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA 01655 USA; [Maranda, Louise] Univ Massachusetts, Dept Quantitat Hlth Sci, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Nwosu, BU (corresponding author), Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA 01655 USA.	Benjamin.Nwosu@umassmemorial.org		Collen, Lauren/0000-0002-7769-8123	Faculty Diversity Scholars Program; Department of Pediatrics, University of Massachusetts Medical School, Worcester, Massachusetts, USA	Faculty Diversity Scholars Program; Department of Pediatrics, University of Massachusetts Medical School, Worcester, Massachusetts, USA	This work was funded in part by the Faculty Diversity Scholars Program, and the Department of Pediatrics, University of Massachusetts Medical School, Worcester, Massachusetts, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bikle D, 2009, J CLIN ENDOCR METAB, V94, P26, DOI 10.1210/jc.2008-1454; Cranney Ann, 2007, Evid Rep Technol Assess (Full Rep), P1; Day AS, 2012, WORLD J GASTROENTERO, V18, P5862, DOI 10.3748/wjg.v18.i41.5862; El-Matary W, 2011, DIGEST DIS SCI, V56, P825, DOI 10.1007/s10620-010-1380-5; Gokhale R, 1998, GASTROENTEROLOGY, V114, P902, DOI 10.1016/S0016-5085(98)70309-9; Gordon CM, 2004, ARCH PEDIAT ADOL MED, V158, P531, DOI 10.1001/archpedi.158.6.531; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; HYAMS JS, 1991, J PEDIATR GASTR NUTR, V12, P439, DOI 10.1097/00005176-199105000-00005; ISSENMAN RM, 1993, J PEDIATR GASTR NUTR, V17, P401, DOI 10.1097/00005176-199311000-00012; Jones G, 2008, AM J CLIN NUTR, V88, p582S, DOI 10.1093/ajcn/88.2.582S; Kuczmarski RJ., 2002, VITAL HLTH STAT, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Levin AD, 2011, DIGEST DIS SCI, V56, P830, DOI 10.1007/s10620-010-1544-3; LICHTIGER S, 1994, NEW ENGL J MED, V330, P1841, DOI 10.1056/NEJM199406303302601; LIEL Y, 1988, CALCIFIED TISSUE INT, V43, P199, DOI 10.1007/BF02555135; Long MD, 2011, INFLAMM BOWEL DIS, V17, P2162, DOI 10.1002/ibd.21585; Pappa HM, 2006, INFLAMM BOWEL DIS, V12, P1162, DOI 10.1097/01.mib.0000236929.74040.b0; Pappa HM, 2006, PEDIATRICS, V118, P1950, DOI 10.1542/peds.2006-0841; Pappa HM, 2012, J CLIN ENDOCR METAB, V97, P2134, DOI 10.1210/jc.2011-3182; Pappa HM, 2011, J PEDIATR GASTR NUTR, V53, P361, DOI 10.1097/MPG.0b013e3182250b3e; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Sacheck J, 2011, J PEDIATR-US, V159, P945, DOI 10.1016/j.jpeds.2011.06.001; SEMERARO LA, 1986, J CLIN GASTROENTEROL, V8, P177, DOI 10.1097/00004836-198604000-00015; Sentongo TA, 2002, AM J CLIN NUTR, V76, P1077, DOI 10.1093/ajcn/76.5.1077; Setty-Shah N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078653; Stewart R, 2010, PSYCHOSOM MED, V72, P608, DOI 10.1097/PSY.0b013e3181e9bf15; Suibhne TN, 2012, J CROHNS COLITIS, V6, P182, DOI 10.1016/j.crohns.2011.08.002; Svoren BM, 2009, J PEDIATR-US, V154, P132, DOI 10.1016/j.jpeds.2008.07.015; Vimaleswaran KS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001383; Zwintscher NP, 2014, J PEDIATR SURG, V49, P265, DOI 10.1016/j.jpedsurg.2013.11.033	30	46	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101583	10.1371/journal.pone.0101583	http://dx.doi.org/10.1371/journal.pone.0101583			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992465	Green Published, gold, Green Submitted			2022-12-27	WOS:000341253400094
J	Wang, X; Singh, P; Gao, Z; Zhang, XB; Johnson, ZI; Wang, GY				Wang, Xin; Singh, Purnima; Gao, Zheng; Zhang, Xiaobo; Johnson, Zackary I.; Wang, Guangyi			Distribution and Diversity of Planktonic Fungi in the West Pacific Warm Pool	PLOS ONE			English	Article							UPWELLING ECOSYSTEM; ORGANIC-MATTER; MARINE; COMMUNITIES; BACTERIAL; ECOLOGY; YEASTS; LIGHT	Fungi contribute substantially to biogeochemical cycles of terrestrial and marine habitats by decomposing matter and recycling nutrients. Yet, the diversity of their planktonic forms in the open ocean is poorly described. In this study, culture-independent and molecular approaches were applied to investigate fungal diversity and abundance derived from samples collected from a broad swath of the Pacific Warm Pool across major environmental gradients Our results revealed that planktonic fungi were molecularly diverse and their diversity patterns were related to major phytoplankton taxa and various nutrients including nitrate, nitrite, orthophosphate and silicic acid. Over 400 fungal phylotypes were recovered across this region and nearly half of them grouped into two major fungal lineages of Ascomycota and Basidiomycota, whose abundance varied among stations. These results suggest that planktonic fungi are a diverse and integral component of the marine microbial community and should be included in future marine microbial ecosystem models.	[Wang, Xin; Wang, Guangyi] Univ Hawaii Manoa, Dept Microbiol, Honolulu, HI 96822 USA; [Singh, Purnima; Wang, Guangyi] Tianjin Univ, Ctr Marine Environm Ecol, Collaborat Innovat Ctr Deep Sea Biol, Sch Environm & Engn, Tianjin 300072, Peoples R China; [Gao, Zheng] Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Zhang, Xiaobo] Zhejiang Univ, Coll Life Sci, Collaborat Innovat Ctr Deep Sea Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Johnson, Zackary I.] Duke Univ, Nicholas Sch Environm, Marine Lab, Durham, NC USA; [Wang, Guangyi] Calif Baptist Univ, Coll Engn, Riverside, CA USA	University of Hawaii System; University of Hawaii Manoa; Tianjin University; Shandong Agricultural University; Zhejiang University; Duke University; California Baptist University	Wang, GY (corresponding author), Univ Hawaii Manoa, Dept Microbiol, Honolulu, HI 96822 USA.	gywang@tju.edu.cn	Johnson, Zackary I/E-4601-2011; Wang, Xin/B-6258-2015	Johnson, Zackary I/0000-0003-0793-8512; Zhang, Xiaobo/0000-0003-4606-212X	National Oceanic and Atmospheric Administration (NOAA) [NA04OAR4600196, NA09AOR4170060]; US Department of Energy award [DE-FG36-08GO18180]; NSF [OCE05-26462, OCE05-50798]; National Science Foundation of China [31170109]; Shenzhen Development and Reform Commission [835]; Division Of Ocean Sciences [1031064] Funding Source: National Science Foundation	National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); US Department of Energy award(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Development and Reform Commission; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was partially funded by National Oceanic and Atmospheric Administration (NOAA) grants NA04OAR4600196 (GWY) and NA09AOR4170060 (GWY, by the US Department of Energy award (DE-FG36-08GO18180) (GWY), by NSF Grant OCE05-26462 (ZJ) and OCE05-50798 (ZJ), and funded by National Science Foundation of China grant 31170109 (GYW) and Shenzhen Development and Reform Commission grant 835 (GYW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buesing N, 2006, APPL ENVIRON MICROB, V72, P596, DOI 10.1128/AEM.72.1.596-605.2006; Carlile M, 2001, FUNGI; Chen YS, 2009, AQUAT BIOL, V8, P55, DOI 10.3354/ab00207; CHRISTENSEN M, 1989, MYCOLOGIA, V81, P1, DOI 10.2307/3759446; Cotner JB, 2002, ECOSYSTEMS, V5, P105, DOI 10.1007/s10021-001-0059-3; Damare S, 2008, MICROB ECOL, V56, P168, DOI 10.1007/s00248-007-9334-y; DeLong EF, 2005, NATURE, V437, P336, DOI 10.1038/nature04157; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gao Z, 2008, APPL ENVIRON MICROB, V74, P6091, DOI 10.1128/AEM.01315-08; Gao Z, 2010, ISME J, V4, P111, DOI 10.1038/ismej.2009.87; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; GESSNER MO, 1994, ECOLOGY, V75, P1807, DOI 10.2307/1939639; Gessner MO, 2007, DRUZHININA IS; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gutierrez MH, 2011, MAR BIOL, V158, P205, DOI 10.1007/s00227-010-1552-z; Gutierrez MH, 2010, GAYANA, V74, P66; Hynes AM, 2009, LIMNOL OCEANOGR, V54, P1438, DOI 10.4319/lo.2009.54.5.1438; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Johnson ZI, 2010, J MAR RES, V68, P283, DOI 10.1357/002224010793721433; Kiorboe T, 2001, LIMNOL OCEANOGR, V46, P1309, DOI 10.4319/lo.2001.46.6.1309; Kutty SN, 2008, YEAST, V25, P465, DOI 10.1002/yea.1599; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Methvin BR, 2003, J N AM BENTHOL SOC, V22, P554, DOI 10.2307/1468352; Moran MA, 2007, NAT REV MICROBIOL, V5, P792, DOI 10.1038/nrmicro1746; Newell RC, 1982, OCEANOL ACTA, P347; Nikolcheva Liliya G., 2004, Mycological Progress, V3, P41, DOI 10.1007/s11557-006-0075-y; OLSON RJ, 1989, CYTOMETRY, V10, P636, DOI 10.1002/cyto.990100520; Pang KL, 2005, BOT MAR, V48, P332, DOI 10.1515/BOT.2005.046; Raghukumar S, 2004, MARINE MICROBIOLOGY, P91; Ranjard L, 2001, APPL ENVIRON MICROB, V67, P4479, DOI 10.1128/AEM.67.10.4479-4487.2001; Richards TA, 2012, ANNU REV MAR SCI, V4, P495, DOI 10.1146/annurev-marine-120710-100802; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Simon M, 2002, AQUAT MICROB ECOL, V28, P175, DOI 10.3354/ame028175; STEELE CW, 1967, PAC SCI, V21, P317; Strickland J.D.H., 1972, PRACTICAL HDB SEWATE, DOI [10.2307/1979241, DOI 10.2307/1979241]; TISDALL JM, 1982, J SOIL SCI, V33, P141, DOI 10.1111/j.1365-2389.1982.tb01755.x; Vogel C, 2007, WATER RES, V41, P1915, DOI 10.1016/j.watres.2007.02.010; Wang Guangyi, 2012, Prog Mol Subcell Biol, V53, P71, DOI 10.1007/978-3-642-23342-5_4; Wang GY, 2009, MARINE PHYTOPLANKTON, P211; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985	40	30	34	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101523	10.1371/journal.pone.0101523	http://dx.doi.org/10.1371/journal.pone.0101523			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992154	Green Published, gold, Green Submitted			2022-12-27	WOS:000341253400083
J	Maejima, H; Nagashio, R; Yanagita, K; Hamada, Y; Amoh, Y; Sato, Y; Katsuoka, K				Maejima, Hideki; Nagashio, Ryo; Yanagita, Kengo; Hamada, Yuko; Amoh, Yasuyuki; Sato, Yuichi; Katsuoka, Kensei			Moesin and Stress-Induced Phosphoprotein-1 Are Possible Sero-Diagnostic Markers of Psoriasis	PLOS ONE			English	Article							C-REACTIVE PROTEIN; LIPOCORTIN-I; HUMAN SKIN; ANNEXIN-I; DISEASE; EXPRESSION; ARTHRITIS; KERATINOCYTES; ETANERCEPT; ACTIVATION	To identify diagnostic markers for psoriasis vulgaris and psoriatic arthritis, autoantibodies in sera from psoriasis vulgaris and psoriatic arthritis patients were screened by two-dimensional immunoblotting (2D-IB). Based on 2D-IB and MADLI TOF/TOF-MS analyses, eleven proteins each in psoriasis vulgaris and psoriatic arthritis were identified as autoantigens. Furthermore, serum levels of moesin, keratin 17 (K17), annexin A1 (ANXA1), and stress-induced phophoprotein-1 (STIP1), which were detected as autoantigens, were studied by dot blot analysis with psoriasis patients and healthy controls. The levels of moesin and STIP1 were significantly higher in sera from patients with psoriasis vulgaris than in the controls (moesin: P<0.05, STIP1: P<0.005). The area under the curve (AUC) for moesin and STIP1 between patients with psoraisis vulgaris and controls was 0.747 and 0.792, respectively. STIP1 and K17 levels were significantly higher in sera from patients with psoriatic arthritis than in those with psoriasis vulgaris (P<0.05 each). The AUC for STIP1 and K17 between patients with psoriatic arthritis and psoriasis vulgaris was 0.69 and 0.72, respectively. The STIP1 or moesin, CK17 serum level was not correlated with disease activity of psoriasis patients. These data suggest that STIP1 and moesin may be novel and differential sero-diagnostic markers for psoriasis vulgaris and psoriatic arthritis.	[Maejima, Hideki; Hamada, Yuko; Amoh, Yasuyuki; Katsuoka, Kensei] Kitasato Univ, Sch Med, Dept Dermatol, Sagamihara, Kanagawa 228, Japan; [Nagashio, Ryo; Yanagita, Kengo; Sato, Yuichi] Kitasato Univ, Grad Sch Med Sci, Dept Appl Tumor Pathol, Sagamihara, Kanagawa 228, Japan; [Nagashio, Ryo; Yanagita, Kengo; Sato, Yuichi] Kitasato Univ, Sch Allied Hlth Sci, Dept Mol Diagnost, Sagamihara, Kanagawa 228, Japan	Kitasato University; Kitasato University; Kitasato University	Sato, Y (corresponding author), Kitasato Univ, Grad Sch Med Sci, Dept Appl Tumor Pathol, Sagamihara, Kanagawa 228, Japan.	yuichi@med.kitasato-u.ac.jp						Boyman O, 2005, BRIT J DERMATOL, V152, P1211, DOI 10.1111/j.1365-2133.2005.06701.x; Caetano FA, 2008, J NEUROSCI, V28, P6691, DOI 10.1523/JNEUROSCI.1701-08.2008; D'Acquisto F, 2008, RHEUMATOLOGY, V47, P636, DOI 10.1093/rheumatology/ken062; Davidovici BB, 2010, J INVEST DERMATOL, V130, P1785, DOI 10.1038/jid.2010.103; DEJONG EMGJ, 1991, ARCH DERMATOL RES, V283, P480, DOI 10.1007/BF00371788; FIERLBECK G, 1990, ARCH DERMATOL, V126, P351, DOI 10.1001/archderm.126.3.351; FREDRIKSSON T, 1978, DERMATOLOGICA, V157, P238, DOI 10.1159/000250839; Fu M, 2012, J DERMATOL SCI, V67, P161, DOI 10.1016/j.jdermsci.2012.06.008; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Hayem G, 1999, ANN RHEUM DIS, V58, P291, DOI 10.1136/ard.58.5.291; Helms C, 2003, NAT GENET, V35, P349, DOI 10.1038/ng1268; Itoh K, 2002, J IMMUNOL, V168, P541, DOI 10.4049/jimmunol.168.2.541; JIANG CK, 1994, MOL CELL BIOL, V14, P4759, DOI 10.1128/MCB.14.7.4759; KITAJIMA Y, 1991, J INVEST DERMATOL, V97, P1032, DOI 10.1111/1523-1747.ep12492494; LANKES WT, 1991, P NATL ACAD SCI USA, V88, P8297, DOI 10.1073/pnas.88.19.8297; Lories RJU, 2008, CLIN EXP RHEUMATOL, V26, P96; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; Nagashio R, 2010, PATHOL INT, V60, P71, DOI 10.1111/j.1440-1827.2009.02487.x; Nagashio R, 2008, LUNG CANCER, V62, P364, DOI 10.1016/j.lungcan.2008.03.026; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Paulus HE, 1999, J RHEUMATOL, V26, P2324; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; RIVERS JK, 1990, BRIT J DERMATOL, V123, P569, DOI 10.1111/j.1365-2133.1990.tb01472.x; SatoMatsumura KC, 1996, ARCH DERMATOL RES, V288, P565, DOI 10.1007/BF02505257; Shi XW, 2011, J INVEST DERMATOL, V131, P2401, DOI 10.1038/jid.2011.222; Song YT, 2005, J BIOL CHEM, V280, P34178, DOI 10.1074/jbc.M505420200; Stern RS, 2004, J INVEST DERM SYMP P, V9, P136, DOI 10.1046/j.1087-0024.2003.09102.x; Strober B, 2008, BRIT J DERMATOL, V159, P322, DOI 10.1111/j.1365-2133.2008.08628.x; Tagoe CE, 2008, J IMMUNOL, V181, P2813, DOI 10.4049/jimmunol.181.4.2813; Takahashi H, 2002, J DERMATOL SCI, V30, P94, DOI 10.1016/S0923-1811(02)00064-6; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; Tsai CL, 2012, CELL REP, V2, P283, DOI 10.1016/j.celrep.2012.07.002; Wang CH, 2013, NAT IMMUNOL, V14, P72, DOI 10.1038/ni.2479	34	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101773	10.1371/journal.pone.0101773	http://dx.doi.org/10.1371/journal.pone.0101773			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010044	Green Published, Green Submitted, gold			2022-12-27	WOS:000338763800037
J	Bourgeois, FT; Kim, JM; Mandl, KD				Bourgeois, Florence T.; Kim, Jeong Min; Mandl, Kenneth D.			Premarket Safety and Efficacy Studies for ADHD Medications in Children	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT-HYPERACTIVITY DISORDER; ONCE-A-DAY; FOLLOW-UP; OROS METHYLPHENIDATE; EXTENDED-RELEASE; DOUBLE-BLIND; OPEN-LABEL; MTA; PHARMACOTHERAPY	Background: Attention-deficit hyperactivity disorder (ADHD) is a chronic condition and pharmacotherapy is the mainstay of treatment, with a variety of ADHD medications available to patients. However, it is unclear to what extent the long-term safety and efficacy of ADHD drugs have been evaluated prior to their market authorization. We aimed to quantify the number of participants studied and their length of exposure in ADHD drug trials prior to marketing. Methods: We identified all ADHD medications approved by the Food and Drug Administration (FDA) and extracted data on clinical trials performed by the sponsor and used by the FDA to evaluate the drug's clinical efficacy and safety. For each ADHD medication, we measured the total number of participants studied and the length of participant exposure and identified any FDA requests for post-marketing trials. Results: A total of 32 clinical trials were conducted for the approval of 20 ADHD drugs. The median number of participants studied per drug was 75 (IQR 0, 419). Eleven drugs (55%) were approved after <100 participants were studied and 14 (70%) after <300 participants. The median trial length prior to approval was 4 weeks (IQR 2, 9), with 5 (38%) drugs approved after participants were studied <4 weeks and 10 (77%) after <6 months. Six drugs were approved with requests for specific additional post-marketing trials, of which 2 were performed. Conclusions: Clinical trials conducted for the approval of many ADHD drugs have not been designed to assess rare adverse events or long-term safety and efficacy. While post-marketing studies can fill in some of the gaps, better assurance is needed that the proper trials are conducted either before or after a new medication is approved.	[Bourgeois, Florence T.; Mandl, Kenneth D.] Boston Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA; [Bourgeois, Florence T.; Mandl, Kenneth D.] Harvard Med Sch, Dept Pediat, Boston, MA USA; [Bourgeois, Florence T.; Mandl, Kenneth D.] Boston Childrens Hosp, Harvard MIT Div Hlth Sci & Technol, Childrens Hosp Informat Program, Boston, MA USA; [Kim, Jeong Min] Wellesley Coll, Fac Arts & Sci, Wellesley, MA 02181 USA; [Mandl, Kenneth D.] Ctr Biomed Informat, Harvard Med Sch, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Wellesley College; Harvard University; Harvard Medical School	Bourgeois, FT (corresponding author), Boston Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA.	florence.bourgeois@childrens.harvard.edu	Bourgeois, Florence/H-6710-2016	Bourgeois, Florence/0000-0001-7798-4560	National Institute of Child Health and Human Development [1R21HD072382]; National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD072382] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Drs. Bourgeois and Mandl were supported by a grant from the National Institute of Child Health and Human Development (1R21HD072382), National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, PHARM PLANN E2E; [Anonymous], 1994, ICH HARM TRIP GUID E; [Anonymous], 1999, ARCH GEN PSYCHIAT, V56, P1073; [Anonymous], 2001, ICH TOP E10 CHOIC CO; Avorn J, 2006, CIRCULATION, V113, P2173, DOI 10.1161/CIRCULATIONAHA.106.625749; Avorn J, 2007, NEW ENGL J MED, V356, P1697, DOI 10.1056/NEJMp078041; Biederman J, 2008, PEDIATRICS, V121, pE73, DOI 10.1542/peds.2006-3695; Biederman J, 2007, BIOL PSYCHIAT, V62, P970, DOI 10.1016/j.biopsych.2007.04.015; Bourgeois FT, 2010, ANN INTERN MED, V153, P158, DOI 10.7326/0003-4819-153-3-201008030-00006; Dopheide JA, 2009, PHARMACOTHERAPY, V29, P656, DOI 10.1592/phco.29.6.656; Duijnhoven RG, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001407; European Medicines Agency, 2008, GUID CLIN INV MED PR; European Medicines Agency, 2012, GUID GOOD PHARM PRAC; Findling RL, 2010, J CHILD ADOL PSYCHOP, V20, P365, DOI 10.1089/cap.2009.0122; Findling RL, 2010, CNS SPECTRUMS, V15, P419, DOI 10.1017/S1092852900000353; Golder S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001026; Huang YS, 2011, CNS DRUGS, V25, P539, DOI 10.2165/11589380-000000000-00000; Jain Rakesh, 2011, Child Adolesc Psychiatry Ment Health, V5, P35, DOI 10.1186/1753-2000-5-35; Jain R, 2011, J AM ACAD CHILD PSY, V50, P171, DOI 10.1016/j.jaac.2010.11.005; Jensen PS, 2007, J AM ACAD CHILD PSY, V46, P989, DOI 10.1097/chi.0b013e3180686d48; Manos MJ, 2007, J MANAGE CARE PHARM, V13, pS2; May DE, 2010, DRUGS, V70, P15, DOI 10.2165/11530540-000000000-00000; Molina BSG, 2009, J AM ACAD CHILD PSY, V48, P484, DOI 10.1097/CHI.0b013e31819c23d0; NIH Consensus Development Program, 1998, DIAGN TREATM ATT DEF; Pelham WE, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.6.e105; Raine J, 2011, CLIN PHARMACOL THER, V89, P650, DOI 10.1038/clpt.2011.28; Swanson JM, 2007, J AM ACAD CHILD PSY, V46, P1015, DOI 10.1097/chi.0b013e3180686d7e; Thomas L, 2012, JAMA-J AM MED ASSOC, V308, P773, DOI 10.1001/jama.2012.9502; U.S. Department of Health and Human Services, FDA REG INF; U.S. Food and Drug Administration, 2004, MED REV FOC XR; U.S. Food and Drug Administration, 1996, APPR LETT ADD; U.S. Food and Drug Administration, 2002, DRUG APPR PACK METH; U.S. Food and Drug Administration, 2012, FED REGISTER, V77, P13339; U.S. Food and Drug Administration, FDA ASKS ATT DEF HYP; U.S. Food and Drug Administration: Center for drug evaluation and research, 2010, SUPPL APPR KAPV; U.S. Food and Drug Administration: Center for drug evaluation and research, 2007, MED REV VYV; Visser SN, 2007, PEDIATRICS, V119, pS99, DOI 10.1542/peds.2006-2089O; Visser SN, 2014, J AM ACAD CHILD PSY, V53, P34, DOI 10.1016/j.jaac.2013.09.001; Voort JLV, 2014, J AM ACAD C IN PRESS; Warikoo N, 2013, EXPERT OPIN PHARMACO; Wigal SB, 2009, CNS DRUGS, V23, P21, DOI 10.2165/00023210-200923000-00004; Wilens T, 2005, J AM ACAD CHILD PSY, V44, P1015, DOI 10.1097/01.chi.0000173291.28688.e7; Wolraich ML, 2001, PEDIATRICS, V108, P883, DOI 10.1542/peds.108.4.883; 2007, FDA NEWS	44	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102249	10.1371/journal.pone.0102249	http://dx.doi.org/10.1371/journal.pone.0102249			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007171	Green Submitted, Green Published, gold			2022-12-27	WOS:000339040600109
J	Brodie, A; Tovia-Brodie, O; Ofran, Y				Brodie, Aharon; Tovia-Brodie, Oholi; Ofran, Yanay			Large Scale Analysis of Phenotype-Pathway Relationships Based on GWAS Results	PLOS ONE			English	Article							GENE SET ENRICHMENT; HUMAN-IMMUNODEFICIENCY-VIRUS; GENOME-WIDE ASSOCIATION; CELL-ADHESION MOLECULES; NASOPHARYNGEAL CARCINOMA; CANCER-RISK; DISEASE; EXPRESSION; NETWORKS; LOCI	The widely used pathway-based approach for interpreting Genome Wide Association Studies (GWAS), assumes that since function is executed through the interactions of multiple genes, different perturbations of the same pathway would result in a similar phenotype. This assumption, however, was not systemically assessed on a large scale. To determine whether SNPs associated with a given complex phenotype affect the same pathways more than expected by chance, we analyzed 368 phenotypes that were studied in >5000 GWAS. We found 216 significant phenotype-pathway associations between 70 of the phenotypes we analyzed and known pathways. We also report 391 strong phenotype-phenotype associations between phenotypes that are affected by the same pathways. While some of these associations confirm previously reported connections, others are new and could shed light on the molecular basis of these diseases. Our findings confirm that phenotype-associated SNPs cluster into pathways much more than expected by chance. However, this is true for <20% (70/368) of the phenotypes. Different types of phenotypes show markedly different tendencies: Virtually all autoimmune phenotypes show strong clustering of SNPs into pathways, while most cancers and metabolic conditions, and all electrophysiological phenotypes, could not be significantly associated with any pathway despite being significantly associated with a large number of SNPs. While this may be due to missing data, it may also suggest that these phenotypes could result only from perturbations of specific genes and not from other perturbations of the same pathway. Further analysis of pathway-associated versus gene-associated phenotypes is, therefore, needed in order to understand disease etiology and in order to promote better drug target selection.	[Brodie, Aharon; Ofran, Yanay] Bar Ilan Univ, Goodman Fac Life Sci, Ramat Gan, Israel; [Tovia-Brodie, Oholi] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Cardiol, IL-69978 Tel Aviv, Israel	Bar Ilan University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Ofran, Y (corresponding author), Bar Ilan Univ, Goodman Fac Life Sci, Nanotechnol Bldg, Ramat Gan, Israel.	Yanay@ofranlab.org	Brodie, Oholi Tovia/AAH-6425-2019		Microsoft Research	Microsoft Research(Microsoft)	This work is supported by Microsoft Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBELDA SM, 1993, LAB INVEST, V68, P4; Alter G, 2006, CURR MOL MED, V6, P621, DOI 10.2174/156652406778195035; Alter G, 2011, NATURE, V476, P96, DOI 10.1038/nature10237; Altfeld M, 2011, NAT REV IMMUNOL, V11, P176, DOI 10.1038/nri2935; Altman T, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-112; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; BEHRENS J, 1993, BREAST CANCER RES TR, V24, P175, DOI 10.1007/BF01833258; BROWN B, 2012, DES ISSUES, V28, P1; Brumme ZL, 2006, AIDS REV, V8, P78; BUELL P, 1974, CANCER RES, V34, P1189; Butte AJ, 2006, NAT BIOTECHNOL, V24, P55, DOI 10.1038/nbt1150; Chang ET, 2006, ENIGMATIC EPIDEMIOLO; Chang JS, 2008, CANCER EPIDEM BIOMAR, V17, P1368, DOI 10.1158/1055-9965.EPI-07-2830; Chen F, 2005, MEDICINE, V84, P98, DOI 10.1097/01.md.0000159082.45703.90; Chou J, 2008, HEAD NECK-J SCI SPEC, V30, P946, DOI 10.1002/hed.20833; Christy AL, 2007, J IMMUNOL, V179, P2673, DOI 10.4049/jimmunol.179.5.2673; Clifford GM, 2005, JNCI-J NATL CANCER I, V97, P425, DOI 10.1093/jnci/dji072; Edwards YJK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016917; Eleftherohorinou H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008068; Emily M, 2009, EUR J HUM GENET, V17, P1231, DOI 10.1038/ejhg.2009.15; Engels EA, 2008, INT J CANCER, V123, P187, DOI 10.1002/ijc.23487; Engsig Frederik N, 2011, Clin Epidemiol, V3, P217, DOI 10.2147/CLEP.S19875; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Franks AL, 2012, ANTICANCER RES, V32, P1119; Fridley BL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012693; Friis AMC, 2012, VACCINE, V30, P6093, DOI 10.1016/j.vaccine.2012.07.041; Garcia-Lora A, 2003, J CELL PHYSIOL, V195, P346, DOI 10.1002/jcp.10290; Goh KI, 2012, BRIEF FUNCT GENOMICS, V11, P533, DOI 10.1093/bfgp/els032; Govindaraju DR, 2008, ADV GENET, V62, P33, DOI 10.1016/S0065-2660(08)00602-0; Gray KA, 2013, NUCLEIC ACIDS RES, V41, pD545, DOI 10.1093/nar/gks1066; Hassen E, 2010, MOL BIOL REP, V37, P119, DOI 10.1007/s11033-009-9548-9; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirohashi S, 2003, CANCER SCI, V94, P575, DOI 10.1111/j.1349-7006.2003.tb01485.x; Holden M, 2008, BIOINFORMATICS, V24, P2784, DOI 10.1093/bioinformatics/btn516; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Jia WH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-446; Jia WH, 2004, CANCER-AM CANCER SOC, V101, P363, DOI 10.1002/cncr.20372; Juliano RL, 1993, CURR OPIN CELL BIOL, V5, P812, DOI 10.1016/0955-0674(93)90030-T; Kahaly GJ, 2009, POLYGLANDULAR AUTOIM; Kalra S, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-2; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Karolchik Donna, 2012, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0104s40; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kim R, 2006, IMMUNOLOGY, V119, P254, DOI 10.1111/j.1365-2567.2006.02430.x; Kofler R, 2012, BIOINFORMATICS, V28, P2084, DOI 10.1093/bioinformatics/bts315; Margulies DH, 2009, NAT IMMUNOL, V10, P566, DOI 10.1038/ni0609-566; Mavilio D, 2003, NATURAL KILLER CELLS; McMurray RW, 1996, SEMIN ARTHRITIS RHEU, V25, P215, DOI 10.1016/S0049-0172(96)80034-5; Menashe I, 2010, CANCER RES, V70, P4453, DOI 10.1158/0008-5472.CAN-09-4502; Naeem H, 2012, BIOINFORMATICS, V28, P1480, DOI 10.1093/bioinformatics/bts164; Newby PR, 2010, EUR J HUM GENET, V18, P1021, DOI 10.1038/ejhg.2010.55; NIEDOBITEK G, 1992, AM J PATHOL, V140, P879; Niller HH, 2008, AUTOIMMUNITY, V41, P298, DOI 10.1080/08916930802024772; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; Peng G, 2010, EUR J HUM GENET, V18, P111, DOI 10.1038/ejhg.2009.115; Robbie-Ryan M, 2002, CURR OPIN IMMUNOL, V14, P728, DOI 10.1016/S0952-7915(02)00394-1; Robinson PN, 2010, CLIN GENET, V77, P525, DOI 10.1111/j.1399-0004.2010.01436.x; Rose NR, 2006, E SCHERING RES FDN W, V55, P141; Rottem M, 2003, INT ARCH ALLERGY IMM, V132, P210, DOI 10.1159/000074301; Rottem Menachem, 2002, Dev Immunol, V9, P161, DOI 10.1080/1044667031000137638; Schoof N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029451; Schriml LM, 2012, NUCLEIC ACIDS RES, V40, pD940, DOI 10.1093/nar/gkr972; Shioda T, 2006, INT J HEMATOL, V84, P12, DOI 10.1532/IJH97.06100; Shnayder Y, 2001, LARYNGOSCOPE, V111, P1842, DOI 10.1097/00005537-200110000-00032; Song GG, 2013, J MOL NEUROSCI, V51, P428, DOI 10.1007/s12031-013-0047-z; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sumpter TL, 2004, ROLE AUTOIMMUNITY OR; Takarabe D, 2010, AUTOIMMUNE DIABETES; Tenzer S, 2009, NAT IMMUNOL, V10, P636, DOI 10.1038/ni.1728; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; Tse KP, 2009, AM J HUM GENET, V85, P194, DOI 10.1016/j.ajhg.2009.07.007; van Baarle D, 2001, BLOOD, V98, P146, DOI 10.1182/blood.V98.1.146; Vandin F, 2012, GENOME RES, V22, P375, DOI 10.1101/gr.120477.111; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang K, 2009, AM J HUM GENET, V84, P399, DOI 10.1016/j.ajhg.2009.01.026; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; WHO, 2012, ICD 10 CLASS MENT BE; Yun HD, 2012, MAYO CLIN PROC, V87, P953, DOI 10.1016/j.mayocp.2012.05.020; Zandman-Goddard Gisele, 2002, Autoimmunity Reviews, V1, P329, DOI 10.1016/S1568-9972(02)00086-1; Zendehdel K, 2003, CANC INCIDENCE PATIE; ZETTER BR, 1993, SEMIN CANCER BIOL, V4, P219; Zheng Z, 1999, HUM PATHOL, V30, P458, DOI 10.1016/S0046-8177(99)90123-5; ZURHAUSE.H, 1970, NATURE, V228, P1056, DOI 10.1038/2281056a0	83	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e100887	10.1371/journal.pone.0100887	http://dx.doi.org/10.1371/journal.pone.0100887			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007247	Green Submitted, gold, Green Published			2022-12-27	WOS:000339040600023
J	Feijen, EAM; van der Pal, HJ; van Dalen, EC; Mulder, RL; Bardi, E; Kuehni, C; Tissing, WJE; Kremer, LCM				Feijen, Elizabeth (Lieke) A. M.; van der Pal, Helena J.; van Dalen, Elvira C.; Mulder, Renee L.; Bardi, Edit; Kuehni, Claudia; Tissing, Wim J. E.; Kremer, Leontine C. M.			A New Method to Facilitate Valid and Consistent Grading Cardiac Events in Childhood Cancer Survivors Using Medical Records	PLOS ONE			English	Article							CONGESTIVE-HEART-FAILURE; WEIGHTED KAPPA; GUIDELINES; DIAGNOSIS; OUTCOMES; COHORT; ESC	Background: Cardiac events (CEs) are among the most serious late effects following childhood cancer treatment. To establish accurate risk estimates for the occurrence of CEs it is essential that they are graded in a valid and consistent manner, especially for international studies. We therefore developed a data-extraction form and a set of flowcharts to grade CEs and tested the validity and consistency of this approach in a series of patients. Methods: The Common Terminology Criteria for Adverse Events version 3.0 and 4.0 were used to define the CEs. Forty patients were randomly selected from a cohort of 72 subjects with known CEs that had been graded by a physician for an earlier study. To establish whether the new method was valid for appropriate grading, a non-physician graded the CEs by using the new method. To evaluate consistency of the grading, the same charts were graded again by two other non-physicians, one with receiving brief introduction and one with receiving extensive training on the new method. We calculated weighted Kappa statistics to quantify inter-observer agreement. Results: The inter-observer agreement was 0.92 (95% CI 0.80-1.00) for validity, and 0.88 (0.79-0.98) and 0.99 (0.96-1.00) for consistency with the outcome assessors who had the brief introduction and the extensive training, respectively. Conclusions: The newly developed standardized method to grade CEs using data from medical records has shown excellent validity and consistency. The study showed that the method can be correctly applied by researchers without a medical background, provided that they receive adequate training.	[Feijen, Elizabeth (Lieke) A. M.; van Dalen, Elvira C.; Mulder, Renee L.; Kremer, Leontine C. M.] Emma Childrens Hosp, Acad Med Ctr, Dept Pediat Oncol, Amsterdam, Netherlands; [van der Pal, Helena J.] Acad Med Ctr, Dept Oncol, Amsterdam, Netherlands; [Bardi, Edit] Semmelweis Univ, Dept Pediat 2, H-1085 Budapest, Hungary; [Kuehni, Claudia] Univ Bern, Inst Social & Prevent Med, Dept Pediat Oncol, Bern, Switzerland; [Tissing, Wim J. E.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Oncol, Groningen, Netherlands	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Semmelweis University; University of Bern; University of Groningen	Feijen, EAM (corresponding author), Emma Childrens Hosp, Acad Med Ctr, Dept Pediat Oncol, Amsterdam, Netherlands.	e.a.feijen@amc.uva.nl		kremer, leontien/0000-0002-7619-7845; Kremer, Leontien/0000-0001-7422-3248; Kuehni, Claudia E./0000-0001-8957-2002	PanCare Childhood and Adolescent Cancer Survivor care and Follow-up studies Consortium (EU-Grant) [257505]; Swiss Cancer League [KLS-02783-02-2011]	PanCare Childhood and Adolescent Cancer Survivor care and Follow-up studies Consortium (EU-Grant); Swiss Cancer League	Financial support for this study was provided in part by a: grant from PanCare Childhood and Adolescent Cancer Survivor care and Follow-up studies Consortium (EU-Grant agreement number 257505) and Swiss Cancer League (KLS-02783-02-2011). The funding agreement ensured the authors' independence in designing the study, interpreting the data, writing, and publishing the report.	Armenian SH, 2008, J CLIN ONCOL, V26, P5537, DOI 10.1200/JCO.2008.17.7428; Atkinson TM, 2012, QUAL LIFE RES, V21, P1159, DOI 10.1007/s11136-011-0031-4; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; FLEISS JL, 1969, PSYCHOL BULL, V72, P323, DOI 10.1037/h0028106; Gatta G, 2009, EUR J CANCER, V45, P992, DOI 10.1016/j.ejca.2008.11.042; Geenen MM, 2007, JAMA-J AM MED ASSOC, V297, P2705, DOI 10.1001/jama.297.24.2705; Green DM, 2001, J CLIN ONCOL, V19, P1926, DOI 10.1200/JCO.2001.19.7.1926; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mulrooney DA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4606; Orwin RG, 1994, HDB RES SYNTHESIS, P177; R Core Team, 2018, R LANG ENV STAT COMP; Reulen RC, 2010, JAMA-J AM MED ASSOC, V304, P172, DOI 10.1001/jama.2010.923; van Dalen EC, 2006, EUR J CANCER, V42, P3191, DOI 10.1016/j.ejca.2006.08.005; van der Pal HJ, 2012, J CLIN ONCOL, V30, P1429, DOI 10.1200/JCO.2010.33.4730	15	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e100432	10.1371/journal.pone.0100432	http://dx.doi.org/10.1371/journal.pone.0100432			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL3PK	25006805	Green Published, gold, Green Submitted			2022-12-27	WOS:000339040600013
J	Roy, A; Modi, KK; Khasnavis, S; Ghosh, S; Watson, R; Pahan, K				Roy, Avik; Modi, Khushbu K.; Khasnavis, Saurabh; Ghosh, Supurna; Watson, Richard; Pahan, Kalipada			Enhancement of Morphological Plasticity in Hippocampal Neurons by a Physically Modified Saline via Phosphatidylinositol-3 Kinase	PLOS ONE			English	Article							TERM SYNAPTIC PLASTICITY; RESPONSE ELEMENT-BINDING; KAPPA-B ACTIVATION; ALZHEIMERS-DISEASE; UP-REGULATION; NITRIC-OXIDE; PROTEIN-LEVELS; EXPRESSION; MEMORY; RECEPTORS	Increase of the density of dendritic spines and enhancement of synaptic transmission through ionotropic glutamate receptors are important events, leading to synaptic plasticity and eventually hippocampus-dependent spatial learning and memory formation. Here we have undertaken an innovative approach to upregulate hippocampal plasticity. RNS60 is a 0.9% saline solution containing charge-stabilized nanobubbles that are generated by subjecting normal saline to Taylor-Couette-Poiseuille (TCP) flow under elevated oxygen pressure. RNS60, but not NS (normal saline), PNS60 (saline containing a comparable level of oxygen without the TCP modification), or RNS10.3 (TCP-modified normal saline without excess oxygen), stimulated morphological plasticity and synaptic transmission via NMDA- and AMPA-sensitive calcium influx in cultured mouse hippocampal neurons. Using mRNA-based targeted gene array, real-time PCR, immunoblot, and immunofluorescence analyses, we further demonstrate that RNS60 stimulated the expression of many plasticity-associated genes in cultured hippocampal neurons. Activation of type IA, but not type IB, phosphatidylinositol-3 (PI-3) kinase by RNS60 together with abrogation of RNS60-mediated upregulation of plasticity-related proteins (NR2A and GluR1) and increase in spine density, neuronal size, and calcium influx by LY294002, a specific inhibitor of PI-3 kinase, suggest that RNS60 upregulates hippocampal plasticity via activation of PI-3 kinase. Finally, in the 5XFAD transgenic model of Alzheimer's disease (AD), RNS60 treatment upregulated expression of plasticity-related proteins PSD95 and NR2A and increased AMPA-and NMDA-dependent hippocampal calcium influx. These results describe a novel property of RNS60 in stimulating hippocampal plasticity, which may help AD and other dementias.	[Roy, Avik; Modi, Khushbu K.; Khasnavis, Saurabh; Pahan, Kalipada] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Ghosh, Supurna; Watson, Richard] Revalesio Corp, Tacoma, WA USA	Rush University	Pahan, K (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA.	Kalipada_Pahan@rush.edu	Khasnavis, Saurabh/K-2249-2019		Revalesio Corporation	Revalesio Corporation	This work was supported by Revalesio Corporation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell KFS, 2008, NEUROBIOL AGING, V29, P554, DOI 10.1016/j.neurobiolaging.2006.11.004; Bito H, 2003, CELL CALCIUM, V34, P425, DOI 10.1016/S0143-4160(03)00140-4; Clayton DA, 2002, J NEUROSCI, V22, P3628; Colangelo V, 2002, J NEUROSCI RES, V70, P462, DOI 10.1002/jnr.10351; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Danysz W, 2003, INT J GERIATR PSYCH, V18, pS23, DOI 10.1002/gps.938; Desjardins S, 1997, NEUROBIOL AGING, V18, P37, DOI 10.1016/S0197-4580(96)00206-0; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Geerts H, 2006, J CLIN PHARMACOL, V46, p8S, DOI 10.1177/0091270006288734; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P18754, DOI 10.1073/pnas.0704908104; Good PF, 1996, AM J PATHOL, V149, P21; Grinevich V, 2012, Endocr Regul, V46, P153; Guzowski JF, 1997, P NATL ACAD SCI USA, V94, P2693, DOI 10.1073/pnas.94.6.2693; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Impey S, 2001, Sci STKE, V2001, ppe1; Isaac J, 2001, NEURON, V32, P963, DOI 10.1016/S0896-6273(01)00545-1; Jacob CP, 2007, J ALZHEIMERS DIS, V11, P97; Jana A, 2013, J NEUROIMMUNE PHARM, V8, P739, DOI 10.1007/s11481-013-9447-7; Jana M, 2007, NEUROCHEM RES, V32, P2015, DOI 10.1007/s11064-007-9340-y; Khasnavis S, 2014, J NEUROIMMUNE PHARM, V9, P218, DOI 10.1007/s11481-013-9503-3; Khasnavis S, 2012, J BIOL CHEM, V287, P29529, DOI 10.1074/jbc.M111.338012; Khasnavis S, 2012, J NEUROIMMUNE PHARM, V7, P424, DOI 10.1007/s11481-011-9286-3; Koyasu S, 2003, NAT IMMUNOL, V4, P313, DOI 10.1038/ni0403-313; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Li L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043810; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; MacDonald John F., 2006, Critical Reviews in Neurobiology, V18, P71; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Medina AE, 2001, NEURON, V32, P553, DOI 10.1016/S0896-6273(01)00514-1; Mishizen-Eberz AJ, 2004, NEUROBIOL DIS, V15, P80, DOI 10.1016/j.nbd.2003.09.016; Mondal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051869; Mondal S, 2012, J NEUROIMMUNE PHARM, V7, P544, DOI 10.1007/s11481-012-9377-9; Myers SJ, 1999, ANNU REV PHARMACOL, V39, P221, DOI 10.1146/annurev.pharmtox.39.1.221; Olney JW, 1998, RESTOR NEUROL NEUROS, V13, P75; Proctor DT, 2010, J ALZHEIMERS DIS, V21, P795, DOI 10.3233/JAD-2010-100090; Reddy PH, 2005, J ALZHEIMERS DIS, V7, P103, DOI 10.3233/jad-2005-7203; Rossom Rebecca, 2004, Am J Geriatr Pharmacother, V2, P303, DOI 10.1016/j.amjopharm.2004.12.006; Roy A, 2013, PLOS ONE, V7; Roy AA, 2006, J BIOL CHEM, V281, P32684, DOI 10.1074/jbc.M604416200; Roy A, 2008, FREE RADICAL BIO MED, V45, P686, DOI 10.1016/j.freeradbiomed.2008.05.026; Roy A, 2013, CELL REP, V4, P724, DOI 10.1016/j.celrep.2013.07.028; Saha RN, 2009, J IMMUNOL, V183, P2068, DOI 10.4049/jimmunol.0801892; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selvakumar B, 2013, P NATL ACAD SCI USA, V110, P1077, DOI 10.1073/pnas.1221295110; Shim KS, 2002, NEUROSCI LETT, V324, P209, DOI 10.1016/S0304-3940(02)00210-0; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; Vetter P, 2001, J NEUROPHYSIOL, V85, P926, DOI 10.1152/jn.2001.85.2.926; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; Xia ZG, 2012, LEARN MEMORY, V19, P369, DOI 10.1101/lm.027128.112; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5	51	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101883	10.1371/journal.pone.0101883	http://dx.doi.org/10.1371/journal.pone.0101883			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007337	Green Published, Green Submitted, gold			2022-12-27	WOS:000339040600075
J	Sun, JJ; Zhang, B; Lan, XY; Zhang, CL; Lei, CZ; Chen, H				Sun, Jiajie; Zhang, Bowen; Lan, Xianyong; Zhang, Chunlei; Lei, Chuzhao; Chen, Hong			Comparative Transcriptome Analysis Reveals Significant Differences in MicroRNA Expression and Their Target Genes between Adipose and Muscular Tissues in Cattle	PLOS ONE			English	Article							MUSCLE LIM PROTEIN; IDENTIFICATION; DIFFERENTIATION; MIR-206; METABOLISM; MYOGENESIS; REGULATOR; MECHANISM; BEHAVIOR; GROWTH	The posttranscriptional gene regulation mediated by microRNAs (miRNAs) plays an important role in various species. However, to date limited miRNAs have been reported between fat and muscle tissues in beef cattle. In this paper, 412 known and 22 novel miRNAs in backfat as well as 334 known and 10 novel miRNAs in longissimus thoracis were identified in the Chinese Qinchuan beef cattle. Bta-miR-199a-3p, -154c, -320a and -432 were expressed at higher levels in backfat tissue, while bta-miR-1, -133a, -206, and -378 were also significantly enriched in muscle tissue. Functional analysis revealed that fat-enriched miRNAs targeted PRKAA1/2, PPARA and PPARG genes to modulate lipid and fatty acid metabolism, and muscle-enriched miRNAs targeted CSRP3 gene to present function involved in skeletal and muscular system development. The results obtained may help in the design of new selection strategies to improve beef quality.	[Sun, Jiajie; Zhang, Bowen; Lan, Xianyong; Lei, Chuzhao; Chen, Hong] Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China; [Zhang, Chunlei] Jiangsu Normal Univ, Inst Cellular & Mol Biol, Xuzhou, Jiangsu, Peoples R China	Northwest A&F University - China; Jiangsu Normal University	Chen, H (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China.	chenhong1212@263.net	Zhang, Bowen/X-4712-2019		National Natural Science Foundation of China [30972080, 30901023, 31272408]; Agricultural Science and Technology Innovation Projects of Shaanxi Province [2012NKC01-13]; Program of National Beef Cattle Industrial Technology System [CARS-38]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agricultural Science and Technology Innovation Projects of Shaanxi Province; Program of National Beef Cattle Industrial Technology System	This study was supported by the National Natural Science Foundation of China (Grant Nos. 30972080, 30901023, 31272408), Agricultural Science and Technology Innovation Projects of Shaanxi Province (No. 2012NKC01-13), and Program of National Beef Cattle Industrial Technology System (CARS-38). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; ARBER S, 1994, CELL, V79, P221, DOI 10.1016/0092-8674(94)90192-9; Artzi S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-39; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031426; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Crist CG, 2009, P NATL ACAD SCI USA, V106, P13383, DOI 10.1073/pnas.0900210106; Davalos A, 2011, P NATL ACAD SCI USA, V108, P9232, DOI 10.1073/pnas.1102281108; Dey BK, 2011, MOL CELL BIOL, V31, P203, DOI 10.1128/MCB.01009-10; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Gu ZL, 2007, FEBS LETT, V581, P981, DOI 10.1016/j.febslet.2007.01.081; Guay C, 2011, TRANSL RES, V157, P253, DOI 10.1016/j.trsl.2011.01.009; Hocquette JF, 2010, ANIMAL, V4, P1797, DOI 10.1017/S1751731110001448; Huang JM, 2011, INT J BIOL SCI, V7, P1016, DOI 10.7150/ijbs.7.1016; Jin WW, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-29; Kahai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007535; Kennell JA, 2008, P NATL ACAD SCI USA, V105, P15417, DOI 10.1073/pnas.0807763105; Kong YF, 1997, MOL CELL BIOL, V17, P4750, DOI 10.1128/MCB.17.8.4750; Laine SK, 2012, J CELL BIOCHEM, V113, P2687, DOI 10.1002/jcb.24144; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee SH, 2007, J BIOCHEM MOL BIOL, V40, P757; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lingenfelter BM, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-40; Long JE, 2009, BIOCHEM GENET, V47, P329, DOI 10.1007/s10528-009-9234-6; McCarthy JJ, 2008, BBA-GENE REGUL MECH, V1779, P682, DOI 10.1016/j.bbagrm.2008.03.001; Missiaglia E, 2010, BRIT J CANCER, V102, P1769, DOI 10.1038/sj.bjc.6605684; Moloney AP, 2001, P NUTR SOC, V60, P221, DOI 10.1079/PNS200077; Naguibneva Irina, 2007, Journal de la Societe de Biologie, V201, P367, DOI 10.1051/jbio:2007902; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Salendo J, 2013, RADIOTHER ONCOL, V108, P451, DOI 10.1016/j.radonc.2013.06.032; Sato MM, 2009, BIOCHEM BIOPH RES CO, V383, P125, DOI 10.1016/j.bbrc.2009.03.142; Tripurani SK, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-25; Tripurani SK, 2010, ANIM REPROD SCI, V120, P16, DOI 10.1016/j.anireprosci.2010.03.001; Wang LW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-154; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wu JJ, 2006, CELL METAB, V4, P61, DOI 10.1016/j.cmet.2006.05.010; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yoon M, 2009, PHARMACOL RES, V60, P151, DOI 10.1016/j.phrs.2009.02.004; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7	45	15	17	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102142	10.1371/journal.pone.0102142	http://dx.doi.org/10.1371/journal.pone.0102142			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006962	Green Published, gold, Green Submitted			2022-12-27	WOS:000339040600100
J	Sun, NX; Ye, C; Zhao, Q; Zhang, Q; Xu, C; Wang, SB; Jin, ZJ; Sun, SH; Wang, F; Li, W				Sun, Ning-xia; Ye, Chen; Zhao, Qian; Zhang, Qing; Xu, Chen; Wang, Shao-bing; Jin, Zhi-jun; Sun, Shu-han; Wang, Fang; Li, Wen			Long Noncoding RNA-EBIC Promotes Tumor Cell Invasion by Binding to EZH2 and Repressing E-Cadherin in Cervical Cancer	PLOS ONE			English	Article							ZESTE HOMOLOG 2; EXPRESSION; GENE; METASTASIS; ENHANCER; PROLIFERATION; ACTIVATION; INSIGHTS; LINKS	In recent years, long noncoding RNAs (lncRNAs) have been demonstrated to play key roles in tumorgenesis. However, the contributions of lncRNAs to cervical cancer (CC) remain largely unknown. In this study, differentially expressed lncRNAs and mRNAs in cervical cancer and paired peritumoral tissues were detected by transcriptome microarray analysis. We found 708 probe sets of lncRNAs increased and 836 probe sets decreased in CC tissues, while 1288 mRNA differential probe sets increased and 901 mRNA probe sets decreased. The results were validated by quantitative real-time polymerase chain reaction (qPCR). Then, we found a specific differentially expressed lncRNA can physically bind to enhancer of zeste homolog2 (EZH2) by using RNA immunoprecipitation. We termed it as EZH2-binding lncRNA in cervical cancer [lncRNA-EBIC]. Wound healing assays and Matrigel invasion assays were used to determine the function of this lncRNA by silencing it. We observed that the migration and invasion of cervical cancer cells in vitro were inhibited upon suppression of lncRNA-EBIC by siRNA. We also found that the association between lncRNA-EBIC and EZH2 was required for the repression of E-cadherin, which was a key molecular in the metastasis of cervical cancer. Conclusion: These results demonstrated that lncRNA-EBIC was an oncogenic lncRNA, which could promote tumor cell invasion in CC by binding to EZH2 and inhibiting E-cadherin expression.	[Sun, Ning-xia; Ye, Chen; Zhao, Qian; Zhang, Qing; Xu, Chen; Jin, Zhi-jun; Li, Wen] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Obstet & Gynaecol, Shanghai, Peoples R China; [Wang, Shao-bing; Sun, Shu-han; Wang, Fang] Second Mil Med Univ, Dept Med Genet, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Wang, F (corresponding author), Second Mil Med Univ, Dept Med Genet, Shanghai, Peoples R China.	wfsjz@163.com; liwenchzh@126.com			Nature Science Foundation of China [81272213]; Natural Science Foundation of Shanghai [13ZR1414300]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	This study was supported by the Nature Science Foundation of China (No. 81272213), http://www.nsfc.gov.cn/Portal0/default152.htm, and the Natural Science Foundation of Shanghai(13ZR1414300), http://www.stcsm.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Chang SCH, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00048; D'Costa ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048954; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Fang J, 2011, AM J MED SCI, V342, P198, DOI 10.1097/MAJ.0b013e31821335a9; Gibb EA, 2012, INT J GYNECOL CANCER, V22, P1557, DOI 10.1097/IGC.0b013e318272f2c9; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Holland D, 2008, CANCER RES, V68, P9964, DOI 10.1158/0008-5472.CAN-08-1134; Huarte M, 2010, HUM MOL GENET, V19, pR152, DOI 10.1093/hmg/ddq353; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Krieger Nancy, 2012, Lancet, V379, P1391, DOI 10.1016/S0140-6736(12)60596-0; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Li H, 2010, MOL CANCER RES, V8, P1610, DOI 10.1158/1541-7786.MCR-10-0398; Lu CH, 2010, CANCER CELL, V18, P185, DOI 10.1016/j.ccr.2010.06.016; Luo M, 2013, CANCER LETT, V333, P213, DOI 10.1016/j.canlet.2013.01.033; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Nagano T, 2011, CELL, V145, P178, DOI 10.1016/j.cell.2011.03.014; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Qin W, 2012, ONCOGENE, V31, P4067, DOI 10.1038/onc.2011.561; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Wang C, 2013, MOL CARCINOGEN, V52, P229, DOI 10.1002/mc.21848; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Yang F, 2011, HEPATOLOGY, V54, P1679, DOI 10.1002/hep.24563; Yang HY, 2005, CLIN EXP METASTAS, V22, P593, DOI 10.1007/s10585-005-6244-6; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	31	106	115	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e100340	10.1371/journal.pone.0100340	http://dx.doi.org/10.1371/journal.pone.0100340			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007342	Green Submitted, gold, Green Published			2022-12-27	WOS:000339040600011
J	Wu, S; Li, XJ; Gunawardana, M; Maguire, K; Guerrero-Given, D; Schaudinn, C; Wang, C; Baum, MM; Webster, P				Wu, Siva; Li, Xiaojin; Gunawardana, Manjula; Maguire, Kathleen; Guerrero-Given, Debbie; Schaudinn, Christoph; Wang, Charles; Baum, Marc M.; Webster, Paul			Beta-Lactam Antibiotics Stimulate Biofilm Formation in Non-Typeable Haemophilus influenzae by Up-Regulating Carbohydrate Metabolism	PLOS ONE			English	Article							ACUTE OTITIS-MEDIA; COAGULASE-NEGATIVE STAPHYLOCOCCI; OBSTRUCTIVE PULMONARY-DISEASE; SUBINHIBITORY CONCENTRATIONS; BACTERIAL BIOFILMS; EXTRACELLULAR DNA; ANTIMICROBIAL TREATMENT; GENE-EXPRESSION; THIN-SECTIONS; CHILDREN	Non-typeable Haemophilus influenzae (NTHi) is a common acute otitis media pathogen, with an incidence that is increased by previous antibiotic treatment. NTHi is also an emerging causative agent of other chronic infections in humans, some linked to morbidity, and all of which impose substantial treatment costs. In this study we explore the possibility that antibiotic exposure may stimulate biofilm formation by NTHi bacteria. We discovered that sub-inhibitory concentrations of beta-lactam antibiotic (i.e., amounts that partially inhibit bacterial growth) stimulated the biofilm-forming ability of NTHi strains, an effect that was strain and antibiotic dependent. When exposed to sub-inhibitory concentrations of beta-lactam antibiotics NTHi strains produced tightly packed biofilms with decreased numbers of culturable bacteria but increased biomass. The ratio of protein per unit weight of biofilm decreased as a result of antibiotic exposure. Antibiotic-stimulated biofilms had altered ultrastructure, and genes involved in glycogen production and transporter function were up regulated in response to antibiotic exposure. Down-regulated genes were linked to multiple metabolic processes but not those involved in stress response. Antibiotic-stimulated biofilm bacteria were more resistant to a lethal dose (10 mg/mL) of cefuroxime. Our results suggest that beta-lactam antibiotic exposure may act as a signaling molecule that promotes transformation into the biofilm phenotype. Loss of viable bacteria, increase in biofilm biomass and decreased protein production coupled with a concomitant up-regulation of genes involved with glycogen production might result in a biofilm of sessile, metabolically inactive bacteria sustained by stored glycogen. These biofilms may protect surviving bacteria from subsequent antibiotic challenges, and act as a reservoir of viable bacteria once antibiotic exposure has ended.	[Wu, Siva] Univ Calif Berkeley, Div Life Sci, Berkeley, CA 94720 USA; [Li, Xiaojin] ApolloGen Inc, Mol Diagnost Lab, Irvine, CA USA; [Gunawardana, Manjula; Baum, Marc M.; Webster, Paul] Oak Crest Inst Sci, Pasadena, CA 91107 USA; [Maguire, Kathleen] Univ Calif San Diego, San Diego, CA 92103 USA; [Guerrero-Given, Debbie] Max Planck Florida Inst, Jupiter, FL USA; [Schaudinn, Christoph] Robert Koch Inst, Berlin, Germany; [Wang, Charles] Loma Linda Univ, Sch Med, Ctr Genom, Loma Linda, CA USA; [Wang, Charles] Loma Linda Univ, Sch Med, Div Microbiol & Mol Genet, Loma Linda, CA USA; [Webster, Paul] Univ So Calif, Ctr Elect Microscopy & Microanal, Los Angeles, CA USA	University of California System; University of California Berkeley; University of California System; University of California San Diego; Max Planck Society; Robert Koch Institute; Loma Linda University; Loma Linda University; University of Southern California	Webster, P (corresponding author), Oak Crest Inst Sci, Pasadena, CA 91107 USA.	pwebster@usc.edu		Webster, Paul/0000-0002-1980-6931; Baum, Marc/0000-0003-1558-5649	National Science Foundation (NSF) [0722354]; NIH/NIDCD [5 P-30 DC006276-03]; Ahmanson Foundation; Los Angeles Hope for Hearing Foundation; Deafness Research Foundation; Fritz Burns Foundation; Hearst Foundation; Capita Foundation; House Research Institute; Oak Crest Institute of Science; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC006276] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); NIH/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Ahmanson Foundation; Los Angeles Hope for Hearing Foundation; Deafness Research Foundation; Fritz Burns Foundation; Hearst Foundation; Capita Foundation; House Research Institute; Oak Crest Institute of Science; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Parts of this work was carried out was carried out using equipment funded by the National Science Foundation (NSF #0722354) as well as support from the NIH/NIDCD (5 P-30 DC006276-03), and the following foundations; Ahmanson Foundation; Los Angeles Hope for Hearing Foundation; Deafness Research Foundation; Fritz Burns Foundation, Hearst Foundation and the Capita Foundation. Additional support was provided by the House Research Institute and the Oak Crest Institute of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Anon JB, 2004, OTOLARYNG HEAD NECK, V130, P1, DOI 10.1016/j.otohns.2003.12.003; [Anonymous], 2000, Otolaryngol Head Neck Surg, V123, P5; [Anonymous], 2004, PEDIATRICS, V5, P1451; Barkai G, 2009, PEDIATR INFECT DIS J, V28, P466, DOI 10.1097/INF.0b013e3181950c74; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Baum MM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-103; Bezakova N, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2525; Bockelmann U, 2006, FEMS MICROBIOL LETT, V262, P31, DOI 10.1111/j.1574-6968.2006.00361.x; CAMPAGNARI AA, 1987, INFECT IMMUN, V55, P882, DOI 10.1128/IAI.55.4.882-887.1987; Canafax DM, 1998, PEDIATR INFECT DIS J, V17, P149, DOI 10.1097/00006454-199802000-00014; Cargill JS, 2009, J CLIN PATHOL, V62, P1112, DOI 10.1136/jcp.2009.069021; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Costerton W, 2003, J CLIN INVEST, V112, P1466, DOI 10.1172/JCI200320365; Davies J, 2006, CURR OPIN MICROBIOL, V9, P445, DOI 10.1016/j.mib.2006.08.006; De Schutter I, 2011, CLIN INFECT DIS, V52, P1437, DOI 10.1093/cid/cir235; DIPERSIO JR, 1974, J GEN MICROBIOL, V83, P349, DOI 10.1099/00221287-83-2-349; Droste JHJ, 2000, CLIN EXP ALLERGY, V30, P1547; DUNNE WM, 1990, ANTIMICROB AGENTS CH, V34, P390, DOI 10.1128/AAC.34.3.390; Fagerlind MG, 2012, J THEOR BIOL, V295, P23, DOI 10.1016/j.jtbi.2011.10.007; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Flemming HC, 2001, WATER SCI TECHNOL, V43, P1; Gallaher TK, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-65; Goh EB, 2002, P NATL ACAD SCI USA, V99, P17025, DOI 10.1073/pnas.252607699; Goodman SD, 2011, MUCOSAL IMMUNOL; GU XX, 1995, INFECT IMMUN, V63, P4115, DOI 10.1128/IAI.63.10.4115-4120.1995; Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202; Herigstad B, 2001, J MICROBIOL METH, V44, P121, DOI 10.1016/S0167-7012(00)00241-4; Hildebrand H, 2008, SCAND J GASTROENTERO, V43, P961, DOI 10.1080/00365520801971736; Hoberman A, 2011, NEW ENGL J MED, V364, P105, DOI 10.1056/NEJMoa0912254; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Hoffman M., 1999, MICROBIAL EXTRACELLU; Hogg JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r103; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07; Jahn A, 1999, BIOFOULING, V14, P49, DOI 10.1080/08927019909378396; Jordens JZ, 1995, EUR J CLIN MICROBIOL, V14, P935, DOI 10.1007/BF01691374; Jurcisek JA, 2007, J BACTERIOL, V189, P3868, DOI 10.1128/JB.01935-06; Kaplan JB, 2011, RES MICROBIOL; Klein JO, 1997, PEDIATR INFECT DIS J, V16, pS5, DOI 10.1097/00006454-199702001-00002; Law DK, 2007, FEMS IMMUNOL MED MIC, V51, P270; Linares JF, 2006, P NATL ACAD SCI USA, V103, P19484, DOI 10.1073/pnas.0608949103; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; Marra F, 2009, PEDIATRICS, V123, P1003, DOI 10.1542/peds.2008-1146; Moghaddam SJ, 2011, INT J CHRONIC OBSTR, V6, P113, DOI 10.2147/COPD.S15417; MUI S, 2005, ENT-EAR NOSE THROAT, V84, P420; Mui S, 2005, ENT-EAR NOSE THROAT, V84, P418; Mui Stanley, 2005, Ear Nose Throat J, V84, P420; Murphy TF, 2004, AM J RESP CRIT CARE, V170, P266, DOI 10.1164/rccm.200403-354OC; Murphy TF, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-7; Murphy TF, 2009, PEDIATR INFECT DIS J, V28, P43, DOI 10.1097/INF.0b013e318184dba2; Novotny LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067629; Pelzer ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049965; Petersen FC, 2005, J BACTERIOL, V187, P4392, DOI 10.1128/JB.187.13.4392-4400.2005; Poje Grant, 2003, Methods Mol Med, V71, P51; Qu Y, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-16; Rachid S, 2000, ANTIMICROB AGENTS CH, V44, P3357, DOI 10.1128/AAC.44.12.3357-3363.2000; Risnes KR, 2011, AM J EPIDEMIOL, V173, P310, DOI 10.1093/aje/kwq400; Sailer FC, 2003, FEMS MICROBIOL LETT, V226, P245, DOI 10.1016/S0378-1097(03)00616-5; SCHADOW KH, 1988, J INFECT DIS, V157, P71, DOI 10.1093/infdis/157.1.71; Schaudin C, 2007, MICROBE, V5, P231, DOI [10.1128/microbe.2.231.1, DOI 10.1128/MICROBE.2.231.1]; Schmelzle J, 2008, CAN FAM PHYSICIAN, V54, P1123; Shen K, 2005, INFECT IMMUN, V73, P3479, DOI 10.1128/IAI.73.6.3479-3491.2005; Sill ML, 2008, ANTIMICROB AGENTS CH, V52, P1551, DOI 10.1128/AAC.01580-07; Smith A, 2011, OTOLARYNG HEAD NECK, V144, P338, DOI 10.1177/0194599810391620; Spoering AL, 2006, CURR OPIN MICROBIOL, V9, P133, DOI 10.1016/j.mib.2006.02.004; Starner TD, 2008, ANTIMICROB AGENTS CH, V52, P137, DOI 10.1128/AAC.00607-07; Starner TD, 2006, AM J RESP CRIT CARE, V174, P213, DOI 10.1164/rccm.200509-1459OC; Steinberger RE, 2005, APPL ENVIRON MICROB, V71, P5404, DOI 10.1128/AEM.71.9.5404-5410.2005; Swords WE, 2004, INFECT IMMUN, V72, P106, DOI 10.1128/IAI.72.1.106-113.2004; Tahtinen PA, 2011, NEW ENGL J MED, V364, P116, DOI 10.1056/NEJMoa1007174; Thanavala Y, 2011, ADV OTO-RHINO-LARYNG, V72, P170, DOI 10.1159/000324785; Vlastarakos PV, 2007, EUR J PEDIATR, V166, P385, DOI 10.1007/s00431-006-0367-x; VYE MV, 1971, J CELL SCI, V9, P727; Wang Q, 2010, ANTIMICROB AGENTS CH, V54, P2707, DOI 10.1128/AAC.01565-09; Wang SW, 2013, ENVIRON MICROBIOL, V15, P2238, DOI 10.1111/1462-2920.12095; Watnick PI, 1999, MOL MICROBIOL, V34, P586, DOI 10.1046/j.1365-2958.1999.01624.x; Webster P, 2004, BIOFILMS, V1, P165, DOI DOI 10.1017/S1479050504001425; Webster P, 2006, J HISTOCHEM CYTOCHEM; Xu QF, 2011, INT J PEDIATR OTORHI, V75, P239, DOI 10.1016/j.ijporl.2010.11.008; Yim G, 2007, PHILOS T R SOC B, V362, P1195, DOI 10.1098/rstb.2007.2044	82	21	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e99204	10.1371/journal.pone.0099204	http://dx.doi.org/10.1371/journal.pone.0099204			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007395	Green Published, Green Submitted, gold			2022-12-27	WOS:000339040600004
J	Avadi, A; Freon, P; Tam, J				Avadi, Angel; Freon, Pierre; Tam, Jorge			Coupled Ecosystem/Supply Chain Modelling of Fish Products from Sea to Shelf: The Peruvian Anchoveta Case	PLOS ONE			English	Article							HUMBOLDT CURRENT ECOSYSTEM; ECOLOGICAL STATUS; SANKEY DIAGRAM; PART II; ECOPATH; IMPACT; INDICATORS; FISHERIES; SYSTEMS; ENERGY	Sustainability assessment of food supply chains is relevant for global sustainable development. A framework is proposed for analysing fishfood (fish products for direct human consumption) supply chains with local or international scopes. It combines a material flow model (including an ecosystem dimension) of the supply chains, calculation of sustainability indicators (environmental, socio-economic, nutritional), and finally multi-criteria comparison of alternative supply chains (e.g. fates of landed fish) and future exploitation scenarios. The Peruvian anchoveta fishery is the starting point for various local and global supply chains, especially via reduction of anchoveta into fishmeal and oil, used worldwide as a key input in livestock and fish feeds. The Peruvian anchoveta supply chains are described, and the proposed methodology is used to model them. Three scenarios were explored: status quo of fish exploitation (Scenario 1), increase in anchoveta landings for food (Scenario 2), and radical decrease in total anchoveta landings to allow other fish stocks to prosper (Scenario 3). It was found that Scenario 2 provided the best balance of sustainability improvements among the three scenarios, but further refinement of the assessment is recommended. In the long term, the best opportunities for improving the environmental and socio-economic performance of Peruvian fisheries are related to sustainability-improving management and policy changes affecting the reduction industry. Our approach provides the tools and quantitative results to identify these best improvement opportunities.	[Avadi, Angel] Univ Montpellier 2, Montpellier, France; [Avadi, Angel; Freon, Pierre] UM2, IFREMER, IRD, EME,UMR212, Sete, France; [Tam, Jorge] Inst Mar Peru IMARPE, Callao, Peru	Universite de Montpellier; Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Instituto del Mar del Peru	Avadi, A (corresponding author), Univ Montpellier 2, Montpellier, France.	angel.avadi@ird.fr	FREON, Pierre/S-4179-2019	Avadi, Angel/0000-0002-8114-916X; Tam, Jorge/0000-0001-8224-4313	Instituto del Mar del Peru (IMARPE); Institut de Recherche pour le Developpement (IRD); LMI DISCOH; Direction des Programmes de Recherche et de la formation au Sud (DPF) of the IRD	Instituto del Mar del Peru (IMARPE); Institut de Recherche pour le Developpement (IRD); LMI DISCOH; Direction des Programmes de Recherche et de la formation au Sud (DPF) of the IRD	This work is a contribution to the cooperative agreement between the Instituto del Mar del Peru (IMARPE), the Institut de Recherche pour le Developpement (IRD), and of the LMI DISCOH. Angel Avadi was financially supported by the Direction des Programmes de Recherche et de la formation au Sud (DPF) of the IRD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder J, 2008, COMP ASSESSMENT BIOD; Alfaro-Shigueto J, 2010, FISH RES, V106, P8, DOI 10.1016/j.fishres.2010.06.004; Alvarado F, 2009, DIAGNOSTICO SOCIAL T; Amaya EA, 2007, AQUACULTURE, V262, P393, DOI 10.1016/j.aquaculture.2006.11.015; [Anonymous], 2010, J STUD MANUF; Aranda M, 2009, FISH RES, V96, P308, DOI 10.1016/j.fishres.2008.11.004; Avadi A., 2014, AQUACULTURE IN PRESS; Avadi A, 2014, ECOL INDIC IN PRESS; Avadi A, 2014, INT J LIFE CYCLE ASS, V19, P1276, DOI 10.1007/s11367-014-0737-y; Avadi A, 2014, J CLEAN PROD, V70, P118, DOI 10.1016/j.jclepro.2014.01.047; Bernal M, 2012, FISH RES, V117, P1, DOI 10.1016/j.fishres.2012.01.001; Bjorndal T, 2004, EUR J OPER RES, V156, P533, DOI 10.1016/S0377-2217(03)00107-3; Borjeson L, 2006, FUTURES, V38, P723, DOI 10.1016/j.futures.2005.12.002; C?rdenas-Alayza S., 2012, PREY ABUNDANCE POPUL; Centrum, 2009, REP SECT SECT PESC; Chavez FP, 2008, PROG OCEANOGR, V79, P95, DOI 10.1016/j.pocean.2008.10.012; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; CHRISTENSEN V, 1992, ECOL MODEL, V61, P169, DOI 10.1016/0304-3800(92)90016-8; Christensen V, 2014, MAR POLICY, V44, P302, DOI 10.1016/j.marpol.2013.09.022; Christensen V, 2011, ECOL MODEL, V222, P857, DOI 10.1016/j.ecolmodel.2010.09.030; Csirke J, 1996, SITUACION RECURSOS A; Csirke J, 1996, B I PERU CALLAO, V19, P25; Dahl AL, 2012, ECOL INDIC, V17, P14, DOI 10.1016/j.ecolind.2011.04.032; de Bruijn H., 2002, HDB LIFE CYCLE ASSES, V7; De Silva SS, 2008, J AGR ENVIRON ETHIC, V21, P459, DOI 10.1007/s10806-008-9109-6; DELAPUENTE O, 2011, PESQUERIA PERUANA AN; Deutsch L, 2007, GLOBAL ENVIRON CHANG, V17, P238, DOI 10.1016/j.gloenvcha.2006.08.004; Drewnowski A, 2008, NUTR REV, V66, P23, DOI 10.1111/j.1753-4887.2007.00003.x; Ecoinvent, 2012, EC CTR PORT; Essington TE, 2007, CAN J FISH AQUAT SCI, V64, P628, DOI 10.1139/F07-042; Arellano CE, 2010, FISH RES, V101, P133, DOI 10.1016/j.fishres.2009.08.007; F.A.O, 2011, COUNTR PROF FOOD SEC; FAO, 2000, PERF NUTR PAIS PER; FAO, 2014, FISHSTATJ SOFTW FISH; FishSource, 2012, ANCH PER NO CENTR ST; Food Policy, 2011, FOOD POLICY, V36, pS1, DOI [10.1016/j.foodpol.2011.01.001, DOI 10.1016/J.FOODPOL.2011.01.001]; Freon P., 2010, B I MAR PERU, V25, P63; Freon P., 2014, CAN J FISH IN PRESS; Freon P, 2010, GLOBEC INT NEWSLETTE, V1, P27; Freon P, 2014, INT J LIFE CYCLE ASS, V19, P1068, DOI 10.1007/s11367-014-0716-3; Freon P, 2014, REV FISH BIOL FISHER, V24, P381, DOI 10.1007/s11160-013-9336-4; Goedkoop M, 2012, 1 MIN HOUS SPAT PLAN; Goedkoop M., 2009, 1 MIN HOUS SPAT PLAN; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Hall CAS, 2011, SUSTAINABILITY-BASEL, V3, P1773, DOI 10.3390/su3101773; Hertlein W, 1995, NAGA ICLARM Q, P41; Hischier Roland., 2010, ECOINVENT REPORT NO; Hornborg S, 2012, D 1 3B BY CATCH METH; Hornborg S, 2012, MAR POLICY, V36, P1193, DOI 10.1016/j.marpol.2012.02.017; Howieson J., 2010, AUSTR NZ MARK AC ANZ, P1; IFPRI, 2006, CHALL HUNG GLOB HUNG; IFU and IFEU, 2005, UMB SOFTW TOOL LIF C; IMARPE, 2009, B I MAR PER INF TERC; IMARPE, 2010, B I MAR PER QUINT PA; INEI, 2011, ENC DEM SAL FAM 2011; INEI, 2012, CONSUMO CPITA PRINCI; INEI, 2012, PER COMP EST 2012 PE; INEI, 2013, POBL VIV; Ingram J., 2010, FOOD SECURITY GLOBAL; International Food Policy and Research Institute (IFPRI), 2012, 2012 GLOB HUNG IND C; Jensen TK, 2010, J AQUAT FOOD PROD T, V19, P214, DOI 10.1080/10498850.2010.508964; Jimenez F., 2005, EVALUACION NUTR GALL; Kasi, 2005, P 38 ANN HAW INT C S, p87B, DOI DOI 10.1109/HICSS.2005.574; Khan A, 2009, ECOPATH 25 YEARS C P, V17; Kloepffer W, 2008, INT J LIFE CYCLE ASS, V13, P89, DOI 10.1065/lca2008.02.376; Kruse SA, 2009, INT J LIFE CYCLE ASS, V14, P8, DOI 10.1007/s11367-008-0040-x; Langlois J, 2014, J CLEAN PROD, V73, P63, DOI 10.1016/j.jclepro.2014.01.087; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Link J, 2002, FISHERIES, V27, P2; McMichael P, 2011, GLOBAL ENVIRON CHANG, V21, P804, DOI 10.1016/j.gloenvcha.2011.03.016; Mendoza D, 2011, PANORAMA ACUICULTURA; Mendoza D., 2013, SITUACION EXTENSIONI; Mullon C, 2009, NAT RESOUR MODEL, V22, P564, DOI 10.1111/j.1939-7445.2009.00053.x; Nellemann C, 2009, ENV FOOD CRISIS THE; Paredes C., 2008, IND ANCHOVETERA PERU; Paredes C, 2013, EFICIENCIA EQUIDAD P, pB6; Paredes C, 2013, GESTION, P23; Paredes C. E., 2010, REFORMANDO SECTOR AN; Paredes CE, 2012, EFICIENCIA EQUIDAD P; Paredes CE, 2013, CORRIENTE ANCHOVETA; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Pauly D, 2000, ICES J MAR SCI, V57, P697, DOI 10.1006/jmsc.2000.0726; Pauly D, 1989, ICLARM C P, V18, P438; Peron G, 2010, MAR POLICY, V34, P815, DOI 10.1016/j.marpol.2010.01.027; PETT, 2012, REG GOV PUN PROYECT; Power A, 1999, ENV DEV SUSTAIN, V1, P185, DOI [10.1023/A:1010074805303, DOI 10.1023/A:1010074805303]; PRe, 2012, SIMAPRO PREC; Prellezo R., 2009, SURVEY EXISTING BIOE; Prellezo R, 2012, MAR POLICY, V36, P423, DOI 10.1016/j.marpol.2011.08.003; PRODUCE, 2009, PLAN NAC DES AC; PRODUCE, 2010, AN EST 2010 SUBS PES; Rokovich J.A., 2009, ESTUDIOS DESARROLLO; Rosenbaum RK, 2008, INT J LIFE CYCLE ASS, V13, P532, DOI 10.1007/s11367-008-0038-4; Sanchez Durand N., 2009, FAO Fisheries and Aquaculture Technical Paper, P325; Schluter M, 2012, NAT RESOUR MODEL, V25, P219, DOI 10.1111/j.1939-7445.2011.00108.x; Schmidt M, 2008, J IND ECOL, V12, P173, DOI 10.1111/j.1530-9290.2008.00015.x; Schmidt M, 2008, J IND ECOL, V12, P82, DOI 10.1111/j.1530-9290.2008.00004.x; Schreiber MA, 2013, ECOL SOC, V18, DOI 10.5751/ES-05319-180212; Schreiber MA, 2012, MAR POLICY, V36, P78, DOI 10.1016/j.marpol.2011.03.010; Shin YJ, 2012, REV FISH BIOL FISHER, V22, P835, DOI 10.1007/s11160-012-9252-z; Shin YJ, 2010, ICES J MAR SCI, V67, P692, DOI 10.1093/icesjms/fsp294; Shin YJ, 2010, ICES J MAR SCI, V67, P686, DOI 10.1093/icesjms/fsp273; SNP, 2011, MEM AN 2011; SNP, 2010, MEM AN 2010; SOFA, 2011, STAT FOOD AGR 2010 1; SOFIA, 2010, STAT WORLD FISH AQ 2; SOFIA, 2012, STAT WORLD FISH AQ 2; Spiertz H, 2010, CURR OPIN ENV SUST, V2, P439, DOI 10.1016/j.cosust.2010.10.006; Sueiro J. C., 2008, ACTIVIDAD PESQUERA P; Sun W., 2009, LIFE CYCLE ASSESSMEN; Tacon A. G. J., 2002, THEMATIC REV FEEDS F; Tacon AGJ., 2011, DEMAND SUPPLY FEED I; Tam J, 2009, B I MAR PERU, V24, P27; Tam J., 2010, B IMARPE, V25, P31; Tam J, 2005, MODELACION ECOTROFIC; Tam J, 2008, PROG OCEANOGR, V79, P352, DOI 10.1016/j.pocean.2008.10.007; Taylor Marc H, 2007, Rev. peru biol., V14, P87; Taylor MH, 2008, PROG OCEANOGR, V79, P366, DOI 10.1016/j.pocean.2008.10.008; Travers M, 2007, PROG OCEANOGR, V75, P751, DOI 10.1016/j.pocean.2007.08.001; Tukker A, 2011, ECOL ECON, V70, P1776, DOI 10.1016/j.ecolecon.2011.05.001; Tveteras S, 2011, INDIVIDUAL FISHING Q; Tveteras S, 2010, J AGR ECON, V61, P381, DOI 10.1111/j.1477-9552.2010.00245.x; Tyedmers PH, 2005, AMBIO, V34, P635, DOI 10.1639/0044-7447(2005)034[0635:FGFF]2.0.CO;2; Tyedmers PH, 2000, SALMON SUSTAINABILIT; USMP, 2013, GESTION, P15; van Zelm R, 2009, INT J LIFE CYCLE ASS, V14, P282, DOI 10.1007/s11367-009-0066-8; Walters C, 1997, REV FISH BIOL FISHER, V7, P139, DOI 10.1023/A:1018479526149; Wognum PM, 2011, ADV ENG INFORM, V25, P65, DOI 10.1016/j.aei.2010.06.001; Zamagni A, 2013, INT J LIFE CYCLE ASS, V18, P1637, DOI 10.1007/s11367-013-0648-3	130	13	13	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e102057	10.1371/journal.pone.0102057	http://dx.doi.org/10.1371/journal.pone.0102057			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003196	Green Published, Green Submitted, gold			2022-12-27	WOS:000339242700102
J	Babcock, HE; Dutta, S; Alur, RP; Brocker, C; Vasiliou, V; Vitale, S; Abu-Asab, M; Brooks, BP				Babcock, Holly E.; Dutta, Sunit; Alur, Ramakrishna P.; Brocker, Chad; Vasiliou, Vasilis; Vitale, Susan; Abu-Asab, Mones; Brooks, Brian P.			aldh7a1 Regulates Eye and Limb Development in Zebrafish	PLOS ONE			English	Article							RETINOIC ACID; OCULAR DEVELOPMENT; COLOBOMA MAC; MUTATIONS; MICROPHTHALMIA; ANOPHTHALMIA; EXPRESSION; GENES; ANTIQUITIN; SPECTRUM	Uveal coloboma is a potentially blinding congenital ocular malformation caused by failure of the optic fissure to close during development. Although mutations in numerous genes have been described, these account for a minority of cases, complicating molecular diagnosis and genetic counseling. Here we describe a key role of aldh7a1 as a gene necessary for normal eye development. We show that morpholino knockdown of aldh7a1 in zebrafish causes uveal coloboma and misregulation of nlz1, another known contributor to the coloboma phenotype, as well as skeletal abnormalities. Knockdown of aldh7a1 leads to reduced cell proliferation in the optic cup of zebrafish, delaying the approximation of the edges of the optic fissure. The aldh7a1 morphant phenotype is partially rescued by co-injection of nlz1 mRNA suggesting that nlz1 is functionally downstream of aldh7a1 in regulating cell proliferation in the optic cup. These results support a role of aldh7a1 in ocular development and skeletal abnormalities in zebrafish.	[Babcock, Holly E.; Dutta, Sunit; Alur, Ramakrishna P.; Brooks, Brian P.] NEI, Unit Pediat Dev & Genet Ophthalmol, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA; [Brocker, Chad; Vasiliou, Vasilis] Univ Colorado Denver, Mol Toxicol & Environm Hlth Sci Program, Dept Pharmaceut Sci, Aurora, CO USA; [Vitale, Susan] NEI, Div Biostat & Epidemiol, Clin Trials Branch, NIH, Bethesda, MD 20892 USA; [Abu-Asab, Mones] NEI, Immunopathol Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Brooks, BP (corresponding author), NEI, Unit Pediat Dev & Genet Ophthalmol, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA.	brooksb@mail.nih.gov		vitale, susan/0000-0002-5972-6848; vasiliou, vasilis/0000-0003-2552-3118; Brocker, Chad/0000-0003-4262-3567	Intramural Program of the National Eye Institute; National Institutes of Health; US Dpt. Of Health and Human Services; NATIONAL EYE INSTITUTE [ZIAEY000469] Funding Source: NIH RePORTER	Intramural Program of the National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Dpt. Of Health and Human Services; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by the Intramural Program of the National Eye Institute, National Institutes of Health, US Dpt. Of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balow SA, 2013, DEV BIOL, V382, P57, DOI 10.1016/j.ydbio.2013.07.026; Bennett CL, 2009, EPILEPSIA, V50, P1167, DOI 10.1111/j.1528-1167.2008.01816.x; Bermejo E, 1998, AM J MED GENET, V75, P497, DOI 10.1002/(SICI)1096-8628(19980217)75:5<497::AID-AJMG8>3.0.CO;2-K; Brocker C, 2011, CHEM-BIOL INTERACT, V191, P269, DOI 10.1016/j.cbi.2011.02.016; Brocker C, 2010, J BIOL CHEM, V285, P18452, DOI 10.1074/jbc.M109.077925; Brooks BP, 2013, EMERY RIMOINS PRINCI, P3952; Brown JD, 2009, P NATL ACAD SCI USA, V106, P1462, DOI 10.1073/pnas.0812017106; Chan CL, 2011, CHEM-BIOL INTERACT, V191, P165, DOI 10.1016/j.cbi.2010.12.019; Chang L, 2006, CURR OPIN OPHTHALMOL, V17, P447, DOI 10.1097/01.icu.0000243020.82380.f6; Dupe V, 2003, P NATL ACAD SCI USA, V100, P14036, DOI 10.1073/pnas.2336223100; Fares-Taie L, 2013, AM J HUM GENET, V92, P265, DOI 10.1016/j.ajhg.2012.12.003; French CR, 2013, INVEST OPHTH VIS SCI, V54, P4636, DOI 10.1167/iovs.13-11674; Gallagher RC, 2009, ANN NEUROL, V65, P550, DOI 10.1002/ana.21568; Gonzalez-Rodriguez J, 2010, BRIT J OPHTHALMOL, V94, P1100, DOI 10.1136/bjo.2009.173500; Gregory-Evans CY, 2004, J MED GENET, V41, P881, DOI 10.1136/jmg.2004.025494; Guo Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000806; Hornby S J, 2000, Ophthalmic Epidemiol, V7, P127; HYATT GA, 1992, P NATL ACAD SCI USA, V89, P8293, DOI 10.1073/pnas.89.17.8293; KRAUSS S, 1991, DEVELOPMENT, V113, P1193; Lehman DM, 2001, AM J MED GENET, V101, P114, DOI 10.1002/ajmg.1330; Liu MN, 2008, DEV DYNAM, V237, P3387, DOI 10.1002/dvdy.21763; Lupo G, 2011, P NATL ACAD SCI USA, V108, P8698, DOI 10.1073/pnas.1103802108; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI 10.1517/17425255.4.6.697 ; MARSHARMSTRONG N, 1994, P NATL ACAD SCI USA, V91, P7286, DOI 10.1073/pnas.91.15.7286; Matt N, 2005, DEVELOPMENT, V132, P4789, DOI 10.1242/dev.02031; Maumenee I H, 1990, Trans Am Ophthalmol Soc, V88, P123; MAUMENEE IH, 1990, T AM OPHTHAL SOC, V88, P133; Mills PB, 2006, NAT MED, V12, P307, DOI 10.1038/nm1366; Mills PB, 2010, BRAIN, V133, P2148, DOI 10.1093/brain/awq143; Molotkov A, 2006, DEVELOPMENT, V133, P1901, DOI 10.1242/dev.02328; Morrison D, 2002, J MED GENET, V39, P16, DOI 10.1136/jmg.39.1.16; Nakamura KM, 2011, ARCH OPHTHALMOL-CHIC, V129, P69, DOI 10.1001/archophthalmol.2010.320; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; PAGON RA, 1981, AM J MED GENET, V9, P189, DOI 10.1002/ajmg.1320090304; Scharer G, 2010, J INHERIT METAB DIS, V33, P571, DOI 10.1007/s10545-010-9187-2; Slorach EM, 2011, GENE DEV, V25, P471, DOI 10.1101/gad.1998111; Take-uchi M, 2003, DEVELOPMENT, V130, P955, DOI 10.1242/dev.00305; Tang WK, 2005, FEBS LETT, V579, P3759, DOI 10.1016/j.febslet.2005.05.070; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; van den Hoogen C, 2011, CLIN EXP METASTAS, V28, P615, DOI 10.1007/s10585-011-9395-7; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Yahyavi M, 2013, HUM MOL GENET, V22, P3250, DOI 10.1093/hmg/ddt179; Zhang XH, 2009, MOL VIS, V15, P2911; ZLOTOGORA J, 1994, AM J MED GENET, V49, P261, DOI 10.1002/ajmg.1320490302	45	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101782	10.1371/journal.pone.0101782	http://dx.doi.org/10.1371/journal.pone.0101782			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004007	gold, Green Submitted, Green Published			2022-12-27	WOS:000339242700064
J	Li, L; Li, XR; Yin, JY; Song, X; Chen, XC; Feng, JE; Gao, HY; Liu, L; Wei, S				Li, Li; Li, Xiaorong; Yin, Jieyun; Song, Xia; Chen, Xiaochen; Feng, Jiane; Gao, Hongyu; Liu, Li; Wei, Sheng			The High Diagnostic Accuracy of Combined Test of Thyroid Transcription Factor 1 and Napsin A to Distinguish between Lung Adenocarcinoma and Squamous Cell Carcinoma: A Meta-Analysis	PLOS ONE			English	Article							TISSUE MICROARRAY; FACTOR-I; IMMUNOHISTOCHEMICAL MARKERS; DIFFERENTIAL-DIAGNOSIS; BIOPSY SPECIMENS; CYTOKERATIN 5/6; DOUBLE STAIN; CANCER; PULMONARY; UTILITY	Background: Accurate classification of non-small cell lung cancer (NSCLC) using morphological features has several limitations. However, the use of thyroid transcription factor 1 (TTF-1) and Napsin A as markers for the identification of various subtypes of NSCLC has shown promise. This meta-analysis was designed to evaluate the diagnostic value of combined TTF-1 and Napsin A test to distinguish lung adenocarcinoma from squamous cell carcinoma. Methods: The Medline, EMBASE and Web of Science databases were searched, along with the reference lists of relevant articles (up to May 4, 2014). Ten studies containing 1,446 subjects were identified. The sensitivity, specificity, diagnostic odds ratio (DOR) and area under the summary receiver operating characteristics curve (AUC) were calculated to estimate the combined diagnostic value of TTF-1 and Napsin A. Results: The pooled sensitivity and specificity were 0.76 (95% CI: 0.69-0.83) and 1.00 (95% CI: 0.92-1.00), respectively. The positive and negative likelihood ratios were 877.60 (95% CI: 8.40-91533.40) and 0.24 (95% CI: 0.18-0.32). The DOR was 3719 (95% CI: 33-414884). The AUC was 0.92 (95% CI: 0.89-0.94). The patient's location was a source of heterogeneity for sensitivity. The patient's location, the study's sample size and the threshold used to determine positive staining were consistently found to be sources of heterogeneity for specificity in subgroup analyses and meta-regression. Conclusions: The combined test of TTF-1 and Napsin A presents a promising alternative method, useful to distinguish between lung adenocarcinoma and squamous cell carcinoma.	[Li, Li; Li, Xiaorong; Yin, Jieyun; Song, Xia; Chen, Xiaochen; Liu, Li; Wei, Sheng] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Hubei, Peoples R China; [Feng, Jiane] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Cardiovasc Surg, Wuhan 430074, Hubei, Peoples R China; [Gao, Hongyu] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Div Renal, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Liu, L (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Hubei, Peoples R China.	gracefulliuly@gmail.com; ws2008cn@gmail.com			ational Science Foundation of China [NSF 81172754, NSF 81172752]	ational Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China http://www.nsfc.gov.cn/(NSF 81172754 and NSF 81172752). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa E, 2011, CANCER CYTOPATHOL, V119, P335, DOI 10.1002/cncy.20162; BISHOP JA, 2013, CLIN CANCER RES, V16, P610; Brown AF, 2013, ARCH PATHOL LAB MED, V137, P1274, DOI 10.5858/arpa.2012-0635-OA; Brunnstrom H, 2013, AM J CLIN PATHOL, V140, P37, DOI 10.1309/AJCP50RDXSCSBTBO; Cohen MH, 2007, ONCOLOGIST, V12, P713, DOI 10.1634/theoncologist.12-6-713; Collins BT, 2013, CANCER CYTOPATHOL, V121, P146, DOI 10.1002/cncy.21222; Fatima N, 2011, CANCER CYTOPATHOL, V119, P127, DOI 10.1002/cncy.20135; Fatima N, 2011, CANCER CYTOPATHOL, V119, P202, DOI 10.1002/cncy.20149; Gu K, 2007, AM J CLIN PATHOL, V128, P382, DOI 10.1309/CADCVWHR2QF6JMVN; Hamamoto J, 2013, MOL MED REP, V8, P456, DOI 10.3892/mmr.2013.1517; Herbst RS, 2008, CLIN LUNG CANCER, V9, P75, DOI 10.3816/CLC.2008.n.011; Herbst RS, 2007, J CLIN ONCOL, V25, P4743, DOI 10.1200/JCO.2007.12.3026; Johansson Leif, 2004, Ann Diagn Pathol, V8, P259, DOI 10.1016/j.anndiagpath.2004.07.001; Johnson H, 2012, ACTA CYTOL, V56, P596, DOI 10.1159/000339793; Kim MJ, 2013, ANN DIAGN PATHOL, V17, P85, DOI 10.1016/j.anndiagpath.2012.07.006; Lebanony D, 2009, J CLIN ONCOL, V27, P2030, DOI 10.1200/JCO.2008.19.4134; Lee HJ, 2013, RADIOLOGY, V268, P254, DOI 10.1148/radiol.13112553; Li AR, 2008, J MOL DIAGN, V10, P242, DOI 10.2353/jmoldx.2008.070178; Loo PS, 2010, J THORAC ONCOL, V5, P442, DOI 10.1097/JTO.0b013e3181d40fac; Mukhopadhyay S, 2011, AM J SURG PATHOL, V35, P15, DOI 10.1097/PAS.0b013e3182036d05; Nicholson AG, 2010, J THORAC ONCOL, V5, P436, DOI 10.1097/JTO.0b013e3181c6ed9b; Noh S, 2012, LUNG CANCER, V76, P51, DOI 10.1016/j.lungcan.2011.09.008; Pereira TC, 2011, APPL IMMUNOHISTO M M, V19, P10, DOI 10.1097/PAI.0b013e3181ecaf1c; Righi L, 2011, CANCER-AM CANCER SOC, V117, P3416, DOI 10.1002/cncr.25830; Roh MH, 2012, DIAGN CYTOPATHOL, V40, P949, DOI 10.1002/dc.21680; Sakai Y, 2013, INT J SURG PATHOL, V21, P476, DOI 10.1177/1066896913489345; Sandler A, 2007, CLIN CANCER RES, V13, p4613S, DOI 10.1158/1078-0432.CCR-07-0647; Savas P, 2013, J THORAC DIS, V5, pS579, DOI 10.3978/j.issn.2072-1439.2013.08.52; Schultz H, 2011, BRIT J CANCER, V105, P673, DOI 10.1038/bjc.2011.281; Sethi S, 2012, CYTOJOURNAL, V9, DOI 10.4103/1742-6413.94570; Stahlman MT, 1996, J HISTOCHEM CYTOCHEM, V44, P673, DOI 10.1177/44.7.8675988; Stang A, 2006, LUNG CANCER, V52, P29, DOI 10.1016/j.lungcan.2005.11.012; Stoll LM, 2010, CANCER CYTOPATHOL, V118, P441, DOI 10.1002/cncy.20108; Tacha D, 2012, APPL IMMUNOHISTO M M, V20, P201, DOI 10.1097/PAI.0b013e31823d7f0e; Tsuta K, 2011, J THORAC ONCOL, V6, P1190, DOI 10.1097/JTO.0b013e318219ac78; Turner BM, 2012, ARCH PATHOL LAB MED, V136, P163, DOI 10.5858/arpa.2011-0320-OA; Ueno T, 2003, BRIT J CANCER, V88, P1229, DOI 10.1038/sj.bjc.6600879; Whithaus K, 2012, ARCH PATHOL LAB MED, V136, P155, DOI 10.5858/arpa.2011-0232-OA; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Yanagita E, 2011, APPL IMMUNOHISTO M M, V19, P1509, DOI 10.1097/PAI.0b013e318212f027; Yang M, 2010, MODERN PATHOL, V23, P654, DOI 10.1038/modpathol.2010.38; Yoshida A, 2011, AM J SURG PATHOL, V35, P1226, DOI 10.1097/PAS.0b013e3182233e06; Zhang P, 2010, ONCOL LETT, V1, P899, DOI 10.3892/ol_00000160	43	3	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e100837	10.1371/journal.pone.0100837	http://dx.doi.org/10.1371/journal.pone.0100837			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003505	Green Submitted, gold, Green Published			2022-12-27	WOS:000339242700014
J	Ritchie, SR; Thomas, MG; Rainey, PB				Ritchie, Stephen R.; Thomas, Mark G.; Rainey, Paul B.			The Genetic Structure of Staphylococcus aureus Populations from the Southwest Pacific	PLOS ONE			English	Article							METHICILLIN-RESISTANT; CLONES; EPIDEMIOLOGY; BACTEREMIA; GENOTYPES; CARRIAGE; STRAINS; EBURST; MODELS	The genetic structure of Staphylococcus aureus populations sampled from diverse regions of the globe have been the subject of numerous investigations. Here we describe the structure of S. aureus populations collected from the Southwest Pacific. Multi-locus sequence typing was performed on 467 isolates obtained from people with nasal colonization or bacteremia in Auckland (NZ), and patients predominantly affected by skin and soft tissue infection in Samoa, Fiji and Tonga. The predominant sequence types (STs) varied between Auckland (ST5), Fiji (ST30), and Samoa (ST1), however, the overall genetic diversity within each region did not differ significantly between locations. Divergent Clonal Complex 75 (CC75) strains were isolated in Auckland and Fiji. When diversity of the Southwest Pacific populations was compared with those previously described from Asia, Europe, North America and Africa no significant differences were detected. With the exception of CC75 strains, the global collection of S. aureus encompasses relatively little diversity, with novel STs arising locally from a small number of widespread lineages.	[Ritchie, Stephen R.; Rainey, Paul B.] Massey Univ, NZ Inst Adv Study, Auckland, New Zealand; [Ritchie, Stephen R.; Rainey, Paul B.] Massey Univ, Allan Wilson Ctr Mol Ecol & Evolut, Auckland, New Zealand; [Ritchie, Stephen R.; Thomas, Mark G.] Univ Auckland, Dept Mol Med & Pathol, Auckland 1, New Zealand; [Rainey, Paul B.] Max Planck Inst Evolutionary Biol, Plon, Germany	Massey University; Massey University; University of Auckland; Max Planck Society	Ritchie, SR (corresponding author), Massey Univ, NZ Inst Adv Study, Auckland, New Zealand.	s.ritchie@auckland.ac.nz	Rainey, Paul/A-3207-2008	Rainey, Paul/0000-0003-0879-5795; Ritchie, Stephen/0000-0001-5001-8899	Health Research Council of New Zealand; University of Auckland	Health Research Council of New Zealand(Health Research Council of New Zealand); University of Auckland	This work was supported by the Health Research Council of New Zealand (http://www.hrc.govt.nz/) (SR) and The University of Auckland (MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alesana-Slater J, 2011, EMERG INFECT DIS, V17, P1023, DOI [10.3201/eid/1706.101083, 10.3201/eid1706.101083]; Anderson M, 2008, PERMANOVA SOFTWARE S; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Breurec S, 2011, CLIN MICROBIOL INFEC, V17, P633, DOI 10.1111/j.1469-0691.2010.03320.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; de Haas CJC, 2004, J EXP MED, V199, P687, DOI 10.1084/jem.20031636; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Fan J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006216; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fowler VG, 2007, J INFECT DIS, V196, P738, DOI 10.1086/520088; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hill PC, 2001, PEDIATR INFECT DIS J, V20, P868, DOI 10.1097/00006454-200109000-00009; Hill PC, 2001, INTERN MED J, V31, P97, DOI 10.1111/j.1444-0903.2001.00029.x; Holt DC, 2011, GENOME BIOL EVOL, V3, P881, DOI 10.1093/gbe/evr078; Jennings B, 2007, HASTINGS CENT REP, V37, P6; Ko KS, 2005, J CLIN MICROBIOL, V43, P421, DOI 10.1128/JCM.43.1.421-426.2005; Kurt K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058155; Lamers RP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016426; Larsen J, 2012, J CLIN MICROBIOL, V50, P2538, DOI 10.1128/JCM.00290-12; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; McVean G, 2002, GENETICS, V160, P1231; Meemken D, 2013, APPL ENVIRON MICROB, V79, P1739, DOI 10.1128/AEM.03189-12; Melles DC, 2008, J CLIN MICROBIOL, V46, P235, DOI 10.1128/JCM.00887-07; Melles DC, 2004, J CLIN INVEST, V114, P1732, DOI 10.1172/JCI200423083; Ng JWS, 2009, J CLIN MICROBIOL, V47, P2295, DOI 10.1128/JCM.00122-09; Peacock SJ, 2002, INFECT IMMUN, V70, P4987, DOI 10.1128/IAI.70.9.4987-4996.2002; Posada D, 2009, METHODS MOL BIOL, V537, P93, DOI 10.1007/978-1-59745-251-9_5; Ritchie SR, 2011, NZ MED J, V124, P4609; Ruimy R, 2008, J BACTERIOL, V190, P3962, DOI 10.1128/JB.01947-07; Ruimy R, 2010, J INFECT DIS, V202, P924, DOI 10.1086/655901; Ruimy R, 2009, J BACTERIOL, V191, P5577, DOI 10.1128/JB.00493-09; Sakwinska O, 2009, APPL ENVIRON MICROB, V75, P175, DOI 10.1128/AEM.01860-08; Schaumburg F, 2012, ENV MICROBIOL REP, V4, P141, DOI 10.1111/j.1758-2229.2011.00316.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Smith EM, 2013, INFECT GENETICS EVOL; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Tong SYC, 2010, J INFECT DIS, V202, P760, DOI 10.1086/655396; Tong SYC, 2009, J INFECT DIS, V199, P1461, DOI 10.1086/598218; Uhlemann AC, 2012, EUR J CLIN MICROBIOL, V31, P505, DOI 10.1007/s10096-011-1339-2; Williamson DA, 2013, PEDIATR INFECT DIS J, V32, P923, DOI 10.1097/INF.0b013e3182905f3d; Williamson DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062020	46	20	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e100300	10.1371/journal.pone.0100300	http://dx.doi.org/10.1371/journal.pone.0100300			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003509	Green Published, Green Submitted, gold			2022-12-27	WOS:000339242700005
J	Barazzoni, R; Cappellari, GG; Semolic, A; Chendi, E; Ius, M; Situlin, R; Zanetti, M; Vinci, P; Guarnieri, G				Barazzoni, Rocco; Cappellari, Gianluca Gortan; Semolic, Annamaria; Chendi, Enrico; Ius, Mario; Situlin, Roberta; Zanetti, Michela; Vinci, Pierandrea; Guarnieri, Gianfranco			The Association between Hematological Parameters and Insulin Resistance Is Modified by Body Mass Index - Results from the North-East Italy MoMa Population Study	PLOS ONE			English	Article							RISK-FACTORS; HEMATOCRIT; SENSITIVITY; VISCOSITY; GLUCOSE; OBESITY	Objective: Increments in red blood cell count (RBC), hemoglobin (Hb) and hematocrit (Ht) levels are reportedly associated with higher insulin resistance (IR). Obesity may cause IR, but underlying factors remain incompletely defined, and interactions between obesity, hematological parameters and IR are incompletely understood. We therefore determined whether: 1) BMI and obesity per se are independently associated with higher RBC, hemoglobin and hematocrit; 2) hematological parameters independently predict insulin resistance in obese individuals. Design and Methods: We investigated the associations between BMI, hematological parameters and insulin resistance as reflected by homeostasis model assessment (HOMA) in a general population cohort from the North-East Italy MoMa epidemiological study (M/F = 865/971, age = 49 +/- 61). Results: In all subjects, age-, sex- and smoking-adjusted hematological parameters were positively associated with BMI in linear regression (P<0.05), but not after adjustment for HOMA or waist circumference (WC) and potential metabolic confounders. No associations were found between hematological parameters and BMI in lean, overweight or obese subgroups. Associations between hematological parameters and HOMA were conversely independent of BMI in all subjects and in lean and overweight subgroups (P<0.01), but not in obese subjects alone. Conclusions: In a North-East Italy general population cohort, obesity per se is not independently associated with altered RBC, Hb and Ht, and the association between BMI and hematological parameters is mediated by their associations with abdominal fat and insulin resistance markers. High hematological parameters could contribute to identify insulin resistance in non-obese individual, but they do not appear to be reliable insulin resistance biomarkers in obese subjects.	[Barazzoni, Rocco; Cappellari, Gianluca Gortan; Semolic, Annamaria; Chendi, Enrico; Ius, Mario; Situlin, Roberta; Zanetti, Michela; Vinci, Pierandrea; Guarnieri, Gianfranco] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy	University of Trieste	Barazzoni, R (corresponding author), Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy.	barazzon@units.it		SITULIN, ROBERTA/0000-0003-0826-4003; ZANETTI, MICHELA/0000-0002-2634-6363; Gortan Cappellari, Gianluca/0000-0002-0438-5003	European Regional Development Fund under the Regional Operational Programme of Friuli Venezia Giulia	European Regional Development Fund under the Regional Operational Programme of Friuli Venezia Giulia	This work received financial support from the European Regional Development Fund under the Regional Operational Programme of Friuli Venezia Giulia - Objective "Regional Competitiveness and Employment" 2007/2013. Friuli-Venezia Giulia Region supported biochemical analyses at Pordenone hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri M, 2001, DIABETOLOGIA, V44, P1232, DOI 10.1007/s001250100634; BARON AD, 1994, AM J PHYSIOL, V266, pE248, DOI 10.1152/ajpendo.1994.266.2.E248; BERSCH N, 1982, J CLIN ENDOCR METAB, V55, P1209, DOI 10.1210/jcem-55-6-1209; Catalano C, 1997, EUR J CLIN INVEST, V27, P634, DOI 10.1046/j.1365-2362.1997.1770714.x; Fessler MB, 2013, J LIPID RES, V54, P3177, DOI 10.1194/jlr.P037614; Gori T, 2011, CLIN HEMORHEOL MICRO, V49, P37, DOI 10.3233/CH-2011-1455; Hanley AJG, 2009, J CLIN ENDOCR METAB, V94, P3824, DOI 10.1210/jc.2009-0719; Hardy OT, 2012, CURR OPIN ENDOCRINOL, V19, P81, DOI 10.1097/MED.0b013e3283514e13; Hocking S, 2013, ENDOCR REV, V34, P463, DOI 10.1210/er.2012-1041; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; NORDBY G, 1995, AM J HYPERTENS, V8, P439, DOI 10.1016/0895-7061(95)00044-P; Tamariz LJ, 2008, AM J EPIDEMIOL, V168, P1153, DOI 10.1093/aje/kwn243; WANNAMETHEE G, 1994, THROMB HAEMOSTASIS, V72, P58	14	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101590	10.1371/journal.pone.0101590	http://dx.doi.org/10.1371/journal.pone.0101590			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000394	Green Submitted, Green Published, gold			2022-12-27	WOS:000338637300061
J	Bjorkenstam, E; Narusyte, J; Alexanderson, K; Ropponen, A; Kjeldgard, L; Svedberg, P				Bjorkenstam, Emma; Narusyte, Jurgita; Alexanderson, Kristina; Ropponen, Annina; Kjeldgard, Linnea; Svedberg, Pia			Associations between Childbirth, Hospitalization and Disability Pension: A Cohort Study of Female Twins	PLOS ONE			English	Article							RISK-FACTORS; SICK LEAVE; FOLLOW-UP; BEHAVIORAL-DISORDERS; BACK-PAIN; HEALTH; WOMEN; PREGNANCY; PREVALENCE; MORTALITY	Background: As the literature on long-term effects of childbirth on risk of morbidity or permanent work incapacity (DP) is limited, we aimed to study associations of childbirth with hospitalization and DP, adjusting for familial factors. Methods: This cohort study included female twins, i.e. women with twin sister, born 1959-1990 in Sweden (n = 5 118). At least one in the twin pair had their first childbirth 1994-2009. Women were followed regarding all-cause and cause-specific (mental or musculoskeletal diagnoses) DP during year 2-5 after first delivery or equivalent. Associations between childbirth, hospitalization and DP were calculated as hazard ratios (HR) with 95% confidence intervals (CI). Results: Women who did not give birth had markedly higher number of DP days/year compared to those giving birth. Hospitalization after first childbirth was associated with a higher HR of DP. Those hospitalized at least once after their first childbirth had a three-fold DP risk (HR: 3.2; 95% CI 1.1-9.6), DP due to mental diagnoses (HR: 3.2; 1.2-8.8), and of DP due to musculoskeletal diagnoses (HR: 6.1; 1.6-22.9). Lower HRs in the discordant twin pair analyses indicated that familial factors may influence the studied associations. Conclusions: Women who did not give birth had a much higher risk for DP than those who did. Among those who gave birth, the risk for DP was markedly higher among those with a previous hospitalization, and especially in women with repeated hospitalizations. The results indicate a health selection into giving birth as well as the importance of morbidity for DP.	[Bjorkenstam, Emma; Narusyte, Jurgita; Alexanderson, Kristina; Kjeldgard, Linnea; Svedberg, Pia] Karolinska Inst, Div Insurance Med, Dept Clin Neurosci, Stockholm, Sweden; [Ropponen, Annina] Finnish Inst Occupat Hlth, Helsinki, Finland	Karolinska Institutet; Finnish Institute of Occupational Health	Bjorkenstam, E (corresponding author), Karolinska Inst, Div Insurance Med, Dept Clin Neurosci, Stockholm, Sweden.	emma.bjorkenstam@ki.se		Kjeldgard, Linnea/0000-0002-4575-7483; Ropponen, Annina/0000-0003-3031-5823	Karolinska Institutet Strategic Research Program in Epidemiology [Dnr 7340/2012]; Swedish Society of Medicine [Dnr SLS-250931, SLS-171611]; Ministry of Health and Social Affairs [S2012/7938/SF]; Swedish Research Council for Health, Working Life and Welfare [2007-1762]; Swedish Research Council; Ministry for Higher Education; AstraZeneca	Karolinska Institutet Strategic Research Program in Epidemiology; Swedish Society of Medicine; Ministry of Health and Social Affairs; Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Ministry for Higher Education; AstraZeneca(AstraZeneca)	This work was supported by funding from the Karolinska Institutet Strategic Research Program in Epidemiology (Dnr 7340/2012), The Swedish Society of Medicine (Dnr SLS-250931 and SLS-171611), the Ministry of Health and Social Affairs (S2012/7938/SF), and the Swedish Research Council for Health, Working Life and Welfare (2007-1762). The Swedish Twin Registry is supported by the Swedish Research Council, the Ministry for Higher Education, and AstraZeneca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexanderson K, 2004, SCAND J PUBLIC HEALT, V32, P12, DOI 10.1080/14034950410021808; Allebeck P, 2004, SCAND J PUBLIC HEALT, V32, P49, DOI 10.1080/14034950410021853; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Battie MC, 2007, PAIN, V131, P272, DOI 10.1016/j.pain.2007.01.010; Beckmann CR, 2010, OBSTET GYNECOLOGY; Bienvenu OJ, 2011, PSYCHOL MED, V41, P33, DOI 10.1017/S003329171000084X; Borg K, 2004, SCAND J PUBLIC HEALT, V32, P272, DOI 10.1080/14034940310019524; Borg-Stein Joanne, 2007, Phys Med Rehabil Clin N Am, V18, P459, DOI 10.1016/j.pmr.2007.05.005; Cheng CY, 2008, WOMEN HEALTH ISS, V18, P267, DOI 10.1016/j.whi.2008.02.004; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Cwikel J, 2006, SOC SCI MED, V62, P1991, DOI 10.1016/j.socscimed.2005.09.006; Floderus B, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000840; Furberg H, 2008, NICOTINE TOB RES, V10, P1727, DOI 10.1080/14622200802443551; Gissler M, 1997, ACTA OBSTET GYN SCAN, V76, P651, DOI 10.3109/00016349709024605; Gjerde LC, 2013, TWIN RES HUM GENET, V16, P759, DOI 10.1017/thg.2013.36; Gustafsson K, 2013, INT J BEHAV MED; Halford C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1103; Harkonmaki K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003402; Haukenes I, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-720; Jocums SB, 1998, OBSTET GYNECOL, V91, P766, DOI 10.1016/S0029-7844(98)00063-5; KENDLER KS, 1995, ARCH GEN PSYCHIAT, V52, P895; Koropeckyj-Cox T, 2007, INT J AGING HUM DEV, V64, P299, DOI 10.2190/8PTL-P745-58U1-3330; Kujala UM, 2002, AM J EPIDEMIOL, V156, P985, DOI 10.1093/aje/kwf151; Lichtenstein P, 2002, J INTERN MED, V252, P184, DOI 10.1046/j.1365-2796.2002.01032.x; Lichtenstein P, 2006, TWIN RES HUM GENET, V9, P875, DOI 10.1375/twin.9.6.875; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Mykletun A, 2006, AM J PSYCHIAT, V163, P1412, DOI 10.1176/appi.ajp.163.8.1412; Narusyte J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023143; National Records of Scotland, 2011, CHANG COD CAUS DEATH; OECD, 2009, SICKN DIS WORK BREAK; Pietikainen S, 2011, OCCUPATIONAL ENV MED, V53; PLOMIN R, 1994, SCIENCE, V264, P1733, DOI 10.1126/science.8209254; Plomin R., 2000, BEHAV GENETICS; Ronsmans C, 2001, INT J EPIDEMIOL, V30, P467, DOI 10.1093/ije/30.3.467; Ropponen A, 2013, EUR J PUBLIC HLTH; Schytt E, 2005, BJOG-INT J OBSTET GY, V112, P210, DOI 10.1111/j.1471-0528.2004.00319.x; Statistics Sweden, 2012, LONG INT DAT HLTH IN; Thorlacius S, 2010, J MENT HEALTH, V19, P176, DOI 10.3109/09638230902968316; To WWK, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-55; Vistnes JP, 1997, IND LABOR RELAT REV, V50, P304, DOI 10.2307/2525088; Williams D, 2003, CURR OPIN OBSTET GYN, V15, P465, DOI 10.1097/00001703-200312000-00002; World Health Organization, 1992, ICD 10 INT STAT CLAS	44	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101566	10.1371/journal.pone.0101566	http://dx.doi.org/10.1371/journal.pone.0101566			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7WB	24999632	Green Published, Green Submitted, gold			2022-12-27	WOS:000338637300056
J	Fiore, APZP; Osaki, LH; Gama, P				Fiore, Ana P. Z. P.; Osaki, Luciana H.; Gama, Patricia			Transforming Growth Factor beta 1 Increases p27 Levels via Synthesis and Degradation Mechanisms in the Hyperproliferative Gastric Epithelium in Rats	PLOS ONE			English	Article							UBIQUITIN-MEDIATED DEGRADATION; INHIBITS CELL-PROLIFERATION; ANAPHASE-PROMOTING COMPLEX; TGF-BETA; PROTEASOMAL DEGRADATION; MESENCHYMAL TRANSITION; HELICOBACTER-PYLORI; CDK INHIBITORS; SUCKLING RATS; ADULT RATS	Throughout postnatal development, the gastric epithelium expresses Transforming Growth Factor beta1 (TGF beta 1), but it is also exposed to luminal peptides that are part of milk. During suckling period, fasting promotes the withdrawal of milk-born molecules while it stimulates gastric epithelial cell proliferation. Such response can be reversed by exogenous TGF beta 1, as it directly affects cell cycle through the regulation of p27 levels. We used fasting condition to induce the hyperproliferation of gastric epithelial cells in 14-day-old Wistar rats, and evaluated the effects of TGF beta 1 gavage on p27 expression, phosphorylation at threonine 187 (phospho-p27(Thr187)) and degradation. p27 protein level was reduced during fasting when compared to suckling counterparts, while phospho-p27(Thr187)/p27 ratio was increased. TGF beta 1 gavage reversed this response, which was confirmed through immunostaining. By using a neutralizing antibody against TGF beta 1, we found that it restored the p27 and phosphorylation levels detected during fasting, indicating the specific role of the growth factor. We noted that neither fasting nor TGF beta 1 changed p27 expression, but after cycloheximide administration, we observed that protein synthesis was influenced by TGF beta 1. Next, we evaluated the capacity of the gastric mucosa to degrade p27 and we recorded a higher concentration of the remaining protein in pups treated with TGF beta 1, suggesting augmented stability under this condition. Thus, we showed for the first time that luminal TGF beta 1 increased p27 levels in the rat gastric mucosa by up-regulating translation and reducing protein degradation. We concluded that such mechanisms might be used by rapidly proliferating cells to respond to milk-born TGF beta 1 and food restriction.	[Fiore, Ana P. Z. P.; Osaki, Luciana H.; Gama, Patricia] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil	Universidade de Sao Paulo	Gama, P (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.	patgama@usp.br	Osaki, Luciana H/I-3624-2012; Fiore, Ana P Z P/I-3257-2012; Gama, Patricia/D-4756-2012	Gama, Patricia/0000-0002-1863-893X; Osaki, Luciana/0000-0003-0665-7567; Zen Petisco Fiore, Ana Paula/0000-0002-0498-6589	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/05393-2, 2011/17415-3]; CAPES	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 2008/05393-2; 2011/17415-3). APZPF was recipient of CAPES PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvares EP, 2007, HISTOL HISTOPATHOL, V22, P147, DOI 10.14670/HH-22.147; ALVARES EP, 1993, BRAZ J MED BIOL RES, V26, P869; ALVARES EP, 1992, BRAZ J MED BIOL RES, V25, P641; Auld CA, 2007, J CELL PHYSIOL, V211, P101, DOI 10.1002/jcp.20915; BARNARD JA, 1989, P NATL ACAD SCI USA, V86, P1578, DOI 10.1073/pnas.86.5.1578; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; Booth D, 2000, INT J CANCER, V86, P53, DOI 10.1002/(SICI)1097-0215(20000401)86:1<53::AID-IJC8>3.0.CO;2-Z; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; CIACCI C, 1993, GASTROENTEROLOGY, V105, P93, DOI 10.1016/0016-5085(93)90014-4; Ciarallo S, 2002, MOL CELL BIOL, V22, P2993, DOI 10.1128/MCB.22.9.2993-3002.2002; Sa ERD, 2008, REGUL PEPTIDES, V146, P293, DOI 10.1016/j.regpep.2007.11.001; Deneme MA, 2006, J SURG RES, V136, P280, DOI 10.1016/j.jss.2006.08.020; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Fujisawa T, 2004, GROWTH FACTORS, V22, P51, DOI 10.1080/0897719042000201659; Fujita T, 2008, AM J PATHOL, V173, P217, DOI 10.2353/ajpath.2008.070957; Gama P, 1998, J GASTROENTEROL, V33, P32, DOI 10.1007/PL00009964; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Huang KT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046072; Kannan A, 2014, EUR J CANCER, V50, P204, DOI 10.1016/j.ejca.2013.08.016; Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105; Koldovsky O, 1995, PHYSIOL RES, V44, P349; Kuzushita N, 2005, GASTROENTEROLOGY, V129, P1544, DOI 10.1053/j.gastro.2005.07.056; Lecanda J, 2007, CANCER RES, V67, P1007, DOI 10.1158/0008-5472.CAN-06-0235; Lecanda J, 2009, CELL CYCLE, V8, P742, DOI 10.4161/cc.8.5.7871; LETTERIO JJ, 1994, SCIENCE, V264, P1936, DOI 10.1126/science.8009224; Li M, 2008, NAT CELL BIOL, V10, P1083, DOI 10.1038/ncb1768; Lipkowitz S, 2011, NAT REV CANCER, V11, P629, DOI 10.1038/nrc3120; Lu ZM, 2010, CELL CYCLE, V9, P2342, DOI 10.4161/cc.9.12.11988; Massague J, 2012, FEBS LETT, V586, P1833, DOI 10.1016/j.febslet.2012.05.030; Masuda T, 2002, CANCER RES, V62, P3819; Mierzejewski P, 2006, NEUROPHARMACOLOGY, V51, P367, DOI 10.1016/j.neuropharm.2006.04.001; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; Myung N, 2000, CANCER LETT, V153, P129, DOI 10.1016/S0304-3835(00)00359-1; Naef M, 1997, INT J CANCER, V71, P131; Nakamura Y, 2009, J NUTR, V139, P1463, DOI 10.3945/jn.109.108761; Nam KT, 2012, LAB INVEST, V92, P883, DOI 10.1038/labinvest.2012.47; Ogias D, 2010, NUTRITION, V26, P224, DOI 10.1016/j.nut.2009.03.014; Ogias D, 2010, AM J PHYSIOL-GASTR L, V298, pG117, DOI 10.1152/ajpgi.00245.2009; Osaki LH, 2011, CELL PROLIFERAT, V44, P174, DOI 10.1111/j.1365-2184.2011.00733.x; Osaki LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066651; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Parekh TV, 2002, CANCER RES, V62, P2778; Pavlides SC, 2013, ENDOCRINOLOGY, V154, P4030, DOI 10.1210/en.2013-1757; Penttila IA, 1998, PEDIATR RES, V44, P524, DOI 10.1203/00006450-199810000-00010; Pillaire MJ, 1999, EXP EYE RES, V68, P193, DOI 10.1006/exer.1998.0583; Playford RJ, 1999, GUT, V44, P653, DOI 10.1136/gut.44.5.653; Qiao XX, 2010, CELL CYCLE, V9, P3904, DOI 10.4161/cc.9.19.13585; Rao X, 2011, ONCOGENE, V30, P1082, DOI 10.1038/onc.2010.487; Rokutan K, 1998, AM J PHYSIOL-GASTR L, V275, pG526, DOI 10.1152/ajpgi.1998.275.3.G526; Sa ERD, 2003, DEV DYNAM, V227, P450, DOI 10.1002/dvdy.10320; SAITO S, 1993, CLIN EXP IMMUNOL, V94, P220, DOI 10.1111/j.1365-2249.1993.tb06004.x; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Shen ZL, 2013, SCAND J GASTROENTERO, V48, P466, DOI 10.3109/00365521.2013.772226; Shirane M, 1999, J BIOL CHEM, V274, P13886, DOI 10.1074/jbc.274.20.13886; Skaar JR, 2009, CURR OPIN CELL BIOL, V21, P816, DOI 10.1016/j.ceb.2009.08.004; Song MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033608; SPORN MB, 1987, J CELL BIOL, V105, P1039, DOI 10.1083/jcb.105.3.1039; Starostina NG, 2012, TRENDS CELL BIOL, V22, P33, DOI 10.1016/j.tcb.2011.10.004; Torquati A, 2004, SURGERY, V136, P310, DOI 10.1016/j.surg.2004.05.005; Tsutsumi S, 2002, EXP BIOL MED, V227, P402, DOI 10.1177/153537020222700606; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Voon DCC, 2012, STEM CELLS, V30, P2088, DOI 10.1002/stem.1183; Wang W, 2004, ONCOGENE, V23, P1064, DOI 10.1038/sj.onc.1207204; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Wen S, 2012, ONCOGENE, V31, P1771, DOI 10.1038/onc.2011.362; Wu WKK, 2010, CANCER LETT, V295, P144, DOI 10.1016/j.canlet.2010.04.025; Zhu L, 2010, CELL RES, V20, P605, DOI 10.1038/cr.2010.71	68	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101965	10.1371/journal.pone.0101965	http://dx.doi.org/10.1371/journal.pone.0101965			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000203	Green Published, Green Submitted, gold			2022-12-27	WOS:000338637300108
J	Gingras, B; Pohler, G; Fitch, WT				Gingras, Bruno; Pohler, Gerald; Fitch, W. Tecumseh			Exploring Shamanic Journeying: Repetitive Drumming with Shamanic Instructions Induces Specific Subjective Experiences but No Larger Cortisol Decrease than Instrumental Meditation Music	PLOS ONE			English	Article							SALIVARY CORTISOL; SEX-DIFFERENCES; RELAXING MUSIC; HEART-RATE; RELAXATION; RESPONSES; IMAGERY; INCREASES; STRESS; STATES	Exposure to repetitive drumming combined with instructions for shamanic journeying has been associated with physiological and therapeutic effects, such as an increase in salivary immunoglobulin A. In order to assess whether the combination of repetitive drumming and shamanic instructions is specifically associated with these effects, we compared the effect of listening to either repetitive drumming or instrumental meditation music for 15 minutes on salivary cortisol concentration and on self-reported physiological and psychological states. For each musical style, two groups of participants were exposed to two conditions: instructions for shamanic journeying or relaxation instructions. A total of 39 participants (24 females) inexperienced in shamanic journeying completed the experiment. Salivary cortisol concentrations were measured before and after exposure to music. In addition, participants filled out a mood questionnaire before and after the experiment and completed a post experiment questionnaire on their experiences. A significant decrease in the concentration in salivary cortisol was observed across all musical styles and instructions, indicating that exposure to 15 minutes of either repetitive drumming or instrumental meditation music, while lying down, was sufficient to induce a decrease in cortisol levels. However, no differences were observed across conditions. Significant differences in reported emotional states and subjective experiences were observed between the groups. Notably, participants exposed to repetitive drumming combined with shamanic instructions reported experiencing heaviness, decreased heart rate, and dreamlike experiences significantly more often than participants exposed to repetitive drumming combined with relaxation instructions. Our findings suggest that the subjective effects specifically attributed to repetitive drumming and shamanic journeying may not be reflected in differential endocrine responses.	[Gingras, Bruno; Pohler, Gerald; Fitch, W. Tecumseh] Univ Vienna, Dept Cognit Biol, Vienna, Austria	University of Vienna	Gingras, B (corresponding author), Univ Vienna, Dept Cognit Biol, Vienna, Austria.	brunogingras@gmail.com	Campailla, Jasmin/AAK-2420-2021		European Research Council (ERC) Advanced Grant SOMACCA [230604]; University of Vienna	European Research Council (ERC) Advanced Grant SOMACCA; University of Vienna	This research was supported by European Research Council (ERC) Advanced Grant SOMACCA [grant number 230604] and a University of Vienna startup grant to W.T.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achterberg J, 1990, GEDANKEN HEILEN KRAF; Atsumi T, 2007, PSYCHIAT RES, V150, P89, DOI 10.1016/j.psychres.2005.12.012; Banks SL, 1998, J MUSCULOSKELET PAIN, V6, P23, DOI 10.1300/J094v06n04_03; Bernardi L, 2006, HEART, V92, P445, DOI 10.1136/hrt.2005.064600; BLIZARD DA, 1975, BIOL PSYCHOL, V3, P49, DOI 10.1016/0301-0511(75)90005-8; Boersma P, 2021, PRAAT DOING PHONETIC; Bonny HL, 1999, NORD J MUSIC THER, V8, P171; Borkenau P., 2008, NEO FFI NEO FUNF FAK, V2.; Cowan T., 1996, SHAMANISM SPIRITUAL; Cruess DG, 2000, J BEHAV MED, V23, P107, DOI 10.1023/A:1005419917023; Eliade M., 2004, SHAMANISM ARCHAIC TE; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fletcher H, 1933, J ACOUST SOC AM, V5, P82, DOI 10.1121/1.1915637; GATCHEL RJ, 1976, J CONSULT CLIN PSYCH, V44, P381, DOI 10.1037/0022-006X.44.3.381; Goodman F. D., 1990, SPIRITS RIDE WIND TR; Goodman FD, 1999, ANTHROPOL CONSCIOUS, V10, P54, DOI [10.1525/ac.1999.10.1.54, DOI 10.1525/AC.1999.10.1.54]; Grosche P, 2011, IEEE T AUDIO SPEECH, V19, P1688, DOI 10.1109/TASL.2010.2096216; Guttman G, 1988, RES B, V27; Harner M, 1997, SHAMANIC JOURNEY SER, V6; Harner M, 1997, SHAMANIC JOURNEY SER, V1; HARNER Michael, 1982, WAY SHAMAN GUIDE POW; Harner S., 2010, J FDN SHAMANIC STUD, V23, P31; Harner S, 2001, SHAMANISM, V14, P19; Haubenhofer DK, 2007, SOC ANIM, V15, P127, DOI 10.1163/156853007X187090; Hevner K, 1937, AM J PSYCHOL, V49, P621, DOI 10.2307/1416385; Hodges D.A., 2010, HDB MUSIC EMOTION TH, P279; Kanji N, 1997, COMPLEMENT THER MED, V5, P162, DOI [10.1016/S0965-2299(97)80060-X, DOI 10.1016/S0965-2299(97)80060-X]; Khalfa S, 2003, ANN NY ACAD SCI, V999, P374, DOI 10.1196/annals.1284.045; KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2; KIRSCHBAUM C, 1989, NEUROPSYCHOBIOLOGY, V22, P150, DOI 10.1159/000118611; Kjellgren A, 2010, INT J TRANSPERS, V29, P1; Knight WEJ, 2001, J MUSIC THER, V38, P254, DOI 10.1093/jmt/38.4.254; Kreutz G, 2004, J BEHAV MED, V27, P623, DOI 10.1007/s10865-004-0006-9; Luthe W, 1969, AUTOGENIC THERAPY ME; Maurer RL, 1997, AM J CLIN HYPN, V40, P130, DOI 10.1080/00029157.1997.10403417; MCFARLAND RA, 1991, INT J PSYCHOPHYSIOL, V11, P295, DOI 10.1016/0167-8760(91)90024-R; MOCKEL M, 1995, DEUT MED WOCHENSCHR, V120, P745, DOI 10.1055/s-2008-1055403; Nater UM, 2006, INT J PSYCHOPHYSIOL, V62, P300, DOI 10.1016/j.ijpsycho.2006.05.011; NEHER A, 1961, ELECTROEN CLIN NEURO, V13, P449, DOI 10.1016/0013-4694(61)90014-1; NEHER A, 1962, HUM BIOL, V34, P151; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; NOLL R, 1985, CURR ANTHROPOL, V26, P443, DOI 10.1086/203305; Palme R, 1997, Z SAUGETIERKD, V62, P192; Pawlow LA, 2002, BIOL PSYCHOL, V60, P1, DOI 10.1016/S0301-0511(02)00010-8; Pelletier CL, 2004, J MUSIC THER, V41, P192, DOI 10.1093/jmt/41.3.192; Pohler G, 1989, ENTSPANNUNG STRESSAB; Pohler G, 2009, PROMED KOMPLEMENTAR, V16, P26; Rock AJ, 2005, ANTHROPOL CONSCIOUS, V16, P72, DOI 10.1525/ac.2005.16.2.72; Rock AJ, 2006, ANTHROPOL CONSCIOUS, V17, P65, DOI 10.1525/ac.2006.17.1.65; SAPOLSKY R M, 1992, P287; Schultz J, 1973, AUTOGENE TRAINING; Shanti O, 2003, LISTENING HEART; SHAPIRO S, 1980, BIOFEEDBACK SELF-REG, V5, P249, DOI 10.1007/BF00998600; Silbernagel S, 1991, TASCHENBUCH PHYSL; Steyer, 1997, MEHRDIMENSIONALE BEF; Steyer R., 1994, DIAGNOSTICA, V40, P320; Sumioka H, 2013, SCI REP-UK, V3, DOI 10.1038/srep03034; Szabo Csaba, 2004, MUSIC THER TODAY, V1, P1; Tang YY, 2007, P NATL ACAD SCI USA, V104, P17152, DOI 10.1073/pnas.0707678104; TART CT, 1972, SCIENCE, V176, P1203, DOI 10.1126/science.176.4040.1203; Thoma MV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070156; Vandana B, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/379645; VOLLER A, 1976, B WORLD HEALTH ORGAN, V53, P55; Vuckovic NH, 2007, ALTERN THER HEALTH M, V13, P18; Walsh R, 1990, SPIRIT SHAMANISM; Will U, 2007, NEUROSCI LETT, V424, P55, DOI 10.1016/j.neulet.2007.07.036; WINKELMAN M, 1986, ETHOS, V14, P174, DOI 10.1525/eth.1986.14.2.02a00040; Woodside L. N., 1997, ANTHR CONSCIOUSNESS, V8, P69, DOI [DOI 10.1525/AC.1997.8.2-3.69, 10.1525/ac.1997.8.2-3.69]; Wooten HR, 2007, J HEART CTR THER, V10, P3	69	11	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e102103	10.1371/journal.pone.0102103	http://dx.doi.org/10.1371/journal.pone.0102103			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7WB	24999623	Green Submitted, Green Published, gold			2022-12-27	WOS:000338637300120
J	LaBonty, M; Szmygiel, C; Byrnes, LE; Hughes, S; Woollard, A; Cram, EJ				LaBonty, Melissa; Szmygiel, Cleo; Byrnes, Lauren E.; Hughes, Samantha; Woollard, Alison; Cram, Erin J.			CACN-1/Cactin Plays a Role in Wnt Signaling in C-elegans	PLOS ONE			English	Article							ASYMMETRIC CELL-DIVISION; BETA-CATENIN; RECIPROCAL ASYMMETRY; GENE-EXPRESSION; AXIS FORMATION; SEAM CELLS; KAPPA-B; PROTEIN; POP-1; CACTIN	Wnt signaling is tightly regulated during animal development and controls cell proliferation and differentiation. In C. elegans, activation of Wnt signaling alters the activity of the TCF/LEF transcription factor, POP-1, through activation of the Wnt/b-catenin or Wnt/b-catenin asymmetry pathways. In this study, we have identified CACN-1 as a potential regulator of POP-1 in C. elegans larval development. CACN-1/Cactin is a well-conserved protein of unknown molecular function previously implicated in the regulation of several developmental signaling pathways. Here we have used activation of POPTOP, a POP-1-responsive reporter construct, as a proxy for Wnt signaling. POPTOP requires POP-1 and SYS-1/b-catenin for activation in L4 uterine cells. RNAi depletion experiments show that CACN-1 is needed to prevent excessive activation of POPTOP and for proper levels and/or localization of POP-1. Surprisingly, high POPTOP expression correlates with increased levels of POP-1 in uterine nuclei, suggesting POPTOP may not mirror endogenous gene expression in all respects. Genetic interaction studies suggest that CACN-1 may act partially through LIT-1/NLK to alter POP-1 localization and POPTOP activation. Additionally, CACN-1 is required for proper proliferation of larval seam cells. Depletion of CACN-1 results in a loss of POP-1 asymmetry and reduction of terminal seam cell number, suggesting an adoption of the anterior, differentiated fate by the posterior daughter cells. These findings suggest CACN-1/Cactin modulates Wnt signaling during larval development.	[LaBonty, Melissa; Szmygiel, Cleo; Byrnes, Lauren E.; Cram, Erin J.] Northeastern Univ, Dept Biol, Boston, MA 02115 USA; [Hughes, Samantha; Woollard, Alison] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	Northeastern University; University of Oxford	Cram, EJ (corresponding author), Northeastern Univ, Dept Biol, Boston, MA 02115 USA.	e.cram@neu.edu		Hughes, Samantha/0000-0001-8447-2563	National Institutes of Health; AICR grant [08-0458, 12-0028]; Worldwide Cancer Research [12-0028] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AICR grant; Worldwide Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant GM085077 from the National Institutes of Health to E. J.C. and AICR grants 08-0458 and 12-0028 to A. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin NM, 2009, DEV BIOL, V331, P350, DOI 10.1016/j.ydbio.2009.05.538; Arata Y, 2006, DEV CELL, V11, P105, DOI 10.1016/j.devcel.2006.04.020; Atzei P, 2010, J BIOL CHEM, V285, P36804, DOI 10.1074/jbc.M110.139113; Atzei P, 2010, GENE EXPR PATTERNS, V10, P199, DOI 10.1016/j.gep.2010.03.003; Baldwin KL, 2013, FEBS LETT, V587, P873, DOI 10.1016/j.febslet.2013.02.041; Barolo S, 2006, ONCOGENE, V25, P7505, DOI 10.1038/sj.onc.1210057; Bhambhani C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004133; Burdine RD, 1998, DEVELOPMENT, V125, P1083; Burdine RD, 1997, P NATL ACAD SCI USA, V94, P2433, DOI 10.1073/pnas.94.6.2433; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Calvo D, 2001, EMBO J, V20, P7197, DOI 10.1093/emboj/20.24.7197; Chang WR, 2004, DEVELOPMENT, V131, P1425, DOI 10.1242/dev.01012; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Costa M, 1998, J CELL BIOL, V141, P297, DOI 10.1083/jcb.141.1.297; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Eisenmann David M, 2005, WormBook, P1, DOI 10.1895/wormbook.1.7.1; Eisenmann DM, 1998, DEVELOPMENT, V125, P3667; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gleason JE, 2010, DEV BIOL, V348, P58, DOI 10.1016/j.ydbio.2010.09.005; Gorrepati L, 2013, DEVELOPMENT, V140, P2093, DOI 10.1242/dev.091124; Green JL, 2008, CELL, V134, P646, DOI 10.1016/j.cell.2008.06.026; Hope IA, 2003, GENE, V304, P43, DOI 10.1016/S0378-1119(02)01175-7; Hope IA., 1999, C ELEGANS PRACTICAL; Hoppler S, 2007, J CELL SCI, V120, P385, DOI 10.1242/jcs.03363; Huang SY, 2007, DEVELOPMENT, V134, P2685, DOI 10.1242/dev.008268; Hughes S, 2013, BIOL OPEN, V2, P718, DOI 10.1242/bio.20134549; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Ji N, 2013, CELL, V155, P869, DOI 10.1016/j.cell.2013.09.060; Jurica MS, 2002, RNA, V8, P426, DOI 10.1017/S1355838202021088; Kaletta T, 1997, NATURE, V390, P294, DOI 10.1038/36869; Kalis AK, 2010, GENETICS, V185, P523, DOI 10.1534/genetics.110.116038; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kerins JA, 2010, DEV DYNAM, V239, P1555, DOI 10.1002/dvdy.22274; Kidd AR, 2005, CELL, V121, P761, DOI 10.1016/j.cell.2005.03.029; Killeen MT, 2008, DEV BIOL, V323, P143, DOI 10.1016/j.ydbio.2008.08.027; Korswagen HC, 2000, NATURE, V406, P527, DOI 10.1038/35020099; Korswagen HC, 2002, BIOESSAYS, V24, P801, DOI 10.1002/bies.10145; Lam N, 2006, CURR BIOL, V16, P287, DOI 10.1016/j.cub.2005.12.015; Lin PH, 2000, MECH DEVELOP, V94, P57, DOI 10.1016/S0925-4773(00)00314-2; Lin RL, 1998, CELL, V92, P229, DOI 10.1016/S0092-8674(00)80917-4; LIN RL, 1995, CELL, V83, P599, DOI 10.1016/0092-8674(95)90100-0; Liu J, 2008, DEV CELL, V14, P751, DOI 10.1016/j.devcel.2008.02.015; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maduro MF, 2005, DEV BIOL, V284, P509, DOI 10.1016/j.ydbio.2005.05.016; Maduro MF, 2002, DEV BIOL, V248, P128, DOI 10.1006/dbio.2002.0721; Maduro MF, 2010, DEV DYNAM, V239, P1315, DOI 10.1002/dvdy.22233; Mizumoto K, 2007, TRENDS CELL BIOL, V17, P465, DOI 10.1016/j.tcb.2007.08.004; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Murray JI, 2012, GENOME RES, V22, P1282, DOI 10.1101/gr.131920.111; Oldenbroek M, 2013, DEVELOPMENT, V140, P4614, DOI 10.1242/dev.096313; Petersen CP, 2009, CELL, V139, P1056, DOI 10.1016/j.cell.2009.11.035; Phillips BT, 2007, P NATL ACAD SCI USA, V104, P3231, DOI 10.1073/pnas.0611507104; Ren HY, 2010, DEV BIOL, V345, P144, DOI 10.1016/j.ydbio.2010.07.002; Riese J, 1997, CELL, V88, P777, DOI 10.1016/S0092-8674(00)81924-8; Rocheleau CE, 1999, CELL, V97, P717, DOI 10.1016/S0092-8674(00)80784-9; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Shetty P, 2005, DEV BIOL, V285, P584, DOI 10.1016/j.ydbio.2005.07.008; Shtutman M, 2008, CELL CYCLE, V7, P2377, DOI 10.4161/cc.6362; Siegfried KR, 2004, GENETICS, V166, P171, DOI 10.1534/genetics.166.1.171; Siegfried KR, 2002, DEVELOPMENT, V129, P443; Streit A, 2002, DEV BIOL, V242, P96, DOI 10.1006/dbio.2001.0544; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Szatanek T, 2012, MOL MICROBIOL, V84, P566, DOI 10.1111/j.1365-2958.2012.08044.x; Takeshita H, 2005, GENE DEV, V19, P1743, DOI 10.1101/gad.1322805; Tannoury H, 2010, DEV BIOL, V341, P176, DOI 10.1016/j.ydbio.2010.02.025; Timmons Lisa, 2006, V351, P119; Yang XD, 2011, DEVELOPMENT, V138, P4255, DOI 10.1242/dev.069054	68	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101945	10.1371/journal.pone.0101945	http://dx.doi.org/10.1371/journal.pone.0101945			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999833	gold, Green Submitted, Green Published			2022-12-27	WOS:000338637300106
J	Lin, M; Zhong, TY; Chen, YG; Wang, JZ; Wu, JR; Lin, F; Tong, X; Yang, HT; Hu, XM; Hu, R; Zhan, XF; Yang, H; Luo, ZY; Li, WY; Yang, LY				Lin, Min; Zhong, Tian-Yu; Chen, Yi-Guo; Wang, Jian-Zhong; Wu, Jiao-Ren; Lin, Fen; Tong, Xin; Yang, Hui-Tian; Hu, Xiao-Mei; Hu, Rong; Zhan, Xiao-Fen; Yang, Hui; Luo, Zhao-Yun; Li, Wen-Yu; Yang, Li-Ye			Molecular Epidemiological Characterization and Health Burden of Thalassemia in Jiangxi Province, P. R. China	PLOS ONE			English	Article							HEMOGLOBIN GENE DISORDERS; BETA-THALASSEMIA; DISEASE; ALPHA; POPULATIONS; FREQUENCY; FEATURES; REGION	Background: Thalassemia is the most common inherited disease in southern China. However, this disorder is usually ignored by Jiangxi provincial health system and government due to lack of epidemiological data. Materials and Methods: A total of 9489 samples from Hakka Han and Gan-speaking Han in three geographical areas of Jiangxi Province were analyzed for both complete blood cell (CBC) count and reverse dot blot (RDB) gene chip for thalassemia. Results: 1182 cases of suspected thalassemia carriers with microcytosis (MCV, 82 fL) were found by CBC count, and were tested by RDB gene chip to reveal a total of 594 mutant chromosomes, including 433 a-thalassemia mutant chromosomes and 172 b-thalassemia mutant chromosomes. Our results indicated a higher prevalence of thalassemia with the heterozygote frequency of 9.49% in southern Jiangxi province, whereas the low frequency was found in middle (3.90%) and northern Jiangxi (2.63%). Conclusions: Based on the epidemiological data, the estimated numbers of pregnancies in Jiangxi province in which the fetus is at risk for b-thalassemia major or intermedia, Bart's hydrops fetalis and Hb H disease are 34 (95% CI, 16 to 58), 79 (95% CI, 50 to 114) and 39 (95% CI, 27 to 58) per year, respectively. We suggested that prevention network of thalassemia should be established, especially in high prevalent southern Jiangxi (Hakka Han), including establishment of thalassemia database collection, hematological analysis laboratories, genetic counselling clinics, prenatal diagnosis centers and neonatal screening centers.	[Lin, Min; Wu, Jiao-Ren; Lin, Fen; Tong, Xin; Yang, Hui-Tian; Hu, Rong; Zhan, Xiao-Fen; Yang, Hui; Luo, Zhao-Yun; Li, Wen-Yu; Yang, Li-Ye] Southern Med Univ, Chaozhou Cent Hosp, Cent Lab, Chaozhou, Guangdong, Peoples R China; [Zhong, Tian-Yu; Hu, Xiao-Mei] Gannan Med Univ, Affiliated Hosp 1, Med Lab, Ganzhou, Jiangxi, Peoples R China; [Chen, Yi-Guo] Jiangxi Prov Peoples Hosp, Med Lab, Nanchang, Jiangxi, Peoples R China; [Wang, Jian-Zhong] Iron Ind Ltd Corp Xinyu, Cent Hosp, Med Lab, Xinyu, Jiangxi, Peoples R China	Southern Medical University - China; Gannan Medical University	Yang, LY (corresponding author), Southern Med Univ, Chaozhou Cent Hosp, Cent Lab, Chaozhou, Guangdong, Peoples R China.	yangleeyee@sina.com	Zhong, Tianyu/K-7444-2016	Zhong, Tianyu/0000-0003-1934-0032	National Natural Science Foundation of China [81101329]; Social Development Program of Guangdong Province [2011B031800329]; Clinical Key Department Project of Guangdong Province (Laboratory Medicine); Natural Science Foundation for Young Scientists of Jiangxi Province [20122BAB215006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Social Development Program of Guangdong Province; Clinical Key Department Project of Guangdong Province (Laboratory Medicine); Natural Science Foundation for Young Scientists of Jiangxi Province	This work was partially supported by the National Natural Science Foundation of China (contract/grant number 81101329 to Min Lin), Social Development Program of Guangdong Province (contract/grant number 2011B031800329 to Min Lin), Clinical Key Department Project of Guangdong Province (Laboratory Medicine), and Natural Science Foundation for Young Scientists of Jiangxi Province (contract/grant number 20122BAB215006 to Tian-Yu Zhong). Reagent discounts and reagent gifts were from Hybribio Biotechnology Limited Corp. The funders had no role in study design and data analysis, decision to publish, or reparation of the manuscript.	Angastiniotis M, 1998, ANN NY ACAD SCI, V850, P251, DOI 10.1111/j.1749-6632.1998.tb10482.x; Chen FE, 2000, NEW ENGL J MED, V343, P544, DOI 10.1056/NEJM200008243430804; Das SK, 2001, HOMO, V52, P93, DOI 10.1078/0018-442X-00022; FUCHAROEN S, 1991, Southeast Asian Journal of Tropical Medicine and Public Health, V22, P16; Fucharoen Suthat, 2011, Indian J Med Res, V134, P498; Galanello R, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-11; Giambona A, 2011, BLOOD CELL MOL DIS, V46, P282, DOI 10.1016/j.bcmd.2011.01.006; Hu SP, 2007, AM J PHYS ANTHROPOL, V132, P140, DOI 10.1002/ajpa.20460; KANOKPONGSAKDI S, 1990, PRENATAL DIAG, V10, P809, DOI 10.1002/pd.1970101208; Leung T N, 2011, Hong Kong Med J, V17, P432; Lin F, 2013, J MOL DIAGN THER, V4, P107; Lin HJ, 2010, INT J LAB HEMATOL, V32, P1, DOI 10.1111/j.1751-553X.2008.01095.x; Lin M, 2013, HEMOGLOBIN, V37, P454, DOI 10.3109/03630269.2013.807285; Lin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055024; Lin M, 2012, BLOOD CELL MOL DIS, V48, P86, DOI 10.1016/j.bcmd.2011.12.001; Liu SC, 2011, HEMOGLOBIN, V35, P228, DOI 10.3109/03630269.2011.572524; Muncie HL, 2009, AM FAM PHYSICIAN, V80, P339; Nkhoma ET, 2009, BLOOD CELL MOL DIS, V42, P267, DOI 10.1016/j.bcmd.2008.12.005; Song T, 2008, BASIC CLIN MED, V8, P878; von Seidlein L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-112; Weatherall DJ, 2001, NAT REV GENET, V2, P245, DOI 10.1038/35066048; Weatherall DJ, 2001, B WORLD HEALTH ORGAN, V79, P704; Xiong F, 2010, CLIN GENET, V78, P139, DOI 10.1111/j.1399-0004.2010.01430.x; Xu Liang-pu, 2013, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V30, P403, DOI 10.3760/cma.j.issn.1003-9406.2013.04.005; Xu XM, 2004, J CLIN PATHOL, V57, P517, DOI 10.1136/jcp.2003.014456; ZENG YT, 1987, J MED GENET, V24, P578, DOI 10.1136/jmg.24.10.578	26	32	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101505	10.1371/journal.pone.0101505	http://dx.doi.org/10.1371/journal.pone.0101505			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000193	Green Submitted, Green Published, gold			2022-12-27	WOS:000338637300052
J	Nuss, P; Eckelman, MJ				Nuss, Philip; Eckelman, Matthew J.			Life Cycle Assessment of Metals: A Scientific Synthesis	PLOS ONE			English	Article							CRITICALITY; RESOURCES; IMPACT	We have assembled extensive information on the cradle-to-gate environmental burdens of 63 metals in their major use forms, and illustrated the interconnectedness of metal production systems. Related cumulative energy use, global warming potential, human health implications and ecosystem damage are estimated by metal life cycle stage (i.e., mining, purification, and refining). For some elements, these are the first life cycle estimates of environmental impacts reported in the literature. We show that, if compared on a per kilogram basis, the platinum group metals and gold display the highest environmental burdens, while many of the major industrial metals (e.g., iron, manganese, titanium) are found at the lower end of the environmental impacts scale. If compared on the basis of their global annual production in 2008, iron and aluminum display the largest impacts, and thallium and tellurium the lowest. With the exception of a few metals, environmental impacts of the majority of elements are dominated by the purification and refining stages in which metals are transformed from a concentrate into their metallic form. Out of the 63 metals investigated, 42 metals are obtained as co-products in multi output processes. We test the sensitivity of varying allocation rationales, in which the environmental burden are allocated to the various metal and mineral products, on the overall results. Monte-Carlo simulation is applied to further investigate the stability of our results. This analysis is the most comprehensive life cycle comparison of metals to date and allows for the first time a complete bottom-up estimate of life cycle impacts of the metals and mining sector globally. We estimate global direct and indirect greenhouse gas emissions in 2008 at 3.4 Gt CO2-eq per year and primary energy use at 49 EJ per year (9.5% of global use), and report the shares for all metals to both impact categories.	[Nuss, Philip] Yale Univ, Sch Forestry & Environm Studies, Ctr Ind Ecol, New Haven, CT 06511 USA; [Eckelman, Matthew J.] Northeastern Univ, Dept Civil & Environm Engn, Boston, MA 02115 USA	Yale University; Northeastern University	Nuss, P (corresponding author), Yale Univ, Sch Forestry & Environm Studies, Ctr Ind Ecol, New Haven, CT 06511 USA.	philip@nuss.me	Nuss, Philip/ABF-6000-2020	Nuss, Philip/0000-0001-9936-6886	Yale Criticality Project	Yale Criticality Project	This research was funded by the Yale Criticality Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT S, 2000, ULLMANNS ENCY IND CH; Allwood JM, 2010, ENVIRON SCI TECHNOL, V44, P1888, DOI 10.1021/es902909k; Althaus H.-J., 2007, LIFE CYCLE INVENTORI; Althaus HJ, 2005, INT J LIFE CYCLE ASS, V10, P43, DOI 10.1065/lca2004.11.181.5; Andrae ASG, 2008, ENVIRON SCI TECHNOL, V42, P3084, DOI 10.1021/es0709829; [Anonymous], 2011, MAGMATIC NI CU PGE D, V17, P1, DOI DOI 10.5382/REV.17; ASHBY MF, 2012, CES EDUPACK ECODESIG; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; *BEST, 2013, BERYLL FACTS FIG; *BIO INT SERV, 2010, ENV IMP SOM RAW MAT; Cardarelli F., 2008, MAT HDB CONCISE DESK; Chapman P.F., 1983, METAL RESOURCES ENER, DOI 10.1016/C2013-0-04151-5; *CHIN SOC RAR EART, 2010, CHIN RAR EARTH YB 20; Classen M., 2009, ECOINVENT, V1; COOPE B, 2006, SPAINS CELESITE CELE; *CPM, 2010, CPM LCA DAT; CUNEY M, 2012, NONRENEWABLE RESOURC, P91; CUNNINGHAM LD, 2004, FLOW STUDIES RECYCLI; DAHMUS J, 2004, ENV ANAL MACHINING A; DEVITO SC, 2000, KIRK OTHMER ENCY CHE; Doka G., 2008, ZRICH; Du XY, 2011, ENVIRON SCI TECHNOL, V45, P4096, DOI 10.1021/es102836s; *EC, 2004, MERC FLOWS EUR WORLD; ecoinvent, 2010, EC LIF CYCL INV DAT; ELSHKAKI A, 2013, J CLEAN PROD; Erdmann L, 2011, ENVIRON SCI TECHNOL, V45, P7620, DOI 10.1021/es200563g; *EUR COMM, 2011, ELCD COR DAT VERS IL; European Commission (EC), 2014, REP CRIT RAW MAT EU; European Commission-Ad-hoc working group on defining critical raw materials, 2010, CRITICAL RAW MAT EU; GAMBOGI J, 2011, ZIRCONIUM HAFNIUM 20; Giegrich J., 2012, INDIKATOREN KENNZAHL; Goedkoop M., 2008, SIMAPRO DATABASE MAN; Goedkoop M., 2009, RECIPE 2008 LIFE CYC; *GPM, 2012, CPM PLAT GROUP MET Y; Graedel T E, 2015, Proc Natl Acad Sci U S A, V112, P6295, DOI 10.1073/pnas.1312752110; Graedel TE, 2012, MRS BULL, V37, P325, DOI 10.1557/mrs.2012.34; Graedel TE, 2012, ENVIRON SCI TECHNOL, V46, P1063, DOI 10.1021/es203534z; Graedel TE, 2011, J IND ECOL, V15, P355, DOI 10.1111/j.1530-9290.2011.00342.x; Graf GG, 2000, ULLMANNS ENCY IND CH; *GRANT DES, 2012, GRANT CES SEL MAT SE; GREBER JF, 2000, ULLMANNS ENCY IND CH; Greenfield A, 2013, RESOUR CONSERV RECY, V74, P1, DOI 10.1016/j.resconrec.2013.02.010; Gruber PW, 2011, J IND ECOL, V15, P760, DOI 10.1111/j.1530-9290.2011.00359.x; GRUND SC, 2000, ULLMANNS ENCY IND CH; Gupta C. K., 2004, EXTRACTIVE METALLURG; GUPTA CK, 2004, CHEM METALLURGY; HAUSSINGER P, 2000, NOBLE CASES ULLMANNS; Hibbins S., 2000, KIRK OTHMER ENCY CHE; Hluchan S. E., 2006, ULLMANNS ENCY IND CH, P483; *IAMGOLD CORP, 2009, NIOB TOUR PRES; *IEA, 2007, TRACK IND EN EFF CO2; IEA, 2020, ENERGY TECHNOLOGY PE, DOI [10.1787/9789264109834-en, DOI 10.1787/9789264109834-EN]; IEA, 2008, ENERGY TECHNOLOGY PE, DOI [10.1787/9789264041431-EN, DOI 10.1787/9789264041431-EN]; *INFOMINE, 2011, CALC MET PROD MARK F; Integrated Pollution Prevention and Control (IPPC), 2001, REF DOC BEST AV TECH; International Energy Agency, 2020, WORLD EN OUTL; ISO, 2006, 140442006 ISO, DOI [10.1136/bmj.332.7550.1107, DOI 10.1016/J.ECOLIND.2011.01.007]; KELLENBERGER D, 2007, LIFE CYCLE INVENTORY; Kenny M., 2007, ULLMANNS ENCY IND CH; Kleijn R, 2011, ENERGY, V36, P5640, DOI 10.1016/j.energy.2011.07.003; KRESSE R, 2000, ULLMANNS ENCY IND CH; LAZNICKA P, 2006, GIANT METALLIC DEPOS; LIDDELL N, 2011, VANADIUM SECTOR REV; LUNDBERG M, 2012, ENV ANAL ZIRCONIUM A; MACMILLAN JP, 2000, ULLMANNS ENCY IND CH; Matthey J, 2013, PLATINUM 2013; McGill I., 2000, ULLMANNS ENCY IND CH; MCNEIL D, 2013, BERYLLIUM; Micke H., 2000, ULLMANNS ENCY IND CH; MILLENSIFER TA, 2000, KIRK OTHMER ENCY CHE; MILLER GL, 1954, VACUUM, V4, P168; MUNNOCH S, 2012, HAFNIUM; Nassar NT, 2012, ENVIRON SCI TECHNOL, V46, P1071, DOI 10.1021/es203535w; National Renewable Energy Laboratory (NREL), 2008, US LIF CYCL INV DAT; National Research Council Minerals, 2008, MINERALS CRITICAL MI, DOI [10.17226/12034, DOI 10.17226/12034]; Naumov A. V., 2007, Russian Journal of Non-Ferrous Metals, V48, P10, DOI 10.3103/S1067821207010038; NIELSEN RH, 2000, ULLMANNS ENCY IND CH; Norgate T, 2010, MINER ENG, V23, P65, DOI 10.1016/j.mineng.2009.10.002; Norgate TE, 2007, J CLEAN PROD, V15, P838, DOI 10.1016/j.jclepro.2006.06.018; Norgate T, 2011, MINER ENG, V24, P1563, DOI 10.1016/j.mineng.2011.08.007; Nuss P, 2014, ENVIRON SCI TECHNOL, V48, P4171, DOI 10.1021/es405044w; *PE INT, 2012, GABI 6 LIF CYCL INV; PETZOW G, 2000, ULLMANNS ENCY IND CH; *RMG, 2006, RAW MAT DAT SOFTW MI; Rosenbaum RK, 2008, INT J LIFE CYCLE ASS, V13, P532, DOI 10.1007/s11367-008-0038-4; Schmidt G., 2013, DESCRIPTION CRITICAL; Smith RD., 2005, ARTILLERY DUKES BURG; STOLL W, 2000, ULLMANNS ENCY IND CH; SUTHERLAND CA, 2000, ULLMANNS ENCY IND CH; SUTTER J, 2007, LIFE CYCLE INVENTORI; *THOMS REUT, 2012, WORLD SILV SURV 2012; *TU DELFT, 2001, IDEMAT LIF CYCL INV; *UBA, 2010, PROBAS LEB KLUSD; United States Geological Survey (USGS), 2022, MINERAL COMMODITY SU, DOI DOI 10.3133/MCS2022; *USBM, 1985, MIN FACTS PROBL; USGS, 2012, MIN COMM SUMM 2012; *USGS, 1999, MET PRIC US 1998; *USGS, 2011, ZIRC HAFN; [USGS USGS National Minerals Information Center], 2012, 2012 MIN YB; *USGS, 2008, 2008 MIN YB; *USGS, 2013, MIN COMM SUMM 2013; USGS, 2011, MIN COMM SUMM 2011; USGS (U.S. Geological Survey), 2010, 2010 MIN YB; VANDERVOET E, 2013, ENV RISK CHALLENGES; Verhoef E. V., 2004, Journal of Industrial Ecology, V8, P23, DOI 10.1162/1088198041269382; VERMAAK CF, 1995, PLATINUM GROUP METAL; VRANA LM, 2000, KIRK OTHMER ENCY CHE; Wang WW, 2011, HYDROMETALLURGY, V108, P100, DOI 10.1016/j.hydromet.2011.03.001; WOOLERY M, 2000, KIRK OTHMER ENCY CHE; World Bank, 2012, WORLD DAT BANK; YELLISHETTY M, 2012, NONRENEWABLE RESOURC, P229, DOI DOI 10.1007/978-90-481-8679-2_12	111	296	298	17	142	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101298	10.1371/journal.pone.0101298	http://dx.doi.org/10.1371/journal.pone.0101298			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999810	Green Published, Green Submitted, gold			2022-12-27	WOS:000338637300033
J	Gawri, R; Moir, J; Ouellet, J; Beckman, L; Steffen, T; Roughley, P; Haglund, L				Gawri, Rahul; Moir, Janet; Ouellet, Jean; Beckman, Lorne; Steffen, Thomas; Roughley, Peter; Haglund, Lisbet			Physiological Loading Can Restore the Proteoglycan Content in a Model of Early IVD Degeneration	PLOS ONE			English	Article							INTERVERTEBRAL DISC DEGENERATION; EXTRACELLULAR-MATRIX; PROTEIN CHONDROADHERIN; DYNAMIC COMPRESSION; ARTICULAR-CARTILAGE; LIMITED NUTRITION; NUCLEUS PULPOSUS; FRAGMENTATION; BIOLOGY; SENESCENCE	A hallmark of early IVD degeneration is a decrease in proteoglycan content. Progression will eventually lead to matrix degradation, a decrease in weight bearing capacity and loss of disc height. In the final stages of IVD degradation, fissures appear in the annular ring allowing extrusion of the NP. It is crucial to understand the interplay between mechanobiology, disc composition and metabolism to be able to provide exercise recommendations to patients with early signs of disc degeneration. This study evaluates the effect of physiological loading compared to no loading on matrix homeostasis in bovine discs with induced degeneration. Bovine discs with trypsin-induced degeneration were cultured for 14 days in a bioreactor under dynamic loading with maintained metabolic activity. Chondroadherin abundance and structure was used to confirm that a functional matrix was preserved in the chosen loading environment. No change was observed in chondroadherin integrity and a non-significant increase in abundance was detected in trypsin-treated loaded discs compared to unloaded discs. The proteoglycan concentration in loaded trypsin-treated discs was significantly higher than in unloaded disc and the newly synthesised proteoglycans were of the same size range as those found in control samples. The proteoglycan showed an even distribution throughout the NP region, similar to that of control discs. Significantly more newly synthesised type II collagen was detected in trypsin-treated loaded discs compared to unloaded discs, demonstrating that physiological load not only stimulates aggrecan production, but also that of type II collagen. Taken together, this study shows that dynamic physiological load has the ability to repair the extracellular matrix depletion typical of early disc degeneration.	[Gawri, Rahul; Moir, Janet; Beckman, Lorne; Steffen, Thomas; Haglund, Lisbet] McGill Univ, Orthopaed Res Lab, Montreal, PQ, Canada; [Roughley, Peter] McGill Univ, Shriners Hosp Children, Montreal, PQ, Canada; [Ouellet, Jean] McGill Scoliosis & Spine Grp, Montreal, PQ, Canada	McGill University; McGill University	Haglund, L (corresponding author), McGill Univ, Orthopaed Res Lab, Montreal, PQ, Canada.	lisbet.haglund@mcgill.ca	Haglund, Lisbet/N-3095-2013; Gawri, Rahul/I-3784-2019	Haglund, Lisbet/0000-0002-1288-2149; Gawri, Rahul/0000-0001-9415-1739	AOSpine [SRN_2011_04_10498]	AOSpine	This work was supported by a grant AOSpine, SRN_2011_04_10498. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; Akhatib B, 2013, J BIOL CHEM, V288, P19280, DOI 10.1074/jbc.M112.443010; Antoniou J, 1996, J CLIN INVEST, V98, P996, DOI 10.1172/JCI118884; BJORNSSON S, 1993, ANAL BIOCHEM, V210, P292, DOI 10.1006/abio.1993.1198; BUCKWALTER JA, 1995, SPINE, V20, P1307, DOI 10.1097/00007632-199506000-00022; Camper L, 1997, J CELL BIOL, V138, P1159, DOI 10.1083/jcb.138.5.1159; Chan SCW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072489; Chan SCW, 2013, SPINE J, V13, P273, DOI 10.1016/j.spinee.2012.12.007; Chan SCW, 2011, EUR SPINE J, V20, P1796, DOI 10.1007/s00586-011-1827-1; Chan SCW, 2011, SPINE, V36, P2021, DOI 10.1097/BRS.0b013e318203aea5; Feng HY, 2006, J BONE JOINT SURG AM, V88A, P25, DOI 10.2106/JBJS.E.01341; Haglund L, 2011, TISSUE ENG C; Haglund L, 2013, J BIOL CHEM, V288, P995, DOI 10.1074/jbc.M112.430512; Haglund L, 2011, J BIOL CHEM, V286, P3925, DOI 10.1074/jbc.M110.161141; Haglund L, 2009, SPINE, V34, P1513, DOI 10.1097/BRS.0b013e3181a8d001; Horner HA, 2001, SPINE, V26, P2543, DOI 10.1097/00007632-200112010-00006; Iatridis JC, 2013, SPINE J, V13, P243, DOI 10.1016/j.spinee.2012.12.002; Iatridis JC, 1999, SPINE, V24, P996, DOI 10.1097/00007632-199905150-00013; Illien-Junger S, 2010, SPINE, V35, P1744, DOI 10.1097/BRS.0b013e3181c48019; Jim B, 2011, EURSPINE J; Junger S, 2009, SPINE, V34, P1264, DOI 10.1097/BRS.0b013e3181a0193d; Korecki CL, 2008, SPINE, V33, P1403, DOI 10.1097/BRS.0b013e318175cae7; Korecki CL, 2009, J ORTHOP RES, V27, P800, DOI 10.1002/jor.20814; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2198; Liebscher T, 2010, SPINE; Malonzo C, 2013, J TISSUE ENG REGEN M; Mansson B, 2001, J BIOL CHEM, V276, P32883, DOI 10.1074/jbc.M101680200; MCNALLY DS, 1992, J BIOMED ENG, V14, P495, DOI 10.1016/0141-5425(92)90102-Q; Melrose J, 2007, EUR SPINE J, V16, P2193, DOI 10.1007/s00586-007-0497-5; Mort John S., 2007, V135, P201; NEAME PJ, 1994, J BIOL CHEM, V269, P21547; Paul CPL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033147; Roberts S, 2006, EUR SPINE J, V15, pS312, DOI 10.1007/s00586-006-0126-8; Roberts S, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-24; ROSENBERG L, 1971, J BONE JOINT SURG AM, VA 53, P69, DOI 10.2106/00004623-197153010-00007; Roughley PJ, 2004, SPINE, V29, P2691, DOI 10.1097/01.brs.0000146101.53784.b1; Sztrolovics R, 1997, BIOCHEM J, V326, P235, DOI 10.1042/bj3260235; Walter BA, 2011, OSTEOARTHR CARTILAGE, V19, P1011, DOI 10.1016/j.joca.2011.04.005; Wuertz K, 2009, JORTHOPRES	39	39	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101233	10.1371/journal.pone.0101233	http://dx.doi.org/10.1371/journal.pone.0101233			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992586	Green Published, Green Submitted, gold			2022-12-27	WOS:000341253400055
J	Wang, JH; Cai, YR; Dong, YJ; Nong, JY; Zhou, LJ; Liu, GM; Su, D; Li, X; Wu, SF; Chen, XJ; Qin, N; Zeng, X; Zhang, HQ; Zhang, ZD; Zhang, SC				Wang, Jinghui; Cai, Yiran; Dong, Yujie; Nong, Jingying; Zhou, Lijuan; Liu, Guimei; Su, Dan; Li, Xi; Wu, Shafei; Chen, Xuejing; Qin, Na; Zeng, Xuan; Zhang, Haiqing; Zhang, Zongde; Zhang, Shucai			Clinical Characteristics and Outcomes of Patients with Primary Lung Adenocarcinoma Harboring ALK Rearrangements Detected by FISH, IHC, and RT-PCR	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; EML4-ALK FUSION; KRAS MUTATIONS; CANCER; IMMUNOHISTOCHEMISTRY; FEATURES; CLASSIFICATION; IDENTIFICATION; GENE; EGFR	EML4-ALK is a new driver gene of non-small cell lung cancer and a target of crizotinib. The objectives of this study were to determine the frequency of ALK rearrangements in a large cohort of patients with primary lung adenocarcinoma and to analyze the association of ALK rearrangements with clinicopathological characteristics and clinical outcomes. The roles of fluorescence in situ hybridization (FISH), Ventana immunohistochemistry (IHC), and reverse transcriptase polymerase chain reaction (RT-PCR) in the detection of ALK rearrangements were evaluated. The ALK rearrangement was detected in 430 specimens from individual patients with primary lung adenocarcinoma using FISH and Ventana IHC based on tissue microarrays. The EGFR status was detected in all of the specimens through DNA sequencing. An RT-PCR was performed on 200 of the specimens and confirmed by sequencing. Of the 430 patients, 46 (10.7%) harbored ALK rearrangements. The ALK rearrangements were associated with a younger age and the EGFR wild type in comparison with ALK-negative patients. The sensitivity and specificity of the Ventana IHC were 100% and 98.2%, respectively, and the concordance rate between the FISH and the Ventana IHC was 98.4%. The sensitivity and specificity of RT-PCR were 95.5% and 87.0%, respectively, and the concordance rate between the FISH and the RT-PCR was 89.0%. The Cox analysis indicated that an early stage and EGFR-activating mutations were independently associated with a longer OS. This study demonstrated that ALK rearrangements are associated with a younger age and the EGFR wild type rather than with other clinicopathological factors. Although the FISH and Ventana IHC have better concordance, and RT-PCR is a more sensitive method and can identify different variants or partners, the IHC and RT-PCR need to be further evaluated in clinical trials to identify their roles in guiding patients' targeted therapy using crizotinib.	[Wang, Jinghui; Nong, Jingying; Li, Xi; Qin, Na; Zhang, Shucai] Capital Med Univ, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Dept Med Oncol, Beijing, Peoples R China; [Cai, Yiran; Dong, Yujie; Zhou, Lijuan; Su, Dan; Chen, Xuejing; Zhang, Haiqing] Capital Med Univ, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Dept Pathol, Beijing, Peoples R China; [Liu, Guimei] Capital Med Univ, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Dept Radiotherapy, Beijing, Peoples R China; [Wu, Shafei; Zeng, Xuan] Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Pathol, Beijing, Peoples R China; [Wu, Shafei; Zeng, Xuan] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Zhang, Zongde] Capital Med Univ, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Beijing Key Lab Drug Resistance TB Res, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Capital Medical University	Zhang, ZD (corresponding author), Capital Med Univ, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Beijing Key Lab Drug Resistance TB Res, Beijing, Peoples R China.	zzd417@163.com; zhangshucai6304@aliyun.com	su, dan/GYJ-1940-2022; Zhou, Li/GSE-4531-2022		National Science and Technology Major Project of China [2013ZX10003003, 2012ZX10003002]; Beijing health systems of high-level health and technical personnel training plan [2009-3-51]	National Science and Technology Major Project of China; Beijing health systems of high-level health and technical personnel training plan	This work was supported by the National Science and Technology Major Project of China (2013ZX10003003 and 2012ZX10003002), and Beijing health systems of high-level health and technical personnel training plan (2009-3-51). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Camidge DR, 2011, J THORAC ONCOL, V6, P774, DOI 10.1097/JTO.0b013e31820cf053; Camidge DR, 2011, J THORAC ONCOL, V6, P411, DOI 10.1097/JTO.0b013e31820cf068; Choi YL, 2008, CANCER RES, V68, P4971, DOI 10.1158/0008-5472.CAN-07-6158; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Han XH, 2013, VIRCHOWS ARCH, V463, P583, DOI 10.1007/s00428-013-1472-7; Heuckmann JM, 2012, CLIN CANCER RES, V18, P4682, DOI 10.1158/1078-0432.CCR-11-3260; Inamura K, 2008, J THORAC ONCOL, V3, P13, DOI 10.1097/JTO.0b013e31815e8b60; Kim HR, 2012, CANCER-AM CANCER SOC, V118, P729, DOI 10.1002/cncr.26311; Koh Y, 2011, J THORAC ONCOL, V6, P905, DOI 10.1097/JTO.0b013e3182111461; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lee HJ, 2012, J THORAC IMAG, V27, P340, DOI 10.1097/RTI.0b013e3182688d62; Lee JO, 2011, J THORAC ONCOL, V6, P1474, DOI 10.1097/JTO.0b013e3182208fc2; Li Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052093; Lin E, 2009, MOL CANCER RES, V7, P1466, DOI 10.1158/1541-7786.MCR-08-0522; Minca EC, 2013, J MOL DIAGN, V15, P341, DOI 10.1016/j.jmoldx.2013.01.004; Mino-Kenudson M, 2010, CLIN CANCER RES, V16, P1561, DOI 10.1158/1078-0432.CCR-09-2845; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rodig SJ, 2009, CLIN CANCER RES, V15, P5216, DOI 10.1158/1078-0432.CCR-09-0802; Rosell R, 2012, ANN ONCOL, V23, P529; Sanders HR, 2011, CANCER GENET-NY, V204, P45, DOI 10.1016/j.cancergencyto.2010.08.024; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Takeuchi K, 2008, CLIN CANCER RES, V14, P6618, DOI 10.1158/1078-0432.CCR-08-1018; Takeuchi K, 2009, CLIN CANCER RES, V15, P3143, DOI 10.1158/1078-0432.CCR-08-3248; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Togashi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031323; Wallander ML, 2012, ARCH PATHOL LAB MED, V136, P796, DOI 10.5858/arpa.2011-0321-OA; Wang R, 2012, CLIN CANCER RES, V18, P4725, DOI 10.1158/1078-0432.CCR-12-0677; Wang ZJ, 2012, ONCOLOGY-BASEL, V83, P248, DOI 10.1159/000341381; Wu SG, 2012, J THORAC ONCOL, V7, P98, DOI 10.1097/JTO.0b013e3182370e30; Wu YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070839; Ying J, 2013, ANN ONCOL, V24, P2589, DOI 10.1093/annonc/mdt295; Zhang XC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-188; Zhang YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064821	34	46	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101551	10.1371/journal.pone.0101551	http://dx.doi.org/10.1371/journal.pone.0101551			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992725	Green Published, Green Submitted, gold			2022-12-27	WOS:000341253400088
J	Zhou, TQ; Zhu, J; Yang, YP; Gorman, J; Ofek, G; Srivatsan, S; Druz, A; Lees, CR; Lu, G; Soto, C; Stuckey, J; Burton, DR; Koff, WC; Connors, M; Kwon, PD				Zhou, Tongqing; Zhu, Jiang; Yang, Yongping; Gorman, Jason; Ofek, Gilad; Srivatsan, Sanjay; Druz, Aliaksandr; Lees, Christopher R.; Lu, Gabriel; Soto, Cinque; Stuckey, Jonathan; Burton, Dennis R.; Koff, Wayne C.; Connors, Mark; Kwon, Peter D.			Transplanting Supersites of HIV-1 Vulnerability	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BROADLY NEUTRALIZING ANTIBODIES; RESPIRATORY SYNCYTIAL VIRUS; HUMAN MONOCLONAL-ANTIBODY; STRUCTURE-BASED DESIGN; N-GLYCAN RECOGNITION; ENVELOPE GLYCOPROTEIN; COMPUTATIONAL DESIGN; VACCINE DEVELOPMENT; EPITOPE-SCAFFOLDS	One strategy for isolating or eliciting antibodies against a specific target region on the envelope glycoprotein trimer (Env) of the human immunodeficiency virus type 1 (HIV-1) involves the creation of site transplants, which present the target region on a heterologous protein scaffold with preserved antibody-binding properties. If the target region is a supersite of HIV-1 vulnerability, recognized by a collection of broadly neutralizing antibodies, this strategy affords the creation of "supersite transplants", capable of binding (and potentially eliciting) antibodies similar to the template collection of effective antibodies. Here we transplant three supersites of HIV-1 vulnerability, each targeted by effective neutralizing antibodies from multiple donors. To implement our strategy, we chose a single representative antibody against each of the target supersites: antibody 10E8, which recognizes the membrane-proximal external region (MPER) on the HIV-1 gp41 glycoprotein; antibody PG9, which recognizes variable regions one and two (V1V2) on the HIV-1 gp120 glycoprotein; and antibody PGT128 which recognizes a glycopeptide supersite in variable region 3 (glycan V3) on gp120. We used a structural alignment algorithm to identify suitable acceptor proteins, and then designed, expressed, and tested antigenically over 100-supersite transplants in a 96-well microtiter-plate format. The majority of the supersite transplants failed to maintain the antigenic properties of their respective template supersite. However, seven of the glycan V3-supersite transplants exhibited nanomolar affinity to effective neutralizing antibodies from at least three donors and recapitulated the mannose(9)-N-linked glycan requirement of the template supersite. The binding of these transplants could be further enhanced by placement into self-assembling nanoparticles. Essential elements of the glycan V3 supersite, embodied by as few as 3 N-linked glycans and similar to 25 Env residues, can be segregated into acceptor scaffolds away from the immune-evading capabilities of the rest of HIV-1 Env, thereby providing a means to focus the immune response on the scaffolded supersite.	[Zhou, Tongqing; Zhu, Jiang; Yang, Yongping; Gorman, Jason; Ofek, Gilad; Srivatsan, Sanjay; Druz, Aliaksandr; Lees, Christopher R.; Lu, Gabriel; Soto, Cinque; Stuckey, Jonathan; Kwon, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Burton, Dennis R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Burton, Dennis R.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Design, La Jolla, CA 92037 USA; [Burton, Dennis R.] Ragon Inst MGH MIT & Harvard, Cambridge, MA USA; [Koff, Wayne C.] IAVI, New York, NY USA; [Connors, Mark] NIAID, HIV Specif Immun Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; International AIDS Vaccine Initiative; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kwon, PD (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	pdkwong@nih.gov	Zhou, Tongqing/A-6880-2010; Cheng, Yushao/E-6256-2011; Gorman, Jason/AGG-9417-2022	Zhou, Tongqing/0000-0002-3935-4637; Gorman, Jason/0000-0002-3775-6560	Intramural Research Program of the Vaccine Research Center; National Institute of Allergy and Infectious Diseases; National Institutes of Health; International AIDS Vaccine Initiative's Neutralizing Antibody Consortium; Bill & Melinda Gates Foundation; Ministry of Foreign Affairs of Denmark; Irish Aid; Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD); United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001090] Funding Source: NIH RePORTER	Intramural Research Program of the Vaccine Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative's Neutralizing Antibody Consortium; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Ministry of Foreign Affairs of Denmark; Irish Aid(CGIAR); Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD)(CGIAR); United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this work was provided by the Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, and by grants from the International AIDS Vaccine Initiative's Neutralizing Antibody Consortium. IAVI's work is made possible by generous support from many donors including: the Bill & Melinda Gates Foundation; the Ministry of Foreign Affairs of Denmark; Irish Aid; the Ministry of Finance of Japan; the Ministry of Foreign Affairs of the Netherlands; the Norwegian Agency for Development Cooperation (NORAD); the United Kingdom Department for International Development (DFID), and the United States Agency for International Development (USAID). The full list of IAVI donors is available at www. iavi. org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azoitei ML, 2012, J MOL BIOL, V415, P175, DOI 10.1016/j.jmb.2011.10.003; Azoitei ML, 2011, SCIENCE, V334, P373, DOI 10.1126/science.1209368; Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541; Bhattacharyya S, 2013, J BIOL CHEM, V288, P9815, DOI 10.1074/jbc.M112.425959; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Chakraborty K, 2006, BIOCHEM J, V399, P483, DOI 10.1042/BJ20060588; Correia BE, 2014, NATURE, V507, P201, DOI 10.1038/nature12966; Correia BE, 2010, STRUCTURE, V18, P1116, DOI 10.1016/j.str.2010.06.010; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Desmet J, 2002, PROTEINS, V48, P31, DOI 10.1002/prot.10131; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Gerhardt S, 2009, J MOL BIOL, V394, P905, DOI 10.1016/j.jmb.2009.10.008; Gray ES, 2011, J VIROL, V85, P7719, DOI 10.1128/JVI.00563-11; Harms JM, 2008, MOL CELL, V30, P26, DOI 10.1016/j.molcel.2008.01.009; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Hraber P, 2014, AIDS, V28, P163, DOI 10.1097/QAD.0000000000000106; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Jakuschev S, 2009, ALGORITHMS, V2, P498, DOI 10.3390/a2010498; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Kanekiyo M, 2013, NATURE, V499, P102, DOI 10.1038/nature12202; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Kobayashi K, 2010, P NATL ACAD SCI USA, V107, P17575, DOI 10.1073/pnas.1009598107; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; McLellan JS, 2011, J MOL BIOL, V409, P853, DOI 10.1016/j.jmb.2011.04.044; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Morris L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023532; Moseri A, 2010, VIROLOGY, V401, P293, DOI 10.1016/j.virol.2010.03.007; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; MUSTER T, 1994, J VIROL, V68, P4031, DOI 10.1128/JVI.68.6.4031-4034.1994; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Pancera M, 2013, NAT STRUCT MOL BIOL, V20, P804, DOI 10.1038/nsmb.2600; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pejchal R, 2009, J VIROL, V83, P8451, DOI 10.1128/JVI.00685-09; Roldao A, 2010, EXPERT REV VACCINES, V9, P1149, DOI [10.1586/erv.10.115, 10.1586/ERV.10.115]; Saikrishnan K, 2005, ACTA CRYSTALLOGR D, V61, P1140, DOI 10.1107/S0907444905016896; Samara NL, 2010, SCIENCE, V328, P1025, DOI 10.1126/science.1190049; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Stanfield RL, 2011, J MOL BIOL, V414, P460, DOI 10.1016/j.jmb.2011.10.014; STARCICH BR, 1986, CELL, V45, P637, DOI 10.1016/0092-8674(86)90778-6; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Stieglitz B, 2008, EMBO J, V27, P1995, DOI 10.1038/emboj.2008.125; Totrov M, 2010, VIROLOGY, V405, P513, DOI 10.1016/j.virol.2010.06.027; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Xiang ZX, 2001, J MOL BIOL, V311, P421, DOI 10.1006/jmbi.2001.4865; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002; Zhu J, 2008, PROTEINS, V72, P1171, DOI 10.1002/prot.22005; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	71	44	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e99881	10.1371/journal.pone.0099881	http://dx.doi.org/10.1371/journal.pone.0099881			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992528	Green Published, Green Submitted, gold			2022-12-27	WOS:000341253400014
J	Privat, M; Radosevic-Robin, N; Aubel, C; Cayre, A; Penault-Llorca, F; Marceau, G; Sapin, V; Bignon, YJ; Morvan, D				Privat, Maud; Radosevic-Robin, Nina; Aubel, Corinne; Cayre, Anne; Penault-Llorca, Frederique; Marceau, Geoffroy; Sapin, Vincent; Bignon, Yves-Jean; Morvan, Daniel			BRCA1 Induces Major Energetic Metabolism Reprogramming in Breast Cancer Cells	PLOS ONE			English	Article							ACETYL-COA CARBOXYLASE; OXIDATIVE STRESS; TUMOR SUPPRESSORS; SDH MUTATIONS; PARAGANGLIOMA; METABOLOMICS; EXPRESSION; WARBURG; AKT; TUMORIGENESIS	The hypermetabolic nature of cancer cells and their increased reliance on "aerobic glycolysis'', as originally described by Otto Warburg and colleagues, are considered metabolic hallmarks of cancer cells. BRCA1 is a major tumor suppressor in breast cancer and it was implicated in numerous pathways resulting in anticarcinogenic functions. The objective of our study was to address specific contributions of BRCA1 to the metabolic features of cancer cells, including the so-called "Warburg effect''. To get a comprehensive approach of the role of BRCA1 in tumor cell metabolism, we performed a global transcriptional and metabolite profiling in a BRCA1-mutated breast cancer cell line transfected or not by wild-type BRCA1. This study revealed that BRCA1 induced numerous modifications of metabolism, including strong inhibition of glycolysis while TCA cycle and oxidative phosphorylation tended to be activated. Regulation of AKT by BRCA1 in both our cell model and BRCA1-mutated breast tumors was suggested to participate in the effect of BRCA1 on glycolysis. We could also show that BRCA1 induced a decrease of ketone bodies and free fatty acids, maybe consumed to supply Acetyl-CoA for TCA cycle. Finally increased activity of antioxidation pathways was observed in BRCA1-transfected cells, that could be a consequence of ROS production by activated oxidative phosphorylation. Our study suggests a new function for BRCA1 in cell metabolic regulation, globally resulting in reversion of the Warburg effect. This could represent a new mechanism by which BRCA1 may exert tumor suppressor function.	[Privat, Maud; Radosevic-Robin, Nina; Aubel, Corinne; Cayre, Anne; Penault-Llorca, Frederique; Bignon, Yves-Jean; Morvan, Daniel] Univ Auvergne, Jean Perrin Comprehens Canc Ctr, Clermont Ferrand, France; [Privat, Maud; Radosevic-Robin, Nina; Aubel, Corinne; Cayre, Anne; Penault-Llorca, Frederique; Bignon, Yves-Jean; Morvan, Daniel] Univ Auvergne, ERTICA Res Team EA4677, Clermont Ferrand, France; [Morvan, Daniel] UNH, UMR 1019, INRA, Clermont Ferrand, France; [Marceau, Geoffroy; Sapin, Vincent] CHU Clermont Ferrand, Ctr Biol, Lab Biochim Med, Clermont Ferrand, France	UNICANCER; Centre Jean Perrin; Universite Clermont Auvergne (UCA); Universite Clermont Auvergne (UCA); INRAE; CHU Clermont Ferrand	Bignon, YJ (corresponding author), Univ Auvergne, Jean Perrin Comprehens Canc Ctr, Clermont Ferrand, France.	Yves-Jean.Bignon@cjp.fr	, bignon/Y-3243-2019; , Maud/ABB-9090-2021; aubel, corinne/Y-7143-2019; Aubel, Corinne/ABB-2346-2021	, Maud/0000-0002-9373-3902; Aubel, Corinne/0000-0003-4500-6505; CAYRE, Anne/0000-0002-2578-8557; MARCEAU, GEOFFROY/0000-0003-4713-7162	Centre Jean Perrin; University of Auvergne; hospital of Clermont-Ferrand; League against the cancer committee of Allier and of Puy de Dome	Centre Jean Perrin; University of Auvergne; hospital of Clermont-Ferrand; League against the cancer committee of Allier and of Puy de Dome	This work was supported by the Centre Jean Perrin, the University of Auvergne, and the hospital of Clermont-Ferrand. Grants were also obtained from the League against the cancer committee of Allier and of Puy de Dome. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae I, 2004, CANCER RES, V64, P7893, DOI 10.1158/0008-5472.CAN-04-1119; Bayet-Robert M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057971; Bayet-Robert M, 2010, MAGN RESON MED, V63, P1172, DOI 10.1002/mrm.22303; Brunet J, 2008, MOL CARCINOGEN, V47, P157, DOI 10.1002/mc.20364; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cao L, 2007, CARCINOGENESIS, V28, P1401, DOI 10.1093/carcin/bgm060; Chautard E, 2010, NEURO-ONCOLOGY, V12, P434, DOI 10.1093/neuonc/nop059; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Delikatny EJ, 2011, NMR BIOMED, V24, P592, DOI 10.1002/nbm.1661; Elstrodt F, 2006, CANCER RES, V66, P41, DOI 10.1158/0008-5472.CAN-05-2853; Fan SJ, 2009, CANCER RES, V69, P6083, DOI 10.1158/0008-5472.CAN-08-3309; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ippolito JE, 2005, P NATL ACAD SCI USA, V102, P9901, DOI 10.1073/pnas.0500756102; Kaelin WG, 2009, CANCER CELL, V16, P180, DOI 10.1016/j.ccr.2009.08.013; Kang HJ, 2006, J BIOL CHEM, V281, P13047, DOI 10.1074/jbc.M513033200; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Magnard C, 2002, ONCOGENE, V21, P6729, DOI 10.1038/sj.onc.1205915; Mathupala SP, 2009, SEMIN CANCER BIOL, V19, P17, DOI 10.1016/j.semcancer.2008.11.006; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Moreau K, 2006, J BIOL CHEM, V281, P3172, DOI 10.1074/jbc.M504652200; Morvan D, 2007, CANCER RES, V67, P2150, DOI 10.1158/0008-5472.CAN-06-2346; Nam H, 2009, BIOINFORMATICS, V25, P3151, DOI 10.1093/bioinformatics/btp558; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pasini B, 2009, J INTERN MED, V266, P19, DOI 10.1111/j.1365-2796.2009.02111.x; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Privat M, 2009, BIOCHEM BIOPH RES CO, V379, P785, DOI 10.1016/j.bbrc.2008.12.151; Reitman ZJ, 2010, JNCI-J NATL CANCER I, V102, P932, DOI 10.1093/jnci/djq187; Robey RB, 2009, SEMIN CANCER BIOL, V19, P25, DOI 10.1016/j.semcancer.2008.11.010; Scatena R, 2008, EXPERT OPIN INV DRUG, V17, P1533, DOI 10.1517/13543784.17.10.1533 ; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Seo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024179; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Thompson CB, 2009, NEW ENGL J MED, V360, P813, DOI 10.1056/NEJMe0810213; van der Groep P, 2008, BREAST CANCER RES TR, V111, P475, DOI 10.1007/s10549-007-9817-z; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xiang T, 2011, ONCOGENE, V30, P2443, DOI 10.1038/onc.2010.603; Xiang T, 2008, CANCER RES, V68, P10040, DOI 10.1158/0008-5472.CAN-08-3009; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yarden RI, 2006, MOL CANCER THER, V5, P1396, DOI 10.1158/1535-7163.MCT-05-0471	45	41	41	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102438	10.1371/journal.pone.0102438	http://dx.doi.org/10.1371/journal.pone.0102438			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010005	Green Published, gold			2022-12-27	WOS:000338763800102
J	Kastrin, A; Rindflesch, TC; Hristovski, D				Kastrin, Andrej; Rindflesch, Thomas C.; Hristovski, Dimitar			Large-Scale Structure of a Network of Co-Occurring MeSH Terms: Statistical Analysis of Macroscopic Properties	PLOS ONE			English	Article							LITERATURE-BASED DISCOVERY; SMALL-WORLD; IDENTIFY; PROTEINS	Concept associations can be represented by a network that consists of a set of nodes representing concepts and a set of edges representing their relationships. Complex networks exhibit some common topological features including small diameter, high degree of clustering, power-law degree distribution, and modularity. We investigated the topological properties of a network constructed from co-occurrences between MeSH descriptors in the MEDLINE database. We conducted the analysis on two networks, one constructed from all MeSH descriptors and another using only major descriptors. Network reduction was performed using the Pearson's chi-square test for independence. To characterize topological properties of the network we adopted some specific measures, including diameter, average path length, clustering coefficient, and degree distribution. For the full MeSH network the average path length was 1.95 with a diameter of three edges and clustering coefficient of 0.26. The Kolmogorov-Smirnov test rejects the power law as a plausible model for degree distribution. For the major MeSH network the average path length was 2.63 edges with a diameter of seven edges and clustering coefficient of 0.15. The Kolmogorov-Smirnov test failed to reject the power law as a plausible model. The power-law exponent was 5.07. In both networks it was evident that nodes with a lower degree exhibit higher clustering than those with a higher degree. After simulated attack, where we removed 10% of nodes with the highest degrees, the giant component of each of the two networks contains about 90% of all nodes. Because of small average path length and high degree of clustering the MeSH network is small-world. A power-law distribution is not a plausible model for the degree distribution. The network is highly modular, highly resistant to targeted and random attack and with minimal dissortativity.	[Kastrin, Andrej] Fac Informat Studies, Novo Mesto, Slovenia; [Rindflesch, Thomas C.] Natl Lib Med, Lister Hill Natl Ctr Biomed Commun, Bethesda, MD USA; [Hristovski, Dimitar] Univ Ljubljana, Fac Med, Inst Biostat & Med Informat, Ljubljana, Slovenia	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University of Ljubljana	Kastrin, A (corresponding author), Fac Informat Studies, Novo Mesto, Slovenia.	andrej.kastrin@guest.arnes.si	Hristovski, Dimitar/A-6288-2009; Kastrin, Andrej/AAH-9234-2021	Kastrin, Andrej/0000-0002-3495-0165; Hristovski, Dimitar/0000-0001-6908-0246	Slovenian Research Agency [P1-0383]; Intramural Research Program of the U.S. National Institutes of Health, National Library of Medicine	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Intramural Research Program of the U.S. National Institutes of Health, National Library of Medicine	This work was supported by Slovenian Research Agency grant P1-0383 and by the Intramural Research Program of the U.S. National Institutes of Health, National Library of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aittokallio T, 2006, BRIEF BIOINFORM, V7, P243, DOI 10.1093/bib/bbl022; Alako BTF, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-51; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; [Anonymous], 2013, MED SUBJ HEAD; [Anonymous], 1990, 6 DEGREES SEPARATION; [Anonymous], 2013, CHECK TAGS; [Anonymous], 2013, R LANG ENV STAT COMP; Bales ME, 2007, J AM MED INFORM ASSN, V14, P788, DOI 10.1197/jamia.M2080; Bales ME, 2006, J BIOMED INFORM, V39, P451, DOI 10.1016/j.jbi.2005.10.007; Barabasi AL, 2003, SCI AM, V288, P60, DOI 10.1038/scientificamerican0503-60; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barbosa-Silva A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-70; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Cancho RFI, 2001, P ROY SOC B-BIOL SCI, V268, P2261, DOI 10.1098/rspb.2001.1800; Choudhury M, 2009, MODEL SIMUL SCI ENG, P145, DOI 10.1007/978-0-8176-4751-3_9; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Frijters R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000943; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Hoffmann R, 2005, BIOINFORMATICS, V21, P252, DOI 10.1093/bioinformatics/bti1142; Hristovski D, 2005, INT J MED INFORM, V74, P289, DOI 10.1016/j.ijmedinf.2004.04.024; Hristovski Dimitar, 2013, Cardiovascular & Hematological Agents in Medicinal Chemistry, V11, P14; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kilicoglu H, 2012, BIOINFORMATICS, V28, P3158, DOI 10.1093/bioinformatics/bts591; Krallinger M, 2009, NUCLEIC ACIDS RES, V37, pW160, DOI 10.1093/nar/gkp484; Mac Carron P, 2012, EPL-EUROPHYS LETT, V99, DOI 10.1209/0295-5075/99/28002; Manning C.D., 1999, FDN STAT NATURAL LAN; MILGRAM S, 1967, PSYCHOL TODAY, V1, P61; Motter AE, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.065102; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Plake C, 2006, BIOINFORMATICS, V22, P2444, DOI 10.1093/bioinformatics/btl408; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; Rebholz-Schuhmann D, 2007, BIOINFORMATICS, V23, pE237, DOI 10.1093/bioinformatics/btl302; Rindflesch TC, 2003, J BIOMED INFORM, V36, P462, DOI 10.1016/j.jbi.2003.11.003; Stapley B J, 2000, Pac Symp Biocomput, P529; Steyvers M, 2005, COGNITIVE SCI, V29, P41, DOI 10.1207/s15516709cog2901_3; SWANSON DR, 1986, PERSPECT BIOL MED, V30, P7; Tauro SL, 2001, GLOB TELECOMM CONF, P1667, DOI 10.1109/GLOCOM.2001.965863; Tsuruoka Y, 2008, BIOINFORMATICS, V24, P2559, DOI 10.1093/bioinformatics/btn469; Ugander J., 2011, ANATOMY FACEBOOK SOC	42	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102188	10.1371/journal.pone.0102188	http://dx.doi.org/10.1371/journal.pone.0102188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006672	Green Published, gold			2022-12-27	WOS:000339040600105
J	Kovalenko, KE; Brady, VJ; Ciborowski, JJH; Ilyushkin, S; Johnson, LB				Kovalenko, Katya E.; Brady, Valerie J.; Ciborowski, Jan J. H.; Ilyushkin, Sergey; Johnson, Lucinda B.			Functional Changes in Littoral Macroinvertebrate Communities in Response to Watershed-Level Anthropogenic Stress	PLOS ONE			English	Article							MULTIPLE SPATIAL SCALES; GREAT-LAKES; SPECIES TRAITS; LAND-COVER; BIODIVERSITY; DIVERSITY; THRESHOLDS; INDICATORS; URBANIZATION; ASSEMBLAGES	Watershed-scale anthropogenic stressors have profound effects on aquatic communities. Although several functional traits of stream macroinvertebrates change predictably in response to land development and urbanization, little is known about macroinvertebrate functional responses in lakes. We assessed functional community structure, functional diversity (Rao's quadratic entropy) and voltinism in macroinvertebrate communities sampled across the full gradient of anthropogenic stress in Laurentian Great Lakes coastal wetlands. Functional diversity and voltinism significantly decreased with increasing development, whereas agriculture had smaller or non-significant effects. Functional community structure was affected by watershed-scale development, as demonstrated by an ordination analysis followed by regression. Because functional community structure affects energy flow and ecosystem function, and functional diversity is known to have important implications for ecosystem resilience to further environmental change, these results highlight the necessity of finding ways to remediate or at least ameliorate these effects.	[Kovalenko, Katya E.; Ciborowski, Jan J. H.] Univ Windsor, Windsor, ON N9B 3P4, Canada; [Kovalenko, Katya E.; Brady, Valerie J.; Johnson, Lucinda B.] Univ Minnesota, Nat Resources Res Inst, Duluth, MN 55812 USA; [Ilyushkin, Sergey] Colorado Sch Mines, Golden, CO 80401 USA	University of Windsor; University of Minnesota System; University of Minnesota Duluth; Colorado School of Mines	Kovalenko, KE (corresponding author), Univ Windsor, Windsor, ON N9B 3P4, Canada.	philarctus@gmail.com	Ciborowski, Jan J.H./AAC-8247-2019	Ciborowski, Jan J.H./0000-0002-6588-0366; Brady, Valerie/0000-0002-2575-1017; Kovalenko, Katya/0000-0001-7363-212X	U.S. Environmental Protection Agency Science [R-8286750]; Protocols for Selection of Classification Systems and Reference Conditions project [R-828777]; U.S. Environmental Protection Agency Great Lakes National Program Office [GL-00E00623-0]; US EPA	U.S. Environmental Protection Agency Science(United States Environmental Protection Agency); Protocols for Selection of Classification Systems and Reference Conditions project; U.S. Environmental Protection Agency Great Lakes National Program Office(United States Environmental Protection Agency); US EPA(United States Environmental Protection Agency)	Data collection for this project was supported by grants from the U.S. Environmental Protection Agency Science to Achieve Results Estuarine and Great Lakes Program through the Great Lakes Environmental Indicators Project (R-8286750) to G.L. Niemi et al. and the Protocols for Selection of Classification Systems and Reference Conditions project (R-828777) to L.B. Johnson et al. Other parts of this project were supported by the second stage GLEI-II Indicator Testing and Refinement project funded by a Great Lakes Restoration Initiative grant from the U.S. Environmental Protection Agency Great Lakes National Program Office to L.B. Johnson et al. (GL-00E00623-0). Although the research described in this work has been partly funded by the US EPA, it has not been subjected to the agency's required review and, therefore, does not necessarily reflect the views of the agency and no official endorsement should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; Batzer DP, 2013, WETLANDS, V33, P1, DOI 10.1007/s13157-012-0360-2; Botta-Dukat Z, 2005, J VEG SCI, V16, P533, DOI 10.1111/j.1654-1103.2005.tb02393.x; Brazner JC, 2007, J GREAT LAKES RES, V33, P42, DOI 10.3394/0380-1330(2007)33[42:ROGLWI]2.0.CO;2; Cardinale BJ, 2002, NATURE, V415, P426, DOI 10.1038/415426a; Compin A, 2007, LANDSCAPE ECOL, V22, P1215, DOI 10.1007/s10980-007-9101-y; Courtney G.W., 2008, INTRO AQUATIC INSECT, P687; Covich AP, 1999, BIOSCIENCE, V49, P119, DOI 10.2307/1313537; Danz NP, 2005, ENVIRON MONIT ASSESS, V102, P41, DOI 10.1007/s10661-005-1594-8; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Doledec S, 2006, J N AM BENTHOL SOC, V25, P44, DOI 10.1899/0887-3593(2006)25[44:COSAFA]2.0.CO;2; Dunne JA, 2005, AQUATIC FOOD WEBS: AN ECOSYSTEM APPROACH, P117; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Gathman JP, 2011, WETLANDS, V31, P329, DOI 10.1007/s13157-010-0140-9; Gromping U, 2006, J STAT SOFTW, V17, DOI 10.18637/jss.v017.i01; Heino J, 2008, LIMNOL OCEANOGR, V53, P1446, DOI 10.4319/lo.2008.53.4.1446; Heino J, 2010, ECOL INDIC, V10, P112, DOI 10.1016/j.ecolind.2009.04.013; Hilderbrand RH, 2010, J N AM BENTHOL SOC, V29, P1009, DOI 10.1899/09-138.1; Hollenhorst TP, 2011, AQUAT ECOSYST HEALTH, V14, P433, DOI 10.1080/14634988.2011.628242; Hooper DU, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P195; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Huryn AD, 2008, AQUATIC INSECTS N AM, P55; Kail J, 2012, ECOL INDIC, V18, P63, DOI 10.1016/j.ecolind.2011.09.038; King RS, 2010, J N AM BENTHOL SOC, V29, P998, DOI 10.1899/09-144.1; Kovalenko KE, 2012, HYDROBIOLOGIA, V685, P1, DOI 10.1007/s10750-011-0974-z; Kovalenko KE, 2014, FRESHW SCI IN PRESS; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Larsen S, 2011, RIVER RES APPL, V27, DOI 10.1002/rra.1361; Larsen S, 2010, BIOL CONSERV, V143, P2638, DOI 10.1016/j.biocon.2010.07.006; Lindeman R., 1980, INTRO BIVARIATE MULT; Loreau M, 1998, P NATL ACAD SCI USA, V95, P5632, DOI 10.1073/pnas.95.10.5632; Loreau M, 2013, ECOL LETT, V16, P106, DOI 10.1111/ele.12073; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Merritt R. W., 2008, INTRO AQUATIC INSECT; MERRITT RW, 1995, INTRO AQUATIC INSECT; Morse JC, 2008, INTRO AQUATIC INSECT, P481; Niemi GJ, 2007, J GREAT LAKES RES, V33, P1, DOI 10.3394/0380-1330(2007)33[1:EIFTCR]2.0.CO;2; Poff NL, 1997, J N AM BENTHOL SOC, V16, P391, DOI 10.2307/1468026; Polhemus J.T., 2008, INTRO AQUATIC INSECT, P385; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Richards C, 1997, FRESHWATER BIOL, V37, P219, DOI 10.1046/j.1365-2427.1997.d01-540.x; SOLIS MA, 2008, INTRO AQUATIC INSECT, P553; Statzner B, 2010, FRESHWATER BIOL, V55, P80, DOI 10.1111/j.1365-2427.2009.02369.x; Stendera S, 2012, HYDROBIOLOGIA, V696, P1, DOI 10.1007/s10750-012-1183-0; Tennessen KJ, 2008, INTRO AQUATIC INSECT, P237; THORP JH, 2001, ECOLOGY CLASSIFICATI; Utz RM, 2011, J N AM BENTHOL SOC, V30, P25, DOI 10.1899/10-007.1; Uzarski D. G., 2004, Aquatic Ecosystem Health & Management, V7, P269, DOI 10.1080/14634980490461498; Verberk WCEP, 2013, FRESHW SCI, V32, P531, DOI 10.1899/12-092.1; WALTZ RD, 2008, INTRO AQUATIC INSECT, P181; Watson D., 1994, NNGRIDR IMPLEMENTATI; Weigel BM, 2003, FRESHWATER BIOL, V48, P1440, DOI 10.1046/j.1365-2427.2003.01076.x; White D.S., 2008, INTRO AQUATIC INSECT, P571	53	16	16	2	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101499	10.1371/journal.pone.0101499	http://dx.doi.org/10.1371/journal.pone.0101499			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006811	Green Submitted, gold, Green Published			2022-12-27	WOS:000339040600040
J	Nephin, J; Juniper, SK; Archambault, P				Nephin, Jessica; Juniper, S. Kim; Archambault, Philippe			Diversity, Abundance and Community Structure of Benthic Macro- and Megafauna on the Beaufort Shelf and Slope	PLOS ONE			English	Article							BATHYMETRIC PATTERNS; MACROFAUNAL BIOMASS; SPECIES-DIVERSITY; CANADIAN SHELF; BARENTS SEA; BIODIVERSITY; SEDIMENT; DYNAMICS; FLUXES; CARBON	Diversity and community patterns of macro- and megafauna were compared on the Canadian Beaufort shelf and slope. Faunal sampling collected 247 taxa from 48 stations with box core and trawl gear over the summers of 2009-2011 between 50 and 1,000 m in depth. Of the 80 macrofaunal and 167 megafaunal taxa, 23% were uniques, present at only one station. Rare taxa were found to increase proportional to total taxa richness and differ between the shelf (< 100 m) where they tended to be sparse and the slope where they were relatively abundant. The macrofauna principally comprised polychaetes with nephtyid polychaetes dominant on the shelf and maldanid polychaetes (up to 92% in relative abundance/station) dominant on the slope. The megafauna principally comprised echinoderms with Ophiocten sp. (up to 90% in relative abundance/station) dominant on the shelf and Ophiopleura sp. dominant on the slope. Macro- and megafauna had divergent patterns of abundance, taxa richness (alpha diversity) and beta diversity. A greater degree of macrofaunal than megafaunal variation in abundance, richness and beta diversity was explained by confounding factors: location (east-west), sampling year and the timing of sampling with respect to sea-ice conditions. Change in megafaunal abundance, richness and beta diversity was greatest across the depth gradient, with total abundance and richness elevated on the shelf compared to the slope. We conclude that megafaunal slope taxa were differentiated from shelf taxa, as faunal replacement not nestedness appears to be the main driver of megafaunal beta diversity across the depth gradient.	[Nephin, Jessica; Juniper, S. Kim] Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC, Canada; [Archambault, Philippe] Univ Quebec, Inst Sci Mer Rimouski, Rimouski, PQ G5L 3A1, Canada	University of Victoria; University of Quebec	Nephin, J (corresponding author), Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC, Canada.	jnephin@uvic.ca	Juniper, Kim/N-6769-2015	Juniper, Kim/0000-0002-7608-260X	ArcticNet - a Network of Centres of Excellence of Canada; Canadian Healthy Oceans Network (CHONe); Amundsen program; BP Exploration Operating Company Limited and Imperial Oil	ArcticNet - a Network of Centres of Excellence of Canada; Canadian Healthy Oceans Network (CHONe); Amundsen program; BP Exploration Operating Company Limited and Imperial Oil	This work was supported by ArcticNet - a Network of Centres of Excellence of Canada (http://www.arcticnet.ulaval.ca/) and by the Canadian Healthy Oceans Network (CHONe) (http://chone.marinebiodiversity.ca/). This study was also supported through a research collaboration between the Amundsen program, BP Exploration Operating Company Limited and Imperial Oil. BP and Imperial Oil had a role in the location of sampling only, as it occurred within their leased exploration areas on the Beaufort shelf. The funders had no role in sampling protocols, data collection, data analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GEOPHYS RES LETT, DOI [10.1029/2007/GL029703, DOI 10.1029/2007GL029703]; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Bekryaev RV, 2010, J CLIMATE, V23, P3888, DOI 10.1175/2010JCLI3297.1; Berge J, 2005, MAR ECOL PROG SER, V303, P167, DOI 10.3354/meps303167; Bodil Bluhm A., 2011, Marine Biodiversity, V41, P87, DOI 10.1007/s12526-010-0078-4; Brault S, 2013, DEEP-SEA RES PT II, V92, P157, DOI 10.1016/j.dsr2.2013.01.018; Carmack EC, 2002, ARCTIC, V55, P29; Carmack EC, 2004, MAR ECOL PROG SER, V277, P37, DOI 10.3354/meps277037; Carney RS, 2005, OCEANOGR MAR BIOL, V43, P211; Carney RS, 1983, DEEP SEA BIOL, P371; Clarke KR, 1999, MAR ECOL PROG SER, V184, P21, DOI 10.3354/meps184021; Clough LM, 2005, CAN J FISH AQUAT SCI, V62, P1756, DOI 10.1139/F05-102; Cochrane SKJ, 2012, J MARINE SYST, V94, P204, DOI 10.1016/j.jmarsys.2011.12.001; Comiso JC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031972; Conlan K, 2013, J MARINE SYST, V127, P76, DOI 10.1016/j.jmarsys.2013.07.013; Conlan K, 2008, J MARINE SYST, V74, P864, DOI 10.1016/j.jmarsys.2007.10.002; Cusson M, 2007, MAR ECOL PROG SER, V331, P291, DOI 10.3354/meps331291; Ellingsen KE, 2007, J SEA RES, V58, P291, DOI 10.1016/j.seares.2007.10.001; Etter RJ, 2001, MARINE COMMUNITY ECOLOGY, P367; Forest A, 2013, BIOGEOSCIENCES, V10, P2833, DOI 10.5194/bg-10-2833-2013; Forest A, 2007, J MARINE SYST, V68, P39, DOI 10.1016/j.jmarsys.2006.10.008; Gage J. D., 1991, DEEP SEA BIOL NATURA; Gaston K.J., 1994, RARITY, P1; Gaston K.J., 2000, PATTERN PROCESS MACR, DOI [10.1002/9780470999592, DOI 10.1002/9780470999592]; Gaston KJ, 1996, OIKOS, V76, P211, DOI 10.2307/3546192; Gaston KJ, 1997, J ANIM ECOL, V66, P579, DOI 10.2307/5951; GRAF G, 1992, OCEANOGR MAR BIOL, V30, P149; Grassle J.F., 1979, AMBIO SPECIAL REPORT, V6, P47; Grebmeier JM, 2006, PROG OCEANOGR, V71, P331, DOI 10.1016/j.pocean.2006.10.001; Grebmeier JM, 2012, ANNU REV MAR SCI, V4, P63, DOI 10.1146/annurev-marine-120710-100926; Grebmeier JM, 2006, SCIENCE, V311, P1461, DOI 10.1126/science.1121365; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Hammerstrom KK, 2012, INTEGR ENVIRON ASSES, V8, P649, DOI 10.1002/ieam.78; Jerosch K, 2013, J MARINE SYST, V127, P5, DOI 10.1016/j.jmarsys.2012.02.013; Kaufman L., 2005, FINDING GROUPS DATA; LAMPITT RS, 1986, MAR BIOL, V93, P69, DOI 10.1007/BF00428656; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; Link H, 2013, BIOGEOSCIENCES, V10, P5911, DOI 10.5194/bg-10-5911-2013; Link H, 2011, POLAR BIOL, V34, P2025, DOI 10.1007/s00300-011-1046-6; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Lyons KG, 2005, CONSERV BIOL, V19, P1019, DOI 10.1111/j.1523-1739.2005.00106.x; MACDONALD RW, 1989, J GEOPHYS RES-OCEANS, V94, P18057, DOI 10.1029/JC094iC12p18057; O'Brien MC, 2006, CONT SHELF RES, V26, P41, DOI 10.1016/j.csr.2005.09.007; Piepenburg D, 2005, POLAR BIOL, V28, P733, DOI 10.1007/s00300-005-0013-5; Piepenburg D, 1996, MAR BIOL, V125, P321, DOI 10.1007/BF00346313; Piepenburg Dieter, 2011, Marine Biodiversity, V41, P51, DOI 10.1007/s12526-010-0059-7; Pitman NCA, 2001, ECOLOGY, V82, P2101, DOI 10.1890/0012-9658(2001)082[2101:DADOTS]2.0.CO;2; Rabinowitz D., 1981, 7 FORMS RARITY BIOLO; Renaud PE, 2007, J EXP MAR BIOL ECOL, V349, P248, DOI 10.1016/j.jembe.2007.05.021; Rex M.A., 1977, European Marine Biology Symposium, P521; Rex M.A., 2010, BIOSCIENCE; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; Robinson JPW, 2014, MAR POLICY, V48, P123, DOI 10.1016/j.marpol.2014.03.012; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Rysgaard S., 2007, MEDDR GRONLAND BIOSC, V58, P206; Shin PKS, 2004, MAR ECOL PROG SER, V276, P25, DOI 10.3354/meps276025; Snelgrove PVR, 2012, FISHERIES, V37, P296, DOI 10.1080/03632415.2012.696002; Snelgrove PVR, 1998, BIODIVERS CONSERV, V7, P1123, DOI 10.1023/A:1008867313340; Soltwedel T, 2009, DEEP-SEA RES PT I, V56, P1856, DOI 10.1016/j.dsr.2009.05.012; Starmans A, 1999, MAR BIOL, V135, P269, DOI 10.1007/s002270050624; Stuart CT, 2009, MAR ECOL-EVOL PERSP, V30, P164, DOI 10.1111/j.1439-0485.2008.00269.x; Stuart CT, 2003, ECOSY WORLD, V28, P295; Tamelander T, 2006, MAR ECOL PROG SER, V310, P33, DOI 10.3354/meps310033; THIEL H, 1975, Internationale Revue der Gesamten Hydrobiologie, V60, P575; Thistle D, 2001, HYDROBIOLOGIA, V453, P255, DOI 10.1023/A:1013152909018; Tremblay JE, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048825; Verberk WCEP, 2010, J ANIM ECOL, V79, P589, DOI 10.1111/j.1365-2656.2010.01660.x; Walker TR, 2008, J MARINE SYST, V74, P794, DOI 10.1016/j.jmarsys.2008.01.006; Warwick RM, 2001, CHANGE MARINE COMMUN; Wassmann P, 2011, GLOBAL CHANGE BIOL, V17, P1235, DOI 10.1111/j.1365-2486.2010.02311.x; Wei CL, 2010, MAR ECOL PROG SER, V399, P1, DOI 10.3354/meps08388; Weslawski Jan Marcin, 2011, Marine Biodiversity, V41, P71, DOI 10.1007/s12526-010-0073-9; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; Williams WJ, 2006, CONT SHELF RES, V26, P2352, DOI 10.1016/j.csr.2006.06.012; Williams WJ, 2008, J MAR RES, V66, P645, DOI 10.1357/002224008787536808; Wlodarska-Kowalczuk M, 2007, MAR ECOL PROG SER, V351, P53, DOI 10.3354/meps07127; Wlodarska-Kowalczuk M, 2012, MAR ECOL PROG SER, V463, P73, DOI 10.3354/meps09858; Yang JY, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005084	78	18	19	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101556	10.1371/journal.pone.0101556	http://dx.doi.org/10.1371/journal.pone.0101556			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007347	Green Published, Green Submitted, gold			2022-12-27	WOS:000339040600045
J	Wei, YH; Huang, Y; Luo, L; Xiao, XC; Liu, L; Yang, ZC				Wei, Yuehong; Huang, Yong; Luo, Lei; Xiao, Xincai; Liu, Lan; Yang, Zhicong			Rapid Increase of Scrub Typhus: An Epidemiology and Spatial-Temporal Cluster Analysis in Guangzhou City, Southern China, 2006-2012	PLOS ONE			English	Article							VECTOR-BORNE DISEASES; ORIENTIA-TSUTSUGAMUSHI; SURVEILLANCE; TAIWAN; LEPTOTROMBIDIUM; RICKETTSIOSES; PREVALENCE; INFECTION; THAILAND; MALAYSIA	Background: Scrub typhus has been increasingly reported in Southern China, and public health authorities are concerned about its increased incidence. Additionally, little evidence is available on the epidemiology of scrub typhus in Southern China. This study aims to analyze the epidemiological and geographic features of ST in Guangzhou City, Southern China, to guide the future prevention efforts. Methods: Scrub typhus surveillance data in Guangzhou City during 2006-2012 were obtained from the Chinese National Communicable Disease Surveillance Network. We first conducted a descriptive analysis to analyze the epidemiological features of scrub typhus. Then we used space-time scan statistic based on a discrete Poisson model to detect and evaluate high-risk spatial-temporal clusters of scrub typhus. Results: There were 4,001 cases of scrub typhus in Guangzhou City during the study period. The incidence of scrub typhus increased from 3.29 per 100,000 in 2006 to 9.85 per 100,000 in 2012. A summer peak was observed in June and July with a second peak in September and October except year 2009 and 2011. The majority of the cases (71.4%) were among persons aged >= 40 years, and female incidence was higher than male incidence in persons >= 50 years. In the space-time analysis, high-risk clusters were concentrated in rural areas in Guangzhou City. Over the past 7 years, Haizhu District, an urban area, was found to be a high-risk cluster for the first time in 2012. Conclusion: The resurgence of scrub typhus epidemics in Guangzhou population in 2012 necessitates more effective measures for minimizing future epidemics. Consideration of high-risk population and historical spatial-temporal clusters may help prevent scrub typhus. The risk of scrub typhus in urban areas should not be neglected and needs more attention from public health authorities.	[Wei, Yuehong; Huang, Yong; Luo, Lei; Xiao, Xincai; Liu, Lan; Yang, Zhicong] Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China		Yang, ZC (corresponding author), Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China.	yangzc@gzcdc.org.cn			United States/NIAID NIH [HHS/AI/1R01AI083202-01A1]; National Natural Science Foundation of China [81273139, 81271880]; Guangzhou Medical Science Program [20121A011124]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083202] Funding Source: NIH RePORTER	United States/NIAID NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou Medical Science Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by United States/NIAID NIH HHS/AI/1R01AI083202-01A1, the National Natural Science Foundation of China (Grant No. 81273139 and 81271880), and the Guangzhou Medical Science Program (Grant No. 20121A011124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CADIGAN FC, 1972, T ROY SOC TROP MED H, V66, P582, DOI 10.1016/0035-9203(72)90303-3; Chinese Center for Disease Control and Prevention (China CDC), 2009, SCRUB TYPH CONTR PRE; Frances SP, 1999, J MED ENTOMOL, V36, P869, DOI 10.1093/jmedent/36.6.869; Guangzhou Bureau of Statistics, 2011, GUANGZH STAT YB; Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326; Hashimoto S, 2007, J EPIDEMIOL, V17, pS48, DOI 10.2188/jea.17.S48; Kelly DJ, 2009, CLIN INFECT DIS, V48, pS203, DOI 10.1086/596576; Kelly DJ, 2002, CLIN INFECT DIS, V34, pS145, DOI 10.1086/339908; KNUDSEN AB, 1992, B WORLD HEALTH ORGAN, V70, P1; Kovats RS, 2001, PHILOS T R SOC B, V356, P1057, DOI 10.1098/rstb.2001.0894; Kulldorff M, 1997, AM J EPIDEMIOL, V146, P161; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Kulldorff M, 2007, STAT MED, V26, P1824, DOI 10.1002/sim.2818; Kuo CC, 2011, ACTA TROP, V120, P52, DOI 10.1016/j.actatropica.2011.05.018; Kweon SS, 2009, EMERG INFECT DIS, V15, P1127, DOI 10.3201/eid1507.080399; Lee YS, 2006, JPN J INFECT DIS, V59, P235; Li J.C., 2000, CHIN J PUBLIC HLTH, V16, P773; Liu YX, 2009, PEDIATR INFECT DIS J, V28, P1111, DOI 10.1097/INF.0b013e3181af8287; Mahajan SK, 2010, EMERG INFECT DIS, V16, P1641, DOI 10.3201/eid1610.100456; Sharma PK, 2009, T ROY SOC TROP MED H, V103, P1153, DOI 10.1016/j.trstmh.2009.02.006; Silpapojakul Khachornsakdi, 1997, Annals Academy of Medicine Singapore, V26, P794; Strickland GT, 2000, HUNTERS TROPICAL MED; Suputtamongkol Y, 2009, ANN NY ACAD SCI, V1166, P172, DOI 10.1111/j.1749-6632.2009.04514.x; Tay ST, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002341; Vallee J, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000909; WANG DQ, 1992, MED VET ENTOMOL, V6, P389, DOI 10.1111/j.1365-2915.1992.tb00639.x; Wang YC, 2013, VECTOR-BORNE ZOONOT, V13, P154, DOI 10.1089/vbz.2012.1059; Watt G, 2003, CURR OPIN INFECT DIS, V16, P429, DOI 10.1097/00001432-200310000-00009; Wu G.H., 2000, CHIN J PUBLIC HLTH, V16, P777; Zhang M, 2012, AM J TROP MED HYG, V87, P1099, DOI 10.4269/ajtmh.2012.12-0306; Zhang Meng, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P419; Zhang SY, 2010, J CLIN MICROBIOL, V48, P1241, DOI 10.1128/JCM.01784-09	33	29	35	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101976	10.1371/journal.pone.0101976	http://dx.doi.org/10.1371/journal.pone.0101976			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006820	gold, Green Submitted, Green Published			2022-12-27	WOS:000339040600084
J	Zhai, YL; Zhu, L; Shi, SF; Liu, LJ; Lv, JC; Zhang, H				Zhai, Ya-Ling; Zhu, Li; Shi, Su-Fang; Liu, Li-Jun; Lv, Ji-Cheng; Zhang, Hong			Elevated Soluble VEGF Receptor sFlt-1 Correlates with Endothelial Injury in IgA Nephropathy	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; GROWTH-FACTOR VEGF; MALIGNANT HYPERTENSION; OXFORD CLASSIFICATION; ANTIBODIES; FLT-1	Background: Endothelial injury, which may present clinically as hypertension, proteinuria and increased von Willebrand Factor (vWF) level, is a common manifestation in IgA nephropathy (IgAN). However, causal factors for endothelial injury in IgAN are not completely understood. An imbalance of vascular endothelial growth factor/Soluble fms-like tyrosine kinase-1 (VEGF/sFlt-1) has been observed in many diseases with endothelial dysfunction, including pre-eclampsia and diabetic retinopathy, but whether it contributes to endothelial injury in IgAN requires further exploration. Methods: Initially, 96 IgAN patients and 22 healthy volunteers were enrolled as a discovery cohort. VEGF/sFlt-1, sFlt-1 and VEGF levels were compared between patients with IgAN and healthy volunteers to explore the underlying factors that contribute to endothelial injury in IgAN. The identified contributor (sFlt-1) was further confirmed in a replication cohort, which included 109 IgAN patients and 30 healthy volunteers. Correlations of sFlt-1 with hypertension, proteinuria, Oxford-E score and plasma vWF were further evaluated in the combined 205 patients with IgAN. Results: VEGF/sFlt-1 levels were significantly lower in IgAN patients than healthy volunteers (0.33 +/- 0.27 vs. 0.43 +/- 0.22, p = 0.02) in the discovery cohort. Within the ratio, plasma sFlt-1 levels were significantly elevated (101.18 +/- 25.19 vs. 79.73 +/- 18.85 pg/ml, p<0.001), but plasma VEGF levels showed no significant differences. Elevated sFlt-1 levels in the replication cohort were confirmed in IgAN patients (93.40 +/- 39.78 vs. 71.92 +/- 15.78 pg/ml, p<0.001). Plasma sFlt-1 levels in IgAN patients correlated with proteinuria (severe (>3.5 g/d) vs. moderate (1-3.5 g/d) vs. mild (<1 g/d) proteinuria: 115.95 +/- 39.09 vs. 99.89 +/- 28.55 vs. 83.24 +/- 33.92 pg/ml; severe vs. mild: p<0.001, moderate vs. mild p = 0.001, severe vs. moderate: p = 0.014), hypertension (with vs. without hypertension: 107.87 +/- 31.94 vs. 87.32 +/- 32.76 pg/ml, p = 0.015) and vWF levels (r = 0.161, p = 0.021). Conclusions: The present study found elevated sFlt-1 in IgAN patients and further identified its correlation with proteinuria, hypertension and vWF levels. These results suggested that elevated sFlt-1 contributes to endothelial injury in IgAN.	[Zhai, Ya-Ling; Zhu, Li; Shi, Su-Fang; Liu, Li-Jun; Lv, Ji-Cheng; Zhang, Hong] Peking Univ, Hosp 1, Dept Med, Div Renal, Beijing 100871, Peoples R China; [Zhai, Ya-Ling; Zhu, Li; Shi, Su-Fang; Liu, Li-Jun; Lv, Ji-Cheng; Zhang, Hong] Peking Univ, Inst Nephrol, Beijing 100871, Peoples R China; [Zhai, Ya-Ling; Zhu, Li; Shi, Su-Fang; Liu, Li-Jun; Lv, Ji-Cheng; Zhang, Hong] Minist Hlth China, Key Lab Renal Dis, Beijing, Peoples R China; [Zhai, Ya-Ling; Zhu, Li; Shi, Su-Fang; Liu, Li-Jun; Lv, Ji-Cheng; Zhang, Hong] Peking Univ, Minist Educ, Key Lab Chron Kidney Dis Prevent & Treatment, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Zhu, L (corresponding author), Peking Univ, Hosp 1, Dept Med, Div Renal, Beijing 100871, Peoples R China.	funnyzhuli@bjmu.edu.cn			National Natural Science Foundation for Innovative Research Groups of China [81021004]; National Natural Science Foundation for Youths of China [81000297, 81200515]	National Natural Science Foundation for Innovative Research Groups of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation for Youths of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation for Innovative Research Groups of China ( Grant No. 81021004) and by the National Natural Science Foundation for Youths of China (Grants No. 81000297 and 81200515). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barratt J, 2005, J AM SOC NEPHROL, V16, P2088, DOI 10.1681/ASN.2005020134; Belgore FM, 2001, AM J CARDIOL, V87, P805, DOI 10.1016/S0002-9149(00)01512-5; Bertaglia G, 1997, NEPHROL DIAL TRANSPL, V12, P474, DOI 10.1093/ndt/12.3.474; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Chen Y, 2005, KIDNEY BLOOD PRESS R, V28, P251, DOI 10.1159/000090058; Clark DE, 1998, BIOL REPROD, V59, P1540, DOI 10.1095/biolreprod59.6.1540; DAMICO G, 1987, Q J MED, V64, P709; Di Marco GS, 2009, J AM SOC NEPHROL, V20, P2235, DOI 10.1681/ASN.2009010061; El Karoui K, 2012, J AM SOC NEPHROL, V23, P137, DOI 10.1681/ASN.2010111130; Hagmann H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085258; Hernandez E, 1997, AM J KIDNEY DIS, V30, P397, DOI 10.1016/S0272-6386(97)90285-7; Javanmard SH, 2012, J RES MED SCI, V17, P1124; Jiang L, 2008, NEPHROL DIAL TRANSPL, V23, P3921, DOI 10.1093/ndt/gfn371; Karalliedde J, 2011, DIABETES CARE, V34, pS291, DOI 10.2337/dc11-s241; Keedy VL, 2007, CANCER SCI, V98, P1825, DOI 10.1111/j.1349-7006.2007.00620.x; Kendall RL, 1996, BIOCHEM BIOPH RES CO, V226, P324, DOI 10.1006/bbrc.1996.1355; Kim NH, 2005, KIDNEY INT, V67, P167, DOI 10.1111/j.1523-1755.2005.00067.x; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Major HD, 2014, AM J OBSTET IN PRESS; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Shibuya Masaubmi, 2006, Angiogenesis, V9, P225, DOI 10.1007/s10456-006-9055-8; Sugimoto H, 2003, J BIOL CHEM, V278, P12605, DOI 10.1074/jbc.C300012200; WOO K T, 1988, Annals Academy of Medicine Singapore, V17, P583; Wu FTH, 2010, J CELL MOL MED, V14, P528, DOI 10.1111/j.1582-4934.2009.00941.x; Zhang JJ, 2008, NEPHROLOGY, V13, P712, DOI 10.1111/j.1440-1797.2008.00983.x	26	33	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101779	10.1371/journal.pone.0101779	http://dx.doi.org/10.1371/journal.pone.0101779			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007257	gold, Green Submitted, Green Published			2022-12-27	WOS:000339040600067
J	Cai, GJ; Zhang, BF; Weng, WJ; Shi, GW; Xue, SL; Song, YB; Ma, CY				Cai, Gaojun; Zhang, Bifeng; Weng, Weijin; Shi, Ganwei; Xue, Sheliang; Song, Yanbin; Ma, Chunyan			E-Selectin Gene Polymorphisms and Essential Hypertension in Asian Population: An Updated Meta-Analysis	PLOS ONE			English	Article							ISCHEMIC-STROKE; BLOOD-PRESSURE	Objective: Epidemiological studies have shown that E-selectin gene polymorphisms (A561C and C1839T) may be associated with essential hypertension (EH), but the results are conflicting in different ethnic populations. Thus, we performed this meta-analysis to investigate a more authentic association between E-selectin gene polymorphisms and the risk of EH. Methods: We searched the relevant studies for the present meta-analysis from the following electronic databases: PubMed, Embase, Cochrane Library, Google Scholar, Web of Science, Wanfang Data, and China National Knowledge Infrastructure (CNKI). Odds ratios (OR) with 95% confidence interval (CI) were used to evaluate the strength of the association between E-selectin gene polymorphisms and EH susceptibility. The pooled ORs were performed for dominant model, allelic model and recessive model. The publication bias was examined by Begg's funnel plots and Egger's test. Results: A total of eleven studies met the inclusion criteria. All studies came from Asians. Ten studies (12 cohorts) evaluated the A561C polymorphism and EH risk, including 2,813 cases and 2,817 controls. The pooled OR was 2.280 (95% CI: 1.893-2.748, P<0.001) in dominant model, 5.284 (95% CI: 2.679-10.420, P<0.001) in recessive model and 2.359 (95% CI: 1.981-2.808, P = 0.001) in allelic model. Four studies (six cohorts) evaluated C1839T polymorphism and EH risk, including 1,700 cases and 1,681 controls. The pooled OR was 0.785 (95% CI: 0.627-0.983, P = 0.035) in dominant model, 1.250 (95% CI: 0.336-4.652, P = 0.739) in recessive model and 0.805 (95% CI: 0.649-0.999, P = 0.049) in allelic model. Conclusion: The current meta-analysis concludes that the C allele of E-selectin A561C gene polymorphism might increase the EH risk in Asian population, whereas the T allele of E-selectin C1839T gene polymorphism might decrease the EH risk.	[Cai, Gaojun; Weng, Weijin; Shi, Ganwei; Xue, Sheliang; Song, Yanbin; Ma, Chunyan] Jiangsu Univ, Wujin Hosp, Dept Cardiol, Changzhou, Jiangsu, Peoples R China; [Zhang, Bifeng] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 4L8, Canada	Jiangsu University; McMaster University	Cai, GJ (corresponding author), Jiangsu Univ, Wujin Hosp, Dept Cardiol, Changzhou, Jiangsu, Peoples R China.	cgj982@126.com						Biino G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059612; Chen Hai-ling, 2005, Zhonghua Xinxueguanbing Zazhi, V33, P603; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Echouffo-Tcheugui JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067370; Haidari M, 2009, CEREBROVASC DIS, V28, P26, DOI 10.1159/000215940; Kamna Srivastava, 2012, Journal of Pharmacy Research, V5, P880; Li MN, 2009, CHINESE J BIRTH HLTH, V17, P23; Li MN, 2009, CHIN J LAB DIAGN, V13, P644; Li Y WY, 2003, CHIN J GERIATR CARDI, V5, P384; [刘兆川 LIU ZhaoChuan], 2006, [第三军医大学学报, Acta Academiae Medicinae Militaris Tertiae], V28, P2383; Maggio ABR, 2012, EUR J CLIN INVEST, V42, P303, DOI 10.1111/j.1365-2362.2011.02583.x; Marteau JB, 2004, J HYPERTENS, V22, P305, DOI 10.1097/00004872-200402000-00014; [宋芸 SONG Yun], 2007, [第四军医大学学报, Journal of the Fourth Military Medical University], V28, P2075; Srivastava K, 2006, J HUM HYPERTENS, V20, P537, DOI 10.1038/sj.jhh.1002034; Sun QL, 2011, NEURAL REGEN RES, V6, P1731, DOI 10.3969/j.issn.1673-5374.2011.22.009; Toker A, 2013, CLIN LAB, V59, P107, DOI 10.7754/Clin.Lab.2012.120128; Wang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079301; Wang Z, 2012, HYPERTENS RES, V35, P413, DOI 10.1038/hr.2011.204; Wang ZG, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-127; WENZEL K, 1994, HUM MOL GENET, V3, P1935, DOI 10.1093/hmg/3.11.1935; Zhang JL, 2007, THESIS YUNNAN U; Zheng WW, 2009, CHINA PRACMED, V4, P5	22	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e102058	10.1371/journal.pone.0102058	http://dx.doi.org/10.1371/journal.pone.0102058			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003340	gold, Green Submitted, Green Published			2022-12-27	WOS:000339242700103
J	He, N; Zheng, H; Li, P; Zhao, YR; Zhang, W; Song, FJ; Chen, KX				He, Na; Zheng, Hong; Li, Pei; Zhao, Yanrui; Zhang, Wei; Song, Fengju; Chen, Kexin			miR-485-5p Binding Site SNP rs8752 in HPGD Gene Is Associated with Breast Cancer Risk	PLOS ONE			English	Article							MICRORNA-RELATED GENES; SINGLE-NUCLEOTIDE POLYMORPHISMS; 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE; TUMOR-SUPPRESSOR; TARGET SITES; VARIANTS; DATABASE; REGION; STAGE	Background: Single nucleotide polymorphisms (SNPs) that reside in microRNA target sites may play an important role in breast cancer development and progression. To reveal the association between microRNA target site SNPs and breast cancer risk, we performed a large case-control study in China. Methods: We performed a two-stage case-control study including 2744 breast cancer cases and 3125 controls. In Stage I, we genotyped 192 SNPs within microRNA binding sites identified from the "Patrocles'' database using custom Illumina GoldenGate VeraCode assays on the Illumina BeadXpress platform. In Stage II, genotyping was performed on SNPs potentially associated with breast cancer risk using the TaqMan platform in an independent replication set. Results: In stage I, 15 SNPs were identified to be significantly associated with breast cancer risk (P<0.05). In stage II, one SNP rs8752 was replicated at P<0.05. This SNP is located in the 3' untranslated region (UTR) of the 15-hydroxyprostaglandin dehydrogenase (HPGD) gene at 4q34-35, a miR-485-5p binding site. Compared with the GG genotype, the combined GA+AA genotypes has a significantly higher risk of breast cancer (OR = 1.18; 95% CI: 1.06-1.31, P = 0.002). Specifically, this SNP was associated with estrogen receptor (ER) positive breast cancer (P = 0.0007), but not with ER negative breast cancer (P = 0.23), though p for heterogeneity not significant. Conclusion: Through a systematic case-control study of microRNA binding site SNPs, we identified a new breast cancer risk variant rs8752 in HPGD in Chinese women. Further studies are warranted to investigate the underling mechanism for this association.	[He, Na; Zheng, Hong; Li, Pei; Zhao, Yanrui; Song, Fengju; Chen, Kexin] Tianjin Med Univ Canc Inst & Hosp, Key Lab Breast Canc Prevent & Therapy, Key Lab Canc Prevent & Therapy,Minist Educ, Dept Epidemiol & Biostat,Natl Clin Res Ctr Canc, Tianjin, Peoples R China; [Zhang, Wei] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	Tianjin Medical University; University of Texas System; UTMD Anderson Cancer Center	Song, FJ (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Key Lab Breast Canc Prevent & Therapy, Key Lab Canc Prevent & Therapy,Minist Educ, Dept Epidemiol & Biostat,Natl Clin Res Ctr Canc, Tianjin, Peoples R China.	songfengju@163.com		Chen, Kexin/0000-0003-4248-7681	Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) in China [IRT1076]; National Key Scientific and Technological Project [2011ZX09307-001-04]; National Natural Science Foundation of China [81172762]; Tianjin Cancer Institute and Hospital; U.S. National Foundation for Cancer Research	Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) in China(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Key Scientific and Technological Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Cancer Institute and Hospital; U.S. National Foundation for Cancer Research	This work was supported by the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) in China (IRT1076), the National Key Scientific and Technological Project (2011ZX09307-001-04), and the National Natural Science Foundation of China (No. 81172762). The tissue bank is jointly supported by the Tianjin Cancer Institute and Hospital and the U.S. National Foundation for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babashah S, 2011, EUR J CANCER, V47, P1127, DOI 10.1016/j.ejca.2011.02.008; Backlund MG, 2005, J BIOL CHEM, V280, P3217, DOI 10.1074/jbc.M411221200; Bhattacharya A, 2014, NUCLEIC ACIDS RES, V42, pD86, DOI 10.1093/nar/gkt1028; Brendle A, 2008, CARCINOGENESIS, V29, P1394, DOI 10.1093/carcin/bgn126; Chen JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086319; Chen KX, 2008, CARCINOGENESIS, V29, P1306, DOI 10.1093/carcin/bgn116; Chen ZW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061008; Chin LJ, 2008, CANCER RES, V68, P8535, DOI 10.1158/0008-5472.CAN-08-2129; Ding YF, 2005, CARCINOGENESIS, V26, P65, DOI 10.1093/carcin/bgh277; Fowler A, 2011, EUR J CANCER, V47, P953, DOI 10.1016/j.ejca.2010.11.026; Gilam A, 2013, BREAST CANCER RES TR, V138, P753, DOI 10.1007/s10549-013-2502-5; Hiard S, 2010, NUCLEIC ACIDS RES, V38, pD640, DOI 10.1093/nar/gkp926; Huang GS, 2008, CANCER RES, V68, P5040, DOI 10.1158/0008-5472.CAN-07-6575; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Jedlinski DJ, 2011, TWIN RES HUM GENET, V14, P417, DOI 10.1375/twin.14.5.417; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084532; Kang S, 2013, INT J ONCOL, V43, P1659, DOI 10.3892/ijo.2013.2094; Kontorovich T, 2010, INT J CANCER, V127, P589, DOI 10.1002/ijc.25065; Landi D, 2008, CARCINOGENESIS, V29, P579, DOI 10.1093/carcin/bgm304; Landi D, 2008, DNA CELL BIOL, V27, P35, DOI 10.1089/dna.2007.0650; Li MN, 2008, CANCER INVEST, V26, P905, DOI 10.1080/07357900802146154; Li XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031146; Lin J, 2010, CARCINOGENESIS, V31, P1805, DOI 10.1093/carcin/bgq168; Lin MB, 2012, CLIN CANCER RES, V18, P3982, DOI 10.1158/1078-0432.CCR-11-2951; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; Pham H, 2008, MOL CARCINOGEN, V47, P466, DOI 10.1002/mc.20404; Ryu YM, 2013, CANCER PREV RES, V6, P349, DOI 10.1158/1940-6207.CAPR-12-0389; Saetrom P, 2009, CANCER RES, V69, P7459, DOI 10.1158/0008-5472.CAN-09-1201; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Slaby O, 2012, J CELL MOL MED, V16, P8, DOI 10.1111/j.1582-4934.2011.01359.x; Song FJ, 2009, CLIN CANCER RES, V15, P6292, DOI 10.1158/1078-0432.CCR-09-0826; Teo MTW, 2012, CARCINOGENESIS, V33, P581, DOI 10.1093/carcin/bgr300; Tong M, 2004, ENDOCRINOLOGY, V145, P2141, DOI 10.1210/en.2003-1229; Wang LH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039845, 10.1371/journal.pone.0051769, 10.1371/journal.pone.0045491, 10.1371/journal.pone.0044596]; Winter J, 2011, METHODS MOL BIOL, V676, P3, DOI 10.1007/978-1-60761-863-8_1; Wolf I, 2006, CANCER RES, V66, P7818, DOI 10.1158/0008-5472.CAN-05-4368; Wu HL, 2009, CELL RES, V19, P439, DOI 10.1038/cr.2009.18; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yang HS, 2008, CANCER RES, V68, P2530, DOI 10.1158/0008-5472.CAN-07-5991; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P4535, DOI 10.1093/nar/gkm480; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079; Zhang LN, 2011, P NATL ACAD SCI USA, V108, P13653, DOI 10.1073/pnas.1103360108; Zheng H, 2011, INT J ONCOL, V38, P1153, DOI 10.3892/ijo.2011.940	44	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e102093	10.1371/journal.pone.0102093	http://dx.doi.org/10.1371/journal.pone.0102093			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003827	gold, Green Published, Green Submitted			2022-12-27	WOS:000339242700107
J	Morken, NH; Travlos, GS; Wilson, RE; Eggesbo, M; Longnecker, MP				Morken, Nils-Halvdan; Travlos, Gregory S.; Wilson, Ralph E.; Eggesbo, Merete; Longnecker, Matthew P.			Maternal Glomerular Filtration Rate in Pregnancy and Fetal Size	PLOS ONE			English	Article							NORWEGIAN MOTHER; CHILD COHORT; PERFLUOROALKYL SUBSTANCES; POLYFLUOROALKYL COMPOUNDS; BIRTH-WEIGHT; PLASMA; GROWTH; WOMEN; EQUATIONS; VOLUME	Background: The relationship of maternal glomerular filtration rate (GFR) in pregnancy to fetal size needs to be better characterized as it impacts an ongoing debate about confounding effect of maternal GFR in investigations of important environmental contaminants. We aimed to characterize the size of the association between maternal GFR and infant birth weight. Materials and Methods: A sub-cohort of 953 selected women (470 women with and 483 women without preeclampsia) in the Norwegian Mother and Child Cohort (MoBa), recruited during 2003-2007 were analyzed. GFR in the second trimester was estimated based on plasma creatinine. Birth weight was ascertained from the Medical Birth Registry of Norway. Multivariate linear regression was used to evaluate the association between maternal GFR in second trimester (estimated by the Cockroft-Gault [GFR-CG] and the modification of diet in renal disease [GFR-MDRD] formulas) and infant birth weight. Partial correlation coefficients were also calculated. Results: Maternal GFR-CG (beta: 0.73 g/ml/min, p = 0.04) and GFR-MDRD (beta: 0.83 g/ml/min, p = 0.04) were associated with infant birth weight in models adjusted for maternal weight in kilograms, preeclampsia, and gestational age at delivery (days). Partial correlation coefficients for the association between infant birth weight and GFR were 0.07 for both formulas. Although the birth weight-GFR association was stronger among the women with preeclampsia, the difference from women without preeclampsia was not statistically significant. Conclusion: These data support an association between GFR during pregnancy and infant birth weight, and indicate that GFR may confound selected epidemiologic associations.	[Morken, Nils-Halvdan] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Morken, Nils-Halvdan] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Morken, Nils-Halvdan] Haukeland Hosp, Dept Obstet & Gynecol, N-5021 Bergen, Norway; [Travlos, Gregory S.; Wilson, Ralph E.] NIEHS, Cellular & Mol Pathol Branch, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA; [Eggesbo, Merete] Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway; [Longnecker, Matthew P.] NIEHS, Epidemiol Branch, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA	University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Norwegian Institute of Public Health (NIPH); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Morken, NH (corresponding author), Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway.	nils-halvdan.morken@kk.uib.no		Longnecker, Matthew/0000-0001-6073-5322; Eggesbo, Merete/0000-0002-0006-5336	University of Bergen; Unger-Vetlesen Medical Fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES044008] Funding Source: NIH RePORTER	University of Bergen; Unger-Vetlesen Medical Fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Nils-Halvdan Morken was supported with funding from the University of Bergen and the Unger-Vetlesen Medical Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SB, 2009, HYPERTENS PREGNANCY, V28, P243, DOI 10.1080/10641950801986720; Akahori Y, 2012, GYNECOL OBSTET INVES, V73, P162, DOI 10.1159/000332391; Al-Delaimy WK, 2006, BIOMARKERS, V11, P370, DOI 10.1080/13547500600799748; Alper AB, 2011, AM J PERINAT, V28, P425, DOI 10.1055/s-0030-1268712; Calafat AM, 2007, ENVIRON SCI TECHNOL, V41, P2237, DOI 10.1021/es062686m; Chen MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042474; Clark S, 2003, INT J EPIDEMIOL, V32, P125, DOI 10.1093/ije/dyg023; Delanaye P, 2013, NAT REV NEPHROL, V9, P513, DOI 10.1038/nrneph.2013.143; DUNLOP W, 1981, BRIT J OBSTET GYNAEC, V88, P1, DOI 10.1111/j.1471-0528.1981.tb00929.x; Duvekot J J, 1994, Obstet Gynecol Surv, V49, pS1, DOI 10.1097/00006254-199412011-00001; Duvekot J J, 1994, Obstet Gynecol Surv, V49, P830, DOI 10.1097/00006254-199412000-00007; DUVEKOT JJ, 1995, OBSTET GYNECOL, V85, P361, DOI 10.1016/0029-7844(94)00417-C; GIBSON HM, 1973, J OBSTET GYN BR COMM, V80, P1067; Halldorsson TI, 2012, ENVIRON HEALTH PERSP, V120, P668, DOI 10.1289/ehp.1104034; Johnson DW, 2012, MED J AUSTRALIA, V197, P224, DOI 10.5694/mja11.11468; Johnson P SP, 2013, C INT SOC ENV EP ISE; Knopp R H, 1985, Diabetes, V34 Suppl 2, P71; Koetje PMJL, 2011, REPROD SCI, V18, P456, DOI 10.1177/1933719110387831; Loccisano A, 2012, TOXICOLOGICAL SCI S, V97; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; Maisonet M, 2012, ENVIRON HEALTH PERSP, V120, P1432, DOI 10.1289/ehp.1003096; Nilsen RM, 2009, PAEDIATR PERINAT EP, V23, P597, DOI 10.1111/j.1365-3016.2009.01062.x; O'Sullivan JJ, 2000, ARCH DIS CHILD, V82, P202, DOI 10.1136/adc.82.3.202; Olson JE, 1997, AM J EPIDEMIOL, V145, P58; Ronningen KS, 2006, EUR J EPIDEMIOL, V21, P619, DOI 10.1007/s10654-006-9041-x; Rule AD, 2004, AM J KIDNEY DIS, V43, P112, DOI 10.1053/j.ajkd.2003.09.026; Smith MC, 2008, BJOG-INT J OBSTET GY, V115, P109, DOI 10.1111/j.1471-0528.2007.01529.x; Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322; Starling AP, 2014, AM J EPIDEMIOL, V179, P824, DOI 10.1093/aje/kwt432; Starling AP, 2014, ENVIRON INT, V62, P104, DOI 10.1016/j.envint.2013.10.004; Whitworth KW, 2012, AM J EPIDEMIOL, V175, P1209, DOI 10.1093/aje/kwr459; Zhou HB, 2007, EPIDEMIOLOGY, V18, P461, DOI 10.1097/EDE.0b013e31806462d3	32	43	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101897	10.1371/journal.pone.0101897	http://dx.doi.org/10.1371/journal.pone.0101897			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003331	Green Published, Green Submitted, gold			2022-12-27	WOS:000339242700085
J	Pakeman, RJ				Pakeman, Robin J.			Leaf Dry Matter Content Predicts Herbivore Productivity, but Its Functional Diversity Is Positively Related to Resilience in Grasslands	PLOS ONE			English	Article							LAND-USE INTENSIFICATION; ECOSYSTEM SERVICES; RESPONSE DIVERSITY; TRAITS; COMMUNITIES; REDUNDANCY; MANAGEMENT; FERTILITY; LANDSCAPE; FRAMEWORK	This paper addresses whether the ecosystem service of animal production from grasslands depends upon plant functional identity, plant functional diversity or if the resilience of production is a function of this diversity. Using the results of nine grazing experiments the paper shows that productivity is highly dependent on one leaf trait, leaf dry matter content, as well as rainfall. Animal (secondary) productivity is not dependent on plant functional diversity, but the variability in productivity of grasslands is related to the functional diversity of leaf dry matter content. This and a range of independent studies have shown that functional diversity is reduced at high levels of grassland productivity, so it appears that there is a trade-off between productivity and the resilience of productivity in the face of environmental variation.	James Hutton Inst, Aberdeen, Scotland	James Hutton Institute	Pakeman, RJ (corresponding author), James Hutton Inst, Aberdeen, Scotland.	robin.pakeman@hutton.ac.uk	Pakeman, Robin Jeffrey/P-7338-2015	Pakeman, Robin Jeffrey/0000-0001-6248-4133	Scottish Government's Rural and Environmental Research and Analysis Services Division	Scottish Government's Rural and Environmental Research and Analysis Services Division	The research was supported by the Scottish Government's Rural and Environmental Research and Analysis Services Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2011, SCIENCE, V333, P1750, DOI 10.1126/science.1204498; [Anonymous], 2010, R LANG ENV STAT COMP; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Biggs R, 2012, ANNU REV ENV RESOUR, V37, P421, DOI 10.1146/annurev-environ-051211-123836; Carpenter SR, 2006, ECOL SOC, V11; Chanteloup P, 2013, BASIC APPL ECOL, V14, P208, DOI 10.1016/j.baae.2013.01.002; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Crawley M.J., 2007, R BOOK; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Duru M, 2008, AGRON J, V100, P1622, DOI 10.2134/agronj2008.0003; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Freckleton RP, 1999, AGR FOREST METEOROL, V93, P39, DOI 10.1016/S0168-1923(98)00106-3; Garcia-Berthou E, 2001, J ANIM ECOL, V70, P708, DOI 10.1046/j.1365-2656.2001.00524.x; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Grant SA, 1996, J APPL ECOL, V33, P1267, DOI 10.2307/2404769; Hodgson JG, 2011, ANN BOT-LONDON, V108, P1337, DOI 10.1093/aob/mcr225; Isbell F, 2013, P NATL ACAD SCI USA, V110, P11911, DOI 10.1073/pnas.1310880110; Kleyer M, 2008, J ECOL, V96, P1266, DOI 10.1111/j.1365-2745.2008.01430.x; Klotz S., 2002, BIOLFLOR EINE DATENB; Klumpp K, 2009, GLOBAL CHANGE BIOL, V15, P2921, DOI 10.1111/j.1365-2486.2009.01905.x; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Laliberte E, 2010, ECOL LETT, V13, P76, DOI 10.1111/j.1461-0248.2009.01403.x; Lavorel S, 2012, J ECOL, V100, P128, DOI 10.1111/j.1365-2745.2011.01914.x; Lavorel S, 2011, J ECOL, V99, P135, DOI 10.1111/j.1365-2745.2010.01753.x; Marriott CA, 2009, AGR ECOSYST ENVIRON, V134, P190, DOI 10.1016/j.agee.2009.07.002; Mason NWH, 2003, J VEG SCI, V14, P571, DOI 10.1111/j.1654-1103.2003.tb02184.x; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Mouillot D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017476; Pakeman RJ, 2004, J ECOL, V92, P893, DOI 10.1111/j.0022-0477.2004.00928.x; Pakeman RJ, 2013, FOLIA GEOBOT, V48, P355, DOI 10.1007/s12224-013-9168-y; Pakeman RJ, 2011, ECOLOGY, V92, P1353, DOI 10.1890/10-1728.1; Pakeman RJ, 2009, J VEG SCI, V20, P148, DOI 10.1111/j.1654-1103.2009.05548.x; Perry M, 2005, INT J CLIMATOL, V25, P1041, DOI 10.1002/joc.1161; Pinheiro J., 2010, NLME LINEAR NONLINEA, P1; Polley HW, 2013, OIKOS, V122, P1275, DOI 10.1111/j.1600-0706.2013.00338.x; Poorter H, 1999, NEW PHYTOL, V143, P163, DOI 10.1046/j.1469-8137.1999.00428.x; Quetier F, 2007, ECOL MONOGR, V77, P33, DOI 10.1890/06-0054; Roscher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036760; Schumacher J, 2009, OIKOS, V118, P1659, DOI 10.1111/j.1600-0706.2009.17711.x; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Walker B, 1999, ECOSYSTEMS, V2, P95, DOI 10.1007/s100219900062; Zuur AF, 2009, STAT BIOL HLTH, P269	44	17	20	6	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101876	10.1371/journal.pone.0101876	http://dx.doi.org/10.1371/journal.pone.0101876			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003997	Green Published, gold, Green Submitted			2022-12-27	WOS:000339242700081
J	Cheema, MU; Damkier, HH; Nielsen, J; Poulsen, ET; Enghild, JJ; Fenton, RA; Praetorius, J				Cheema, Muhammad Umar; Damkier, Helle Hasager; Nielsen, Jakob; Poulsen, Ebbe Toftgaard; Enghild, Jan J.; Fenton, Robert A.; Praetorius, Jeppe			Distal Renal Tubules Are Deficient in Aggresome Formation and Autophagy upon Aldosterone Administration	PLOS ONE			English	Article							DIABETIC-NEPHROPATHY; SODIUM TRANSPORT; PROTEIN; PLASMA; MINERALOCORTICOIDS; ACTIVATION; MECHANISM; EXCRETION; APOPTOSIS; BLOCKADE	Prolonged elevations of plasma aldosterone levels are associated with renal pathogenesis. We hypothesized that renal distress could be imposed by an augmented aldosterone-induced protein turnover challenging cellular protein degradation systems of the renal tubular cells. Cellular accumulation of specific protein aggregates in rat kidneys was assessed after 7 days of aldosterone administration. Aldosterone induced intracellular accumulation of 60 s ribosomal protein L22 in protein aggregates, specifically in the distal convoluted tubules. The mineralocorticoid receptor inhibitor spironolactone abolished aldosterone-induced accumulation of these aggregates. The aldosterone-induced protein aggregates also contained proteasome 20 s subunits. The partial de-ubiquitinase ataxin-3 was not localized to the distal renal tubule protein aggregates, and the aggregates only modestly colocalized with aggresome transfer proteins dynactin p62 and histone deacetylase 6. Intracellular protein aggregation in distal renal tubules did not lead to development of classical juxta-nuclear aggresomes or to autophagosome formation. Finally, aldosterone treatment induced foci in renal cortex of epithelial vimentin expression and a loss of E-cadherin expression, as signs of cellular stress. The cellular changes occurred within high, but physiological aldosterone concentrations. We conclude that aldosterone induces protein accumulation in distal renal tubules; these aggregates are not cleared by autophagy that may lead to early renal tubular damage.	[Cheema, Muhammad Umar; Damkier, Helle Hasager; Nielsen, Jakob; Fenton, Robert A.; Praetorius, Jeppe] Aarhus Univ, Membranes Ctr, Dept Biomed, Aarhus, Denmark; [Cheema, Muhammad Umar; Damkier, Helle Hasager; Nielsen, Jakob; Fenton, Robert A.; Praetorius, Jeppe] Aarhus Univ, InterPrET Pilot Ctr, Aarhus, Denmark; [Poulsen, Ebbe Toftgaard; Enghild, Jan J.] Aarhus Univ, iNano, Dept Mol Biol & Genet, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Praetorius, J (corresponding author), Aarhus Univ, Membranes Ctr, Dept Biomed, Aarhus, Denmark.	jp@ana.au.dk	Fenton, Robert/AFR-6983-2022; Praetorius, Jeppe/AAU-7893-2020; Fenton, Robert A/ABD-9824-2021	Fenton, Robert/0000-0003-1623-199X; Praetorius, Jeppe/0000-0001-6109-247X; Toftgaard Poulsen, Ebbe/0000-0002-4416-0431; Damkier, Helle/0000-0001-7518-4017; Enghild, Jan Johannes/0000-0001-9292-9172	Graduate School of Health Sciences, Aarhus University; Water and Salt Research Center at Aarhus University - (Danish National Research Foundation); Lundbeck Foundation; Danish Heart Association	Graduate School of Health Sciences, Aarhus University; Water and Salt Research Center at Aarhus University - (Danish National Research Foundation); Lundbeck Foundation(Lundbeckfonden); Danish Heart Association	Muhammad Umar Cheema was supported by a PhD stipend co-financed by Graduate School of Health Sciences, Aarhus University and the Water and Salt Research Center at Aarhus University (established and supported by the Danish National Research Foundation). Financial support for running costs were granted by the Lundbeck Foundation and the Danish Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts A, 2008, MOL BIOL CELL; Bernini G, 2008, J HYPERTENS, V26, P981, DOI 10.1097/HJH.0b013e3282f61f8c; Bertocchio JP, 2011, KIDNEY INT, V79, P1051, DOI 10.1038/ki.2011.48; Brezniceanu ML, 2010, J AM SOC NEPHROL, V21, P943, DOI 10.1681/ASN.2009030242; Brown NJ, 2000, KIDNEY INT, V58, P1219, DOI 10.1046/j.1523-1755.2000.00277.x; Cheema MU, 2013, PHYSL REPORTS, V1; Christensen BM, 2006, AM J PHYSIOL-RENAL, V291, pF39, DOI 10.1152/ajprenal.00383.2005; Dyrlund TF, 2012, PROTEOMICS, V12, P2792, DOI 10.1002/pmic.201200109; EDELMAN IS, 1963, P NATL ACAD SCI USA, V50, P1169, DOI 10.1073/pnas.50.6.1169; Feria I, 2003, KIDNEY INT, V63, P43, DOI 10.1046/j.1523-1755.2003.00707.x; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; HANDLER JS, 1969, J BIOL CHEM, V244, P3194; Hol EM, 2006, EXPERT REV NEUROTHER, V6, P1337, DOI 10.1586/14737175.6.9.1337; Hollenberg NK, 2004, KIDNEY INT, V65, P1435, DOI 10.1111/j.1523-1755.2004.00524.x; HORISBERGER JD, 1983, AM J PHYSIOL, V245, pF89, DOI 10.1152/ajprenal.1983.245.1.F89; Johnston JA, 2002, CELL MOTIL CYTOSKEL, V53, P26, DOI 10.1002/cm.10057; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Ku NO, 2010, NAT CELL BIOL, V12, P876, DOI 10.1038/ncb2091; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Morcos M, 2002, DIABETES, V51, P3532, DOI 10.2337/diabetes.51.12.3532; Nagase M, 2010, CLIN EXP NEPHROL, V14, P303, DOI 10.1007/s10157-010-0298-8; Nagata S, 2010, PEPTIDES, V31, P889, DOI 10.1016/j.peptides.2010.02.008; Nielsen J, 2007, AM J PHYSIOL-RENAL, V292, pF382, DOI 10.1152/ajprenal.00212.2005; Ouyang H, 2012, J BIOL CHEM, V287, P2317, DOI 10.1074/jbc.M111.273730; Patni H, 2007, AM J PHYSIOL-RENAL, V293, pF1065, DOI 10.1152/ajprenal.00147.2007; PFLEIDERER S, 1993, CLIN INVESTIGATOR, V71, P972; Reilly RF, 2000, PHYSIOL REV, V80, P277, DOI 10.1152/physrev.2000.80.1.277; Rosenbaek LL, 2012, J PHYSIOL-LONDON, V590, P6121, DOI 10.1113/jphysiol.2012.240986; SHARP GWG, 1965, J BIOL CHEM, V240, P4816; SIMPSON SA, 1954, EXPERIENTIA, V10, P132, DOI 10.1007/BF02158515; Thomas ME, 1999, KIDNEY INT, V55, P890, DOI 10.1046/j.1523-1755.1999.055003890.x; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; YAQOOB M, 1994, Q J MED, V87, P601	33	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101258	10.1371/journal.pone.0101258	http://dx.doi.org/10.1371/journal.pone.0101258			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000288	Green Submitted, gold, Green Published			2022-12-27	WOS:000338637300028
J	Endmann, A; Kluender, K; Kapp, K; Riede, O; Oswald, D; Talman, EG; Schroff, M; Kleuss, C; Ruiters, MHJ; Juhls, C				Endmann, Anne; Klunder, Katharina; Kapp, Kerstin; Riede, Oliver; Oswald, Detlef; Talman, Eduard G.; Schroff, Matthias; Kleuss, Christiane; Ruiters, Marcel H. J.; Juhls, Christiane			Cationic Lipid-Formulated DNA Vaccine against Hepatitis B Virus: Immunogenicity of MIDGE-Th1 Vectors Encoding Small and Large Surface Antigen in Comparison to a Licensed Protein Vaccine	PLOS ONE			English	Article							IMMUNE-RESPONSES; PARTICLE MORPHOGENESIS; EXPRESSION CONSTRUCTS; MEDIATED IMMUNIZATION; ANTIBODY-RESPONSES; ENVELOPE PROTEINS; HUMORAL RESPONSE; GENE DELIVERY; T-CELL; MICE	Currently marketed vaccines against hepatitis B virus (HBV) based on the small (S) hepatitis B surface antigen (HBsAg) fail to induce a protective immune response in about 10% of vaccinees. DNA vaccination and the inclusion of PreS1 and PreS2 domains of HBsAg have been reported to represent feasible strategies to improve the efficacy of HBV vaccines. Here, we evaluated the immunogenicity of SAINT-18-formulated MIDGE-Th1 vectors encoding the S or the large (L) protein of HBsAg in mice and pigs. In both animal models, vectors encoding the secretion-competent S protein induced stronger humoral responses than vectors encoding the L protein, which was shown to be retained mainly intracellularly despite the presence of a heterologous secretion signal. In pigs, SAINT-18-formulated MIDGE-Th1 vectors encoding the S protein elicited an immune response of the same magnitude as the licensed protein vaccine Engerix-B, with S protein-specific antibody levels significantly higher than those considered protective in humans, and lasting for at least six months after the third immunization. Thus, our results provide not only the proof of concept for the SAINT-18-formulated MIDGE-Th1 vector approach but also confirm that with a cationic-lipid formulation, a DNA vaccine at a relatively low dose can elicit an immune response similar to a human dose of an aluminum hydroxide-adjuvanted protein vaccine in large animals.	[Endmann, Anne; Klunder, Katharina; Kapp, Kerstin; Riede, Oliver; Oswald, Detlef; Schroff, Matthias; Kleuss, Christiane; Juhls, Christiane] MOLOGEN AG, Berlin, Germany; [Talman, Eduard G.; Ruiters, Marcel H. J.] Synvolux Therapeut BV, Groningen, Netherlands; [Ruiters, Marcel H. J.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands	Mologen AG; University of Groningen	Endmann, A (corresponding author), MOLOGEN AG, Berlin, Germany.	endmann@mologen.com			Federal Ministry for Education and Research (BMBF), Germany [0315723]; Ministry of Economic Affairs (AgentschapNL), The Netherlands [09001]	Federal Ministry for Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); Ministry of Economic Affairs (AgentschapNL), The Netherlands	This study was supported by grants received from the Federal Ministry for Education and Research (BMBF, www.bmbf.de), Germany (ERA-Net EuroTransBio-4, grant no. 0315723 to MOLOGEN AG) and from the Ministry of Economic Affairs (AgentschapNL (EZ), http://www.rvo.nl), The Netherlands (grant no. 09001 to Synvolux Therapeutics B.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianov AK, 2009, P NATL ACAD SCI USA, V106, P18936, DOI 10.1073/pnas.0908842106; Babiuk S, 2004, J BIOTECHNOL, V110, P1, DOI 10.1016/j.jbiotec.2004.01.015; Babiuk S, 2002, VACCINE, V20, P3399, DOI 10.1016/S0264-410X(02)00269-4; BRUSS V, 1995, J VIROL, V69, P6652, DOI 10.1128/JVI.69.11.6652-6657.1995; Cooper C, 2011, EXPERT REV VACCINES, V10, P417, DOI [10.1586/ERV.10.162, 10.1586/erv.10.162]; Crawley A, 2003, VACCINE, V21, P2911, DOI 10.1016/S0264-410X(03)00142-7; Davis HL, 1996, P NATL ACAD SCI USA, V93, P7213, DOI 10.1073/pnas.93.14.7213; Endmann A, 2014, VACCINE IN PRESS; Endmann A, 2010, VACCINE, V28, P3642, DOI 10.1016/j.vaccine.2010.03.034; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; Ge GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041573; Geissler M, 1997, GASTROENTEROLOGY, V112, P1307, DOI 10.1016/S0016-5085(97)70145-8; Gilca V, 2013, VACCINE, V31, P448, DOI 10.1016/j.vaccine.2012.11.037; Jones CD, 1999, VACCINE, V17, P2528, DOI 10.1016/S0264-410X(99)00061-4; Kao JH, 2002, LANCET INFECT DIS, V2, P395, DOI 10.1016/S1473-3099(02)00315-8; Luxembourg A, 2008, VACCINE, V26, P4025, DOI 10.1016/j.vaccine.2008.05.021; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; MICHEL ML, 1995, P NATL ACAD SCI USA, V92, P5307, DOI 10.1073/pnas.92.12.5307; Moreno S, 2004, VACCINE, V22, P1709, DOI 10.1016/j.vaccine.2003.09.051; NEURATH AR, 1987, MOL IMMUNOL, V24, P561, DOI 10.1016/0161-5890(87)90036-8; NEURATH AR, 1986, VACCINE, V4, P35, DOI 10.1016/S0264-410X(86)80001-9; Obeng-Adjei N, 2013, CANCER GENE THER, V20, P652, DOI 10.1038/cgt.2013.65; Panjaworayan N, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-136; Patient R, 2007, J VIROL, V81, P3842, DOI 10.1128/JVI.02741-06; Podda Audino, 2003, Expert Rev Vaccines, V2, P197, DOI 10.1586/14760584.2.2.197; Prange R, 1999, VACCINE, V17, P617, DOI 10.1016/S0264-410X(98)00243-6; Prange R, 2012, MED MICROBIOL IMMUN, V201, P449, DOI 10.1007/s00430-012-0267-9; Raz R, 2001, ISRAEL MED ASSOC J, V3, P328; Rendi-Wagner P, 2006, VACCINE, V24, P2781, DOI 10.1016/j.vaccine.2006.01.007; Rottinghaus ST, 2003, VACCINE, V21, P4604, DOI 10.1016/S0264-410X(03)00447-X; Schirmbeck R, 2001, J MOL MED-JMM, V79, P343, DOI 10.1007/s001090100227; Shapira MY, 2001, J HEPATOL, V34, P123, DOI 10.1016/S0168-8278(00)00082-9; Shen ML, 2010, VACCINE, V28, P7288, DOI 10.1016/j.vaccine.2010.08.081; Tacket CO, 1999, VACCINE, V17, P2826, DOI 10.1016/S0264-410X(99)00094-8; Tong NKC, 2005, KIDNEY INT, V68, P2298, DOI 10.1111/j.1523-1755.2005.00689.x; VanDerWoude I, 1997, P NATL ACAD SCI USA, V94, P1160, DOI 10.1073/pnas.94.4.1160; Vardaxis NJ, 1997, J ANAT, V190, P601, DOI 10.1046/j.1469-7580.1997.19040601.x; WHO, 2009, WKLY EPIDEMIOL REC, V40, P20; Zanetti AR, 2008, VACCINE, V26, P6266, DOI 10.1016/j.vaccine.2008.09.056; Zheng C, 2006, VACCINE, V24, P4625, DOI 10.1016/j.vaccine.2005.08.046	40	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101715	10.1371/journal.pone.0101715	http://dx.doi.org/10.1371/journal.pone.0101715			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992038	Green Published, gold, Green Submitted			2022-12-27	WOS:000341253400107
J	Rykalina, VN; Shadrin, AA; Amstislavskiy, VS; Rogaev, EI; Lehrach, H; Borodina, TA				Rykalina, Vera N.; Shadrin, Alexey A.; Amstislavskiy, Vyacheslav S.; Rogaev, Evgeny I.; Lehrach, Hans; Borodina, Tatiana A.			Exome Sequencing from Nanogram Amounts of Starting DNA: Comparing Three Approaches	PLOS ONE			English	Article							WHOLE-GENOME AMPLIFICATION; LIBRARY PREPARATION; COMPLEX TRAITS; MUTATIONS; BIAS; PCR	Hybridization-based target enrichment protocols require relatively large starting amounts of genomic DNA, which is not always available. Here, we tested three approaches to pre-capture library preparation starting from 10 ng of genomic DNA: (i and ii) whole-genome amplification of DNA samples with REPLI-g (Qiagen) and GenomePlex (Sigma) kits followed by standard library preparation, and (iii) library construction with a low input oriented ThruPLEX kit (Rubicon Genomics). Exome capture with Agilent SureSelect(XT2) Human AllExon v4+UTRs capture probes, and HiSeq2000 sequencing were performed for test libraries along with the control library prepared from 1 mu g of starting DNA. Tested protocols were characterized in terms of mapping efficiency, enrichment ratio, coverage of the target region, and reliability of SNP genotyping. REPLI-g- and ThruPLEX-FD-based protocols seem to be adequate solutions for exome sequencing of low input samples.	[Rykalina, Vera N.; Shadrin, Alexey A.; Amstislavskiy, Vyacheslav S.; Lehrach, Hans; Borodina, Tatiana A.] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Rykalina, Vera N.; Borodina, Tatiana A.] AlacrisTheranost GmbH, Berlin, Germany; [Rykalina, Vera N.; Shadrin, Alexey A.] Free Univ Berlin, Berlin, Germany; [Rogaev, Evgeny I.] Vavilov Inst Gen Genet, Moscow, Russia	Max Planck Society; Free University of Berlin; Russian Academy of Sciences; Vavilov Institute of General Genetics	Borodina, TA (corresponding author), Max Planck Inst Mol Genet, Ihnestr 73, D-14195 Berlin, Germany.	t.borodina@alacris.de	Rogaev, Evgeny/AAN-7662-2020	Borodina, Tatiana/0000-0002-6978-016X	7th framework programme of the European Union (ADAMS) [242257, FP7-HEALTH-2009]	7th framework programme of the European Union (ADAMS)	This work was supported by the 7th framework programme of the European Union (ADAMS) [242257, FP7-HEALTH-2009]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Barker DL, 2004, GENOME RES, V14, P901, DOI 10.1101/gr.1949704; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Biesecker LG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-128; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Giardina E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-159; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Kozarewa I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032617; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmore JP, 2002, PHARMACOGENOMICS, V3, P557, DOI 10.1517/14622416.3.4.557; Lepere C, 2011, FEMS MICROBIOL ECOL, V76, P513, DOI 10.1111/j.1574-6941.2011.01072.x; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li MX, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003143; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Oyola SO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-1; Panoutsopoulou K, 2013, HUM MOL GENET, V22, pR16, DOI 10.1093/hmg/ddt376; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Wagner MJ, 2013, PHARMACOGENOMICS, V14, P413, DOI [10.2217/PGS.13.36, 10.2217/pgs.13.36]; Wang K, 2013, ISRN HEPATOL, V2013, P1; Woo HM, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-72; Zhang X, 2012, J MED GENET, V49, P727, DOI 10.1136/jmedgenet-2012-101134	26	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101154	10.1371/journal.pone.0101154	http://dx.doi.org/10.1371/journal.pone.0101154			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992588	Green Submitted, Green Published, gold			2022-12-27	WOS:000341253400047
J	Shinko, A; Agari, T; Kameda, M; Yasuhara, T; Kondo, A; Tayra, JT; Sato, K; Sasaki, T; Sasada, S; Takeuchi, H; Wakamori, T; Borlongan, CV; Date, I				Shinko, Aiko; Agari, Takashi; Kameda, Masahiro; Yasuhara, Takao; Kondo, Akihiko; Tayra, Judith Thomas; Sato, Kenichiro; Sasaki, Tatsuya; Sasada, Susumu; Takeuchi, Hayato; Wakamori, Takaaki; Borlongan, Cesario V.; Date, Isao			Spinal Cord Stimulation Exerts Neuroprotective Effects against Experimental Parkinson's Disease	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CEREBRAL-BLOOD-FLOW; SUBTHALAMIC NUCLEUS STIMULATION; DORSAL COLUMN STIMULATION; ELECTRICAL-STIMULATION; SUBARACHNOID HEMORRHAGE; DOPAMINERGIC-NEURONS; RAT MODEL; IN-VITRO; PAIN	In clinical practice, deep brain stimulation (DBS) is effective for treatment of motor symptoms in Parkinson's disease (PD). However, the mechanisms have not been understood completely. There are some reports that electrical stimulation exerts neuroprotective effects on the central nervous system diseases including cerebral ischemia, head trauma, epilepsy and PD, although there are a few reports on neuroprotective effects of spinal cord stimulation (SCS). We investigated the neuroprotective effects of high cervical SCS on PD model of rats. Adult female Sprague-Dawley rats received hour-long SCS (2, 50 or 200 Hz) with an epidural electrode at C1-2 level for 16 consecutive days. At 2 days after initial SCS, 6-hydroxydopamine (6-OHDA) was injected into the right striatum of rats. Behavioral evaluations of PD symptoms were employed, including cylinder test and amphetamine-induced rotation test performed at 1 and 2 weeks after 6-OHDA injection. Animals were subsequently euthanized for immunohistochemical investigations. In order to explore neurotrophic and growth factor upregulation induced by SCS, another cohort of rats that received 50 Hz SCS was euthanized at 1 and 2 weeks after lesion for protein assays. Behavioral tests revealed that the number of amphetamine-induced rotations decreased in SCS groups. Immunohistochemically, tyrosine hydroxylase (TH)-positive fibers in the striatum were significantly preserved in SCS groups. TH-positive neurons in the substantia nigra pars compacta were significantly preserved in 50 Hz SCS group. The level of vascular endothelial growth factor (VEGF) was upregulated by SCS at 1 week after the lesion. These results suggest that high cervical SCS exerts neuroprotection in PD model of rats, at least partially by upregulation of VEGF. SCS is supposed to suppress or delay PD progression and might become a less invasive option for PD patients, although further preclinical and clinical investigations are needed to confirm the effectiveness and safety.	[Shinko, Aiko; Agari, Takashi; Kameda, Masahiro; Yasuhara, Takao; Kondo, Akihiko; Tayra, Judith Thomas; Sato, Kenichiro; Sasaki, Tatsuya; Sasada, Susumu; Takeuchi, Hayato; Wakamori, Takaaki; Date, Isao] Okayama Univ, Grad Sch Med, Dept Neurol Surg, Okayama, Japan; [Borlongan, Cesario V.] Univ S Florida, Coll Med, Dept Neurosurg, Tampa, FL USA	Okayama University; State University System of Florida; University of South Florida	Agari, T (corresponding author), Okayama Univ, Grad Sch Med, Dept Neurol Surg, Okayama, Japan.	agarit@cc.okayama-u.ac.jp	Yasuhara, Takao/AEU-1075-2022; Borlongan, Cesar/I-5696-2012; Kondo, Akihiko/A-2130-2015; Sheshukova, Ekaterina/O-1365-2013	Borlongan, Cesar/0000-0002-2966-9782; Shindyapina, Anastasia/0000-0002-7336-3086; Sheshukova, Ekaterina/0000-0002-0934-3902				Baba T, 2009, STROKE, V40, pE598, DOI 10.1161/STROKEAHA.109.563627; CHANDLER MJ, 1993, EUR HEART J, V14, P96, DOI 10.1093/eurheartj/14.1.96; Cui JG, 1996, PAIN, V66, P287, DOI 10.1016/0304-3959(96)03069-2; Cui JG, 1997, PAIN, V73, P87, DOI 10.1016/S0304-3959(97)00077-8; DRAKE CJ, 1995, P NATL ACAD SCI USA, V92, P7657, DOI 10.1073/pnas.92.17.7657; EDVINSSON L, 1989, J CEREBR BLOOD F MET, V9, P212, DOI 10.1038/jcbfm.1989.31; Fuentes R, 2009, SCIENCE, V323, P1578, DOI 10.1126/science.1164901; Goksel HM, 2001, ACTA NEUROCHIR, V143, P383, DOI 10.1007/s007010170094; Gurelik M, 2005, NEUROSCIENCE, V134, P827, DOI 10.1016/j.neuroscience.2005.04.062; Harnack D, 2008, EXP NEUROL, V210, P257, DOI 10.1016/j.expneurol.2007.10.002; HOSOBUCHI Y, 1991, PACE, V14, P122, DOI 10.1111/j.1540-8159.1991.tb04056.x; HOSOBUCHI Y, 1985, APPL NEUROPHYSIOL, V48, P372, DOI 10.1159/000101161; Isono M, 1995, STEREOT FUNCT NEUROS, V64, P40, DOI 10.1159/000098732; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Kadota T, 2009, BRAIN RES, V1254, P120, DOI 10.1016/j.brainres.2008.11.094; Kemler MA, 2000, NEW ENGL J MED, V343, P618, DOI 10.1056/NEJM200008313430904; Kumar K, 2007, PAIN, V132, P179, DOI 10.1016/j.pain.2007.07.028; Lee JY, 2008, J NEUROSURG, V109, P1148, DOI 10.3171/JNS.2008.109.12.1148; LEVIN BE, 1980, NEUROLOGY, V30, P65, DOI 10.1212/WNL.30.1.65; LINDEROTH B, 1995, NEUROSURGERY, V37, P266, DOI 10.1227/00006123-199508000-00011; LINDEROTH B, 1992, NEUROSURGERY, V31, P289, DOI 10.1227/00006123-199208000-00014; Maesawa S, 2004, J NEUROSURG, V100, P679, DOI 10.3171/jns.2004.100.4.0679; Maher J, 2009, NEUROGASTROENT MOTIL, V21, DOI 10.1111/j.1365-2982.2008.01237.x; Maher J, 2009, NEUROGASTROENT MOTIL, V21, pe633; MEGLIO M, 1991, PACE, V14, P127, DOI 10.1111/j.1540-8159.1991.tb04057.x; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Morimoto T, 2011, CELL TRANSPLANT, V20, P1049, DOI 10.3727/096368910X544915; Patel S, 2004, NEUROSURGERY, V55, P201, DOI 10.1227/01.NEU.0000126949.28912.71; Patel S, 2003, J NEUROSURG, V99, P754, DOI 10.3171/jns.2003.99.4.0754; Paxions G, 1998, RAT BRAIN STEREOTAXI; Pitzer MR, 2003, EXP NEUROL, V182, P435, DOI 10.1016/S0014-4886(03)00100-6; Rajput AH, 2004, PARKINSONISM RELAT D, V10, P221, DOI 10.1016/j.parkreldis.2004.01.004; Roof RL, 2001, STROKE, V32, P2648, DOI 10.1161/hs1101.097397; Sagher O, 2003, J NEUROSURG, V99, P131, DOI 10.3171/jns.2003.99.1.0131; Sagher Oren, 2006, Neurosurg Focus, V21, pE2; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schechtmann G, 2008, PAIN, V139, P136, DOI 10.1016/j.pain.2008.03.023; SHEALY CN, 1967, ANESTH ANAL CURR RES, V46, P489; Silverman WF, 1999, NEUROSCIENCE, V90, P1529, DOI 10.1016/S0306-4522(98)00540-5; Song ZY, 2008, NEUROSCI LETT, V436, P7, DOI 10.1016/j.neulet.2008.02.044; Spieles-Engemann AL, 2011, J PARKINSON DIS, V1, P123, DOI 10.3233/JPD-2011-11008; Stiller CO, 1996, NEUROSURGERY, V39, P367, DOI 10.1097/00006123-199608000-00026; Temel Y, 2006, BRAIN RES, V1120, P100, DOI 10.1016/j.brainres.2006.08.082; Thevathasan W, 2010, NEUROLOGY, V74, P1325, DOI 10.1212/WNL.0b013e3181d9ed58; Vajkoczy P, 2005, J NEUROSURG, V103, P9, DOI 10.3171/jns.2005.103.1.0009; Visocchi M, 2001, STEREOT FUNCT NEUROS, V76, P262, DOI 10.1159/000066729; Visocchi M, 2001, STEREOT FUNCT NEUROS, V76, P269, DOI 10.1159/000066730; Visocchi M, 2001, ACTA NEUROCHIR, V143, P177; Yadav AP, 2014, SCI REP-UK, V4, DOI 10.1038/srep03839; Yakhnitsa V, 1999, PAIN, V79, P223, DOI 10.1016/S0304-3959(98)00169-9; Yang X, 2008, NEUROSCIENCE, V152, P950, DOI 10.1016/j.neuroscience.2008.01.009; Yasuhara T, 2004, REV NEUROSCIENCE, V15, P293; Yuan WJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-75; Zhong J, 2004, ACTA NEUROCHIR, V146, P1227, DOI 10.1007/s00701-004-0364-7	55	24	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101468	10.1371/journal.pone.0101468	http://dx.doi.org/10.1371/journal.pone.0101468			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25009993	Green Submitted, Green Published, gold			2022-12-27	WOS:000338763800025
J	Koundourakis, NE; Androulakis, NE; Malliaraki, N; Tsatsanis, C; Venihaki, M; Margioris, AN				Koundourakis, Nikolaos E.; Androulakis, Nikolaos E.; Malliaraki, Niki; Tsatsanis, Christos; Venihaki, Maria; Margioris, Andrew N.			Discrepancy between Exercise Performance, Body Composition, and Sex Steroid Response after a Six-Week Detraining Period in Professional Soccer Players	PLOS ONE			English	Article							SKELETAL-MUSCLE; ENDURANCE; ADAPTATIONS; STRENGTH; HORMONE; TESTOSTERONE; SPRINT; POWER; MEN; PROTEIN	Purpose: The aim of this study was to examine the effects of a six-week off-season detraining period on exercise performance, body composition, and on circulating sex steroid levels in soccer players. Methods: Fifty-five professional male soccer players, members of two Greek Superleague Teams (Team A, n = 23; Team B, n = 22), participated in the study. The first two weeks of the detraining period the players abstained from any physical activity. The following four weeks, players performed low-intensity (50%-60% of VO(2)max) aerobic running of 20 to 30 minutes duration three times per week. Exercise performance testing, anthropometry, and blood sampling were performed before and after the six-week experimental period. Results: Our data showed that in both teams A and B the six-week detraining period resulted in significant reductions in maximal oxygen consumption (60,31 +/- 2,52 vs 57,67 +/- 2,54; p<0.001, and 60,47 +/- 4,13 vs 58,30 +/- 3,88; p<0.001 respectively), squat-jump (39,70 +/- 3,32 vs 37,30 +/- 3,08; p<0.001, and 41,05 +/- 3,34 vs 38,18 +/- 3,03; p<0.001 respectively), and countermovement-jump (41,04 +/- 3,99 vs 39,13 +/- 3,26; p<0.001 and 42,82 +/- 3,60 vs 40,09 +/- 2,79; p<0.001 respectively), and significant increases in 10-meters sprint (1,74<0,063 vs 1,79 +/- 0,064; p<0.001, and 1,73 +/- 0,065 vs 1,78 +/- 0,072; p<0.001 respectively), 20-meters sprint (3,02 +/- 0,05 vs 3,06 +/- 0,06; p<0.001, and 3,01 +/- 0,066 vs 3,06 +/- 0,063; p<0.001 respectively), body fat percentage (Team A; p<0.001, Team B; p<0.001), and body weight (Team A; p<0.001, Team B; p<0.001). Neither team displayed any significant changes in the resting concentrations of total-testosterone, free-testosterone, dehydroepiandrosterone-sulfate, Delta 4-androstenedione, estradiol, luteinizing hormone, follicle-stimulating hormone, and prolactin. Furthermore, sex steroids levels did not correlate with exercise performance parameters. Conclusion: Our results suggest that the six-week detraining period resulted in a rapid loss of exercise performance adaptations and optimal body composition status, but did not affect sex steroid resting levels. The insignificant changes in sex steroid concentration indicate that these hormones were a non-contributing parameter for the observed negative effects of detraining on exercise performance and body composition.	[Koundourakis, Nikolaos E.; Malliaraki, Niki; Tsatsanis, Christos; Venihaki, Maria; Margioris, Andrew N.] Univ Crete, Sch Med, Dept Clin Chem Biochem, Iraklion, Greece; [Androulakis, Nikolaos E.] Univ Hosp, Dept Hematol Lab, Iraklion, Greece; [Malliaraki, Niki; Margioris, Andrew N.] Univ Hosp, Iraklion, Greece	University of Crete; University of Patras; University of Patras	Koundourakis, NE (corresponding author), Univ Crete, Sch Med, Dept Clin Chem Biochem, Iraklion, Greece.	nkoyndoy@hotmail.com	Tsatsanis, Christos/AAM-9362-2020; Tsatsanis, Christos/C-2516-2018; Koundourakis, Nikolaos E/AAA-7667-2021	Tsatsanis, Christos/0000-0003-1214-4151; Tsatsanis, Christos/0000-0003-1214-4151; Androulakis, Nikolaos/0000-0001-8842-2360; Koundourakis, Nikolaos/0000-0002-3385-4956				AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Alison B1 MD, 2004, PRINCIPLES GENDER SP, P759; Amigo N, 1998, J SPORT MED PHYS FIT, V38, P298; ANDERSON KE, 1987, LIFE SCI, V40, P1761, DOI 10.1016/0024-3205(87)90086-5; Benardot D, 2006, ADV SPORTS NUTR, P309; Borer T, 2003, EXERCISE ENDOCRINOLO; Caldwell BP, 2009, J STRENGTH COND RES, V23, P1370, DOI 10.1519/JSC.0b013e3181a4e82f; Cangemi R, 2010, AGING CELL, V9, P236, DOI 10.1111/j.1474-9726.2010.00553.x; COYLE EF, 1984, J APPL PHYSIOL, V57, P1857, DOI 10.1152/jappl.1984.57.6.1857; Day DS, 2005, J CLIN ENDOCR METAB, V90, P3312, DOI 10.1210/jc.2004-1344; Esbjornsson-Liljedahl M, 1999, J APPL PHYSIOL, V87, P1326, DOI 10.1152/jappl.1999.87.4.1326; Garcia-Pallares J, 2010, EUR J APPL PHYSIOL, V110, P99, DOI 10.1007/s00421-010-1484-9; GEORGIADIS EI, 1992, HORM METAB RES, V24, P488, DOI 10.1055/s-2007-1003369; Gibney J, 2005, AM J PHYSIOL-ENDOC M, V289, pE266, DOI 10.1152/ajpendo.00483.2004; Hackney A C, 1989, Br J Sports Med, V23, P194; HAKKINEN K, 1985, EUR J APPL PHYSIOL O, V53, P287, DOI 10.1007/BF00422840; HAKKINEN K, 1983, MED SCI SPORT EXER, V15, P455; Hall HL, 1999, CLIN J SPORT MED, V9, P203, DOI 10.1097/00042752-199910000-00004; Hardman AE, 1998, J APPL PHYSIOL, V84, P1895, DOI 10.1152/jappl.1998.84.6.1895; HICKSON RC, 1982, J APPL PHYSIOL, V53, P225, DOI 10.1152/jappl.1982.53.1.225; Horstman AM, 2012, J GERONTOL A-BIOL, V67, P1140, DOI 10.1093/gerona/gls068; HORTOBAGYI T, 1993, MED SCI SPORT EXER, V25, P929; Hoshikawa Y, 2004, J SPORTS SCI, V22, P531; HOUMARD JA, 1992, INT J SPORTS MED, V13, P572, DOI 10.1055/s-2007-1024567; Izquierdo M, 2007, J STRENGTH COND RES, V21, P768; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; Kalapotharakos VI, 2011, J STRENGTH COND RES, V25, P1502, DOI 10.1519/JSC.0b013e3181da85a9; Kraemer WJ, 2002, J STRENGTH COND RES, V16, P373; Labrie F, 1997, J CLIN ENDOCR METAB, V82, P2396, DOI 10.1210/jc.82.8.2396; LaForgia J, 1999, EUR J CLIN NUTR, V53, P126, DOI 10.1038/sj.ejcn.1600689; MADSEN K, 1993, J APPL PHYSIOL, V75, P1444, DOI 10.1152/jappl.1993.75.4.1444; Markovic G, 2004, J STRENGTH COND RES, V18, P551, DOI 10.1519/00124278-200408000-00028; MARTIN WH, 1986, J AM COLL CARDIOL, V7, P982, DOI 10.1016/S0735-1097(86)80215-7; Maughan RJ, 1997, J SPORT SCI, V15, P265; McArdle W, 2009, EXERCISE PHYSL ENERG, P192; MOORE RL, 1987, J APPL PHYSIOL, V63, P1719, DOI 10.1152/jappl.1987.63.5.1719; Mujika I, 2000, SPORTS MED, V30, P79, DOI 10.2165/00007256-200030020-00002; NELSON AG, 1990, PHYS THER, V70, P287, DOI 10.1093/ptj/70.5.287; NEUFER PD, 1989, SPORTS MED, V8, P302, DOI 10.2165/00007256-198908050-00004; Ormsbee MJ, 2012, J STRENGTH COND RES, V26, P2087, DOI 10.1519/JSC.0b013e31823b874c; Orwoll E, 2006, J CLIN ENDOCR METAB, V91, P1336, DOI 10.1210/jc.2005-1830; Ostojic SM., 2003, J EXERC PHYSL ONLINE, V6, P3; Perez-Gomez J, 2008, EUR J APPL PHYSIOL, V102, P685, DOI 10.1007/s00421-007-0648-8; Phillips GB, 1996, EUR J ENDOCRINOL, V134, P201, DOI 10.1530/eje.0.1340201; Ramirez ME, 1997, METABOLISM, V46, P179, DOI 10.1016/S0026-0495(97)90299-7; Reilly T., 2003, SCI SOCCER; Rodriguez NR, 2009, MED SCI SPORT EXER, V41, P709, DOI 10.1249/MSS.0b013e31890eb86; Ross A, 2001, SPORTS MED, V31, P1063, DOI 10.2165/00007256-200131150-00003; Stolen T, 2005, SPORTS MED, V35, P501; Stone MH, 2003, J STRENGTH COND RES, V17, P140; Thorstensson, 1976, Acta Physiol Scand Suppl, V443, P1; Tremblay MS, 2004, J APPL PHYSIOL, V96, P531, DOI 10.1152/japplphysiol.00656.2003; Wang PT, 2006, CHINESE J PHYSIOL, V49, P251	53	65	67	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e87803	10.1371/journal.pone.0087803	http://dx.doi.org/10.1371/journal.pone.0087803			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586293	Green Published, gold, Green Submitted			2022-12-27	WOS:000331711900019
J	Xu, MY; Xie, F; Wang, K				Xu, Min-Yun; Xie, Fan; Wang, Kun			Response of Vegetation and Soil Carbon and Nitrogen Storage to Grazing Intensity in Semi-Arid Grasslands in the Agro-Pastoral Zone of Northern China	PLOS ONE			English	Article							INNER-MONGOLIA; SPATIAL VARIABILITY; PHYSICAL-PROPERTIES; SHORTGRASS STEPPE; ORGANIC-CARBON; ROOT BIOMASS; BULK-DENSITY; MIXED-GRASS; LAND-USE; MANAGEMENT	Overgrazing has been the primary cause of grassland degradation in the semi-arid grasslands of the agro-pastoral transition zone in northern China. However, there has been little evidence regarding grazing intensity impacts on vegetation change and soil C and N dynamics in this region. This paper reports the effects of four grazing intensities namely un-grazed (UG), lightly grazed (LG), moderately grazed (MG) and heavily grazed (HG) on vegetation characteristics and soil properties of grasslands in the Guyuan county in the agro-pastoral transition region, Hebei province, northern China. Our study showed that the vegetation height, canopy cover, plant species abundance and aboveground biomass decreased significantly with increased grazing intensity. Similarly, soil organic carbon (SOC) and total nitrogen (STN) in the 0-50 cm were highest under UG (13.3 kg C m(-2) and 1.69 kg N m(-2)) and lowest under HG (9.8 kg C m(-2) and 1.22 kg N m(-2)). Soil available nitrogen (SAN) was significantly lower under HG (644 kg N hm(-2)) than under other treatments (725-731 kg N hm(-2)) in the 0-50 cm. Our results indicate that the pasture management of ''take half-leave half'' has potential benefits for primary production and livestock grazing in this region. However, grazing exclusion was perhaps the most effective choice for restoring degraded grasslands in this region. Therefore, flexible rangeland management should be adopted in this region.	[Xu, Min-Yun] Peking Univ, Coll Urban & Environm Sci, Dept Ecol, Beijing 100871, Peoples R China; [Xu, Min-Yun] Hebei Agr Univ, Coll Anim Sci & Technol, Baoding, Hebei Province, Peoples R China; [Xie, Fan] China Natl Light Ind Council, Dept Party Affairs, Beijing, Peoples R China; [Wang, Kun] China Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China	Peking University; Hebei Agricultural University; China Agricultural University	Xu, MY (corresponding author), Peking Univ, Coll Urban & Environm Sci, Dept Ecol, Beijing 100871, Peoples R China.	xuminyun@pku.edu.cn			Baoding Science and Technology Development Project [13zf063]	Baoding Science and Technology Development Project	This research was funded by Baoding Science and Technology Development Project (Grant No. 13zf063). The funder (URL: http://www. bdskjj.gov.cn/) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao S.D, 2000, SOIL AGRO CHEM ANAL, P49; BAUER A, 1987, SOIL SCI SOC AM J, V51, P176, DOI 10.2136/sssaj1987.03615995005100010037x; Chen Z., 2000, TYPICAL STEPPE ECOSY; Chen ZQ, 2001, J GEOGR SCI, V11, P433, DOI DOI 10.1007/BF02837971; Christensen L, 2004, CLIMATIC CHANGE, V63, P351, DOI 10.1023/B:CLIM.0000018513.60904.fe; Derner JD, 2007, J SOIL WATER CONSERV, V62, P77; Ding HA, 2007, INT J SUST DEV WORLD, V14, P391; FRANK AB, 1995, J RANGE MANAGE, V48, P470, DOI 10.2307/4002255; Gan L, 2012, PEDOSPHERE, V22, P165, DOI 10.1016/S1002-0160(12)60003-4; Gao YZ, 2008, PLANT SOIL, V307, P41, DOI 10.1007/s11104-008-9579-3; Gao YH, 2007, POL J ECOL, V55, P469; Gill R, 1999, ECOSYSTEMS, V2, P226; Gong DY, 2004, J ARID ENVIRON, V59, P771, DOI 10.1016/j.jaridenv.2004.02.006; Haynes RJ, 1999, BIOL FERT SOILS, V28, P253, DOI 10.1007/s003740050490; He NP, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00017.1; He NP, 2008, SOIL BIOL BIOCHEM, V40, P2952, DOI 10.1016/j.soilbio.2008.08.018; Hiernaux P, 1998, PLANT ECOL, V138, P191, DOI 10.1023/A:1009752606688; HOLLAND EA, 1992, AM NAT, V140, P685, DOI 10.1086/285435; HOLLAND EA, 1990, ECOLOGY, V71, P1040, DOI 10.2307/1937372; Huang D, 2007, J ARID ENVIRON, V70, P120, DOI 10.1016/j.jaridenv.2006.12.009; Institute of Soil Science Chinese Academy of Sciences, 1978, SOIL PHYS CHEM AN; LEHOUEROU HN, 1988, J ARID ENVIRON, V15, P1, DOI 10.1016/S0140-1963(18)31001-2; LEIBOLD MA, 1989, AM NAT, V134, P922, DOI 10.1086/285022; Li Yong-Hong, 1993, Acta Botanica Sinica, V35, P877; [刘全友 Liu Quanyou], 2003, [生态学报, Acta Ecologica Sinica], V23, P1025; Liu TZ, 2011, NUTR CYCL AGROECOSYS, V91, P67, DOI 10.1007/s10705-011-9445-1; Liu Yingru, 2004, Yingyong Shengtai Xuebao, V15, P1604; McNaughton SJ, 1997, SCIENCE, V278, P1798, DOI 10.1126/science.278.5344.1798; McNaughton SJ, 1998, ECOLOGY, V79, P587, DOI 10.1890/0012-9658(1998)079[0587:RBAPIA]2.0.CO;2; MILCHUNAS DG, 1993, ECOL MONOGR, V63, P327, DOI 10.2307/2937150; Milchunas DG, 1998, OIKOS, V83, P65, DOI 10.2307/3546547; NAETH MA, 1991, CAN J SOIL SCI, V71, P313, DOI 10.4141/cjss91-031; NAETH MA, 1995, J RANGE MANAGE, V48, P528, DOI 10.2307/4003065; Neff JC, 2005, ECOL APPL, V15, P87, DOI 10.1890/04-0268; Page A.L., 1983, METHODS SOIL ANAL 2; Reeder JD, 2002, ENVIRON POLLUT, V116, P457, DOI 10.1016/S0269-7491(01)00223-8; Ren JZ, 1985, GRASSLAND SURVEY PLA; Schuman GE, 1999, ECOL APPL, V9, P65, DOI 10.1890/1051-0761(1999)009[0065:IOGMOT]2.0.CO;2; Stavi I, 2008, CATENA, V75, P288, DOI 10.1016/j.catena.2008.07.007; Steffens M, 2008, GEODERMA, V143, P63, DOI 10.1016/j.geoderma.2007.09.004; Su YZ, 2004, SOIL TILL RES, V75, P27, DOI 10.1016/S0167-1987(03)00157-0; Tracy BF, 1998, OECOLOGIA, V114, P556, DOI 10.1007/s004420050480; VANHAVEREN BP, 1983, J RANGE MANAGE, V36, P586; Wen L, 2013, PLANT SOIL, V368, P329, DOI 10.1007/s11104-012-1500-4; WILLMS WD, 1993, J RANGE MANAGE, V46, P320, DOI 10.2307/4002466; Wu L, 2008, J ENVIRON QUAL, V37, P663, DOI 10.2134/jeq2007.0196; Xu MY, 2011, AFR J BIOTECHNOL, V10, P4844; Zhao Y, 2007, ECOL MODEL, V205, P241, DOI 10.1016/j.ecolmodel.2007.02.019; Zhou ZC, 2010, CATENA, V82, P87, DOI 10.1016/j.catena.2010.05.005; Zhou ZY, 2007, BIOGEOCHEMISTRY, V82, P127, DOI 10.1007/s10533-006-9058-y	50	24	28	8	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96604	10.1371/journal.pone.0096604	http://dx.doi.org/10.1371/journal.pone.0096604			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	25003849	Green Published, Green Submitted, gold			2022-12-27	WOS:000336653300023
J	Ou, X; Liu, ML; Luo, HR; Dong, LQ; Liu, F				Ou, Xiang; Liu, Meilian; Luo, Hairong; Dong, Lily Q.; Liu, Feng			Ursolic Acid Inhibits Leucine-Stimulated mTORC1 Signaling by Suppressing mTOR Localization to Lysosome	PLOS ONE			English	Article							AMINO-ACIDS; RAG GTPASES; TSC1-TSC2 COMPLEX; MAMMALIAN TARGET; SKELETAL-MUSCLE; ACTIVATION; GROWTH; CELL; PATHWAY; RAPTOR	Ursolic acid (UA), a pentacyclic triterpenoid widely found in medicinal herbs and fruits, has been reported to possess a wide range of beneficial properties including anti-hyperglycemia, anti-obesity, and anti-cancer. However, the molecular mechanisms underlying the action of UA remain largely unknown. Here we show that UA inhibits leucine-induced activation of the mechanistic target of rapamycin complex 1 (mTORC1) signaling pathway in C2C12 myotubes. The UA-mediated inhibition of mTORC1 is independent of Akt, tuberous sclerosis complex 1/2 (TSC1/2), and Ras homolog enriched in brain (Rheb), suggesting that UA negatively regulates mTORC1 signaling by targeting at a site downstream of these mTOR regulators. UA treatment had no effect on the interaction between mTOR and its activator Raptor or inhibitor Deptor, but suppressed the binding of RagB to Raptor and inhibited leucine-induced mTOR lysosomal localization. Taken together, our study identifies UA as a direct negative regulator of the mTORC1 signaling pathway and suggests a novel mechanism by which UA exerts its beneficial function.	[Ou, Xiang; Liu, Meilian; Luo, Hairong; Liu, Feng] Cent S Univ, Xiangya Hosp 2, Metab Syndrome Res Ctr, Changsha, Hunan, Peoples R China; [Ou, Xiang; Liu, Meilian; Luo, Hairong; Liu, Feng] Cent S Univ, Xiangya Hosp 2, Key Lab Diabet Immunol, Ctr Diabet, Changsha, Hunan, Peoples R China; [Ou, Xiang; Liu, Meilian; Liu, Feng] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Dong, Lily Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	Central South University; Central South University; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Liu, F (corresponding author), Cent S Univ, Xiangya Hosp 2, Metab Syndrome Res Ctr, Changsha, Hunan, Peoples R China.	liuf@uthscsa.edu	Liu, Feng/CAG-8962-2022		NIH RO1 grant [DK100697]; National Nature Science Foundation of China [81130015]; National Basic Research Program of China [2014CB910500]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100697] Funding Source: NIH RePORTER	NIH RO1 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by an NIH RO1 grant (DK100697, http://grants.nih.gov/grants/funding/r01.htm), a grant from the National Nature Science Foundation of China (81130015, http://www.nsfc.gov.cn/nsfc/cen/00/download.html), and a grant from the National Basic Research Program of China (2014CB910500, http://www.most.gov.cn/kjjh/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alqahtani A, 2013, CURR MED CHEM, V20, P908; Atherton PJ, 2010, AMINO ACIDS, V38, P1533, DOI 10.1007/s00726-009-0377-x; Babcock JT, 2011, CURR DRUG TARGETS, V12, P1223; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Csibi A, 2013, CELL, V153, P840, DOI 10.1016/j.cell.2013.04.023; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Gao N, 2012, BRIT J PHARMACOL, V165, P1813, DOI 10.1111/j.1476-5381.2011.01684.x; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; Greiwe JS, 2001, AM J PHYSIOL-ENDOC M, V281, pE466, DOI 10.1152/ajpendo.2001.281.3.E466; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Howell JJ, 2013, BIOCHEM SOC T, V41, P906, DOI 10.1042/BST20130041; Howell JJ, 2011, TRENDS ENDOCRIN MET, V22, P94, DOI 10.1016/j.tem.2010.12.003; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kimball SR, 1999, J BIOL CHEM, V274, P11647, DOI 10.1074/jbc.274.17.11647; Kunkel SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039332; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee J, 2010, CHEM-BIOL INTERACT, V188, P635, DOI 10.1016/j.cbi.2010.09.019; Leng SL, 2013, INT J CANCER, V133, P2781, DOI 10.1002/ijc.28301; Li Y, 2010, MOL NUTR FOOD RES, V54, P1609, DOI 10.1002/mnfr.200900564; Liobikas J, 2011, J NAT PROD, V74, P1640, DOI 10.1021/np200060p; Liu ML, 2010, J BIOL CHEM, V285, P36387, DOI 10.1074/jbc.M110.169284; Liu ZQ, 2002, J CLIN ENDOCR METAB, V87, P5553, DOI 10.1210/jc.2002-020424; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shanmugam MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032476; Wang AP, 2011, J BIOL CHEM, V286, P60, DOI 10.1074/jbc.M110.188144; Wang RH, 2011, J CLIN INVEST, V121, P4477, DOI 10.1172/JCI46243; Wang X, 2011, J HEPATOL, V55, P379, DOI 10.1016/j.jhep.2010.10.040; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Yang TT, 2009, NEUROSCI LETT, V465, P177, DOI 10.1016/j.neulet.2009.08.026; Yeh CT, 2010, MOL NUTR FOOD RES, V54, P1285, DOI 10.1002/mnfr.200900414; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056; Zou J, 2011, DEV CELL, V20, P97, DOI 10.1016/j.devcel.2010.11.020	46	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95393	10.1371/journal.pone.0095393	http://dx.doi.org/10.1371/journal.pone.0095393			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	25003527	Green Published, Green Submitted, gold			2022-12-27	WOS:000336863900138
J	Zhang, XY; Zhang, T; Young, AA; Li, XS				Zhang, Xingyu; Zhang, Tao; Young, Alistair A.; Li, Xiaosong			Applications and Comparisons of Four Time Series Models in Epidemiological Surveillance Data	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; NEURAL-NETWORK; HYBRID ARIMA; PREDICTION; FORECAST; FEVER	Public health surveillance systems provide valuable data for reliable predication of future epidemic events. This paper describes a study that used nine types of infectious disease data collected through a national public health surveillance system in mainland China to evaluate and compare the performances of four time series methods, namely, two decomposition methods (regression and exponential smoothing), autoregressive integrated moving average (ARIMA) and support vector machine (SVM). The data obtained from 2005 to 2011 and in 2012 were used as modeling and forecasting samples, respectively. The performances were evaluated based on three metrics: mean absolute error (MAE), mean absolute percentage error (MAPE), and mean square error (MSE). The accuracy of the statistical models in forecasting future epidemic disease proved their effectiveness in epidemiological surveillance. Although the comparisons found that no single method is completely superior to the others, the present study indeed highlighted that the SVMs outperforms the ARIMA model and decomposition methods in most cases.	[Zhang, Xingyu; Zhang, Tao; Li, Xiaosong] Sichuan Univ, West China Sch Publ Hlth, Dept Med Stat, Chengdu 610064, Sichuan, Peoples R China; [Zhang, Xingyu; Young, Alistair A.] Univ Auckland, Dept Anat Radiol, Auckland 1, New Zealand	Sichuan University; University of Auckland	Li, XS (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Dept Med Stat, Chengdu 610064, Sichuan, Peoples R China.	lixiaosong1101@126.com		Zhang, Xingyu/0000-0001-8108-1997; Young, Alistair/0000-0001-5702-4220	National Special Foundation for Health Research of China [200802133]	National Special Foundation for Health Research of China	The entire study and the paper were financially supported by the National Special Foundation for Health Research of China (grant no. 200802133). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowerman B. L., 1993, FORECASTING TIME SER; Chadwick D, 2006, J CLIN VIROL, V35, P147, DOI 10.1016/j.jcv.2005.06.002; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Christodoulos C, 2011, TECHNOL FORECAST SOC, V78, P163, DOI 10.1016/j.techfore.2010.08.007; Davision AC, 1997, BOOTSTRAP METHODS TH, P23; Farrington C, 2003, MONITORING HLTH POPU, V2003, P203; Galbraith JW, 1999, J ECONOMETRICS, V93, P25, DOI 10.1016/S0304-4076(98)00097-9; Gonzalez-Parra G, 2009, COMMUN NONLINEAR SCI, V14, P3967, DOI 10.1016/j.cnsns.2009.02.023; Grahn T., 1995, J TIMES SERIES ANAL, V16, P509, DOI [DOI 10.1111/J.1467-9892.1995.TB00251.X, 10.1111/j.1467-9892.1995.tb00251.x]; Hamilton J.D., 1994, TIME SERIES ANAL, V2, DOI 10.2307/j.ctv14jx6sm; Ho SL, 2002, COMPUT IND ENG, V42, P371, DOI 10.1016/S0360-8352(02)00036-0; Hong WC, 2006, INT J ADV MANUF TECH, V28, P154, DOI 10.1007/s00170-004-2340-z; KOEHLER AB, 1988, J R STAT SOC C-APPL, V37, P187; Li Q, 2012, AM J TROP MED HYG, V87, P364, DOI 10.4269/ajtmh.2012.11-0472; Liu Q, 2011, BMC INFECT DIS, V11; Luz PM, 2008, AM J TROP MED HYG, V79, P933, DOI 10.4269/ajtmh.2008.79.933; MOGHRAM I, 1989, IEEE T POWER SYST, V4, P1484, DOI 10.1109/59.41700; Muller K.-R., 1997, Artificial Neural Networks - ICANN '97. 7th International Conference Proceedings, P999, DOI 10.1007/BFb0020283; Nobre FF, 2001, STAT MED, V20, P3051, DOI 10.1002/sim.963; Pai PF, 2005, INT J ADV MANUF TECH, V27, P205, DOI 10.1007/s00170-004-2139-y; Pai PF, 2005, OMEGA-INT J MANAGE S, V33, P497, DOI 10.1016/j.omega.2004.07.024; Rios M, 2000, EUR J EPIDEMIOL, V16, P483, DOI 10.1023/A:1007653329972; Smola AJ, 2004, STAT COMPUT, V14, P199, DOI 10.1023/B:STCO.0000035301.49549.88; Spaeder MC, 2012, EPIDEMIOL INFECT, V140, P602, DOI 10.1017/S0950268811001026; Tay FEH, 2002, NEUROCOMPUTING, V48, P847, DOI 10.1016/S0925-2312(01)00676-2; Tay FEH, 2001, OMEGA-INT J MANAGE S, V29, P309, DOI 10.1016/S0305-0483(01)00026-3; Thiessen U, 2003, CHEMOMETR INTELL LAB, V69, P35, DOI 10.1016/S0169-7439(03)00111-4; Thomason M., 1999, J COMPUT FINANC, V7, P36; Ture M, 2006, EXPERT SYST APPL, V31, P41, DOI 10.1016/j.eswa.2005.09.002; Wei W. W.-S., 1994, TIME SERIES ANAL; Wongkoon S, 2012, ASIAN PAC J TROP MED, V5, P249, DOI 10.1016/S1995-7645(12)60034-0; Yan WR, 2010, JPN J INFECT DIS, V63, P264; Zhang GP, 2003, NEUROCOMPUTING, V50, P159, DOI 10.1016/S0925-2312(01)00702-0; Zhang X-G, 2000, ACTA AUTOMATICA SIN, V26, P32; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063116	37	122	129	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88075	10.1371/journal.pone.0088075	http://dx.doi.org/10.1371/journal.pone.0088075			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA1AT	24505382	Green Submitted, gold, Green Published			2022-12-27	WOS:000330829200110
J	Wang, QM; Liu, SP; Tang, Y; Liu, QH; Yao, YJ				Wang, Qingmin; Liu, Shupeng; Tang, Ying; Liu, Qiuhong; Yao, Yongjie			MPT64 Protein from Mycobacterium tuberculosis Inhibits Apoptosis of Macrophages through NF-kB-miRNA21-Bcl-2 Pathway	PLOS ONE			English	Article							NF-KAPPA-B; BCL-2 UP-REGULATION; ANTIGEN MPT64; MICRORNAS; EXPRESSION; VIRULENT; IMMUNITY; NECROSIS; PLAYERS	MPT64 is one of the secreted proteins from Mycobacterium tuberculosis. Little is known about its role in infection by Mycobacterium tuberculosis. In this study, we demonstrated that MPT64 could dose-dependently inhibit the apoptosis of RAW264.7 macrophages induced by PPD-BCG. Quantitative real-time PCR results showed that the expression of bcl-2 increased in macrophages treated with MPT64 compared with PPD-treated cells. Furthermore, the results provided strong evidence that bcl-2 up-regulation was positively controlled by miRNA-21. Finally, NF-kappa B was identified as the transcription factor for miRNA-21 using a ChIP assay. It can be concluded from our study that MPT64 could inhibit the apoptosis of RAW264.7 macrophages through the NF-kappa B-miRNA21-Bcl-2 pathway.	[Wang, Qingmin; Tang, Ying; Liu, Qiuhong; Yao, Yongjie] Naval Med Res Inst, Div Aviat Med, Shanghai, Peoples R China; [Liu, Shupeng] Second Mil Med Univ, Changhai Hosp, Shanghai, Peoples R China	Naval Medical University	Wang, QM (corresponding author), Naval Med Res Inst, Div Aviat Med, Shanghai, Peoples R China.	wqm_8888@hotmail.com	; Lau, Susanna Kar Pui/C-4321-2009; Woo, Patrick Chiu Yat/C-4449-2009	liu, fei/0000-0003-1175-4070; Lau, Susanna Kar Pui/0000-0002-1383-7374; Woo, Patrick Chiu Yat/0000-0001-9401-1832	National Natural Science Foundation [31070121]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This article is supported by the grants of National Natural Science Foundation (Nos. 31070121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bai XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061925; Barre B, 2010, CELL CYCLE, V9, P4795, DOI 10.4161/cc.9.24.14245; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Briken V, 2008, FUTURE MICROBIOL, V3, P415, DOI 10.2217/17460913.3.4.415; Danelishvili L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010474; Derrick SC, 2007, CELL MICROBIOL, V9, P1547, DOI 10.1111/j.1462-5822.2007.00892.x; Dong J, 2011, ARCH MED RES, V42, P8, DOI 10.1016/j.arcmed.2011.01.006; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Ghorpade DS, 2012, MOL CELL BIOL, V32, P2239, DOI 10.1128/MCB.06597-11; Harries AD, 2006, ANN TROP MED PARASIT, V100, P415, DOI 10.1179/136485906X91477; Hossein A, 2004, J NEUROSCI, V24, P2963; Jayakumar D, 2008, CELL MICROBIOL, V10, P365, DOI 10.1111/j.1462-5822.2007.01049.x; Lin XJ, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/258695; Loeuillet C, 2006, J IMMUNOL, V177, P6245, DOI 10.4049/jimmunol.177.9.6245; Lopez M, 2003, J IMMUNOL, V170, P2409, DOI 10.4049/jimmunol.170.5.2409; Marquitz AR, 2011, VIROLOGY, V412, P392, DOI 10.1016/j.virol.2011.01.028; Mogga SJ, 2002, SCAND J IMMUNOL, V56, P383, DOI 10.1046/j.1365-3083.2002.01140.x; Mustafa T, 2008, VIRCHOWS ARCH, V452, P449, DOI 10.1007/s00428-008-0575-z; Philpott DJ, 2000, J IMMUNOL, V165, P903, DOI 10.4049/jimmunol.165.2.903; Rosenkrands I, 2000, ELECTROPHORESIS, V21, P3740, DOI 10.1002/1522-2683(200011)21:17<3740::AID-ELPS3740>3.3.CO;2-V; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Sanchez A, 2009, SCAND J IMMUNOL, V69, P20, DOI 10.1111/j.1365-3083.2008.02193.x; Sohn H, 2009, SCAND J IMMUNOL, V69, P43, DOI 10.1111/j.1365-3083.2008.02188.x; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Spira A, 2003, AM J RESP CELL MOL, V29, P545, DOI 10.1165/rcmb.2002-0310OC; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; Tato CM, 2002, INFECT IMMUN, V70, P3311, DOI 10.1128/IAI.70.7.3311-3317.2002; Wang ZH, 2007, J MOL BIOL, V366, P375, DOI 10.1016/j.jmb.2006.11.039; Wu ZW, 2012, FEBS LETT, V586, P2459, DOI 10.1016/j.febslet.2012.06.004; Yamada H, 2001, INFECT IMMUN, V69, P7100, DOI 10.1128/IAI.69.11.7100-7105.2001; Yamamoto T, 2006, YAKUGAKU ZASSHI, V126, P1235, DOI 10.1248/yakushi.126.1235; Zhang JL, 2005, MICROBIOL IMMUNOL, V49, P845, DOI 10.1111/j.1348-0421.2005.tb03673.x	36	74	79	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e100949	10.1371/journal.pone.0100949	http://dx.doi.org/10.1371/journal.pone.0100949			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000291	Green Published, Green Submitted, gold			2022-12-27	WOS:000338637300020
J	Stopczynski, A; Sekara, V; Sapiezynski, P; Cuttone, A; Madsen, MM; Larsen, JE; Lehmann, S				Stopczynski, Arkadiusz; Sekara, Vedran; Sapiezynski, Piotr; Cuttone, Andrea; Madsen, Mette My; Larsen, Jakob Eg; Lehmann, Sune			Measuring Large-Scale Social Networks with High Resolution	PLOS ONE			English	Article							HUMAN MOBILITY; PRIVACY; PREDICTABILITY; RELIABILITY; MULTISCALE; CONTAGION; DYNAMICS; PATTERNS; VALIDITY; SPREAD	This paper describes the deployment of a large-scale study designed to measure human interactions across a variety of communication channels, with high temporal resolution and spanning multiple years-the Copenhagen Networks Study. Specifically, we collect data on face-to-face interactions, telecommunication, social networks, location, and background information (personality, demographics, health, politics) for a densely connected population of 1 000 individuals, using state-of-the-art smartphones as social sensors. Here we provide an overview of the related work and describe the motivation and research agenda driving the study. Additionally, the paper details the data-types measured, and the technical infrastructure in terms of both backend and phone software, as well as an outline of the deployment procedures. We document the participant privacy procedures and their underlying principles. The paper is concluded with early results from data analysis, illustrating the importance of multi-channel high-resolution approach to data collection.	[Stopczynski, Arkadiusz; Sekara, Vedran; Sapiezynski, Piotr; Cuttone, Andrea; Larsen, Jakob Eg; Lehmann, Sune] Tech Univ Denmark, DTU Compute, DK-2800 Lyngby, Denmark; [Lehmann, Sune] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Madsen, Mette My] Univ Copenhagen, Dept Anthropol, Copenhagen, Denmark	Technical University of Denmark; University of Copenhagen; Niels Bohr Institute; University of Copenhagen	Stopczynski, A (corresponding author), Tech Univ Denmark, DTU Compute, DK-2800 Lyngby, Denmark.	arks@dtu.dk	Szymczak, Piotr/A-9268-2008	Szymczak, Piotr/0000-0001-8940-7891; Lehmann, Sune/0000-0001-6099-2345; Madsen, Mette My/0000-0002-8832-2279; Sekara, Vedran/0000-0003-4490-3757; Larsen, Jakob Eg/0000-0002-7461-9901	Villum Foundation; UCPH; Villum Fonden [00007192] Funding Source: researchfish	Villum Foundation(Villum Fonden); UCPH; Villum Fonden(Villum Fonden)	The SensibleDTU project was made possible by a Young Investigator Grant from the Villum Foundation (High Resolution Networks, awarded to SL). Scaling the project up to 1 000 individuals in 2013 was made possible by a interdisciplinary UCPH 2016 grant, Social Fabric (PI David Dreyer Lassen, SL is co-PI) focusing mainly on the social and basic science elements of the project. This grant has funded purchase of the smartphones, as well as technical personnel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 2003, VLDB J, V12, P157, DOI [10.1007/s000778-003-0097-x, 10.1007/s00778-003-0097-x]; Aharony N, 2011, PERVASIVE MOB COMPUT, V7, P643, DOI 10.1016/j.pmcj.2011.09.004; Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Altshuler Y, 2011, SECURITY PRIVACY SOC, P133; [Anonymous], 2013, FUNF OPEN SENSING FR; [Anonymous], 2013, FACEBOOK REPORTS 3 Q; [Anonymous], 2013, STATSMODELS NONPARAM; [Anonymous], 2010, P 8 INT C MOB SYST A, DOI DOI 10.1145/1814433.1814437; [Anonymous], 2013, FACEBOOK REPORTS 1 Q; [Anonymous], 2013, SENSIBLEDTU INFORM C; [Anonymous], DELIBERATIVE DEMOCRA, DOI [10.7551/mitpress/11633.003.0005, DOI 10.7551/MITPRESS/2324.003.0014, DOI 10.7551/MITPRESS/8022.001.0001]; Aral S, 2012, SCIENCE, V337, P337, DOI 10.1126/science.1215842; Aral S, 2009, P NATL ACAD SCI USA, V106, P21544, DOI 10.1073/pnas.0908800106; Back MD, 2013, J PERS SOC PSYCHOL, V105, P1013, DOI 10.1037/a0034431; Bagrow JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017680; Bagrow JP, 2011, ARXIV11025085; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Barbaro M, 2006, NY TIMES, V9, p8For; Bech P, 2001, J AFFECT DISORDERS, V66, P159, DOI 10.1016/S0165-0327(00)00309-8; Blondel V, 2010, BRUSS STUD, P1, DOI 10.4000/brussels.806; Bluml V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076646; Blum A., 2005, P 24 ACM SIGMOD SIGA, P128; Boneh D, 1996, PROCEEDINGS OF THE SIXTH ANNUAL USENIX SECURITY SYMPOSIUM: FOCUSING ON APPLICATIONS OF CRYPTOGRAPHY, P91; Carlotto A, 2008, P 1 ACM INT WORKSH M, P43, DOI DOI 10.1145/1410012.1410023; Carreras I., 2012, 2012 IEEE International Conference on Pervasive Computing and Communications Workshops (PerCom Workshops), P253, DOI 10.1109/PerComW.2012.6197489; Cattuto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011596; Cha M., 2010, ICWSM, V10, P30, DOI DOI 10.1145/2897659.2897663; Chawla S, 2005, LECT NOTES COMPUT SC, V3378, P363; Cheng J, 2010, P 2010 ACM SIGMOD IN, P459, DOI DOI 10.1145/1807167.1807218; Chittaranjan G, 2011, IEEE INT SYM WRBL CO, P29, DOI 10.1109/ISWC.2011.29; Christakis N.A., 2009, CONNECTED SURPRISING; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Chronis I, 2009, P ICMI MLMI 09 WORKS, P1; Clauset A, 2007, DYDAN WORKSH COMP ME; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cornelius C, 2008, MOBISYS'08: PROCEEDINGS OF THE SIXTH INTERNATIONAL CONFERENCE ON MOBILE SYSTEMS, APPLICATIONS, AND SERVICES, P211; Cox I. J., 2000, Proceedings International Conference on Information Technology: Coding and Computing (Cat. No.PR00540), P6, DOI 10.1109/ITCC.2000.844175; Cox IJ, 1998, IEEE J SEL AREA COMM, V16, P587, DOI 10.1109/49.668980; Cranshaw J, 2010, UBICOMP 2010: PROCEEDINGS OF THE 2010 ACM CONFERENCE ON UBIQUITOUS COMPUTING, P119; Cuttone A, 2013, P 1 ACM INT WORKSH P, P27, DOI DOI 10.1145/2509352.97; De Domenico M, 2013, PERVASIVE MOB COMPUT, V9, P798, DOI 10.1016/j.pmcj.2013.07.008; de Montjoye Yves-Alexandre, 2013, Social Computing, Behavioral-Cultural Modeling and Prediction. 6th International Conference, SBP 2013. Proceedings, P48, DOI 10.1007/978-3-642-37210-0_6; de Montjoye YA, 2012, IEEE DATA ENG B, V35, P5; de Montjoye YA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01376; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dinur I., 2003, P 22 ACM SIGMOD SIGA, P202, DOI DOI 10.1145/773153.773173; Dwork C, 2004, ADV CRYPTOLOGY CRYPT, P134; Eagle N, 2006, PERS UBIQUIT COMPUT, V10, P255, DOI 10.1007/s00779-005-0046-3; Eagle N, 2010, SCIENCE, V328, P1029, DOI 10.1126/science.1186605; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Ellen R.F., 1984, ETHNOGRAPHIC RES GUI; FIEDLER M, 1975, CZECH MATH J, V25, P607; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Froehlich J, 2007, MOBISYS '07: PROCEEDINGS OF THE FIFTH INTERNATIONAL CONFERENCE ON MOBILE SYSTEMS, APPLICATIONS, AND SERVICES, P57; Ganjali A, 2012, P 7 ACM WORKSH SCAL, P79; Geambasu R, 2009, P 18 USENIX SEC S, P56; Gentry C, 2009, FULLY HOMOMORPHIC EN; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Gulbahce N, 2008, BIOESSAYS, V30, P934, DOI 10.1002/bies.20820; Hariharan R, 2004, LECT NOTES COMPUT SC, V3234, P106; Hidalgo CA, 2008, PHYSICA A, V387, P3017, DOI 10.1016/j.physa.2008.01.073; Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001; Hu XP, 2013, IEEE T EMERG TOP COM, V1, P148, DOI 10.1109/TETC.2013.2273359; Isaacman S, 2011, LECT NOTES COMPUT SC, V6696, P133, DOI 10.1007/978-3-642-21726-5_9; Isella L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017144; John O.P., 1999, HDB PERSONALITY THEO, V1999, P102, DOI DOI 10.1037/A0019265; Kalish Y, 2006, SOC NETWORKS, V28, P56, DOI 10.1016/j.socnet.2005.04.004; Kapoor A, 2010, AAAI SPRING S ART IN; Karikoski Juuso, 2011, International Journal of Social Computing and Cyber-Physical Systems, V1, P98, DOI 10.1504/IJSCCPS.2011.043606; Karsai M, 2013, ARXIV13035966; Kiukkonen Niko, 2010, P ICPS, P68; Kjaergaard M.B., 2012, P 1 ACM WORKSHOP MOB, P17, DOI [10.1145/2307863.2307869, DOI 10.1145/2307863.2307869]; Klasnja P, 2009, LECT NOTES COMPUT SC, V5538, P176, DOI 10.1007/978-3-642-01516-8_13; Kossinets G, 2006, SCIENCE, V311, P88, DOI 10.1126/science.1116869; Kossinets G, 2006, SOC NETWORKS, V28, P247, DOI 10.1016/j.socnet.2005.07.002; Kostakos V, 2008, HDB RES URBAN INFORM, P195; Krings G, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds4; LaMarca A, 2005, LECT NOTES COMPUT SC, V3468, P116; Lambiotte R, 2008, PHYSICA A, V387, P5317, DOI 10.1016/j.physa.2008.05.014; Lane N, 2012, P 3 INT WORKSH SENS, P3; Larsen J.E., 2013, P 1 ACM INT WORKSH P, P11, DOI [DOI 10.1145/2509352.2509399, 10.1145/2509352.2509399]; Larsen JE, 2009, LECT NOTES COMPUT SC, V5741, P193, DOI 10.1007/978-3-642-04471-7_15; Larsen JE, 2013, CHI 2013 WORKSH PERS; Laumann EO, 1983, APPL NETWORK ANAL, P18; Laurila J. K., 2012, PERVASIVE COMPUTING; Lauter K, 2011, PROCEEDINGS OF THE 3RD ACM WORKSHOP CLOUD COMPUTING SECURITY WORKSHOP (CCSW'11), P113; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036439; Li I, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P557; Li N, 2007, P ICDE, P106; Li TC, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P517; Lin M, 2013, PERVASIVE MOBILE COM; Lund R, 2014, J AGING HEALTH, V26, P128, DOI 10.1177/0898264313510033; Lyons Russel, 2011, STAT POLITICS POLICY, V2, P1, DOI DOI 10.2202/2151-7509.1024; Machanavajjhala A., 2006, ACM T KNOWL DISCOV D, V1, P3, DOI DOI 10.1145/1217299.1217302; Madan A, 2012, IEEE PERVAS COMPUT, V11, P36, DOI 10.1109/MPRV.2011.79; Madan A, 2011, LECT NOTES COMPUT SC, V6696, P214, DOI 10.1007/978-3-642-21726-5_14; Madden M., 2013, TEENS SOCIAL MEDIA P; Madrigal A, 2013, DARK SOCIAL WE HAVE; Mahato H, 2008, CHI 08 HUM FACT COMP, P3093; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Miller G, 2012, PERSPECT PSYCHOL SCI, V7, P221, DOI 10.1177/1745691612441215; Miluzzo E, 2008, SENSYS'08: PROCEEDINGS OF THE 6TH ACM CONFERENCE ON EMBEDDED NETWORKED SENSOR SYSTEMS, P337; Miritello G, 2013, SOC NETWORKS, V35, P89, DOI 10.1016/j.socnet.2013.01.003; Mislove A., 2010, P 3 ACM INT C WEB SE, P251, DOI DOI 10.1145/1718487.1718519; Molina A, 2009, P 1 ACM WORKSH SEC P, P21, DOI DOI 10.1145/1655084.1655089; Montoliu R, 2010, P 9 INT C MOB UB MUL, P12, DOI DOI 10.1145/1899475.1899487; Mucha PJ, 2010, SCIENCE, V328, P876, DOI 10.1126/science.1184819; Mulder I, 2005, P MEAS BEH WAG AUG S, P355; Mundada Y., 2011, P 3 HOTCLOUD PORTL; Narayanan A, 2008, P IEEE S SECUR PRIV, P111, DOI 10.1109/SP.2008.33; Olguin DO, 2011, STUD COMPUT INTELL, V352, P575; Olguin DO, 2009, IEEE T SYST MAN CY B, V39, P43, DOI 10.1109/TSMCB.2008.2006638; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Onnela JP, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/179; Onnela JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016939; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Pappas V, 2012, CLOUDFENCE ENABLING; Perlman R, 2005, SEC STOR WORKSH 2005, P6; Perlman R, 2005, TECHNICAL REPORT; Polastre J, 2005, 2005 Fourth International Symposium on Information Processing in Sensor Networks, P364; Popa R, 2009, USENIX SEC S, P335; Quercia D, 2012, P ACM 2012 C COMP SU, P955, DOI DOI 10.1145/2145204.2145346; Raento M, 2005, IEEE PERVAS COMPUT, V4, P51, DOI 10.1109/MPRV.2005.29; Raento M, 2009, SOCIOL METHOD RES, V37, P426, DOI 10.1177/0049124108330005; Ranjan G, 2012, MOB COMPUT COMMUN RE, V16, P33, DOI 10.1145/2412096.2412101; Ribeiro B, 2013, SCI REP-UK, V3, DOI 10.1038/srep03006; Rivest R. L., 1978, FOUND SEC COMPUT, V4, P169; Rocha LEC, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001109; Rosenberg M., 1965, SOC ADOLESCENT SELF; ROTTER JB, 1966, PSYCHOL MONOGR, V80, P1, DOI 10.1037/h0092976; Russell DW, 1996, J PERS ASSESS, V66, P20, DOI 10.1207/s15327752jpa6601_2; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; Saramaki J, 2014, P NATL ACAD SCI USA, V111, P942, DOI 10.1073/pnas.1308540110; Schmitt DP, 2007, J CROSS CULT PSYCHOL, V38, P173, DOI 10.1177/0022022106297299; Sekara V, 2014, ARXIV14015836; Sevtsuk A, 2010, J URBAN TECHNOL, V17, P41, DOI 10.1080/10630731003597322; Sfaxi L, 2010, CONCURRENCY COMPUTAT; Shalizi CR, 2011, SOCIOL METHOD RES, V40, P211, DOI 10.1177/0049124111404820; Shampanier K, 2007, MARKET SCI, V26, P742, DOI 10.1287/mksc.1060.0254; SHERER M, 1982, PSYCHOL REP, V51, P663, DOI 10.2466/pr0.1982.51.2.663; Shokri R, 2011, P IEEE S SECUR PRIV, P247, DOI 10.1109/SP.2011.18; Srivatsa M, 2012, P 2012 ACM C COMP CO, P628, DOI DOI 10.1145/2382196.2382262; Staiano J, 2012, UBICOMP'12: PROCEEDINGS OF THE 2012 ACM INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING, P321; Steglich C, 2010, SOCIOL METHODOL, V40, P329, DOI 10.1111/j.1467-9531.2010.01225.x; Stehle J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023176; Stopczynski A, 2014, ARXIV14035299; Stopczynski A, 2013, INT CONF PERVAS COMP, P242; Sun LJ, 2013, P NATL ACAD SCI USA, V110, P13774, DOI 10.1073/pnas.1306440110; Sweeney L, 2002, INT J UNCERTAIN FUZZ, V10, P557, DOI 10.1142/S0218488502001648; Sweeney L., 2000, HEALTH-SAN FRANCISCO, V671, P1, DOI DOI 10.1184/R1/6625769.V1; Swickert RJ, 2002, PERS INDIV DIFFER, V32, P877, DOI 10.1016/S0191-8869(01)00093-9; Szell M, 2010, P NATL ACAD SCI USA, V107, P13636, DOI 10.1073/pnas.1004008107; Tebaa M., 2012, PROC WORLD C ENG, V1, P4; Wang P, 2009, SCIENCE, V324, P1071, DOI 10.1126/science.1167053; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wesolowski A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0986; Whitehead M, 2012, EUROPEAN MOBILE IND; Wu L, 2008, MINING FACE TO FACE; Zdancewic S.A., 2002, THESIS CORNELL U; Zeldovich N., 2008, P 5 USENIX S NETW SY, P293; Zheng V.W., 2010, P 19 INT C WORLD WID, DOI DOI 10.1145/1772690.1772795; Zheng Y., 2009, P 18 INT C WORLD WID, P791, DOI DOI 10.1145/1526709.1526816; Zhou B, 2008, PROC INT CONF DATA, P506, DOI 10.1109/ICDE.2008.4497459	173	213	220	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2014	9	4							e95978	10.1371/journal.pone.0095978	http://dx.doi.org/10.1371/journal.pone.0095978			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3CM	24999984	Green Published, Green Submitted, gold			2022-12-27	WOS:000336736600020
J	Arancibia, S; Espinoza, C; Salazar, F; Del Campo, M; Tampe, R; Zhong, TY; De Ioannes, P; Moltedo, B; Ferreira, J; Lavelle, EC; Manubens, A; De Ioannes, AE; Becker, MI				Arancibia, Sergio; Espinoza, Cecilia; Salazar, Fabian; Del Campo, Miguel; Tampe, Ricardo; Zhong, Ta-Ying; De Ioannes, Pablo; Moltedo, Bruno; Ferreira, Jorge; Lavelle, Ed C.; Manubens, Augusto; De Ioannes, Alfredo E.; Ines Becker, Maria			A Novel Immunomodulatory Hemocyanin from the Limpet Fissurella latimarginata Promotes Potent Anti-Tumor Activity in Melanoma	PLOS ONE			English	Article							RAPANA-THOMASIANA-HEMOCYANIN; CONCHOLEPAS HEMOCYANIN; DENDRITIC CELLS; BLADDER-CANCER; IMMUNE-RESPONSE; SUBUNIT ORGANIZATION; CONJUGATE VACCINES; RECENT PROGRESS; N-GLYCANS; IN-VIVO	Hemocyanins, the huge oxygen-transporting glycoproteins of some mollusks, are used as immunomodulatory proteins with proven anti-cancer properties. The biodiversity of hemocyanins has promoted interest in identifying new anti-cancer candidates with improved immunological properties. Hemocyanins promote Th1 responses without known side effects, which make them ideal for long-term sustained treatment of cancer. In this study, we evaluated a novel hemocyanin from the limpet/gastropod Fissurella latimarginata (FLH). This protein has the typical hollow, cylindrical structure of other known hemocyanins, such as the keyhole limpet hemocyanin (KLH) and the Concholepas hemocyanin (CCH). FLH, like the KLH isoforms, is composed of a single type of polypeptide with exposed N- and O-linked oligosaccharides. However, its immunogenicity was significantly greater than that of KLH and CCH, as FLH induced a stronger humoral immune response and had more potent anti-tumor activity, delaying tumor growth and increasing the survival of mice challenged with B16F10 melanoma cells, in prophylactic and therapeutic settings. Additionally, FLH-treated mice demonstrated increased IFN-gamma production and higher numbers of tumor-infiltrating CD4(+) lymphocytes. Furthermore, in vitro assays demonstrated that FLH, but not CCH or KLH, stimulated the rapid production of pro-inflammatory cytokines (IL-6, IL-12, IL-23 and TNF-alpha) by dendritic cells, triggering a pro-inflammatory milieu that may explain its enhanced immunological activity. Moreover, this effect was abolished when deglycosylated FLH was used, suggesting that carbohydrates play a crucial role in the innate immune recognition of this protein. Altogether, our data demonstrate that FLH possesses increased anti-tumor activity in part because it activates a more potent innate immune response in comparison to other known hemocyanins. In conclusion, FLH is a potential new marine adjuvant for immunization and possible cancer immunotherapy.	[Arancibia, Sergio; Espinoza, Cecilia; Salazar, Fabian; Del Campo, Miguel; Tampe, Ricardo; Zhong, Ta-Ying; De Ioannes, Pablo; Moltedo, Bruno; Ines Becker, Maria] Fdn Ciencia & Tecnol Desarrollo FUCITED, Santiago, Chile; [Ferreira, Jorge; Ines Becker, Maria] Univ Chile, Inst Ciencias Biomed ICBM, Clin & Mol Pharmacol Program, Santiago, Chile; [Lavelle, Ed C.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Adjuvant Res Grp, Dublin, Ireland; [Manubens, Augusto; De Ioannes, Alfredo E.] Biosonda Corp, Dept Res & Dev, Santiago, Chile	Universidad de Chile; Trinity College Dublin	Becker, MI (corresponding author), Fdn Ciencia & Tecnol Desarrollo FUCITED, Santiago, Chile.	mariaines.becker@fucited.cl	Becker, María/R-8252-2019; Salazar, Fabian/AAW-2488-2020; Lavelle, Ed/A-1716-2008; Brito de Azevedo, Eduardo/M-4266-2013; Hortal, Joaquin/A-1531-2008; Lobo, Jorge/E-2309-2013; Gabriel, Rosalina/F-1598-2013; Coelho dos Santos, Ana Margarida/E-7598-2010; Patino, Jairo/J-9595-2014; Borges, Paulo/B-2780-2008	Lavelle, Ed/0000-0002-3167-1080; Brito de Azevedo, Eduardo/0000-0001-5172-7742; Hortal, Joaquin/0000-0002-8370-8877; Lobo, Jorge/0000-0002-3152-4769; Gabriel, Rosalina/0000-0002-3550-8010; Manubens, Augusto/0000-0002-7931-4314; Coelho dos Santos, Ana Margarida/0000-0002-9197-792X; Patino, Jairo/0000-0001-5532-166X; Borges, Paulo/0000-0002-8448-7623; Salazar Lizama, Fabian/0000-0001-5139-2292	Fundacion COPEC-Universidad Catolica [CQ057]; FONDECYT [1110651]	Fundacion COPEC-Universidad Catolica; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was partially supported by research grants from Fundacion COPEC-Universidad Catolica No. CQ057 and FONDECYT 1110651 to Maria Ines Becker. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arancibia S., 2012, HEMOCYANINS IMMUNOTH, VINTECH; Arancibia S, 2012, EUR J IMMUNOL, V42, P688, DOI 10.1002/eji.201142011; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Becker MI, 2009, INT IMMUNOPHARMACOL, V9, P330, DOI 10.1016/j.intimp.2008.12.011; CEROTTINI JC, 1971, J IMMUNOL, V106, P732; De Ioannes P, 2004, J BIOL CHEM, V279, P26134, DOI 10.1074/jbc.M400903200; Decker H, 2007, INTEGR COMP BIOL, V47, P631, DOI 10.1093/icb/icm063; del Campo M, 2011, REV MED CHILE, V139, P236, DOI /S0034-98872011000200015; Delamarre L, 2006, J EXP MED, V203, P2049, DOI 10.1084/jem.20052442; Dolashka-Angelova P, 2008, IMMUNOL INVEST, V37, P822, DOI 10.1080/08820130802403366; Gathuru JK, 2005, VACCINE, V23, P4727, DOI 10.1016/j.vaccine.2005.05.007; Gatsogiannis C, 2009, J MOL BIOL, V385, P963, DOI 10.1016/j.jmb.2008.10.080; Gebauer W, 1999, ARCH BIOCHEM BIOPHYS, V372, P128, DOI 10.1006/abbi.1999.1478; Geyer H, 2005, J BIOL CHEM, V280, P40731, DOI 10.1074/jbc.M505985200; GUPTA RK, 1995, VACCINE, V13, P1263, DOI 10.1016/0264-410X(95)00011-O; Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681; Harris Jr, 1999, METH MOL B, V117, P13; HERSCOWITZ HB, 1972, IMMUNOLOGY, V22, P51; Idakieva K, 2008, J FLUORESC, V18, P715, DOI 10.1007/s10895-008-0338-x; Junankar SR, 2006, J INVEST DERM SYMP P, V11, P36, DOI 10.1038/sj.jidsymp.5650024; Kato K, 1972, BIOCHEM BIOPH RES CO, V371, P698; Kim SK, 2000, VACCINE, V19, P530, DOI 10.1016/S0264-410X(00)00195-X; Kochenderfer JN, 2007, EXP BIOL MED, V232, P1128, DOI 10.3181/0702-MR-42; Kurokawa T, 2002, EUR J BIOCHEM, V269, P5459, DOI 10.1046/j.1432-1033.2002.03244.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamm DL, 2000, EUR UROL, V37, P41, DOI 10.1159/000052391; Lamm DL, 2003, J CLIN ONCOL, V21, P4259, DOI 10.1200/JCO.2003.08.099; Lammers RJM, 2012, J CLIN ONCOL, V30, P2273, DOI 10.1200/JCO.2011.39.2936; Leyton P, 2005, J CHIL CHEM SOC, V50, P725, DOI 10.4067/S0717-97072005000400014; Lo-Man R, 2004, CANCER RES, V64, P4987, DOI 10.1158/0008-5472.CAN-04-0252; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Levy EM, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/676198; Moltedo B, 2006, J UROLOGY, V176, P2690, DOI 10.1016/j.juro.2006.07.136; MOLTO LM, 1991, EUR UROL, V19, P74; MULE JJ, 1986, J IMMUNOL, V136, P3899; Musselli C, 2001, J CANCER RES CLIN, V127, pR20, DOI 10.1007/BF01470995; Oliva H, 2002, HYBRIDOMA HYBRIDOM, V21, P365, DOI 10.1089/153685902761022715; Paccagnella M, 2004, MICRON, V35, P21, DOI 10.1016/j.micron.2003.10.007; Pashine A, 2005, NAT MED, V11, pS63, DOI 10.1038/nm1210; Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.0818-9641.2004.01272.x; Ponder WF, 2008, PHYLOGENY EVOLUTION; Presicce P, 2008, MOL IMMUNOL, V45, P1136, DOI 10.1016/j.molimm.2007.07.020; Qi CJ, 2011, BLOOD, V117, P6825, DOI 10.1182/blood-2011-02-339812; Ragupathi G, 2002, VACCINE, V20, P1030, DOI 10.1016/S0264-410X(01)00451-0; Ragupathi G, 2008, VACCINE, V26, P4860, DOI 10.1016/j.vaccine.2008.06.098; Rizvi I, 2007, AM J SURG, V194, P628, DOI 10.1016/j.amjsurg.2007.08.005; SANGER F, 1945, BIOCHEM J, V39, P507, DOI 10.1042/bj0390507; Shimizu K, 2001, CANCER RES, V61, P2618; Siddiqui NI, 2007, BIOCHEM BIOPH RES CO, V361, P705, DOI 10.1016/j.bbrc.2007.07.098; Slovin SF, 2005, IMMUNOL CELL BIOL, V83, P418, DOI 10.1111/j.1440-1711.2005.01350.x; Strioga M, 2013, INNATE IMMUN-LONDON, V19, P98, DOI 10.1177/1753425912449549; Swerdlow RD, 1996, COMP BIOCHEM PHYS B, V113, P537, DOI 10.1016/0305-0491(95)02091-8; Tchorbanov A, 2008, INT IMMUNOPHARMACOL, V8, P1033, DOI 10.1016/j.intimp.2008.03.008; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; van Vliet SJ, 2008, J IMMUNOL, V181, P3148, DOI 10.4049/jimmunol.181.5.3148; vanHolde KE, 1995, ADV PROTEIN CHEM, V47, P1, DOI 10.1016/S0065-3233(08)60545-8; Watford WT, 2003, CYTOKINE GROWTH F R, V14, P361, DOI 10.1016/S1359-6101(03)00043-1; Wells Christine A, 2003, BMC Immunol, V4, P5, DOI 10.1186/1471-2172-4-5; WIRGUIN I, 1995, CANCER IMMUNOL IMMUN, V40, P307, DOI 10.1007/BF01519630; Zhang SL, 1996, CANCER RES, V56, P3315	60	56	59	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87240	10.1371/journal.pone.0087240	http://dx.doi.org/10.1371/journal.pone.0087240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	25003186	Green Published, gold, Green Submitted			2022-12-27	WOS:000330288000202
J	Wang, YP; Nie, JX; Yap, PT; Li, G; Shi, F; Geng, XJ; Guo, L; Shen, DG				Wang, Yaping; Nie, Jingxin; Yap, Pew-Thian; Li, Gang; Shi, Feng; Geng, Xiujuan; Guo, Lei; Shen, Dinggang		Alzheimers Dis Neuroimaging Initia	Knowledge-Guided Robust MRI Brain Extraction for Diverse Large-Scale Neuroimaging Studies on Humans and Non-Human Primates	PLOS ONE			English	Article							SKULL STRIPPING PROBLEM; ALZHEIMERS-DISEASE; AUTOMATIC SEGMENTATION; GRAY-MATTER; IMAGES; CLASSIFICATION; REGISTRATION; ALGORITHM; VOLUMES; CORTEX	Accurate and robust brain extraction is a critical step in most neuroimaging analysis pipelines. In particular, for the large-scale multi-site neuroimaging studies involving a significant number of subjects with diverse age and diagnostic groups, accurate and robust extraction of the brain automatically and consistently is highly desirable. In this paper, we introduce population-specific probability maps to guide the brain extraction of diverse subject groups, including both healthy and diseased adult human populations, both developing and aging human populations, as well as non-human primates. Specifically, the proposed method combines an atlas-based approach, for coarse skull-stripping, with a deformable-surface-based approach that is guided by local intensity information and population-specific prior information learned from a set of real brain images for more localized refinement. Comprehensive quantitative evaluations were performed on the diverse large-scale populations of ADNI dataset with over 800 subjects (55 similar to 90 years of age, multi-site, various diagnosis groups), OASIS dataset with over 400 subjects (18 similar to 96 years of age, wide age range, various diagnosis groups), and NIH pediatrics dataset with 150 subjects (5 similar to 18 years of age, multi-site, wide age range as a complementary age group to the adult dataset). The results demonstrate that our method consistently yields the best overall results across almost the entire human life span, with only a single set of parameters. To demonstrate its capability to work on non-human primates, the proposed method is further evaluated using a rhesus macaque dataset with 20 subjects. Quantitative comparisons with popularly used state-of-the-art methods, including BET, Two-pass BET, BET-B, BSE, HWA, ROBEX and AFNI, demonstrate that the proposed method performs favorably with superior performance on all testing datasets, indicating its robustness and effectiveness.	[Wang, Yaping; Guo, Lei] Northwestern Polytech Univ, Sch Automat, Xian 710072, Shaanxi Provinc, Peoples R China; [Wang, Yaping; Nie, Jingxin; Yap, Pew-Thian; Li, Gang; Shi, Feng; Shen, Dinggang] Univ N Carolina, Dept Radiol, Chapel Hill, NC 27515 USA; [Wang, Yaping; Nie, Jingxin; Yap, Pew-Thian; Li, Gang; Shi, Feng; Shen, Dinggang] Univ N Carolina, BRIC, Chapel Hill, NC USA; [Geng, Xiujuan] NIDA, Neuroimaging Res Branch, Baltimore, MD USA; [Shen, Dinggang] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	Northwestern Polytechnical University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Korea University	Shen, DG (corresponding author), Univ N Carolina, Dept Radiol, Chapel Hill, NC 27515 USA.	dgshen@med.unc.edu	Shen, Dinggang/ABF-6812-2020; Li, Gang/D-3324-2013; Geng, Xiujuan/AAR-4306-2020	Shen, Dinggang/0000-0002-7934-5698; Li, Gang/0000-0001-9585-1382; Geng, Xiujuan/0000-0003-4953-0208	NIH [EB008374, EB006733, EB009634, AG041721, MH100217, AG042599]; National Natural Science Foundation of China [61273362, 61333017]; National Research Foundation grant of Korea [2012-005741]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant) [U01 AG024904]; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR021382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009634, R01EB006733, R01EB008374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100217, P50MH071616, R01MH056584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021910, K01AG030514, P50AG005681, R01AG041721, P01AG003991, P30AG010129, R01AG042599, U01AG024904] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Research Foundation grant of Korea(National Research Foundation of Korea); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by NIH grants EB008374, EB006733, EB009634, AG041721, MH100217, AG042599, National Natural Science Foundation of China (No. 61273362, No. 61333017), and National Research Foundation grant of Korea (No. 2012-005741). The University of North Carolina at Chapel Hill's Libraries provided support for open access publication. ADNI data collection and sharing for this project was supported by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904), P30 AG010129, K01 AG030514, the Dana Foundation. OASIS data collection and sharing for this project was supported by P50 AG05681, P01 AG03991, R01 AG021910, P50 MH071616, U24 RR021382, R01 MH56584. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins MS, 1998, IEEE T MED IMAGING, V17, P98, DOI 10.1109/42.668699; BOMANS M, 1990, IEEE T MED IMAGING, V9, P177, DOI 10.1109/42.56342; BRUMMER ME, 1993, IEEE T MED IMAGING, V12, P153, DOI 10.1109/42.232244; Carass A, 2011, NEUROIMAGE, V56, P1982, DOI 10.1016/j.neuroimage.2011.03.045; Chiverton J, 2007, COMPUT BIOL MED, V37, P342, DOI 10.1016/j.compbiomed.2006.04.001; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DANIELSSON PE, 1980, COMPUT VISION GRAPH, V14, P227, DOI 10.1016/0146-664X(80)90054-4; Evans AC, 2006, NEUROIMAGE, V30, P184, DOI 10.1016/j.neuroimage.2005.09.068; Fennema-Notestine C, 2006, HUM BRAIN MAPP, V27, P99, DOI 10.1002/hbm.20161; Germond L, 2000, ARTIF INTELL MED, V20, P77, DOI 10.1016/S0933-3657(00)00054-3; Hahn HK, 2000, LECT NOTES COMPUT SC, V1935, P134; HOHNE KH, 1992, J COMPUT ASSIST TOMO, V16, P285, DOI 10.1097/00004728-199203000-00019; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Huh S, 2002, COMPUT BIOL MED, V32, P311, DOI 10.1016/S0010-4825(02)00023-9; Iglesias JE, 2011, IEEE T MED IMAGING; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kapur T, 1996, Med Image Anal, V1, P109, DOI 10.1016/S1361-8415(96)80008-9; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Lee C, 1998, COMPUT BIOL MED, V28, P309, DOI 10.1016/S0010-4825(98)00013-4; Lemieux L, 1999, MAGN RESON MED, V42, P127, DOI 10.1002/(SICI)1522-2594(199907)42:1<127::AID-MRM17>3.0.CO;2-O; Leung KK, 2011, NEUROIMAGE, V55, P1091, DOI 10.1016/j.neuroimage.2010.12.067; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Miura N, 2002, J COMPUT ASSIST TOMO, V26, P927, DOI 10.1097/00004728-200211000-00012; Mueller SG, 2005, NEUROIMAG CLIN N AM, V15, P869, DOI 10.1016/j.nic.2005.09.008; Popescu V, 2012, NEUROIMAGE, V61, P1484, DOI 10.1016/j.neuroimage.2012.03.074; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Rehm K, 2004, NEUROIMAGE, V22, P1262, DOI 10.1016/j.neuroimage.2004.03.011; Rex DE, 2004, NEUROIMAGE, V23, P625, DOI 10.1016/j.neuroimage.2004.06.019; Rodrigue KM, 2004, J NEUROSCI, V24, P956, DOI 10.1523/JNEUROSCI.4166-03.2004; Sadananthan SA, 2010, NEUROIMAGE, V49, P225, DOI 10.1016/j.neuroimage.2009.08.050; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Shan ZY, 2002, NEUROIMAGE, V17, P1587, DOI 10.1006/nimg.2002.1287; Shannon C, 1998, AM J PRIMATOL, V46, P311, DOI 10.1002/(SICI)1098-2345(1998)46:4<311::AID-AJP3>3.0.CO;2-L; Shattuck DW, 2009, NEUROIMAGE, V45, P431, DOI 10.1016/j.neuroimage.2008.10.066; Shattuck DW, 2001, NEUROIMAGE, V13, P856, DOI 10.1006/nimg.2000.0730; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Sowell ER, 1999, NEUROIMAGE, V9, P587, DOI 10.1006/nimg.1999.0436; Stokking R, 2000, NEUROIMAGE, V12, P726, DOI 10.1006/nimg.2000.0661; Styner M, 2000, IEEE T MED IMAGING, V19, P153, DOI 10.1109/42.845174; Tisserand DJ, 2004, CEREB CORTEX, V14, P966, DOI 10.1093/cercor/bhh057; van der Kouwe AJW, 2008, NEUROIMAGE, V40, P559, DOI 10.1016/j.neuroimage.2007.12.025; Vercauteren T., 2007, LNCS, V10, P319, DOI DOI 10.1016/J.NEUR0IMAGE.2008.10.040; Wang Y, 2012, GROUPWISE SEGMENTATI, P185; Wang YP, 2013, I S BIOMED IMAGING, P1364; Wang YP, 2011, LECT NOTES COMPUT SC, V6893, P635, DOI 10.1007/978-3-642-23626-6_78; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zhuang AH, 2006, NEUROIMAGE, V32, P79, DOI 10.1016/j.neuroimage.2006.03.019	49	298	308	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e77810	10.1371/journal.pone.0077810	http://dx.doi.org/10.1371/journal.pone.0077810			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489639	Green Submitted, Green Published, gold			2022-12-27	WOS:000330570000002
J	Zhang, ZX; Zhao, H; Tang, J; Li, Z; Li, Z; Chen, DM; Lin, WX				Zhang, Zhixing; Zhao, Hong; Tang, Jun; Li, Zhong; Li, Zhou; Chen, Dongmei; Lin, Wenxiong			A Proteomic Study on Molecular Mechanism of Poor Grain-Filling of Rice (Oryza sativa L.) Inferior Spikelets	PLOS ONE			English	Article							STARCH BIOSYNTHETIC-ENZYMES; JAPONICA/INDICA HYBRID RICE; 14-3-3 PROTEINS; POSTANTHESIS DEVELOPMENT; SUPERIOR SPIKELETS; PLANT-METABOLISM; DIFFERENTIAL EXPRESSION; SIGNAL-TRANSDUCTION; DIFFERENT POSITIONS; BARLEY GRAINS	Cultivars of rice (Oryza sativa L.), especially of the type with large spikelets, often fail to reach the yield potential as expected due to the poor grain-filling on the later flowering inferior spikelets (in contrast to the earlier-flowering superior spikelets). The present study showed that the size and grain weight of superior spikelets (SS) was greater than those of inferior spikelets (IS), and the carbohydrate supply should not be the major problem for the poor grain-filling because there was adequate amount of sucrose in IS at the initial grain-filling stage. High resolution two-dimensional gel electrophoresis (2-DE) in combination with Coomassie-brilliant blue (CBB) and Pro-Q Diamond phosphoprotein fluorescence stain revealed that 123 proteins in abundance and 43 phosphoproteins generated from phosphorylation were significantly different between SS and IS. These proteins and phosphoproteins were involved in different cellular and metabolic processes with a prominently functional skew toward metabolism and protein synthesis/destination. Expression analyses of the proteins and phosphoproteins associated with different functional categories/subcategories indicated that the starch synthesis, central carbon metabolism, N metabolism and cell growth/division were closely related to the poor grain-filling of IS. Functional and expression pattern studies also suggested that 14-3-3 proteins played important roles in IS poor grain-filling by regulating the activity of starch synthesis enzymes. The proteome and phosphoproteome obtained from this study provided a better understanding of the molecular mechanism of the IS poor grain-filling. They were also expected to be highly useful for improving the grain filling of rice.	[Zhang, Zhixing; Zhao, Hong; Tang, Jun; Li, Zhong; Lin, Wenxiong] Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Fujian, Peoples R China; [Zhang, Zhixing; Zhao, Hong; Tang, Jun; Li, Zhong; Li, Zhou; Chen, Dongmei; Lin, Wenxiong] Fujian Agr & Forestry Univ, Fujian Prov Key Lab Agroecol Proc & Safety Monito, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University	Lin, WX (corresponding author), Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Fujian, Peoples R China.	wenxiong181@163.com		liu, chun ming/0000-0002-7271-362X; Hoi, Maggie Pui Man/0000-0003-2630-3707; Zhang, Zhao/0000-0002-7323-5500; Song, Yin/0000-0002-6037-777X	National Natural Science Foundation of China [31271670]; Provincial Natural Science Foundation of Fujian, China [2012J01075, 2013J01092]; Department of Education Science and Technology Project of Fujian, China [JK2011014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Natural Science Foundation of Fujian, China(Natural Science Foundation of Fujian Province); Department of Education Science and Technology Project of Fujian, China	This work was sponsored by the National Natural Science Foundation of China (No. 31271670), Provincial Natural Science Foundation of Fujian, China (No. 2012J01075, 2013J01092), and Department of Education Science and Technology Project of Fujian, China (No. JK2011014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal GK, 2006, MOL CELL PROTEOMICS, V5, P2044, DOI 10.1074/mcp.M600084-MCP200; Alexander RD, 2006, PROTEOMICS, V6, P1886, DOI 10.1002/pmic.200500548; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Cans C, 2003, P NATL ACAD SCI USA, V100, P13892, DOI 10.1073/pnas.2335950100; Chitteti BR, 2007, PROTEOMICS, V7, P1473, DOI 10.1002/pmic.200600871; Chung HJ, 1999, TRENDS PLANT SCI, V4, P367, DOI 10.1016/S1360-1385(99)01462-4; COHEN P, 1985, EUR J BIOCHEM, V151, P439, DOI 10.1111/j.1432-1033.1985.tb09121.x; Colleoni C., 2003, Journal of Applied Glycoscience, V50, P207; Comparot S, 2003, J EXP BOT, V54, P595, DOI 10.1093/jxb/erg057; COOPER JA, 1984, J BIOL CHEM, V259, P7835; Dinges JR, 2003, PLANT CELL, V15, P666, DOI 10.1105/tpc.007575; El-Sharkawy I, 2010, J EXP BOT, V61, P1761, DOI 10.1093/jxb/erq043; Fageria NK, 2007, J PLANT NUTR, V30, P843, DOI 10.1080/15226510701374831; Farre EM, 2001, PLANT PHYSIOL, V127, P685, DOI 10.1104/pp.127.2.685; Ferl RJ, 1996, ANNU REV PLANT PHYS, V47, P49, DOI 10.1146/annurev.arplant.47.1.49; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; GARRELS JI, 1983, METHOD ENZYMOL, V100, P411; Geigenberger P, 2003, CURR OPIN PLANT BIOL, V6, P247, DOI 10.1016/S1369-5266(03)00038-4; Gururaj A, 2004, ONCOGENE, V23, P8118, DOI 10.1038/sj.onc.1207969; Hennen-Bierwagen TA, 2009, PLANT PHYSIOL, V149, P1541, DOI 10.1104/pp.109.135293; Ishimaru T, 2005, PLANT CELL PHYSIOL, V46, P620, DOI 10.1093/pcp/pci066; Ishimaru T, 2003, FUNCT PLANT BIOL, V30, P1139, DOI 10.1071/FP03122; Kato T, 2007, PLANT PROD SCI, V10, P442, DOI 10.1626/pps.10.442; Kikuchi H, 1999, PLANT MOL BIOL, V39, P149, DOI 10.1023/A:1006156214716; Kim YM, 2012, MOL CELLS, V33, P617, DOI 10.1007/s10059-012-0080-8; Lin XM, 2008, J PROTEOME RES, V7, P1235, DOI 10.1021/pr7005928; LUR HS, 1993, PLANT PHYSIOL, V103, P273, DOI 10.1104/pp.103.1.273; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Mayer U, 2002, CURR OPIN PLANT BIOL, V5, P494, DOI 10.1016/S1369-5266(02)00302-3; Mechin V, 2007, PLANT PHYSIOL, V143, P1203, DOI 10.1104/pp.106.092148; Membre N, 1997, PLANT MOL BIOL, V35, P459, DOI 10.1023/A:1005833028582; Meyer LJ, 2012, PLANT PHYSIOL, V159, P517, DOI 10.1104/pp.111.191700; Mohapatra PK, 2009, PLANT SCI, V176, P256, DOI 10.1016/j.plantsci.2008.11.001; MOHAPATRA PK, 1993, AUST J PLANT PHYSIOL, V20, P231, DOI 10.1071/PP9930231; MURTY PSS, 1982, INDIAN J PLANT PHYSI, V25, P40; Negrutskii BS, 1998, PROG NUCLEIC ACID RE, V60, P47, DOI 10.1016/S0079-6603(08)60889-2; Peng S, 1999, CROP SCI, V39, P1552, DOI 10.2135/cropsci1999.3961552x; Peng T, 2011, J EXP BOT, V62, P4943, DOI 10.1093/jxb/err205; Ramasamy S, 1997, FIELD CROP RES, V51, P65, DOI 10.1016/S0378-4290(96)01039-8; Roberts MR, 2003, TRENDS PLANT SCI, V8, P218, DOI 10.1016/S1360-1385(03)00056-6; Rolletschek H, 2004, J EXP BOT, V55, P1351, DOI 10.1093/jxb/erh130; Schoonheim PJ, 2007, PLANT J, V49, P289, DOI 10.1111/j.1365-313X.2006.02955.x; Sehnke PC, 1996, CURR BIOL, V6, P1403, DOI 10.1016/S0960-9822(96)00742-7; Sehnke PC, 2001, P NATL ACAD SCI USA, V98, P765, DOI 10.1073/pnas.021304198; Song JianMin, 2009, Acta Agronomica Sinica, V35, P1445, DOI 10.3724/SP.J.1006.2009.01445; Tadege M, 1999, TRENDS PLANT SCI, V4, P320, DOI 10.1016/S1360-1385(99)01450-8; Tang T, 2009, J EXP BOT, V60, P2641, DOI 10.1093/jxb/erp114; Tao LongXing, 2003, Chinese Journal of Rice Science, V17, P149; Teng B, 2012, MOL BREEDING, V30, P583, DOI 10.1007/s11032-011-9647-x; Teo CJ, 2011, ACTA PHYSIOL PLANT, V33, P2259, DOI 10.1007/s11738-011-0765-1; Tetlow IJ, 2008, PLANT PHYSIOL, V146, P1878, DOI 10.1104/pp.108.116244; Tetlow IJ, 2004, PLANT CELL, V16, P694, DOI 10.1105/tpc.017400; Thitisaksakul M, 2012, J CEREAL SCI, V56, P67, DOI 10.1016/j.jcs.2012.04.002; van Dongen JT, 2004, PLANT PHYSIOL, V135, P1809, DOI 10.1104/pp.104.040980; Vassileva V. N., 2005, PLANT BIOTECHNOL, V22, P171; Wojtaszek P, 1997, J EXP BOT, V48, P2015, DOI 10.1093/jexbot/48.317.2015; Xu SB, 2008, PLANT PHYSIOL, V148, P908, DOI 10.1104/pp.108.125633; Yang JC, 2006, J EXP BOT, V57, P149, DOI 10.1093/jxb/erj018; Yang JC, 2003, PLANT GROWTH REGUL, V41, P185, DOI 10.1023/B:GROW.0000007503.95391.38; Yang JC, 2002, CROP SCI, V42, P766, DOI 10.2135/cropsci2002.0766; Yang JC, 2010, J EXP BOT, V61, P1, DOI 10.1093/jxb/erp348; YOSHIDA S, 1972, ANN REV PLANT PHYSIO, V23, P437, DOI 10.1146/annurev.pp.23.060172.002253; Yoshida S, 1976, ANNU REV PLANT PHYS, P46; Zhang H, 2009, PLANT PHYSIOL BIOCH, V47, P195, DOI 10.1016/j.plaphy.2008.11.012; Zhang ZhiXing, 2012, Australian Journal of Crop Science, V6, P316; Zhang ZX, 2012, PLANT SCI, V185, P259, DOI 10.1016/j.plantsci.2011.11.012; Zhu GH, 2011, J EXP BOT, V62, P3907, DOI 10.1093/jxb/err088; Zhu QS, 1988, ACTA AGRON SIN, V3, P182; Zhu T, 2003, PLANT BIOTECHNOL J, V1, P59, DOI 10.1046/j.1467-7652.2003.00006.x	70	98	104	4	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89140	10.1371/journal.pone.0089140	http://dx.doi.org/10.1371/journal.pone.0089140			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24992590	gold, Green Published, Green Submitted			2022-12-27	WOS:000331717900056
